PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Legendre, CR; Demeure, MJ; Whitsett, TG; Gooden, GC; Bussey, KJ; Jung, S; Waibhav, T; Kim, S; Salhia, B				Legendre, Christophe R.; Demeure, Michael J.; Whitsett, Timothy G.; Gooden, Gerald C.; Bussey, Kimberly J.; Jung, Sungwon; Waibhav, Tembe; Kim, Seungchan; Salhia, Bodour			Pathway Implications of Aberrant Global Methylation in Adrenocortical Cancer	PLOS ONE			English	Article							UNITED-STATES; IN-VIVO; CARCINOMA; TUMORS; P53; IDENTIFICATION; DICKKOPF-3; EXPRESSION; MANAGEMENT; MUTATIONS	Context Adrenocortical carcinomas (ACC) are a rare tumor type with a poor five-year survival rate and limited treatment options. Objective Understanding of the molecular pathogenesis of this disease has been aided by genomic analyses highlighting alterations in TP53, WNT, and IGF signaling pathways. Further elucidation is needed to reveal therapeutically actionable targets in ACC. Design In this study, global DNA methylation levels were assessed by the Infinium HumanMethylation450 BeadChip Array on 18 ACC tumors and 6 normal adrenal tissues. A new, non-linear correlation approach, the discretization method, assessed the relationship between DNA methylation/gene expression across ACC tumors. Results This correlation analysis revealed epigenetic regulation of genes known to modulate TP53, WNT, and IGF signaling, as well as silencing of the tumor suppressor MARCKS, previously unreported in ACC. Conclusions DNA methylation may regulate genes known to play a role in ACC pathogenesis as well as known tumor suppressors.	[Legendre, Christophe R.; Demeure, Michael J.; Whitsett, Timothy G.; Gooden, Gerald C.; Bussey, Kimberly J.; Waibhav, Tembe; Kim, Seungchan; Salhia, Bodour] Translat Genom Res Inst, Phoenix, AZ USA; [Bussey, Kimberly J.] NantOmics LLC, Phoenix, AZ USA; [Jung, Sungwon] Gachon Univ, Sch Med, Dept Genome Med & Sci, Inchon 21565, South Korea; [Jung, Sungwon] Gachon Univ, Gil Med Ctr, Gachon Inst Genome Med & Sci, Inchon 21565, South Korea	Translational Genomics Research Institute; Gachon University; Gachon University	Salhia, B (corresponding author), Translat Genom Res Inst, Phoenix, AZ USA.	bsalhia@tgen.org	Bussey, Kimberly J./D-2567-2011	Kim, Seungchan/0000-0003-4183-4338; Bussey, Kimberly/0000-0003-1001-8207; Whitsett, Timothy/0000-0002-0447-5682	ATAC Research Fund; Kirsten's Legacy Fund; Virginia G. Piper Charitable Trust	ATAC Research Fund; Kirsten's Legacy Fund; Virginia G. Piper Charitable Trust	The authors would like to acknowledge support provided by the ATAC Research Fund and the Kirsten's Legacy Fund. Research reported in this publication was supported by a generous philanthropic contribution from Mr. Ray Thurston. Funding support was also provided by the Virginia G. Piper Charitable Trust (TGW and BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allolio B, 2004, CLIN ENDOCRINOL, V60, P273, DOI 10.1046/j.1365-2265.2003.01881.x; Anglim PP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-62; Assie G, 2014, NAT GENET, V46, P607, DOI 10.1038/ng.2953; Barreau O, 2013, J CLIN ENDOCR METAB, V98, pE174, DOI 10.1210/jc.2012-2993; Bickeboller M, 2015, ONCOGENE, V34, P1150, DOI 10.1038/onc.2014.40; Bilimoria KY, 2008, CANCER, V113, P3130, DOI 10.1002/cncr.23886; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Clayton PE, 2012, CLIN ENDOCRINOL, V77, P335, DOI 10.1111/j.1365-2265.2012.04428.x; Demeure M J, 1998, Surg Oncol Clin N Am, V7, P791; Demeure MJ, 2013, SURGERY, V154, P1405, DOI 10.1016/j.surg.2013.06.058; Demeure Michael J., 2011, Hormones & Cancer, V2, P385, DOI 10.1007/s12672-011-0090-6; Fassnacht M, 2012, NEW ENGL J MED, V366, P2189, DOI 10.1056/NEJMoa1200966; Fonseca AL, 2012, GENE CHROMOSOME CANC, V51, P949, DOI 10.1002/gcc.21978; Fotouhi O, 2014, EPIGENETICS, V9, P7; Gaujoux S, 2011, CLIN CANCER RES, V17, P328, DOI 10.1158/1078-0432.CCR-10-2006; Giordano TJ, 2009, CLIN CANCER RES, V15, P668, DOI 10.1158/1078-0432.CCR-08-1067; Golden SH, 2009, J CLIN ENDOCR METAB, V94, P1853, DOI 10.1210/jc.2008-2291; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jung S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052626; Kebebew E, 2006, WORLD J SURG, V30, P872, DOI 10.1007/s00268-005-0329-x; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Leal LF, 2011, J CLIN ENDOCR METAB, V96, P3106, DOI 10.1210/jc.2011-0363; Libe R, 2007, ENDOCR-RELAT CANCER, V14, P13, DOI 10.1677/erc.1.01130; Meani N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004273; Rechache NS, 2012, J CLIN ENDOCR METAB, V97, pE1004, DOI 10.1210/jc.2011-3298; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; REINCKE M, 1994, J CLIN ENDOCR METAB, V78, P790, DOI 10.1210/jc.78.3.790; Shu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027346; Sidhu S, 2005, EJSO, V31, P549, DOI 10.1016/j.ejso.2005.01.013; Suwa T, 2003, J ENDOCRINOL, V178, P149, DOI 10.1677/joe.0.1780149; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; Tokumoto M, 2011, J TOXICOL SCI, V36, P191, DOI 10.2131/jts.36.191; Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013	36	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150629	10.1371/journal.pone.0150629	http://dx.doi.org/10.1371/journal.pone.0150629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963385	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000045
J	Ramakrishnan, VM; Tien, KT; McKinley, TR; Bocard, BR; McCurry, TM; Williams, SK; Hoying, JB; Boyd, NL				Ramakrishnan, Venkat M.; Tien, Kevin T.; McKinley, Thomas R.; Bocard, Braden R.; McCurry, Terry M.; Williams, Stuart K.; Hoying, James B.; Boyd, Nolan L.			Wnt5 alpha Regulates the Assembly of Human Adipose Derived Stromal Vascular Fraction-Derived Microvasculatures	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; IN-VITRO; BONE-MARROW; TISSUE; WNT5A; MORPHOGENESIS; ANGIOGENESIS; ACTIVATION; PROLIFERATION	Human adipose-derived stromal vascular fraction (hSVF) cells are an easily accessible, heterogeneous cell system that can spontaneously self-assemble into functional microvasculatures in vivo. However, the mechanisms underlying vascular self-assembly and maturation are poorly understood, therefore we utilized an in vitro model to identify potential in vivo regulatory mechanisms. We utilized passage one (P1) hSVF because of the rapid UEA1+ endothelium (EC) loss at even P2 culture. We exposed hSVF cells to a battery of angiogenesis inhibitors and found that the pan-Wnt inhibitor IWP2 produced the most significant hSVF-EC networking decrease (similar to 25%). To determine which Wnt isoform(s) and receptor(s) may be involved, hSVF was screened by PCR for isoforms associated with angiogenesis, with only WNT5A and its receptor, FZD4, being expressed for all time points observed. Immunocytochemistry confirmed Wnt5a protein expression by hSVF. To see if Wnt5a alone could restore IWP2-induced EC network inhibition, recombinant human Wnt5a (0-150 ng/ml) was added to IWP2-treated cultures. The addition of rhWnt5a significantly increased EC network area and significantly decreased the ratio of total EC network length to EC network area compared to untreated controls. To determine if Wnt5a mediates in vivo microvascular self-assembly, 3D hSVF constructs containing an IgG isotype control, anti-Wnt5a neutralizing antibody or rhWnt5a were implanted subcutaneously for 2w in immune compromised mice. Compared to IgG controls, anti-Wnt5a treatment significantly reduced vessel length density by similar to 41%, while rhWnt5a significantly increased vessel length density by similar to 62%. However, anti-Wnt5a or rhWnt5a did not significantly affect the density of segments and nodes, both of which measure vascular complexity. Taken together, this data demonstrates that endogenous Wnt5a produced by hSVF plays a regulatory role in microvascular self-assembly in vivo. These findings also suggest that manipulating Wnt signaling could enhance control of hSVF vascularization in tissue engineering applications.	[Ramakrishnan, Venkat M.; Tien, Kevin T.; McKinley, Thomas R.; Bocard, Braden R.; Williams, Stuart K.; Hoying, James B.; Boyd, Nolan L.] Univ Louisville, Div Cardiovasc Therapeut, Cardiovasc Innovat Inst, Louisville, KY 40292 USA; [Ramakrishnan, Venkat M.; Williams, Stuart K.; Hoying, James B.; Boyd, Nolan L.] Univ Louisville, Dept Physiol, Louisville, KY 40292 USA; [Bocard, Braden R.] Georgetown Coll, Georgetown, KY USA; [McCurry, Terry M.] Univ Louisville, Dept Surg, Div Plast Surg, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville	Boyd, NL (corresponding author), Univ Louisville, Div Cardiovasc Therapeut, Cardiovasc Innovat Inst, Louisville, KY 40292 USA.; Boyd, NL (corresponding author), Univ Louisville, Dept Physiol, Louisville, KY 40292 USA.	nolan.boyd@louisville.edu			UofL Department of Physiology; NIH/NIGMS [P30 GM103507];  [AHA11SDG7500025];  [P30103607]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103507] Funding Source: NIH RePORTER	UofL Department of Physiology; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by NLB: AHA11SDG7500025; www.heart.org and JBH: P30103607; www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank Jason Beare (University of Louisville) for his technical assistance and Mary Boyd for her editorial guidance. We also thank the UofL Department of Physiology for their support. This project utilized Kentucky Spinal Cord Injury Research Center (KSCIRC) Neuroscience core facilities that are supported by the NIH/NIGMS P30 GM103507 grant. Lastly, we dedicate this paper to the memory of A. Sarojini Govind.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Arderiu G, 2014, J MOL CELL BIOL, V6, P380, DOI 10.1093/jmcb/mju036; Bian WJ, 2015, DEV NEUROBIOL, V75, P805, DOI 10.1002/dneu.22250; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Boyd NL, 2011, TISSUE ENG PT A, V17, P1537, DOI [10.1089/ten.tea.2010.0397, 10.1089/ten.TEA.2010.0397]; Boyd NL, 2013, TISSUE ENG PT A, V19, P211, DOI 10.1089/ten.tea.2011.0408; Catalan V, 2014, J CLIN ENDOCR METAB, V99, pE1407, DOI 10.1210/jc.2014-1191; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Cheng CW, 2008, BIOCHEM BIOPH RES CO, V365, P285, DOI 10.1016/j.bbrc.2007.10.166; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Davis GE, 2000, IN VITRO CELL DEV-AN, V36, P513; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Ekstrom EJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-88; Gherghe CM, 2011, FASEB J, V25, P1836, DOI 10.1096/fj.10-172981; Gimble JM, 2011, STEM CELLS, V29, P749, DOI 10.1002/stem.629; Gong Z, 2008, FASEB J; Goodwin AM, 2006, DEV DYNAM, V235, P3110, DOI 10.1002/dvdy.20939; Han J, 2010, BLOOD, V115, P957, DOI 10.1182/blood-2009-05-219923; Himmelreich N, 2015, J INHERIT METAB DIS, V38, P1137, DOI 10.1007/s10545-015-9874-0; Ilan N, 1998, J CELL SCI, V111, P3621; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; Jover B, 2013, FUND CLIN PHARMACOL, V27, P465, DOI 10.1111/j.1472-8206.2012.01044.x; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Klein D, 2009, ANGIOGENESIS, V12, P251, DOI 10.1007/s10456-009-9145-5; Koh YJ, 2011, ARTERIOSCL THROM VAS, V31, P1141, DOI 10.1161/ATVBAHA.110.218206; Korn C, 2014, DEVELOPMENT, V141, P1757, DOI 10.1242/dev.104422; Langer R, 2007, TISSUE ENG, V13, P1, DOI 10.1089/ten.2006.0219; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807; Lin L., 2007, STRUCTURE PROPERTIES, P1; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; Maijub JG, 2015, CELL TRANSPLANT, V24, P2029, DOI 10.3727/096368914X685401; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Melgar-Lesmes P, 2015, J HEPATOL, V63, P917, DOI 10.1016/j.jhep.2015.05.011; MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648; Morris ME, 2015, STEM CELL TRANSL MED, V4, P369, DOI 10.5966/sctm.2014-0252; Murdoch CE, 2014, BIOCHEM SOC T, V42, P1665, DOI 10.1042/BST20140213; Naderi H, 2011, J BIOMATER APPL, V26, P383, DOI 10.1177/0885328211408946; Newman AC, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-13; Noel D, 2008, EXP CELL RES, V314, P1575, DOI 10.1016/j.yexcr.2007.12.022; Nunes SS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02141; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Ramakrishnan VM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13231; Reis M, 2012, J EXP MED, V209, P1611, DOI 10.1084/jem.20111580; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Sen M, 2001, ARTHRITIS RHEUM, V44, P772, DOI 10.1002/1529-0131(200104)44:4<772::AID-ANR133>3.3.CO;2-C; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Williams S K, 1989, Ann Vasc Surg, V3, P146, DOI 10.1016/S0890-5096(06)62008-6; WILLIAMS SK, 1994, J VASC SURG, V19, P916, DOI 10.1016/S0741-5214(94)70019-2; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	58	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151402	10.1371/journal.pone.0151402	http://dx.doi.org/10.1371/journal.pone.0151402			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963616	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000146
J	Utt, A; Quirin, T; Saul, S; Hellstrom, K; Ahola, T; Merits, A				Utt, Age; Quirin, Tania; Saul, Sirle; Hellstrom, Kirsi; Ahola, Tero; Merits, Andres			Versatile Trans-Replication Systems for Chikungunya Virus Allow Functional Analysis and Tagging of Every Replicase Protein	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; MINICIRCLE DNA VECTORS; STRAND RNA-SYNTHESIS; SINDBIS-VIRUS; MINUS-STRAND; NONSTRUCTURAL PROTEIN-2; TEMPORAL REGULATION; EXPRESSION VECTORS; PLASMA-MEMBRANE; GENE-EXPRESSION	Chikungunya virus (CHIKV; genus Alphavirus, family Togaviridae) has recently caused several major outbreaks affecting millions of people. There are no licensed vaccines or antivirals, and the knowledge of the molecular biology of CHIKV, crucial for development of efficient antiviral strategies, remains fragmentary. CHIKV has a 12 kb positive-strand RNA genome, which is translated to yield a nonstructural (ns) or replicase polyprotein. CHIKV structural proteins are expressed from a subgenomic RNA synthesized in infected cells. Here we have developed CHIKV trans-replication systems, where replicase expression and RNA replication are uncoupled. Bacteriophage T7 RNA polymerase or cellular RNA polymerase II were used for production of mRNAs for CHIKV ns polyprotein and template RNAs, which are recognized by CHIKV replicase and encode for reporter proteins. CHIKV replicase efficiently amplified such RNA templates and synthesized large amounts of subgenomic RNA in several cell lines. This system was used to create tagged versions of ns proteins including nsP1 fused with enhanced green fluorescent protein and nsP4 with an immunological tag. Analysis of these constructs and a matching set of replicon vectors revealed that the replicases containing tagged ns proteins were functional and maintained their subcellular localizations. When cells were co-transfected with constructs expressing template RNA and wild type or tagged versions of CHIKV replicases, formation of characteristic replicase complexes (spherules) was observed. Analysis of mutations associated with noncytotoxic phenotype in CHIKV replicons showed that a low level of RNA replication is not a pre-requisite for reduced cytotoxicity. The CHIKV trans-replicase does not suffer from genetic instability and represents an efficient, sensitive and reliable tool for studies of different aspects of CHIKV RNA replication process.	[Utt, Age; Saul, Sirle; Merits, Andres] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia; [Quirin, Tania; Hellstrom, Kirsi; Ahola, Tero] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland	University of Tartu; University of Helsinki	Merits, A (corresponding author), Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia.	andres.merits@ut.ee	Utt, Age/G-6335-2019; Merits, Andres/H-3125-2015	Utt, Age/0000-0002-6709-2507; Merits, Andres/0000-0001-8193-0071	Estonian Ministry of Education and Research [IUT20-27]; Estonian Science Foundation [9400]; European Union [261202]; European Union through the European Regional Development Fund [10.1-9/1008]; Center of Excellence in Chemical Biology; Academy of Finland [1265997]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation; European Union(European Commission); European Union through the European Regional Development Fund(European Commission); Center of Excellence in Chemical Biology; Academy of Finland(Academy of Finland)	This work was supported by institutional research funding (IUT20-27) of the Estonian Ministry of Education and Research, the Estonian Science Foundation (grant 9400), the European Union 7th Framework Integrated Chikungunya Research project (grant agreement number 261202), the European Union through the European Regional Development Fund (grant agreement 10.1-9/1008) and via the Center of Excellence in Chemical Biology (to AM). This work was also supported by Academy of Finland grant number 1265997 (to TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola T, 2015, VECTOR-BORNE ZOONOT, V15, P250, DOI 10.1089/vbz.2014.1681; Ahola T, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0050-0; Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12; Atasheva S, 2007, J VIROL, V81, P5046, DOI 10.1128/JVI.02746-06; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Bochkov YA, 2006, BIOTECHNIQUES, V41, P283, DOI 10.2144/000112243; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Cristea IM, 2006, J BIOL CHEM, V281, P30269, DOI 10.1074/jbc.M603980200; Cristea IM, 2010, J VIROL, V84, P6720, DOI 10.1128/JVI.01983-09; Das PK, 2014, J BIOL CHEM, V289, P5635, DOI 10.1074/jbc.M113.503433; DEGROOT RJ, 1990, EMBO J, V9, P2631, DOI 10.1002/j.1460-2075.1990.tb07445.x; Frolov I, 2001, RNA, V7, P1638, DOI 10.1017/S135583820101010X; Frolova E, 2006, J VIROL, V80, P4122, DOI 10.1128/JVI.80.8.4122-4134.2006; Frolova EI, 2010, J VIROL, V84, P11679, DOI 10.1128/JVI.01441-10; Fros JJ, 2015, J GEN VIROL, V96, P580, DOI 10.1099/vir.0.071845-0; Fros JJ, 2013, J VIROL, V87, P10394, DOI 10.1128/JVI.00884-13; Fros JJ, 2012, J VIROL, V86, P10873, DOI 10.1128/JVI.01506-12; Fros JJ, 2010, J VIROL, V84, P10877, DOI 10.1128/JVI.00949-10; Glasker S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-235; Gorchakov R, 2005, J VIROL, V79, P9397, DOI 10.1128/JVI.79.15.9397-9409.2005; Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13; Hardy RW, 2005, J VIROL, V79, P4630, DOI 10.1128/JVI.79.8.4630-4639.2005; Hellstrom K, 2015, METHODS, V90, P49, DOI 10.1016/j.ymeth.2015.04.019; Jones PH, 2013, VIROLOGY, V438, P37, DOI 10.1016/j.virol.2013.01.010; Kallio K, 2016, J VIROL, V90, P1687, DOI 10.1128/JVI.02484-15; Kallio K, 2013, J VIROL, V87, P9125, DOI 10.1128/JVI.00660-13; Karpe YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022336; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; Khromykh AA, 1999, J VIROL, V73, P10272, DOI 10.1128/JVI.73.12.10272-10280.1999; Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998; LEMM JA, 1993, J VIROL, V67, P1916, DOI 10.1128/JVI.67.4.1916-1926.1993; LEMM JA, 1994, EMBO J, V13, P2925, DOI 10.1002/j.1460-2075.1994.tb06587.x; LEVIS R, 1986, CELL, V44, P137, DOI 10.1016/0092-8674(86)90492-7; LEVIS R, 1990, J VIROL, V64, P1726, DOI 10.1128/JVI.64.4.1726-1733.1990; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Lulla A, 2012, J VIROL, V86, P553, DOI 10.1128/JVI.05195-11; Lulla V, 2013, J VIROL, V87, P10207, DOI 10.1128/JVI.01485-13; Mai JB, 2009, J VIROL, V83, P8553, DOI 10.1128/JVI.00056-09; Malet H, 2009, J VIROL, V83, P6534, DOI 10.1128/JVI.00189-09; Maniar LEG, 2013, MOL THER, V21, P131, DOI 10.1038/mt.2012.244; McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994; Neuvonen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002383; Nikonov A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003610; Panas MD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004659; Panas MD, 2012, MOL BIOL CELL, V23, P4701, DOI 10.1091/mbc.E12-08-0619; Perri S, 2000, J VIROL, V74, P9802, DOI 10.1128/JVI.74.20.9802-9807.2000; Pohjala L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028923; Rathore APS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-36; Rikkonen M, 1996, VIROLOGY, V218, P352, DOI 10.1006/viro.1996.0204; Rubach JK, 2009, VIROLOGY, V384, P201, DOI 10.1016/j.virol.2008.10.030; Salonen A, 2003, J VIROL, V77, P1691, DOI 10.1128/JVI.77.3.1691-1702.2003; Scholte FEM, 2015, J VIROL, V89, P4457, DOI 10.1128/JVI.03612-14; Shirako Y, 1998, J VIROL, V72, P2310, DOI 10.1128/JVI.72.3.2310-2315.1998; Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10; Spuul P, 2007, J VIROL, V81, P872, DOI 10.1128/JVI.01785-06; Spuul P, 2011, J VIROL, V85, P4739, DOI 10.1128/JVI.00085-11; Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10; Steel JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084930; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sun CQ, 2014, J VIROL, V88, P2035, DOI 10.1128/JVI.02990-13; Tamm K, 2008, J GEN VIROL, V89, P676, DOI 10.1099/vir.0.83320-0; Thaa B, 2015, J VIROL, V89, P11420, DOI 10.1128/JVI.01579-15; TYNDALL C, 1981, NUCLEIC ACIDS RES, V9, P6231, DOI 10.1093/nar/9.23.6231; Utt A, 2015, J VIROL, V89, P3145, DOI 10.1128/JVI.03213-14; Varjak M, 2010, J VIROL, V84, P2352, DOI 10.1128/JVI.01540-09; Vasiljeva L, 2003, J BIOL CHEM, V278, P41636, DOI 10.1074/jbc.M307481200; Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016; Zusinaite E, 2007, J GEN VIROL, V88, P1977, DOI 10.1099/vir.0.82865-0	69	49	50	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151616	10.1371/journal.pone.0151616	http://dx.doi.org/10.1371/journal.pone.0151616			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963103	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000164
J	Kon, TC; Onu, A; Berbecila, L; Lupulescu, E; Ghiorgisor, A; Kersten, GF; Cui, YQ; Amorij, JP; Van der Pol, L				Kon, Theone C.; Onu, Adrian; Berbecila, Laurentiu; Lupulescu, Emilia; Ghiorgisor, Alina; Kersten, Gideon F.; Cui, Yi-Qing; Amorij, Jean-Pierre; Van der Pol, Leo			Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes	PLOS ONE			English	Article							VIRUS-VACCINES; WHOLE VIRUS; HEMAGGLUTININ; IMMUNOGENICITY; RESPONSES; CHILDREN; IMMUNITY; VIRION; ASSAY; H5N1	The aim of this study was to evaluate the impact of different inactivation and splitting procedures on influenza vaccine product composition, stability and recovery to support transfer of process technology. Four split and two whole inactivated virus (WIV) influenza vaccine bulks were produced and compared with respect to release criteria, stability of the bulk and haemagglutinin recovery. One clarified harvest of influenza H3N2 A/Uruguay virus prepared on 25.000 fertilized eggs was divided equally over six downstream processes. The main unit operation for purification was sucrose gradient zonal ultracentrifugation. The inactivation of the virus was performed with either formaldehyde in phosphate buffer or with beta-propiolactone in citrate buffer. For splitting of the viral products in presence of Tweeng (R), either Triton (TM) X-100 or di-ethyl-ether was used. Removal of ether was established by centrifugation and evaporation, whereas removal of Triton-X100 was performed by hydrophobic interaction chromatography. All products were sterile filtered and subjected to a 5 months real time stability study. In all processes, major product losses were measured after sterile filtration; with larger losses for split virus than for WIV. The beta-propiolactone inactivation on average resulted in higher recoveries compared to processes using formaldehyde inactivation. Especially ether split formaldehyde product showed low recovery and least stability over a period of five months.	[Kon, Theone C.; Cui, Yi-Qing] Inst Translat Vaccinol, Intravacc, Prod Dev Dept, Bilthoven, Netherlands; [Onu, Adrian] Cantacuzino Natl Res Inst, Biotechnol Lab, Bucharest, Romania; [Berbecila, Laurentiu] Cantacuzino Natl Res Inst, Unit Influenza Vaccine Prod, Bucharest, Romania; [Lupulescu, Emilia; Ghiorgisor, Alina] Cantacuzino Natl Res Inst, Lab Resp Viral Infect, Bucharest, Romania; [Kersten, Gideon F.; Van der Pol, Leo] Inst Translat Vaccinol, Intravacc, Dept Res, Bilthoven, Netherlands; [Amorij, Jean-Pierre] Inst Translat Vaccinol, Intravacc, Dept Business Dev, Bilthoven, Netherlands		Kon, TC (corresponding author), Inst Translat Vaccinol, Intravacc, Prod Dev Dept, Bilthoven, Netherlands.	theone.kon@intravacc.nl	Onu, Adrian/AAP-8415-2021; Onu, Adrian/G-1858-2016	Onu, Adrian/0000-0001-8724-9754; Onu, Adrian/0000-0001-8724-9754				Amorij JP, 2008, PHARM RES-DORDR, V25, P1256, DOI 10.1007/s11095-008-9559-6; Amorij JP, 2010, LANCET INFECT DIS, V10, P699, DOI 10.1016/S1473-3099(10)70157-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beyer WEP, 1998, CLIN DRUG INVEST, V15, P1, DOI 10.2165/00044011-199815010-00001; BRANDON FB, 1967, J IMMUNOL, V98, P800; Chaloupka I, 1996, EUR J CLIN MICROBIOL, V15, P121, DOI 10.1007/BF01591484; Coenen F, 2006, VACCINE, V24, P525, DOI 10.1016/j.vaccine.2005.07.081; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Crovari P, 2011, J Prev Med Hyg, V52, P91; DAVENPORT FM, 1964, J LAB CLIN MED, V63, P5; Delrue I, 2012, EXPERT REV VACCINES, V11, P695, DOI [10.1586/ERV.12.38, 10.1586/erv.12.38]; ENNIS FA, 1977, J INFECT DIS, V136, pS397, DOI 10.1093/infdis/136.Supplement_3.S397; FDA, 2015, FDA LIST APPR VACC; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Harris A, 2001, VIROLOGY, V289, P34, DOI 10.1006/viro.2001.1119; Harvey R, 2008, VACCINE, V26, P6550, DOI 10.1016/j.vaccine.2008.09.050; Hendriks J, 2011, VACCINE, V29, pA8, DOI 10.1016/j.vaccine.2011.04.124; Hondt EJD, 2012, PROCESS PRODUCING IN; JOHANNSEN R, 1985, VACCINE, V3, P235, DOI 10.1016/0264-410X(85)90114-8; Lina B, 2000, BIOLOGICALS, V28, P95, DOI 10.1006/biol.2000.0245; Lupulescu E, 1997, Bacteriol Virusol Parazitol Epidemiol, V42, P110; MalvernInstrumentsLimited, 2011, INF WHIT PAP DYN LIG; MCELHANEY JE, 1994, J GERONTOL, V49, pM37, DOI 10.1093/geronj/49.2.M37; Meiring HD, 2002, J SEP SCI, V25, P557, DOI 10.1002/1615-9314(20020601)25:9<557::AID-JSSC557>3.0.CO;2-F; Metz B, 2006, BIOCONJUGATE CHEM, V17, P815, DOI 10.1021/bc050340f; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; PURI A, 1990, J VIROL, V64, P3824, DOI 10.1128/JVI.64.8.3824-3832.1990; RUIGROK RWH, 1992, J GEN VIROL, V73, P995, DOI 10.1099/0022-1317-73-4-995; Sciencelab, 2013, MAT SAF DAT SHEET ET; Soema PC, 2015, PHARM RES-DORDR, V32, P1505, DOI 10.1007/s11095-014-1556-3; Stohr K, 2014, NATURE, V507, pS20, DOI 10.1038/507S20a; Uittenbogaard JP, 2011, J BIOL CHEM, V286, P36198, DOI 10.1074/jbc.M111.279232; Vaarala O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114361; Veit M, 2011, ADV VIROL, V2011, DOI 10.1155/2011/370606; Vijayakrishnan S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003413; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; Wu JA, 2010, VACCINE, V28, P6221, DOI 10.1016/j.vaccine.2010.07.008	38	41	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150700	10.1371/journal.pone.0150700	http://dx.doi.org/10.1371/journal.pone.0150700			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959983	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300065
J	Norris, A; Hachey, K; Curtis, A; Bourdeaux, M				Norris, Alison; Hachey, Kevin; Curtis, Andrew; Bourdeaux, Margaret			Crippling Violence: Conflict and Incident Polio in Afghanistan	PLOS ONE			English	Article							ERADICATION; POLIOMYELITIS; LESSONS	Background Designing effective public health campaigns in areas of armed conflict requires a nuanced understanding of how violence impacts the epidemiology of the disease in question. Methods We examine the geographical relationship between violence (represented by the location of detonated Improvised Explosive Devices) and polio incidence by generating maps of IEDs and polio incidence during 2010, and by comparing the mean number of IED detonations in polio high-risk districts with non polio high-risk districts during 2004-2009. Results We demonstrate a geographic relationship between IED violence and incident polio. Districts that have high-risk for polio have highly statistically significantly greater mean numbers of IEDs than non polio high-risk districts (p-values 0.0010-0.0404). Conclusions The geographic relationship between armed conflict and polio incidence provides valuable insights as to how to plan a vaccination campaign in violent contexts, and allows us to anticipate incident polio in the regions of armed conflict. Such information permits vaccination planners to engage interested armed combatants to co-develop strategies to mitigate the effects of violence on polio.	[Norris, Alison] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA; [Hachey, Kevin] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Curtis, Andrew] Kent State Univ, Dept Geog, Hlth & Hazards Lab, GIS, Kent, OH 44242 USA; [Bourdeaux, Margaret] Brigham & Womens Hosp, Div Global Hlth, 75 Francis St, Boston, MA 02115 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Harvard University; Brigham & Women's Hospital	Norris, A (corresponding author), Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA.	anorris@cph.osu.edu	Curtis, Andrew/U-8674-2019	Hachey, Kevin/0000-0003-4756-9299	Ohio State University College of Public Health; Mershon Center for International Security Studies Student Research Grant	Ohio State University College of Public Health; Mershon Center for International Security Studies Student Research Grant	This work was supported by the Ohio State University College of Public Health and the Mershon Center for International Security Studies Student Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afghan Ministry of Public Health, 2010, ANN REP POL ER IN AF, P26; Afghan Ministry of Public Health, 2010, ANN REP POL ER IN, P1; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2497, DOI 10.1001/jama.2013.284182; [Anonymous], 2011, LANCET INFECT DIS, V11, P721, DOI 10.1016/S1473-3099(11)70258-4; [Anonymous], 2007, EMERGING INFECT DIS, V13; [Anonymous], 2010, PROGR POLIOMYELITIS; [Anonymous], DEF EXP POL VACC PRO; Asia MR, 2010, THESIS U SAN DIEGO S; Bhutta ZA, 2013, JAMA-J AM MED ASSOC, V310, P905, DOI 10.1001/jama.2013.276583; Ehreth J, 2003, VACCINE, V21, P596, DOI 10.1016/S0264-410X(02)00623-0; Grover M, 2013, J TROP PEDIATRICS, V59, P512, DOI 10.1093/tropej/fmt046; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; Larson HJ, 2011, NATURE, V473, P446, DOI 10.1038/473446a; Mohammadi D, 2012, LANCET, V380, P460, DOI 10.1016/S0140-6736(12)61279-3; Murray P, 2005, MED MICROBIOLOGY, P579; O'Reilly KM, 2012, LANCET, V380, P491, DOI 10.1016/S0140-6736(12)60648-5; O'Reilly KM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001109; Organization W.H., 1988, GLOB ER POL YEAR 200; Pallansch MA, 2006, NEW ENGL J MED, V355, P2508, DOI 10.1056/NEJMp068200; Smith J, 2015, B WORLD HEALTH ORGAN, V82, P24; Sommershof A, 2009, BRAIN BEHAV IMMUN, V23, P1117, DOI 10.1016/j.bbi.2009.07.003; WHO/WMO, 2012, ATL HLTH CLIM, P7	22	16	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149074	10.1371/journal.pone.0149074	http://dx.doi.org/10.1371/journal.pone.0149074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26958854	gold, Green Submitted, Green Published			2022-12-27	WOS:000371992300005
J	Schripsema, NR; van Trigt, AM; van der Wal, MA; Cohen-Schotanus, J				Schripsema, Nienke R.; van Trigt, Anke M.; van der Wal, Martha A.; Cohen-Schotanus, Janke			How Different Medical School Selection Processes Call upon Different Personality Characteristics	PLOS ONE			English	Article							MULTIPLE MINI-INTERVIEW; 5-FACTOR MODEL; STUDENT PERSONALITY; PREDICTIVE-VALIDITY; FAKING GOOD; PERFORMANCE; MOTIVATION; TRAITS; APPLICANTS; ADMISSIONS	Background Research indicates that certain personality traits relate to performance in the medical profession. Yet, personality testing during selection seems ineffective. In this study, we examine the extent to which different medical school selection processes call upon desirable personality characteristics in applicants. Methods 1019 of all 1055 students who entered the Dutch Bachelor of Medicine at University of Groningen, the Netherlands in 2009, 2010 and 2011 were included in this study. Students were admitted based on either top pre-university grades (n = 139), acceptance in a voluntary multifaceted selection process (n = 286), or lottery weighted for pre-university GPA. Within the lottery group, we distinguished between students who had not participated (n = 284) and students who were initially rejected (n = 310) in the voluntary selection process. Two months after admission, personality was assessed with the NEO-FFI, a measure of the five factor model of personality. We performed ANCOVA modelling with gender as a covariate to examine personality differences between the four groups. Results The multifaceted selection group scored higher on extraversion than all other groups (p<0.01), higher on conscientiousness than both lottery-admitted groups(p<0.01), and lower on neuroticism than the lottery-admitted group that had not participated in the voluntary selection process. The latter group scored lower on conscientiousness than all other groups(p<0.05) and lower on agreeableness than the multifaceted selection group and the top pre-university group(p<0.01). Conclusions Differences between the four admission groups, though statistically significant, were relatively small. Personality scores in the group admitted through the voluntary multifaceted selection process seemed most fit for the medical profession. Personality scores in the lottery-admitted group that had not participated in this process seemed least fit for the medical profession. It seems that in order to select applicants with suitable personalities, an admission process that calls upon desirable personality characteristics is beneficial.	[Schripsema, Nienke R.; van der Wal, Martha A.] Univ Groningen, Univ Med Ctr Groningen, Ctr Educ Dev & Res Hlth Profess CEDAR, Inst Med Educ, Groningen, Netherlands; [van Trigt, Anke M.; Cohen-Schotanus, Janke] Univ Groningen, Univ Med Ctr Groningen, Inst Med Educ, Groningen, Netherlands	University of Groningen; University of Groningen	Schripsema, NR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Educ Dev & Res Hlth Profess CEDAR, Inst Med Educ, Groningen, Netherlands.	N.R.Schripsema@umcg.nl						Albanese MA, 2003, ACAD MED, V78, P313, DOI 10.1097/00001888-200303000-00016; American Board of Internal Medicine, 1995, PROJ PROF; Azman MAZ, 2014, PROCD SOC BEHV, V116, P2281, DOI 10.1016/j.sbspro.2014.01.560; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; Costa PT, 2007, REVISED NEO PERSONAL; Doherty EM, 2011, MED EDUC, V45, P132, DOI 10.1111/j.1365-2923.2010.03760.x; Eva KW, 2014, MED EDUC, V48, P604, DOI 10.1111/medu.12402; Eva KW, 2009, MED EDUC, V43, P767, DOI 10.1111/j.1365-2923.2009.03407.x; Eva KW, 2004, MED EDUC, V38, P314, DOI 10.1046/j.1365-2923.2004.01776.x; Ferguson E, 2000, J OCCUP ORGAN PSYCH, V73, P321, DOI 10.1348/096317900167056; General Medical Council, 2013, GOOD MED PRACTICE; Griffin B, 2004, INT J SELECT ASSESS, V12, P243, DOI 10.1111/j.0965-075X.2004.278_1.x; Griffin B, 2004, PERS INDIV DIFFER, V36, P1545, DOI 10.1016/j.paid.2003.06.004; Griffin B, 2012, ADV HEALTH SCI EDUC, V17, P377, DOI 10.1007/s10459-011-9316-1; Griffin B, 2012, MED EDUC, V46, P485, DOI 10.1111/j.1365-2923.2011.04208.x; Haight SJ, 2012, ACAD MED, V87, P476, DOI 10.1097/ACM.0b013e318248e9d0; Hojat M, 2013, MED TEACH, V35, pE1267, DOI 10.3109/0142159X.2013.785654; Jerant A, 2012, ACAD MED, V87, P1250, DOI 10.1097/ACM.0b013e31826102ad; Judge TA, 2002, J APPL PSYCHOL, V87, P797, DOI 10.1037//0021-9010.87.4.797; Le H, 2011, J APPL PSYCHOL, V96, P113, DOI 10.1037/a0021016; Lievens F, 2002, MED EDUC, V36, P1050, DOI 10.1046/j.1365-2923.2002.01328.x; Lievens F, 2009, J APPL PSYCHOL, V94, P1514, DOI 10.1037/a0016137; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; McManus IC, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-29; Powis D, 2009, MED TEACH, V31, P1045, DOI 10.3109/01421590903390601; RHOADS JM, 1974, J MED EDUC, V49, P1119; Schripsema NR, 2014, MED EDUC, V48, P1201, DOI 10.1111/medu.12537; Siu E, 2009, ADV HEALTH SCI EDUC, V14, P759, DOI 10.1007/s10459-009-9160-8; Urlings-Strop LC, 2011, MED EDUC, V45, P1032, DOI 10.1111/j.1365-2923.2011.04031.x; Urlings-Strop LC, 2009, MED EDUC, V43, P175, DOI 10.1111/j.1365-2923.2008.03267.x; Wilson I, 2013, MED TEACH, V35, P944, DOI 10.3109/0142159X.2013.827331; Wouters A, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-200; Wright TA, 2003, ACAD MANAGE EXEC, V17, P131, DOI 10.5465/AME.2003.17541768	33	17	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150645	10.1371/journal.pone.0150645	http://dx.doi.org/10.1371/journal.pone.0150645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TF	26959489	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300062
J	Chen, S; Liu, JQ; Xiao, H; Zhang, J; Liu, A				Chen, Sha; Liu, Jun Qiu; Xiao, Hui; Zhang, Jun; Liu, An			Simultaneous Qualitative Assessment and Quantitative Analysis of Metabolites (Phenolics, Nucleosides and Amino Acids) from the Roots of Fresh Gastrodia elata Using UPLC-ESI-Triple Quadrupole Ion MS and ESI- Linear Ion Trap High-Resolution MS	PLOS ONE			English	Article							METHANOL EXTRACTS; ETHER FRACTION; MEDICINAL HERB; IDENTIFICATION; PROTECTS; ALCOHOL; RHIZOME; DAMAGE; BLUME	A sensitive, effective and optimized method, based on ultra performance liquid chromatography (UPLC) coupled with ESI-triple quadrupole ion MS and ESI-linear ion trap high-resolution MS, has been developed for the simultaneous quantitative and qualitative determination of phenolics, nucleosides and amino acids in the roots of fresh Gastrodia elata. Optimization of the analytical method provided higher separation efficiency and better peak resolution for the targeted compounds. The simultaneous separation protocols were also optimized by routinely using accurate mass measurements, within 5 ppm error, for each molecular ion and the subsequent fragment ions. In total, 31 compounds, including 23 phenolics, two nucleosides, four amino acids, one gastrodin and one other compound were identified or tentatively characterized. Mono-substituted parishin glucoside (9), methoxy mono-substituted parishin (13), methyl parishin (26), p-hydroxybenzyl di-substituted parishin (29), and p-hydroxybenzyl parishin (31) were tentatively identified as new compounds. Principal metabolite content analysis and the composition of eight representative G. elata cultivars of various species indicated that geographic insulation was the main contributor to clustering.	[Chen, Sha; Liu, Jun Qiu; Xiao, Hui; Zhang, Jun; Liu, An] China Acad Chinese Med Sci, Inst Chinese Mat Med, Key Lab Beijing Identificat & Safety Evaluat Chin, 16 Nanxiaojie, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Liu, A (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Key Lab Beijing Identificat & Safety Evaluat Chin, 16 Nanxiaojie, Beijing, Peoples R China.	liuan@icmm.ac.cn	Liu, An/GOG-8435-2022		National Science & Technology Pillar Program [2011BAI13B04]; National Basic Research Program of China (973 Program) [2010CB530600]; Major Projects of Guizhou Province [[2011] 6005]; Major Projects of Guiyang city [2011401, 6-1]; Major Scientific and Technological Special Project for "Significant New Drugs Creation" [2014ZX09304307]	National Science & Technology Pillar Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Major Projects of Guizhou Province; Major Projects of Guiyang city; Major Scientific and Technological Special Project for "Significant New Drugs Creation"	The authors are grateful for financial support from the National Science & Technology Pillar Program (No. 2011BAI13B04), the National Basic Research Program of China (973 Program, No. 2010CB530600), the Major Projects of Guizhou Province ([2011] 6005) and the Major Projects of Guiyang city (2011401 No. 6-1). The authors are grateful for financial support from the Major Scientific and Technological Special Project for "Significant New Drugs Creation" (No. 2014ZX09304307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for financial support from the Major Scientific and Technological Special Project for "Significant New Drugs Creation" (No. 2014ZX09304307), the Major Projects of Guizhou Province ([2011] 6005) and the Major Projects of Guiyang city (2011401 No. 6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn EK, 2007, J ETHNOPHARMACOL, V110, P476, DOI 10.1016/j.jep.2006.10.006; Chen S, 2012, ANAL CHIM ACTA, V724, P127, DOI 10.1016/j.aca.2012.02.051; Choi JH, 2006, CHEM PHARM BULL, V54, P1720, DOI 10.1248/cpb.54.1720; Cox KD, 2006, PLANTA, V224, P1373, DOI 10.1007/s00425-006-0322-0; Ha JH, 2000, J ETHNOPHARMACOL, V73, P329, DOI 10.1016/S0378-8741(00)00313-5; Hayashi J, 2002, PHYTOCHEMISTRY, V59, P513, DOI 10.1016/S0031-9422(02)00008-0; Hsieh CL, 2007, J ETHNOPHARMACOL, V109, P241, DOI 10.1016/j.jep.2006.07.024; Hsieh CL, 2001, AM J CHINESE MED, V29, P331, DOI 10.1142/S0192415X01000356; Kim HJ, 2003, PHYTOTHER RES, V17, P909, DOI 10.1002/ptr.1246; Kim HJ, 2001, NEUROSCI LETT, V314, P65, DOI 10.1016/S0304-3940(01)02296-0; Li HB, 2004, J CHROMATOGR A, V1052, P229, DOI 10.1016/j.chroma.2004.09.005; Li ZF, 2015, J CHROMATOGR B, V988, P45, DOI 10.1016/j.jchromb.2015.02.020; Ong ES, 2007, J SEP SCI, V30, P2130, DOI 10.1002/jssc.200700002; Park EJ, 2012, HORTIC ENVIRON BIOTE, V53, P415, DOI 10.1007/s13580-012-0046-y; Tang W., 1992, CHINESE DRUGS PLANT, P545, DOI DOI 10.4049/jimmunol.1100225; Wang HX, 2007, PLANT CELL REP, V26, P253, DOI 10.1007/s00299-006-0226-2; Wang L, 2009, CHEMINFORM, P40; Wang L, 2007, J SEP SCI, V30, P1488, DOI 10.1002/jssc.200600469; Wang L, 2012, J ASIAN NAT PROD RES, V14, P457, DOI 10.1080/10286020.2012.669755; [王莉 WANG Li], 2009, [中草药, Chinese Traditional and Herbal Drugs], V40, P1186; Wu CR, 1996, PLANTA MED, V62, P317, DOI 10.1055/s-2006-957892; Yeh CL, 2011, NORD J BOT, V29, P417, DOI 10.1111/j.1756-1051.2011.01147.x; Yu SJ, 2005, BIOL PHARM BULL, V28, P1016, DOI 10.1248/bpb.28.1016; Zhang ZC, 2013, J ASIAN NAT PROD RES, V15, P619, DOI 10.1080/10286020.2013.791286	24	6	11	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150647	10.1371/journal.pone.0150647	http://dx.doi.org/10.1371/journal.pone.0150647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954012	Green Submitted, gold, Green Published			2022-12-27	WOS:000371991300040
J	Tyagi, K; Hossain, ME; Thakur, V; Aggarwal, P; Malhotra, P; Mohmmed, A; Sharma, YD				Tyagi, Kriti; Hossain, Mohammad Enayet; Thakur, Vandana; Aggarwal, Praveen; Malhotra, Pawan; Mohmmed, Asif; Sharma, Yagya Dutta			Plasmodium vivax Tryptophan Rich Antigen PvTRAg36.6 Interacts with PvETRAMP and PvTRAg56.6 Interacts with PvMSP7 during Erythrocytic Stages of the Parasite	PLOS ONE			English	Article							MALARIA PARASITE; FALCIPARUM MEROZOITES; MULTIGENE FAMILY; RHOPTRY PROTEIN; CELL INVASION; SURFACE; LOCALIZATION; MEMBRANE; APICOPLAST; COMPLEX	Plasmodium vivax is most wide spread and a neglected malaria parasite. There is a lack of information on parasite biology of this species. Genome of this parasite encodes for the largest number of tryptophan-rich proteins belonging to 'Pv-fam-a' family and some of them are potential drug/vaccine targets but their functional role(s) largely remains unexplored. Using bacterial and yeast two hybrid systems, we have identified the interacting partners for two of the P. vivax tryptophan-rich antigens called PvTRAg36.6 and PvTRAg56.2. The PvTRAg36.6 interacts with early transcribed membrane protein (ETRAMP) of P. vivax. It is apically localized in merozoites but in early stages it is seen in parasite periphery suggesting its likely involvement in parasitophorous vacuole membrane (PVM) development or maintenance. On the other hand, PvTRAg56.2 interacts with P. vivax merozoite surface protein7 (PvMSP7) and is localized on merozoite surface. Co-localization of PvTRAg56.2 with PvMSP1 and its molecular interaction with PvMSP7 probably suggest that, PvTRAg56.2 is part of MSP-complex, and might assist or stabilize the protein complex at the merozoite surface. In conclusion, the PvTRAg proteins have different sub cellular localizations and specific associated functions during intra-erythrocytic developmental cycle.	[Tyagi, Kriti; Sharma, Yagya Dutta] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Hossain, Mohammad Enayet; Thakur, Vandana; Malhotra, Pawan; Mohmmed, Asif] Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India; [Aggarwal, Praveen] All India Inst Med Sci, Dept Emergency Med, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Sharma, YD (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.; Mohmmed, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India.	amohd@icgeb.res.in; ydsharma_aiims@yahoo.com			Indian Council of Medical Research [61/4/2012-BMS]; Department of Biotechnology, Govt. of India [BT/01/CEIB/11/V/01]; Council of Scientific and Industrial Research Senior Research Fellowships; ICGEB Pre-doctoral Research Fellowships	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research Senior Research Fellowships; ICGEB Pre-doctoral Research Fellowships	Funding provided by Indian Council of Medical Research [Grant No. 61/4/2012-BMS to Y. D. Sharma]; Program support grant by Department of Biotechnology, Govt. of India, [BT/01/CEIB/11/V/01 to A. Mohammad and P. Malhotra]; Council of Scientific and Industrial Research Senior Research Fellowships to K. Tyagi and ICGEB Pre-doctoral Research Fellowships to M. E. Hossain. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baldi DL, 2000, EMBO J, V19, P2435, DOI 10.1093/emboj/19.11.2435; BANNISTER LH, 1990, BLOOD CELLS, V16, P257; BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; Bender A, 2003, MOL BIOCHEM PARASIT, V132, P59, DOI 10.1016/j.molbiopara.2003.07.001; Bora H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016294; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; BROWN GV, 1985, J EXP MED, V162, P774, DOI 10.1084/jem.162.2.774; Burns JM, 2000, MOL BIOCHEM PARASIT, V110, P11, DOI 10.1016/S0166-6851(00)00252-8; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Curtidor H, 2006, BIOCHEM BIOPH RES CO, V339, P888, DOI 10.1016/j.bbrc.2005.11.089; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Deplaine G, 2011, ANTIMICROB AGENTS CH, V55, P2576, DOI 10.1128/AAC.01409-10; Dubremetz JF, 1998, INT J PARASITOL, V28, P1007, DOI 10.1016/S0020-7519(98)00076-9; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Hiller NL, 2003, J BIOL CHEM, V278, P48413, DOI 10.1074/jbc.M307266200; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hossain MJ, 2010, GENE, V468, P48, DOI 10.1016/j.gene.2010.08.004; Jaijyan DK, 2015, J BIOL CHEM; Kadekoppala M, 2010, INT J PARASITOL, V40, P1155, DOI 10.1016/j.ijpara.2010.04.008; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Lavazec C, 2006, NUCLEIC ACIDS RES, V34, P6696, DOI 10.1093/nar/gkl942; LUSTIGMAN S, 1988, MOL BIOCHEM PARASIT, V30, P217, DOI 10.1016/0166-6851(88)90090-4; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; Mello K, 2002, EUKARYOT CELL, V1, P915, DOI 10.1128/EC.1.6.915-925.2002; Ntumngia FB, 2004, MOL BIOCHEM PARASIT, V137, P349, DOI 10.1016/j.molbiopara.2004.06.008; Pachebat JA, 2001, MOL BIOCHEM PARASIT, V117, P83, DOI 10.1016/S0166-6851(01)00336-X; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Rathore S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.142; Rathore S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.118; Rathore S, 2010, MOL MICROBIOL, V77, P873, DOI 10.1111/j.1365-2958.2010.07251.x; Richard D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000328; Soldati D, 2004, TRENDS PARASITOL, V20, P567, DOI 10.1016/j.pt.2004.09.009; Spielmann T, 2003, MOL BIOL CELL, V14, P1529, DOI 10.1091/mbc.E02-04-0240; Spielmann T, 2000, MOL BIOCHEM PARASIT, V111, P453, DOI 10.1016/S0166-6851(00)00333-9; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tachibana SI, 2012, NAT GENET, V44, P1051, DOI 10.1038/ng.2375; Topolska AE, 2004, J BIOL CHEM, V279, P4648, DOI 10.1074/jbc.M307859200; TRAGER W, 1992, INFECT IMMUN, V60, P4656, DOI 10.1128/IAI.60.11.4656-4661.1992; Trucco C, 2001, MOL BIOCHEM PARASIT, V112, P91, DOI 10.1016/S0166-6851(00)00350-9; Tyagi RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050754; Uhlemann AC, 2001, MOL BIOCHEM PARASIT, V118, P41, DOI 10.1016/S0166-6851(01)00370-X; Venkatesan M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-41; Wang B, 2015, INFECT IMMUN, V83, P3083, DOI 10.1128/IAI.03067-14; Wickramarachchi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001732; Zeeshan M, 2015, INFECT IMMUN; Zeeshan M, 2015, J INFECT DIS, V211, P1111, DOI 10.1093/infdis/jiu558; Zeeshan M, 2013, J INFECT DIS, V207, P175, DOI 10.1093/infdis/jis650; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	52	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151065	10.1371/journal.pone.0151065	http://dx.doi.org/10.1371/journal.pone.0151065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954579	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300080
J	Aagesen, L; Biganzoli, F; Bena, J; Godoy-Burki, AC; Reinheimer, R; Zuloaga, FO				Aagesen, Lone; Biganzoli, Fernando; Bena, Julia; Godoy-Burki, Ana C.; Reinheimer, Renata; Zuloaga, Fernando O.			Macro-Climatic Distribution Limits Show Both Niche Expansion and Niche Specialization among C(4)Panicoids	PLOS ONE			English	Article							C-4 PHOTOSYNTHESIS; MOLECULAR PHYLOGENY; POACEAE; EVOLUTIONARY; PANICOIDEAE; GRASSES; PANICEAE; DIVERSITY; SUGGESTS; ORIGINS	Grasses are ancestrally tropical understory species whose current dominance in warm open habitats is linked to the evolution of C-4 photosynthesis. C-4 grasses maintain high rates of photosynthesis in warm and water stressed environments, and the syndrome is considered to induce niche shifts into these habitats while adaptation to cold ones may be compromised. Global biogeographic analyses of C-4 grasses have, however, concentrated on diversity patterns, while paying little attention to distributional limits. Using phylogenetic contrast analyses, we compared macro-climatic distribution limits among similar to 1300 grasses from the subfamily Panicoideae, which includes 4/5 of the known photosynthetic transitions in grasses. We explored whether evolution of C-4 photosynthesis correlates with niche expansions, niche changes, or stasis at subfamily level and within the two tribes Paniceae and Paspaleae. We compared the climatic extremes of growing season temperatures, aridity, and mean temperatures of the coldest months. We found support for all the known biogeographic distribution patterns of C-4 species, these patterns were, however, formed both by niche expansion and niche changes. The only ubiquitous response to a change in the photosynthetic pathway within Panicoideae was a niche expansion of the C-4 species into regions with higher growing season temperatures, but without a withdrawal from the inherited climate niche. Other patterns varied among the tribes, as macro-climatic niche evolution in the American tribe Paspaleae differed from the pattern supported in the globally distributed tribe Paniceae and at family level.	[Aagesen, Lone; Bena, Julia; Godoy-Burki, Ana C.; Zuloaga, Fernando O.] Consejo Nacl Invest Cient & Tecn, ANCEFN, Inst Bot Darwin, Labarden 200,B1642HYD, Buenos Aires, DF, Argentina; [Biganzoli, Fernando] UBA, Fac Agron, Dept Metodos Cuantitat & Sistemas Informac, Buenos Aires, DF, Argentina; [Reinheimer, Renata] Inst Agrobiotecnol Litoral, Santa Fe De La Vera Cruz, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Aagesen, L (corresponding author), Consejo Nacl Invest Cient & Tecn, ANCEFN, Inst Bot Darwin, Labarden 200,B1642HYD, Buenos Aires, DF, Argentina.	laagesen@darwin.edu.ar		Bena, Maria Julia/0000-0002-2184-9738; Biganzoli, Fernando/0000-0003-0004-5295	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP 0207]; National Geographic Society [8365-07, 8862-10]; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT 0207]; Myndel Botanical Foundation	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Geographic Society(National Geographic Society); Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Myndel Botanical Foundation	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (http://www.conicet.gov.ar, research grant - PIP 0207), National Geographic Society (grant nos. 8365-07 and 8862-10 supported Field work), Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (http://www.agencia.mincyt.gob.ar/, research grant - PICT 0207), and Myndel Botanical Foundation supported field work.	Ackerly DD, 2000, EVOLUTION, V54, P1480, DOI 10.1111/j.0014-3820.2000.tb00694.x; Acosta JM, 2014, PLANT SYST EVOL, V300, P2155, DOI 10.1007/s00606-014-1034-8; Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Cayssials V, 2013, EVOL ECOL, V27, P393, DOI 10.1007/s10682-012-9601-3; Christin PA, 2015, MOL BIOL EVOL, V32, P846, DOI 10.1093/molbev/msu410; Christin PA, 2013, PHOTOSYNTH RES, V117, P163, DOI 10.1007/s11120-013-9852-z; Christin PA, 2012, J EXP BOT, V63, P6297, DOI 10.1093/jxb/ers282; Clayton W. D., 1986, Kew Bulletin Additional Series, V13; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Edwards EJ, 2013, J EXP BOT, V64, P4047, DOI 10.1093/jxb/ert220; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Edwards EJ, 2010, P NATL ACAD SCI USA, V107, P2532, DOI 10.1073/pnas.0909672107; Furley PA, 1999, GLOBAL ECOL BIOGEOGR, V8, P223, DOI 10.1046/j.1466-822X.1999.00142.x; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2012, CLADISTICS, V28, P503, DOI 10.1111/j.1096-0031.2012.00400.x; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Humphreys AM, 2013, NEW PHYTOL, V198, P1261, DOI 10.1111/nph.12244; Ibrahim DG, 2009, ANN BOT-LONDON, V103, P127, DOI 10.1093/aob/mcn204; Kadereit G, 2012, P ROY SOC B-BIOL SCI, V279, P3304, DOI 10.1098/rspb.2012.0440; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Kellogg EA, 2000, ANNU REV ECOL SYST, V31, P217, DOI 10.1146/annurev.ecolsys.31.1.217; KILLEEN TJ, 1992, J TROP ECOL, V8, P389, DOI 10.1017/S0266467400006714; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Liu MZ, 2013, J EXP BOT, V64, P2183, DOI 10.1093/jxb/ert075; Liu MZ, 2008, J EXP BOT, V59, P4161, DOI 10.1093/jxb/ern257; Liu Q, 2011, PLANT ECOL, V212, P1733, DOI 10.1007/s11258-011-9946-7; Lizarazu MA, 2014, TAXON, V63, P265, DOI 10.12705/632.34; Lopez A, 2012, SYST BOT, V37, P671, DOI 10.1600/036364412X648625; Lundgren MR, 2015, ECOL LETT, V18, P1021, DOI 10.1111/ele.12484; Maldonado C, 2015, GLOBAL ECOL BIOGEOGR, V24, P973, DOI 10.1111/geb.12326; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Miller M.A., 2010, P GAT COMP ENV WORKS; Monson R.K., 1999, C4 PLANT BIOL, P339; Morrone O, 2008, SYST BOT, V33, P66, DOI 10.1600/036364408783887393; Morrone O, 2012, CLADISTICS, V28, P333, DOI 10.1111/j.1096-0031.2011.00384.x; Osborne CP, 2009, P ROY SOC B-BIOL SCI, V276, P1753, DOI 10.1098/rspb.2008.1762; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pau S, 2013, GLOBAL CHANGE BIOL, V19, P184, DOI 10.1111/gcb.12037; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pinheiro J, 2020, R PACKAGE VERSION 31; PRENDERGAST HDV, 1985, AUST J BOT, V33, P317, DOI 10.1071/BT9850317; Rambaut A., 2014, TRACER V1 6; Ripley B, 2010, ANN BOT-LONDON, V105, P493, DOI 10.1093/aob/mcp307; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Safriel U, 2005, DRYLAND SYSTEMS, P917; Sage RF, 2002, OECOLOGIA, V132, P501, DOI 10.1007/s00442-002-0959-8; Sage RF, 2012, ANNU REV PLANT BIOL, V63, P19, DOI 10.1146/annurev-arplant-042811-105511; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Sage RF, 2011, ADV PHOTOSYNTH RESP, V32, P161; Salariato DL, 2010, MOL PHYLOGENET EVOL, V56, P355, DOI 10.1016/j.ympev.2010.02.009; Sede SM, 2008, SYST BOT, V33, P284, DOI 10.1600/036364408784571626; Sede SM, 2009, TAXON, V58, P365, DOI 10.1002/tax.582004; Soreng RJ, 2015, J SYST EVOL, V53, P117, DOI 10.1111/jse.12150; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Taylor SH, 2011, PLANT CELL ENVIRON, V34, P65, DOI 10.1111/j.1365-3040.2010.02226.x; Team R Core, 2014, R LANG ENV STAT COMP; Trabucco A, 2009, CGIAR CONSORT SPATIA; Vega AS, 2008, ANN MO BOT GARD, V95, P511, DOI 10.3417/2006084; Wiens JJ, 2011, PHILOS T R SOC B, V366, P2336, DOI 10.1098/rstb.2011.0059; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014; Zuloaga Fernando O., 2003, Contributions from the United States National Herbarium, V46, P1; Zuloaga FO, 2015, PLANT SYST EVOL, V301, P1693, DOI 10.1007/s00606-014-1186-6; Zuloaga FO, 2010, TAXON, V59, P1535, DOI 10.1002/tax.595017; Zuloaga FO, 1985, S MITHSONIAN CONTRIB	73	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0151075	10.1371/journal.pone.0151075	http://dx.doi.org/10.1371/journal.pone.0151075			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950074	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100088
J	Wang, Z; Gu, ZK; Shen, Y; Wang, Y; Li, J; Lv, H; Huo, KK				Wang, Zhe; Gu, Zhongkai; Shen, Yan; Wang, Yang; Li, Jing; Lv, Hong; Huo, Keke			The Natural Product Resveratrol Inhibits Yeast Cell Separation by Extensively Modulating the Transcriptional Landscape and Reprogramming the Intracellular Metabolome	PLOS ONE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; GENE-EXPRESSION; CYCLE CONTROL; ALPHA; REPLICATION; TRANSLATION; APOPTOSIS; RESOURCE; PROTEIN	An increasing number of studies have shown that the promising compound resveratrol treats multiple diseases, such as cancer and aging; however, the resveratrol mode-ofaction (MoA) remains largely unknown. Here, by virtue of multiple omics approaches, we adopted fission yeast as a model system with the goal of dissecting the common MoA of the anti-proliferative activity of resveratrol. We found that the anti-proliferative activity of resveratrol is mainly due to its unique role of inhibiting the separation of sister cells, similar phenotype with the C2H2 zinc finger transcription factor Ace2 knock-out strain. Microarray analysis shown that resveratrol has extensive impact on the fission yeast transcription levels. Among the changed gene's list, 40% of up-regulated genes are Core Environmental Stress Responses genes, and 57% of the down-regulated genes are periodically expressed. Moreover, resveratrol leverages the metabolome, which unbalances the intracellular pool sizes of several classes of amino acids, nucleosides, sugars and lipids, thus reflecting the remodulated metabolic networks. The complexity of the resveratrol MoA displayed in previous reports and our work demonstrates that multiple omics approaches must be applied together to obtain a complete picture of resveratrol's anti-proliferative function.	[Wang, Zhe; Gu, Zhongkai; Lv, Hong; Huo, Keke] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, 2005 Song Hu Rd, Shanghai 200438, Peoples R China; [Wang, Zhe] Cornell Univ, Weill Med Coll, Div Infect Dis, 413 E 69th St, New York, NY 10021 USA; [Gu, Zhongkai; Shen, Yan; Wang, Yang] Fudan Univ, Inst Biomed Sci, 130 Dong An Rd, Shanghai 200032, Peoples R China; [Li, Jing] Tsinghua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Fudan University; Cornell University; Fudan University; Tsinghua University	Wang, Z; Lv, H; Huo, KK (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, 2005 Song Hu Rd, Shanghai 200438, Peoples R China.; Wang, Z (corresponding author), Cornell Univ, Weill Med Coll, Div Infect Dis, 413 E 69th St, New York, NY 10021 USA.	zhw2001@med.cornell.edu; honglv@fudan.edu.cn; kkhuo@fudan.edu.cn	Wang, Zhe/H-9269-2019		National Natural Science Foundation of China [30900018]; China Postdoctoral Science Foundation [20090450651, 201003240]; Shanghai Postdoctoral Science Foundation [08R214105]; National Key Basic Research Program of China [2013CB531603, 2010CB912602]; National Science Foundation for Postdoctoral Scientists of China [20090450651]; Shanghai Science Foundation for Postdoctoral Scientists [08R214105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Key Basic Research Program of China(National Basic Research Program of China); National Science Foundation for Postdoctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC)); Shanghai Science Foundation for Postdoctoral Scientists	This work was supported by National Natural Science Foundation of China (30900018), China Postdoctoral Science Foundation (20090450651, 201003240) Shanghai Postdoctoral Science Foundation (08R214105) awarded to Zhe Wang. This work was also supported by National Key Basic Research Program of China (2013CB531603 and 2010CB912602) to KeKe Huo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Drs. Lin Xu and Hyungjin Eoh for their critical discussion and comments. This work is supported by National Key Basic Research Program of China (2013CB531603 and 2010CB912602) to Keke Huo, and by National Natural Science Foundation of China (No.30900018), National Science Foundation for Postdoctoral Scientists of China (No.20090450651), Shanghai Science Foundation for Postdoctoral Scientists (No.08R214105) to Zhe Wang.	Alonso-Nunez ML, 2005, MOL BIOL CELL, V16, P2003, DOI 10.1091/mbc.E04-06-0442; AVES SJ, 1985, EMBO J, V4, P457, DOI 10.1002/j.1460-2075.1985.tb03651.x; Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Baselga-Escudero L, 2014, NUCLEIC ACIDS RES, V42, P882, DOI 10.1093/nar/gkt1011; Bitton DA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00330; Bollmann F, 2014, NUCLEIC ACIDS RES, V42, P12555, DOI 10.1093/nar/gku1033; Britton RG, 2015, ANN NY ACAD SCI, V1348, P124, DOI 10.1111/nyas.12796; Bulmer R, 2004, EUKARYOT CELL, V3, P944, DOI 10.1128/EC.3.4.944-954.2004; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; Cortes JCG, 2005, J CELL SCI, V118, P157, DOI 10.1242/jcs.01585; Cortes JCG, 2012, J CELL BIOL, V198, P637, DOI 10.1083/jcb.201202015; Delmas D, 2006, CURR DRUG TARGETS, V7, P423, DOI 10.2174/138945006776359331; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; DURSO G, 1995, J CELL SCI, V108, P3109; Fontecave M, 1998, FEBS LETT, V421, P277, DOI 10.1016/S0014-5793(97)01572-X; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Garcia I, 2005, BIOL CELL, V97, P569; Garg A, 2015, NUCLEIC ACIDS RES, P1; Gatz SA, 2008, CARCINOGENESIS, V29, P321, DOI 10.1093/carcin/bgm276; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Hayles J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130053; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep11113; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Iwaki T, 2006, MICROBIOL-SGM, V152, P2309, DOI 10.1099/mic.0.28952-0; Jager W, 2011, OMICS, V15, P9, DOI 10.1089/omi.2010.0114; Linder T, 2008, NUCLEIC ACIDS RES, V36, P2489, DOI 10.1093/nar/gkn070; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Maaheimo H, 2001, EUR J BIOCHEM, V268, P2464, DOI 10.1046/j.1432-1327.2001.02126.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; NURSE P, 1985, J GEN MICROBIOL, V131, P2123; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; Reiter W, 2008, J BIOL CHEM, V283, P9945, DOI 10.1074/jbc.M710428200; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; SARABIA MJF, 1993, MOL GEN GENET, V238, P241, DOI 10.1007/BF00279553; Schuster S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091045; Simon JA, 2004, NAT REV CANCER, V4, P481, DOI 10.1038/nrc1372; Sprouse AA, 2014, BREAST CANC CELLS, V5374, P5363; Timmers S, 2012, AGING-US, V4, P146, DOI 10.18632/aging.100445; Vanamala J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-238; Wang XQ, 2015, CELL BIOCHEM BIOPHYS, V73, P527, DOI 10.1007/s12013-015-0696-3; Whillier S, 2011, FEBS J, V278, P3152, DOI 10.1111/j.1742-4658.2011.08241.x; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374	48	6	7	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150156	10.1371/journal.pone.0150156	http://dx.doi.org/10.1371/journal.pone.0150156			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950930	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100023
J	Zhu, QL; Li, F; Wang, JL; Shen, LX; Sheng, XY				Zhu, Qingling; Li, Feng; Wang, Junli; Shen, Lixiao; Sheng, Xiaoyang			Fecal Calprotectin in Healthy Children Aged 1-4 Years	PLOS ONE			English	Article							INTESTINAL INFLAMMATION; COLORECTAL INFLAMMATION; CALCIUM-BINDING; PROTEIN; L1; GRANULOCYTES; MARKER	Objective Calprotectin has been well emulated recently in adults as well as in children. The aim of this study was to assess fecal calprotectin concentrations in healthy children aged from 1 to 4 years. Methods Volunteers were enlisted from 3 nurseries. A brief questionnaire was used to ensure these children meet the inclusion criteria, and some clinical and sociodemographic factors were collected. Anthro software (version 3.1) was used to calculated Length-for-age Z-scores (LAZ), weight-for-age Z-scores (WAZ), and weight-for-length Z-scores (WLZ) respectively. Fecal calprotectin was detected by a commercially available ELISA. Results In total 274 children were recruited, with age ranging from 1 to 4 years old. The median FC concentration was 83.19 mu g/g [range 4.58 to 702.50 mu g/g, interquartile range (IQR) 14.69-419.45 mu g/g] or 1.92 log10 mu g/g (range 0.66 log10 to 2.85 log10 mu g/g, IQR 1.17 log10-2.62 log10 mu g/g). All of the children were divided into three groups, 1-2 years (12-24 months), 2-3 years (24-36 months), 3-4 years (36-48 months), with median FC concentrations 96.14 mu g/g (1.98 log10 mu g/g), 81.48 mu g/g (1.91 log10 mu g/g), 65.36 mu g/g (1.82 log10 mu g/g), respectively. There was similar FC level between boys and girls. FC concentrations showed a downward trend by the growing age groups. A statistic difference was found in FC concentrations among groups 1-2 years, 2-3 years and 3-4 years (P = 0.016). In inter-groups comparison, a significant difference was found between children aged 1-2 years and children aged 3-4 years (P = 0.007). A negative correlation trend was found between age and FC concentration (Spearman's rho = -0.167, P = 0.005) in all the participants. A simple correlation was performed among WLZ, WAZ, birth weight, or birth length with FC, and there was no correlation being observed. Conclusion Children aged from 1 to 4 years old have lower FC concentrations compared with healthy infants (<1years), and higher FC concentrations when comparing with children older than 4 years and adults.	[Zhu, Qingling; Li, Feng; Wang, Junli; Shen, Lixiao; Sheng, Xiaoyang] Shanghai Jiao Tong Univ, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Dept Child & Adolescent Healthcare,Sch Med, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University	Sheng, XY (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Dept Child & Adolescent Healthcare,Sch Med, Shanghai 200092, Peoples R China.	shengxiaoyangcn@aliyun.com			Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition [11DZ2260500]; National Natural Science Foundation of China [81172686, 81302446]	Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition (No.11DZ2260500) and National Natural Science Foundation of China (No.81172686, No.81302446). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have declared that no competing interests exist.	Aomatsu T, 2011, DIGEST DIS SCI, V56, P2372, DOI 10.1007/s10620-011-1633-y; BERNTZEN HB, 1990, SCAND J CLIN LAB INV, V50, P769, DOI 10.3109/00365519009091071; Bunn SK, 2001, J PEDIATR GASTR NUTR, V33, P14, DOI 10.1097/00005176-200107000-00003; Burri E, 2015, DIGEST DIS SCI, V60, P485, DOI 10.1007/s10620-014-3383-0; Canani RB, 2006, J PEDIATR GASTR NUTR, V42, P9, DOI 10.1097/01.mpg.0000187818.76954.9a; DALE I, 1985, AM J CLIN PATHOL, V84, P24, DOI 10.1093/ajcp/84.1.24; DALE I, 1983, EUR J BIOCHEM, V134, P1, DOI 10.1111/j.1432-1033.1983.tb07522.x; Dhaliwal J, 2015, J PEDIATR GASTR NUTR, V60, P521, DOI 10.1097/MPG.0000000000000683; Diamanti A, 2008, INFLAMM BOWEL DIS, V14, P1229, DOI 10.1002/ibd.20472; Dolwani S, 2004, ALIMENT PHARM THER, V20, P615, DOI 10.1111/j.1365-2036.2004.02128.x; Dumoulin EN, 2015, CLIN CHEM LAB MED, V53, P65, DOI 10.1515/cclm-2014-0568; Ezri J, 2011, Rev Med Suisse, V7, P69; Fagerberg UL, 2005, J PEDIATR GASTR NUTR, V40, P450, DOI 10.1097/01.MPG.0000154657.08994.94; Fagerberg UL, 2003, J PEDIATR GASTR NUTR, V37, P468, DOI 10.1097/00005176-200310000-00013; Fagerhol MK, 1996, J CLIN PATHOL-CL MOL, V49, pM74; Garcia Sanchez Mdel V, 2006, MED CLIN-BARCELONA, V127, P41; Herting E, 2003, LANCET, V361, P311, DOI 10.1016/S0140-6736(03)12334-3; Hestvik E, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-9; Kolho KL, 2012, J PEDIATR GASTR NUTR, V55, P751, DOI 10.1097/MPG.0b013e31825f4c77; Kostakis ID, 2013, DIGEST DIS SCI, V58, P309, DOI 10.1007/s10620-012-2347-5; Li F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119574; Limburg PJ, 2000, AM J GASTROENTEROL, V95, P2831, DOI 10.1016/S0002-9270(00)01987-0; Liu JR, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-129; Ma JQ, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0418-4; Manolakis AC, 2011, DIGEST DIS SCI, V56, P1601, DOI 10.1007/s10620-010-1494-9; Manz M, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-5; NAESSANDRESEN CF, 1995, J CLIN PATHOL-CL MOL, V48, pM278; Oord T, 2014, SCAND J CLIN LAB INV, V74, P254, DOI 10.3109/00365513.2013.879732; Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; Roseth AG, 2003, DIGEST LIVER DIS, V35, P607, DOI 10.1016/S1590-8658(03)00375-X; SAVERYMUTTU SH, 1985, GUT, V26, P955, DOI 10.1136/gut.26.9.955; STEINBAKK M, 1990, LANCET, V336, P763, DOI 10.1016/0140-6736(90)93237-J; Tibble J, 2000, GUT, V47, P506, DOI 10.1136/gut.47.4.506; Tibble JA, 1999, GUT, V45, P362, DOI 10.1136/gut.45.3.362	35	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150725	10.1371/journal.pone.0150725	http://dx.doi.org/10.1371/journal.pone.0150725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950440	Green Submitted, Green Published, gold			2022-12-27	WOS:000371990100055
J	Muller, RD; Qin, XD; Sandwell, DT; Dutkiewicz, A; Williams, SE; Flament, N; Maus, S; Seton, M				Mueller, R. Dietmar; Qin, Xiaodong; Sandwell, David T.; Dutkiewicz, Adriana; Williams, Simon E.; Flament, Nicolas; Maus, Stefan; Seton, Maria			The GPlates Portal: Cloud-Based Interactive 3D Visualization of Global Geophysical and Geological Data in a Web Browser	PLOS ONE			English	Article							TOPOGRAPHY; HISTORY; MODELS; BASIN; EARTH	The pace of scientific discovery is being transformed by the availability of 'big data' and open access, open source software tools. These innovations open up new avenues for how scientists communicate and share data and ideas with each other and with the general public. Here, we describe our efforts to bring to life our studies of the Earth system, both at present day and through deep geological time. The GPlates Portal (portal.gplates.org) is a gateway to a series of virtual globes based on the Cesium Javascript library. The portal allows fast interactive visualization of global geophysical and geological data sets, draped over digital terrain models. The globes use WebGL for hardware-accelerated graphics and are cross-platform and cross-browser compatible with complete camera control. The globes include a visualization of a high-resolution global digital elevation model and the vertical gradient of the global gravity field, highlighting small-scale seafloor fabric such as abyssal hills, fracture zones and seamounts in unprecedented detail. The portal also features globes portraying seafloor geology and a global data set of marine magnetic anomaly identifications. The portal is specifically designed to visualize models of the Earth through geological time. These space-time globes include tectonic reconstructions of the Earth's gravity and magnetic fields, and several models of long-wavelength surface dynamic topography through time, including the interactive plotting of vertical motion histories at selected locations. The globes put the on-the-fly visualization of massive data sets at the fingertips of end-users to stimulate teaching and learning and novel avenues of inquiry.	[Mueller, R. Dietmar; Qin, Xiaodong; Dutkiewicz, Adriana; Williams, Simon E.; Flament, Nicolas; Seton, Maria] Univ Sydney, EarthByte Grp, Sch Geosci, Sydney, NSW 2006, Australia; [Sandwell, David T.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Maus, Stefan] Univ Colorado, CIRES, Boulder, CO 80309 USA	University of Sydney; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Colorado System; University of Colorado Boulder	Muller, RD (corresponding author), Univ Sydney, EarthByte Grp, Sch Geosci, Sydney, NSW 2006, Australia.	dietmar.muller@sydney.edu.au	Seton, Maria/H-8272-2013; Müller, Dietmar/L-1200-2019; Flament, Nicolas/N-8344-2013; Flament, Nicolas/I-5904-2019	Seton, Maria/0000-0001-8541-1367; Müller, Dietmar/0000-0002-3334-5764; Flament, Nicolas/0000-0002-3237-0757; Flament, Nicolas/0000-0002-3237-0757; Sandwell, David/0000-0001-5657-8707; Williams, Simon/0000-0003-4670-8883	AuScope National Collaborative Research Infrastructure; Big Data Knowledge Discovery project (SIEF project) [RP 04-174]; Australian Research Council [FT130101564, FL0992245]; Science Industry Endowment Fund [RP 04-174]; ARC Laureate Fellowship [FL0992245]; Nectar Cloud; Australian National Data Service (ANDS)	AuScope National Collaborative Research Infrastructure(Australian GovernmentDepartment of Industry, Innovation and Science); Big Data Knowledge Discovery project (SIEF project); Australian Research Council(Australian Research Council); Science Industry Endowment Fund; ARC Laureate Fellowship(Australian Research Council); Nectar Cloud; Australian National Data Service (ANDS)	This project was supported by the AuScope National Collaborative Research Infrastructure and a Big Data Knowledge Discovery project (SIEF project RP 04-174), Australian Research Council grant FT130101564 (MS), Australian Research Council grant FL0992245 (RDM), Science Industry Endowment Fund grant RP 04-174 RDM, and an ARC Laureate Fellowship (FL0992245) and the Auscope National Collaborative Research Infrastructure. The authors also acknowledge support by the Nectar Cloud and the Australian National Data Service (ANDS).	Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; Bel DG, 2007, AER C 2007 IEEE; Berger W.H., 1974, GEOLOGY CONTINENTAL, P213, DOI DOI 10.1007/978-3-662-01141-6_16; Bower DJ, 2015, PHYS EARTH PLANET IN, V238, P8, DOI 10.1016/j.pepi.2014.10.013; Cannon J, 2014, SOLID EARTH, V5, P741, DOI 10.5194/se-5-741-2014; Dutkiewicz A, 2015, GEOLOGY, V43, P795, DOI 10.1130/G36883.1; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Flament N, 2015, EARTH PLANET SC LETT, V430, P9, DOI 10.1016/j.epsl.2015.08.006; Flament N, 2014, EARTH PLANET SC LETT, V387, P107, DOI 10.1016/j.epsl.2013.11.017; Flament N, 2013, LITHOSPHERE-US, V5, P189, DOI 10.1130/L245.1; Holovaty A., 2009, DEFINITIVE GUIDE DJA; Maus S, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002471; Maus S, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001949; Moucha R, 2011, NAT GEOSCI, V4, P707, DOI [10.1038/ngeo1235, 10.1038/NGEO1235]; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Munshi A, 2008, OPENGL ES 2 0 PROGRA; Obe R., 2011, POSTGIS IN ACTION; Olson C.J., 2014, P AGU FALL M 2014 SA; Palankar M.R., 2008, BOOK AMAZON S3 SCI G, P5564; Pavlis NK, 2008, EGU GEN ASSEM, V10, P13; PILGRIM M., 2010, HTML5 UP AND RUNNING; Prandi F, 2015, INT ARCH PHOTOGRAMM, V40-3, P601, DOI 10.5194/isprsarchives-XL-3-W3-601-2015; Sandwell DT, 2014, SCIENCE, V346, P65, DOI 10.1126/science.1258213; Scrutton R. A., 1982, Dynamics of passive margins, P5, DOI 10.1029/GD006p0005; Seton M, 2012, EARTH-SCI REV, V113, P212, DOI 10.1016/j.earscirev.2012.03.002; Seton M, 2014, GEOCHEM GEOPHY GEOSY, V15, P1629, DOI 10.1002/2013GC005176; SHARPTON VL, 1993, SCIENCE, V261, P1564, DOI 10.1126/science.261.5128.1564; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Wegener A., 1924, ORIGIN CONTINENTS OC; Wessel Paul, 2013, Eos, Transactions American Geophysical Union, V94, P409, DOI 10.1002/2013EO450001; Williams S.E., 2012, GSA TODAY, V22, P4, DOI [10.1130/GSATG139A.1, DOI 10.1130/GSATG139A.1, 10.1016/j.earscirev.2012.03.002]; Yu L, 2012, INT J REMOTE SENS, V33, P3966, DOI 10.1080/01431161.2011.636081	33	29	31	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150883	10.1371/journal.pone.0150883	http://dx.doi.org/10.1371/journal.pone.0150883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960151	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300084
J	Turgeman, T; Shatil-Cohen, A; Moshelion, M; Teper-Bamnolker, P; Skory, CD; Lichter, A; Eshel, D				Turgeman, Tidhar; Shatil-Cohen, Arava; Moshelion, Menachem; Teper-Bamnolker, Paula; Skory, Christopher D.; Lichter, Amnon; Eshel, Dani			The Role of Aquaporins in pH-Dependent Germination of Rhizopus delemar Spores	PLOS ONE			English	Article							PLASMA-MEMBRANE AQUAPORINS; CONIDIAL GERMINATION; WATER PERMEABILITY; GENE-EXPRESSION; ASPERGILLUS-OCHRACEUS; QUANTITATIVE PCR; HIGHLY DIVERGENT; MOLECULAR-BASIS; PIP AQUAPORINS; DROUGHT STRESS	Rhizopus delemar and associated species attack a wide range of fruit and vegetables after harvest. Host nutrients and acidic pH are required for optimal germination of R. delemar, and we studied how this process is triggered. Glucose induced spore swelling in an acidic environment, expressed by an up to 3-fold increase in spore diameter, whereas spore diameter was smaller in a neutral environment. When suspended in an acidic environment, the spores started to float, indicating a change in their density. Treatment of the spores with HgCl2, an aquaporin blocker, prevented floating and inhibited spore swelling and germ-tube emergence, indicating the importance of water uptake at the early stages of germination. Two putative candidate aquaporin-encoding genes-RdAQP1 and RdAQP2-were identified in the R. delemar genome. Both presented the conserved NPA motif and six-transmembrane domain topology. Expressing RdAQP1 and RdAQP2 in Arabidopsis protoplasts increased the cells' osmotic water permeability coefficient (Pf) compared to controls, indicating their role as water channels. A decrease in R. delemar aquaporin activity with increasing external pH suggested pH regulation of these proteins. Substitution of two histidine (His) residues, positioned on two loops facing the outer side of the cell, with alanine eliminated the pH sensing resulting in similar Pf values under acidic and basic conditions. Since hydration is critical for spore switching from the resting to activate state, we suggest that pH regulation of the aquaporins can regulate the initial phase of R. delemar spore germination, followed by germ-tube elongation and host-tissue infection.	[Turgeman, Tidhar; Teper-Bamnolker, Paula; Lichter, Amnon; Eshel, Dani] Agr Res Org, Volcani Ctr, Dept Postharvest Sci Fresh Produce, IL-50250 Bet Dagan, Israel; [Turgeman, Tidhar; Shatil-Cohen, Arava; Moshelion, Menachem] Hebrew Univ Jerusalem, Dept Plant Sci & Genet Agr, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Skory, Christopher D.] NTL Ctr Agr Utilizat Res, Renewable Prod Technol Res Unit, Peoria, IL USA	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem	Eshel, D (corresponding author), Agr Res Org, Volcani Ctr, Dept Postharvest Sci Fresh Produce, IL-50250 Bet Dagan, Israel.	dani@agri.gov.il	Eshel, Dani/AAH-8174-2020		Chief Scientist, Ministry of Agriculture, Israel Grant [430-0421-12]; Israel Science Foundation [1131/12]; ARS [ARS-0427981] Funding Source: Federal RePORTER	Chief Scientist, Ministry of Agriculture, Israel Grant; Israel Science Foundation(Israel Science Foundation); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by Chief Scientist, Ministry of Agriculture, Israel Grant 430-0421-12 to D.E., http://agriscience.co.il/, and Israel Science Foundation Grant 1131/12 to M.M., http://www.isf.org.il/.	Amiri A, 2011, J PLANT PATHOL, V93, P603; Aroca R, 2007, NEW PHYTOL, V173, P808, DOI 10.1111/j.1469-8137.2006.01961.x; Aroca R, 2009, MOL PLANT MICROBE IN, V22, P1169, DOI 10.1094/MPMI-22-9-1169; Arocho A, 2006, DIAGN MOL PATHOL, V15, P56, DOI 10.1097/00019606-200603000-00009; Barad S, 2014, MOL PLANT MICROBE IN, V27, P66, DOI 10.1094/MPMI-05-13-0138-R; BARER R., 1958, JOUR APPL BACT, V21, P146, DOI 10.1111/j.1365-2672.1958.tb00129.x; Barnita Ghosh, 2011, Journal of Applied Sciences, V11, P2470, DOI 10.3923/jas.2011.2470.2486; Bignell E, 2012, ADV APPL MICROBIOL, V79, P1, DOI 10.1016/B978-0-12-394318-7.00001-2; Carlile M, 1994, FUNGI, P153; Chaky J, 2001, PHYTOPATHOLOGY, V91, P558, DOI 10.1094/PHYTO.2001.91.6.558; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; COOK R H, 1983, National Research Council Canada Associate Committee on Scientific Criteria for Environmental Quality Publication, P1; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; DELP CJ, 1954, PHYTOPATHOLOGY, V44, P615; dEnfert C, 1997, FUNGAL GENET BIOL, V21, P163, DOI 10.1006/fgbi.1997.0975; Dietz S, 2011, NEW PHYTOL, V190, P927, DOI 10.1111/j.1469-8137.2011.03651.x; Doehlemann G, 2005, FUNGAL GENET BIOL, V42, P601, DOI 10.1016/j.fgb.2005.03.001; EKUNDAYO JA, 1964, J GEN MICROBIOL, V35, P261, DOI 10.1099/00221287-35-2-261; EKUNDAYO JA, 1966, J GEN MICROBIOL, V42, P283, DOI 10.1099/00221287-42-2-283; Engel A, 2000, EMBO J, V19, P800, DOI 10.1093/emboj/19.5.800; Estrada AB, 2000, PLANT PATHOL, V49, P608, DOI 10.1046/j.1365-3059.2000.00492.x; Feofilova EP, 2012, APPL BIOCHEM MICRO+, V48, P1, DOI 10.1134/S0003683812010048; Fischer M, 2008, J BIOL CHEM, V283, P33889, DOI 10.1074/jbc.M803865200; Gerbeau P, 2002, PLANT J, V30, P71, DOI 10.1046/j.1365-313X.2002.01268.x; Gock MA, 2003, INT J FOOD MICROBIOL, V81, P11, DOI 10.1016/S0168-1605(02)00166-6; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; GOTTLIEB D, 1968, MYCOLOGIA, V60, P571, DOI 10.2307/3757424; Griffin D, 1994, SPORE DORMANCY GERMI, P375; HASHIMOTO T, 1972, J BACTERIOL, V112, P967, DOI 10.1128/JB.112.2.967-976.1972; Hill AE, 2004, J MEMBRANE BIOL, V197, P1, DOI 10.1007/s00232-003-0639-6; Holmes GJ, 2002, PLANT DIS, V86, P345, DOI 10.1094/PDIS.2002.86.4.345; Ibrahim AS, 2010, MOL MICROBIOL, V77, P587, DOI 10.1111/j.1365-2958.2010.07234.x; Ishida Y, 2012, J CHEM ECOL, V38, P1057, DOI 10.1007/s10886-012-0157-z; JACKSON AM, 1991, WORLD J MICROB BIOT, V7, P494, DOI 10.1007/BF00303376; Janisiewicz WJ, 2002, ANNU REV PHYTOPATHOL, V40, P411, DOI 10.1146/annurev.phyto.40.120401.130158; Kaldenhoff R, 2007, METHOD ENZYMOL, V428, P505, DOI 10.1016/S0076-6879(07)28028-0; Katsuhara M, 2008, PFLUG ARCH EUR J PHY, V456, P687, DOI 10.1007/s00424-007-0434-9; Kope HH, 2008, BIOCONTROL, V53, P489, DOI 10.1007/s10526-007-9087-z; Kruse E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-206; Li BQ, 2010, J PROTEOME RES, V9, P298, DOI 10.1021/pr900622j; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locatelli F, 2003, PLANT CELL REP, V21, P865, DOI 10.1007/s00299-003-0593-x; LopezMalo A, 1997, FOOD MICROBIOL, V14, P117, DOI 10.1006/fmic.1996.0078; MAGAN N, 1984, T BRIT MYCOL SOC, V82, P71, DOI 10.1016/S0007-1536(84)80213-2; Manteau S, 2003, FEMS MICROBIOL ECOL, V43, P359, DOI 10.1111/j.1574-6941.2003.tb01076.x; MARCHANT R, 1966, J GEN MICROBIOL, V42, P237, DOI 10.1099/00221287-42-2-237; Maurel C, 1997, ANNU REV PLANT PHYS, V48, P399, DOI 10.1146/annurev.arplant.48.1.399; Maurel C, 2011, NEW PHYTOL, V190, P815, DOI 10.1111/j.1469-8137.2011.03731.x; Mayzlish-Gati E, 2010, J EXP BOT, V61, P3129, DOI 10.1093/jxb/erq138; McQuilken MP, 1997, MYCOL RES, V101, P11, DOI 10.1017/S0953756296002018; MEDWID RD, 1984, APPL ENVIRON MICROB, V48, P1067, DOI 10.1128/AEM.48.6.1067-1071.1984; Moshelion M, 2002, PLANT CELL, V14, P727, DOI 10.1105/tpc.010351; Moshelion M, 2004, PLANT PHYSIOL, V135, P2301, DOI 10.1104/pp.104.043000; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nehls U, 2014, APPL MICROBIOL BIOT, V98, P8835, DOI 10.1007/s00253-014-6049-0; Nemeth-Cahalan KL, 2004, J GEN PHYSIOL, V123, P573, DOI 10.1085/jgp.200308990; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; Ohrui T, 2007, PLANTA, V227, P47, DOI 10.1007/s00425-007-0593-0; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Pardo E, 2005, J SCI FOOD AGR, V85, P1681, DOI 10.1002/jsfa.2171; PASS T, 1972, CAN J MICROBIOL, V18, P1453, DOI 10.1139/m72-223; PELSER PDT, 1977, PHYTOPATHOLOGY, V67, P747; Pettersson N, 2005, BIOL CELL, V97, P487, DOI 10.1042/BC20040144; Porcel R, 2006, PLANT MOL BIOL, V60, P389, DOI 10.1007/s11103-005-4210-y; Pou A, 2013, PLANT CELL ENVIRON, V36, P828, DOI 10.1111/pce.12019; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Sautour M, 2001, J APPL MICROBIOL, V91, P900, DOI 10.1046/j.1365-2672.2001.01449.x; Schmidt P, 2008, PROTEOMICS, V8, P534, DOI 10.1002/pmic.200700845; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shatil-Cohen A, 2014, JOVE-J VIS EXP, V92; Shatil-Cohen A, 2011, PLANT J, V67, P72, DOI 10.1111/j.1365-313X.2011.04576.x; Sidoux-Walter F, 2004, P NATL ACAD SCI USA, V101, P17422, DOI 10.1073/pnas.0404337101; Tanghe A, 2006, TRENDS MICROBIOL, V14, P78, DOI 10.1016/j.tim.2005.12.001; Tanghe A, 2002, APPL ENVIRON MICROB, V68, P5981, DOI 10.1128/AEM.68.12.5981-5989.2002; Thanh NV, 2005, J APPL MICROBIOL, V99, P1204, DOI 10.1111/j.1365-2672.2005.02692.x; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Turgeman T, 2014, PHYTOPATHOLOGY, V104, P240, DOI 10.1094/PHYTO-08-13-0245-R; Volkov V, 2007, J EXP BOT, V58, P377, DOI 10.1093/jxb/erl203; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Wang XP, 2014, CARBON, V68, P798, DOI 10.1016/j.carbon.2013.11.072; WEBER D, 1962, PHYTOPATHOLOGY, V52, P756; WEBER DJ, 1965, PHYTOPATHOLOGY, V55, P262; Will JL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000893; Wu B, 2007, CELL MOL LIFE SCI, V64, P2413, DOI 10.1007/s00018-007-7163-2; Xu H, 2013, BOTANY, V91, P495, DOI 10.1139/cjb-2013-0041; YARWOOD CE, 1950, AM J BOT, V37, P636, DOI 10.2307/2437874; Zheng RY, 2007, SYDOWIA, V59, P273	89	16	16	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150543	10.1371/journal.pone.0150543	http://dx.doi.org/10.1371/journal.pone.0150543			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959825	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300055
J	Baggio, JAO; Mazin, SSC; Alessio-Alves, FF; Barros, CGC; Carneiro, AAO; Leite, JP; Pontes-Neto, OM; Santos-Pontelli, TEG				Baggio, Jussara A. O.; Mazin, Suleimy S. C.; Alessio-Alves, Frederico F.; Barros, Camila G. C.; Carneiro, Antonio A. O.; Leite, Joao P.; Pontes-Neto, Octavio M.; Santos-Pontelli, Taiza E. G.			Verticality Perceptions Associate with Postural Control and Functionality in Stroke Patients	PLOS ONE			English	Article							PRESSURE MEASURES; BALANCE RECOVERY; RELIABILITY; SCALE; INDIVIDUALS; DISORDERS; DISEASE; NEGLECT; HUMANS; SYSTEM	Deficits of postural control and perceptions of verticality are disabling problems observed in stroke patients that have been recently correlated to each other. However, there is no evidence in the literature confirming this relationship with quantitative posturography analysis. Therefore, the objectives of the present study were to analyze the relationship between Subjective Postural Vertical (SPV) and Haptic Vertical (HV) with posturography and functionality in stroke patients. We included 45 stroke patients. The study protocol was composed by clinical interview, evaluation of SPV and HV in roll and pitch planes and posturography. Posturography was measured in the sitting and standing positions under the conditions: eyes open, stable surface (EOSS); eyes closed, stable surface (ECSS); eyes open, unstable surface (EOUS); and eyes closed, unstable surface (ECUS). The median PV in roll plane was 0.34 degrees (-1.44 degrees to 2.54 degrees) and in pitch plane 0.36 degrees (-2.72 degrees to 2.45 degrees). The median of HV in roll and pitch planes were -0.94 degrees (-5.86 degrees to 3.84 degrees) and 3.56 degrees (-0.68 degrees to 8.36 degrees), respectively. SPV in the roll plane was correlated with all posturagraphy parameters in sitting position in all conditions (r = 0.35 to 0.47; p < 0.006). There were moderate correlations with the verticality perceptions and all the functional scales. Linear regression model showed association between speed and SPV in the roll plane in the condition EOSS (R2 of 0.37; p = 0.005), in the condition ECSS (R2 of 0.13; p = 0.04) and in the condition EOUS (R2 of 0.22; p = 0.03). These results suggest that verticality perception is a relevant component of postural control and should be systematically evaluated, particularly in patients with abnormal postural control.	[Baggio, Jussara A. O.; Mazin, Suleimy S. C.; Alessio-Alves, Frederico F.; Leite, Joao P.; Pontes-Neto, Octavio M.; Santos-Pontelli, Taiza E. G.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Neurosci & Behav Sci, BR-14049 Ribeirao Preto, SP, Brazil; [Barros, Camila G. C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Ophthalmol Otorhinolaryngol & Head & Neck Su, BR-14049 Ribeirao Preto, SP, Brazil; [Carneiro, Antonio A. O.] Univ Sao Paulo, Dept Math & Phys, Ribeirao Preto Sch Philosophy Sci & Letters, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Santos-Pontelli, TEG (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Neurosci & Behav Sci, BR-14049 Ribeirao Preto, SP, Brazil.	taiza@fmrp.usp.br	Leite, Joao/B-9070-2012; de Oliveira Baggio, Jussara Almeida/H-7251-2012; Carneiro, Antonio Adilton O./F-3557-2012; Baggio, Jussara Almeida de Oliveira/AGK-7651-2022; Edwards, Taiza GS/F-9214-2012; Pontes-Neto, Octavio Marques/G-4294-2012	Leite, Joao/0000-0003-0558-3519; de Oliveira Baggio, Jussara Almeida/0000-0003-2508-1364; Carneiro, Antonio Adilton O./0000-0002-1752-7170; Edwards, Taiza GS/0000-0003-3033-2981; Pontes-Neto, Octavio Marques/0000-0003-0317-843X; De Giacomo Carneiro, Camila/0000-0003-3101-335X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) TEGSP and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) JAOB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babyar SR, 2014, NEUROREHAB NEURAL RE, V8, P1; Barbieri G, 2008, EXP BRAIN RES, V185, P545, DOI 10.1007/s00221-007-1177-8; Barbieri G, 2010, AGE, V32, P51, DOI 10.1007/s11357-009-9112-5; Barra J, 2009, NEUROLOGY, V72, P1582, DOI 10.1212/WNL.0b013e3181a4123a; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; Bisdorff AR, 1996, BRAIN, V119, P1523, DOI 10.1093/brain/119.5.1523; Bonan IV, 2007, J NEUROL NEUROSUR PS, V78, P49, DOI 10.1136/jnnp.2006.087791; BROTT T, 1989, STROKE, V20, P694, DOI 10.1161/01.STR.20.5.694; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Cincura C, 2009, CEREBROVASC DIS, V27, P119, DOI 10.1159/000177918; Ferreira AD, 2014, J BIOMECH, V47, P2919, DOI 10.1016/j.jbiomech.2014.07.010; Fujimoto H, 2014, NEUROIMAGE, V85, P547, DOI 10.1016/j.neuroimage.2013.05.014; Funk J, 2011, NEUROSCIENCE, V173, P124, DOI 10.1016/j.neuroscience.2010.10.067; Funk J, 2010, NEUROPSYCHOLOGIA, V48, P298, DOI 10.1016/j.neuropsychologia.2009.09.018; Genthon N, 2008, STROKE, V39, P1793, DOI 10.1161/STROKEAHA.107.497701; Gray VL, 2014, GAIT POSTURE, V40, P198, DOI 10.1016/j.gaitpost.2014.03.191; Hashimoto K, 2007, NEUROREHAB NEURAL RE, V21, P353, DOI 10.1177/1545968306297870; Israel I, 2012, J VESTIBUL RES-EQUIL, V22, P173, DOI 10.3233/VES-2012-0450; Karim HT, 2014, BRAIN RES, V1555, P20, DOI 10.1016/j.brainres.2014.01.033; Karnath HO, 2007, NEUROREHAB NEURAL RE, V21, P370, DOI 10.1177/1545968307300702; Karnath HO, 2000, NEUROLOGY, V55, P1298, DOI 10.1212/WNL.55.9.1298; Lai SM, 1998, STROKE, V29, P1838, DOI 10.1161/01.STR.29.9.1838; MAHONEY F I, 1965, Md State Med J, V14, P61; Manckoundia P, 2007, CLIN NEUROPHYSIOL, V118, P786, DOI 10.1016/j.clinph.2006.11.274; Mansfield A, 2013, GAIT POSTURE, V38, P428, DOI 10.1016/j.gaitpost.2013.01.005; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; Moghadam M, 2011, GAIT POSTURE, V33, P651, DOI 10.1016/j.gaitpost.2011.02.016; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveira CB, 2011, CLINICS, V66, P2043, DOI 10.1590/S1807-59322011001200008; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Perennou D, 2006, RESTOR NEUROL NEUROS, V24, P319; Riberto M, 2004, ACTA FISIATRICA, V11, P3; Rocchi L, 2006, NEUROSCI LETT, V394, P140, DOI 10.1016/j.neulet.2005.10.020; Rohrmeier C, 2013, OTOL NEUROTOL, V34, P297, DOI 10.1097/MAO.0b013e31827d0901; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Saeys W, 2012, DISABIL REHABIL, V34, P1965, DOI 10.3109/09638288.2012.671883; Schmid AA, 2013, TOP STROKE REHABIL, V20, P340, DOI 10.1310/tsr2004-340; Utz KS, 2011, NEUROSCIENCE, V188, P68, DOI 10.1016/j.neuroscience.2011.04.068	38	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150754	10.1371/journal.pone.0150754	http://dx.doi.org/10.1371/journal.pone.0150754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954679	Green Published, gold			2022-12-27	WOS:000371991300046
J	Li, J; Jia, ZQ; Kong, J; Zhang, FY; Fang, SM; Li, XJ; Li, WW; Yang, XS; Luo, Y; Lin, BC; Liu, TJ				Li, Jiao; Jia, Zhuqiang; Kong, Jing; Zhang, Fuyin; Fang, Shimeng; Li, Xiaojie; Li, Wuwei; Yang, Xuesong; Luo, Yong; Lin, Bingcheng; Liu, Tingjiao			Carcinoma-Associated Fibroblasts Lead the Invasion of Salivary Gland Adenoid Cystic Carcinoma Cells by Creating an Invasive Track	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; TUMOR MICROENVIRONMENT; BREAST-CANCER; LUNG-CANCER; GROWTH; PROGRESSION; EXPRESSION; METASTASIS; MATRIX; STROMA	Carcinoma-associated fibroblasts (CAFs) are critical in determining tumor invasion and metastasis. However the role of CAFs in the invasion of salivary gland adenoid cystic carcinoma (ACC) is poorly understood. In this study, we isolated primary CAFs from two ACC patients. ACC-derived CAFs expressed typical CAF biomarkers and showed increased migration and invasion activity. Conditioned medium collected from CAFs significantly promoted ACC cell migration and invasion. Co-culture of CAFs with ACC cells in a microfluidic device further revealed that CAFs localized at the invasion front and ACC cells followed the track behind the CAFs. Interfering of both matrix metalloproteinase and CXCL12/CXCR4 pathway inhibited ACC invasion promoted by CAFs. Overall, our study demonstrates that ACC-derived CAFs exhibit the most important defining feature of CAFs by promoting cancer invasion. In addition to secretion of soluble factors, CAFs also lead ACC invasion by creating an invasive track in the ECM.	[Li, Jiao; Kong, Jing; Fang, Shimeng; Li, Xiaojie; Li, Wuwei; Liu, Tingjiao] Dalian Med Univ, Coll Stomatol, Dalian, Peoples R China; [Jia, Zhuqiang] Dalian Med Univ, Affiliated Hosp 1, Dept Oral Surg, Dalian, Peoples R China; [Zhang, Fuyin] Dalian Med Univ, Affiliated Hosp 2, Dept Oral Surg, Dalian, Peoples R China; [Yang, Xuesong] Dalian Med Univ, Dept Biochem & Mol Biol, Dalian, Peoples R China; [Luo, Yong; Lin, Bingcheng] Dalian Univ Technol, Fac Chem Environm & Biol Sci & Technol, Dalian, Peoples R China; [Lin, Bingcheng] Chinese Acad Sci, Dalian Inst Chem Phys, Dept Biotechnol, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian University of Technology; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Liu, TJ (corresponding author), Dalian Med Univ, Coll Stomatol, Dalian, Peoples R China.	tingjiao@dlmedu.edu.cn			National Natural Science Foundation of China [81171425]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81171425). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Natural Science Foundation of China (No. 81171425)	Augsten M, 2009, P NATL ACAD SCI USA, V106, P3414, DOI 10.1073/pnas.0813144106; Cabezon T, 2007, INT J CANCER, V121, P1433, DOI 10.1002/ijc.22850; Cortez E, 2014, SEMIN CANCER BIOL, V25, P3, DOI 10.1016/j.semcancer.2013.12.010; De Herdt MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P2516, DOI 10.2741/2863; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; DeAngelis AF, 2011, INT J ORAL MAX SURG, V40, P710, DOI 10.1016/j.ijom.2011.02.010; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gao M, 2013, INT J ORAL MAX SURG, V42, P923, DOI 10.1016/j.ijom.2013.04.006; Guan HJ, 2015, HISTOPATHOLOGY, V66, P781, DOI 10.1111/his.12519; Jung DW, 2010, INT J CANCER, V127, P332, DOI 10.1002/ijc.25060; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Liu H, 2015, ONCOTARGET, V6, P11477, DOI 10.18632/oncotarget.3411; Liu TJ, 2010, LAB CHIP, V10, P1671, DOI 10.1039/c000022a; Liu TJ, 2009, ELECTROPHORESIS, V30, P4285, DOI 10.1002/elps.200900289; Luo HJ, 2015, CANCER LETT, V361, P155, DOI 10.1016/j.canlet.2015.02.018; Lyons JG, 2008, CLIN EXP METASTAS, V25, P665, DOI 10.1007/s10585-007-9134-2; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olaso E, 2003, HEPATOLOGY, V37, P674, DOI 10.1053/jhep.2003.50068; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paulsson J, 2014, SEMIN CANCER BIOL, V25, P61, DOI 10.1016/j.semcancer.2014.02.006; Pena C, 2013, CANCER RES, V73, P1287, DOI 10.1158/0008-5472.CAN-12-1875; Saito RA, 2010, CANCER RES, V70, P2644, DOI 10.1158/0008-5472.CAN-09-3644; Shekhar MPV, 2003, BREAST CANCER RES, V5, P130, DOI 10.1186/bcr580; Taniwaki K, 2007, CANCER RES, V67, P4311, DOI 10.1158/0008-5472.CAN-06-4761; Wald O, 2011, J THORAC CARDIOV SUR, V141, P1503, DOI 10.1016/j.jtcvs.2010.11.056; Wang JH, 2010, CANCER RES, V70, P471, DOI 10.1158/0008-5472.CAN-09-2863; Wen SM, 2015, INT J ONCOL, V47, P719, DOI 10.3892/ijo.2015.3060; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Xu R, 2011, INTEGR BIOL-UK, V3, P368, DOI 10.1039/c0ib00087f	32	35	35	9	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150247	10.1371/journal.pone.0150247	http://dx.doi.org/10.1371/journal.pone.0150247			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954362	gold, Green Submitted, Green Published			2022-12-27	WOS:000371991300018
J	Abad, R; Medina, V; Stella, M; Boccadifuoco, G; Comanducci, M; Bambini, S; Muzzi, A; Vazquez, JA				Abad, Raquel; Medina, Veronica; Stella, Maria; Boccadifuoco, Giuseppe; Comanducci, Maurizio; Bambini, Stefania; Muzzi, Alessandro; Vazquez, Julio A.			Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries	PLOS ONE			English	Article							SEROGROUP-B; NEISSERIA-MENINGITIDIS; QUANTITATIVE ASSESSMENT; PROTEIN; DISEASE; IMMUNOGENICITY; DIVERSITY; ANTIGENS; EFFICACY; ANTIBODY	Background A novel meningococcal multicomponent vaccine, 4CMenB (Bexsero (R)), has been approved in Europe, Canada, Australia and US. The potential impact of 4CMenB on strain coverage is being estimated by using Meningococcal Antigen Typing System (MATS), an ELISA assay which measures vaccine antigen expression and diversity in each strain. Here we show the genetic characterization and the 4CMenB potential coverage of Spanish invasive strains (collected during one epidemiological year) compared to other European countries and discuss the potential reasons for the lower estimate of coverage in Spain. Material and Methods A panel of 300 strains, a representative sample of all serogroup B Neisseria meningitidis notified cases in Spain from 2009 to 2010, was characterized by multilocus sequence typing (MLST) and FetA variable region determination. 4CMenB vaccine antigens, PorA, factor H binding protein (fHbp), Neisseria Heparin Binding Antigen (NHBA) and Neisserial adhesin A (NadA) were molecularly typed by sequencing. PorA coverage was assigned to strain with VR2 = 4. The levels of expression and cross-reactivity of fHbp, NHBA and NadA were analyzed using MATS ELISA. Findings Global estimated strain coverage by MATS was 68.67% (95% CI: 47.77-84.59%), with 51.33%, 15.33% and 2% of strains covered by one, two and three vaccine antigens, respectively. The predicted strain coverage by individual antigens was: 42% NHBA, 36.33% fHbp, 8.33% PorA and 1.33% NadA. Coverage within the most prevalent clonal complexes (cc) was 70.37% for cc 269, 30.19% for cc 213 and 95.83% for cc 32. Conclusions Clonal complexes (cc) distribution accounts for variations in strain coverage, so that country-by-country investigations of strain coverage and cc prevalence are important. Because the cc distribution could also vary over time, which in turn could lead to changes in strain coverage, continuous detailed surveillance and monitoring of vaccine antigens expression is needed in those countries where the multicomponent vaccine is introduced. This is really important in countries like Spain where most of the strains are predicted to be covered by only one vaccine antigen and the chance for escape mutants to emerge with vaccine use is higher. Based on the observed data, cc213 should receive special attention as it is associated with low predicted strain coverage, and has recently emerged in Spain.	[Abad, Raquel; Medina, Veronica; Vazquez, Julio A.] Inst Salud Carlos III, Natl Ctr Microbiol, Reference Lab Meningococci, Madrid, Spain; [Stella, Maria; Boccadifuoco, Giuseppe; Comanducci, Maurizio; Bambini, Stefania; Muzzi, Alessandro] Novartis Vaccines & Diagnost, Siena, Italy	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Novartis	Abad, R (corresponding author), Inst Salud Carlos III, Natl Ctr Microbiol, Reference Lab Meningococci, Madrid, Spain.	rabad@isciii.es	Abad, Raquel/L-7595-2015	Abad, Raquel/0000-0002-8339-0950; Vazquez, Julio A/0000-0003-3326-8831	Novartis Vaccines Diagnostics	Novartis Vaccines Diagnostics	This work was partially supported by Novartis Vaccines & Diagnostics.	Abad R, 2015, CLIN VACCINE IMMUNOL, V22, P357, DOI 10.1128/CVI.00669-14; Abad R, 2011, P083 11 EMGM M; Alcala B, 2004, J MED MICROBIOL, V53, P515, DOI 10.1099/jmm.0.05517-0; [Anonymous], 2012, ACT BACT COR SURV RE; Bambini S, 2014, CLIN VACCINE IMMUNOL, V21, P966, DOI 10.1128/CVI.00825-13; Bettinger JA, 2013, VACCINE, V32, P124, DOI 10.1016/j.vaccine.2013.03.063; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; Borrow R, 2013, VACCINE, V31, P4477, DOI 10.1016/j.vaccine.2013.07.083; BOSLEGO J, 1995, VACCINE, V13, P821, DOI 10.1016/0264-410X(94)00037-N; Caron F, 2011, LANCET INFECT DIS, V11, P455, DOI 10.1016/S1473-3099(11)70027-5; DEMORAES JC, 1992, LANCET, V340, P1074; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; European Centre for Disease Prevention and Control, 2011, SURV INV BACT DIS EU; Fagnocchi L, 2013, INFECT IMMUN, V81, P560, DOI 10.1128/IAI.01085-12; FINNE J, 1987, J IMMUNOL, V138, P4402; Frosi G, 2013, VACCINE, V31, P4968, DOI 10.1016/j.vaccine.2013.08.006; Galloway Y, 2009, INT J EPIDEMIOL, V38, P413, DOI 10.1093/ije/dyn228; Garrido M, 2014, ENFERMEDAD MENINGOCO; Granoff DM, 2010, CLIN INFECT DIS, V50, pS54, DOI 10.1086/648966; Hoiseth SK, 2013, PEDIATR INFECT DIS J, V32, P1096, DOI 10.1097/INF.0b013e31829aa63b; Krizova P, 2014, EPIDEMIOL MIKROBI IM, V63, P103; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Plikaytis BD, 2012, CLIN VACCINE IMMUNOL, V19, P1609, DOI 10.1128/CVI.00202-12; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Sadarangani M, 2010, LANCET INFECT DIS, V10, P112, DOI 10.1016/S1473-3099(09)70324-X; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Tappero JW, 1999, JAMA-J AM MED ASSOC, V281, P1520, DOI 10.1001/jama.281.16.1520; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Tozer SJ, 2013, 27 ICP AUG 24 29; Tzanakaki G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-111; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9	36	34	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150721	10.1371/journal.pone.0150721	http://dx.doi.org/10.1371/journal.pone.0150721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950303	Green Submitted, Green Published, gold			2022-12-27	WOS:000371990100054
J	Gaub, P; de Leon, A; Gibon, J; Soubannier, V; Dorval, G; Seguela, P; Barker, PA				Gaub, Perrine; de Leon, Andres; Gibon, Julien; Soubannier, Vincent; Dorval, Genevieve; Seguela, Philippe; Barker, Philip A.			HBpF-proBDNF: A New Tool for the Analysis of Pro-Brain Derived Neurotrophic Factor Receptor Signaling and Cell Biology	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NEURONAL APOPTOSIS; ALZHEIMERS-DISEASE; CONE RETRACTION; PRECURSOR; COMPLEX; PROTEIN; BDNF; PURIFICATION; ACTIVATION	Neurotrophins activate intracellular signaling pathways necessary for neuronal survival, growth and apoptosis. The most abundant neurotrophin in the adult brain, brain-derived neurotrophic factor (BDNF), is first synthesized as a proBDNF precursor and recent studies have demonstrated that proBDNF can be secreted and that it functions as a ligand for a receptor complex containing p75NTR and sortilin. Activation of proBDNF receptors mediates growth cone collapse, reduces synaptic activity, and facilitates developmental apoptosis of motoneurons but the precise signaling cascades have been difficult to discern. To address this, we have engineered, expressed and purified HBpF-proBDNF, an expression construct containing a 6X-HIS tag, a biotin acceptor peptide (BAP) sequence, a PreScission (TM) Protease cleavage site and a FLAG-tag attached to the N-terminal part of murine proBDNF. Intact HBpF-proBDNF has activities indistinguishable from its wild-type counterpart and can be used to purify proBDNF signaling complexes or to monitor proBDNF endocytosis and retrograde transport. HBpF-proBDNF will be useful for characterizing proBDNF signaling complexes and for deciphering the role of proBDNF in neuronal development, synapse function and neurodegenerative disease.	[Gaub, Perrine; de Leon, Andres; Gibon, Julien; Soubannier, Vincent; Dorval, Genevieve; Seguela, Philippe; Barker, Philip A.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Barker, PA (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada.	phil.barker@ubc.ca		Gibon, Julien/0000-0001-7216-5806	Canadian Institutes of Health Research [37850]; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This project was supported by a grant from the Canadian Institutes of Health Research (funding reference number 37850). JG was supported by a fellowship from the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JG was supported by a fellowship from the Fonds de la Recherche en Sante du Quebec. PAB is Tier 1 Canada Research Chair in Molecular Neuroscience. This project was supported by a grant from the Canadian Institutes of Health Research (funding reference number 37850).	Anastasia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3490; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bergami M, 2008, J CELL BIOL, V183, P213, DOI 10.1083/jcb.200806137; Bierl MA, 2005, NEUROSCI LETT, V380, P133, DOI 10.1016/j.neulet.2005.01.029; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; CLARY DO, 1994, MOL BIOL CELL, V5, P549, DOI 10.1091/mbc.5.5.549; Deinhardt K, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002060; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Gibon J, 2015, J NEUROSCI, V35, P9741, DOI 10.1523/JNEUROSCI.4655-14.2015; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hasan W, 2003, J NEUROBIOL, V57, P38, DOI 10.1002/neu.10250; Hauburger A, 2007, FEBS LETT, V581, P4159, DOI 10.1016/j.febslet.2007.07.063; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 1999, DEVELOPMENT, V126, P2191; Kliemannel M, 2007, PROTEIN SCI, V16, P411, DOI 10.1110/ps.062376207; Koshimizu H, 2010, NEUROSCI LETT, V473, P229, DOI 10.1016/j.neulet.2010.02.055; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Majdan M, 1997, J NEUROSCI, V17, P6988; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Paoletti F, 2006, BIOCHEM SOC T, V34, P605, DOI 10.1042/BST0340605; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035883; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Teng KK, 2010, DEV NEUROBIOL, V70, P350, DOI 10.1002/dneu.20768; Yang F, 2009, J CELL BIOL, V185, P727, DOI 10.1083/jcb.200811147; Yang JM, 2014, CELL REP, V7, P796, DOI 10.1016/j.celrep.2014.03.040	33	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150601	10.1371/journal.pone.0150601	http://dx.doi.org/10.1371/journal.pone.0150601			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950209	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100044
J	Eyun, SI; Moriyama, H; Hoffmann, FG; Moriyama, EN				Eyun, Seong-il; Moriyama, Hideaki; Hoffmann, Federico G.; Moriyama, Etsuko N.			Molecular Evolution and Functional Divergence of Trace Amine-Associated Receptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MULTIPLE SEQUENCE ALIGNMENT; DETECTING POSITIVE SELECTION; OLFACTORY RECEPTOR; MAXIMUM-LIKELIHOOD; PHYLOGENETIC TREES; TRANSMEMBRANE TOPOLOGY; CHEMOSENSORY RECEPTORS; DNA-SEQUENCES; ACID SITES	Trace amine-associated receptors (TAARs) are a member of the G-protein-coupled receptor superfamily and are known to be expressed in olfactory sensory neurons. A limited number of molecular evolutionary studies have been done for TAARs so far. To elucidate how lineage-specific evolution contributed to their functional divergence, we examined 30 metazoan genomes. In total, 493 TAAR gene candidates (including 84 pseudogenes) were identified from 26 vertebrate genomes. TAARs were not identified from non-vertebrate genomes. An ancestral-type TAAR-like gene appeared to have emerged in lamprey. We found four therian-specific TAAR subfamilies (one eutherian-specific and three metatherian-specific) in addition to previously known nine subfamilies. Many species-specific TAAR gene duplications and losses contributed to a large variation of TAAR gene numbers among mammals, ranging from 0 in dolphin to 26 in flying fox. TAARs are classified into two groups based on binding preferences for primary or tertiary amines as well as their sequence similarities. Primary amine-detecting TAARs (TAAR1-4) have emerged earlier, generally have single-copy orthologs (very few duplication or loss), and have evolved under strong functional constraints. In contrast, tertiary amine-detecting TAARs (TAAR5-9) have emerged more recently and the majority of them experienced higher rates of gene duplications. Protein members that belong to the tertiary amine-detecting TAAR group also showed the patterns of positive selection especially in the area surrounding the ligand-binding pocket, which could have affected ligand-binding activities and specificities. Expansions of the tertiary amine-detecting TAAR gene family may have played important roles in terrestrial adaptations of therian mammals. Molecular evolution of the TAAR gene family appears to be governed by a complex, species-specific, interplay between environmental and evolutionary factors.	[Eyun, Seong-il; Moriyama, Hideaki; Moriyama, Etsuko N.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Eyun, Seong-il] Univ Nebraska, Ctr Biotechnol, Lincoln, NE 68588 USA; [Hoffmann, Federico G.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Hoffmann, Federico G.] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Moriyama, Etsuko N.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Mississippi State University; Mississippi State University; University of Nebraska System; University of Nebraska Lincoln	Moriyama, EN (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.; Moriyama, EN (corresponding author), Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA.	emoriyama2@unl.edu	Eyun, Seong-il/Q-8872-2019; Hoffmann, Federico/B-7134-2009	Eyun, Seong-il/0000-0003-4687-1066; Hoffmann, Federico/0000-0001-5056-4929	National Library of Medicine at the National Institute of Health [R01LM009219]; National Science Foundation [EPS-0903787]; NATIONAL LIBRARY OF MEDICINE [R01LM009219] Funding Source: NIH RePORTER	National Library of Medicine at the National Institute of Health; National Science Foundation(National Science Foundation (NSF)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by in part the National Library of Medicine at the National Institute of Health (grant number R01LM009219 to E.N.M.) and the National Science Foundation (EPS-0903787 to F.G.H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alioto TS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-173; Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arakawa M, 2010, PROTEIN SCI, V19, P85, DOI 10.1002/pro.285; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Branchek TA, 2003, CURR OPIN PHARMACOL, V3, P90, DOI 10.1016/S1471-4892(02)00028-0; Broadley KJ, 2010, PHARMACOL THERAPEUT, V125, P363, DOI 10.1016/j.pharmthera.2009.11.005; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Chelikani P, 2007, P NATL ACAD SCI USA, V104, P7027, DOI 10.1073/pnas.0702024104; Churcher AM, 2011, GENOME BIOL EVOL, V3, P36, DOI 10.1093/gbe/evq079; Dewan A, 2013, NATURE, V497, P486, DOI 10.1038/nature12114; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dong D, 2009, GENOME BIOL EVOL, V1, P258, DOI 10.1093/gbe/evp026; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Feng P, 2014, GENOME BIOL EVOL, V6, P1254, DOI 10.1093/gbe/evu095; Ferrero DM, 2012, ACS CHEM BIOL, V7, P1184, DOI 10.1021/cb300111e; Ferrero DM, 2011, P NATL ACAD SCI USA, V108, P11235, DOI 10.1073/pnas.1103317108; Flames N, 2011, ANNU REV NEUROSCI, V34, P153, DOI 10.1146/annurev-neuro-061010-113824; Fleischer J, 2007, CHEM SENSES, V32, P623, DOI 10.1093/chemse/bjm032; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Gloriam DE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-338; Go Y, 2008, MOL BIOL EVOL, V25, P1897, DOI 10.1093/molbev/msn135; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Grus WE, 2008, MOL BIOL EVOL, V25, P1593, DOI 10.1093/molbev/msn107; Grus WE, 2007, MOL BIOL EVOL, V24, P2153, DOI 10.1093/molbev/msm157; Hashiguchi Y, 2007, MOL BIOL EVOL, V24, P2099, DOI 10.1093/molbev/msm140; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; Heringa J, 1999, COMPUT CHEM, V23, P341, DOI 10.1016/S0097-8485(99)00012-1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hussain A, 2013, P NATL ACAD SCI USA, V110, P19579, DOI 10.1073/pnas.1318596110; Hussain A, 2009, P NATL ACAD SCI USA, V106, P4313, DOI 10.1073/pnas.0803229106; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kleinau G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027073; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Lindemann L, 2005, GENOMICS, V85, P372, DOI 10.1016/j.ygeno.2004.11.010; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; McClellan DA, 2001, MOL BIOL EVOL, V18, P917, DOI 10.1093/oxfordjournals.molbev.a003892; Mueller JC, 2008, J HERED, V99, P174, DOI 10.1093/jhered/esm113; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Niimura Y, 2005, GENE, V346, P13, DOI 10.1016/j.gene.2004.09.025; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Pitari G, 2000, FEBS LETT, V483, P149, DOI 10.1016/S0014-5793(00)02110-4; Quignon P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r83; Ringstad N, 2009, SCIENCE, V325, P96, DOI 10.1126/science.1169243; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato T, 1999, BRIT J PHARMACOL, V128, P272, DOI 10.1038/sj.bjp.0702813; Staubert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011133; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STRADER CD, 1989, J BIOL CHEM, V264, P13572; Stromberg S, 2009, J PROTEOME RES, V8, P1639, DOI 10.1021/pr800745e; Teeling EC, 2009, TRENDS ECOL EVOL, V24, P351, DOI 10.1016/j.tree.2009.02.012; Tessarolo JA, 2014, G3-GENES GENOM GENET, V4, P1135, DOI 10.1534/g3.114.010660; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vallender EJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-51; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Xia XH, 1998, J MOL EVOL, V47, P557, DOI 10.1007/PL00006412; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhao HB, 2011, MOL BIOL EVOL, V28, P7, DOI 10.1093/molbev/msq207; Zhao HB, 2010, MOL BIOL EVOL, V27, P2642, DOI 10.1093/molbev/msq152; Zhao HB, 2009, P NATL ACAD SCI USA, V106, P8980, DOI 10.1073/pnas.0813201106; Zucchi R, 2006, BRIT J PHARMACOL, V149, P967, DOI 10.1038/sj.bjp.0706948	88	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151023	10.1371/journal.pone.0151023	http://dx.doi.org/10.1371/journal.pone.0151023			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963722	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000092
J	Fischer, M; Spies-Weisshart, B; Schrenk, K; Gruhn, B; Wittig, S; Glaser, A; Hochhaus, A; Scholl, S; Schnetzke, U				Fischer, Mike; Spies-Weisshart, Baerbel; Schrenk, Karin; Gruhn, Bernd; Wittig, Susan; Glaser, Anita; Hochhaus, Andreas; Scholl, Sebastian; Schnetzke, Ulf			Polymorphisms of Dectin-1 and TLR2 Predispose to Invasive Fungal Disease in Patients with Acute Myeloid Leukemia	PLOS ONE			English	Article							BETA-GLUCAN RECEPTOR; INDUCTION; CHEMOTHERAPY; POSACONAZOLE; RECOGNITION; PROPHYLAXIS; INFECTIONS; GENE	Background Patients with acute myeloid leukemia (AML) who undergo induction chemotherapy are at high risk for invasive fungal disease (IFD). Dectin-1, a C-type lectin family member represents one of the most important pattern recognition receptors of the innate immune system and single nucleotide polymorphisms (SNPs) in the Dectin-1 gene have been associated with an increased risk of infectious complications. We sought to investigate the impact of three different Dectin-1 SNPs and one TLR2 SNP on developing IFD in 186 adult patients with newly diagnosed AML following anthracycline-based induction chemotherapy. Patients and methods Genotyping of Dectin-1 SNPs (rs16910526, rs3901533 and rs7309123) and TLR2 SNP (rs5743708) was performed by TaqMan method and pyrosequencing. IFD was defined according to the EORTC/MSG consensus guidelines. Multiple logistic regression analyses were applied to evaluate the association between the polymorphisms and the occurrence of pulmonary infections. Dectin-1 expression studies with SNP genotyped human monocytes were performed to elucidate susceptibility to IFD following chemotherapy. Results We could demonstrate that patients carrying the Dectin-1 SNP rs7309123 G/G (n = 47) or G/G and C/G (n = 133) genotype revealed a significant higher risk for developing both pneumonia in general (adjusted odds ratio (OR): 2.5; p = 0.014 and OR: 3.0, p = 0.004) and pulmonary IFD (OR: 2.6; p = 0.012 and OR: 2.4, p = 0.041, respectively). Patients carrying the TLR2 SNP rs5743708 (R753Q, GA/AA genotype, n = 12) also revealed a significantly higher susceptibility to pneumonia including IFD. Furthermore, Dectin-1 mRNA expression in human monocytes was lower following chemotherapy. Conclusion To our best knowledge, this study represents the first analysis demonstrating that harbouring polymorphisms of Dectin-1 (rs7309123) or TLR2 (rs5743708) represents an independent risk factor of developing IFD in patients with AML undergoing induction chemotherapy.	[Fischer, Mike; Spies-Weisshart, Baerbel; Schrenk, Karin; Hochhaus, Andreas; Scholl, Sebastian; Schnetzke, Ulf] Univ Klinikum Jena, Abt Hamatol & Internist Onkol, Klin Innere Med 2, Jena, Germany; [Gruhn, Bernd; Wittig, Susan] Univ Klinikum Jena, Klin Kinder & Jugendmed, Jena, Germany; [Glaser, Anita] Univ Klinikum Jena, Inst Humangenet, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Schnetzke, U (corresponding author), Univ Klinikum Jena, Abt Hamatol & Internist Onkol, Klin Innere Med 2, Jena, Germany.	ulf.schnetzke@med.uni-jena.de		Hochhaus, Andreas/0000-0003-0626-0834	'Forderprogramm Infektiologie' from Gilead (Munich, Germany)	'Forderprogramm Infektiologie' from Gilead (Munich, Germany)	This work was supported by the 'Forderprogramm Infektiologie 2013' as a grant from Gilead (Munich, Germany).	Basara N, 2009, LEUKEMIA, V23, P635, DOI 10.1038/leu.2008.352; Becker C A H, 2004, ASH ANN M 2004, V2004; Brothman AR, 2009, CYTOGENET GENOME RES, V127, P1, DOI 10.1159/000279442; Chai LYA, 2011, J INFECT DIS, V203, P736, DOI 10.1093/infdis/jiq102; Cunha C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003434; Cunha C, 2010, BLOOD, V116, P5394, DOI 10.1182/blood-2010-04-279307; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Garcia Javier Barreda, 2013, Ann Am Thorac Soc, V10, P432, DOI 10.1513/AnnalsATS.201304-097OC; Goodridge Helen S., 2008, V183, P87; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gupta A, 2010, MED ONCOL, V27, P1037, DOI 10.1007/s12032-009-9330-9; Heyl KA, 2014, MBIO, V5, DOI 10.1128/mBio.01492-14; Kang SH, 2012, J INFECT DIS, V205, P639, DOI 10.1093/infdis/jir819; Kung HC, 2014, CANCER MED-US, V3, P667, DOI 10.1002/cam4.225; Lee SO, 2011, LIVER TRANSPLANT, V17, P1081, DOI 10.1002/lt.22327; Netea MG, 2002, J INFECT DIS, V185, P1483, DOI 10.1086/340511; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Peterson L, 2013, MYCOSES, V56, P651, DOI 10.1111/myc.12086; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Sainz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032273; Schrenk KG, 2015, J CANCER RES CLIN, V141, P1661, DOI 10.1007/s00432-015-1962-x; Schroder NWJ, 2003, J MOL MED-JMM, V81, P368, DOI 10.1007/s00109-003-0443-x; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Xiong YB, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375493; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406	30	25	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150632	10.1371/journal.pone.0150632	http://dx.doi.org/10.1371/journal.pone.0150632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963509	Green Submitted, gold, Green Published			2022-12-27	WOS:000371993000046
J	Norton, DJ; Nguyen, VA; Lewis, MF; Reynolds, GO; Somers, DC; Cronin-Golomb, A				Norton, Daniel J.; Nguyen, Victoria A.; Lewis, Michaela F.; Reynolds, Gretchen O.; Somers, David C.; Cronin-Golomb, Alice			Visuospatial Attention to Single and Multiple Objects Is Independently Impaired in Parkinson's Disease	PLOS ONE			English	Article							SUPERIOR-COLLICULUS; TRACKING; PARIETAL; NEGLECT; RESOURCES	Parkinson's disease (PD) is associated with deficits in visuospatial attention. It is as yet unknown whether these attentional deficits begin at a perceptual level or instead reflect disruptions in oculomotor or higher-order processes. In the present study, non-demented individuals with PD and matched normal control adults (NC) participated in two tasks requiring sustained visuospatial attention, both based on a multiple object tracking paradigm. Eye tracking was used to ensure central fixation. In Experiment 1 (26 PD, 21 NC), a pair of identical red dots (one target, one distractor) rotated randomly for three seconds at varied speeds. The task was to maintain the identity of the sole target, which was labeled prior to each trial. PD were less accurate than NC overall (p = .049). When considering only trials where fixation was maintained, however, there was no significant group difference, suggesting that the deficit's origin is closely related to oculomotor processing. To determine whether PD had additional impairment in multifocal attention, in Experiment 2 (25 PD, 15 NC), two targets were presented along with distractors at a moderate speed, along with a control condition in which dots remained stationary. PD were less accurate than NC for moving (p = 0.02) but not stationary targets. This group difference remained significant when considering only trials where fixation was maintained, suggesting the source of the PD deficit was independent from oculomotor processing. Taken together, the results implicate separate mechanisms for single vs. multiple object tracking deficits in PD.	[Norton, Daniel J.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Norton, Daniel J.] Harvard Univ, Sch Med, Boston, MA USA; [Nguyen, Victoria A.; Reynolds, Gretchen O.; Somers, David C.; Cronin-Golomb, Alice] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA; [Lewis, Michaela F.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University; Brown University	Norton, DJ (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.; Norton, DJ (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	danieljnorton@gmail.com	Somers, David C./G-5802-2010	Somers, David C./0000-0002-4169-5895; Norton, Daniel/0000-0002-7787-3294	NINDS [F31 NS07682, RO1NS067128]; NEI [R01EY022229]; NATIONAL EYE INSTITUTE [R01EY022229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067128] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by NINDS (F31 NS07682 to DJN; RO1NS067128 to ACG) and NEI (R01EY022229 to DCS).	Alvarez GA, 2005, PSYCHOL SCI, V16, P637, DOI 10.1111/j.1467-9280.2005.01587.x; ANTONINI A, 1995, ARCH NEUROL-CHICAGO, V52, P1183, DOI 10.1001/archneur.1995.00540360061017; Beck A., 1993, BECK ANXIETY INVENTO; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bettencourt KC, 2009, J VISION, V9, DOI 10.1167/9.7.9; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Booij J, 1997, J NEUROL NEUROSUR PS, V62, P133, DOI 10.1136/jnnp.62.2.133; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Briand KA, 2001, NEUROPSYCHOLOGIA, V39, P1240, DOI 10.1016/S0028-3932(01)00045-8; Chaudhuri KR, 2011, PARKINSONISM RELAT D, V17, P717, DOI 10.1016/j.parkreldis.2011.02.018; Cronin-Golomb A, 2010, NEUROPSYCHOL REV, V20, P191, DOI 10.1007/s11065-010-9128-8; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; Ebersbach G, 1996, BRAIN, V119, P79, DOI 10.1093/brain/119.1.79; Fehd HM, 2010, J VISION, V10, DOI 10.1167/10.4.19; Franconeri SL, 2010, PSYCHOL SCI, V21, P920, DOI 10.1177/0956797610373935; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Hafed ZM, 2008, J NEUROSCI, V28, P8124, DOI 10.1523/JNEUROSCI.1317-08.2008; Harris JP, 2003, NEUROPSYCHOLOGIA, V41, P795, DOI 10.1016/S0028-3932(02)00285-3; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Holcombe AO, 2012, COGNITION, V123, P218, DOI 10.1016/j.cognition.2011.10.003; Ibarretxe-Bilbao N, 2009, MOVEMENT DISORD, V24, pS748, DOI 10.1002/mds.22670; Klepac N, 2008, EUR J NEUROL, V15, P128, DOI 10.1111/j.1468-1331.2007.02011.x; Koldewyn K, 2013, J AUTISM DEV DISORD, V43, P1394, DOI 10.1007/s10803-012-1694-6; Lee AC, 2001, NEUROPSYCHOLOGIA, V39, P1097, DOI 10.1016/S0028-3932(01)00032-X; Lee AC, 2001, VISION RES, V41, P2677, DOI 10.1016/S0042-6989(01)00129-8; McHaffie JG, 2006, NEUROSCIENCE, V138, P221, DOI 10.1016/j.neuroscience.2005.11.015; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Pereira JB, 2009, MOVEMENT DISORD, V24, P1193, DOI 10.1002/mds.22560; Possin KL, 2009, NEUROPSYCHOLOGIA, V47, P1694, DOI 10.1016/j.neuropsychologia.2009.02.006; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Redgrave P, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00132; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P698, DOI 10.1152/jn.1995.74.2.698; Sampaio J, 2011, NEUROPSYCHOLOGIA, V49, P34, DOI 10.1016/j.neuropsychologia.2010.11.002; Sekuler R, 2008, PERCEPTION, V37, P867, DOI 10.1068/p5923; Shim WM, 2010, CEREB CORTEX, V20, P1341, DOI 10.1093/cercor/bhp197; STERN Y, 1987, Neurology, V37, P179; Tinaz S, 2011, MOVEMENT DISORD, V26, P436, DOI 10.1002/mds.23453; VILLARDITA C, 1983, ARCH NEUROL-CHICAGO, V40, P737, DOI 10.1001/archneur.1983.04050110055008; Wilkinson G, 1993, WRAT 3 WIDE RANGE AC; WRIGHT MJ, 1990, NEUROPSYCHOLOGIA, V28, P151, DOI 10.1016/0028-3932(90)90097-8; Wurtz R H, 1972, Bibl Ophthalmol, V82, P149	42	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150013	10.1371/journal.pone.0150013	http://dx.doi.org/10.1371/journal.pone.0150013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963388	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000023
J	Sheikh, IA; Turki, RF; Abuzenadah, AM; Damanhouri, GA; Beg, MA				Sheikh, Ishfaq A.; Turki, Rola F.; Abuzenadah, Adel M.; Damanhouri, Ghazi A.; Beg, Mohd A.			Endocrine Disruption: Computational Perspectives on Human Sex Hormone-Binding Globulin and Phthalate Plasticizers	PLOS ONE			English	Article							REPRODUCTIVE HORMONES; BISPHENOL-A; EXPOSURE; CHEMICALS; IDENTIFICATION; DIESTERS; AFFINITY; LIGANDS; PUBERTY	Phthalates are a class of high volume production chemicals used as plasticizers for household and industrial use. Several members of this chemical family have endocrine disrupting activity. Owing to ubiquitous environmental distribution and exposure of human population at all stages of life, phthalate contamination is a continuous global public health problem. Clinical and experimental studies have indicated that several phthalates are associated with adverse effects on development and function of human and animal systems especially the reproductive system and exposures during pregnancy and early childhood are by far of utmost concern. Sex hormone-binding globulin (SHBG) is a plasma carrier protein that binds androgens and estrogens and represents a potential target for phthalate endocrine disruptor function in the body. In the present study, the binding mechanism of the nine phthalates i.e. DMP, DBP, DIBP, BBP, DNHP, DEHP, DNOP, DINP, DIDP with human SHBG was delineated by molecular docking simulation. Docking complexes of the nine phthalates displayed interactions with 15-31 amino acid residues of SHBG and a commonality of 55-95% interacting residues between natural ligand of SHBG, dihydrotestosterone, and the nine phthalate compounds was observed. The binding affinity values were more negative for long chain phthalates DEHP, DNOP, DINP, and DIDP compared to short chain phthalates such as DMP and DBP. The Dock score and Glide score values were also higher for long chain phthalates compared to short chain phthalates. Hence, overlapping of interacting amino acid residues between phthalate compounds and natural ligand, dihydrotestosterone, suggested potential disrupting activity of phthalates in the endocrine homeostasis function of SHBG, with long chain phthalates expected to be more potent than the short chain phthalates.	[Sheikh, Ishfaq A.; Damanhouri, Ghazi A.; Beg, Mohd A.] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia; [Turki, Rola F.; Abuzenadah, Adel M.] King Abdulaziz Univ, KACST Technol Innovat Ctr Personalized Med, Jeddah 21413, Saudi Arabia; [Turki, Rola F.] King Abdulaziz Univ, Fac Med, Dept Obstet & Gynecol, Jeddah 21413, Saudi Arabia	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University	Beg, MA (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia.	mabeg51@gmail.com	Beg, Mohd A/K-3366-2013; Damanhouri, Ghazi/Q-7901-2019; Sheikh, Ishfaq A/H-9611-2012	Beg, Mohd A/0000-0002-8495-4738; 	National Plan for Science, Technology and Innovation (MAARIFAH) - King Abdulaziz City for Science and Technology-the Kingdom of Saudi Arabia [12-BIO3082-03]	National Plan for Science, Technology and Innovation (MAARIFAH) - King Abdulaziz City for Science and Technology-the Kingdom of Saudi Arabia	This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH) - King Abdulaziz City for Science and Technology-the Kingdom of Saudi Arabia - award number (12-BIO3082-03). The authors also acknowledge with thanks Science and Technology Unit, King Abdulaziz University for technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DC, 1974, CLIN ENDOCRINOL, V3, P69, DOI 10.1111/j.1365-2265.1974.tb03298.x; APTER D, 1984, ACTA ENDOCRINOL-COP, V107, P413, DOI 10.1530/acta.0.1070413; Avvakumov GV, 2010, MOL CELL ENDOCRINOL, V316, P13, DOI 10.1016/j.mce.2009.09.005; BELGOROSKY A, 1986, J CLIN ENDOCR METAB, V63, P510, DOI 10.1210/jcem-63-2-510; Braun JM, 2013, CURR OPIN PEDIATR, V25, P247, DOI 10.1097/MOP.0b013e32835e1eb6; CDC, 2015, 4 NAT REP HUM EXP EN; Cherkasov A, 2008, J MED CHEM, V51, P2047, DOI 10.1021/jm7011485; Cullen S., 2012, PLASTICIZER PVC CONS, P1; Dechaud H, 1999, STEROIDS, V64, P328, DOI 10.1016/S0039-128X(98)00114-7; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Ferguson KK, 2014, REPROD TOXICOL, V47, P70, DOI 10.1016/j.reprotox.2014.06.002; FIELD EA, 1993, TERATOLOGY, V48, P33, DOI 10.1002/tera.1420480107; Gore A.C., 2014, ENDOCRINE SOC REPORT, P1; Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350; Hammond GL, 2011, BIOL REPROD, V85, P431, DOI 10.1095/biolreprod.111.092593; HAMMOND GL, 1984, FERTIL STERIL, V42, P44; Hannon PR, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00008; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Hong HX, 2015, TOXICOL SCI, V143, P333, DOI 10.1093/toxsci/kfu231; Joensen UN, 2012, ENVIRON HEALTH PERSP, V120, P1397, DOI 10.1289/ehp.1205113; Josh MKS, 2016, J APPL TOXICOL, V36, P836, DOI 10.1002/jat.3221; Jury HH, 2000, J STEROID BIOCHEM, V75, P167, DOI 10.1016/S0960-0760(00)00168-0; Kambia N, 2015, J ENZYM INHIB MED CH, V5, P1; Kay VR, 2014, CRIT REV TOXICOL, V44, P467, DOI 10.3109/10408444.2013.875983; Kay VR, 2013, CRIT REV TOXICOL, V43, P200, DOI 10.3109/10408444.2013.766149; Kim BN, 2009, BIOL PSYCHIAT, V66, P958, DOI 10.1016/j.biopsych.2009.07.034; Kim Y, 2011, ENVIRON HEALTH PERSP, V119, P1495, DOI 10.1289/ehp.1003178; Laurent MR, 2014, NAT REV ENDOCRINOL, V10, P516, DOI 10.1038/nrendo.2014.120; Lioy PJ, 2015, J EXPO SCI ENV EPID, V25, P343, DOI 10.1038/jes.2015.33; Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075; Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403; Mendiola J, 2012, J ANDROL, V33, P488, DOI 10.2164/jandrol.111.013557; Miles-Richardson SR, 2004, HDB PLASTICIZERS, P557; Nabuurs SB, 2007, J MED CHEM, V50, P6507, DOI 10.1021/jm070593p; Nagel SC, 1997, ENVIRON HEALTH PERSP, V105, P70, DOI 10.1289/ehp.9710570; Patel S, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130336; Qureshi MS, 2015, CRIT REV ANAL CHEM; Rosner W, 2010, MOL CELL ENDOCRINOL, V316, P79, DOI 10.1016/j.mce.2009.08.009; Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766; Saxena AK, 2014, SAR QSAR ENVIRON RES, V25, P407, DOI 10.1080/1062936X.2014.909197; Schecter A, 2013, ENVIRON HEALTH PERSP, V121, P473, DOI 10.1289/ehp.1206367; Specht IO, 2014, ENVIRON INT, V66, P146, DOI 10.1016/j.envint.2014.02.002; Suzuki Y, 2012, INT J ANDROL, V35, P236, DOI 10.1111/j.1365-2605.2011.01190.x; Swan SH, 2015, HUM REPROD, V30, P963, DOI 10.1093/humrep/deu363; Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x; Thorsteinson N, 2009, TOXICOL APPL PHARM, V234, P47, DOI 10.1016/j.taap.2008.07.014; WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; Zhang YH, 2008, DIS MARKERS, V24, P277, DOI 10.1155/2008/905025	49	46	47	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151444	10.1371/journal.pone.0151444	http://dx.doi.org/10.1371/journal.pone.0151444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963243	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000154
J	Vynnycky, E; Adams, EJ; Cutts, FT; Reef, SE; Navar, AM; Simons, E; Yoshida, LM; Brown, DWJ; Jackson, C; Strebel, PM; Dabbagh, AJ				Vynnycky, Emilia; Adams, Elisabeth J.; Cutts, Felicity T.; Reef, Susan E.; Navar, Ann Marie; Simons, Emily; Yoshida, Lay-Myint; Brown, David W. J.; Jackson, Charlotte; Strebel, Peter M.; Dabbagh, Alya J.			Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review	PLOS ONE			English	Article							PREGNANT-WOMEN; VACCINATION; INFECTION; ELIMINATION; IMPACT; URBAN; AGE	Background The burden of Congenital Rubella Syndrome (CRS) is typically underestimated in routine surveillance. Updated estimates are needed following the recent WHO position paper on rubella and recent GAVI initiatives, funding rubella vaccination in eligible countries. Previous estimates considered the year 1996 and only 78 (developing) countries. Methods We reviewed the literature to identify rubella seroprevalence studies conducted before countries introduced rubella-containing vaccination (RCV). These data and the estimated vaccination coverage in the routine schedule and mass campaigns were incorporated in mathematical models to estimate the CRS incidence in 1996 and 2000-2010 for each country, region and globally. Results The estimated CRS decreased in the three regions (Americas, Europe and Eastern Mediterranean) which had introduced widespread RCV by 2010, reaching <2 per 100,000 live births (the Americas and Europe) and 25 (95% CI 4-61) per 100,000 live births (the Eastern Mediterranean). The estimated incidence in 2010 ranged from 90 (95% CI: 46-195) in the Western Pacific, excluding China, to 116 (95% CI: 56-235) and 121 (95% CI: 31-238) per 100,000 live births in Africa and SE Asia respectively. Highest numbers of cases were predicted in Africa (39,000, 95% CI: 18,000-80,000) and SE Asia (49,000, 95% CI: 11,00097,000). In 2010, 105,000 (95% CI: 54,000-158,000) CRS cases were estimated globally, compared to 119,000 (95% CI: 72,000-169,000) in 1996. Conclusions Whilst falling dramatically in the Americas, Europe and the Eastern Mediterranean after vaccination, the estimated CRS incidence remains high elsewhere. Well-conducted seroprevalence studies can help to improve the reliability of these estimates and monitor the impact of rubella vaccination.	[Vynnycky, Emilia; Adams, Elisabeth J.; Brown, David W. J.] Publ Hlth England, 61 Colindale Ave, London NW9 5EQ, England; [Adams, Elisabeth J.] Aquarius Populat Hlth, London, England; [Adams, Elisabeth J.] Univ Bristol, Sch Social & Community Med, Canynge Hall,39 Whatley Rd, Bristol BS8 2PS, Avon, England; [Navar, Ann Marie] Duke Univ, Med Ctr, Durham, NC USA; [Navar, Ann Marie] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Vynnycky, Emilia; Cutts, Felicity T.; Jackson, Charlotte] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England; [Simons, Emily; Strebel, Peter M.; Dabbagh, Alya J.] WHO, 20 Ave Appia, CH-1211 Geneva 27, Switzerland; [Reef, Susan E.] Ctr Dis Control & Prevent, 1600 Clifton RD NE, Atlanta, GA 30333 USA; [Yoshida, Lay-Myint] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Jackson, Charlotte] UCL, London, England; [Brown, David W. J.] Fiocruz MS, IOC, Influenza & Measles Lab, BR-21045900 Rio De Janeiro, Brazil	Public Health England; University of Bristol; Duke University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Centers for Disease Control & Prevention - USA; Nagasaki University; University of London; University College London; Fundacao Oswaldo Cruz	Vynnycky, E (corresponding author), Publ Hlth England, 61 Colindale Ave, London NW9 5EQ, England.; Vynnycky, E (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	emilia.vynnycky@phe.gov.uk	Simons, Emily/AAD-4740-2020	Simons, Emily/0000-0002-6043-5052; YOSHIDA, LAYMYINT/0000-0002-7567-3248; Jackson, Charlotte/0000-0001-8544-7685	World Health Organization; Bill and Melinda Gates Foundation; Child Health Epidemiology Reference Group	World Health Organization(World Health Organization); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Child Health Epidemiology Reference Group	EA and EV were funded by a grant provided by the World Health Organization. AMNB was funded by the Bill and Melinda Gates Foundation in support of the Global Burden of Disease project and the Child Health Epidemiology Reference Group.	Brown DWJ, 2004, EVALUATION COMPLEMEN; Bukbuk D N, 2002, Cent Eur J Public Health, V10, P21; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burton A, 2009, B WORLD HEALTH ORGAN, V87, P535, DOI 10.2471/BLT.08.053819; Castillo-Solorzano C, 2011, J INFECT DIS, V204, pS571, DOI 10.1093/infdis/jir472; Cheffins T, 1998, BRIT J OBSTET GYNAEC, V105, P998, DOI 10.1111/j.1471-0528.1998.tb10264.x; Cumberland P, 2007, J INFECT DIS, V196, P550, DOI 10.1086/519845; Cutts FT, 2012, LANCET, V380, P217, DOI 10.1016/S0140-6736(12)61215-X; Cutts FT, 1999, INT J EPIDEMIOL, V28, P1176, DOI 10.1093/ije/28.6.1176; Cutts FT, 2000, EPIDEMIOL INFECT, V124, P467, DOI 10.1017/S0950268899003532; De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014; DEVELOUX M, 1991, B SOC PATHOL EXOT, V84, P509; GAVI, RUB VACC SUPP 2012; GHIDINI A, 1993, WESTERN J MED, V159, P366; Harvard university Institute for Health Metrics and evaluation at the university of Washington Johns Hopkins university University of Queensland World Health Organization, 2009, GBD STUD OP MAN; Malakmadze N, 2004, CLIN INFECT DIS, V38, P1780, DOI 10.1086/421018; Metcalf CJE, 2012, EPIDEMIOL INFECT, V140, P2290, DOI 10.1017/S0950268812000131; Metcalf CJE, 2011, J R SOC INTERFACE, V8, P369, DOI 10.1098/rsif.2010.0320; Miyakawa M, 2014, VACCINE, V32, P1192, DOI 10.1016/j.vaccine.2013.08.076; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Mou J, 2010, VACCINE, V28, P7844, DOI 10.1016/j.vaccine.2010.09.082; Muench H., CATALYTIC MODELS EPI, P8928; Muscat M, 2012, VACCINE, V30, P1999, DOI 10.1016/j.vaccine.2011.12.016; Nessa A, 2008, INDIAN J MED MICROBI, V26, P94; OUATTARA SA, 1987, B SOC PATHOL EXOT, V80, P149; Panagiotopoulos T, 1999, BRIT MED J, V319, P1462, DOI 10.1136/bmj.319.7223.1462; Press W. H., 1992, ART SCI COMPUTING; Reef SE, 2011, J INFECT DIS, V204, pS24, DOI 10.1093/infdis/jir155; Robertson SE, 1997, B WORLD HEALTH ORGAN, V75, P69; Robertson Susan E., 2003, Rev Panam Salud Publica, V14, P306, DOI 10.1590/S1020-49892003001000005; Shkedy Z, 2006, STAT MED, V25, P1577, DOI 10.1002/sim.2291; STRAUSS J, 1989, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V33, P163; SU WN, 1985, REV INFECT DIS, V7, pS72; Toda K, 2015, VACCINE, V33, P3673, DOI 10.1016/j.vaccine.2015.06.035; UN Statistics Division United Nations Population Division, 2008, WORLD POP PROSP; Vynnycky E, 2003, VACCINE, V21, P2708, DOI 10.1016/S0264-410X(03)00229-9; Who Publication, 2011, Vaccine, V29, P8767, DOI 10.1016/j.vaccine.2011.08.061; World Health Organization, PROT CHILDR MEASL RU; World Health Organization, 2016, GLOB MEASL RUB STRAT; Zimmerman LA, 2011, J INFECT DIS, V204, pS381, DOI 10.1093/infdis/jir104	40	75	78	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149160	10.1371/journal.pone.0149160	http://dx.doi.org/10.1371/journal.pone.0149160			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26962867	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000371993000009
J	Alkner, S; Bendahl, PO; Ehinger, A; Lovgren, K; Ryden, L; Ferno, M				Alkner, Sara; Bendahl, Par-Ola; Ehinger, Anna; Lovgren, Kristina; Ryden, Lisa; Ferno, Marten			Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer	PLOS ONE			English	Article							RECEPTOR COACTIVATOR AIB1; COMPARATIVE GENOMIC HYBRIDIZATION; ESTROGEN-RECEPTOR; ENDOCRINE TREATMENT; CROSS-TALK; RESISTANCE; CARCINOMAS; GROWTH; TUMOR; ONCOGENE	Aim The estrogen receptor coactivator Amplified in Breast Cancer 1 (AIB1) has been associated with an improved response to adjuvant tamoxifen in breast cancer, but also with endocrine treatment resistance. We hereby use metachronous contralateral breast cancer (CBC) developed despite prior adjuvant tamoxifen for the first tumor as an "in vivo"-model for tamoxifen resistance. AIB1-expression in the presumable resistant (CBC after prior tamoxifen) and naive setting (CBC without prior tamoxifen) is compared and correlated to prognosis after CBC. Methods From a well-defined population-based cohort of CBC-patients we have constructed a unique tissue-microarray including >700 patients. Results CBC developed after adjuvant tamoxifen more often had a HER2-positive/triple negative subtype and a high AIB1-expression (37% vs. 23%, p = 0.009), than if no prior endocrine treatment had been administered. In patients with an estrogen receptor (ER) positive CBC, a high AIB1-expression correlated to an inferior prognosis. However, these patients seemed to respond to tamoxifen, but only if endocrine therapy had not been administered for BC1. Conclusions Metachronous CBC developed after prior endocrine treatment has a decreased ER -expression and an increased HER2-expression. This is consistent with endocrine treatment escape mechanisms previously suggested, and indicates metachronous CBC to be a putative model for studies of treatment resistance "in vivo". The increased AIB1-expression in CBC developed after prior tamoxifen suggests a role of AIB1 in endocrine treatment resistance. In addition, we found indications that the response to tamoxifen in CBC with a high AIB1-expression seem to differ depending on previous exposure to this drug. A different function for AIB1 in the tamoxifen treatment naive vs. resistant setting is suggested, and may explain previously conflicting results where a high AIB1-expression has been correlated to both a good response to adjuvant tamoxifen and tamoxifen resistance.	[Alkner, Sara; Bendahl, Par-Ola; Ehinger, Anna; Lovgren, Kristina; Ryden, Lisa; Ferno, Marten] Lund Univ, Div Oncol & Pathol, Dept Clin Sci, SE-22363 Lund, Sweden; [Alkner, Sara] Skane Univ Hosp Lund, Skane Clin Oncol, SE-22241 Lund, Sweden; [Ehinger, Anna] Blekinge Cty Hosp, Dept Pathol & Cytol, SE-37185 Karlskrona, Sweden; [Ryden, Lisa] Skane Univ Hosp Lund, Surg Clin, SE-22241 Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Alkner, S (corresponding author), Lund Univ, Div Oncol & Pathol, Dept Clin Sci, SE-22363 Lund, Sweden.; Alkner, S (corresponding author), Skane Univ Hosp Lund, Skane Clin Oncol, SE-22241 Lund, Sweden.	Sara.Alkner@med.lu.se	Ehinger, Anna/I-8516-2014	Ehinger, Anna/0000-0001-9225-7396	Swedish Breast Cancer Association (BRO); Skane University Hospital foundation [201494413]; Percy Falk Foundation; Swedish Cancer Society [13 0499]; Swedish Research Council [B0262601, 521-2011-3021]; Gunnar Nilsson Cancer Foundation; Mrs. Berta Kamprad Foundation [11/2014]; Anna and Edwin Berger's Foundation; Skane County Council's Research and Development Foundation [REGSKANE-434091, 286421]; Swedish Cancer and Allergy Foundation [150423/2014]; Governmental Funding of Clinical Research within the National Health Service	Swedish Breast Cancer Association (BRO); Skane University Hospital foundation; Percy Falk Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Gunnar Nilsson Cancer Foundation; Mrs. Berta Kamprad Foundation; Anna and Edwin Berger's Foundation; Skane County Council's Research and Development Foundation; Swedish Cancer and Allergy Foundation; Governmental Funding of Clinical Research within the National Health Service	This work was supported by the Swedish Breast Cancer Association (BRO) (2011, 2014, SA); the Skane University Hospital foundation (201494413, SA); the Percy Falk Foundation (2011, SA); the Swedish Cancer Society (13 0499, MF); the Swedish Research Council (B0262601, 521-2011-3021, MF); the Gunnar Nilsson Cancer Foundation (2013, 2014, MF); the Mrs. Berta Kamprad Foundation (11/2014, MF); the Anna and Edwin Berger's Foundation (2014, MF); Skane County Council's Research and Development Foundation (REGSKANE-434091, 286421, SA and LR); the Swedish Cancer and Allergy Foundation (150423/2014, MF); and the Governmental Funding of Clinical Research within the National Health Service (2011-2014, MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkner S, 2013, ANN ONCOL, V24, P1244, DOI 10.1093/annonc/mds613; Alkner S, 2010, ANN ONCOL, V21, P238, DOI 10.1093/annonc/mdp293; Alkner S, 2015, EUR J CANCER, V51, P2304, DOI 10.1016/j.ejca.2015.07.016; Alkner S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-114; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Atanaskova N, 2002, ONCOGENE, V21, P4000, DOI 10.1038/sj.onc.1205506; Azorsa DO, 2001, BREAST CANCER RES TR, V70, P89, DOI 10.1023/A:1012972808558; Bachleitner-Hofmann T, 2002, CLIN CANCER RES, V8, P3427; Balmer NN, 2006, MODERN PATHOL, V19, P1593, DOI 10.1038/modpathol.3800696; Banelli B, 2010, ANN ONCOL, V21, P1237, DOI 10.1093/annonc/mdp470; Bautista S, 1998, CLIN CANCER RES, V4, P2925; Bertelsen L, 2008, JNCI-J NATL CANCER I, V100, P32, DOI 10.1093/jnci/djm267; Bouras T, 2001, CANCER RES, V61, P903; Dihge L, 2008, BREAST CANCER RES TR, V109, P255, DOI 10.1007/s10549-007-9645-1; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Guan XY, 1996, CANCER RES, V56, P3446; Hartman M, 2007, J CLIN ONCOL, V25, P4210, DOI 10.1200/JCO.2006.10.5056; Hu ZZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020410; Hudelist G, 2003, BREAST CANCER RES TR, V78, P193, DOI 10.1023/A:1022930710850; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Janschek E, 2001, BREAST CANCER RES TR, V67, P1, DOI 10.1023/A:1010661514306; Kirkegaard T, 2007, CLIN CANCER RES, V13, P1405, DOI 10.1158/1078-0432.CCR-06-1933; Kuligina ES, 2007, J CANCER RES CLIN, V133, P57, DOI 10.1007/s00432-006-0146-0; List HJ, 2001, BREAST CANCER RES TR, V68, P21, DOI 10.1023/A:1017910924390; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Matsuo K, 2001, J SURG ONCOL, V77, P31, DOI 10.1002/jso.1062; Mehta A, 2014, BREAST, V23, P2, DOI 10.1016/j.breast.2013.09.006; Murphy LC, 2000, CANCER RES, V60, P6266; Myers E, 2005, CLIN CANCER RES, V11, P2111, DOI 10.1158/1078-0432.CCR-04-1192; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Redmond AM, 2009, CLIN CANCER RES, V15, P2098, DOI 10.1158/1078-0432.CCR-08-1649; Russnes HG, 2011, CANCER GENET-NY, V204, P96, DOI 10.1016/j.cancergencyto.2010.09.012; Sandberg MEC, 2012, BREAST CANCER RES TR, V134, P793, DOI 10.1007/s10549-012-2096-3; Seo MY, 2004, INT J MOL MED, V13, P17; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Song XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140011; Su QB, 2008, ONCOLOGY-BASEL, V75, P159, DOI 10.1159/000159267; Suspitsin EN, 2007, INT J CANCER, V120, P297, DOI 10.1002/ijc.22265; Teixeira MR, 2004, BRIT J CANCER, V91, P775, DOI 10.1038/sj.bjc.6602021; Torres-Arzayus MI, 2006, CANCER RES, V66, P11381, DOI 10.1158/0008-5472.CAN-06-2316; Torres-Arzayus MI, 2010, CANCER RES, V70, P4102, DOI 10.1158/0008-5472.CAN-09-4080; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Tse GMK, 2003, AM J CLIN PATHOL, V120, P168, DOI 10.1209/6YEPMCHACPG2BD15; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Weiner M, 2013, ANN ONCOL, V24, P1994, DOI 10.1093/annonc/mdt159; Zhao WH, 2009, BIOCHEM BIOPH RES CO, V380, P699, DOI 10.1016/j.bbrc.2009.01.155	46	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150977	10.1371/journal.pone.0150977	http://dx.doi.org/10.1371/journal.pone.0150977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959415	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300089
J	Cigliola, V; Populaire, C; Pierri, CL; Deutsch, S; Haefliger, JA; Fadista, J; Lyssenko, V; Groop, L; Rueedi, R; Thorel, F; Herrera, PL; Meda, P				Cigliola, Valentina; Populaire, Celine; Pierri, Ciro L.; Deutsch, Samuel; Haefliger, Jacques-Antoine; Fadista, Joao; Lyssenko, Valeriya; Groop, Leif; Rueedi, Rico; Thorel, Fabrizio; Herrera, Pedro Luis; Meda, Paolo			A Variant of GJD2, Encoding for Connexin 36, Alters the Function of Insulin Producing beta-Cells	PLOS ONE			English	Article							GAP-JUNCTIONS; MESSENGER-RNA; GENE; EXPRESSION; ASSOCIATION; CX36; OSCILLATIONS; SECRETION; SYNCHRONIZATION; COMMUNICATION	Signalling through gap junctions contributes to control insulin secretion and, thus, blood glucose levels. Gap junctions of the insulin-producing beta-cells are made of connexin 36 (Cx36), which is encoded by the GJD2 gene. Cx36-null mice feature alterations mimicking those observed in type 2 diabetes (T2D). GJD2 is also expressed in neurons, which share a number of common features with pancreatic beta-cells. Given that a synonymous exonic single nucleotide polymorphism of human Cx36 (SNP rs3743123) associates with altered function of central neurons in a subset of epileptic patients, we investigated whether this SNP also caused alterations of beta-cell function. Transfection of rs3743123 cDNA in connexin-lacking HeLa cells resulted in altered formation of gap junction plaques and cell coupling, as compared to those induced by wild type (WT) GJD2 cDNA. Transgenic mice expressing the very same cDNAs under an insulin promoter revealed that SNP rs3743123 expression consistently lead to a post-natal reduction of islet Cx36 levels and beta-cell survival, resulting in hyperglycemia in selected lines. These changes were not observed in sex-and agematched controls expressing WT hCx36. The variant GJD2 only marginally associated to heterogeneous populations of diabetic patients. The data document that a silent polymorphism of GJD2 is associated with altered beta-cell function, presumably contributing to T2D pathogenesis.	[Cigliola, Valentina; Thorel, Fabrizio; Herrera, Pedro Luis] Univ Geneva, Fac Med, Dept Genet Med & Dev, Geneva, Switzerland; [Populaire, Celine] Ctr Hosp Reg Univ Besancon, Besancon, France; [Pierri, Ciro L.] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Deutsch, Samuel] Joint Genome Inst, Walnut Creek, CA USA; [Haefliger, Jacques-Antoine] CHU Vaudois, Dept Med, Lausanne, Switzerland; [Fadista, Joao; Lyssenko, Valeriya; Groop, Leif] Lund Univ, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Lyssenko, Valeriya] Steno Diabet Ctr AS, Gentofte, Denmark; [Rueedi, Rico] Univ Lausanne, Dept Computat Biol, Rue Bugnon 27, CH-1011 Lausanne, Switzerland; [Rueedi, Rico] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Meda, Paolo] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland	University of Geneva; Universite de Franche-Comte; CHU Besancon; Universita degli Studi di Bari Aldo Moro; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Lund University; Steno Diabetes Center; University of Lausanne; Swiss Institute of Bioinformatics; University of Geneva	Cigliola, V (corresponding author), Univ Geneva, Fac Med, Dept Genet Med & Dev, Geneva, Switzerland.; Meda, P (corresponding author), Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland.	valentina.cigliola@unige.ch; paolo.meda@unige.ch	Fadista, Joao/AAM-4870-2020; Pierri, Ciro Leonardo L/G-4753-2013; Cigliola, Valentina/AAM-9083-2020	Fadista, Joao/0000-0003-2539-634X; Pierri, Ciro Leonardo L/0000-0003-1816-548X; Haefliger, Jacques-Antoine/0000-0003-2732-1667; Valentina, Cigliola/0000-0002-1596-7332; Herrera Merino, Pedro Luis/0000-0003-0771-9504	Swiss National Science Foundation (SNF) [310030_141162]; Juvenile Diabetes Research Foundation (JDRF) [40-2011-11]; SNF; NIH/NIDDK; Novo Nordisk Fonden [NNF15OC0016416] Funding Source: researchfish	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); SNF; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Swiss National Science Foundation (SNF; 310030_141162) and the Juvenile Diabetes Research Foundation (JDRF; 40-2011-11) to PM, and from the SNF, JDRF and NIH/NIDDK to PLH.	Allagnat F, 2013, CELL DEATH DIFFER, V20, P1742, DOI 10.1038/cdd.2013.134; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; BAETENS D, 1978, DIABETES, V27, P1, DOI 10.2337/diabetes.27.1.1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Benninger RKP, 2011, J PHYSIOL-LONDON, V589, P5453, DOI 10.1113/jphysiol.2011.218909; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; Bukauskas FF, 2012, J MEMBRANE BIOL, V245, P243, DOI 10.1007/s00232-012-9445-3; Calabrese A, 2003, DIABETES, V52, P417, DOI 10.2337/diabetes.52.2.417; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Carvalho CPF, 2010, DIABETOLOGIA, V53, P1428, DOI 10.1007/s00125-010-1726-8; Charpantier E, 2007, DIABETOLOGIA, V50, P2332, DOI 10.1007/s00125-007-0807-9; Cigliola V, 2013, DIABETES RES CLIN PR, V99, P250, DOI 10.1016/j.diabres.2012.10.016; Condorelli DF, 1998, EUR J NEUROSCI, V10, P1202, DOI 10.1046/j.1460-9568.1998.00163.x; Condorelli DF, 2000, BRAIN RES REV, V32, P72, DOI 10.1016/S0165-0173(99)00068-5; Cornelis MC, 2012, ANNU REV NUTR, V32, P245, DOI 10.1146/annurev-nutr-071811-150648; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Fonseca VA, 2009, DIABETES CARE, V32, pS151, DOI 10.2337/dc09-S301; Franks PW, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/482186; Guldenagel M, 2001, J NEUROSCI, V21, P6036, DOI 10.1523/JNEUROSCI.21-16-06036.2001; Haefliger JA, 2013, J MOL ENDOCRINOL, V51, P49, DOI 10.1530/JME-13-0054; Head WS, 2012, DIABETES, V61, P1700, DOI 10.2337/db11-1312; Hempelmann A, 2006, EPILEPSY RES, V71, P223, DOI 10.1016/j.eplepsyres.2006.06.021; Herve JC, 2013, CELL TISSUE RES, V352, P21, DOI 10.1007/s00441-012-1485-6; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Ivanova E, 2016, EXP EYE RES, V150, P81, DOI 10.1016/j.exer.2015.05.013; Jung SK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-340; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Klee P, 2011, J CLIN INVEST, V121, P4870, DOI 10.1172/JCI40509; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Lindgren CM, 2002, AM J HUM GENET, V70, P509, DOI 10.1086/338629; Mas C, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.017954; MEDA P, 1979, J CELL BIOL, V82, P441, DOI 10.1083/jcb.82.2.441; MEDA P, 1980, AM J PHYSIOL, V238, pC114, DOI 10.1152/ajpcell.1980.238.3.C114; Meda P, 2012, DIABETES, V61, P1656, DOI 10.2337/db12-0336; Michon L, 2005, BBA-BIOMEMBRANES, V1719, P82, DOI 10.1016/j.bbamem.2005.11.003; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Pal DK, 2006, BRAIN DEV-JPN, V28, P92, DOI 10.1016/j.braindev.2005.05.009; Potolicchio I, 2012, BBA-BIOMEMBRANES, V1818, P1919, DOI 10.1016/j.bbamem.2011.09.022; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Ren SX, 2001, CONTEMP TOP LAB ANIM, V40, P27; Ritz J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S6; Serre-Beinier V, 2000, DIABETES, V49, P727, DOI 10.2337/diabetes.49.5.727; Serre-Beinier V, 2009, HUM MOL GENET, V18, P428, DOI 10.1093/hmg/ddn370; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; Sohl G, 2004, BRAIN RES REV, V47, P245, DOI 10.1016/j.brainresrev.2004.05.006; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Striedinger K, 2005, EUR J NEUROSCI, V22, P605, DOI 10.1111/j.1460-9568.2005.04228.x; Taneera J, 2012, CELL METAB, V16, P122, DOI 10.1016/j.cmet.2012.06.006; Theis M, 2004, EXP CELL RES, V294, P18, DOI 10.1016/j.yexcr.2003.09.031; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	59	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150880	10.1371/journal.pone.0150880	http://dx.doi.org/10.1371/journal.pone.0150880			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959991	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300083
J	Kasar, S; Underbayev, C; Hassan, M; Ilev, I; Degheidy, H; Bauer, S; Marti, G; Lutz, C; Raveche, E; Batish, M				Kasar, Siddha; Underbayev, Chingiz; Hassan, Moinuddin; Ilev, Ilko; Degheidy, Heba; Bauer, Steven; Marti, Gerald; Lutz, Carol; Raveche, Elizabeth; Batish, Mona			Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL)	PLOS ONE			English	Article							B-CELL LYMPHOCYTOSIS; ZEALAND BLACK MOUSE; SIDE POPULATION; INFRARED-SPECTROSCOPY; DROSHA-DGCR8 COMPLEX; PRIMARY MICRORNA; MATURE MICRORNA; PROGRESSION; EXPRESSION; IDENTIFICATION	New Zealand Black (NZB) mice, a de novo model of CLL, share multiple characteristics with CLL patients, including decreased expression of miR-15a/16-1. We previously discovered a point mutation and deletion in the 3' flanking region of mir-16-1 of NZB and a similar mutation has been found in a small number of CLL patients. However, it was unknown whether the mutation is the cause for the reduced miR-15a/16-1 expression and CLL development. Using PCR and in vitro microRNA processing assays, we found that the NZB sequence alterations in the mir-15a/16-1 loci result in deficient processing of the precursor forms of miR-15a/16-1, in particular, we observe impaired conversion of pri-miR-15a/16-1 to pre-miR-15a/16-1. The in vitro data was further supported by derivation of congenic strains with replaced mir-15a/16-1 loci at one or both alleles: NZB congenic mice (NmiR+/-) and DBA congenic mice (DmiR-/-). The level of miR-15a/16-1 reflected the configuration of the mir-15a/16-1 loci with DBA congenic mice (DmiR-/-) showing reduced miR-15a levels compared to homozygous wild-type allele, while the NZB congenic mice (NmiR+/-) showed an increase in miR-15a levels relative to homozygous mutant allele. Similar to Monoclonal B-cell Lymphocytosis (MBL), the precursor stage of the human disease, an overall expansion of the B-1 population was observed in DBA congenic mice (DmiR-/-) relative to wild-type (DmiR+/+). These studies support our hypothesis that the mutations in the mir-15a/16-1 loci are responsible for decreased expression of this regulatory microRNA leading to B-1 expansion and CLL development.	[Kasar, Siddha; Underbayev, Chingiz; Lutz, Carol; Raveche, Elizabeth; Batish, Mona] Rutgers State Univ, New Jersey Med Sch, Newark, NJ 07103 USA; [Hassan, Moinuddin; Ilev, Ilko; Marti, Gerald] US FDA, OSEL, CDRH, White Oak, MD USA; [Degheidy, Heba; Bauer, Steven] US FDA, CBER, White Oak, MD USA; [Kasar, Siddha] Dana Faber Canc Inst, Boston, MA USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Harvard University; Dana-Farber Cancer Institute	Batish, M (corresponding author), Rutgers State Univ, New Jersey Med Sch, Newark, NJ 07103 USA.	batishmo@njms.rutgers.edu	Batish, Mona/AAG-8296-2019; Underbayev, Chingiz/J-2970-2019; Ilev, Ilko/CAJ-3359-2022	Batish, Mona/0000-0001-9039-6149; 	NIH [R01CA12926]; NIH Director's Early Independence Award [DP5OD012160-01]; UMDNJ-NJMS Flow Cytometry Core, Molecular Resource Facility; Transgenic Core; NATIONAL CANCER INSTITUTE [R01CA129826] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012160] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Early Independence Award; UMDNJ-NJMS Flow Cytometry Core, Molecular Resource Facility; Transgenic Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH R01CA12926 (ESR) and NIH Director's Early Independence Award DP5OD012160-01 (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH R01CA12926 (ESR) and NIH Director's Early Independence Award DP5OD012160-01 (MB). We thank the UMDNJ-NJMS Flow Cytometry Core, Molecular Resource Facility and the Transgenic Core for their support.	Allegra D, 2014, LEUKEMIA, V28, P98, DOI 10.1038/leu.2013.246; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Caporaso NE, 2010, CYTOM PART B-CLIN CY, V78B, pS115, DOI 10.1002/cyto.b.20555; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Czarneski J, 2004, LEUKEMIA, V18, P597, DOI 10.1038/sj.leu.2403244; Dillman RO, 2008, J CLIN ONCOL, V26, P1193, DOI 10.1200/JCO.2007.14.1424; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Foster AE, 2010, LEUKEMIA, V24, P563, DOI 10.1038/leu.2009.281; Foster AE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-106; Gaigneaux A, 2002, EUR J BIOCHEM, V269, P1968, DOI 10.1046/j.1432-1033.2002.02841.x; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gross E, 2010, LEUKEMIA, V24, P1885, DOI 10.1038/leu.2010.176; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hassan M, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4803182; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309; Janas MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002330; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Kasar S, 2014, ONCOGENE, V33, P3307, DOI 10.1038/onc.2013.291; Kasar S, 2012, GENES IMMUN, V13, P109, DOI 10.1038/gene.2011.58; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; KIM KJ, 1979, J IMMUNOL, V122, P549; Lambert NJ, 2011, NUCLEIC ACIDS RES, V39, P4827, DOI 10.1093/nar/gkr077; Lanasa MC, 2010, LEUKEMIA, V24, P133, DOI 10.1038/leu.2009.192; Landgren O, 2009, NEW ENGL J MED, V360, P659, DOI 10.1056/NEJMoa0806122; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Moshaver B, 2008, STEM CELLS, V26, P3059, DOI 10.1634/stemcells.2007-0861; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; Ozek NS, 2010, ANALYST, V135, P3094, DOI 10.1039/c0an00543f; PENG BH, 1994, J IMMUNOL, V153, P1869; Petriz J., 2007, CURR PROTOC CYTOM, V23; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Sahu R K, 2005, Future Oncol, V1, P635, DOI 10.2217/14796694.1.5.635; Salerno E, 2010, CYTOM PART B-CLIN CY, V78B, pS98, DOI 10.1002/cyto.b.20544; Sampath D, 2012, BLOOD, V119, P1162, DOI 10.1182/blood-2011-05-351510; Scaglione BJ, 2007, BRIT J HAEMATOL, V139, P645, DOI 10.1111/j.1365-2141.2007.06851.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Simonetti G, 2014, BLOOD, V124, P1010, DOI 10.1182/blood-2014-05-577122; Simonova D, 2013, BIOTECHNOL BIOTEC EQ, V27, P4200, DOI 10.5504/BBEQ.2013.0106; Underbayev C, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-4791; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Wu MQ, 2008, CARCINOGENESIS, V29, P1710, DOI 10.1093/carcin/bgn073; Xing J-L, 2011, CANC EPIDEMIOLOGY BI; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149331	10.1371/journal.pone.0149331	http://dx.doi.org/10.1371/journal.pone.0149331			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959643	Green Published, gold			2022-12-27	WOS:000371992300009
J	Kleiven, AR; Fernandez-Chacon, A; Nordahl, JH; Moland, E; Espeland, SH; Knutsen, H; Olsen, EM				Kleiven, Alf Ring; Fernandez-Chacon, Albert; Nordahl, Jan-Harald; Moland, Even; Espeland, Sigurd Heiberg; Knutsen, Halvor; Olsen, Esben Moland			Harvest Pressure on Coastal Atlantic Cod (Gadus morhua) from Recreational Fishing Relative to Commercial Fishing Assessed from Tag-Recovery Data	PLOS ONE			English	Article							REPORTING RATE ESTIMATION; POPULATION; SCALE; SEA; FISHERIES; IMPACT; EXTENT	Marine recreational fishing is a popular outdoor activity. However, knowledge about the magnitude of recreational catches relative to commercial catches in coastal fisheries is generally sparse. Coastal Atlantic cod (Gadus morhua) is a target species for recreational fishers in the North Atlantic. In Norway, recreational fishers are allowed to use a variety of traps and nets as well as long-line and rod and line when fishing for cod. From 2005 to 2013, 9729 cod (mean size: 40 cm, range: 15-93 cm) were tagged and released in coastal Skagerrak, southeast Norway. Both high-reward (NOK 500) and low-reward tags (NOK 50) were used in this study. Because some harvested fish (even those posting high-reward tags) may go unreported by fishers, reporting rates were estimated from mark-recovery models that incorporate detection parameters in their structure, in addition to survival and mortality estimates. During 2005 to 2013, a total of 1707 tagged cod were recovered and reported by fishers. We estimate the overall annual survival to be 33% (SE 1.5). Recreational rod and line fishing were responsible for 33.7%(SE 2.4) of total mortality, followed by commercial fisheries (15.1% SE 0.8) and recreational fixed gear (6.8% SE 0.4). Natural mortality was 44.4% (SE 2.5) of total mortality. Our findings suggest that recreational fishing-rod and line fishing in particular-is responsible for a substantial part of fishing mortality exerted on coastal cod in southern Norway.	[Kleiven, Alf Ring; Fernandez-Chacon, Albert; Moland, Even; Espeland, Sigurd Heiberg; Knutsen, Halvor; Olsen, Esben Moland] Inst Marine Res, Flodevigen Marine Res Stn, Nye Flodevigveien 20, N-4817 His, Norway; [Nordahl, Jan-Harald] Inst Marine Res, Matre Res Stn, N-5984 Matredal, Norway; [Knutsen, Halvor] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, POB 1066 Blindern, N-0316 Oslo, Norway; [Moland, Even; Knutsen, Halvor; Olsen, Esben Moland] Univ Agder, Dept Nat Sci, Ctr Coastal Res, Fac Sci & Engn, N-4604 Kristiansand, Norway	Institute of Marine Research - Norway; Institute of Marine Research - Norway; University of Oslo; University of Agder	Kleiven, AR (corresponding author), Inst Marine Res, Flodevigen Marine Res Stn, Nye Flodevigveien 20, N-4817 His, Norway.	alf.ring.kleiven@imr.no	Olsen, Esben Moland/B-1894-2012; Kleiven, Alf Ring/ABK-6111-2022; Moland, Even/A-7788-2013; Knutsen, Halvor/A-4261-2009	Olsen, Esben Moland/0000-0003-3807-7524; Knutsen, Halvor/0000-0002-7627-7634; Fernandez-Chacon, Albert/0000-0003-4105-0090	Research Council of Norway; Insitute of Marine Research; Institute of Marine Research through the Coastal Zone Ecosystem Programme	Research Council of Norway(Research Council of Norway); Insitute of Marine Research; Institute of Marine Research through the Coastal Zone Ecosystem Programme	The research has been funded by the Research Council of Norway and the Insitute of Marine Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by The Research Council of Norway and supported by the Institute of Marine Research through the Coastal Zone Ecosystem Programme. We wish to express our gratitude to the late S.E. Enersen, and thank K. Enersen, S. Bosgraaf, P. Baardsen, K. Hansen, H. Sannaes, R. Johansen for field assistance. The numerous individuals that have supplied reporting letters throughout the study period are recognised for their highly valuable contribution. Former eel fisherman and knowledgeable local of Risor; H. Larsen, deserves special thanks for hosting cod tagging researchers onboard his vessel on numerous occasions throughout the study. We also thank the two anonymous referees for providing insightful reviews that increased the quality of this study.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Cadigan NG, 2006, CAN J FISH AQUAT SCI, V63, P1944, DOI 10.1139/F06-096; Choquet R, 2010, E SURGE 1 7 USERS MA; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Ciannelli L, 2010, ECOLOGY, V91, P2918, DOI 10.1890/09-1548.1; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Cook RM, 1997, NATURE, V385, P521, DOI 10.1038/385521a0; Cooke SJ, 2004, BIOSCIENCE, V54, P857, DOI 10.1641/0006-3568(2004)054[0857:TRORFI]2.0.CO;2; Dannevig A., 1954, Rapport Conseil Exploration Mer, V136, P7; Espeland SH, 2007, ICES J MAR SCI, V64, P920, DOI 10.1093/icesjms/fsm028; Espeland SH, 2008, MAR ECOL PROG SER, V372, P231, DOI 10.3354/meps07721; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Jorde PE, 2007, MAR ECOL PROG SER, V343, P229, DOI 10.3354/meps06922; Julliard R, 2001, NATURAL MORTALITY FI; Kleiven AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031216; Knutsen H, 2004, P ROY SOC B-BIOL SCI, V271, P1337, DOI 10.1098/rspb.2004.2721; Knutsen H, 2011, MOL ECOL, V20, P768, DOI 10.1111/j.1365-294X.2010.04979.x; Knutsen H, 2003, MOL ECOL, V12, P385, DOI 10.1046/j.1365-294X.2003.01750.x; Knutsen H, 2007, MAR ECOL PROG SER, V333, P249, DOI 10.3354/meps333249; Lebreton JD, 1999, BIRD STUDY, V46, P39; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; McPhee D. P., 2002, Pacific Conservation Biology, V8, P40; Olsen EM, 2004, J FISH BIOL, V64, P1725, DOI 10.1111/j.0022-1112.2004.00402.x; Olsen EM, 2008, EVOL APPL, V1, P524, DOI 10.1111/j.1752-4571.2008.00024.x; Olsen EM, 2011, EVOL ECOL, V25, P695, DOI 10.1007/s10682-010-9427-9; Olsen EM, 2009, ECOL LETT, V12, P622, DOI 10.1111/j.1461-0248.2009.01311.x; Pawson MG, 2008, MAR POLICY, V32, P339, DOI 10.1016/j.marpol.2007.07.001; Pine WE, 2003, FISHERIES, V28, P10, DOI 10.1577/1548-8446(2003)28[10:AROTMF]2.0.CO;2; Pollock KH, 2001, N AM J FISH MANAGE, V21, P521, DOI 10.1577/1548-8675(2001)021<0521:TRREAE>2.0.CO;2; Pollock KH, 2002, N AM J FISH MANAGE, V22, P727, DOI 10.1577/1548-8675(2002)022<0727:TRREUO>2.0.CO;2; Pradel R, 2003, BIOMETRICS, V59, P43, DOI 10.1111/1541-0420.00006; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Rogers LA, 2014, MAR ECOL PROG SER, V511, P153, DOI 10.3354/meps10944; Schaub M, 2004, ECOLOGY, V85, P930, DOI 10.1890/03-0012; Schroeder DM, 2002, CAL COOP OCEAN FISH, V43, P182; Sparrevohn CR, 2012, ICES J MAR SCI, V69, P323, DOI 10.1093/icesjms/fss005; Stenseth NC, 2006, P R SOC B, V273, P1085, DOI 10.1098/rspb.2005.3290; Strehlow HV, 2012, ICES J MAR SCI, V69, P1769, DOI 10.1093/icesjms/fss152; Sumaila UR, 2006, MAR POLICY, V30, P696, DOI 10.1016/j.marpol.2005.11.001; Svedang H, 2007, MAR ECOL PROG SER, V345, P1, DOI 10.3354/meps07140; Svedang H, 2003, ICES J MAR SCI, V60, P32, DOI 10.1006/jmsc.2002.1330; Volstad JH, 2011, ICES J MAR SCI, V68, P1785, DOI 10.1093/icesjms/fsr077; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2	43	19	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149595	10.1371/journal.pone.0149595	http://dx.doi.org/10.1371/journal.pone.0149595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959371	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000371992300016
J	Lima, GFMD; Lucchi, NW; Silva-Flannery, L; Macedo-de-Oliveira, A; Hristov, AD; Inoue, J; Costa-Nascimento, MD; Udhayakumar, V; Di Santi, SM				Maciel de Castro Lima, Giselle Fernandes; Lucchi, Naomi W.; Silva-Flannery, Luciana; Macedo-de-Oliveira, Alexandre; Hristov, Angelica D.; Inoue, Juliana; Costa-Nascimento, Maria de Jesus; Udhayakumar, Venkatachalam; Di Santi, Silvia M.			Still Searching for a Suitable Molecular Test to Detect Hidden Plasmodium Infection: A Proposal for Blood Donor Screening in Brazil	PLOS ONE			English	Article							REAL-TIME PCR; MALARIA DIAGNOSIS; NESTED PCR; TRANSFUSION; AMPLIFICATION; AREAS; VIVAX	Background Efforts have been made to establish sensitive diagnostic tools for malaria screening in blood banks in order to detect malaria asymptomatic carriers. Microscopy, the malaria reference test in Brazil, is time consuming and its sensitivity depends on microscopist experience. Although molecular tools are available, some aspects need to be considered for large-scale screening: accuracy and robustness for detecting low parasitemia, affordability for application to large number of samples and flexibility to perform on individual or pooled samples. Methodology In this retrospective study, we evaluated four molecular assays for detection of malaria parasites in a set of 56 samples previously evaluated by expert microscopy. In addition, we evaluated the effect of pooling samples on the sensitivity and specificity of the molecular assays. A well-characterized cultured sample with 1 parasite/mu L was included in all the tests evaluated. DNA was extracted with QIAamp DNA Blood Mini Kit and eluted in 50 mu L to concentrate the DNA. Pools were assembled with 10 samples each. Molecular protocols targeting 18S rRNA, included one qPCR genus specific (Lima-genus), one duplex qPCR genus/Pf (PET-genus, PET-Pf) and one duplex qPCR specie-specific (Rougemont: RougPf/Pv and Roug-Pm/Po). Additionally a nested PCR protocol specie-specific was used (Snou-Pf, Snou-Pv, Snou-Pm and Snou-Po). Results The limit of detection was 3.5 p/mu L and 0.35p/mu l for the PET-genus and Lima-genus assays, respectively. Considering the positive (n = 13) and negative (n = 39) unpooled individual samples according to microscopy, the sensitivity of the two genus qPCR assays was 76.9% (Lima-genus) and 72.7% (PET-genus). The Lima-genus and PET-genus showed both sensitivity of 86.7% in the pooled samples. The genus protocols yielded similar results (Kappa value of 1.000) in both individual and pooled samples. Conclusions Efforts should be made to improve performance of molecular tests to enable the detection of low-density parasitemia if these tests are to be utilized for blood transfusion screening.	[Maciel de Castro Lima, Giselle Fernandes; Hristov, Angelica D.; Inoue, Juliana; Di Santi, Silvia M.] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, SP, Brazil; [Lucchi, Naomi W.; Silva-Flannery, Luciana; Macedo-de-Oliveira, Alexandre; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, 4770 Buford Highway,Mail Stop F-12, Atlanta, GA USA; [Silva-Flannery, Luciana] Atlanta Res & Educ Fdn, Atlanta, GA USA; [Costa-Nascimento, Maria de Jesus; Di Santi, Silvia M.] Univ Sao Paulo, Secretaria Estado Saude Sao Paulo, Nucleo Estudos Malaria Superintendencia Controle, Inst Med Trop Sao Paulo, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Centers for Disease Control & Prevention - USA; Universidade de Sao Paulo	Lima, GFMD (corresponding author), Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, SP, Brazil.	giselledecastro@usp.br	Lima, Giselle/HGD-5458-2022; Lima, Giselle FMC/M-8335-2014; Di Santi, Silvia/D-8973-2012	Di Santi, Silvia/0000-0001-8049-2014; Lucchi, Naomi/0000-0001-8789-8041	U.S. Agency for International Development (USAID) through the Amazon Malaria Initiative (AMI); Sao Paulo Research Foundation (FAPESP) [2012/18014-5]; Superintendencia de Controle de Endemias (SUCEN); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	U.S. Agency for International Development (USAID) through the Amazon Malaria Initiative (AMI)(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Superintendencia de Controle de Endemias (SUCEN); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by the U.S. Agency for International Development (USAID) through the Amazon Malaria Initiative (AMI). Author who received the funding AMO; Sao Paulo Research Foundation (FAPESP) by grant #2012/18014-5. Author who received the funding SMDS; Superintendencia de Controle de Endemias (SUCEN). Author who received the funding SMDS; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). Author who received the funding GFMCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, BMJ; Anthony CN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-308; Assennato SM, 2014, TRANSFUSION, V54, P2419, DOI 10.1111/trf.12650; Bharti AR, 2009, AM J TROP MED HYG, V81, P754, DOI 10.4269/ajtmh.2009.09-0274; Brouwer EE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-439; de Freitas DRC, 2014, TRANSFUS APHER SCI, V50, P242, DOI 10.1016/j.transci.2014.01.016; Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P21, DOI 10.1590/0074-0276140102; Di Santi Silvia Maria, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P183, DOI 10.1590/S0036-46652004000400002; Gama BE, 2007, EXP PARASITOL, V116, P427, DOI 10.1016/j.exppara.2007.02.011; Hanscheid T, 1999, AM J TROP MED HYG, V61, P179; Haydoura S, 2011, PARASITOL INT, V60, P114, DOI 10.1016/j.parint.2010.10.005; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Hristov AD, 2014, MEM I OSWALDO CRUZ, V109, P1014, DOI 10.1590/0074-0276140229; Imwong M, 2014, J CLIN MICROBIOL, V52, P3303, DOI 10.1128/JCM.01057-14; Inoue J, 2010, REV INST MED TROP SP, V52, P281, DOI 10.1590/S0036-46652010000500012; Lima GFMC, 2011, MEM I OSWALDO CRUZ, V106, P691, DOI 10.1590/S0074-02762011000600008; Lucchi NW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056677; Mekonnen SK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-48; MILNE LM, 1994, J CLIN PATHOL, V47, P740, DOI 10.1136/jcp.47.8.740; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; MS/SVS, 2005, MAN DIAGN LAB MAL; MS/SVS-Ministerio da Saude/Secretaria de Vigilancia em Sau-de, 2015, B EPIDEMIOLOGICO, V46; Proux S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-323; Rogawski ET, 2012, AM J TROP MED HYG, V86, P789, DOI 10.4269/ajtmh.2012.11-0617; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Scuracchio P, 2011, REV INST MED TROP SP, V53, P55, DOI 10.1590/S0036-46652011000100010; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Taylor SM, 2010, J CLIN MICROBIOL, V48, P512, DOI 10.1128/JCM.01800-09; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	29	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150391	10.1371/journal.pone.0150391	http://dx.doi.org/10.1371/journal.pone.0150391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959994	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300047
J	Hou, XH; Qiu, JZ; Chen, PZ; Lu, J; Ma, XJ; Lu, JM; Weng, JP; Ji, LN; Shan, ZY; Liu, J; Tian, HM; Ji, QH; Zhu, DL; Ge, JP; Lin, LX; Chen, L; Guo, XH; Zhao, ZG; Li, Q; Zhou, ZG; Yang, WY; Jia, WP				Hou, Xuhong; Qiu, Jieyuzhen; Chen, Peizhu; Lu, Jun; Ma, Xiaojing; Lu, Juming; Weng, Jianping; Ji, Linong; Shan, Zhongyan; Liu, Jie; Tian, Haoming; Ji, Qiuhe; Zhu, Dalong; Ge, Jiapu; Lin, Lixiang; Chen, Li; Guo, Xiaohui; Zhao, Zhigang; Li, Qiang; Zhou, Zhiguang; Yang, Wenying; Jia, Weiping		China Natl Diabet Metab Disorders	Cigarette Smoking Is Associated with a Lower Prevalence of Newly Diagnosed Diabetes Screened by OGTT than Non-Smoking in Chinese Men with Normal Weight	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; GENERAL-POPULATION; GLUCOSE-TOLERANCE; FOLLOW-UP; RISK; MELLITUS; WOMEN; OBESITY; CESSATION	Different studies have produced conflicting results regarding the association between smoking and diabetes mellitus, and detailed analysis of this issue in Chinese males based on nationwide samples is lacking. We explored the association between cigarette smoking and newly-diagnosed diabetes mellitus (NDM) in Chinese males using a population-based case-control analysis; 16,286 male participants without previously diagnosed diabetes were included. Prediabetes and NDM were diagnosed using the oral glucose tolerance test. The cohort included 6,913 non-smokers (42.4%), 1,479 ex-smokers (9.1%) and 7,894 current smokers (48.5%). Age-adjusted glucose concentrations (mmol/L) were significantly lower at fasting and 120 min in current smokers than non-smokers (5.25 vs. 5.30, 6.46 vs. 6.55, respectively, both P < 0.01). After adjustment for demographic and behavioral variables (age, region, alcohol consumption status, physical activity, education, and family history of diabetes), logistic regression revealed significant negative associations between smoking and NDM in males of a normal weight (BMI < 25 kg/m(2): adjusted odds ratio [AOR] = 0.75, P = 0.007; waist circumference < 90 cm: AOR = 0.71, P = 0.001) and males living in southern China (AOR = 0.75, P = 0.009), but not in males who were overweight/obese, males with central obesity, or males living in northern China. Compared to non-smokers, current smokers were less likely to be centrally obese or have elevated BP (AOR: 0.82 and 0.74, both P < 0.05), and heavy smokers (>= 20 pack-years) were less likely to have elevated TG (AOR = 0.84, P = 0.012) among males of a normal weight. There were no significant associations between quitting smoking and metabolic disorders either among males of a normal weight or males who were overweight/obese. In conclusion, smokers have a lower likelihood of NDM than non-smokers among Chinese males with a lower BMI/smaller waist.	[Hou, Xuhong; Qiu, Jieyuzhen; Chen, Peizhu; Lu, Jun; Ma, Xiaojing; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Dept Endocrinol & Metab,Shanghai Clin Ctr Diabet, Shanghai 200030, Peoples R China; [Lu, Juming] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Endocrinol & Metab, Guangzhou 510275, Guangdong, Peoples R China; [Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China; [Shan, Zhongyan] China Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Shenyang 110001, Liaoning, Peoples R China; [Liu, Jie] Shanxi Prov Peoples Hosp, Dept Endocrinol & Metab, Taiyuan, Shanxi, Peoples R China; [Tian, Haoming] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610064, Sichuan, Peoples R China; [Ji, Qiuhe] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol & Metab, Xian 710032, Shaanxi, Peoples R China; [Zhu, Dalong] Nanjing Univ, Affiliated Drum Tower Hosp, Sch Med, Dept Endocrinol & Metab, Nanjing 210008, Jiangsu, Peoples R China; [Ge, Jiapu] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Endocrinol & Metab, Urumqi, Xinjiang, Peoples R China; [Lin, Lixiang] Fujian Prov Hosp, Dept Endocrinol & Metab, Fuzhou, Fujian, Peoples R China; [Chen, Li] Shandong Univ, Qilu Hosp, Dept Endocrinol & Metab, Jinan, Shandong, Peoples R China; [Guo, Xiaohui] Peking Univ, Hosp 1, Dept Endocrinol & Metab, Beijing 100871, Peoples R China; [Zhou, Zhiguang] Henan Prov Peoples Hosp, Dept Endocrinol & Metab, Zhengzhou, Henan, Peoples R China; [Li, Qiang] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol & Metab, Harbin, Heilongjiang, Peoples R China; [Zhou, Zhiguang] Cent S Univ, Xiangya Hosp 2, Dept Endocrinol & Metab, Changsha, Hunan, Peoples R China; [Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China	Shanghai Jiao Tong University; Chinese People's Liberation Army General Hospital; Sun Yat Sen University; Peking University; China Medical University; Shanxi People's Hospital; Sichuan University; Air Force Military Medical University; Nanjing University; Fujian Provincial Hospital; Shandong University; Peking University; Zhengzhou University; Harbin Medical University; Central South University; China-Japan Friendship Hospital	Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Dept Endocrinol & Metab,Shanghai Clin Ctr Diabet, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	Linong, Ji/AAB-6543-2020	Weng, Jianping/0000-0002-7889-1697; Zhou, Zhiguang/0000-0002-0374-1838	Chinese Medical Association Foundation; Chinese Diabetes Society [07020470055]	Chinese Medical Association Foundation; Chinese Diabetes Society	This study was supported by grants from the Chinese Medical Association Foundation and the Chinese Diabetes Society (grant numbers: 07020470055). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens W, 2005, HDB EPIDEMIOLOGY, P15; [Anonymous], 2007, ZHONGHUA XIN XUE GUA, V35, P390, DOI DOI 10.3760/J.ISSN:0253-3758.2007.05.003; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beziaud F, 2004, DIABETES METAB, V30, P161, DOI 10.1016/S1262-3636(07)70102-7; Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Canoy D, 2005, OBES RES, V13, P1466, DOI 10.1038/oby.2005.177; CEDERHOLM J, 1990, DIABETES RES CLIN PR, V10, P167, DOI 10.1016/0168-8227(90)90040-Z; Chen CC, 2008, METABOLISM, V57, P544, DOI 10.1016/j.metabol.2007.11.018; Cho NH, 2009, CLIN ENDOCRINOL, V71, P679, DOI 10.1111/j.1365-2265.2009.03586.x; Collins LC, 1996, METABOLISM, V45, P923, DOI 10.1016/S0026-0495(96)90256-5; Daniel M, 2004, DIABETIC MED, V21, P188, DOI 10.1046/j.1464-5491.2003.01064.x; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; Fukushima M, 1999, DIABETES CARE, V22, P1911, DOI 10.2337/diacare.22.11.1911; GREEN MS, 1986, AM HEART J, V111, P932, DOI 10.1016/0002-8703(86)90645-9; HOFSTETTER A, 1986, NEW ENGL J MED, V314, P79, DOI 10.1056/NEJM198601093140204; Hou XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057319; International Diabetes Federation, 2013, IDF DIABETES ATLAS; JANZON L, 1983, DIABETOLOGIA, V25, P86; Ko GTC, 2001, POSTGRAD MED J, V77, P240, DOI 10.1136/pmj.77.906.240; Lee WY, 2005, DIABETES RES CLIN PR, V67, P70, DOI 10.1016/j.diabres.2004.05.006; Lindberg S, 2015, EUR J PREV CARDIOL, V22, P276, DOI 10.1177/2047487313514894; Luepker R. V., 2004, CARDIOVASCULAR SURVE; Lycett D, 2015, LANCET DIABETES ENDO, V3, P423, DOI 10.1016/S2213-8587(15)00082-0; Masulli M, 2006, NUTR METAB CARDIOVAS, V16, P364, DOI 10.1016/j.numecd.2005.06.005; Meisinger C, 2006, DIABETOLOGIA, V49, P1770, DOI 10.1007/s00125-006-0298-0; Nagaya T, 2008, ANN EPIDEMIOL, V18, P113, DOI 10.1016/j.annepidem.2007.07.107; Njolstad I, 1998, AM J EPIDEMIOL, V147, P49; Ntuk UE, 2014, DIABETES CARE, V37, P2500, DOI 10.2337/dc13-2966; Oh SW, 2005, DIABETES CARE, V28, P2064, DOI 10.2337/diacare.28.8.2064; Onat A, 2007, ATHEROSCLEROSIS, V193, P380, DOI 10.1016/j.atherosclerosis.2006.07.002; Onat A, 2012, CLIN BIOCHEM, V45, P37, DOI 10.1016/j.clinbiochem.2011.10.002; Pan A, 2015, LANCET DIABETES ENDO, V3, P958, DOI 10.1016/S2213-8587(15)00316-2; Pearce N, 2005, HDB EPIDEMIOLOGY, p[116, 371]; Seeley RJ, 2011, NATURE, V475, P176, DOI 10.1038/475176a; Shi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077919; Soulimane S, 2014, DIABETOLOGIA, V57, P30, DOI 10.1007/s00125-013-3058-y; Spijkerman AMW, 2014, DIABETES CARE, V37, P3164, DOI 10.2337/dc14-1020; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047791; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tsai AC, 2015, CLIN NUTR, V34, P937, DOI 10.1016/j.clnu.2014.09.021; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wareham NJ, 1996, METABOLISM, V45, P1551, DOI 10.1016/S0026-0495(96)90187-0; Will JC, 2001, INT J EPIDEMIOL, V30, P540, DOI 10.1093/ije/30.3.540; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP; Xu F, 2007, ASIA PAC J CLIN NUTR, V16, P240; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005; Zhang LX, 2011, DIABETES CARE, V34, P892, DOI 10.2337/dc10-2087; Zhu YX, 2011, BIOMED ENVIRON SCI, V24, P475, DOI 10.3967/0895-3988.2011.05.004	51	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0149234	10.1371/journal.pone.0149234	http://dx.doi.org/10.1371/journal.pone.0149234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954355	Green Submitted, Green Published, gold			2022-12-27	WOS:000371991300006
J	Li, XH; Cui, J; Yu, Y; Li, W; Hou, YJ; Wang, X; Qin, DP; Zhao, C; Yao, XS; Zhao, J; Pei, G				Li, Xiaohang; Cui, Jin; Yu, Yang; Li, Wei; Hou, Yujun; Wang, Xin; Qin, Dapeng; Zhao, Cun; Yao, Xinsheng; Zhao, Jian; Pei, Gang			Traditional Chinese Nootropic Medicine Radix Polygalae and Its Active Constituent Onjisaponin B Reduce beta-Amyloid Production and Improve Cognitive Impairments	PLOS ONE			English	Article							GAMMA-SECRETASE CLEAVAGE; PRECURSOR PROTEIN TRAFFICKING; TARGET-DIRECTED LIGANDS; ALZHEIMERS-DISEASE; THERAPEUTIC STRATEGIES; TRANSMEMBRANE DOMAIN; CASCADE HYPOTHESIS; MOUSE MODEL; WATER-MAZE; IN-VIVO	Decline of cognitive function is the hallmark of Alzheimer's disease (AD), regardless of the pathological mechanism. Traditional Chinese medicine has been used to combat cognitive impairments and has been shown to improve learning and memory. Radix Polygalae (RAPO) is a typical and widely used herbal medicine. In this study, we aimed to follow the beta-amyloid (A beta) reduction activity to identify active constituent(s) of RAPO. We found that Onjisaponin B of RAPO functioned as RAPO to suppress A beta production without direct inhibition of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) and gamma-secretase activities. Our mechanistic study showed that Onjisaponin B promoted the degradation of amyloid precursor protein (APP). Further, oral administration of Onjisaponin B ameliorated A beta pathology and behavioral defects in APP/PS1 mice. Taken together, our results indicate that Onjisaponin B is effective against AD, providing a new therapeutic agent for further drug discovery.	[Li, Xiaohang; Cui, Jin; Li, Wei; Hou, Yujun; Wang, Xin; Zhao, Cun; Zhao, Jian; Pei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China; [Li, Xiaohang; Cui, Jin; Li, Wei; Wang, Xin; Zhao, Cun] Chinese Acad Sci, Univ Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Yu, Yang; Qin, Dapeng; Yao, Xinsheng] Jinan Univ, Coll Pharm, Inst Tradit Chinese Med & Nat Prod, Guangzhou, Guangdong, Peoples R China; [Zhao, Jian] Tongji Univ, Shanghai East Hosp, Sch Med, Translat Med Ctr Stem Cell Therapy, Shanghai 200092, Peoples R China; [Pei, Gang] Tongji Univ, Collaborat Innovat Ctr Brain Sci, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jinan University; Tongji University; Tongji University	Zhao, J; Pei, G (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China.; Zhao, J (corresponding author), Tongji Univ, Shanghai East Hosp, Sch Med, Translat Med Ctr Stem Cell Therapy, Shanghai 200092, Peoples R China.; Pei, G (corresponding author), Tongji Univ, Collaborat Innovat Ctr Brain Sci, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	jzhao@sibs.ac.cn; gpei@sibs.ac.cn	Hou, Yujun/AFX-2626-2022; Zhao, Jian/E-2008-2019	Zhao, Jian/0000-0002-8862-0591; Li, Xiaohang/0000-0002-7316-2196; Hou, Yujun/0000-0003-1778-1176; Wang, Xin/0000-0001-6250-910X	National Natural Science Foundation of China [31371419]; Ministry of Health [2012BAI10B03]; Shanghai Municipal Commission for Science and Technology [13401900600, 14DZ1900402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health; Shanghai Municipal Commission for Science and Technology	This research was supported by the National Natural Science Foundation of China (31371419), Ministry of Health (2012BAI10B03) and Shanghai Municipal Commission for Science and Technology (13401900600, 14DZ1900402).	Agholme L, 2012, J ALZHEIMERS DIS, V31, P343, DOI 10.3233/JAD-2012-120001; Agis-Torres A, 2014, CURR NEUROPHARMACOL, V12, P2, DOI 10.2174/1570159X113116660047; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Bai XF, 2009, THROMB HAEMOSTASIS, V102, P1212, DOI 10.1160/TH09-01-0038; Bajda M, 2011, CURR MED CHEM, V18, P4949, DOI 10.2174/092986711797535245; Baranello RJ, 2015, CURR ALZHEIMER RES, V12, P32, DOI 10.2174/1567205012666141218140953; Bunnell WL, 1998, J BIOL CHEM, V273, P31947, DOI 10.1074/jbc.273.48.31947; Cavieres VA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136313; Cheong MH, 2011, J ETHNOPHARMACOL, V137, P1402, DOI 10.1016/j.jep.2011.08.008; Choi JG, 2011, J ETHNOPHARMACOL, V134, P414, DOI 10.1016/j.jep.2010.12.030; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cui J, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.21; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 2015, ANNU REV PHARMACOL, V55, P419, DOI 10.1146/annurev-pharmtox-010814-124309; Di Domenico F, 2013, BBA-MOL BASIS DIS, V1832, P1249, DOI 10.1016/j.bbadis.2013.04.013; El Ayadi A, 2012, P NATL ACAD SCI USA, V109, P13416, DOI 10.1073/pnas.1206786109; Gallagher JJ, 2013, NEURODEGENER DIS, V11, P33, DOI 10.1159/000337458; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; GIANNAKOPOULOS P, 1994, ACTA NEUROPATHOL, V87, P456; Guzior N, 2015, CURR MED CHEM, V22, P373; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HEINONEN O, 1995, NEUROSCIENCE, V64, P375, DOI 10.1016/0306-4522(94)00422-2; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Hou YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111215; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jardanhazi-Kurutz D, 2010, NEUROCHEM INT, V57, P375, DOI 10.1016/j.neuint.2010.02.001; Jiang Yong LJ, China patent CN, Patent No. [1315497C. 2005 2005-07-20, 1315497C]; Jung ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep08805; Karakida F, 2007, BIOL PHARM BULL, V30, P514, DOI 10.1248/bpb.30.514; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lin ZH, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/692621; Liu P, 2010, PHYTOMEDICINE, V17, P794, DOI 10.1016/j.phymed.2010.01.004; Liu P, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/642128; Liu XS, 2013, CELL RES, V23, P351, DOI 10.1038/cr.2012.167; May BH, 2013, J ACUPUNCT MERIDIAN, V6, P2, DOI 10.1016/j.jams.2012.11.009; McKinnon C, 2014, ANTIOXID REDOX SIGN, V21, P2302, DOI 10.1089/ars.2013.5802; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murphy MP, 2000, J BIOL CHEM, V275, P26277, DOI 10.1074/jbc.M002812200; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nijholt DAT, 2011, CURR MED CHEM, V18, P2459; Nunan J, 2003, J NEUROSCI RES, V74, P378, DOI 10.1002/jnr.10646; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Oh JJ, 2013, TROP J PHARM RES, V12, P755, DOI 10.4314/tjpr.v12i5.14; Parihar MS, 2004, J CLIN NEUROSCI, V11, P456, DOI 10.1016/j.jocn.2003.12.007; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; RICHTERRUOFF B, 1992, FEBS LETT, V302, P192, DOI 10.1016/0014-5793(92)80438-M; Sommer B, 2002, CURR OPIN PHARMACOL, V2, P87, DOI 10.1016/S1471-4892(01)00126-6; Steinhilb ML, 2002, J NEUROCHEM, V80, P1019, DOI 10.1046/j.0022-3042.2002.00764.x; Sun Yan, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P1199; Sun ZK, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-6; Svedruzic ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050759; TAGAWA K, 1991, BIOCHEM BIOPH RES CO, V177, P377, DOI 10.1016/0006-291X(91)91994-N; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tischer E, 1996, J BIOL CHEM, V271, P21914, DOI 10.1074/jbc.271.36.21914; Tomita Taisuke, 2012, Rinsho Shinkeigaku, V52, P1165; Villegas S, 2015, MED CLIN-BARCELONA, V145, P76, DOI 10.1016/j.medcli.2014.05.023; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang X, 2015, J ALZHEIMERS DIS, V47, P927, DOI 10.3233/JAD-150313; Wang Y, 2015, J ALZHEIMERS DIS, V45, P1185, DOI 10.3233/JAD-143183; Watanabe T, 2012, J NEUROSCI, V32, P3352, DOI 10.1523/JNEUROSCI.5659-11.2012; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Weitz TM, 2014, AM J PATHOL, V184, P2855, DOI 10.1016/j.ajpath.2014.07.004; West S, 2015, BRIT J CLIN PHARMACO, V80, P221, DOI 10.1111/bcp.12621; Wu AG, 2013, INT J MOL SCI, V14, P22618, DOI 10.3390/ijms141122618; Yabe T, 1997, PHYTOMEDICINE, V4, P199, DOI 10.1016/S0944-7113(97)80068-2; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200; Younkin SG, 1991, BRAIN PATHOL, V1, P253, DOI 10.1111/j.1750-3639.1991.tb00668.x; Zhang H, 2008, PHYTOMEDICINE, V15, P587, DOI 10.1016/j.phymed.2007.12.004; Zhao H, 2015, MOL MED REP, V12, P2771, DOI 10.3892/mmr.2015.3781	77	33	46	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151147	10.1371/journal.pone.0151147	http://dx.doi.org/10.1371/journal.pone.0151147			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954017	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300088
J	Partos, TR; Cropper, SJ; Rawlings, D				Partos, Timea R.; Cropper, Simon J.; Rawlings, David			You Don't See What I See: Individual Differences in the Perception of Meaning from Visual Stimuli	PLOS ONE			English	Article							SPATIAL-FREQUENCY; BRAIN MECHANISMS; WORKING-MEMORY; NATURAL IMAGES; SCHIZOTYPY; PSYCHOSIS; CONTRAST; BELIEF; FACES; NOISE	Everyone has their own unique version of the visual world and there has been growing interest in understanding the way that personality shapes one's perception. Here, we investigated meaningful visual experiences in relation to the personality dimension of schizotypy. In a novel approach to this issue, a non-clinical sample of subjects (total n = 197) were presented with calibrated images of scenes, cartoons and faces of varying visibility embedded in noise; the spatial properties of the images were constructed to mimic the natural statistics of the environment. In two experiments, subjects were required to indicate what they saw in a large number of unique images, both with and without actual meaningful structure. The first experiment employed an open-ended response paradigm and used a variety of different images in noise; the second experiment only presented a series of faces embedded in noise, and required a forced-choice response from the subjects. The results in all conditions indicated that a high positive schizotypy score was associated with an increased tendency to perceive complex meaning in images comprised purely of random visual noise. Individuals high in positive schizotypy seemed to be employing a looser criterion (response bias) to determine what constituted a 'meaningful' image, while also being significantly less sensitive at the task than those low in positive schizotypy. Our results suggest that differences in perceptual performance for individuals high in positive schizotypy are not related to increased suggestibility or susceptibility to instruction, as had previously been suggested. Instead, the observed reductions in sensitivity along with increased response bias toward seeing something that is not there, indirectly implicated subtle neurophysiological differences associated with the personality dimension of schizotypy, that are theoretically pertinent to the continuum of schizophrenia and hallucination-proneness.	[Cropper, Simon J.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Partos, Timea R.] Kings Coll London, Natl Addict Ctr, 4 Windsor Walk,Denmark Hill, London SE5 8BB, England	University of Melbourne; University of London; King's College London	Cropper, SJ (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	scropper@unimelb.edu.au	Rawlings, David/CAI-4751-2022	Partos, Timea/0000-0002-4049-9200; Cropper, Simon James/0000-0002-3574-6414				Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012; [Anonymous], 2006, MATLAB; Badcock Johanna C, 2005, Cogn Neuropsychiatry, V10, P125, DOI 10.1080/13546800344000363; Balcetis E, 2006, J PERS SOC PSYCHOL, V91, P612, DOI 10.1037/0022-3514.91.4.612; Barrantes-Vidal N, 2013, J ABNORM PSYCHOL, V122, P1077, DOI 10.1037/a0034793; Behrendt RP, 2004, BEHAV BRAIN SCI, V27, P771, DOI 10.1017/S0140525X04000184; BENTALL RP, 1990, PSYCHOL BULL, V107, P82, DOI 10.1037/0033-2909.107.1.82; Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; Blackmore Susan, 1994, EUROPEAN J PARAPSYCH, V10, P91; Bosten JM, 2008, PERCEPTION, V37, P105; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bressan P, 2002, APPL COGNITIVE PSYCH, V16, P17, DOI 10.1002/acp.754; BRUGGER P, 1993, PSYCHOPATHOLOGY, V26, P261, DOI 10.1159/000284831; CAMPBELL FW, 1965, J PHYSIOL-LONDON, V181, P576, DOI 10.1113/jphysiol.1965.sp007784; Cella M, 2007, PERS INDIV DIFFER, V43, P59, DOI 10.1016/j.paid.2006.11.007; CHAPMAN LJ, 1994, J ABNORM PSYCHOL, V103, P171, DOI 10.1037/0021-843X.103.2.171; Claridge G, 1996, BRIT J CLIN PSYCHOL, V35, P103, DOI 10.1111/j.2044-8260.1996.tb01166.x; Claridge G.S., 1997, SCHIZOTYPY IMPLICATI; Cropper Simon J, 2005, Behav Cogn Neurosci Rev, V4, P192, DOI 10.1177/1534582305285120; Cropper SJ, 2011, PERCEPTION; Cropper SJ, 2014, NATURE MAKES ABSTRAC; Cropper SJ, 2011, AUSTR J PSYCHOL; Cropper SJ, 2014, PERCEPTION VSAC ABST; DAITCH JM, 1969, VISION RES, V9, P947, DOI 10.1016/0042-6989(69)90100-X; Dakin S, 2005, CURR BIOL, V15, pR822, DOI 10.1016/j.cub.2005.10.015; ECKBLAD M, 1983, J CONSULT CLIN PSYCH, V51, P215, DOI 10.1037/0022-006X.51.2.215; Eysenck H.J., 1967, BIOL BASIS PERSONALI; Farias M, 2005, PERS INDIV DIFFER, V39, P979, DOI 10.1016/j.paid.2005.04.003; Feigelson EM, 1984, RAD CLOUDY ATMOSPHER, P4; Ffytche DH, 1996, NEUROIMAGE, V3, P104, DOI 10.1006/nimg.1996.0012; Field DJ, 1997, VISION RES, V37, P3367, DOI 10.1016/S0042-6989(97)00181-8; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Friston KJ, 2002, PROG NEUROBIOL, V68, P113, DOI 10.1016/S0301-0082(02)00076-X; Gosselin F, 2003, PSYCHOL SCI, V14, P505, DOI 10.1111/1467-9280.03452; Goto SG, 2010, SOC COGN AFFECT NEUR, V5, P242, DOI 10.1093/scan/nsp038; Green DM, 1966, SIGNAL DETECTION THE; Grossberg S, 2000, J INT NEUROPSYCH SOC, V6, P583, DOI 10.1017/S135561770065508X; GUDJONSSON GH, 1984, PERS INDIV DIFFER, V5, P303, DOI 10.1016/0191-8869(84)90069-2; Hansen BC, 2008, VISION RES, V48, P2523, DOI 10.1016/j.visres.2008.08.016; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; Hesselmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009926; Hesselmann G, 2008, J NEUROSCI, V28, P14481, DOI 10.1523/JNEUROSCI.4398-08.2008; Iacobucci D, 2015, J CONSUM PSYCHOL, V25, P690, DOI 10.1016/j.jcps.2015.06.014; Iacobucci D, 2015, J CONSUM PSYCHOL, V25, P652, DOI 10.1016/j.jcps.2014.12.002; JAKES S, 1986, PERS INDIV DIFFER, V7, P121, DOI 10.1016/0191-8869(86)90118-2; Keilp JG, 2007, PSYCHIAT RES, V149, P139, DOI 10.1016/j.psychres.2006.09.014; Kent BW, 2011, SCHIZOPHR RES, V127, P144, DOI 10.1016/j.schres.2010.05.013; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Koychev I, 2011, NEUROPSYCHOLOGIA, V49, P2866, DOI 10.1016/j.neuropsychologia.2011.06.012; Krummenacher P, 2010, J COGNITIVE NEUROSCI, V22, P1670, DOI 10.1162/jocn.2009.21313; Lau HC, 2008, PROG BRAIN RES, V168, P35, DOI 10.1016/S0079-6123(07)68004-2; Lin A, 2013, COMPR PSYCHIAT, V54, P173, DOI 10.1016/j.comppsych.2012.06.011; Loftus GR, 2004, J EXP PSYCHOL HUMAN, V30, P104, DOI 10.1037/0096-1523.30.1.104; Macmillan N. A., 1991, DETECTION THEORY USE; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; MASON O, 1995, PERS INDIV DIFFER, V18, P7, DOI 10.1016/0191-8869(94)00132-C; Mason O, 2006, SCHIZOPHR RES, V82, P203, DOI 10.1016/j.schres.2005.12.845; Mason O., 1997, SCHIZOTYPY IMPLICATI, P19, DOI [10.1093/med:psych/9780198523536.003.0002, DOI 10.1093/MED:PSYCH/9780198523536.003.0002]; McClelland GH, 2015, J CONSUM PSYCHOL, V25, P679, DOI 10.1016/j.jcps.2015.05.006; MCCOLLOUGH C, 1965, SCIENCE, V149, P1115, DOI 10.1126/science.149.3688.1115; McCreery C, 1996, PERS INDIV DIFFER, V21, P739, DOI 10.1016/0191-8869(96)00115-8; Meese TS, 2005, J VISION, V5, P928, DOI 10.1167/5.11.2; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Mohr C, 2015, SCHIZOPHRENIA BULL, V41, pS436, DOI 10.1093/schbul/sbu185; Morita T, 2004, NEUROIMAGE, V21, P1665, DOI 10.1016/j.neuroimage.2003.12.019; Nelson MT, 2013, NEUROSCI BIOBEHAV R, V37, P317, DOI 10.1016/j.neubiorev.2013.01.004; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Partos T, 2012, HALLUCINATION PRONEN; Pelli D.G, 1981, EFFECTS VISUAL NOISE; Pelli DG, 1999, J OPT SOC AM A, V16, P647, DOI 10.1364/JOSAA.16.000647; Phillips WA, 2004, PERCEPTION, V33, P79, DOI 10.1068/p5110; Reed P, 2008, J BEHAV THER EXP PSY, V39, P276, DOI 10.1016/j.jbtep.2007.07.005; Rensink RA, 2000, VISION RES, V40, P1469, DOI 10.1016/S0042-6989(00)00003-1; Riekki T, 2012, APPL COGNITIVE PSYCH; Riekki T, 2014, SOC NEUROSCI-UK, V9, P400, DOI 10.1080/17470919.2014.906366; Rieth CA, 2011, I-PERCEPTION, V2, P458, DOI 10.1068/i0421; Righart R, 2010, CEREB CORTEX, V20, P1878, DOI 10.1093/cercor/bhp254; Roalf D, 2006, BRAIN COGNITION, V60, P32, DOI 10.1016/j.bandc.2005.09.008; Rossler W, 2013, SCHIZOPHR RES, V150, P197, DOI 10.1016/j.schres.2013.07.042; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rucker DD, 2015, J CONSUM PSYCHOL, V25, P666, DOI 10.1016/j.jcps.2015.04.004; Schmack K, 2013, J NEUROSCI, V33, P13701, DOI 10.1523/JNEUROSCI.1778-13.2013; SHEEHAN PW, 1967, J CLIN PSYCHOL, V23, P386, DOI 10.1002/1097-4679(196707)23:3<386::AID-JCLP2270230328>3.0.CO;2-S; SILVERSTEIN SM, 1992, J ABNORM PSYCHOL, V101, P265, DOI 10.1037/0021-843X.101.2.265; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Simoncelli EP, 2003, TRENDS COGN SCI, V7, P51, DOI 10.1016/S1364-6613(02)00043-8; Smith ML, 2012, CURR BIOL, V22, P191, DOI 10.1016/j.cub.2011.11.061; SOLOMON JA, 1994, NATURE, V369, P395, DOI 10.1038/369395a0; Tanner Jr WP, 1954, T IRE PROF GROUP INF, P213, DOI DOI 10.1109/TIT.1954.1057461; Tsakanikos E, 2005, BRIT J CLIN PSYCHOL, V44, P295, DOI 10.1348/014466505X28757; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; Wang MG, 2013, P NATL ACAD SCI USA, V110, pE3350, DOI 10.1073/pnas.1221945110; Wild HA, 2004, PSYCHON B REV, V11, P475, DOI 10.3758/BF03196598; Willmore B, 2000, PERCEPTION, V29, P1017, DOI 10.1068/p2963; Winterer G, 2004, AM J PSYCHIAT, V161, P490, DOI 10.1176/appi.ajp.161.3.490; Woods RL, 2010, INVEST OPHTH VIS SCI, V51, P6077, DOI 10.1167/iovs.09-5013; Yuille AL, 1996, PERCEPTION BAYESIAN, P123, DOI DOI 10.1017/CBO9780511984037.006	97	29	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150615	10.1371/journal.pone.0150615	http://dx.doi.org/10.1371/journal.pone.0150615			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SW	26954696	Green Published, gold			2022-12-27	WOS:000371991300035
J	Schumacher, SG; Sohn, H; Qin, ZZ; Gore, G; Davis, JL; Denkinger, CM; Pai, M				Schumacher, Samuel G.; Sohn, Hojoon; Qin, Zhi Zhen; Gore, Genevieve; Davis, J. Lucian; Denkinger, Claudia M.; Pai, Madhukar			Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study Methodologies	PLOS ONE			English	Review							MULTIDRUG-RESISTANT TUBERCULOSIS; INTERRUPTED TIME-SERIES; XPERT MTB/RIF ASSAY; CAUSAL-INFERENCE; INSTRUMENTAL VARIABLES; PULMONARY TUBERCULOSIS; QUALITY ASSESSMENT; MTBDRPLUS ASSAY; CARE; REGRESSION	Background Several reviews on the accuracy of Tuberculosis (TB) Nucleic Acid Amplification Tests (NAATs) have been performed but the evidence on their impact on patient-important outcomes has not been systematically reviewed. Given the recent increase in research evaluating such outcomes and the growing list of TB NAATs that will reach the market over the coming years, there is a need to bring together the existing evidence on impact, rather than accuracy. We aimed to assess the approaches that have been employed to measure the impact of TB NAATs on patient-important outcomes in adults with possible pulmonary TB and/or drug-resistant TB. Methods We first develop a conceptual framework to clarify through which mechanisms the improved technical performance of a novel TB test may lead to improved patient outcomes and outline which designs may be used to measure them. We then systematically review the literature on studies attempting to assess the impact of molecular TB diagnostics on such outcomes and provide a narrative synthesis of designs used, outcomes assessed and risk of bias across different study designs. Results We found 25 eligible studies that assessed a wide range of outcomes and utilized a variety of experimental and observational study designs. Many potentially strong design options have never been used. We found that much of the available evidence on patient-important outcomes comes from a small number of settings with particular epidemiological and operational context and that confounding, time trends and incomplete outcome data receive insufficient attention. Conclusions A broader range of designs should be considered when designing studies to assess the impact of TB diagnostics on patient outcomes and more attention needs to be paid to the analysis as concerns about confounding and selection bias become relevant in addition to those on measurement that are of greatest concern in accuracy studies.	[Schumacher, Samuel G.; Sohn, Hojoon; Qin, Zhi Zhen; Denkinger, Claudia M.; Pai, Madhukar] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Schumacher, Samuel G.; Sohn, Hojoon; Qin, Zhi Zhen; Denkinger, Claudia M.; Pai, Madhukar] McGill Int TB Ctr, Montreal, PQ, Canada; [Gore, Genevieve] McGill Univ, Schulich Lib Sci & Engn, Montreal, PQ, Canada; [Davis, J. Lucian] UCSF Pulm & Crit Care Med, San Francisco, CA USA; [Denkinger, Claudia M.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA	McGill University; McGill University; Harvard University; Beth Israel Deaconess Medical Center	Pai, M (corresponding author), McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada.; Pai, M (corresponding author), McGill Int TB Ctr, Montreal, PQ, Canada.	madhukar.pai@mcgill.ca	Sohn, Hojoon/AAL-2856-2020; Davis, J. Lucian/AAC-8376-2019; PAL, MRINAL/ABG-9676-2020; Gore, Genevieve/CAF-4925-2022; Pai, Madhukar/AAX-9901-2021	Sohn, Hojoon/0000-0001-5837-3844; Davis, J. Lucian/0000-0002-8629-9992; PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Schumacher, Samuel G/0000-0002-6136-206X; Gore, Genevieve/0000-0003-1072-2683; Qin, Zhi Zhen/0000-0002-3956-5223	Canadian Institutes of Health Research, Ottawa, ONT, Canada [MOP-89918]; Fonds de Recherche du Quebec - Sante, Montreal, QC, USA; Richard Tomlinson Fellowship at McGill University; Burroughs-Wellcome Fund from the American Society of Tropical Medicine and Hygiene, Deerfield, IL, USA; Max Binz Fellowship at McGill University; Fonds de Recherche du Quebec-Sante, Montreal, QC, USA	Canadian Institutes of Health Research, Ottawa, ONT, Canada(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec - Sante, Montreal, QC, USA; Richard Tomlinson Fellowship at McGill University; Burroughs-Wellcome Fund from the American Society of Tropical Medicine and Hygiene, Deerfield, IL, USA; Max Binz Fellowship at McGill University; Fonds de Recherche du Quebec-Sante, Montreal, QC, USA	This project was funded by a grant from the Canadian Institutes of Health Research, Ottawa, ONT, Canada (grants MOP-89918). MP is supported by the Fonds de Recherche du Quebec - Sante, Montreal, QC, USA. CMD was supported by a Richard Tomlinson Fellowship at McGill University and a fellowship of the Burroughs-Wellcome Fund from the American Society of Tropical Medicine and Hygiene, Deerfield, IL, USA. SGS was supported by the Max Binz Fellowship at McGill University. The funders had no role in the study design, data collection, analysis, decision to publish, or manuscript preparation.; This project was funded by a grant from the Canadian Institutes of Health Research, Ottawa, ONT, Canada (grants MOP-89918). MP is supported by the Fonds de Recherche du Quebec-Sante, Montreal, QC, USA. CMD was supported by a Richard Tomlinson Fellowship at McGill University and a fellowship of the Burroughs-Wellcome Fund from the American Society of Tropical Medicine and Hygiene, Deerfield, IL, USA. SGS was supported by the Max Binz Fellowship at McGill University. The funders had no role in the study design, data collection, analysis, decision to publish, or manuscript preparation.	AHRQ, 2012, METH GUID MED TEST R, P1; AHRQ, 2013, METH GUID EFF COMP E; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Anderson LM, 2011, RES SYNTH METHODS, V2, P33, DOI 10.1002/jrsm.32; Angrist J, 2001, INSTRUMENTAL VARIABL, DOI [10.3386/w8456, DOI 10.3386/W8456]; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Arnold BF, 2010, P NATL ACAD SCI USA, V107, P22605, DOI 10.1073/pnas.1008944107; Balcells ME, 2012, INT J TUBERC LUNG D, V16, P1349, DOI 10.5588/ijtld.12.0156; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Bor J, 2015, EPIDEMIOLOGY, V26, pE28, DOI 10.1097/EDE.0000000000000256; Bor J, 2014, EPIDEMIOLOGY, V25, P729, DOI 10.1097/EDE.0000000000000138; Bossuyt PMM, 2012, CLIN CHEM, V58, P1636, DOI 10.1373/clinchem.2012.182576; Bradley E, 1993, MONOGRAPHS STAT APPL; Ramirez HLB, 2014, INT J TUBERC LUNG D, V18, P435, DOI 10.5588/ijtld.13.0747; Campbell Marion K, 2012, BMJ, V345, pe5661, DOI 10.1136/bmj.e5661; Chaisson LH, 2014, CLIN INFECT DIS, V59, P1353, DOI 10.1093/cid/ciu620; Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X; Cobelens F, 2012, J INFECT DIS, V205, pS191, DOI 10.1093/infdis/jis188; Cohen GM, 2014, J ACQ IMMUN DEF SYND, P1; Collaboration C, 2010, COCHR RISK BIAS TOOL; Collaboration The Cochrane, 2011, COD ET PROF PER VEN, P1; Cousens S, 2011, J EPIDEMIOL COMMUN H, V65, P576, DOI 10.1136/jech.2008.082610; Cox HS, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv014; Cox HS, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001760; Davis JL, 2014, AM J RESP CRIT CARE, V189, P1551, DOI 10.1164/rccm.201311-1974OC; Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814; Detjen AK, 2015, LANCET RESP MED, V3, P451, DOI 10.1016/S2213-2600(15)00095-8; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Durovni B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001766; Eldridge S, 2012, PRACTICAL GUIDE CLUS, DOI [10.1002/9781119966241.ch3, DOI 10.1002/9781119966241.CH3]; Friedmen LM, 2010, FUNDAMENTALS OF CLINICAL TRIALS, FOURTH EDITION, P1; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gertler PJ, 2011, IMPACT EVALUATION IN PRACTICE, P1, DOI 10.1596/978-0-8213-8541-8; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Greenland S, 2004, INT J EPIDEMIOL, V33, P1389, DOI 10.1093/ije/dyh276; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Greenland S, 2015, ANNU REV PUBL HEALTH, V36, P89, DOI 10.1146/annurev-publhealth-031914-122559; Groenwold RHH, 2014, CAN MED ASSOC J, V186, P1153, DOI 10.1503/cmaj.131353; Groenwold RHH, 2013, CAN MED ASSOC J, V185, P401, DOI 10.1503/cmaj.120592; Groenwold RHH, 2012, AM J EPIDEMIOL, V175, P210, DOI 10.1093/aje/kwr302; GUYATT GH, 1986, J CHRON DIS, V39, P295, DOI 10.1016/0021-9681(86)90051-2; GUYATT GH, 1986, CAN MED ASSOC J, V134, P587; Hanrahan CF, 2012, IMPACT EXPANDED TEST, V7, DOI [10.1371/journal.pone.0049898, DOI 10.1371/JOURNAL.PONE.0049898]; Hanrahan CF, 2013, TIME TREATMENT PATIE, V8, pe65421, DOI [10.1371/journal.pone.0065421.t003, DOI 10.1371/JOURNAL.PONE.0065421.T003]; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hayes RJ, 2009, INTERD STAT, P3; Hepple P, 2011, INT J TUBERC LUNG D, V15, P405; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Husereau D, 2013, EUR J HEALTH ECON, V14, P367, DOI 10.1007/s10198-013-0471-6; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Jacobson KR, 2013, CLIN INFECT DIS, V56, P503, DOI 10.1093/cid/cis920; Jani IV, 2013, NEW ENGL J MED, V368, P2319, DOI 10.1056/NEJMsb1214197; Khandker S.R., 2010, HDB IMPACT EVALUATIO; Kik SV, 2014, EUR RESPIR J, V43, P1793, DOI 10.1183/09031936.00217313; Kipiani M, 2014, CLIN INFECT DIS, V59, P1559, DOI 10.1093/cid/ciu631; Knottnerus JA, 2009, EVIDENCE BASE CLIN D, P1; Knottnerus JA, 2008, DIAGNOSTIC STUDY ASS, P83, DOI [10.1002/9781444300574.ch5, DOI 10.1002/9781444300574.CH5]; Kwak N, 2013, DIAGNOSTIC ACCURACY, V8, pe77456, DOI [10.1371/journal.pone.0077456.t006, DOI 10.1371/JOURNAL.PONE.0077456.T006]; Lagarde M, 2012, HEALTH POLICY PLANN, V27, P76, DOI 10.1093/heapol/czr004; Lam E, 2014, EMERG INFECT DIS, V20, P400, DOI 10.3201/eid2003.130951; Lash TL, 2014, INT J EPIDEMIOL, V43, P1969, DOI 10.1093/ije/dyu149; Lash TL, 2009, APPL QUANTITATIVE BI; Lee DS, 2009, REGRESSION DISCONTIN; Li TJ, 2015, ANN INTERN MED, V162, P287, DOI 10.7326/M14-1603; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Lippincott CK, 2014, CLIN INFECT DIS, V59, DOI 10.1093/cid/ciu212; Lord Sarah J, 2009, Med Decis Making, V29, pE1, DOI 10.1177/0272989X09340584; Lyu J, 2013, INT J TUBERC LUNG D, V17, P120, DOI 10.5588/ijtld.12.0197; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Martens EP, 2006, EPIDEMIOLOGY, V17, P260, DOI 10.1097/01.ede.0000215160.88317.cb; Meads CA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-3; Meyer BD, 1995, J BUSINESS EC STAT; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moons KG, 2014, EVALUATION NEW TECHN, P1; Moscoe E, 2015, J CLIN EPIDEMIOL, V68, P132, DOI 10.1016/j.jclinepi.2014.06.021; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Mupfumi L, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu038; Naidoo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103328; Oxlade O, 2013, METHODOLOGIC DIFFERE, V8, pe56044, DOI [10.1371/journal.pone.0056044.s008, DOI 10.1371/JOURNAL.PONE.0056044.S008]; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Pant-Pai N, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001306.t002, DOI 10.1371/JOURNAL.PMED.1001306.T002]; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Philips Z, 2004, HEALTH TECHNOL ASSES, V8, P1; Ramsay A, 2010, INT J TUBERC LUNG D, V14, P1506; Reddy EA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-89; Rockers PC, 2015, HEALTH POLICY, V119, P511, DOI 10.1016/j.healthpol.2014.10.006; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Ryan AM, 2015, HEALTH SERV RES, V50, P1211, DOI 10.1111/1475-6773.12270; Sauer BC, 2013, PHARMACOEPIDEM DR S, V22, P1139, DOI 10.1002/pds.3506; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Singla N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102989; Skenders G, 2011, INT J TUBERC LUNG D, V15, P1546, DOI 10.5588/ijtld.11.0067; Sohn H, 2014, CLIN INFECT DIS, V58, P970, DOI 10.1093/cid/ciu022; Squire SB, 2011, INT J TUBERC LUNG D, V15, P862, DOI 10.5588/ijtld.11.0161; Stall N, 2011, INT J TUBERC LUNG D, V15, P641, DOI 10.5588/ijtld.10.0195; Staub LP, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-12; Staub LP, 2012, INT J TECHNOL ASSESS, V28, P52, DOI 10.1017/S0266462311000717; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Sun AY, 2014, EUR RESPIR J, V44, P1366, DOI 10.1183/09031936.00111014; Swanson SA, 2013, EPIDEMIOLOGY, V24, P370, DOI 10.1097/EDE.0b013e31828d0590; Taljaard M, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-77; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Trikalinos Thomas A, 2009, Med Decis Making, V29, pE22, DOI 10.1177/0272989X09345022; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; Van Rie A, 2013, INT J TUBERC LUNG D, V17, P368, DOI 10.5588/ijtld.12.0392; Weyer K, 2011, WHO POLICY STATEMENT, P1; White H, 2009, J DEV EFFECT, V1, P271, DOI 10.1080/19439340903114628; Whiting P, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8250; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WHO, 2014, TECHN OP CONS IMPL H, P1; World Health Organization, GLOB TUB REP 2015; Yoon C, 2012, IMPACT XPERT MTB RIF, V7, pe48599, DOI [10.1371/journal.pone.0048599.t002, DOI 10.1371/JOURNAL.PONE.0048599.T002]; Zwerling A, 2013, EXPERT REV PHARM OUT, V13, P313, DOI [10.1586/erp.13.27, 10.1586/ERP.13.27]	120	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151073	10.1371/journal.pone.0151073	http://dx.doi.org/10.1371/journal.pone.0151073			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954678	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300081
J	Walker, RS; Kesler, DC; Hill, KR				Walker, Robert S.; Kesler, Dylan C.; Hill, Kim R.			Are Isolated Indigenous Populations Headed toward Extinction?	PLOS ONE			English	Article							EPIDEMICS	At least 50 indigenous groups spread across lowland South America remain isolated and have only intermittent and mostly hostile interactions with the outside world. Except in emergency situations, the current policy of governments in Brazil, Colombia, and Peru towards isolated tribes is a "leave them alone" strategy, in which isolated groups are left uncontacted. However, these no-contact policies are based on the assumption that isolated populations are healthy and capable of persisting in the face of mounting external threats, and that they can maintain population viability in the long-term. Here, we test this assumption by tracking the sizes and movements of cleared horticultural areas made by 8 isolated groups over the last 10-14 years. We used deforestation data derived from remote sensing Landsat satellite sensors to identify clearings, and those were then validated and assessed with high-resolution imagery. We found only a single example of a relatively large and growing population (c. 50 cleared ha and 400 people), whereas all of the other 7 groups exhibited much smaller villages and gardens with no sizable growth through time. These results indicated that the smaller groups are critically endangered, and it prompts an urgent re-thinking of policies toward isolated populations, including plans for well-organized contacts that may help save lives and rescue isolated indigenous populations from imminent extinction.	[Walker, Robert S.] Univ Missouri, Dept Anthropol, 200 Swallow Hall, Columbia, MO 65211 USA; [Kesler, Dylan C.] Inst Bird Populat, Point Reyes Stn, CA USA; [Hill, Kim R.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Hill, Kim R.] Arizona State Univ, Inst Human Origins, Tempe, AZ USA	University of Missouri System; University of Missouri Columbia; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Walker, RS (corresponding author), Univ Missouri, Dept Anthropol, 200 Swallow Hall, Columbia, MO 65211 USA.	walkerro@missouri.edu			National Geographic Society [9165-12, 9764-15]; University of Missouri Research Council and Research Board	National Geographic Society(National Geographic Society); University of Missouri Research Council and Research Board	Financial support was provided by grants from the National Geographic Society (#9165-12 and #9764-15) and University of Missouri Research Council and Research Board. The authors appreciate the investment of The Institute for Bird Populations for this published contribution number 516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AWB, 2014, POVOS INDIGENAS ISOL; [Anonymous], 2012, METAPOPULATION DYNAM; Beckerman S., 1987, COMP FARMING SYSTEMS, P55; BLACK FL, 1975, SCIENCE, V187, P515, DOI 10.1126/science.163483; BLACK FL, 1992, SCIENCE, V258, P1739, DOI 10.1126/science.1465610; Bodard L, 1974, GREEN HELL MASSACRE; Burivalova Z, 2015, BIOTROPICA, V47, P267, DOI 10.1111/btp.12194; Castillo BH, 2004, INDIGENOUS PEOPLES I; Chagnon N. A, 1976, NEW YORK ACAD SCI, V16, P14; CROSBY AW, 1976, WILLIAM MARY QUART, V33, P289, DOI 10.2307/1922166; Diamond Jared, 1993, DISCOVER, V14, P48; Hamilton MJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04541; Hanski I., 1999, METAPOPULATION ECOLO; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hemming J., 1978, RED GOLD CONQUEST BR; Hemming John, 2003, DIE YOU MUST BRAZILI; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Hurtado M, 2001, CURR ANTHROPOL, V42, P425, DOI 10.1086/320482; JORALEMON D, 1982, J ANTHROPOL RES, V38, P108, DOI 10.1086/jar.38.1.3629951; Justice CO, 2002, REMOTE SENS ENVIRON, V83, P244, DOI 10.1016/S0034-4257(02)00076-7; Kesler DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125113; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; MAC ARTHUR ROBERT H., 1967; Pappalardo SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066293; Potapov PV, 2012, REMOTE SENS ENVIRON, V122, P106, DOI 10.1016/j.rse.2011.08.027; R Core Team, 2018, R LANG ENV STAT COMP; Ricardo Beto, 2011, POVOS INDIGENAS BRAS; Shepard G. H. Jr., 2010, Journal of Sustainable Forestry, V29, P252, DOI 10.1080/10549810903548153; Vaz A, 2011, ISOLADOS BRASIL POLI; Walker RS, 2015, SCI REP-UK, V5, DOI 10.1038/srep14032; Walker RS, 2015, SCIENCE, V348, P1061, DOI 10.1126/science.aac6540; Walker RS, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140246; Walker RS, 2014, HUM NATURE-INT BIOS, V25, P465, DOI 10.1007/s12110-014-9209-0; Walker RS, 2014, AM J HUM BIOL, V26, P570, DOI 10.1002/ajhb.22552; Walker RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035025; Wallace S, 2011, SEARCH AMAZONS LAST; Wurm S. A, 2001, ATLAS WORLDS LANGUAG	37	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150987	10.1371/journal.pone.0150987	http://dx.doi.org/10.1371/journal.pone.0150987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954672	gold, Green Published, Green Submitted			2022-12-27	WOS:000371991300069
J	Buchfellner, A; Yurlova, L; Nuske, S; Scholz, AM; Bogner, J; Ruf, B; Zolghadr, K; Drexler, SE; Drexler, GA; Girst, S; Greubel, C; Reindl, J; Siebenwirth, C; Romer, T; Friedl, AA; Rothbauer, U				Buchfellner, Andrea; Yurlova, Larisa; Nueske, Stefan; Scholz, Armin M.; Bogner, Jacqueline; Ruf, Benjamin; Zolghadr, Kourosh; Drexler, Sophie E.; Drexler, Guido A.; Girst, Stefanie; Greubel, Christoph; Reindl, Judith; Siebenwirth, Christian; Romer, Tina; Friedl, Anna A.; Rothbauer, Ulrich			A New Nanobody-Based Biosensor to Study Endogenous PARP1 In Vitro and in Live Human Cells	PLOS ONE			English	Article							HUMAN POLY(ADP-RIBOSE) POLYMERASE-1; TRANSCRIPTIONALLY ACTIVE NUCLEOLI; FLUORESCENT 2-HYBRID ASSAY; DNA-DAMAGE RESPONSE; ACTINOMYCIN-D; RNA-SYNTHESIS; LIVING CELLS; CHROMATIN-STRUCTURE; ANTIBODY FRAGMENTS; MAMMALIAN-CELLS	Poly(ADP-ribose) polymerase 1 (PARP1) is a key player in DNA repair, genomic stability and cell survival and it emerges as a highly relevant target for cancer therapies. To deepen our understanding of PARP biology and mechanisms of action of PARP1-targeting anti-cancer compounds, we generated a novel PARP1-affinity reagent, active both in vitro and in live cells. This PARP1-biosensor is based on a PARP1-specific single-domain antibody fragment (similar to 15 kDa), termed nanobody, which recognizes the N-terminus of human PARP1 with nanomolar affinity. In proteomic approaches, immobilized PARP1 nanobody facilitates quantitative immunoprecipitation of functional, endogenous PARP1 from cellular lysates. For cellular studies, we engineered an intracellularly functional PARP1 chromobody by combining the nanobody coding sequence with a fluorescent protein sequence. By following the chromobody signal, we were for the first time able to monitor the recruitment of endogenous PARP1 to DNA damage sites in live cells. Moreover, tracing of the sub-nuclear translocation of the chromobody signal upon treatment of human cells with chemical substances enables real-time profiling of active compounds in high content imaging. Due to its ability to perform as a biosensor at the endogenous level of the PARP1 enzyme, the novel PARP1 nanobody is a unique and versatile tool for basic and applied studies of PARP1 biology and DNA repair.	[Buchfellner, Andrea; Yurlova, Larisa; Bogner, Jacqueline; Ruf, Benjamin; Zolghadr, Kourosh; Romer, Tina] ChromoTek GmbH, IZB, Martinsried, Germany; [Nueske, Stefan; Scholz, Armin M.] Univ Munich, Fac Vet Med, Livestock Ctr, Munich, Germany; [Drexler, Sophie E.; Drexler, Guido A.; Friedl, Anna A.] Univ Munich, Dept Radiat Oncol, Munich, Germany; [Girst, Stefanie; Greubel, Christoph; Reindl, Judith] Bundeswehr Univ Munich, Inst Appl Phys & Metrol, Neubiberg, Germany; [Siebenwirth, Christian] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-80290 Munich, Germany; [Friedl, Anna A.] Helmholtz Ctr Munich, Clin Cooperat Grp Personalized Radiotherapy Head, Neuherberg, Germany; [Rothbauer, Ulrich] Univ Tubingen, Nat & Med Inst, Reutlingen, Germany; [Rothbauer, Ulrich] Univ Tubingen, Pharmaceut Biotechnol, Tubingen, Germany	University of Munich; University of Munich; Bundeswehr University Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Romer, T (corresponding author), ChromoTek GmbH, IZB, Martinsried, Germany.	t.romer@chromotek.com	Rothbauer, Ulrich/C-7712-2018; Friedl, Anna A/B-1628-2010; Scholz, Armin M./AAE-2360-2019	Rothbauer, Ulrich/0000-0001-5923-8986; Friedl, Anna A/0000-0002-7425-6151; Scholz, Armin M./0000-0001-7075-0067; Reindl, Judith/0000-0002-3238-8586	GoBio grant of the German Federal Ministry of Education and Research (BMBF); GoBio and ChromoTek GmbH; DFG-Cluster of Excellence "Munich-Centre for Advanced Photonics"	GoBio grant of the German Federal Ministry of Education and Research (BMBF); GoBio and ChromoTek GmbH; DFG-Cluster of Excellence "Munich-Centre for Advanced Photonics"(German Research Foundation (DFG))	This work was funded in part by the GoBio grant of the German Federal Ministry of Education and Research (BMBF) to ChromoTek. GoBio and ChromoTek GmbH provided support in form of salaries for authors (AB, LY, JB, BR, KZ and TR). The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Microirradiation at SNAKE was partially supported by the DFG-Cluster of Excellence "Munich-Centre for Advanced Photonics".	Augustin A, 2003, J CELL SCI, V116, P1551, DOI 10.1242/jcs.00341; Bethuyne J, 2014, NUCLEIC ACIDS RES, V42, P12928, DOI 10.1093/nar/gku962; Buchfellner A., 2014, THESIS U TUBINGEN; Burgess A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045726; Dantzer F, 1998, NUCLEIC ACIDS RES, V26, P1891, DOI 10.1093/nar/26.8.1891; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; DEMURCIA G, 1988, BIOCHEM CELL BIOL, V66, P626, DOI 10.1139/o88-072; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Desnoyers S, 1996, EXP CELL RES, V227, P146, DOI 10.1006/excr.1996.0259; Drexler GA, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0350-7; Ekblad T, 2013, FEBS J, V280, P3563, DOI 10.1111/febs.12298; Fahrer J, 2007, THESIS U KONSTANZ; FAKAN S, 1988, EXP CELL RES, V179, P517, DOI 10.1016/0014-4827(88)90289-3; Ferrando-May Elisa, 2013, Frontiers in Genetics, V4, P135, DOI 10.3389/fgene.2013.00135; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gray MD, 1998, EXP CELL RES, V242, P487, DOI 10.1006/excr.1998.4124; Hable V, 2009, NUCL INSTRUM METH B, V267, P2090, DOI 10.1016/j.nimb.2009.03.071; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Hauptner A, 2004, RADIAT ENVIRON BIOPH, V42, P237, DOI 10.1007/s00411-003-0222-7; Hermans P, 2014, METHODS MOL BIOL, V1131, P297, DOI 10.1007/978-1-62703-992-5_19; Jobling SA, 2003, NAT BIOTECHNOL, V21, P77, DOI 10.1038/nbt772; KAMESHITA I, 1984, J BIOL CHEM, V259, P4770; KAUFMANN SH, 1991, EXP CELL RES, V192, P524, DOI 10.1016/0014-4827(91)90072-3; KIEHLBAUCH CC, 1993, ANAL BIOCHEM, V208, P26, DOI 10.1006/abio.1993.1004; Kielbassa C, 1997, CARCINOGENESIS, V18, P811, DOI 10.1093/carcin/18.4.811; LAMARRE D, 1988, BIOCHIM BIOPHYS ACTA, V950, P147, DOI 10.1016/0167-4781(88)90007-3; Langelier MF, 2008, J BIOL CHEM, V283, P4105, DOI 10.1074/jbc.M708558200; Langelier MF, 2013, CURR OPIN STRUC BIOL, V23, P134, DOI 10.1016/j.sbi.2013.01.003; Leonhardt H, 1998, J CELL BIOCHEM, P243, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<243::AID-JCB30>3.0.CO;2-6; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; Nunes-Silva S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07373; OGATA N, 1981, J BIOL CHEM, V256, P4135; Oyen D, 2011, J MOL BIOL, V407, P138, DOI 10.1016/j.jmb.2011.01.017; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Rancourt A, 2009, DNA REPAIR, V8, P286, DOI 10.1016/j.dnarep.2008.11.018; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Rocchetti A, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-12; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Rouleau M, 2007, J CELL BIOCHEM, V100, P385, DOI 10.1002/jcb.21051; Saxena A, 2002, HUM MOL GENET, V11, P2319, DOI 10.1093/hmg/11.19.2319; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Seiler DM, 2011, CHROMOSOME RES, V19, P883, DOI 10.1007/s10577-011-9244-1; SHANMUGAM G, 1968, BIOCHEM J, V108, P741, DOI 10.1042/bj1080741; Siebenwirth C, 2015, NUCL INSTRUM METH B, V348, P137, DOI 10.1016/j.nimb.2015.01.064; SNYDERWINE EG, 1992, CANCER RES, V52, P4183; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Splinter J, 2010, MUTAGENESIS, V25, P289, DOI 10.1093/mutage/geq005; Stadler C, 2013, NAT METHODS, V10, P315, DOI [10.1038/NMETH.2377, 10.1038/nmeth.2377]; Tallis M, 2014, CHROMOSOMA, V123, P79, DOI 10.1007/s00412-013-0442-9; Tao ZH, 2008, BIOCHEMISTRY-US, V47, P5804, DOI 10.1021/bi800018a; Thorslund T, 2005, MOL CELL BIOL, V25, P7625, DOI 10.1128/MCB.25.17.7625-7636.2005; Traenkle B, 2015, MOL CELL PROTEOMICS, V14, P707, DOI 10.1074/mcp.M114.044016; Vignard J, 2013, RADIOTHER ONCOL, V108, P362, DOI 10.1016/j.radonc.2013.06.013; Wang HK, 1997, MED RES REV, V17, P367, DOI 10.1002/(SICI)1098-1128(199707)17:4<367::AID-MED3>3.0.CO;2-U; WATSON WE, 1968, J PHYSIOL-LONDON, V196, P655, DOI 10.1113/jphysiol.1968.sp008528; WU RS, 1971, P NATL ACAD SCI USA, V68, P3009, DOI 10.1073/pnas.68.12.3009; YAMANAKA H, 1987, J CLIN INVEST, V80, P900, DOI 10.1172/JCI113150; YU YN, 1986, MUTAT RES, V174, P233, DOI 10.1016/0165-7992(86)90157-0; YUNG BY, 1990, CANCER RES, V50, P5987; Yung TMC, 2004, J BIOL CHEM, V279, P39686, DOI 10.1074/jbc.M402729200; Yurlova L, 2014, J BIOMOL SCREEN, V19, P516, DOI 10.1177/1087057113518067; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200; Zolghadr Kourosh, 2012, Methods Mol Biol, V911, P569, DOI 10.1007/978-1-61779-968-6_36	67	27	27	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0151041	10.1371/journal.pone.0151041	http://dx.doi.org/10.1371/journal.pone.0151041			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950694	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100084
J	Moss, JWE; Davies, TS; Garaiova, I; Plummer, SF; Michael, DR; Ramji, DP				Moss, Joe W. E.; Davies, Thomas S.; Garaiova, Iveta; Plummer, Sue F.; Michael, Daryn R.; Ramji, Dipak P.			A Unique Combination of Nutritionally Active Ingredients Can Prevent Several Key Processes Associated with Atherosclerosis In Vitro	PLOS ONE			English	Article							N-3 FATTY-ACIDS; PLANT STEROLS; EICOSAPENTAENOIC ACID; FISH-OIL; CHOLESTEROL; EXPRESSION; CYTOKINES; DISEASE; GAMMA; OMEGA-3-FATTY-ACIDS	Introduction Atherosclerosis is the underlying cause of cardiovascular disease that leads to more global mortalities each year than any other ailment. Consumption of active food ingredients such as phytosterols, omega-3 polyunsaturated fatty acids and flavanols are known to impart beneficial effects on cardiovascular disease although the combined actions of such agents in atherosclerosis is poorly understood. The aim of this study was to screen a nutritional supplement containing each of these active components for its anti-atherosclerotic effect on macrophages in vitro. Results The supplement attenuated the expression of intercellular adhesion molecule-1 and macrophage chemoattractant protein-1 in human and murine macrophages at physiologically relevant doses. The migratory capacity of human monocytes was also hindered, possibly mediated by eicosapentaenoic acid and catechin, while the ability of foam cells to efflux cholesterol was improved. The polarisation of murine macrophages towards a proinflammatory phenotype was also attenuated by the supplement. Conclusion The formulation was able to hinder multiple key steps of atherosclerosis development in vitro by inhibiting monocyte recruitment, foam cell formation and macrophage polarisation towards an inflammatory phenotype. This is the first time a combination these ingredients has been shown to elicit such effects and supports its further study in preclinical in vivo models.	[Moss, Joe W. E.; Davies, Thomas S.; Ramji, Dipak P.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Garaiova, Iveta; Plummer, Sue F.; Michael, Daryn R.] Cultech Ltd, Baglan Ind Pk, Port Talbot, Wales	Cardiff University	Michael, DR (corresponding author), Cultech Ltd, Baglan Ind Pk, Port Talbot, Wales.	darynm@cultech.co.uk	; Ramji, Dipak/A-7092-2010	Moss, Joe/0000-0002-1866-9752; Ramji, Dipak/0000-0002-6419-5578	School of Biosciences (Cardiff University); Welsh Assembly [2014/BIV/340 R SS]; Cultech Ltd	School of Biosciences (Cardiff University); Welsh Assembly; Cultech Ltd	Financial support for the study was provided by the School of Biosciences (Cardiff University), Cultech Ltd (www.cultech.co.uk) and an Innovation voucher (2014/BIV/340 R SS) granted by the Welsh Assembly. Cultech Ltd and the School of Biosciences are funders of JWEM who is performing a collaborative PhD studentship from these institutions. Cultech Ltd also provided support in the form of salaries for the authors, DRM, IG and SFP, who are employees of Cultech Ltd. IG and SFP were responsible for project conception. DRM was involved in the design of the study and contributed to manuscript writing. The Innovation voucher (2014/BIV/340 R SS) provided additional research materials.	Andersson SW, 2004, EUR J CLIN NUTR, V58, P1378, DOI 10.1038/sj.ejcn.1601980; Banach M, 2015, ARCH MED SCI, V11, P1, DOI 10.5114/aoms.2015.49807; Bang HO, 1980, ADV NUTR RES; Batta AK, 2006, METABOLISM, V55, P292, DOI 10.1016/j.metabol.2005.08.024; Brown AL, 2012, ARTERIOSCL THROM VAS, V32, P2122, DOI 10.1161/ATVBAHA.112.253435; Buckley ML, 2015, BBA-MOL BASIS DIS, V1852, P1498, DOI 10.1016/j.bbadis.2015.04.011; BURR ML, 1989, LANCET, V2, P757; Byun EB, 2014, IMMUNOBIOLOGY, V219, P866, DOI 10.1016/j.imbio.2014.07.010; Chan YM, 2006, NUTR REV, V64, P385, DOI [10.1301/nr.2006.sept.385-402, 10.1111/j.1753-4887.2006.tb00224.x]; Claude S, 2014, MOL NUTR FOOD RES, V58, P1016, DOI 10.1002/mnfr.201300658; De Boer AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085037; Garaiova I, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-4; Garaiova I, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-7; Grewal T, 2001, ARTERIOSCL THROM VAS, V21, P825, DOI 10.1161/01.ATV.21.5.825; Gylling H, 2014, ATHEROSCLEROSIS, V232, P346, DOI 10.1016/j.atherosclerosis.2013.11.043; Harris WS, 2013, CURR OPIN CLIN NUTR, V16, P141, DOI 10.1097/MCO.0b013e32835bf380; Harvey EJ, 2005, CARDIOVASC RES, V67, P11, DOI 10.1016/j.cardiores.2005.04.019; Hsu SP, 2007, AM J CLIN NUTR, V86, P1539, DOI 10.1093/ajcn/86.5.1539; Huddy K, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-012-0301-9; Hughes DA, 1996, J NUTR, V126, P603, DOI 10.1093/jn/126.3.603; Katan MB, 2003, MAYO CLIN PROC, V78, P965, DOI 10.4065/78.8.965; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Khan N, 2014, NUTRIENTS, V6, P844, DOI 10.3390/nu6020844; Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Klingenberg R, 2009, EUR HEART J, V30, P2838, DOI 10.1093/eurheartj/ehp477; Le Goff W, 2014, ATHEROSCLEROSIS, V235, P358, DOI 10.1016/j.atherosclerosis.2014.03.038; Leitinger N, 2013, ARTERIOSCL THROM VAS, V33, P1120, DOI 10.1161/ATVBAHA.112.300173; Li N, 2010, J IMMUNOL, V185, P3041, DOI 10.4049/jimmunol.1000993; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60; McLaren JE, 2011, LIPIDS, V46, P1053, DOI 10.1007/s11745-011-3598-1; McLaren JE, 2011, PROG LIPID RES, V50, P331, DOI 10.1016/j.plipres.2011.04.002; McLaren JE, 2010, J IMMUNOL, V185, P1222, DOI 10.4049/jimmunol.1000520; McLaren JE, 2010, J IMMUNOL, V184, P5827, DOI 10.4049/jimmunol.0903782; McLaren JE, 2009, CYTOKINE GROWTH F R, V20, P125, DOI 10.1016/j.cytogfr.2008.11.003; Melgarejo E, 2009, BRIT J PHARMACOL, V158, P1705, DOI 10.1111/j.1476-5381.2009.00452.x; Michael DR, 2012, BBA-MOL BASIS DIS, V1822, P1608, DOI 10.1016/j.bbadis.2012.06.002; Monagas M, 2009, AM J CLIN NUTR, V90, P1144, DOI 10.3945/ajcn.2009.27716; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Oliver E, 2012, J NUTR BIOCHEM, V23, P1192, DOI 10.1016/j.jnutbio.2011.06.014; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; PARKS JS, 1990, ARTERIOSCLEROSIS, V10, P1102, DOI 10.1161/01.ATV.10.6.1102; Ramji DP, 2015, CYTOKINE GROWTH F R, V26, P673, DOI 10.1016/j.cytogfr.2015.04.003; Sabeva NS, 2011, J NUTR BIOCHEM, V22, P777, DOI 10.1016/j.jnutbio.2010.07.002; SINCLAIR HM, 1953, P NUTR SOC, V12, P69, DOI 10.1079/PNS19530016; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Tull SP, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000177; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	51	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0151057	10.1371/journal.pone.0151057	http://dx.doi.org/10.1371/journal.pone.0151057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950833	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000371990100085
J	Roessler, K; Takuno, S; Gaut, BS				Roessler, Kyria; Takuno, Shohei; Gaut, Brandon S.			CG Methylation Covaries with Differential Gene Expression between Leaf and Floral Bud Tissues of Brachypodium distachyon	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; DNA METHYLATION; TRANSPOSABLE ELEMENTS; ARABIDOPSIS-THALIANA; CYTOSINE METHYLATION; DEMETHYLATION; EPIGENOME; HYPOMETHYLATION; TRANSPOSITION; DIVERGENCE	DNA methylation has the potential to influence plant growth and development through its influence on gene expression. To date, however, the evidence from plant systems is mixed as to whether patterns of DNA methylation vary significantly among tissues and, if so, whether these differences affect tissue-specific gene expression. To address these questions, we analyzed both bisulfite sequence (BSseq) and transcriptomic sequence data from three biological replicates of two tissues (leaf and floral bud) from the model grass species Brachypodium distachyon. Our first goal was to determine whether tissues were more differentiated in DNA methylation than explained by variation among biological replicates. Tissues were more differentiated than biological replicates, but the analysis of replicated data revealed high (>50%) false positive rates for the inference of differentially methylated sites (DMSs) and differentially methylated regions (DMRs). Comparing methylation to gene expression, we found that differential CG methylation consistently covaried negatively with gene expression, regardless as to whether methylation was within genes, within their promoters or even within their closest transposable element. The relationship between gene expression and either CHG or CHH methylation was less consistent. In total, CG methylation in promoters explained 9% of the variation in tissue-specific expression across genes, suggesting that CG methylation is a minor but appreciable factor in tissue differentiation.	[Roessler, Kyria; Gaut, Brandon S.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Takuno, Shohei] SOKENDAI Grad Univ Adv Studies, Hayama, Kanagawa, Japan	University of California System; University of California Irvine; Graduate University for Advanced Studies - Japan	Gaut, BS (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	bgaut@uci.edu		Takuno, Shohei/0000-0001-9538-7487	National Institute of Biomedical Imaging and Bioengineering, National Research Service Award from the University of California, Irvine, Center for Complex Biological Systems [EB009418]; SOKENDAI; JSPS [15K18585]; NSF [IOS-1542703]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009418] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1542703] Funding Source: National Science Foundation	National Institute of Biomedical Imaging and Bioengineering, National Research Service Award from the University of California, Irvine, Center for Complex Biological Systems; SOKENDAI; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	KR was supported by the National Institute of Biomedical Imaging and Bioengineering, National Research Service Award EB009418 from the University of California, Irvine, Center for Complex Biological Systems. ST is supported by an internal grant from SOKENDAI and JSPS Grant-in-Aid for Young Scientists (B) (Grant No. 15K18585). The work was supported by NSF grant IOS-1542703 to BSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to D. Garvin (USDA, Minnesota) for plant material and to R.L. Gaut for generating the BSseq and RNAseq dataset. K. Roessler was supported by the National Institute of Biomedical Imaging and Bioengineering, National Research Service Award EB009418 from the University of California, Irvine, Center for Complex Biological Systems. S. Takuno is supported by an internal grant from SOKENDAI and JSPS Grant-in-Aid for Young Scientists (B) (Grant No. 15K18585). The work was supported by NSF grant IOS-1542703 to BSG.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bird A, 1997, TRENDS GENET, V13, P469, DOI 10.1016/S0168-9525(97)01310-3; Candaele J, 2014, PLANT PHYSIOL, V164, P1350, DOI 10.1104/pp.113.233312; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Coleman-Derr D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002988; Diez CM, 2014, CURR OPIN PLANT BIOL, V18, P1, DOI 10.1016/j.pbi.2013.11.017; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Franklin GC, 1996, PLACENTA, V17, P3, DOI 10.1016/S0143-4004(05)80638-1; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Gent JI, 2013, GENOME RES, V23, P628, DOI 10.1101/gr.146985.112; Greaves IK, 2012, P NATL ACAD SCI USA, V109, P3570, DOI 10.1073/pnas.1201043109; Harris EY, 2010, BIOINFORMATICS, V26, P572, DOI 10.1093/bioinformatics/btp706; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hollister JD, 2011, P NATL ACAD SCI USA, V108, P2322, DOI 10.1073/pnas.1018222108; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Ibarra CA, 2012, SCIENCE, V337, P1360, DOI 10.1126/science.1224839; Ji L, 2015, MOL PLANT; Lauria M, 2004, PLANT CELL, V16, P510, DOI 10.1105/tpc.017780; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Nussbaumer T, 2013, NUCLEIC ACIDS RES, V41, pD1144, DOI 10.1093/nar/gks1153; Ong-Abdullah M, 2015, NATURE, V525, P533, DOI 10.1038/nature15365; Regulski M, 2013, GENOME RES, V23, P1651, DOI 10.1101/gr.153510.112; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Richards EJ, 1997, TRENDS GENET, V13, P319, DOI 10.1016/S0168-9525(97)01199-2; Schmitz RJ, 2013, GENOME RES, V23, P1663, DOI 10.1101/gr.152538.112; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Seymour DK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004785; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Song QX, 2013, MOL PLANT, V6, P1961, DOI 10.1093/mp/sst123; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Sun DQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r38; Takuno S, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.222, 10.1038/nplants.2015.222]; Takuno S, 2013, P NATL ACAD SCI USA, V110, P1797, DOI 10.1073/pnas.1215380110; Takuno S, 2012, MOL BIOL EVOL, V29, P219, DOI 10.1093/molbev/msr188; Team RDC, 2019, R LANG ENV STAT COMP; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vining Kelly J, 2012, BMC Genomics, V13, P27, DOI 10.1186/1471-2164-13-27; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang MS, 2011, PLANT PHYSIOL, V156, P1955, DOI 10.1104/pp.111.176842; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929; Ziller MJ, 2014, NAT METHODS	56	20	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150002	10.1371/journal.pone.0150002	http://dx.doi.org/10.1371/journal.pone.0150002			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950546	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100020
J	Watanabe, Y; Arase, S; Nagaoka, N; Kawai, M; Matsumoto, S				Watanabe, Yohei; Arase, Sohei; Nagaoka, Noriko; Kawai, Mitsuhisa; Matsumoto, Satoshi			Chronic Psychological Stress Disrupted the Composition of the Murine Colonic Microbiota and Accelerated a Murine Model of Inflammatory Bowel Disease	PLOS ONE			English	Article							GUT MICROBIOTA; CLOSTRIDIUM-PERFRINGENS; MOUSE MODEL; BACTERIA; SEQUENCES; SELECTION; GENOTYPE; EXPOSURE; LEVEL	The effect of psychological stress on the gastrointestinal microbiota is widely recognized. Chronic psychological stress may be associated with increased disease activity in inflammatory bowel disease, but the relationships among psychological stress, the gastrointestinal microbiota, and the severity of colitis is not yet fully understood. Here, we examined the impact of 12-week repeated water-avoidance stress on the microbiota of two inbred strains of T cell receptor alpha chain gene knockout mouse (background, BALB/c and C57BL/6) by means of next-generation sequencing of bacterial 16S rRNA genes. In both mouse strains, knockout of the T cell receptor alpha chain gene caused a loss of gastrointestinal microbial diversity and stability. Chronic exposure to repeated water-avoidance stress markedly altered the composition of the colonic microbiota of C57BL/6 mice, but not of BALB/c mice. In C57BL/6 mice, the relative abundance of genus Clostridium, some members of which produce the toxin phospholipase C, was increased, which was weakly positively associated with colitis severity, suggesting that expansion of specific populations of indigenous pathogens may be involved in the exacerbation of colitis. However, we also found that colitis was not exacerbated in mice with a relatively diverse microbiota even if their colonic microbiota contained an expanded phospholipase C-producing Clostridium population. Exposure to chronic stress also altered the concentration of free immunoglobulin A in colonic contents, which may be related to both the loss of bacterial diversity in the colonic microbiota and the severity of the colitis exacerbation. Together, these results suggest that long-term exposure to psychological stress induces dysbiosis in the immunodeficient mouse in a strain-specific manner and also that alteration of microbial diversity, which may be related to an altered pattern of immunoglobulin secretion in the gastrointestinal tract, might play a crucial role in the development of chronic stress-induced colitis.	[Watanabe, Yohei; Arase, Sohei; Nagaoka, Noriko; Kawai, Mitsuhisa; Matsumoto, Satoshi] Yakult Cent Inst, Kunitachi, Tokyo, Japan	Yakult Honsha Company, Limited	Watanabe, Y (corresponding author), Yakult Cent Inst, Kunitachi, Tokyo, Japan.	yohei-watanabe@yakult.co.jp		Watanabe, Yohei/0000-0001-7740-1361	Yakult Central Institute	Yakult Central Institute	This work was funded by the Yakult Central Institute (http://institute.yakult.co.jp/). The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors declare no potential conflicts of interest with respect to the authorship and publication.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Baumgart DC, 2011, INFLAMM BOWEL DIS, V17, P639, DOI 10.1002/ibd.21409; Bernstein CN, 2010, AM J GASTROENTEROL, V105, P1994, DOI 10.1038/ajg.2010.140; Berry D, 2012, ISME J, V6, P2091, DOI 10.1038/ismej.2012.39; Bhan A K, 2000, Int Rev Immunol, V19, P123, DOI 10.3109/08830180009048393; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Galley JD, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-189; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jawad N, 2011, RECENT RESULTS CANC, V185, P99, DOI 10.1007/978-3-642-03503-6_6; Julio-Pieper M, 2012, STRESS, V15, P218, DOI 10.3109/10253890.2011.607524; Karasawa T, 2003, INFECT IMMUN, V71, P641, DOI 10.1128/IAI.71.2.641-646.2003; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Krych L, 2015, GUT MICROBES, V6, P101, DOI 10.1080/19490976.2015.1011876; Leonard BE, 2005, EUR PSYCHIAT, V20, pS302, DOI 10.1016/S0924-9338(05)80180-4; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsumoto S, 2001, DIGESTION, V64, P92, DOI 10.1159/000048846; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Nagpal R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0561-y; Nagy-Szakal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056685; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Perez-Munoz ME, 2014, GUT MICROBES, V5, P286, DOI 10.4161/gmic.28622; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Sakurai J, 2004, J BIOCHEM, V136, P569, DOI 10.1093/jb/mvh161; Sun YD, 2013, GASTROENTEROLOGY, V144, P1478, DOI 10.1053/j.gastro.2013.02.038; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe Y, 2012, APPL ENVIRON MICROB, V78, P511, DOI 10.1128/AEM.06035-11; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	48	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150559	10.1371/journal.pone.0150559	http://dx.doi.org/10.1371/journal.pone.0150559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950850	Green Published, gold			2022-12-27	WOS:000371990100040
J	Fujimura, T; Shibata, S; Shimojima, N; Morikawa, Y; Okano, H; Kuroda, T				Fujimura, Takumi; Shibata, Shinsuke; Shimojima, Naoki; Morikawa, Yasuhide; Okano, Hideyuki; Kuroda, Tatsuo			Fluorescence Visualization of the Enteric Nervous Network in a Chemically Induced Aganglionosis Model	PLOS ONE			English	Article							HIRSCHSPRUNGS-DISEASE; INTERSTITIAL-CELLS; STEM-CELL; BENZALKONIUM CHLORIDE; MYENTERIC PLEXUS; DEFICIENT MICE; COLON; MULTIPOTENT; SYSTEM; CAJAL	Gastrointestinal motility disorders, severe variants in particular, remain a therapeutic challenge in pediatric surgery. Absence of enteric ganglion cells that originate from neural crest cells is a major cause of dysmotility. However, the limitations of currently available animal models of dysmotility continue to impede the development of new therapeutics. Indeed, the short lifespan and/or poor penetrance of existing genetic models of dysmotility prohibit the functional evaluation of promising approaches, such as stem cell replacement strategy. Here, we induced an aganglionosis model using topical benzalkonium chloride in a P0-Cre/GFP transgenic mouse in which the neural crest lineage is labeled by green fluorescence. Pathological abnormalities and functional changes in the gastrointestinal tract were evaluated 2-8 weeks after chemical injury. Laparotomy combined with fluorescence microscopy allowed direct visualization of the enteric neural network in vivo. Immunohistochemical evaluation further confirmed the irreversible disappearance of ganglion cells, glial cells, and interstitial cell of Cajal. Remaining stool weight and bead expulsion time in particular supported the pathophysiological relevance of this chemically-induced model of aganglionosis. Interestingly, we show that chemical ablation of enteric ganglion cells is associated with a long lifespan. By combining genetic labeling of neural crest derivatives and chemical ablation of enteric ganglion cells, we developed a newly customized model of aganglionosis. Our results indicate that this aganglionosis model exhibits decreased gastrointestinal motility and shows sufficient survival for functional evaluation. This model may prove useful for the development of future therapies against motility disorders.	[Fujimura, Takumi; Shimojima, Naoki; Morikawa, Yasuhide; Kuroda, Tatsuo] Keio Univ, Sch Med, Dept Pediat Surg, Shinjuku Ku, Tokyo, Japan; [Fujimura, Takumi; Shibata, Shinsuke; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Morikawa, Yasuhide] Int Univ Hlth & Welf, Dept Pediat Surg, Ohtawara, Tochigi, Japan	Keio University; Keio University; International University of Health & Welfare	Kuroda, T (corresponding author), Keio Univ, Sch Med, Dept Pediat Surg, Shinjuku Ku, Tokyo, Japan.; Okano, H (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan.	hidokano@keio.jp; kuroda-t@keio.jp	Okano, Hideyuki/I-7584-2019; Fujimura, Takumi/AAK-8079-2020; Shibata, Shinsuke/AAM-6620-2020; Okano, Hideyuki/X-9131-2019	Okano, Hideyuki/0000-0001-7482-5935; Shibata, Shinsuke/0000-0002-1185-9043	MEXT (Ministry of Education, Culture, Sports, Science and Technology) / JSPS (Japan Society for the Promotion of Science) KAKENHI [24791890, 26462714]; Keio University; (KAKENHI) from MEXT/JSPS [24791890, 26462714]	MEXT (Ministry of Education, Culture, Sports, Science and Technology) / JSPS (Japan Society for the Promotion of Science) KAKENHI; Keio University; (KAKENHI) from MEXT/JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grant from MEXT (Ministry of Education, Culture, Sports, Science and Technology) / JSPS (Japan Society for the Promotion of Science) KAKENHI (grant numbers 24791890, 26462714) to TF, SS; https://kaken.nii.ac.jp/d/p/26462714.en.html, https://kaken.nii.ac.jp/d/p/24791890.en.html, and the grant from Keio University Grant-in-Aid for Encouragement of Young Medical Scientists to TF. http://www.med.keio.ac.jp/en/research/index.html.r We are grateful to Drs. M. Nakamura, F. Renault-Mihara, M. Mori, G. Itai for their instruction, excellent technical assistance, and critical reading of the manuscript. We thank Douglas Sipp for critical discussion of the manuscript. We thank all members of the Okano laboratory and Kuroda laboratory for their invaluable comments. This work was supported by the Grant-in-Aid for Scientific Research (KAKENHI, grant number 24791890, 26462714) to TF, SS from MEXT/JSPS, and the grant in aid from Keio University Grant-in-Aid for Encouragement of Young Medical Scientists to TF.	Amiel J, 2001, J MED GENET, V38, P729, DOI 10.1136/jmg.38.11.729; BADNER JA, 1990, AM J HUM GENET, V46, P568; Friedmacher F, 2011, PEDIATR SURG INT, V27, P1053, DOI 10.1007/s00383-011-2958-5; Hanani M, 2003, J COMP NEUROL, V462, P315, DOI 10.1002/cne.10721; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Hotta R, 2013, J CLIN INVEST, V123, P1182, DOI 10.1172/JCI65963; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; KOSLO RJ, 1986, J PHARMACOL EXP THER, V238, P62; Kulkami M, 2011, J MED IMAG RADIAT ON, V55, P183, DOI 10.1111/j.1754-9485.2011.02249.x; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Micci MA, 2005, GASTROENTEROLOGY, V129, P1817, DOI 10.1053/j.gastro.2005.08.055; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Nishikawa R, 2015, CYTOTECHNOLOGY, V67, P661, DOI 10.1007/s10616-014-9754-8; Ono H, 2014, NEUROGASTROENT MOTIL, V26, P1396, DOI 10.1111/nmo.12387; Parisi MA, 2000, CURR OPIN PEDIATR, V12, P610, DOI 10.1097/00008480-200012000-00017; Parr EJ, 1997, CELL TISSUE RES, V289, P253, DOI 10.1007/s004410050872; Passarge E, 2002, NAT GENET, V31, P11, DOI 10.1038/ng878; Ro S, 2006, AM J PHYSIOL-GASTR L, V290, pG710, DOI 10.1152/ajpgi.00420.2005; SATO A, 1978, J PEDIATR SURG, V13, P399, DOI 10.1016/S0022-3468(78)80464-3; SCHUCHARDT A, 1995, J INTERN MED, V238, P327, DOI 10.1111/j.1365-2796.1995.tb01206.x; Shibata S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-31; Skinner MA, 1996, CURR PROB SURG, V33, P394, DOI 10.1016/S0011-3840(96)80009-8; Spencer NJ, 2008, NEUROSCIENCE, V153, P518, DOI 10.1016/j.neuroscience.2008.02.054; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Torihashi S, 2004, AUTON NEUROSCI-BASIC, V113, P16, DOI 10.1016/j.autneu.2004.05.004; Uesaka T, 2008, J CLIN INVEST, V118, P1890, DOI 10.1172/JCI34425; Wang HF, 2009, NEUROSCI LETT, V451, P208, DOI 10.1016/j.neulet.2009.01.015; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Yoneda A, 2002, PEDIATR SURG INT, V18, P234, DOI 10.1007/s003830100681; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156; Zarate N, 2003, GUT, V52, P966, DOI 10.1136/gut.52.7.966	32	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150579	10.1371/journal.pone.0150579	http://dx.doi.org/10.1371/journal.pone.0150579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943905	Green Submitted, Green Published, gold			2022-12-27	WOS:000371739400033
J	Mattern, C; Pourette, D; Raboanary, E; Kesteman, T; Piola, P; Randrianarivelojosia, M; Rogier, C				Mattern, Chiarella; Pourette, Dolores; Raboanary, Emma; Kesteman, Thomas; Piola, Patrice; Randrianarivelojosia, Milijaona; Rogier, Christophe			"Tazomoka Is Not a Problem". Local Perspectives on Malaria, Fever Case Management and Bed Net Use in Madagascar	PLOS ONE			English	Article							CARE-SEEKING; PERCEPTIONS; BARRIERS; NIGER; AREA	Background Although its incidence has been decreasing during the last decade, malaria is still a major public health issue in Madagascar. The use of Long Lasting Insecticidal Nets (LLIN) remains a key malaria control intervention strategy in Madagascar, however, it encounters some obstacles. The present study aimed to explore the local terminology related to malaria, information channels about malaria, attitude towards bed nets, and health care seeking practices in case of fever. This article presents novel qualitative findings about malaria. Until now, no such data has been published for Madagascar. Methods A comparative qualitative study was carried out at four sites in Madagascar, each differing by malaria epidemiology and socio-cultural background of the populations. Seventy-one semi-structured interviews were conducted with biomedical and traditional caregivers, and members of the local population. In addition, observations of the living conditions and the uses of bed net were conducted. Results Due to the differences between local and biomedical perspectives on malaria, official messages did not have the expected impact on population in terms of prevention and care seeking behaviors. Rather, most information retained about malaria was spread through informal information circulation channels. Most interviewees perceived malaria as a disease that is simple to treat. Tazomoka ("mosquito fever"), the Malagasy biomedical word for malaria, was not used by populations. Tazo ("fever") and tazomahery ("strong fever") were the terms more commonly used by members of the local population to refer to malaria related symptoms. According to local perceptions in all areas, tazo and tazomahery were not caused by mosquitos. Each of these symptoms required specific health recourse. The usual fever management strategies consisted of self-medication or recourse to traditional and biomedical caregivers. Usage of bed nets was intermittent and was not directly linked to protection against malaria in the eyes of most Malagasy people. Conclusions This article highlights the conflicting understanding of malaria between local perceptions and the biomedical establishment in Madagascar. Local perceptions of malaria present a holistic vision of the disease that includes various social and cultural dimensions, rather than reflecting one universal understanding, as in the biomedical image. The consideration of this "holistic vision" and other socio-cultural aspects surrounding the understanding of malaria is essential in implementing successful control intervention strategies.	[Mattern, Chiarella; Raboanary, Emma; Piola, Patrice] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Pourette, Dolores] Inst Rech Dev, Ctr Populat & Dev CEPED, Paris, France; [Pourette, Dolores] Univ Catholique Madagascar, Antananarivo, Madagascar; [Kesteman, Thomas; Randrianarivelojosia, Milijaona] Inst Pasteur Madagascar, Malaria Res Unit, Antananarivo, Madagascar; [Rogier, Christophe] Inst Pasteur Madagascar, Antananarivo, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Mattern, C (corresponding author), Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar.	chiarellam@pasteur.mg	Kesteman, Thomas/AAN-2707-2021	Kesteman, Thomas/0000-0002-7951-8261; Randrianarivelojosia, Milijaona/0000-0003-2767-0349; Pourette, Dolores/0000-0002-3599-8806	france expertise internationale	france expertise internationale	This work was supported by france expertise internationale.	Bauch J, 2013, MALAR J, V12; Baxerres C, 2004, SCI SOC SANTE, V22, P5, DOI 10.3406/sosan.2004.1634; Beiersmann C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-106; Bloch M, 1991, DICT ETHNOLOGIE ANTH, P429; Chandler CIR, 2008, HEALTH POLICY PLANN, V23, P170, DOI 10.1093/heapol/czm046; Das A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-39; de Savigny D, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-27; Doannio J M C, 2006, Med Trop (Mars), V66, P45; Esse C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-224; Faye S, 2004, AFRICAIN POPUL STU S, V19, P221; Franckel A, 2009, J BIOSOC SCI, V41, P1, DOI 10.1017/S0021932008002885; Fremigacci J., 2014, AFRIQUE CONT, V251, P125, DOI [10.3917/afco.251.0125, DOI 10.3917/AFCO.251.0125]; Galvin KT, 2011, J MULTIDISCIP HEALTH, V4, P73, DOI 10.2147/JMDH.S15917; Grietens KP, 2012, PLOS ONE, V7; Guillebaud J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-379; Institut Natonional de la Statistique Programme National de Lutte contre le Pludisme Institut Pasteur de Madagascar, 2013, ENQ IND PAL; Iskander D, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0770-8; Jaffre Y., 1999, CONSTRUCTION SOCIALE; Kesteman T, 2014, NATIONWIDE EVALUATIO, DOI [10.1186/1475-2875-13-465, DOI 10.1186/1475-2875-13-465]; Kesteman T, 2015, INVESTIGATION MALARI; Kesteman T, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-465; Legesse M, 2009, ETHIOP J HEALTH DEV, V23, P40; Loha E., 2013, MALARIA J, V12, P1; Martin N., 2011, ETUDES OCEAN INDIEN, P46; Mazigo H. D., 2010, MALAR RES TREAT; McCombie SC, 2002, HEALTH POLICY PLANN, V17, P333, DOI 10.1093/heapol/17.4.333; Mestre C, 2014, MALADIES VIOLENCES O; Ministere de la sante Publique de Madagascar, 2015, PLAN DEV SECT SANT 2; Molyneux CS, 1999, TROP MED INT HEALTH, V4, P836, DOI 10.1046/j.1365-3156.1999.00489.x; Monroe A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-82; Ndour C T, 2006, Bull Soc Pathol Exot, V99, P290; Nsagha D. S., 2011, Journal of Public Health and Epidemiology, V3, P294; Oshikoya KA, 2007, PAEDIAT PERINAT DRUG, V8; Pilkington H, 2004, J EPIDEMIOL COMMUN H, V58, P826, DOI 10.1136/jech.2003.016089; Pourette D, 2013, RAPPORT MISSION LETU; RBM-Partnership, 2013, ROLL BACK MAL ANN RE, P44; Roll Back Malaria, 2013, POL ER ENDG IN PRESS, P1; Sangare LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039712; Seck I, 2008, Med Trop (Mars), V68, P629; Toe LP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-175; Warsame M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000149	41	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0151068	10.1371/journal.pone.0151068	http://dx.doi.org/10.1371/journal.pone.0151068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943672	Green Submitted, Green Published, gold			2022-12-27	WOS:000371739400076
J	Moriuchi, KS; Friesen, ML; Cordeiro, MA; Badri, M; Vu, WT; Main, BJ; Aouani, ME; Nuzhdin, SV; Strauss, SY; von Wettberg, EJB				Moriuchi, Ken S.; Friesen, Maren L.; Cordeiro, Matilde A.; Badri, Mounawer; Vu, Wendy T.; Main, Bradley J.; Aouani, Mohamed Elarbi; Nuzhdin, Sergey V.; Strauss, Sharon Y.; von Wettberg, Eric J. B.			Salinity Adaptation and the Contribution of Parental Environmental Effects in Medicago truncatula	PLOS ONE			English	Article							ACID STRESS TOLERANCE; LOCAL ADAPTATION; TRANSGENERATIONAL PLASTICITY; POPULATION DIFFERENTIATION; GEOGRAPHIC-VARIATION; RANA-ARVALIS; MOOR FROG; EVOLUTION; SELECTION; MECHANISMS	High soil salinity negatively influences plant growth and yield. Some taxa have evolved mechanisms for avoiding or tolerating elevated soil salinity, which can be modulated by the environment experienced by parents or offspring. We tested the contribution of the parental and offspring environments on salinity adaptation and their potential underlying mechanisms. In a two-generation greenhouse experiment, we factorially manipulated salinity concentrations for genotypes of Medicago truncatula that were originally collected from natural populations that differed in soil salinity. To compare population level adaptation to soil salinity and to test the potential mechanisms involved we measured two aspects of plant performance, reproduction and vegetative biomass, and phenological and physiological traits associated with salinity avoidance and tolerance. Saline-origin populations had greater biomass and reproduction under saline conditions than non-saline populations, consistent with local adaptation to saline soils. Additionally, parental environmental exposure to salt increased this difference in performance. In terms of environmental effects on mechanisms of salinity adaptation, parental exposure to salt spurred phenological differences that facilitated salt avoidance, while offspring exposure to salt resulted in traits associated with greater salt tolerance. Non-saline origin populations expressed traits associated with greater growth in the absence of salt while, for saline adapted populations, the ability to maintain greater performance in saline environments was also associated with lower growth potential in the absence of salt. Plastic responses induced by parental and offspring environments in phenology, leaf traits, and gas exchange contribute to salinity adaptation in M. truncatula. The ability of plants to tolerate environmental stress, such as high soil salinity, is likely modulated by a combination of parental effects and within-generation phenotypic plasticity, which are likely to vary in populations from contrasting environments.	[Moriuchi, Ken S.; Cordeiro, Matilde A.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Friesen, Maren L.; Vu, Wendy T.; Main, Bradley J.; Nuzhdin, Sergey V.] Univ So Calif, Mol & Computat Biol, Los Angeles, CA USA; [Friesen, Maren L.] Michigan State Univ, Dept Plant Biol, Lansing, MI 48824 USA; [Cordeiro, Matilde A.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Plant Cell Biotechnol, Oeiras, Portugal; [Badri, Mounawer; Aouani, Mohamed Elarbi] Ctr Biotechnol Borj Cedria, BP 901, Hammam Lif, Tunisia; [Strauss, Sharon Y.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Strauss, Sharon Y.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [von Wettberg, Eric J. B.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [von Wettberg, Eric J. B.] Florida Int Univ, Int Ctr Trop Bot, Miami, FL 33199 USA; [von Wettberg, Eric J. B.] Fairchild Trop Bot Garden, Kushlan Inst Trop Sci, Coral Gables, FL USA	University of California System; University of California Davis; University of Southern California; Michigan State University; Universidade Nova de Lisboa; Centre de Biotechnologie de Borj Cedria; University of California System; University of California Davis; University of California System; University of California Davis; State University System of Florida; Florida International University; State University System of Florida; Florida International University	von Wettberg, EJB (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.; von Wettberg, EJB (corresponding author), Florida Int Univ, Int Ctr Trop Bot, Miami, FL 33199 USA.; von Wettberg, EJB (corresponding author), Fairchild Trop Bot Garden, Kushlan Inst Trop Sci, Coral Gables, FL USA.	eric.vonwettberg@fiu.edu	von Wettberg, Eric/C-1115-2016; Strauss, Sharon/J-1827-2012	von Wettberg, Eric/0000-0002-2724-0317; Strauss, Sharon/0000-0002-6117-4085; Friesen, Maren/0000-0002-4274-8928; Main, Bradley/0000-0002-8481-2721	US National Science Foundation Plant Genome Research Program [08-20846]; Portuguese Fundacao para a Ciencia e Tecnologia fellowship [SFRH/BD/39905/2007]	US National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Portuguese Fundacao para a Ciencia e Tecnologia fellowship	This work was supported by US National Science Foundation Plant Genome Research Program 08-20846 (SVN PI, EvW, SYS co-PI). MAC was supported by a Portuguese Fundacao para a Ciencia e Tecnologia fellowship SFRH/BD/39905/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Amzallag GN, 2000, NEW PHYTOL, V146, P483, DOI 10.1046/j.1469-8137.2000.00664.x; [Anonymous], 2006, SAS MIXED MODELS; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Ballerini ES, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-4; Bischoff A, 2010, OIKOS, V119, P445, DOI 10.1111/j.1600-0706.2009.17776.x; Bonnin I, 2001, MOL ECOL, V10, P1371, DOI 10.1046/j.1365-294X.2001.01278.x; Brachi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032069; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Castro BM, 2013, J ECOL, V101, P1281, DOI 10.1111/1365-2745.12125; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cook DR, 1999, CURR OPIN PLANT BIOL, V2, P301, DOI 10.1016/S1369-5266(99)80053-3; Cordeiro MA, 2014, AM J BOT, V101, P488, DOI 10.3732/ajb.1300285; Diggle PK, 2010, ANN BOT-LONDON, V106, P309, DOI 10.1093/aob/mcq110; Donohue K, 2000, EVOLUTION, V54, P1956, DOI 10.1111/j.0014-3820.2000.tb01240.x; Dyer AR, 2010, EVOL APPL, V3, P179, DOI 10.1111/j.1752-4571.2010.00118.x; Flowers TJ, 2010, FUNCT PLANT BIOL, V37, P604, DOI 10.1071/FP09269; Friesen ML, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1160; Friesen ML, 2010, PLANT J, V63, P623, DOI 10.1111/j.1365-313X.2010.04267.x; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Galloway LF, 2009, NEW PHYTOL, V182, P1003, DOI 10.1111/j.1469-8137.2009.02803.x; Galloway LF, 1995, EVOLUTION, V49, P1095, DOI 10.1111/j.1558-5646.1995.tb04436.x; Gama PBS, 2007, AFR J BIOTECHNOL, V6, P79; Germain RM, 2014, ECOL LETT, V17, P662, DOI 10.1111/ele.12267; Griffith TM, 2005, J EVOLUTION BIOL, V18, P1601, DOI 10.1111/j.1420-9101.2005.01021.x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Hall MC, 2006, EVOLUTION, V60, P2466, DOI 10.1554/05-688.1; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Herman JJ, 2012, INTEGR COMP BIOL, V52, P77, DOI 10.1093/icb/ics041; Herman JJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00102; Heschel MS, 2005, AM J BOT, V92, P37, DOI 10.3732/ajb.92.1.37; Hillel D., 1980, Fundamentals of soil physics.; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Lacey EP, 2005, AM J BOT, V92, P920, DOI 10.3732/ajb.92.6.920; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Lazrek F, 2009, GENETICA, V135, P391, DOI 10.1007/s10709-008-9285-3; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lesins K. A., 1979, Genus Medicago (Leguminosae). A taxogenetic study.; LONGSTRETH DJ, 1979, PLANT PHYSIOL, V63, P700, DOI 10.1104/pp.63.4.700; Meyre D, 2001, J PLANT PHYSIOL, V158, P1145, DOI 10.1078/S0176-1617(04)70141-8; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Niinemets U, 2010, FOREST ECOL MANAG, V260, P1623, DOI 10.1016/j.foreco.2010.07.054; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Rasanen K, 2005, OECOLOGIA, V142, P546, DOI 10.1007/s00442-004-1762-5; Rasanen K, 2003, EVOLUTION, V57, P352, DOI 10.1554/0014-3820(2003)057[0352:GVIAST]2.0.CO;2; Rasanen K, 2003, EVOLUTION, V57, P363, DOI 10.1554/0014-3820(2003)057[0363:GVIAST]2.0.CO;2; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Roff D.A., 1997, EVOLUTIONARY QUANTIT; SAS/Stat User's Guide, 2011, SAS STAT US GUID VER; Smekens MJ, 2001, ACTA OECOL, V22, P187, DOI 10.1016/S1146-609X(01)01120-1; Stanton ML, 2000, EVOLUTION, V54, P93, DOI 10.1111/j.0014-3820.2000.tb00011.x; Strauss SY, 2004, J ECOL, V92, P132, DOI 10.1111/j.1365-2745.2004.00843.x; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sultan SE, 2010, CURR OPIN PLANT BIOL, V13, P96, DOI 10.1016/j.pbi.2009.09.021; Sultan SE, 2009, ECOLOGY, V90, P1831, DOI 10.1890/08-1064.1; Suter L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080819; Suter L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060364; Tansley AG, 1917, J ECOL, V5, P173, DOI 10.2307/2255655; Terry N, 1984, CALIF AGR, V38, P38; Touchette BW, 2009, J EXP MAR BIOL ECOL, V380, P106, DOI 10.1016/j.jembe.2009.08.015; Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Van Zandt PA, 2004, EVOL ECOL RES, V6, P813; VANTIENDEREN PH, 1991, EVOLUTION, V45, P1317, DOI [10.1111/j.1558-5646.1991.tb02638.x, 10.2307/2409882]; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Vu WT, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0322-4; Wright JW, 2006, EVOL ECOL RES, V8, P1; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625	73	14	15	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150350	10.1371/journal.pone.0150350	http://dx.doi.org/10.1371/journal.pone.0150350			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943813	Green Published, gold			2022-12-27	WOS:000371739400023
J	Yang, JJ; He, ZB; Du, J; Chen, LF; Zhu, X				Yang, Junjun; He, Zhibin; Du, Jun; Chen, Longfei; Zhu, Xi			Uncertainty in Ecohydrological Modeling in an Arid Region Determined with Bayesian Methods	PLOS ONE			English	Article							SURFACE SOIL-MOISTURE; CALIBRATION; VALIDATION; FREQUENCY; FRAMEWORK; FLOW	In arid regions, water resources are a key forcing factor in ecosystem circulation, and soil moisture is the critical link that constrains plant and animal life on the soil surface and underground. Simulation of soil moisture in arid ecosystems is inherently difficult due to high variability. We assessed the applicability of the process-oriented CoupModel for forecasting of soil water relations in arid regions. We used vertical soil moisture profiling for model calibration. We determined that model-structural uncertainty constituted the largest error; the model did not capture the extremes of low soil moisture in the desert-oasis ecotone (DOE), particularly below 40 cm soil depth. Our results showed that total uncertainty in soil moisture prediction was improved when input and output data, parameter value array, and structure errors were characterized explicitly. Bayesian analysis was applied with prior information to reduce uncertainty. The need to provide independent descriptions of uncertainty analysis (UA) in the input and output data was demonstrated. Application of soil moisture simulation in arid regions will be useful for dune-stabilization and revegetation efforts in the DOE.	[Yang, Junjun; He, Zhibin; Du, Jun; Chen, Longfei; Zhu, Xi] Chinese Acad Sci, Linze Inland River Basin Res Stn, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Ecohydrol Inland River Basin,Chinese Ecos, Lanzhou, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	He, ZB (corresponding author), Chinese Acad Sci, Linze Inland River Basin Res Stn, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Ecohydrol Inland River Basin,Chinese Ecos, Lanzhou, Peoples R China.	hzbmail@lzb.ac.cn	Zhu, Xi/AGP-2199-2022		National Program on Basic Research Project of China [2013CB429906]; Chinese Academy of Sciences [29Y127D11]	National Program on Basic Research Project of China; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded through the National Program on Basic Research Project of China (2013CB429906), the One Hundred Person Project of The Chinese Academy of Sciences (no. 29Y127D11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2004, J HYDROL, V290, P63, DOI 10.1016/j.jhydrol.2003.11.028; Adams R, 2013, J HYDROL, V503, P209, DOI 10.1016/j.jhydrol.2013.09.009; Ajami NK, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004745; Chen M, 2014, HYDROL PROCESS, V28, P171, DOI 10.1002/hyp.9518; DIRMEYER PA, 1995, B AM METEOROL SOC, V76, P2234; Dorazio RM, 2003, ECOL APPL, V13, P556, DOI 10.1890/1051-0761(2003)013[0556:BIADTA]2.0.CO;2; Gilks WR, 1996, MARKOV CHAIN MONTE C; de Goncalves LGG, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006309; Gupta HV, 1998, WATER RESOUR RES, V34, P751, DOI 10.1029/97WR03495; Habib E, 2001, J HYDROL ENG, V6, P159, DOI 10.1061/(ASCE)1084-0699(2001)6:2(159); Huard D, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR005949; Jansson PE, 2012, T ASABE, V55, P1335; Ji XB, 2006, ENVIRON GEOL, V50, P793, DOI 10.1007/s00254-006-0251-z; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Kamali B, 2013, HYDROL PROCESS, V27, P4028, DOI 10.1002/hyp.9510; Kersten MS, 1949, TRANSPORTATION RES B, V28, P19; Kurc SA, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005011; Linhoss A, 2013, J HYDROL ENG, V18, P1767, DOI 10.1061/(ASCE)HE.1943-5584.0000755; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Merz R, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009505; Mittelbach H, 2012, J HYDROL, V430, P39, DOI 10.1016/j.jhydrol.2012.01.041; Ramin M, 2013, ECOL INFORM, V18, P107, DOI 10.1016/j.ecoinf.2013.07.001; Renard B, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008328; Richards LA, 1931, PHYSICS-J GEN APPL P, V1, P318, DOI 10.1063/1.1745010; Robinson DA, 2008, VADOSE ZONE J, V7, P358, DOI 10.2136/vzj2007.0143; Sahoo GB, 2006, J HYDROL, V327, P94, DOI 10.1016/j.jhydrol.2005.11.012; SMITH AFM, 1993, J ROY STAT SOC B MET, V55, P3; TOPP GC, 1984, CAN J SOIL SCI, V64, P313, DOI 10.4141/cjss84-033; Van Oijen M, 2005, TREE PHYSIOL, V25, P915, DOI 10.1093/treephys/25.7.915; Vaze J, 2010, J HYDROL, V394, P447, DOI 10.1016/j.jhydrol.2010.09.018; Wellen C, 2014, HYDROL PROCESS, V28, P1260, DOI 10.1002/hyp.9614; Wilby RL, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004065; Williams BK, 1996, J WILDLIFE MANAGE, V60, P223, DOI 10.2307/3802220; Wilson DJ, 2005, ADV WATER RESOUR, V28, P43, DOI 10.1016/j.advwatres.2004.09.007; Yang K, 2009, J HYDROMETEOROL, V10, P780, DOI 10.1175/2008JHM1065.1; Zhang PP, 2013, J HYDROL, V505, P91, DOI 10.1016/j.jhydrol.2013.08.045; Zhang WT, 2008, J GREAT LAKES RES, V34, P698, DOI 10.3394/0380-1330-34.4.698; Zhao WZ, 2008, ECOL ENG, V33, P119, DOI 10.1016/j.ecoleng.2008.02.010	38	1	1	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151283	10.1371/journal.pone.0151283	http://dx.doi.org/10.1371/journal.pone.0151283			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963523	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000134
J	Conaco, C; Tsoulfas, P; Sakarya, O; Dolan, A; Werren, J; Kosik, KS				Conaco, Cecilia; Tsoulfas, Pantelis; Sakarya, Onur; Dolan, Amanda; Werren, John; Kosik, Kenneth S.			Detection of Prokaryotic Genes in the Amphimedon queenslandica Genome	PLOS ONE			English	Article							HORIZONTAL TRANSFER; ISOPRENOID BIOSYNTHESIS; LATERAL TRANSFER; EVOLUTION; ENZYMES; METAZOAN; ORIGINS; ALIGNMENTS; EXPRESSION; PROTEASE	Horizontal gene transfer (HGT) is common between prokaryotes and phagotrophic eukaryotes. In metazoans, the scale and significance of HGT remains largely unexplored but is usually linked to a close association with parasites and endosymbionts. Marine sponges (Porifera), which host many microorganisms in their tissues and lack an isolated germ line, are potential carriers of genes transferred from prokaryotes. In this study, we identified a number of potential horizontally transferred genes within the genome of the sponge, Amphimedon queenslandica. We further identified homologs of some of these genes in other sponges. The transferred genes, most of which possess catalytic activity for carbohydrate or protein metabolism, have assimilated host genome characteristics and are actively expressed. The diversity of functions contributed by the horizontally transferred genes is likely an important factor in the adaptation and evolution of A. queenslandica. These findings highlight the potential importance of HGT on the success of sponges in diverse ecological niches.	[Conaco, Cecilia] Univ Philippines, Inst Marine Sci, Quezon City 1101, Philippines; [Tsoulfas, Pantelis] Univ Miami, Sch Med, Dept Neurosurg, Miami, FL USA; [Tsoulfas, Pantelis] Univ Miami, Sch Med, Dept Cell Biol, Miami, FL USA; [Sakarya, Onur] Natera, San Carlos, CA USA; [Dolan, Amanda; Werren, John] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of the Philippines System; University of the Philippines Diliman; University of Miami; University of Miami; University of Rochester; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Conaco, C (corresponding author), Univ Philippines, Inst Marine Sci, Quezon City 1101, Philippines.	cconaco@msi.upd.edu.ph	Tsoulfas, Pantelis/GNH-1922-2022	Conaco, Cecilia/0000-0002-3594-2810; Werren, John/0000-0001-9353-2070	University of the Philippines System [OVPAA-BPhD-2012-04]; L'Oreal-UNESCO For Women in Science National Fellowship; US NSF [DEB1257053]; Natera, Inc.	University of the Philippines System; L'Oreal-UNESCO For Women in Science National Fellowship(L'Oreal Group); US NSF(National Science Foundation (NSF)); Natera, Inc.	This work was supported by a gift from Harvey Karp to KSK. CC was supported by the University of the Philippines System (OVPAA-BPhD-2012-04) and a L'Oreal-UNESCO For Women in Science National Fellowship. JHW and AD were supported by the US NSF DEB1257053. Natera, Inc. provided support in the form of salaries for OS, who was involved in data generation, analysis and manuscript writing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnadottir H, 2009, J BACTERIOL, V191, P403, DOI 10.1128/JB.00847-08; Benoit J, 2015, NATURE COMM IN PRESS; Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Bilewitch JP, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-228; Bochar DA, 1999, MOL GENET METAB, V66, P122, DOI 10.1006/mgme.1998.2786; Boto L, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2450; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Brembu T, 2013, MARINE GENOMICS; Bruto M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0848; Buckley Julia J, 2015, Front Biosci (Schol Ed), V7, P168; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Conaco C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-209; Crisp A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0607-3; Degnan SM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00638; Ereskovsky AV, 2010, COMPARATIVE EMBRYOLOGY OF SPONGES, P1, DOI 10.1007/978-90-481-8575-7; Fernandez-Valverde SL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1588-z; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Fitzpatrick DA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-181; Foerstner KU, 2005, EMBO REP, V6, P1208, DOI 10.1038/sj.embor.7400538; Folio P, 2008, INT J FOOD MICROBIOL, V127, P26, DOI 10.1016/j.ijfoodmicro.2008.05.039; Friedman R, 2012, CURR MICROBIOL, V65, P639, DOI 10.1007/s00284-012-0205-5; Friesen JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-248; Funayama N, 2010, DEV GROWTH DIFFER, V52, P1, DOI 10.1111/j.1440-169X.2009.01162.x; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Graham LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002616; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Guzman C, 2016, SCI REP-UK, V6, DOI 10.1038/srep18774; Hemmrich G, 2008, BIOESSAYS, V30, P1010, DOI 10.1002/bies.20813; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hotopp JCD, 2011, TRENDS GENET, V27, P157, DOI 10.1016/j.tig.2011.01.005; Izumikawa M, 2010, J NAT PROD, V73, P208, DOI 10.1021/np900747t; Jackson DJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-238; Jain R, 2003, MOL BIOL EVOL, V20, P1598, DOI 10.1093/molbev/msg154; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Ku C, 2015, NATURE; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lombard J, 2011, MOL BIOL EVOL, V28, P87, DOI 10.1093/molbev/msq177; MCGARVEY DJ, 1995, PLANT CELL, V7, P1015, DOI 10.1105/tpc.7.7.1015; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Moran Y, 2012, MOL BIOL EVOL, V29, P2223, DOI 10.1093/molbev/mss089; Mungpakdee S, 2014, GENOME BIOL EVOL, V6, P1408, DOI 10.1093/gbe/evu109; Nakashima K, 2004, DEV GENES EVOL, V214, P81, DOI 10.1007/s00427-003-0379-8; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ragan MA, 2001, FEMS MICROBIOL LETT, V201, P187, DOI 10.1111/j.1574-6968.2001.tb10755.x; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Richelle-Maurer E, 2001, CELL TISSUE RES, V306, P157, DOI 10.1007/s004410100437; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruppert EE, 1995, SPONGES PLACOZOANS I, P73; Sakarya O, 2008, BIOINFORMATICS, V24, P606, DOI 10.1093/bioinformatics/btn005; Schmitt I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004437; Schuiki I, 2009, IUBMB LIFE, V61, P151, DOI 10.1002/iub.159; Simpson JS, 2004, ORG BIOMOL CHEM, V2, P939, DOI 10.1039/b315894b; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Starcevic A, 2008, P NATL ACAD SCI USA, V105, P2533, DOI 10.1073/pnas.0707388105; Sun BF, 2015, SCI REP-UK, V5, DOI 10.1038/srep18676; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Szitenberg A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-288; Tamames J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-136; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wheeler D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059262; Won H, 2003, P NATL ACAD SCI USA, V100, P10824, DOI 10.1073/pnas.1833775100; Yue JP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-729; Zou HS, 2012, MICROBIOL-SGM, V158, P2372, DOI 10.1099/mic.0.059964-0	71	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151092	10.1371/journal.pone.0151092	http://dx.doi.org/10.1371/journal.pone.0151092			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959231	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300096
J	Katada, Y; Negishi, K; Watanabe, K; Shigeno, Y; Saiki, M; Torii, H; Kaido, M; Tsubota, K				Katada, Yusaku; Negishi, Kazuno; Watanabe, Kazuhiro; Shigeno, Yuta; Saiki, Megumi; Torii, Hidemasa; Kaido, Minako; Tsubota, Kazuo			Functional Visual Acuity of Early Presbyopia	PLOS ONE			English	Article							AGE-RELATED-CHANGES; HUMAN CRYSTALLINE LENS; DRY EYE PATIENTS; CONTRAST SENSITIVITY; OCULAR ABERRATIONS; LIGHT SCATTER; PERFORMANCE; CORNEAL; SYSTEM; PUPIL	Purpose To evaluate visual function in patients with early presbyopia using the functional visual acuity (FVA) test. Methods This study included 27 eyes of 27 healthy older volunteers (mean age, 44.1 +/- 2.6 years) and 14 eyes of 14 healthy young volunteers (mean age, 28.4 +/- 4.8 years). The distance-corrected visual acuity (DCVA), distance-corrected near VA (DCNVA), subjective amplitude of accommodation (AA), and distance and near pupillary diameters were measured. The distance FVA and distance-corrected near FVA (DCNFVA) were measured using the FVA Measurement System. The standard Schirmer test and standard tear break-up time measurement also were performed. Results The logarithm of the minimum angle of resolution (logMAR) DCVA was better than 0 in all subjects. The percentages of subjects with logMAR DCNVA below 0 was significantly lower in the presbyopia group than in the young group. The DCNFVA in the presbyopia group was significantly (P < 0.001) poorer than the DCNVA in that group. Significant linear negative correlations were seen between the DCNVA and AA (r = -0.507, P < 0.001) and the DCNFVA and AA (r = -0.681, P < 0.001) in the older subjects. Stepwise regression analysis showed that only the AA was a significant factor predictive of the DCNFVA in the presbyopia group. Tear function parameters were not adopted in the regression model. Conclusions Measurement of the DCNFVA can detect decreased AA in early presbyopia better than measurement of the conventional near VA. The DCNFVA is a good index for early presbyopia.	[Katada, Yusaku; Negishi, Kazuno; Watanabe, Kazuhiro; Shigeno, Yuta; Saiki, Megumi; Torii, Hidemasa; Kaido, Minako; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Shinanomachi, Japan	Keio University	Negishi, K (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Shinanomachi, Japan.	fwic7788@mb.infoweb.ne.jp	Negishi, Kazuno/AAG-3260-2021	Negishi, Kazuno/0000-0002-2892-9810				Akutsu H., 1991, J GERONTOL B-PSYCHOL, V46, P325; Amano S, 2004, AM J OPHTHALMOL, V137, P988, DOI 10.1016/j.ajo.2004.01.005; Artal P, 2002, J OPT SOC AM A, V19, P137, DOI 10.1364/JOSAA.19.000137; Artal Pablo, 2003, International Ophthalmology Clinics, V43, P63; Berrio E., 2010, J VIS, V10, P1; BIRREN JE, 1950, J GERONTOL, V5, P216, DOI DOI 10.1093/GER0NJ/5.3.216; COOK CA, 1994, VISION RES, V34, P2945, DOI 10.1016/0042-6989(94)90266-6; DEREFELDT G, 1979, ACTA OPHTHALMOL, V57, P679; Fujikado T, 2004, AM J OPHTHALMOL, V138, P143, DOI 10.1016/j.ajo.2004.01.051; George Bennett R B R, 2007, BENNETT RABBETTS CLI, P27; Glasser A, 1998, VISION RES, V38, P209, DOI 10.1016/S0042-6989(97)00102-8; Goto E, 2003, AM J OPHTHALMOL, V135, P704, DOI 10.1016/S0002-9394(02)02147-5; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; Guirao A, 2000, J OPT SOC AM A, V17, P1697, DOI 10.1364/JOSAA.17.001697; Gupta N, 2009, J CATARACT REFR SURG, V35, P1401, DOI 10.1016/j.jcrs.2009.03.026; Hennelly ML, 1998, OPHTHAL PHYSL OPT, V18, P197, DOI 10.1016/S0275-5408(97)00077-X; Ishida R, 2005, AM J OPHTHALMOL, V139, P253, DOI 10.1016/j.ajo.2004.08.075; Ishioka M, 2009, ACTA OPHTHALMOL, V87, P574, DOI 10.1111/j.1755-3768.2008.01230.x; KADLECOVA V, 1958, NATURE, V182, P1520, DOI 10.1038/1821520a0; Kaido M, 2007, CORNEA, V26, pS29, DOI 10.1097/ICO.0b013e31812f6913; Kaido M, 2006, AM J OPHTHALMOL, V142, P917, DOI 10.1016/j.ajo.2006.07.055; Kawamorita T, 2010, J REFRACT SURG, V26, P378, DOI 10.3928/1081597X-20100212-01; KLINE D W, 1975, Experimental Aging Research, V1, P17, DOI 10.1080/03610737508257943; Kuroda T, 2002, J REFRACT SURG, V18, pS598; Lott LA, 2001, OPTOMETRY VISION SCI, V78, P316, DOI 10.1097/00006324-200105000-00015; McLellan JS, 2001, INVEST OPHTH VIS SCI, V42, P1390; Myron Y, 2008, OPHTHALMOLOGY, P1059; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Owsley C, 2011, VISION RES, V51, P1610, DOI 10.1016/j.visres.2010.10.020; Schefrin BE, 1999, VISION RES, V39, P3728, DOI 10.1016/S0042-6989(99)00072-3; Shahidi M, 2004, OPTOMETRY VISION SCI, V81, P853, DOI 10.1097/01.OPX.0000145022.74296.45; Tanaka M, 2004, J CATARACT REFR SURG, V30, P2311, DOI 10.1016/j.jcrs.2004.02.086; Teramoto W, 2012, ATTEN PERCEPT PSYCHO, V74, P1722, DOI 10.3758/s13414-012-0360-6; Toda I, 2009, J REFRACT SURG, V25, P69, DOI 10.3928/1081597X-20090101-09; Wakamatsu TH, 2011, J CATARACT REFR SURG, V37, P258, DOI 10.1016/j.jcrs.2010.08.048; WALSH DA, 1979, J GERONTOL, V34, P234, DOI 10.1093/geronj/34.2.234; WALSH DA, 1976, J GERONTOL, V31, P178, DOI 10.1093/geronj/31.2.178; Watanabe K, 2013, J REFRACT SURG, V29, P19, DOI 10.3928/1081597X-20121211-01; Woods RL, 1991, J BR CONTACT LENS AS, V14, P115, DOI [10.1016/0141-7037(91)80004-6, DOI 10.1016/0141-7037(91)80004-6]; WRIGHT CE, 1985, DOC OPHTHALMOL, V59, P385, DOI 10.1007/BF00159172; Yamaguchi T, 2009, J REFRACT SURG, V25, P410, DOI 10.3928/1081597X-20090422-02	41	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151094	10.1371/journal.pone.0151094	http://dx.doi.org/10.1371/journal.pone.0151094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959362	Green Submitted, gold, Green Published			2022-12-27	WOS:000371992300097
J	Schleifenbaum, S; Prietzel, T; Aust, G; Boldt, A; Fritsch, S; Keil, I; Koch, H; Mobius, R; Scheidt, HA; Wagner, MFX; Hammer, N				Schleifenbaum, Stefan; Prietzel, Torsten; Aust, Gabriela; Boldt, Andreas; Fritsch, Sebastian; Keil, Isabel; Koch, Holger; Moebius, Robert; Scheidt, Holger A.; Wagner, Martin F. X.; Hammer, Niels			Acellularization-Induced Changes in Tensile Properties Are Organ Specific - An In-Vitro Mechanical and Structural Analysis of Porcine Soft Tissues	PLOS ONE			English	Article							DERMAL MATRIX; EXTRACELLULAR-MATRIX; ACHILLES-TENDON; REPAIR; GRAFT; DECELLULARIZATION; TRANSPLANTATION; RECONSTRUCTION; AUGMENTATION	Introduction Though xenogeneic acellular scaffolds are frequently used for surgical reconstruction, knowledge of their mechanical properties is lacking. This study compared the mechanical, histological and ultrastructural properties of various native and acellular specimens. Materials and Methods Porcine esophagi, ureters and skin were tested mechanically in a native or acellular condition, focusing on the elastic modulus, ultimate tensile stress and maximum strain. The testing protocol for soft tissues was standardized, including the adaption of the tissue's water content and partial plastination to minimize material slippage as well as templates for normed sample dimensions and precise cross-section measurements. The native and acellular tissues were compared at the microscopic and ultrastructural level with a focus on type I collagens. Results Increased elastic modulus and ultimate tensile stress values were quantified in acellular esophagi and ureters compared to the native condition. In contrast, these values were strongly decreased in the skin after acellularization. Acellularization-related decreases in maximum strain were found in all tissues. Type I collagens were well-preserved in these samples; however, clotting and a loss of cross-linking type I collagens was observedultrastructurally. Elastins and fibronectins were preserved in the esophagi and ureters. A loss of the epidermal layer and decreased fibronectin content was present in the skin. Discussion Acellularization induces changes in the tensile properties of soft tissues. Some of these changes appear to be organ specific. Loss of cross-linking type I collagen may indicate increased mechanical strength due to decreasing transverse forces acting upon the scaffolds, whereas fibronectin loss may be related to decreased load-bearing capacity. Potentially, the alterations in tissue mechanics are linked to organ function and to the interplay of cells and the extracellular matrix, which is different in hollow organs when compared to skin.	[Schleifenbaum, Stefan; Prietzel, Torsten] Univ Leipzig, Dept Orthoped Trauma & Plast Surg, D-04109 Leipzig, Germany; [Aust, Gabriela] Univ Leipzig, Dept Surg, Res Labs, D-04109 Leipzig, Germany; [Boldt, Andreas] Univ Leipzig, Inst Clin Immunol, D-04109 Leipzig, Germany; [Fritsch, Sebastian; Keil, Isabel; Wagner, Martin F. X.] Tech Univ Chemnitz, Inst Mat Sci & Engn, Chemnitz, Germany; [Keil, Isabel; Moebius, Robert] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Koch, Holger] Translat Ctr Regenerat Med TRM, Leipzig, Germany; [Scheidt, Holger A.] Univ Leipzig, Inst Med Phys & Biophys, D-04109 Leipzig, Germany; [Hammer, Niels] Univ Otago, Dept Anat, Dunedin, New Zealand	Leipzig University; Leipzig University; Leipzig University; Technische Universitat Chemnitz; Leipzig University; Leipzig University; University of Otago	Hammer, N (corresponding author), Univ Otago, Dept Anat, Dunedin, New Zealand.	nlshammer@googlemail.com	Wagner, Martin FX/A-6880-2008; Wagner, Martin/M-9684-2019	Wagner, Martin/0000-0003-4082-2618; Hammer, Niels/0000-0001-8230-9383; Schleifenbaum, Stefan/0000-0002-9075-3756				Adams JE, 2006, ARTHROSCOPY, V22, P700, DOI 10.1016/j.arthro.2006.03.016; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Barber FA, 2009, ARTHROSCOPY, V25, P1233, DOI 10.1016/j.arthro.2009.05.012; Borschel GH, 2003, J SURG RES, V114, P133, DOI 10.1016/S0022-4804(03)00255-5; Branch JP, 2011, J FOOT ANKLE SURG, V50, P257, DOI 10.1053/j.jfas.2010.12.015; Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7; Byrom MJ, 2013, ANN CARDIOTHORAC SUR, V2, P435, DOI 10.3978/j.issn.2225-319X.2013.05.04; Cebotari Serghei, 2002, Circulation, V106, pI; Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61; Chung S, 2003, PLAST RECONSTR SURG, V111, P225, DOI 10.1097/01.PRS.0000034934.05304.ED; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Deutsches Institut fur Normung e. V.: Prufung metallischer Werkstoffe, 2009, 501257704010 DIN; Ehsan A, 2012, J HAND SURG-AM, V37A, P1538, DOI 10.1016/j.jhsa.2012.04.043; Ellis CV, 2012, PLAST RECONSTR SURG, V130, p256S, DOI 10.1097/PRS.0b013e318265a5cf; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Hammer N, 2016, J MECH BEHAV BIOMEDI; Hammer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105037; Hammer N, 2012, J MECH BEHAV BIOMED, V16, P81, DOI 10.1016/j.jmbbm.2012.04.025; Hoganson DM, 2010, BIOMATERIALS, V31, P6730, DOI 10.1016/j.biomaterials.2010.05.019; Hopper RA, 2003, ANN PLASTIC SURG, V51; Hulsmann J, 2012, XENOTRANSPLANTATION, V19, P286, DOI 10.1111/j.1399-3089.2012.00719.x; Jo WM, 2007, J KOREAN MED SCI, V22, P262, DOI 10.3346/jkms.2007.22.2.262; Koch H, 2012, J BIOMED BIOTECHNOL, V2012, P11; Koch H, 2015, FRONTIERS BIOENGINEE, V3; Lee DK, 2008, J FOOT ANKLE SURG, V47, P8, DOI 10.1053/j.jfas.2007.08.015; Lovati AB, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7276150; Pridgen BC, 2011, TISSUE ENG PART C-ME, V17, P819, DOI 10.1089/ten.tec.2010.0457; Rao BM, 2012, INT ORTHOP, V36, P2049, DOI 10.1007/s00264-012-1630-6; Rovak JM, 2005, J RECONSTR MICROSURG, V21, P207, DOI 10.1055/s-2005-869828; Rubin Laurence, 2005, Clin Podiatr Med Surg, V22, P533, DOI 10.1016/j.cpm.2005.08.002; Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4; Schulze-Tanzil Gundula, 2012, Cells, V1, P1010, DOI 10.3390/cells1041010; Sichting F, 2015, J MECH BEHAV BIOMED, V49, P112, DOI 10.1016/j.jmbbm.2015.04.028; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; Steinke H, 2012, MED ENG PHYS, V34, P1221, DOI 10.1016/j.medengphy.2011.12.009; Sundermann SH, 2015, INTERACT CARDIOV TH, V20, P10, DOI 10.1093/icvts/ivu310; Tischer T, 2010, TISSUE ENG PT A, V16, P1031, DOI [10.1089/ten.tea.2009.0043, 10.1089/ten.TEA.2009.0043]; Wainwright David, 1996, Journal of Burn Care and Rehabilitation, V17, P124, DOI 10.1097/00004630-199603000-00006	38	25	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151223	10.1371/journal.pone.0151223	http://dx.doi.org/10.1371/journal.pone.0151223			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960134	gold, Green Published, Green Submitted			2022-12-27	WOS:000371992300111
J	Bauer, RJ; Evans, TC; Lohman, GJS				Bauer, Robert J.; Evans, Thomas C., Jr.; Lohman, Gregory J. S.			The Inhibitory Effect of Non-Substrate and Substrate DNA on the Ligation and Self-Adenylylation Reactions Catalyzed by T4 DNA Ligase	PLOS ONE			English	Article							KINETIC MECHANISM; NICK RECOGNITION; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; POLYMERASE-I; DUPLEX DNA; FIDELITY; SPECIFICITY; ADENYLATE	DNA ligases are essential both to in vivo replication, repair and recombination processes, and in vitro molecular biology protocols. Prior characterization of DNA ligases through gel shift assays has shown the presence of a nick site to be essential for tight binding between the enzyme and its dsDNA substrate, with no interaction evident on dsDNA lacking a nick. In the current study, we observed a significant substrate inhibition effect, as well as the inhibition of both the self-adenylylation and nick-sealing steps of T4 DNA ligase by non-nicked, non-substrate dsDNA. Inhibition by non-substrate DNA was dependent only on the total DNA concentration rather than the structure; with 1 mu g/mL of 40-mers, 75-mers, or circular plasmid DNA all inhibiting ligation equally. A > 15-fold reduction in T4 DNA ligase self-adenylylation rate when in the presence of high non-nicked dsDNA concentrations was observed. Finally, EMSAs were utilized to demonstrate that non-substrate dsDNA can compete with nicked dsDNA substrates for enzyme binding. Based upon these data, we hypothesize the inhibition of T4 DNA ligase by non-nicked dsDNA is direct evidence for a two-step nick-binding mechanism, with an initial, nick-independent, transient dsDNA-binding event preceding a transition to a stable binding complex in the presence of a nick site.	[Bauer, Robert J.; Evans, Thomas C., Jr.; Lohman, Gregory J. S.] New England Biolabs Inc, DNA Enzymes Div, Ipswich, MA 01938 USA	New England Biolabs	Evans, TC; Lohman, GJS (corresponding author), New England Biolabs Inc, DNA Enzymes Div, Ipswich, MA 01938 USA.	evanst@neb.com; lohman@neb.com		Lohman, Gregory/0000-0002-0638-7555; Bauer, Robert/0000-0001-6317-6933	New England Biolabs, Ipswich, MA	New England Biolabs, Ipswich, MA	This work was funded internally by New England Biolabs, Ipswich, MA, of which all authors are employees. The specific roles of the authors are articulated in the 'author contributions' section. Employees and owners of New England Biolabs not on the author list did not contribute to the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Critical feedback and proofreading of the manuscript was provided by additional members of the NEB Research Department as indicated in the Acknowledgments.	Baldwin MR, 2009, BIOCHEMISTRY-US, V48, P6022, DOI 10.1021/bi900517y; Bauer RJ, 2012, BIOCHEMISTRY-US, V51, P1996, DOI 10.1021/bi201799a; Bremer Hans, 2008, EcoSal Plus, V3, DOI 10.1128/ecosal.5.2.3; BRYANT FR, 1983, BIOCHEMISTRY-US, V22, P3537, DOI 10.1021/bi00284a001; Cherepanov AV, 2003, EUR J BIOCHEM, V270, P4315, DOI 10.1046/j.1432-1033.2003.03824.x; Cherepanov AV, 2002, EUR J BIOCHEM, V269, P5993, DOI 10.1046/j.1432-1033.2002.03309.x; Cherepanov AV, 2002, J BIOL CHEM, V277, P1695, DOI 10.1074/jbc.M109616200; CIARROCCHI G, 1993, NUCLEIC ACIDS RES, V21, P5934, DOI 10.1093/nar/21.25.5934; de Saro FJL, 2001, P NATL ACAD SCI USA, V98, P8376, DOI 10.1073/pnas.121009498; Doherty AJ, 2000, J MOL BIOL, V296, P43, DOI 10.1006/jmbi.1999.3423; GELLERT M, 1967, P NATL ACAD SCI USA, V57, P148, DOI 10.1073/pnas.57.1.148; Greenough L, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv899; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Ivanchenko M, 1996, BIOCHEM BIOPH RES CO, V226, P498, DOI 10.1006/bbrc.1996.1384; Jahic H, 2012, BIOCHEM PHARMACOL, V84, P654, DOI 10.1016/j.bcp.2012.06.017; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Kukshal V, 2015, NUCLEIC ACIDS RES, V43, P7021, DOI 10.1093/nar/gkv652; LEHMAN IR, 1974, SCIENCE, V186, P790; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; Lohman GJS, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv898; Lohman GJS, 2014, NUCLEIC ACIDS RES, V42, P1831, DOI 10.1093/nar/gkt1032; Lohman GJS, 2011, J BIOL CHEM, V286, P44187, DOI 10.1074/jbc.M111.284992; MODRICH P, 1973, J BIOL CHEM, V248, P7502; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nakatani M, 2002, EUR J BIOCHEM, V269, P650, DOI 10.1046/j.0014-2956.2001.02695.x; Nandakumar J, 2004, J BIOL CHEM, V279, P31337, DOI 10.1074/jbc.M402394200; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; NILSSON SV, 1982, NUCLEIC ACIDS RES, V10, P1425, DOI 10.1093/nar/10.5.1425; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; OLIVERA BM, 1968, P NATL ACAD SCI USA, V61, P237, DOI 10.1073/pnas.61.1.237; OLIVERA BM, 1967, P NATL ACAD SCI USA, V57, P1426, DOI 10.1073/pnas.57.5.1426; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; RAAE AJ, 1975, EUR J BIOCHEM, V60, P437, DOI 10.1111/j.1432-1033.1975.tb21021.x; Rossi R, 1997, NUCLEIC ACIDS RES, V25, P2106, DOI 10.1093/nar/25.11.2106; Samai P, 2012, J BIOL CHEM, V287, P28609, DOI 10.1074/jbc.M112.380428; Samai P, 2011, J BIOL CHEM, V286, P22642, DOI 10.1074/jbc.M111.245399; Sannai P, 2011, J BIOL CHEM, V286, P13314, DOI 10.1074/jbc.M111.226191; Segel IH., 1993, ENZYME KINETICS BEHA; Sekiguchi J, 1997, J VIROL, V71, P9679, DOI 10.1128/JVI.71.12.9679-9684.1997; Shapiro Adam B, 2014, BMC Res Notes, V7, P287, DOI 10.1186/1756-0500-7-287; Shuman S, 1995, BIOCHEMISTRY-US, V34, P16138, DOI 10.1021/bi00049a029; Shuman S, 2009, J BIOL CHEM, V284, P17365, DOI 10.1074/jbc.R900017200; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P3536, DOI 10.1093/nar/26.15.3536; Subramanya HS, 1996, CELL, V85, P607, DOI 10.1016/S0092-8674(00)81260-X; Taylor EL, 2015, BIOCHEMISTRY-US, V54, P898, DOI 10.1021/bi501356x; Taylor MR, 2011, J BIOL CHEM, V286, P23054, DOI 10.1074/jbc.M111.248831; TERAOKA H, 1983, BIOCHIM BIOPHYS ACTA, V747, P117, DOI 10.1016/0167-4838(83)90129-2; Tong J, 1999, NUCLEIC ACIDS RES, V27, P788, DOI 10.1093/nar/27.3.788; WU DY, 1989, GENE, V76, P245, DOI 10.1016/0378-1119(89)90165-0; Yaginuma H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06522	52	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150802	10.1371/journal.pone.0150802	http://dx.doi.org/10.1371/journal.pone.0150802			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954034	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300052
J	Katoh, J; Kawana-Tachikawa, A; Shimizu, A; Zhu, DY; Han, CY; Nakamura, H; Koga, M; Kikuchi, T; Adachi, E; Koibuchi, T; Gao, GF; Brumme, ZL; Iwamoto, A				Katoh, Jiro; Kawana-Tachikawa, Ai; Shimizu, Akihisa; Zhu, Dayong; Han, Chungyong; Nakamura, Hitomi; Koga, Michiko; Kikuchi, Tadashi; Adachi, Eisuke; Koibuchi, Tomohiko; Gao, George F.; Brumme, Zabrina L.; Iwamoto, Aikichi			Rapid HIV-1 Disease Progression in Individuals Infected with a Virus Adapted to Its Host Population	PLOS ONE			English	Article							T-LYMPHOCYTE ESCAPE; BLOOD MONONUCLEAR-CELLS; IMMUNE-RESPONSES; CTL EPITOPES; HLA; TYPE-1; IDENTIFICATION; ADAPTATION; SELECTION; PLASMA	HIV-1 escape from CTL is predictable based on the Human Leukocyte Antigen (HLA) class I alleles expressed by the host. As such, HIV-1 sequences circulating in a population of hosts will harbor escape mutations specific to the HLA alleles of that population. In theory, this should increase the frequency of escape mutation transmission to persons expressing the restricting HLA allele, thereby compromising host immunity to the incoming HIV-1 strain. However, the clinical impact of infection with HIV-1 containing immune escape mutations has not conclusively been demonstrated. Japan's population features limited HLA diversity which is driving population-level HIV adaptation: for example, >60% of Japanese express HLA-A*24:02 and its associated Nef-Y135F escape mutation represents the population consensus. As such, Japan is an ideal population in which to examine this phenomenon. Here, we combine genetic and immunological analyses to identify A*24:02-positive individuals likely to have been infected with Y135F-containing HIV-1. Over a similar to 5 year follow-up, these individuals exhibited significantly lower CD4 counts compared to individuals inferred to have been infected with wild-type HIV-1. Our results support a significant negative clinical impact of pathogen adaptation to host pressures at the population level.	[Katoh, Jiro; Kawana-Tachikawa, Ai; Shimizu, Akihisa; Zhu, Dayong; Han, Chungyong; Koga, Michiko; Kikuchi, Tadashi; Iwamoto, Aikichi] Univ Tokyo, Inst Med Sci, Div Infect Dis, Adv Clin Res Ctr, Tokyo, Japan; [Katoh, Jiro; Iwamoto, Aikichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba, Japan; [Nakamura, Hitomi; Iwamoto, Aikichi] Univ Tokyo, Inst Med Sci, Dept Infect Dis Control, Int Res Ctr Infect Dis, Tokyo, Japan; [Nakamura, Hitomi; Koga, Michiko; Kikuchi, Tadashi; Adachi, Eisuke; Koibuchi, Tomohiko; Iwamoto, Aikichi] Univ Tokyo, Inst Med Sci, Dept Infect Dis & Appl Immunol, Hosp, Tokyo, Japan; [Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Brumme, Zabrina L.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Brumme, Zabrina L.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Katoh, Jiro; Iwamoto, Aikichi] Univ Tokyo, Inst Med Sci, Asian Res Ctr Infect Dis, Tokyo, Japan; [Katoh, Jiro] Med & Biol Labs Co Ltd, Nagoya, Aichi, Japan; [Kawana-Tachikawa, Ai] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Shimizu, Akihisa] NEC Solut Innovators Ltd, Kashiwa, Chiba 2770882, Japan; [Han, Chungyong] Natl Canc Ctr, Canc Immunol Branch, Div Canc Biol, Goyang Si 410769, Gyeongi Do, South Korea; [Nakamura, Hitomi] Shinagawa East Med Clin, Tokyo, Japan; [Iwamoto, Aikichi] Japan Agcy Med Res & Dev, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Chinese Academy of Sciences; Institute of Microbiology, CAS; Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; University of Tokyo; National Institute of Infectious Diseases (NIID); National Cancer Center - Korea (NCC)	Iwamoto, A (corresponding author), Univ Tokyo, Inst Med Sci, Div Infect Dis, Adv Clin Res Ctr, Tokyo, Japan.; Iwamoto, A (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba, Japan.; Iwamoto, A (corresponding author), Univ Tokyo, Inst Med Sci, Dept Infect Dis Control, Int Res Ctr Infect Dis, Tokyo, Japan.; Iwamoto, A (corresponding author), Univ Tokyo, Inst Med Sci, Dept Infect Dis & Appl Immunol, Hosp, Tokyo, Japan.; Iwamoto, A (corresponding author), Univ Tokyo, Inst Med Sci, Asian Res Ctr Infect Dis, Tokyo, Japan.; Iwamoto, A (corresponding author), Japan Agcy Med Res & Dev, Tokyo, Japan.	aikichi@zj9.so-net.ne.jp	Gao, George Fu/ABD-5229-2021	Brumme, Zabrina/0000-0002-8157-1037	Ministry of Health, Labour, and Welfare of Japan [H25-AIDS-IPPAN-007]; JSPS KAKENHI [25293226]; Research grant from Banyu Life Science Foundation International; Canadian Institutes for Health Research; Michael Smith Foundation for Health Research	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research grant from Banyu Life Science Foundation International; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported in part by a contract research fund from Grants for AIDS research (H25-AIDS-IPPAN-007) (AKT) from the Ministry of Health, Labour, and Welfare of Japan; JSPS KAKENHI (25293226) (AKT); Research grant from Banyu Life Science Foundation International (AKT); New Investigator Award from the Canadian Institutes for Health Research, and a Scholar Award from the Michael Smith Foundation for Health Research (ZLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Carlsen T, 2012, FUNGAL ECOL, V5, P747, DOI 10.1016/j.funeco.2012.06.003; COUILLIN I, 1994, J EXP MED, V180, P1129, DOI 10.1084/jem.180.3.1129; Devereux HL, 2000, AIDS RES HUM RETROV, V16, P1025, DOI 10.1089/08892220050075273; Dong T, 2011, BLOOD, V118, P98, DOI 10.1182/blood-2010-06-291963; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fujiwara M, 2008, J VIROL, V82, P138, DOI 10.1128/JVI.01452-07; Furutsuki T, 2004, J VIROL, V78, P8437, DOI 10.1128/JVI.78.16.8437-8445.2004; Goulder PJR, 1997, AIDS, V11, P1883, DOI 10.1097/00002030-199715000-00015; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Han CY, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-38; Ikeda-Moore Y, 1997, J IMMUNOL, V159, P6242; Karakas A, 2015, J VIROL, V89, P10693, DOI 10.1128/JVI.01355-15; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Koga I, 2006, MICROBES INFECT, V8, P2872, DOI 10.1016/j.micinf.2006.09.003; Koga M, 2010, MICROBIOL IMMUNOL, V54, P196, DOI 10.1111/j.1348-0421.2010.00206.x; Kuzushima K, 2001, BLOOD, V98, P1872, DOI 10.1182/blood.V98.6.1872; Lank SM, 2010, HUM IMMUNOL, V71, P1011, DOI 10.1016/j.humimm.2010.07.012; Lewis MJ, 2012, J VIROL, V86, P7126, DOI 10.1128/JVI.00878-12; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Miyazaki E, 2009, AIDS, V23, P651, DOI 10.1097/QAD.0b013e32832605e6; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Mwimanzi P, 2013, VIROLOGY, V439, P74, DOI 10.1016/j.virol.2013.02.005; Nomura S, 2013, J VIROL, V87, P1465, DOI 10.1128/JVI.02122-12; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Payne R, 2014, P NATL ACAD SCI USA, V111, pE5393, DOI 10.1073/pnas.1413339111; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; Shimizu A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03097; Smith T.F., 1981, ADV APPL MATH, V2, P482, DOI DOI 10.1016/0196-8858(81)90046-4; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sun XM, 2014, J IMMUNOL, V193, P77, DOI 10.4049/jimmunol.1400375; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Verhofstede C, 2004, JAIDS-J ACQ IMM DEF, V35, P473, DOI 10.1097/00126334-200404150-00005; Yokomaku Y, 2004, J VIROL, V78, P1324, DOI 10.1128/JVI.78.3.1324-1332.2004	42	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150397	10.1371/journal.pone.0150397	http://dx.doi.org/10.1371/journal.pone.0150397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953793	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300026
J	O'Rourke, TW; Reines, D				O'Rourke, Thomas W.; Reines, Daniel			Determinants of Amyloid Formation for the Yeast Termination Factor Nab3	PLOS ONE			English	Article							RNA-POLYMERASE-II; CRYPTIC UNSTABLE TRANSCRIPTS; LOW-COMPLEXITY DOMAINS; BINDING PROTEINS NRD1; CELL-FREE FORMATION; PRION-LIKE DOMAINS; HNRNP-C; PHOSPHORYLATION; DEGRADATION; INTERACTS	Low complexity protein sequences are often intrinsically unstructured and many have the potential to polymerize into amyloid aggregates including filaments and hydrogels. RNA-binding proteins are unusually enriched in such sequences raising the question as to what function these domains serve in RNA metabolism. One such yeast protein, Nab3, is an 802 amino acid termination factor that contains an RNA recognition motif and a glutamine/proline rich domain adjacent to a region with structural similarity to a human hnRNP. A portion of the C-terminal glutamine/proline-rich domain assembles into filaments that organize into a hydrogel. Here we analyze the determinants of filament formation of the isolated low complexity domain as well as examine the polymerization properties of full-length Nab3. We found that the C-terminal region with structural homology to hnRNP-C is not required for assembly, nor is an adjacent stretch of 16 glutamines. However, reducing the overall glutamine composition of this 134-amino acid segment from 32% to 14% destroys its polymerization ability. Importantly, full-length wildtype Nab3 also formed filaments with a characteristic cross-beta structure which was dependent upon the glutamine/proline-rich region. When full length Nab3 with reduced glutamine content in its low complexity domain was exchanged for wildtype Nab3, cells were not viable. This suggests that polymerization of Nab3 is normally required for its function. In an extension of this idea, we show that the low complexity domain of another yeast termination factor, Pcf11, polymerizes into amyloid fibers and a hydrogel. These findings suggest that, like many other RNA binding proteins, termination factors share a common biophysical trait that may be important for their function.	[O'Rourke, Thomas W.; Reines, Daniel] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Reines, D (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	dreines@emory.edu	excellency, Your/R-2357-2019	excellency, Your/0000-0003-0832-6243	National Institutes of General Medical Sciences; NIH grant [S10RR025679]; Emory School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046331, R01GM120271] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of General Medical Sciences and NIH grant S10RR025679. The authors also thank the Emory School of Medicine for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. D. Libri for plasmid pDL469, Hong Yi of the Emory Electron Microscopy Core, Dr. M. Hampsey for yeast strains, and Dr. E. Ortlund for use of the Synergy fluorimeter. We also acknowledge Lola Olufemi for plasmid construction. This work was supported, in whole or in part, by the National Institutes of General Medical Sciences, and NIH grant S10RR025679. The authors also thank the Emory School of Medicine for support.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Arndt KM, 2015, ANN REV BIOCH; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Barilla D, 2001, P NATL ACAD SCI USA, V98, P445, DOI 10.1073/pnas.021545298; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hennig S, 2015, J CELL BIOL, V210, P529, DOI 10.1083/jcb.201504117; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kayatekin C, 2014, P NATL ACAD SCI USA, V111, P12085, DOI 10.1073/pnas.1412504111; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Loya TJ, 2013, J BIOL CHEM, V288, P34158, DOI 10.1074/jbc.M113.516765; Loya TJ, 2013, J BIOL CHEM, V288, P2111, DOI 10.1074/jbc.M112.430678; Loya TJ, 2012, NUCLEIC ACIDS RES, V40, P7476, DOI 10.1093/nar/gks377; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; O'Rourke TW, 2015, PRION, V9, P34, DOI 10.1080/19336896.2014.997618; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Patturajan M, 1998, MOL CELL BIOL, V18, P2406, DOI 10.1128/MCB.18.4.2406; REINES D, 1985, J BIOL CHEM, V260, P4248; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Sadowski M, 2003, EMBO J, V22, P2167, DOI 10.1093/emboj/cdg200; Schwartz JC, 2012, GENE DEV, V26, P2690, DOI 10.1101/gad.204602.112; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Steinmetz EJ, 1998, P NATL ACAD SCI USA, V95, P6699, DOI 10.1073/pnas.95.12.6699; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; Tudek A, 2014, MOL CELL, V55, P467, DOI 10.1016/j.molcel.2014.05.031; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Whitson SR, 2005, J MOL BIOL, V350, P319, DOI 10.1016/j.jmb.2005.05.002; Wickner RB, 2013, BIOCHEMISTRY-US, V52, P1514, DOI 10.1021/bi301686a; Wolfe KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095914; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017; Zhu XF, 2015, NUCLEIC ACIDS RES, V43, P7306, DOI 10.1093/nar/gkv629	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150865	10.1371/journal.pone.0150865	http://dx.doi.org/10.1371/journal.pone.0150865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954508	gold, Green Submitted, Green Published			2022-12-27	WOS:000371991300055
J	Slot, E; Hogema, BM; Molier, M; Bart, A; Zaaijer, HL				Slot, Ed; Hogema, Boris M.; Molier, Michel; Bart, Aldert; Zaaijer, Hans L.			Risk Factors and Screening for Trypanosoma cruzi Infection of Dutch Blood Donors	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; CHAGAS-DISEASE; CONGENITAL TRANSMISSION; NORTH-AMERICA; EPIDEMIOLOGY; ANTIBODY; SURVEILLANCE; PREVALENCE; ASSAY; AREA	Background Blood donors unaware of Trypanosoma cruzi infection may donate infectious blood. Risk factors and the presence of T. cruzi antibodies in at-risk Dutch blood donors were studied to assess whether specific blood safety measures are warranted in the Netherlands. Methodology Birth in a country endemic for Chagas disease (CEC), having a mother born in a CEC, or having resided for at least six continuous months in a CEC were considered risk factors for T. cruzi infection. From March through September 2013, risk factor questions were asked to all donors who volunteered to donate blood or blood components. Serum samples were collected from donors reporting one or more risk factors, and screened for IgG antibodies to T. cruzi by EIA. Results Risk factors for T. cruzi infection were reported by 1,426 of 227,278 donors (0.6%). Testing 1,333 at-risk donors, none (0.0%; 95%, CI 0.0-0.4%) was seroreactive for IgG antibodies to T. cruzi. A total of 472 donors were born in a CEC; 553 donors reported their mother being born in a CEC; and 1,121 donors reported a long-term stay in a CEC. The vast majority of reported risk factors were related to Suriname and Brazil. Overall, the participants resided for 7,694 years in CECs, which equals 2.8 million overnight stays. Of those, 1.9 million nights were spent in Suriname. Conclusions/Significance Asymptomatic T. cruzi infection appears to be extremely rare among Dutch blood donors. Blood safety interventions to mitigate the risk of T. cruzi transmission by transfusion would be highly cost-ineffective in the Netherlands, and are thus not required.	[Slot, Ed; Hogema, Boris M.; Molier, Michel; Zaaijer, Hans L.] Sanquin Blood Supply Fdn, Sanquin Res, Dept Blood Borne Infect, Amsterdam, Netherlands; [Hogema, Boris M.; Zaaijer, Hans L.] Sanquin Blood Supply Fdn, Sanquin Diagnost Serv, Dept Virol, Amsterdam, Netherlands; [Bart, Aldert; Zaaijer, Hans L.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol CINIMA, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Slot, E (corresponding author), Sanquin Blood Supply Fdn, Sanquin Res, Dept Blood Borne Infect, Amsterdam, Netherlands.	e.slot@sanquin.nl	Bart, Aldert/B-9520-2008	Bart, Aldert/0000-0001-6605-6347; Slot, Ed/0000-0002-2459-2448	Sanquin Blood Supply Foundation	Sanquin Blood Supply Foundation	The study has been funded by Sanquin Blood Supply Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barona-Vilar C, 2012, EPIDEMIOL INFECT, V140, P1896, DOI 10.1017/S0950268811002482; Basile L, 2011, EUROSURVEILLANCE, V16, P14, DOI 10.2807/ese.16.37.19968-en; Benjamin RJ, 2012, TRANSFUSION, V52, P1913, DOI 10.1111/j.1537-2995.2011.03554.x; Buekens P, 2008, MATERN CHILD HLTH J, V12, P283, DOI 10.1007/s10995-007-0246-8; Cancino-Faure B, 2015, TRANSFUSION, V55, P1249, DOI 10.1111/trf.12989; Custer B, 2012, TRANSFUSION, V52, P1901, DOI 10.1111/j.1537-2995.2012.03569.x; Dzib D, 2009, VECTOR-BORNE ZOONOT, V9, P235, DOI 10.1089/vbz.2007.0278; El Ghouzzi MH, 2010, TRANSFUSION, V50, P575, DOI 10.1111/j.1537-2995.2009.02476.x; Flores-Chavez M.D., 2011, EURO SURVEILL, V16; Gabrielli S, 2013, BLOOD TRANSFUS-ITALY, V11, P558, DOI 10.2450/2013.0055-13; Gorlin J, 2008, TRANSFUSION, V48, P531, DOI 10.1111/j.1537-2995.2007.01566.x; Howard EJ, 2014, BJOG-INT J OBSTET GY, V121, P22, DOI 10.1111/1471-0528.12396; Huprikar S, 2013, AM J TRANSPLANT, V13, P2418, DOI 10.1111/ajt.12340; Jackson Y, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000592; Kessler DA, 2013, TRANSFUSION, V53, P1083, DOI 10.1111/j.1537-2995.2012.03856.x; Kitchen AD, 2012, TRANSFUSION, V52, P1931, DOI 10.1111/j.1537-2995.2012.03599.x; Kransdorf EP, 2014, CURR OPIN INFECT DIS, V27, P418, DOI 10.1097/QCO.0000000000000088; Leiby DA, 2010, VOX SANG, V99, P64; Lescure FX, 2010, LANCET INFECT DIS, V10, P556, DOI 10.1016/S1473-3099(10)70098-0; Martin DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095398; Miles MA, 2009, PARASITOLOGY, V136, P1509, DOI 10.1017/S0031182009990977; Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005; MORAESSOUZA H, 1995, TRANSFUSION, V35, P723, DOI 10.1046/j.1537-2995.1995.35996029154.x; Norman FF, 2014, T ROY SOC TROP MED H, V108, P388, DOI 10.1093/trstmh/tru062; Orti-Lucas Rafael M, 2014, J Parasitol Res, V2014, P514794, DOI 10.1155/2014/514794; Otani MM, 2009, TRANSFUSION, V49, P1076, DOI 10.1111/j.1537-2995.2009.02107.x; Pan American Health Organization WHO Department of Control of Neglected Tropical Diseases, OPSHDMCD42506 PAHO; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Schmunis GA, 2007, MEM I OSWALDO CRUZ, V102, P75, DOI 10.1590/S0074-02762007005000093; Tobler LH, 2007, TRANSFUSION, V47, P90, DOI 10.1111/j.1537-2995.2007.01068.x; World Health Organization, WHOHTMNTDIDM20101; Yasukawa K, 2014, TRANSFUSION, V54, P745, DOI 10.1111/trf.12505; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0151038	10.1371/journal.pone.0151038	http://dx.doi.org/10.1371/journal.pone.0151038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950434	gold, Green Published, Green Submitted			2022-12-27	WOS:000371990100082
J	Thompson, J; Ma, FR; Quinn, M; Xiang, SH				Thompson, Jesse; Ma, Fangrui; Quinn, Meghan; Xiang, Shi-Hua			Genome-Wide Search for Host Association Factors during Ovine Progressive Pneumonia Virus Infection	PLOS ONE			English	Article							SMALL-RUMINANT LENTIVIRUSES; HUMAN-IMMUNODEFICIENCY-VIRUS; MAEDI-VISNA VIRUS; RESTRICTION FACTORS; ENVELOPE GLYCOPROTEIN; REVERSE-TRANSCRIPTASE; PHYLOGENETIC ANALYSIS; RETROVIRAL INFECTION; HIV-1 INFECTION; GENE-EXPRESSION	Ovine progressive pneumonia virus (OPPV) is an important virus that causes serious diseases in sheep and goats with a prevalence of 36% in the USA. Although OPPV was discovered more than half of a century ago, little is known about the infection and pathogenesis of this virus. In this report, we used RNA-seq technology to conduct a genome-wide probe for cellular factors that are associated with OPPV infection. A total of approximately 22,000 goat host genes were detected of which 657 were found to have been significantly up-regulated and 889 down-regulated at 12 hours post-infection. In addition to previously known restriction factors from other viral infections, a number of factors which may be specific for OPPV infection were uncovered. The data from this RNA-seq study will be helpful in our understanding of OPPV infection, and also for further study in the prevention and intervention of this viral disease.	[Thompson, Jesse; Ma, Fangrui; Quinn, Meghan; Xiang, Shi-Hua] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Thompson, Jesse; Quinn, Meghan; Xiang, Shi-Hua] Univ Nebraska, Sch Vet Med & Biol Sci, Lincoln, NE USA; [Ma, Fangrui] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Xiang, SH (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA.; Xiang, SH (corresponding author), Univ Nebraska, Sch Vet Med & Biol Sci, Lincoln, NE USA.	sxiang2@unl.edu			School of Veterinary Medicine and Biomedical Science at the University of Nebraska-Lincoln; Agricultural Research Division at the University of Nebraska-Lincoln; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER	School of Veterinary Medicine and Biomedical Science at the University of Nebraska-Lincoln; Agricultural Research Division at the University of Nebraska-Lincoln; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by start-up funds provided to Shi-Hua Xiang from the School of Veterinary Medicine and Biomedical Science at the University of Nebraska-Lincoln, and a strategic grant provided to Shi-Hua Xiang from the Agricultural Research Division at the University of Nebraska-Lincoln. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieniasz PD, 2003, TRENDS MICROBIOL, V11, P286, DOI 10.1016/S0966-842X(03)00123-9; Blacklaws BA, 2010, CURR HIV RES, V8, P26, DOI 10.2174/157016210790416406; BLONDIN I, 1989, ANN RECH VET, V20, P153; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Brinkhof JMA, 2010, VET MICROBIOL, V142, P193, DOI 10.1016/j.vetmic.2009.09.060; Burdick R, 2010, J VIROL, V84, P10241, DOI 10.1128/JVI.00585-10; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Caroline L, 2010, CURR HIV RES, V8, P94, DOI 10.2174/157016210790416415; CHARLETY P, 1987, Annales de Recherches Veterinaires, V18, P245; Chebloune Y, 1996, J GEN VIROL, V77, P2037, DOI 10.1099/0022-1317-77-9-2037; Clements JE, 1996, CLIN MICROBIOL REV, V9, P100, DOI 10.1128/CMR.9.1.100; CUTLIP RC, 1988, VET MICROBIOL, V17, P237, DOI 10.1016/0378-1135(88)90068-5; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; DUKES TW, 1979, CAN J COMP MED, V43, P313; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; GENDELMAN HE, 1986, J VIROL, V58, P67, DOI 10.1128/JVI.58.1.67-74.1986; Giammarioli M, 2011, VIRUS GENES, V43, P380, DOI 10.1007/s11262-011-0653-1; Glaria I, 2009, VET MICROBIOL, V138, P156, DOI 10.1016/j.vetmic.2009.03.002; Goff SP, 2004, MOL CELL, V16, P849, DOI 10.1016/j.molcel.2004.12.001; Grego E, 2007, J GEN VIROL, V88, P3423, DOI 10.1099/vir.0.83292-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harbers M, 2005, NAT METHODS, V2, P495, DOI 10.1038/NMETH768; Heaton MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055490; Herrmann LM, 2004, VIRUS RES, V102, P215, DOI 10.1016/j.virusres.2004.02.001; Jauregui P, 2012, J VIROL, V86, P9504, DOI 10.1128/JVI.00440-12; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Kluge SF, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.019; Kuhar U, 2013, VET MICROBIOL, V162, P201, DOI 10.1016/j.vetmic.2012.08.024; L'Homme Y, 2015, VIROLOGY, V475, P159, DOI 10.1016/j.virol.2014.11.006; Leroux C, 1997, ARCH VIROL, V142, P1125, DOI 10.1007/s007050050147; Li MH, 2014, P NATL ACAD SCI USA, V111, pE3699, DOI 10.1073/pnas.1404851111; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Olech M, 2012, VIRUS RES, V163, P528, DOI 10.1016/j.virusres.2011.11.019; Pepin M, 1998, VET RES, V29, P341; Pyndiah N, 2015, CURR OPIN HIV AIDS, V10, P79, DOI 10.1097/COH.0000000000000138; Reina R, 2011, VET IMMUNOL IMMUNOP, V139, P237, DOI 10.1016/j.vetimm.2010.11.001; RHO HM, 1981, VIROLOGY, V112, P355, DOI 10.1016/0042-6822(81)90642-5; RUSSO P, 1984, ANN RECH VET, V15, P3; Shah C, 2004, J VIROL, V78, P7518, DOI 10.1128/JVI.78.14.7518-7522.2004; Shah C, 2004, VIROLOGY, V319, P12, DOI 10.1016/j.virol.2003.09.047; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; TANESE N, 1991, J VIROL, V65, P4387, DOI 10.1128/JVI.65.8.4387-4397.1991; Thormar H, 2005, AIDS REV, V7, P233; Valas S, 1997, VIROLOGY, V237, P307, DOI 10.1006/viro.1997.8800; Wang XJ, 2010, J BIOL CHEM, V285, P14346, DOI 10.1074/jbc.M110.109314; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Yu JY, 2015, CELL REP, V13, P145, DOI 10.1016/j.celrep.2015.08.055; Zheng YH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-112	51	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150344	10.1371/journal.pone.0150344	http://dx.doi.org/10.1371/journal.pone.0150344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950733	Green Published, gold			2022-12-27	WOS:000371990100030
J	Wang, K; Peng, ED; Huang, AS; Xia, D; Vermont, SJ; Lentini, G; Lebrun, M; Wastling, JM; Bradley, PJ				Wang, Kevin; Peng, Eric D.; Huang, Amy S.; Xia, Dong; Vermont, Sarah J.; Lentini, Gaelle; Lebrun, Maryse; Wastling, Jonathan M.; Bradley, Peter J.			Identification of Novel O-Linked Glycosylated Toxoplasma Proteins by Vicia villosa Lectin Chromatography	PLOS ONE			English	Article							DENSE GRANULE PROTEIN; MICRONEMAL PROTEINS; GONDII; FAMILY; EXPRESSION; ORGANELLES; GENE	Toxoplasma gondii maintains its intracellular life cycle using an extraordinary arsenal of parasite-specific organelles including the inner membrane complex (IMC), rhoptries, micronemes, and dense granules. While these unique compartments play critical roles in pathogenesis, many of their protein constituents have yet to be identified. We exploited the Vicia villosa lectin (VVL) to identify new glycosylated proteins that are present in these organelles. Purification of VVL-binding proteins by lectin affinity chromatography yielded a number of novel proteins that were subjected to further study, resulting in the identification of proteins from the dense granules, micronemes, rhoptries and IMC. We then chose to focus on three proteins identified by this approach, the SAG1 repeat containing protein SRS44, the rhoptry neck protein RON11 as well as a novel IMC protein we named IMC25. To assess function, we disrupted their genes by homologous recombination or CRISPR/Cas9. The knockouts were all successful, demonstrating that these proteins are not essential for invasion or intracellular survival. We also show that IMC25 undergoes substantial proteolytic processing that separates the C-terminal domain from the predicted glycosylation site. Together, we have demonstrated that lectin affinity chromatography is an efficient method of identifying new glycosylated parasite-specific proteins.	[Wang, Kevin; Peng, Eric D.; Huang, Amy S.; Bradley, Peter J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Xia, Dong; Vermont, Sarah J.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Lentini, Gaelle; Lebrun, Maryse] Univ Montpellier 1 & 2, UMR CNRS 5235, F-34095 Montpellier, France; [Wastling, Jonathan M.] Keele Univ, Fac Nat Sci, Keele, Staffs, England	University of California System; University of California Los Angeles; University of Liverpool; Universite de Montpellier; Keele University	Bradley, PJ (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	pbradley@ucla.edu	Lebrun, Maryse/I-7728-2016	Xia, Dong/0000-0003-4571-2776; Huang, Amy/0000-0002-5303-2191; Lentini, Gaelle/0000-0003-0836-9972; Lebrun, Maryse/0000-0002-0962-0156	National Institutes of Health [AI064616]; Biotechnology and Biological Sciences Research Council [BBS/B/08493]; intramural HHMI Undergraduate Research Program Fellowship; Fondation pour la Recherche Medicale (Equipe FRM) [DEQ20130326508]; FRM (Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); intramural HHMI Undergraduate Research Program Fellowship; Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (https://grants.nih.gov/grants/oer.htm) grant #AI064616 to PJB and Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk) grant #BBS/B/08493 to JMW. KW was supported by an intramural HHMI Undergraduate Research Program Fellowship. This work was supported by the Fondation pour la Recherche Medicale (Equipe FRM DEQ20130326508) to ML. GL was the recipient of a PhD fellowship of the FRM (Fondation pour la Recherche Medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; Beck JR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004025; Beck JR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003162; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Boothroyd JC, 1997, PHILOS T ROY SOC B, V352, P1347, DOI 10.1098/rstb.1997.0119; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Bougdour A, 2013, CELL HOST MICROBE, V13, P489, DOI 10.1016/j.chom.2013.03.002; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Caffaro CE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003331; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers Vern B., 2008, V47, P33; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; Cerede O, 2005, J EXP MED, V201, P453, DOI 10.1084/jem.20041672; Chen AL, 2015, MBIO, V6, DOI 10.1128/mBio.02357-14; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Fauquenoy S, 2008, MOL CELL PROTEOMICS, V7, P891, DOI 10.1074/mcp.M700391-MCP200; Fauquenoy S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.008953, 10.1074/mcp.A111.008953]; Frenal K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004504; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gould SB, 2008, MOL BIOL EVOL, V25, P1219, DOI 10.1093/molbev/msn070; Gubbels MJ, 2006, J CELL SCI, V119, P2236, DOI 10.1242/jcs.02949; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Hung SS, 2011, TRENDS PARASITOL, V27, P131, DOI 10.1016/j.pt.2010.11.003; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Karasov AO, 2005, INT J PARASITOL, V35, P285, DOI 10.1016/j.ijpara.2004.11.015; Kato K, 2008, BIOCHEM BIOPH RES CO, V371, P698, DOI 10.1016/j.bbrc.2008.04.120; Lamarque MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5098; Luk FCY, 2008, MOL BIOCHEM PARASIT, V157, P169, DOI 10.1016/j.molbiopara.2007.10.012; Mercier C, 2015, TRENDS PARASITOL, V31, P60, DOI 10.1016/j.pt.2014.12.002; Miller SA, 2001, J BIOL CHEM, V276, P45341, DOI 10.1074/jbc.M106665200; Rome ME, 2008, INFECT IMMUN, V76, P4865, DOI 10.1128/IAI.00782-08; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Stwora-Wojczyk MM, 2004, INT J PARASITOL, V34, P309, DOI 10.1016/j.ijpara.2003.11.016; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; TOLLEFSEN SE, 1983, J BIOL CHEM, V258, P5165; Tomita T, 2013, PLOS PATHOG, V9, DOI [10.1371/journal.ppat.1003823, DOI 10.1371/journal.ppat.1003823]; Yamada K, 2013, PLANT PHYSIOL, V161, P108, DOI 10.1104/pp.112.207654	39	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150561	10.1371/journal.pone.0150561	http://dx.doi.org/10.1371/journal.pone.0150561			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950937	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000371990100041
J	Wang, ZC; Sha, QY; Zhang, SL				Wang, Zhenchuan; Sha, Qiuying; Zhang, Shuanglin			Joint Analysis of Multiple Traits Using "Optimal" Maximum Heritability Test	PLOS ONE			English	Article							RARE VARIANTS; PRINCIPAL-COMPONENTS; GENETIC ASSOCIATION; CORRELATED PHENOTYPES; DETECTING ASSOCIATION; QUANTITATIVE TRAITS; SEMIPARAMETRIC TEST; COMMON DISEASES; GENOMIC CONTROL; MODEL APPROACH	The joint analysis of multiple traits has recently become popular since it can increase statistical power to detect genetic variants and there is increasing evidence showing that pleiotropy is a widespread phenomenon in complex diseases. Currently, most of existing methods use all of the traits for testing the association between multiple traits and a single variant. However, those methods for association studies may lose power in the presence of a large number of noise traits. In this paper, we propose an "optimal" maximum heritability test (MHT-O) to test the association between multiple traits and a single variant. MHT-O includes a procedure of deleting traits that have weak or no association with the variant. Using extensive simulation studies, we compare the performance of MHT-O with MHT, Trait-based Association Test uses Extended Simes procedure (TATES), SUM_SCORE and MANOVA. Our results show that, in all of the simulation scenarios, MHT-O is either the most powerful test or comparable to the most powerful test among the five tests we compared.	[Wang, Zhenchuan; Sha, Qiuying; Zhang, Shuanglin] Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA	Michigan Technological University	Zhang, SL (corresponding author), Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA.	shuzhang@mtu.edu		WANG, ZHENCHUAN/0000-0002-6247-2156				Aschard H, 2014, AM J HUM GENET, V94, P662, DOI 10.1016/j.ajhg.2014.03.016; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Casale FP, 2015, NAT METHODS, V12, P755, DOI [10.1038/nmeth.3439, 10.1038/NMETH.3439]; Chen HS, 2003, ANN HUM GENET, V67, P250, DOI 10.1046/j.1469-1809.2003.00036.x; Derkach A, 2013, GENET EPIDEMIOL, V37, P110, DOI 10.1002/gepi.21689; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Falconer DS, 1996, INTRO QUANTITATIVE G, Vxiii; Feng Tao, 2007, BMC Proc, V1 Suppl 1, pS84; Ge YC, 2003, TEST-SPAIN, V12, P1, DOI 10.1007/BF02595811; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kim J, 2015, GENET EPIDEMIOL, V39, P651, DOI 10.1002/gepi.21931; Klei L, 2008, GENET EPIDEMIOL, V32, P9, DOI 10.1002/gepi.20257; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lange C, 2004, STAT APPL GENET MOL, V3, P1544, DOI [10.2202/1544-6115.1067, DOI 10.2202/1544-6115.1067]; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Ott J, 1999, HUM HERED, V49, P106, DOI 10.1159/000022854; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Yang Q, 2012, J PROBAB STAT, V2012, DOI 10.1155/2012/652569; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Rifai N, 2002, CURR OPIN LIPIDOL, V13, P383, DOI 10.1097/00041433-200208000-00005; Sha QY, 2014, GENET EPIDEMIOL, V38, P494, DOI 10.1002/gepi.21834; Sha QY, 2012, GENET EPIDEMIOL, V36, P561, DOI 10.1002/gepi.21649; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stephens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065245; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Tang CS, 2012, BIOINFORMATICS, V28, P845, DOI 10.1093/bioinformatics/bts051; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; van der Sluis S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003235; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Wang YF, 2015, GENET EPIDEMIOL, V39, P259, DOI 10.1002/gepi.21895; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yan T, 2013, GENET EPIDEMIOL, V37, P571, DOI 10.1002/gepi.21738; Yang QO, 2010, GENET EPIDEMIOL, V34, P444, DOI 10.1002/gepi.20497; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Zawistowski M, 2010, AM J HUM GENET, V87, P604, DOI 10.1016/j.ajhg.2010.10.012; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196; Zhang YW, 2014, NEUROIMAGE, V96, P309, DOI 10.1016/j.neuroimage.2014.03.061; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou JJ, 2015, HUM HERED, V79, P93, DOI 10.1159/000381641; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/nmeth.2848, 10.1038/NMETH.2848]; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	56	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150975	10.1371/journal.pone.0150975	http://dx.doi.org/10.1371/journal.pone.0150975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950849	gold, Green Published, Green Submitted			2022-12-27	WOS:000371990100076
J	El Obaid, Y; Al Hamiz, A; Abdulle, A; Hayes, RB; Sherman, S; Ali, R				El Obaid, Yusra; Al Hamiz, Aisha; Abdulle, Abdishakur; Hayes, Richard B.; Sherman, Scott; Ali, Raghib			Perceptions and Attitudes towards Medical Research in the United Arab Emirates: Results from the Abu Dhabi Cohort Study (ADCS) Focus Group Discussions	PLOS ONE			English	Article							PARTICIPATORY RESEARCH; RESEARCH EXPERIENCES; PUBLIC-HEALTH; PARTNERSHIP; CONSENT	Background In developing medical research, particularly in regions where medical research is largely unfamiliar, it is important to understand public perceptions and attitudes towards medical research. In preparation for starting the first cohort study in the United Arab Emirates, the Abu Dhabi Cohort Study (ADCS), we sought to understand how we could improve the quality of the research process for participants and increase public trust and awareness of research. Methods We conducted six focus groups (FG), consisting of Emirati men and women aged above 18 years to resemble the target population for the ADCS. Sampling was purposive and convenient. Data collection was an iterative process until saturation was reached with no new themes identified. Text from each FG was analyzed separately by identifying emerging issues and organizing related concepts into categories or themes. A coding tree was developed, consisting of the main concepts, themes, subthemes and corresponding quotes. Both themes and main ideas were identified using inductive analysis. Results Forty-two participants enrolled at 3 academic centers (New York University Abu Dhabi, UAE University, Zayed University) and the Abu Dhabi blood bank. Focus group participants described lack of awareness of research as a challenge to participation in clinical research studies. Altruism, personal relevance of the research, and the use of role models were commonly identified motivators. Participants were generally satisfied with the informed consent process for the ADCS, but would be disappointed if not provided test results or study outcomes. Fear of a breach in confidentiality was a frequently expressed concern. Conclusions Participants join research studies for varied, complex reasons, notably altruism and personal relevance. Based on these insights, we propose specific actions to enhance participant recruitment, retention and satisfaction in the ADCS. We identified opportunities to improve the research experience through improved study materials and communication to participants and the broader community.	[El Obaid, Yusra] United Arab Emirates Univ, Inst Publ Hlth, Al Ain, U Arab Emirates; [Al Hamiz, Aisha; Abdulle, Abdishakur; Ali, Raghib] NYU Abu Dhabi, Publ Hlth Res Ctr, Abu Dhabi, U Arab Emirates; [Hayes, Richard B.; Sherman, Scott] NYU, Sch Med, Dept Populat Hlth, New York, NY USA	United Arab Emirates University; New York University	Ali, R (corresponding author), NYU Abu Dhabi, Publ Hlth Res Ctr, Abu Dhabi, U Arab Emirates.	Raghib.ali@nyu.edu	; Elobaid, Yusra/A-7726-2019	Hayes, Richard/0000-0002-0918-661X; Sherman, Scott/0000-0003-1752-7303; Elobaid, Yusra/0000-0002-1531-7743	New York University Abu Dhabi [G1206]	New York University Abu Dhabi	RA, AAH and AA are employed by New York University Abu Dhabi. YEO is employed by United Arab Emirates University. RH and SS are employed by New York University School of Medicine. The study was funded by an internal grant [no. G1206] from New York University Abu Dhabi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahram M, 2013, EUR J HUM GENET, V21, P567, DOI 10.1038/ejhg.2012.213; Aw TC, 2011, ASIAN PAC J CANCER P, V12, P1641; Christopher S, 2008, AM J PUBLIC HEALTH, V98, P1398, DOI 10.2105/AJPH.2007.125757; El-Azami-El-Idrissi M, 2013, LANCET, V382, P2066, DOI 10.1016/S0140-6736(13)62692-6; Elger BS, 2006, EMBO REP, V7, P661, DOI 10.1038/sj.embor.7400740; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Kelley K, 2003, INT J QUAL HEALTH C, V15, P261, DOI 10.1093/intqhc/mzg031; Kost RG, 2011, CTS-CLIN TRANSL SCI, V4, P403, DOI 10.1111/j.1752-8062.2011.00349.x; Lichtenberg PA, 2004, J AGING HEALTH, V16, p78S, DOI 10.1177/0898264304268150; Ma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036050; Manafa OU, 2006, ONLINE J HLTH ETHICS, V3, DOI 10.18785/ojhe.0301.06; Minkler M, 2003, AM J PUBLIC HEALTH, V93, P1210, DOI 10.2105/AJPH.93.8.1210; Trauth J M, 2000, J Health Soc Policy, V12, P23; World Health Organization, 2004, WORLD REP KNOWL BETT	14	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0149609	10.1371/journal.pone.0149609	http://dx.doi.org/10.1371/journal.pone.0149609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG0FG	26943636	Green Published, gold			2022-12-27	WOS:000371739400004
J	Blevins, M; Wehbe, FH; Rebeiro, PF; Caro-Vega, Y; McGowan, CC; Shepherd, BE				Blevins, Meridith; Wehbe, Firas H.; Rebeiro, Peter F.; Caro-Vega, Yanink; McGowan, Catherine C.; Shepherd, Bryan E.		Caribbean Cent South Amer Network	Interactive Data Visualization for HIV Cohorts: Leveraging Data Exchange Standards to Share and Reuse Research Tools	PLOS ONE			English	Article							INFORMATION-SYSTEMS; PUBLIC-HEALTH	Objective To develop and disseminate tools for interactive visualization of HIV cohort data. Design and Methods If a picture is worth a thousand words, then an interactive video, composed of a long string of pictures, can produce an even richer presentation of HIV population dynamics. We developed an HIV cohort data visualization tool using open-source software (R statistical language). The tool requires that the data structure conform to the HIV Cohort Data Exchange Protocol (HICDEP), and our implementation utilized Caribbean, Central and South America network (CCASAnet) data. Results This tool currently presents patient-level data in three classes of plots: (1) Longitudinal plots showing changes in measurements viewed alongside event probability curves allowing for simultaneous inspection of outcomes by relevant patient classes. (2) Bubble plots showing changes in indicators over time allowing for observation of group level dynamics. (3) Heat maps of levels of indicators changing over time allowing for observation of spatial-temporal dynamics. Examples of each class of plot are given using CCASAnet data investigating trends in CD4 count and AIDS at antiretroviral therapy (ART) initiation, CD4 trajectories after ART initiation, and mortality. Conclusions We invite researchers interested in this data visualization effort to use these tools and to suggest new classes of data visualization. We aim to contribute additional shareable tools in the spirit of open scientific collaboration and hope that these tools further the participation in open data standards like HICDEP by the HIV research community.	[Blevins, Meridith; Wehbe, Firas H.; Rebeiro, Peter F.; McGowan, Catherine C.; Shepherd, Bryan E.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Caro-Vega, Yanink] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico; [Wehbe, Firas H.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA	Vanderbilt University; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Northwestern University; Feinberg School of Medicine	Blevins, M (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	meridith.blevins@vanderbilt.edu; c.mcgowan@vanderbilt.edu	Wehbe, Firas/Q-6176-2019	Wehbe, Firas/0000-0002-3984-9584; Rebeiro, Peter/0000-0003-1951-9104	National Institute of Allergy and Infectious Diseases (NIAID) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) [U01 AI069923]; TN-CFAR [P30 AI110527, R01 AI093234]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI110527, R01AI093234, U01AI069923] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); TN-CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA): U01 AI069923. Partial support was provided by TN-CFAR P30 AI110527 and R01 AI093234.	Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Carriquiry G, 2015, JIAS IN PRESS; Carroll LN, 2014, J BIOMED INFORM, V51, P287, DOI 10.1016/j.jbi.2014.04.006; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Edwards JK, 2015, CLIN INFECT DIS; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fauci AS, 1996, ANN INTERN MED, V124, P654, DOI 10.7326/0003-4819-124-7-199604010-00006; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Gao S, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-8; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Harger JR, 2012, COMP OPEN SOURCE VIS; Harrell FE, 2001, REGRESSION MODELING; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kjaer J, 2004, ANTIVIR THER, V9, P631; Luz PM, 2015, CD4 RESPONS IN PRESS; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073; Richards TB, 1999, PUBLIC HEALTH REP, V114, P359, DOI 10.1093/phr/114.4.359; Robinson AC, 2011, HEALTH INFORM J, V17, P191, DOI 10.1177/1460458211409718; Rosling H, 2011, J EPIDEMIOL GLOB HEA, V1, P11, DOI 10.1016/j.jegh.2011.07.001; Silverman B.W., 1986, DENSITY ESTIMATION S; Snow J., 1855, MODE COMMUNICATION C; Tukey JW, 1977, EXPLORATORY DATA ANA; Weidmann NB, 2010, INT INTERACT, V36, P86, DOI 10.1080/03050620903554614; Yi Q, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-29	28	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151201	10.1371/journal.pone.0151201	http://dx.doi.org/10.1371/journal.pone.0151201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963255	Green Submitted, gold, Green Published			2022-12-27	WOS:000371993000121
J	Conklin, AI; Ponce, NA; Frank, J; Nandi, A; Heymann, J				Conklin, Annalijn I.; Ponce, Ninez A.; Frank, John; Nandi, Arijit; Heymann, Jody			Minimum Wage and Overweight and Obesity in Adult Women: A Multilevel Analysis of Low and Middle Income Countries	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; HEALTH; WEIGHT; INSECURITY; INEQUALITY; FOOD	Objectives To describe the relationship between minimum wage and overweight and obesity across countries at different levels of development. Methods A cross-sectional analysis of 27 countries with data on the legislated minimum wage level linked to socio-demographic and anthropometry data of non-pregnant 190,892 adult women (24-49 y) from the Demographic and Health Survey. We used multilevel logistic regression models to condition on country-and individual-level potential confounders, and post-estimation of average marginal effects to calculate the adjusted prevalence difference. Results We found the association between minimum wage and overweight/obesity was independent of individual-level SES and confounders, and showed a reversed pattern by country development stage. The adjusted overweight/obesity prevalence difference in low-income countries was an average increase of about 0.1 percentage points (PD 0.075 [0.065, 0.084]), and an average decrease of 0.01 percentage points in middle-income countries (PD -0.014 [-0.019, -0.009]). The adjusted obesity prevalence difference in low-income countries was an average increase of 0.03 percentage points (PD 0.032 [0.021, 0.042]) and an average decrease of 0.03 percentage points in middle-income countries (PD -0.032 [-0.036, -0.027]). Conclusion This is among the first studies to examine the potential impact of improved wages on an important precursor of non-communicable diseases globally. Among countries with a modest level of economic development, higher minimum wage was associated with lower levels of obesity.	[Conklin, Annalijn I.; Heymann, Jody] Univ Calif Los Angeles, Fielding Sch Publ Hlth, WORLD Policy Anal Ctr, Los Angeles, CA USA; [Ponce, Ninez A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA; [Frank, John] Univ Edinburgh, Scottish Collaborat Publ Hlth Res & Policy, Edinburgh, Midlothian, Scotland; [Nandi, Arijit] McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada; [Nandi, Arijit] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Edinburgh; McGill University; McGill University	Conklin, AI (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, WORLD Policy Anal Ctr, Los Angeles, CA USA.	aconklin@ph.ucla.edu	Frank, John/AAZ-1169-2020	Frank, John/0000-0003-3912-4214; Heymann, Jody/0000-0003-0008-4198; Ponce, Ninez/0000-0001-5151-6718; Conklin, Annalijn/0000-0002-6532-8790	Canadian Institute for Health Research [MFE-135520]; Canadian Institutes of Health Research Operating Grant, "Examining the impact of social policies on health equity" [ROH-115209]; WORLD Policy Analysis Center of UCLA; Medical Research Council [MR/K023209/1, MR/K007017/1] Funding Source: researchfish; MRC [MR/K007017/1, MR/K023209/1] Funding Source: UKRI	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Operating Grant, "Examining the impact of social policies on health equity"(Canadian Institutes of Health Research (CIHR)); WORLD Policy Analysis Center of UCLA; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Canadian Institute for Health Research Postdoctoral Fellowship Award (MFE-135520); the Canadian Institutes of Health Research Operating Grant, "Examining the impact of social policies on health equity" (ROH-115209); and the WORLD Policy Analysis Center of UCLA. No sponsors participated in the study design, data analysis or interpretation of results.	[Anonymous], 2008, CLOS GAP GEN HLTH EQ; Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056; Borodulin K, 2012, INT J BEHAV MED, V19, P14, DOI 10.1007/s12529-010-9138-1; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Brewis AA, 2011, CURR ANTHROPOL, V52, P269, DOI 10.1086/659309; Chen M.A., 2007, 46 DESA UN; Conklin A.I., 2014, GENDER DIET QUALITY; Conklin AI, 2014, OBESITY, V22, P2606, DOI 10.1002/oby.20875; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; DHS Program, 2015, PROT PRIV DHS SURV R; Diez-Roux AV, 2000, SOC SCI MED, V50, P673, DOI 10.1016/S0277-9536(99)00320-2; Dinour LM, 2007, J AM DIET ASSOC, V107, P1952, DOI 10.1016/j.jada.2007.08.006; Egger G, 2012, ECON HUM BIOL, V10, P147, DOI 10.1016/j.ehb.2012.01.002; Friel S, 2007, BRIT MED J, V335, P1241, DOI 10.1136/bmj.39377.622882.47; Goryakin Y, 2015, SOC SCI MED, V133, P67, DOI 10.1016/j.socscimed.2015.03.030; Heymann J., 2006, FORGOTTEN FAMILIES E; International Labor Organization, 2011, STAT UPD EMPL INF EC; Jones-Smith JC, 2011, AM J EPIDEMIOL, V173, P667, DOI 10.1093/aje/kwq428; Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063; Lakdawalla D, 2009, ECON HUM BIOL, V7, P283, DOI 10.1016/j.ehb.2009.08.001; McCarrier KP, 2006, APHA 134 ANN M BOST; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Meltzer DO, 2011, IMPACT MINIMUM WAGE, P17; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Neuman M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099327, DOI 10.1371/journal.pone.0099327]; Neuman M, 2011, AM J CLIN NUTR; Offer A, 2010, ECON HUM BIOL, V8, P297, DOI 10.1016/j.ehb.2010.07.002; Organization WH, 2009, GLOB HLTH RISKS MORT; Pampel FC, 2005, AM J PUBLIC HEALTH, V95, P1009, DOI 10.2105/AJPH.2004.056895; Pickett KE, 2005, J EPIDEMIOL COMMUN H, V59, P670, DOI 10.1136/jech.2004.028795; Smith T., 2009, J BIOECONOMICS, V11, P249, DOI [DOI 10.1007/S10818-009-9067-8, 10.1007/s10818-009-9067-8]; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Subramanian S, 2013, INT J EPIDEMIOL, V42, P140; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; Wan Muda M., 2007, REFLECTIONS HUMAN CO; WHO, 2008, PHARMAFORUM 0121	36	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150736	10.1371/journal.pone.0150736	http://dx.doi.org/10.1371/journal.pone.0150736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TL	26963247	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000055
J	Novakovic, P; Harding, JCS; Al-Dissi, AN; Ladinig, A; Detmer, SE				Novakovic, Predrag; Harding, John C. S.; Al-Dissi, Ahmad N.; Ladinig, Andrea; Detmer, Susan E.			Pathologic Evaluation of Type 2 Porcine Reproductive and Respiratory Syndrome Virus Infection at the Maternal-Fetal Interface of Late Gestation Pregnant Gilts	PLOS ONE			English	Article							MICROSCOPIC LESIONS; IMPLANTATION SITES; IN-UTERO; PATHOGENESIS; FETUSES; PIGS; REPLICATION; VASCULITIS; IMPACT; PRRS	The pathogenesis of fetal death caused by porcine reproductive and respiratory syndrome virus (PRRSV) remains unclear. The objective of this study was to improve our understanding of the pathogenesis by assessing potential relationships between specific histopathological lesions and PRRSV RNA concentration in the fetuses and the maternal-fetal interface. Pregnant gilts were inoculated with PRRSV (n = 114) or sham inoculated (n = 19) at 85 +/- 1 days of gestation. Dams and their litters were humanely euthanized and necropsied 21 days later. PRRSV RNA concentration was measured by qRT-PCR in the maternal-fetal interface and fetal thymus (n = 1391). Presence of fetal lesions was positively related to PRRSV RNA concentration in the maternal-fetal interface and fetal thymus (P<0.05 for both), but not to the distribution or severity of vasculitis, or the severity of endometrial inflammation. The presence of fetal and umbilical lesions was associated with greater odds of meconium staining (P<0.05 for both). The distribution and severity of vasculitis in endometrium were not significantly related to PRRSV RNA concentration in maternal-fetal interface or fetal thymus. Endometrial inflammation severity was positively related to distribution and severity of vasculitis in endometrium (P<0.001 for both). Conclusions from this study suggest that type 2 PRRSV infection in pregnant gilts induces significant histopathological lesions at maternal-fetal interface, but they are not associated with presence of PRRSV in the maternal-fetal interface at 21 days post infection. Conversely, fetal pathological lesions are associated with presence of PRRSV in the maternal-fetal interface and fetal thymus, and meconium staining is significantly associated with the presence of both fetal and umbilical lesions observed 21 days post infection.	[Novakovic, Predrag; Al-Dissi, Ahmad N.; Detmer, Susan E.] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Pathol, Saskatoon, SK S7N 0W0, Canada; [Harding, John C. S.; Ladinig, Andrea] Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada; [Ladinig, Andrea] Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Univ Clin Swine, Vienna, Austria	University of Saskatchewan; University of Saskatchewan; University of Veterinary Medicine Vienna	Novakovic, P (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Vet Pathol, Saskatoon, SK S7N 0W0, Canada.	predrag.novakovic@usask.ca		Ladinig, Andrea/0000-0001-5037-7269; Al-Dissi, Ahmad/0000-0002-3124-3502; Detmer, Susan/0000-0002-4064-3460	Genome Canada; Genome Prairie (Saskatchewan Agriculture Development Fund)	Genome Canada(Genome Canada); Genome Prairie (Saskatchewan Agriculture Development Fund)	Funding for this study was provided by Genome Canada (2010 Large-Scale Applied Research Program) and Genome Prairie (Saskatchewan Agriculture Development Fund) with administrative support provided by Genome Alberta.	Allende R, 2000, ARCH VIROL, V145, P1149, DOI 10.1007/s007050070115; Boddicker NJ, 2014, ANIM GENET, V45, P48, DOI 10.1111/age.12079; Cano JP, 2009, CAN J VET RES, V73, P303; Cheon DS, 2001, J COMP PATHOL, V124, P231, DOI 10.1053/jcpa.2000.0457; CHRISTIANSON WT, 1993, CAN J VET RES, V57, P262; Cribier B, 1999, AM J DERMATOPATH, V21, P532, DOI 10.1097/00000372-199912000-00005; Done SH, 1996, BRIT VET J, V152, P153, DOI 10.1016/S0007-1935(96)80071-6; Gross WL, 2000, RHEUMATOLOGY, V39, P245, DOI 10.1093/rheumatology/39.3.245; HALBUR PG, 1995, VET PATHOL, V32, P200, DOI 10.1177/030098589503200218; Han K, 2012, J COMP PATHOL, V147, P275, DOI 10.1016/j.jcpa.2011.12.010; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Karniychuk UU, 2012, THERIOGENOLOGY, V78, P1527, DOI 10.1016/j.theriogenology.2012.06.015; Karniychuk UU, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-95; Karniychuk UU, 2011, MICROB PATHOGENESIS, V51, P194, DOI 10.1016/j.micpath.2011.04.001; Ladinig A, 2014, PLOS ONE, V9, P96; Ladinig A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0251-7; Ladinig A, 2015, VIRUS RES, V203, P24, DOI 10.1016/j.virusres.2015.03.005; Lager KM, 1996, J VET DIAGN INVEST, V8, P275, DOI 10.1177/104063879600800301; LAGER KM, 1995, CAN J VET RES, V59, P187; Plagemann PGW, 2003, EMERG INFECT DIS, V9, P903; Rossow KD, 1996, VET PATHOL, V33, P95, DOI 10.1177/030098589603300115; Rossow KD, 1998, VET PATHOL, V35, P1, DOI 10.1177/030098589803500101; ROSSOW KD, 1994, J VET DIAGN INVEST, V6, P3, DOI 10.1177/104063879400600102; ROSSOW KD, 1994, J VET DIAGN INVEST, V6, P368, DOI 10.1177/104063879400600316; Rowland RRR, 2010, VIRUS RES, V154, P114, DOI 10.1016/j.virusres.2010.09.001; Rowland RRR, 2003, VET MICROBIOL, V96, P219, DOI 10.1016/j.vetmic.2003.07.006; Zimmerman J., 2012, DIS SWINE, V10, P461	27	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151198	10.1371/journal.pone.0151198	http://dx.doi.org/10.1371/journal.pone.0151198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963101	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000120
J	Pollett, S; Banner, P; O'Sullivan, MVN; Ralph, AP				Pollett, Simon; Banner, Pamela; O'Sullivan, Matthew V. N.; Ralph, Anna P.			Epidemiology, Diagnosis and Management of Extra-Pulmonary Tuberculosis in a Low-Prevalence Country: A Four Year Retrospective Study in an Australian Tertiary Infectious Diseases Unit	PLOS ONE			English	Article							EXTRAPULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; INTESTINAL TUBERCULOSIS; TB; MENINGITIS; RISK	Objectives Extra-pulmonary tuberculosis (EPTB) is relatively neglected and increasing in incidence, in comparison to pulmonary tuberculosis (PTB) in low-burden settings. It poses particular diagnostic and management challenges. We aimed to determine the characteristics of EPTB in Western Sydney, Australia, and to conduct a quality assurance investigation of adherence to guidelines among Infectious Diseases (ID) practitioners managing EPTB cases. Methods All adult EPTB cases managed by a large ID service during 01/01/2008-31/12/2011 were eligible for inclusion in the retrospective review. Data were extracted from patient medical records on demographic, diagnostic, clinical and management details, and on clinician adherence to local and international TB guidelines. Results 129 cases managed by the ID service were identified, with files available for 117. 98 cases were managed by the Respiratory service and were excluded. 98.2%(112/114) had been born in a country other than Australia. HIV status was tested or previously known in 97 people, and positive in 4 (4%). Microbiological confirmation was obtained in 68/117 (58.1%), an additional 24 had histopathological findings considered confirmatory (92/117, 78.6%), with the remainder diagnosed on clinical and/or radiological grounds. Median time to diagnosis post-migration from a high TB-burden country was 5 years (range 0-41). 95 cases were successfully treated, 11 cases defaulted, refused therapy or transferred, 2 cases relapsed and outcomes unknown or pending in 9 cases. No deaths occurred in the sample analysed. Clinician adherence to guidelines was high, but with scope for improvement in offering testing for co-infections, performing eye checks, monitoring blood glucose in patients receiving adjunctive corticosteroids, and considering drug interactions. Conclusions Despite excellent TB outcomes in this setting, the low proportion of cases with susceptibility data is worrying in this era of increasing drug resistance, and illustrates the diagnostic difficulties faced even in a well-resourced setting. Vigilance for EPTB needs to remain high in those moving from high prevalence countries to Australia, even decades after immigration.	[Pollett, Simon; O'Sullivan, Matthew V. N.; Ralph, Anna P.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Banner, Pamela] NSW TB Program, Sydney, NSW, Australia; [O'Sullivan, Matthew V. N.] Ctr Infect Dis & Microbiol, Sydney, NSW, Australia; [Ralph, Anna P.] Menzies Sch Hlth Res, Global & Trop Hlth, Darwin, NT, Australia; [Ralph, Anna P.] Royal Darwin Hosp, Dept Med, Darwin, NT, Australia	University of Sydney; Charles Darwin University; Menzies School of Health Research	Pollett, S (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia.	spollett@med.usyd.edu.au	Ralph, Anna/AAB-6103-2021	O'Sullivan, Matthew/0000-0001-8783-5323	National Health and Medical Research Council [605806, 1016567]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	APR is supported by National Health and Medical Research Council grant 605806 and fellowship 1016567. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2003, MMWR Recomm Rep, V52, P1; [Anonymous], 2012, COMMUN DIS INTELL, V36, pE286; [Anonymous], 1987, Am Rev Respir Dis, V136, P1339; [Anonymous], 1996, STAND METH HPLC ID M; Antibiotic Expert Group, 2010, THER GUID ANT VERS 1; Barry C, 2012, COMMUN DIS INTELL, V36, P82; CABIE A, 1995, PRESSE MED, V24, P601; Cagatay AA, 2004, SCAND J INFECT DIS, V36, P799, DOI 10.1080/00365540410025339; Cheng VCC, 2005, EUR J CLIN MICROBIOL, V24, P711, DOI 10.1007/s10096-005-0039-1; Chien JY, 2010, INT J TUBERC LUNG D, V14, P616; Cho OH, 2011, J INFECTION, V63, P362, DOI 10.1016/j.jinf.2011.06.010; Dobler CC, 2008, MED J AUSTRALIA, V188, P153, DOI 10.5694/j.1326-5377.2008.tb01558.x; Ducomble T, 2013, EURO SURVEILL, V18; Fain, 2000, Eur J Intern Med, V11, P145, DOI 10.1016/S0953-6205(00)00076-5; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Jin XJ, 2010, WORLD J GASTROENTERO, V16, P2496, DOI 10.3748/wjg.v16.i20.2496; Jover-Diaz Francisco, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P341, DOI 10.1177/1545109712456879; Khan FA, 2010, CLIN INFECT DIS, V50, P1288, DOI 10.1086/651686; Kherad O, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-217; Li Y, 2012, J CROHNS COLITIS, V6, P317, DOI 10.1016/j.crohns.2011.09.002; Lin JN, 2009, INT J TUBERC LUNG D, V13, P620; Lumb R, 2011, COMMUN DIS INTELL, V35, P154; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; Marks Guy B, 2013, N S W Public Health Bull, V24, P22, DOI 10.1071/NB13007; Mayosi B.M., 2002, COCHRANE DB SYST REV, V4), DOI [10.1002/14651858.CD000526, DOI 10.1002/14651858.CD000526]; Mfinanga SG, 2014, LANCET INFECT DIS, V14, P563, DOI 10.1016/S1473-3099(14)70733-9; Naidoo K, 2013, CURR OPIN INFECT DIS, V26, P35, DOI 10.1097/QCO.0b013e32835ba8f9; Parimon T, 2008, CHEST, V134, P589, DOI 10.1378/chest.08-0319; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Porkert MT, 1997, AM J MED SCI, V313, P325, DOI 10.1097/00000441-199706000-00002; Roberts-Witteveen April R, 2010, N S W Public Health Bull, V21, P174, DOI 10.1071/NB10005; Sandgren A, 2013, EURO SURVEILL, V18; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Singanayagam A, 2012, AM J RESP CRIT CARE, V185, P653, DOI 10.1164/rccm.201105-0850OC; STRANG JIG, 1988, LANCET, V2, P759; Tay EL, 2013, ADV TUB AUSTR REG PE; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; Wang JY, 2011, J INFECTION, V62, P448, DOI 10.1016/j.jinf.2011.04.005; WHO, 2009, TREATM TUB GUID; Yoon HJ, 2004, YONSEI MED J, V45, P453, DOI 10.3349/ymj.2004.45.3.453	43	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149372	10.1371/journal.pone.0149372	http://dx.doi.org/10.1371/journal.pone.0149372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963244	Green Submitted, gold, Green Published			2022-12-27	WOS:000371993000011
J	Chen, CC; Wang, SL; Wu, MT; Wang, YH; Huang, PC; Chen, BH; Sun, CW; Ho, CK; Shih, YC; Shiu, MN; Pan, WH; Chen, ML; Lee, CC; Hsiung, CA				Chen, Chu-Chih; Wang, Shu-Li; Wu, Ming-Tsang; Wang, Yin-Han; Huang, Po-Chin; Chen, Bai-Hsiun; Sun, Chien-Wen; Ho, Chi-Kung; Shih, Yang-Chih; Shiu, Ming-Neng; Pan, Wen-Harn; Chen, Mei-Lien; Lee, Ching-Chang; Hsiung, Chao A.			Exposure Estimation for Risk Assessment of the Phthalate Incident in Taiwan	PLOS ONE			English	Article							DIETARY EXPOSURE; CHILDREN; METABOLITES; BEVERAGES; EXCRETION; GROWTH; FOODS	Background In May 2011, di(2-ethylhexyl) phthalates (DEHP) and, to a lesser extent, di-iso-nonyl phthalate (DiNP) were found to have been illegally used for many years in Taiwan as clouding agents in foods including sports drinks, juice beverages, tea drinks, fruit jam/nectar/jelly, and health or nutrient supplements. Objective To estimate the DEHP exposure for the study participants for the follow-up epidemiological study and health risk assessment. Methods A total of 347 individuals possibly highly exposed to phthalate-tainted foods participated in the study. Exposure assessment was performed based on the participants' responses to a structured questionnaire, self-report of exposure history, urinary metabolite concentrations, and DEHP concentration information in 2449 food records. A Bayesian statistical approach using Markov chain Monte Carlo simulation was employed to deal with the uncertainties in the DEHP concentrations of the contaminated foods and the participants' likelihood of being exposed. Results An estimated 37% and 15% of children younger than 12 years old were exposed to DEHP at medium (20-50 mu g/kg_bw/day) and high AvDIs (50-100 mu g/kg_bw/day), respectively, prior to the episode (9% and 3% in adults, respectively). Moreover, 11% of children and 1% of adults were highly exposed (> 100 mu g/kg_bw/day), with a maximum of 414.1 mu g/kg_bw/day and 126.4 mu g/kg_bw/day, respectively. Conclusions The phthalate exposure-associated adverse health effects for these participants warrant further investigation. The estimation procedure may be applied to other exposure assessment with various sources of uncertainties.	[Chen, Chu-Chih; Wang, Yin-Han; Hsiung, Chao A.] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan; [Wang, Shu-Li; Huang, Po-Chin; Sun, Chien-Wen] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ, Dept Publ Hlth, Coll Hlth Sci, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Municipal Hsiaokang Hosp, Ctr Environm & Occupat Med, Kaohsiung, Taiwan; [Chen, Bai-Hsiun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Lab Med & Pediat, Kaohsiung, Taiwan; [Chen, Bai-Hsiun] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Ho, Chi-Kung] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan; [Ho, Chi-Kung] Kaohsiung Med Univ Hosp, Dept Occupat & Environm Med, Kaohsiung, Taiwan; [Ho, Chi-Kung] Kaohsiung City Govt, Dept Hlth, Kaohsiung, Taiwan; [Shih, Yang-Chih; Shiu, Ming-Neng] Minist Hlth & Welf, Taipei, Taiwan; [Pan, Wen-Harn] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Prevent Med & Hlth Serv Res, Miaoli, Taiwan; [Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Mei-Lien] Natl Yang Ming Univ, Coll Med, Inst Environm & Occupat Hlth Sci, Taipei 112, Taiwan; [Lee, Ching-Chang] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Lee, Ching-Chang] Natl Cheng Kung Univ, Res Ctr Environm Trace Tox Subst, Tainan 701, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Cheng Kung University; National Cheng Kung University	Chen, CC; Hsiung, CA (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan.	ccchen@nhri.org.tw; hsiung@nhri.org.tw	Wu, Ming-Tsang/G-5637-2012; Pan, Wen-Harn/F-9972-2010; Chen, Chu-Chih/B-8308-2015	Wu, Ming-Tsang/0000-0001-7307-7816; Pan, Wen-Harn/0000-0001-9136-0658; Chen, Chu-Chih/0000-0002-4594-4991; Huang, Po-Chin/0000-0002-9243-0838; Wang, Shu-Li/0000-0002-0686-4729; Ho, Chi-Kung/0000-0001-8001-0601; Chen, Bai Hsiun/0000-0001-9496-553X	Ministry of Health and Welfare of Taiwan [02A1-EHSP01-023, 03A1-EHSP01-023, 04A1-EHSP01-023]	Ministry of Health and Welfare of Taiwan	This work was supported by Ministry of Health and Welfare of Taiwan (grants 02A1-EHSP01-023, 03A1-EHSP01-023, and 04A1-EHSP01-023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WAC, 2011, FOOD CHEM TOXICOL, V49, P2022, DOI 10.1016/j.fct.2011.05.013; Brauer C, 2010, INT ARCH OCC ENV HEA, V83, P639, DOI 10.1007/s00420-010-0511-9; Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004; Chen W, 2010, PEDIATR NEONATOL, V51, P69, DOI 10.1016/S1875-9572(10)60014-9; Fierens T, 2012, FOOD CHEM TOXICOL, V50, P2575, DOI 10.1016/j.fct.2012.04.029; Gilks WR, 1996, MARKOV CHAIN MONTE C; Halden RU, 2010, ANNU REV PUBL HEALTH, V31, P179, DOI 10.1146/annurev.publhealth.012809.103714; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804; Hines CJ, 2011, J EXPO SCI ENV EPID, V21, P133, DOI 10.1038/jes.2009.62; Huang HB, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0076-1; Huang PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133782; Jurewicz J, 2011, INT J OCCUP MED ENV, V24, P115, DOI 10.2478/s13382-011-0022-2; Kim Shin Hye, 2014, Ann Pediatr Endocrinol Metab, V19, P69, DOI 10.6065/apem.2014.19.2.69; Larsson M, 2010, INDOOR AIR, V20, P494, DOI 10.1111/j.1600-0668.2010.00671.x; Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079; Lorber M, 2013, ENVIRON INT, V59, P469, DOI 10.1016/j.envint.2013.07.010; Lorber M, 2010, J EXPO SCI ENV EPID, V20, P38, DOI 10.1038/jes.2008.74; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; Piro FN, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-9; Remer T, 2002, AM J CLIN NUTR, V75, P561, DOI 10.1093/ajcn/75.3.561; Sakhi AK, 2014, ENVIRON INT, V73, P259, DOI 10.1016/j.envint.2014.08.005; Schecter A, 2013, ENVIRON HEALTH PERSP, V121, P473, DOI 10.1289/ehp.1206367; Wittassek M, 2007, INT J HYG ENVIR HEAL, P35; Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121; Wu CF, 2013, ENVIRON SCI TECHNOL, V47, P13754, DOI 10.1021/es403141u; Wu MT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055005, 10.1371/journal.pone.0055044]; Wu MT, 2012, ENVIRON INT, V44, P75, DOI 10.1016/j.envint.2012.01.014; Yang J, 2013, FOOD CHEM TOXICOL, V58, P362, DOI 10.1016/j.fct.2013.05.010; Yen TH, 2011, J FORMOS MED ASSOC, V110, P671, DOI 10.1016/j.jfma.2011.09.002	29	13	14	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151070	10.1371/journal.pone.0151070	http://dx.doi.org/10.1371/journal.pone.0151070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960145	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300093
J	Hua, XL; Yu, LL; You, RX; Yang, Y; Liao, J; Chen, DS; Yu, LX				Hua, Xiaoli; Yu, Lili; You, Ruxu; Yang, Yu; Liao, Jing; Chen, Dongsheng; Yu, Lixiu			Association among Dietary Flavonoids, Flavonoid Subclasses and Ovarian Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							ISOFLAVONE INTAKE; REDUCED RISK; PHYTOCHEMICALS; SOY; HEALTH; ALPHA; BIAS	Background Previous studies have indicated that intake of dietary flavonoids or flavonoid subclasses is associated with the ovarian cancer risk, but presented controversial results. Therefore, we conducted a meta-analysis to derive a more precise estimation of these associations. Methods We performed a search in PubMed, Google Scholar and ISI Web of Science from their inception to April 25, 2015 to select studies on the association among dietary flavonoids, flavonoid subclasses and ovarian cancer risk. The information was extracted by two independent authors. We assessed the heterogeneity, sensitivity, publication bias and quality of the articles. A random-effects model was used to calculate the pooled risk estimates. Results Five cohort studies and seven case-control studies were included in the final meta-analysis. We observed that intake of dietary flavonoids can decrease ovarian cancer risk, which was demonstrated by pooled RR (RR = 0.82, 95% CI = 0.68-0.98). In a subgroup analysis by flavonoid subtypes, the ovarian cancer risk was also decreased for isoflavones (RR = 0.67, 95% CI = 0.50-0.92) and flavonols (RR = 0.68, 95% CI = 0.58-0.80). While there was no compelling evidence that consumption of flavones (RR = 0.86, 95% CI = 0.71-1.03) could decrease ovarian cancer risk, which revealed part sources of heterogeneity. The sensitivity analysis indicated stable results, and no publication bias was observed based on the results of Funnel plot analysis and Egger's test (p = 0.26). Conclusions This meta-analysis suggested that consumption of dietary flavonoids and subtypes (isoflavones, flavonols) has a protective effect against ovarian cancer with a reduced risk of ovarian cancer except for flavones consumption. Nevertheless, further investigations on a larger population covering more flavonoid subclasses are warranted.	[Hua, Xiaoli; You, Ruxu; Yang, Yu; Liao, Jing; Chen, Dongsheng; Yu, Lixiu] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pharm, Wuhan 430022, Peoples R China; [Yu, Lili] Huazhong Univ Sci & Technol, Dept Obstet & Gynecol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yu, LX (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pharm, Wuhan 430022, Peoples R China.	ylx120515@163.com			National Natural Science Foundation of China [81372807, 81503427]; Natural Science Foundation of Hubei Province [2015CKB751]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This study was supported by the research grant from National Natural Science Foundation of China (81372807 and 81503427) and Natural Science Foundation of Hubei Province (2015CKB751). The URLs of the National Natural Science Foundation of China (81372807 and 81503427) is "http://www.isisn.nsfc.gov.cn.". The URLs of the Natural Science Foundation of Hubei Province (2015CKB751) is "http://jhsb.hbstd.gov.cn.".LLY and LXY were responsible for the initial plan, study design, data collection including data extraction, interpretation and statistical analysis; LXY is still for data collection, data extraction, and critical revision of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG 2013; Aune D, 2011, GASTROENTEROLOGY, V141, P106, DOI 10.1053/j.gastro.2011.04.013; Bandera EV, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-40; Cassidy A, 2014, AM J CLIN NUTR, V100, P1344, DOI 10.3945/ajcn.114.088708; Chang ET, 2007, AM J EPIDEMIOL, V165, P802, DOI 10.1093/aje/kwk065; Chang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054318; Chen XW, 2001, NUTR CANCER, V41, P165, DOI 10.1207/S15327914NC41-1&amp;2_23; Corcoran Michael P., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P176, DOI 10.1080/21551197.2012.698219; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Crane TE, 2014, CANCER EPIDEM BIOMAR, V23, P255, DOI 10.1158/1055-9965.EPI-13-0515; D'Archivio Massimo, 2007, Ann Ist Super Sanita, V43, P348; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gates MA, 2007, INT J CANCER, V121, P2225, DOI 10.1002/ijc.22790; Gates MA, 2009, INT J CANCER, V124, P1918, DOI 10.1002/ijc.24151; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Hedelin M, 2011, CANCER EPIDEM BIOMAR, V20, P308, DOI 10.1158/1055-9965.EPI-10-0752; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hwang KA, 2013, TOXICOL APPL PHARM, V272, P637, DOI 10.1016/j.taap.2013.07.027; Kicinski M, 2015, STAT MED, V34, P2781, DOI 10.1002/sim.6525; Kim MK, 2008, NUTR CANCER, V60, P568, DOI 10.1080/01635580801966203; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750; Lee AH, 2014, NUTR RES, V34, P302, DOI 10.1016/j.nutres.2014.02.005; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; McCann SE, 2003, J NUTR, V133, P1937, DOI 10.1093/jn/133.6.1937; Neergheen VS, 2010, TOXICOLOGY, V278, P229, DOI 10.1016/j.tox.2009.10.010; Neill AS, 2014, BRIT J NUTR, V111, P1430, DOI 10.1017/S0007114513003899; Pesec M, 2015, FUTURE ONCOL, V11, P2235, DOI 10.2217/fon.15.142; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Rossi M, 2008, INT J CANCER, V123, P895, DOI 10.1002/ijc.23549; Shen DanPing, 2013, Soybean Science, V32, P814; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tang NP, 2009, JPN J CLIN ONCOL, V39, P352, DOI 10.1093/jjco/hyp028; US Department of Agriculture, 2002, IOW STAT U DAT IS CO; USDA (United States Department of Agriculture), 2003, USDA DAT FLAV CONT S; Vanden Berghe W, 2012, PHARMACOL RES, V65, P565, DOI 10.1016/j.phrs.2012.03.007; Wang L, 2009, AM J CLIN NUTR, V89, P905, DOI 10.3945/ajcn.2008.26913; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019; Wells G.A., NEWCASTLE OTTAWA SCA; Zhang M, 2004, NUTR CANCER, V49, P125, DOI 10.1207/s15327914nc4902_2	46	33	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151134	10.1371/journal.pone.0151134	http://dx.doi.org/10.1371/journal.pone.0151134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960146	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300102
J	Oshida, K; Vasani, N; Waxman, DJ; Corton, JC				Oshida, Keiyu; Vasani, Naresh; Waxman, David J.; Corton, J. Christopher			Disruption of STAT5b-Regulated Sexual Dimorphism of the Liver Transcriptome by Diverse Factors Is a Common Event	PLOS ONE			English	Article							GROWTH-HORMONE-SECRETION; FEMALE MOUSE-LIVER; GENE-EXPRESSION; SIGNAL TRANSDUCER; GLUCOCORTICOID-RECEPTOR; NUCLEAR FACTOR-4-ALPHA; MICROARRAY ANALYSIS; BODY GROWTH; CROSS-TALK; GH ACTION	Signal transducer and activator of transcription 5b (STAT5b) is a growth hormone (GH)-activated transcription factor and a master regulator of sexually dimorphic gene expression in the liver. Disruption of the GH hypothalamo-pituitary-liver axis controlling STAT5b activation can lead to metabolic dysregulation, steatosis, and liver cancer. Computational approaches were developed to identify factors that disrupt STAT5b function in a mouse liver gene expression compendium. A biomarker comprised of 144 STAT5b-dependent genes was derived using comparisons between wild-type male and wild-type female mice and between STAT5b-null and wild-type mice. Correlations between the STAT5b biomarker gene set and a test set comprised of expression datasets (biosets) with known effects on STAT5b function were evaluated using a rank-based test (the Running Fisher algorithm). Using a similarity p-value <= 10(-4), the test achieved a balanced accuracy of 99% and 97% for detection of STAT5b activation or STAT5b suppression, respectively. The STAT5b biomarker gene set was then used to identify factors that activate (masculinize) or suppress (feminize) STAT5b function in an annotated mouse liver and primary hepatocyte gene expression compendium of similar to 1,850 datasets. Disruption of GH-regulated STAT5b is a common phenomenon in liver in vivo, with 5% and 29% of the male datasets, and 11% and 13% of the female datasets, associated with masculinization or feminization, respectively. As expected, liver STAT5b activation/masculinization occurred at puberty and suppression/feminization occurred during aging and in mutant mice with defects in GH signaling. A total of 70 genes were identified that have effects on STAT5b activation in genetic models in which the gene was inactivated or overexpressed. Other factors that affected liver STAT5b function were shown to include fasting, caloric restriction and infections. Together, these findings identify diverse factors that perturb the hypothalamo-pituitary-liver GH axis and disrupt GH-dependent STAT5b activation in mouse liver.	[Oshida, Keiyu; Vasani, Naresh; Corton, J. Christopher] US EPA, Integrated Syst Toxicol Div, NHEERL ORD, Res Triangle Pk, NC 27711 USA; [Waxman, David J.] Boston Univ, Dept Biol, Div Cell & Mol Biol, Boston, MA 02215 USA; [Waxman, David J.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Oshida, Keiyu] Toray Industries Ltd, Kamakura, Kanagawa, Japan	United States Environmental Protection Agency; Boston University; Boston University; Toray Industries, Inc.	Corton, JC (corresponding author), US EPA, Integrated Syst Toxicol Div, NHEERL ORD, Res Triangle Pk, NC 27711 USA.	corton.chris@epa.gov	Vasani, Naresh B/K-9082-2019	Vasani, Naresh/0000-0003-4814-3310; Waxman, David/0000-0001-7982-9206	U.S. Environmental Protection Agency; NIH [DK33765]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK033765, R01DK033765] Funding Source: NIH RePORTER	U.S. Environmental Protection Agency(United States Environmental Protection Agency); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The information in this document has been funded in part by the U.S. Environmental Protection Agency, and by NIH grant DK33765 (to DJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay JL, 2010, MOL ENDOCRINOL, V24, P204, DOI 10.1210/me.2009-0233; Bartke A, 2012, GERONTOLOGY, V58, P337, DOI 10.1159/000335166; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Chia DJ, 2014, MOL ENDOCRINOL, V28, P1012, DOI 10.1210/me.2014-1099; Choi HK, 1999, ENDOCRINOLOGY, V140, P5126, DOI 10.1210/en.140.11.5126; Choi HK, 2000, ENDOCRINOLOGY, V141, P3245, DOI 10.1210/en.141.9.3245; Choi HK, 2000, GROWTH HORM IGF RES, V10, P1, DOI 10.1016/S1096-6374(00)80002-7; Clodfelter KH, 2007, PHYSIOL GENOMICS, V31, P63, DOI 10.1152/physiolgenomics.00055.2007; Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489; Collins LL, 2004, P NATL ACAD SCI USA, V101, P15058, DOI 10.1073/pnas.0405700101; Conforto TL, 2012, MOL CELL BIOL, V32, P4611, DOI 10.1128/MCB.00886-12; Conforto TL, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-9; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dhir RN, 2006, J PHARMACOL EXP THER, V316, P87, DOI 10.1124/jpet.105.093773; Diczfalusy U, 2011, BRIT J CLIN PHARMACO, V71, P183, DOI 10.1111/j.1365-2125.2010.03773.x; Fernando J, 2013, J IMMUNOL, V191, P4505, DOI 10.4049/jimmunol.1202723; Frank SJ, 2001, GROWTH HORM IGF RES, V11, P201, DOI 10.1054/ghir.2001.0237; Frijters R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-359; FUJITA S, 1990, J PHARMACOL EXP THER, V253, P369; Geter DR, 2014, TOXICOL SCI, V138, P425, DOI 10.1093/toxsci/kfu014; Guo Q, 2012, EUR J IMMUNOL, V42, P1500, DOI 10.1002/eji.201142051; Hand NJ, 2009, HEPATOLOGY, V49, P618, DOI 10.1002/hep.22656; HARTMAN ML, 1993, HORM RES, V40, P37, DOI 10.1159/000183766; Herrington J, 2001, TRENDS ENDOCRIN MET, V12, P252, DOI 10.1016/S1043-2760(01)00423-4; Holloway MG, 2006, MOL ENDOCRINOL, V20, P647, DOI 10.1210/me.2005-0328; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Holloway MG, 2007, ENDOCRINOLOGY, V148, P1977, DOI 10.1210/en.2006-1419; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128; Jiang YJ, 2013, MECH AGEING DEV, V134, P407, DOI 10.1016/j.mad.2013.08.003; Kang HS, 2011, DIABETES, V60, P177, DOI 10.2337/db10-0628; Kim YD, 2012, J BIOL CHEM, V287, P37098, DOI 10.1074/jbc.M112.339887; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Laz EV, 2007, ENDOCRINOLOGY, V148, P3327, DOI 10.1210/en.2006-1192; Lee C, 2012, CAN J PHYSIOL PHARM, V90, P1354, DOI [10.1139/Y2012-099, 10.1139/y2012-099]; Lee JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024381; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lichanska AM, 2008, TRENDS GENET, V24, P41, DOI 10.1016/j.tig.2007.10.006; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Ling GY, 2010, MOL CELL BIOL, V30, P5531, DOI 10.1128/MCB.00601-10; Martinez CS, 2013, GROWTH HORM IGF RES, V23, P19, DOI 10.1016/j.ghir.2012.11.002; Meinhardt UJ, 2007, ENDOCRIN METAB CLIN, V36, P57, DOI 10.1016/j.ecl.2006.11.009; Mueller KM, 2012, MOL CELL ENDOCRINOL, V361, P1, DOI 10.1016/j.mce.2012.03.026; Mugford CA, 1998, DRUG METAB REV, V30, P441, DOI 10.3109/03602539808996322; Oberley CC, 2015, MOL CARCINOGEN, V54, P959, DOI 10.1002/mc.22165; Oshida K, 2015, PLOS ONE UNPUB; Oshida K, 2015, TOXICOLOGY, V336, P99, DOI 10.1016/j.tox.2015.07.005; Oshida Keiyu, 2015, Nucl Recept Signal, V13, pe002, DOI 10.1621/nrs.13002; Oshida K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0112655; Park SH, 2001, J BIOL CHEM, V276, P43031, DOI 10.1074/jbc.M107597200; Park SH, 2006, BIOCHEM J, V397, P159, DOI 10.1042/BJ20060332; Parrish Rudolph S, 2004, J Biopharm Stat, V14, P575, DOI 10.1081/BIP-200025650; Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S12; Shipley JM, 2004, TOXICOL APPL PHARM, V199, P275, DOI 10.1016/j.taap.2003.12.020; Shipley JM, 2003, MOL PHARMACOL, V64, P355, DOI 10.1124/mol.64.2.355; Steyn FJ, 2011, ENDOCRINOLOGY, V152, P3165, DOI 10.1210/en.2011-0253; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun K, 2009, HEPATOLOGY, V49, P1645, DOI 10.1002/hep.22834; Tannenbaum GS, 2001, ENDOCRINOLOGY, V142, P4599, DOI 10.1210/en.142.11.4599; Textoris J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012190; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Veldhuis J D, 2001, Growth Horm IGF Res, V11 Suppl A, pS25, DOI 10.1016/S1096-6374(01)80005-8; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; WAXMAN DJ, 1995, J BIOL CHEM, V270, P13262, DOI 10.1074/jbc.270.22.13262; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Woelfle J, 2003, J BIOL CHEM, V278, P51261, DOI 10.1074/jbc.M309486200; Wolbold R, 2003, HEPATOLOGY, V38, P978, DOI 10.1053/jhep.2003.50393; Yu JH, 2010, HEPATOLOGY, V52, P1808, DOI 10.1002/hep.23882; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11; Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024; Zhuang SG, 2013, CELL SIGNAL, V25, P1924, DOI 10.1016/j.cellsig.2013.05.007	78	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0148308	10.1371/journal.pone.0148308	http://dx.doi.org/10.1371/journal.pone.0148308			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959975	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300002
J	Dall'Oglio, OT; Ribeiro, RC; Ramalho, FD; Fernandes, FL; Wilcken, CF; de Assis, SL; Rueda, RAP; Serrao, JE; Zanuncio, JC				Dall'Oglio, Onice Teresinha; Ribeiro, Rafael Coelho; Ramalho, Francisco de Souza; Fernandes, Flavio Lemes; Wilcken, Carlos Frederico; de Assis Junior, Sebastiao Lourenco; Plata Rueda, Rosa Angelica; Serrao, Jose Eduardo; Zanuncio, Jose Cola			Can the Understory Affect the Hymenoptera Parasitoids in a Eucalyptus Plantation?	PLOS ONE			English	Article							APISAON DAHMAN LEPIDOPTERA; BIOLOGICAL-CONTROL; SPECIES RICHNESS; AGRICULTURAL INTENSIFICATION; LANDSCAPE COMPOSITION; FOREST REMNANTS; MINAS-GERAIS; DIVERSITY; BIODIVERSITY; POPULATION	The understory in forest plantations can increase richness and diversity of natural enemies due to greater plant species richness. The objective of this study was to test the hypothesis that the presence of the understory and climatic season in the region (wet or dry) can increase the richness and abundance of Hymenoptera parasitoids in Eucalyptus plantations, in the municipality of Belo Oriente, Minas Gerais State, Brazil. In each eucalyptus cultivation (five areas of cultivation) ten Malaise traps were installed, five with the understory and five without it. A total of 9,639 individuals from 30 families of the Hymenoptera parasitoids were collected, with Mymaridae, Scelionidae, Encyrtidae and Braconidae being the most collected ones with 4,934, 1,212, 619 and 612 individuals, respectively. The eucalyptus stands with and without the understory showed percentage of individuals 45.65% and 54.35% collected, respectively. The understory did not represent a positive effect on the overall abundance of the individuals Hymenoptera in the E. grandis stands, but rather exerted a positive effect on the specific families of the parasitoids of this order.	[Dall'Oglio, Onice Teresinha] Univ Fed Mato Grosso, Inst Ciencias Agr & Ambientais, Campus Univ Tocantins CUNTINS, Sinop, MT, Brazil; [Ribeiro, Rafael Coelho] Fed Univ Para, Fac Agron, Cameta, PA, Brazil; [Ramalho, Francisco de Souza] Embrapa Algodao, Unidade Controle Biol, Campina Grande, PB, Brazil; [Fernandes, Flavio Lemes] Univ Fed Vicosa, Campus Rio Paranaiba, Rio Paranaiba, MG, Brazil; [Wilcken, Carlos Frederico] UNESP, Fac Ciencias Agron, Dept Protecao Vegetal, BR-18610307 Botucatu, SP, Brazil; [de Assis Junior, Sebastiao Lourenco] Univ Fed Vales Jequitinhonha & Mucuri, Dept Engn Florestal, BR-39100000 Diamantina, MG, Brazil; [Plata Rueda, Rosa Angelica] Univ Fed Vicosa, Dept Fitotecnia, BR-36570900 Vicosa, MG, Brazil; [Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Geral, BR-36570900 Vicosa, MG, Brazil; [Zanuncio, Jose Cola] Univ Fed Vicosa, Dept Entomol BIOAGRO, BR-36570900 Vicosa, MG, Brazil	Universidade Federal de Mato Grosso; Universidade Federal do Para; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Vicosa; Universidade Estadual Paulista; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Zanuncio, JC (corresponding author), Univ Fed Vicosa, Dept Entomol BIOAGRO, BR-36570900 Vicosa, MG, Brazil.	zanuncio@ufv.br	Rueda, Angelica Plata/H-4519-2013; Fernandes, Flávio/I-4777-2018; Wilcken, Carlos F/D-1596-2012; FS, Ramalho/AAC-8058-2019	Rueda, Angelica Plata/0000-0002-2114-8237; Fernandes, Flávio/0000-0003-0532-8593; Wilcken, Carlos F/0000-0001-9875-4158; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funding was received from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG).; To "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)", "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)" and "Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)" for financial support. Global Edico Services corrected and edited the English of this manuscript.	ALTIERI MA, 1979, HORTSCIENCE, V14, P12; Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; ANDERSEN AN, 1995, BIOL CONSERV, V73, P39, DOI 10.1016/0006-3207(95)90059-4; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; Balmford A, 1996, P ROY SOC B-BIOL SCI, V263, P1267, DOI 10.1098/rspb.1996.0186; Barbosa VS, 2005, NEOTROP ENTOMOL, V34, P701, DOI 10.1590/S1519-566X2005000500001; Barlow J, 2008, BIODIVERS CONSERV, V17, P1089, DOI 10.1007/s10531-007-9240-0; Batary P, 2011, P ROY SOC B-BIOL SCI, V278, P1894, DOI 10.1098/rspb.2010.1923; Batary P, 2010, BIOL CONSERV, V143, P2020, DOI 10.1016/j.biocon.2010.05.005; Benrey B, 1997, ECOLOGY, V78, P987, DOI 10.2307/2265852; Bernays EA, 1997, ECOL ENTOMOL, V22, P121, DOI 10.1046/j.1365-2311.1997.00042.x; Berta CD, 2013, ACTA ZOOL LILL, V57, P14; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Both S, 2011, J VEG SCI, V22, P1120, DOI 10.1111/j.1654-1103.2011.01324.x; Bradford MA, 2010, BIOL INVASIONS, V12, P721, DOI 10.1007/s10530-009-9480-x; Cancino ER, 2014, REV MEX BIODIVERS, V85, P385; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Concepcion ED, 2008, LANDSCAPE ECOL, V23, P135, DOI 10.1007/s10980-007-9150-2; Cortesero AM, 2000, BIOL CONTROL, V17, P35, DOI 10.1006/bcon.1999.0777; Dall'Oglio OT, 2013, FLA ENTOMOL, V96, P887, DOI 10.1653/024.096.0324; DARLING DC, 1988, CAN ENTOMOL, V120, P787, DOI 10.4039/Ent120787-8; De Souza AR, 2011, J ECON ENTOMOL, V104, P1120, DOI 10.1603/EC11060; Dejean A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027004; Fernandes LBD, 2010, REV BRAS ENTOMOL, V54, P263, DOI 10.1590/S0085-56262010000200009; Frew A, 2013, FOREST ECOL MANAG, V306, P275, DOI 10.1016/j.foreco.2013.06.051; Gagic V, 2011, P ROY SOC B-BIOL SCI, V278, P2946, DOI 10.1098/rspb.2010.2645; Gamez-Virues S, 2009, BIOCONTROL, V54, P211, DOI 10.1007/s10526-008-9182-9; Gibson GAP, 1997, ANNOTED KEYS GENERA; Givnish TJ, 1999, J ECOL, V87, P193, DOI 10.1046/j.1365-2745.1999.00333.x; Goulet H., 1993, HYMENOPTERA WORLD ID, V1894E; Grissell EE., 1990, HDB FAMILIES NEARCTI; GROSBERG RK, 1981, NATURE, V290, P700, DOI 10.1038/290700a0; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Heraty JM, 2013, CLADISTICS, V29, P466, DOI 10.1111/cla.12006; Huber John T., 2009, P270; Jakel A, 2004, EUR J FOREST RES, V123, P203, DOI 10.1007/s10342-004-0030-x; Kapranas A, 2015, ANNU REV ENTOMOL, V60, P195, DOI 10.1146/annurev-ento-010814-021053; Lee JC, 2008, J ANIM ECOL, V77, P565, DOI 10.1111/j.1365-2656.2008.01355.x; Lotfalizadeh Hosseinali, 2012, Munis Entomology & Zoology, V7, P309; Macedo-Reis LE, 2013, FLA ENTOMOL, V96, P941, DOI 10.1653/024.096.0331; Morin PJ, 2002, COMMUNITY ECOLOGY; Murta AF, 2008, NEOTROP ENTOMOL, V37, P229, DOI 10.1590/S1519-566X2008000200019; Mutitu EK, 2013, J ECON ENTOMOL, V106, P1979, DOI 10.1603/EC13135; ORR DB, 1988, FLA ENTOMOL, V71, P506, DOI 10.2307/3495011; Parks D, 2011, CLIMATE CHANGE CATER; Pereira FF, 2008, BRAZ ARCH BIOL TECHN, V51, P259, DOI 10.1590/S1516-89132008000200004; Plecas M, 2014, AGR ECOSYST ENVIRON, V183, P1, DOI 10.1016/j.agee.2013.10.016; Potter KM, 2014, FOREST SCI, V60, P851, DOI 10.5849/forsci.13-115; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Querino RB, 2011, BRAZ J BIOL, V71, P865, DOI 10.1590/S1519-69842011000500007; Roschewitz I, 2005, AGR ECOSYST ENVIRON, V108, P218, DOI 10.1016/j.agee.2005.02.005; Santiago LS, 2005, TREES-STRUCT FUNCT, V19, P349, DOI 10.1007/s00468-004-0389-9; Santolamazza S, 2011, ENTOMOL SCI, V14, P366, DOI 10.1111/j.1479-8298.2011.00454.x; SEBENS KP, 1981, SCIENCE, V213, P785, DOI 10.1126/science.213.4509.785; SIH A, 1982, ECOLOGY, V63, P786, DOI 10.2307/1936799; Sousa SM, 2010, NEOTROP ENTOMOL, V39, P681, DOI 10.1590/S1519-566X2010000500001; Stephan JG, 2015, BIOCONTROL, V1, P1; Thies C, 2005, P ROY SOC B-BIOL SCI, V272, P203, DOI 10.1098/rspb.2004.2902; Thies C, 2011, ECOL APPL, V21, P2187, DOI 10.1890/10-0929.1; Tillman PG, 2010, ENVIRON ENTOMOL, V39, P1184, DOI 10.1603/EN09323; TOWNES H, 1972, Entomological News, V83, P239; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2007, BIOL CONTROL, V43, P294, DOI 10.1016/j.biocontrol.2007.08.006; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Van Driesche R. G., 1996, BIOL CONTROL; Vance CC, 2007, ENVIRON ENTOMOL, V36, P1073, DOI 10.1603/0046-225X(2007)36[1073:DBFTAV]2.0.CO;2; Vockenhuber EA, 2011, PERSPECT PLANT ECOL, V13, P111, DOI 10.1016/j.ppees.2011.02.004; Vollhardt IMG, 2008, AGR ECOSYST ENVIRON, V126, P289, DOI 10.1016/j.agee.2008.01.024; WEDRAOGO FX, 1993, BIOL FERT SOILS, V15, P28, DOI 10.1007/BF00336284; Wilf P, 2001, P NATL ACAD SCI USA, V98, P6221, DOI 10.1073/pnas.111069498; Withers TM, 2001, AUSTRAL ECOL, V26, P467, DOI 10.1046/j.1442-9993.2001.01140.x; Zanuncio JC, 2003, ANIM BIOL, V53, P17, DOI 10.1163/157075603769682549; Zanuncio JC, 2000, REV BIOL TROP, V48, P989; Zanuncio JC, 2009, AN ACAD BRAS CIENC, V81, P61, DOI 10.1590/S0001-37652009000100008; Zanuncio JC, 2014, FORESTS, V5, P72, DOI 10.3390/f5010072; Zappala L, 2012, B INSECTOL, V65, P51	76	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151165	10.1371/journal.pone.0151165	http://dx.doi.org/10.1371/journal.pone.0151165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954578	Green Submitted, Green Published, gold			2022-12-27	WOS:000371991300092
J	Fagerlund, A; Langsrud, S; Schirmer, BCT; Moretro, T; Heir, E				Fagerlund, Annette; Langsrud, Solveig; Schirmer, Bjorn C. T.; Moretro, Trond; Heir, Even			Genome Analysis of Listeria monocytogenes Sequence Type 8 Strains Persisting in Salmon and Poultry Processing Environments and Comparison with Related Strains	PLOS ONE			English	Article							PLANTS; TOOL; EPIDEMIOLOGY; SURVEILLANCE; EXPRESSION; INTERNALIN; MUTATIONS; DIVERSITY; OUTBREAKS; SELECTION	Listeria monocytogenes is an important foodborne pathogen responsible for the disease listeriosis, and can be found throughout the environment, in many foods and in food processing facilities. The main cause of listeriosis is consumption of food contaminated from sources in food processing environments. Persistence in food processing facilities has previously been shown for the L. monocytogenes sequence type (ST) 8 subtype. In the current study, five ST8 strains were subjected to whole-genome sequencing and compared with five additionally available ST8 genomes, allowing comparison of strains from salmon, poultry and cheese industry, in addition to a human clinical isolate. Genome-wide analysis of single-nucleotide polymorphisms (SNPs) confirmed that almost identical strains were detected in a Danish salmon processing plant in 1996 and in a Norwegian salmon processing plant in 2001 and 2011. Furthermore, we show that L. monocytogenes ST8 was likely to have been transferred between two poultry processing plants as a result of relocation of processing equipment. The SNP data were used to infer the phylogeny of the ST8 strains, separating them into two main genetic groups. Within each group, the plasmid and prophage content was almost entirely conserved, but between groups, these sequences showed strong divergence. The accessory genome of the ST8 strains harbored genetic elements which could be involved in rendering the ST8 strains resilient to incoming mobile genetic elements. These included two restriction-modification loci, one of which was predicted to show phase variable recognition sequence specificity through site-specific domain shuffling. Analysis indicated that the ST8 strains harbor all important known L. monocytogenes virulence factors, and ST8 strains are commonly identified as the causative agents of invasive listeriosis. Therefore, the persistence of this L. monocytogenes subtype in food processing facilities poses a significant concern for food safety.	[Fagerlund, Annette; Langsrud, Solveig; Schirmer, Bjorn C. T.; Moretro, Trond; Heir, Even] Nofima, Norwegian Inst Food Fisheries & Aquaculture Res, As, Norway; [Schirmer, Bjorn C. T.] Norwegian Vet Inst, Oslo, Norway	Nofima; Norwegian Veterinary Institute	Fagerlund, A (corresponding author), Nofima, Norwegian Inst Food Fisheries & Aquaculture Res, As, Norway.	annette.fagerlund@nofima.no	Langsrud, Solveig/I-1241-2012; Moretro, Trond/AAZ-5689-2021	Langsrud, Solveig/0000-0001-6415-017X; Moretro, Trond/0000-0001-5176-1158; Fagerlund, Annette/0000-0001-7146-4265	Norwegian Research Funding for Agriculture and Food Industry; Research Council of Norway [234355, 207765, 224921]; Norwegian Seafood Research Fund [900521]	Norwegian Research Funding for Agriculture and Food Industry; Research Council of Norway(Research Council of Norway); Norwegian Seafood Research Fund	This work was supported by Norwegian Research Funding for Agriculture and Food Industry and by the Research Council of Norway (https://www.slf.dep.no/no/fou-midler/landbruks-og-matforskning, http://www.forskningsradet.no/, grants no. 234355, 207765, and 224921) and by the Norwegian Seafood Research Fund (http://www.fhf.no/, grant no. 900521). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus D, 2014, FOODBORNE PATHOG DIS, V11, P753, DOI 10.1089/fpd.2014.1747; Aronesty E., 2011, EA UTILS COMMAND LIN; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Becavin C, 2014, MBIO, V5, DOI 10.1128/mBio.00969-14; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; Cao GJ, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01203-14; Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Chiara M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00282-14; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; Ciolacu L, 2015, INT J FOOD MICROBIOL, V209, P44, DOI 10.1016/j.ijfoodmicro.2014.08.035; Croucher NJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0202; Denes T, 2015, APPL ENVIRON MICROB, V81, P4295, DOI 10.1128/AEM.00087-15; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; Dutta V, 2013, APPL ENVIRON MICROB, V79, P6067, DOI 10.1128/AEM.01751-13; Dy RL, 2014, ANNU REV VIROL, V1, P307, DOI 10.1146/annurev-virology-031413-085500; Ebner R, 2015, FOOD CONTROL, V57, P321, DOI 10.1016/j.foodcont.2015.04.030; Eugster MR, 2012, J BACTERIOL, V194, P6498, DOI 10.1128/JB.00808-12; Ferreira V, 2014, J FOOD PROTECT, V77, P150, DOI 10.4315/0362-028X.JFP-13-150; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hawkey J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-800; Holch A, 2013, APPL ENVIRON MICROB, V79, P2944, DOI 10.1128/AEM.03715-12; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-8; Jensen A, 2008, INT J FOOD MICROBIOL, V123, P254, DOI 10.1016/j.ijfoodmicro.2008.02.016; Knabel SJ, 2012, J CLIN MICROBIOL, V50, P1748, DOI 10.1128/JCM.06185-11; Koren S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-126; Kosman DJ, 2010, J BIOL INORG CHEM, V15, P15, DOI 10.1007/s00775-009-0590-9; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Laing C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-461; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsen MH, 2014, FOOD CONTROL, V44, P92, DOI 10.1016/j.foodcont.2014.03.039; LEBRUN M, 1994, J BACTERIOL, V176, P3049, DOI 10.1128/JB.176.10.3049-3061.1994; Lindstedt BA, 2008, J MICROBIOL METH, V72, P141, DOI 10.1016/j.mimet.2007.11.012; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P20, DOI 10.1093/nar/gkt847; Loessner MJ, 2000, MOL MICROBIOL, V35, P324, DOI 10.1046/j.1365-2958.2000.01720.x; Lunden JM, 2002, J FOOD PROTECT, V65, P1129, DOI 10.4315/0362-028X-65.7.1129; Magoc T, 2013, BIOINFORMATICS, V29, P1718, DOI 10.1093/bioinformatics/btt273; Mammina C, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-152; Martin B, 2014, FOOD MICROBIOL, V44, P119, DOI 10.1016/j.fm.2014.05.014; Moretro T., 2004, Biofilms, V1, P107, DOI 10.1017/S1479050504001322; Muller A, 2014, FEMS MICROBIOL LETT, V361, P166, DOI 10.1111/1574-6968.12626; Nightingale KK, 2005, APPL ENVIRON MICROB, V71, P8764, DOI 10.1128/AEM.71.12.8764-8772.2005; Norton DM, 2001, APPL ENVIRON MICROB, V67, P198, DOI 10.1128/AEM.67.1.198-205.2001; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; Parkhill J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-230; Pightling AW, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00637-15; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Rychli K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089964; Salipante SJ, 2015, J CLIN MICROBIOL, V53, P1072, DOI 10.1128/JCM.03385-14; Schmid D, 2014, CLIN MICROBIOL INFEC, V20, P431, DOI 10.1111/1469-0691.12638; Schmitz-Esser S, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00150-15; Schmitz-Esser S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00380; Seed KD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004847; Sesto N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004065; Sitaraman R, 1997, MOL MICROBIOL, V26, P109, DOI 10.1046/j.1365-2958.1997.5571938.x; Stasiewicz MJ, 2015, APPL ENVIRON MICROB, V81, P6024, DOI 10.1128/AEM.01049-15; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tasara T, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01248-14; Van Stelten A, 2010, APPL ENVIRON MICROB, V76, P2783, DOI 10.1128/AEM.02651-09; Verghese B, 2011, APPL ENVIRON MICROB, V77, P3279, DOI 10.1128/AEM.00546-11; Vogel BF, 2001, APPL ENVIRON MICROB, V67, P2586, DOI 10.1128/AEM.67.6.2586-2595.2001; Wang Y, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-119; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	73	70	72	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151117	10.1371/journal.pone.0151117	http://dx.doi.org/10.1371/journal.pone.0151117			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953695	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300085
J	Falcicchia, C; Trempat, P; Binaschi, A; Perrier-Biollay, C; Roncon, P; Soukupova, M; Berthomme, H; Simonato, M				Falcicchia, Chiara; Trempat, Pascal; Binaschi, Anna; Perrier-Biollay, Coline; Roncon, Paolo; Soukupova, Marie; Berthomme, Herve; Simonato, Michele			Silencing Status Epilepticus-Induced BDNF Expression with Herpes Simplex Virus Type-1 Based Amplicon Vectors	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; SPONTANEOUS SEIZURES; CONVERGENT TRANSCRIPTION; GENETIC INTERFERENCE; RNA INTERFERENCE; MESSENGER-RNAS; RAT FOREBRAIN; ADULT-RAT; EPILEPTOGENESIS; EPILEPSY	Brain-derived neurotrophic factor (BDNF) has been found to produce pro-but also anti-epileptic effects. Thus, its validity as a therapeutic target must be verified using advanced tools designed to block or to enhance its signal. The aim of this study was to develop tools to silence the BDNF signal. We generated Herpes simplex virus type 1 (HSV-1) derived amplicon vectors, i.e. viral particles containing a genome of 152 kb constituted of concatameric repetitions of an expression cassette, enabling the expression of the gene of interest in multiple copies. HSV-1 based amplicon vectors are non-pathogenic and have been successfully employed in the past for gene delivery into the brain of living animals. Therefore, amplicon vectors should represent a logical choice for expressing a silencing cassette, which, in multiple copies, is expected to lead to an efficient knock-down of the target gene expression. Here, we employed two amplicon-based BDNF silencing strategies. The first, antisense, has been chosen to target and degrade the cytoplasmic mRNA pool of BDNF, whereas the second, based on the convergent transcription technology, has been chosen to repress transcription at the BDNF gene. Both these amplicon vectors proved to be effective in down-regulating BDNF expression in vitro, in BDNF-expressing mesoangioblast cells. However, only the antisense strategy was effective in vivo, after inoculation in the hippocampus in a model of status epilepticus in which BDNF mRNA levels are strongly increased. Interestingly, the knocking down of BDNF levels induced with BDNF-antisense was sufficient to produce significant behavioral effects, in spite of the fact that it was produced only in a part of a single hippocampus. In conclusion, this study demonstrates a reliable effect of amplicon vectors in knocking down gene expression in vitro and in vivo. Therefore, this approach may find broad applications in neurobiological studies.	[Falcicchia, Chiara; Trempat, Pascal; Binaschi, Anna; Roncon, Paolo; Soukupova, Marie; Simonato, Michele] Univ Ferrara, Ctr Neurosci, Pharmacol Sect, Dept Med Sci, I-44100 Ferrara, Italy; [Falcicchia, Chiara; Trempat, Pascal; Binaschi, Anna; Roncon, Paolo; Soukupova, Marie; Simonato, Michele] Natl Inst Neurosci, Ferrara, Italy; [Falcicchia, Chiara; Trempat, Pascal; Perrier-Biollay, Coline; Berthomme, Herve] Univ Lyon 1, Bioviron, F-69622 Villeurbanne, France; [Simonato, Michele] Technopole Ferrara, Lab Technol Adv Therapy LTTA, Ferrara, Italy	University of Ferrara; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Falcicchia, C (corresponding author), Univ Ferrara, Ctr Neurosci, Pharmacol Sect, Dept Med Sci, I-44100 Ferrara, Italy.; Falcicchia, C (corresponding author), Natl Inst Neurosci, Ferrara, Italy.; Falcicchia, C (corresponding author), Univ Lyon 1, Bioviron, F-69622 Villeurbanne, France.	chiara.falcicchia@unife.it	Simonato, Michele/AIA-0028-2022	Simonato, Michele/0000-0002-3586-2693; Falcicchia, Chiara/0000-0002-9648-5713; Soukupova, Marie/0000-0002-0489-1977	European Community [285827]	European Community(European Commission)	This work has been supported by a grant from the European Community [FP7-PEOPLE-2011-IAPP project 285827 (EPIXCHANGE)] to MS and HB.	Biagini G, 2001, J NEUROCHEM, V76, P1814, DOI 10.1046/j.1471-4159.2001.00163.x; Binder DK, 1999, J NEUROSCI, V19, P4616; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Bovolenta R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-81; Chiaruttini C, 2008, MOL CELL NEUROSCI, V37, P11, DOI 10.1016/j.mcn.2007.08.011; Cho-Chung YS, 2003, NAT BIOTECHNOL, V21, P492, DOI 10.1038/nbt0503-492a; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Elmer E, 1998, NEUROSCIENCE, V83, P351, DOI 10.1016/S0306-4522(97)00387-4; Epstein AL, 2005, GENE THER, V12, pS154, DOI 10.1038/sj.gt.3302617; Epstein AL, 2009, MEM I OSWALDO CRUZ, V104, P399, DOI 10.1590/S0074-02762009000300002; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Giordano E, 2002, GENETICS, V160, P637; Gullerova M, 2012, NAT STRUCT MOL BIOL, V19, P1193, DOI 10.1038/nsmb.2392; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Kavi HH, 2008, CURR TOP MICROBIOL, V320, P37; Khorooshi R, 2015, ACTA NEUROPATHOL, V130, P107, DOI 10.1007/s00401-015-1418-z; KOKAIA M, 1995, EXP NEUROL, V133, P215, DOI 10.1006/exnr.1995.1024; KWONG AD, 1984, J VIROL, V51, P595, DOI 10.1128/JVI.51.3.595-603.1984; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Liu GM, 2013, NEURON, V79, P31, DOI 10.1016/j.neuron.2013.04.027; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Mudo G, 1996, EPILEPSIA, V37, P198, DOI 10.1111/j.1528-1157.1996.tb00012.x; Oehmig A, 2004, MOL THER, V10, P630, DOI 10.1016/j.ymthe.2004.06.641; Paradiso B, 2011, EPILEPSIA, V52, P572, DOI 10.1111/j.1528-1167.2010.02930.x; Paradiso B, 2009, P NATL ACAD SCI USA, V106, P7191, DOI 10.1073/pnas.0810710106; Pellegrino L. J., 1979, STEREOTAXIC ATLAS RA; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Scharfman HE, 1999, J NEUROSCI, V19, P5619; Scharfman HE, 1997, J NEUROPHYSIOL, V78, P1082, DOI 10.1152/jn.1997.78.2.1082; Shendure J, 2002, GENOME BIOL, V3; Shi HF, 2000, RNA, V6, P1069, DOI 10.1017/S1355838200000297; Simonato M, 1998, EUR J NEUROSCI, V10, P955, DOI 10.1046/j.1460-9568.1998.00105.x; Simonato M, 2006, TRENDS PHARMACOL SCI, V27, P631, DOI 10.1016/j.tips.2006.10.002; Simonato M, 2010, EPILEPSIA, V51, P48, DOI 10.1111/j.1528-1167.2010.02609.x; Su T, 2012, CELL TRANSPLANT, V21, P1613, DOI 10.3727/096368912X640475; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tongiorgi E, 2004, J NEUROSCI, V24, P6842, DOI 10.1523/JNEUROSCI.5471-03.2004; Tran N, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-21; Tsitoura E, 2009, J GEN VIROL, V90, P2209, DOI 10.1099/vir.0.012203-0; Wang J, 2005, METHOD ENZYMOL, V392, P36, DOI 10.1016/S0076-6879(04)92003-4; Wang J, 2003, P NATL ACAD SCI USA, V100, P5103, DOI 10.1073/pnas.0931345100; Wang S, 2002, METHOD ENZYMOL, V346, P593; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765	45	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150995	10.1371/journal.pone.0150995	http://dx.doi.org/10.1371/journal.pone.0150995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954758	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300071
J	Montolio, FGJ; Meems, W; Janssens, MSA; Stam, L; Jansonius, NM				Montolio, Francisco G. Junoy; Meems, Wilma; Janssens, Marieke S. A.; Stam, Lucas; Jansonius, Nomdo M.			Lateral Inhibition in the Human Visual System in Patients with Glaucoma and Healthy Subjects: A Case-Control Study	PLOS ONE			English	Article							ADAPTATION ABNORMALITIES; PARVOCELLULAR PATHWAYS; SENSITIVITY; NEURONS	In glaucoma, the density of retinal ganglion cells is reduced. It is largely unknown how this influences retinal information processing. An increase in spatial summation and a decrease in contrast gain control and contrast adaptation have been reported. A decrease in lateral inhibition might also arise. This could result in a larger than expected response to some stimuli, which could mask ganglion cell loss on functional testing (structure-function discrepancy). The aim of this study was to compare lateral inhibition between glaucoma patients and healthy subjects; we used a case-control design. Cases (n = 18) were selected to have advanced visual field loss in combination with a normal visual acuity. Controls (n = 50) were not allowed to have symptoms or signs of any eye disease. Lateral inhibition was measured psychophysically on a computer screen, with (1) a modified illusory movement experiment and (2) a contrast sensitivity (CS) test. Illusory movement was quantified by nulling it with a real movement; measure of lateral inhibition was the amount of illusory movement. CS was measured at 1 and 4 cycles per degree (cpd); measure of lateral inhibition was the difference between log CS at 4 and 1 cpd. Both measures were compared between cases and controls; analyses were adjusted for age and gender. There was no difference between cases and controls for these two measures of lateral inhibition (p = 0.58 for illusory movement; p = 0.20 for CS). The movement threshold was higher in cases than in controls (p = 0.008) and log CS was lower, at both 1 (-0.20; p = 0.008) and 4 (-0.28; p = 0.001) cpd. Our results indicate that spatially antagonisticmechanisms are not specifically affected in glaucoma, at least not in the intact center of a severely damaged visual field. This suggests that the structure-function discrepancy in glaucoma is not related to a decrease in lateral inhibition.	[Montolio, Francisco G. Junoy; Meems, Wilma; Janssens, Marieke S. A.; Stam, Lucas; Jansonius, Nomdo M.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Jansonius, Nomdo M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	University of Groningen; Erasmus University Rotterdam; Erasmus MC	Jansonius, NM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.; Jansonius, NM (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.	n.m.jansonius@umcg.nl		Jansonius, Nomdo/0000-0002-6495-6568; Junoy Montolio, Francisco/0000-0002-6773-766X	University Medical Center Groningen, Stichting Nederlands Oogheelkundig Onderzoek [2011-09]; Uitzicht (Glaucoomfond) [2012-37]; Uitzicht (ANVVB) [2012-37]; Uitzicht (LSBS) [2012-37]	University Medical Center Groningen, Stichting Nederlands Oogheelkundig Onderzoek; Uitzicht (Glaucoomfond); Uitzicht (ANVVB); Uitzicht (LSBS)	This research was supported by the University Medical Center Groningen, Stichting Nederlands Oogheelkundig Onderzoek (2011-09; NJ), and Uitzicht (2012-37; NJ; www.uitzicht.nl; Glaucoomfonds, ANVVB, LSBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Dul M, 2015, INVEST OPHTH VIS SCI, V56, P1329, DOI 10.1167/iovs.14-15725; DZN HD, 1954, J OPT SOC AM, V44, P380, DOI 10.1364/JOSA.44.000380; Fernaandez-Saanchez L, 2014, INVEST OPHTH VIS SCI, V55, P6059, DOI 10.1167/iovs.14-14421; Fuchs M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044645; Hecht S, 1933, J GEN PHYSIOL, V17, P251, DOI 10.1085/jgp.17.2.251; Heeg GP, 2005, ACTA OPHTHALMOL SCAN, V83, P46, DOI 10.1111/j.1600-0420.2005.00423.x; Hood DC, 1997, VISION RES, V37, P1177, DOI 10.1016/S0042-6989(96)00228-3; Jansonius NM, 1997, OPHTHAL PHYSL OPT, V17, P128, DOI 10.1111/j.1475-1313.1997.tb00030.x; Jansonius NM, 1989, NEURAL MECH BEHAV, P202; Jansonius NM, 2014, PERCEPTION, V43, P1329, DOI 10.1068/p7716; Janssen P, 1997, GER J OPHTHALMOL, V5, P378; KELLY D H, 1964, Doc Ophthalmol, V18, P16, DOI 10.1007/BF00160561; Kooi F, 1986, INVEST OPHTHALMOL VI; KORTH M, 1989, GRAEF ARCH CLIN EXP, V227, P428, DOI 10.1007/BF02172893; LEVINSON J, 1964, Doc Ophthalmol, V18, P36, DOI 10.1007/BF00160562; LUNDH BL, 1985, ACTA OPHTHALMOL, V63, P487; LUSTGARTEN JS, 1990, CLIN VISION SCI, V5, P407; McKendrick AM, 2004, INVEST OPHTH VIS SCI, V45, P1846, DOI 10.1167/iovs.03-1225; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Moon JI, 2005, CELL TISSUE RES, V320, P51, DOI 10.1007/s00441-004-1062-8; Nio YK, 2005, OPHTHAL PHYSL OPT, V25, P18, DOI 10.1111/j.1475-1313.2004.00240.x; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Redmond T, 2010, INVEST OPHTH VIS SCI, V51, P6540, DOI 10.1167/iovs.10-5718; ROSS JE, 1984, BRIT J OPHTHALMOL, V68, P821, DOI 10.1136/bjo.68.11.821; Shabana N, 2003, SURV OPHTHALMOL, V48, P92, DOI 10.1016/S0039-6257(02)00401-0; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Snippe HP, 2000, VISUAL NEUROSCI, V17, P449, DOI 10.1017/S0952523800173110; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Sun H, 2008, VISION RES, V48, P2633, DOI 10.1016/j.visres.2008.04.008; SUNGA RN, 1970, AM J OPHTHALMOL, V70, P244, DOI 10.1016/0002-9394(70)90014-0; VAEGAN, 1995, EXP EYE RES, V60, P697, DOI 10.1016/S0014-4835(05)80011-9; von Bekesy G, 1967, SENSORY INHIBITION; WERBLIN FS, 1973, SCI AM, V228, P71; WESTHEIMER G, 1967, J PHYSIOL-LONDON, V190, P139, DOI 10.1113/jphysiol.1967.sp008198; Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309; WOOD JM, 1992, ACTA OPHTHALMOL, V70, P610	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151006	10.1371/journal.pone.0151006	http://dx.doi.org/10.1371/journal.pone.0151006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953590	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300072
J	Cardon, G; De Bourdeaudhuij, I; Iotova, V; Latomme, J; Socha, P; Koletzko, B; Moreno, L; Manios, Y; Androutsos, O; De Craemer, M				Cardon, Greet; De Bourdeaudhuij, Ilse; Iotova, Violeta; Latomme, Julie; Socha, Piotr; Koletzko, Berthold; Moreno, Luis; Manios, Yannis; Androutsos, Odysseas; De Craemer, Marieke		ToyBox-Study Grp	Health Related Behaviours in Normal Weight and Overweight Preschoolers of a Large Pan-European Sample: The ToyBox-Study	PLOS ONE			English	Article							BALANCE-RELATED BEHAVIORS; PHYSICAL-ACTIVITY; RISK-FACTORS; CHILDREN; OBESITY; CHILDHOOD; SLEEP; INTERVENTION; ADOLESCENTS; RELIABILITY	The aim of this study was to investigate the associations of health related behaviours (HRB) with Body Mass Index (BMI) in preschoolers, and to study the likelihood of being overweight/obese in relation to compliance with recommended HRB. The sample consisted of 3301 normal weight and overweight/obese preschoolers (mean age: 4.7 years; 52% boys, 85% normal weight) from six European countries (Belgium, Bulgaria, Germany, Greece, Poland, Spain). Height and weight were measured, total daily step counts were registered during six days, and HRB were assessed with validated parental surveys in 2012. Multiple linear and logistic regression analyses were performed. Only few HRB were significantly associated with BMI. In boys, higher water intake and higher soft drink and higher fruit consumption were significantly associated with higher BMI. Boys drinking less water than recommended were less likely to be overweight/obese (OR = 0.60), while boys who consume soft drinks were more likely to be overweight/obese (OR = 1.52). In girls, higher water intake, higher vegetable consumption, and more TV time on weekend days were significantly associated with higher BMI. Girls eating less vegetables than recommended were less likely to be overweight/obese (OR = 0.62), and girls who engaged in quiet play for more than 90 minutes on weekend days were more likely to be overweight/obese (OR = 1.64). In general, the associations between HRB and BMI or being overweight/obese were limited and mainly related to dietary intake. Awareness campaigns for caregivers should stress that HRB of young children are important and independent of children's weight status.	[Cardon, Greet; De Bourdeaudhuij, Ilse; Latomme, Julie; De Craemer, Marieke] Univ Ghent, B-9000 Ghent, Belgium; [Iotova, Violeta] Med Univ Varna, Varna, Bulgaria; [Socha, Piotr] Childrens Mem Hlth Inst, Warsaw, Poland; [Koletzko, Berthold] Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany; [Moreno, Luis] Univ Zaragoza, Zaragoza, Spain; [Manios, Yannis; Androutsos, Odysseas] Harokopio Univ, Sch Hlth Sci & Educ, Dept Nutr Dietet, Athens, Greece	Ghent University; Medical University Varna; Children's Memorial Health Institute; University of Munich; University of Zaragoza; Harokopio University Athens	Cardon, G (corresponding author), Univ Ghent, B-9000 Ghent, Belgium.	greet.cardon@ugent.be	De+Bourdeaudhuij, Ilse/AAC-5528-2019; Iotova, Violeta/AAO-2387-2021; De Craemer, Marieke/Z-3050-2019; Androutsos, Odysseas/ABF-8670-2021; De Craemer, Marieke/P-6072-2016; Moreno, Luis/S-1780-2019; Manios, Yannis/AAM-8953-2021	De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; De Craemer, Marieke/0000-0002-5220-7850; Moreno, Luis/0000-0003-0454-653X; Manios, Yannis/0000-0001-6486-114X; Iotova, Violeta/0000-0003-4160-1200; Cardon, Greet/0000-0003-4983-6557; Socha, Piotr/0000-0002-1621-464X; Kulaga, Zbigniew/0000-0003-0509-1004	Seventh Framework Programme (CORDIS FP7) of the European Commission [245200]	Seventh Framework Programme (CORDIS FP7) of the European Commission	The ToyBox-Study is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commission under grant agreement no 245200.; The ToyBox-study is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commission under grant agreement no 245200. The content of this article reflects only the authors' views and the European Community is not liable for any use that may be made of the information contained therein. The ToyBox-study group consists of: Co-ordinator: Yannis Manios; Steering Committee: Yannis Manios, Berthold Koletzko, Ilse De Bourdeaudhuij, Mai Chin A Paw, Luis Moreno, Carolyn Summerbell, Tim Lobstein, Lieven Annemans, Goof Buijs; External Advisors: John Reilly, Boyd Swinburn, Dianne Ward; Harokopio University (Greece): Yannis Manios, Odysseas Androutsos, Eva Grammatikaki, Christina Katsarou, Eftychia Apostolidou, Eirini Efstathopoulou; Ludwig Maximilians Universitaet Muenchen (Germany): Berthold Koletzko, Kristin Duvinage, Sabine Ibrugger, Angelika Strauss, Birgit Herbert, Julia Birnbaum, Annette Payr, Christine Geyer; Ghent University (Belgium): Department of Movement and Sports Sciences: Ilse De Bourdeaudhuij, Greet Cardon, Marieke De Craemer, Ellen De Decker and Department of Public Health: Lieven Annemans, Stefaan De Henauw, Lea Maes, Carine Vereecken, Jo Van Assche, Lore Pil; VU University Medical Center EMGO Institute for Health and Care Research (the Netherlands): EMGO Institute for Health and Care Research: Mai Chin A Paw, Saskia te Velde; University of Zaragoza (Spain): Luis Moreno, Theodora Mouratidou, Juan Fernandez, Maribel Mesana, Pilar De Miguel-Etayo, Esther Gonzalez, Luis Gracia-Marco, Beatriz Oves; Oslo and Akershus University College of Applied Sciences (Norway): Agneta Yngve, Susanna Kugelberg, Christel Lynch, Annhild Mosdol; University of Durham (UK): Carolyn Summerbell, Helen Moore, Wayne Douthwaite, Catherine Nixon; State Institute of Early Childhood Research (Germany): Susanne Kreichauf, Andreas Wildgruber; Children's Memorial Health Institute (Poland): Piotr Socha, Zbigniew Kulaga, Kamila Zych, Magdalena Gozdz, Beata Gurzkowska, Katarzyna Szott; Medical University of Varna (Bulgaria): Violeta Iotova, Mina Lateva, Natalya Usheva, Sonya Galcheva, Vanya Marinova, Zhaneta Radkova, Nevyana Feschieva; International Association for the Study of Obesity (UK): Tim Lobstein, Andrea Aikenhead; National Institute for Health Promotion and Disease Prevention (the Netherlands): Goof Buijs, Annemiek Dorgelo, Aviva Nethe, Jan Jansen; AOK- Verlag (Germany): Otto Gmeiner, Jutta Retterath, Julia Wildeis, Axel Gunthersberger; Roehampton University (UK): Leigh Gibson; University of Luxembourg (Luxembourg): Claus Voegele.	Ahrens W, 2014, INT J OBESITY, V38, pS99, DOI 10.1038/ijo.2014.140; Belgian Health Council, 2009, VOED BELG; Birch LL, 1998, PEDIATRICS, V101, P539; Brug J, 2012, PEDIATR OBES, V7, P399, DOI 10.1111/j.2047-6310.2012.00067.x; Brug J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034742; Cardona Cano S, 2015, INT J EAT DISORD; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Collings PJ, 2013, AM J CLIN NUTR, V97, P1020, DOI 10.3945/ajcn.112.045088; De Craemer M, 2012, OBES REV, V13, P13, DOI 10.1111/j.1467-789X.2011.00941.x; De Craemer M, 2015, J SCI MED SPORT, V18, P289, DOI 10.1016/j.jsams.2014.06.001; De Craemer M, 2015, J SPORT SCI, V33, P1051, DOI 10.1080/02640414.2014.981850; De Craemer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118303; De Miguel-Etayo P, 2014, OBES REV, V15, P67, DOI 10.1111/obr.12181; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dev DA, 2013, CHILD OBES, V9, P399, DOI 10.1089/chi.2012.0150; European Food Information Council, 2009, FOOD BAS DIET GUID E; Gonzalez-Gil EM, 2014, OBES REV, V15, P61, DOI 10.1111/obr.12184; Hancox RJ, 2006, INT J OBESITY, V30, P171, DOI 10.1038/sj.ijo.0803071; Hardy LL, 2012, PREV MED, V55, P433, DOI 10.1016/j.ypmed.2012.09.009; Huybrechts I, 2009, INT J ENV RES PUB HE, V6, P382, DOI 10.3390/ijerph6010382; Johnson L, 2008, AM J CLIN NUTR, V87, P846, DOI 10.1093/ajcn/87.4.846; Kovacs E, 2014, INT J OBESITY, V38, pS144, DOI 10.1038/ijo.2014.145; Landhuis CE, 2008, PEDIATRICS, V122, P955, DOI 10.1542/peds.2007-3521; Lissner L, 2012, EUR J EPIDEMIOL, V27, P705, DOI 10.1007/s10654-012-9718-2; Manios Y, 2012, OBES REV, V13, P3, DOI 10.1111/j.1467-789X.2011.00974.x; Matricciani L, 2013, SLEEP, V36, P527, DOI 10.5665/sleep.2538; Mouratidou T, 2014, OBES REV, V15, P53, DOI 10.1111/obr.12183; Nader PR, 2006, PEDIATRICS, V118, pE594, DOI 10.1542/peds.2005-2801; Nixon GM, 2008, SLEEP, V31, P71, DOI 10.1093/sleep/31.1.71; OECD, 2011, ENR CHILDC PRESCH; Rampersaud GC, 2009, AM J LIFESTYLE MED, V3, P86, DOI 10.1177/1559827608327219; Rowe DA, 2004, PEDIATR EXERC SCI, V16, P343, DOI 10.1123/pes.16.4.343; Saelens BE, 2002, J DEV BEHAV PEDIATR, V23, DOI 10.1097/00004703-200206000-00001; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Speirs KE, 2014, SLEEP MED, V15, P1590, DOI 10.1016/j.sleep.2014.08.006; Trost SG, 2003, INT J OBESITY, V27, P834, DOI 10.1038/sj.ijo.0802311; van Stralen MM, 2012, OBES REV, V13, P29, DOI 10.1111/j.1467-789X.2011.00959.x; Velde SJT, 2012, OBES REV, V13, P56, DOI 10.1111/j.1467-789X.2011.00960.x; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; Wijtzes AI, 2012, PREV MED, V55, P325, DOI 10.1016/j.ypmed.2012.07.023; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816	41	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150580	10.1371/journal.pone.0150580	http://dx.doi.org/10.1371/journal.pone.0150580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SL	26950063	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100043
J	Sherwood, JM; Reina-Torres, E; Bertrand, JA; Rowe, B; Overby, DR				Sherwood, Joseph M.; Reina-Torres, Ester; Bertrand, Jacques A.; Rowe, Barnaby; Overby, Darryl R.			Measurement of Outflow Facility Using iPerfusion	PLOS ONE			English	Article							AQUEOUS-HUMOR DYNAMICS; INTRAOCULAR-PRESSURE; GLAUCOMA PROGRESSION; TRABECULAR MESHWORK; VENOUS-PRESSURE; MOUSE; PERFUSION; MICE; ANESTHESIA; RESISTANCE	Elevated intraocular pressure (IOP) is the predominant risk factor for glaucoma, and reducing IOP is the only successful strategy to prevent further glaucomatous vision loss. IOP is determined by the balance between the rates of aqueous humour secretion and outflow, and a pathological reduction in the hydraulic conductance of outflow, known as outflow facility, is responsible for IOP elevation in glaucoma. Mouse models are often used to investigate the mechanisms controlling outflow facility, but the diminutive size of the mouse eye makes measurement of outflow technically challenging. In this study, we present a new approach to measure and analyse outflow facility using iPerfusion (TM), which incorporates an actuated pressure reservoir, thermal flow sensor, differential pressure measurement and an automated computerised interface. In enucleated eyes from C57BL/6J mice, the flow-pressure relationship is highly non-linear and is well represented by an empirical power law model that describes the pressure dependence of outflow facility. At zero pressure, the measured flow is indistinguishable from zero, confirming the absence of any significant pressure independent flow in enucleated eyes. Comparison with the commonly used 2-parameter linear outflow model reveals that inappropriate application of a linear fit to a non-linear flow-pressure relationship introduces considerable errors in the estimation of outflow facility and leads to the false impression of pressure-independent outflow. Data from a population of enucleated eyes from C57BL/6J mice show that outflow facility is best described by a lognormal distribution, with 6-fold variability between individuals, but with relatively tight correlation of facility between fellow eyes. iPerfusion represents a platform technology to accurately and robustly characterise the flow-pressure relationship in enucleated mouse eyes for the purpose of glaucoma research and with minor modifications, may be applied in vivo to mice, as well as to eyes from other species or different biofluidic systems.	[Sherwood, Joseph M.; Reina-Torres, Ester; Bertrand, Jacques A.; Overby, Darryl R.] Univ London Imperial Coll Sci Technol & Med, Fac Engn, Dept Bioengn, London, England; [Rowe, Barnaby] UCL, Fac Math & Phys Sci, Dept Phys & Astron, London, England	Imperial College London; University of London; University College London	Overby, DR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Engn, Dept Bioengn, London, England.	d.overby@imperial.ac.uk	Sherwood, Joseph M/P-9619-2018; Overby, Darryl/G-1520-2011	Sherwood, Joseph M/0000-0002-4402-9767; Overby, Darryl/0000-0001-9894-7515; Rowe, Barnaby/0000-0002-7042-9174; Reina-Torres, Ester/0000-0002-4572-2539	EPSRC, First Grant Scheme [EP/J010499/1]; National Institutes of Health, National Eye Institute [1 R01 EY022359-01]; Fight for Sight, PhD Studentship [1385]; National Glaucoma Research Grant, BrightFocus Foundation [G2013-0248]; Unrestricted Research Gift, Allergan Inc.; Engineering and Physical Sciences Research Council [EP/J010499/1] Funding Source: researchfish; Fight for Sight [1385/86] Funding Source: researchfish; EPSRC [EP/J010499/1] Funding Source: UKRI; NATIONAL EYE INSTITUTE [R01EY022359] Funding Source: NIH RePORTER	EPSRC, First Grant Scheme(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Fight for Sight, PhD Studentship; National Glaucoma Research Grant, BrightFocus Foundation(BrightFocus Foundation); Unrestricted Research Gift, Allergan Inc.; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Fight for Sight; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by EPSRC, First Grant Scheme, EP/J010499/1 (DRO JMS, https://www.epsrc.ac.uk/); National Institutes of Health, National Eye Institute, 1 R01 EY022359-01 (DRO JMS, https://nei.nih.gov/); Fight for Sight, PhD Studentship (Ref 1385) (DRO ERT, http://fightforsight.org.uk/); National Glaucoma Research Grant, BrightFocus Foundation (formerly AHAF), G2013-0248 (DRO, http://www.brightfocus.org/); and Unrestricted Research Gift, Allergan Inc. (DRO JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P5168, DOI 10.1167/iovs.03-0504; Alm A, 2009, EXP EYE RES, V88, P760, DOI 10.1016/j.exer.2008.12.012; [Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; Avila MY, 2001, INVEST OPHTH VIS SCI, V42, P1841; BARANY EH, 1964, INVEST OPHTH VISUAL, V3, P135; Boussommier-Calleja A, 2015, INVEST OPHTH VIS SCI, V56, P8331, DOI 10.1167/iovs.15-17106; Boussommier-Calleja A, 2013, INVEST OPHTH VIS SCI, V54, P8251, DOI 10.1167/iovs.13-13025; Boussommier-Calleja A, 2012, INVEST OPHTH VIS SCI, V53, P5838, DOI 10.1167/iovs.12-9923; BRUBAKER RF, 1975, INVEST OPHTH VISUAL, V14, P286; Brubaker RF, 2004, EXP EYE RES, V78, P633, DOI 10.1016/j.exer.2003.07.002; Burke J A, 1986, J Ocul Pharmacol, V2, P9, DOI 10.1089/jop.1986.2.9; Camras LJ, 2010, CURR EYE RES, V35, P819, DOI 10.3109/02713683.2010.494241; Chang JYH, 2014, J OCUL PHARMACOL TH, V30, P213, DOI 10.1089/jop.2013.0182; Cone FE, 2012, EXP EYE RES, V99, P27, DOI 10.1016/j.exer.2012.04.006; Crowston JG, 2004, INVEST OPHTH VIS SCI, V45, P2240, DOI 10.1167/iovs.03-0990; Dai Y, 2009, INVEST OPHTH VIS SCI, V50, P5749, DOI 10.1167/iovs.08-3367; ELLINGSEN BA, 1971, INVEST OPHTH VISUAL, V10, P430; ETHIER CR, 1993, CURR EYE RES, V12, P765, DOI 10.3109/02713689308995773; Gabelt BT, 2011, ADLERS PHYSL EYE, P237; GRANT WM, 1951, AMA ARCH OPHTHALMOL, V46, P113; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Johnson M., 2000, PRINC PRACT OPHTHALM, V1, P2577; JOHNSON MC, 1983, INVEST OPHTH VIS SCI, V24, P320; Kaufman PL, 2012, INVEST OPHTH VIS SCI, V53, P2495, DOI 10.1167/iovs.12-9483m; Kee C, 1997, CURR EYE RES, V16, P1198, DOI 10.1076/ceyr.16.12.1198.5023; Ko MK, 2014, MOL VIS, V20, P163; Kumar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072447; Lei YA, 2011, INVEST OPHTH VIS SCI, V52, P1865, DOI 10.1167/iovs.10-6019; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Limpert E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021403; Mermoud A, 1996, GRAEF ARCH CLIN EXP, V234, pS198, DOI 10.1007/BF02343072; Millar JC, 2011, INVEST OPHTH VIS SCI, V52, P685, DOI 10.1167/iovs.10-6069; Millard LH, 2011, INVEST OPHTH VIS SCI, V52, P3506, DOI 10.1167/iovs.10-6510; MOSES RA, 1977, SURV OPHTHALMOL, V22, P88, DOI 10.1016/0039-6257(77)90088-1; Overby DR, 2014, INVEST OPHTH VIS SCI, V55, P3727, DOI 10.1167/iovs.13-13699; PEDERSON JE, 1977, INVEST OPHTH VIS SCI, V16, P1008; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Reitsamer HA, 2002, INVEST OPHTH VIS SCI, V43, P3728; Shepard AR, 2010, INVEST OPHTH VIS SCI, V51, P2067, DOI 10.1167/iovs.09-4567; Smith R S, 2001, BMC Dev Biol, V1, P3, DOI 10.1186/1471-213X-1-3; SPERBER GO, 1984, EXP EYE RES, V39, P435, DOI 10.1016/0014-4835(84)90044-7; Stamer WD, 2012, CURR OPIN OPHTHALMOL, V23, P135, DOI 10.1097/ICU.0b013e32834ff23e; Stamer WD, 2011, INVEST OPHTH VIS SCI, V52, P9438, DOI 10.1167/iovs.11-7839; Swaminathan SS, 2014, J CATARACT REFR SURG, V40, P1263, DOI 10.1016/j.jcrs.2014.06.020; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Whitlock NA, 2010, INVEST OPHTH VIS SCI, V51, P6496, DOI 10.1167/iovs.10-5430; Wood G A, 1982, Exerc Sport Sci Rev, V10, P308; Woodward DF, 2009, INVEST OPHTH VIS SCI, V50, P3320, DOI 10.1167/iovs.08-3031; Yablonski ME, 2003, J GLAUCOMA, V12, P90, DOI 10.1097/00061198-200302000-00019; Yun HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107446; Zamora DO, 2009, INVEST OPHTH VIS SCI, V50, P2949, DOI 10.1167/iovs.08-3048; Zhang D, 2002, J GEN PHYSIOL, V119, P561, DOI 10.1085/jgp.20028597; Zhang YW, 2009, INVEST OPHTH VIS SCI, V50, P765, DOI 10.1167/iovs.08-2501	56	62	63	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150694	10.1371/journal.pone.0150694	http://dx.doi.org/10.1371/journal.pone.0150694			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26949939	Green Submitted, Green Published, gold			2022-12-27	WOS:000371990100051
J	Yao, M; Lu, X; Lei, YF; Yang, J; Zhao, HW; Qiao, QH; Han, PJ; Xu, ZK; Yin, W				Yao, Min; Lu, Xin; Lei, Yingfeng; Yang, Jing; Zhao, Haiwei; Qiao, Qinghua; Han, Peijun; Xu, Zhikai; Yin, Wen			Conditional Inducible Triple-Transgenic Mouse Model for Rapid Real-Time Detection of HCV NS3/4A Protease Activity	PLOS ONE			English	Article							HEPATITIS-C VIRUS; CRE-MEDIATED RECOMBINATION; CELL-BASED ASSAY; GENE-EXPRESSION; IN-VIVO; MAMMALIAN-CELLS; HUMANIZED MICE; INFECTION; REPORTER; INHIBITOR	Hepatitis C virus (HCV) frequently establishes persistent infections that can develop into severe liver disease. The HCV NS3/4A serine protease is not only essential for viral replication but also cleaves multiple cellular targets that block downstream interferon activation. Therefore, NS3/4A is an ideal target for the development of anti-HCV drugs and inhibitors. In the current study, we generated a novel NS3/4A/Lap/LC-1 triple-transgenic mouse model that can be used to evaluate and screen NS3/4A protease inhibitors. The NS3/4A protease could be conditionally inducibly expressed in the livers of the triple-transgenic mice using a dual Tet-On and Cre/loxP system. In this system, doxycycline (Dox) induction resulted in the secretion of Gaussia luciferase (Gluc) into the blood, and this secretion was dependent on NS3/4A protease-mediated cleavage at the 4B5A junction. Accordingly, NS3/4A protease activity could be quickly assessed in real time simply by monitoring Gluc activity in plasma. The results from such monitoring showed a 70-fold increase in Gluc activity levels in plasma samples collected from the triple-transgenic mice after Dox induction. Additionally, this enhanced plasma Gluc activity was well correlated with the induction of NS3/4A protease expression in the liver. Following oral administration of the commercial NS3/4A-specific inhibitors telaprevir and boceprevir, plasma Gluc activity was reduced by 50% and 65%, respectively. Overall, our novel transgenic mouse model offers a rapid real-time method to evaluate and screen potential NS3/4A protease inhibitors.	[Yao, Min; Lu, Xin; Lei, Yingfeng; Yang, Jing; Zhao, Haiwei; Qiao, Qinghua; Han, Peijun; Xu, Zhikai; Yin, Wen] Fourth Mil Med Univ, Dept Microbiol, Xian 710032, Peoples R China; [Yin, Wen] Fourth Mil Med Univ, Xijng Hosp, Dept Blood Transfus, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Xu, ZK; Yin, W (corresponding author), Fourth Mil Med Univ, Dept Microbiol, Xian 710032, Peoples R China.; Yin, W (corresponding author), Fourth Mil Med Univ, Xijng Hosp, Dept Blood Transfus, Xian 710032, Peoples R China.	zhikaixu@fmmu.edu.cn; yinwen@fmmu.edu.cn			National Natural Science Foundation of China [30872218, 81171637]; National High Technology Research and Development Program [2007AA02Z154]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (No. 30872218, 81171637); the National High Technology Research and Development Program (2007AA02Z154); http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Billerbeck E, 2013, CURR TOP MICROBIOL, V369, P49, DOI 10.1007/978-3-642-27340-7_3; Boonstra A, 2009, HEPATOLOGY, V50, P1646, DOI 10.1002/hep.23138; Chen JZ, 2014, CELL RES, V24, P1050, DOI 10.1038/cr.2014.116; Chung RT, 2014, NEW ENGL J MED, V370, P1576, DOI 10.1056/NEJMp1400986; Chung V, 2005, ANTIMICROB AGENTS CH, V49, P1381, DOI 10.1128/AAC.49.4.1381-1390.2005; Forestier N, 2007, HEPATOLOGY, V46, P640, DOI 10.1002/hep.21774; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Haenebalcke L, 2013, CELL REP, V3, P335, DOI 10.1016/j.celrep.2013.01.016; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kamiya N, 2010, J GEN VIROL, V91, P1668, DOI 10.1099/vir.0.019315-0; Kim HY, 2013, ANTIVIR RES, V99, P6, DOI 10.1016/j.antiviral.2013.04.020; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Lan HY, 2014, MOL BIOL REP, V41, P7349, DOI 10.1007/s11033-014-3621-8; Lee JC, 2004, J VIROL METHODS, V116, P27, DOI 10.1016/j.jviromet.2003.10.007; Lee JC, 2003, ANAL BIOCHEM, V316, P162, DOI 10.1016/S0003-2697(03)00053-8; Lei YF, 2008, ACTA VIROL, V52, P133; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Ohara E, 2011, J HEPATOL, V54, P872, DOI 10.1016/j.jhep.2010.08.033; Perni RB, 2006, ANTIMICROB AGENTS CH, V50, P899, DOI 10.1128/AAC.50.3.899-909.2006; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Slomski A, 2014, JAMA-J AM MED ASSOC, V311, P2262, DOI 10.1001/jama.2014.5277; Tannous BA, 2011, BIOTECHNOL ADV, V29, P997, DOI 10.1016/j.biotechadv.2011.08.021; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Venkatraman S, 2012, TRENDS PHARMACOL SCI, V33, P289, DOI 10.1016/j.tips.2012.03.012; von Schaewen M, 2014, J IMMUNOL METHODS, V410, P50, DOI 10.1016/j.jim.2014.03.006; Wang LC, 2010, ANTIVIR RES, V87, P50, DOI 10.1016/j.antiviral.2010.04.010; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Yu HMI, 2005, P NATL ACAD SCI USA, V102, P8615, DOI 10.1073/pnas.0500124102	34	1	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150894	10.1371/journal.pone.0150894	http://dx.doi.org/10.1371/journal.pone.0150894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943641	Green Published, gold			2022-12-27	WOS:000371739400058
J	Huang, CY; Wu, CL; Wu, JS; Chang, JW; Cheng, YY; Kuo, YC; Yang, YC; Lee, CC; Guo, HR				Huang, Chien-Yuan; Wu, Cheng-Long; Wu, Jin-Shang; Chang, Jung-Wei; Cheng, Ya-Yun; Kuo, Yau-Chang; Yang, Yi-Ching; Lee, Ching-Chang; Guo, How-Ran			Association between Blood Dioxin Level and Chronic Kidney Disease in an Endemic Area of Exposure	PLOS ONE			English	Article							DIBENZO-P-DIOXINS; RENAL-FUNCTION; DIABETES-MELLITUS; UNITED-STATES; URIC-ACID; SERUM; HYPERTENSION; TAIWANESE; 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN; ENDOMETRIOSIS	Background Dioxin is an industrial pollutant related to various diseases, but epidemiological data on its effects on the kidney are limited. Therefore, we conducted a study to evaluate the association between dioxin exposure and chronic kidney disease (CKD) and identify the related factors. Methods We conducted a community-based cross-sectional study and recruited participants from an area where the residents were exposed to dioxin released from a factory. We defined a "high dioxin level" as polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) >= 20 pg WHO98-TEQ(DF)/g lipid in the serum and defined CKD as having an estimated glomerular filtration rate (e-GFR) <= 60 mL/min/1.73m(2) or a diagnosis of CKD by a physician. The renal function was assessed between 2005 and 2010, and we excluded those who had had kidney diseases before the study started. Comparisons between patients of CKD and those who did not have CKD were made to identify the risk factors for CKD. Results Of the 2898 participants, 1427 had high dioxin levels, and 156 had CKD. In the univariate analyses, CKD was associated with high dioxin levels, age, gender, metabolic syndrome, diabetes mellitus, hypertension, and high insulin and uric acid levels. After adjusting for other factors, we found high dioxin levels (adjusted odds ratio [AOR] = 1.76, 95% confidence interval [CI]: 1.04-2.99), female gender (AOR = 1.74, 95% CI: 1.20-2.53), hypertension (AOR = 1.68, 95% CI: 1.17-2.42), high insulin levels (AOR = 2.14, 95% CI: 1.26-3.61), high uric acid levels (AOR = 4.25, 95% CI: 2.92-6.20), and older age (AOR = 4.66, 95% CI: 1.87-11.62 for 40-64 year and AOR = 26.66, 95% CI: 10.51-67.62 for age >= 65 year) were independent predictors of CKD. Conclusion A high dioxin level was associated with an increased prevalence of CKD. Therefore, the kidney function of populations with exposure to dioxin should be monitored.	[Huang, Chien-Yuan; Wu, Cheng-Long; Cheng, Ya-Yun; Lee, Ching-Chang; Guo, How-Ran] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Huang, Chien-Yuan] Tainan Sci Pk Clin, Chi Mei Med Ctr, Tainan, Taiwan; [Huang, Chien-Yuan] Chang Jung Christian Univ, Dept Occupat Safety & Hlth, Tainan, Taiwan; [Wu, Cheng-Long; Kuo, Yau-Chang; Guo, How-Ran] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan; [Wu, Cheng-Long; Kuo, Yau-Chang; Guo, How-Ran] Natl Cheng Kung Univ, Coll Med, Dept Occupat & Environm Med, Tainan 70101, Taiwan; [Wu, Jin-Shang; Chang, Jung-Wei; Yang, Yi-Ching] Natl Cheng Kung Univ, Coll Med, Dept Family Med, Tainan 70101, Taiwan; [Lee, Ching-Chang; Guo, How-Ran] Natl Cheng Kung Univ, Res Ctr Environm Trace Tox Subst, Tainan 701, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ, Occupat Safety Hlth & Med Res Ctr, Tainan 701, Taiwan	National Cheng Kung University; Chi Mei Hospital; Chang Jung Christian University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Lee, CC; Guo, HR (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.; Guo, HR (corresponding author), Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan.; Guo, HR (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Occupat & Environm Med, Tainan 70101, Taiwan.; Lee, CC; Guo, HR (corresponding author), Natl Cheng Kung Univ, Res Ctr Environm Trace Tox Subst, Tainan 701, Taiwan.; Guo, HR (corresponding author), Natl Cheng Kung Univ, Occupat Safety Hlth & Med Res Ctr, Tainan 701, Taiwan.	cclee@mail.ncku.edu.tw; hrguo@mail.ncku.edu.tw	Guo, How-Ran/AAK-9063-2020; CHENG, YA-YUN/AAK-5272-2020	Guo, How-Ran/0000-0003-3343-3446; CHENG, YA-YUN/0000-0003-2571-4707	Tainan City Government	Tainan City Government	This work was funded by Tainan City Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 1998, TOX PROF CHLOR DIB P; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; ANAIZI NH, 1978, J PHARMACOL EXP THER, V207, P748; [Anonymous], 1997, IARC Monogr Eval Carcinog Risks Hum, V69, P33; Baccarelli A, 2008, PLOS MED, V5, P1133, DOI 10.1371/journal.pmed.0050161; Buckalew VM, 1996, AM J KIDNEY DIS, V28, P811, DOI 10.1016/S0272-6386(96)90380-7; Bureau for Health Promotion, MAN MET SYNDR; Calvert GM, 1999, OCCUP ENVIRON MED, V56, P270, DOI 10.1136/oem.56.4.270; Chang JW, 2010, CHEMOSPHERE, V81, P1027, DOI 10.1016/j.chemosphere.2010.08.050; Chang JW, 2013, EPIDEMIOLOGY, V24, P582, DOI 10.1097/EDE.0b013e318294ef68; Chang JW, 2010, EPIDEMIOLOGY, V21, P56, DOI 10.1097/EDE.0b013e3181c2fc6e; Chen HL, 2004, CHEMOSPHERE, V54, P1421, DOI 10.1016/j.chemosphere.2003.10.033; Chen HL, 2005, SCI TOTAL ENVIRON, V337, P31, DOI 10.1016/j.scitotenv.2004.06.021; Chen ZH, 2004, CARCINOGENESIS, V25, P2005, DOI 10.1093/carcin/bgh183; Cummings AM, 1996, TOXICOL APPL PHARM, V138, P131, DOI 10.1006/taap.1996.0106; DEVITO MJ, 1995, ENVIRON HEALTH PERSP, V103, P820, DOI 10.2307/3432395; Dong B, 2010, BIOCHEM PHARMACOL, V79, P487, DOI 10.1016/j.bcp.2009.08.031; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fathallah-Shaykh SA, 2014, PEDIATR NEPHROL, V29, P999, DOI 10.1007/s00467-013-2549-x; Fierens S, 2003, BIOMARKERS, V8, P529, DOI 10.1080/1354750032000158420; Fujii-Kuriyama Y, 2005, BIOCHEM BIOPH RES CO, V338, P311, DOI 10.1016/j.bbrc.2005.08.162; Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342; Henriksen GL, 1997, EPIDEMIOLOGY, V8, P252, DOI 10.1097/00001648-199705000-00005; Ilhan S, 2015, TOXICOL IND HLTH; Imamura Tomoaki, 2009, BMC Res Notes, V2, P27, DOI 10.1186/1756-0500-2-27; Kang DH, 2011, SEMIN NEPHROL, V31, P447, DOI 10.1016/j.semnephrol.2011.08.009; Kerkvliet NI, 2002, INT IMMUNOPHARMACOL, V2, P277, DOI 10.1016/S1567-5769(01)00179-5; Kitamura K, 2000, J Epidemiol, V10, P262; Kopf PG, 2008, CARDIOVASC TOXICOL, V8, P181, DOI 10.1007/s12012-008-9027-x; Lee C-C, 2006, INVESTIGATION BACKGR; Lee CC, 2006, ENVIRON POLLUT, V141, P381, DOI 10.1016/j.envpol.2005.08.032; Lee CC, 2006, CHEMOSPHERE, V65, P436, DOI 10.1016/j.chemosphere.2006.01.063; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Lu CF, 2009, ARCH ENVIRON CON TOX, V57, P767, DOI 10.1007/s00244-009-9323-x; Ma J, 2008, ENVIRON SCI TECHNOL, V42, P8252, DOI 10.1021/es8017573; Manabe I, 2011, CIRC J, V75, P2739, DOI 10.1253/circj.CJ-11-1184; McDonald SP, 2003, NEPHROL DIAL TRANSPL, V18, P1555, DOI 10.1093/ndt/gfg199; Michalek JE, 2008, J OCCUP ENVIRON MED, V50, P330, DOI 10.1097/JOM.0b013e31815f889b; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Ni HG, 2010, ENVIRON TOXICOL CHEM, V29, P1237, DOI 10.1002/etc.160; Paustenbach DJ, 2013, CHEMOSPHERE, V91, P200, DOI 10.1016/j.chemosphere.2012.12.047; PEGG DG, 1976, J TOXICOL ENV HEALTH, V2, P55, DOI 10.1080/15287397609529417; PETERSON RE, 1993, CRIT REV TOXICOL, V23, P283, DOI 10.3109/10408449309105013; Putri AY, 2014, ACTA MED INDONES, V46, P244; RIER SE, 1993, FUND APPL TOXICOL, V21, P433, DOI 10.1006/faat.1993.1119; Schnaper HW, 2006, J AM SOC NEPHROL, V17, P1777, DOI 10.1681/ASN.2006030267; Shah SV, 2007, J AM SOC NEPHROL, V18, P16, DOI 10.1681/ASN.2006050500; Staessen JA, 2001, LANCET, V357, P1660, DOI 10.1016/S0140-6736(00)04822-4; Wang SL, 2008, DIABETES CARE, V31, P1574, DOI 10.2337/dc07-2449; Warnock DG, 2005, KIDNEY INT, V68, P1427, DOI 10.1111/j.1523-1755.2005.00553.x; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Whaley-Connell AT, 2008, AM J KIDNEY DIS, V51, pS13, DOI 10.1053/j.ajkd.2007.12.016; Wu WZ, 2001, ENVIRON INT, V26, P323, DOI 10.1016/S0160-4120(01)00007-1	53	4	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150248	10.1371/journal.pone.0150248	http://dx.doi.org/10.1371/journal.pone.0150248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963719	gold, Green Submitted, Green Published			2022-12-27	WOS:000371993000026
J	Sarkar, H; Arya, S; Rai, U; Majumdar, SS				Sarkar, Hironmoy; Arya, Satyapal; Rai, Umesh; Majumdar, Subeer S.			A Study of Differential Expression of Testicular Genes in Various Reproductive Phases of Hemidactylus flaviviridis (Wall Lizard) to Derive Their Association with Onset of Spermatogenesis and Its Relevance to Mammals	PLOS ONE			English	Article							TYPE-1 HEXOKINASE; LEYDIG-CELL; FSH; AZOOSPERMIA; HOMOLOG; HHARI	Testis of Hemidactylus flaviviridis, commonly known as Indian wall lizard, displays a lack of cellular and metabolic activity in regressed phase of testis during non-breeding season of the year. Retracted Sertoli cells (Sc), fibroid myoid cells and pre-meiotic resting spermatogonia are observed in such testis. This situation is akin to certain forms of infertility in men where hormone supplementation fails to generate sperm despite the presence of Sc and germ cells (Gc) in testis. In testis of lizard, spermatogenesis is reinitiated upon increased level of hormones during appropriate season (phase of recrudescence). Study of genes associated with generation of sperm, from regressed adult testis in lizard, may provide valuable information for understanding certain forms of male idiopathic infertility. Subtractive hybridization using testicular RNA obtained from the regressed and active phases of lizard reproductive cycle led to identify eight partial mRNA sequences that showed sequence homology with mice genes. We further evaluated the gene expression prolife by real-time PCR in three different reproductive phases of H. flaviviridis: regressed (pre-meiotic), recrudescent (meiotic) and active (post meiotic), for comparison with the corresponding testicular phases found in testis of 5 days (pre-meiotic), 20 days (meiotic) and 60 days (post-meiotic) old mouse. This is the first report where genes associated with progression of spermatogenesis during active phase, which follows a regressed state of adult testis, were identified in lizard and found to be conserved in mouse. Six important genes, Hk1, Nme5, Akap4, Arih1, Rassf7 and Tubb4b were found to be strictly associated with active spermatogenesis in both mouse and lizard. Factors interfering with the expression of any of these genes may potentially abrogate the process of spermatogenesis leading to infertility. Such information may shed light on unknown causes of idiopathic male infertility.	[Sarkar, Hironmoy; Rai, Umesh] Univ Delhi, Dept Zool, Delhi 110007, India; [Arya, Satyapal; Majumdar, Subeer S.] Natl Inst Immunol, Cellular Endocrinol Lab, New Delhi 110067, India	University of Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Rai, U (corresponding author), Univ Delhi, Dept Zool, Delhi 110007, India.; Majumdar, SS (corresponding author), Natl Inst Immunol, Cellular Endocrinol Lab, New Delhi 110067, India.	rai_u@rediffmail.com; subeer@nii.ac.in	Sarkar, Hironmoy/I-5075-2015	Sarkar, Hironmoy/0000-0001-9713-0300; Majumdar, Subeer/0000-0003-1724-7483	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [BT/PR14644/AAQ/01/448/2010]	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	SSM and UR received the funding from Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India, under the grant No-BT/PR14644/AAQ/01/448/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; Ardley HC, 2001, J BIOL CHEM, V276, P19640, DOI 10.1074/jbc.M011028200; Bhattacharya I, 2015, ENDOCRINOLOGY, V156, P1143, DOI 10.1210/en.2014-1746; Bhattacharya I, 2012, AM J PHYSIOL-ENDOC M, V303, pE886, DOI 10.1152/ajpendo.00293.2012; Brown PR, 2003, BIOL REPROD, V68, P2241, DOI 10.1095/biolreprod.102.013466; CLERMONT Y, 1958, EXP CELL RES, V15, P438, DOI 10.1016/0014-4827(58)90052-1; De Rooij DG, 2000, J ANDROL, V21, P776; Elmehdawi F, 2013, EXP CELL RES, V319, P161, DOI 10.1016/j.yexcr.2012.10.002; FAWCETT DW, 1973, BIOL REPROD, V9, P500, DOI 10.1093/biolreprod/9.5.500; Gatta V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-401; Gautam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058276; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Hu YQ, 2009, REPRODUCTION, V137, P645, DOI 10.1530/REP-08-0337; Hwang KC, 2003, BIOCHEM BIOPH RES CO, V306, P198, DOI 10.1016/S0006-291X(03)00916-1; Hyakutake K, 2015, DEV GROWTH DIFFER, V57, P389, DOI 10.1111/dgd.12219; Kerr JB, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P827; Khan U. W., 2004, Indian Journal of Experimental Biology, V42, P378; Khan UW, 2008, GEN COMP ENDOCR, V156, P44, DOI 10.1016/j.ygcen.2007.10.006; Khan UW, 2007, J ENDOCRINOL, V194, P441, DOI 10.1677/JOE-06-0225; Kumar S, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 3: REPTILES, P63; Lachance C, 2011, BIOL REPROD, V85, P1222, DOI 10.1095/biolreprod.111.092379; Lock FE, 2010, ONCOGENE, V29, P4307, DOI 10.1038/onc.2010.192; Majumdar SS, 2012, HUM REPROD, V27, P2515, DOI 10.1093/humrep/des184; Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728; Munier A, 2003, EXP CELL RES, V289, P295, DOI 10.1016/S0014-4827(03)00268-4; Munier A, 1998, FEBS LETT, V434, P289, DOI 10.1016/S0014-5793(98)00996-X; Nakamura N, 2008, BIOL REPROD, V79, P537, DOI 10.1095/biolreprod.108.067561; Nakamura N, 2008, MOL REPROD DEV, V75, P632, DOI 10.1002/mrd.20791; NEBEL BR, 1961, SCIENCE, V134, P832, DOI 10.1126/science.134.3482.832; Parelkar SS, 2012, J MOL NEUROSCI, V46, P109, DOI 10.1007/s12031-011-9535-1; Recino A, 2010, BIOCHEM J, V430, P207, DOI 10.1042/BJ20100883; Russel L. D., 1990, HISTOLOGICAL HISTOPA; SANYAL MK, 1967, COPEIA, P627; Schindler A, 2013, CELL SIGNAL, V25, P2685, DOI 10.1016/j.cellsig.2013.08.035; Stukenborg JB, 2014, HORM RES PAEDIAT, V81, P2, DOI 10.1159/000355599; Takahashi S, 2011, CELL DEATH DIFFER, V18, P645, DOI 10.1038/cdd.2010.137; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	37	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151150	10.1371/journal.pone.0151150	http://dx.doi.org/10.1371/journal.pone.0151150			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963275	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000110
J	Fang, C; Lu, WH; Li, CY; Peng, X; Wang, Y; Huang, XL; Yao, ZH; Cai, NL; Huang, YG; Zhang, XL; Tan, JX				Fang, Chao; Lu, Weihong; Li, Chengyan; Peng, Xi; Wang, Yang; Huang, Xiulan; Yao, Zhihong; Cai, Nali; Huang, Yuge; Zhang, Xingliang; Tan, Jianxin			MiR-3162-3p Is a Novel MicroRNA That Exacerbates Asthma by Regulating beta-Catenin	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PRODUCTION; AIRWAY INFLAMMATION; SIGNALING PATHWAY; MESENCHYMAL TRANSITION; MURINE MODEL; EXPRESSION; ANTAGONISM; DISEASE; TARGET; SUPPRESSES	Asthma is a common chronic respiratory disease. In a previous study, we found several circulating microRNA signatures associated with childhood asthma and selected miR-3162-3p for subsequent studies. Since the target proteins and underlying molecular mechanisms of miR-3162-3p in asthma etiopathogenesis are not well characterized, we designed this study to clarify its role. We employed bioinformatics and quantitative PCR methods as a first step to determine the target of miR-3162-3p, and we elucidated beta-catenin. Luciferase assays and western blot analysis confirmed beta-catenin as a direct target of miR-3162-3p as the 3'-untranslated region of beta-catenin mRNA possesses a specific miR-3162-3p pairing site. The correlation between the expression levels of miR-3162-3p and beta-catenin is confirmed by quantitative PCR and western blot studies in A549, Beas-2B and H1299 cell lines and OVA-induced asthma mouse model. Of note, upregulation of the endogenous miR-3162-3p level is concomitant with the reduction of beta-catenin mRNA and protein expression levels. MiR-3162-3p antagomir treatment antagonizes the endogenous miR-3162-3p and effectively rescues the attenuation of endogenous beta-catenin in OVA-induced asthmatic mice, which alleviates airway hyperresponsiveness and ameliorates airway inflammation. Collectively, our findings suggest a novel relationship between miR-3162-3p and beta-catenin and clarify their mechanistic role in asthma etiopathogenesis.	[Fang, Chao; Lu, Weihong; Li, Chengyan; Peng, Xi; Huang, Xiulan; Yao, Zhihong; Cai, Nali; Huang, Yuge; Zhang, Xingliang; Tan, Jianxin] Guangdong Med Coll, Affiliated Hosp, Dept Pediat, Zhanjiang 524001, Peoples R China; [Wang, Yang] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA	Guangdong Medical University; National Jewish Health	Zhang, XL (corresponding author), Guangdong Med Coll, Affiliated Hosp, Dept Pediat, Zhanjiang 524001, Peoples R China.	xingliang_zhang@163.com	Li, Chengyan/AAS-4540-2021		National Natural Science Foundation of China [31300602]; Guangdong Natural Science Foundation [S2013040012902]; Guangdong Province Science and Technology Plan Projects [2013B021800077]; Scientific Research Start-up grant from Guangdong Medical College [XB1341]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Province Science and Technology Plan Projects; Scientific Research Start-up grant from Guangdong Medical College	This work was supported by the National Natural Science Foundation of China (31300602; http://isisn.nsfc.gov.cn/egrantweb/), the Guangdong Natural Science Foundation (S2013040012902; http://pro.gdstc.gov.cn/egrantweb/), the Guangdong Province Science and Technology Plan Projects (2013B021800077; http://pro.gdstc.gov.cn/egrantweb/), and the Scientific Research Start-up grant from Guangdong Medical College (XB1341; http://www.gdmc.edu.cn/).	Agache I, 2012, ALLERGY, V67, P835, DOI 10.1111/j.1398-9995.2012.02832.x; Akbas F, 2012, EXP LUNG RES, V38, P286, DOI 10.3109/01902148.2012.689088; Ariel D, 2012, CURR OPIN ALLERGY CL, V12, P49, DOI 10.1097/ACI.0b013e32834ecb7f; Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002; Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V301, pL956, DOI 10.1152/ajplung.00123.2011; Bae S, 2012, CLIN BIOCHEM, V45, P1187, DOI 10.1016/j.clinbiochem.2012.05.002; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Cha YH, 2012, CELL CYCLE, V11, P1273, DOI 10.4161/cc.19618; Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079; Collison A, 2011, J ALLERGY CLIN IMMUN, V128, P160, DOI 10.1016/j.jaci.2011.04.005; Collison A, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-29; Feng MJ, 2012, INT IMMUNOPHARMACOL, V13, P347, DOI 10.1016/j.intimp.2012.05.001; Ghahhari NM, 2015, EUR J CANCER, V51, P1638, DOI 10.1016/j.ejca.2015.04.021; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hirata H, 2012, CARCINOGENESIS, V33, P41, DOI 10.1093/carcin/bgr239; Jardim MJ, 2012, AM J RESP CELL MOL, V47, P536, DOI 10.1165/rcmb.2011-0160OC; Kim NH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001744; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Kumawat K, 2014, EXPERT OPIN THER TAR, V18, P1023, DOI 10.1517/14728222.2014.934813; Kumawat K, 2013, FASEB J, V27, P1631, DOI 10.1096/fj.12-217539; Lee H, 2012, IMMUNOPHARM IMMUNOT, V34, P56, DOI 10.3109/08923973.2011.574704; Levanen B, 2013, J ALLERGY CLIN IMMUN, V131, P894, DOI 10.1016/j.jaci.2012.11.039; Liou CJ, 2014, ALLERGY ASTHMA IMMUN, V6, P548, DOI 10.4168/aair.2014.6.6.548; Liu HP, 2012, CELL MOL LIFE SCI, V69, P3587, DOI 10.1007/s00018-012-1128-9; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079409; Lomask M, 2006, EXP TOXICOL PATHOL, V57, P13, DOI 10.1016/j.etp.2006.02.014; Lu TX, 2013, J ALLERGY CLIN IMMUN, V132, P3, DOI 10.1016/j.jaci.2013.04.039; Lu TX, 2012, J ALLERGY CLIN IMMUN, V129, P1064, DOI 10.1016/j.jaci.2012.01.060; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Mitzner W, 2003, J APPL PHYSIOL, V94, P828, DOI 10.1152/japplphysiol.00815.2002; Oglesby IK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-148; Okamoto N, 2006, INT ARCH ALLERGY IMM, V141, P172, DOI 10.1159/000094896; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Pua HH, 2015, CURR OPIN IMMUNOL, V36, P101, DOI 10.1016/j.coi.2015.07.006; Qin HB, 2012, INFLAMMATION, V35, P1595, DOI 10.1007/s10753-012-9474-1; Rebane A, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0424-x; Rebane A, 2013, J ALLERGY CLIN IMMUN, V132, P15, DOI 10.1016/j.jaci.2013.04.011; Reuter S, 2014, J IMMUNOL, V193, P485, DOI 10.4049/jimmunol.1400013; Rogacki K, 2015, POL J PATHOL, V66, P9, DOI 10.5114/PJP.2015.51148; Sharma A, 2012, J APPL PHYSIOL, V113, P459, DOI 10.1152/japplphysiol.00001.2012; Shen JJ, 2011, J ETHNOPHARMACOL, V135, P646, DOI 10.1016/j.jep.2011.03.065; Song JL, 2015, CELL SIGNAL, V27, P1380, DOI 10.1016/j.cellsig.2015.03.018; Su J, 2012, INT J ONCOL, V40, P1162, DOI 10.3892/ijo.2011.1322; Tomankova T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-159; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wang WC, 2012, J CELL BIOCHEM, V113, P3567, DOI 10.1002/jcb.24235; Wang YH, 2015, CLIN LAB, V61, P467, DOI 10.7754/Clin.Lab.2014.141020; Wang Y, 2013, MOL MED REP, V7, P1506, DOI 10.3892/mmr.2013.1384; Warner SM, 2008, CURR OPIN ALLERGY CL, V8, P44, DOI 10.1097/ACI.0b013e3282f3b5cb; Williams AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005889; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yao LH, 2015, TOXICOL SCI, V147, P168, DOI 10.1093/toxsci/kfv120; Zhang JX, 2014, ANN ONCOL, V25, P2196, DOI 10.1093/annonc/mdu439; Zhang XL, 2015, J ASTHMA, V52, P785, DOI 10.3109/02770903.2015.1036437	59	21	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149257	10.1371/journal.pone.0149257	http://dx.doi.org/10.1371/journal.pone.0149257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959414	Green Published, gold			2022-12-27	WOS:000371992300008
J	Freire, SM; Teodoro, D; Wei-Kleiner, F; Sundvall, E; Karlsson, D; Lambrix, P				Freire, Sergio Miranda; Teodoro, Douglas; Wei-Kleiner, Fang; Sundvall, Erik; Karlsson, Daniel; Lambrix, Patrick			Comparing the Performance of NoSQL Approaches for Managing Archetype-Based Electronic Health Record Data	PLOS ONE			English	Article								This study provides an experimental performance evaluation on population-based queries of NoSQL databases storing archetype-based Electronic Health Record (EHR) data. There are few published studies regarding the performance of persistence mechanisms for systems that use multilevel modelling approaches, especially when the focus is on population-based queries. A healthcare dataset with 4.2 million records stored in a relational database (MySQL) was used to generate XML and JSON documents based on the openEHR reference model. Six datasets with different sizes were created from these documents and imported into three single machine XML databases (BaseX, eXistdb and Berkeley DB XML) and into a distributed NoSQL database system based on the MapReduce approach, Couchbase, deployed in different cluster configurations of 1, 2, 4, 8 and 12 machines. Population-based queries were submitted to those databases and to the original relational database. Database size and query response times are presented. The XML databases were considerably slower and required much more space than Couchbase. Overall, Couchbase had better response times than MySQL, especially for larger datasets. However, Couchbase requires indexing for each differently formulated query and the indexing time increases with the size of the datasets. The performances of the clusters with 2, 4, 8 and 12 nodes were not better than the single node cluster in relation to the query response time, but the indexing time was reduced proportionally to the number of nodes. The tested XML databases had acceptable performance for openEHR-based data in some querying use cases and small datasets, but were generally much slower than Couchbase. Couchbase also outperformed the response times of the relational database, but required more disk space and had a much longer indexing time. Systems like Couchbase are thus interesting research targets for scalable storage and querying of archetype-based EHR data when population-based use cases are of interest.	[Freire, Sergio Miranda; Teodoro, Douglas] Univ Estado Rio de Janeiro, Dept Tecnol Informacao & Educ Saude, BR-20550011 Rio De Janeiro, RJ, Brazil; [Freire, Sergio Miranda; Sundvall, Erik; Karlsson, Daniel] Linkoping Univ, Dept Biomed Engn, Linkoping, Sweden; [Wei-Kleiner, Fang; Lambrix, Patrick] Linkoping Univ, Dept Comp & Informat Sci, S-58183 Linkoping, Sweden; [Sundvall, Erik] Reg Ostergotland, Linkoping, Sweden; [Lambrix, Patrick] Swedish E Sci Res Ctr, Linkoping, Sweden	Universidade do Estado do Rio de Janeiro; Linkoping University; Linkoping University	Freire, SM (corresponding author), Univ Estado Rio de Janeiro, Dept Tecnol Informacao & Educ Saude, BR-20550011 Rio De Janeiro, RJ, Brazil.; Freire, SM (corresponding author), Linkoping Univ, Dept Biomed Engn, Linkoping, Sweden.	sergio@lampada.uerj.br	Teodoro, Douglas H/H-5122-2012; MirandaFreire, Sergio/D-6068-2015; Teodoro, Douglas/AAN-8343-2020	Teodoro, Douglas H/0000-0001-6238-4503; MirandaFreire, Sergio/0000-0002-4376-3564; Teodoro, Douglas/0000-0001-6238-4503; Lambrix, Patrick/0000-0002-9084-0470	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES Foundation - Brazil) [4055/11]; Conselho Brasileiro de Desenvolvimento Cientifico e Tecnologico (CNPq) [150916/2013-2]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES Foundation - Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Brasileiro de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Support was provided by SMF - scholarship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES Foundation - Brazil - grant 4055/11 - www.capes.gov.br); and a DT - scholarship from the Conselho Brasileiro de Desenvolvimento Cientifico e Tecnologico (CNPq - grant 150916/2013-2, www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, DATA WAREHOUSE LIFEC; Atalag K, 2014, INT J MED INFORM, V83, P849, DOI 10.1016/j.ijmedinf.2014.07.006; BaseX, THE XML DAT; Bastos EA, 2011, THESIS U FEDERAL RIO; Beale T., NODE PATH PERSISTENC; Brewer E, 2012, COMPUTER, V45, P23, DOI 10.1109/MC.2012.37; eXistdb, OP SOURC NAT XML DAT; Frade S, 2013, COMP MED SY, P303, DOI 10.1109/CBMS.2013.6627806; Freire Sergio Miranda, 2015, Res. Biomed. Eng., V31, P196, DOI 10.1590/2446-4740.0666; Freire SM, 2012, COMPUT METH PROG BIO, V108, P90, DOI 10.1016/j.cmpb.2012.01.007; Green J.W., 2008, COMP RELATIVE PERFOR; Haerder T, 1983, ACM COMPUT SURV, V15, P287, DOI DOI 10.1145/289.291; Immon W. H., 2005, BUILDING DATA WAREHO; International Organization for Standardization, 2008, IS 13606 HLTH INF 1; Jaitla J, 2013, COUCHBASE 103 Q A; Johnson SB, 1996, J AM MED INFORM ASSN, V3, P328, DOI 10.1136/jamia.1996.97035024; Kimura E, 2015, STUD HEALTH TECHNOL, V210, P687, DOI 10.3233/978-1-61499-512-8-687; Lee KKY, 2013, COMPUT METH PROG BIO, V110, P99, DOI 10.1016/j.cmpb.2012.10.018; Marco-Ruiz L, 2015, INT J MED INFORM, V84, P702, DOI 10.1016/j.ijmedinf.2015.05.016; Miranda S., 2012, SCAND C HLTH INF SWE, P51; Munoz A, 2007, J AM MED INFORM ASSN, V14, P118, DOI 10.1197/jamia.M2058; Nadkarni PM, 1999, J AM MED INFORM ASSN, V6, P478, DOI 10.1136/jamia.1999.0060478; Ocean Informatics, OC TEMPL DES; Ocean Informatics, CLIN KNOWL MAN CKM; Ocean Informatics, OC ARCH ED; Oracle Corporation, MYSQL DAT; Oracle Corporation, BERK DB XML; Parker Z, 2013, P 51 ACM SE C SAV GA; Sundvall E, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-57; Wang L, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0212-0	31	24	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150069	10.1371/journal.pone.0150069	http://dx.doi.org/10.1371/journal.pone.0150069			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26958859	gold, Green Published, Green Submitted			2022-12-27	WOS:000371992300032
J	Kander, T; Larsson, A; Taune, V; Schott, U; Tynngard, N				Kander, Thomas; Larsson, Anna; Taune, Victor; Schott, Ulf; Tynngard, Nahreen			Assessment of Haemostasis in Disseminated Intravascular Coagulation by Use of Point-of-Care Assays and Routine Coagulation Tests, in Critically Ill Patients; A Prospective Observational Study	PLOS ONE			English	Article							SEVERE SEPSIS; ORGAN FAILURE; SEPTIC SHOCK; TRAUMA; TRANSFUSION; THROMBOELASTOGRAPHY; MORTALITY; ADMISSION; PHASE; SCORE	Background Disseminated intravascular coagulopathy (DIC) relates to the consumption of coagulation factors and platelets with bleeding and micro thrombosis events. Aim The aim of this study was to compare haemostasis parameters in critically ill patients with DIC versus patients without DIC, and in survivors versus non-survivors over time. Correlations between the DIC-score, the degree of organ failure and the haemostasis were assessed. Method Patients admitted to the intensive care unit with a condition known to be associated with DIC and with an expected length of stay of >3 days were included. Routine laboratory tests, prothrombin time, activated partial thromboplastin time, platelet count, fibrinogen concentration and D-dimer were measured. Coagulation and platelet function were assessed with two point-of-care devices; Multiplate and ROTEM. DIC scores were calculated according to the International Society on Thrombosis and Haemostasis and Japanese Association for Acute Medicine. Results Blood was sampled on days 0-1, 2-3 and 4-10 from 136 patients with mixed diagnoses during 290 sampling events. The point-of-care assays indicated a hypocoagulative response (decreased platelet aggregation and reduced clot strength) in patients with DIC and, over time, in non-survivors compared to survivors. Patients with DIC as well as non-survivors had decreased fibrinolysis as shown by ROTEM. DIC scores were higher in non-survivors than in survivors. Conclusions Patients with DIC displayed signs of a hypocoagulative response and impaired fibrinolysis, which was also evident over time in non-survivors. Patients with DIC had a higher mortality rate than non-DIC patients, and DIC scores were higher in non-survivors than in survivors.	[Kander, Thomas; Larsson, Anna; Taune, Victor; Schott, Ulf] Lund Univ, Fac Med, Lund, Sweden; [Kander, Thomas; Schott, Ulf] Skane Univ Hosp Lund, Dept Intens & Perioperat Care, S-22185 Lund, Sweden; [Tynngard, Nahreen] Linkoping Univ, Dept Clin Immunol & Transfus Med, Linkoping, Sweden; [Tynngard, Nahreen] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Tynngard, Nahreen] Linkoping Univ, Dept Clin Chem, Linkoping, Sweden	Lund University; Lund University; Skane University Hospital; Linkoping University; Linkoping University; Linkoping University	Kander, T (corresponding author), Lund Univ, Fac Med, Lund, Sweden.; Kander, T (corresponding author), Skane Univ Hosp Lund, Dept Intens & Perioperat Care, S-22185 Lund, Sweden.	thomas.kander@med.lu.se	Kander, Thomas/H-8206-2019; Schott, Ulf/AAY-6982-2020	Kander, Thomas/0000-0002-5404-2981; Tynngard, Nahreen/0000-0001-8591-6074				Adamzik M, 2011, SHOCK, V35, P339, DOI 10.1097/SHK.0b013e318204bff6; Afshari A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007871.pub2; Akca S, 2002, CRIT CARE MED, V30, P753, DOI 10.1097/00003246-200204000-00005; Andersen MG, 2014, ACTA ANAESTH SCAND, V58, P525, DOI 10.1111/aas.12290; Bolliger D, 2012, TRANSFUS MED REV, V26, P1, DOI 10.1016/j.tmrv.2011.07.005; Brenner T, 2012, ACTA ANAESTH SCAND, V56, P1277, DOI 10.1111/j.1399-6576.2012.02750.x; Gorlinger K, 2013, CURR OPIN ANESTHESIO, V26, P230, DOI 10.1097/ACO.0b013e32835ddca6; Haase N, 2015, INTENS CARE MED, V41, P77, DOI 10.1007/s00134-014-3552-9; Hakimi CS, 2014, THROMB RES, V134, P895, DOI 10.1016/j.thromres.2014.05.023; Hayakawa M, 2015, SEMIN THROMB HEMOST, V41, P35, DOI 10.1055/s-0034-1398379; Hjorleifsson E, 2015, ACTA ANAESTH SCAND, V59, P870, DOI 10.1111/aas.12537; Hunt BJ, 2014, NEW ENGL J MED, V370, P847, DOI 10.1056/NEJMra1208626; Johansson PI, 2010, MED HYPOTHESES, V75, P564, DOI 10.1016/j.mehy.2010.07.031; Kozek-Langenecker SA, 2010, BEST PRACT RES-CLIN, V24, P27, DOI 10.1016/j.bpa.2009.09.009; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Larsson A, 2015, J CRIT CARE; Levi M, 2006, CRIT CARE, V10, DOI 10.1186/cc4975; Levi M, 2013, CRIT CARE, V17, DOI 10.1186/cc12859; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Nystrup KB, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-52; Ohuchi M., 2015, J ATHEROSCLER THROMB; Oshiro A, 2014, CRIT CARE, V18, DOI 10.1186/cc13816; Ostrowski SR, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.09.003; Panigada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136463; Prakash S, 2015, J CRIT CARE, V30, P264, DOI 10.1016/j.jcrc.2014.10.014; Sawamura A, 2009, THROMB RES, V124, P706, DOI 10.1016/j.thromres.2009.06.036; Schochl H, 2013, J TRAUMA ACUTE CARE, V74, P1587, DOI 10.1097/TA.0b013e31828c3171; Schott U, 2013, BRIT J ANAESTH, V111, P864, DOI 10.1093/bja/aet289; Sharma P, 2010, AM J CLIN PATHOL, V134, P97, DOI 10.1309/AJCPPZ4J6CAFYDVM; Sivula M, 2009, BLOOD COAGUL FIBRIN, V20, P419, DOI 10.1097/MBC.0b013e32832a76e1; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; Stissing T, 2011, CLIN APPL THROMB-HEM, V17, pE211, DOI 10.1177/1076029610397183; Takemitsu T, 2011, THROMB HAEMOSTASIS, V105, P40, DOI 10.1160/TH10-05-0293; Thachil J, 2009, BLOOD REV, V23, P167, DOI 10.1016/j.blre.2009.04.002; Tynngard N, 2015, THROMB J, V13, DOI 10.1186/s12959-015-0036-2; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Williamson DR, 2013, CHEST, V144, P1207, DOI 10.1378/chest.13-0121	37	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151202	10.1371/journal.pone.0151202	http://dx.doi.org/10.1371/journal.pone.0151202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959974	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300110
J	Jurchott, K; Schulz, AR; Bozzetti, C; Pohlmann, D; Stervbo, U; Warth, S; Malzer, JN; Waldner, J; Schweiger, B; Olek, S; Grutzkau, A; Babel, N; Thiel, A; Neumann, AU				Juerchott, Karsten; Schulz, Axel Ronald; Bozzetti, Cecilia; Pohlmann, Dominika; Stervbo, Ulrik; Warth, Sarah; Maelzer, Julia Nora; Waldner, Julian; Schweiger, Brunhilde; Olek, Sven; Gruetzkau, Andreas; Babel, Nina; Thiel, Andreas; Neumann, Avidan Uriel			Highly Predictive Model for a Protective Immune Response to the A(H1N1)pdm2009 Influenza Strain after Seasonal Vaccination	PLOS ONE			English	Article								Understanding the immune response after vaccination against new influenza strains is highly important in case of an imminent influenza pandemic and for optimization of seasonal vaccination strategies in high risk population groups, especially the elderly. Models predicting the best sero-conversion response among the three strains in the seasonal vaccine were recently suggested. However, these models use a large number of variables and/or information post-vaccination. Here in an exploratory pilot study, we analyzed the baseline immune status in young (<31 years, N = 17) versus elderly (>= 50 years, N = 20) donors sero-negative to the newly emerged A(H1N1)pdm09 influenza virus strain and correlated it with the serological response to that specific strain after seasonal influenza vaccination. Extensive multi-chromatic FACS analysis (36 lymphocyte sub-populations measured) was used to quantitatively assess the cellular immune status before vaccination. We identified CD4(+) T cells, and amongst them particularly naive CD4+ T cells, as the best correlates for a successful A(H1N1) pdm09 immune response. Moreover, the number of influenza strains a donor was sero-negative to at baseline (NSSN) in addition to age, as expected, were important predictive factors. Age, NSSN and CD4+ T cell count at baseline together predicted sero-protection (HAI >= 40) to A(H1N1) pdm09 with a high accuracy of 89%(p-value = 0.00002). An additional validation study (N = 43 vaccinees sero-negative to A(H1N1) pdm09) has confirmed the predictive value of age, NSSN and baseline CD4(+) counts (accuracy = 85%, p-value = 0.0000004). Furthermore, the inclusion of donors at ages 31-50 had shown that the age predictive function is not linear with age but rather a sigmoid with a midpoint at about 50 years. Using these results we suggest a clinically relevant predictionmodel that gives the probability for non-protection to A(H1N1)pdm09 influenza strain after seasonalmulti-valent vaccination as a continuous function of age, NSSN and baseline CD4 count.	[Juerchott, Karsten; Schulz, Axel Ronald; Bozzetti, Cecilia; Pohlmann, Dominika; Stervbo, Ulrik; Warth, Sarah; Maelzer, Julia Nora; Waldner, Julian; Babel, Nina; Thiel, Andreas; Neumann, Avidan Uriel] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany; [Juerchott, Karsten; Neumann, Avidan Uriel] Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany; [Schweiger, Brunhilde] Robert Koch Inst, Natl Reference Ctr Influenza, Berlin, Germany; [Olek, Sven] Epiontis GmbH, Ivana Turbcachova Lab Epigent, Berlin, Germany; [Gruetzkau, Andreas] German Rheumatism Res Ctr DRFZ, Berlin, Germany; [Neumann, Avidan Uriel] Bar Ilan Univ, Goodman Fac Life Sci, Ramat Gan, Israel; [Neumann, Avidan Uriel] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Robert Koch Institute; Epiontis GmbH; Deutsches Rheuma-Forschungszentrum (DRFZ); Bar Ilan University; Swiss Institute of Allergy & Asthma Research; University of Zurich	Neumann, AU (corresponding author), Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany.; Neumann, AU (corresponding author), Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany.; Neumann, AU (corresponding author), Bar Ilan Univ, Goodman Fac Life Sci, Ramat Gan, Israel.; Neumann, AU (corresponding author), Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland.	auneumann@gmail.com	Babel, Nina/AAK-2034-2021; Stervbo, Ulrik/AAV-1561-2020; Thiel, Andreas/F-1539-2013	Stervbo, Ulrik/0000-0002-2831-8868; Schulz, Axel Ronald/0000-0002-5106-0148; Pohlmann, Dominika/0000-0002-9866-0431; Babel, Nina/0000-0003-3673-712X; Thiel, Andreas/0000-0002-5515-4002; Jurchott, Karsten/0000-0003-1589-0037	Bundesministerium fur Bildung und Forschung; Gerontosys Program (BMBF) - Primage; e:Med Program (BMBF) - e:Kid; Epiontis GmbH; BMBF; EFRE; EFRE grant "ProFit"	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Gerontosys Program (BMBF) - Primage(Federal Ministry of Education & Research (BMBF)); e:Med Program (BMBF) - e:Kid(Federal Ministry of Education & Research (BMBF)); Epiontis GmbH; BMBF(Federal Ministry of Education & Research (BMBF)); EFRE; EFRE grant "ProFit"	This work was funded by the following sources: Bundesministerium fur Bildung und Forschung; http://www.bmbf.de/; Gerontosys Program (BMBF) - Primage. Project: KJ, AS, US, SO, AG, NB, AT, AUN. Bundesministerium fur Bildung und Forschung; http://www.bmbf.de/; e:Med Program (BMBF) - e:Kid. Project: NB, AUN. EFRE grant "ProFit": NB. Epiontis GmbH: SO. The funding organizations (BMBF and EFRE) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials. Epiontis GmbH provided support in the form of salaries for authors (SO), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author (SO) are articulated in the 'author contributions' section.	[Anonymous], 1980, B WORLD HEALTH ORGAN, V58, P585; [Anonymous], WHO INFL SEAS; [Anonymous], 2014, R LANG ENV STAT COMP; Csardi G, 2006, INTERJOURNAL; Danishuddin M, 2009, BIOINFORMATION, V4, P94, DOI 10.6026/97320630004094; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Kreijtz JHCM, 2011, VIRUS RES, V162, P19, DOI 10.1016/j.virusres.2011.09.022; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nayak JL, 2013, J INFECT DIS, V207, P297, DOI 10.1093/infdis/jis684; Rambal V, 2014, MED MICROBIOL IMMUN, V203, P35, DOI 10.1007/s00430-013-0312-3; Tebas P, 2010, AIDS, V24, P2187, DOI 10.1097/QAD.0b013e32833c6d5c; Trtica-Majnaric L, 2010, J BIOMED INFORM, V43, P774, DOI 10.1016/j.jbi.2010.04.011; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Venables WN., 2002, MODERN APPL STAT S 4; Yang JB, 2013, INT IMMUNOL, V25, P447, DOI 10.1093/intimm/dxt005	15	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150812	10.1371/journal.pone.0150812	http://dx.doi.org/10.1371/journal.pone.0150812			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954292	Green Published, gold			2022-12-27	WOS:000371991300053
J	Khoonsari, PE; Haggmark, A; Lonnberg, M; Mikus, M; Kilander, L; Lannfelt, L; Bergquist, J; Ingelsson, M; Nilsson, P; Kultima, K; Shevchenko, G				Khoonsari, Payam Emami; Haggmark, Anna; Lonnberg, Maria; Mikus, Maria; Kilander, Lena; Lannfelt, Lars; Bergquist, Jonas; Ingelsson, Martin; Nilsson, Peter; Kultima, Kim; Shevchenko, Ganna			Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; TANDEM MASS-SPECTROMETRY; RECEPTOR TYROSINE PHOSPHATASES; HUMAN BREAST-CANCER; PEPTIDE IDENTIFICATION; MULTIPLE-SCLEROSIS; ALTERED EXPRESSION; PLASMA BIOMARKERS; NERVOUS-SYSTEM; HUMAN-SERUM	Alzheimer's disease is a neurodegenerative disorder accounting for more than 50% of cases of dementia. Diagnosis of Alzheimer's disease relies on cognitive tests and analysis of amyloid beta, protein tau, and hyperphosphorylated tau in cerebrospinal fluid. Although these markers provide relatively high sensitivity and specificity for early disease detection, they are not suitable for monitor of disease progression. In the present study, we used label-free shotgun mass spectrometry to analyse the cerebrospinal fluid proteome of Alzheimer's disease patients and non-demented controls to identify potential biomarkers for Alzheimer's disease. We processed the data using five programs (DecyderMS, Maxquant, OpenMS, PEAKS, and Sieve) and compared their results by means of reproducibility and peptide identification, including three different normalization methods. After depletion of high abundant proteins we found that Alzheimer's disease patients had lower fraction of low-abundance proteins in cerebrospinal fluid compared to healthy controls (p<0.05). Consequently, global normalization was found to be less accurate compared to using spiked-in chicken ovalbumin for normalization. In addition, we determined that Sieve and OpenMS resulted in the highest reproducibility and PEAKS was the programs with the highest identification performance. Finally, we successfully verified significantly lower levels (p<0.05) of eight proteins (A2GL, APOM, C1QB, C1QC, C1S, FBLN3, PTPRZ, and SEZ6) in Alzheimer's disease compared to controls using an antibody-based detection method. These proteins are involved in different biological roles spanning from cell adhesion and migration, to regulation of the synapse and the immune system.	[Khoonsari, Payam Emami; Kultima, Kim] Uppsala Univ, Dept Med Sci Canc Pharmacol & Computat Med, Uppsala, Sweden; [Haggmark, Anna; Mikus, Maria; Nilsson, Peter] KTH Royal Inst Technol, Sch Biotechnol, Affin Prote, Sci Life Lab, Stockholm, Sweden; [Lonnberg, Maria; Bergquist, Jonas; Shevchenko, Ganna] Uppsala Univ, Dept Chem BMC, Analyt Chem, Uppsala, Sweden; [Kilander, Lena; Lannfelt, Lars; Ingelsson, Martin] Uppsala Univ, Dept Publ Hlth Geriatr, Uppsala, Sweden	Uppsala University; Royal Institute of Technology; Uppsala University; Uppsala University	Kultima, K (corresponding author), Uppsala Univ, Dept Med Sci Canc Pharmacol & Computat Med, Uppsala, Sweden.	kim.kultima@medsci.uu.se	Nilsson, Peter/E-4547-2010	Nilsson, Peter/0000-0002-4657-8532; Mikus, Maria/0000-0001-6560-6124; Emami Khoonsari, Payam/0000-0002-4137-5517; Bergquist, Jonas/0000-0002-4597-041X; Kultima, Kim/0000-0002-0680-1410	Uppsala Berzelii Technology Centre for Neurodiagnostics; Swedish Governmental Agency for Innovation Systems; Knut and Alice Wallenberg Foundation; KTH Center for Applied Proteomics; ProNova Vinn Excellence Center; Marianne and Marcus Wallenbergs Foundation; Swedish Alzheimer's foundation; Swedish Brain Foundation; Gun och Bertil Stohnes stiftelse; Geriatriska fonden; Swedish Research Council FORMAS; Swedish Research Council [P29797-1, 621-2011-4423]; SciLifeLab	Uppsala Berzelii Technology Centre for Neurodiagnostics; Swedish Governmental Agency for Innovation Systems(Vinnova); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); KTH Center for Applied Proteomics; ProNova Vinn Excellence Center; Marianne and Marcus Wallenbergs Foundation; Swedish Alzheimer's foundation; Swedish Brain Foundation; Gun och Bertil Stohnes stiftelse; Geriatriska fonden; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council(Swedish Research CouncilEuropean Commission); SciLifeLab	This research was supported by Uppsala Berzelii Technology Centre for Neurodiagnostics, with financing from the Swedish Governmental Agency for Innovation Systems, the Knut and Alice Wallenberg Foundation, KTH Center for Applied Proteomics, ProNova Vinn Excellence Center, Marianne and Marcus Wallenbergs Foundation, Swedish Alzheimer's foundation, Swedish Brain Foundation, Gun och Bertil Stohnes stiftelse, Geriatriska fonden, the Swedish Research Council FORMAS, the Swedish Research Council P29797-1 JB grant (621-2011-4423) as well from SciLifeLab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Ai J, 2008, J LEUKOCYTE BIOL, V83, P1277, DOI 10.1189/jlb.1107751; America AHP, 2008, PROTEOMICS, V8, P731, DOI 10.1002/pmic.200700694; Andersen JD, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-21; Andreev VP, 2012, J PROTEOME RES, V11, P3053, DOI 10.1021/pr3001546; [Anonymous], 2014, OPEN SOURCE LIB FRAM, V1844, P63, DOI [10.1016/j.bbapap.2013.02.032, DOI 10.1016/J.BBAPAP.2013.02.032]; Arregui CO, 2000, NEUROCHEM RES, V25, P95, DOI 10.1023/A:1007595617447; Banerjee S, 2012, ARCH MED RES, V43, P705, DOI 10.1016/j.arcmed.2012.10.006; Beranova-Giorgianni S, 2003, TRAC-TREND ANAL CHEM, V22, P273, DOI 10.1016/S0165-9936(03)00508-9; Bixby JL, 2000, NEUROREPORT, V11, pR5, DOI 10.1097/00001756-200007140-00001; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Brosch M, 2008, MOL CELL PROTEOMICS, V7, P962, DOI 10.1074/mcp.M700293-MCP200; Calza S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-140; Cappadona S, 2012, AMINO ACIDS, V43, P1087, DOI 10.1007/s00726-012-1289-8; Chamrad DC, 2004, PROTEOMICS, V4, P619, DOI 10.1002/pmic.200300612; Chen S, 2012, NEUROCHEM RES, V37, P2805, DOI 10.1007/s11064-012-0874-2; Coble JB, 2014, J CHROMATOGR A, V1358, P155, DOI 10.1016/j.chroma.2014.06.100; Colaert N, 2011, METHODS MOL BIOL, V753, P373, DOI 10.1007/978-1-61779-148-2_25; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Donovan LE, 2012, PROTEOM CLIN APPL, V6, P201, DOI 10.1002/prca.201100068; Echan LA, 2005, PROTEOMICS, V5, P3292, DOI 10.1002/pmic.200401228; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; GARTON MJ, 1991, J NEUROL SCI, V104, P74, DOI 10.1016/0022-510X(91)90218-V; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gunther R, MOL NEURODEGENERATIO; Haggmark A, 2013, PROTEOMICS, V13, P2256, DOI 10.1002/pmic.201200580; Han Yonghua, 2005, Journal of Bioinformatics and Computational Biology, V3, P697; Hansson O, 2009, NEUROBIOL AGING, V30, P165, DOI 10.1016/j.neurobiolaging.2007.06.009; Hansson SF, 2009, J ALZHEIMERS DIS, V16, P389, DOI 10.3233/JAD-2009-0966; Henkel AW, 2012, J NEURAL TRANSM, V119, P779, DOI 10.1007/s00702-012-0781-3; Hwang CF, 2010, J PATHOL, V222, P367, DOI 10.1002/path.2776; Jahn H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026540; Johnsen LG, 2013, ANALYST, V138, P3502, DOI 10.1039/c3an36276k; Kairouz R, 2000, BREAST CANCER RES, V2, P197, DOI 10.1186/bcr54; Kang JH, 2013, CLIN CHEM, V59, P903, DOI 10.1373/clinchem.2013.202937; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kultima K, 2009, MOL CELL PROTEOMICS, V8, P2285, DOI 10.1074/mcp.M800514-MCP200; Kwon SK, 2010, J BIOL CHEM, V285, P13966, DOI 10.1074/jbc.M109.061127; Lin WC, 2000, ONCOGENE, V19, P5680, DOI 10.1038/sj.onc.1203924; Luo RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070511; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Mattsson N, 2012, J ALZHEIMERS DIS, V30, P767, DOI 10.3233/JAD-2012-120019; McHugh L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040012; Moulder R, 2005, PROTEOMICS, V5, P2748, DOI 10.1002/pmic.200401187; Musunuri S, 2014, J PROTEOME RES, V13, P2056, DOI 10.1021/pr401202d; Nahnsen S, 2011, J PROTEOME RES, V10, P3332, DOI 10.1021/pr2002879; Perez-Pinera P, 2007, BIOCHEM BIOPH RES CO, V362, P5, DOI 10.1016/j.bbrc.2007.06.050; Plomgaard P, 2009, J INTERN MED, V266, P258, DOI 10.1111/j.1365-2796.2009.02095.x; Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955; Puchades M, 2003, MOL BRAIN RES, V118, P140, DOI 10.1016/j.molbrainres.2003.08.005; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Shevchenko G, 2012, J PROTEOME RES, V11, P6159, DOI 10.1021/pr300808h; Shteynberg D, 2013, MOL CELL PROTEOMICS, V12, P2383, DOI 10.1074/mcp.R113.027797; Simonsen A H, 2012, Int J Proteomics, V2012, P824024, DOI 10.1155/2012/824024; Smyth G. K., 2014, LIMMA LINEAR MODELS, P397, DOI DOI 10.1007/0-387-29362-0_23; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Song F, 2009, BRAIN RES REV, V61, P69, DOI 10.1016/j.brainresrev.2009.05.003; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; Terry RD, 2006, J GERIATR PSYCH NEUR, V19, P125, DOI 10.1177/0891988706291079; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Toledo JB, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt266; Tumani H, 2008, EXPERT REV MOL DIAGN, V8, P479, DOI 10.1586/14737159.8.4.479; Van Vactor D, 1998, CURR OPIN CELL BIOL, V10, P174, DOI 10.1016/S0955-0674(98)80139-7; Weisser H, 2013, J PROTEOME RES, V12, P1628, DOI 10.1021/pr300992u; Worley B, 2013, ANAL BIOCHEM, V433, P102, DOI 10.1016/j.ab.2012.10.011; Wu Chew-Wun, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004337; Xu S, 2014, ONCOL REP, V31, P79, DOI 10.3892/or.2013.2799; Yin GN, 2009, BRAIN RES, V1265, P158, DOI 10.1016/j.brainres.2009.01.058; Zhang J, MOL CELLULAR PROTEOM; Zheng L, 2014, ACM T KNOWL DISCOV D, V9, DOI 10.1145/2611380; Zhou A, 2013, BIOCHEMISTRY-US, V52, P3446, DOI 10.1021/bi400230u	83	62	62	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150672	10.1371/journal.pone.0150672	http://dx.doi.org/10.1371/journal.pone.0150672			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950848	gold, Green Published, Green Submitted			2022-12-27	WOS:000371990100049
J	Vieira, A; Cabral, A; Fino, J; Azinheira, HG; Loureiro, A; Talhinhas, P; Pires, AS; Varzea, V; Moncada, P; Oliveira, H; Silva, MD; Paulo, OS; Batista, D				Vieira, Ana; Cabral, Ana; Fino, Joana; Azinheira, Helena G.; Loureiro, Andreia; Talhinhas, Pedro; Pires, Ana Sofia; Varzea, Vitor; Moncada, Pilar; Oliveira, Helena; Silva, Maria do Ceu; Paulo, Octavio S.; Batista, Dora			Comparative Validation of Conventional and RNA-Seq Data-Derived Reference Genes for qPCR Expression Studies of Colletotrichum kahawae	PLOS ONE			English	Article							REAL-TIME PCR; MELANIN BIOSYNTHESIS; COFFEE RESISTANCE; NORMALIZATION; IDENTIFICATION; SELECTION; INFECTION; REDUCTASE; DISEASES; MODEL	Colletotrichum kahawae is an emergent fungal pathogen causing severe epidemics of Coffee Berry Disease on Arabica coffee crops in Africa. Currently, the molecular mechanisms underlying the Coffea arabica-C. kahawae interaction are still poorly understood, as well as the differences in pathogen aggressiveness, which makes the development of functional studies for this pathosystem a crucial step. Quantitative real time PCR (qPCR) has been one of the most promising approaches to perform gene expression analyses. However, proper data normalization with suitable reference genes is an absolute requirement. In this study, a set of 8 candidate reference genes were selected based on two different approaches (literature and Illumina RNA-seq datasets) to assess the best normalization factor for qPCR expression analysis of C. kahawae samples. The gene expression stability of candidate reference genes was evaluated for four isolates of C. kahawae bearing different aggressiveness patterns (Ang29, Ang67, Zim12 and Que2), at different stages of fungal development and key time points of the plant-fungus interaction process. Gene expression stability was assessed using the pairwise method incorporated in geNorm and the model-based method used by NormFinder software. For C. arabica-C. kahawae interaction samples, the best normalization factor included the combination of PP1, Act and ck34620 genes, while for C. kahawae samples the combination of PP1, Act and ck20430 revealed to be the most appropriate choice. These results suggest that RNA-seq analyses can provide alternative sources of reference genes in addition to classical reference genes. The analysis of expression profiles of bifunctional catalase-peroxidase (cat2) and trihydroxynaphthalene reductase (thr1) genes further enabled the validation of the selected reference genes. This study provides, for the first time, the tools required to conduct accurate qPCR studies in C. kahawae considering its aggressiveness pattern, developmental stage and host interaction.	[Vieira, Ana; Cabral, Ana; Fino, Joana; Azinheira, Helena G.; Loureiro, Andreia; Talhinhas, Pedro; Pires, Ana Sofia; Varzea, Vitor; Silva, Maria do Ceu; Batista, Dora] Univ Lisbon, Inst Super Agron, CIFC, Oeiras, Portugal; [Vieira, Ana; Fino, Joana; Paulo, Octavio S.; Batista, Dora] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes CE3c, Computat Biol & Populat Genom Grp, Lisbon, Portugal; [Cabral, Ana; Azinheira, Helena G.; Loureiro, Andreia; Talhinhas, Pedro; Varzea, Vitor; Oliveira, Helena; Silva, Maria do Ceu; Batista, Dora] Univ Lisbon, Inst Super Agron, LEAF Linking Landscape Environm Agr & Food, P-1699 Lisbon, Portugal; [Talhinhas, Pedro; Pires, Ana Sofia] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Plant Cell Biol, P-2780156 Oeiras, Portugal; [Moncada, Pilar] Cenicafe, Manizales, Colombia	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Universidade Nova de Lisboa	Cabral, A (corresponding author), Univ Lisbon, Inst Super Agron, CIFC, Oeiras, Portugal.; Cabral, A (corresponding author), Univ Lisbon, Inst Super Agron, LEAF Linking Landscape Environm Agr & Food, P-1699 Lisbon, Portugal.	anacabral@isa.ulisboa.pt	Batista, Dora/N-7385-2013; Cabral, Ana/J-9799-2013; Paulo, Octávio/D-9921-2011; Pires, Ana Sofia/AGE-6615-2022; Loureiro, Andreia/Q-6716-2019; Azinheira, Helena/ADX-1184-2022; do Céu Silva, Maria/AAP-9668-2021; Pires, Ana S/G-8621-2012; do Céu ML Silva, Maria/M-6236-2013	Batista, Dora/0000-0003-4031-8999; Cabral, Ana/0000-0001-5007-7661; Paulo, Octávio/0000-0001-5408-5212; Pires, Ana Sofia/0000-0002-4572-231X; Loureiro, Andreia/0000-0002-8886-545X; Azinheira, Helena/0000-0002-9007-0082; do Céu Silva, Maria/0000-0002-1628-7128; Pires, Ana S/0000-0002-4572-231X; do Céu ML Silva, Maria/0000-0002-1628-7128; Vieira, Ana/0000-0003-4384-6746; Vieira Fino, Joana Rita/0000-0002-3266-9011; Varzea, Vitor/0000-0002-9507-3311; Oliveira, Helena/0000-0002-8274-9757	Portuguese national funds through Fundacao para a Ciencia e a Tecnologia (project PTDC/AGR) [GPL/112217/2009, SFRH/BD/89397/2012, SFRH/BPD/65686/2009, SFRH/BPD/88994/2012, SFRH/BPD/84508/2012, SFRH/BPD/104629/2014]; Portuguese national funds through Fundacao para a Ciencia e a Tecnologia (FCT Unit funding) [UID/AGR/04129/2013]	Portuguese national funds through Fundacao para a Ciencia e a Tecnologia (project PTDC/AGR); Portuguese national funds through Fundacao para a Ciencia e a Tecnologia (FCT Unit funding)	This work was funded by Portuguese national funds through Fundacao para a Ciencia e a Tecnologia (project PTDC/AGR GPL/112217/2009 and grants SFRH/BD/89397/2012, SFRH/BPD/65686/2009; SFRH/BPD/88994/2012, SFRH/BPD/84508/2012 and SFRH/BPD/104629/2014 attributed to AV, ASP, PT, AC and DB, respectively and FCT Unit funding UID/AGR/04129/2013).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Borges AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111399; Bourdais A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029820; Brown SH, 2008, MOL PLANT PATHOL, V9, P171, DOI 10.1111/J.1364-3703.2007.00454.X; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; Silva Maria do Céu, 2006, Braz. J. Plant Physiol., V18, P119, DOI 10.1590/S1677-04202006000100010; Fang WG, 2006, MYCOL RES, V110, P1165, DOI 10.1016/j.mycres.2006.04.014; Figueiredo Andreia, 2013, BMC Res Notes, V6, P388, DOI 10.1186/1756-0500-6-388; Fino J, 2015, P 25 INT C COFF SCI, P222; Gichuru EK, 2008, PLANT PATHOL, V57, P1117, DOI 10.1111/j.1365-3059.2008.01846.x; Hindorf H, 2011, J ADV RES, V2, P109, DOI 10.1016/j.jare.2010.08.006; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Kim HK, 2011, PLANT PATHOLOGY J, V27, P301, DOI 10.5423/PPJ.2011.27.4.301; Kleemann J, 2008, MICROBIOL-SGM, V154, P1204, DOI 10.1099/mic.0.2007/014944-0; Lin F, 2014, PLANT MOL BIOL, V86, P543, DOI 10.1007/s11103-014-0246-1; Llanos A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1224-y; Loureiro A, 2012, PHYSIOL MOL PLANT P, V77, P23, DOI 10.1016/j.pmpp.2011.11.002; Loureiro A, 2015, FUNGAL BIOL-UK, V119, P1093, DOI 10.1016/j.funbio.2015.08.008; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Perpetua NS, 1996, MOL PLANT MICROBE IN, V9, P323, DOI 10.1094/MPMI-9-0323; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Silva MC, 1999, INT J PLANT SCI, V160, P79, DOI 10.1086/314113; Tanabe S, 2011, MOL PLANT MICROBE IN, V24, P163, DOI 10.1094/MPMI-07-10-0175; Thompson JE, 2000, J BIOL CHEM, V275, P34867, DOI 10.1074/jbc.M006659200; Tsuji G, 2003, MYCOL RES, V107, P854, DOI 10.1017/S0953756203008001; van der Vossen HAM, 2009, EUPHYTICA, V165, P105, DOI 10.1007/s10681-008-9769-3; VANDERVOSSEN HAM, 1976, EUPHYTICA, V25, P733, DOI 10.1007/BF00041613; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Vieira A, 2011, FUNGAL BIOL-UK, V115, P891, DOI 10.1016/j.funbio.2011.07.002; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yarden O, 2014, PHYSIOL MOL PLANT P, V85, P34, DOI 10.1016/j.pmpp.2013.12.001; Zhou YH, 2012, APPL MICROBIOL BIOT, V93, P679, DOI 10.1007/s00253-011-3561-3; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172	39	9	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150651	10.1371/journal.pone.0150651	http://dx.doi.org/10.1371/journal.pone.0150651			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950697	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100048
J	Pennington, M; Grieve, R; Black, N; van der Meulen, JH				Pennington, Mark; Grieve, Richard; Black, Nick; van der Meulen, Jan H.			Cost-Effectiveness of Five Commonly Used Prosthesis Brands for Total Knee Replacement in the UK: A Study Using the NJR Dataset	PLOS ONE			English	Article							ARTHROPLASTY; REVISION; HIP	Background There is a lack of evidence on the effectiveness or cost-effectiveness of alternative brands of prosthesis for total knee replacement (TKR). We compared patient-reported outcomes, revision rates, and costs, and estimated the relative cost-effectiveness of five frequently used cemented brands of unconstrained prostheses with fixed bearings (PFC Sigma, AGC Biomet, Nexgen, Genesis 2, and Triathlon). Methods We used data from three national databases for patients who had a TKR between 2003 and 2012, to estimate the effect of prosthesis brand on post-operative quality of life (QOL) (EQ-5D-3L) in 53 126 patients at six months. We compared TKR revision rates by brand over 10 years for 239 945 patients. We used a fully probabilistic Markov model to estimate lifetime costs and quality-adjusted life years (QALYs), incremental cost effectiveness ratios (ICERs), and the probability that each prosthesis brand is the most cost effective at alternative thresholds of willingness-to-pay for a QALY gain. Findings Revision rates were lowest with the Nexgen and PFC Sigma (2.5% after 10 years in 70year-old women). Average lifetime costs were lowest with the AGC Biomet ( pound 9 538); mean post-operative QOL was highest with the Nexgen, which was the most cost-effective brand across all patient subgroups. For example, for 70-year-old men and women, the ICERs for the Nexgen compared to the AGC Biomet were 2 pound 300 per QALY. At realistic cost per QALY thresholds (10 pound 000 to 30 pound 000), the probabilities that the Nexgen is the most costeffective brand are about 98%. These results were robust to alternative modelling assumptions. Conclusions AGC Biomet prostheses are the least costly cemented unconstrained fixed brand for TKR but Nexgen prostheses lead to improved patient outcomes, at low additional cost. These results suggest that Nexgen should be considered as a first choice prosthesis for patients with osteoarthritis who require a TKR.	[Pennington, Mark] Kings Coll London, Inst Psychiat Psychol & Neurosci, Kings Hlth Econ, London, England; [Grieve, Richard; Black, Nick; van der Meulen, Jan H.] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, Tavistock Pl, London WC1, England	University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine	Pennington, M (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Kings Hlth Econ, London, England.	mark.w.pennington@kcl.ac.uk	Pennington, Mark/AAS-9946-2020	Pennington, Mark/0000-0002-1392-8700; Grieve, Richard/0000-0001-8899-1301; van der Meulen, Jan/0000-0002-9451-2335	Department of Health, United Kingdom (Commissioning Development); Medical Research Council [G106/1173] Funding Source: researchfish; National Institute for Health Research [SRF-2013-06-016] Funding Source: researchfish; MRC [G106/1173] Funding Source: UKRI	Department of Health, United Kingdom (Commissioning Development); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MP, NB and JvdM were supported by the Department of Health, United Kingdom (Commissioning Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18190; [Anonymous], 2011, ORTHOPEDIC NEWS NETW, V22; [Anonymous], 2010, PROV MONTHL PAT REP; Ara R, 2009, HLTH RELATED Q UNPUB; Australian Orthopaedic Association National Joint Replacement Registry, 2013, ANN REPORT; Baker PN, 2012, J BONE JOINT SURG BR, V94B, P1058, DOI 10.1302/0301-620X.94B8.28786; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Bauwens K, 2007, J BONE JOINT SURG AM, V89A, P261, DOI 10.2106/JBJS.F.00601; Breeman S, 2011, J BONE JOINT SURG AM, V93A, P1473, DOI 10.2106/JBJS.J.00725; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Browne JP, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-128; Dawson J, 1998, J BONE JOINT SURG BR, V80B, P63, DOI 10.1302/0301-620X.80B1.7859; Department of Health, HOSP EP STAT; Endres S, 2011, J ORTHOPAEDIC SURG, V19; Gothesen O, 2013, BONE JOINT J, V95B, P636, DOI 10.1302/0301-620X.95B5.30271; Gudex C, 1995, SOCIAL TARIFF EUROQO; Koskinen E, 2010, SCAND J SURG, V99, P250, DOI 10.1177/145749691009900414; Kurtz SM, 2011, INT ORTHOP, V35, P1783, DOI 10.1007/s00264-011-1235-5; Lambert PC, 2006, FLEXIBLE PARAMETRIC; Leonard S, 2011, QMED 2011; Lygre SHL, 2011, ACTA ORTHOP, V82, P282, DOI 10.3109/17453674.2011.570672; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; Mont Michael A, 2003, Instr Course Lect, V52, P397; National Institute for Health and Care Excellence, 2008, GUID METH TECHN APPR; National Joint Registry for England Wales and Northern Ireland, 2012, PROSTH US HIP KNEE A; New Zealand Joint Registry, 2012, 13 YEAR REP JAN 1999; Noble M, 2007, ENGLISH INDICES DEPR; Pennington M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1026; Porter M, 2013, 10 ANN REPORT 2013 N; Pradhan NR, 2006, KNEE, V13, P7, DOI 10.1016/j.knee.2005.06.004; Robertsson O, 2007, J BONE JOINT SURG BR, V89B, P599, DOI 10.1302/0301-620X.89B5.18355; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Sundberg M, 2012, ANN REPORT 2012 SWED; The Danish Knee Arthroplasty Register, DAN KNEE ARTHR REG A; The Norwegian Arthroplasty Register, REP 2010; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	37	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150074	10.1371/journal.pone.0150074	http://dx.doi.org/10.1371/journal.pone.0150074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943789	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000371739400013
J	Chiba, Y; Yamada, T; Tsukita, S; Takahashi, K; Munakata, Y; Shirai, Y; Kodama, S; Asai, Y; Sugisawa, T; Uno, K; Sawada, S; Imai, J; Nakamura, K; Katagiri, H				Chiba, Yumiko; Yamada, Tetsuya; Tsukita, Sohei; Takahashi, Kei; Munakata, Yuichiro; Shirai, Yuta; Kodama, Shinjiro; Asai, Yoichiro; Sugisawa, Takashi; Uno, Kenji; Sawada, Shojiro; Imai, Junta; Nakamura, Kazuhiro; Katagiri, Hideki			Dapagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, Acutely Reduces Energy Expenditure in BAT via Neural Signals in Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; DIET; THERMOGENESIS; COMBINATION; IMPROVES; PATHWAY	Selective sodium glucose cotransporter-2 inhibitor (SGLT2i) treatment promotes urinary glucose excretion, thereby reducing blood glucose as well as body weight. However, only limited body weight reductions are achieved with SGLT2i treatment. Hyperphagia is reportedly one of the causes of this limited weight loss. However, the effects of SGLT2i treatment on systemic energy expenditure have not been fully elucidated. Herein, we investigated the acute effects of dapagliflozin, a SGLT2i, on systemic energy expenditure in mice. Eighteen hours after dapagliflozin treatment oxygen consumption and brown adipose tissue (BAT) expression of ucp1, a thermogenesis-related gene, were significantly decreased as compared to those after vehicle treatment. In addition, dapagliflozin significantly suppressed norepinephrine (NE) turnover in BAT and c-fos expression in the rostral raphe pallidus nucleus (rRPa) which contains the sympathetic premotor neurons responsible for thermogenesis. These findings indicate that the dapagliflozin-mediated acute decrease in energy expenditure involves a reduction in BAT thermogenesis via decreased sympathetic nerve activity from the rRPa. Furthermore, common hepatic branch vagotomy abolished the reductions in ucp1 expression and NE contents in BAT and c-fos expression in the rRPa. In addition, alterations in hepatic carbohydrate metabolism, such as decreases in glycogen contents and upregulation of phosphoenolpyruvate carboxykinase, manifested prior to the suppression of BAT thermogenesis, e.g. 6 hours after dapagliflozin treatment. Collectively, these results suggest that SGLT2i treatment acutely suppresses energy expenditure in BAT via regulation of an inter-organ neural network consisting of the common hepatic vagal branch and sympathetic nerves.	[Chiba, Yumiko; Yamada, Tetsuya; Tsukita, Sohei; Takahashi, Kei; Munakata, Yuichiro; Shirai, Yuta; Kodama, Shinjiro; Asai, Yoichiro; Sugisawa, Takashi; Uno, Kenji; Sawada, Shojiro; Imai, Junta; Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Dept Metab & Diabet, Sendai, Miyagi 9808575, Japan; [Nakamura, Kazuhiro] Nagoya Univ, Grad Sch Med, Dept Integrat Physiol, Nagoya, Aichi 4668550, Japan; [Katagiri, Hideki] Japan Agcy Med Res & Dev AMED, CREST, Sendai, Miyagi 9808575, Japan	Tohoku University; Nagoya University; Japan Science & Technology Agency (JST)	Yamada, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Metab & Diabet, Sendai, Miyagi 9808575, Japan.	yamatetsu-tky@umin.ac.jp	Nakamura, Kazuhiro/A-5431-2008	Nakamura, Kazuhiro/0000-0002-6095-8996	Japan Society for the Promotion of Science [26293215, 25253067]; Grants-in-Aid for Scientific Research [15K09407, 26713009] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by: Tetsuya Yamada (26293215) and Hideki Katagiri (25253067), Grants-in-Aid for Scientific Research, The Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision of publish, or preparation of the manuscript.	Bailey CJ, 2011, TRENDS PHARMACOL SCI, V32, P63, DOI 10.1016/j.tips.2010.11.011; Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Chen LH, 2013, DIABETES OBES METAB, V15, P392, DOI 10.1111/dom.12064; DESAUTELS M, 1988, AM J PHYSIOL, V255, pE120, DOI 10.1152/ajpendo.1988.255.2.E120; Devenny JJ, 2012, OBESITY, V20, P1645, DOI 10.1038/oby.2012.59; Ferrannini E, 2012, NAT REV ENDOCRINOL, V8, P495, DOI 10.1038/nrendo.2011.243; Ferrannini G, 2015, DIABETES CARE, V38, P1730, DOI 10.2337/dc15-0355; Izumida Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3316; Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, pR285, DOI 10.1152/ajpregu.00652.2010; List JF, 2009, DIABETES CARE, V32, P650, DOI 10.2337/dc08-1863; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Nagata T, 2013, BRIT J PHARMACOL, V170, P519, DOI 10.1111/bph.12269; Nakamura K, 2002, J NEUROSCI, V22, P4600, DOI 10.1523/JNEUROSCI.22-11-04600.2002; NIIJIMA A, 1988, PHYSIOL BEHAV, V44, P661, DOI 10.1016/0031-9384(88)90332-0; SHIBATA H, 1987, J APPL PHYSIOL, V63, P465, DOI 10.1152/jappl.1987.63.2.465; Tahara A, 2012, N-S ARCH PHARMACOL, V385, P423, DOI 10.1007/s00210-011-0713-z; Takahashi K, 2013, AM J PHYSIOL-ENDOC M, V304, pE301, DOI 10.1152/ajpendo.00388.2012; Tsukita S, 2012, CELL METAB, V16, P825, DOI 10.1016/j.cmet.2012.11.006; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Uno K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8940; Vallon V, 2015, ANNU REV MED, V66, P255, DOI 10.1146/annurev-med-051013-110046; Vickers SP, 2014, DIABETES METAB SYNDR, V7, P265, DOI 10.2147/DMSO.S58786; Yokono M, 2014, EUR J PHARMACOL, V727, P66, DOI 10.1016/j.ejphar.2014.01.040; YOUNG JB, 1982, J CLIN INVEST, V69, P1061, DOI 10.1172/JCI110541	24	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150756	10.1371/journal.pone.0150756	http://dx.doi.org/10.1371/journal.pone.0150756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963613	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000058
J	Lin, PS; Hsieh, CC; Cheng, HS; Tseng, TJ; Su, SC				Lin, Pay-Shin; Hsieh, Chih-Chin; Cheng, Huey-Shinn; Tseng, Tsai-Jou; Su, Shin-Chang			Association between Physical Fitness and Successful Aging in Taiwanese Older Adults	PLOS ONE			English	Article							FUNCTIONAL DEPENDENCE; FOLLOW-UP; PERFORMANCE; PREVALENCE; DISABILITY; MACARTHUR; SAMPLE; DEFINITIONS; VALIDATION; PREDICTORS	Population aging is escalating in numerous countries worldwide; among them is Taiwan, which will soon become an aged society. Thus, aging successfully is an increasing concern. One of the factors for achieving successful aging (SA) is maintaining high physical function. The purpose of this study was to determine the physical fitness factors associated with SA in Taiwanese older adults (OAs), because these factors are intervenable. Community-dwelling OAs aged more than 65 years and residing in Northern Taiwan were recruited in this study. They received a comprehensive geriatric assessment, which includes sociodemographic data, health conditions and behaviors, activities of daily living (ADL) and instrumental ADL (IADL) function, cognitive and depressive status, and quality of life. Physical fitness tests included the grip strength (GS), 30-second sit-to-stand (30s STS), timed up-and-go (TUG), functional reach (FR), one-leg standing, chair sit-and-reach, and reaction time (drop ruler) tests as well as the 6-minute walk test (6MWT). SA status was defined as follows: complete independence in performing ADL and IADL, satisfactory cognitive status (Mini-Mental State Examination >= 24), no depression (Geriatric Depression Scale < 5), and favorable social function (SF subscale >= 80 in SF-36). Adjusted multiple logistic regression analyses were performed. Among the total recruited OAs (n = 378), 100 (26.5%) met the aforementioned SA criteria. After adjustment for sociodemographic characteristics and health condition and behaviors, some physical fitness tests, namely GS, 30s STS, 6MWT, TUG, and FR tests, were significantly associated with SA individually, but not in the multivariate model. Among the physical fitness variables tested, cardiopulmonary endurance, mobility, muscle strength, and balance were significantly associated with SA in Taiwanese OAs. Early detection of deterioration in the identified functions and corresponding intervention is essential to ensuring SA.	[Lin, Pay-Shin; Hsieh, Chih-Chin; Tseng, Tsai-Jou; Su, Shin-Chang] Chang Gung Univ, Coll Med, Dept Phys Therapy, Taoyuan, Taiwan; [Lin, Pay-Shin; Hsieh, Chih-Chin; Tseng, Tsai-Jou; Su, Shin-Chang] Chang Gung Univ, Coll Med, Grad Inst Rehabil Sci, Taoyuan, Taiwan; [Lin, Pay-Shin] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan; [Lin, Pay-Shin] Chang Gung Mem Hosp, Taoyuan, Taiwan; [Cheng, Huey-Shinn] Chang Gung Mem Hosp, LinKou Branch, Internal & Geriatr Med, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lin, PS (corresponding author), Chang Gung Univ, Coll Med, Dept Phys Therapy, Taoyuan, Taiwan.; Lin, PS (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Rehabil Sci, Taoyuan, Taiwan.; Lin, PS (corresponding author), Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan.; Lin, PS (corresponding author), Chang Gung Mem Hosp, Taoyuan, Taiwan.	pslin@mail.cgu.edu.tw			Ministry of science and technology, Executive Yuan, Taiwan [MOST 99-2410-H-182-037, 100-2410-H-182-016-MY2]; Chang Gung Medical Research Fund (CMRPD) [19002, 1B0332]	Ministry of science and technology, Executive Yuan, Taiwan; Chang Gung Medical Research Fund (CMRPD)	This study was supported by the Ministry of science and technology, Executive Yuan, Taiwan (MOST 99-2410-H-182-037 & 100-2410-H-182-016-MY2) and Chang Gung Medical Research Fund (CMRPD 19002 & 1B0332). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour EC, 2011, REJUV RES, V14, P215, DOI 10.1089/rej.2010.1101; Baker J, 2009, J AGING PHYS ACTIV, V17, P223, DOI 10.1123/japa.17.2.223; BERKMAN LF, 1993, J CLIN EPIDEMIOL, V46, P1129, DOI 10.1016/0895-4356(93)90112-E; Chang HT, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-274; Chen HT, 2009, J NURS RES, V17, P30, DOI 10.1097/JNR.0b013e3181999d4c; Chou KL, 2002, INT J AGING HUM DEV, V54, P1, DOI 10.2190/9K7T-6KXM-C0C6-3D64; Chow HW, 2014, GERIATR GERONTOL INT, V14, P596, DOI 10.1111/ggi.12143; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cosco TD, 2014, INT PSYCHOGERIATR, V26, P373, DOI 10.1017/S1041610213002287; den Ouden MEM, 2013, MATURITAS, V74, P89, DOI 10.1016/j.maturitas.2012.10.011; den Ouden MEM, 2011, MATURITAS, V69, P208, DOI 10.1016/j.maturitas.2011.04.008; Depp CA, 2006, AM J GERIAT PSYCHIAT, V14, P6, DOI 10.1097/01.JGP.0000192501.03069.bc; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Formiga F, 2011, REJUV RES, V14, P309, DOI 10.1089/rej.2010.1131; GILL TM, 1995, J AM GERIATR SOC, V43, P603, DOI 10.1111/j.1532-5415.1995.tb07192.x; Gill TM, 1996, J GERONTOL A-BIOL, V51, pM283, DOI 10.1093/gerona/51A.6.M283; Guo NW, 1988, TAIWAN J PHYS MED RE, V16, P52; Hardy SE, 2009, J AM GERIATR SOC, V57, P722, DOI 10.1111/j.1532-5415.2008.02168.x; Hsu HC, 2012, GERONTOLOGIST, V52, P843, DOI 10.1093/geront/gns005; IBM, 2011, IBM SPSS MISS VAL 20, V20; Johnson L, 1986, PRACTICAL MEASUREMEN; Kalache A, 2003, Adv Gerontol, V11, P7; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kuh D, 2014, P NUTR SOC, V73, P237, DOI 10.1017/S0029665113003923; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee H.-c.B., 1993, CLIN GERONTOLOGIST, V14, P37; Li CB, 2006, INT PSYCHOGERIATR, V18, P551, DOI 10.1017/S1041610205002966; Lim PPJ, 2000, INT J GERIATR PSYCH, V15, P824, DOI 10.1002/1099-1166(200009)15:9<824::AID-GPS207>3.0.CO;2-C; Liu CK, 1996, J FORMOS MED ASSOC, V95, P762; LIU HC, 1995, J AM GERIATR SOC, V43, P144, DOI 10.1111/j.1532-5415.1995.tb06379.x; McLaughlin SJ, 2010, J GERONTOL B-PSYCHOL, V65, P216, DOI 10.1093/geronb/gbp101; Montross LP, 2006, AM J GERIAT PSYCHIAT, V14, P43, DOI 10.1097/01.JGP.0000192489.43179.31; Ng TP, 2009, AM J GERIAT PSYCHIAT, V17, P407, DOI 10.1097/JGP.0b013e31819a808e; Parslow RA, 2011, J AM GERIATR SOC, V59, P2077, DOI 10.1111/j.1532-5415.2011.03665.x; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rikli R.E., 2012, SENIOR FITNESS TEST, V2nd; Rikli RE, 2013, GERONTOLOGIST, V53, P255, DOI 10.1093/geront/gns071; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Schaubert KL, 2005, J STRENGTH COND RES, V19, P717, DOI 10.1519/R-15954.1; SEEMAN TE, 1994, J GERONTOL, V49, pM97, DOI 10.1093/geronj/49.3.M97; SEEMAN TE, 1995, J GERONTOL A-BIOL, V50, pM177, DOI 10.1093/gerona/50A.4.M177; Shimada H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002424; Therapists A. S. o. H., 1992, CLIN ASSESSMENT RECO; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Toraman A, 2010, ARCH GERONTOL GERIAT, V51, P222, DOI 10.1016/j.archger.2009.10.012; Tseng HM., 2003, TAIWAN J PUBLIC HLTH, V22, P512, DOI DOI 10.6288/TJPH2003-22-06-10; Vellas BJ, 1997, AGING CLIN EXP RES, V9, P95, DOI 10.1007/BF03340133; Wang CY, 2011, ARCH GERONTOL GERIAT, V52, P1, DOI 10.1016/j.archger.2009.11.001; Young Y, 2009, J AM MED DIR ASSOC, V10, P87, DOI 10.1016/j.jamda.2008.11.003	49	62	64	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150389	10.1371/journal.pone.0150389	http://dx.doi.org/10.1371/journal.pone.0150389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TL	26963614	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000036
J	Liu, ZQ; Ma, JF; Jiang, ZY; Miao, YB; Gao, C				Liu, Zhiquan; Ma, Jianfeng; Jiang, Zhongyuan; Miao, Yinbin; Gao, Cong			IRLT: Integrating Reputation and Local Trust for Trustworthy Service Recommendation in Service-Oriented Social Networks	PLOS ONE			English	Article								With the prevalence of Social Networks (SNs) and services, plenty of trust models for Trustworthy Service Recommendation (TSR) in Service-oriented SNs (S-SNs) have been proposed. The reputation-based schemes usually do not contain user preferences and are vulnerable to unfair rating attacks. Meanwhile, the local trust-based schemes generally have low reliability or even fail to work when the trust path is too long or does not exist. Thus it is beneficial to integrate them for TSR in S-SNs. This work improves the state-of-the-art Combining Global and Local Trust (CGLT) scheme and proposes a novel Integrating Reputation and Local Trust (IRLT) model which mainly includes four modules, namely Service Recommendation Interface (SRI) module, Local Trust-based Trust Evaluation (LTTE) module, Reputation-based Trust Evaluation (RTE) module and Aggregation Trust Evaluation (ATE) module. Besides, a synthetic S-SN based on the famous Advogato dataset is deployed and the well-known Discount Cumulative Gain (DCG) metric is employed to measure the service recommendation performance of our IRLT model with comparing to that of the excellent CGLT model. The results illustrate that our IRLT model is slightly superior to the CGLT model in honest environment and significantly outperforms the CGLT model in terms of the robustness against unfair rating attacks.	[Liu, Zhiquan; Ma, Jianfeng; Gao, Cong] Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China; [Ma, Jianfeng; Jiang, Zhongyuan] Xidian Univ, Sch Cyber Engn, Xian, Shaanxi, Peoples R China; [Miao, Yinbin] Xidian Univ, Sch Telecommun Engn, Xian, Shaanxi, Peoples R China	Xidian University; Xidian University; Xidian University	Ma, JF (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China.; Ma, JF (corresponding author), Xidian Univ, Sch Cyber Engn, Xian, Shaanxi, Peoples R China.	jfma@mail.xidian.edu.cn	Ma, Jianfeng/GZB-0110-2022	Liu, Zhiquan/0000-0002-3934-2177	National High Technology Research and Development Program (863 Program) [2015AA016007]; National Natural Science Foundation of China [61502375]; NSFC [U1405255]; Major Natural Science Foundation of China [61370078]	National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); Major Natural Science Foundation of China	This work was supported by National High Technology Research and Development Program (863 Program) (No. 2015AA016007), National Natural Science Foundation of China (No. 61502375), Key Program of NSFC Grant (No. U1405255) and Major Natural Science Foundation of China (No. 61370078).	Abu Salih B, 2015, IEEE INT CONGR BIG, P460, DOI 10.1109/BigDataCongress.2015.74; Dellarocas C., 2000, EC'00. Proceedings of the 2nd ACM Conference on Electronic Commerce, P150, DOI 10.1145/352871.352889; Golbeck J., 2006, ACM Transactions on Internet Technology, V6, P497, DOI 10.1145/1183463.1183470; Goto S., 2011, 2011 Proceedings of IEEE International Conference on Services Computing (SCC 2011), P330, DOI 10.1109/SCC.2011.111; Gregg DG, 2008, COMMUN ACM, V51, P69, DOI 10.1145/1330311.1330326; Guha R., 2004, P 13 INT C WORLD WID, P403, DOI [10.1145/988672.988727, DOI 10.1145/988672.988727]; Hien Trang Nguyen, 2010, 2010 IEEE International Conference on Web Services (ICWS), P251, DOI 10.1109/ICWS.2010.36; Jarvelin K, 2002, ACM T INFORM SYST, V20, P422, DOI 10.1145/582415.582418; Josang A, 2008, LECT NOTES COMPUT SC, V5185, P90, DOI 10.1007/978-3-540-85735-8_10; Josang A, 2007, DECIS SUPPORT SYST, V43, P618, DOI 10.1016/j.dss.2005.05.019; Kim YA, 2011, KNOWL-BASED SYST, V24, P1360, DOI 10.1016/j.knosys.2011.06.009; Korkmaz T, 2001, IEEE INFOCOM SER, P834, DOI 10.1109/INFCOM.2001.916274; Liang XH, 2014, IEEE T PARALL DISTR, V25, P310, DOI 10.1109/TPDS.2013.37; Liu G., 2011, AAAI, P1222; Liu GF, 2014, 2014 IEEE 21ST INTERNATIONAL CONFERENCE ON WEB SERVICES (ICWS 2014), P121, DOI 10.1109/ICWS.2014.29; Liu GF, 2010, AAAI CONF ARTIF INTE, P1391; Liu S., 2013, P 2013 INT C AUTONOM, P821; Mislove A, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P29; Sherchan W, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2501654.2501661; Singh, 2009, P 8 INT C AUT AG MUL, V2, P1025; Tang MD, 2014, 2014 IEEE 21ST INTERNATIONAL CONFERENCE ON WEB SERVICES (ICWS 2014), P305, DOI 10.1109/ICWS.2014.52; Vavilis S, 2014, DECIS SUPPORT SYST, V61, P147, DOI 10.1016/j.dss.2014.02.002; Whitby A., 2004, P 7 INT WORKSH TRUST, V6, P106; Wu Y, 2013, IEEE T AUTOM SCI ENG, V10, P634, DOI 10.1109/TASE.2013.2238231; Xu Y, 2012, INTEGR CANC THER, V9, P9; Xu ZQ, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON WEB SERVICES, PROCEEDINGS, P249; Ye B, 2015, P 2015 IEEE INT C WE, P121; Zhou RF, 2007, IEEE T PARALL DISTR, V18, P460, DOI [10.1109/TPDS.2007.1021, 10.1109/TPDS.2007.1015]	28	4	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151438	10.1371/journal.pone.0151438	http://dx.doi.org/10.1371/journal.pone.0151438			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963089	Green Submitted, gold, Green Published			2022-12-27	WOS:000371993000153
J	Cushing, BS				Cushing, Bruce S.			Estrogen Receptor Alpha Distribution and Expression in the Social Neural Network of Monogamous and Polygynous Peromyscus	PLOS ONE			English	Article							MALE PRAIRIE VOLES; MICROTUS-OCHROGASTER; PATERNAL BEHAVIOR; AGGRESSIVE-BEHAVIOR; STRIA TERMINALIS; MATING SYSTEM; BED NUCLEUS; NEONATAL CASTRATION; SPECIES-DIFFERENCES; EXTENDED AMYGDALA	In microtine and dwarf hamsters low levels of estrogen receptor alpha (ER alpha) in the bed nucleus of the stria terminalis (BST) and medial amygdala (MeA)play a critical role in the expression of social monogamy in males, which is characterized by high levels of affiliation and low levels of aggression. In contrast, monogamous Peromyscus males display high levels of aggression and affiliative behavior with high levels of testosterone and aromatase activity. Suggesting the hypothesis that in Peromyscus ERa expression will be positively correlated with high levels of male prosocial behavior and aggression. ERa expression was compared within the social neural network, including the posterior medial BST, MeA posterodorsal, medial preoptic area (MPOA), ventromedial hypothalamus (VMH), and arcuate nucleus in two monogamous species, P. californicus and P. polionotus, and two polygynous species, P. leucopus and P. maniculatus. The results supported the prediction, with male P. polionotus and P. californicus expressing higher levels of ERa in the BST than their polygynous counter parts, and ERa expression was sexually dimorphic in the polygynous species, with females expressing significantly more than males in the BST in both polygynous species and in the MeA in P. leucopus. Peromyscus ERa expression also differed from rats, mice and microtines as in neither the MPOA nor the VMH was ERa sexually dimorphic. The results supported the hypothesis that higher levels of ERa are associated with monogamy in Peromyscus and that differential expression of ERa occurs in the same regions of the brains regardless of whether high or low expression is associated with social monogamy. Also discussed are possible mechanisms regulating this differential relationship.	[Cushing, Bruce S.] Univ Maryland, Dept Zool, College Pk, MD 20742 USA; [Cushing, Bruce S.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA	University System of Maryland; University of Maryland College Park; University of Texas System; University of Texas El Paso	Cushing, BS (corresponding author), Univ Maryland, Dept Zool, College Pk, MD 20742 USA.; Cushing, BS (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	bcushing@utep.edu			National Institute of Mental Health BSC, NIMH.gov [MH01992]; NIMH [MH01992]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH001992] Funding Source: NIH RePORTER	National Institute of Mental Health BSC, NIMH.gov; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health BSC, NIMH.gov, MH01992.; I want to thank Dr. Kristin Kramer for her help with the preparing tissue and intellectual input, Nancy Cushing for her comments on the numerous drafts of the manuscript, and the members, graduate and undergraduate, of my lab for their tireless effort that has made this manuscript possible. I also want to acknowledge the many researchers that have studied the mechanisms regulating social behavior who have made the hypotheses presented possible. Funding was provided by NIMH MH01992.	Blair WF, 1951, POPULATION STRUCTURE; Brown AE, 1999, DEV BRAIN RES, V115, P171, DOI 10.1016/S0165-3806(99)00061-9; CARTER CS, 1993, SCI AM, V268, P100, DOI 10.1038/scientificamerican0693-100; Choleris E, 2003, P NATL ACAD SCI USA, V100, P6192, DOI 10.1073/pnas.0631699100; Curtis JT, 2003, PHYSIOL BEHAV, V80, P95, DOI 10.1016/S0031-9384(03)00226-9; Cushing BS, 2008, J NEUROSCI, V28, P10399, DOI 10.1523/JNEUROSCI.1928-08.2008; Cushing BS, 2006, J COMP NEUROL, V494, P595, DOI 10.1002/cne.20826; Cushing BS, 2005, NEUROSCI BIOBEHAV R, V29, P1089, DOI 10.1016/j.neubiorev.2005.04.001; Cushing BS, 2004, BRAIN RES, V1016, P247, DOI 10.1016/j.brainres.2004.05.010; Cushing BS, 2003, J NEUROENDOCRINOL, V15, P1021, DOI 10.1046/j.1365-2826.2003.01097.x; Cushing BS, 2003, BRAIN RES, V965, P203, DOI 10.1016/S0006-8993(02)04199-9; Cushing BS, 1996, CAN J ZOOL, V74, P473, DOI 10.1139/z96-055; de Jong TR, 2009, HORM BEHAV, V56, P220, DOI 10.1016/j.yhbeh.2009.05.001; Fink S, 2006, P NATL ACAD SCI USA, V103, P10956, DOI 10.1073/pnas.0602380103; FOLTZ DW, 1981, AM NAT, V117, P665, DOI 10.1086/283751; Fudge JL, 2001, NEUROSCIENCE, V104, P807, DOI 10.1016/S0306-4522(01)00112-9; Fuxjager MJ, 2011, P ROY SOC B-BIOL SCI, V278, P3497, DOI 10.1098/rspb.2011.0301; Gabor CS, 2012, BEHAV NEUROSCI, V126, P97, DOI 10.1037/a0026464; GAINES MS, 1985, CAN J ZOOL, V63, P2525, DOI 10.1139/z85-374; Gettler LT, 2011, P NATL ACAD SCI USA, V108, P16194, DOI 10.1073/pnas.1105403108; GETZ LL, 1981, BEHAV ECOL SOCIOBIOL, V8, P189, DOI 10.1007/BF00299829; GILBERT AN, 1984, J COMP PSYCHOL, V98, P232, DOI 10.1037/0735-7036.98.3.232; Gleason ED, 2010, HORM BEHAV, V57, P147, DOI 10.1016/j.yhbeh.2009.10.006; Gobrogge KL, 2007, J COMP NEUROL, V502, P1109, DOI 10.1002/cne.21364; GUBERNICK DJ, 1987, J COMP PSYCHOL, V101, P169, DOI 10.1037/0735-7036.101.2.169; Hnatczuk O, 1994, J NEUROENDOCRINOL; KIRKPATRICK B, 1994, BRAIN RES, V658, P112, DOI 10.1016/S0006-8993(09)90016-6; Kramer KM, 2006, HORM BEHAV, V49, P206, DOI 10.1016/j.yhbeh.2005.07.001; Kramer KM, 2005, BRAIN RES, V1032, P154, DOI 10.1016/j.brainres.2004.10.070; Kramer KM, 2008, HORM BEHAV, V53, P358, DOI 10.1016/j.yhbeh.2007.11.002; Landeros RV, 2012, ENDOCRINOLOGY, V153, P949, DOI 10.1210/en.2011-1745; Lee AW, 2007, PHYSIOL BEHAV, V92, P617, DOI 10.1016/j.physbeh.2007.05.008; Lei K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008931; Lonstein JS, 2002, HORM BEHAV, V41, P80, DOI 10.1006/hbeh.2001.1740; Luis J, REV DE BIOL TROP, V57, P433; Murakami G, 2011, EUR J NEUROSCI, V34, P469, DOI 10.1111/j.1460-9568.2011.07761.x; Murphy AZ, 1999, HORM BEHAV, V36, P98, DOI 10.1006/hbeh.1999.1528; Nair HP, 2006, PHYSIOLOGY, V21, P146, DOI 10.1152/physiol.00049.2005; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Northcutt KV, 2011, BRAIN BEHAV EVOLUT, V77, P176, DOI 10.1159/000326618; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5058, DOI 10.1210/en.139.12.5058; Oyegbile TO, 2006, PHYSIOL BEHAV, V89, P171, DOI 10.1016/j.physbeh.2006.05.044; Parker KJ, 2001, BEHAV NEUROSCI, V115, P1341, DOI 10.1037/0735-7044.115.6.1341; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pei-Yuan Z, 2008, ACTA ZOOL SINICA; Perry AN, 2009, BEHAV BRAIN RES, V205, P154, DOI 10.1016/j.bbr.2009.08.021; Pfaus JG, 1997, BRAIN RES BULL, V44, P397, DOI 10.1016/S0361-9230(97)00219-0; PIERCE JD, 1991, AGGRESSIVE BEHAV, V17, P337, DOI 10.1002/1098-2337(1991)17:6<337::AID-AB2480170605>3.0.CO;2-F; RIBBLE DO, 1991, BEHAV ECOL SOCIOBIOL, V29, P161, DOI 10.1007/BF00166397; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; THOMAS JA, 1979, BEHAV ECOL SOCIOBIOL, V5, P171, DOI 10.1007/BF00293304; Trainor BC, 2003, NEUROENDOCRINOLOGY, V78, P36, DOI 10.1159/000071704; Trainor BC, 2002, P ROY SOC B-BIOL SCI, V269, P823, DOI 10.1098/rspb.2001.1954; Trainor BC, 2007, EUR J NEUROSCI, V26, P207, DOI 10.1111/j.1460-9568.2007.05654.x; Trainor BC, 2006, HORM BEHAV, V50, P338, DOI 10.1016/j.yhbeh.2006.04.002; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TURNER BN, 1973, ECOLOGY, V54, P967, DOI 10.2307/1935564; Turner LM, 2010, MOL BIOL EVOL, V27, P1269, DOI 10.1093/molbev/msq013; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Yokosuka M, 1997, J COMP NEUROL, V389, P81, DOI 10.1002/(SICI)1096-9861(19971208)389:1<81::AID-CNE6>3.0.CO;2-A	60	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150373	10.1371/journal.pone.0150373	http://dx.doi.org/10.1371/journal.pone.0150373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959827	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300046
J	Czaczkes, TJ; Weichselgartner, T; Bernadou, A; Heinze, J				Czaczkes, Tomer J.; Weichselgartner, Tobias; Bernadou, Abel; Heinze, Juergen			The Effect of Trail Pheromone and Path Confinement on Learning of Complex Routes in the Ant Lasius niger	PLOS ONE			English	Article							MELOPHORUS-BAGOTI; LANDMARK GUIDANCE; FOOD RECRUITMENT; DESERT ANTS; BEHAVIOR; METACOGNITION; NAVIGATION; MEMORY; BEES	Route learning is key to the survival of many central place foragers, such as bees and many ants. For ants which lay pheromone trails, the presence of a trail may act as an important source of information about whether an error has been made. The presence of trail pheromone has been demonstrated to support route learning, and the effect of pheromones on route choice have been reported to persist even after the pheromones have been removed. This could be explained in two ways: the pheromone may constrain the ants onto the correct route, thus preventing errors and aiding learning. Alternatively, the pheromones may act as a 'reassurance', signalling that the learner is on the right path and that learning the path is worthwhile. Here, we disentangle pheromone presence from route confinement in order to test these hypotheses, using the ant Lasius niger as a model. Unexpectedly, we did not find any evidence that pheromones support route learning. Indeed, there was no evidence that ants confined to the correct route learned at all. Thus, while we cannot support the 'reassurance' hypothesis, we can rule out the 'confinement' hypothesis. Other findings, such as a reduction in pheromone deposition in the presence of trail pheromones, are remarkably consistent with previous experiments. As previously reported, ants which make errors on their outward journey upregulate pheromone deposition on their return. Surprisingly, ants which would go on to make an error down-regulate pheromone deposition on their outward journey, hinting at a capacity for ants to gauge the quality of their own memories.	[Czaczkes, Tomer J.; Weichselgartner, Tobias; Bernadou, Abel; Heinze, Juergen] Univ Regensburg, LS Zool Evolut Biol, Fak Biol & Vorklin Med, D-93053 Regensburg, Germany	University of Regensburg	Czaczkes, TJ (corresponding author), Univ Regensburg, LS Zool Evolut Biol, Fak Biol & Vorklin Med, D-93053 Regensburg, Germany.	tomer.czaczkes@biologie.uni-regensburg.de		Bernadou, Abel/0000-0001-5600-587X; Wallner, Tobias/0000-0001-9135-6456	Alexander von Humboldt Postdoctoral Research Scholarship	Alexander von Humboldt Postdoctoral Research Scholarship	This work was supported by an Alexander von Humboldt Postdoctoral Research Scholarship to TJC.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Baddeley B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002336; Baddeley B, 2011, ADAPT BEHAV, V19, P3, DOI 10.1177/1059712310395410; Basari N, 2014, NATURWISSENSCHAFTEN, P1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BECKERS R, 1992, INSECT SOC, V39, P59, DOI 10.1007/BF01240531; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; Collett M, 2013, CURR BIOL, V23, pR789, DOI 10.1016/j.cub.2013.07.020; Collett TS, 2002, NAT REV NEUROSCI, V3, P542, DOI 10.1038/nrn872; COLLETT TS, 1983, TRENDS NEUROSCI, V6, P101, DOI 10.1016/0166-2236(83)90048-6; Colquhoun D, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140216; Crystal JD, 2009, COMP COGN BEHAV REV, V4, P1, DOI 10.3819/ccbr.2009.40001; Czaczkes TJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0679; Czaczkes TJ, 2015, ANNU REV ENTOMOL, V60, P581, DOI 10.1146/annurev-ento-010814-020627; Czaczkes TJ, 2014, J THEOR BIOL, V360, P172, DOI 10.1016/j.jtbi.2014.07.005; Czaczkes TJ, 2013, BEHAV ECOL, V24, P1177, DOI 10.1093/beheco/art046; Czaczkes TJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1009; Czaczkes TJ, 2013, J EXP BIOL, V216, P188, DOI 10.1242/jeb.076570; Czaczkes TJ, 2012, BEHAV ECOL SOCIOBIOL, V66, P1149, DOI 10.1007/s00265-012-1367-7; Czaczkes TJ, 2011, BIOL LETTERS, V7, P521, DOI 10.1098/rsbl.2011.0067; DENEUBOURG JL, 1983, J THEOR BIOL, V105, P259, DOI 10.1016/S0022-5193(83)80007-1; Evison SEF, 2008, BEHAV ECOL SOCIOBIOL, V63, P261, DOI 10.1007/s00265-008-0657-6; Foote AL, 2007, CURR BIOL, V17, P551, DOI 10.1016/j.cub.2007.01.061; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; Graham P, 2006, J EXP BIOL, V209, P3677, DOI 10.1242/jeb.02414; Gruter C, 2008, P R SOC B, V275, P1321, DOI 10.1098/rspb.2008.0186; Gruter C, 2015, ANIM BEHAV, V104, P189, DOI 10.1016/j.anbehav.2015.03.017; Gruter C, 2011, BEHAV ECOL SOCIOBIOL, V65, P141, DOI 10.1007/s00265-010-1020-2; Hampton RR, 2009, COMP COGN BEHAV REV, V4, P17, DOI 10.3819/ccbr.2009.40002; HARRISON JF, 1989, ANIM BEHAV, V37, P869, DOI 10.1016/0003-3472(89)90076-6; Jeanson R, 2003, PHYSIOL ENTOMOL, V28, P192, DOI 10.1046/j.1365-3032.2003.00332.x; Johnson PCD, 2015, METHODS ECOL EVOL, V6, P133, DOI 10.1111/2041-210X.12306; Judd SPD, 1998, NATURE, V392, P710, DOI 10.1038/33681; Knaden M, 2016, ANNU REV ENTOMOL, V61, P63, DOI 10.1146/annurev-ento-010715-023703; Kohler M, 2005, NEUROBIOL LEARN MEM, V83, P1, DOI 10.1016/j.nlm.2004.05.011; LEHRER M, 1991, NATURWISSENSCHAFTEN, V78, P274, DOI 10.1007/BF01134357; Lent DD, 2010, P NATL ACAD SCI USA, V107, P16348, DOI 10.1073/pnas.1006021107; MAUTZ D, 1971, Z VERGL PHYSIOL, V72, P197, DOI 10.1007/BF00297822; Merkle T, 2006, J EXP BIOL, V209, P3545, DOI 10.1242/jeb.02395; Nicholson DJ, 1999, J EXP BIOL, V202, P1831; Perry CJ, 2013, P NATL ACAD SCI USA, V110, P19155, DOI 10.1073/pnas.1314571110; Poulsen M, 2002, BEHAV ECOL SOCIOBIOL, V52, P151, DOI 10.1007/s00265-002-0489-8; R Core Team, 2021, R LANGUAGE ENV STAT; Sakiyama T, 2013, INSECT SOC, V60, P155, DOI 10.1007/s00040-012-0279-x; Schultheiss P, 2011, ANIM BEHAV, V81, P1031, DOI 10.1016/j.anbehav.2011.02.008; Schwarz S, 2012, BEHAV PROCESS, V91, P298, DOI 10.1016/j.beproc.2012.09.013; SIMON T, 1991, INSECT SOC, V38, P17, DOI 10.1007/BF01242709; Smith JD, 2012, PHILOS T R SOC B, V367, P1297, DOI 10.1098/rstb.2011.0366; SMITH JD, 1995, J EXP PSYCHOL GEN, V124, P391, DOI 10.1037/0096-3445.124.4.391; Tanner DA, 2006, BEHAV ECOL SOCIOBIOL, V59, P571, DOI 10.1007/s00265-005-0082-z; Thomson JD, 1996, BEHAV ECOL, V7, P158, DOI 10.1093/beheco/7.2.158; VERHAEGHE JC, 1982, INSECT SOC, V29, P67, DOI 10.1007/BF02224528; von Frisch K., 1967, DANCE LANGUAGE ORIEN; von Thienen W, 2014, BEHAV ECOL SOCIOBIOL, V68, P1611, DOI 10.1007/s00265-014-1770-3; Wei CA, 2002, J COMP PHYSIOL A, V188, P725, DOI 10.1007/s00359-002-0346-2; Weidenmuller A, 1999, BEHAV ECOL SOCIOBIOL, V46, P190, DOI 10.1007/s002650050609	57	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149720	10.1371/journal.pone.0149720	http://dx.doi.org/10.1371/journal.pone.0149720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959996	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300020
J	Dowling, TE; Markle, DF; Tranah, GJ; Carson, EW; Wagman, DW; May, BP				Dowling, Thomas E.; Markle, Douglas F.; Tranah, Greg J.; Carson, Evan W.; Wagman, David W.; May, Bernard P.			Introgressive Hybridization and the Evolution of Lake-Adapted Catostomid Fishes	PLOS ONE			English	Article							FRESH-WATER FISHES; GENETIC-VARIATION; SOCKEYE-SALMON; DNA; SPECIATION; POPULATION; TELEOSTEI; TAXONOMY; FIXATION; SUCKERS	Hybridization has been identified as a significant factor in the evolution of plants as groups of interbreeding species retain their phenotypic integrity despite gene exchange among forms. Recent studies have identified similar interactions in animals; however, the role of hybridization in the evolution of animals has been contested. Here we examine patterns of gene flow among four species of catostomid fishes from the Klamath and Rogue rivers using molecular and morphological traits. Catostomus rimiculus from the Rogue and Klamath basins represent a monophyletic group for nuclear and morphological traits; however, the Klamath form shares mtDNA lineages with other Klamath Basin species (C. snyderi, Chasmistes brevirostris, Deltistes luxatus). Within other Klamath Basin taxa, D. luxatus was largely fixed for alternate nuclear alleles relative to C. rimiculus, while Ch. brevirostris and C. snyderi exhibited a mixture of these alleles. Deltistes luxatus was the only Klamath Basin species that exhibited consistent covariation of nuclear and mitochondrial traits and was the primary source of mismatched mtDNA in Ch. brevirostris and C. snyderi, suggesting asymmetrical introgression into the latter species. In Upper Klamath Lake, D. luxatus spawning was more likely to overlap spatially and temporally with C. snyderi and Ch. brevirostris than either of those two with each other. The latter two species could not be distinguished with any molecular markers but were morphologically diagnosable in Upper Klamath Lake, where they were largely spatially and temporally segregated during spawning. We examine parallel evolution and syngameon hypotheses and conclude that observed patterns are most easily explained by introgressive hybridization among Klamath Basin catostomids.	[Dowling, Thomas E.; Carson, Evan W.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Markle, Douglas F.; Wagman, David W.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Tranah, Greg J.; May, Bernard P.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Dowling, Thomas E.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Tranah, Greg J.] Univ Calif San Francisco, Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94143 USA; [Carson, Evan W.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Carson, Evan W.] Univ New Mexico, Museum Southwestern Biol, Albuquerque, NM 87131 USA; [Wagman, David W.] Oregon Dept Fish & Wildlife, Newport, OR USA	Arizona State University; Arizona State University-Tempe; Oregon State University; University of California System; University of California Davis; Wayne State University; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; University of New Mexico; University of New Mexico	Dowling, TE (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	thomas.dowling@wayne.edu	Carson, Evan/AAD-6482-2021		Cooperative Agreement [9-FC-20-17650]; Bureau of Reclamation (Reclamation) Klamath Project, U.S. Department of Interior; Reclamation's mission to manage, develop, and protect water and related resources in an environmentally and economically sound manner in the interest of the American public; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110907] Funding Source: NIH RePORTER	Cooperative Agreement; Bureau of Reclamation (Reclamation) Klamath Project, U.S. Department of Interior; Reclamation's mission to manage, develop, and protect water and related resources in an environmentally and economically sound manner in the interest of the American public; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Cooperative Agreement 9-FC-20-17650 (http://www.usbr.gov/mp/kbao/). This report was funded by the Bureau of Reclamation (Reclamation) Klamath Project, U.S. Department of Interior, as part of Reclamation's mission to manage, develop, and protect water and related resources in an environmentally and economically sound manner in the interest of the American public. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Andreasen J. K., 1975, THESIS OREGON STATE; Arnold M. L., 2006, EVOLUTION GENETIC EX; Asahida T, 1996, FISHERIES SCI, V62, P727, DOI 10.2331/fishsci.62.727; ASMUSSEN MA, 1994, GENETICS, V138, P1351; Beiko RG, 2008, SYST BIOL, V57, P844, DOI 10.1080/10635150802559265; BERNATCHEZ L, 1995, CAN J FISH AQUAT SCI, V52, P179, DOI 10.1139/f95-018; Bernatchez L, 2010, PHILOS T R SOC B, V365, P1783, DOI 10.1098/rstb.2009.0274; Bielawski JP, 1996, MOL BIOL EVOL, V13, P889, DOI 10.1093/oxfordjournals.molbev.a025649; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Carson EW, 2006, MOL ECOL, V15, P667, DOI 10.1111/j.1365-294X.2005.02763.x; Chan KMA, 2005, EVOLUTION, V59, P720; Cole DD, 2008, MOL ECOL, V17, P5189, DOI 10.1111/j.1365-294X.2008.03990.x; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Coyne J.A., 2004, SPECIATION; DERISH PA, 1988, HUM BIOL, V60, P801; DIECKMANN U, 2004, ADAPTIVE SPECIATION; DOWLING TE, 1989, EVOLUTION, V43, P620, DOI 10.1111/j.1558-5646.1989.tb04257.x; Dowling TE, 1997, COPEIA, P758, DOI 10.2307/1447293; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; DOWLING TE, 1991, EVOLUTION, V45, P944, DOI 10.1111/j.1558-5646.1991.tb04362.x; Dowling TE, 1997, EVOLUTION, V51, P1574, DOI 10.1111/j.1558-5646.1997.tb01480.x; Dowling TE, 1996, MOL ECOL, V14, P123; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J, 2004, INFERRING PHYLOGENIE; FOOTE CJ, 1988, BEHAVIOUR, V106, P43, DOI 10.1163/156853988X00089; Gerber AS, 2001, EVOLUTION, V55, P2028; Grant V., 1981, PLANT SPECIATION; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Houde ED, 1987, AM FISH SOC S, V2, P17; Hubbs C. L., 1943, CONTRIB LAB VERT BIO, V22, P1; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; KAFATOS FC, 1979, NUCLEIC ACIDS RES, V7, P1541, DOI 10.1093/nar/7.6.1541; KARL SA, 1993, MOL BIOL EVOL, V10, P342; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kulathinal RJ, 2000, EVOLUTION, V54, P2176, DOI 10.1111/j.0014-3820.2000.tb01263.x; LESSA EP, 1990, SYST ZOOL, V39, P242, DOI 10.2307/2992184; Lexer C, 2008, PHILOS T R SOC B, V363, P3023, DOI 10.1098/rstb.2008.0078; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Markle DF, 2005, WEST N AM NATURALIST, V65, P473; Martin CH, 2015, EVOLUTION, V69, P1406, DOI 10.1111/evo.12674; Martinsen GD, 2001, EVOLUTION, V55, P1325, DOI 10.1111/j.0014-3820.2001.tb00655.x; MAYR E., 1966, ANIMAL SPECIES EVOLU; McCune B., 2002, ANAL ECOLOGICAL COMM; McCune B., 2011, PC ORD MULTIVARIATE; MILLER R R, 1981, Occasional Papers of the Museum of Zoology University of Michigan, P1; Mock KE, 2006, MOL ECOL, V15, P2223, DOI 10.1111/j.1365-294X.2006.02932.x; Muir G, 2000, NATURE, V405, P1016, DOI 10.1038/35016640; NELLEN W, 1986, MEERESFORSCHUNG, V31, P75; Nosil P, 2012, PHILOS T R SOC B, V367, P332, DOI 10.1098/rstb.2011.0263; Ohno S., 1970, P1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Scoppettone G.G., 1991, P359; SCOPPETTONE GG, 1988, T AM FISH SOC, V117, P301, DOI 10.1577/1548-8659(1988)117<0301:GALOTC>2.3.CO;2; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2003, P ROY SOC B-BIOL SCI, V270, P129, DOI 10.1098/rspb.2002.2153; Seehausen O, 2014, ANNU REV ECOL EVOL S, V45, P621, DOI 10.1146/annurev-ecolsys-120213-091818; Smith G.R., 1993, P778; Smith G. R., 1975, U MICH MUS PALEO PAP, V14, P1; Smith Gerald R., 2013, Occasional Papers of the Museum of Zoology University of Michigan, V743, P1; SMITH GR, 1992, SYST BIOL, V41, P41, DOI 10.2307/2992505; Smith GR, 2002, SMITHSON CONTRIB EAR, P175; SMITH GR, 1981, ANNU REV ECOL SYST, V12, P163, DOI 10.1146/annurev.es.12.110181.001115; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; TAGGART JB, 1992, J FISH BIOL, V40, P963, DOI 10.1111/j.1095-8649.1992.tb02641.x; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor EB, 1996, EVOLUTION, V50, P401, DOI [10.2307/2410810, 10.1111/j.1558-5646.1996.tb04502.x]; Taylor EB, 1999, REV FISH BIOL FISHER, V9, P299, DOI 10.1023/A:1008955229420; Templeton A.R., 1989, P3; Templeton AR, 1998, ENDLESS FORMS, P32; Terwilliger MR, 2010, ENVIRON BIOL FISH, V89, P239, DOI 10.1007/s10641-010-9679-9; Tibbets CA, 1996, EVOLUTION, V50, P1280, DOI 10.1111/j.1558-5646.1996.tb02368.x; Ting CT, 2000, P NATL ACAD SCI USA, V97, P5313, DOI 10.1073/pnas.090541597; Tranah GJ, 2003, CONSERV GENET, V4, P537, DOI 10.1023/A:1024715130637; Tranah GJ, 2006, T AM FISH SOC, V135, P306, DOI 10.1577/T05-026.1; UYENO T, 1972, SCIENCE, V175, P644, DOI 10.1126/science.175.4022.644; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wagman DW, 2003, THESIS OREGON STATE; White P. Scott, 1992, P29; Wilson CC, 1998, MOL ECOL, V7, P127, DOI 10.1046/j.1365-294x.1998.00302.x	83	15	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149884	10.1371/journal.pone.0149884	http://dx.doi.org/10.1371/journal.pone.0149884			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959681	gold, Green Published			2022-12-27	WOS:000371992300027
J	Evans, LS; Hicks, CC; Adger, WN; Barnett, J; Perry, AL; Fidelman, P; Tobin, R				Evans, Louisa S.; Hicks, Christina C.; Adger, W. Neil; Barnett, Jon; Perry, Allison L.; Fidelman, Pedro; Tobin, Renae			Structural and Psycho-Social Limits to Climate Change Adaptation in the Great Barrier Reef Region	PLOS ONE			English	Article							OCEAN ACIDIFICATION; AUSTRALIA; FISHERIES; FUTURE; RISK	Adaptation, as a strategy to respond to climate change, has limits: there are conditions under which adaptation strategies fail to alleviate impacts from climate change. Research has primarily focused on identifying absolute bio-physical limits. This paper contributes empirical insight to an emerging literature on the social limits to adaptation. Such limits arise from the ways in which societies perceive, experience and respond to climate change. Using qualitative data from multi-stakeholder workshops and key-informant interviews with representatives of the fisheries and tourism sectors of the Great Barrier Reef region, we identify psycho-social and structural limits associated with key adaptation strategies, and examine how these are perceived as more or less absolute across levels of organisation. We find that actors experience social limits to adaptation when: i) the effort of pursuing a strategy exceeds the benefits of desired adaptation outcomes; ii) the particular strategy does not address the actual source of vulnerability, and; iii) the benefits derived from adaptation are undermined by external factors. We also find that social limits are not necessarily more absolute at higher levels of organisation: respondents perceived considerable opportunities to address some psycho-social limits at the national-international interface, while they considered some social limits at the local and regional levels to be effectively absolute.	[Evans, Louisa S.; Adger, W. Neil] Univ Exeter, Coll Life & Environm Sci, Geog, Exeter, Devon, England; [Evans, Louisa S.; Hicks, Christina C.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Hicks, Christina C.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Barnett, Jon] Univ Melbourne, Sch Geog, Melbourne, Vic, Australia; [Perry, Allison L.] Oceana, C Leganitos 47, Madrid 28013, Spain; [Fidelman, Pedro] Univ Sunshine Coast, Sustainabil Res Ctr, Sunshine Coast, Australia; [Tobin, Renae] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Sch Earth Environm Sci, Townsville, Qld 4811, Australia	University of Exeter; James Cook University; Lancaster University; University of Melbourne; University of the Sunshine Coast; James Cook University	Evans, LS (corresponding author), Univ Exeter, Coll Life & Environm Sci, Geog, Exeter, Devon, England.; Evans, LS (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	Louisa.evans@exeter.ac.uk	Fidelman, Pedro/N-1466-2014; Barnett, Jon/AAQ-9002-2021; Adger, Neil/F-7676-2010; Hicks, Christina/M-6182-2015	Fidelman, Pedro/0000-0001-7780-0952; Barnett, Jon/0000-0002-0862-0808; Adger, Neil/0000-0003-4244-2854; Hicks, Christina/0000-0002-7399-4603	Australian National Climate Change Adaptation Research Facility; HELIX (High-End Climate Impacts and Extremes) project - European Union; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Australian National Climate Change Adaptation Research Facility; HELIX (High-End Climate Impacts and Extremes) project - European Union; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Australian National Climate Change Adaptation Research Facility (no grant number) funded a project on limits to climate change adaptation. The project on the Great Barrier Reef was one component. WNA acknowledges support from the HELIX (High-End Climate Impacts and Extremes) project funded by the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger W. N., 2007, CLIMATE CHANGE 2007, P717, DOI DOI 10.1017/CB09781107415324.004; Adger WN, 2009, ENVIRON PLANN A, V41, P2800, DOI 10.1068/a42244; Adger WN, 2009, CLIMATIC CHANGE, V93, P335, DOI 10.1007/s10584-008-9520-z; Adger WN, 2005, GLOBAL ENVIRON CHANG, V15, P77, DOI [10.1016/j.gloenvcha.2004.12.005, 10.1016/j.gloenvcha.2005.03.001]; Agrawal A, 2009, ADAPTING TO CLIMATE CHANGE: THRESHOLDS, VALUES, GOVERNANCE, P350; Agrawala S., 2008, EC ASPECTS ADAPTATIO; Barnett J, 2015, ECOL SOC, V20, DOI 10.5751/ES-07698-200305; Brodie J, 2012, ESTUAR COAST SHELF S, V104, P1, DOI 10.1016/j.ecss.2012.03.012; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Burt RS, 2005, BROKERAGE CLOSURE IN; Coulthard S, 2008, GLOBAL ENVIRON CHANG, V18, P479, DOI 10.1016/j.gloenvcha.2008.04.003; de Sherbinin A, 2011, SCIENCE, V334, P456, DOI 10.1126/science.1208821; Dow K, 2013, CURR OPIN ENV SUST, V5, P384, DOI 10.1016/j.cosust.2013.07.005; Dow K, 2013, NAT CLIM CHANGE, V3, P305, DOI 10.1038/nclimate1847; Evans LS, 2013, HUM ECOL, V41, P841, DOI 10.1007/s10745-013-9601-0; Fabinyi M, 2012, ENVIRON CONSERV, V39, P83, DOI 10.1017/S0376892911000609; Felgenhauer T, 2015, ENVIRON SCI POLICY, V50, P214, DOI 10.1016/j.envsci.2015.03.003; Finan TJ, 2009, ADAPTING TO CLIMATE CHANGE: THRESHOLDS, VALUES, GOVERNANCE, P335; Gifford R, 2011, AM PSYCHOL, V66, P290, DOI 10.1037/a0023566; Grothmann T, 2005, GLOBAL ENVIRON CHANG, V15, P199, DOI 10.1016/j.gloenvcha.2005.01.002; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Kinzig AP, 2011, SCIENCE, V334, P603, DOI 10.1126/science.1210297; Klein RJT, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P899; Laube W, 2012, CLIMATIC CHANGE, V111, P753, DOI 10.1007/s10584-011-0199-1; Macintosh A, 2015, J ENVIRON PLANN MAN, V58, P1432, DOI 10.1080/09640568.2014.930706; Mapstone BD, 2008, FISH RES, V94, P315, DOI 10.1016/j.fishres.2008.07.013; Marino E, 2012, GLOBAL ENVIRON CHANG, V22, P323, DOI 10.1016/j.gloenvcha.2012.03.001; Marshall NA, 2007, ECOL SOC, V12, DOI 10.5751/es-01940-120101; Metzger MJ, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/031001; Ministry of Resources Energy and Tourism, 2011, EXTR 2 MILL BRINGS Q; Moloney S, 2010, ENERG POLICY, V38, P7614, DOI 10.1016/j.enpol.2009.06.058; Moser SC, 2010, P NATL ACAD SCI USA, V107, P22026, DOI 10.1073/pnas.1007887107; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Park SE, 2012, GLOBAL ENVIRON CHANG, V22, P115, DOI 10.1016/j.gloenvcha.2011.10.003; Pound D, TRAINING MANUAL; Reinert ES, 2009, ADAPTING TO CLIMATE CHANGE: THRESHOLDS, VALUES, GOVERNANCE, P417; Satterfield TA, 2004, RISK ANAL, V24, P115, DOI 10.1111/j.0272-4332.2004.00416.x; Smith MS, 2011, PHILOS T R SOC A, V369, P196, DOI 10.1098/rsta.2010.0277; Tobin A., 2010, 2008103 J COOK U FIS, P1; Tompkins EL, 2001, ENV HAZARDS, V8, P263; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Travis WR, 2010, CLIMATIC CHANGE, V98, P1, DOI 10.1007/s10584-009-9661-8; UNESCO, 2012, 36 SESS SAINT PET RU; Warner BP, 2015, GLOBAL ENVIRON CHANG, V30, P101, DOI 10.1016/j.gloenvcha.2014.11.002; Waycott M., 2007, CLIMATE CHANGE GREAT, P193	46	21	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150575	10.1371/journal.pone.0150575	http://dx.doi.org/10.1371/journal.pone.0150575			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TF	26960200	gold, Green Accepted, Green Published			2022-12-27	WOS:000371992300058
J	Gao, Y; Wang, XL; Yan, HL; Zeng, J; Ma, S; Niu, YY; Zhou, GX; Jiang, Y; Chen, YL				Gao, Ye; Wang, Xiaolong; Yan, Hailong; Zeng, Jie; Ma, Sen; Niu, Yiyuan; Zhou, Guangxian; Jiang, Yu; Chen, Yulin			Comparative Transcriptome Analysis of Fetal Skin Reveals Key Genes Related to Hair Follicle Morphogenesis in Cashmere Goats	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; EXPRESSION PATTERNS; CHANGING PATTERNS; DIFFERENTIATION; KERATIN; PROTEIN; BIOLOGY; HOXC13; ANAGEN; KINASE	Cashmere goat skin contains two types of hair follicles (HF): primary hair follicles (PHF) and secondary hair follicles (SHF). Although multiple genetic determinants associated with HF formation have been identified, the molecules that determine the independent morphogenesis of HF in cashmere goats remain elusive. The growth and development of SHF directly influence the quantity and quality of cashmere production. Here, we report the transcriptome profiling analysis of nine skin samples from cashmere goats using 60- and 120-dayold embryos (E60 and E120, respectively), as well as newborns (NB), through RNAsequencing (RNA-seq). HF morphological changes indicated that PHF were initiated at E60, with maturation from E120, while differentiation of SHF was identified at E120 until formation of cashmere occurred after birth (NB). The RNA-sequencing analysis generated over 20.6 million clean reads from each mRNA library. The number of differentially expressed genes (DEGs) in E60 vs. E120, E120 vs. NB, and E60 vs. NB were 1,024, 0 and 1,801, respectively, indicating that no significant differences were found at transcriptomic levels between E120 and NB. Key genes including B4GALT4, TNC, a-integrin, and FGFR1, were up-regulated and expressed in HF initiation from E60 to E120, while regulatory genes such as GPRC5D, PAD3, HOXC13, PRR9, VSIG8, LRRC15, LHX2, MSX-2, and FOXN1 were up-regulated and expressed in HF keratinisation and hair shaft differentiation from E120 and NB to E60. Several genes belonging to the KRT and KRTAP gene families were detected throughout the three HF developmental stages. The transcriptional trajectory analyses of all DEGs indicated that immune privilege, glycosaminoglycan biosynthesis, extracellular matrix receptor interaction, and growth factor receptors all played dominant roles in the epithelial-mesenchymal interface and HF formation. We found that the Wnt, transforming growth factor-beta/bone morphogenetic protein, and Notch family members played vital roles in HF differentiation and maturation. The DEGs we found could be attributed to the generation and development of HF, and thus will be critically important for improving the quantity and quality of fleece production in animals for fibres.	[Gao, Ye; Wang, Xiaolong; Yan, Hailong; Zeng, Jie; Ma, Sen; Niu, Yiyuan; Zhou, Guangxian; Jiang, Yu; Chen, Yulin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China; [Gao, Ye; Yan, Hailong] Yulin Univ, Coll Life Sci, Yulin, Peoples R China	Northwest A&F University - China; Yulin University	Chen, YL (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China.	chenyulin@nwafu.edu.cn	Jiang, Yu/O-5114-2015	Jiang, Yu/0000-0003-4821-3585; Niu, Yiyuan/0000-0003-1195-0223	National Science Foundation Council [31372279, 31402038, 31572369]; Major Projects for New Varieties of Genetically Modified Organisms of China [2014ZX08008-002]; Natural Science Foundation [2014JM3068]; International Sci-Tech Cooperation Program of Shaanxi Province [2014KW14-01]	National Science Foundation Council(National Natural Science Foundation of China (NSFC)); Major Projects for New Varieties of Genetically Modified Organisms of China; Natural Science Foundation(National Natural Science Foundation of China (NSFC)); International Sci-Tech Cooperation Program of Shaanxi Province	This work was supported by grants from National Science Foundation Council (31372279, 31402038, and 31572369), Major Projects for New Varieties of Genetically Modified Organisms of China (2014ZX08008-002), Natural Science Foundation (2014JM3068) and International Sci-Tech Cooperation Program (2014KW14-01) of Shaanxi Province.	Akiyama M, 2000, J INVEST DERMATOL, V114, P321, DOI 10.1046/j.1523-1747.2000.00857.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ansari-Renani HR, 2011, SMALL RUMINANT RES, V95, P128, DOI 10.1016/j.smallrumres.2010.09.013; AUBER L., 1952, TRANS ROY SOC EDINBURGH, V62, P191; Benjamini Y, 2001, ANN STAT, V29, P1165; CARTER H. B., 1957, AUSTRALIAN JOUR AGRIC RES, V8, P91, DOI 10.1071/AR9570091; Chang KW, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1202-9; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Fan RW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-389; Galbraith H, 2000, LIVEST PROD SCI, V64, P81, DOI 10.1016/S0301-6226(00)00177-9; Galbraith H, 2010, ANIMAL, V4, P1490, DOI 10.1017/S175173111000025X; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Geng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062704; Giesen M, 2011, EXP DERMATOL, V20, P759, DOI 10.1111/j.1600-0625.2011.01301.x; GRIMBLE R F, 2002, NUTR IMMUNE FUNCTION, V1, P133; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hardy MH, 1996, ACTA ANAT, V157, P169; Hubmacher D, 2013, CURR OPIN RHEUMATOL, V25, P65, DOI 10.1097/BOR.0b013e32835b137b; Iino M, 2007, J INVEST DERMATOL, V127, P1318, DOI 10.1038/sj.jid.5700728; Inoue S, 2004, J INVEST DERMATOL, V122, P565, DOI 10.1046/j.0022-202X.2004.12628.x; Jave-Suarez LF, 2002, J BIOL CHEM, V277, P3718, DOI 10.1074/jbc.M101616200; KAPLAN ED, 1994, DEV DYNAM, V199, P141, DOI 10.1002/aja.1001990207; Krause K, 2006, BIOL HAIR FOLLICLE B, P2; Laatsch CN, 2014, PEERJ, V2, DOI 10.7717/peerj.506; Langbein L, 2005, INT REV CYTOL, V243, P1, DOI 10.1016/S0074-7696(05)43001-6; Langbein L, 2009, J INVEST DERMATOL, V130, P55; Lee J, 2012, HAIRY TALE SIGNALING, P906; Li J, 2007, DIFFERENTIATION, V75, P694, DOI 10.1111/j.1432-0436.2007.00176.x; Liu HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077062; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Ma L, 2003, DEVELOPMENT, V130, P379, DOI 10.1242/dev.00201; Malgouries S, 2008, BRIT J DERMATOL, V158, P234, DOI 10.1111/j.1365-2133.2007.08339.x; MCDONALD BJ, 1987, AUST J AGR RES, V38, P597, DOI 10.1071/AR9870597; McDowall A, 2008, CYTOKINE GROWTH F R, V19, P415, DOI [10.1016/j.cytogfr.2009.08.005, 10.1016/j.cytogfr.2008.08.005]; Nachat R, 2005, J INVEST DERMATOL, V125, P34, DOI 10.1111/j.0022-202X.2005.23763.x; NIXON AJ, 1993, BIOTECH HISTOCHEM, V68, P316, DOI 10.3109/10520299309105637; Pi LQ, 2013, NEUROPEPTIDES, V47, P51, DOI 10.1016/j.npep.2012.07.008; POWELL BC, 1991, ANN NY ACAD SCI, V642, P1; RENDL M., 2005, PLOS BIOL, V3, P331; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rishikaysh P, 2014, INT J MOL SCI, V15, P1647, DOI 10.3390/ijms15011647; Rogers GE, 2004, INT J DEV BIOL, V48, P163, DOI 10.1387/ijdb.15272381; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; SORRELL JM, 1990, HISTOCHEMISTRY, V94, P269; Su R, 2009, CAN J ANIM SCI, V89, P457, DOI 10.4141/CJAS08130; TETI A, 1992, J AM SOC NEPHROL, V2, pS83; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; WILLEN MD, 1991, J INVEST DERMATOL, V96, P968, DOI 10.1111/1523-1747.ep12476335; Wu JH, 2009, AGR SCI CHINA, V8, P491, DOI 10.1016/S1671-2927(08)60237-0; Xu T, 2013, GENE, V520, P30, DOI 10.1016/j.gene.2013.01.068; Yu ZD, 2009, DIFFERENTIATION, V77, P307, DOI 10.1016/j.diff.2008.10.009; Zhang YanJun, 2007, Scientia Agricultura Sinica, V40, P1017; Zhu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076282	57	49	58	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151118	10.1371/journal.pone.0151118	http://dx.doi.org/10.1371/journal.pone.0151118			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959817	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300100
J	Li, H; Li, DF; Chen, AG; Tang, HJ; Li, JJ; Huang, SQ				Li, Hui; Li, Defang; Chen, Anguo; Tang, Huijuan; Li, Jianjun; Huang, Siqi			Characterization of the Kenaf (Hibiscus cannabinus) Global Transcriptome Using Illumina Paired-End Sequencing and Development of EST-SSR Markers	PLOS ONE			English	Article							GENETIC DIVERSITY; SRAP; VARIETIES; TOOL	Kenaf (Hibiscus cannabinus L.) is an economically important natural fiber crop grown worldwide. However, only 20 expressed tag sequences (ESTs) for kenaf are available in public databases. The aim of this study was to develop large-scale simple sequence repeat (SSR) markers to lay a solid foundation for the construction of genetic linkage maps and marker-assisted breeding in kenaf. We used Illumina paired-end sequencing technology to generate new EST-simple sequences and MISA software to mine SSR markers. We identified 71,318 unigenes with an average length of 1143 nt and annotated these unigenes using four different protein databases. Overall, 9324 complementary pairs were designated as EST-SSR markers, and their quality was validated using 100 randomly selected SSR markers. In total, 72 primer pairs reproducibly amplified target amplicons, and 61 of these primer pairs detected significant polymorphism among 28 kenaf accessions. Thus, in this study, we have developed large-scale SSR markers for kenaf, and this new resource will facilitate construction of genetic linkage maps, investigation of fiber growth and development in kenaf, and also be of value to novel gene discovery and functional genomic studies.	[Li, Hui; Li, Defang; Chen, Anguo; Tang, Huijuan; Li, Jianjun; Huang, Siqi] Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Bast Fiber Crops, CAAS	Li, DF (corresponding author), Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China.	chinakenaf@126.com			China Agriculture Technology Research System [CARS-19-E07]; Agricultural Science and Technology Innovation Program [ASTIP-IBFC03]	China Agriculture Technology Research System; Agricultural Science and Technology Innovation Program	This work was supported by China Agriculture Technology Research System (CARS-19-E07), Agricultural Science and Technology Innovation Program (ASTIP-IBFC03).	Alexopoulou E, 2000, IND CROP PROD, V11, P163, DOI 10.1016/S0926-6690(99)00064-3; Banuelos GS, 2002, IND CROP PROD, V15, P237, DOI 10.1016/S0926-6690(01)00119-4; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Chen MX, 2011, PLANT BREEDING, V130, P679, DOI 10.1111/j.1439-0523.2011.01879.x; Chen P, 2014, MOL BREEDING, V34, P1879, DOI 10.1007/s11032-014-0146-8; Cheng Z, 2002, HEREDITAS, V136, P231, DOI 10.1034/j.1601-5223.2002.1360309.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kemble LJ, 2002, BIOSYST ENG, V81, P49, DOI 10.1006/bioe.2001.0005; KORTT AA, 1991, EUR J BIOCHEM, V195, P329, DOI 10.1111/j.1432-1033.1991.tb15710.x; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Liu A. M., 2000, P 2000 INT KEN S HIR, P30; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; [刘倩 Liu Qian], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P1974; Liu TM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-125; Simbaqueba J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026719; Squirrell J, 2003, MOL ECOL, V12, P1339, DOI 10.1046/j.1365-294X.2003.01825.x; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; Wang Bin, 2011, Acta Agronomica Sinica, V37, P1116, DOI 10.3724/SP.J.1006.2011.01116; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Webber C. L. III, 2002, Trends in new crops and new uses. Proceedings of the Fifth National Symposium, Atlanta, Georgia, USA, 10-13 November, 2001, P348; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Xu JT, 2013, BIOCHEM SYST ECOL, V49, P94, DOI 10.1016/j.bse.2013.03.006; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu JM, 2009, PLANT GENOME-US, V2, P63, DOI 10.3835/plantgenome2008.09.0009; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang LW, 2013, BIOCHEM GENET, V51, P800, DOI 10.1007/s10528-013-9608-7	31	12	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150548	10.1371/journal.pone.0150548	http://dx.doi.org/10.1371/journal.pone.0150548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960153	Green Submitted, gold, Green Published			2022-12-27	WOS:000371992300057
J	Song, H; Abnet, CC; Andren-Sandberg, A; Chaturvedi, AK; Ye, WM				Song, Huan; Abnet, Christian C.; Andren-Sandberg, Ake; Chaturvedi, Anil K.; Ye, Weimin			Risk of Gastrointestinal Cancers among Patients with Appendectomy: A Large-Scale Swedish Register-Based Cohort Study during 1970-2009	PLOS ONE			English	Article							ACUTE APPENDICITIS; HELICOBACTER-PYLORI; INCIDENTAL APPENDECTOMY; NEGATIVE APPENDECTOMY; EPIDEMIOLOGY; CHILDHOOD; DIAGNOSIS; ACCURACY; CHILDREN; SMOKING	Background Removal of the appendix might induce physiological changes in the gastrointestinal tract, and subsequently play a role in carcinogenesis. Therefore, we conducted a nationwide register-based cohort study in Sweden to investigate whether appendectomy is associated with altered risks of gastrointestinal cancers. Methods A population-based cohort study was conducted using the Swedish national registries, including 480,382 eligible patients followed during the period of 1970-2009 for the occurrence of site-specific gastrointestinal cancer (esophageal/gastric/colon/rectal cancer). Outcome and censoring information was collected by linkage to health and demography registers. We examined the incidence of appendectomy in Sweden using data from 1987-2009. We also calculated standardized incidence ratios (SIRs) with 95% confidence intervals (CIs) to estimate the relative gastrointestinal cancer risk through comparison to the general population. Results We noted an overall decrease in the age-standardized incidence of appendectomy among the entire Swedish population from 189.3 to 105.6 per 100,000 individuals between 1987 and 2009. Grouped by different discharge diagnosis, acute appendicitis, incidental appendectomy, and entirely negative appendectomy continuously decreased over the study period, while the perforation ratio (18%-23%) stayed relatively constant. Compared to the general population, no excess cancer risk was observed for gastrointestinal cancers under study with the exception of a marginally elevated risk for esophageal adenocarcinoma (SIR 1.32, 95% CI 1.09-1.58). Conclusions In Sweden, the incidence of appendectomy and acute appendicitis has decreased during 1987-2009. No excess gastrointestinal cancer risks were observed among these appendectomized patients, with the possible exception of esophageal adenocarcinoma.	[Song, Huan; Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Abnet, Christian C.; Chaturvedi, Anil K.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Andren-Sandberg, Ake] Karolinska Univ Hosp, Dept Digest Dis, Stockholm, Sweden	Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Karolinska Institutet; Karolinska University Hospital	Song, H; Ye, WM (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	huan.song@ki.se; weimin.ye@ki.se	Abnet, Christian C/C-4111-2015	Abnet, Christian C/0000-0002-3008-7843; Song, Huan/0000-0003-3845-8079	Swedish Research Council (SIMSAM Grant) [80748301]; Intramural Research Program of the National Cancer Institute, NIH; China Scholarship Council	Swedish Research Council (SIMSAM Grant); Intramural Research Program of the National Cancer Institute, NIH; China Scholarship Council(China Scholarship Council)	This work was supported by grants from Swedish Research Council (SIMSAM Grant, grant number: 80748301) and Intramural Research Program of the National Cancer Institute, NIH; H.S. was also partly supported by a scholarship from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Anderson JE, 2012, WORLD J SURG, V36, P2787, DOI 10.1007/s00268-012-1749-z; Andersson RE, 2013, WORLD J SURG, V37, P974, DOI 10.1007/s00268-012-1856-x; Andreu-Ballester JC, 2009, DIGEST SURG, V26, P406, DOI 10.1159/000235956; [Anonymous], 2013, CANC INC SWED 2011; Bendeck SE, 2002, RADIOLOGY, V225, P131, DOI 10.1148/radiol.2251011780; Blomqvist P, 1998, J CLIN EPIDEMIOL, V51, P859, DOI 10.1016/S0895-4356(98)00065-1; Bollinger RR, 2007, J THEOR BIOL, V249, P826, DOI 10.1016/j.jtbi.2007.08.032; Buckius MT, 2012, J SURG RES, V175, P185, DOI 10.1016/j.jss.2011.07.017; Charfi S, 2014, INT J COLORECTAL DIS, V29, P1009, DOI 10.1007/s00384-014-1934-7; Cope JU, 2003, PEDIATRICS, V111, P1343, DOI 10.1542/peds.111.6.1343; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Ekbom A, 1998, GUT, V43, P451, DOI 10.1136/gut.43.4.451; Ekstrom AM, 1999, JNCI-J NATL CANCER I, V91, P786, DOI 10.1093/jnci/91.9.786; FRIEDMAN GD, 1990, CANCER RES, V50, P7549; Guinane CM, 2013, MBIO, V4, DOI 10.1128/mBio.00366-12; HELDENBERG D, 1995, AM J GASTROENTEROL, V90, P906; Kell MR, 1999, BRIT J SURG, V86, P1538, DOI 10.1046/j.1365-2168.1999.01268.x; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; MALATY HM, 1994, GUT, V35, P742, DOI 10.1136/gut.35.6.742; MALT RA, 1986, NEW ENGL J MED, V315, P1546, DOI 10.1056/NEJM198612113152409; Mellemkjaer L, 1998, CANCER CAUSE CONTROL, V9, P183, DOI 10.1023/A:1008834311514; Montgomery SM, 1999, LANCET, V353, P379, DOI 10.1016/S0140-6736(05)74951-5; Nordenvall C, 2011, INT J CANCER, V128, P157, DOI 10.1002/ijc.25305; Pinto F, 2013, CRIT ULTRASOUND J, V5, DOI 10.1186/2036-7902-5-S1-S2; Saito JM, 2013, PEDIATRICS, V131, pE37, DOI 10.1542/peds.2012-1665; Salminen P, 2015, JAMA-J AM MED ASSOC, V313, P2340, DOI 10.1001/jama.2015.6154; Salom EM, 2003, AM J OBSTET GYNECOL, V189, P1563, DOI 10.1016/S0002-9378(03)00936-0; VOITK AJ, 1988, CAN J SURG, V31, P448; Webb EM, 2011, AM J ROENTGENOL, V197, P861, DOI 10.2214/AJR.10.5369; WHO, 2002, WORLD HLTH REP RED R; Wu SC, 2015, PLOS ONE, P10; Ye W, 2003, GUT, V52, P938, DOI 10.1136/gut.52.7.938	33	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151262	10.1371/journal.pone.0151262	http://dx.doi.org/10.1371/journal.pone.0151262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959234	gold, Green Submitted, Green Published			2022-12-27	WOS:000371992300114
J	Tsevegmid, K; Neumann, P; Yanez, O				Tsevegmid, Khaliunaa; Neumann, Peter; Yanez, Orlando			The Honey Bee Pathosphere of Mongolia: European Viruses in Central Asia	PLOS ONE			English	Article							DEFORMED WING VIRUS; APIS-MELLIFERA L.; NOSEMA-CERANAE; VARROA-DESTRUCTOR; MICROSPORIDIAN PARASITE; PREVALENCE; MITE; PATHOGENS; SPREAD; PCR	Parasites and pathogens are apparent key factors for the detrimental health of managed European honey bee subspecies, Apis mellifera. Apicultural trade is arguably the main factor for the almost global distribution of most honey bee diseases, thereby increasing chances for multiple infestations/infections of regions, apiaries, colonies and even individual bees. This imposes difficulties to evaluate the effects of pathogens in isolation, thereby creating demand to survey remote areas. Here, we conducted the first comprehensive survey for 14 honey bee pathogens in Mongolia (N = 3 regions, N = 9 locations, N = 151 colonies), where honey bee colonies depend on humans to overwinter. In Mongolia, honey bees, Apis spp., are not native and colonies of European A. mellifera subspecies have been introduced similar to 60 years ago. Despite the high detection power and large sample size across Mongolian regions with beekeeping, the mite Acarapis woodi, the bacteria Melissococcus plutonius and Paenibacillus larvae, the microsporidian Nosema apis, Acute bee paralysis virus, Kashmir bee virus, Israeli acute paralysis virus and Lake Sinai virus strain 2 were not detected, suggesting that they are either very rare or absent. The mite Varroa destructor, Nosema ceranae and four viruses (Sacbrood virus, Black queen cell virus, Deformed wing virus (DWV) and Chronic bee paralysis virus) were found with different prevalence. Despite the positive correlation between the prevalence of V. destructor mites and DWV, some areas had only mites, but not DWV, which is most likely due to the exceptional isolation of apiaries (up to 600 km). Phylogenetic analyses of the detected viruses reveal their clustering and European origin, thereby supporting the role of trade for pathogen spread and the isolation of Mongolia from South-Asian countries. In conclusion, this survey reveals the distinctive honey bee pathosphere of Mongolia, which offers opportunities for exciting future research.	[Tsevegmid, Khaliunaa; Neumann, Peter; Yanez, Orlando] Univ Bern, Vetsuisse Fac, Inst Bee Hlth, Bern, Switzerland; [Tsevegmid, Khaliunaa] Mongolian State Univ Agr, Ulaanbaatar, Mongolia; [Neumann, Peter] Swiss Bee Res Ctr, Agroscope, Bern, Switzerland; [Neumann, Peter] Chiang Mai Univ, Fac Sci, Bee Protect Lab, Chiang Mai 50000, Thailand	University of Bern; Mongolian University of Life Sciences; Swiss Federal Research Station Agroscope; Chiang Mai University	Yanez, O (corresponding author), Univ Bern, Vetsuisse Fac, Inst Bee Hlth, Bern, Switzerland.	orlando.yanez@vetsuisse.unibe.ch	Yanez, Orlando/AAQ-8347-2020; Neumann, Peter/C-9964-2015; Yanez, Orlando/I-2428-2016	Yanez, Orlando/0000-0001-8493-2726; Neumann, Peter/0000-0001-5163-5215; Yanez, Orlando/0000-0001-8493-2726	Swiss Government Excellence Scholarship; Vinetum Foundation; Swiss National Science Foundation (SNF) [31003A_141006/1]	Swiss Government Excellence Scholarship; Vinetum Foundation; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	Financial support was granted to KT via a Swiss Government Excellence Scholarship and to OY and PN via the Vinetum Foundation (http://www.vinetum.ch) and the Swiss National Science Foundation (SNF 31003A_141006/1; http://www.snf.ch) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebil A, 2012, TRENDS ECOL EVOL, V27, P142, DOI 10.1016/j.tree.2011.11.017; Ai HX, 2012, J INVERTEBR PATHOL, V109, P160, DOI 10.1016/j.jip.2011.10.006; [Anonymous], 2013, YB MS; BAILEY L, 1983, ANN APPL BIOL, V103, P13, DOI 10.1111/j.1744-7348.1983.tb02735.x; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Chauzat P, 2014, PAN EUROPEAN EPIDEMI; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crane, 2013, WORLD HIST BEEKEEPIN; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; de Graaf DC, 2001, APIDOLOGIE, V32, P587, DOI 10.1051/apido:2001146; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; Evans JD, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.11; Forsgren E, 2010, J INVERTEBR PATHOL, V103, pS5, DOI 10.1016/j.jip.2009.06.016; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; Fries I., 2013, J APICULT RES, V52, P1, DOI [10.3896/ IBRA. 1.52.1.14, DOI 10.3896/IBRA.1.52.1.14]; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Gajger IT, 2014, APIDOLOGIE, V45, P701, DOI 10.1007/s13592-014-0287-0; Genersch E, 2003, APIDOLOGIE, V34, P195, DOI 10.1051/apido:2003025; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Human H, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.10; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Kojima Y, 2011, MICROB ECOL, V62, P895, DOI 10.1007/s00248-011-9947-z; Lomakina NF, 2012, MOL GENET MICROBIOL+, V27, P127, DOI 10.3103/S0891416812030068; Mutinelli F, 2011, REV SCI TECH OIE, V30, P257; Navajas M, 2010, APIDOLOGIE, V41, P181, DOI 10.1051/apido/2009068; Neumann P, 2012, TRENDS PARASITOL, V28, P353, DOI 10.1016/j.pt.2012.06.004; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Pirk CWW, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.13; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Ravoet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072443; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Ryba S, 2012, BIOLOGIA, V67, P590, DOI 10.2478/s11756-012-0038-5; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Vanbergen AJ., 2012, INSECT POLLINATORS L; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wilkins S, 2007, PEST MANAG SCI, V63, P1062, DOI 10.1002/ps.1461; Yang B, 2013, ECOL EVOL, V3, P298, DOI 10.1002/ece3.464	48	12	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151164	10.1371/journal.pone.0151164	http://dx.doi.org/10.1371/journal.pone.0151164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959221	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300105
J	Gozli, DG; Pratt, J; Martin, KZ; Chasteen, AL				Gozli, Davood G.; Pratt, Jay; Martin, K. Zoe; Chasteen, Alison L.			Implied Spatial Meaning and Visuospatial Bias: Conceptual Processing Influences Processing of Visual Targets and Distractors	PLOS ONE			English	Article							POLARITY CORRESPONDENCE; VERTICAL SPACE; SYMBOLIC VALUE; OBJECT WORDS; ATTENTION; DRIVEN; SHIFTS; TIME; ASSOCIATIONS; PERCEPTION	Concepts with implicit spatial meaning (e.g., "hat", "boots") can bias visual attention in space. This result is typically found in experiments with a single visual target per trial, which can appear at one of two locations (e.g., above vs. below). Furthermore, the interaction is typically found in the form of speeded responses to targets appearing at the compatible location (e.g., faster responses to a target above fixation, after reading "hat"). It has been argued that these concept-space interactions could also result from experimentally-induced associations between the binary set of locations and the conceptual categories with upward and downward meaning. Thus, rather than reflecting a conceptually driven spatial bias, the effect could reflect a benefit for compatible cue-target sequences that occurs only after target onset. We addressed these concerns by going beyond a binary set of locations and employing a search display consisting of four items (above, below, left, and right). Within each search trial, before performing a visual search task, participants performed a conceptual task involving concepts with implicit upward or downward meaning. The search display, in addition to including a target, could also include a salient distractor. Assuming a conceptually driven visual bias, we expected to observe, first, a benefit for target processing at the compatible location and, second, an increase in the cost of the salient distractor. The findings confirmed both predictions, suggesting that concepts do indeed generate a spatial bias. Finally, results from a control experiment, without the conceptual task, suggest the presence of an axis-specific effect, in addition to the location-specific effect, suggesting that concepts might cause both location-specific and axis-specific spatial bias. Taken together, our findings provide additional support for the involvement of spatial processing in conceptual understanding.	[Gozli, Davood G.; Pratt, Jay; Martin, K. Zoe; Chasteen, Alison L.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Gozli, Davood G.] Leiden Univ, Inst Psychol, Leiden, Netherlands	University of Toronto; Leiden University; Leiden University - Excl LUMC	Gozli, DG (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada.; Gozli, DG (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.	d.ghara.gozli@fsw.leidenuniv.nl	Gozli, Davood/J-8829-2019	Gozli, Davood/0000-0002-9623-4914	Natural Sciences and Engineering Research Council of Canada (NSERC); Alexander Graham Bell doctoral scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alexander Graham Bell doctoral scholarship	This study was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), in the form of Discovery grants awarded to JP and ALC, and an Alexander Graham Bell doctoral scholarship awarded to DGG.	Ansorge U, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00081; Ansorge U, 2010, COGNITION, V116, P303, DOI 10.1016/j.cognition.2010.05.010; BACON WF, 1994, PERCEPT PSYCHOPHYS, V55, P485, DOI 10.3758/BF03205306; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P637, DOI 10.1017/S0140525X99532147; Bergen BK, 2007, COGNITIVE SCI, V31, P733, DOI 10.1080/03640210701530748; Chasteen AL, 2010, NEUROPSYCHOLOGIA, V48, P627, DOI 10.1016/j.neuropsychologia.2009.09.029; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Davis GJ, 2012, J EXP PSYCHOL HUMAN, V38, P1192, DOI 10.1037/a0027595; Dodd MD, 2008, COGNITION, V108, P810, DOI 10.1016/j.cognition.2008.04.006; Dudschig C, 2014, CORTEX, V58, P151, DOI 10.1016/j.cortex.2014.06.003; Dudschig C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056872; Dudschig C, 2012, MEM COGNITION, V40, P1081, DOI 10.3758/s13421-012-0201-9; Dudschig C, 2012, COGN PROCESS, V13, pS151, DOI 10.1007/s10339-012-0480-x; Estes Z, 2008, PSYCHOL SCI, V19, P93, DOI 10.1111/j.1467-9280.2008.02051.x; Estes Z, 2015, J MEM LANG, V84, P167, DOI 10.1016/j.jml.2015.06.002; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gibson BS, 2014, CURR DIR PSYCHOL SCI, V23, P271, DOI 10.1177/0963721414536728; Gibson BS, 2005, PERCEPT PSYCHOPHYS, V67, P749, DOI 10.3758/BF03193530; Gozli DG, 2013, VIS COGN, V21, P628, DOI 10.1080/13506285.2013.815680; Gozli DG, 2013, J EXP PSYCHOL GEN, V142, P1028, DOI 10.1037/a0030362; Gozli DG, 2011, ATTEN PERCEPT PSYCHO, V73, P2448, DOI 10.3758/s13414-011-0203-x; Hommel B, 2004, TRENDS COGN SCI, V8, P494, DOI 10.1016/j.tics.2004.08.007; Hommel B, 2001, PSYCHOL SCI, V12, P360, DOI 10.1111/1467-9280.00367; Lachmair M, 2011, PSYCHON B REV, V18, P1180, DOI 10.3758/s13423-011-0158-x; Lakens D, 2012, J EXP PSYCHOL LEARN, V38, P726, DOI 10.1037/a0024955; Lakens D, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00021; Leblanc E, 2010, J EXP PSYCHOL HUMAN, V36, P1314, DOI 10.1037/a0019954; Louwerse M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00105; Lu A, 2014, CAN J EXP PSYCHOL, V68, P77, DOI 10.1037/cep0000008; Lynott D, 2014, PSYCHON B REV, V21, P218, DOI 10.3758/s13423-013-0481-5; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Pecher D, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00030; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Pratt J, 2010, J EXP PSYCHOL HUMAN, V36, P1321, DOI 10.1037/a0019996; Proctor RW, 2006, PSYCHOL BULL, V132, P416, DOI 10.1037/0033-2909.132.3.416; Proctor RW, 2015, CURR DIR PSYCHOL SCI, V24, P446, DOI 10.1177/0963721415607305; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Richardson DC, 2003, COGNITIVE SCI, V27, P767, DOI 10.1016/S0364-0213(03)00064-8; Ristic J, 2006, Q J EXP PSYCHOL, V59, P1921, DOI 10.1080/17470210500416367; Santiago J, 2015, ACTA PSYCHOL, V156, P179, DOI 10.1016/j.actpsy.2014.09.016; Santiago J, 2012, COGNITIVE SCI, V36, P1051, DOI 10.1111/j.1551-6709.2012.01240.x; Schubo A, 2004, PSYCHOL RES-PSYCH FO, V68, P208, DOI 10.1007/s00426-003-0133-x; Schubo A, 2001, PSYCHOL RES-PSYCH FO, V65, P145, DOI 10.1007/s004260100061; SMITH L, 1990, J EXP PSYCHOL LEARN, V16, P852, DOI 10.1037/0278-7393.16.5.852; Taylor JET, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137704; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V50, P184, DOI 10.3758/BF03212219; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Thornton T, 2013, J EXP PSYCHOL HUMAN, V39, P964, DOI 10.1037/a0030467; Tipples J, 2002, PSYCHON B REV, V9, P314, DOI 10.3758/BF03196287; Van Dantzig S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00040; Weger UW, 2008, PSYCHON B REV, V15, P426, DOI 10.3758/PBR.15.2.426; Xie J, 2015, FRONT PSYCHOL, P6; Xie JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099479; Yantis S, 1999, J EXP PSYCHOL HUMAN, V25, P661, DOI 10.1037/0096-1523.25.3.661; Zhang ET, 2013, EXP BRAIN RES, V227, P199, DOI 10.1007/s00221-013-3500-x; Zwaan Rolf A., 2008, SYMBOLS EMBODIMENT D, P165, DOI DOI 10.1093/ACPROF:OSO/9780199217274.003.0009	58	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150928	10.1371/journal.pone.0150928	http://dx.doi.org/10.1371/journal.pone.0150928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SW	26953570	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300060
J	Oni-Orisan, A; Kaushal, M; Li, WJ; Leschke, J; Ward, BD; Vedantam, A; Kalinosky, B; Budde, MD; Schmit, BD; Li, SJ; Muqeet, V; Kurpad, SN				Oni-Orisan, Akinwunmi; Kaushal, Mayank; Li, Wenjun; Leschke, Jack; Ward, B. Douglas; Vedantam, Aditya; Kalinosky, Benjamin; Budde, Matthew D.; Schmit, Brian D.; Li, Shi-Jiang; Muqeet, Vaishnavi; Kurpad, Shekar N.			Alterations in Cortical Sensorimotor Connectivity following Complete Cervical Spinal Cord Injury: A Prospective Resting-State fMRI Study	PLOS ONE			English	Article							SOMATOSENSORY-EVOKED POTENTIALS; MOTOR CORTEX; REORGANIZATION; BRAIN; ATROPHY; REPRESENTATION; DISABILITY; NETWORKS; PAIN	Functional magnetic resonance imaging (fMRI) studies have demonstrated alterations during task-induced brain activation in spinal cord injury (SCI) patients. The interruption to structural integrity of the spinal cord and the resultant disrupted flow of bidirectional communication between the brain and the spinal cord might contribute to the observed dynamic reorganization (neural plasticity). However, the effect of SCI on brain resting-state connectivity patterns remains unclear. We undertook a prospective resting-state fMRI (rs-fMRI) study to explore changes to cortical activation patterns following SCI. With institutional review board approval, rs-fMRI data was obtained in eleven patients with complete cervical SCI (> 2 years post injury) and nine age-matched controls. The data was processed using the Analysis of Functional Neuroimages software. Region of interest (ROI) based analysis was performed to study changes in the sensorimotor network using pre- and post-central gyri as seed regions. Two-sampled t-test was carried out to check for significant differences between the two groups. SCI patients showed decreased functional connectivity in motor and sensory cortical regions when compared to controls. The decrease was noted in ipsilateral, contralateral, and interhemispheric regions for left and right precentral ROIs. Additionally, the left postcentral ROI demonstrated increased connectivity with the thalamus bilaterally in SCI patients. Our results suggest that cortical activation patterns in the sensorimotor network undergo dynamic reorganization following SCI. The presence of these changes in chronic spinal cord injury patients is suggestive of the inherent neural plasticity within the central nervous system.	[Oni-Orisan, Akinwunmi; Kurpad, Shekar N.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Kaushal, Mayank; Kalinosky, Benjamin; Schmit, Brian D.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA; [Li, Wenjun; Ward, B. Douglas; Budde, Matthew D.; Li, Shi-Jiang] Marquette Univ, Dept Biophys, Milwaukee, WI 53233 USA; [Leschke, Jack] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Vedantam, Aditya] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Muqeet, Vaishnavi] Clement J Zablocki Vet Affairs Med Ctr, Dept Phys Med & Rehabil, Milwaukee, WI USA	Medical College of Wisconsin; Marquette University; Marquette University; Medical College of Wisconsin; Baylor College of Medicine	Oni-Orisan, A (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.	aoni@mcw.edu	Li, Shi-Jiang/M-2534-2017; Kurpad, Shekar/V-2188-2019; Kaushal, Mayank/AAK-7667-2020	Kaushal, Mayank/0000-0002-4121-6751	Research Administration Committee of the Department of Physical Medicine and Rehabilitation at the Medical College of Wisconsin, Marquette University; Falk Foundation; Bryon Riesch Paralysis Foundation	Research Administration Committee of the Department of Physical Medicine and Rehabilitation at the Medical College of Wisconsin, Marquette University; Falk Foundation; Bryon Riesch Paralysis Foundation	This work was supported by the Research Administration Committee of the Department of Physical Medicine and Rehabilitation at the Medical College of Wisconsin, Marquette University, the Falk Foundation, and the Bryon Riesch Paralysis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Chen G, 2012, MAGN RESON MED, V68, P1828, DOI 10.1002/mrm.24201; Choe AS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00290; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; Curt A, 2002, BRAIN, V125, P2567, DOI 10.1093/brain/awf250; Curt A, 1996, ARCH PHYS MED REHAB, V77, P48, DOI 10.1016/S0003-9993(96)90219-1; Curt A, 1997, ARCH PHYS MED REHAB, V78, P39, DOI 10.1016/S0003-9993(97)90007-1; Dietz V, 2006, LANCET NEUROL, V5, P688, DOI 10.1016/S1474-4422(06)70522-1; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Hotz-Boenden-Naker S, 2008, NEUROIMAGE, V39, P383, DOI 10.1016/j.neuroimage.2007.07.065; Hou JM, 2014, NEUROSCIENCE, V277, P446, DOI 10.1016/j.neuroscience.2014.07.045; Jurkiewicz MT, 2006, NEUROLOGY, V66, P762, DOI 10.1212/01.wnl.0000201276.28141.40; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Lotze M, 2006, RESTOR NEUROL NEUROS, V24, P97; Lotze M, 1999, RESTOR NEUROL NEUROS, V14, P183; Lundell H, 2011, NEUROIMAGE, V54, P1254, DOI 10.1016/j.neuroimage.2010.09.009; Min YS, 2015, J NEUROTRAUM, V32, P1422, DOI 10.1089/neu.2014.3661; Mohammadi B, 2009, EXP NEUROL, V217, P147, DOI 10.1016/j.expneurol.2009.01.025; NSCIS, 2015, NAT SPIN CORD INJ ST; Oudega M, 2012, J PHYSIOL-LONDON, V590, P3647, DOI 10.1113/jphysiol.2012.233189; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Rao JS, 2014, MAGN RESON IMAGING, V32, P482, DOI 10.1016/j.mri.2014.02.001; Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91; Seminowicz DA, 2012, J NEUROSCI, V32, P15843, DOI 10.1523/JNEUROSCI.2927-12.2012; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Turner JA, 2003, NEUROREHAB NEURAL RE, V17, P37, DOI 10.1177/0888439002250443; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Wrigley PJ, 2009, PAIN, V141, P52, DOI 10.1016/j.pain.2008.10.007; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072	45	39	43	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150351	10.1371/journal.pone.0150351	http://dx.doi.org/10.1371/journal.pone.0150351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954693	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300023
J	Clark, RG				Clark, Robert Graham			Statistical Efficiency in Distance Sampling	PLOS ONE			English	Article							SPATIAL MODELS; TRANSECT; INFERENCE; DENSITY	Distance sampling is a technique for estimating the abundance of animals or other objects in a region, allowing for imperfect detection. This paper evaluates the statistical efficiency of the method when its assumptions are met, both theoretically and by simulation. The theoretical component of the paper is a derivation of the asymptotic variance penalty for the distance sampling estimator arising from uncertainty about the unknown detection parameters. This asymptotic penalty factor is tabulated for several detection functions. It is typically at least 2 but can be much higher, particularly for steeply declining detection rates. The asymptotic result relies on a model which makes the strong assumption that objects are uniformly distributed across the region. The simulation study relaxes this assumption by incorporating over-dispersion when generating object locations. Distance sampling and strip transect estimators are calculated for simulated data, for a variety of overdispersion factors, detection functions, sample sizes and strip widths. The simulation results confirm the theoretical asymptotic penalty in the non-overdispersed case. For a more realistic overdispersion factor of 2, distance sampling estimation outperforms strip transect estimation when a half-normal distance function is correctly assumed, confirming previous literature. When the hazard rate model is correctly assumed, strip transect estimators have lower mean squared error than the usual distance sampling estimator when the strip width is close enough to its optimal value (+/- 75% when there are 100 detections; +/- 50% when there are 200 detections). Whether the ecologist can set the strip width sufficiently accurately will depend on the circumstances of each particular study.	[Clark, Robert Graham] Univ Wollongong, Natl Inst Appl Stat Res Australia, Wollongong, NSW, Australia	University of Wollongong	Clark, RG (corresponding author), Univ Wollongong, Natl Inst Appl Stat Res Australia, Wollongong, NSW, Australia.	rclark@uow.edu.au		Clark, Robert/0000-0003-4368-5145				[Anonymous], 2013, TEXTS STAT SCI SERIE; Azhar B, 2009, J SUSTAINABLE DEV, V1, P63, DOI [10.5539/jsd.v1n2p63, DOI 10.5539/JSD.V1N2P63]; Barry SC, 2001, J ROY STAT SOC B, V63, P31; Borchers D.L., 2002, ESTIMATING ANIMAL AB; Buckland S., 2004, ADV DISTANCE SAMPLIN; Buckland S.T., 2001, pi; Buckland ST, 2015, J AGR BIOL ENVIR ST, P1; BURNHAM KP, 1985, J WILDLIFE MANAGE, V49, P1012, DOI 10.2307/3801387; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Clark RG., 2015, 1515 NIASRA; Clark RG, 2016, DISTANCE SAMPLE SIZE; Fewster RM, 2009, BIOMETRIKA, V96, P805, DOI 10.1093/biomet/asp051; Fewster RM, 2005, BIOMETRICS, V61, P856, DOI 10.1111/j.1541-0420.2005.00413_1.x; Harville D., 1997, MATRIX ALGEBRA STAT; Hedley SL, 2004, J AGR BIOL ENVIR ST, V9, P181, DOI 10.1198/1085711043578; Johnson DS, 2010, BIOMETRICS, V66, P310, DOI 10.1111/j.1541-0420.2009.01265.x; Johnson N., 1997, DISCRETE MULTIVARIAT; Kruger JM, 2008, WILDLIFE RES, V35, P371, DOI 10.1071/WR07084; Lehmann E. L., 1999, ELEMENTS LARGE SAMPL; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Marques TA, 2007, AUK, V124, P1229, DOI 10.1642/0004-8038(2007)124[1229:IEOBDU]2.0.CO;2; Melville GJ, 2008, WILDLIFE RES, V35, P310, DOI 10.1071/WR07080; Melville GJ, 2014, AUST NZ J STAT, V56, P257, DOI 10.1111/anzs.12084; Melville GJ, 2001, BIOMETRICS, V57, P1130, DOI 10.1111/j.0006-341X.2001.01130.x; Miller D. A., 2014, DISTANCE SIMPLE WAY; Miller DL, 2013, METHODS ECOL EVOL, V4, P1001, DOI 10.1111/2041-210X.12105; Oedekoven C, 2014, J AGR BIOL ENVIR ST, P1; Oppel Steffen, 2006, International Journal of Odonatology, V9, P81; R Core Team, 2021, R LANGUAGE ENV STAT; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Walter MJ, 2003, WILDLIFE SOC B, V31, P1138; Welsh AH, 2002, AUST NZ J STAT, V44, P13, DOI 10.1111/1467-842X.00204	32	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0149298	10.1371/journal.pone.0149298	http://dx.doi.org/10.1371/journal.pone.0149298			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950934	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100014
J	Kong, ZZ; Zhao, PP; Liu, HB; Yu, X; Qin, YY; Su, ZL; Wang, SJ; Xu, HX; Chen, JG				Kong, Zhenzhen; Zhao, Peipei; Liu, Haibing; Yu, Xiang; Qin, Yanyan; Su, Zhaoliang; Wang, Shengjun; Xu, Huaxi; Chen, Jianguo			Whole-Genome Sequencing for the Investigation of a Hospital Outbreak of MRSA in China	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; FIELD GEL-ELECTROPHORESIS; METHICILLIN-RESISTANT; EPIDEMIOLOGY; TRANSMISSION; EVOLUTION; VIRULENCE; CLONES; RECOMBINATION; GENERATION	Staphylococcus aureus is a globally disseminated drug-resistant bacterial species. It remains a leading cause of hospital-acquired infection, primarily among immunocompromised patients. In 2012, the Affiliated People's Hospital of Jiangsu University experienced a putative outbreak of methicillin-resistant S. aureus (MRSA) that affected 12 patients in the Neurosurgery Department. In this study, whole-genome sequencing (WGS) was used to gain insight into the epidemiology of the outbreak caused by MRSA, and traditional bacterial genotyping approaches were also applied to provide supportive evidence for WGS. We sequenced the DNA from 6 isolates associated with the outbreak. Phylogenetic analysis was constructed by comparing single-nucleotide polymorphisms (SNPs) in the core genome of 6 isolates in the present study and another 3 referenced isolates from GenBank. Of the 6 MRSA sequences in the current study, 5 belonged to the same group, clustering with T0131, while the other one clustered closely with TW20. All of the isolates were identified as ST239-SCCmecIII clones. Whole-genome analysis revealed that four of the outbreak isolates were more tightly clustered into a group and SA13002 together with SA13009 were distinct from the outbreak strains, which were considered non-outbreak strains. Based on the sequencing results, the antibiotic-resistance gene status (present or absent) was almost perfectly concordant with the results of phenotypic susceptibility testing. Various toxin genes were also analyzed successfully. Our analysis demonstrates that using traditional molecular methods and WGS can facilitate the identification of outbreaks and help to control nosocomial transmission.	[Kong, Zhenzhen; Zhao, Peipei; Liu, Haibing; Wang, Shengjun; Chen, Jianguo] Jiangsu Univ, Affiliated Peoples Hosp, Dept Clin Lab, Zhenjiang, Peoples R China; [Kong, Zhenzhen; Zhao, Peipei; Liu, Haibing; Qin, Yanyan; Su, Zhaoliang; Xu, Huaxi] Jiangsu Univ, Inst Lab Med, Dept Immunol, Zhenjiang, Peoples R China; [Yu, Xiang] Jiangsu Univ, Affiliated Peoples Hosp, Dept Neurosurg, Zhenjiang, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University	Chen, JG (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Clin Lab, Zhenjiang, Peoples R China.	cjg02@126.com	, 雷克思/ABG-3956-2020	, 雷克思/0000-0003-4102-8934	Foundation of Social Development Item of Zhenjiang City [SH2012036, SH 201203]	Foundation of Social Development Item of Zhenjiang City	This research was supported by the Foundation of Social Development Item of Zhenjiang City (grant no. SH2012036). The funder participated in the study design, data collection and analysis, decision to publish.; This research was supported by the Foundation of Social Development Item of Zhenjiang City (grant No. SH 201203).	Al Laham N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120008; Al-Bakri AG, 2013, EPIDEMIOL INFECT, V141, P2384, DOI 10.1017/S0950268813000010; Anderson DJ, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu096; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Castillo-Ramirez S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r126; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Creamer E, 2014, J HOSP INFECT, V86, P201, DOI 10.1016/j.jhin.2013.12.005; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Golubchik T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061319; Gordon NC, 2014, J CLIN MICROBIOL, V52, P1182, DOI 10.1128/JCM.03117-13; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Kaito C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003269; Ko KS, 2005, J CLIN MICROBIOL, V43, P421, DOI 10.1128/JCM.43.1.421-426.2005; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Laabei M, 2014, GENOME RES, V24, P839, DOI 10.1101/gr.165415.113; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Li Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027246; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nadig S, 2010, J MED MICROBIOL, V59, P815, DOI 10.1099/jmm.0.017632-0; Pallen MJ, 2011, GENOME MED, V3, DOI 10.1186/gm269; Parkhill J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-230; Perez-Losada M, 2006, INFECT GENET EVOL, V6, P97, DOI 10.1016/j.meegid.2005.02.003; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; Shukla SK, 2012, J CLIN MICROBIOL, V50, P3526, DOI 10.1128/JCM.01168-12; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Uhlemann AC, 2014, P NATL ACAD SCI USA, V111, P6738, DOI 10.1073/pnas.1401006111; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wang Z, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-529; Xiao M, 2013, J CLIN MICROBIOL, V51, P3638, DOI 10.1128/JCM.01375-13; Xu BL, 2009, J HOSP INFECT, V71, P245, DOI 10.1016/j.jhin.2008.10.029; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	42	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0149844	10.1371/journal.pone.0149844	http://dx.doi.org/10.1371/journal.pone.0149844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950298	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100018
J	Tien, YC; Chiu, YM; Liu, MP				Tien, Ya-Chih; Chiu, Ying-Ming; Liu, Mei-Ping			Frequency of Lost to Follow-Up and Associated Factors for Patients with Rheumatic Diseases	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ADHERENCE; ARTHRITIS; DISCONTINUATION; RECOMMENDATIONS; PREVALENCE; THERAPIES; COHORT; RACE	Objective To determine the frequency of lost to follow-up (LTFU) in the setting of usual care for outpatients with rheumatic diseases including RA, SLE, AS, and Ps/PsA, to explore the associated demographic factors, and to investigate the reasons for being LTFU from the original medical care. Methods Patients registered between May 2011 and January 2014 at the rheumatology outpatient department of a medical center were included. Those who did not attend their scheduled appointment were defined as LTFU. Univariate and multivariate logistic regression were used to analyze the factors for being LTFU. Results A total of 781 patients were enrolled, including 406 patients with RA, 174 with SLE, 136 with AS, and 65 with Ps/PsA. The frequency of LTFU was 23.9%, 25.9%, 35.3%, and 35.4%, respectively. The frequency of LTFU was significantly different between the four rheumatic diseases (p = 0.028). In multivariate logistic regression analysis, an older age increased being LTFU in the patients with RA (OR 1.02; 95% CI 1.00-1.04; p = 0.033), but reduced being LTFU in those with Ps/PsA (OR 0.96; 95% CI 0.92-0.99; p = 0.021). Female patients with SLE and Ps/PsA were more likely to be LTFU, although this did not reach statistical significance (p = 0.056 and 0.071, respectively). The most common reason for being LTFU was moving to other district hospitals from the original medical center due to convenience for the patients with RA and SLE, and stopping medication due to minimal symptoms for the patients with AS and Ps/PsA. Conclusions The frequency of LTFU in patients with rheumatic diseases is high. Associated demographic factors included older age in RA, female gender in SLE and Ps/PsA, and younger age in Ps/PsA, with various reasons for being LTFU. Recognizing these associated factors and reasons for being LTFU may help to improve the attendance of patients and the quality of medical care.	[Tien, Ya-Chih; Chiu, Ying-Ming; Liu, Mei-Ping] Changhua Christian Hosp, Allergy Immunol & Rheumatol Div, Dept Internal Med, Changhua, Taiwan; [Chiu, Ying-Ming] HungKuang Univ, Dept Nursing, Coll Med & Nursing, Taichung, Taiwan	Changhua Christian Hospital; Hungkuang University	Chiu, YM (corresponding author), Changhua Christian Hosp, Allergy Immunol & Rheumatol Div, Dept Internal Med, Changhua, Taiwan.; Chiu, YM (corresponding author), HungKuang Univ, Dept Nursing, Coll Med & Nursing, Taichung, Taiwan.	129273@cch.org.tw		Tien, Ya-Chih/0000-0001-5388-2463				Andrade RM, 2007, ARTHRITIS RHEUM-US, V56, P622, DOI 10.1002/art.22375; Ash Z, 2012, ANN RHEUM DIS, V71, P319, DOI 10.1136/ard.2011.150995; Bertoli AM, 2006, LUPUS, V15, P19, DOI 10.1191/0961203306lu2257oa; Brandt J, 2006, BEST PRACT RES CL RH, V20, P559, DOI 10.1016/j.berh.2006.03.009; CERVERA R, 1993, MEDICINE, V72, P113, DOI 10.1097/00005792-199303000-00005; Cooper GS, 2002, LUPUS, V11, P161, DOI 10.1191/0961203302lu161oa; de Klerk E, 2003, J RHEUMATOL, V30, P44; Foocharoen C, 2014, JCR-J CLIN RHEUMATOL, V20, P456, DOI 10.1097/RHU.0000000000000198; Gladman DD, 2000, LUPUS, V9, P363, DOI 10.1191/096120300678828325; GLAVETESTINO C, 1994, CLIN EXP RHEUMATOL, V12, P589; Hagg D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063619; Mosca M, 2013, CLIN EXP RHEUMATOL, V31, pS71; Mosley-Williams A, 2002, ARTHRIT RHEUM-ARTHR, V47, P630, DOI 10.1002/art.10790; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; PETRI M, 1991, AM J MED, V91, P345, DOI 10.1016/0002-9343(91)90151-M; Pincus T, 2013, CLIN EXP RHEUMATOL, V31, pS1; PISTINER M, 1991, SEMIN ARTHRITIS RHEU, V21, P55, DOI 10.1016/0049-0172(91)90057-7; Popa-Lisseanu MGG, 2005, J RHEUMATOL, V32, P913; Rojas-Serrano J, 2000, LUPUS, V9, P601, DOI 10.1191/096120300678828785; Schwartzman-Morris J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/604892; Solmaz D, 2013, ANN RHEUM DIS; Tanaka Y, 2013, CLIN EXP RHEUMATOL, V31, pS22; Thorneloe RJ, 2013, BRIT J DERMATOL, V168, P20, DOI 10.1111/bjd.12039; Uribe AG, 2004, LUPUS, V13, P561, DOI 10.1191/0961203304lu1061oa; Uribe AG, 2004, ARTHRIT RHEUM-ARTHR, V51, P258, DOI 10.1002/art.20226; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684; van Vollenhoven RF, 2014, ANN RHEUM DIS, V73, P958, DOI 10.1136/annrheumdis-2013-205139; World Health Organisation, 2003, ADHERENCE LONG TERM; Zhu TY, 2011, RHEUMATOLOGY, V50, P1293, DOI 10.1093/rheumatology/ker014	29	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150816	10.1371/journal.pone.0150816	http://dx.doi.org/10.1371/journal.pone.0150816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950470	gold, Green Published			2022-12-27	WOS:000371990100064
J	Tomberg, K; Khoriaty, R; Westrick, RJ; Fairfield, HE; Reinholdt, G; Brodsky, GL; Davizon-Castillo, P; Ginsburg, D; Di Paola, J				Tomberg, Kaert; Khoriaty, Rami; Westrick, Randal J.; Fairfield, Heather E.; Reinholdt, Laura G.; Brodsky, Gary L.; Davizon-Castillo, Pavel; Ginsburg, David; Di Paola, Jorge			Spontaneous 8bp Deletion in Nbeal2 Recapitulates the Gray Platelet Syndrome in Mice	PLOS ONE			English	Article							MUTATION-RATES; LOCUS TEST; GENE; DEFICIENCY; THROMBOSIS; PHENOTYPE; BEACH; IRS1	During the analysis of a whole genome ENU mutagenesis screen for thrombosis modifiers, a spontaneous 8 base pair (bp) deletion causing a frameshift in exon 27 of the Nbeal2 gene was identified. Though initially considered as a plausible thrombosis modifier, this Nbeal2 mutation failed to suppress the synthetic lethal thrombosis on which the original ENU screen was based. Mutations in NBEAL2 cause Gray Platelet Syndrome (GPS), an autosomal recessive bleeding disorder characterized by macrothrombocytopenia and gray-appearing platelets due to lack of platelet alpha granules. Mice homozygous for the Nbeal2 8 bp deletion (Nbeal2(gps/gps)) exhibit a phenotype similar to human GPS, with significantly reduced platelet counts compared to littermate controls (p = 1.63 x 10(-7)). Nbeal2(gps/gps) mice also have markedly reduced numbers of platelet alpha granules and an increased level of emperipolesis, consistent with previously characterized mice carrying targeted Nbeal2 null alleles. These findings confirm previous reports, provide an additional mouse model for GPS, and highlight the potentially confounding effect of background spontaneous mutation events in well-characterized mouse strains.	[Tomberg, Kaert; Ginsburg, David] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Khoriaty, Rami; Ginsburg, David] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Westrick, Randal J.] Oakland Univ, Dept Biol Sci, Rochester, MI USA; [Fairfield, Heather E.; Reinholdt, Laura G.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Brodsky, Gary L.; Davizon-Castillo, Pavel; Di Paola, Jorge] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Ginsburg, David] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Di Paola, Jorge] Univ Colorado Denver, Human Med Genet & Genom Program, Aurora, CO USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Oakland University; Jackson Laboratory; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Ginsburg, D (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.; Ginsburg, D (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.; Ginsburg, D (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.; Ginsburg, D (corresponding author), Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu	Tomberg, Kärt/L-2561-2017; Tomberg, Kärt/V-6398-2019	Tomberg, Kärt/0000-0002-6144-3601; Tomberg, Kärt/0000-0002-6144-3601; Ginsburg, David/0000-0002-6436-8942	NIH [P01-HL057346]; Fulbright International Science and Technology Award; American Heart Association Predoctoral Fellowship [14PRE20120048]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL128794, P01HL057346] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD021325] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright International Science and Technology Award; American Heart Association Predoctoral Fellowship(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by NIH grant P01-HL057346 to DG. KT is the recipient of a Fulbright International Science and Technology Award (http://scienceandtech.fulbrightonline.org) and of an American Heart Association Predoctoral Fellowship Grant (14PRE20120048). DG is an investigator of the Howard Hughes Medical Institute. JD is the Postle Family Chair in Pediatric Cancer and Blood Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2011, NAT GENET, V43, P735, DOI 10.1038/ng.885; Andrews TD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120061; Bannister LA, 2007, PLOS BIOL, V5, P1016, DOI 10.1371/journal.pbio.0050105; Brunck MEG, 2014, CYTOM PART A, V85A, P1057, DOI 10.1002/cyto.a.22503; Campbell CD, 2013, TRENDS GENET, V29, P575, DOI 10.1016/j.tig.2013.04.005; Cui JS, 2000, BLOOD, V96, P4222, DOI 10.1182/blood.V96.13.4222.h8004222_4222_4226; Cullinane AR, 2013, TRAFFIC, V14, P749, DOI 10.1111/tra.12069; Davis AP, 1998, GENETICS, V148, P7; Davisson MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029538; De Candia E, 2007, J THROMB HAEMOST, V5, P551, DOI 10.1111/j.1538-7836.2007.02329.x; DeMambro VE, 2010, J ENDOCRINOL, V204, P241, DOI 10.1677/JOE-09-0328; Deppermann C, 2013, J CLIN INVEST, V123, P3331, DOI 10.1172/JCI69210; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drake JW, 1998, GENETICS, V148, P1667; Eitzman DT, 2002, CIRCULATION, V105, P2139, DOI 10.1161/01.CIR.0000017361.39256.82; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fairfield H, 2015, GENOME RES, V25, P948, DOI 10.1101/gr.186882.114; Falik-Zaccai TC, 2001, MOL GENET METAB, V74, P303, DOI 10.1006/mgme.2001.3247; Guerrero JA, 2014, BLOOD, V124, P3624, DOI 10.1182/blood-2014-04-566760; Gunay-Aygun M, 2011, NAT GENET, V43, P732, DOI 10.1038/ng.883; Huang ZF, 1997, BLOOD, V90, P944, DOI 10.1182/blood.V90.3.944.944_944_951; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kahr WHA, 2013, BLOOD, V122, P3349, DOI 10.1182/blood-2013-04-499491; Kahr WHA, 2011, NAT GENET, V43, P738, DOI 10.1038/ng.884; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Khoriaty R, 2014, MOL CELL BIOL, V34, P3721, DOI 10.1128/MCB.00287-14; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lewis ND, 2013, J IMMUNOL, V190, P3533, DOI 10.4049/jimmunol.1201810; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lorenz-Depiereux B, 2004, MAMM GENOME, V15, P151, DOI 10.1007/s00335-003-2310-z; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; McCarty OJT, 2006, J THROMB HAEMOST, V4, P1367, DOI 10.1111/j.1538-7836.2006.01966.x; Montagutelli X, 2000, J AM SOC NEPHROL, V11, pS101; Monteferrario D, 2014, NEW ENGL J MED, V370, P245, DOI 10.1056/NEJMoa1308130; Moresco EMY, 2013, AM J PATHOL, V182, P1462, DOI 10.1016/j.ajpath.2013.02.002; Nurden AT, 2007, BLOOD REV, V21, P21, DOI 10.1016/j.blre.2005.12.003; R Core Team, R LANG ENV STAT COMP; RACCUGLIA G, 1971, AM J MED, V51, P818, DOI 10.1016/0002-9343(71)90311-1; RUSSELL WL, 1979, P NATL ACAD SCI USA, V76, P5818, DOI 10.1073/pnas.76.11.5818; SCHLAGER G, 1967, GENETICS, V57, P319; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Strobel MC, 2015, LAB ANIMAL MED; Taft RA, 2006, TRENDS GENET, V22, P649, DOI 10.1016/j.tig.2006.09.010; Tomberg K, 2015, GITHUB REPOSITORY WE; Uchimura A, 2015, GENOME RES, V25, P1125, DOI 10.1101/gr.186148.114; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Westrick RJ, 2010, P NATL ACAD SCI USA, V107, P16904, DOI 10.1073/pnas.1012050107; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432	49	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150852	10.1371/journal.pone.0150852	http://dx.doi.org/10.1371/journal.pone.0150852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950939	gold, Green Submitted, Green Published			2022-12-27	WOS:000371990100068
J	van der Walt, M; Lancaster, J; Shean, K				van der Walt, Martie; Lancaster, Joey; Shean, Karen			Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa	PLOS ONE			English	Article							MORTALITY; OUTCOMES	Introduction South Africa has the highest reported rates of multi-drug resistant TB in Africa, typified by poor treatment outcomes, attributable mainly to high default and death rates. Concomitant HIV has become the strongest predictor of death among MDR-TB patients, while anti-retroviral therapy (ART) has dramatically reduced mortality. TB Case fatality rate (CFR) is an indicator that specifically reports on deaths due to TB. Aim The aim of this paper was to investigate causes of death amongst MDR-TB patients, the contribution of conditions other than TB to deaths, and to determine if causes differ between HIV-uninfected patients, HIV-infected patients receiving ART and those without ART. Methods We carried out a retrospective review of data captured from the register of the MDR-TB programme of the North West Province, South Africa. We included 671 patients treated between 2000-2008; 59% of the cohort was HIV-infected and 33% had received ART during MDR treatment. The register contained data on treatment outcomes and causes of death. Results Treatment outcomes between HIV-uninfected cases, HIV-infected cases receiving ART and HIV-infected without ART differed significantly (p < 0.000). The cohort death rate was 24%, 13% for HIV-uninfected cases and 31% for HIV-infected cases. TB caused most of the deaths, resulting in a cohort CFR of 15%, 9% for HIV-uninfected cases and 20% for HIV-infected cases. Cohort mortality rate due to other conditions was 2%. AIDS-conditions rather than TB caused significantly more deaths among HIV-infected cases receiving ART than those not (p = 0.02). Conclusions The deaths among HIV-infected individuals contribute substantially to the high death rate. ART co-therapy protected HIV-infected cases from death due to TB and AIDS-conditions. Mechanisms need to be in place to ensure that HIV-infected individuals are retained in care upon completion of their MDR-TB treatment.	[van der Walt, Martie; Lancaster, Joey; Shean, Karen] S African MRC, TB Platform, Pretoria, South Africa	South African Medical Research Council	van der Walt, M (corresponding author), S African MRC, TB Platform, Pretoria, South Africa.	dwalt@mrc.ac.za	van der Walt, Martie/CAH-0101-2022	van der Walt, Martie/0000-0001-9987-3167	South African Medical Research Council	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the South African Medical Research Council.	Arentz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047370; Blondal K, 2013, INT J TUBERC LUNG D, V17, P961, DOI 10.5588/ijtld.12.0946; Corbett E, 2003, ARCH INTERN MED, V163; De Cock K, 2013, N ENGL J MED; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Korenromp EL, 2009, INT J TUBERC LUNG D, V13, P283; Lawn S, 2012, AIDS, V26; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Manosuthi W, 2006, ACQUIR IMMUNE DEFIC, V43; Mathew TA, 2006, INT J TUBERC LUNG D, V10, P857; Mitnick CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058664; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Palacios E, 2012, INT J TUBERC LUNG D, V16, P348, DOI 10.5588/ijtld.11.0473; Park MM, 1996, AM J RESP CRIT CARE, V153, P317, DOI 10.1164/ajrccm.153.1.8542137; Satti H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046943; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; South African Medical Research Council, 2000, DOTS PLUS STAND MAN; Straetemans M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020755; Straetemans M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015241; van't Hoog AH, 2012, INT J TUBERC LUNG D, V16, P1649, DOI 10.5588/ijtld.12.0135; Vijay S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021008; Waisman JL, 2001, MEDICINA-BUENOS AIRE, V61, P810; WHO, 2010, PRIOR RES QUEST TB H; World Health Organisation, 2014, UND US TUB DAT; World Health Organisation, UN ACC DIAGN TREATM; World Health Organisation, TUB MDR TB XDR TB 20; World Health Organization, 2006, GUID PROGR MAN DRUG	29	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0144249	10.1371/journal.pone.0144249	http://dx.doi.org/10.1371/journal.pone.0144249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950554	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100002
J	Vedula, SS; Malpani, AO; Tao, LL; Chen, G; Gao, YX; Poddar, P; Ahmidi, N; Paxton, C; Vidal, R; Khudanpur, S; Hager, GD; Chen, CCG				Vedula, S. Swaroop; Malpani, Anand O.; Tao, Lingling; Chen, George; Gao, Yixin; Poddar, Piyush; Ahmidi, Narges; Paxton, Christopher; Vidal, Rene; Khudanpur, Sanjeev; Hager, Gregory D.; Chen, Chi Chiung Grace			Analysis of the Structure of Surgical Activity for a Suturing and Knot-Tying Task	PLOS ONE			English	Article							SURGERY; SKILLS	Background Surgical tasks are performed in a sequence of steps, and technical skill evaluation includes assessing task flow efficiency. Our objective was to describe differences in task flow for expert and novice surgeons for a basic surgical task. Methods We used a hierarchical semantic vocabulary to decompose and annotate maneuvers and gestures for 135 instances of a surgeon's knot performed by 18 surgeons. We compared counts of maneuvers and gestures, and analyzed task flow by skill level. Results Experts used fewer gestures to perform the task (26.29; 95% CI = 25.21 to 27.38 for experts vs. 31.30; 95% CI = 29.05 to 33.55 for novices) and made fewer errors in gestures than novices (1.00; 95% CI = 0.61 to 1.39 vs. 2.84; 95% CI = 2.3 to 3.37). Transitions among maneuvers, and among gestures within each maneuver for expert trials were more predictable than novice trials. Conclusions Activity segments and state flow transitions within a basic surgical task differ by surgical skill level, and can be used to provide targeted feedback to surgical trainees.	[Vedula, S. Swaroop; Malpani, Anand O.; Gao, Yixin; Poddar, Piyush; Ahmidi, Narges; Paxton, Christopher; Khudanpur, Sanjeev; Hager, Gregory D.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Tao, Lingling; Khudanpur, Sanjeev] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Chen, George; Vidal, Rene] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Chen, Chi Chiung Grace] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Vedula, SS (corresponding author), Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA.	vedula@jhu.edu	Malpani, Anand/K-1971-2019	Malpani, Anand/0000-0001-9477-9403	Swirnow Family Foundation;  [NSF-NRI 1227277];  [NSF-CPS 0931805];  [NSF-CDI-II 0941362];  [NIH 1R21EB009143-01A1]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009143] Funding Source: NIH RePORTER	Swirnow Family Foundation; ; ; ; ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was conducted within the Language of Surgery project at The Johns Hopkins University, which has been supported in part through funds from the following grant awards: NSF-NRI 1227277, NSF-CPS 0931805, NSF-CDI-II 0941362, NIH 1R21EB009143-01A1, and an Intuitive Surgical, Inc. Fellowship(s). None of these sponsors played a role in the study development, data collection, analysis or interpretation. The Swirnow Family Foundation provided funds to construct the Mock Operating Room at The Johns Hopkins University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmidi N, 2013, LECT NOTES COMPUT SC, V8149, P26, DOI 10.1007/978-3-642-40811-3_4; Bell RH, 2009, SURGERY, V146, P533, DOI 10.1016/j.surg.2009.06.044; Birkmeyer JD, 2013, NEW ENGL J MED, V369, P1434, DOI 10.1056/NEJMsa1300625; Cao CGL, 1999, ST HEAL T, V62, P83; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Darzi A, 2001, QUAL HEALTH CARE, V10, P64; De Novi G, 2012, WORKSH P 8 INT C INT; Ellson J, 2004, MATH VIS, P127; Ericsson KA, 2004, ACAD MED, V79, pS70, DOI 10.1097/00001888-200410001-00022; Goh AC, 2012, J UROLOGY, V187, P247, DOI 10.1016/j.juro.2011.09.032; Golenberg LP, 2010, TASK ANAL MODELING A; Haro BB, 2012, LECT NOTES COMPUT SC, V7510, P34, DOI 10.1007/978-3-642-33415-3_5; Immenroth M, 2007, ANN SURG, V245, P385, DOI 10.1097/01.sla.0000251575.95171.b3; Kumar R, 2012, INT J MED ROBOT COMP, V8, P118, DOI 10.1002/rcs.449; Kumar R, 2012, J THORAC CARDIOV SUR, V143, P528, DOI 10.1016/j.jtcvs.2011.11.002; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Lin H. C., 2010, STRUCTURE SURG MOTIO; Lingling Tao, 2012, Information Processing in Computer-Assisted Interventions. Proceedings Third International Conference, IPCAI 2012, P167, DOI 10.1007/978-3-642-30618-1_17; Malpani Anand, 2014, Information Processing in Computer-Assisted Interventions. 5th International Conference, IPCAI 2014. Proceedings: LNCS 8498, P138, DOI 10.1007/978-3-319-07521-1_15; Martin JA, 1997, BRIT J SURG, V84, P273, DOI 10.1046/j.1365-2168.1997.02502.x; Naikavde YR, 2012, ROBOTIC SURG SKILL A; Nikulin M.S., ENCY MATH; Regenbogen SE, 2007, ANN SURG, V246, P705, DOI 10.1097/SLA.0b013e31815865f8; Reiley CE, 2009, LECT NOTES COMPUT SC, V5761, P435, DOI 10.1007/978-3-642-04268-3_54; Rosen J, 2006, IEEE T BIO-MED ENG, V53, P399, DOI 10.1109/TBME.2005.869771; Saggio G, 2014, 6 IEEE INT S MED MEA, DOI [10.1109/MeMeA.2011.5966681, DOI 10.1109/MEMEA.2011.5966681]; Satava RM, 2003, J AM COLL SURGEONS, V196, P933, DOI 10.1016/S1072-7515(03)00237-0; Smink DS, 2012, AM J SURG, V203, P540, DOI 10.1016/j.amjsurg.2011.11.002; Speidel Stefanie, 2009, Proceedings of the SPIE - The International Society for Optical Engineering, V7261, DOI 10.1117/12.811140; Varadarajan Balakrishnan, 2011, LEARNING INFERENCE A; Velmahos GC, 2004, AM J SURG, V187, P114, DOI 10.1016/j.amjsurg.2002.12.005; Yates K, 2012, AM J SURG, V203, P76, DOI 10.1016/j.amjsurg.2011.07.011	32	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0149174	10.1371/journal.pone.0149174	http://dx.doi.org/10.1371/journal.pone.0149174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950551	gold, Green Published, Green Submitted			2022-12-27	WOS:000371990100011
J	Aguiar, PM; Brito, GD; Lima, TD; Santos, APAL; Lyra, DP; Storpirtis, S				Aguiar, Patricia Melo; Brito, Giselle de Carvalho; Lima, Tacio de Mendonca; Alves Lima Santos, Ana Patricia; Lyra, Divaldo Pereira, Jr.; Storpirtis, Silvia			Investigating Sources of Heterogeneity in Randomized Controlled Trials of the Effects of Pharmacist Interventions on Glycemic Control in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							PHARMACEUTICAL CARE PROGRAM; COMPLEX INTERVENTIONS; MEDICAL APPOINTMENTS; CLINICAL PHARMACIST; RISK-FACTORS; FOLLOW-UP; MANAGEMENT; MODEL; EDUCATION; SERVICES	Objective To assess the effect of pharmacist interventions on glycemic control in type 2 diabetic patients and to examine factors that could explain the variation across studies. Methods A comprehensive literature search was performed in PubMed, Scopus, and LILACS databases for randomized controlled trials (RCTs) published up to July 2015. The search strategy included the use of MeSH terms or text words related to pharmacist interventions, type 2 diabetes, and randomized controlled trials. RCTs published in English, Portuguese, or Spanish that evaluated the effect of pharmacist intervention on glycemic control in type 2 diabetic outpatients were included. Two independent authors executed study selection, data extraction, and risk of bias assessment. Mean differences in glycosylated hemoglobin (HbA1c) were estimated using random-effect models, and heterogeneity was evaluated by subgroup and meta-regression analyses. Results The literature search yielded 963 records of potential interest, of which 30 were included in the systematic review and 22 in the meta-analysis. Most of these RCTs were conducted in the United States in patients in outpatient clinics using face-to-face contact only. All RCTs performed patient education, and most executed the medication review. The appraised sample showed uncertain or high risk of bias in most of the items evaluated, resulting in low-quality studies. In comparison with usual care, pharmacist interventions were associated with significant reductions in HbA1c levels (-8.5% [95% CI: -1.06, -0.65]; P < 0.0001; I-2 = 67.3%). Subgroup analysis indicated differences of heterogeneity by country, baseline HbA1c levels, setting, intervention frequency, and random allocation. Age and HbA1c levels partly explained the variability across studies by meta-regression. Conclusions Our findings confirmed that pharmacist interventions improve glycemic control in patients with type 2 diabetes compared with usual care and suggest that younger patients or with higher baseline HbA1c levels may be the main beneficiaries of pharmacist care. Protocol PROSPERO Registration Number CRD42014007457	[Aguiar, Patricia Melo; Lima, Tacio de Mendonca; Storpirtis, Silvia] Univ Sao Paulo, Dept Pharm, Sao Paulo, SP, Brazil; [Brito, Giselle de Carvalho; Alves Lima Santos, Ana Patricia; Lyra, Divaldo Pereira, Jr.] Univ Fed Sergipe, Dept Pharm, Sao Cristovao, Sergipe, Brazil	Universidade de Sao Paulo; Universidade Federal de Sergipe	Aguiar, PM (corresponding author), Univ Sao Paulo, Dept Pharm, Sao Paulo, SP, Brazil.	aguiar.pm@usp.br	Storpirtis, Sílvia/G-9986-2015; Lyra, Divaldo P/G-4622-2012; Junior, Divaldo Lyra/AAU-9987-2020; Aguiar, Patricia Melo/D-7095-2013; de Mendonça Lima, Tacio/N-7649-2015	Lyra, Divaldo P/0000-0002-0266-0702; Junior, Divaldo Lyra/0000-0002-0266-0702; Aguiar, Patricia Melo/0000-0002-3957-4533; de Mendonça Lima, Tacio/0000-0003-4395-2098	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/11145-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)-Grant Number 2011/11145-4 and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes). The funders had no role in study design, data collection and analysis, writing of the report, or decision to publish.	Aguiar PM, 2014, ANN PHARMACOTHER, V48, P887, DOI 10.1177/1060028014529411; Mazroui NR, 2009, BRIT J CLIN PHARMACO, V67, P547, DOI 10.1111/j.1365-2125.2009.03391.x; Ali M, 2012, DIABETIC MED, V29, pE326, DOI 10.1111/j.1464-5491.2012.03725.x; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Baba M, 2015, PRIM CARE DIABETES, V9, P155, DOI 10.1016/j.pcd.2014.05.004; Benhalima K, 2011, J DIABETES COMPLICAT, V25, P202, DOI 10.1016/j.jdiacomp.2010.03.002; Bolen SD, 2014, J GEN INTERN MED, V29, P1166, DOI 10.1007/s11606-014-2855-4; Campbell RK, 2002, AM J HEALTH-SYST PH, V59, pS18, DOI 10.1093/ajhp/59.suppl_9.S18; Cani CG, 2015, CLINICS, V70, P102, DOI 10.6061/clinics/2015(02)06; Castejon AM, 2013, J HEALTH CARE POOR U, V24, P48, DOI 10.1353/hpu.2014.0003; Chan CW, 2012, J CARDIOVASC PHARM T, V17, P57, DOI 10.1177/1074248410396216; Choe HM, 2005, AM J MANAG CARE, V11, P253; Chung WW, 2014, PATIENT PREFER ADHER, V8, P1185, DOI 10.2147/PPA.S66619; Clifford RM, 2005, DIABETES CARE, V28, P771, DOI 10.2337/diacare.28.4.771; Cohen LB, 2011, DIABETES EDUCATOR, V37, P801, DOI 10.1177/0145721711423980; Collins C, 2011, DIABETES RES CLIN PR, V92, P145, DOI 10.1016/j.diabres.2010.09.023; Correr CJ, 2013, ANN PHARMACOTHER, V47, P946, DOI 10.1345/aph.1S006; Doucette WR, 2009, ANN PHARMACOTHER, V43, P882, DOI 10.1345/aph.1L605; Elissen AMJ, 2013, J EVAL CLIN PRACT, V19, P753, DOI 10.1111/j.1365-2753.2012.01817.x; Farsaei S, 2011, J RES MED SCI, V16, P43; Fornos JA, 2006, PHARM WORLD SCI, V28, P65, DOI 10.1007/s11096-006-9003-0; Friedman AJ, 2011, J CANCER EDUC, V26, P12, DOI 10.1007/s13187-010-0183-x; Guirguis LM, 2001, CAN J DIABETES CARE, V25, P266; HEPLER CD, 1990, AM J HOSP PHARM, V47, P533, DOI 10.1093/ajhp/47.3.533; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Honkasalo MT, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-26; Jaber LA, 1996, ANN PHARMACOTHER, V30, P238, DOI 10.1177/106002809603000305; Jacobs M, 2012, J AM PHARM ASSOC, V52, P613, DOI 10.1331/JAPhA.2012.10183; Jahangard-Rafsanjani Z, 2015, DIABETES EDUCATOR, V41, P127, DOI 10.1177/0145721714559132; Jameson JP, 2010, AM J MANAG CARE, V16, P250; Jarab AS, 2012, J MANAGE CARE PHARM, V18, P516, DOI 10.18553/jmcp.2012.18.7.516; Krass I, 2007, DIABETIC MED, V24, P677, DOI 10.1111/j.1464-5491.2007.02143.x; Leach MJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1212; Liang X, 2011, DIABETIC MED, V28, P455, DOI 10.1111/j.1464-5491.2010.03180.x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Machado M, 2007, ANN PHARMACOTHER, V41, P1569, DOI 10.1345/aph.1K151; Mourao AOM, 2013, INT J CLIN PHARM-NET, V35, P79, DOI 10.1007/s11096-012-9710-7; Mehuys E, 2011, J CLIN PHARM THER, V36, P602, DOI 10.1111/j.1365-2710.2010.01218.x; Odegard PS, 2005, ANN PHARMACOTHER, V39, P433, DOI 10.1345/aph.1E438; Petticrew M, 2013, J CLIN EPIDEMIOL, V66, P1230, DOI 10.1016/j.jclinepi.2013.06.005; Pigott T, 2013, J CLIN EPIDEMIOL, V66, P1244, DOI 10.1016/j.jclinepi.2013.06.013; Rothman RL, 2005, AM J MED, V118, P276, DOI 10.1016/j.amjmed.2004.09.017; Rotta I, 2015, J EVAL CLIN PRACT, V21, P584, DOI 10.1111/jep.12339; Salgado TM, 2013, ANN PHARMACOTHER, V47, P1498, DOI 10.1177/1060028013501802; Sarkadi A, 2004, PATIENT EDUC COUNS, V53, P291, DOI 10.1016/j.pec.2003.10.009; Schlaifer M, 2010, J AM PHARM ASSOC, V50, pE35, DOI 10.1331/JAPhA.2010.10510; Scott DM, 2006, AM J HEALTH-SYST PH, V63, P2116, DOI 10.2146/ajhp060040; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shrivastava SR, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-14; Squires JE, 2013, J CLIN EPIDEMIOL, V66, P1215, DOI 10.1016/j.jclinepi.2013.05.013; Sriram S, 2011, J RES MED SCI, V16, P16; Suppapitiporn Suchat, 2005, J Med Assoc Thai, V88 Suppl 4, pS134; Taveira TH, 2011, ANN PHARMACOTHER, V45, P1346, DOI 10.1345/aph.1Q212; Taveira TH, 2010, DIABETES EDUCATOR, V36, P109, DOI 10.1177/0145721709352383; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Van C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-320; Wang Y, 2015, DIABET MED; WHO, 2011, GLOB STAT REP NONC D; Wishah RA, 2014, DIABETES METAB SYNDR	59	24	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150999	10.1371/journal.pone.0150999	http://dx.doi.org/10.1371/journal.pone.0150999			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963251	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000088
J	Borgdorff, H; Armstrong, SD; Tytgat, HLP; Xia, D; Ndayisaba, GF; Wastling, JM; van de Wijgert, JHHM				Borgdorff, Hanneke; Armstrong, Stuart D.; Tytgat, Hanne L. P.; Xia, Dong; Ndayisaba, Gilles F.; Wastling, Jonathan M.; van de Wijgert, Janneke H. H. M.			Unique Insights in the Cervicovaginal Lactobacillus iners and L. crispatus Proteomes and Their Associations with Microbiota Dysbiosis	PLOS ONE			English	Article							ADHESIVE MOONLIGHTING PROTEINS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; VAGINAL MICROBIOTA; SEX WORKERS; BACTERIA; RESISTANCE; HEALTH; CELLS; GAPDH	Background A Lactobacillus-dominated cervicovaginal microbiota (VMB) protects women from adverse reproductive health outcomes, but the role of L. iners in the VMB is poorly understood. Our aim was to explore the association between the cervicovaginal L. iners and L. crispatus proteomes and VMB composition. Methods The vaginal proteomes of 50 Rwandan women at high HIV risk, grouped into four VMB groups (based on 16S rDNA microarray results), were investigated by mass spectrometry using cervicovaginal lavage (CVL) samples. Only samples with positive 16S results for L. iners and/or L. crispatus within each group were included in subsequent comparative protein analyses: Lactobacillus crispatus-dominated VMB cluster (with 16S-proven L. iners (n(i)) = 0, and with 16S-proven L. crispatus (n(c)) = 5), L. iners-dominated VMB cluster (n(i) = 11, n(c) = 4), moderate dysbiosis (n(i) = 12, n(c) = 2); and severe dysbiosis (n(i) = 8, n(c) = 2). The relative abundances of proteins that were considered specific for L. iners and L. crispatus were compared among VMB groups. Results Forty Lactobacillus proteins were identified of which 7 were specific for L. iners and 11 for L. crispatus. The relative abundances of L. iners DNA starvation/stationary phase protection protein (DPS), and the glycolysis enzymes glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and glucose-6-phosphate isomerase (GPI), were significantly decreased in women with L. iners-containing dysbiosis compared to women with a L. iners-dominated VMB, independent of vaginal pH and L. iners abundance. Furthermore, L. iners DPS, GAPDH, GPI, and fructose-bisphosphate aldolase (ALDO) were significantly negatively associated with vaginal pH. Glycolysis enzymes of L. crispatus showed a similar negative, but nonsignificant, trend related to dysbiosis. Conclusions Most identified Lactobacillus proteins had conserved intracellular functions, but their high abundance in CVL supernatant might imply an additional extracellular (moonlighting) role. Our findings suggest that these proteins can be important in maintaining a Lactobacillusdominated VMB. Functional studies are needed to investigate their roles in vaginal bacterial communities and whether they can be used to prevent vaginal dysbiosis.	[Borgdorff, Hanneke] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Borgdorff, Hanneke] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Armstrong, Stuart D.; Xia, Dong; Wastling, Jonathan M.; van de Wijgert, Janneke H. H. M.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Tytgat, Hanne L. P.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Tytgat, Hanne L. P.] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Leuven, Belgium; [Tytgat, Hanne L. P.] Univ Antwerp, Lab Environm Ecol & Appl Microbiol, B-2020 Antwerp, Belgium; [Ndayisaba, Gilles F.; van de Wijgert, Janneke H. H. M.] Rinda Ubuzima, Kigali, Rwanda; [Wastling, Jonathan M.] Keele Univ, Fac Nat Sci, Keele ST5 5BG, Staffs, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Liverpool; Wageningen University & Research; KU Leuven; University of Antwerp; Keele University	van de Wijgert, JHHM (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.; van de Wijgert, JHHM (corresponding author), Rinda Ubuzima, Kigali, Rwanda.	j.vandewijgert@liverpool.ac.uk	Tytgat, Hanne L.P./B-4388-2013	Tytgat, Hanne L.P./0000-0001-6270-2110; Xia, Dong/0000-0003-4571-2776; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	Institute of Infection and Global Health of the University of Liverpool; Aids Fonds Netherlands [201102]; European and Developing Countries Clinical Trials Partnership [CT.2005.33070.001]; European Commission (CHAARM consortium)	Institute of Infection and Global Health of the University of Liverpool; Aids Fonds Netherlands; European and Developing Countries Clinical Trials Partnership; European Commission (CHAARM consortium)(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the Institute of Infection and Global Health of the University of Liverpool, the Aids Fonds Netherlands (project number 201102), European and Developing Countries Clinical Trials Partnership (project number CT.2005.33070.001) and the European Commission (CHAARM consortium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Antikainen J, 2007, J BACTERIOL, V189, P4539, DOI 10.1128/JB.00378-07; Birse KDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130404; Borgdorff H, 2016, MUCOSAL IMMUNOL, V9, P621, DOI 10.1038/mi.2015.86; Borgdorff H, 2015, SEX TRANSM DIS, V42, P143, DOI 10.1097/OLQ.0000000000000245; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Bradshaw CS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1027-4; Braunstein SL, 2011, SEX TRANSM DIS, V38, P385, DOI 10.1097/OLQ.0b013e31820b8eba; Burgener A, 2011, J PROTEOME RES, V10, P5139, DOI 10.1021/pr200596r; Gautam R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0831-1; Glenting J, 2013, MICROBIOL RES, V168, P245, DOI 10.1016/j.micres.2013.01.003; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Henderson B, 2014, BIOCHEM SOC T, V42, P1720, DOI 10.1042/BST20140236; Hurmalainen V, 2007, MICROBIOL-SGM, V153, P1112, DOI 10.1099/mic.0.2006/000901-0; Kainulainen Veera, 2014, Biology (Basel), V3, P178, DOI 10.3390/biology3010178; Kainulainen V, 2012, J BACTERIOL, V194, P2509, DOI 10.1128/JB.06704-11; Kalyoussef S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049506; Kinoshita H, 2008, J APPL MICROBIOL, V104, P1667, DOI 10.1111/j.1365-2672.2007.03679.x; Lacqua A, 2006, APPL ENVIRON MICROB, V72, P956, DOI 10.1128/AEM.72.1.956-959.2006; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Macklaim JM, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-12; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; Madureira P, 2007, J IMMUNOL, V178, P1379, DOI 10.4049/jimmunol.178.3.1379; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Ramiah K, 2008, RES MICROBIOL, V159, P470, DOI 10.1016/j.resmic.2008.06.002; Shams F, 2014, BIOCHEM SOC T, V42, P1792, DOI 10.1042/BST20140203; Siciliano RA, 2008, BBA-PROTEINS PROTEOM, V1784, P335, DOI 10.1016/j.bbapap.2007.11.007; Smith JL, 2004, CRIT REV MICROBIOL, V30, P173, DOI 10.1080/10408410490435151; Tsivtsivadze E, 2013, LECT NOTES ARTIF INT, V8193, P80, DOI 10.1007/978-3-642-40705-5_8; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang GQ, 2014, CURR ISSUES MOL BIOL, V16, P15; Xu YF, 2014, MICROBIOL-SGM, V160, P2627, DOI 10.1099/mic.0.082156-0; Zegels G, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-17	34	35	39	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150767	10.1371/journal.pone.0150767	http://dx.doi.org/10.1371/journal.pone.0150767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963809	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000060
J	de Souza, RTF; Gerhardt, GJL; Schonwald, SV; Rybarczyk, JL; Lemke, N				Fernandes de Souza, Rafael Toledo; Lewczuk Gerhardt, Guenther Johannes; Schoenwald, Suzana Veiga; Rybarczyk-Filho, Jose Luiz; Lemke, Ney			Synchronization and Propagation of Global Sleep Spindles	PLOS ONE			English	Article							NEOCORTICAL DYNAMICS; STANDING WAVES; HUMAN BRAIN; EEG; KURAMOTO; AREAS; MODEL	Sleep spindles occur thousands of times during normal sleep and can be easily detected by visual inspection of EEG signals. These characteristics make spindles one of the most studied EEG structures in mammalian sleep. In this work we considered global spindles, which are spindles that are observed simultaneously in all EEG channels. We propose a methodology that investigates both the signal envelope and phase/frequency of each global spindle. By analysing the global spindle phase we showed that 90% of spindles synchronize with an average latency time of 0.1 s. We also measured the frequency modulation ( chirp) of global spindles and found that global spindle chirp and synchronization are not correlated. By investigating the signal envelopes and implementing a homogeneous and isotropic propagation model, we could estimate both the signal origin and velocity in global spindles. Our results indicate that this simple and non-invasive approach could determine with reasonable precision the spindle origin, and allowed us to estimate a signal speed of 0.12 m/s. Finally, we consider whether synchronization might be useful as a non-invasive diagnostic tool.	[Fernandes de Souza, Rafael Toledo; Rybarczyk-Filho, Jose Luiz; Lemke, Ney] Univ Estadual Paulista, UNESP, Dept Fis & Biofis, Botucatu, SP, Brazil; [Lewczuk Gerhardt, Guenther Johannes] Univ Caxias do Sul, Dept Quim & Fis, Caxias Do Sul, Brazil; [Schoenwald, Suzana Veiga] Hosp Clin Porto Alegre, Neurol Sect, Porto Alegre, RS, Brazil; [Schoenwald, Suzana Veiga] Hosp Clin Porto Alegre, Pulmonol Sect, Porto Alegre, RS, Brazil	Universidade Estadual Paulista; Universidade de Caxias do Sul	de Souza, RTF (corresponding author), Univ Estadual Paulista, UNESP, Dept Fis & Biofis, Botucatu, SP, Brazil.	rafael@ibb.unesp.br	Lemke, Ney/L-6761-2019; Schonwald, Suzana/E-5302-2016; Lemke, Ney/A-8213-2008; Filho, José Luiz Rybarczyk/ABC-6502-2020	Lemke, Ney/0000-0001-7463-4303; Schonwald, Suzana/0000-0002-8405-0966; Lemke, Ney/0000-0001-7463-4303; Filho, José Luiz Rybarczyk/0000-0002-0757-3608	Fapesp [2012/22413-2, 2013/02018-4]	Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fapesp, grants 2012/22413-2 and 2013/02018-4, and resources supplied by the Sao Paulo State University (UNESP) Center for Scientific Computing (NCC/GridUNESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Andrillon T, 2011, J NEUROSCI, V31, P17821, DOI 10.1523/JNEUROSCI.2604-11.2011; Astori S, 2013, TRENDS NEUROSCI, V36, P738, DOI 10.1016/j.tins.2013.10.001; Ayoub A, 2013, SLEEP, V36, P905, DOI 10.5665/sleep.2722; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Buzsaki G, 1996, CEREBRAL CORTEX; Carvalho DZ, 2014, CLIN NEUROPHYSIOL, V125, P306, DOI 10.1016/j.clinph.2013.07.005; Crick F., 1990, SEMINARS NEUROSCIENC; DESTEXHE A, 1994, J NEUROPHYSIOL, V72, P803, DOI 10.1152/jn.1994.72.2.803; Destexhe A, 2010, HDB BRAIN THEORY NEU; Destexhe A, 2009, ENCY NEUROSCIENCE; Durka PJ, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-1; Durka PJ, 2002, J NEUROSCI METH, V117, P65, DOI 10.1016/S0165-0270(02)00075-4; Durka PJ, 2001, IEEE T SIGNAL PROCES, V49, P507, DOI 10.1109/78.905866; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Frauscher B, 2015, NEUROIMAGE, V105, P1, DOI 10.1016/j.neuroimage.2014.10.048; GENERAL A, 2005, DIAGN COD MAN; Girard P, 2001, J NEUROPHYSIOL, V85, P1328, DOI 10.1152/jn.2001.85.3.1328; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Iber C, 1970, AASM MANUAL SCORING; Ingber L, 2011, MATH BIOSCI, V229, P160, DOI 10.1016/j.mbs.2010.12.003; Inostroza M, 2013, ANNU REV NEUROSCI, V36, P79, DOI 10.1146/annurev-neuro-062012-170429; JANKEL WR, 1985, J CLIN NEUROPHYSIOL, V2, P1, DOI 10.1097/00004691-198501000-00001; Kocsis B, 2001, EUR J NEUROSCI, V13, P381, DOI 10.1046/j.0953-816X.2000.01392.x; Loomis A L, 1935, Science, V82, P198, DOI 10.1126/science.82.2122.198; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Manjarrez E, 2007, BRAIN RES, V1145, P239, DOI 10.1016/j.brainres.2007.01.114; Mizuhara H, 2004, NEUROREPORT, V15, P1233, DOI 10.1097/01.wnr.0000126755.09715.b3; Mizuhara H, 2007, NEUROIMAGE, V36, P232, DOI 10.1016/j.neuroimage.2007.02.026; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO, V6; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; NUNEZ P L, 1974, Mathematical Biosciences, V21, P279, DOI 10.1016/0025-5564(74)90020-0; Nunez PL, 2006, CLIN NEUROPHYSIOL, V117, P2424, DOI 10.1016/j.clinph.2006.06.754; Nunez PL, 2014, BRAIN RES, V1542, P138, DOI 10.1016/j.brainres.2013.10.036; Nunez PL, 2000, BEHAV BRAIN SCI, V23, P415, DOI 10.1017/S0140525X00403250; O'Reilly C, 2014, J NEUROSCI METH, V221, P215, DOI 10.1016/j.jneumeth.2013.08.014; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; Schonwald SV, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-89; Schonwald SV, 2011, J NEUROSCI METH, V197, P158, DOI 10.1016/j.jneumeth.2011.01.025; Schonwald SV, 2006, J NEUROSCI METH, V156, P314, DOI 10.1016/j.jneumeth.2006.01.026; Shanahan M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00089; Sitnikova Evgenia, 2014, Neurosci J, V2014, P370764, DOI 10.1155/2014/370764; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Subha DP, 2010, J MED SYST, V34, P195, DOI 10.1007/s10916-008-9231-z; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Walker M P, 2014, NEUROSCIENCE PSYCHOA	55	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151369	10.1371/journal.pone.0151369	http://dx.doi.org/10.1371/journal.pone.0151369			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963102	gold, Green Published			2022-12-27	WOS:000371993000142
J	Militz, TA; Kinch, J; Foale, S; Southgate, PC				Militz, Thane A.; Kinch, Jeff; Foale, Simon; Southgate, Paul C.			Fish Rejections in the Marine Aquarium Trade: An Initial Case Study Raises Concern for Village-Based Fisheries	PLOS ONE			English	Article							HOME-RANGE; REEF FISH; MORTALITY; IMPACT; HOST; SIZE	A major difficulty in managing wildlife trade is the reliance on trade data (rather than capture data) to monitor exploitation of wild populations. Collected organisms that die or are rejected before a point of sale often go unreported. For the global marine aquarium trade, identifying the loss of collected fish from rejection, prior to export, is a first step in assessing true collection levels. This study takes a detailed look at fish rejections by buyers before export using the Papua New Guinea marine aquarium fishery as a case study. Utilizing collection invoices detailing the species and quantity of fish (Actinopteri and Elasmobranchii) accepted or rejected by the exporting company it was determined that, over a six month period, 24.2% of the total fish catch reported (n = 13,886) was rejected. Of the ten most collected fish families, rejection frequency was highest for the Apogonidae (54.2%), Chaetodontidae (26.3%), and Acanthuridae (18.2%) and lowest for Labridae (6.6%) and Hemiscylliidae (0.7%). The most frequently cited reasons for rejection were fin damage (45.6% of cases), undersized fish (21.8%), and fish deemed too thin (11.1%). Despite fishers receiving feedback on invoices explaining rejections, there was no improvement in rejection frequencies over time (r = -0.33, P = 0.15) with weekly rejection frequencies being highly inconsistent (range: 2.8% to 79.4%; s = 16.3%). These findings suggest that export/import statistics can greatly underestimate collection for the marine aquarium trade as additional factors such as fisher discards, escapees, post-collection mortalities, and unregulated domestic trade would further contribute to this disparity.	[Militz, Thane A.] James Cook Univ, Coll Marine & Environm Sci, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Kinch, Jeff] Natl Fisheries Author, Natl Fisheries Coll, Kavieng, Papua N Guinea; [Foale, Simon] James Cook Univ, Ctr Trop Biodivers & Climate Change, Coll Arts Soc & Educ, Townsville, Qld 4811, Australia; [Militz, Thane A.; Southgate, Paul C.] Univ Sunshine Coast, Australian Ctr Pacific Isl Res, Maroochydore, Australia; [Militz, Thane A.; Southgate, Paul C.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Maroochydore, Australia	James Cook University; James Cook University; University of the Sunshine Coast; University of the Sunshine Coast	Militz, TA (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia.; Militz, TA (corresponding author), Univ Sunshine Coast, Australian Ctr Pacific Isl Res, Maroochydore, Australia.; Militz, TA (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Maroochydore, Australia.	thane.militz@my.jcu.edu.au	Militz, Thane A./AAQ-1854-2021; Foale, Simon/M-5872-2014	Militz, Thane A./0000-0002-6476-8559; Foale, Simon/0000-0003-0809-872X	Australian Centre for International Agriculture Research (ACIAR); National Fisheries Authority (NFA) through ACIAR [FIS/2010/054]	Australian Centre for International Agriculture Research (ACIAR)(Australian Ctr Intl Agr Res); National Fisheries Authority (NFA) through ACIAR	This study was supported by the Australian Centre for International Agriculture Research (ACIAR) and the National Fisheries Authority (NFA) through ACIAR project FIS/2010/054 "Mariculture Development in New Ireland, Papua New Guinea" awarded to PCS for which the University of the Sunshine Coast is the Commissioned Organization (http://aciar.gov.au/project/fis/2010/054). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Aquarium Fish Ltd, 1990, 9030 S PAC FOR FISH; Balboa CM, 2003, MARINE ORNAMENTAL SPECIES: COLLECTION, CULTURE & CONSERVATION, P65, DOI 10.1002/9780470752722.ch5; Bartholomew A, 2005, REV FISH BIOL FISHER, V15, P129, DOI 10.1007/s11160-005-2175-1; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Blundell AG, 2005, CONSERV BIOL, V19, P2020, DOI 10.1111/j.1523-1739.2005.00253.x; Bondad-Reantaso MG, 2005, VET PARASITOL, V132, P249, DOI 10.1016/j.vetpar.2005.07.005; Choat JH, 1996, MAR ECOL PROG SER, V134, P15, DOI 10.3354/meps134015; Cinner JE, 2006, ENVIRON CONSERV, V33, P73, DOI 10.1017/S0376892906002748; Dandava-Oli L, 2013, SPC FISHERIES NEWSLE, V141, P37; Doherty PJ, 2004, ECOLOGY, V85, P2422, DOI 10.1890/04-0366; Elliott JK, 2001, MAR BIOL, V138, P23, DOI 10.1007/s002270000441; Erdmann MV, 2001, CORAL REEFS, V20, P252, DOI 10.1007/s003380100174; Ferse SCA, 2012, COAST MANAGE, V40, P525, DOI 10.1080/08920753.2012.694801; Filer C., 2004, DEV LOCAL KNOWLEDGE, P64; Foale S., 2001, ASIA PAC J ANTHR, V2, P44, DOI [10.1080/14442210110001706105, DOI 10.1080/14442210110001706105]; Gonzales E, 2005, EPR03014; Guo FC, 2009, VET PARASITOL, V163, P207, DOI 10.1016/j.vetpar.2009.06.016; Gutowsky LFG, 2015, FISH RES, V167, P64, DOI 10.1016/j.fishres.2015.02.002; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Holmberg RJ, 2015, MAR POLICY, V53, P7, DOI 10.1016/j.marpol.2014.10.024; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones KMM, 2007, ENVIRON BIOL FISH, V80, P35, DOI 10.1007/s10641-006-9104-6; Kinch J, 2009, P SUBR WORKSH MAR OR; Kinch J, 2004, MARINE AQUARIUM TRAD; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Lilley R., 2007, SPC LIVE REEF FISH I, V17, P11; Lilley Ron, 2008, SPC Live Reef Fish Information Bulletin, V18, P3; Lock JM, 1986, 863 DEP PRIM INDD; Macintyre M., 2004, GLOBALIZATION CULTUR, P149; Madduppa HH, 2014, OCEAN COAST MANAGE, V100, P41, DOI 10.1016/j.ocecoaman.2014.07.013; Manez KS, 2014, MAR POLICY, V44, P279, DOI 10.1016/j.marpol.2013.09.018; Marine Aquarium Council, 2001, COR COLL FISH HOLD I; Marine Aquarium Council, 2001, COR EC FISH MAN INT; Marine Aquarium Council, 2006, REP ROV COLL CAS STU; McCormick MI, 2012, P ROY SOC B-BIOL SCI, V279, P3899, DOI 10.1098/rspb.2012.0854; Murray JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105982; Rhyne AL, 2012, CONSERV LETT, V5, P478, DOI 10.1111/j.1755-263X.2012.00265.x; Rhyne AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035808; SALE PF, 1971, COPEIA, P324; Shuman CS, 2004, ENVIRON CONSERV, V31, P339, DOI 10.1017/S0376892904001663; Stevenson TC, 2011, ICES J MAR SCI, V68, P813, DOI 10.1093/icesjms/fsr020; Teitelbaum A., 2010, SPC LIVE REEF FISH I, V19, P3; Thornhill DJ, 2012, ECOLOGICAL IMPACTS P, P187; Tlusty M, 2002, AQUACULTURE, V205, P203, DOI 10.1016/S0044-8486(01)00683-4; Trip EDL, 2014, CORAL REEFS, V33, P879, DOI 10.1007/s00338-014-1182-x; Vagelli A, 2008, MAR GENOM, V1, P129, DOI 10.1016/j.margen.2009.01.001; Wabnitz C, 2003, OCEAN AQUARIUM; Wood E., 2001, COLLECTION CORAL REE; WoRMS, 2015, WORLD REGISTER MARIN; Yeeting BM, 2010, REV MARINE AQUARIM T	50	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151624	10.1371/journal.pone.0151624	http://dx.doi.org/10.1371/journal.pone.0151624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963259	Green Published, gold, Green Accepted			2022-12-27	WOS:000371993000165
J	Patel, H; Mansuri, MS; Singh, M; Begum, R; Shastri, M; Misra, A				Patel, Hinal; Mansuri, Mohmmad Shoab; Singh, Mala; Begum, Rasheedunnisa; Shastri, Minal; Misra, Ambikanandan			Association of Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) and Thyroglobulin (TG) Genetic Variants with Autoimmune Hypothyroidism	PLOS ONE			English	Article							GLOBAL IODINE STATUS; THYROID-DISEASE; SOLUBLE CTLA-4; GRAVES-DISEASE; POLYMORPHISM; SUSCEPTIBILITY; PREVALENCE; GENOTYPE; MARKER; EXON-1	Autoimmune hypothyroidism is known to be caused by immune responses related to the thyroid gland and its immunological feature includes presence of autoimmune antibodies. Therefore the aim was to analyze presence of anti-TPO antibodies in hypothyroidism patients in Gujarat. Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) is one of the susceptibility genes for various autoimmune diseases. Hence, exon1 +49A/G and 3'UTR CT60A/G single nucleotide polymorphisms (SNPs) in CTLA4 and its mRNA expression levels were investigated in autoimmune hypothyroidism patients. Thyroglobulin (TG) is known to be associated with autoimmune thyroid disorders and thus exon 33 (E33) SNP in TG was investigated. We analyzed the presence of anti-TPO antibodies in the plasma samples of 84 hypothyroidism patients and 62 controls by ELISA. PCR-RFLP technique was used for genotyping of polymorphisms. sCTLA4 and flCTLA4 mRNA expression levels were assessed by real time PCR. 59.52% of hypothyroid patients had anti-TPO antibodies in their circulation. The genotype and allele frequencies differed significantly for +49A/G (p = 0.0004 for +49AG, p = 0.0019 for +49GG & p = 0.0004 for allele), CT60 (p = 0.0110 for CT60AG, p = 0.0005 for CT60GG & p<0.0001 for allele) and TG E33 (p = 0.0003 for E33TC p<0.0001 for E33CC& p<0.0001 for allele) SNPs between patients and controls. Patients had significantly decreased mRNA levels of both sCTLA4 (p = 0.0017) and flCTLA4 (p<0.0001) compared to controls. +49A/G and CT60 polymorphisms of CTLA4 were in moderate linkage disequilibrium. Logistic regression analysis indicated significant association of CT49A/G, CT60A/G and TG exon 33 polymorphisms with susceptibility to autoimmune hypothyroidism when adjusted for age and gender. Our results suggest +49A/G and CT60 polymorphism of CTLA4 and E33 polymorphism of TG may be genetic risk factors for autoimmune hypothyroidism susceptibility and down regulation of both forms of CTLA4 advocates the crucial role of CTLA4 in pathogenesis of autoimmune hypothyroidism.	[Patel, Hinal; Misra, Ambikanandan] Maharaja Sayajirao Univ Baroda, Fac Engn & Technol, Dept Pharm, Vadodara, Gujarat, India; [Mansuri, Mohmmad Shoab; Singh, Mala; Begum, Rasheedunnisa] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Vadodara, Gujarat, India; [Shastri, Minal] Maharaja Sayajirao Univ Baroda, Sir Sayajirao Gaekwad Hosp, Fac Med, Dept Med, Vadodara, Gujarat, India	Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda; Baroda Medical College	Misra, A (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Engn & Technol, Dept Pharm, Vadodara, Gujarat, India.; Begum, R (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Vadodara, Gujarat, India.	rasheedunnisab@yahoo.co.in; misraan@hotmail.com	Begum, Rasheedunnisa/AAF-2981-2020; Misra, Ambikanandan/V-8757-2018	Misra, Ambikanandan/0000-0002-9100-3789				Andersson M, 2005, B WORLD HEALTH ORGAN, V83, P518; Andersson M, 2012, J NUTR, V142, P744, DOI 10.3945/jn.111.149393; [Anonymous], 2006, REV POL GUID NAT IOD; Ban Y, 2005, AUTOIMMUNITY, V38, P151, DOI 10.1080/08916930500050319; Ban Y, 2003, P NATL ACAD SCI USA, V100, P15119, DOI 10.1073/pnas.2434175100; Barbesino G, 1998, J CLIN ENDOCR METAB, V83, P1580, DOI 10.1210/jc.83.5.1580; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cooper DS, 2001, NEW ENGL J MED, V345, P260, DOI 10.1056/NEJM200107263450406; Daroszewski J, 2009, EUR J ENDOCRINOL, V161, P787, DOI 10.1530/EJE-09-0600; Dodd Nina S., 1992, Indian Journal of Pediatrics, V59, P585, DOI 10.1007/BF02832996; Dwivedi M, 2011, PIGM CELL MELANOMA R, V24, P737, DOI 10.1111/j.1755-148X.2011.00892.x; Eguchi K, 2001, INTERNAL MED, V40, P275, DOI 10.2169/internalmedicine.40.275; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Furugaki K, 2004, J HUM GENET, V49, P166, DOI 10.1007/s10038-003-0120-5; Gerold KD, 2011, DIABETES, V60, P1955, DOI 10.2337/db11-0130; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hoogendoorn EH, 2006, CLIN CHEM, V52, P104, DOI 10.1373/clinchem.2005.055194; Kavvoura FK, 2007, J CLIN ENDOCR METAB, V92, P3162, DOI 10.1210/jc.2007-0147; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Kouki T, 2002, J ENDOCRINOL INVEST, V25, P208, DOI 10.1007/BF03343992; Marwaha RK, 2003, CLIN ENDOCRINOL, V59, P672, DOI 10.1046/j.1365-2265.2003.01895.x; Mayans S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-3; McCoy KD, 1999, IMMUNOL CELL BIOL, V77, P1, DOI 10.1046/j.1440-1711.1999.00795.x; Ni J, 2014, ENDOCR RES, V39, P180, DOI 10.3109/07435800.2013.879167; Nithiyananthan R, 2002, THYROID, V12, P3, DOI 10.1089/105072502753451896; Orozco G, 2004, TISSUE ANTIGENS, V64, P667, DOI 10.1111/j.1399-0039.2004.00318.x; Park YJ, 2000, THYROID, V10, P453, DOI 10.1089/thy.2000.10.453; Roberts CGP, 2004, LANCET, V363, P793, DOI 10.1016/S0140-6736(04)15696-1; Saverino D, 2007, CLIN IMMUNOL, V123, P190, DOI 10.1016/j.clim.2007.01.003; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Sood A, 1997, NATL MED J INDIA, V10, P290; Stassi G, 2002, NAT REV IMMUNOL, V2, P195, DOI 10.1038/nri750; Strieder TGA, 2003, CLIN ENDOCRINOL, V59, P396, DOI 10.1046/j.1365-2265.2003.01862.x; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Tomer Y, 2003, ENDOCR REV, V24, P694, DOI 10.1210/er.2002-0030; Tomoyose T, 2002, THYROID, V12, P673, DOI 10.1089/105072502760258640; Torres B, 2004, ARTHRITIS RHEUM-US, V50, P2211, DOI 10.1002/art.20347; Toteja G. S., 2004, Indian Journal of Pediatrics, V71, P25, DOI 10.1007/BF02725651; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Unnikrishnan Ambika Gopalakrishnan, 2013, Indian J Endocrinol Metab, V17, P647, DOI 10.4103/2230-8210.113755; Vaidya B, 2004, EUR J ENDOCRINOL, V150, P619, DOI 10.1530/eje.0.1500619; World Health Organization (WHO), 2004, WHO GLOB DAT IOD DEF; YANAGAWA T, 1995, J CLIN ENDOCR METAB, V80, P41, DOI 10.1210/jc.80.1.41	43	19	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149441	10.1371/journal.pone.0149441	http://dx.doi.org/10.1371/journal.pone.0149441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963610	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000014
J	Pereira, EIP; Suddick, EC; Six, J				Pereira, Engil Isadora Pujol; Suddick, Emma C.; Six, Johan			Carbon Abatement and Emissions Associated with the Gasification of Walnut Shells for Bioenergy and Biochar Production	PLOS ONE			English	Article							NITROUS-OXIDE EMISSION; N2O EMISSIONS; BLACK CARBON; SOIL; PYROLYSIS; MINERALIZATION; CO2	By converting biomass residue to biochar, we could generate power cleanly and sequester carbon resulting in overall greenhouse gas emissions (GHG) savings when compared to typical fossil fuel usage and waste disposal. We estimated the carbon dioxide (CO2) abatements and emissions associated to the concurrent production of bioenergy and biochar through biomass gasification in an organic walnut farm and processing facility in California, USA. We accounted for (i) avoided-CO2 emissions from displaced grid electricity by bioenergy; (ii) CO2 emissions from farm machinery used for soil amendment of biochar; (iii) CO2 sequestered in the soil through stable biochar-C; and (iv) direct CO2 and nitrous oxide (N2O) emissions from soil. The objective of these assessments was to pinpoint where the largest C offsets can be expected in the bioenergy-biochar chain. We found that energy production from gasification resulted in 91.8% of total C offsets, followed by stable biochar-C (8.2% of total C sinks), offsetting a total of 107.7 kg CO2-C eq Mg-1 feedstock. At the field scale, we monitored gas fluxes from soils for 29 months (180 individual observations) following field management and precipitation events in addition to weekly measurements within three growing seasons and two tree dormancy periods. We compared four treatments: control, biochar, compost, and biochar combined with compost. Biochar alone or in combination with compost did not alter total N2O and CO2 emissions from soils, indicating that under the conditions of this study, biochar-prompted C offsets may not be expected from the mitigation of direct soil GHG emissions. However, this study revealed a case where a large environmental benefit was given by the waste-to-bioenergy treatment, addressing farm level challenges such as waste management, renewable energy generation, and C sequestration.	[Pereira, Engil Isadora Pujol; Suddick, Emma C.; Six, Johan] Univ Calif Davis, Dept Plant Sci, One Shields Ave, Davis, CA 95616 USA; [Pereira, Engil Isadora Pujol; Six, Johan] ETH, Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Agr Sci, Zurich, Switzerland; [Suddick, Emma C.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA	University of California System; University of California Davis; Swiss Federal Institutes of Technology Domain; ETH Zurich; State University System of Florida; Florida State University	Pereira, EIP (corresponding author), ETH, Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Agr Sci, Zurich, Switzerland.	engil.pereira@usys.ethz.ch	six, johan/J-5228-2015; Pereira, Engil Isadora Pujol/D-3447-2016	six, johan/0000-0001-9336-4185; Pereira, Engil Isadora Pujol/0000-0002-6355-118X	California Energy Commission [PIR-08-004]; National Research Council of Brazil (CNPq)	California Energy Commission; National Research Council of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank California Energy Commission (Contract Number: PIR-08-004) for financial support and the National Research Council of Brazil (CNPq) for scholarship to E. Pereira.	Ahmed I, 2009, APPL ENERG, V86, P1813, DOI 10.1016/j.apenergy.2009.01.025; Alef K., 1995, METHODS APPL SOIL MI, P350; [Anonymous], 2001, TOTAL ENERGY INDICAT; Bateman EJ, 2005, BIOL FERT SOILS, V41, P379, DOI 10.1007/s00374-005-0858-3; Biederman LA, 2013, GCB BIOENERGY, V5, P202, DOI 10.1111/gcbb.12037; Brewer CE, 2009, ENVIRON PROG SUSTAIN, V28, P386, DOI 10.1002/ep.10378; Bruun EW, 2011, BIOMASS BIOENERG, V35, P1182, DOI 10.1016/j.biombioe.2010.12.008; Bruun S, 2008, ORG GEOCHEM, V39, P839, DOI 10.1016/j.orggeochem.2008.04.020; California Department of Food and Agriculture, 2012, CAL COUNT AGR COMM R; Case SDC, 2012, SOIL BIOL BIOCHEM, V51, P125, DOI 10.1016/j.soilbio.2012.03.017; Cayuela ML, 2014, AGR ECOSYST ENVIRON, V191, P5, DOI 10.1016/j.agee.2013.10.009; Cheng CH, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000642; Department for Environment Food & Rural Affairs (Defra-UK), GUID CO REP GREENH G; Digman B, 2009, ENVIRON PROG SUSTAIN, V28, P47, DOI 10.1002/ep.10336; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; Environmental Protection Agency (EPA-USA), 2014, EGRID US ANN NONB CO; Felber R, 2014, EUR J SOIL SCI, V65, P128, DOI 10.1111/ejss.12093; Firestone M.K., 1989, EXCHANGE TRACE GASES, V47, P7, DOI DOI 10.1017/CBO9781107415324.004; Gaunt J., 2009, BIOCHAR ENV MANAGEME, P317, DOI DOI 10.4324/; Hammes K, 2008, APPL GEOCHEM, V23, P2113, DOI 10.1016/j.apgeochem.2008.04.023; Hammond J, 2011, ENERG POLICY, V39, P2646, DOI 10.1016/j.enpol.2011.02.033; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Karhu K, 2011, AGR ECOSYST ENVIRON, V140, P309, DOI 10.1016/j.agee.2010.12.005; Kuzyakov Y, 2009, SOIL BIOL BIOCHEM, V41, P210, DOI 10.1016/j.soilbio.2008.10.016; Luo Y, 2011, SOIL BIOL BIOCHEM, V43, P2304, DOI 10.1016/j.soilbio.2011.07.020; Cayuela ML, 2013, SCI REP-UK, V3, DOI 10.1038/srep01732; Manya JJ, 2003, IND ENG CHEM RES, V42, P434, DOI 10.1021/ie020218p; Maraseni TN, 2010, AGR WATER MANAGE, V97, P382, DOI 10.1016/j.agwat.2009.10.007; Mukome FND, 2013, GEODERMA, V200, P90, DOI 10.1016/j.geoderma.2013.02.004; Mukome FND, 2013, J AGR FOOD CHEM, V61, P2196, DOI 10.1021/jf3049142; Novak JM, 2010, GEODERMA, V154, P281, DOI 10.1016/j.geoderma.2009.10.014; Pereira D E I P, 2015, BIOL FERT SOILS, V51, P1; Roberts KG, 2010, ENVIRON SCI TECHNOL, V44, P827, DOI 10.1021/es902266r; Robertson G., 2007, SOIL MICROBIOLOGY EC, V3rd ed., P341, DOI [10.1016/B978-0-08-047514-1.50017-2, DOI 10.1016/B978-0-08-047514-1.50017-2, DOI 10.1016/B978-0-12-415955-6.00014-1]; Scheer C, 2011, PLANT SOIL, V345, P47, DOI 10.1007/s11104-011-0759-1; Singh BP, 2010, J ENVIRON QUAL, V39, P1224, DOI 10.2134/jeq2009.0138; Smith KA, 2001, GLOBAL CHANGE BIOL, V7, P933, DOI 10.1046/j.1354-1013.2001.00450.x; Spokas K.A., 2009, ANN ENV SCI, V3, P4; Spokas KA, 2012, J ENVIRON QUAL, V41, P973, DOI 10.2134/jeq2011.0069; Suddick EC, 2013, SCI TOTAL ENVIRON, V465, P298, DOI 10.1016/j.scitotenv.2013.01.094; van Zwieten L, 2010, AUST J SOIL RES, V48, P555, DOI 10.1071/SR10004; Verhoeven E, 2014, AGR ECOSYST ENVIRON, V191, P27, DOI 10.1016/j.agee.2014.03.008; Wardle DA, 2008, SCIENCE, V320, P629, DOI 10.1126/science.1154960; Yanai Y, 2007, SOIL SCI PLANT NUTR, V53, P181, DOI 10.1111/j.1747-0765.2007.00123.x; Yiqi L., 2010, SOIL RESP ENV; Zheng JY, 2012, J ENVIRON QUAL, V41, P1361, DOI 10.2134/jeq2012.0019; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005	48	14	14	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150837	10.1371/journal.pone.0150837	http://dx.doi.org/10.1371/journal.pone.0150837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963623	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000069
J	Saleem, H; Nahid, N; Shakir, S; Ijaz, S; Murtaza, G; Khan, AA; Mubin, M; Nawaz-ul-Rehman, MS				Saleem, Huma; Nahid, Nazia; Shakir, Sara; Ijaz, Sehrish; Murtaza, Ghulam; Khan, Asif Ali; Mubin, Muhammad; Nawaz-ul-Rehman, Muhammad Shah			Diversity, Mutation and Recombination Analysis of Cotton Leaf Curl Geminiviruses	PLOS ONE			English	Article							CHLOROTIC DWARF VIRUS; CASSAVA MOSAIC-VIRUS; GENETIC-VARIABILITY; DISEASE; BEGOMOVIRUS; STRAIN; IDENTIFICATION; SATELLITE; CHICKPEA	The spread of cotton leaf curl disease in China, India and Pakistan is a recent phenomenon. Analysis of available sequence data determined that there is a substantial diversity of cotton-infecting geminiviruses in Pakistan. Phylogenetic analyses indicated that recombination between two major groups of viruses, cotton leaf curl Multan virus (CLCuMuV) and cotton leaf curl Kokhran virus (CLCuKoV), led to the emergence of several new viruses. Recombination detection programs and phylogenetic analyses showed that CLCuMuV and CLCuKoV are highly recombinant viruses. Indeed, CLCuKoV appeared to be a major donor virus for the coat protein (CP) gene, while CLCuMuV donated the Rep gene in the majority of recombination events. Using recombination free nucleotide datasets the substitution rates for CP and Rep genes were determined. We inferred similar nucleotide substitution rates for the CLCuMuV-Rep gene (4.96X10(-4)) and CLCuKoV-CP gene (2.706X10(-4)), whereas relatively higher substitution rates were observed for CLCuMuV-CP and CLCuKoV-Rep genes. The combination of sequences with equal and relatively low substitution rates, seemed to result in the emergence of viral isolates that caused epidemics in Pakistan and India. Our findings also suggest that CLCuMuV is spreading at an alarming rate, which can potentially be a threat to cotton production in the Indian subcontinent.	[Saleem, Huma; Shakir, Sara; Ijaz, Sehrish; Murtaza, Ghulam; Khan, Asif Ali; Mubin, Muhammad; Nawaz-ul-Rehman, Muhammad Shah] Univ Agr Faisalabad, Ctr Agr Biochem & Biotechnol, Virol Lab, Faisalabad, Pakistan; [Nahid, Nazia] GC Univ Faisalabad, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan	University of Agriculture Faisalabad; Government College University Faisalabad	Nawaz-ul-Rehman, MS (corresponding author), Univ Agr Faisalabad, Ctr Agr Biochem & Biotechnol, Virol Lab, Faisalabad, Pakistan.	msnawazulrehman@uaf.edu.pk	Ijaz, Sehrish/ABG-1472-2021; Asif, Ali/P-9684-2017; Directorate of CABB, Muhammad Shah Nawaz-ul-Rehman - Associate Professor/AAF-3137-2021	Asif, Ali/0000-0002-4474-164X; Shakir, Sara/0000-0002-8830-5989	Higher Education Commission of Pakistan; International Foundation for Science	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); International Foundation for Science(International Foundation for Science)	This work was supported by the Higher Education Commission of Pakistan and International Foundation for Science.	Ahmed MZ, 2011, PEST MANAG SCI, V67, P307, DOI 10.1002/ps.2067; Amrao L, 2010, VIRUS RES, V153, P161, DOI 10.1016/j.virusres.2010.07.003; Amrao L, 2010, VIRUS RES, V152, P153, DOI 10.1016/j.virusres.2010.06.019; Ashfaq M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104485; Briddon RW, 2001, VIROLOGY, V285, P234, DOI 10.1006/viro.2001.0949; Cai JH, 2010, PLANT PATHOL, V59, P794, DOI 10.1111/j.1365-3059.2010.02266.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duffy S, 2009, J GEN VIROL, V90, P1539, DOI 10.1099/vir.0.009266-0; FAUQUET C, 1990, PLANT DIS, V74, P404, DOI 10.1094/PD-74-0404; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; Fondong VN, 2011, VIROLOGY, V413, P275, DOI 10.1016/j.virol.2011.02.024; Fondong VN, 2000, J GEN VIROL, V81, P287, DOI 10.1099/0022-1317-81-1-287; Hameed U, 2014, PLANT DIS, V98, P1447, DOI 10.1094/PDIS-04-14-0345-PDN; HORN NM, 1993, ANN APPL BIOL, V122, P467, DOI 10.1111/j.1744-7348.1993.tb04050.x; Hussain T., 1991, Pakistan Journal of Phytopathology, V3, P57; Idris AM, 2005, VIRUS RES, V109, P19, DOI 10.1016/j.virusres.2004.10.002; Jose J, 2003, VIROLOGY, V305, P310, DOI 10.1006/viro.2002.1768; Kirthi N, 2004, ARCH VIROL, V149, P2047, DOI 10.1007/s00705-004-0352-5; Kumar A, 2010, VIRUS GENES, V40, P282, DOI 10.1007/s11262-009-0439-x; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Mansoor S, 2003, ARCH VIROL, V148, P1969, DOI 10.1007/s00705-003-0149-y; Manzoor MT, 2014, ARCH VIROL, V159, P1217, DOI 10.1007/s00705-013-1911-4; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Monjane AL, 2011, J VIROL, V85, P9623, DOI 10.1128/JVI.00640-11; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Nahid N, 2008, ARCH VIROL, V153, P1441, DOI 10.1007/s00705-008-0133-7; Nawaz-Ul-Rehman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040050; Nour AM, 1964, EMP COTT GR REV, V70, P99; Rajagopalan PA, 2012, ARCH VIROL, V157, P855, DOI 10.1007/s00705-012-1225-y; Reddy RVC, 2005, PLANT PATHOL, V54, P570, DOI 10.1111/j.1365-3059.2005.01214.x; Sattar MN, 2013, J GEN VIROL, V94, P695, DOI 10.1099/vir.0.049627-0; Sinha V., 2013, New Disease Reports, V27, P9, DOI 10.5197/j.2044-0588.2013.027.009; Srivastava A, 2013, N DIS REP, V28; Tahir MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020366; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsai WS, 2013, PLANT DIS, V97, P291, DOI 10.1094/PDIS-09-12-0847-PDN; Zhou XP, 1998, J GEN VIROL, V79, P915, DOI 10.1099/0022-1317-79-4-915	37	29	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151161	10.1371/journal.pone.0151161	http://dx.doi.org/10.1371/journal.pone.0151161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963635	Green Published, gold			2022-12-27	WOS:000371993000113
J	Alcolea, PJ; Alonso, A; Moreno-Izquierdo, MA; Degayon, MA; Moreno, I; Larraga, V				Alcolea, Pedro J.; Alonso, Ana; Moreno-Izquierdo, Miguel A.; Degayon, Maria A.; Moreno, Inmaculada; Larraga, Vicente			Serum Removal from Culture Induces Growth Arrest, Ploidy Alteration, Decrease in Infectivity and Differential Expression of Crucial Genes in Leishmania infantum Promastigotes	PLOS ONE			English	Article							MAJOR FRIEDLIN CHROMOSOME-1; DEFINED MEDIUM; GENOME; STAGE; TRANSCRIPTION; REPLICATION; CULTIVATION; ANEUPLOIDY; PROTEINS; DONOVANI	Leishmania infantum is one of the species responsible for visceral leishmaniasis. This species is distributed basically in the Mediterranean basin. A recent outbreak in humans has been reported in Spain. Axenic cultures are performed for most procedures with Leishmania spp. promastigotes. This model is stable and reproducible and mimics the conditions of the gut of the sand fly host, which is the natural environment of promastigote development. Culture media are undefined because they contain mammalian serum, which is a rich source of complex lipids and proteins. Serum deprivation slows down the growth kinetics and therefore, yield in biomass. In fact, we have confirmed that the growth rate decreases, as well as infectivity. Ploidy is also affected. Regarding the transcriptome, a high-throughput approach has revealed a low differential expression rate but important differentially regulated genes. The most remarkable profiles are: up-regulation of the GINS Psf3, the fatty acyl-CoA synthase (FAS1), the glyoxylase I (GLO1), the hydrophilic surface protein B (ASPB), the methylmalonyl-CoA epimerase (MMCE) and an amastin gene; and down-regulation of the gPEPCK and the arginase. Implications for metabolic adaptations, differentiation and infectivity are discussed herein.	[Alcolea, Pedro J.; Alonso, Ana; Moreno-Izquierdo, Miguel A.; Degayon, Maria A.; Larraga, Vicente] CSIC, Ctr Invest Biol, Dept Mol Microbiol & Biol Infect, CIB CSIC, Madrid, Spain; [Moreno, Inmaculada] Inst Salud Carlos III CNM ISCIII, Ctr Nacl Microbiol Virol & Inmunol Sanitarias, Microbial Immunol Unit, Majadahonda, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Alcolea, PJ (corresponding author), CSIC, Ctr Invest Biol, Dept Mol Microbiol & Biol Infect, CIB CSIC, Madrid, Spain.	pjalcolea@cib.csic.es	Alcolea Alcolea, Pedro José/O-5654-2016	Alcolea Alcolea, Pedro José/0000-0002-0729-8941; Moreno, Inmaculada/0000-0001-5001-3764; Larraga, Vicente/0000-0003-1260-7400; Alonso Ayala, Ana Maria/0000-0002-1228-7331	CSIC [I3P-BPD2003-1]; Spanish Ministry of Economy and Competitiveness [BES-2011-047361]	CSIC; Spanish Ministry of Economy and Competitiveness(Spanish Government)	PA thanks CSIC for the I3P-BPD2003-1 grant and two contracts of employment at a position included in the A1 group (respectively developed from January 16th to July 23rd 2008 and from October 16th 2008 to April 15th 2009). MAD thanks the Spanish Ministry of Economy and Competitiveness for the FPI Pre-doctoral fellowship BES-2011-047361.; Our gratitude to Alfredo Torano, Mercedes Dominguez, Victor Parro, Manuel J. Gomez and Juan F. Gimenez for their support in different experimental procedures. Thanks to Paul Michels for lending us kindly the anti-L. mexicana gGAPDH antibody. PA thanks CSIC for the I3P-BPD2003-1 grant and two contracts of employment at a position included in the A1 group (respectively developed from January 16th to July 23rd 2008 and from October 16th 2008 to April 15th 2009). MAD thanks the Spanish Ministry of Economy and Competitiveness for the FPI Pre-doctoral fellowship BES-2011-047361.	ALBON N, 1978, P NATL ACAD SCI USA, V75, P2258, DOI 10.1073/pnas.75.5.2258; Alcolea PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113837; Alcolea PJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-849; Alcolea PJ, 2011, INT MICROBIOL, V14, P1, DOI 10.2436/20.1501.01.129; Alcolea PJ, 2010, INT J PARASITOL, V40, P1497, DOI 10.1016/j.ijpara.2010.05.013; Alcolea Pedro J, 2010, BMC Genomics, V11, P31, DOI 10.1186/1471-2164-11-31; Alcolea PJ, 2009, GENOMICS, V93, P551, DOI 10.1016/j.ygeno.2009.01.007; Arce A, 2013, EUROSURVEILLANCE, V18, P5, DOI 10.2807/1560-7917.ES2013.18.30.20546; Barros VC, 2006, EXP PARASITOL, V112, P152, DOI 10.1016/j.exppara.2005.10.005; Bates PA, 2008, CURR OPIN MICROBIOL, V11, P340, DOI 10.1016/j.mib.2008.06.003; Bates PA, 2006, TRENDS PARASITOL, V22, P447, DOI 10.1016/j.pt.2006.08.003; BERENS RL, 1978, J PARASITOL, V64, P160, DOI 10.2307/3279633; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Cunningham ML, 2001, SCIENCE, V292, P285, DOI 10.1126/science.1057740; Depledge DP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000476; Dominguez M, 2002, J EXP MED, V195, P451, DOI 10.1084/jem.20011319; Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096; Gonzalez-Aseguinolaza G, 1999, EUR J BIOCHEM, V259, P909, DOI 10.1046/j.1432-1327.1999.00122.x; Holzer TR, 2006, MOL BIOCHEM PARASIT, V146, P198, DOI 10.1016/j.molbiopara.2005.12.009; Jackson AP, 2010, MOL BIOL EVOL, V27, P33, DOI 10.1093/molbev/msp214; Jimenez M, 2014, VET PARASITOL, V202, P296, DOI 10.1016/j.vetpar.2014.03.027; Kamada Katsuhiko, 2012, Subcell Biochem, V62, P135, DOI 10.1007/978-94-007-4572-8_8; Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2; Kuhnl J, 2005, FEBS J, V272, P1465, DOI 10.1111/j.1742-4658.2005.04579.x; Lachaud L, 2014, MICROBES INFECT, V16, P61, DOI 10.1016/j.micinf.2013.09.005; Lahav T, 2011, FASEB J, V25, P515, DOI 10.1096/fj.10-157529; LEE AG, 1977, BIOCHIM BIOPHYS ACTA, V472, P237, DOI 10.1016/0304-4157(77)90018-1; Leifso K, 2007, MOL BIOCHEM PARASIT, V152, P35, DOI 10.1016/j.molbiopara.2006.11.009; LEMMA A, 1964, EXP PARASITOL, V15, P503, DOI 10.1016/0014-4894(64)90043-8; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; McConville MJ, 2002, MICROBIOL MOL BIOL R, V66, P122, DOI 10.1128/MMBR.66.1.122-154.2002; MINTA JO, 1985, AM J PATHOL, V119, P111; Molina R, 2012, VET PARASITOL, V190, P268, DOI 10.1016/j.vetpar.2012.05.006; Myler PJ, 1999, P NATL ACAD SCI USA, V96, P2902, DOI 10.1073/pnas.96.6.2902; NEAL RA, 1963, NATURE, V198, P210, DOI 10.1038/198210b0; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; PAPADOPOULOU B, 1994, MOL BIOCHEM PARASIT, V65, P39, DOI 10.1016/0166-6851(94)90113-9; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Rochette A, 2009, MOL BIOCHEM PARASIT, V165, P32, DOI 10.1016/j.molbiopara.2008.12.012; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Sadlova J, 2010, CELL MICROBIOL, V12, P1765, DOI 10.1111/j.1462-5822.2010.01507.x; Schadewaldt P, 1996, ANAL BIOCHEM, V238, P65, DOI 10.1006/abio.1996.0252; SIMON MW, 1978, J BACTERIOL, V135, P895, DOI 10.1128/JB.135.3.895-899.1978; STEIGER RF, 1976, J PARASITOL, V62, P1010, DOI 10.2307/3279200; Sterkers Y, 2011, CELL MICROBIOL, V13, P274, DOI 10.1111/j.1462-5822.2010.01534.x; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Thomas S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-152; van Luenen HGAM, 2012, CELL, V150, P909, DOI 10.1016/j.cell.2012.07.030; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P4201, DOI 10.1093/nar/gkg469; Zilberstein Dan, 2008, P107; Zuckerman A, 1977, PARASITIC PROTOZOA, P66	51	4	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150172	10.1371/journal.pone.0150172	http://dx.doi.org/10.1371/journal.pone.0150172			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959417	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300035
J	Bagheri, A; Maassoumi, AA; Rahiminejad, MR; Blattner, FR				Bagheri, Ali; Maassoumi, Ali Asghar; Rahiminejad, Mohammad Reza; Blattner, Frank R.			Molecular Phylogeny and Morphological Analysis Support a New Species and New Synonymy in Iranian Astragalus (Leguminosae)	PLOS ONE			English	Article								As a result of a taxonomic and phylogenetic revision of Astragalus section Hymenostegis we identified a new species of Astragalus from northwestern Iran, namely A. remotispicatus spec. nov., which is described and illustrated here. It is morphologically similar to A. karlheinzii in possessing a lax inflorescence. Phylogenetic inference of the nuclear ribosomal DNA internal transcribed spacer (ITS) region support A. remotispicatus as a clearly distinct species within the lax-inflorescence group of this section. Also the placement of A. sciureus var. subsessilis was found to be wrong and this taxon should be treated as a synonym within A. kohrudicus.	[Bagheri, Ali; Rahiminejad, Mohammad Reza] Univ Isfahan, Dept Biol, Fac Sci, Esfahan, Iran; [Maassoumi, Ali Asghar] Res Inst Forests & Rangelands, Dept Bot, Tehran, Iran; [Blattner, Frank R.] Leibniz Inst Plant Genet & Crop Res IPK, Gatersleben, Germany; [Blattner, Frank R.] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	University of Isfahan; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Bagheri, A (corresponding author), Univ Isfahan, Dept Biol, Fac Sci, Esfahan, Iran.	a.bagheri@sci.ui.ac.ir	Bagheri, Ali/AAB-6765-2022; Bagheri, Ali/A-1294-2016; Blattner, Frank/G-7402-2014	Bagheri, Ali/0000-0002-2580-9776; Bagheri, Ali/0000-0002-2580-9776; Blattner, Frank/0000-0001-7731-7741; Maassoumi, Ali Asghar/0000-0002-0134-4986	Leibniz Institute of Plant Genetics and Crop Research (IPK); University of Isfahan	Leibniz Institute of Plant Genetics and Crop Research (IPK); University of Isfahan	This study was supported by Leibniz Institute of Plant Genetics and Crop Research (IPK) and the University of Isfahan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri A, 2014, PHYTOTAXA, V178, P38, DOI 10.11646/phytotaxa.178.1.4; Blattner FR, 1999, BIOTECHNIQUES, V27, P1180, DOI 10.2144/99276st04; Bornmuller JFN, 1905, B HERBIER BOISSIER 2, V5, P752; Maassoumi A. A., 2007, Iranian Journal of Botany, V13, P78; Maassoumi AA., 1995, GENUS ASTRAGALUS IRA, V3; Maassoumi AA., 1998, ASTRAGALUS OLD WORLD; Parsa A., 1948, FLORE DE LIRAN, V2, P124; Podlech D., 2001, FLORA IRANICA, V175, P127; Podlech D., 2011, THESAURUS ASTRAGALOR; Podlech D, 2013, TAXONOMIC REVISION G, V1, P1; Podlech D, 2012, FLORA IRANICA PAPILI, V179; Rechinger KH., 1959, ANZEIGER OSTERR MN 1, V168, P95; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Zarre-M. S., 1996, Sendtnera, V3, P255	15	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149726	10.1371/journal.pone.0149726	http://dx.doi.org/10.1371/journal.pone.0149726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960159	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300021
J	Moon, JY; Woo, JS; Seo, JW; Lee, A; Kim, DJ; Kim, YG; Kim, SY; Lee, KH; Lim, SJ; Cheng, XW; Lee, SH; Kim, W				Moon, Ju-Young; Woo, Jong Shin; Seo, Jung-Woo; Lee, Arah; Kim, Dong Jin; Kim, Yang-Gyun; Kim, Se-Yeun; Lee, Kyung Hye; Lim, Sung-Jig; Cheng, Xian Wu; Lee, Sang-Ho; Kim, Weon			The Dose-Dependent Organ-Specific Effects of a Dipeptidyl Peptidase-4 Inhibitor on Cardiovascular Complications in a Model of Type 2 Diabetes	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; PROTECTION; TRANSITION; NEPHROPATHY; HYPERTROPHY; EXENATIDE; INJURY; DPP-4; GLP-1	Objective Although dipeptidyl peptidase-4 (DPP-4) inhibitors have been suggested to have a non-glucoregulatory protective effect in various tissues, the effects of long-term inhibition of DPP-4 on the micro- and macro-vascular complications of type 2 diabetes remain uncertain. The aim of the present study was to investigate the organ-specific protective effects of DPP-4 inhibitor in rodent model of type 2 diabetes. Methods Eight-week-old diabetic and obese db/db mice and controls (db/m mice) received vehicle or one of two doses of gemigliptin (0.04 and 0.4%) daily for 12 weeks. Urine albumin excretion and echocardiography measured at 20 weeks of age. Heart and kidney tissue were subjected to molecular analysis and immunohistochemical evaluation. Results Gemigliptin effectively suppressed plasma DPP-4 activation in db/db mice in a dose-dependent manner. The HbA1c level was normalized in the 0.4% gemigliptin, but not in the 0.04% gemigliptin group. Gemigliptin showed a dose-dependent protective effect on podocytes, anti-apoptotic and anti-oxidant effects in the diabetic kidney. However, the dose-dependent effect of gemigliptin on diabetic cardiomyopathy was ambivalent. The lower dose significantly attenuated left ventricular (LV) dysfunction, apoptosis, and cardiac fibrosis, but the higher dose could not protect the LV dysfunction and cardiac fibrosis. Conclusion Gemigliptin exerted non-glucoregulatory protective effects on both diabetic nephropathy and cardiomyopathy. However, high-level inhibition of DPP-4 was associated with an organ-specific effect on cardiovascular complications in type 2 diabetes.	[Moon, Ju-Young; Seo, Jung-Woo; Lee, Arah; Kim, Dong Jin; Kim, Yang-Gyun; Kim, Se-Yeun; Lee, Sang-Ho] Kyung Hee Univ, Coll Med, Dept Internal Med, Div Nephrol, Seoul, South Korea; [Woo, Jong Shin; Lee, Kyung Hye; Cheng, Xian Wu; Kim, Weon] Kyung Hee Univ, Coll Med, Div Cardiol, Dept Internal Med, Seoul, South Korea; [Lim, Sung-Jig] Kyung Hee Univ, Dept Pathol, Coll Med, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University	Lee, SH (corresponding author), Kyung Hee Univ, Coll Med, Dept Internal Med, Div Nephrol, Seoul, South Korea.; Kim, W (corresponding author), Kyung Hee Univ, Coll Med, Div Cardiol, Dept Internal Med, Seoul, South Korea.	lshkidney@khu.ac.kr; mylovekw@hanmail.net	KIM, YANG GYUN/AAI-9821-2020; /W-5371-2019	KIM, YANG GYUN/0000-0002-3497-5514; 	National Research Foundation of Korea [NRF-2012R1A1B4002291]	National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by a grant from the National Research Foundation of Korea in 2012 (NRF-2012R1A1B4002291).	Frustaci A, 2000, CIRC RES, V87, P1123, DOI 10.1161/01.RES.87.12.1123; Gomez L, 2008, CIRCULATION, V117, P2761, DOI 10.1161/CIRCULATIONAHA.107.755066; Grimm D, 2002, CARDIOVASC PATHOL, V11, P229, DOI 10.1016/S1054-8807(01)00116-8; Ha SJ, 2012, ARTERIOSCL THROM VAS, V32, P474, DOI 10.1161/ATVBAHA.110.222653; Hausenloy DJ, 2008, CIRC-HEART FAIL, V1, P147, DOI 10.1161/CIRCHEARTFAILURE.108.810887; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kanasaki K, 2014, DIABETES, V63, P2120, DOI 10.2337/db13-1029; Liu WJ, 2012, J PHARMACOL EXP THER, V340, P248, DOI 10.1124/jpet.111.186866; Marques C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/538737; Mega C, 2011, EXP DIABETES RES, DOI 10.1155/2011/162092; Ohori K, 2008, AM J PHYSIOL-HEART C, V295, pH2079, DOI 10.1152/ajpheart.00092.2008; Panchapakesan U, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.S9-007; Panchapakesan U, 2013, CLIN SCI, V124, P17, DOI 10.1042/CS20120167; Sauve M, 2010, DIABETES, V59, P1063, DOI 10.2337/db09-0955; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Sharkovska Y, 2014, J HYPERTENS, V32, P2211, DOI 10.1097/HJH.0000000000000328; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wolf CM, 2005, P NATL ACAD SCI USA, V102, P18123, DOI 10.1073/pnas.0509145102; Woo JS, 2013, ARTERIOSCL THROM VAS, V33, P2252, DOI 10.1161/ATVBAHA.113.301586	20	25	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150745	10.1371/journal.pone.0150745	http://dx.doi.org/10.1371/journal.pone.0150745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959365	Green Submitted, gold, Green Published			2022-12-27	WOS:000371992300070
J	Seshadri, KS; Singal, R; Priti, H; Ravikanth, G; Vidisha, MK; Saurabh, S; Pratik, M; Gururaja, KV				Seshadri, K. S.; Singal, Ramit; Priti, H.; Ravikanth, G.; Vidisha, M. K.; Saurabh, S.; Pratik, M.; Gururaja, Kotambylu Vasudeva			Microhyla laterite sp nov., A New Species of Microhyla Tschudi, 1838 (Amphibia: Anura: Microhylidae) from a Laterite Rock Formation in South West India	PLOS ONE			English	Article							PHYLOGENETIC INFERENCE; FROGS ANURA; BIODIVERSITY; HISTORY; GHATS; PATTERNS	In recent times, several new species of amphibians have been described from India. Many of these discoveries are from biodiversity hotspots or from within protected areas. We undertook amphibian surveys in human dominated landscapes outside of protected areas in south western region of India between years 2013-2015. We encountered a new species of Microhyla which is described here as Microhyla laterite sp. nov. It was delimited using molecular, morphometric and bioacoustics comparisons. Microhyla laterite sp. nov. appears to be restricted to areas of the West coast of India dominated by laterite rock formations. The laterite rock formations date as far back as the Cretaceous-Tertiary boundary and are considered to be wastelands in-spite of their intriguing geological history. We identify knowledge gaps in our understanding of the genus Microhyla from the Indian subcontinent and suggest ways to bridge them.	[Seshadri, K. S.] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4,Block S3, Singapore 117548, Singapore; [Singal, Ramit] B-14 Law Apartments, Delhi, India; [Priti, H.] Manipal Univ, Manipal, Karnataka, India; [Priti, H.; Ravikanth, G.] Ashoka Trust Res Ecol & Environm, Suri Sehgal Ctr Biodivers & Conservat, Jakkur Po, Bengaluru, India; [Vidisha, M. K.; Gururaja, Kotambylu Vasudeva] Gubbi Labs LLP, Sci Media Ctr, Entrepreneurship Ctr, Soc Innovat & Dev, WS-5,Floor,Indian Inst Sci Campus, Bengaluru, India; [Saurabh, S.] A-103 Gokul,BP Rd,Dahisar W, Bombay, Maharashtra, India; [Pratik, M.] 3C-704 Whispering Palms, Bombay, Maharashtra, India	National University of Singapore; Manipal Academy of Higher Education (MAHE)	Seshadri, KS (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4,Block S3, Singapore 117548, Singapore.; Gururaja, KV (corresponding author), Gubbi Labs LLP, Sci Media Ctr, Entrepreneurship Ctr, Soc Innovat & Dev, WS-5,Floor,Indian Inst Sci Campus, Bengaluru, India.	seshadri@u.nus.edu; gururaja@gubbilabs.in	Shamanna, Seshadri Kadaba/AAT-5309-2020; G, Ravikanth/AAI-5668-2020	Shamanna, Seshadri Kadaba/0000-0002-6788-7860; G, Ravikanth/0000-0002-9399-8580; Kulkarni, Vidisha/0000-0003-3213-847X; Hebbar, Priti/0000-0002-4526-139X	Rufford Foundation [15102]; Mohamed bin Zayed Species Conservation Fund [14258557]; Chicago Board of Trade (CBOT) Endangered Species Fund; Earthwatch Institute India	Rufford Foundation; Mohamed bin Zayed Species Conservation Fund; Chicago Board of Trade (CBOT) Endangered Species Fund; Earthwatch Institute India	Funded by 1. Rufford Foundation (www.rufford.org), 15102 to RS, 2. The Mohamed bin Zayed Species Conservation Fund (www.speciesconservation.org), 14258557 to KSS, 3. Chicago Board of Trade (CBOT) Endangered Species Fund to KSS, and 4. Earthwatch Institute India to KVG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhargav P, LEGAL FRAMEWORK WILD; Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; Bossuyt F, 2004, SCIENCE, V306, P479, DOI 10.1126/science.1100167; Brown R, 2012, PATTERNS BIODIVERSIT, P348; Chandran MDS, 1997, CURR SCI INDIA, V73, P146; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Dinesh KP, CHECKLIST AMPHIBIANS; Diniz JAF, 2013, TRENDS ECOL EVOL, V28, P689, DOI 10.1016/j.tree.2013.09.003; Dutta S.K., 2000, Hamadryad, V25, P38; Fermor L, 1911, GEOL MAG, V8, P454; Fernando Prithiviraj, 1996, Journal of South Asian Natural History, V2, P135; Frost DR, AMPHIBIAN SPECIES WO; GADGIL M, 1992, AMBIO, V21, P266; Gururaja KV, 2014, ZOOTAXA, V3796, P33, DOI 10.11646/zootaxa.3796.1.2; Hasan M, 2014, ZOOTAXA, V 3755, P401, DOI 10.11646/zootaxa.3755.5.1; Howlader MSA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119825; IUCN, IUCN RED LIST THREAT; Karanth KP, 2006, CURR SCI INDIA, V90, P789; Kasthurba AK, 2007, CONSTR BUILD MATER, V21, P73, DOI 10.1016/j.conbuildmat.2005.07.006; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kok P. J. R., 2008, ABC TAXA SERIES MANU, V5; Mani MS., 1974, ECOLOGY BIOGEOGRAPHY, P698, DOI DOI 10.1007/978-94-010-2331-3_24; Matsui M, 2013, ZOOTAXA, V3670, P579, DOI 10.11646/zootaxa.3670.4.9; Matsui M, 2011, MOL PHYLOGENET EVOL, V61, P167, DOI 10.1016/j.ympev.2011.05.015; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, V1st ed., P3; MOEF, PROT AR NETW IND; NBA, BIOD HER SIT; NRSC, 2010, WAST ATL IND; Ollier C, 2008, J EARTH SYST SCI, V117, P537, DOI 10.1007/s12040-008-0051-9; Pandit MK, 2007, BIODIVERS CONSERV, V16, P153, DOI 10.1007/s10531-006-9038-5; Parker H., 1948, J NAT HIST, V1, P759, DOI [10.1080/00222934808653944, DOI 10.1080/00222934808653944]; Parker HW, 1934, MONOGRAPH FROGS FAMI; Peloso PLV, 2016, CLADISTICS, V32, P113, DOI 10.1111/cla.12118; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Development Core Team, R LANG ENV STAT COMP; Rao GR, 2012, LAKE 2012 NAT C CONS; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Seshadri Kadaba Shamanna, 2012, Zootaxa, V3410, P19; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vences Miguel, 2012, Methods Mol Biol, V858, P79, DOI 10.1007/978-1-61779-591-6_5; Vijayakumar SP, 2014, ZOOTAXA, V3893, P451, DOI 10.11646/zootaxa.3893.4.1; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Widdowson M, 1996, EARTH PLANET SC LETT, V137, P57, DOI 10.1016/0012-821X(95)00211-T	45	22	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149727	10.1371/journal.pone.0149727	http://dx.doi.org/10.1371/journal.pone.0149727			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960208	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000371992300022
J	Taich, P; Requejo, F; Asprea, M; Sgroi, M; Gobin, P; Abramson, DH; Chantada, G; Schaiquevich, P				Taich, Paula; Requejo, Flavio; Asprea, Marcelo; Sgroi, Mariana; Gobin, Pierre; Abramson, David H.; Chantada, Guillermo; Schaiquevich, Paula			Topotecan Delivery to the Optic Nerve after Ophthalmic Artery Chemosurgery	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTERS; INTERNATIONAL RETINOBLASTOMA; NEOADJUVANT CHEMOTHERAPY; PHARMACOKINETIC ANALYSIS; COMBINATION; MODEL; GUIDELINES; MANAGEMENT; MELPHALAN; INFUSION	Extraocular retinoblastoma is a major challenge worldwide, especially in developing countries. Current treatment involves the administration of systemic chemotherapy combined with radiation, but there is a clear need for improvement of chemotherapy bioavailability in the optic nerve. Our aim was to study the ophthalmic artery chemosurgery (OAC) local route for drug delivery assessing ocular and optic nerve exposure to chemotherapy and to compare it to exposure after intravenous infusion (IV) of the same dose in an animal model. Topotecan was used as a prototype drug that is active in retinoblastoma and based on the extensive knowledge of its pharmacokinetics in preclinical and clinical settings. Five Land-race pigs received 4mg of topotecan via OAC as performed in retinoblastoma patients. At the end of the infusion, the eyes were enucleated, the optic nerve and retina were dissected, and the vitreous and plasma were separated. After recovery and a wash-out period, the animals received a 30-min IV infusion of topotecan (4 mg). The remaining eye was enucleated and tissues and fluids were separated. All samples were stored until quantitation using HPLC. A significantly higher concentration of topotecan in the optic nerve, vitreous, and retina was obtained in eyes after OAC compared to IV infusion (p<0.05). The median (range) ratio between topotecan concentration attained after OAC to IV infusion in the optic nerve, retina and vitreous was 84(54-668), 143(49-200) and 246(56-687), respectively. However, topotecan systemic exposure after OAC and IV infusion remained comparable (p>0.05). The median optic nerve-to-plasma ratio after OAC and IV was 44 and 0.35, respectively. Topotecan OAC delivery attained an 80-fold higher concentration in the optic nerve compared to the systemic infusion of the same dose with similar plasma concentrations in a swine model. Patients with retinoblastoma extension into the optic nerve may benefit from OAC for tumor burden by increased chemotherapy bioavailability in the optic nerve without increasing systemic exposure or toxicity.	[Taich, Paula; Schaiquevich, Paula] Hosp Pediat JP Garrahan, Clin Pharmacokinet Unit, Buenos Aires, DF, Argentina; [Taich, Paula; Schaiquevich, Paula] Consejo Nacl Invest Cient & Tecn, Natl Sci & Tech Res Council, RA-1033 Buenos Aires, DF, Argentina; [Requejo, Flavio] Hosp Pediat JP Garrahan, Serv Intervent Radiol, Buenos Aires, DF, Argentina; [Asprea, Marcelo] Hosp Pediat JP Garrahan, Anim Facil, Buenos Aires, DF, Argentina; [Sgroi, Mariana] Hosp Pediat JP Garrahan, Serv Ophthalmol, Buenos Aires, DF, Argentina; [Gobin, Pierre; Abramson, David H.] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [Chantada, Guillermo] Hosp Pediat JP Garrahan, Res Inst, Buenos Aires, DF, Argentina	Hospital de Pediatria Doctor Juan Garrahan; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Hospital de Pediatria Doctor Juan Garrahan; University of Buenos Aires; Hospital de Pediatria Doctor Juan Garrahan; University of Buenos Aires; Hospital de Pediatria Doctor Juan Garrahan; University of Buenos Aires; Memorial Sloan Kettering Cancer Center; Hospital de Pediatria Doctor Juan Garrahan; University of Buenos Aires	Schaiquevich, P (corresponding author), Hosp Pediat JP Garrahan, Clin Pharmacokinet Unit, Buenos Aires, DF, Argentina.; Schaiquevich, P (corresponding author), Consejo Nacl Invest Cient & Tecn, Natl Sci & Tech Res Council, RA-1033 Buenos Aires, DF, Argentina.	paulas@conicet.gov.ar	Chantada, Guillermo Luis/S-9310-2019; Schaiquevich, Paula/AAF-8915-2019	Leggas, Markos/0000-0003-4314-4533; Sgroi, Mariana/0000-0003-2770-7009	Fund for Ophthalmic Knowledge, New York, NY, USA; Instituto Nacional del Cancer [44/14]; Ministerio de Salud, Argentina; Fundacion Natalie D Flexer de Ayuda al Nino con Cancer, Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP) [11220120100383CO01]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Fund for Ophthalmic Knowledge, New York, NY, USA; Instituto Nacional del Cancer; Ministerio de Salud, Argentina; Fundacion Natalie D Flexer de Ayuda al Nino con Cancer, Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by Fund for Ophthalmic Knowledge (GLC, ACF), New York, NY, USA; Instituto Nacional del Cancer (grant # 44/14), Ministerio de Salud, Argentina; Fundacion Natalie D Flexer de Ayuda al Nino con Cancer (GLC), Argentina; and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP # 11220120100383CO01).	Abramson D H, 1999, Ophthalmic Genet, V20, P31, DOI 10.1076/opge.20.1.31.2302; Abramson DH, 2015, JAMA OPHTHALMOL, V133, P1341, DOI 10.1001/jamaophthalmol.2015.3108; Abramson DH, 2014, ANNU REV MED, V65, P171, DOI 10.1146/annurev-med-061312-123455; Asashima T, 2006, PHARM RES-DORDR, V23, P1235, DOI 10.1007/s11095-006-0067-2; Bellaton E, 2003, BRIT J OPHTHALMOL, V87, P327, DOI 10.1136/bjo.87.3.327; Brisse HJ, 2015, EUR RADIOL, V25, P1443, DOI 10.1007/s00330-014-3514-1; Canturk S, 2010, BRIT J OPHTHALMOL, V94, P1432, DOI 10.1136/bjo.2009.168062; Chantada G, 2015, PEDIATR DRUGS, V17, P185, DOI 10.1007/s40272-015-0121-9; Chantada GL, 2014, PEDIATR BLOOD CANCER, V61, P821, DOI 10.1002/pbc.24857; Chantada GL, 2009, PEDIATR BLOOD CANCER, V52, P218, DOI 10.1002/pbc.21735; de Graaf P, 2012, PEDIATR RADIOL, V42, P2, DOI 10.1007/s00247-011-2201-5; Dondelinger RF, 1998, EUR RADIOL, V8, P1254, DOI 10.1007/s003300050545; Dunkel IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108692; Dunkel IJ, 2010, PEDIATR BLOOD CANCER, V55, P149, DOI 10.1002/pbc.22491; Dunkel IJ, 2010, PEDIATR BLOOD CANCER, V55, P55, DOI 10.1002/pbc.22504; Francis JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072441; Gobin YP, 2015, ESSENT OPHTHALMOL, P27, DOI 10.1007/978-3-319-19467-7_3; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; Kaliki S, 2013, OPHTHALMOLOGY, V120, P997, DOI 10.1016/j.ophtha.2012.10.044; Laurent VE, 2013, EUR J CANCER, V49, P2892, DOI 10.1016/j.ejca.2013.04.021; Laurie NA, 2005, CLIN CANCER RES, V11, P7569, DOI 10.1158/1078-0432.CCR-05-0849; Leal-Leal Carlos A, 2006, Clin Transl Oncol, V8, P39, DOI 10.1007/s12094-006-0093-x; Leggas M, 2006, CANCER RES, V66, P4802, DOI 10.1158/0008-5472.CAN-05-2915; Mannermaa E, 2006, ADV DRUG DELIVER REV, V58, P1136, DOI 10.1016/j.addr.2006.07.024; May CA, 2008, OPEN OPHTHALMOL J, V2, P94, DOI 10.2174/1874364100802010094; Mealey KL, 2012, J VET PHARMACOL THER, V35, P105, DOI 10.1111/j.1365-2885.2011.01313.x; Qaddoumi I, 2012, CANCER-AM CANCER SOC, V118, P5663, DOI 10.1002/cncr.27563; R Core Team, 2019, R LANG ENV STAT COMP; Radhakrishnan V, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.029; Requejo F, 2014, J INVEST SURG, V27, P291, DOI 10.3109/08941939.2014.894599; Santana VM, 2005, J CLIN ONCOL, V23, P4039, DOI 10.1200/JCO.2005.02.097; Santana VM, 2003, CLIN CANCER RES, V9, P633; SAROSY G, 1988, J CLIN ONCOL, V6, P1768, DOI 10.1200/JCO.1988.6.11.1768; Sastre X, 2009, ARCH PATHOL LAB MED, V133, P1199, DOI 10.1043/1543-2165-133.8.1199; Schaiquevich P, 2014, RETINA-J RET VIT DIS, V34, P1719, DOI 10.1097/IAE.0000000000000253; Schaiquevich P, 2012, INVEST OPHTH VIS SCI, V53, P4205, DOI 10.1167/iovs.12-9501; Schaiquevich P, 2012, RETINA-J RET VIT DIS, V32, P387, DOI 10.1097/IAE.0b013e31821e9f8a; Shen J, 2009, CANCER RES, V69, P5885, DOI 10.1158/0008-5472.CAN-09-0700; SHIELDS CL, 1994, CANCER, V73, P692, DOI 10.1002/1097-0142(19940201)73:3<692::AID-CNCR2820730331>3.0.CO;2-8; Tagami M, 2009, BRAIN RES, V1283, P186, DOI 10.1016/j.brainres.2009.05.095; Taich P, 2014, OPHTHALMOLOGY, V121, P889, DOI 10.1016/j.ophtha.2013.10.045; Tiwari AK, 2013, MOL CANCER THER, V12, P1343, DOI 10.1158/1535-7163.MCT-13-0100; Torbidoni AV, 2015, JAMA OPHTHALMOL, V133, P805, DOI 10.1001/jamaophthalmol.2015.0900; Tse BC, 2013, JAMA OPHTHALMOL, V131, P903, DOI 10.1001/jamaophthalmol.2013.2065	44	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151343	10.1371/journal.pone.0151343	http://dx.doi.org/10.1371/journal.pone.0151343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959658	Green Published, gold			2022-12-27	WOS:000371992300117
J	Kim, HS; Park, S; Koo, JS; Kim, S; Kim, JY; Nam, S; Park, HS; Kim, SI; Park, BW				Kim, Hyung Sun; Park, Seho; Koo, Ja Seung; Kim, Sanghwa; Kim, Jee Ye; Nam, Sanggeun; Park, Hyung Seok; Kim, Seung Il; Park, Byeong-Woo			Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; AMERICAN SOCIETY; PRIMARY THERAPY; KI67; RECOMMENDATIONS; PROLIFERATION; HIGHLIGHTS; MANAGEMENT	Purpose The Ki-67 labelling index is significant for the management of breast cancer. However, the concordance of Ki-67 expression between preoperative biopsy and postoperative surgical specimens has not been well evaluated. This study aimed to find the correlation in Ki-67 expression between biopsy and surgical specimens and to determine the clinicopathological risk factors associated with discordant values. Patients and Methods Ki-67 levels were immunohistochemically measured using paired biopsy and surgical specimens in 310 breast cancer patients between 2008 and 2013. Delta Ki-67 was calculated by postoperative Ki-67 minus preoperative levels. The outliers of Delta Ki-67 were defined as [lower quartile of Delta Ki-67-1.5 x interquartile range (IQR)] or (upper quartile + 1.5 x IQR) and were evaluated according to clinicopathological parameters by logistic regression analysis. Results The median preoperative and postoperative Ki-67 levels were 10 (IQR, 15) and 10 (IQR, 25), respectively. Correlation of Ki-67 levels between the two specimens indicated a moderately positive relationship (coefficient = 0.676). Of 310 patients, 44 (14.2%) showed outliers of Delta Ki-67 (range, <=-20 or >= 28). A significant association with poor prognostic factors was found among these patients. Multivariate analysis determined that significant risk factors for outliers of Delta Ki-67 were tumor size > 1 cm, negative progesterone receptor (PR) expression, grade III cancer, and age <= 35 years. Among 171 patients with luminal human epidermal growth factor receptor 2-negative tumors, breast cancer subtype according to preoperative or postoperative Ki-67 levels discordantly changed in 46 (26.9%) patients and a significant proportion of patients with discordant cases had >= 1 risk factor. Conclusion Ki-67 expression showed a substantial concordance between biopsy and surgical specimens. Extremely discordant Ki-67 levels may be associated with aggressive tumor biology. In patients with luminal subtype disease, clinical application of Ki-67 values should be cautious considering types of specimens and clinicopathological risk factors.	[Kim, Hyung Sun; Park, Seho; Kim, Sanghwa; Kim, Jee Ye; Nam, Sanggeun; Park, Hyung Seok; Kim, Seung Il; Park, Byeong-Woo] Yonsei Univ, Coll Med, Dept Surg, Seoul 120749, South Korea; [Park, Seho] Yonsei Univ, Frontier Res Inst Convergence Sports Sci, Seoul 120749, South Korea; [Koo, Ja Seung] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System	Park, S (corresponding author), Yonsei Univ, Coll Med, Dept Surg, Seoul 120749, South Korea.; Park, S (corresponding author), Yonsei Univ, Frontier Res Inst Convergence Sports Sci, Seoul 120749, South Korea.	psh1025@yuhs.ac		Park, Hyung Seok/0000-0001-5322-6036; koo, ja seung/0000-0003-4546-4709; Park, Seho/0000-0001-8089-2755; Park, Byeong-Woo/0000-0003-1353-2607; Kim, Hyung Sun/0000-0002-9002-3569	Ministry of Education of the Republic of Korea; National Research Foundation of Korea [NRF-2015S1A5B8036349]	Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2015S1A5B8036349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chen XS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-390; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Han A, 2014, J BREAST CANCER, V17, P308, DOI 10.4048/jbc.2014.17.4.308; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Knutsvik G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112121; Luporsi E, 2012, BREAST CANCER RES TR, V132, P895, DOI 10.1007/s10549-011-1837-z; Maisonneuve P, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3679; Mizuno Y, 2012, J CANC THERAPY, V3, P841; Ough M, 2011, AM J SURG, V201, P685, DOI 10.1016/j.amjsurg.2010.02.015; Patani N, 2013, INT J CANCER, V133, P1, DOI 10.1002/ijc.27997; Pathmanathan N, 2013, J CLIN PATHOL, V66, P512, DOI 10.1136/jclinpath-2012-201085; Planeix F, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0128-7; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Ricci MD, 2012, REV ASSOC MED BRAS, V58, P532; Romero Q, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-341; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	22	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151054	10.1371/journal.pone.0151054	http://dx.doi.org/10.1371/journal.pone.0151054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954364	gold, Green Published, Green Submitted			2022-12-27	WOS:000371991300078
J	Reininger, V; Schlegel, M				Reininger, Vanessa; Schlegel, Markus			Analysis of the Phialocephala subalpina Transcriptome during Colonization of Its Host Plant Picea abies	PLOS ONE			English	Article							DARK SEPTATE ENDOPHYTES; FORTINII S.L.; ENZYME SETS; FUNGI; IRON; GROWTH; SEEDLINGS; INSIGHTS; FOREST; GENES	Background Phialocephala subalpina belongs to the Phialocephala fortinii s.l.-Acepphala applanata species complex (PAC) forming one of the major groups belonging to the dark septate endophytes (DSE). Depending on the strain, PAC was shown to form neutral to pathogenic associations with its host plant Picea abies. To understand PACs lifestyle we investigated the effect of presence/absence of Picea abies on the transcriptome of strain 6_70_1. Materials and Methods PAC strain 6_70_1 was grown in liquid Pachlewski media either induced by its host plant Picea abies or without host plant as a control. Mycelia were harvested in a time course (1, 2, 3, 4, 7, 11, 18 days) with and without induction by the host plant and the fungal transcriptome revealed by Illumina sequencing. Differential gene expression analysis over the time course comparing control and treatment at each time point using the 'edgeR glm approach' and a gene enrichment analysis using GO categories were performed. Results The three main functional groups within differentially expressed genes were 'metabolism', 'transport' and 'cell rescue, defense and virulence'. Additionally, genes especially involved in iron metabolism could be detected by gene set enrichment analysis. Conclusion In conclusion, we found PAC strain 6_70_1 to be metabolically very active during colonization of its host plant Picea abies. A major shift in functional groups over the time course of this experiment could not be observed but GO categories which were found to be enriched showed different emphasis depending in the day post induction.	[Reininger, Vanessa; Schlegel, Markus] ETH, Inst Integrat Biol, Univ Str 16, CH-8092 Zurich, Switzerland; [Reininger, Vanessa] Inst Plant Prod Sci IPS, Agroscope, Schloss 1, CH-8820 Wadenswil, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Research Station Agroscope	Reininger, V (corresponding author), ETH, Inst Integrat Biol, Univ Str 16, CH-8092 Zurich, Switzerland.; Reininger, V (corresponding author), Inst Plant Prod Sci IPS, Agroscope, Schloss 1, CH-8820 Wadenswil, Switzerland.	Vanessa.Reininger@env.ethz.ch	Reininger, Vanessa/F-7014-2011	Schlegel, Markus/0000-0003-3453-4783				Addy HD, 2000, MYCOL RES, V104, P1213, DOI 10.1017/S0953756200002896; Alberton O, 2010, PLANT SOIL, V328, P459, DOI 10.1007/s11104-009-0125-8; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aznar A, 2014, PLANT PHYSIOL, V164, P2167, DOI 10.1104/pp.113.233585; Bartholdy BA, 2001, BIOMETALS, V14, P33, DOI 10.1023/A:1016687021803; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-321; Bever JD, 2012, ANNU REV MICROBIOL, V66, P265, DOI 10.1146/annurev-micro-092611-150107; Cairns T, 2010, FEMS MICROBIOL LETT, V307, P1, DOI 10.1111/j.1574-6968.2010.01961.x; Compant S, 2010, FEMS MICROBIOL ECOL, V73, P197, DOI 10.1111/j.1574-6941.2010.00900.x; Condon BJ, 2014, MOL PLANT MICROBE IN, V27, P793, DOI 10.1094/MPMI-11-13-0328-R; De Vleesschauwer D, 2009, ADV BOT RES, V51, P223, DOI 10.1016/S0065-2296(09)51006-3; Del Sorbo G, 2000, FUNGAL GENET BIOL, V30, P1, DOI 10.1006/fgbi.2000.1206; Ding C, 2014, MOL MICROBIOL, V93, P10, DOI 10.1111/mmi.12653; Eaton CJ, 2011, PLANT SCI, V180, P190, DOI 10.1016/j.plantsci.2010.10.002; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Grunig CR, 2008, MYCOLOGIA, V100, P47, DOI 10.3852/mycologia.100.1.47; Grunig CR, 2008, BOTANY, V86, P1355, DOI 10.1139/B08-108; Hause G, 2005, J EXP BOT, V56, P2131, DOI 10.1093/jxb/eri211; Idnurm A, 2001, MOL PLANT PATHOL, V2, P241, DOI 10.1046/j.1464-6722.2001.00070.x; Johnson L, 2008, MYCOL RES, V112, P170, DOI 10.1016/j.mycres.2007.11.012; Jumpponen A, 1998, CAN J BOT, V76, P1205, DOI 10.1139/cjb-76-7-1205; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kajula M, 2010, FUNGAL BIOL-UK, V114, P248, DOI 10.1016/j.funbio.2010.01.004; Khan A, 2010, AUSTRALAS PLANT PATH, V39, P467, DOI 10.1071/AP09084; Knogge W, 1998, CURR OPIN PLANT BIOL, V1, P324, DOI 10.1016/1369-5266(88)80054-2; Kunjeti SG, 2012, MOL PLANT PATHOL, V13, P454, DOI 10.1111/j.1364-3703.2011.00761.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; McGoldrick S, 2005, FEMS MICROBIOL LETT, V242, P1, DOI 10.1016/j.femsle.2004.10.033; Morel M, 2009, CELL MOL LIFE SCI, V66, P3711, DOI 10.1007/s00018-009-0104-5; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2021, R LANGUAGE ENV STAT; Reininger V., 2012, THESIS ETH ZURICH ZU, P122; Reininger V, 2013, ENV MICROBIOL REP, V5, P892, DOI 10.1111/1758-2229.12091; Reininger V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042865; Reininger V, 2012, ENVIRON MICROBIOL, V14, P1064, DOI 10.1111/j.1462-2920.2011.02686.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ross-Davis AL, 2013, FOREST PATHOL, V43, P468, DOI 10.1111/efp.12056; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Saikia S, 2014, INFECT IMMUN, V82, P839, DOI 10.1128/IAI.01357-13; Saxe H, 2001, NEW PHYTOL, V149, P369, DOI 10.1046/j.1469-8137.2001.00057.x; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Seifert M, 2008, IMMUNOBIOLOGY, V213, P767, DOI 10.1016/j.imbio.2008.07.010; Shalaby S, 2015, CURR GENET, V61, P347, DOI 10.1007/s00294-014-0458-6; Sieber Thomas N., 2007, Fungal Biology Reviews, V21, P75, DOI 10.1016/j.fbr.2007.05.004; Sieber TN, 2006, MICROBIAL ROOT ENDOP, P107, DOI DOI 10.1007/3-540-33526-9_7; Sieber TN, 2013, FUNGAL ROOT ENDOPHYT; Sipos G, 2006, CURR DRUG TARGETS, V7, P471, DOI 10.2174/138945006776359403; STOYKE G, 1992, CAN J BOT, V70, P2009, DOI 10.1139/b92-250; Tellenbach C, 2011, THESIS ETH ZURICH, P104; Tellenbach C, 2011, ENVIRON MICROBIOL, V13, P2508, DOI 10.1111/j.1462-2920.2011.02523.x; Tholl D, 2015, ADV BIOCHEM ENG BIOT, V148, P63, DOI 10.1007/10_2014_295; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Venu RC, 2011, METHODS MOL BIOL, V722, P167, DOI 10.1007/978-1-61779-040-9_12; Weinberg ED, 1999, J EUKARYOT MICROBIOL, V46, P231, DOI 10.1111/j.1550-7408.1999.tb05119.x; Zuccaro A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002290	60	7	7	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150591	10.1371/journal.pone.0150591	http://dx.doi.org/10.1371/journal.pone.0150591			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954682	Green Submitted, gold, Green Published			2022-12-27	WOS:000371991300034
J	Ward, ZJ; Long, MW; Resch, SC; Gortmaker, SL; Cradock, AL; Giles, C; Hsiao, A; Wang, YC				Ward, Zachary J.; Long, Michael W.; Resch, Stephen C.; Gortmaker, Steven L.; Cradock, Angie L.; Giles, Catherine; Hsiao, Amber; Wang, Y. Claire			Redrawing the US Obesity Landscape: Bias-Corrected Estimates of State-Specific Adult Obesity Prevalence	PLOS ONE			English	Article							HEALTH	Background State-level estimates from the Centers for Disease Control and Prevention (CDC) underestimate the obesity epidemic because they use self-reported height and weight. We describe a novel bias-correction method and produce corrected state-level estimates of obesity and severe obesity. Methods Using non-parametric statistical matching, we adjusted self-reported data from the Behavioral Risk Factor Surveillance System (BRFSS) 2013 (n = 386,795) using measured data from the National Health and Nutrition Examination Survey (NHANES) (n = 16,924). We validated our national estimates against NHANES and estimated bias-corrected state-specific prevalence of obesity (BMI >= 30) and severe obesity (BMI >= 35). We compared these results with previous adjustment methods. Results Compared to NHANES, self-reported BRFSS data underestimated national prevalence of obesity by 16% (28.67% vs 34.01%), and severe obesity by 23% (11.03% vs 14.26%). Our method was not significantly different from NHANES for obesity or severe obesity, while previous methods underestimated both. Only four states had a corrected obesity prevalence below 30%, with four exceeding 40%-in contrast, most states were below 30% in CDC maps. Conclusions Twelve million adults with obesity (including 6.7 million with severe obesity) were misclassified by CDC state-level estimates. Previous bias-correction methods also resulted in underestimates. Accurate state-level estimates are necessary to plan for resources to address the obesity epidemic.	[Ward, Zachary J.; Resch, Stephen C.] Harvard Univ, TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA; [Long, Michael W.] George Washington Univ, Dept Prevent & Community Hlth, Milken Inst, Sch Publ Hlth, Washington, DE USA; [Gortmaker, Steven L.; Cradock, Angie L.; Giles, Catherine] Harvard Univ, Dept Social & Behav Sci, TH Chan Sch Publ Hlth, Boston, MA USA; [Hsiao, Amber; Wang, Y. Claire] Columbia Univ, Dept Hlth Policy & Management, Mailman Sch Publ Hlth, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; George Washington University; Harvard University; Harvard T.H. Chan School of Public Health; Columbia University	Ward, ZJ (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA.	zward@hsph.harvard.edu		Long, Michael/0000-0002-3953-3424; Ward, Zachary/0000-0002-4007-2207	JPB Foundation; National Cancer Institute [1R01CA172814-01A1]; JPB Foundation; National Cancer Institute [1R01CA172814-01A1]; NATIONAL CANCER INSTITUTE [R01CA172814] Funding Source: NIH RePORTER	JPB Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); JPB Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from The JPB Foundation (http://jpbfoundation.org) and the National Cancer Institute (www.cancer.gov) (Grant No. 1R01CA172814-01A1).	Andreyeva T, 2014, J OCCUP ENVIRON MED, V56, P1120, DOI 10.1097/JOM.0000000000000298; Andridge RR, 2010, INT STAT REV, V78, P40, DOI 10.1111/j.1751-5823.2010.00103.x; [Anonymous], OB PREV MAPS; [Anonymous], HLTH EQ RES TOOLK ST; [Anonymous], 2014, ANN EST RES POP SEL; [Anonymous], OB PREV; [Anonymous], CONSTR WEIGHTS COMB; Arterburn DE, 2005, INT J OBESITY, V29, P334, DOI 10.1038/sj.ijo.0802896; Cawley J, 2006, NBER WORKING PAPER S, V2006; Cawley J, 2014, PHARMACOECONOMICS; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; D'Orazio M, 2014, STAT MATCHING IMPUTA; D'Orazio M, 2006, STAT MATCHING THEORY; Dwyer-Lindgren L, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-7; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; GAVIN NI, 1985, HEALTH SERV RES, V20, P183; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Hollander M, 2014, NONPARAMETRIC STAT M; Jain RB, 2010, INT J OBESITY, V34, P1655, DOI 10.1038/ijo.2010.80; Johnson NB, 2013, MORB MORTAL WKLY S4, V63, P3; Kruppe T, 2014, LABOUR MARKET EFFECT; Le A, 2014, OBESITY, V22, P300, DOI 10.1002/oby.20451; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Masterson T, 2014, WORKING PAPER NO 793; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Muller K, 2014, TRANSP RES BOARD ANN; Scullion JJ, 2014, BIOL CONSERV, V171, P247, DOI 10.1016/j.biocon.2014.01.036; SILVERMAN BW, 1987, BIOMETRIKA, V74, P469, DOI 10.2307/2336686; Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x; Vantaggi B, 2008, INT J APPROX REASON, V49, P701, DOI 10.1016/j.ijar.2008.07.005; Yun S, 2006, INT J OBESITY, V30, P164, DOI 10.1038/sj.ijo.0803125	33	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150735	10.1371/journal.pone.0150735	http://dx.doi.org/10.1371/journal.pone.0150735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954566	gold, Green Published, Green Submitted			2022-12-27	WOS:000371991300044
J	Griesinger, G; Verweij, PJM; Gates, D; Devroey, P; Gordon, K; Stegmann, BJ; Tarlatzis, BC				Griesinger, Georg; Verweij, Pierre J. M.; Gates, Davis; Devroey, Paul; Gordon, Keith; Stegmann, Barbara J.; Tarlatzis, Basil C.			Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; POLYCYSTIC OVARIES; OOCYTE MATURATION; RECOMBINANT FSH; WOMEN; STIMULATION; IVF; METAANALYSIS; PREVENTION; OHSS	Study Question What is the threshold for the prediction of moderate to severe or severe ovarian hyperstimulation syndrome (OHSS) based on the number of growing follicles >= 11 mm and/or estradiol (E-2) levels? Summary Answer The optimal threshold of follicles >= 11 mm on the day of hCG to identify those at risk was 19 for both moderate to severe OHSS and for severe OHSS. Estradiol (E-2) levels were less prognostic of OHSS than the number of follicles >= 11 mm. What Is Known Already In comparison to long gonadotropin-releasing hormone (GnRH) agonist protocols, the risk of severe OHSS is reduced by approximately 50% in a GnRH antagonist protocol for ovarian stimulation prior to in vitro fertilisation (IVF), while the two protocols provide equal chances of pregnancy per initiated cycle. Nevertheless, moderate to severe OHSS may still occur in GnRH antagonist protocols if human chorionic gonadotropin (hCG) is administered to trigger final oocyte maturation, especially in high responder patients. Severe OHSS following hCG trigger may occur with an incidence of 1-2% in a relatively young (aged 18 to 36 years) IVF population treated in a GnRH-antagonist protocol. Study Design, Size, Duration From the Engage, Ensure and Trust trials, in total, 2,433 women who received hCG for oocyte maturation and for whom the number of follicles >= 11 mm and the level of E-2 on the day of hCG administration were known were included in the analyses. Participants/Materials, Setting, Methods The threshold for OHSS prediction of moderate and severe OHSS was assessed in women treated with corifollitropin alfa or daily recombinant follicle stimulation hormone (rFSH) in a gonadotropin-releasing hormone (GnRH)-antagonist protocol. Receiver operating characteristics curve analyses for moderate to severe OHSS and severe OHSS were performed on the combined dataset and the sensitivity and specificity for the optimal threshold of number of follicles >= 11 mm, E-2 levels on the day of (hCG), and a combination of both, were determined. Main Results and the Role of Chance The optimal threshold of follicles >= 11 mm on the day of hCG to identify those at risk of moderate to severe OHSS was 19 (sensitivity and specificity 62.3% and 75.6%, respectively) and for severe OHSS was also 19 (sensitivity and specificity 74.3% and 75.3%, respectively). The positive and negative predictive values were 6.9% and 98.6%, respectively, for moderate to severe OHSS, and 4.2% and 99.5% for severe OHSS. Limitations, Reasons for Caution This was a retrospective analysis of combined data from three trials following ovarian stimulation with two different gonadotropins. Wider Implications of the Findings For patients with 19 follicles or more >= 11 mm on the day of hCG, measures to prevent the development of OHSS should be considered. Secondary preventive measures include cycle cancellation or coasting, use of a GnRH agonist to trigger final oocyte maturation in place of hCG and a freeze all strategy.	[Griesinger, Georg] Univ Hosp Schleswig Holstein, Dept Reprod Med & Gynecol Endocrinol, Campus Luebeck, Lubeck, Germany; [Verweij, Pierre J. M.] MSD BV, Oss, Netherlands; [Gates, Davis; Gordon, Keith; Stegmann, Barbara J.] Merck & Co Inc, Kenilworth, NJ USA; [Devroey, Paul] Univ Ziekenhuis Brussel, Ctr Reprod Med, Brussels, Belgium; [Tarlatzis, Basil C.] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Dept Obstet & Gynecol 1, Sch Med, GR-54006 Thessaloniki, Greece	University of Kiel; Schleswig Holstein University Hospital; Merck & Company; University Hospital Brussels; Vrije Universiteit Brussel; Aristotle University of Thessaloniki; Papageorgiou Hospital	Griesinger, G (corresponding author), Univ Hosp Schleswig Holstein, Dept Reprod Med & Gynecol Endocrinol, Campus Luebeck, Lubeck, Germany.	georg.griesinger@uni-luebeck.de	Verweij, P.E./H-8108-2014; Tarlatzis, Basil/M-6964-2013	Verweij, P.E./0000-0002-8600-9860; Tarlatzis, Basil/0000-0001-7183-2515; Griesinger, Georg/0000-0002-0606-5804	Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ; Merck & Co., Inc., Kenilworth, NJ	Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ; Merck & Co., Inc., Kenilworth, NJ(Merck & Company)	Financial support for this study was provided by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ. The funder provided financial support in the form of salaries for authors PJMV, DG, KG and BJS, and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section of the paper.; Financial support for this study was provided by Merck & Co., Inc., Kenilworth, NJ. Medical writing and editorial assistance was provided by P. Milner of PAREXEL, UK and C. McCrary Sisk and K. Lewis, both of Merck & Co., Inc., Kenilworth, NJ, USA. The assistance by PAREXEL, UK was funded by Merck & Co. Inc., Kenilworth, NJ.	Agents stimulating gonadal function in the human, WHO TECH REP SER, V514, P1; Alper Michael M, 2009, J Exp Clin Assist Reprod, V6, P3; Child TJ, 2002, OBSTET GYNECOL, V100, P665, DOI 10.1016/S0029-7844(02)02193-2; Delbaere A, 2005, ENDOCRINE, V26, P285, DOI 10.1385/ENDO:26:3:285; Delvigne A, 2002, HUM REPROD UPDATE, V8, P559, DOI 10.1093/humupd/8.6.559; Devroey P, 2009, HUM REPROD, V24, P3063, DOI 10.1093/humrep/dep291; Devroey P, 2011, HUM REPROD, V26, P2593, DOI 10.1093/humrep/der251; Fadini R, 2009, REPROD BIOMED ONLINE, V19, P343, DOI 10.1016/S1472-6483(10)60168-X; Gremeau AS, 2012, FERTIL STERIL, V98, P355, DOI 10.1016/j.fertnstert.2012.04.046; Griesinger G, 2007, HUM REPROD, V22, P1348, DOI 10.1093/humrep/dem006; Griesinger G, 2006, REPROD BIOMED ONLINE, V13, P628, DOI 10.1016/S1472-6483(10)60652-9; Griesinger G, 2011, FERTIL STERIL, V95, P2029, DOI 10.1016/j.fertnstert.2011.01.163; Junk SM, 2012, FERTIL STERIL, V98, P888, DOI 10.1016/j.fertnstert.2012.06.055; Kahnberg A, 2009, ACTA OBSTET GYN SCAN, V88, P1373, DOI 10.3109/00016340903287482; Klemetti R, 2005, HUM REPROD, V20, P3293, DOI 10.1093/humrep/dei253; Kol S, 2004, FERTIL STERIL, V81, P1, DOI 10.1016/j.fertnstert.2003.05.032; Kolibianakis EM, 2006, HUM REPROD UPDATE, V12, P651, DOI 10.1093/humupd/dml038; Kwee J, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-9; Leitao VMS, 2014, FERTIL STERIL, V101, P664, DOI 10.1016/j.fertnstert.2013.11.005; Manzanares MA, 2010, FERTIL STERIL, V93, P1215, DOI 10.1016/j.fertnstert.2008.12.019; Mathur RS, 2000, FERTIL STERIL, V73, P901, DOI 10.1016/S0015-0282(00)00492-1; Norman RJ, 2011, HUM REPROD, V26, P2200, DOI 10.1093/humrep/der163; Obruca A, 2010, REPROD BIOMED ONLINE, V21, P66, DOI 10.1016/j.rbmo.2010.03.019; Papanikolaou EG, 2006, FERTIL STERIL, V85, P112, DOI 10.1016/j.fertnstert.2005.07.1292; Tang HL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008605.pub2; Tarlatzis BC, 2012, REPROD BIOMED ONLINE, V24, P410, DOI 10.1016/j.rbmo.2012.01.005; Tso LO, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006105.pub3; Walls ML, 2015, HUM REPROD, V30, P88, DOI 10.1093/humrep/deu248	28	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0149615	10.1371/journal.pone.0149615	http://dx.doi.org/10.1371/journal.pone.0149615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950065	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100016
J	Lai, HW; Chen, ST; Chen, DR; Chen, SL; Chang, TW; Kuo, SJ; Kuo, YL; Hung, CS				Lai, Hung-Wen; Chen, Shou-Tung; Chen, Dar-Ren; Chen, Shu-Ling; Chang, Tsai-Wang; Kuo, Shou-Jen; Kuo, Yao-Lung; Hung, Chin-Sheng			Current Trends in and Indications for Endoscopy-Assisted Breast Surgery for Breast Cancer: Results from a Six-Year Study Conducted by the Taiwan Endoscopic Breast Surgery Cooperative Group	PLOS ONE			English	Article							NIPPLE-SPARING MASTECTOMY; 20-YEAR FOLLOW-UP; CONSERVING SURGERY; IMMEDIATE RECONSTRUCTION; SUBCUTANEOUS MASTECTOMY; CONSERVATIVE TREATMENT; AXILLARY DISSECTION; COSMETIC SEQUELAE; AUGMENTATION; CLASSIFICATION	Background Endoscopy-assisted breast surgery (EABS) performed through minimal axillary and/or peri-areolar incisions is a possible alternative to open surgery for certain patients with breast cancer. In this study, we report the early results of an EABS program in Taiwan. Methods The medical records of patients who underwent EABS for breast cancer during the period May 2009 to December 2014 were collected from the Taiwan Endoscopic Breast Surgery Cooperative Group database. Data on clinicopathologic characteristics, type of surgery, method of breast reconstruction, complications and recurrence were analyzed to determine the effectiveness and oncologic safety of EABS in Taiwan. Results A total of 315 EABS procedures were performed in 292 patients with breast cancer, including 23 (7.8%) patients with bilateral disease. The number of breast cancer patients who underwent EABS increased initially from 2009 to 2012 and then stabilized during the period 2012-2014. The most commonly performed EABS was endoscopy-assisted total mastectomy (EATM) (85.4%) followed by endoscopy-assisted partial mastectomy (EAPM) (14.6%). Approximately 74% of the EATM procedures involved breast reconstruction, with the most common types of reconstruction being implant insertion and autologous pedicled TRAM flap surgery. During the six-year study period, there was an increasing trend in the performance of EABS for the management of breast cancer when total mastectomy was indicated. The positive surgical margin rate was 1.9%. Overall, the rate of complications associated with EABS was 15.2% and all were minor and wound-related. During a median follow-up of 26.8 (3.3-68.6) months, there were 3 (1%) cases of local recurrence, 1 (0.3%) case of distant metastasis and 1 (0.3%) death. Conclusion The preliminary results from the EABS program in Taiwan show that EABS is a safe procedure and results in acceptable cosmetic outcome. These findings could help to promote this under-used surgical technique in the field of breast cancer.	[Lai, Hung-Wen; Chen, Shou-Tung; Chen, Dar-Ren; Chen, Shu-Ling] Changhua Christian Hosp, Endoscopy & Oncoplast Breast Surg Ctr, 135 Nanxiao St, Changhua 500, Taiwan; [Lai, Hung-Wen; Chen, Shou-Tung; Chen, Dar-Ren; Kuo, Shou-Jen] Changhua Christian Hosp, Div Gen Surg, 135 Nanxiao St, Changhua 500, Taiwan; [Lai, Hung-Wen; Chen, Shou-Tung; Chen, Dar-Ren; Chen, Shu-Ling; Kuo, Shou-Jen] Changhua Christian Hosp, Comprehens Breast Canc Ctr, Dept Surg, 135 Nanxiao St, Changhua 500, Taiwan; [Lai, Hung-Wen] Natl Yang Ming Univ, Sch Med, 155,Sec 2,Linong St, Taipei 112, Taiwan; [Kuo, Yao-Lung] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Tainan & Dou Liou Branch,Dept Surg, 138 Sheng Li Rd, Tainan 704, Taiwan; [Hung, Chin-Sheng] Taipei Med Univ Hosp, Div Gen Surg, Dept Surg, 252 Wu Hsing St, Taipei 110, Taiwan	Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; National Yang Ming Chiao Tung University; National Cheng Kung University; National Cheng Kung University Hospital; Taipei Medical University; Taipei Medical University Hospital	Kuo, YL (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Tainan & Dou Liou Branch,Dept Surg, 138 Sheng Li Rd, Tainan 704, Taiwan.; Hung, CS (corresponding author), Taipei Med Univ Hosp, Div Gen Surg, Dept Surg, 252 Wu Hsing St, Taipei 110, Taiwan.	ylkuo@mail.ncku.edu.tw; hungcs@tmu.edu.tw		Hung, Chin-sheng/0000-0002-9515-2036	Ministry of Science and Technology of Taiwan [104-2314-B-371-006-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by the Ministry of Science and Technology of Taiwan, and the number of this funding was: 104-2314-B-371-006-MY3. The principal investigator HWL, YLK, and CSH received the funding.	Anderson BO, 2005, LANCET ONCOL, V6, P145, DOI 10.1016/S1470-2045(05)01765-1; [Anonymous], 2014, NCCN CLIN PRACT GUID; Blair SL, 2009, J AM COLL SURGEONS, V209, P608, DOI 10.1016/j.jamcollsurg.2009.07.026; Carbonell AM, 2011, SURG CLIN N AM, V91, P1089, DOI 10.1016/j.suc.2011.06.006; Clough KB, 2004, PLAST RECONSTR SURG, V114, P1743, DOI 10.1097/01.PRS.0000142442.62956.78; Clough KB, 1998, ANN PLAS SURG, V41, P471, DOI 10.1097/00000637-199811000-00004; EAVES FF, 1995, CLIN PLAST SURG, V22, P683; Fan LJ, 2009, CHINESE MED J-PEKING, V122, P2945, DOI 10.3760/cmaj.issn.0366-6999.2009.24.005; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Ho WS, 2002, SURG ENDOSC, V16, P302, DOI 10.1007/s004640000203; Holmes DR, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/303879; Ingram D, 2008, ANZ J SURG, V78, P837, DOI 10.1111/j.1445-2197.2008.04676.x; Ito KI, 2008, ANZ J SURG, V78, P894, DOI 10.1111/j.1445-2197.2008.04687.x; Jagsi R, 2014, J CLIN ONCOL, V32, P919, DOI 10.1200/JCO.2013.52.2284; Kerbl DC, 2011, J UROLOGY, V185, P1150, DOI 10.1016/j.juro.2010.10.040; Kitamura K, 2002, SURGERY, V131, pS324, DOI 10.1067/msy.2002.120120; Lai HW, 2015, SURG INNOV, V22, P382, DOI 10.1177/1553350614546003; Lai HW, 2010, SURG ENDOSC, V24, P2210, DOI 10.1007/s00464-010-0930-4; Lee EK, 2006, WORLD J SURG, V30, P957, DOI 10.1007/s00268-005-0202-y; Leff DR, 2011, BREAST CANCER RES TR, V125, P607, DOI 10.1007/s10549-010-1258-4; Liu H, 2009, WORLD J SURG, V33, P2572, DOI 10.1007/s00268-009-0225-x; Luketich JD, 2012, ANN SURG, V256, P95, DOI 10.1097/SLA.0b013e3182590603; Momeni A, 2006, J PLAST RECONSTR AES, V59, P1076, DOI 10.1016/j.bjps.2006.01.031; Nakajima H, 2002, BIOMED PHARMACOTHER, V56, p205S; Nakajima H, 2009, ANN SURG, V249, P91, DOI 10.1097/SLA.0b013e31818e3fa6; Newman LA, 1998, ANN SURG ONCOL, V5, P620, DOI 10.1007/BF02303832; Osanai T, 2002, SURG LAPARO ENDO PER, V12, P100, DOI 10.1097/00129689-200204000-00005; Ozaki S, 2013, J LAPAROENDOSC ADV S, V23, P91, DOI 10.1089/lap.2012.0224; Park HS, 2011, J BREAST CANCER, V14, P52, DOI 10.4048/jbc.2011.14.1.52; PATEY DH, 1948, BRIT J CANCER, V2, P7, DOI 10.1038/bjc.1948.2; Petit JY, 2006, BREAST CANCER RES TR, V96, P47, DOI 10.1007/s10549-005-9033-7; Petit JY, 2005, BREAST, V14, P527, DOI 10.1016/j.breast.2005.08.028; Sakamoto N, 2009, ANN SURG ONCOL, V16, P3406, DOI 10.1245/s10434-009-0661-8; Takahashi H, 2014, SURG TODAY, V44, P2037, DOI 10.1007/s00595-013-0767-2; Tamaki Y, 2001, SURG LAPARO ENDO PER, V11, P356, DOI 10.1097/00019509-200112000-00003; Tukenmez M, 2014, J LAPAROENDOSC ADV S, V24, P77, DOI 10.1089/lap.2013.0172; Ulusal BG, 2006, PLAST RECONSTR SURG, V118, P1293, DOI 10.1097/01.prs.0000239460.94909.4d; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Yamashita K, 2009, SURG ENDOSC, V23, P633, DOI 10.1007/s00464-008-9809-z; Yamashita K, 2009, SURG ENDOSC, V23, P1574, DOI 10.1007/s00464-009-0343-4; Yamashita K, 2008, AM J SURG, V196, P578, DOI 10.1016/j.amjsurg.2008.06.028; Yamashita Koji, 2006, Journal of Nippon Medical School, V73, P193, DOI 10.1272/jnms.73.193; Zurrida S, 2011, INT J SURG ONCOL, V2011, DOI 10.1155/2011/980158	45	36	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150310	10.1371/journal.pone.0150310	http://dx.doi.org/10.1371/journal.pone.0150310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950469	gold, Green Published, Green Submitted			2022-12-27	WOS:000371990100028
J	Ren, JH; Chen, X; Zhou, L; Tao, NN; Zhou, HZ; Liu, B; Li, WY; Huang, AL; Chen, J				Ren, Ji-Hua; Chen, Xiang; Zhou, Li; Tao, Na-Na; Zhou, Hong-Zhong; Liu, Bo; Li, Wan-Yu; Huang, Ai-Long; Chen, Juan			Protective Role of Sirtuin3 (SIRT3) in Oxidative Stress Mediated by Hepatitis B Virus X Protein Expression	PLOS ONE			English	Article							FATTY-ACID OXIDATION; NF-KAPPA-B; CELL-DEATH; SUPEROXIDE-DISMUTASE; CALORIE RESTRICTION; MITOCHONDRIAL-DNA; DEACETYLATION; CARDIOMYOCYTES; GLUTATHIONE; ACETYLOME	Background/Aim The hepatitis B virus (HBV) infection is accompanied by the induction of oxidative stress, especially mediated by HBV X protein (HBx). Oxidative stress has been implicated in a series of pathological states, such as DNA damage, cell survival and apoptosis. However, the host factor by which cells protect themselves under this oxidative stress is poorly understood. Methodology/Principal Findings In this study, we first confirmed that HBV infection significantly induced oxidative stress. Moreover, viral protein HBx plays a major role in the oxidative stress induced by HBV. Importantly, we found that mitochondrial protein SIRT3 overexpression could decrease reactive oxygen species (ROS) induced by HBx while SIRT3 knockdown increased HBx-induced ROS. Importantly, SIRT3 overexpression abolished oxidative damage of HBx-expressing cells as evidenced by gamma H2AX and AP sites measurements. In contrast, SIRT3 knockdown promoted HBx-induced oxidative damage. In addition, we also observed that oxidant H2O2 markedly promoted HBV replication while the antioxidant N-acetyl-L-cysteine (NAC) inhibited HBV replication. Significantly, SIRT3 overexpression inhibited HBV replication by reducing cellular ROS level. Conclusions/Significance Collectively, these data suggest HBx expression induces oxidative stress, which promotes cellular oxidative damage and viral replication during HBV pathogenesis. Mitochondrial protein SIRT3 protected HBx expressing-cells from oxidative damage and inhibited HBV replication possibly by decreased cellular ROS level. These studies shed new light on the physiological significance of SIRT3 on HBx-induced oxidative stress, which can contribute to the liver pathogenesis.	[Ren, Ji-Hua; Chen, Xiang; Tao, Na-Na; Zhou, Hong-Zhong; Liu, Bo; Li, Wan-Yu; Huang, Ai-Long; Chen, Juan] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Inst Viral Hepatitis,Dept Infect Dis,Affiliated H, Chongqing, Peoples R China; [Zhou, Li; Huang, Ai-Long] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Zhou, Li] Chongqing Med Univ, Dept Epidemiol, Sch Publ Hlth & Management, Chongqing, Peoples R China	Chongqing Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Chongqing Medical University	Huang, AL; Chen, J (corresponding author), Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Inst Viral Hepatitis,Dept Infect Dis,Affiliated H, Chongqing, Peoples R China.; Huang, AL (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.	ahuang1964@163.com; yixin_xinyuan@163.com			National Natural Science Foundation of China [81472271, 81201282]; National Science and Technology Major Project [2013ZX10002002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project	This work was funded by National Natural Science Foundation of China (81472271) (http://www.nsfc.gov.cn/) (to JC and JHR), National Natural Science Foundation of China (81201282) (http://www.nsfc.gov.cn/) (to JC, JHR, and XC), and National Science and Technology Major Project (2013ZX10002002) (http://www.nmp.gov.cn/) (to ALH and JC).	Aquaro S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-76; Bause AS, 2013, EXP GERONTOL, V48, P634, DOI 10.1016/j.exger.2012.08.007; Bolukbas C, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-95; Cai JY, 2003, FREE RADICAL BIO MED, V34, P928, DOI 10.1016/S0891-5849(03)00023-6; Chen CJ, 2013, BIOCHEM BIOPH RES CO, V430, P798, DOI 10.1016/j.bbrc.2012.11.066; Chen J, 2007, J VIROL, V81, P6757, DOI 10.1128/JVI.00172-07; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Cheng ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113234; Cheng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.254; Chrobot A M, 2000, Med Sci Monit, V6, P713; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Demirdag K, 2003, HEPATO-GASTROENTEROL, V50, P766; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hu L, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-43; Irshad M, 2002, HEPATOL RES, V23, P178, DOI 10.1016/S1386-6346(01)00181-4; Jung SY, 2013, CANCER LETT, V331, P76, DOI 10.1016/j.canlet.2012.12.004; Lee YI, 2004, J BIOL CHEM, V279, P15460, DOI 10.1074/jbc.M309280200; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Rahmani Z, 2000, J VIROL, V74, P2840, DOI 10.1128/JVI.74.6.2840-2846.2000; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Shulyakova N, 2014, BRAIN RES, V1587, P40, DOI 10.1016/j.brainres.2014.08.066; Smith KT, 2009, NAT BIOTECHNOL, V27, P917, DOI 10.1038/nbt1009-917; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Swietek K, 1997, J VIRAL HEPATITIS, V4, P139; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Toyokuni S, 2006, ANTIOXID REDOX SIGN, V8, P1373, DOI 10.1089/ars.2006.8.1373; Waris G, 2001, MOL CELL BIOL, V21, P7721, DOI 10.1128/MCB.21.22.7721-7730.2001; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206	37	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150961	10.1371/journal.pone.0150961	http://dx.doi.org/10.1371/journal.pone.0150961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950437	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100073
J	Fabbretti, F; Iannetti, I; Guglielmi, L; Perconti, S; Evangelistella, C; De Santis, LP; Bongiorni, S; Prantera, G				Fabbretti, Fabiana; Iannetti, Ilaria; Guglielmi, Loredana; Perconti, Susanna; Evangelistella, Chiara; De Santis, Luca Proietti; Bongiorni, Silvia; Prantera, Giorgio			Confocal Analysis of Nuclear Lamina Behavior during Male Meiosis and Spermatogenesis in Drosophila melanogaster	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEINS; ENVELOPE BREAKDOWN; PACHYTENE SPERMATOCYTES; SPINDLE FORMATION; PORE COMPLEXES; ORGANIZATION; EXPRESSION; CHROMATIN; MITOSIS; GENE	Lamin family proteins are structural components of a filamentous framework, the nuclear lamina (NL), underlying the inner membrane of nuclear envelope. The NL not only plays a role in nucleus mechanical support and nuclear shaping, but is also involved in many cellular processes including DNA replication, gene expression and chromatin positioning. Spermatogenesis is a very complex differentiation process in which each stage is characterized by nuclear architecture dramatic changes, from the early mitotic stage to the sperm differentiation final stage. Nevertheless, very few data are present in the literature on the NL behavior during this process. Here we show the first and complete description of NL behavior during meiosis and spermatogenesis in Drosophila melanogaster. By confocal imaging, we characterized the NL modifications from mitotic stages, through meiotic divisions to sperm differentiation with an anti-laminDm0 antibody against the major component of the Drosophila NL. We observed that continuous changes in the NL structure occurred in parallel with chromatin reorganization throughout the whole process and that meiotic divisions occurred in a closed context. Finally, we analyzed NL in solofuso meiotic mutant, where chromatin segregation is severely affected, and found the strict correlation between the presence of chromatin and that of NL.	[Fabbretti, Fabiana; Iannetti, Ilaria; Guglielmi, Loredana; Perconti, Susanna; Evangelistella, Chiara; De Santis, Luca Proietti; Bongiorni, Silvia; Prantera, Giorgio] Univ Tuscia, Dept Ecol & Biol, Viterbo, Italy	Tuscia University	Fabbretti, F; Prantera, G (corresponding author), Univ Tuscia, Dept Ecol & Biol, Viterbo, Italy.	fabianafabbretti@yahoo.it; prantera@unitus.it	De Santis, Luca Proietti/A-4119-2015	De Santis, Luca Proietti/0000-0002-2715-9113; Prantera, Giorgio/0000-0003-0970-9561; Bongiorni, Silvia/0000-0001-5111-0566	Universita della Tuscia	Universita della Tuscia	The FF PhD was funded by Universita della Tuscia. The authors received no specific funding for this work.	Alsheimer M, 1999, MOL BIOL CELL, V10, P1235, DOI 10.1091/mbc.10.4.1235; Alsheimer M, 1998, J CELL SCI, V111, P2227; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; BOSSIE CA, 1993, J CELL SCI, V104, P1263; Bucciarelli E, 2003, J CELL BIOL, V160, P993, DOI 10.1083/jcb.200211029; CENCI G, 1994, J CELL SCI, V107, P3521; Dechat T., 2010, CSH PERSPECT BIOL, V2, pa000547, DOI [10.1101/cshperspect.a000547, DOI 10.1101/cshperspect.a000547]; Emmert, 2013, FLYBASE HIGH THROUGH; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; FRANKE WW, 1974, INT REV CYTOL, P71; FUCHS JP, 1983, J CELL SCI, V64, P331; Fuller Margaret T., 1993, P71; FURUKAWA K, 1993, EMBO J, V12, P97, DOI 10.1002/j.1460-2075.1993.tb05635.x; Georgatos SD, 1997, J CELL SCI, V110, P2129; GERACE L, 1978, J CELL BIOL, V79, P546, DOI 10.1083/jcb.79.2.546; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; GRUENBAUM Y, 1988, J CELL BIOL, V106, P585, DOI 10.1083/jcb.106.3.585; Gurudatta BV, 2010, J GENET, V89, P37, DOI 10.1007/s12041-010-0009-y; HAREL A, 1989, J CELL SCI, V94, P463; HEATH IB, 1980, INT REV CYTOL, V64, P1, DOI 10.1016/S0074-7696(08)60235-1; HIRAOKA Y, 1990, J CELL BIOL, V111, P2815, DOI 10.1083/jcb.111.6.2815; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; LenzBohme B, 1997, J CELL BIOL, V137, P1001, DOI 10.1083/jcb.137.5.1001; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; LUDERUS MEE, 1992, CELL, V70, P949, DOI 10.1016/0092-8674(92)90245-8; MCKEON FD, 1986, NATURE, V319, P463, DOI 10.1038/319463a0; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; Mylonis I, 2004, J BIOL CHEM, V279, P11626, DOI 10.1074/jbc.M311949200; Paddy MR, 1996, J CELL SCI, V109, P591; PADDY MR, 1990, CELL, V62, P89, DOI 10.1016/0092-8674(90)90243-8; POLLARD KM, 1990, MOL CELL BIOL, V10, P2164, DOI 10.1128/MCB.10.5.2164; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; RIEMER D, 1995, J CELL SCI, V108, P3189; Schirmer EC, 2007, EXP CELL RES, V313, P2167, DOI 10.1016/j.yexcr.2007.03.012; Schutz W, 2005, EXP CELL RES, V307, P285, DOI 10.1016/j.yexcr.2005.03.023; SMITH A, 1992, DIFFERENTIATION, V52, P55, DOI 10.1111/j.1432-0436.1992.tb00499.x; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; VESTER B, 1993, J CELL SCI, V104, P557; Volpi S, 2013, J CELL SCI, V126, P3541, DOI 10.1242/jcs.111328; White-Cooper H, 2010, REPRODUCTION, V139, P11, DOI 10.1530/REP-09-0083	40	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151231	10.1371/journal.pone.0151231	http://dx.doi.org/10.1371/journal.pone.0151231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963718	Green Submitted, gold, Green Published			2022-12-27	WOS:000371993000125
J	Grandclement, C; Pick, H; Vogel, H; Held, W				Grandclement, Camille; Pick, Horst; Vogel, Horst; Held, Werner			NK Cells Respond to Haptens by the Activation of Calcium Permeable Plasma Membrane Channels	PLOS ONE			English	Article							TRPC CHANNELS; ADAPTIVE IMMUNITY; RECEPTOR	Natural Killer (NK) cells mediate innate immunity to infected and transformed cells. Yet, NK cells can also mount hapten-specific recall responses thereby contributing to contact hypersensitivity (CHS). However, since NK cells lack antigen receptors that are used by the adaptive immune system to recognize haptens, it is not clear if NK cells respond directly to haptens and, if so, what mediates these responses. Here we show that among four haptens the two that are known to induce NK cell-dependent CHS trigger the rapid influx of extracellular Ca2+ into NK cells and lymphocyte cell lines. Thus lymphocytes can respond to haptens independent of antigen presentation and antigen receptors. We identify the Ca-2 (+)-permeable cation channel TRPC3 as a component of the lymphocyte response to one of these haptens. These data suggest that the response to the second hapten is based on a distinct mechanism, consistent with the capacity of NK cells to discriminate haptens. These findings raise the possibility that antigen-receptor independent activation of immune cells contributes to CHS.	[Grandclement, Camille; Held, Werner] Univ Lausanne, Ludwig Ctr Canc Res, Dept Oncol, CH-1066 Epalinges, Switzerland; [Pick, Horst; Vogel, Horst] Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Held, W (corresponding author), Univ Lausanne, Ludwig Ctr Canc Res, Dept Oncol, CH-1066 Epalinges, Switzerland.	Werner.Held@unil.ch	Vogel, Horst/AAJ-5490-2021		Oncosuisse grant [KFS-02736-02-2011]; European Community [613879]	Oncosuisse grant; European Community(European Commission)	This work was supported by Oncosuisse grant KFS-02736-02-2011 to WH, and European Community FP7/2007-2013 grant agreement 613879 to HV.	Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Bogeski Ivan, 2010, Expert Rev Clin Pharmacol, V3, P291, DOI 10.1586/ecp.10.23; Brenker C, 2012, EMBO J, V31, P1654, DOI 10.1038/emboj.2012.30; Carrillo C, 2012, BBA-MOL CELL BIOL L, V1821, P618, DOI 10.1016/j.bbalip.2012.01.008; Cebecauer M, 2005, J BIOL CHEM, V280, P23820, DOI 10.1074/jbc.M500654200; Cheng KT, 2013, CURR TOP MEMBR, V71, P149, DOI 10.1016/B978-0-12-407870-3.00007-X; Engel MA, 2011, GASTROENTEROLOGY, V141, P1346, DOI 10.1053/j.gastro.2011.07.002; Erkes DA, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/175265; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; Guia S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001608; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Jacquier V, 2006, J NEUROCHEM, V97, P537, DOI 10.1111/j.1471-4159.2006.03771.x; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Majewska-Szczepanik M, 2013, IMMUNOLOGY, V140, P98, DOI 10.1111/imm.12120; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Numaga T, 2010, J CELL SCI, V123, P927, DOI 10.1242/jcs.061051; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Paust S, 2010, IMMUNOL REV, V235, P286, DOI 10.1111/j.0105-2896.2010.00906.x; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Spehr M, 2004, CURR BIOL, V14, pR832, DOI 10.1016/j.cub.2004.09.034; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Xu SZ, 2005, BRIT J PHARMACOL, V145, P405, DOI 10.1038/sj.bjp.0706197; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zozulya S, 2001, GENOME BIOL, V2	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151031	10.1371/journal.pone.0151031	http://dx.doi.org/10.1371/journal.pone.0151031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963818	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000093
J	Hu, JH; Akula, N; Wang, N				Hu, Jiahuai; Akula, Nagaraju; Wang, Nian			Development of a Microemulsion Formulation for Antimicrobial SecA Inhibitors	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER ASIATICUS; STABILITY; IDENTIFICATION; RECOGNITION; DISCOVERY; SEQUENCE; DRIVEN; HLB	In our previous study, we have identified five antimicrobial small molecules via structure based design, which inhibit SecA of Candidatus Liberibacter asiaticus (Las). SecA is a critical protein translocase ATPase subunit and is involved in pre-protein translocation across and integration into the cellular membrane in bacteria. In this study, eleven compounds were identified using similarity search method based on the five lead SecA inhibitors identified previously. The identified SecA inhibitors have poor aqueous solubility. Thus a microemulsion master mix (MMX) was developed to address the solubility issue and for application of the antimicrobials. MMX consists of N-methyl-2-pyrrolidone and dimethyl sulfoxide as solvent and co-solvent, as well as polyoxyethylated castor oil, polyalkylene glycol, and polyoxyethylene tridecyl ether phosphate as surfactants. MMX has significantly improved the solubility of SecA inhibitors and has no or little phytotoxic effects at concentrations less than 5.0% (v/v). The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the SecA inhibitors and streptomycin against eight bacteria including Agrobacterium tumefaciens, Liberibacter crescens, Rhizobium etli, Bradyrhizobium japonicum, Mesorhizobium loti, and Sinorhizobium meliloti phylogenetically related to Las were determined using the broth microdilution method. MIC and MBC results showed that the 16 SecA inhibitors have antibacterial activities comparable to that of streptomycin. Overall, we have identified 11 potent SecA inhibitors using similarity search method. We have developed a microemulsion formulation for SecA inhibitors which improved the antimicrobial activities of SecA inhibitors.	[Hu, Jiahuai; Akula, Nagaraju; Wang, Nian] Univ Florida, Inst Food & Agr Sci, Ctr Citrus Res & Educ, Lake Alfred, FL USA	State University System of Florida; University of Florida	Wang, N (corresponding author), Univ Florida, Inst Food & Agr Sci, Ctr Citrus Res & Educ, Lake Alfred, FL USA.	nianwang@ufl.edu	Wang, Nian/HDM-2087-2022	Wang, Nian/0000-0001-7743-0728	Citrus Research and Development Foundation [773]	Citrus Research and Development Foundation	Support was provided by the Citrus Research and Development Foundation, Grant Number: 773 [http://citrusrdf.org/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula N, 2012, EUR J MED CHEM, V54, P919, DOI 10.1016/j.ejmech.2012.05.035; Akula N, 2011, BIOORG MED CHEM LETT, V21, P4183, DOI 10.1016/j.bmcl.2011.05.086; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; ATTWOOD D, 1992, INT J PHARMACEUT, V88, P417, DOI 10.1016/0378-5173(92)90341-X; Barloy-Hubler F, 2004, MICROBIOL-SGM, V150, P657, DOI 10.1099/mic.0.26764-0; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Bove JM, 2006, J PLANT PATHOL, V88, P7; BOYD J, 1972, J COLLOID INTERF SCI, V41, P359, DOI 10.1016/0021-9797(72)90122-1; Chen F, 2003, PESTICIDES, V4; Chin CP, 2012, IND ENG CHEM RES, V51, P4710, DOI 10.1021/ie201151p; DEAN PM, 1994, BIOESSAYS, V16, P683, DOI 10.1002/bies.950160915; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Dombrecht B, 2005, MOL MICROBIOL, V55, P1207, DOI 10.1111/j.1365-2958.2005.04457.x; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Ellegaard MD, 2010, IND ENG CHEM RES, V49, P11620, DOI 10.1021/ie101059y; Fagen JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084469; Feng Z, 2010, TENSIDE SURFACT DET, V47, P113, DOI 10.3139/113.110060; Friesner RA, 2006, ABSTR PAP AM CHEM S, V232, P42; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Ghosh S, 2010, TENSIDE SURFACT DET, V47, P369, DOI 10.3139/113.110088; Gottwald T. R., 2007, Outlooks on Pest Management, V18, P274, DOI 10.1564/18dec09; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Hanyu M, 2009, J BACTERIOL, V191, P1463, DOI 10.1128/JB.01583-08; Hoffman MT, 2013, PHYTOPATHOLOGY, V103, P15, DOI 10.1094/PHYTO-06-12-0138-R; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; KABALNOV A, 1995, J PHYS CHEM-US, V99, P6220, DOI 10.1021/j100016a068; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Lawrence MJ, 2000, ADV DRUG DELIVER REV, V45, P89, DOI 10.1016/S0169-409X(00)00103-4; Leng PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109580; Lin HL, 2010, APPL ENVIRON MICROB, V76, P1683, DOI 10.1128/AEM.00824-09; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; McManus PS, 2001, PLANT HLTH PROG, V2, P14, DOI DOI 10.1094/PHP-2001-0327-01-RV; OKAMOTO K, 1977, YAKUGAKU ZASSHI, V97, P257, DOI 10.1248/yakushi1947.97.3_257; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Pratap AP, 2008, J DISPER SCI TECHNOL, V29, P1325, DOI 10.1080/01932690701866815; SALMOND GPC, 1994, ANNU REV PHYTOPATHOL, V32, P181, DOI 10.1146/annurev.py.32.090194.001145; SCHNEIDER H, 1968, PHYTOPATHOLOGY, V58, P1155; Shah R, 2006, J BACTERIOL, V188, P7600, DOI 10.1128/JB.00671-06; Silva IC, 2013, J BACTERIOL, V195, P85, DOI 10.1128/JB.01442-12; Solans C, 1997, CURR OPIN COLLOID IN, V2, P464, DOI 10.1016/S1359-0294(97)80093-3; Sotriffer C, 2002, FARMACO, V57, P243, DOI 10.1016/S0014-827X(02)01211-9; Stachurski J, 1996, J COLLOID INTERF SCI, V184, P433, DOI 10.1006/jcis.1996.0637; Stansly PA, 2014, PEST MANAG SCI, V70, P415, DOI 10.1002/ps.3577; Tyler HL, 2009, MOL PLANT MICROBE IN, V22, P1624, DOI 10.1094/MPMI-22-12-1624; VELEV OD, 1994, COLLOID SURFACE A, V83, P43, DOI 10.1016/0927-7757(93)02639-V; WALLACE RJ, 1986, J CLIN MICROBIOL, V24, P976, DOI 10.1128/JCM.24.6.976-981.1986; Wang N, 2013, PHYTOPATHOLOGY, V103, P652, DOI 10.1094/PHYTO-12-12-0331-RVW; Warisnoicharoen W, 2000, AAPS PHARMSCI, V2; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Zhang MQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111032; Zhang MQ, 2012, PHYTOPATHOLOGY, V102, P567, DOI 10.1094/PHYTO-09-11-0265	52	15	15	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150433	10.1371/journal.pone.0150433	http://dx.doi.org/10.1371/journal.pone.0150433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963811	Green Submitted, gold, Green Published			2022-12-27	WOS:000371993000038
J	Jackson, R; Tesfay, FH; Godefay, H; Gebrehiwot, TG				Jackson, Ruth; Tesfay, Fisaha Haile; Godefay, Hagos; Gebrehiwot, Tesfay Gebregzabher			Health Extension Workers' and Mothers' Attitudes to Maternal Health Service Utilization and Acceptance in Adwa Woreda, Tigray Region, Ethiopia	PLOS ONE			English	Article							RURAL ETHIOPIA; DELIVERY CARE; WOMENS GROUPS; MORTALITY; INTERVENTIONS; CHILDBIRTH; HOME	Background The maternal health system in Ethiopia links health posts in rural communities (kebeles) with district (woreda) health centres, and health centres with primary hospitals. At each health post two Health Extension Workers (HEWs) assist women with birth preparedness, complication readiness, and mobilize communities to facilitate timely referral to mid-level service providers. This study explored HEWs' and mother's attitudes to maternal health services in Adwa Woreda, Tigray Region. Methods In this qualitative study, we trained 16 HEWs to interview 45 women to gain a better understanding of the social context of maternal health related behaviours. Themes included barriers to health services; women's social status and mobility; and women's perceptions of skilled birth attendant's care. All data were analyzed thematically. Findings There have been substantial efforts to improve maternal health and reduce maternal mortality in Adwa Woreda. Women identified barriers to healthcare including distance and lack of transportation due to geographical factors; the absence of many husbands due to off-woreda farming; traditional factors such as zwar (some pregnant women are afraid of meeting other pregnant women), and discouragement from mothers and mothers-in-law who delivered their children at home. Some women experienced disrespectful care at the hospital. Facilitators to skilled birth attendance included: identification of pregnant women through Women's Development Groups (WDGs), and referral by ambulance to health facilities either before a woman's Expected Due Date (EDD) or if labour started at home. Conclusion With the support of WDGs, HEWs have increased the rate of skilled birth attendance by calling ambulances to transfer women to health centres either before their EDD or when labour starts at home. These findings add to the growing body of evidence that health workers at the community level can work with women's groups to improve maternal health, thus reducing the need for emergency obstetric care in low-income countries.	[Jackson, Ruth] Deakin Univ, Alfred Deakin Inst Citizenship & Globalisat, Geelong, Vic 3217, Australia; [Tesfay, Fisaha Haile; Gebrehiwot, Tesfay Gebregzabher] Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Tigray Region, Ethiopia; [Godefay, Hagos] Tigray Reg Hlth Bur, Mekelle, Tigray Region, Ethiopia	Deakin University; Mekelle University	Jackson, R (corresponding author), Deakin Univ, Alfred Deakin Inst Citizenship & Globalisat, Geelong, Vic 3217, Australia.	r.jackson@deakin.edu.au		Tesfay (PhD), Fisaha Haile/0000-0003-0399-1711; Jackson, Ruth/0000-0003-3750-9372	Australian government's Department of Foreign Affairs and Trade through the Australian Development Awards Scheme [66420]	Australian government's Department of Foreign Affairs and Trade through the Australian Development Awards Scheme(Australian Government)	This research was funded by the Australian government's Department of Foreign Affairs and Trade through the Australian Development Awards Scheme under an award titled, 'Improving the use of maternal, neonatal and child health services in rural and pastoralist Ethiopia' (AusAID Agreement 66420). The views expressed in the publication are those of the author(s) and not necessarily those of the Commonwealth of Australia. The Commonwealth of Australia accepts no responsibility for any loss, damage or injury resulting from reliance on any of the information or views contained in this publication. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. More information can be found at: http://dfat.gov.au/aid/topics/developmentissues/research/Pages/2012-adras-award-recipients.aspx.	Admassie A, 2009, J DEV EFFECT, V1, P430, DOI 10.1080/19439340903375724; Adwa Health Office, 2014, STAT ADW HLTH OFF; Bedford J, 2013, MATERN CHILD HLTH J, V17, P230, DOI 10.1007/s10995-012-0965-3; Berhane Y, 2000, WOMENS HLTH REPRODUC; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bullough C, 2005, BJOG-INT J OBSTET GY, V112, P1180, DOI 10.1111/j.1471-0528.2005.00718.x; Campbell O, 2001, STUDIES HLTH SERVICE, V17, P412; *CENTR STAT AG, 2006, ETH DEM HLTH SURV 20; Central Statistical Agency, 2013, POP PROJ ETH ALL REG; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Central Statistical Agency and Ministry of Health, 2014, ETH MIN HLTH SURV 20; Costello A, 2004, BMJ-BRIT MED J, V329, P1166, DOI 10.1136/bmj.329.7475.1166; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Federal Democratic Republic of Ethiopia Ministry of Health, 2013, HLTH SECT DEV PROGR; Feyissa TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097194; Gebrehiwot T, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-137; Gebrehiwot T, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-113; Godefay H, 2015, J GLOB HEALTH, V5; Grepin K., 2013, CLOSING DEADLY GAP W; Hadley C, 2011, MANHEP FORMATIVE RES; Hailu M, 2010, ETHIOP J HEALTH SCI, V20, P25; Hailu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021432; Health FDRoEMo, 2012, ROAD MAP ACC RED MAT; Hemmings J, 2008, ETHIOPIAN WOMENS PER; Jackson R, 2013, ETHIOP J HEALTH DEV, V27, P118; Karim AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065160; Koblinsky M, 2010, ETHIOP J HEALTH DEV, V24, P105; Kruk ME, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2009.087973; Liamputtong P., 2005, QUALITATIVE RES METH; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Medhanyie A, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-44; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; Ministry Health of Ethiopia, 2010, HLTH SECT DEV PROGR; Ooms G, 2010, J PUBLIC HEALTH POL, V31, P102; Price N, 2002, SOC SCI MED, V55, P1325, DOI 10.1016/S0277-9536(01)00277-5; Price N, 2005, DEV PRACT, V15, P151, DOI 10.1080/09614520500041138; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Roy SS, 2013, B WORLD HEALTH ORGAN, V91, P426, DOI 10.2471/BLT.12.105171; Shiferaw S, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-5; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tigray Regional Health Bureau, 2014, FIN 9 YEAR HLTH B; Warren CE, 2013, BMC PREGNANCY CHILDB, V13, DOI [10.1186/1471-2393-13-21, 10.1186/1471-2393-13-150]; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Workie NW, 2013, HLTH EXTENSION PROGR; Worku AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060171; Worku AG, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-20; Yaya Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096294; Yesuf EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095439	49	32	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150747	10.1371/journal.pone.0150747	http://dx.doi.org/10.1371/journal.pone.0150747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963507	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000057
J	Lemanis, R; Korn, D; Zachow, S; Rybacki, E; Hoffmann, R				Lemanis, Robert; Korn, Dieter; Zachow, Stefan; Rybacki, Erik; Hoffmann, Rene			The Evolution and Development of Cephalopod Chambers and Their Shape	PLOS ONE			English	Article							SUTURAL COMPLEXITY; AMMONOID SEPTA; BUOYANCY; AMMONITES; NAUTILUS; ORIGIN; GROWTH; CONSTRAINTS; SIPHUNCLE; ECOLOGY	The Ammonoidea is a group of extinct cephalopods ideal to study evolution through deep time. The evolution of the planispiral shell and complexly folded septa in ammonoids has been thought to have increased the functional surface area of the chambers permitting enhanced metabolic functions such as: chamber emptying, rate of mineralization and increased growth rates throughout ontogeny. Using nano-computed tomography and synchrotron radiation based micro-computed tomography, we present the first study of ontogenetic changes in surface area to volume ratios in the phragmocone chambers of several phylogenetically distant ammonoids and extant cephalopods. Contrary to the initial hypothesis, ammonoids do not possess a persistently high relative chamber surface area. Instead, the functional surface area of the chambers is higher in earliest ontogeny when compared to Spirula spirula. The higher the functional surface area the quicker the potential emptying rate of the chamber; quicker chamber emptying rates would theoretically permit faster growth. This is supported by the persistently higher siphuncular surface area to chamber volume ratio we collected for the ammonite Amauroceras sp. compared to either S. spirula or nautilids. We demonstrate that the curvature of the surface of the chamber increases with greater septal complexity increasing the potential refilling rates. We further show a unique relationship between ammonoid chamber shape and size that does not exist in S. spirula or nautilids. This view of chamber function also has implications for the evolution of the internal shell of coleoids, relating this event to the decoupling of soft-body growth and shell growth.	[Lemanis, Robert; Hoffmann, Rene] Ruhr Univ Bochum, Inst Geol Mineral & Geophys, Univ Str 150, Bochum, Germany; [Korn, Dieter] Leibniz Inst Evolut & Biodivers Forsch, Museum Naturkunde Berlin, Berlin, Germany; [Zachow, Stefan] Zuse Inst, Dept Sci Visualizat & Data Anal, Berlin, Germany; [Rybacki, Erik] Deutsch GeoForschungsZentrum, Helmholtz Zentrum Potsdam, Potsdam, Germany	Ruhr University Bochum; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Zuse Institute Berlin; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Lemanis, R (corresponding author), Ruhr Univ Bochum, Inst Geol Mineral & Geophys, Univ Str 150, Bochum, Germany.	Robert.Lemanis@rub.de	Korn, Dieter/B-2963-2009	Korn, Dieter/0000-0003-1104-6939; Hoffmann, Rene/0000-0001-7992-1264; Lemanis, Robert/0000-0002-7259-3410	Deutsche Forschungsgemeinschaft (DFG) [HO 4674/2-1]; Deutsche Forschungsgemeinschaft [HO 4674/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Grant: HO 4674/2-1 to RH (http://www.dfg.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is funded by the Deutsche Forschungsgemeinschaft, grant number HO 4674/2-1. We would like to thank H. Knappe and D. Weyer for the Arnsbergites sp. specimen and S. R. Gerden who segmented it. The specimen of Kosmoceras sp. was donated by S. Schneider, Cadoceras sp. was donated by V. Mitta, and F. Rudolph donated the Amauroceras specimen. L. Wulff segmented the pathological S. spirula. H. Wesendonk at the TPW (Neuss, Germany) provided several nano-CT scans. Julia Shultz scanned the N. pompilius and pathologic S. spirula at the Steinmann Institute. K. Stevens for fruitful discussions. Additionally M. Ehlke provided continued support for ZIBAmira.	Alexander RM., 2003, PRINCIPLES ANIMAL LO; Arnold JM, 2010, NAUTILUS, P353, DOI DOI 10.1007/978-90-481-3299-7_26; ARONSON RB, 1991, B MAR SCI, V49, P245; Bayer U., 1978, NEUES JB GEOL PAL, V154, P290; BIGELOW KA, 1992, MAR ECOL PROG SER, V82, P31, DOI 10.3354/meps082031; BOYAJIAN G, 1992, GEOLOGY, V20, P983, DOI 10.1130/0091-7613(1992)020<0983:EOBCAI>2.3.CO;2; Boyle PR, 1996, PHILOS T R SOC B, V351, P985, DOI 10.1098/rstb.1996.0089; Calow P, 1987, CEPHALOPOD LIFE CYCL; CHAMBERLAIN J A, 1976, Palaeontology (Oxford), V19, P539; Chamberlain JA., 1978, NEUES JB GEOLOGIE PA, V3, P29; Chamberlain John A. Jr, 1993, Geobios Memoire Special (Villeurbanne), V15, P49; Clarke MR, 2013, PALEONTOLOGY NEONATO; Crick R. E., 1988, SENCKENBERG LETH, V69, P2; Daniel TL, 1997, PALEOBIOLOGY, V23, P470, DOI 10.1017/S0094837300019849; De Baets K, 2015, TOP GEOBIOL, V43, P113, DOI 10.1007/978-94-017-9630-9_5; De Baets K, 2012, EVOLUTION, V66, P1788, DOI 10.1111/j.1558-5646.2011.01567.x; DENTON EJ, 1971, J MAR BIOL ASSOC UK, V51, P363, DOI 10.1017/S0025315400031842; DENTON EJ, 1966, J MAR BIOL ASSOC UK, V46, P723, DOI 10.1017/S0025315400033440; DENTON EJ, 1973, ADV MAR BIOL, V11, P197, DOI 10.1016/S0065-2881(08)60270-9; Engeser Theo, 1996, Topics in Geobiology, V13, P3; GARCIARUIZ JM, 1990, PALEOBIOLOGY, V16, P349, DOI 10.1017/S0094837300010046; Gottobrio WE, 2005, PALEOBIOLOGY, V31, P233, DOI 10.1666/0094-8373(2005)031[0233:TCDFIO]2.0.CO;2; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Hassan MA, 2002, PALEOBIOLOGY, V28, P113, DOI 10.1666/0094-8373(2002)028<0113:FEAOSA>2.0.CO;2; Hewitt R.A., 1986, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V172, P47; Hewitt R.A., 1987, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V174, P135; Hewitt RA, 2003, J PALEONTOL, V77, P792, DOI 10.1666/0022-3360(2003)077<0792:ROHAAA>2.0.CO;2; Hewitt RA, 1997, LETHAIA, V30, P205; Hill A. V., 1950, Science Progress London, V38, P209; Hoffmann R, 2014, BIOGEOSCIENCES, V11, P2721, DOI 10.5194/bg-11-2721-2014; Hoffmann R., 2014, Denisia, P33; Hoffmann R, 2015, SWISS J PALAEONTOL, V134, P207, DOI 10.1007/s13358-015-0083-0; JACOBS DK, 1992, PALEOBIOLOGY, V18, P203, DOI 10.1017/S009483730001397X; Kerr JP, 2015, PALAEOGEOGR PALAEOCL, V440, P632, DOI 10.1016/j.palaeo.2015.08.047; Klug C, 2015, AMMONOID PALEOBIOLOG; Klug C, 2016, ACTA PALAEONTOL POL, V61, P1, DOI 10.4202/app.00220.2015; Klug C, 2015, LETHAIA, V48, P267, DOI 10.1111/let.12104; Klug C, 2008, LETHAIA, V41, P477, DOI 10.1111/j.1502-3931.2008.00100.x; Kroger B, 2011, BIOESSAYS, V33, P602, DOI 10.1002/bies.201100001; Kroger B, 2002, LETHAIA, V35, P61, DOI 10.1080/002411602317345876; Landing E, 2012, PALAEOGEOGR PALAEOCL, V353, P21, DOI 10.1016/j.palaeo.2012.06.023; Landman NH, 2015, TOP GEOBIOL, V44, P497, DOI 10.1007/978-94-017-9633-0_19; Laptikhovsky VV, 2013, B GEOSCI, V88, P83, DOI 10.3140/bull.geosci.1351; LAPTIKHOVSKY VV, 1993, J PLANKTON RES, V15, P375, DOI 10.1093/plankt/15.4.375; Lee PN, 2003, NATURE, V424, P1061, DOI 10.1038/nature01872; Lehmann J, 2016, LETHAIA, V49, P73, DOI 10.1111/let.12133; Lemanis R, 2015, PALEOBIOLOGY, V41, P313, DOI 10.1017/pab.2014.17; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Monnet C, 2015, TOP GEOBIOL, V44, P95, DOI 10.1007/978-94-017-9633-0_5; Monnet C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-115; Mutvei H., 1967, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V129, P157; Mutvei H, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P239, DOI 10.1007/978-1-4020-6806-5_12; Mutvei H, 2011, PALAEONTOLOGY, V54, P705, DOI 10.1111/j.1475-4983.2011.01041.x; Mutvei H, 2010, GFF, V132, P161, DOI 10.1080/11035897.2010.510204; Naglik C, 2015, TOP GEOBIOL, V43, P649, DOI 10.1007/978-94-017-9630-9_17; Naglik C, 2015, LETHAIA, V48, P29, DOI 10.1111/let.12085; NEWELL ND, 1949, EVOLUTION, V3, P103, DOI 10.2307/2405545; ODOR RK, 1986, CAN J ZOOL, V64, P1591, DOI 10.1139/z86-241; ODOR RK, 1990, J EXP BIOL, V154, P383; Oloriz F, 2002, LETHAIA, V35, P158, DOI 10.1080/002411602320184015; OLORIZ F, 1995, LETHAIA, V28, P167, DOI 10.1111/j.1502-3931.1995.tb01608.x; Oloriz F, 1999, ADVANCING RESEARCH ON LIVING AND FOSSIL CEPHALOPODS, P273; da Silva VCP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103480, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0095536, 10.1371/journal.pone.0099366, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0095422]; Perez-Claros JA, 2005, PALEOBIOLOGY, V31, P221, DOI 10.1666/0094-8373(2005)031[0221:AAFEIA]2.0.CO;2; Perez-Claros JA, 2007, LETHAIA, V40, P253, DOI 10.1111/j.1502-3931.2007.00022.x; Polizzotto K, 2015, AMMONOID PALEOBIOLOG, VI; RAUP DAVID M., 1967, J PALEONTOL, V41, P566; Ritterbush KA, 2014, J ZOOL, V292, P229, DOI 10.1111/jzo.12118; Ritterbush KA, 2012, PALEOBIOLOGY, V38, P424, DOI 10.1666/10027.1; Rodhouse PG, 1998, BIOL BULL-US, V195, P17, DOI 10.2307/1542771; RUNNEGAR B, 1974, SCIENCE, V186, P311, DOI 10.1126/science.186.4161.311; SAUNDERS WB, 1995, PALEOBIOLOGY, V21, P343, DOI 10.1017/S0094837300013348; Seilacher A., 1988, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V177, P41; Seilacher A, 1993, NEUES JB GEOL PAL, V190, P73; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Staaf DJ, 2014, J EXP BIOL; Tajika A, 2015, PEERJ, V3, DOI 10.7717/peerj.1306; Tajika A, 2015, HIST BIOL, V27, P181, DOI 10.1080/08912963.2013.872097; Tanabe K, 2000, LETHAIA, V33, P83, DOI 10.1080/00241160050150212; Tanabe K, 2015, TOP GEOBIOL, V43, P531, DOI 10.1007/978-94-017-9630-9_13; Tendler A, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0149-z; Trueman AE., 1940, Q J GEOL SOC LOND, V96, P339, DOI DOI 10.1144/GSL.JGS.1940.096.01-04.14; Ubukata T, 2008, ACTA PALAENTOL POL, P1; Vinther J, 2015, PALAEONTOLOGY, V58, P19, DOI 10.1111/pala.12140; WARD P, 1982, PALEOBIOLOGY, V8, P426, DOI 10.1017/S0094837300007168; WARD P, 1981, PALEOBIOLOGY, V7, P481, DOI 10.1017/S0094837300025537; Ward P. D., 1987, NATURAL HIST NAUTILU; WARD PD, 1986, VELIGER, V28, P356; Watson D. M. S., 1949, Genetics Paleontology and Evolution, P45; Wells MJ, 1996, PHILOS T R SOC B, V351, P1083, DOI 10.1098/rstb.1996.0095; WELLS MJ, 1990, CAN J ZOOL, V68, P815, DOI 10.1139/z90-117; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; WESTERMANN GEG, 1982, LETHAIA, V15, P373, DOI 10.1111/j.1502-3931.1982.tb01702.x; Westermann Gerd E.G., 1996, Topics in Geobiology, V13, P607; Westermann Gerd E.G., 1999, P263; YOCHELSON EL, 1973, LETHAIA, V6, P275, DOI 10.1111/j.1502-3931.1973.tb01199.x	96	31	31	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151404	10.1371/journal.pone.0151404	http://dx.doi.org/10.1371/journal.pone.0151404			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963712	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000147
J	Lombardo, M; Parravano, M; Serrao, S; Ziccardi, L; Giannini, D; Lombardo, G				Lombardo, Marco; Parravano, Mariacristina; Serrao, Sebastiano; Ziccardi, Lucia; Giannini, Daniela; Lombardo, Giuseppe			Investigation of Adaptive Optics Imaging Biomarkers for Detecting Pathological Changes of the Cone Mosaic in Patients with Type 1 Diabetes Mellitus	PLOS ONE			English	Article							PHOTORECEPTOR DENSITY; PATTERN-FORMATION; RETINA; NEURODEGENERATION; ECCENTRICITY; ORIENTATION; RETINOPATHY; QUALITY; LIMIT; EYE	Purpose To investigate a set of adaptive optics (AO) imaging biomarkers for the assessment of changes of the cone mosaic spatial arrangement in patients with type 1 diabetes mellitus (DM1). Methods 16 patients with >= 20/20 visual acuity and a diagnosis of DM1 in the past 8 years to 37 years and 20 age-matched healthy volunteers were recruited in this study. Cone density, cone spacing and Voronoi diagrams were calculated on 160x160 mu m images of the cone mosaic acquired with an AO flood illumination retinal camera at 1.5 degrees eccentricity from the fovea along all retinal meridians. From the cone spacing measures and Voronoi diagrams, the linear dispersion index (LDi) and the heterogeneity packing index (HPi) were computed respectively. Logistic regression analysis was conducted to discriminate DM1 patients without diabetic retinopathy from controls using the cone metrics as predictors. Results Of the 16 DM1 patients, eight had no signs of diabetic retinopathy (noDR) and eight had mild nonproliferative diabetic retinopathy (NPDR) on fundoscopy. On average, cone density, LDi and HPi values were significantly different (P<0.05) between noDR or NPDR eyes and controls, with these differences increasing with duration of diabetes. However, each cone metric alone was not sufficiently sensitive to discriminate entirely between membership of noDR cases and controls. The complementary use of all the three cone metrics in the logistic regression model gained 100% accuracy to identify noDR cases with respect to controls. Conclusion The present set of AO imaging biomarkers identified reliably abnormalities in the spatial arrangement of the parafoveal cones in DM1 patients, even when no signs of diabetic retinopathy were seen on fundoscopy.	[Lombardo, Marco; Parravano, Mariacristina; Serrao, Sebastiano; Ziccardi, Lucia; Giannini, Daniela] Fdn GB Bietti IRCCS, Via Livenza 3, I-00198 Rome, Italy; [Lombardo, Giuseppe] CNR, Ist Proc Chim Fis, Viale Stagno DAlcontres 37, I-98158 Messina, Italy; [Lombardo, Giuseppe] Vis Engn Italy Srl, Via Adda 7, I-00198 Rome, Italy	IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR)	Lombardo, M (corresponding author), Fdn GB Bietti IRCCS, Via Livenza 3, I-00198 Rome, Italy.	mlombardo@visioeng.it	Ziccardi, Lucia/AAQ-9066-2020; Vasi, Cirino S/N-7275-2015; Giannini, Daniela/V-5431-2017; Lombardo, Giuseppe/B-2656-2012	Ziccardi, Lucia/0000-0002-5563-1243; Vasi, Cirino S/0000-0002-7255-0787; Giannini, Daniela/0000-0001-5704-3931; Lombardo, Marco/0000-0001-8842-7102; Lombardo, Giuseppe/0000-0002-9416-967X	Italian Ministry of Health; National Framework Program for Research and Innovation PON [01_00110]; Fondazione Roma; Vision Engineering Italy srl	Italian Ministry of Health(Ministry of Health, Italy); National Framework Program for Research and Innovation PON; Fondazione Roma(Fondazione RomaEuropean Commission); Vision Engineering Italy srl	Research for this work was supported by the Italian Ministry of Health (5x1000 funding), by the National Framework Program for Research and Innovation PON (grant n. 01_00110) and by Fondazione Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Vision Engineering Italy srl funder provided support in the form of salaries for author GL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 1991, OPHTHALMOLOGY, V98, P823; Baraas RC, 2007, J OPT SOC AM A, V24, P1438, DOI 10.1364/JOSAA.24.001438; Barber AJ, 2003, PROG NEURO-PSYCHOPH, V27, P283, DOI 10.1016/S0278-5846(03)00023-X; BROSTOW W, 1978, J COMPUT PHYS, V29, P81, DOI 10.1016/0021-9991(78)90110-9; Coletta NJ, 2006, VISION RES, V46, P636, DOI 10.1016/j.visres.2005.05.025; Cook JE, 1996, VISUAL NEUROSCI, V13, P15, DOI 10.1017/S0952523800007094; Costa LD, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011913; Costa LD, 2007, NEUROINFORMATICS, V5, P59, DOI 10.1385/NI:5:1:59; CURCIO CA, 1992, VISUAL NEUROSCI, V9, P169, DOI 10.1017/S0952523800009639; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; DRASDO N, 1974, BRIT J OPHTHALMOL, V58, P709, DOI 10.1136/bjo.58.8.709; Duyckaerts C, 2000, J CHEM NEUROANAT, V20, P83, DOI 10.1016/S0891-0618(00)00064-8; Eglen SJ., 2012, COMPUTATIONAL SYSTEM, P365; Fletcher Erica L, 2005, Clin Exp Optom, V88, P132; HIRSCH J, 1987, J OPT SOC AM A, V4, P1481, DOI 10.1364/JOSAA.4.001481; HIRSCH J, 1984, VISION RES, V24, P347, DOI 10.1016/0042-6989(84)90060-9; Holopigian K, 1997, INVEST OPHTH VIS SCI, V38, P2355; Larson DE, 2008, CELL POSITIONING DRO, P2; Lee R, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0026-2; Li KY, 2007, J OPT SOC AM A, V24, P1358, DOI 10.1364/JOSAA.24.001358; Lieth E, 2000, CLIN EXP OPHTHALMOL, V28, P3, DOI 10.1046/j.1442-9071.2000.00222.x; Lombardo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107402; Lombardo M, 2014, RETINA-J RET VIT DIS, V34, P546, DOI 10.1097/IAE.0b013e3182a10850; Lombardo M, 2013, BIOMED OPT EXPRESS, V4, P1318, DOI 10.1364/BOE.4.001318; Lombardo M, 2013, OPHTHAL PHYSL OPT, V33, P516, DOI 10.1111/opo.12053; Lombardo M, 2013, SENSORS-BASEL, V13, P334, DOI 10.3390/s130100334; Lombardo M, 2012, J CATARACT REFR SURG, V38, P1147, DOI 10.1016/j.jcrs.2012.02.033; Martin-Merino E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100283; Mochizuki A, 2002, J THEOR BIOL, V215, P345, DOI 10.1006/jtbi.2001.2508; PACKER O, 1990, J COMP NEUROL, V298, P472, DOI 10.1002/cne.902980408; Park SP, 2013, EXP EYE RES, V108, P1, DOI 10.1016/j.exer.2012.12.011; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; PRESS SJ, 1978, J AM STAT ASSOC, V73, P699, DOI 10.2307/2286261; PUM D, 1990, VISUAL NEUROSCI, V5, P511, DOI 10.1017/S0952523800000687; Raymond PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085325; Reese BE, 2002, PROG RETIN EYE RES, V21, P153, DOI 10.1016/S1350-9462(01)00024-6; Salbreux G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002618; Simo R, 2014, TRENDS ENDOCRIN MET, V25, P23, DOI 10.1016/j.tem.2013.09.005; Stenkamp DL, 2002, MOL VIS, V8, P280; Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479; Tan W, 2015, INVEST OPHTH VIS SCI, V56, P6339, DOI 10.1167/iovs.15-16817; Yu PK, 2010, INVEST OPHTH VIS SCI, V51, P447, DOI 10.1167/iovs.09-3978; Zagers NPA, 2005, VISION RES, V45, P1745, DOI 10.1016/j.visres.2004.12.011	44	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151380	10.1371/journal.pone.0151380	http://dx.doi.org/10.1371/journal.pone.0151380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963392	Green Published, gold			2022-12-27	WOS:000371993000144
J	Manzar, MD; Rajput, MM; Zannat, W; Pandi-Perumal, SR; BaHammam, AS; Hussain, ME				Manzar, Md Dilshad; Rajput, Mohammad Muntafa; Zannat, Wassilatul; Pandi-Perumal, Seithikurippu R.; BaHammam, Ahmed S.; Hussain, M. Ejaz			Spontaneous K-Complex Density in Slow-Wave Sleep	PLOS ONE			English	Article							STAGE-2; AMPLITUDE	Purpose To study spontaneous K-complex (KC) densities during slow-wave sleep. The secondary objective was to estimate intra-non-rapid eye movement (NREM) sleep differences in KC density. Materials and Methods It is a retrospective study using EEG data included in polysomnographic records from the archive at the sleep research laboratory of the Centre for Physiotherapy and Rehabilitation Sciences, Jamia Millia Islamia, India. The EEG records of 4459 minutes were used. The study presents a manual identification investigation of KCs in 17 healthy young adult male volunteers (age = 23.82 +/- 3.40 years and BMI = 23.42 +/- 4.18 kg/m(2)). Results N3 had a higher KC density than N2 (Z = -2.485, p = 0.013) for all of the probes taken together. Four EEG probes had a higher probe-specific KC density during N3. The inter-probe KC density differed significantly during N2 (chi(2) = 67.91, p < .001), N3 (chi(2) = 70.62, p < .001) and NREM (chi(2) = 68.50, p < .001). The percent distribution of KC decreased uniformly with sleep cycles. Conclusion The inter-probe differences during N3 establish the fronto-central dominance of the KC density regardless of sleep stage. This finding supports one local theory of KC generation. The significantly higher KC density during N3 may imply that the neuro-anatomical origin of slow-wave activity and KC is the same. This temporal alignment with slow-wave activity supports the sleep-promoting function of the KC.	[Manzar, Md Dilshad; Zannat, Wassilatul; Hussain, M. Ejaz] Jamia Millia Islamia, Ctr Physiotherapy & Rehabil Sci, New Delhi 110025, India; [Manzar, Md Dilshad] Mizan Tepi Univ, Dept Biomed Sci, Coll Hlth Sci, Mizan Teferi, Ethiopia; [Rajput, Mohammad Muntafa] Univ Delhi, Dept Biochem, Inst Home Econ, New Delhi, India; [Pandi-Perumal, Seithikurippu R.] Somnogen Canada Inc, Coll St, Toronto, ON, Canada; [BaHammam, Ahmed S.] King Saud Univ, Coll Med, Dept Med, Univ Sleep Disorders Ctr, Riyadh 11461, Saudi Arabia; [BaHammam, Ahmed S.] King Saud Univ, Coll Med, NSTIP Strateg Technol Program, Riyadh 11461, Saudi Arabia	Jamia Millia Islamia; University of Delhi; King Saud University; King Saud University	Hussain, ME (corresponding author), Jamia Millia Islamia, Ctr Physiotherapy & Rehabil Sci, New Delhi 110025, India.	ehusain@jmi.ac.in	BaHammam, Ahmed S/D-7521-2011; Pandi-Perumal, Seithikurippu R/HDM-2070-2022; Manzar, Md Dilshad/HHC-5599-2022; mohamady, mahin/G-2175-2016; BaHammam, Ahmed Salem/B-9037-2008; Pandi-Perumal, Seithikurippu R./Q-8281-2016	BaHammam, Ahmed S/0000-0002-1706-6167; Manzar, Md Dilshad/0000-0002-5571-3310; BaHammam, Ahmed Salem/0000-0002-1706-6167; Pandi-Perumal, Seithikurippu R./0000-0002-8686-7259	Indian Council of Medical Research (ICMR) [3/1/JRF-2007/MPD, 37222/2009]; University Grants Commission (UGC); Strategic Technologies Program of the National Plan for Sciences and Technology and Innovation in the Kingdom of Saudi Arabia	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); University Grants Commission (UGC)(University Grants Commission, India); Strategic Technologies Program of the National Plan for Sciences and Technology and Innovation in the Kingdom of Saudi Arabia	The grants-3/1/JRF-2007/MPD and 37222/2009 (SR-) from the Indian Council of Medical Research (ICMR) and the University Grants Commission (UGC), respectively, funded the research. The funders had no role in the study design, data collection and analysis, preparation of the manuscript, or the decision to publish. This work was also supported by the Strategic Technologies Program of the National Plan for Sciences and Technology and Innovation in the Kingdom of Saudi Arabia. None of the study sponsors played any role in the study design, the collection, analysis or interpretation of data, writing the manuscript, or the decision to submit the manuscript. The funder provided support in the form of salaries for the authors [SRP] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are described in the 'author contributions' section.	Bellesi M, 2014, FRONT SYST NEUROSCI, V8; Colrain IM, 2011, SLEEP, V34, P787, DOI 10.5665/SLEEP.1050; Colrain IM, 2005, SLEEP, V28, P255, DOI 10.1093/sleep/28.2.255; Cote KA, 1999, J SLEEP RES, V8, P263, DOI 10.1046/j.1365-2869.1999.00164.x; Crowley K, 2002, J SLEEP RES, V11, P129, DOI 10.1046/j.1365-2869.2002.00293.x; Curcio G, 2003, CLIN NEUROPHYSIOL, V114, P2279, DOI 10.1016/S1388-2457(03)00276-1; Davis H, 1939, J NEUROPHYSIOL, V2, P500, DOI 10.1152/jn.1939.2.6.500; De Gennaro L, 2000, NEUROSCI LETT, V291, P41, DOI 10.1016/S0304-3940(00)01366-5; Forget D, 2011, SLEEP, V34, P1251, DOI 10.5665/SLEEP.1250; Iber C., 2007, AASM MANUAL SCORING; Kokkinos V, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00163; Laurino M, 2014, NEUROIMAGE, V86, P433, DOI 10.1016/j.neuroimage.2013.10.030; Loomis AL, 1938, J NEUROPHYSIOL, V1, P413, DOI 10.1152/jn.1938.1.5.413; McCormick L, 1997, SLEEP, V20, P939, DOI 10.1093/sleep/20.11.939; Nicholas CL, 2002, SLEEP, V25, P882; Rodenbeck R., 2006, SOMNOLOGIE, V10, P159, DOI [DOI 10.1111/J.1439-054X.2006.00101.X, DOI 10.1111/J]; Ruiter ME, 2011, SLEEP MED, V12, P209, DOI 10.1016/j.sleep.2010.12.010; Wennberg R, 2010, CLIN NEUROPHYSIOL, V121, P1176, DOI 10.1016/j.clinph.2009.12.039	18	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150929	10.1371/journal.pone.0150929	http://dx.doi.org/10.1371/journal.pone.0150929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963714	Green Submitted, gold, Green Published			2022-12-27	WOS:000371993000081
J	Murphy, BA; Miller, JP; Gunalan, K; Ajiboye, AB				Murphy, Brian A.; Miller, Jonathan P.; Gunalan, Kabilar; Ajiboye, A. Bolu			Contributions of Subsurface Cortical Modulations to Discrimination of Executed and Imagined Grasp Forces through Stereoelectroencephalography	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; DEEP BRAIN-STIMULATION; HUMAN CEREBRAL-CORTEX; POWER GRIP FORCE; GAMMA-OSCILLATIONS; MOVEMENT TRAJECTORIES; SENSORIMOTOR CORTEX; EPILEPSY SURGERY; COMPLICATIONS; TASK	Stereoelectroencephalographic (SEEG) depth electrodes have the potential to record neural activity from deep brain structures not easily reached with other intracranial recording technologies. SEEG electrodes were placed through deep cortical structures including central sulcus and insular cortex. In order to observe changes in frequency band modulation, participants performed force matching trials at three distinct force levels using two different grasp configurations: a power grasp and a lateral pinch. Signals from these deeper structures were found to contain information useful for distinguishing force from rest trials as well as different force levels in some participants. High frequency components along with alpha and beta bands recorded from electrodes located near the primary motor cortex wall of central sulcus and electrodes passing through sensory cortex were found to be the most useful for classification of force versus rest although one participant did have significant modulation in the insular cortex. This study electrophysiologically corroborates with previous imaging studies that show force-related modulation occurs inside of central sulcus and insular cortex. The results of this work suggest that depth electrodes could be useful tools for investigating the functions of deeper brain structures as well as showing that central sulcus and insular cortex may contain neural signals that could be used for control of a grasp force BMI.	[Murphy, Brian A.; Gunalan, Kabilar; Ajiboye, A. Bolu] Case Western Reserve Univ, Dept Biomed Engn, 10900 Euclid Ave, Cleveland, OH 44106 USA; [Miller, Jonathan P.] Univ Hosp Case Med Ctr, Dept Neurosurg, Neurol Inst, 11100 Euclid Ave, Cleveland, OH 44106 USA; [Murphy, Brian A.; Ajiboye, A. Bolu] Louis Stokes Cleveland VA Med Ctr, 10701 East Blvd, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Ajiboye, AB (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, 10900 Euclid Ave, Cleveland, OH 44106 USA.; Ajiboye, AB (corresponding author), Louis Stokes Cleveland VA Med Ctr, 10701 East Blvd, Cleveland, OH 44106 USA.	aba20@case.edu		Miller, Jonathan/0000-0001-5441-1751	United States Department of Veterans Affairs [B9043W]; National Institute of Biomedical Imaging and Bioengineering T32 training grant [5T32EB004314-14]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB004314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	United States Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Biomedical Imaging and Bioengineering T32 training grant; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Career Development Award # B9043W from the United States Department of Veterans Affairs, ABA BAM; National Institute of Biomedical Imaging and Bioengineering T32 training grant 5T32EB004314-14, http://www.nibib.nih.gov/, BAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrese JC, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066014; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Cardinale F, 2013, NEUROSURGERY, V72, P353, DOI 10.1227/NEU.0b013e31827d1161; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; Chestek CA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026002; Cheyne D, 2008, NEUROIMAGE, V42, P332, DOI 10.1016/j.neuroimage.2008.04.178; Cossu M, 2005, NEUROSURGERY, V57, P706, DOI 10.1227/01.NEU.0000176656.33523.1e; Crone NE, 2011, INT J PSYCHOPHYSIOL, V79, P9, DOI 10.1016/j.ijpsycho.2010.10.013; Decety J, 1996, COGNITIVE BRAIN RES, V3, P87, DOI 10.1016/0926-6410(95)00033-X; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dettmers C, 1995, RELATION CEREBRAL AC, V74; Ehrsson HH, 2001, J NEUROPHYSIOL, V85, P2613, DOI 10.1152/jn.2001.85.6.2613; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Flint RD, 2014, NEUROIMAGE, V101, P695, DOI 10.1016/j.neuroimage.2014.07.049; Fukushima M, 2014, J NEUROSCI METH, V233, P155, DOI 10.1016/j.jneumeth.2014.06.022; Giannicola G, 2012, EXP NEUROL, V237, P312, DOI 10.1016/j.expneurol.2012.06.012; Hader WJ, 2013, EPILEPSIA, V54, P840, DOI 10.1111/epi.12161; Hamer HM, 2002, NEUROLOGY, V58, P97, DOI 10.1212/WNL.58.1.97; Hedegard E, 2014, J NEUROL NEUROSUR PS, V85, P716, DOI 10.1136/jnnp-2013-306465; Heed T, 2011, J NEUROSCI, V31, P3066, DOI 10.1523/JNEUROSCI.4370-10.2011; Hermes D, 2012, HUM BRAIN MAPP, V33, P1689, DOI 10.1002/hbm.21314; Hirata M, 2014, ALPHA BAND FUNCTIONA, V8, P1, DOI [10.3389/fnhum.2014.00620, DOI 10.3389/FNHUM.2014.00620]; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jochumsen M, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056015; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; Keisker B, 2010, EUR J NEUROSCI, V31, P1483, DOI 10.1111/j.1460-9568.2010.07172.x; Keisker B, 2009, HUM BRAIN MAPP, V30, P2453, DOI 10.1002/hbm.20676; Kent AR, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046010; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Kristeva-Feige R, 2002, CLIN NEUROPHYSIOL, V113, P124, DOI 10.1016/S1388-2457(01)00722-2; Lachaux JP, 2007, HUM BRAIN MAPP, V28, P1368, DOI 10.1002/hbm.20352; Lempka SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059839; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Matsuo T, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00034; McConnell GC, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/056003; Meier JD, 2008, J NEUROPHYSIOL, V100, P1800, DOI 10.1152/jn.90531.2008; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Mima T, 1999, NEUROSCI LETT, V275, P77, DOI 10.1016/S0304-3940(99)00734-X; Muthukumaraswamy SD, 2010, J NEUROPHYSIOL, V104, P2873, DOI 10.1152/jn.00607.2010; Mutschler I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000259; Mutschler I, 2009, NEUROSCI LETT, V457, P66, DOI 10.1016/j.neulet.2009.03.101; Neely KA, 2013, HUM BRAIN MAPP, V34, P698, DOI 10.1002/hbm.21467; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Neurology D, 2006, COMPLICATIONS INVASI, V105, P343; Omlor W, 2007, NEUROIMAGE, V34, P1191, DOI 10.1016/j.neuroimage.2006.10.018; Onal C, 2003, J NEUROSURG, V98, P1017, DOI 10.3171/jns.2003.98.5.1017; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Rosa M, 2011, NEUROSIGNALS, V19, P151, DOI 10.1159/000328508; Saleh M, 2010, NEURON, V65, P461, DOI 10.1016/j.neuron.2010.02.001; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Siero JCW, 2013, J CEREBR BLOOD F MET, V33, P1448, DOI 10.1038/jcbfm.2013.97; Stephani C, 2011, BRAIN STRUCT FUNCT, V216, P137, DOI 10.1007/s00429-010-0296-3; Szurhaj W, 2006, EUR J NEUROSCI, V24, P947, DOI 10.1111/j.1460-9568.2006.04876.x; Thickbroom GW, 1998, EXP BRAIN RES, V121, P59, DOI 10.1007/s002210050437; Vuckovic A, 2008, MED BIOL ENG COMPUT, V46, P529, DOI 10.1007/s11517-008-0345-8; WEILLER C, 1993, ANN NEUROL, V33, P181; White LE, 1997, STRUCTURE HUMAN SENS, P18; Yanagisawa T, 2009, NEUROIMAGE, V45, P1099, DOI 10.1016/j.neuroimage.2008.12.069	68	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150359	10.1371/journal.pone.0150359	http://dx.doi.org/10.1371/journal.pone.0150359			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963246	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000033
J	Yu, SQ; Cai, YY; Lyons, C; Johnson, RF; Postnikova, E; Mazur, S; Johnson, JC; Radoshitzky, SR; Bailey, AL; Lauck, M; Goldberg, TL; O'Connor, DH; Jahrling, PB; Friedrich, TC; Kuhn, JH				Yu, Shuiqing; Cai, Yingyun; Lyons, Cassandra; Johnson, Reed F.; Postnikova, Elena; Mazur, Steven; Johnson, Joshua C.; Radoshitzky, Sheli R.; Bailey, Adam L.; Lauck, Michael; Goldberg, Tony L.; O'Connor, David H.; Jahrling, Peter B.; Friedrich, Thomas C.; Kuhn, Jens H.			Specific Detection of Two Divergent Simian Arteriviruses Using RNAscope In Situ Hybridization	PLOS ONE			English	Article							RESPIRATORY-SYNDROME-VIRUS; HEMORRHAGIC-FEVER; MACAQUES; DISEASE; TISSUES; RNA; CIRCOVIRUS; INFECTION	Simian hemorrhagic fever (SHF) is an often lethal disease of Asian macaques. Simian hemorrhagic fever virus (SHFV) is one of at least three distinct simian arteriviruses that can cause SHF, but pathogenesis studies using modern methods have been scarce. Even seemingly straightforward studies, such as examining viral tissue and cell tropism in vivo, have been difficult to conduct due to the absence of standardized SHFV-specific reagents. Here we report the establishment of an in situ hybridization assay for the detection of SHFV and distantly related Kibale red colobus virus 1 (KRCV-1) RNA in cell culture. In addition, we detected SHFV RNA in formalin-fixed, paraffin-embedded tissues from an infected rhesus monkey (Macaca mulatta). The assay is easily performed and can clearly distinguish between SHFV and KRCV-1. Thus, if further developed, this assay may be useful during future studies evaluating the mechanisms by which a simian arterivirus with a restricted cell tropism can cause a lethal nonhuman primate disease similar in clinical presentation to human viral hemorrhagic fevers.	[Yu, Shuiqing; Cai, Yingyun; Lyons, Cassandra; Postnikova, Elena; Mazur, Steven; Johnson, Joshua C.; Jahrling, Peter B.; Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD USA; [Johnson, Reed F.; Jahrling, Peter B.] NIAID, Emerging Infect Pathogens Sect, NIH, Frederick, MD USA; [Radoshitzky, Sheli R.] US Army Med Res Inst Infect Dis, Frederick, MD USA; [Bailey, Adam L.; Lauck, Michael; Goldberg, Tony L.; O'Connor, David H.; Friedrich, Thomas C.] Univ Wisconsin, Madison, WI USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; University of Wisconsin System; University of Wisconsin Madison	Kuhn, JH (corresponding author), NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD USA.	kuhnjens@mail.nih.gov	Kuhn, Jens H./B-7615-2011; Radoshitzky, Sheli S/F-2766-2019; Radoshitzky, Sheli/L-8410-2019	Kuhn, Jens H./0000-0002-7800-6045; Radoshitzky, Sheli/0000-0001-8976-8056; Cai, Yingyun/0000-0002-1101-0920; Johnson, Joshua/0000-0002-5677-3841; Friedrich, Thomas/0000-0001-9831-6895	Battelle Memorial Institute's prime contract the US National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200700016I]; Battelle Memorial Institute; Tunnell Government Services; MRIGlobal; NIAID Division of Intramural Research; National Institutes of Health (NIH) [TW009237, R01 AI077376]; Office of Research Infrastructure Programs (ORIP) [P51OD011106]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIDAI009006, ZIAAI001025] Funding Source: NIH RePORTER	Battelle Memorial Institute's prime contract the US National Institute of Allergy and Infectious Diseases (NIAID); Battelle Memorial Institute; Tunnell Government Services; MRIGlobal; NIAID Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research Infrastructure Programs (ORIP); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The content of this publication does not necessarily reflect the views or policies of the US Department of Defense, the US Department of Health and Human Services, the US Department of the Army, or the institutions and companies affiliated with the authors. This work was funded in part through Battelle Memorial Institute's prime contract the US National Institute of Allergy and Infectious Diseases (NIAID) under Contract No. HHSN272200700016I (S.Y., Y.C., C.L., E.P., S.M., J.C.J., P.B.J., J.H.K.). S.Y. and J.C.J. performed this work as employees of Battelle Memorial Institute. Subcontractors to Battelle Memorial Institute who performed this work are: Y.C., C.L., E.P., and J.H.K, employees of Tunnell Government Services, Inc.; and S.M., an employee of MRIGlobal. Battelle Memorial Institute, Tunnell Government Services, and MRIGlobal provided support in the form of salaries, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All work under contract HHSN272200700016I is performed under the agreement/understanding that it will belong to the client and will be affiliated directly to the NIH/NIAID Integrated Research Facility at Fort Detrick. The specific roles of these authors are articulated in the 'author contributions' section. This work was also supported, in part, by the NIAID Division of Intramural Research (R.F.J., P.B.J.), by National Institutes of Health (NIH) grant TW009237 as part of the joint NIH-NSF Ecology of Infectious Disease program, grant R01 AI077376, and by the Office of Research Infrastructure Programs (ORIP) grant P51OD011106 (A.L.B., M.L., T.L.G., D.H.O'C., T.C.F.). These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN AM, 1968, AM J TROP MED HYG, V17, P413, DOI 10.4269/ajtmh.1968.17.413; Bailey AL, 2014, J VIROL, V88, P13231, DOI 10.1128/JVI.02203-14; Bailey AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090714; Bexton S, 2015, EMERG INFECT DIS, V21, P1205, DOI 10.3201/eid2107.150228; Bowling AJ, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400011; Brostoff T, 2014, J VIROL, V88, P12816, DOI [10.1128/JVI.01912-14, 10.1128/jvi.01912-14]; Cai YY, 2015, J VIROL, V89, P844, DOI 10.1128/JVI.02697-14; Hu SP, 2013, TRANSBOUND EMERG DIS, V60, P351, DOI 10.1111/j.1865-1682.2012.01354.x; Johnson RF, 2011, VIROLOGY, V421, P129, DOI 10.1016/j.virol.2011.09.016; Lamers SL, 2015, J NEUROVIROL, DOI [10.1007/s13365-015-0399-v, DOI 10.1007/S13365-015-0399-V]; Lapin B. A., 2015, Voprosy Virusologii, V60, P5; Larochelle R, 1997, J VIROL METHODS, V68, P161, DOI 10.1016/S0166-0934(97)00130-4; Lauck M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00978-14; Lauck M, 2015, J VIROL, V89, P8082, DOI 10.1128/JVI.01046-15; Lauck M, 2013, J VIROL, V87, P688, DOI 10.1128/JVI.02433-12; Lauck M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019056; Trang NT, 2015, J VET DIAGN INVEST, V27, P326, DOI 10.1177/1040638715579260; O'Shannessy DJ, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0156-0; Saravia J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005217; Sirinarumitr T, 2001, J VET DIAGN INVEST, V13, P68, DOI 10.1177/104063870101300113; Stoddard DG, 2015, OTOLARYNG HEAD NECK, V152, P752, DOI 10.1177/0194599815571285; TAURASO NM, 1968, AM J TROP MED HYG, V17, P422, DOI 10.4269/ajtmh.1968.17.422; Vatter HA, 2015, VIROLOGY, V474, P186, DOI 10.1016/j.virol.2014.10.018; Vatter HA, 2014, VIROLOGY, V462, P351, DOI 10.1016/j.virol.2014.06.001; Vatter HA, 2014, J VIROL, V88, P2095, DOI 10.1128/JVI.02633-13; Wahl-Jensen V, 2016, MBIO, V7, DOI 10.1128/mBio.02009-15; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang HW, 2014, METHODS MOL BIOL, V1211, P139, DOI 10.1007/978-1-4939-1459-3_12	28	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151313	10.1371/journal.pone.0151313	http://dx.doi.org/10.1371/journal.pone.0151313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963736	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000136
J	Bianchi, CM; Mariotti, F; Verger, EO; Huneau, JF				Bianchi, Clelia M.; Mariotti, Francois; Verger, Eric O.; Huneau, Jean-Francois			Pregnancy Requires Major Changes in the Quality of the Diet for Nutritional Adequacy: Simulations in the French and the United States Populations	PLOS ONE			English	Article							INDEX; WOMEN; OUTCOMES; ENERGY; RISK	Background Maternal nutrition is critical to the health of both mother and offspring, but there is a paucity of data on the nutritional adequacy of diets during pregnancy. Objective Our objective was to identify to what extent pregnancy reduces the nutritional adequacy of the expecting mother's diet and if this nutritional gap can be resolved by simple quantitative or qualitative changes in the diet. Materials and Methods We evaluated the observed overall nutritional adequacy of diets of French and American women of childbearing age participating in ENNS (n = 344) and NHANES (n = 563) using the probabilistic approach of the PANDiet system, resulting in a 100-point score. Then, we simulated the changes in the PANDiet scores of women of childbearing age who would remain on their diet during pregnancy. Finally, by either increasing the quantity of consumed foods or using eleven snacks recommended during pregnancy, we simulated the effect of a 150-kcal increase in the energy intake of French women. Results Observed PANDiet scores were equal to 59.3 +/- 7.0 and 58.8 +/- 9.3 points respectively in France and in the US. Simulation of pregnancy for women of childbearing age led to a decrease in nutritional adequacy for key nutrients during pregnancy and resulted in reducing PANDiet scores by 3.3 +/- 0.1 and 3.7 +/- 0.1 points in France and in the US. Simulated 150-kcal increases in energy intake proved to be only partially effective in filling the gap both when the quantity of food consumed was increased and when recommended snacks were used. Conclusions The decrease in nutritional adequacy induced by pregnancy cannot be addressed by simply following generic dietary guidelines.	[Bianchi, Clelia M.; Mariotti, Francois; Huneau, Jean-Francois] Univ Paris Saclay, INRA, AgroParisTech, UMR Physiol Nutr & Comportement Alimentaire, F-75005 Paris, France; [Verger, Eric O.] INSERM, UMR S U1166, Nutr Team, F-75013 Paris, France; [Verger, Eric O.] Hop La Pitie Salpetriere, AP HP, ICAN, Inst Cardiometab & Nutr, F-75013 Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Mariotti, F (corresponding author), Univ Paris Saclay, INRA, AgroParisTech, UMR Physiol Nutr & Comportement Alimentaire, F-75005 Paris, France.	francois.mariotti@agroparistech.fr	Mariotti, François/F-9651-2017; Verger, Eric/J-9163-2016	Mariotti, François/0000-0002-4516-3853; Verger, Eric/0000-0002-8689-8290	Fonds Francais Alimentation Sante	Fonds Francais Alimentation Sante	This study was conducted with the framework of the ECAP project (http://alimentation-sante.org/aap2013projet2-2/) supported by a grant from the Fonds Francais Alimentation & Sante (FFAS: http://alimentation-sante.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Agence frangaise de securite sanitaire des aliments, 2001, APP NUTR CONS POP FR; Agence nationale de securite sanitaire de l'alimentation de l'environnement et du travail, 2011, ACT APP NUTR CONS AC, P323; Agence nationale de securite sanitaire de l'alimentation de l'environnement et du travail, 2013, TABL CIQ 2013 COMP N; Alwan NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084684; Arnault N, 2005, TABLE COMPOSITION AL; Bath SC, 2013, LANCET, V382, P331, DOI 10.1016/S0140-6736(13)60436-5; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Blumfield ML, 2013, NUTR REV, V71, P118, DOI 10.1111/nure.12003; Blumfield ML, 2012, AM J CLIN NUTR, V96, P1032, DOI 10.3945/ajcn.111.033241; Blumfield ML, 2012, NUTR REV, V70, P322, DOI 10.1111/j.1753-4887.2012.00481.x; Bodnar LM, 2002, PUBLIC HEALTH NUTR, V5, P801, DOI 10.1079/PHN2002348; Bresson J, 2001, APPORTS NUTR CONSEIL, P293; Carmichael SL, 2003, MED HYPOTHESES, V60, P351, DOI 10.1016/S0306-9877(02)00402-4; Castetbon K, 2009, BRIT J NUTR, V102, P733, DOI 10.1017/S0007114509274745; Christian P, 2010, J NUTR, V140, P437, DOI 10.3945/jn.109.116327; Commission of the European Communities, 1993, NUTR EN INT EUR COMM, P12; Dean SV, 2014, REPROD HEALTH, V11, DOI [10.1186/1742-4755-11-S3-S1, 10.1186/1742-4755-11-S3-S3]; Dore N, 2014, MIEUX VIVRE AVEC NOT, P37; Food and Nutrition Board: Institute of Medicine, 2006, DIETARY REFERENCE IN, P82; Food and Nutrition Service-United States Department of Agriculture, 2013, TIPS PREGN WOM; Food Nutrition Board, 2006, DIETARY REFERENCE IN; Gresham E, 2014, AM J CLIN NUTR, V100, P1298, DOI 10.3945/ajcn.113.080655; Grieger JA, 2014, J NUTR, V144, P1075, DOI 10.3945/jn.114.190686; Hercberg S, 2002, SUVIMAX PORTIONS ALI, P132; Institut National de Prevention pour l'Education et la Sante, 2007, GUID NUTR PEND APR G; Johnson C.L., 2013, ANAL GUIDEL, P1999; Laraia BA, 2007, PUBLIC HLTH NUTR, V10; Larque E, 2012, BRIT J NUTR, V107, pS77, DOI 10.1017/S0007114512001481; Mariscal-Arcas M, 2009, BRIT J NUTR, V102, P744, DOI 10.1017/S0007114509274769; Melere C, 2013, REV SAUDE PUBL, V47, P20, DOI 10.1590/S0034-89102013000100004; National Health Service, 2013, HLTH DIET PREGN PREG; Nordic Co-operation, 2008, NORD NUTR REC 2012, P161; Pick ME, 2005, J AM DIET ASSOC, V105, P240, DOI 10.1016/j.jada.2004.11.028; Pinto E, 2009, PUBLIC HEALTH NUTR, V12, P922, DOI 10.1017/S1368980008003595; Societe Suisse de Nutrition, 2011, AL FEMM ENC; Szwajcer E, 2012, FAM PRACT, V29, pi82, DOI 10.1093/fampra/cmr107; U.S. Department of Agriculture Agricultural Research Service, 2012, USDA FOOD NUTR DAT D; U.S. Department of Agriculture Agriculture Research Service, 2014, USDA NAT NUTR DAT ST; United Nations University World Health Organization Food and Agriculture Organization, 2001, HUM EN REQ REP JOINT; van Eijsden M, 2008, AM J CLIN NUTR, V87, P887, DOI 10.1093/ajcn/87.4.887; Vannice G, 2014, J ACAD NUTR DIET, V114, P136, DOI 10.1016/j.jand.2013.11.001; Verger EO, 2014, J NUTR, V144, P929, DOI 10.3945/jn.113.188284; Verger EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042155; Zipf G, 2013, VITAL HLTH STAT, V56, P1	45	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149858	10.1371/journal.pone.0149858	http://dx.doi.org/10.1371/journal.pone.0149858			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959492	Green Published, gold			2022-12-27	WOS:000371992300026
J	Ghiwot, TT; Sime, AG; Sime, AG; Tafese, W; Hajito, KW; Gemeda, DH				Ghiwot, Tsegaye Tewelde; Sime, Abiot Girma; Deresa, Benti; Tafese, Wubit; Hajito, Kifle Weldemichael; Gemeda, Desta Hiko			Community Health Seeking Behavior for Suspected Human and Animal Rabies Cases, Gomma District, Southwest Ethiopia	PLOS ONE			English	Article							ELIMINATE RABIES; CANINE RABIES; SURVEILLANCE; DISEASES; AFRICA; BURDEN	Background Timely presentation to appropriate health service provider of sick animals/humans from zoonotic diseases like rabies is important for early case/outbreak detection and management. However, data on community's health seeking practice for rabies in Ethiopia is limited. Therefore the objective of this study was to determine community's health seeking behavior on rabies, Southwest Ethiopia. Methods A cross-sectional survey was conducted from January 16-February 14, 2015 to collect data from 808 respondents where the respondents were selected using multistage sampling technique. Data were collected using interviewer administered structured questionnaire by trained epidemiology graduate level students. Data were entered to Epidata version 3.1 and analyzed using SPSS version 20 for windows. Result Eight hundred three (99.4%) respondents participated in the study. Out of 28 respondents who reported their family members' exposure to rabies, 8 of them replied that the exposed family members sought treatment from traditional healers. More than nine in ten respondents perceived that humans and domestic animals with rabies exposure should seek help of which 85% of them suggested modern health care facilities as the preferred management option for the sick humans and domestic animals. However, among those who reported sick domestic animals, near to 72% of them had either slaughtered for human consumption, sold immediately, visited traditional healer, given home care or did nothing for the sick domestic animals. Conclusion Majority of the respondents had favorable perception of seeking treatment from modern health care facilities for rabies. However, significant number of them had managed inappropriately for the sick domestic animals from rabies. Hence, raising awareness of the community about management of sick domestic animals from rabies and the need for reporting to both human and animal health service providers is needed.	[Ghiwot, Tsegaye Tewelde; Sime, Abiot Girma; Hajito, Kifle Weldemichael; Gemeda, Desta Hiko] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Epidemiol & Biostat, Jimma, Ethiopia; [Deresa, Benti; Tafese, Wubit] Jimma Univ, Coll Vet Med & Agr, Dept Vet Med, Jimma, Ethiopia	Jimma University; Jimma University	Ghiwot, TT (corresponding author), Jimma Univ, Coll Publ Hlth & Med Sci, Dept Epidemiol & Biostat, Jimma, Ethiopia.	tsegaye.tewelde@yahoo.com		Gemeda, Desta/0000-0002-7799-6550; /0000-0003-4845-715X	One Health Central and Eastern Africa (OHCEA) [0714/16 / Surveillance System-16]	One Health Central and Eastern Africa (OHCEA)	The source of financial fund was from One Health Central and Eastern Africa (OHCEA) with a grant number of 0714/16 / Surveillance System-16, website: (ohcea.org) and AG receives the fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHOMEL B, 1988, REV INFECT DIS, V10, pS697; de Balogh K, 2013, REV SCI TECH OIE, V32, P539; Dedmon R, 2010, INT J INFECT DIS, V14, pE159, DOI 10.1016/j.ijid.2010.02.1833; Gino CM, 2007, ENVIRON HEALTH PREV, V12, P84, DOI [10.1007/BF02898154, DOI 10.1007/BF02898154]; HENDERSON DA, 1976, INT J EPIDEMIOL, V5, P19, DOI 10.1093/ije/5.1.19; Henderson DA, 1970, NEW DELH INT SEM SUR, P3; Jemal S, 2014, THESIS MEKELLE U; Kabeta T, 2013, THESIS JIMMA U; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Lapiz SMD, PLOS NEGLEC IN PRESS; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Maudlin I, 2009, PHILOS T R SOC B, V364, P2777, DOI 10.1098/rstb.2009.0067; Rashid R, BASELINE ASSESSMENT, DOI [10.1016/j.ijid.2008.05.1285, DOI 10.1016/J.IJID.2008.05.1285]; Sambo M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003310; Schneider M C, 2005, Epidemiol Bull, V26, P2; Townsend SE, 2013, COMP IMMUNOL MICROB, V36, P249, DOI 10.1016/j.cimid.2012.10.008; Yin WW, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-23	18	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149363	10.1371/journal.pone.0149363	http://dx.doi.org/10.1371/journal.pone.0149363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959816	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300010
J	Amaral, KE; Palace, M; O'Brien, KM; Fenderson, LE; Kovach, AI				Amaral, Katrina E.; Palace, Michael; O'Brien, Kathleen M.; Fenderson, Lindsey E.; Kovach, Adrienne I.			Anthropogenic Habitats Facilitate Dispersal of an Early Successional Obligate: Implications for Restoration of an Endangered Ecosystem	PLOS ONE			English	Article							GENETIC POPULATION-STRUCTURE; NEW-ENGLAND COTTONTAIL; LEAST-COST PATH; RESISTANCE SURFACES; LANDSCAPE GENETICS; CIRCUIT-THEORY; SCALE; FLOW; CONNECTIVITY; DIFFERENTIATION	Landscape modification and habitat fragmentation disrupt the connectivity of natural landscapes, with major consequences for biodiversity. Species that require patchily distributed habitats, such as those that specialize on early successional ecosystems, must disperse through a landscape matrix with unsuitable habitat types. We evaluated landscape effects on dispersal of an early successional obligate, the New England cottontail (Sylvilagus transitionalis). Using a landscape genetics approach, we identified barriers and facilitators of gene flow and connectivity corridors for a population of cottontails in the northeastern United States. We modeled dispersal in relation to landscape structure and composition and tested hypotheses about the influence of habitat fragmentation on gene flow. Anthropogenic and natural shrubland habitats facilitated gene flow, while the remainder of the matrix, particularly development and forest, impeded gene flow. The relative influence of matrix habitats differed between study areas in relation to a fragmentation gradient. Barrier features had higher explanatory power in the more fragmented site, while facilitating features were important in the less fragmented site. Landscape models that included a simultaneous barrier and facilitating effect of roads had higher explanatory power than models that considered either effect separately, supporting the hypothesis that roads act as both barriers and facilitators at all spatial scales. The inclusion of LiDAR-identified shrubland habitat improved the fit of our facilitator models. Corridor analyses using circuit and least cost path approaches revealed the importance of anthropogenic, linear features for restoring connectivity between the study areas. In fragmented landscapes, human-modified habitats may enhance functional connectivity by providing suitable dispersal conduits for early successional specialists.	[Amaral, Katrina E.; Palace, Michael; Kovach, Adrienne I.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA; [Palace, Michael] Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; [O'Brien, Kathleen M.] US Fish & Wildlife Serv, Rachel Carson Natl Wildlife Refuge, Wells, ME USA; [Fenderson, Lindsey E.] US Fish & Wildlife Serv, Northeast Fishery Ctr, Conservat Genet Lab, Lamar, PA USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service	Kovach, AI (corresponding author), Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA.	akovach@unh.edu	Fenderson, Lindsey/W-9698-2019	Fenderson, Lindsey/0000-0002-2921-6636; Kovach, Adrienne/0000-0002-6791-0610	United States Fish and Wildlife Service, Region 5, Division of Natural Resources, National Wildlife Refuge System; Maine Outdoor Heritage Fund; National Science Foundation (GSS Grant) [1263601]; USDA National Institute of Food and Agriculture through its McIntire-Stennis Project [225575]; New Hampshire Agricultural Experiment Station	United States Fish and Wildlife Service, Region 5, Division of Natural Resources, National Wildlife Refuge System; Maine Outdoor Heritage Fund; National Science Foundation (GSS Grant); USDA National Institute of Food and Agriculture through its McIntire-Stennis Project; New Hampshire Agricultural Experiment Station	Funding for this research was provided by the United States Fish and Wildlife Service, Region 5, Division of Natural Resources, National Wildlife Refuge System; Maine Outdoor Heritage Fund; the National Science Foundation (GSS Grant #1263601); the USDA National Institute of Food and Agriculture through its McIntire-Stennis Project Number 225575; and the New Hampshire Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or peparation of the manuscript.; Funding for this research was provided by the United States Fish and Wildlife Service, Region 5, Division of Natural Resources, National Wildlife Refuge System; Maine Outdoor Heritage Fund; the National Science Foundation (GSS Grant # 1263601); the USDA National Institute of Food and Agriculture-through its McIntire-Stennis Project Number 225575; and the New Hampshire Agricultural Experiment Station. Thanks to J. Walsh and S. Coster for their help with ArcGIS troubleshooting and M. Routhier for providing computational space for Circuits-cape models. Thanks also to D. Hocking and W. Peterman for statistical consultation. K. Boland and W. Jakubas provided input on landscape variables and cottontail occupancy. J. Walsh, T. Kristensen, B. Benvenuti, and C. Mills provided helpful suggestions on an earlier version of this manuscript. This is Scientific Contribution Number 2651 of the New Hampshire Agricultural Experiment Station. The findings and conclusions of this article are those of the authors and do not necessarily represent the views of the United States Fish and Wildlife Service.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Angelone S, 2011, ECOGRAPHY, V34, P714, DOI 10.1111/j.1600-0587.2010.06494.x; Balkenhol N, 2009, MOL ECOL, V18, P4151, DOI 10.1111/j.1365-294X.2009.04322.x; Balkenhol N, 2009, ECOGRAPHY, V32, P818, DOI 10.1111/j.1600-0587.2009.05807.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beier P, 2009, ECOL APPL, V19, P2067, DOI 10.1890/08-1898.1; Bissonette JA, 2009, ECOL SOC, V14; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Braunisch V, 2010, MOL ECOL, V19, P3664, DOI 10.1111/j.1365-294X.2010.04703.x; Brooks RT, 2003, FOREST ECOL MANAG, V185, P65, DOI 10.1016/S0378-1127(03)00246-9; Brubaker DR, 2014, WILDLIFE SOC B, V38, P513, DOI 10.1002/wsb.416; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Centeno-Cuadros A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024613; Crispo E, 2011, BIOESSAYS, V33, P508, DOI 10.1002/bies.201000154; Crooks K. R., 2006, CONNECTIVITY CONSERV; Cushman SA, 2010, MOL ECOL, V19, P3952; Cushman Samuel A., 2013, Diversity-Basel, V5, P51; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Etherington TR, 2011, METHODS ECOL EVOL, V2, P52, DOI 10.1111/j.2041-210X.2010.00048.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fenderson LE, 2014, ECOL EVOL, V4, P1853, DOI 10.1002/ece3.1068; Fenderson LE, 2011, CONSERV GENET, V12, P943, DOI 10.1007/s10592-011-0197-x; Ficetola GF, 2014, INT J GEOGR INF SCI, V28, P1723, DOI 10.1080/13658816.2014.891222; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Frantz AC, 2010, MOL ECOL, V19, P1663, DOI 10.1111/j.1365-294X.2010.04605.x; Gabrielsen CG, 2013, CONSERV GENET, V14, P1083, DOI 10.1007/s10592-013-0497-4; Gillies CS, 2008, PNAS, V105, P18774; Goetz SJ, 2010, ECOLOGY, V91, P1569, DOI 10.1890/09-1670.1; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Graf RF, 2009, FOREST ECOL MANAG, V257, P160, DOI 10.1016/j.foreco.2008.08.021; Graves TA, 2013, MOL ECOL, V22, P3888, DOI 10.1111/mec.12348; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Holderegger R, 2010, BASIC APPL ECOL, V11, P522, DOI 10.1016/j.baae.2010.06.006; Holzhauer SIJ, 2006, LANDSCAPE ECOL, V21, P891, DOI 10.1007/s10980-005-0438-9; Howey MCL, 2011, J ARCHAEOL SCI, V38, P2523, DOI 10.1016/j.jas.2011.03.024; Hudak AT, 2009, REMOTE SENS-BASEL, V1, P934, DOI 10.3390/rs1040934; Keller D, 2013, MOL ECOL, V22, P2467, DOI 10.1111/mec.12265; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; King DI, 2014, FOREST ECOL MANAG, V324, P186, DOI 10.1016/j.foreco.2013.12.001; Kuefler D, 2010, ECOLOGY, V91, P944, DOI 10.1890/09-0614.1; LaPoint S, 2013, LANDSCAPE ECOL, V28, P1615, DOI 10.1007/s10980-013-9910-0; Laurence S, 2013, ECOL EVOL, V3, P3524, DOI 10.1002/ece3.741; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Litvaitis JA, 2003, FOREST ECOL MANAG, V185, P113, DOI 10.1016/S0378-1127(03)00250-0; Litvaitis JA, 2003, WILDLIFE SOC B, V24, P686; Litvaitis JA, 2006, WILDLIFE SOC B, V34, P1190, DOI 10.2193/0091-7648(2006)34[1190:ARSTDT]2.0.CO;2; Lorimer CG, 2003, FOREST ECOL MANAG, V185, P41, DOI 10.1016/S0378-1127(03)00245-7; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Mazerolle MJ, 2012, AICCMODAVG MODEL SEL; McGaughey R., 2009, FUSION LDV SOFTWARE; McRae B., 2009, CIRCUITSCAPE USER GU; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; MDIFW, 2007, REC CHANG MAIN LIST; Mullen LB, 2010, MOL ECOL, V19, P898, DOI 10.1111/j.1365-294X.2010.04541.x; NHFG, 2008, END THREAT WILDL NEW; Palace MW, 2015, REMOTE SENS ENVIRON, V161, P1, DOI 10.1016/j.rse.2015.01.020; Pereoglou F, 2013, MOL ECOL, V22, P1267, DOI 10.1111/mec.12172; Perez-Espona S, 2008, MOL ECOL, V17, P981, DOI 10.1111/j.1365-294X.2007.03629.x; Peterman WE, 2014, MOL ECOL, V23, P2402, DOI 10.1111/mec.12747; Pinto N, 2009, LANDSCAPE ECOL, V24, P253, DOI 10.1007/s10980-008-9303-y; Poor EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049390; R Development Core Team, 2005, R LANG ENV STAT COMP; Razgour O, 2014, DIVERS DISTRIB, V20, P1173, DOI 10.1111/ddi.12200; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Roever CL, 2013, BIOL CONSERV, V157, P128, DOI 10.1016/j.biocon.2012.06.025; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Row JR, 2010, MOL ECOL, V19, P5157, DOI 10.1111/j.1365-294X.2010.04872.x; Sackett LC, 2012, CONSERV GENET, V13, P407, DOI 10.1007/s10592-011-0293-y; Schlossberg S., 2007, ECOLOGY MANAGEMENT S; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; Shah V.B.., 2008, PROC 7 PYTHON SCI C, V7, P62; Shirk AJ, 2010, MOL ECOL, V19, P3603, DOI 10.1111/j.1365-294X.2010.04745.x; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Tash JP, 2007, BIOL CONSERV, V137, P584, DOI 10.1016/j.biocon.2007.03.017; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; Underhill J. E., 2000, Environmental Reviews, V8, P21, DOI 10.1139/er-8-1-21; Van Strien MJ, 2012, MOL ECOL, V21, P4010, DOI 10.1111/j.1365-294X.2012.05687.x; Wang YH, 2008, LANDSCAPE ECOL, V23, P989, DOI 10.1007/s10980-008-9262-3; Weckworth BV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1756; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	88	28	29	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0148842	10.1371/journal.pone.0148842	http://dx.doi.org/10.1371/journal.pone.0148842			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954014	Green Published, gold			2022-12-27	WOS:000371991300004
J	Aziz, S; Wik, E; Knutsvik, G; Klingen, TA; Chen, Y; Davidsen, B; Aas, H; Aas, T; Akslen, LA				Aziz, Sura; Wik, Elisabeth; Knutsvik, Goril; Klingen, Tor Audun; Chen, Ying; Davidsen, Benedicte; Aas, Hans; Aas, Turid; Akslen, Lars A.			Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer	PLOS ONE			English	Article							NOTTINGHAM PROGNOSTIC INDEX; DECISION-MAKING; KI67 EXPRESSION; BIOMARKERS; THERAPY; PROGESTERONE; DISCORDANCE; INFORMATION; CARCINOMA; RECEPTOR	Few studies have addressed the risk of recurrence by assessing proliferation markers in lymph node metastasis from breast cancer. Here, we aimed to examine Ki-67 expression and mitotic count in lymph nodes in comparison with primary tumors. A cohort of node positive breast cancer (n = 168) was studied as a part of the prospective Norwegian Breast Cancer Screening Program (1996-2009). The percentage of Ki-67 positivity was counted per 500 tumor cells in hot-spot areas (x630). Mitotic count was conducted in the most cellular and mitotic active areas in 10 high power fields (x400). Our results showed that Ki-67 and mitotic count were significantly correlated between primary tumor and lymph nodes (Spear-man's correlation 0.56 and 0.46, respectively) and were associated with most of the histologic features of the primary tumor. Univariate survival analysis (log-rank test) showed that high Ki-67 and mitotic count in the primary tumor and lymph node metastasis significantly predicted risk of recurrence. In multivariate analysis, mitotic count in the lymph node metastasis was an independent predictor of tumor recurrence. In conclusion, proliferation markers in lymph node metastases significantly predicted disease free survival in node positive breast cancer.	[Aziz, Sura; Wik, Elisabeth; Knutsvik, Goril; Klingen, Tor Audun; Chen, Ying; Akslen, Lars A.] Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Sect Pathol, Bergen, Norway; [Aziz, Sura; Wik, Elisabeth; Knutsvik, Goril; Akslen, Lars A.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Klingen, Tor Audun] Vestfold Hosp Trust, Dept Pathol, Tonsberg, Norway; [Chen, Ying] Akershus Univ Hosp, Dept Pathol, Lorenskog, Norway; [Davidsen, Benedicte; Aas, Turid] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway; [Aas, Hans] Vestfold Hosp Trust, Dept Surg, Tonsberg, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo; University of Bergen; Haukeland University Hospital	Akslen, LA (corresponding author), Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Sect Pathol, Bergen, Norway.; Akslen, LA (corresponding author), Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway.	lars.akslen@uib.no	Akslen, Lars A./AAG-6097-2021; Wik, E./AAA-9105-2020; Akslen, Lars A/C-1202-2017	Akslen, Lars A./0000-0003-2710-9543; Akslen, Lars A/0000-0003-2710-9543	Research Council of Norway through Centre of Excellence funding scheme [223250]; Norwegian Cancer Society; Helse Vest RHF; Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen and Vestfold Hospital Research Fund	Research Council of Norway through Centre of Excellence funding scheme(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Helse Vest RHF; Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen and Vestfold Hospital Research Fund	This work was partly supported by the Research Council of Norway through its Centre of Excellence funding scheme, project number 223250. The study was also supported by the Norwegian Cancer Society, Helse Vest RHF, and the Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen and Vestfold Hospital Research Fund.	Amir E, 2012, J CLIN ONCOL, V30, P587, DOI 10.1200/JCO.2010.33.5232; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Chen Y, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0230-8; Cserni G, 2008, J CLIN PATHOL, V61, P115, DOI 10.1136/jcp.2007.047357; Cserni G, 2005, HISTOPATHOLOGY, V46, P697, DOI 10.1111/j.1365-2559.2005.02143.x; Cserni G, 2007, BREAST, V16, P152, DOI 10.1016/j.breast.2006.07.004; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Dowsett M, 2008, CLIN CANCER RES, V14, P8019, DOI 10.1158/1078-0432.CCR-08-0974; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Falato C, 2014, BREAST CANCER RES TR, V147, P407, DOI 10.1007/s10549-014-3096-2; Falck AK, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-558; Falck AK, 2013, BREAST CANCER RES TR, V140, P93, DOI 10.1007/s10549-013-2617-8; Falck AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-403; Falck AK, 2010, WORLD J SURG, V34, P1434, DOI 10.1007/s00268-010-0499-z; Gabor C, 2014, ORVOSI HETILAP, V155, P203, DOI 10.1556/OH.2014.29816; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Group NBC, 2013, OV NBCGS RETN ADJ SY; Gudlaugsson E, 2013, POL J PATHOL, V64, P1, DOI 10.5114/PJP.2013.34596; Hasebe T, 2011, HUM PATHOL, V42, P1823, DOI 10.1016/j.humpath.2011.02.015; Ibrahim T, 2013, ONCOLOGY-BASEL, V84, P150, DOI 10.1159/000345795; Inwald EC, 2013, BREAST CANCER RES TR, V139, P539, DOI 10.1007/s10549-013-2560-8; Klingen TA, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-80; Knutsvik G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112121; Koda M, 2004, ONCOL REP, V11, P753; Koda M, 2007, ONCOL REP, V18, P113; Lee AHS, 2008, PATHOL ONCOL RES, V14, P113, DOI 10.1007/s12253-008-9067-3; Ogba N, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0489-4; Pathmanathan N, 2013, J CLIN PATHOL, V66, P512, DOI 10.1136/jclinpath-2012-201085; Petrelli F, 2015, BREAST CANC RES TREA; Rakha EA, 2014, BRIT J CANCER, V110, P1688, DOI 10.1038/bjc.2014.120; Rampaul RS, 2001, EUR J SURG ONCOL, V27, P229, DOI 10.1053/ejso.2001.1114; Rocca A, 2015, BREAST CANCER RES TR, V152, P57, DOI 10.1007/s10549-015-3423-2; Rossi S, 2015, CLIN BREAST CANC; Senol EP, 2013, BRATISL MED J, V114, P645, DOI 10.4149/BLL_2013_138; Sheri A, 2012, ANN ONCOL, V23, P219, DOI 10.1093/annonc/mds307; Skibinski A, 2015, ONCOGENE, V34, P5309, DOI 10.1038/onc.2014.475; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tawfik K, 2013, HUM PATHOL, V44, P39, DOI 10.1016/j.humpath.2012.05.007; VANDIEST PJ, 1991, J CLIN PATHOL, V44, P416, DOI 10.1136/jcp.44.5.416; WEIDNER N, 1994, HUM PATHOL, V25, P337, DOI 10.1016/0046-8177(94)90140-6; Yao ZX, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0798-y; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	42	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150979	10.1371/journal.pone.0150979	http://dx.doi.org/10.1371/journal.pone.0150979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954367	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300066
J	Carriedo, N; Corral, A; Montoro, PR; Herrero, L; Ballestrino, P; Sebastian, I				Carriedo, Nuria; Corral, Antonio; Montoro, Pedro R.; Herrero, Laura; Ballestrino, Patricia; Sebastian, Iraia			The Development of Metaphor Comprehension and Its Relationship with Relational Verbal Reasoning and Executive Function	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; METONYMY COMPREHENSION; WORKING-MEMORY; CHILDREN	Our main objective was to analyse the different contributions of relational verbal reasoning (analogical and class inclusion) and executive functioning to metaphor comprehension across development. We postulated that both relational reasoning and executive functioning should predict individual and developmental differences. However, executive functioning would become increasingly involved when metaphor comprehension is highly demanding, either because of the metaphors' high difficulty (relatively novel metaphors in the absence of a context) or because of the individual's special processing difficulties, such as low levels of reading experience or low semantic knowledge. Three groups of participants, 11-year-olds, 15-year-olds and young adults, were assessed in different relational verbal reasoning tasks-analogical and class-inclusion-and in executive functioning tasks-updating information in working memory, inhibition, and shifting. The results revealed clear progress in metaphor comprehension between ages 11 and 15 and between ages 15 and 21. However, the importance of executive function in metaphor comprehension was evident by age 15 and was restricted to updating information in working memory and cognitive inhibition. Participants seemed to use two different strategies to interpret metaphors: relational verbal reasoning and executive functioning. This was clearly shown when comparing the performance of the "more efficient" participants in metaphor interpretation with that of the "less efficient" ones. Whereas in the first case none of the executive variables or those associated with relational verbal reasoning were significantly related to metaphor comprehension, in the latter case, both groups of variables had a clear predictor effect.	[Carriedo, Nuria; Corral, Antonio; Ballestrino, Patricia; Sebastian, Iraia] Natl Distance Educ Univ UNED, Dept Psicol Evolut & Educ, Madrid, Spain; [Montoro, Pedro R.] Natl Distance Educ Univ UNED, Dept Psicol Basica 1, Madrid, Spain; [Herrero, Laura] Camilo Jose Cela Univ, Fac Educ, Madrid, Spain	Universidad Nacional de Educacion a Distancia (UNED); Universidad Nacional de Educacion a Distancia (UNED); Camilo Jose Cela University	Carriedo, N (corresponding author), Natl Distance Educ Univ UNED, Dept Psicol Evolut & Educ, Madrid, Spain.	ncarriedo@psi.uned.es	Herrero, Laura/ACB-3563-2022; CARRIEDO, NURIA/D-1336-2012; Montoro, Pedro R. R/B-2270-2014; Corral, Antonio/K-4288-2017	Herrero, Laura/0000-0002-9526-8725; CARRIEDO, NURIA/0000-0003-2719-6333; Montoro, Pedro R. R/0000-0002-5665-8587; Corral, Antonio/0000-0002-0069-4642	Ministerio de Economia y Competitividad [EDU2011-22699]; Secretaria de Estado de Investigacion, Desarrollo e Innovacion;  [MINECO EDU2011-22699]	Ministerio de Economia y Competitividad(Spanish Government); Secretaria de Estado de Investigacion, Desarrollo e Innovacion; 	Support was provided by the Ministerio de Economia y Competitividad EDU2011-22699 and Secretaria de Estado de Investigacion, Desarrollo e Innovacion.; We would like to thank Pilar Pozo for her help in data collection and the students and teachers who collaborated in this research. This work was financially supported by project MINECO EDU2011-22699. We want to thank Paula Rubio-Fernandez and an anonymous reviewer for their valuable suggestions.	BILLOW RM, 1975, DEV PSYCHOL, V11, P415, DOI 10.1037/h0076668; BLASKO DG, 1993, J EXP PSYCHOL LEARN, V19, P295, DOI 10.1037/0278-7393.19.2.295; Blasko DG, 1999, J PRAGMATICS, V31, P1675, DOI 10.1016/S0378-2166(99)00009-0; Bowdle BF, 2005, PSYCHOL REV, V112, P193, DOI 10.1037/0033-295X.112.1.193; Carriedo N, 2016, DEV PSYCHOL, V52, P666, DOI 10.1037/dev0000091; Carston R, 2011, LANG COGN, V3, P283, DOI 10.1515/LANGCOG.2011.010; Chiappe DL, 2007, J MEM LANG, V56, P172, DOI 10.1016/j.jml.2006.11.006; Christ SE, 2006, DEV NEUROPSYCHOL, V30, P845, DOI 10.1207/s15326942dn3003_5; COMETA MS, 1978, CHILD DEV, V49, P649, DOI 10.2307/1128232; Coney J, 2006, CURR PSYCHOL, V25, P93, DOI 10.1007/s12144-006-1006-4; De Beni R, 2004, MEMORY, V12, P75, DOI 10.1080/09658210244000568; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; GENTNER D, 1988, CHILD DEV, V59, P47, DOI 10.2307/1130388; Gentner D, 1988, ANALOGICAL REASONING, P171, DOI DOI 10.1007/978-94-015-7811-0_8; Gernsbacher MA, 2001, J MEM LANG, V45, P433, DOI 10.1006/jmla.2000.2782; GLUCKSBERG S, 1990, PSYCHOL REV, V97, P3, DOI 10.1037/0033-295X.97.1.3; Glucksberg S, 1997, J MEM LANG, V36, P50, DOI 10.1006/jmla.1996.2479; Glucksberg S., 2001, METAPHOR SYMBOL, V16, P277, DOI [DOI 10.1080/10926488.2001.9678898, 10.1080/10926488.2001.9678898]; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; JOHNSON J, 1989, J EXP CHILD PSYCHOL, V48, P1, DOI 10.1016/0022-0965(89)90038-6; JOHNSON J, 1993, APPL PSYCHOLINGUIST, V14, P159, DOI 10.1017/S014271640000953X; Kazmerski VA, 2003, MEM COGNITION, V31, P673, DOI 10.3758/BF03196107; KEIL FC, 1986, COGNITIVE DEV, V1, P73, DOI 10.1016/S0885-2014(86)80024-7; Lechuga MT, 2006, ACTA PSYCHOL, V123, P279, DOI 10.1016/j.actpsy.2006.01.006; Mashal N, 2011, RES DEV DISABIL, V32, P2045, DOI 10.1016/j.ridd.2011.08.012; MEDNICK SA, 1962, PSYCHOL REV, V69, P220, DOI 10.1037/h0048850; Miller G. A., 1979, METAPHOR THOUGHT, P202, DOI DOI 10.1017/CBO9781139173865.019; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MOOD AM, 1971, AM EDUC RES J, V8, P191, DOI 10.3102/00028312008002191; Munro S., 2006, COGN NEUR SOC ANN M; Nall SL, 1983, THESIS WAKE FOREST U; ORTONY A, 1979, PSYCHOL REV, V86, P161, DOI 10.1037/0033-295X.86.3.161; Ozcaliskan S, 2005, COGN LINGUIST, V16, P207, DOI 10.1515/cogl.2005.16.1.207; Paivio A., 1979, METAPHOR THOUGHT, P150; Pouscoulous N., 2011, BELGIAN J LINGUISTIC, V25, P51, DOI DOI 10.1075/BJL.25.04POU; Prat CS, 2012, J EXP PSYCHOL LEARN, V38, P282, DOI 10.1037/a0026037; Prat CS, 2011, CEREB CORTEX, V21, P1747, DOI 10.1093/cercor/bhq241; Recanati F, 2004, LITERAL MEANING; Reyna V. F., 1996, METAPHOR IMPLICATION, P39; REYNA VF, 1995, METAPHOR SYMB ACT, V10, P309, DOI 10.1207/s15327868ms1004_5; Rubio-Fernandez P, 2015, J PSYCHOLINGUISTIC R, P1; Rubio-Fernandez PR, 2007, J SEMANT, V24, P345; Rundblad G, 2010, AUTISM, V14, P29, DOI 10.1177/1362361309340667; Seibold D.R., 1979, HUMAN COMMUNICATION, V5, P355, DOI [DOI 10.1111/J.1468-2958.1979.TB00649.X, 10.1111/j.1468-2958.1979.tb00649.x]; Stemler S.E., 2004, PRACT ASSESS RES EVA, V9; TOURANGEAU R, 1982, COGNITION, V11, P203, DOI 10.1016/0010-0277(82)90016-6; Trick Lana, 1986, METAPHOR SYMBOLIC AC, V1, P185, DOI DOI 10.1207/S15327868MS0103_3; Van Herwegen J, 2013, RES DEV DISABIL, V34, P1300, DOI 10.1016/j.ridd.2013.01.017; Wilcox RR, 2003, PSYCHOL METHODS, V8, P254, DOI 10.1037/1082-989X.8.3.254; WINNER E, 1980, J EXP CHILD PSYCHOL, V30, P22, DOI 10.1016/0022-0965(80)90072-7; WINNER E, 1976, DEV PSYCHOL, V12, P289, DOI 10.1037/0012-1649.12.4.289; Wisler CE, 1969, STUDY OUR NATIONS SC; WOLFF P, 1992, PROCEEDINGS OF THE FOURTEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P504; Xu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077770	56	31	31	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150289	10.1371/journal.pone.0150289	http://dx.doi.org/10.1371/journal.pone.0150289			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SW	26954501	gold, Green Submitted, Green Published			2022-12-27	WOS:000371991300019
J	Godin, LM; Sandri, BJ; Wagner, DE; Meyer, CM; Price, AP; Akinnola, I; Weiss, DJ; Panoskaltsis-Mortari, A				Godin, Lindsay M.; Sandri, Brian J.; Wagner, Darcy E.; Meyer, Carolyn M.; Price, Andrew P.; Akinnola, Ifeolu; Weiss, Daniel J.; Panoskaltsis-Mortari, Angela			Decreased Laminin Expression by Human Lung Epithelial Cells and Fibroblasts Cultured in Acellular Lung Scaffolds from Aged Mice	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX SCAFFOLD; INDUCED PULMONARY-FIBROSIS; AGING LUNG; CONNECTIVE-TISSUE; DEPENDENT CHANGES; TGF-BETA; GENDER; INJURY; DISEASE; QUANTIFICATION	The lung changes functionally and structurally with aging. However, age-related effects on the extracellular matrix (ECM) and corresponding effects on lung cell behavior are not well understood. We hypothesized that ECM from aged animals would induce aging-related phenotypic changes in healthy inoculated cells. Decellularized whole organ scaffolds provide a powerful model for examining how ECM cues affect cell phenotype. The effects of age on ECM composition in both native and decellularized mouse lungs were assessed as was the effect of young vs old acellular ECM on human bronchial epithelial cells (hBECs) and lung fibroblasts (hLFs). Native aged (1 year) lungs demonstrated decreased expression of laminins alpha 3 and alpha 4, elastin and fibronectin, and elevated collagen, compared to young (3 week) lungs. Proteomic analyses of decellularized ECM demonstrated similar findings, and decellularized aged lung ECM contained less diversity in structural proteins compared to young ECM. When seeded in old ECM, hBECs and hLFs demonstrated lower gene expression of laminins alpha 3 and alpha 4, respectively, as compared to young ECM, paralleling the laminin deficiency of aged ECM. ECM changes appear to be important factors in potentiating aging-related phenotypes and may provide clues to mechanisms that allow for aging-related lung diseases.	[Godin, Lindsay M.; Meyer, Carolyn M.; Price, Andrew P.; Panoskaltsis-Mortari, Angela] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Sandri, Brian J.; Panoskaltsis-Mortari, Angela] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Wagner, Darcy E.; Weiss, Daniel J.] Univ Vermont, Dept Med, Burlington, VT USA; [Akinnola, Ifeolu] Univ Minnesota, Sch Med, MSTP Program, Minneapolis, MN 55455 USA; [Godin, Lindsay M.] Boston Sci, Maple Grove, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Vermont; University of Minnesota System; University of Minnesota Twin Cities; Boston Scientific	Panoskaltsis-Mortari, A (corresponding author), Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA.; Panoskaltsis-Mortari, A (corresponding author), Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.	panos001@umn.edu	Wagner, Darcy E/R-4718-2017; Sandri, Brian/AGY-7615-2022	Wagner, Darcy E/0000-0003-3794-1309; Akinnola, Ifeolu/0000-0002-5187-693X; Sandri, Brian/0000-0003-4935-6502	National Institutes of Health [HL07741, R21 HL102570, R01 HL108627, R01HL107612, RC4 HL106625, R21HL108689, P20GM103449]; MSTP training grant NIH [T32 GM008244]; UVM Lung Biology Training grant T32 National Institutes of Health [HL076122]; National Science Foundation [1147079]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007741, R21HL108689, RC4HL106625, R21HL102570, R01HL107612, R01HL108627, T32HL076122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449, T32GM008244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSTP training grant NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UVM Lung Biology Training grant T32 National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded in part by the "Training in Lung Science" T32 training grant from the National Institutes of Health HL07741 (for LMG and BJS), National Institutes of Health R21 HL102570 (APM), National Institutes of Health R01 HL108627 (APM), National Institutes of Health R01HL107612 (for BJS), MSTP training grant NIH T32 GM008244 (for IA), UVM Lung Biology Training grant T32 National Institutes of Health HL076122 (DEW), National Institutes of Health RC4 HL106625 (DJW), National Institutes of Health R21HL108689 (DJW), and P20GM103449 (funding the Vermont Genomics Network). GalaxyP infrastructure is supported by National Science Foundation grant 1147079 (to UMN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrass CK, 2010, AM J PATHOL, V176, P839, DOI 10.2353/ajpath.2010.090570; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; Bianchi-Frias D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012501; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; Calvi CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020712; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; CLARK RAF, 1995, J CELL SCI, V108, P1251; Damodarasamy M, 2015, IN VITRO CELL DEV-AN, V51, P50, DOI 10.1007/s11626-014-9800-z; DERRICO A, 1989, VIRCHOWS ARCH A, V415, P137, DOI 10.1007/BF00784351; Dworatzek E, 2016, PROTEOM CLIN APPL, V10, P84, DOI 10.1002/prca.201500031; Fulop T, 2001, PATHOL BIOL, V49, P339, DOI 10.1016/S0369-8114(01)00143-2; Gharaee-Kermani M, 2005, AM J PATHOL, V166, P1593, DOI 10.1016/S0002-9440(10)62470-4; Groves AM, 2013, AM J PHYSIOL-LUNG C, V305, pL555, DOI 10.1152/ajplung.00027.2013; Hagood JS, 2005, AM J PATHOL, V167, P365, DOI 10.1016/S0002-9440(10)62982-3; Haston CK, 2002, HUM MOL GENET, V11, P1855, DOI 10.1093/hmg/11.16.1855; Hill RC, 2015, MOL CELL PROTEOMICS, V14, P961, DOI 10.1074/mcp.M114.045260; Huang KW, 2007, J APPL PHYSIOL, V102, P200, DOI 10.1152/japplphysiol.00400.2006; Iivanainen A, 1997, J BIOL CHEM, V272, P27862, DOI 10.1074/jbc.272.44.27862; Jugdutt Bodh I., 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P1, DOI 10.2174/1568006033337276; KENT S, 1978, GERIATRICS, V33, P124; Kielty CM, 2002, PHILOS T R SOC B, V357, P207, DOI 10.1098/rstb.2001.1029; Kligys K, 2013, AM J RESP CELL MOL, V49, P731, DOI 10.1165/rcmb.2012-0509OC; Komosinska-Vassev K, 2011, GERONTOLOGY, V57, P44, DOI 10.1159/000295775; Kulkarni T, 2016, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2015-0166PS, DOI 10.1165/RCMB.2015-0166PS]; Lekgabe ED, 2006, ENDOCRINOLOGY, V147, P5575, DOI 10.1210/en.2006-0533; Lin YM, 2010, TISSUE ENG PT A, V16, P1515, DOI [10.1089/ten.tea.2009.0232, 10.1089/ten.TEA.2009.0232]; Lynch K, 2014, ORGANOGENESIS, V10, P289, DOI 10.4161/15476278.2014.970089; MAYS PK, 1989, AM REV RESPIR DIS, V140, P410, DOI 10.1164/ajrccm/140.2.410; McGee SP, 2014, INT J MOL EPIDEMIOL, V5, P71; Meiners S, 2015, EUR RESPIR J, V45, P807, DOI 10.1183/09031936.00186914; Melo E, 2014, J MECH BEHAV BIOMED, V37, P186, DOI 10.1016/j.jmbbm.2014.05.019; Nakayama KH, 2011, TISSUE ENG PT A, V17, P2891, DOI [10.1089/ten.TEA.2010.0714, 10.1089/ten.tea.2010.0714]; Nastase MV, 2014, BBA-GEN SUBJECTS, V1840, P2460, DOI 10.1016/j.bbagen.2014.01.035; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Nguyen NM, 2006, DEV BIOL, V294, P271, DOI 10.1016/j.ydbio.2006.03.032; Olafsdottir IS, 2010, RESPIROLOGY, V15, P530, DOI 10.1111/j.1440-1843.2010.01718.x; Osakabe T, 2001, ANN CLIN BIOCHEM, V38, P527, DOI 10.1258/0004563011901118; Parker MW, 2014, J CLIN INVEST, V124, P1622, DOI 10.1172/JCI71386; Price AP, 2010, TISSUE ENG PT A, V16, P2581, DOI [10.1089/ten.tea.2009.0659, 10.1089/ten.TEA.2009.0659]; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schiller HB, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156123; SEYER JM, 1976, J CLIN INVEST, V57, P1498, DOI 10.1172/JCI108420; Sherratt MJ, 2013, ADV WOUND CARE, V2, P11, DOI 10.1089/wound.2011.0328; Sicari BM, 2012, BIOMATERIALS, V33, P5524, DOI 10.1016/j.biomaterials.2012.04.017; Sokocevic D, 2013, BIOMATERIALS, V34, P3256, DOI 10.1016/j.biomaterials.2013.01.028; Sueblinvong Viranuj, 2014, Adv Biosci Biotechnol, V5, P19; Sueblinvong V, 2012, AM J MED SCI, V344, P41, DOI 10.1097/MAJ.0b013e318234c132; Thannickal VJ, 2015, AM J RESP CRIT CARE, V191, P261, DOI 10.1164/rccm.201410-1876PP; Urich D, 2011, J CELL SCI, V124, P2927, DOI 10.1242/jcs.080911; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Voltz JW, 2008, AM J RESP CELL MOL, V39, P45, DOI 10.1165/rcmb.2007-0340OC; Xia H, 2014, AM J PATHOL, V184, P1369, DOI 10.1016/j.ajpath.2014.01.012; Yousif LF, 2013, CELL ADHES MIGR, V7, P101, DOI 10.4161/cam.22680; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004	55	37	38	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150966	10.1371/journal.pone.0150966	http://dx.doi.org/10.1371/journal.pone.0150966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954258	Green Submitted, gold, Green Published			2022-12-27	WOS:000371991300065
J	Lee, H; Kang, S; Kim, W				Lee, Haeseung; Kang, Seungmin; Kim, Wankyu			Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures	PLOS ONE			English	Article							SMALL MOLECULES; CELL-GROWTH; DATABASE; IDENTIFICATION; MAPROTILINE; INHIBITION; AMLODIPINE; ANTIDEPRESSANTS; PROLIFERATION; INTEGRATION	An in silico chemical genomics approach is developed to predict drug repositioning (DR) candidates for three types of cancer: glioblastoma, lung cancer, and breast cancer. It is based on a recent large-scale dataset of similar to 20,000 drug-induced expression profiles in multiple cancer cell lines, which provides i) a global impact of transcriptional perturbation of both known targets and unknown off-targets, and ii) rich information on drug's mode-of-action. First, the drug-induced expression profile is shown more effective than other information, such as the drug structure or known target, using multiple HTS datasets as unbiased benchmarks. Particularly, the utility of our method was robustly demonstrated in identifying novel DR candidates. Second, we predicted 14 high-scoring DR candidates solely based on expression signatures. Eight of the fourteen drugs showed significant anti-proliferative activity against glioblastoma; i.e., ivermectin, trifluridine, astemizole, amlodipine, maprotiline, apomorphine, mometasone, and nortriptyline. Our DR score strongly correlated with that of cell-based experimental results; the top seven DR candidates were positive, corresponding to an approximately 20-fold enrichment compared with conventional HTS. Despite diverse original indications and known targets, the perturbed pathways of active DR candidates show five distinct patterns that form tight clusters together with one or more known cancer drugs, suggesting common transcriptome-level mechanisms of anti-proliferative activity.	[Lee, Haeseung; Kang, Seungmin; Kim, Wankyu] Ewha Womans Univ, Ewha Res Ctr Syst Biol, Div Mol & Life Sci, Seoul, South Korea	Ewha Womans University	Kim, W (corresponding author), Ewha Womans Univ, Ewha Res Ctr Syst Biol, Div Mol & Life Sci, Seoul, South Korea.	wkim@ewha.ac.kr		kim, wankyu/0000-0003-3181-0594	National Research Foundation (NRF) [NRF-2014R1A2A2A01007166]; Technology Innovation Program - Ministry of Trade, industry & Energy of Korea [10050154]	National Research Foundation (NRF); Technology Innovation Program - Ministry of Trade, industry & Energy of Korea	WK was supported by National Research Foundation (NRF) grant (NRF-2014R1A2A2A01007166) and Technology Innovation Program (10050154) funded by Ministry of Trade, industry & Energy of Korea.	Abdou HS, 2013, ENDOCRINOLOGY, V154, P511, DOI 10.1210/en.2012-1767; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Chen B, 2009, J CHEM INF MODEL, V49, P2044, DOI 10.1021/ci9001876; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Ciceri P, 2014, NAT CHEM BIOL, V10, P305, DOI 10.1038/nchembio.1471; Cloonan SM, 2010, LEUKEMIA LYMPHOMA, V51, P523, DOI 10.3109/10428190903552112; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Ejsing TB, 2005, HUM PSYCHOPHARM CLIN, V20, P149, DOI 10.1002/hup.667; Ekins S, 2011, DRUG DISCOV TODAY, V16, P298, DOI 10.1016/j.drudis.2011.02.016; Garcia-Sosa AT, 2012, J CHEM INF MODEL, V52, P2165, DOI 10.1021/ci200587h; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Hashimoto H, 2009, DRUG DISCOV THER, V3, P243; Hsu SS, 2004, CLIN EXP PHARMACOL P, V31, P444, DOI 10.1111/j.1440-1681.2004.04024.x; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Huang BS, 2003, J CARDIOVASC PHARM, V42, P153, DOI 10.1097/00005344-200308000-00001; Huang X, 2012, GENE DEV, V26, P1780, DOI 10.1101/gad.193789.112; Hurle MR, 2013, CLIN PHARMACOL THER, V93, P335, DOI 10.1038/clpt.2013.1; Iorio F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139446; Iorio F, 2010, AUTOPHAGY, V6, P1204, DOI [10.4161/auto.6.8.13551, 10.1073/pnas.1000138107]; Iskar M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.20; Iwata H, 2015, J CHEM INF MODEL, V55, P446, DOI 10.1021/ci500670q; Jan CR, 2013, TOXICOLOGY, V304, P1, DOI 10.1016/j.tox.2012.11.013; Jangi SM, 2006, CARCINOGENESIS, V27, P1787, DOI 10.1093/carcin/bgl021; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kumar V, 2015, METHODS, V71, P64, DOI 10.1016/j.ymeth.2014.08.010; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lissoni P, 2003, PSYCHOONCOLOGY CANC, P24; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Liu YB, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau124; Liu ZC, 2013, DRUG DISCOV TODAY, V18, P110, DOI 10.1016/j.drudis.2012.08.005; Lussier YA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001512; Ma DL, 2013, CHEM SOC REV, V42, P2130, DOI 10.1039/c2cs35357a; MARKMAN M, 1984, NEW ENGL J MED, V311, P549, DOI 10.1056/NEJM198408303110901; Melotti A, 2014, EMBO MOL MED, V6, P1263, DOI 10.15252/emmm.201404084; Neef C, 1999, CLIN PHARMACOKINET, V37, P257, DOI 10.2165/00003088-199937030-00004; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ohba T, 2008, BIOCHEM BIOPH RES CO, V369, P376, DOI 10.1016/j.bbrc.2008.02.075; Olah M, 2007, WOMBAT WOMBAT PK BIO, DOI [10.1002/9783527619375, DOI 10.1002/9783527619375]; Parker KA, 2012, ANTI-CANCER DRUG, V23, P65, DOI 10.1097/CAD.0b013e32834b1894; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; Pilkington G.J., 2006, RADIOL ONCOL, V40, P73; RESULTS/DISCUSSION, 1988, RESULTS DISCUSSION O, V14, P60201; Rojo LE, 2010, J ALZHEIMERS DIS, V19, P573, DOI 10.3233/JAD-2010-1262; Roth BL, 2000, NEUROSCIENTIST, V6, P252, DOI 10.1177/107385840000600408; Shin E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17784; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tanaka N, 2014, ONCOL REP, V32, P2319, DOI 10.3892/or.2014.3487; TAYLOR JM, 1992, CANCER RES, V52, P2413; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Vidovic D, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00342; Wang KJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003315; Wang YL, 2010, NUCLEIC ACIDS RES, V38, pD255, DOI 10.1093/nar/gkp965; Wang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078518; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028025; Ye H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087864; Yoshida J, 2007, BIOCHEM PHARMACOL, V73, P943, DOI 10.1016/j.bcp.2006.12.011; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	69	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150460	10.1371/journal.pone.0150460	http://dx.doi.org/10.1371/journal.pone.0150460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954019	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300028
J	Bhattacharjee, S; Zhao, YH; Dua, P; Rogaev, EI; Lukiw, WJ				Bhattacharjee, Surjyadipta; Zhao, Yuhai; Dua, Prerna; Rogaev, Evgeny I.; Lukiw, Walter J.			microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration	PLOS ONE			English	Article							NF-KAPPA-B; ALZHEIMERS-DISEASE AD; MYELOID CELLS-2; AMYLOID-BETA; EXPRESSION; ABUNDANCE; INSIGHTS; GENES; NEUROINFLAMMATION; TRANSCRIPTION	The aggregation of A beta 42-peptides and the formation of drusen in age-related macular degeneration (AMD) are due in part to the inability of homeostatic phagocytic mechanisms to clear self-aggregating A beta 42-peptides from the extracellular space. The triggering receptor expressed in myeloid/microglial cells-2 (TREM2), a trans-membrane-spanning, sensor-receptor of the immune-globulin/lectin-like gene superfamily is a critical component of A beta 42-peptide clearance. Here we report a significant deficit in TREM2 in AMD retina and in cytokine-or oxidatively-stressed microglial (MG) cells. RT-PCR, miRNA-array, LED-Northern and Western blot studies indicated up-regulation of a microglial-enriched NF-kappa B-sensitive miRNA-34a coupled to a down-regulation of TREM2 in the same samples. Bioinformatics/transfection-luciferase reporter assays indicated that miRNA-34a targets the 299 nucleotide TREM2-mRNA-3'UTR, resulting in TREM2 down-regulation. C8B4-microglial cells challenged with A beta 42 were able to phagocytose these peptides, while miRNA-34a down-regulated both TREM2 and the ability of microglial-cells to phagocytose. Treatment of TNF alpha-stressed MG cells with phenyl-butyl nitrone (PBN), caffeic-acid phenethyl ester (CAPE), the NF-B-inhibitor/resveratrol analog CAY10512 or curcumin abrogated these responses. Incubation of anti-miRNA-34a (AM-34a) normalized miRNA-34a abundance and restored TREM2 back to homeostatic levels. These data support five novel observations: (i) that a ROS-and NF-B-sensitive, miRNA-34a-mediated modulation of TREM2 may in part regulate the phagocytic response; (ii) that gene products encoded on two different chromosomes (miRNA-34a at chr1q36.22 and TREM2 at chr6p21.1) orchestrate a phagocytic-A beta 42-peptide clearance-system; (iii) that this NF-kB-mediated-miRNA-34a-TREM2 mechanism is inducible from outside of the cell; (iv) that when operating normally, this pathway can clear A beta 42 peptide monomers from the extracellular medium; and (v) that anti-NF-kB and/or anti-miRNA (AM)-based therapeutic strategies may be useful against deficits in TREM-2 receptor-based-sensing and -phagocytic signaling that promote pathogenic amyloidogenesis.	[Bhattacharjee, Surjyadipta; Zhao, Yuhai; Lukiw, Walter J.] Louisiana State Univ, Hlth Sci Ctr, LSU Neurosci Ctr, New Orleans, LA 70112 USA; [Zhao, Yuhai] Louisiana State Univ, Hlth Sci Ctr, Dept Anat & Cell Biol, New Orleans, LA 70112 USA; [Dua, Prerna] Louisiana State Tech Univ, Ruston, LA 71270 USA; [Rogaev, Evgeny I.] Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01604 USA; [Rogaev, Evgeny I.; Lukiw, Walter J.] Russian Acad Sci, Dept Genom & Human Genet, Lab Evolutionary Genom, Vavilov Inst Gen Genet, Moscow 119991, Russia; [Rogaev, Evgeny I.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 119234, Russia; [Lukiw, Walter J.] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA; [Lukiw, Walter J.] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Massachusetts System; University of Massachusetts Worcester; Russian Academy of Sciences; Vavilov Institute of General Genetics; Lomonosov Moscow State University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Lukiw, WJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, LSU Neurosci Ctr, New Orleans, LA 70112 USA.; Lukiw, WJ (corresponding author), Russian Acad Sci, Dept Genom & Human Genet, Lab Evolutionary Genom, Vavilov Inst Gen Genet, Moscow 119991, Russia.; Lukiw, WJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA.; Lukiw, WJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, New Orleans, LA 70112 USA.	wlukiw@lsuhsc.edu	Bhattacharjee, Surjyadipta/AAD-7586-2021; Rogaev, Evgeny/AAN-7662-2020; Bhattacharjee, Surjyadipta/I-5354-2016	Bhattacharjee, Surjyadipta/0000-0003-0185-553X; Bhattacharjee, Surjyadipta/0000-0003-0185-553X	COBRE III Pilot Project NIH/NIGMS Grant [P30-GM103340]; Research to Prevent Blindness (RPB); Louisiana Biotechnology Research Network (LBRN); NIH [NEI EY006311, NIA AG18031, NIA AG038834]; Russian Science Foundation [14-44-00077, 14-15-01121, 14-50-00029]; NIH NIA [AG029360]; NATIONAL EYE INSTITUTE [R01EY006311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038834, R01AG018031] Funding Source: NIH RePORTER	COBRE III Pilot Project NIH/NIGMS Grant; Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Louisiana Biotechnology Research Network (LBRN); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Science Foundation(Russian Science Foundation (RSF)); NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research on miRNA in the Lukiw laboratory involving the innate-immune response in AD, AMD and in retinal disease, amyloidogenesis and neuroinflammation was supported through a COBRE III Pilot Project NIH/NIGMS Grant P30-GM103340, an unrestricted grant to the LSU Eye Center from Research to Prevent Blindness (RPB); the Louisiana Biotechnology Research Network (LBRN) and NIH grants NEI EY006311, NIA AG18031 and NIA AG038834.; This work was presented in part at the Association for Research in Vision and Ophthalmology (ARVO) Annual meeting 3-7 May 2015 in Denver CO, USA and at the Society for Neuroscience (SFN) Annual Conference 17-21 October 2015 in Chicago IL, USA. Sincere thanks are extended to Drs. L. Carver, H. LeBlanc, F. Culicchia, C. Eicken and C. Hebel for short post-mortem interval (PMI) human brain tissues or extracts, miRNA array work and initial data interpretation, and to D Guillot and AI Pogue for expert technical assistance. Thanks are also extended to the many neuropathologists, ophthalmologists, physicians and researchers of Canada, Russia and the US who have provided high quality, short post-mortem interval (PMI) human CNS and retinal tissues or total brain and retinal RNA for scientific study. Research on miRNA in the WJ Lukiw laboratory involving the innate-immune response in AD, AMD and retinal disease, amyloidogenesis and neuroinflammation was supported through a COBRE III Pilot Project NIH/NIGMS Grant P30-GM103340, an unrestricted grant to the LSU Eye Center from Research to Prevent Blindness (RPB); the Louisiana Biotechnology Research Network (LBRN) and NIH grants NEI EY006311, NIA AG18031 and NIA AG038834; research on aging and AD, miRNA, gene expression and bioinformatics in the EIR laboratory was supported, in part, by Russian Science Foundation grant No 14-44-00077 (miRNA and targets in the brain), grant No 14-15-01121 (AD-neurodegeneration related gene network analysis), No 14-50-00029 (computational bioinformatics). EIR is supported, in part, by NIH NIA AG029360.	Agostini M, 2014, ONCOTARGET; Agostini M, 2011, P NATL ACAD SCI USA, V108, P21099, DOI 10.1073/pnas.1112063108; Alexandrov PN, 2013, J INORG BIOCHEM, V128, P267, DOI 10.1016/j.jinorgbio.2013.05.010; Alexandrov PN, 2011, NEUROREPORT, V22, P623, DOI 10.1097/WNR.0b013e3283497334; Benitez BA, 2013, NEW ENGL J MED, V369, P1567, DOI 10.1056/NEJMc1306509; Bhatnagar S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00002; Bhattacharjee S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00062; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Boshette NB, 2014, REV NEUROL-FRANCE, V170, P151, DOI 10.1016/j.neurol.2013.11.002; Boutajangout Allal, 2013, Int J Cell Biol, V2013, P576383, DOI 10.1155/2013/576383; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Cardoso AL, 2016, CURR OPIN PHARMACOL, V26, P1, DOI 10.1016/j.coph.2015.09.001; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Correale C, 2013, GASTROENTEROLOGY, V144, P346, DOI [10.1053/j.gastro.2012.10.040, 10.1053/j.gastro.2012.12.016]; Cui JG, 2010, J BIOL CHEM, V285, P38951, DOI 10.1074/jbc.M110.178848; Dorey E, 2014, NEUROSCI BULL, V30, P317, DOI 10.1007/s12264-013-1422-z; Exley C, 2005, SUB CELL BIOCHEM, V38, P225; Forabosco P, 2013, NEUROBIOL AGING, V34, P2699, DOI 10.1016/j.neurobiolaging.2013.05.001; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Gao HF, 2013, J NEURO-ONCOL, V113, P221, DOI 10.1007/s11060-013-1119-1; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro R, 2013, NEW ENGL J MED, V369, P1569, DOI 10.1056/NEJMc1306509; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Henshall DC, 2014, CURR OPIN NEUROL, V27, P199, DOI 10.1097/WCO.0000000000000079; Hickman SE, 2014, BIOCHEM PHARMACOL, V88, P495, DOI 10.1016/j.bcp.2013.11.021; Hill JM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00347; Hill JM, 2015, NEUROCHEM RES; Hu N, 2014, NEUROSCI LETT, V563, P51, DOI 10.1016/j.neulet.2014.01.004; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang T, 2015, NEUROBIOL AGING, V36, P3176, DOI 10.1016/j.neurobiolaging.2015.08.019; Jiang T, 2014, NEUROBIOL AGING, V35, P1243, DOI 10.1016/j.neurobiolaging.2013.11.026; Jin SC, 2014, HUM MOL GENET; Jones BM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00094; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Kofman AV, 2013, CELL CYCLE, V12, P3500, DOI 10.4161/cc.26459; Li J, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-4; Li XL, 2011, AGING-US, V3, P985, DOI 10.18632/aging.100371; Li YY, 2011, NEUROSCI LETT, V499, P109, DOI 10.1016/j.neulet.2011.05.044; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Lukiw WJ, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00133; Lukiw WJ, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00024; Lukiw WJ, 2012, EXP NEUROL, V235, P484, DOI 10.1016/j.expneurol.2011.11.022; Maciotta S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00265; Mager PP, 1998, MED RES REV, V18, P403, DOI 10.1002/(SICI)1098-1128(199811)18:6<403::AID-MED4>3.0.CO;2-C; Mehler MF, 2007, PHYSIOL REV, V87, P799, DOI 10.1152/physrev.00036.2006; Miyashita A, 2014, J ALZHEIMERS DIS, V41, P1031, DOI 10.3233/JAD-140225; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Neumann H, 2013, NEW ENGL J MED, V368, P182, DOI 10.1056/NEJMe1213157; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Olson MV, 2012, ANNU REV GENOM HUM G, V13, P1, DOI 10.1146/annurev-genom-090711-163825; Paradowska-Gorycka A, 2013, HUM IMMUNOL, V74, P730, DOI 10.1016/j.humimm.2013.02.003; Piccio L, 2007, EUR J IMMUNOL, V37, P1290, DOI 10.1002/eji.200636837; Pogue AI, 2014, BRAIN RES, V1584, P73, DOI 10.1016/j.brainres.2014.03.042; Pogue AL, 2014, FRONT NEUROL, V5, DOI [10.3389/fneur.2014.00262, 10.3389/fneur.2014.00043]; Reitz C, 2014, BIOCHEM PHARMACOL, V88, P640, DOI 10.1016/j.bcp.2013.12.024; Rivest S, 2015, CELL RES, V25, P535, DOI 10.1038/cr.2015.37; Satoh J, 2012, CELL MOL NEUROBIOL, V32, P337, DOI 10.1007/s10571-011-9769-z; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Shinohara M, 2014, BRAIN; Sieber MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052982; Srinivasan M, 2015, EXPERT OPIN THER TAR, V19, P471, DOI 10.1517/14728222.2014.989834; Sundermeier TR, 2015, FASEB J; Veleri S, 2015, DIS MODEL MECH, V8, P109, DOI 10.1242/dmm.017913; Villegas-Llerena C, 2016, CURR OPIN NEUROBIOL, V36, P74, DOI 10.1016/j.conb.2015.10.004; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Wan YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121975; Wang XY, 2009, BRAIN RES BULL, V80, P268, DOI 10.1016/j.brainresbull.2009.08.006; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Watson D, 2005, NEUROL RES, V27, P869, DOI 10.1179/016164105X49436; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yang XG, 2014, MOL NEUROBIOL, V50, P119, DOI 10.1007/s12035-014-8652-6; Zhao YH, 2014, MOL NEUROBIOL, V50, P97, DOI 10.1007/s12035-013-8595-3; Zhao YH, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00131; Zhao YH, 2013, NEUROREPORT, V24, P318, DOI 10.1097/WNR.0b013e32835fb6b0; Zhao YH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015816, 10.1371/journal.pone.0016470]	84	91	94	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150211	10.1371/journal.pone.0150211	http://dx.doi.org/10.1371/journal.pone.0150211			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26949937	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100024
J	dos Santos, LF; Fregapani, RM; Falcao, LL; Togawa, RC; Costa, MMD; Lopes, UV; Gramacho, KP; Alves, RM; Micheli, F; Marcellino, LH				dos Santos, Lucas Ferraz; Fregapani, Roberta Moreira; Falcao, Loeni Ludke; Togawa, Roberto Coiti; do Carmo Costa, Marcos Mota; Lopes, Uilson Vanderlei; Gramacho, Karina Peres; Alves, Rafael Moyses; Micheli, Fabienne; Marcellino, Lucilia Helena			First Microsatellite Markers Developed from Cupuassu ESTs: Application in Diversity Analysis and Cross-Species Transferability to Cacao	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; THEOBROMA-CACAO; SSR-MARKERS; WITCHES-BROOM; MONILIOPHTHORA-PERNICIOSA; CRINIPELLIS-PERNICIOSA; GRANDIFLORUM; L.; IDENTIFICATION; SELECTION	The cupuassu tree (Theobroma grandiflorum) (Willd. ex Spreng.) Schum. is a fruitful species from the Amazon with great economical potential, due to the multiple uses of its fruit's pulp and seeds in the food and cosmetic industries, including the production of cupulate, an alternative to chocolate. In order to support the cupuassu breeding program and to select plants presenting both pulp/seed quality and fungal disease resistance, SSRs from Next Generation Sequencing ESTs were obtained and used in diversity analysis. From 8,330 ESTs, 1,517 contained one or more SSRs (1,899 SSRs identified). The most abundant motifs identified in the EST-SSRs were hepta-and trinucleotides, and they were found with a minimum and maximum of 2 and 19 repeats, respectively. From the 1,517 ESTs containing SSRs, 70 ESTs were selected based on their functional annotation, focusing on pulp and seed quality, as well as resistance to pathogens. The 70 ESTs selected contained 77 SSRs, and among which, 11 were polymorphic in cupuassu genotypes. These EST-SSRs were able to discriminate the cupuassu genotype in relation to resistance/susceptibility to witches' broom disease, as well as to pulp quality (SST/ATT values). Finally, we showed that these markers were transferable to cacao genotypes, and that genome availability might be used as a predictive tool for polymorphism detection and primer design useful for both Theobroma species. To our knowledge, this is the first report involving EST-SSRs from cupuassu and is also a pioneer in the analysis of marker transferability from cupuassu to cacao. Moreover, these markers might contribute to develop or saturate the cupuassu and cacao genetic maps, respectively.	[dos Santos, Lucas Ferraz; Micheli, Fabienne] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ctr Biotecnol & Genet, Rodovia Ilheus Itabuna,Km 16, BR-45662900 Ilheus, BA, Brazil; [dos Santos, Lucas Ferraz; Fregapani, Roberta Moreira; Falcao, Loeni Ludke; Togawa, Roberto Coiti; do Carmo Costa, Marcos Mota; Marcellino, Lucilia Helena] Embrapa Recursos Genet & Biotecnol, BR-70770917 Brasilia, DF, Brazil; [Lopes, Uilson Vanderlei; Gramacho, Karina Peres] CEPLAC CEPEC, Cocoa Res Ctr, BR-45600970 Itabuna, BA, Brazil; [Alves, Rafael Moyses] Embrapa Amazonia Oriental, BR-66095903 Belem, Para, Brazil; [Micheli, Fabienne] CIRAD, UMR AGAP, F-34398 Montpellier, France	Universidade Estadual de Santa Cruz; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CIRAD; Universite de Montpellier	Micheli, F (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Ctr Biotecnol & Genet, Rodovia Ilheus Itabuna,Km 16, BR-45662900 Ilheus, BA, Brazil.; Micheli, F (corresponding author), CIRAD, UMR AGAP, F-34398 Montpellier, France.	fabienne.micheli@cirad.fr	Micheli, Fabienne/AAL-9895-2021; Marcellino, Lucilia H/N-1967-2016; GRAMACHO, KARINA PERES/J-3868-2014; GRAMACHO, KARINA PERES/AAO-8862-2020	Marcellino, Lucilia H/0000-0002-0430-2490; GRAMACHO, KARINA PERES/0000-0003-4037-1554; GRAMACHO, KARINA PERES/0000-0003-4037-1554; Togawa, Roberto/0000-0001-7179-3210; Micheli, Fabienne/0000-0002-9031-362X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Empresa Brasileira de Pesquisa Agropecuaria project called "Theobroma"; Empresa Brasileira de Pesquisa Agropecuaria/Macroprogram project called "Geneacu"	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Empresa Brasileira de Pesquisa Agropecuaria project called "Theobroma"; Empresa Brasileira de Pesquisa Agropecuaria/Macroprogram project called "Geneacu"	This research was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and the Empresa Brasileira de Pesquisa Agropecuaria project called "Theobroma" (coordinated by FM), and by the Empresa Brasileira de Pesquisa Agropecuaria/Macroprogram project called "Geneacu" (coordinated by RMA).	Adal AM, 2015, PLANTA, V241, P987, DOI 10.1007/s00425-014-2226-8; Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Aggarwal RK, 2007, THEOR APPL GENET, V114, P359, DOI 10.1007/s00122-006-0440-x; Aime MC, 2005, MYCOLOGIA, V97, P1012, DOI 10.3852/mycologia.97.5.1012; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alves RM, 2006, MOL ECOL NOTES, V6, P1219, DOI 10.1111/j.1471-8286.2006.01496.x; Alves RM, 2013, REV BRAS FRUTIC, V35, P818, DOI 10.1590/S0100-29452013000300019; Alves RM, 2010, REV BRAS FRUTIC, V32, P204, DOI 10.1590/S0100-29452010005000010; Alves RM, 2009, REV BRAS FRUTIC, V31, P1022, DOI 10.1590/S0100-29452009000400015; Alves RM, 2003, PESQUI AGROPECU BRAS, V38, P807, DOI 10.1590/S0100-204X2003000700004; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; [Anonymous], [No title captured]; [Anonymous], 1996, 5000 CNRS UMR; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Argout X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-512; Asadi AA, 2014, MOL GENET GENOMICS, V289, P625, DOI 10.1007/s00438-014-0839-z; Backiyarani S, 2013, APPL BIOCHEM BIOTECH, V169, P228, DOI 10.1007/s12010-012-9975-2; Bhawna, 2015, APPL BIOCHEM BIOTECH, V175, P2206, DOI 10.1007/s12010-014-1395-z; Bosamia TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129127; Bueno Silvia M., 2002, Revista do Instituto Adolfo Lutz, V61, P121; Calzavara BBG, 1984, FRUTICULTURA TROPICA; Castillo A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-97; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Clement C. R., 2010, Diversity, V2, P72; Cohen Kelly de Oliveira, 2005, Food Sci. Technol (Campinas), V25, P182, DOI 10.1590/S0101-20612005000100030; Costa Marta Cristina, 2003, Rev. Bras. Frutic., V25, P213, DOI 10.1590/S0100-29452003000200007; de Oliveira Thiago Belchior, 2015, PharmaNutrition, V3, P20, DOI 10.1016/j.phanu.2015.01.002; de Oliveira TB, 2013, FOOD RES INT, V51, P929, DOI 10.1016/j.foodres.2013.02.019; Doyle JJ, ISOLATION PLANT DNA; Faleiro FG, 2006, EUPHYTICA, V149, P227, DOI 10.1007/s10681-005-9070-7; Fan L, 2013, PLANT MOL BIOL REP, V31, P1271, DOI 10.1007/s11105-013-0586-z; Feltus FA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-379; Ferrao LFV, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0247-z; Santos RMF, 2013, TREE GENET GENOMES, V9, P117, DOI 10.1007/s11295-012-0539-y; Gesteira AS, 2007, ANN BOT-LONDON, V100, P129, DOI 10.1093/aob/mcm092; Goncalves MVVA, 2013, PERSPECTIVAS ONLINE, V3; Gong L, 2010, MOL BREEDING, V26, P125, DOI 10.1007/s11032-009-9380-x; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Jones PG, 2002, PLANTA, V216, P255, DOI 10.1007/s00425-002-0882-6; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Kuhn DN, 2010, TREE GENET GENOMES, V6, P783, DOI 10.1007/s11295-010-0291-0; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lanaud C, 1999, MOL ECOL, V8, P2141, DOI 10.1046/j.1365-294x.1999.00802.x; Lannes SCdS, 2002, FORMULACAO CHOCOLATE, V38, P7, DOI [10.1590/s1516-93322002000400009, DOI 10.1590/S1516-93322002000400009]; Lannes SCS, 2003, GRASAS ACEITES, V54, P253; Lannes Suzana Caetano da Silva, 2003, Rev. Bras. Cienc. Farm., V39, P115, DOI 10.1590/S1516-93322003000100012; Leal GA, 2007, MOL PLANT PATHOL, V8, P279, DOI 10.1111/J.1364-3703.2007.00393.X; Lee GA, 2015, MOLECULES, V20, P6432, DOI 10.3390/molecules20046432; LEWIS PO, 2001, GENETIC DATA ANAL; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Lima LS, 2010, TREE GENET GENOMES, V6, P663, DOI 10.1007/s11295-010-0282-1; Metzgar D, 2000, GENOME RES, V10, P72; Micheli F, 2010, ADV BOT RES, V55, P119, DOI 10.1016/S0065-2296(10)55003-1; Naganeeswaran SA, 2012, BIOINFORMATION, V8, P65; Nicot N, 2004, THEOR APPL GENET, V109, P800, DOI 10.1007/s00122-004-1685-x; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Raveendar S, 2015, MOLECULES, V20, P1543, DOI 10.3390/molecules20011543; Reisdorff C, 2004, J SCI FOOD AGR, V84, P693, DOI 10.1002/jsfa.1717; Sahu J, 2015, OMICS, V19, P52, DOI 10.1089/omi.2014.0113; Santos GM, 2010, CIENC RURAL, V40, P1636, DOI 10.1590/S0103-84782010005000103; Santos Jean C S, 2015, BMC Res Notes, V8, P83, DOI 10.1186/s13104-015-1044-9; *SAS I INC, SAS STAT US GUID REL; Sayid R, 2013, DAILY MIRROR ON 1231; Shrivastava D, 2014, MOL BIOL REP, V41, P5669, DOI 10.1007/s11033-014-3436-7; Taniguchi F, 2012, BREEDING SCI, V62, P186, DOI 10.1270/jsbbs.62.186; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; ul Haq S, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/863948; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; VASCONCELOS M N L, 1975, Acta Amazonica, V5, P293; Verica JA, 2004, PLANT CELL REP, V23, P404, DOI 10.1007/s00299-004-0852-5; Wang LX, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0259-8; Yang H, 2003, J NAT PROD, V66, P1501, DOI 10.1021/np034002j	73	8	8	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0151074	10.1371/journal.pone.0151074	http://dx.doi.org/10.1371/journal.pone.0151074			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26949967	Green Published, gold			2022-12-27	WOS:000371990100087
J	Broen, MPG; Marsman, VAM; Kuijf, ML; Van Oostenbrugge, RJ; van Os, J; Leentjens, AFG				Broen, Martijn P. G.; Marsman, Vera A. M.; Kuijf, Mark L.; Van Oostenbrugge, Robert J.; van Os, Jim; Leentjens, Albert F. G.			Unraveling the Relationship between Motor Symptoms, Affective States and Contextual Factors in Parkinson's Disease: A Feasibility Study of the Experience Sampling Method	PLOS ONE			English	Article							MOMENTARY ASSESSMENT; DAILY-LIFE; DEPRESSION; ANXIETY; MOOD; FLUCTUATIONS; VALIDATION; QUALITY; ONSET	Background In Parkinson's disease (PD), the complex relationship between motor symptoms, affective states, and contextual factors remains to be elucidated. The Experience Sampling Method provides (ESM) a novel approach to this issue. Using a mobile device with a special purpose application (app), motor symptoms, affective states and contextual factors are assessed repeatedly at random moments in the flow of daily life, yielding an intensive time series of symptoms and experience. The aim of this study was to study the feasibility of this method. Method We studied the feasibility of a five-day period of ESM in PD and its ability to objectify diurnal fluctuations in motor symptom severity and their relation with affect and contextual factors in five PD patients with motor fluctuations. Results Participants achieved a high compliance, with 84% of assessment moments completed without disturbance of daily activities. The utility of the device was rated 8 on a 10-point scale. We were able to capture extensive diurnal fluctuations that were not revealed by routine clinical assessment. In addition, we were able to detect clinically relevant associations between motor symptoms, emotional fluctuations and contextual factors at an intra-individual level. Conclusions ESM represents a viable and novel approach to elucidate relationships between motor symptoms, affective states and contextual factors at the level of individual subjects. ESM holds promise for clinical practice and scientific research.	[Broen, Martijn P. G.; Kuijf, Mark L.; Van Oostenbrugge, Robert J.] Maastricht Univ, Med Ctr, Dept Neurol, NL-6200 MD Maastricht, Netherlands; [Marsman, Vera A. M.; van Os, Jim; Leentjens, Albert F. G.] Maastricht Univ, Med Ctr, Dept Psychiat & Psychol, NL-6200 MD Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England	Maastricht University; Maastricht University; University of London; King's College London	Broen, MPG (corresponding author), Maastricht Univ, Med Ctr, Dept Neurol, NL-6200 MD Maastricht, Netherlands.	martijn.broen@mumc.nl	van Os, Jim/C-2113-2014; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/V-8884-2019	van Os, Jim/0000-0002-7245-1586	Michael J Fox Foundation; Stichting Internationaal Parkinson Fonds; Elsevier Inc	Michael J Fox Foundation; Stichting Internationaal Parkinson Fonds; Elsevier Inc	M. Broen, V. Marsman, M. Kuijf and R. Van Oostenbrugge have nothing to disclose. J. van Os has potential financial competing interests since he received unrestricted investigator-led research grants or recompense for presenting research at meetings from Eli Lilly, Bristol-Myers Squibb, Lundbeck, Organon, Takeda, Janssen-Cilag, GlaxoSmithKline, AstraZeneca, Pfizer and Servier. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. A.F.G. Leentjens has potential financial competing interests since he received research grants from the Michael J Fox Foundation and the Stichting Internationaal Parkinson Fonds, as well as royalties from Reed-Elsevier, de Tijdstroom and Van Gorcum publishers. In addition he receives payment from Elsevier Inc as Editor-in-Chief of the Journal of Psychosomatic Research. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Barge-Schaapveld DQCM, 2002, J CLIN PSYCHIAT, V63, P477, DOI 10.4088/JCP.v63n0603; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Benka Wallen M, 2015, PHYS THER; CANTELLO R, 1986, J NEUROL NEUROSUR PS, V49, P1182, DOI 10.1136/jnnp.49.10.1182; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; Csikszentmihalyi M., 2006, EXPERIENCE PSYCHOPAT; Delespaul P.A.E.G., 1995, ASSESSING SCHIZOPHRE; deRijk MC, 1997, NEUROLOGY, V48, P1277, DOI 10.1212/WNL.48.5.1277; Dunton GF, 2015, HEALTH PSYCHOL, V34, P1145, DOI 10.1037/hea0000223; Fahn S., 1987, RECENT DEV PARKINSON, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hartmann JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128095; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Houtveen JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072827; Hufford M.R., 2001, PROGR AMBULATORY ASS, P69; Jacobs N, 2011, BRIT J CLIN PSYCHOL, V50, P19, DOI 10.1348/014466510X491397; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Kizilbash AH, 2002, ARCH CLIN NEUROPSYCH, V17, P57, DOI 10.1016/S0887-6177(00)00101-3; Kramer I, 2014, WORLD PSYCHIATRY, V13, P68, DOI 10.1002/wps.20090; Leentjens AFG, 2012, PARKINSONISM RELAT D, V18, P1084, DOI 10.1016/j.parkreldis.2012.06.007; Leentjens AFG, 2014, MOVEMENT DISORD, V29, P1035, DOI 10.1002/mds.25919; Louter M, 2015, J NEUROL NEUROSUR PS, V86, P32, DOI 10.1136/jnnp-2013-306851; Mujagic Z, 2015, NEUROGASTROENT MOTIL, V27, P1295, DOI 10.1111/nmo.12624; Mulvaney SA, 2013, J MED INTERNET RES, V15, P130, DOI 10.2196/jmir.2413; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; NISSENBAUM H, 1987, PSYCHOL MED, V17, P899, DOI 10.1017/S0033291700000702; Odawara M, 2015, INT J BEHAV MED; Peeters F, 2006, EMOTION, V6, P383, DOI 10.1037/1528-3542.6.3.383; Rahman S, 2008, MOVEMENT DISORD, V23, P1428, DOI 10.1002/mds.21667; Richard IH, 2001, J NEUROPSYCH CLIN N, V13, P35, DOI 10.1176/appi.neuropsych.13.1.35; Richard Irene H, 2004, Cogn Behav Neurol, V17, P201; Sotgiu I, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00336; van de Leemput IA, 2014, P NATL ACAD SCI USA, V111, P87, DOI 10.1073/pnas.1312114110; van Os J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115254; van Os J, 2013, WORLD PSYCHIATRY, V12, P113, DOI 10.1002/wps.20046; Walz LC, 2014, J ANXIETY DISORD, V28, P925, DOI 10.1016/j.janxdis.2014.09.022; Wichers M, 2011, ACTA PSYCHIAT SCAND, V124, P262, DOI 10.1111/j.1600-0447.2011.01749.x; Wichers MC, 2009, NEUROPSYCHOPHARMACOL, V34, P923, DOI 10.1038/npp.2008.66	38	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151195	10.1371/journal.pone.0151195	http://dx.doi.org/10.1371/journal.pone.0151195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26962853	Green Submitted, gold, Green Published			2022-12-27	WOS:000371993000119
J	Abascal, JFPJ; Abella, M; Marinetto, E; Pascau, J; Desco, M				Abascal, Juan F. P. J.; Abella, Monica; Marinetto, Eugenio; Pascau, Javier; Desco, Manuel			A Novel Prior- and Motion-Based Compressed Sensing Method for Small-Animal Respiratory Gated CT	PLOS ONE			English	Article							MICRO-CT; TEMPORAL RESOLUTION; IMAGE; RECONSTRUCTION; REGISTRATION; ALGORITHM; PICCS; INTERPOLATION; PERFORMANCE; SPARSITY	Low-dose protocols for respiratory gating in cardiothoracic small-animal imaging lead to streak artifacts in the images reconstructed with a Feldkamp-Davis-Kress (FDK) method. We propose a novel prior-and motion-based reconstruction (PRIMOR) method, which improves prior-based reconstruction (PBR) by adding a penalty function that includes a model of motion. The prior image is generated as the average of all the respiratory gates, reconstructed with FDK. Motion between respiratory gates is estimated using a nonrigid registration method based on hierarchical B-splines. We compare PRIMOR with an equivalent PBR method without motion estimation using as reference the reconstruction of high dose data. From these data acquired with a micro-CT scanner, different scenarios were simulated by changing photon flux and number of projections. Methods were evaluated in terms of contrast-to-noise-ratio (CNR), mean square error (MSE), streak artefact indicator (SAI), solution error norm (SEN), and correction of respiratory motion. Also, to evaluate the effect of each method on lung studies quantification, we have computed the Jaccard similarity index of the mask obtained from segmenting each image as compared to those obtained from the high dose reconstruction. Both iterative methods greatly improved FDK reconstruction in all cases. PBR was prone to streak artifacts and presented blurring effects in bone and lung tissues when using both a low number of projections and low dose. Adopting PBR as a reference, PRIMOR increased CNR up to 33% and decreased MSE, SAI and SEN up to 20%, 4% and 13%, respectively. PRIMOR also presented better compensation for respiratory motion and higher Jaccard similarity index. In conclusion, the new method proposed for low-dose respiratory gating in small-animal scanners shows an improvement in image quality and allows a reduction of dose or a reduction of the number of projections between two and three times with respect to previous PBR approaches.	[Abascal, Juan F. P. J.; Abella, Monica; Marinetto, Eugenio; Pascau, Javier; Desco, Manuel] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroesp, Madrid, Spain; [Abascal, Juan F. P. J.; Abella, Monica; Marinetto, Eugenio; Pascau, Javier; Desco, Manuel] Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain; [Desco, Manuel] Ctr Invest Red Salud Mental CIBERSAM, Madrid, Spain	Universidad Carlos III de Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Abella, M (corresponding author), Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroesp, Madrid, Spain.; Abella, M (corresponding author), Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain.	monica.abella@uc3m.es	Pascau, Javier/B-5734-2013; Desco, Manuel/AAD-7137-2019; ABASCAL, JUAN FPJ/L-7062-2014; ABELLA, MONICA/AAE-7616-2019	Pascau, Javier/0000-0003-1484-731X; Desco, Manuel/0000-0003-0989-3231; ABASCAL, JUAN FPJ/0000-0002-2757-8676; ABELLA, MONICA/0000-0002-4847-7233	Spanish Ministerio de Economia y Competitividad [IDI-20130301, TEC2013-47270-R, IPT-2012-0401-300000, RTC-2014-3028-1, RD12/0042/0057]; Innovative Medicines Initiative Joint Undertaking [115337]; European Union's Seventh Framework Programme FP7; EFPIA companies	Spanish Ministerio de Economia y Competitividad(Spanish Government); Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme FP7; EFPIA companies	This work was funded by the Spanish Ministerio de Economia y Competitividad (www.mineco.gob.es/) with projects IDI-20130301, TEC2013-47270-R, IPT-2012-0401-300000, RTC-2014-3028-1, and RD12/0042/0057. Also, the research leading to these results has received funding from the Innovative Medicines Initiative (www.imi.europa.eu) Joint Undertaking under grant agreement n degrees 115337, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal JFPJ, 2011, MED PHYS, V38, P6275, DOI 10.1118/1.3656063; Abascal JFPJ, 2014, IFMBE P, P233; Abascal JFPJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120140; Abascal JFPJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110594; Abella M, 2012, COMPUT METH PROG BIO, V107, P218, DOI 10.1016/j.cmpb.2011.06.008; Asif MS, 2013, MAGN RESON MED, V70, P800, DOI 10.1002/mrm.24524; Badea CT, 2011, PHYS MED BIOL, V56, P3351, DOI 10.1088/0031-9155/56/11/011; Blu T, 2003, IEEE T IMAGE PROCESS, V12, P1297, DOI 10.1109/TIP.2003.818018; Blu T, 2001, IEEE T IMAGE PROCESS, V10, P1069, DOI 10.1109/83.931101; Boone John M, 2004, Mol Imaging, V3, P149, DOI 10.1162/1535350042380326; Bruckstein AM, 2009, SIAM REV, V51, P34, DOI 10.1137/060657704; Buckheit JB, 1995, WAVELAB REFERENCE MA; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2005, P SPIE COMPUTATIONAL, V5914; Candes E, 2007, INVERSE PROBL, V23, P969, DOI 10.1088/0266-5611/23/3/008; Chavarrias C, 2008, PHYS MED BIOL, V53, P4683, DOI 10.1088/0031-9155/53/17/015; Chen GH, 2008, MED PHYS, V35, P660, DOI 10.1118/1.2836423; Dang H, 2014, PHYS MED BIOL, V59, P4799, DOI 10.1088/0031-9155/59/17/4799; Ford NL, 2014, J BIO SCI ENG, V7, P157; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Heusser T, 2014, MED PHYS, V41, DOI 10.1118/1.4851536; Hill DLG, 2001, PHYS MED BIOL, V46, pR1, DOI 10.1088/0031-9155/46/3/201; Jeong YJ, 2008, AM J ROENTGENOL, V191, P834, DOI 10.2214/AJR.07.3896; Leng S, 2008, PHYS MED BIOL, V53, P5653, DOI 10.1088/0031-9155/53/20/006; Maier J, 2014, MED PHYS, V41, DOI 10.1118/1.4870983; MCKINNON GC, 1981, IEEE T BIO-MED ENG, V28, P123, DOI 10.1109/TBME.1981.324785; Nett B, 2009, P SOC PHOTO-OPT INS, V7258; Nett BE, 2010, PHYS MED BIOL, V55, P2333, DOI 10.1088/0031-9155/55/8/014; Osher S, 2005, MULTISCALE MODEL SIM, V4, P460, DOI 10.1137/040605412; Pan XC, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123009; Qi ZH, 2011, PHYS MED BIOL, V56, P6709, DOI 10.1088/0031-9155/56/20/013; Ramani S, 2012, IEEE T MED IMAGING, V31, P677, DOI 10.1109/TMI.2011.2175233; Ritschl L, 2012, PHYS MED BIOL, V57, P1517, DOI 10.1088/0031-9155/57/6/1517; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sawall S, 2011, MED PHYS, V38, P1416, DOI 10.1118/1.3551993; Stayman JW, 2011, PROC SPIE, V7961, DOI 10.1117/12.878075; Sureshbabu W, 2005, J NUCL MED TECHNOL, V33, P156; Tang J, 2010, MED PHYS, V37, P4377, DOI 10.1118/1.3460318; Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4; Vaquero JJ, 2008, IEEE T NUCL SCI, V55, P898, DOI 10.1109/TNS.2008.922814; Wang H, 2005, PHYS MED BIOL, V50, P2887, DOI 10.1088/0031-9155/50/12/011; Wang YL, 2008, SIAM J IMAGING SCI, V1, P248, DOI 10.1137/080724265; Zhang QH, 2007, MED PHYS, V34, P4772, DOI 10.1118/1.2804576; Zhang QH, 2010, MED PHYS, V37, P2901, DOI 10.1118/1.3397460	44	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149841	10.1371/journal.pone.0149841	http://dx.doi.org/10.1371/journal.pone.0149841			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959370	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300025
J	Hancock, SP; Stella, S; Cascio, D; Johnson, RC				Hancock, Stephen P.; Stella, Stefano; Cascio, Duilio; Johnson, Reid C.			DNA Sequence Determinants Controlling Affinity, Stability and Shape of DNA Complexes Bound by the Nucleoid Protein Fis	PLOS ONE			English	Article							INTEGRATION HOST FACTOR; RRNB P1 PROMOTER; PROP P2 PROMOTER; ESCHERICHIA-COLI; GENE-EXPRESSION; RNA-POLYMERASE; TRANSCRIPTIONAL ACTIVATOR; BACTERIAL CHROMATIN; MAXIMUM-LIKELIHOOD; CRYSTAL-STRUCTURE	The abundant Fis nucleoid protein selectively binds poorly related DNA sequences with high affinities to regulate diverse DNA reactions. Fis binds DNA primarily through DNA backbone contacts and selects target sites by reading conformational properties of DNA sequences, most prominently intrinsic minor groove widths. High-affinity binding requires Fis-stabilized DNA conformational changes that vary depending on DNA sequence. In order to better understand the molecular basis for high affinity site recognition, we analyzed the effects of DNA sequence within and flanking the core Fis binding site on binding affinity and DNA structure. X-ray crystal structures of Fis-DNA complexes containing variable sequences in the noncontacted center of the binding site or variations within the major groove interfaces show that the DNA can adapt to the Fis dimer surface asymmetrically. We show that the presence and position of pyrimidine-purine base steps within the major groove interfaces affect both local DNA bending and minor groove compression to modulate affinities and lifetimes of Fis-DNA complexes. Sequences flanking the core binding site also modulate complex affinities, lifetimes, and the degree of local and global Fis-induced DNA bending. In particular, a G immediately upstream of the 15 bp core sequence inhibits binding and bending, and A-tracts within the flanking base pairs increase both complex lifetimes and global DNA curvatures. Taken together, our observations support a revised DNA motif specifying high-affinity Fis binding and highlight the range of conformations that Fis-bound DNA can adopt. The affinities and DNA conformations of individual Fis-DNA complexes are likely to be tailored to their context-specific biological functions.	[Hancock, Stephen P.; Stella, Stefano; Cascio, Duilio; Johnson, Reid C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Cascio, Duilio] Univ Calif Los Angeles, Inst Genom & Prote, Dept Energy, Los Angeles, CA USA; [Cascio, Duilio; Johnson, Reid C.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Stella, Stefano] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Prot Struct & Funct Programme, Copenhagen, Denmark	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Copenhagen	Johnson, RC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.; Johnson, RC (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.	rcjohnson@mednet.ucla.edu			National Institutes of Health [GM038509, P41 RR015301, P41 GM103403]; Department of Energy [DE-FC0302ER63421, DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038509, R01GM038509, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grant GM038509 to RCJ. The UCLA X-ray core facility is supported in part by the Department of Energy grant DE-FC0302ER63421. The Advanced Photon Source beamline ID-24 of Argonne National Laboratory is supported by National Institutes of Health grants P41 RR015301 and P41 GM103403. Use of the Advanced Photon Source is supported by Department of Energy under Contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aiyar SE, 2002, J MOL BIOL, V316, P501, DOI 10.1006/jmbi.2001.5390; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Benoff B, 2002, SCIENCE, V297, P1562, DOI 10.1126/science.1076376; BETERMIER M, 1994, BIOCHIMIE, V76, P958, DOI 10.1016/0300-9084(94)90021-3; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BOKAL AJ, 1995, J MOL BIOL, V245, P197, DOI 10.1006/jmbi.1994.0016; Bokal AJ, 1997, EMBO J, V16, P154, DOI 10.1093/emboj/16.1.154; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; Cho BK, 2008, GENOME RES, V18, P900, DOI 10.1101/gr.070276.107; CROTHERS DM, 1992, METHOD ENZYMOL, V212, P46; Dame RT, 2005, MOL MICROBIOL, V56, P858, DOI 10.1111/j.1365-2958.2005.04598.x; Dickerson RE, 1998, NUCLEIC ACIDS RES, V26, P1906, DOI 10.1093/nar/26.8.1906; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Feldman-Cohen LS, 2006, J BACTERIOL, V188, P2081, DOI 10.1128/JB.188.6.2081-2095.2006; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; HALES LM, 1994, J BACTERIOL, V176, P2999, DOI 10.1128/JB.176.10.2999-3006.1994; Hales LM, 1996, NUCLEIC ACIDS RES, V24, P1780, DOI 10.1093/nar/24.9.1780; Hancock SP, 2013, NUCLEIC ACIDS RES, V41, P6750, DOI 10.1093/nar/gkt357; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; Hengen PN, 1997, NUCLEIC ACIDS RES, V25, P4994, DOI 10.1093/nar/25.24.4994; HUBNER P, 1989, EMBO J, V8, P577, DOI 10.1002/j.1460-2075.1989.tb03412.x; JOHNSON RC, 2008, RSC BIOMOL SCI, P176; Johnson RC, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0047-2014; Johnson Reid C., 2005, P65; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Kelly A, 2004, MICROBIOL-SGM, V150, P2037, DOI 10.1099/mic.0.27209-0; KOCH C, 1991, NUCLEIC ACIDS RES, V19, P5915, DOI 10.1093/nar/19.21.5915; KOSTREWA D, 1991, NATURE, V349, P178, DOI 10.1038/349178a0; Landy A, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0051-2014; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; LAZARUS LR, 1993, EMBO J, V12, P2483, DOI 10.1002/j.1460-2075.1993.tb05903.x; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mauro SA, 2003, J BIOL CHEM, V278, P12955, DOI 10.1074/jbc.M212667200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLean MM, 2013, ELIFE, V2, DOI 10.7554/eLife.01211; McLeod SM, 1999, J MOL BIOL, V294, P333, DOI 10.1006/jmbi.1999.3262; McLeod SM, 2002, J MOL BIOL, V316, P517, DOI 10.1006/jmbi.2001.5391; McLeod SM, 2001, CURR OPIN MICROBIOL, V4, P152, DOI 10.1016/S1369-5274(00)00181-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neidle S., 1999, OXFORD HDB NUCL ACID, P1; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; OSUNA R, 1991, EMBO J, V10, P1593, DOI 10.1002/j.1460-2075.1991.tb07680.x; Pan CQ, 1996, J MOL BIOL, V264, P675, DOI 10.1006/jmbi.1996.0669; Papagiannis CV, 2007, J MOL BIOL, V367, P328, DOI 10.1016/j.jmb.2006.12.071; PerkinsBalding D, 1997, J BACTERIOL, V179, P4747, DOI 10.1128/jb.179.15.4747-4753.1997; PRENTKI P, 1987, NUCLEIC ACIDS RES, V15, P10060, DOI 10.1093/nar/15.23.10060; Radman-Livaja M, 2005, P NATL ACAD SCI USA, V102, P3913, DOI 10.1073/pnas.0500844102; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Seah NE, 2014, P NATL ACAD SCI USA, V111, P12372, DOI 10.1073/pnas.1413019111; Shao YP, 2008, J MOL BIOL, V380, P327, DOI 10.1016/j.jmb.2008.04.075; Shao YP, 2008, J MOL BIOL, V376, P771, DOI 10.1016/j.jmb.2007.11.101; Sitlani A, 1998, P NATL ACAD SCI USA, V95, P1404, DOI 10.1073/pnas.95.4.1404; Skoko D, 2006, J MOL BIOL, V364, P777, DOI 10.1016/j.jmb.2006.09.043; Stella S, 2010, GENE DEV, V24, P814, DOI 10.1101/gad.1900610; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; THOMPSON JF, 1987, CELL, V50, P901, DOI 10.1016/0092-8674(87)90516-2; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; Travers A, 2005, CURR OPIN GENET DEV, V15, P507, DOI 10.1016/j.gde.2005.08.006; Typas A, 2007, MOL MICROBIOL, V63, P780, DOI 10.1111/j.1365-2958.2006.05560.x; Ussery D, 2001, BIOCHIMIE, V83, P201, DOI 10.1016/S0300-9084(00)01225-6; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064688; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; YUAN HS, 1991, P NATL ACAD SCI USA, V88, P9558, DOI 10.1073/pnas.88.21.9558; ZINKEL SS, 1987, NATURE, V328, P178, DOI 10.1038/328178a0	73	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150189	10.1371/journal.pone.0150189	http://dx.doi.org/10.1371/journal.pone.0150189			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959646	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300036
J	Samy, AM; Peterson, AT				Samy, Abdallah M.; Peterson, A. Townsend			Climate Change Influences on the Global Potential Distribution of Bluetongue Virus	PLOS ONE			English	Article							EPIZOOTIC HEMORRHAGIC-DISEASE; UNIQUE FEATURES; CULICOIDES; EUROPE; VECTORS; EPIDEMIOLOGY; FUTURE; RISK; SURVEILLANCE; TRANSMISSION	The geographic distribution of arboviruses has received considerable attention after several dramatic emergence events around the world. Bluetongue virus (BTV) is classified among category "A" diseases notifiable to the World Organization of Animal Health (OIE), and is transmitted among ruminants by biting midges of the genus Culicoides. Here, we developed a comprehensive occurrence data set to map the current distribution, estimate the ecological niche, and explore the future potential distribution of BTV globally using ecological niche modeling and based on diverse future climate scenarios from general circulation models (GCMs) for four representative concentration pathways (RCPs). The broad ecological niche and potential geographic distribution of BTV under present-day conditions reflected the disease's current distribution across the world in tropical, subtropical, and temperate regions. All model predictions were significantly better than random expectations. As a further evaluation of model robustness, we compared our model predictions to 331 independent records from most recent outbreaks from the Food and Agriculture Organization Emergency Prevention System for Transboundary Animal and Plant Pests and Diseases Information System (EMPRES-i); all were successfully anticipated by the BTV model. Finally, we tested ecological niche similarity among possible vectors and BTV, and could not reject hypotheses of niche similarity. Under future-climate conditions, the potential distribution of BTV was predicted to broaden, especially in central Africa, United States, and western Russia.	[Samy, Abdallah M.; Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Samy, Abdallah M.] Ain Shams Univ, Fac Sci, Dept Entomol, Cairo, Egypt	University of Kansas; Egyptian Knowledge Bank (EKB); Ain Shams University	Samy, AM (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.; Samy, AM (corresponding author), Ain Shams Univ, Fac Sci, Dept Entomol, Cairo, Egypt.	samy@ku.edu	Samy, Abdallah/B-4375-2010; Peterson, A. Townsend/I-5697-2013	Samy, Abdallah/0000-0003-3978-1134; Peterson, A. Townsend/0000-0003-0243-2379	Graduate Fulbright Egyptian Mission Program (EFMP); KU ENM group; Department of Entomology; Research and Training Center on Vectors of Diseases of Ain Shams University	Graduate Fulbright Egyptian Mission Program (EFMP); KU ENM group; Department of Entomology; Research and Training Center on Vectors of Diseases of Ain Shams University	AMS was supported by the Graduate Fulbright Egyptian Mission Program (EFMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AMS was funded by the Graduate Egyptian Fulbright Mission Program (EFMP). The authors thank the KU ENM group, and the Department of Entomology and the Research and Training Center on Vectors of Diseases of Ain Shams University, for their support during this work. Thanks also go to Qiao Huijie for his support and assistance during the study.	[Anonymous], 2011, ECOLOGICAL NICHES GE; Barve N., 2013, ENMGADGETS TOOLS PRE; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Dash AP, 2013, J VECTOR DIS, V50, P77; Faes C, 2013, PREV VET MED, V110, P149, DOI 10.1016/j.prevetmed.2012.11.026; [FAOSTAT Food and Agriculture Organization of the United Nations], 2015, FAOSTAT DAT; Gerdes GH, 2004, VETER ITAL SER, V40, P39; Guichard S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112491; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Lager IA, 2004, VETER ITAL SER, V40, P141; Legisa DM, 2014, VIRUS RES, V182, P87, DOI 10.1016/j.virusres.2013.10.030; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; MacLachlan N J, 2004, Vet Ital, V40, P462; Maclachlan NJ, 2013, ANTIVIR RES, V99, P79, DOI 10.1016/j.antiviral.2013.04.021; McVey DS, 2015, VECTOR-BORNE ZOONOT, V15, P385, DOI 10.1089/vbz.2014.1698; Mouchet J, 1997, Sante, V7, P263; Patakakis MJ, 2009, J VECTOR ECOL, V34, P243, DOI [10.3376/038.034.0211, 10.1111/j.1948-7134.2009.00033.x]; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Pfannenstiel RS, 2015, VECTOR-BORNE ZOONOT, V15, P374, DOI 10.1089/vbz.2014.1705; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pigott DM, 2014, ELIFE, V3, DOI 10.7554/eLife.04395; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; R Development Core Team, 2015, LANG ENV STAT COMP; Racloz V, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-42; Racloz Vanessa, 2007, Vet Ital, V43, P513; Radostits O., 2007, VET MED TXB DIS CATT, V10; Ruder MG, 2015, VECTOR-BORNE ZOONOT, V15, P348, DOI 10.1089/vbz.2014.1703; Samy AM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003250; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Sreenivasulu D, 2004, VETER ITAL SER, V40, P73; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Tabachnick WJ, 2010, J EXP BIOL, V213, P946, DOI 10.1242/jeb.037564; Tabachnick WJ, 1996, ANNU REV ENTOMOL, V41, P23, DOI 10.1146/annurev.en.41.010196.000323; TANYA VN, 1992, VET MICROBIOL, V32, P1, DOI 10.1016/0378-1135(92)90002-B; Tatem AJ, 2003, VET MICROBIOL, V97, P13, DOI 10.1016/j.vetmic.2003.08.009; Torina A, 2004, MED VET ENTOMOL, V18, P81, DOI 10.1111/j.0269-283X.2004.00493.x; Turner J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00319; Venter GJ, 2006, MED VET ENTOMOL, V20, P329, DOI 10.1111/j.1365-2915.2006.00635.x; Verwoerd DW, 2009, ONDERSTEPOORT J VET, V76, P99; Walton TE, 2004, VETER ITAL SER, V40, P31; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Webb D, 2008, EC SOCIAL IMPACT I A; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Zuliani A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130294	46	35	36	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150489	10.1371/journal.pone.0150489	http://dx.doi.org/10.1371/journal.pone.0150489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959424	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300053
J	Hirth, S; Buhler, A; Buhrdel, JB; Rudeck, S; Dahme, T; Rottbauer, W; Just, S				Hirth, Sofia; Buehler, Anja; Buehrdel, John B.; Rudeck, Steven; Dahme, Tillman; Rottbauer, Wolfgang; Just, Steffen			Paxillin and Focal Adhesion Kinase (FAK) Regulate Cardiac Contractility in the Zebrafish Heart	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; DILATED CARDIOMYOPATHY; ADAPTER PROTEIN; EMBRYONIC HEART; VINCULIN; CARDIOMYOCYTES; BINDING; ILK; LOCALIZATION; HYPERTROPHY	An orchestrated interplay of adaptor and signaling proteins at mechano-sensitive sites is essential to maintain cardiac contractility and when defective leads to heart failure. We recently showed that Integrin-linked Kinase (ILK), beta-Parvin and PINCH form the IPP-complex to grant tuned Protein Kinase B (PKB) signaling in the heart. Loss of one of the IPP-complex components results in destabilization of the whole complex, defective PKB signaling and finally heart failure. Two components of IPP, ILK and beta-Parvin directly bind to Paxillin; however, the impact of this direct interaction on the maintenance of heart function is not known yet. Here, we show that targeted gene inactivation of Paxillin results in progressive decrease of cardiac contractility and heart failure in zebrafish without affecting IPP-complex stability and PKB phosphorylation. However, we found that Paxillin deficiency leads to the destabilization of its known binding partner Focal Adhesion Kinase (FAK) and vice versa resulting in degradation of Vinculin and thereby heart failure. Our findings highlight an essential role of Paxillin and FAK in controlling cardiac contractility via the recruitment of Vinculin to mechano-sensitive sites in cardiomyocytes.	[Hirth, Sofia; Buehler, Anja; Buehrdel, John B.; Rudeck, Steven; Just, Steffen] Univ Ulm, Mol Cardiol, D-89069 Ulm, Germany; [Dahme, Tillman; Rottbauer, Wolfgang] Univ Ulm, Dept Med 2, Ulm, Germany	Ulm University; Ulm University	Just, S (corresponding author), Univ Ulm, Mol Cardiol, D-89069 Ulm, Germany.; Rottbauer, W (corresponding author), Univ Ulm, Dept Med 2, Ulm, Germany.	wolfgang.rottbauer@uniklinik-ulm.de; steffen.just@uniklinik-ulm.de	Dahme, Tillman/AAN-4511-2021	Dahme, Tillman/0000-0002-6211-7162; Buhler, Anja/0000-0003-2927-2379	Deutsche Forschungsgemeinschaft [RO2173/3-1, RO2173/3-2, RO2173/4-2, JU2859/1-2]; Bundesministerium fuur Bildung und Forschung [01GS1104, 01KU0901C, 01ZX1407A]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fuur Bildung und Forschung	This work was supported by the following sources of funding: Deutsche Forschungsgemeinschaft, RO2173/3-1 (WR), RO2173/3-2 (WR), RO2173/4-2 (WR), JU2859/1-2 (SJ) (www.dfg.de/) and Bundesministerium fuur Bildung und Forschung, 01GS1104 (WR), 01KU0901C (WR), 01ZX1407A (SJ) (https://www.bmbf.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Goldmann WH, 2013, CELL BIOL INT, V37, P397, DOI 10.1002/cbin.10064; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hannigan GE, 2007, CIRC RES, V100, P1408, DOI 10.1161/01.RES.0000265233.40455.62; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knoll R, 2007, CIRCULATION, V116, P515, DOI 10.1161/CIRCULATIONAHA.107.689984; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Meder B, 2011, MOL CELL BIOL, V31, P3424, DOI 10.1128/MCB.05269-11; Meder B, 2010, J CELL SCI, V123, P2613, DOI 10.1242/jcs.067967; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; PARDO JV, 1983, J CELL BIOL, V97, P1081, DOI 10.1083/jcb.97.4.1081; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Peng X, 2006, J CLIN INVEST, V116, P217, DOI 10.1172/JCI24497; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Rottbauer W, 2005, GENE DEV, V19, P1624, DOI 10.1101/gad.1319405; Sander V, 2013, NAT PROTOC, V8, P800, DOI 10.1038/nprot.2013.041; Schaller MD, 2004, J CELL BIOL, V166, P157, DOI 10.1083/jcb.200406151; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Stiegler AL, 2012, J BIOL CHEM, V287, P32566, DOI 10.1074/jbc.M112.367342; Thomas SM, 1999, J CELL SCI, V112, P181; Vogel B, 2009, BIOCHEM BIOPH RES CO, V390, P516, DOI 10.1016/j.bbrc.2009.09.129; Westerfied M, 1993, ZEBRAFISH BOOK GUIDE; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Yang JC, 2012, JOVE-J VIS EXP, DOI 10.3791/3510; Yund EE, 2009, J MOL CELL CARDIOL, V47, P520, DOI 10.1016/j.yjmcc.2009.06.006; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07	28	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150323	10.1371/journal.pone.0150323	http://dx.doi.org/10.1371/journal.pone.0150323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954676	gold, Green Published, Green Submitted			2022-12-27	WOS:000371991300021
J	Kaur, PK; Tripathi, N; Desale, J; Neelagiri, S; Yadav, S; Bharatam, PV; Singh, S				Kaur, Preet Kamal; Tripathi, Neha; Desale, Jayesh; Neelagiri, Soumya; Yadav, Shailendra; Bharatam, Prasad V.; Singh, Sushma			Mutational and Structural Analysis of Conserved Residues in Ribose-5-Phosphate Isomerase B from Leishmania donovani: Role in Substrate Recognition and Conformational Stability	PLOS ONE			English	Article							RIBOSE 5-PHOSPHATE ISOMERASE; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; D-RIBOSE-5-PHOSPHATE ISOMERASE; CLOSTRIDIUM-THERMOCELLUM; COMPETITIVE INHIBITORS; REACTION-MECHANISM; TRYPANOSOMA-CRUZI; D-ALLOSE; ENZYME	Ribose-5-phosphate isomerase B from Leishmania donovani (LdRpiB) is one of the potential drug targets against visceral leishmaniasis. In the present study, we have targeted several conserved amino acids for mutational analysis (i.e. Cys69, His11, His102, His138, Asp45, Tyr46, Pro47 and Glu149) to gain crucial insights into their role in substrate binding, catalysis and conformational stability of the enzyme. All the eight LdRpiB variants were cloned, sequenced, expressed and purified. C69S, H102N, D45N and E149A mutants exhibited complete loss of enzyme activity indicating that they are indispensable for the enzyme activity. Kinetic parameters were altered in case of H138N, H11N and P47A variants; however Y46F exhibited similar kinetic behaviour as wild type. All the mutants except H138N exhibited altered protein structure as determined by CD and fluorescence spectral analysis. This data was supported by the atomic level details of the conformational changes and substrate binding using molecular dynamic simulations. LdRpiB also exhibited activity with D-form of various aldose substrates in the order of D-ribose > D-talose > D-allose > D-arabinose. Our study provides insights for better understanding of substrate enzyme interactions which can rationalize the process of drug design against parasite RpiB.	[Kaur, Preet Kamal; Desale, Jayesh; Neelagiri, Soumya; Yadav, Shailendra; Singh, Sushma] Natl Inst Pharmaceut Educ & Res, Dept Biotechnol, Mohali, Punjab, India; [Tripathi, Neha; Bharatam, Prasad V.] Natl Inst Pharmaceut Educ & Res, Dept Pharmacoinformat, Mohali, Punjab, India; [Bharatam, Prasad V.] Natl Inst Pharmaceut Educ & Res, Dept Med Chem, Mohali, Punjab, India	National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali); National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali); National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Singh, S (corresponding author), Natl Inst Pharmaceut Educ & Res, Dept Biotechnol, Mohali, Punjab, India.	sushmasingh@niper.ac.in	yadav, Shailendra/G-1295-2017	yadav, Shailendra/0000-0002-0520-266X; Singh, Sushma/0000-0002-7089-6442; SOUMYA, NEELAGIRI/0000-0003-3286-7760	Department of Pharmaceuticals, India [KA01]; CSIR, New Delhi	Department of Pharmaceuticals, India; CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Department of Pharmaceuticals, India (KA01) and Director, NIPER, S.A.S. Nagar. NT was supported by CSIR, New Delhi for her fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MAESTR VERS 9 3; Boitz JM, 2012, J BIOL CHEM, V287, P7626, DOI 10.1074/jbc.M111.307884; Capriles PVSZ, 2015, J MOL GRAPH MODEL, V55, P134, DOI 10.1016/j.jmgm.2014.11.002; Case D.A., 2010, AMBER VERSION 11; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jung CH, 2000, ARCH BIOCHEM BIOPHYS, V373, P409, DOI 10.1006/abbi.1999.1554; Kaur PK, 2014, APPL BIOCHEM BIOTECH, V173, P1870, DOI 10.1007/s12010-014-0973-4; Kaur PK, 2012, BIOCHEM BIOPH RES CO, V421, P51, DOI 10.1016/j.bbrc.2012.03.107; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Korndorfer IP, 2000, J MOL BIOL, V300, P917, DOI 10.1006/jmbi.2000.3896; Loureiro I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003430; Mariano S, 2009, CARBOHYD RES, V344, P869, DOI 10.1016/j.carres.2009.02.024; Maugeri DA, 2003, MOL BIOCHEM PARASIT, V130, P117, DOI 10.1016/S0166-6851(03)00173-7; Park CS, 2007, BIOTECHNOL LETT, V29, P1387, DOI 10.1007/s10529-007-9393-7; Roos AK, 2005, J BIOL CHEM, V280, P6416, DOI 10.1074/jbc.M412018200; Roos AK, 2004, J MOL BIOL, V335, P799, DOI 10.1016/j.jmb.2003.11.021; Roos AK, 2008, J MOL BIOL, V382, P667, DOI 10.1016/j.jmb.2008.06.090; Sansom FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056064; Sorensen KI, 1996, J BACTERIOL, V178, P1003, DOI 10.1128/jb.178.4.1003-1011.1996; Stern AL, 2007, BIOCHEM J, V401, P279, DOI 10.1042/BJ20061049; Stern AL, 2011, FEBS J, V278, P793, DOI 10.1111/j.1742-4658.2010.07999.x; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; WHITLOW M, 1991, PROTEINS, V9, P153, DOI 10.1002/prot.340090302; Woods AS, 2005, J PROTEOME RES, V4, P1397, DOI 10.1021/pr050077s; Yeom SJ, 2010, BIOTECHNOL LETT, V32, P829, DOI 10.1007/s10529-010-0224-x; Yoon RY, 2009, J BIOTECHNOL, V139, P26, DOI 10.1016/j.jbiotec.2008.09.012; Zhang RG, 2003, STRUCTURE, V11, P31, DOI 10.1016/S0969-2126(02)00933-4	34	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150764	10.1371/journal.pone.0150764	http://dx.doi.org/10.1371/journal.pone.0150764			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953696	gold, Green Published, Green Submitted			2022-12-27	WOS:000371991300049
J	Hua, YJ; Zhang, XL; Utheim, TP; Huang, JH; Pan, C; Tan, WN; Wang, QM				Hua, Yanjun; Zhang, Xiaolan; Utheim, Tor Paaske; Huang, Jinhai; Pan, Chao; Tan, Weina; Wang, Qinmei			Evaluation of Equivalent Keratometry Readings Obtained by Pentacam HR (High Resolution)	PLOS ONE			English	Article							INTRAOCULAR-LENS POWER; CORNEAL REFRACTIVE SURGERY; MYOPIC PHOTOREFRACTIVE KERATECTOMY; IN-SITU KERATOMILEUSIS; DOUBLE-K METHOD; CATARACT-SURGERY; SCHEIMPFLUG CAMERA; EYES; ACCURACY; LASIK	Purpose To assess the repeatability of Equivalent Keratometry Readings (EKRs) obtained by the Pentacam HR (high resolution) in untreated and post-LASIK eyes, and to compare them with the keratometry (K) values obtained by other algorithms. Methods In this prospective study, 100 untreated eyes and 71 post-LASIK eyes were included. In the untreated group, each eye received 3 consecutive scans using the Pentacam HR, and EKR values in all central corneal zone, the true net power (K-net) and the simulated K (SimK) were obtained for each scan. In the post-LASIK group, each eye received subjective refraction and 3 consecutive scans with the Pentacam HR preoperatively. During the 3-month post-surgery exam, the same examinations and the use of an IOLMaster were conducted for each eye. The EKRs in all zone, the K-net, the mean K (K-m) by IOLMaster and the K values by clinical history method (K-CHM) were obtained. The repeatability of the EKRs was assessed by the within-subject standard deviation (S-w), 2.77S(w), coefficient of variation (CVw) and intraclass correlation coefficient (ICC). The bonferroni corrected multiple comparisons were performed to analyze the differences among the EKRs and K values calculated by other algorithms within the 2 groups. The 95% limits of agreement (LoA) were calculated. Results The EKR values in all central corneal zone were repeatable in both the untreated group (S-w <= 0.19 D, 2.77S(w)<= 0.52 D, CVw <= 1%, ICC >= 0.978) and the post-LASIK group (S-w <= 0.22 D, 2.77S(w)<= 0.62 D, CVw <= 1%, ICC >= 0.980). In the untreated group, the EKR in 4mm zone was close to SimK (P = 1.000), and the 95% LoA was (-0.13 to 0.15 D). The difference between K-net and SimK was -1.30 +/- 0.13 D (95% LoA-1.55 to -1.55 D, P<0.001). In the post-LASIK group, all the EKRs were significantly higher than K-CHM (all P<0.001). The differences between the EKR in 4mm zone and K-CHM, the EKR in 7mm zone and K-CHM, K-net and K-CHM, K-m and K-CHM, SimK and K-net were 0.64 +/- 0.50 D (95% LoA, -0.33 to 1.62 D), 1.77 +/- 0.88 D (95% LoA, 0.04 to 3.51 D), -0.98 +/- 0.48 D (95% LoA, -1.92 to -0.04 D), 0.64 +/- 0.53 D (95% LoA, -0.40 to 1.68 D), and 1.73 +/- 0.20 D (95% LoA, 1.33 to 2.13 D), respectively. Conclusions The EKRs obtained by the Pentacam HR were repeatable in both untreated eyes and post-LASIK eyes. Compared to the total corneal power obtained by the clinical history method, the EKR values generally overestimated the total corneal power in post-LASIK eyes. So, further calibrations for the EKR values should be conducted, before they were used for the total corneal power assessment in post-LASIK eyes.	[Hua, Yanjun] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Zhang, Xiaolan] Shanghai Eighth Peoples Hosp, Dept Geriatr, Shanghai, Peoples R China; [Utheim, Tor Paaske] Univ Coll South East Norway, Natl Ctr Opt Vis & Eye Care, Kongsberg, Norway; [Utheim, Tor Paaske] Vestre Viken Hosp Trust, Dept Ophthalmol, Drammen, Norway; [Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, N-0450 Oslo, Norway; [Huang, Jinhai; Pan, Chao; Tan, Weina; Wang, Qinmei] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Peoples R China; [Huang, Jinhai; Pan, Chao; Tan, Weina; Wang, Qinmei] Wenzhou Med Univ, Hosp Eye, Wenzhou, Peoples R China	Shanghai Jiao Tong University; University College of Southeast Norway; University of Oslo; Wenzhou Medical University; Wenzhou Medical University	Hua, YJ (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Ophthalmol, Shanghai 200030, Peoples R China.	hyj1860@hotmail.com	Huang, Jinhai/ABH-4519-2020	HUA, YANJUN/0000-0001-6461-3576				Aramberri J, 2003, J CATARACT REFR SURG, V29, P2063, DOI 10.1016/S0886-3350(03)00957-X; Bland JM, 1996, BRIT MED J, V313, P744; Borasio E, 2006, J CATARACT REFR SURG, V32, P2004, DOI 10.1016/j.jcrs.2006.08.037; Falavarjani KG, 2010, CLIN EXP OPHTHALMOL, V38, P341, DOI 10.1111/j.1442-9071.2010.02286.x; Feiz V, 2010, MIDDLE EAST AFR J OP, V17, P63, DOI 10.4103/0974-9233.61219; Goss DA, 2002, INTRO OPTICS EYE, P113; Haigis W, 2003, J CATARACT REFR SURG, V29, P1397, DOI 10.1016/S0886-3350(02)02044-8; Ho JD, 2008, J CATARACT REFR SURG, V34, P137, DOI 10.1016/j.jcrs.2007.09.033; Holladay JT, 2010, J CATARACT REFR SURG, V36, P182, DOI 10.1016/j.jcrs.2009.09.010; Holladay JT, 2009, J REFRACT SURG, V25, P862, DOI 10.3928/1081597X-20090917-07; HOLLADAY JT, 1989, AM J OPHTHALMOL, V107, P428, DOI 10.1016/0002-9394(89)90671-5; Jin HY, 2012, J CATARACT REFR SURG, V38, P1749, DOI 10.1016/j.jcrs.2012.06.048; Jin HY, 2010, J CATARACT REFR SURG, V36, P87, DOI 10.1016/j.jcrs.2009.07.011; Kalyani SD, 2008, CURR OPIN OPHTHALMOL, V19, P357, DOI 10.1097/ICU.0b013e3282fec43e; Maloney RK, 2000, J REFRACT SURG, V16, P756; McAlinden C, 2011, INVEST OPHTH VIS SCI, V52, P7731, DOI 10.1167/iovs.10-7093; McCarthy M, 2011, OPHTHALMOLOGY, V118, P940, DOI 10.1016/j.ophtha.2010.08.048; Saiki M, 2013, J CATARACT REFR SURG, V39, P556, DOI 10.1016/j.jcrs.2012.10.044; Savini G, 2008, J CATARACT REFR SURG, V34, P809, DOI 10.1016/j.jcrs.2008.01.012; Savini G, 2010, J REFRACT SURG, V26, P388, DOI 10.3928/1081597X-20100423-01; Savini G, 2009, J REFRACT SURG, V25, P534, DOI 10.3928/1081597X-20090512-07; Seitz B, 1999, OPHTHALMOLOGY, V106, P693, DOI 10.1016/S0161-6420(99)90153-7; Seitz B, 2000, J REFRACT SURG, V16, P349; Shammas HJ, 2007, J CATARACT REFR SURG, V33, P31, DOI 10.1016/j.jcrs.2006.08.045; Shammas HJ, 2003, AM J OPHTHALMOL, V136, P426, DOI 10.1016/S0002-9394(03)00275-7; Tang ML, 2010, J CATARACT REFR SURG, V36, P2115, DOI 10.1016/j.jcrs.2010.07.018; Tang QY, 2009, J CATARACT REFR SURG, V35, P1198, DOI 10.1016/j.jcrs.2009.02.030; Wang L, 2004, OPHTHALMOLOGY, V111, P1825, DOI 10.1016/j.ophtha.2004.04.022	28	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150121	10.1371/journal.pone.0150121	http://dx.doi.org/10.1371/journal.pone.0150121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950834	gold, Green Published, Green Submitted			2022-12-27	WOS:000371990100022
J	Kapoula, Z; Ruiz, S; Spector, L; Mocorovi, M; Gaertner, C; Quilici, C; Vernet, M				Kapoula, Zoi; Ruiz, Sarah; Spector, Lisa; Mocorovi, Marion; Gaertner, Chrystal; Quilici, Catherine; Vernet, Marine			Education Influences Creativity in Dyslexic and Non-Dyslexic Children and Teenagers	PLOS ONE			English	Article							DIVERGENT THINKING; ABILITY; TALENT	Background and Study Hypothesis Are dyslexic children and teenagers more creative than non-dyslexic children and teenagers? Whether creativity is higher in dyslexia, and whether this could be related to neurological development specific to the dyslexic disorder, or to compensatory strategies acquired later in life, remains unclear. Here, we suggest an additional role of differential educational approaches taken in each school that could either enhance or suppress an already higher baseline creativity of dyslexic children and teenagers. Results Creativity in dyslexic and non-dyslexic children and teenagers from different schools in France and in Belgium, as well as in students from different universities, was evaluated with the Torrance Test of Creative Thinking (TTCT). Children and teenagers with dyslexia and/or with other similar dysfunctions showed higher creativity scores than non-dyslexic participants. Moreover, the educational approach could further enhance the creative scores in dyslexia, which could be as high as those measured in students from art universities. Conclusions We conclude that dyslexic children and teenagers can be highly creative. Yet, expression of creativity can be modulated by educational approach, indicating a probable advantage for personal follow-up compared to normalizing education strategies.	[Kapoula, Zoi; Gaertner, Chrystal; Vernet, Marine] Univ Paris 05, CNRS, Neurosci FR3636, IRIS Team Physiopathol Binocular Motor Control &, 45 Rue St Peres, F-75006 Paris, France; [Ruiz, Sarah; Spector, Lisa; Mocorovi, Marion] Ecole Psychol Praticiens, 23 Rue Montparnasse, F-75006 Paris, France; [Quilici, Catherine] Coll & Lycee St Sulpice, 68 Rue Assas, F-75006 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Kapoula, Z (corresponding author), Univ Paris 05, CNRS, Neurosci FR3636, IRIS Team Physiopathol Binocular Motor Control &, 45 Rue St Peres, F-75006 Paris, France.	zoi.kapoula@gmail.com			Fondation Dyslexie Belgique; CNRS	Fondation Dyslexie Belgique; CNRS(Centre National de la Recherche Scientifique (CNRS))	The authors thank the Fondation Dyslexie Belgique and the CNRS for their support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attree EA, 2009, CYBERPSYCHOL BEHAV, V12, P163, DOI 10.1089/cpb.2008.0204; Barkul O., 2009, ITU J FACULTY ARCHIT, V6, P44; Chakravarty A, 2009, MED HYPOTHESES, V73, P569, DOI 10.1016/j.mehy.2009.05.034; Chevrie-Muller C, 1997, BATTERIE LANGAGE ORA; Clapham MM, 2000, CREATIVITY RES J, V13, P335; Corlu M, 2007, BEHAV NEUROL, V18, P217, DOI 10.1155/2007/327530; De Souza L, 2009, REV NEUROLOGIQUE S1, V165, P86; Dietrich A, 2004, PSYCHON B REV, V11, P1011, DOI 10.3758/BF03196731; Drago V, 2009, J NEUROL SCI, V276, P179, DOI 10.1016/j.jns.2008.09.026; Everatt J., 1999, DYSLEXIA, V5, P28, DOI [DOI 10.1002/(SICI)1099-0909(199903)5, 10.1002/(SICI)1099-0909 (199903)5:13.0.CO;2-K, DOI 10.1002/(SICI)1099-0909(199903)5:13.0.CO;2-K]; HALPIN G, 1973, J CREATIVE BEHAV, V7, P51, DOI 10.1002/j.2162-6057.1973.tb00946.x; HORNE JA, 1988, SLEEP, V11, P528, DOI 10.1093/sleep/11.6.528; Kim KH, 2006, EDUC PSYCHOL MEAS, V66, P459, DOI 10.1177/0013164405282456; ORMEJOHNSON DW, 1981, INT J NEUROSCI, V13, P211, DOI 10.3109/00207458108985804; RACK L, 1981, J LEARN DISABIL, V14, P262, DOI 10.1177/002221948101400506; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Stein J, 2012, VISUAL ASPECTS DYSLE; Sternberg R.J., 1999, HDB CREAT, V1, P3; Sternberg RJ, 2006, CREATIVITY RES J, V18, P87, DOI 10.1207/s15326934crj1801_10; Torrance, 2008, TORRANCE TESTS CREAT; von Karolyi C, 2003, BRAIN LANG, V85, P427, DOI 10.1016/S0093-934X(03)00052-X; Wolff Ulrika, 2002, Dyslexia, V8, P34, DOI 10.1002/dys.211	23	9	9	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150421	10.1371/journal.pone.0150421	http://dx.doi.org/10.1371/journal.pone.0150421			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SL	26950067	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100034
J	O'Donnell, JL; Kelly, RP; Lowell, NC; Port, JA				O'Donnell, James L.; Kelly, Ryan P.; Lowell, Natalie C.; Port, Jesse A.			Indexed PCR Primers Induce Template-Specific Bias in Large-Scale DNA Sequencing Studies	PLOS ONE			English	Article							BARCODED PRIMERS; DIVERSITY; AMPLIFICATION; MULTIPLEX; INFERENCE; PATTERNS; MISMATCH; SAMPLES; FUNGI; BLAST	Massively parallel sequencing is rapidly emerging as an efficient way to quantify biodiversity at all levels, from genetic variation and expression to ecological community assemblage. However, the number of reads produced per sequencing run far exceeds the number required per sample for many applications, compelling researchers to sequence multiple samples per run in order to maximize efficiency. For studies that include a PCR step, this can be accomplished using primers that include an index sequence allowing sample origin to be determined after sequencing. The use of indexed primers assumes they behave no differently than standard primers; however, we found that indexed primers cause substantial template sequence-specific bias, resulting in radically different profiles of the same environmental sample. Likely the outcome of differential amplification efficiency due to primertemplate mismatch, two indexed primer sets spuriously change the inferred sequence abundance from the same DNA extraction by up to 77.1%. We demonstrate that a double PCR approach alleviates these effects in applications where indexed primers are necessary.	[O'Donnell, James L.; Kelly, Ryan P.; Lowell, Natalie C.] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA; [Port, Jesse A.] Stanford Univ, Woods Inst Environm, Ctr Ocean Solut, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; Stanford University	O'Donnell, JL; Kelly, RP (corresponding author), Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA.	jimmyod@uw.edu; rpkelly@uw.edu		Kelly, Ryan/0000-0001-5037-2441	David and Lucile Packard Foundation [2014-39827]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was supported by grant number 2014-39827 from the David and Lucile Packard Foundation (http://www.packard.org/) to RPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Coissac Eric, 2012, Methods Mol Biol, V888, P13, DOI 10.1007/978-1-61779-870-2_2; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ficetola G.F., 2014, MOL ECOLOGY RESOURCE; Gibson J, 2014, P NATL ACAD SCI USA, V111, P8007, DOI 10.1073/pnas.1406468111; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Lahoz-Monfort JJ, 2016, MOL ECOL RESOUR, V16, P673, DOI 10.1111/1755-0998.12486; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Pinol J, 2014, MOL ECOLOGY RESOURCE; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Renshaw MA, 2015, MOL ECOL RESOUR, V15, P168, DOI 10.1111/1755-0998.12281; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Schnell IB, 2015, MOL ECOLOGY RESOURCE; Shelton AO, ECOLOGICAL APPL; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Son MS, 2011, CURRENT PROTOCOLS MI; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taylor DL, 2008, MOL ECOL RESOUR, V8, P742, DOI 10.1111/j.1755-0998.2008.02094.x; Valentini A, 2015, MOL ECOLOGY; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Wu JH, 2009, J MICROBIOL METH, V77, P267, DOI 10.1016/j.mimet.2009.03.001; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	38	69	70	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0148698	10.1371/journal.pone.0148698	http://dx.doi.org/10.1371/journal.pone.0148698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950069	Green Submitted, Green Published, gold			2022-12-27	WOS:000371990100007
J	Trinies, V; Chard, AN; Mateo, T; Freeman, MC				Trinies, Victoria; Chard, Anna N.; Mateo, Tommy; Freeman, Matthew C.			Effects of Water Provision and Hydration on Cognitive Function among Primary-School Pupils in Zambia: A Randomized Trial	PLOS ONE			English	Article							VOLUNTARY DEHYDRATION; URINARY INDEXES; HEAT-STRESS; PERFORMANCE; EXERCISE	There is a well-established link between hydration and improved cognitive performance among adults, with evidence of similar findings among children. No trials have investigated the impact of water provision on cognitive performance among schoolchildren in hot and arid low-resource settings. We conducted a randomized-controlled trial in five schools with limited water access in Chipata district in Eastern province, Zambia, to assess the efficacy of water provision on cognition. Pupils in grades 3-6 were randomly assigned to either receive a bottle of drinking water that they could refill throughout the day (water group, n = 149) or only have access to drinking water that was normally available at the school (control group, n = 143). Hydration was assessed in the morning before provision of water and in the afternoon through urine specific gravity (U-sg) measured with a portable refractometer. In the afternoon we administered six cognitive tests to assess short-term memory, concentration, visual attention, and visual motor skills. Morning prevalence of dehydration, defined as U-sg >= 1.020, was 42%. Afternoon dehydration increased to 67% among the control arm and dropped to 10% among the intervention arm. We did not find that provision of water or hydration impacted cognitive test scores, although there were suggestive relationships between both water provision and hydration and increased scores on tests measuring visual attention. We identified key improvements to the study design that are warranted to further investigate this relationship.	[Trinies, Victoria; Chard, Anna N.; Freeman, Matthew C.] Emory Univ, Dept Environm Hlth, Rollins Sch Environm Hlth, Atlanta, GA 30322 USA; [Mateo, Tommy] FHI 360, Sch Promoting Learning Achievement Sanitat & Hyg, Lusaka, Zambia	Emory University	Trinies, V (corresponding author), Emory Univ, Dept Environm Hlth, Rollins Sch Environm Hlth, Atlanta, GA 30322 USA.	vtrinies@gmail.com	Freeman, Matthew/ABE-6245-2020	Freeman, Matthew/0000-0002-1517-2572; Trinies, Victoria/0000-0002-7863-7509	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	This study was made possible by the generous support of the United States Agency for International Development (USAID) through its WASHplus (global) and SPLASH/Zambia projects. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. The funders of the study had no role in study design, data collection and analysis, decision to publish, or initial preparation of the manuscript. Staff of FHI360, the lead implementing organization for WASHplus, provided comments on the manuscript.	Armstrong LE, 2007, J AM COLL NUTR, V26, p575S, DOI 10.1080/07315724.2007.10719661; Armstrong LE, 2012, J NUTR, V142, P382, DOI 10.3945/jn.111.142000; Armstrong LE, 1998, INT J SPORT NUTR, V8, P345, DOI 10.1123/ijsn.8.4.345; ARMSTRONG LE, 1994, INT J SPORT NUTR, V4, P265, DOI 10.1123/ijsn.4.3.265; Baker LB, 2007, MED SCI SPORT EXER, V39, P976, DOI 10.1097/mss.0b013e3180471ff2; Bangirana P, 2009, Afr Health Sci, V9, P186; Bar-David Y, 2005, ACTA PAEDIATR, V94, P1667, DOI 10.1080/08035250500254670; Bar-David Y, 2009, J HUM NUTR DIET, V22, P455, DOI 10.1111/j.1365-277X.2009.00960.x; Benton D, 2009, APPETITE, V53, P143, DOI 10.1016/j.appet.2009.05.006; Bryan J, 2004, NUTR REV, V62, P295, DOI 10.1301/nr.2004.aug.295-306; Cian C, 2001, INT J PSYCHOPHYSIOL, V42, P243, DOI 10.1016/S0167-8760(01)00142-8; Cian C, 2000, J PSYCHOPHYSIOL, V14, P29, DOI 10.1027//0269-8803.14.1.29; Dean AG, OPENEPI OPEN SOURCE; Edmonds CJ, 2009, APPETITE, V53, P469, DOI 10.1016/j.appet.2009.10.002; Edmonds CJ, 2009, APPETITE, V52, P776, DOI 10.1016/j.appet.2009.02.010; ELLERSHAW JE, 1995, J PAIN SYMPTOM MANAG, V10, P192, DOI 10.1016/0885-3924(94)00123-3; Fadda R, 2012, APPETITE, V59, P730, DOI 10.1016/j.appet.2012.07.005; GOPINATHAN PM, 1988, ARCH ENVIRON HEALTH, V43, P15, DOI 10.1080/00039896.1988.9934367; Greenfield PM, 1997, AM PSYCHOL, V52, P1115, DOI 10.1037/0003-066X.52.10.1115; GREENLEAF JE, 1965, J APPL PHYSIOL, V20, P719, DOI 10.1152/jappl.1965.20.4.719; Holding PA, 2004, J INT NEUROPSYCH SOC, V10, P246, DOI 10.1017/S1355617704102166; Holding PA, 2001, AM J TROP MED HYG, V64, P68, DOI 10.4269/ajtmh.2001.64.68; Kavouras SA, 2002, CURR OPIN CLIN NUTR, V5, P519, DOI 10.1097/00075197-200209000-00010; LeBlond R. F., 2009, DEGOWINS DIAGNOSTIC; Manz F, 2003, EUR J CLIN NUTR, V57, pS10, DOI 10.1038/sj.ejcn.1601896; Masento NA, 2014, BRIT J NUTR, V111, P1841, DOI 10.1017/S0007114513004455; Mckean SC, 2012, PRINCIPLES PRACTICE; Oppliger RA, 2002, SPORTS MED, V32, P959, DOI 10.2165/00007256-200232150-00001; Rogers PJ, 2001, APPETITE, V36, P57, DOI 10.1006/appe.2000.0374; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Shirreffs SM, 2004, BRIT J NUTR, V91, P951, DOI 10.1079/BJN20041149; Steiner MJ, 2007, PEDIATR EMERG CARE, V23, P298, DOI 10.1097/01.pec.0000270162.76453.fa; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; UNICEF, 2012, RAIS EV MOR CLEAN HA	34	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150071	10.1371/journal.pone.0150071	http://dx.doi.org/10.1371/journal.pone.0150071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SL	26950696	gold, Green Published, Green Submitted			2022-12-27	WOS:000371990100021
J	Kim, J; Shin, H				Kim, Jinkwon; Shin, Hangsik			Simple and Robust Realtime QRS Detection Algorithm Based on Spatiotemporal Characteristic of the QRS Complex	PLOS ONE			English	Article							FILTER	The purpose of this research is to develop an intuitive and robust realtime QRS detection algorithm based on the physiological characteristics of the electrocardiogram waveform. The proposed algorithm finds the QRS complex based on the dual criteria of the amplitude and duration of QRS complex. It consists of simple operations, such as a finite impulse response filter, differentiation or thresholding without complex and computational operations like a wavelet transformation. The QRS detection performance is evaluated by using both an MIT-BIH arrhythmia database and an AHA ECG database (a total of 435,700 beats). The sensitivity (SE) and positive predictivity value (PPV) were 99.85% and 99.86%, respectively. According to the database, the SE and PPV were 99.90% and 99.91% in the MIT-BIH database and 99.84% and 99.84% in the AHA database, respectively. The result of the noisy environment test using record 119 from the MIT-BIH database indicated that the proposed method was scarcely affected by noise above 5 dB SNR (SE = 100%, PPV > 98%) without the need for an additional de-noising or back searching process.	[Kim, Jinkwon] Hyundai Motors, Adv Safety Vehicle Dev Team, Hwaseong Si, Gyeonggi Do, South Korea; [Shin, Hangsik] Chonnam Natl Univ, Dept Biomed Engn, Yeosu, Jeollanam Do, South Korea	Hyundai Kia Motors; Chonnam National University	Shin, H (corresponding author), Chonnam Natl Univ, Dept Biomed Engn, Yeosu, Jeollanam Do, South Korea.	hangsik.shin@jnu.ac.kr	Shin, Hangsik/AAM-1788-2021	Shin, Hangsik/0000-0002-3353-0310	MSIP (Ministry of Science, ICT and Future Planning), Korea under the C-ITRC (Convergence Information Technology Research Center) [IITP-2015-H8601-15-1009]; Hyundai Motors	MSIP (Ministry of Science, ICT and Future Planning), Korea under the C-ITRC (Convergence Information Technology Research Center); Hyundai Motors	Hangsik Shin was supported by the MSIP (Ministry of Science, ICT and Future Planning), Korea, under the C-ITRC (Convergence Information Technology Research Center) (IITP-2015-H8601-15-1009) supervised by the IITP (Institute for Information & communications Technology Promotion) website: http://www.iitp.kr/main.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Jinkwon Kim is employed by Hyundai Motors. Hyundai Motors provided support in the form of salary for author JK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abibullaev B, 2011, J MED SYST, V35, P683, DOI 10.1007/s10916-009-9405-3; Adnane M, 2009, COMPUT METH PROG BIO, V93, P20, DOI 10.1016/j.cmpb.2008.07.010; Afonso VX, 1999, IEEE T BIO-MED ENG, V46, P192, DOI 10.1109/10.740882; Benali R, 2012, J MED SYST, V36, P883, DOI 10.1007/s10916-010-9551-7; Bruch C, 2001, J AM COLL CARDIOL, V38, P219, DOI 10.1016/S0735-1097(01)01313-4; Chen SW, 2006, COMPUT METH PROG BIO, V82, P187, DOI 10.1016/j.cmpb.2005.11.012; Christov II, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-28; Dotsinsky IA, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-3; FRIESEN GM, 1990, IEEE T BIO-MED ENG, V37, P85, DOI 10.1109/10.43620; Hermes R. E., 1980, Computers in Cardiology, P263; Kohler BU, 2002, IEEE ENG MED BIOL, V21, P42, DOI 10.1109/51.993193; Kunzmann U, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 2, P875, DOI 10.1515/bmte.2002.47.s1b.875; Lee J, 1996, BRIDG DISC BIOM P 18; LI CW, 1995, IEEE T BIO-MED ENG, V42, P21, DOI 10.1109/10.362922; Mark R., 1997, MIT BIH ARRHYTHMIA D; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Paoletti M, 2006, COMPUT METH PROG BIO, V82, P20, DOI 10.1016/j.cmpb.2006.01.005; Portet F, 2005, MED BIOL ENG COMPUT, V43, P379, DOI 10.1007/BF02345816; So H, 1997, ENG MED BIOL SOC 199; Tabakov S, 2008, ANN BIOMED ENG, V36, P1805, DOI 10.1007/s10439-008-9553-5; Tan K, 2000, IEE C PUBL, V476; Yeh YC, 2008, COMPUT METH PROG BIO, V91, P245, DOI 10.1016/j.cmpb.2008.04.006	22	25	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150144	10.1371/journal.pone.0150144	http://dx.doi.org/10.1371/journal.pone.0150144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943949	Green Published, gold, Green Submitted			2022-12-27	WOS:000371739400015
J	Chasse, H; Mulner-Lorillon, O; Boulben, S; Glippa, V; Morales, J; Cormier, P				Chasse, Heloise; Mulner-Lorillon, Odile; Boulben, Sandrine; Glippa, Virginie; Morales, Julia; Cormier, Patrick			Cyclin B Translation Depends on mTOR Activity after Fertilization in Sea Urchin Embryos	PLOS ONE			English	Article							CAP-BINDING PROTEIN; MESSENGER-RNA; CELL-CYCLE; INITIATION-FACTOR; EIF4E-BINDING PROTEINS; IN-VITRO; EGGS; KINASE; PHOSPHORYLATION; DISSOCIATION	The cyclin B/CDK1 complex is a key regulator of mitotic entry. Using PP242, a specific ATP-competitive inhibitor of mTOR kinase, we provide evidence that the mTOR signalling pathway controls cyclin B mRNA translation following fertilization in Sphaerechinus granularis and Paracentrotus lividus. We show that PP242 inhibits the degradation of the cap-dependent translation repressor 4E-BP (eukaryotic initiation factor 4E-Binding Protein). PP242 inhibits global protein synthesis, delays cyclin B accumulation, cyclin B/CDK1 complex activation and consequently entry into the mitotic phase of the cell cycle triggered by fertilization. PP242 inhibits cyclin B mRNA recruitment into active polysomes triggered by fertilization. An amount of cyclin B mRNA present in active polysomes appears to be insensitive to PP242 treatment. Taken together, our results suggest that, following sea urchin egg fertilization, cyclin B mRNA translation is controlled by two independent mechanisms: a PP242-sensitive and an additional PP242-insentitive mechanism.	[Chasse, Heloise; Mulner-Lorillon, Odile; Boulben, Sandrine; Glippa, Virginie; Morales, Julia; Cormier, Patrick] Univ Paris 06, Sorbonne Univ, UMR 8227,Stn Biol Roscoff, Integrat Biol Marine Models,Translat Cell Cycle &, CS 90074, F-29688 Roscoff, France; [Chasse, Heloise; Mulner-Lorillon, Odile; Boulben, Sandrine; Glippa, Virginie; Morales, Julia; Cormier, Patrick] CNRS, UMR 8227, Stn Biol Roscoff, Integrat Biol Marine Models, CS 90074, F-29688 Roscoff, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Mulner-Lorillon, O; Morales, J; Cormier, P (corresponding author), Univ Paris 06, Sorbonne Univ, UMR 8227,Stn Biol Roscoff, Integrat Biol Marine Models,Translat Cell Cycle &, CS 90074, F-29688 Roscoff, France.; Mulner-Lorillon, O; Morales, J; Cormier, P (corresponding author), CNRS, UMR 8227, Stn Biol Roscoff, Integrat Biol Marine Models, CS 90074, F-29688 Roscoff, France.	mulner@sb-roscoff.fr; morales@sb-roscoff.fr; cormier@sb-roscoff.fr		Morales, Julia/0000-0003-1632-5419	La Ligue contre le Cancer (coordination du Grand Ouest [comites Finistere, Cotes d'Armor, Deux-Sevres, Morbihan]); Region Bretagne; Conseil General du Finistere; ITMO AVIESAN CNRS/INSERM	La Ligue contre le Cancer (coordination du Grand Ouest [comites Finistere, Cotes d'Armor, Deux-Sevres, Morbihan]); Region Bretagne(Region Bretagne); Conseil General du Finistere(Region Bretagne); ITMO AVIESAN CNRS/INSERM	This work was supported by research grants from "La Ligue contre le Cancer (coordination du Grand Ouest [comites Finistere, Cotes d'Armor, Deux-Sevres, Morbihan])", the "Region Bretagne", and the "Conseil General du Finistere"; by ITMO AVIESAN CNRS/INSERM for equipment grant. H. Chasse is a PhD fellow supported by the Region Bretagne.	Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; Cormier P, 2001, DEV BIOL, V232, P275, DOI 10.1006/dbio.2001.0206; Cormier Patrick, 2003, Prog Cell Cycle Res, V5, P469; Elia A, 2008, ONCOGENE, V27, P811, DOI 10.1038/sj.onc.1210678; Eltschinger S, 2016, TRENDS CELL BIOL, V26, P148, DOI 10.1016/j.tcb.2015.10.003; EPEL D, 1967, P NATL ACAD SCI USA, V57, P899, DOI 10.1073/pnas.57.4.899; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Faye MD, 2014, JOVE-J VIS EXP, DOI 10.3791/52295; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fernandez-Guerra A, 2006, DEV BIOL, V300, P238, DOI 10.1016/j.ydbio.2006.09.012; Fonseca BD, 2014, SEMIN CELL DEV BIOL, V36, P102, DOI 10.1016/j.semcdb.2014.09.014; GENEVIEREGARRIGUES AM, 1995, J CELL SCI, V108, P2693; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hernandez G, 2009, TRENDS BIOCHEM SCI, V34, P166, DOI 10.1016/j.tibs.2009.02.001; JAGUS R, 1992, J BIOL CHEM, V267, P15530; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Kang Q, 2012, MOL BIOL CELL, V23, P284, DOI 10.1091/mbc.E11-09-0768; Kronja I, 2011, PHILOS T R SOC B, V366, P3638, DOI 10.1098/rstb.2011.0084; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Lapasset L, 2008, MOL REPROD DEV, V75, P1617, DOI 10.1002/mrd.20905; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laurent S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00117; Le Breton M, 2005, BIOCHIMIE, V87, P805, DOI 10.1016/j.biochi.2005.04.014; Lewis CW, 2013, FEBS LETT, V587, P3089, DOI 10.1016/j.febslet.2013.08.003; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; LOPO AC, 1989, BIOCHEM J, V258, P553, DOI 10.1042/bj2580553; Lozano JC, 1998, J CELL BIOL, V140, P283, DOI 10.1083/jcb.140.2.283; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Martineau Y, 2013, ONCOGENE, V32, P671, DOI 10.1038/onc.2012.116; Merrick W C, 2001, Curr Protoc Cell Biol, VChapter 11, DOI 10.1002/0471143030.cb1109s08; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Morales J, 2006, DEV BIOL, V300, P293, DOI 10.1016/j.ydbio.2006.07.036; Oulhen N, 2007, J CELL SCI, V120, P425, DOI 10.1242/jcs.03339; Oulhen N, 2014, GENESIS, V52, P279, DOI 10.1002/dvg.22737; Oulhen N, 2010, MOL REPROD DEV, V77, P83, DOI 10.1002/mrd.21110; Oulhen N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005070; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; Rousseau D, 1996, ONCOGENE, V13, P2415; Salaun P, 2003, DEV BIOL, V255, P428, DOI 10.1016/S0012-1606(02)00099-4; Smith AB, 2006, MOL BIOL EVOL, V23, P1832, DOI 10.1093/molbev/msl039; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; SPIETH J, 1980, DEV BIOL, V79, P95, DOI 10.1016/0012-1606(80)90075-5; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vardy L, 2007, DEV CELL, V12, P157, DOI 10.1016/j.devcel.2006.10.017; Voronina E, 2003, DEV BIOL, V256, P258, DOI 10.1016/S0012-1606(02)00134-3; Voronina E, 2008, DEV BIOL, V314, P276, DOI 10.1016/j.ydbio.2007.11.039; WAGENAAR EB, 1983, EXP CELL RES, V144, P393, DOI 10.1016/0014-4827(83)90419-6; WILT FH, 1977, CELL, V11, P673, DOI 10.1016/0092-8674(77)90084-8; Yajima M, 2011, DEVELOPMENT, V138, P2217, DOI 10.1242/dev.065052; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004	59	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150318	10.1371/journal.pone.0150318	http://dx.doi.org/10.1371/journal.pone.0150318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26962866	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000031
J	Cuccurullo, A; Greco, E; Lupia, E; De Giuli, P; Bosco, O; Martin-Conte, E; Spatola, T; Turco, E; Montrucchio, G				Cuccurullo, Alessandra; Greco, Elisabetta; Lupia, Enrico; De Giuli, Paolo; Bosco, Ornella; Martin-Conte, Erica; Spatola, Tiziana; Turco, Emilia; Montrucchio, Giuseppe			Blockade of Thrombopoietin Reduces Organ Damage in Experimental Endotoxemia and Polymicrobial Sepsis	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; CRITICALLY-ILL PATIENTS; PLATELET ACTIVATION; SEPTIC SHOCK; BLOOD-PLATELETS; CECAL LIGATION; LUNG INJURY; MOUSE MODEL; DYSFUNCTION; AGGREGATION	Background and Purpose Thrombopoietin (TPO), a growth factor primarily involved in thrombopoiesis may also have a role in the pathophysiology of sepsis. In patients with sepsis, indeed, TPO levels are markedly increased, with disease severity being the major independent determinant of TPO concentrations. Moreover, TPO increases and correlates with ex vivo indices of platelet activation in patients with burn injury upon sepsis development, and may contribute to depress cardiac contractility in septic shock. Still, the role of TPO in sepsis pathophysiology remains controversial, given the protective role of TPO in other experimental disease models, for instance in doxorubicin-induced cardiotoxicity and myocardial ischemia/reperfusion injury. The aim of our study was to define the contribution of TPO in the development of organ damage induced by endotoxemia or sepsis, and to investigate the effects of inhibiting TPO in these conditions. Methods We synthesized a chimeric protein able to inhibit TPO, mTPOR-MBP, and studied its effect in two murine experimental models, acute endotoxemia and cecal ligation and puncture (CLP) model. Results In both models, TPO levels markedly increased, from 289.80 +/- 27.87 pg/mL to 465.60 +/- 45.92 pg/mL at 3 hours in the LPS model (P<0.01), and from 265.00 +/- 26.02 pg/mL to 373.70 +/- 26.20 pg/mL in the CLP model (P<0.05), respectively. Paralleling TPO levels, also platelet-monocyte aggregates increased, from 32.86 +/- 2.48% to 46.13 +/- 1.39% at 3 hours in the LPS model (P<0.01), and from 43.68 +/- 1.69% to 56.52 +/- 4.66% in the CLP model (P<0.05). Blockade of TPO by mTPOR-MBP administration reduced histological damage in target organs, namely lung, liver, and gut. In particular, neutrophil infiltration and lung septal thickening were reduced from a score of 1.86 +/- 0.34 to 0.60 +/- 0.27 (P<0.01) and from 1.43 +/- 0.37 to 0.40 +/- 0.16 (P<0.05), respectively, in the LPS model at 3 hours, and from a score of 1.75 +/- 0.37 to 0.38 +/- 0.18 (P<0.01) and from 1.25 +/- 0.31 to 0.13 +/- 0.13 (P<0.001), respectively, in the CLP model. Similarly, the number of hepatic microabscesses was decreased from 14.14 +/- 1.41 to 3.64 +/- 0.56 in the LPS model at 3 hours (P<0.001), and from 1.71 +/- 0.29 to 0.13 +/- 0.13 in the CLP model (P<0.001). Finally, the diameter of intestinal villi decreased from 90.69 +/- 3.95 mum to 70.74 +/- 3.60 mum in the LPS model at 3 hours (P<0.01), and from 74.29 +/- 4.29 mum to 57.50 +/- 1.89 mum in the CLP model (P<0.01). This protective effect was associated with the blunting of the increase in platelet-monocyte adhesion, and, on the contrary, with increased platelet-neutrophil aggregates in the circulation, which may be related to decreased neutrophil sequestration into the inflamed tissues. Conversely, circulating cytokine levels were not significantly changed, in both models, by mTPOR-MBP administration. Conclusion Our results demonstrate that TPO participates in the development of organ damage induced by experimental endotoxemia or polymicrobial sepsis via a mechanism involving increased platelet-leukocyte adhesion, but not cytokine release, and suggest that blocking TPO may be useful in preventing organ damage in patients affected by systemic inflammatory response or sepsis.	[Cuccurullo, Alessandra; Greco, Elisabetta; Lupia, Enrico; Bosco, Ornella; Spatola, Tiziana; Montrucchio, Giuseppe] Univ Turin, Dept Med Sci, Turin, Italy; [De Giuli, Paolo] San Lazzaro Hosp, Anat Patolog, Alba, Italy; [Martin-Conte, Erica] Univ Turin, Dept Anaesthesiol & Crit Care, Turin, Italy; [Turco, Emilia] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy	University of Turin; University of Turin; University of Turin	Montrucchio, G (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	giuseppe.montrucchio@unito.it	Bosco, Ornella/AAB-2105-2019; greco, elisabetta/AAB-3802-2019; Lupia, Enrico/AAB-7505-2019	Conte, Erica/0000-0002-2699-9591	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (MURST); Progetto di Ricerca Sanitaria Finalizzata - Regione Piemonte	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (MURST)(Ministry of Education, Universities and Research (MIUR)); Progetto di Ricerca Sanitaria Finalizzata - Regione Piemonte(Regione Piemonte)	This work was supported by Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (MURST) ex-60% to EL and GM, and by Progetto di Ricerca Sanitaria Finalizzata - Regione Piemonte to GM and EL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akca S, 2002, CRIT CARE MED, V30, P753, DOI 10.1097/00003246-200204000-00005; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Aoshiba K, 2009, CRIT CARE MED, V37, P889, DOI 10.1097/CCM.0b013e31819b8371; AVANZI GC, 1990, J CELL PHYSIOL, V145, P458, DOI 10.1002/jcp.1041450310; Baker JE, 2008, CARDIOVASC RES, V77, P44, DOI 10.1093/cvr/cvm026; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; Brizzi MF, 1997, J CLIN INVEST, V99, P1576, DOI 10.1172/JCI119320; Brizzi MF, 1999, CIRC RES, V84, P785; Chou FS, 2011, J CELL BIOCHEM, V112, P1491, DOI 10.1002/jcb.23089; Corral J, 2005, AM J PATHOL, V166, P1089, DOI 10.1016/S0002-9440(10)62329-2; DAVIS RB, 1960, CIRC RES, V8, P234, DOI 10.1161/01.RES.8.1.234; De Backer D, 2014, VIRULENCE, V5, P73, DOI 10.4161/viru.26482; De Blasi RA, 2013, INTENS CARE MED, V39, P636, DOI 10.1007/s00134-012-2725-7; de Stoppelaar SF, 2014, THROMB HAEMOSTASIS, V112, P666, DOI 10.1160/TH14-02-0126; Del Sorbo L FV, 2011, CRIT CARE, V15, P207; Ehrenreich H, 2005, P NATL ACAD SCI USA, V102, P862, DOI 10.1073/pnas.0406008102; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Folman CC, 2000, THROMB HAEMOSTASIS, V83, P923, DOI 10.1055/s-0037-1613944; Freedman JE, 2002, CIRCULATION, V105, P2130, DOI 10.1161/01.CIR.0000017140.26466.F5; GAWAZ M, 1995, EUR J CLIN INVEST, V25, P843, DOI 10.1111/j.1365-2362.1995.tb01694.x; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Gonzalez-Rey E, 2006, J EXP MED, V203, P563, DOI 10.1084/jem.20052017; HEFFNER JE, 1987, AM REV RESPIR DIS, V135, P482; Hwaiz R, 2015, BRIT J PHARMACOL, V172, P5347, DOI 10.1111/bph.13325; Ivanova A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-77; Kaushansky K, 2003, J THROMB HAEMOST, V1, P1587, DOI 10.1046/j.1538-7836.2003.00273.x; Kuter DJ, 2002, BLOOD, V100, P3457, DOI 10.1182/blood.V100.10.3457; Levi M, 2003, BLOOD, V101, P4823, DOI 10.1182/blood-2002-10-3254; Li K, 2006, CIRCULATION, V113, P2211, DOI 10.1161/CIRCULATIONAHA.105.560250; Lupia E, 2009, J THROMB HAEMOST, V7, P1000, DOI 10.1111/j.1538-7836.2009.03348.x; Lupia E, 2006, J AM COLL CARDIOL, V48, P2195, DOI 10.1016/j.jacc.2006.04.106; Lupia E, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/390892; Lupia E, 2010, BASIC RES CARDIOL, V105, P609, DOI 10.1007/s00395-010-0103-6; Montrucchio G, 1996, BLOOD, V87, P2762, DOI 10.1182/blood.V87.7.2762.bloodjournal8772762; Moreau D, 2007, CHEST, V131, P1735, DOI 10.1378/chest.06-2233; Oda A, 1996, BLOOD, V87, P4664, DOI 10.1182/blood.V87.11.4664.bloodjournal87114664; Page G, 2013, INT IMMUNOPHARMACOL, V17, P1176, DOI 10.1016/j.intimp.2013.06.004; Rahman M, 2009, ANN SURG, V250, P783, DOI 10.1097/SLA.0b013e3181bd95b7; Ramella R, 2011, REGUL PEPTIDES, V167, P5, DOI 10.1016/j.regpep.2010.12.008; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; Secor D, 2010, INTENS CARE MED, V36, P1928, DOI 10.1007/s00134-010-1969-3; Seidel M, 2009, J THROMB HAEMOST, V7, P1030, DOI 10.1111/j.1538-7836.2009.03352.x; Shen JQ, 2012, CYTOKINE, V60, P294, DOI 10.1016/j.cyto.2012.05.005; Shibazaki M, 1999, INFECT IMMUN, V67, P5186, DOI 10.1128/IAI.67.10.5186-5191.1999; Singer G, 2006, MICROCIRCULATION, V13, P89, DOI 10.1080/10739680500466343; Tibbles HE, 2002, BIOCHEM BIOPH RES CO, V292, P987, DOI 10.1006/bbrc.2002.6759; Toner P, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1091-6; Vincent JL, 2002, CRIT CARE MED, V30, pS313, DOI 10.1097/00003246-200205001-00022; WEISS HJ, 1972, BLOOD-J HEMATOL, V39, P187, DOI 10.1182/blood.V39.2.187.187; Winning J, 2009, PLATELETS, V20, P50, DOI 10.1080/09537100802503368; Wolber EM, 2000, J INTERF CYTOK RES, V20, P499, DOI 10.1089/10799900050023915; Yaguchi A, 2004, J THROMB HAEMOST, V2, P2096, DOI 10.1111/j.1538-7836.2004.01009.x; Zakynthinos SG, 2004, CRIT CARE MED, V32, P1004, DOI 10.1097/01.CCM.0000121433.61546.A0; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499; Zhang M, 2014, ANESTHESIOLOGY, V121, P1270, DOI 10.1097/ALN.0000000000000337; Zhang Q, 2004, BIOL PHARM BULL, V27, P219, DOI 10.1248/bpb.27.219; Zou L, 2013, J IMMUNOL, V191, P5625, DOI 10.4049/jimmunol.1301903	59	22	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151088	10.1371/journal.pone.0151088	http://dx.doi.org/10.1371/journal.pone.0151088			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963510	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000101
J	Khari, FIM; Karunakaran, R; Rosli, R; Tay, ST				Khari, Fatin Izzati Mohd; Karunakaran, Rina; Rosli, Roshalina; Tay, Sun Tee			Genotypic and Phenotypic Detection of AmpC beta-lactamases in Enterobacter spp. Isolated from a Teaching Hospital in Malaysia	PLOS ONE			English	Article							PLASMID-MEDIATED AMPC; KLEBSIELLA-PNEUMONIAE; EXTENDED-SPECTRUM; ESCHERICHIA-COLI; MOLECULAR EPIDEMIOLOGY; MULTIPLEX PCR; RESISTANCE; CLOACAE; GENES; ACT-1	Objectives The objective of this study was to determine the occurrence of chromosomal and plasmid-mediated beta-lactamases (AmpC) genes in a collection of Malaysian isolates of Enterobacter species. Several phenotypic tests for detection of AmpC production of Enterobacter spp. were evaluated and the agreements between tests were determined. Methods Antimicrobial susceptibility profiles for 117 Enterobacter clinical isolates obtained from the Medical Microbiology Diagnostic Laboratory, University Malaya Medical Centre, Malaysia, from November 2012-February 2014 were determined in accordance to CLSI guidelines. AmpC genes were detected using a multiplex PCR assay targeting the MIR/ACT gene (closely related to chromosomal EBC family gene) and other plasmid-mediated genes, including DHA, MOX, CMY, ACC, and FOX. The AmpC beta-lactamase production of the isolates was assessed using cefoxitin disk screening test, D69C AmpC detection set, cefoxitin- cloxacillin double disk synergy test (CC-DDS) and AmpC induction test. Results Among the Enterobacter isolates in this study, 39.3% were resistant to cefotaxime and ceftriaxone and 23.9% were resistant to ceftazidime. Ten (8.5%) of the isolates were resistant to cefepime, and one isolate was resistant to meropenem. Chromosomal EBC family gene was amplified from 36 (47.4%) E. cloacae and three (25%) E. asburiae. A novel blaDHA type plasmid-mediated AmpC gene was identified for the first time from an E. cloacae isolate. AmpC beta-lactamase production was detected in 99 (89.2%) of 111 potential AmpC beta-lactamase producers (positive in cefoxitin disk screening) using D69C AmpC detection set. The detection rates were lower with CC-DDS (80.2%) and AmpC induction tests (50.5%). There was low agreement between the D69C AmpC detection set and the other two phenotypic tests. Of the 40 isolates with AmpC genes detected in this study, 87.5%, 77.5% and 50.0% of these isolates were positive by the D69C AmpC detection set, CC-DDS and AmpC induction tests, respectively. Conclusions Besides MIR/ACT gene, a novel plasmid-mediated AmpC gene belonging to the DHA-type was identified in this study. Low agreement was noted between the D69C AmpC detection set and two other phenotypic tests for detection of AmpC production in Enterobacter spp. As plasmid-mediated genes may serve as the reservoir for the emergence of antibiotic resistance in a clinical setting, surveillance and infection control measures are necessary to limit the spread of these genes in the hospital.	[Khari, Fatin Izzati Mohd; Karunakaran, Rina; Rosli, Roshalina; Tay, Sun Tee] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Tay, ST (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.	tayst@um.edu.my	N.KARUNAKARAN, RINA/B-9576-2010; Tay, Sun Tee/N-2295-2019	Tay, Sun Tee/0000-0002-3120-6998	University of Malaya [PG0512014A, RG462-12HTM]	University of Malaya(Universiti Malaya)	This study was supported by PG0512014A University of Malaya STT and RG462-12HTM University of Malaya RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Marzooq F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133654; Bradford PA, 1997, ANTIMICROB AGENTS CH, V41, P563, DOI 10.1128/AAC.41.3.563; Brenwald NP, 2005, J ANTIMICROB CHEMOTH, V56, P600, DOI 10.1093/jac/dki278; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; Conceicao T, 2004, FEMS MICROBIOL LETT, V230, P197, DOI 10.1016/S0378-1097(03)00891-7; Coudron PE, 2003, J CLIN MICROBIOL, V41, P772, DOI 10.1128/JCM.41.2.772-777.2003; Denton M, 2007, INT J ANTIMICROB AG, V29, pS9, DOI 10.1016/S0924-8579(07)72174-X; Grover Naveen, 2013, Med J Armed Forces India, V69, P4, DOI 10.1016/j.mjafi.2012.02.001; Halstead FD, 2012, J ANTIMICROB CHEMOTH, V67, P2303, DOI 10.1093/jac/dks170; Hernandez-Alles S, 2000, J ANTIMICROB CHEMOTH, V46, P273, DOI 10.1093/jac/46.2.273; Husickova V, 2011, CURR MICROBIOL, V62, P1664, DOI 10.1007/s00284-011-9911-7; Iabadene H, 2009, INT J ANTIMICROB AG, V34, P340, DOI 10.1016/j.ijantimicag.2009.05.011; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Gude MJ, 2013, INT J MED MICROBIOL, V303, P553, DOI 10.1016/j.ijmm.2013.07.007; Perez-Llarena FJ, 2014, ANTIMICROB AGENTS CH, V58, P6544, DOI 10.1128/AAC.03144-14; Kao CC, 2010, J MICROBIOL IMMUNOL, V43, P180, DOI 10.1016/S1684-1182(10)60029-1; Kasper DL, 2010, HARRISONS INFECT DIS; Kiratisin P, 2011, T ROY SOC TROP MED H, V105, P46, DOI 10.1016/j.trstmh.2010.07.010; Livermore DM, 1998, J ANTIMICROB CHEMOTH, V41, P25, DOI 10.1093/jac/41.suppl_4.25; Marchese A, 1998, ANTIMICROB AGENTS CH, V42, P464; Mezzatesta ML, 2012, FUTURE MICROBIOL, V7, P887, DOI [10.2217/FMB.12.61, 10.2217/fmb.12.61]; PAPANICOLAOU GA, 1990, ANTIMICROB AGENTS CH, V34, P2200, DOI 10.1128/AAC.34.11.2200; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pfaller MA, 2006, DIAGN MICR INFEC DIS, V56, P63, DOI 10.1016/j.diagmicrobio.2006.02.009; Polsfuss S, 2011, J CLIN MICROBIOL, V49, P2798, DOI 10.1128/JCM.00404-11; Qin Xuan, 2004, Ann Clin Microbiol Antimicrob, V3, P13, DOI 10.1186/1476-0711-3-13; Reuland EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113033; Rottman M, 2002, FEMS MICROBIOL LETT, V210, P87, DOI 10.1016/S0378-1097(02)00613-4; Sheng WH, 2013, ANTIMICROB AGENTS CH, V57, P2981, DOI 10.1128/AAC.00971-12; Song W, 2006, DIAGN MICR INFEC DIS, V55, P219, DOI 10.1016/j.diagmicrobio.2006.01.012; Tamma PD, 2013, CLIN INFECT DIS, V57, P781, DOI 10.1093/cid/cit395; Tan TY, 2009, ANTIMICROB AGENTS CH, V53, P146, DOI 10.1128/AAC.00862-08; Thomson KS, 2001, EMERG INFECT DIS, V7, P333, DOI 10.3201/eid0702.010238; Vimont S, 2007, J ANTIMICROB CHEMOTH, V60, P1045, DOI 10.1093/jac/dkm317; Vlieghe ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059775; Voets GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052102; Walsht F, 2012, J MED MICROBIOL, V61, P142, DOI 10.1099/jmm.0.035246-0; Wang R, 2009, FRONT MED-PRC, V3, P72; Wassef M, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.8556; Yagi T, 2005, J CLIN MICROBIOL, V43, P2551, DOI 10.1128/JCM.43.6.2551-2558.2005; Zaki ME, 2007, J INFECT DEV COUNTR, V1, P269, DOI 10.3855/jidc.363	42	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150643	10.1371/journal.pone.0150643	http://dx.doi.org/10.1371/journal.pone.0150643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963619	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000047
J	Napp, S; Allepuz, A; Purse, BV; Casal, J; Garcia-Bocanegra, I; Burgin, LE; Searle, KR				Napp, S.; Allepuz, A.; Purse, B. V.; Casal, J.; Garcia-Bocanegra, I.; Burgin, L. E.; Searle, K. R.			Understanding Spatio-Temporal Variability in the Reproduction Ratio of the Bluetongue (BTV-1) Epidemic in Southern Spain (Andalusia) in 2007 Using Epidemic Trees	PLOS ONE			English	Article							BITING MIDGES; TRANSMISSION; IMICOLA; EUROPE	Andalusia (Southern Spain) is considered one of the main routes of introduction of bluetongue virus (BTV) into Europe, evidenced by a devastating epidemic caused by BTV-1 in 2007. Understanding the pattern and the drivers of BTV-1 spread in Andalusia is critical for effective detection and control of future epidemics. A long-standing metric for quantifying the behaviour of infectious diseases is the case-reproduction ratio (R-t), defined as the average number of secondary cases arising from a single infected case at time t (for t>0). Here we apply a method using epidemic trees to estimate the between-herd case reproduction ratio directly from epidemic data allowing the spatial and temporal variability in transmission to be described. We then relate this variability to predictors describing the hosts, vectors and the environment to better understand why the epidemic spread more quickly in some regions or periods. The R-t value for the BTV-1 epidemic in Andalusia peaked in July at 4.6, at the start of the epidemic, then decreased to 2.2 by August, dropped below 1 by September (0.8), and by October it had decreased to 0.02. BTV spread was the consequence of both local transmission within established disease foci and BTV expansion to distant new areas (i.e. new foci), which resulted in a high variability in BTV transmission, not only among different areas, but particularly through time, which suggests that general control measures applied at broad spatial scales are unlikely to be effective. This high variability through time was probably due to the impact of temperature on BTV transmission, as evidenced by a reduction in the value of R-t by 0.0041 for every unit increase (day) in the extrinsic incubation period (EIP), which is itself directly dependent on temperature. Moreover, within the range of values at which BTV-1 transmission occurred in Andalusia (20.6 degrees C to 29.5 degrees C) there was a positive correlation between temperature and R-t values, although the relationship was not linear, probably as a result of the complex relationship between temperature and the different parameters affecting BTV transmission. R-t values for BTV-1 in Andalusia fell below the threshold of 1 when temperatures dropped below 21 degrees C, a much higher threshold than that reported in other BTV outbreaks, such as the BTV-8 epidemic in Northern Europe. This divergence may be explained by differences in the adaptation to temperature of the main vectors of the BTV-1 epidemic in Andalusia (Culicoides imicola) compared those of the BTV-8 epidemic in Northern Europe (Culicoides obsoletus). Importantly, we found that BTV transmission (R-t value) increased significantly in areas with higher densities of sheep. Our analysis also established that control of BTV-1 in Andalusia was complicated by the simultaneous establishment of several distant foci at the start of the epidemic, which may have been caused by several independent introductions of infected vectors from the North of Africa. We discuss the implications of these findings for BTV surveillance and control in this region of Europe.	[Napp, S.; Allepuz, A.; Casal, J.] Ctr Recerca Sanitat Anim, Inst Recerca & Tecnol Agroalimentaries, Campus UAB, Barcelona 08193, Spain; [Allepuz, A.; Casal, J.] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain; [Purse, B. V.] Ctr Ecol & Hydrol, MacLean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England; [Garcia-Bocanegra, I.] Univ Cordoba, Dept Sanidad Anim, Fac Vet, Campus Univ Rabanales, E-14071 Cordoba, Spain; [Burgin, L. E.] Met Off, FitzRoy Rd, Exeter EX1 3PB, Devon, England; [Searle, K. R.] Ctr Ecol & Hydrol, Bush Estate, Penicuik EH26 0QB, Midlothian, Scotland	Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; UK Centre for Ecology & Hydrology (UKCEH); Universidad de Cordoba; Met Office - UK; UK Centre for Ecology & Hydrology (UKCEH)	Napp, S (corresponding author), Ctr Recerca Sanitat Anim, Inst Recerca & Tecnol Agroalimentaries, Campus UAB, Barcelona 08193, Spain.	sebastian.napp@irta.es	Napp, Sebastian/F-3331-2016; Purse, Bethan V/I-6640-2012; Bocanegra, Ignacio Garcia/G-1443-2016; Casal, Jordi/F-3020-2016; Searle, Kate R/F-4922-2011; Allepuz, Alberto/N-2398-2014	Napp, Sebastian/0000-0001-5813-7286; Purse, Bethan V/0000-0001-5140-2710; Bocanegra, Ignacio Garcia/0000-0003-3388-2604; Casal, Jordi/0000-0002-6909-9366; Searle, Kate R/0000-0003-4624-9023; Allepuz, Alberto/0000-0003-3518-1991; Burgin, Laura/0000-0003-1247-9971	EU [EDENext FP7-261504]; NERC Centre for Ecology and Hydrology National Capability allocation; Natural Environment Research Council [ceh020002] Funding Source: researchfish; NERC [ceh020002] Funding Source: UKRI	EU(European Commission); NERC Centre for Ecology and Hydrology National Capability allocation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the EDENext FP7-261504 EU project. Additional support was provided for KS and BP from the NERC Centre for Ecology and Hydrology National Capability allocation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NS, 2014, OPEN HEAL DATA, V2, pe2, DOI DOI 10.5334/0HD.AH); Allepuz A, 2010, PREV VET MED, V96, P263, DOI 10.1016/j.prevetmed.2010.06.005; ANDERSON R M, 1991; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2007, B OFICIAL ESTADO; Boender GJ, 2014, VET RES, V45, DOI 10.1186/s13567-014-0075-x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carpenter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027987; Davies T, 2005, Q J ROY METEOR SOC, V131, P1759, DOI 10.1256/qj.04.101; de Koeijer AA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-53; Garcia-Bocanegra I, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-88; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P121, DOI 10.1098/rspb.2002.2191; Jarvis A., 2008, CGIAR CSI SRTM 90 M, DOI DOI 10.1111/ecog.00774; Keeling MJ, 2000, J THEOR BIOL, V203, P51, DOI 10.1006/jtbi.1999.1064; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kluiters G, 2013, J APPL ECOL, V50, P232, DOI 10.1111/1365-2664.12030; Koumbati M, 1999, VET MICROBIOL, V64, P277, DOI 10.1016/S0378-1135(98)00255-7; Maan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026147; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Matthews L, 2005, NAT REV MICROBIOL, V3, P529, DOI 10.1038/nrmicro1178; Meroc E, 2008, VET MICROBIOL, V131, P133, DOI 10.1016/j.vetmic.2008.03.012; Mintiens K, 2008, PREV VET MED, V87, P145, DOI 10.1016/j.prevetmed.2008.06.010; Napp S, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-4; Paweska JT, 2002, MED VET ENTOMOL, V16, P10, DOI 10.1046/j.1365-2915.2002.00334.x; de Diego ACP, 2014, TRANSBOUND EMERG DIS, V61, pE1, DOI 10.1111/tbed.12068; Pinheiro J, 2015, NLME LINEAR NONLINEA; Purse BV, 2015, ANNU REV ENTOMOL, V60, P373, DOI 10.1146/annurev-ento-010814-020614; Purse BV, 2007, J APPL ECOL, V44, P1231, DOI 10.1111/j.1365-2664.2007.01342.x; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Saegerman C, 2008, BLUETONGUE NO EUROPE; Santman-Berends IMGA, 2013, PREV VET MED, V108, P276, DOI 10.1016/j.prevetmed.2012.11.004; Searle K.R., 2015, IMPACT DECADE 2004 2, P83, DOI [10.13140/RG.2.1.4382.6400, DOI 10.13140/RG.2.1.4382.6400]; Sedda L, 2012, P ROY SOC B-BIOL SCI, V279, P2354, DOI 10.1098/rspb.2011.2555; Verhoef FA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-384; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; WINT W, 2014, OPEN HLTH DATA, V2, pE1, DOI DOI 10.5334/0HD.AG); Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	41	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151151	10.1371/journal.pone.0151151	http://dx.doi.org/10.1371/journal.pone.0151151			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963397	gold, Green Accepted, Green Published			2022-12-27	WOS:000371993000111
J	Zhang, S; Zheng, DH; Wu, YG; Lin, W; Chen, ZC; Meng, LH; Liu, J; Zhou, Y				Zhang, Shen; Zheng, Dahan; Wu, Yonggen; Lin, Wei; Chen, Zaichong; Meng, Luhe; Liu, Jun; Zhou, Ying			Simulated Microgravity Using a Rotary Culture System Compromises the In Vitro Development of Mouse Preantral Follicles	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; ENDOTHELIAL-CELLS; GROWING TISSUES; OOCYTES; EXPRESSION; GDF-9; LIVE; WEIGHTLESSNESS; FERTILIZATION; CYTOSKELETON	Background Growing cells in simulated weightlessness condition might be a highly promising new technique to maintain or generate tissue constructs in a scaffold-free manner. There is limited evidence that microgravity condition may affect development of ovarian follicles. The objective of the present study was to investigate the effects of simulated microgravity on the in vitro development of mouse preantral follicles. Methods and Results Ovarian tissue from 14-day-old mice, or preantral follicles mechanically isolated from 14-day-old mouse ovaries were cultured at a simulated microgravity condition generated using a rotating wall vessel apparatus. Follicle survival was assessed quantitatively using H&E staining. Follicle diameter and oocyte diameter were measured under an inverted microscope. Ultrastructure of oocytes was evaluated using transmission electron microscopy. We observed that simulated microgravity compromised follicle survival in vitro, down-regulated PCNA and GDF-9 expressions, and caused ultrastructural abnormalities in oocytes. Conclusion This study showed for the first time that three-dimensional culture condition generated by simulated microgravity is detrimental to the initial stage development of mouse preantral follicles in vitro. The experimental setup provides a model to further investigate the mechanisms involved in the in vitro developmental processes of oocytes/granulosa cells under the microgravity condition.	[Zhang, Shen; Wu, Yonggen; Chen, Zaichong; Meng, Luhe; Zhou, Ying] Wenzhou Med Univ, Affiliated Hosp 1, Reprod Med Ctr, Wenzhou, Zhejiang, Peoples R China; [Zheng, Dahan; Lin, Wei] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Zhejiang, Peoples R China; [Liu, Jun] Monash Univ, Dept Mat Engn, Stem Cells & Genet Engn Grp, Clayton, Vic 3168, Australia; [Zhou, Ying] Wenzhou Med Univ, Dept Histol & Embryol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Monash University; Wenzhou Medical University	Zhou, Y (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Reprod Med Ctr, Wenzhou, Zhejiang, Peoples R China.; Liu, J (corresponding author), Monash Univ, Dept Mat Engn, Stem Cells & Genet Engn Grp, Clayton, Vic 3168, Australia.; Zhou, Y (corresponding author), Wenzhou Med Univ, Dept Histol & Embryol, Wenzhou, Zhejiang, Peoples R China.	jun.liu@monash.edu; zy-yin@163.com		Zhang, Shen/0000-0002-6429-8008; Liu, Jun/0000-0003-4561-1190	Natural Science Foundation of Zhejiang Province [LY13C12002]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by The Natural Science Foundation of Zhejiang Province (grant number: LY13C12002) to YZ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen J, 1999, J CLIN ENDOCR METAB, V84, P2744, DOI 10.1210/jc.84.8.2744; Abir R, 2006, HISTOL HISTOPATHOL, V21, P887, DOI 10.14670/HH-21.887; Beck M, 2012, INT J MOL MED, V30, P309, DOI 10.3892/ijmm.2012.1001; COGOLI A, 1984, SCIENCE, V225, P228, DOI 10.1126/science.6729481; Dang BR, 2014, LIFE SCI, V97, P123, DOI 10.1016/j.lfs.2013.12.008; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1018, DOI 10.1210/me.13.6.1018; EPPIG JJ, 1989, BIOL REPROD, V41, P268, DOI 10.1095/biolreprod41.2.268; Grimm D, 2014, TISSUE ENG PART B-RE, V20, P555, DOI [10.1089/ten.teb.2013.0704, 10.1089/ten.TEB.2013.0704]; Grimm D, 2010, TISSUE ENG PT A, V16, P1559, DOI [10.1089/ten.tea.2009.0524, 10.1089/ten.TEA.2009.0524]; Grimm D, 2009, TISSUE ENG PT A, V15, P2267, DOI 10.1089/ten.tea.2008.0576; Hayashi M, 1999, ENDOCRINOLOGY, V140, P1236, DOI 10.1210/en.140.3.1236; Huangfu Jie, 2015, Bioengineered, V6, P251, DOI 10.1080/21655979.2015.1056942; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; Infanger M, 2006, CELL TISSUE RES, V324, P267, DOI 10.1007/s00441-005-0142-8; Jaatinen R, 1999, MOL CELL ENDOCRINOL, V156, P189, DOI 10.1016/S0303-7207(99)00100-8; Joyce IM, 2000, BIOL REPROD, V63, P1669, DOI 10.1095/biolreprod63.6.1669; Liu J, 2001, BIOL REPROD, V64, P171, DOI 10.1095/biolreprod64.1.171; Maier JAM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/434803; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Parrish EM, 2011, REPRODUCTION, V142, P309, DOI 10.1530/REP-10-0481; Pietsch J, 2013, INT J MOL SCI, V14, P1164, DOI 10.3390/ijms14011164; Sadeu JC, 2008, REPRODUCTION, V136, P195, DOI 10.1530/REP-08-0065; Shea LD, 2014, ANNU REV BIOMED ENG, V16, P29, DOI 10.1146/annurev-bioeng-071813-105131; Tauber S, 2015, CELL PHYSIOL BIOCHEM, V35, P1034, DOI 10.1159/000373930; Ulbrich C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/928507; Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901; Wang YC, 2009, REPROD SCI, V16, P947, DOI 10.1177/1933719109337544; Wu CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022214; Xu M, 2006, TISSUE ENG, V12, P2739, DOI 10.1089/ten.2006.12.2739; Xu M, 2006, BIOL REPROD, V75, P916, DOI 10.1095/biolreprod.106.054833; Yu B, 2011, BIOCHEM BIOPH RES CO, V414, P412, DOI 10.1016/j.bbrc.2011.09.103; Zhu M, 2014, GENET MOL RES, V13, P6060, DOI 10.4238/2014.August.7.20	34	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151062	10.1371/journal.pone.0151062	http://dx.doi.org/10.1371/journal.pone.0151062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963099	gold, Green Submitted, Green Published			2022-12-27	WOS:000371993000098
J	Zhong, J; Huang, WL; Deng, QC; Wu, MH; Jiang, HL; Lin, XL; Sun, YF; Huang, X; Yuan, J				Zhong, Jing; Huang, Weilan; Deng, Qiuchan; Wu, Minhao; Jiang, Huaili; Lin, Xiaolei; Sun, Yifang; Huang, Xi; Yuan, Jin			Inhibition of TREM-1 and Dectin-1 Alleviates the Severity of Fungal Keratitis by Modulating Innate Immune Responses	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; MYELOID CELLS-1 TREM-1; ASPERGILLUS-FUMIGATUS; PATHOGEN RECOGNITION; INFECTION; FUSARIUM; INFLAMMATION; NEUTROPHILS; EXPRESSION; CYTOKINES	Purpose To explore the possibility that inhibiting triggering receptor expressed on myeloid cells-1 (TREM-1) and Dendritic cell-associated C-type lectin-1(Dectin-1) could modulate the innate immune response and alleviate the severity of corneal fungal keratitis. Method TREM-1 and Dectin-1 expression was detected in fungus-infected human corneal specimens by real-time PCR. C57BL/6 (B6) mice were injected with Aspergillus fumigatus and divided into 4 groups that received subconjunctival injections of PBS and IgG as a control (group I), mTREM-1/IgG fusion protein (group II), the soluble beta-glucan antagonist laminarin (group III), or mTREM-1/Fc and laminarin (group IV). Corneal virulence was evaluated based on clinical scores. TREM-1 and Dectin-1 mRNA levels were assayed using real-time PCR. The distribution patterns of TREM-1, Dectin-1 and cellular infiltrates in fungus-infected corneas were examined by immunohistochemistry. Moreover, changes in T Helper Type1 (Th1)-/T Helper Type1 (Th2)-type cytokines and proinflammatory cytokines were measured. Results The expression of TREM-1 and Dectin-1 increased significantly and correlated positively with the progression of fungal keratitis. Most infiltrated cells were neutrophils and secondarily macrophages in infected cornea. The clinical scores decreased after interfering with TREM-1 and Dectin-1 expression in infected mouse corneas. Levels of Th1-type cytokines including interleukin-12 (IL-12), IL-18 and interferon-gamma (IFN-gamma) were decreased in the cornea, while the levels of Th2-type cytokines, including IL-4, IL-5 and IL-10, showed obvious increases. Conclusion TREM-1 and Dectin-1 function concurrently in the corneal innate immune response by regulating inflammatory cytokine expression in fungal keratitis. Inhibition of TREM-1 and Dectin-1 can alleviate the severity of corneal damage by downregulating the excessive inflammatory response.	[Zhong, Jing; Huang, Weilan; Lin, Xiaolei; Sun, Yifang; Yuan, Jin] Sun Yat Sen Univ, Zhongshan Sch Med, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510064, Guangdong, Peoples R China; [Deng, Qiuchan; Wu, Minhao; Huang, Xi] Sun Yat Sen Univ, Dept Immunol, Inst Human Virol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China; [Deng, Qiuchan; Wu, Minhao; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China; [Jiang, Huaili] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Otolaryngol Head & Neck Surg, Guangzhou 510064, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhong, J; Yuan, J (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510064, Guangdong, Peoples R China.; Huang, X (corresponding author), Sun Yat Sen Univ, Dept Immunol, Inst Human Virol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China.; Huang, X (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China.	huangxi6@mail.sysu.edu.cn; yuanjincornea@126.com			National Natural Science Foundation of China [81270972, U0832006]; Sun Yat-sen University [11ykpy66]; Guangdong Innovative Research Team Program [2009010058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sun Yat-sen University; Guangdong Innovative Research Team Program	This investigation was supported by grants from the National Natural Science Foundation of China to JY (81270972) and XH (U0832006); the fund of young prominent scholars of Sun Yat-sen University to JY (grant 11ykpy66); and the Guangdong Innovative Research Team Program to XH (2009010058).	Arts RJW, 2013, J LEUKOCYTE BIOL, V93, P209, DOI 10.1189/jlb.0312145; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Buckland KF, 2011, IMMUNOL INVEST, V40, P692, DOI 10.3109/08820139.2011.578270; Chang DC, 2006, JAMA-J AM MED ASSOC, V296, P953, DOI 10.1001/jama.296.8.953; Dennehy KM, 2007, J LEUKOCYTE BIOL, V82, P253, DOI 10.1189/jlb.1206753; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Garcia-Vidal C, 2013, CURR OPIN INFECT DIS, V26, P270, DOI 10.1097/QCO.0b013e32835fb920; Goodridge Helen S., 2008, V183, P87; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Huang HB, 2012, J IMMUNOL, V189, P312, DOI 10.4049/jimmunol.1200603; Jurkunas U, 2009, CORNEA, V28, P638, DOI 10.1097/ICO.0b013e318191695b; Karthikeyan RS, 2011, J INFECT DIS, V204, P942, DOI 10.1093/infdis/jir426; Keay LJ, 2011, OPHTHALMOLOGY, V118, P920, DOI 10.1016/j.ophtha.2010.09.011; Leal SM, 2012, CYTOKINE, V58, P107, DOI 10.1016/j.cyto.2011.12.022; Leal SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000976; McClellan SA, 2006, INVEST OPHTH VIS SCI, V47, P256, DOI 10.1167/iovs.05-1050; O'Dea EM, 2014, INFECT IMMUN, V82, P3199, DOI 10.1128/IAI.01990-14; Ornatowska M, 2007, AM J PHYSIOL-LUNG C, V293, pL1377, DOI 10.1152/ajplung.00140.2007; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Prajna NV, 2012, EYE, V26, P1226, DOI 10.1038/eye.2012.99; Schulze-Koops H, 2001, BEST PRACT RES CL RH, V15, P677, DOI 10.1053/berh.2001.0187; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Taylor PR, 2014, J IMMUNOL, V192, P3319, DOI 10.4049/jimmunol.1302235; Tessarz AS, 2007, J IMMUNOL, V178, P1991, DOI 10.4049/jimmunol.178.4.1991; Thomas PA, 2013, CLIN MICROBIOL INFEC, V19, P210, DOI 10.1111/1469-0691.12126; van Bremen T, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-24; Wu MH, 2011, INFECT IMMUN, V79, P2709, DOI 10.1128/IAI.00144-11; Wu TG, 2003, INVEST OPHTH VIS SCI, V44, P210, DOI 10.1167/iovs.02-0446; Yuan XY, 2010, INVEST OPHTH VIS SCI, V51, P2094, DOI 10.1167/iovs.09-4330; Zhang HB, 2013, EUR J IMMUNOL, V43, P2671, DOI 10.1002/eji.201242891	31	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150114	10.1371/journal.pone.0150114	http://dx.doi.org/10.1371/journal.pone.0150114			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963514	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000024
J	Bavi, O; Vossoughi, M; Naghdabadi, R; Jamali, Y				Bavi, Omid; Vossoughi, Manouchehr; Naghdabadi, Reza; Jamali, Yousef			The Combined Effect of Hydrophobic Mismatch and Bilayer Local Bending on the Regulation of Mechanosensitive Ion Channels	PLOS ONE			English	Article							LARGE-CONDUCTANCE; GATING MECHANISMS; LIPID-COMPOSITION; PRESSURE PROFILE; MSCL; MEMBRANE; PROTEIN; CURVATURE; INSIGHTS; TREK-1	The hydrophobic mismatch between the lipid bilayer and integral membrane proteins has well-defined effect on mechanosensitive (MS) ion channels. Also, membrane local bending is suggested to modulate MS channel activity. Although a number of studies have already shown the significance of each individual factor, the combined effect of these physical factors on MS channel activity have not been investigated. Here using finite element simulation, we study the combined effect of hydrophobic mismatch and local bending on the archetypal mechanosensitive channel MscL. First we show how the local curvature direction impacts on MS channel modulation. In the case of MscL, we show inward (cytoplasmic) bending can more effectively gate the channel compared to outward bending. Then we indicate that in response to a specific local curvature, MscL inserted in a bilayer with the same hydrophobic length is more expanded in the constriction pore region compared to when there is a protein-lipid hydrophobic mismatch. Interestingly in the presence of a negative mismatch (thicker lipids), MscL constriction pore is more expanded than in the presence of positive mismatch (thinner lipids) in response to an identical membrane curvature. These results were confirmed by a parametric energetic calculation provided for MscL gating. These findings have several biophysical consequences for understanding the function of MS channels in response to two major physical stimuli in mechanobiology, namely hydrophobic mismatch and local membrane curvature.	[Bavi, Omid; Vossoughi, Manouchehr; Naghdabadi, Reza] Sharif Univ Technol, Inst Nanosci & Nanotechnol, Tehran, Iran; [Vossoughi, Manouchehr] Biochem & Bioenvironm Res Ctr, Tehran, Iran; [Naghdabadi, Reza] Sharif Univ Technol, Dept Mech Engn, Tehran, Iran; [Jamali, Yousef] Tarbiat Modares Univ, Dept Math, Tehran, Iran; [Jamali, Yousef] Sch Nanosci Inst Res Fundamental Sci IPM, Computat Phys Sci Res Lab, Tehran, Iran	Sharif University of Technology; Sharif University of Technology; Tarbiat Modares University	Jamali, Y (corresponding author), Tarbiat Modares Univ, Dept Math, Tehran, Iran.; Jamali, Y (corresponding author), Sch Nanosci Inst Res Fundamental Sci IPM, Computat Phys Sci Res Lab, Tehran, Iran.	y.jamali@ipm.ir	Bavi, Omid/L-9086-2018; Bavi, Omid/CAA-9972-2022; Jamali, Yousef/V-5156-2019	Bavi, Omid/0000-0003-3539-0849; Bavi, Omid/0000-0003-3539-0849; Jamali, Yousef/0000-0002-5709-3821				Barbosa LRS, 2006, J PHYS CHEM B, V110, P13086, DOI 10.1021/jp056486t; Battle A, 2015, BIOCH BIOPHYSICA ACT; Bavi N, 2015, BIOPHYS J, V108, p564A, DOI 10.1016/j.bpj.2014.11.3089; Bavi N, 2014, P NATL ACAD SCI USA, V111, P13864, DOI 10.1073/pnas.1409011111; Bavi N, 2014, BIOPHYS J, V106, p554A, DOI 10.1016/j.bpj.2013.11.3085; Bavi O, 2014, CHANNELS, V8, P344, DOI 10.4161/chan.29572; Berrier C, 2013, J BIOL CHEM, V288, P27307, DOI 10.1074/jbc.M113.478321; Birkner JP, 2012, P NATL ACAD SCI USA, V109, P12944, DOI 10.1073/pnas.1205270109; Blount P, 1997, Gravit Space Biol Bull, V10, P43; Bozic B, 2015, SOFT MATTER, V11, P2479, DOI 10.1039/c4sm02289k; Brohawn SG, 2015, ANN NY ACAD SCI, V1352, P20, DOI 10.1111/nyas.12874; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Cantor RS, 2004, BIOPHYS J, V86, p330A; Cantor RS, 1999, BIOPHYS J, V76, P2625, DOI 10.1016/S0006-3495(99)77415-1; Chemin J, 2007, PFLUG ARCH EUR J PHY, V455, P97, DOI 10.1007/s00424-007-0250-2; Chen X, 2008, BIOPHYS J, V95, P563, DOI 10.1529/biophysj.107.128488; Corry B, 2010, J GEN PHYSIOL, V136, P483, DOI 10.1085/jgp.200910376; Cox CD, 2015, NAT COMMUN; Elmore DE, 2003, BIOPHYS J, V85, P1512, DOI 10.1016/S0006-3495(03)74584-6; EVANS EA, 1974, BIOPHYS J, V14, P923, DOI 10.1016/S0006-3495(74)85959-X; FAUCON JF, 1989, J PHYS-PARIS, V50, P2389, DOI 10.1051/jphys:0198900500170238900; Gullingsrud J, 2001, BIOPHYS J, V80, P2074, DOI 10.1016/S0006-3495(01)76181-4; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; HASE CC, 1995, J BIOL CHEM, V270, P18329, DOI 10.1074/jbc.270.31.18329; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Jensen MO, 2004, BBA-BIOMEMBRANES, V1666, P205, DOI 10.1016/j.bbamem.2004.06.009; Jensen MO, 2004, J CHEM PHYS, V120, P9729, DOI 10.1063/1.1697379; Kocer A, 2015, CURR OPIN CHEM BIOL, V29, P120, DOI 10.1016/j.cbpa.2015.10.006; Lewis AH, 2015, ELIFE, V4, DOI 10.7554/eLife.12088; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; MARKIN VS, 1991, BIOPHYS J, V60, P1120, DOI 10.1016/S0006-3495(91)82147-6; Martinac B, 2002, P NATL ACAD SCI USA, V99, P4308, DOI 10.1073/pnas.072632899; Mukherjee N, 2014, FASEB J, V28, P4292, DOI 10.1096/fj.14-251579; Nomura T, 2015, FASEB J; Nomura T, 2012, P NATL ACAD SCI USA, V109, P8770, DOI 10.1073/pnas.1200051109; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Suetsugu S, 2010, SEMIN CELL DEV BIOL; Sukharev SI, 1997, ANNU REV PHYSIOL, V59, P633, DOI 10.1146/annurev.physiol.59.1.633; Svetina S, 2015, EUR BIOPHYS J BIOPHY, V44, P513, DOI 10.1007/s00249-015-1046-5; Tang YY, 2008, CELL BIOCHEM BIOPHYS, V52, P1, DOI 10.1007/s12013-008-9024-5; Tang YY, 2008, BIOPHYS J, V95, P581, DOI 10.1529/biophysj.107.128496; Teng J, 2014, PFLUGERS ARCH EUROPE, P1; Vanegas JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113947; Wang Y, 2014, ELIFE, V3, DOI 10.7554/eLife.01834; Yoo J, 2009, BIOPHYS J, V97, P2267, DOI 10.1016/j.bpj.2009.07.051	49	18	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150578	10.1371/journal.pone.0150578	http://dx.doi.org/10.1371/journal.pone.0150578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26958847	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300059
J	Branco, BHM; Fukuda, DH; Andreato, LV; Santos, JFD; Esteves, JVD; Franchini, E				Magnani Branco, Braulio Henrique; Fukuda, David Hideyoshi; Andreato, Leonardo Vidal; da Silva Santos, Jonatas Ferreira; Del Conti Esteves, Joao Victor; Franchini, Emerson			The Effects of Hyperbaric Oxygen Therapy on Post-Training Recovery in Jiu-Jitsu Athletes	PLOS ONE			English	Article							TESTOSTERONE	Objectives The present study aimed to evaluate the effects of using hyperbaric oxygen therapy during post-training recovery in jiu-jitsu athletes. Methods Eleven experienced Brazilian jiu-jitsu athletes were investigated during and following two training sessions of 1h30min. Using a cross-over design, the athletes were randomly assigned to passive recovery for 2 hours or to hyperbaric oxygen therapy (OHB) for the same duration. After a 7-day period, the interventions were reversed. Before, immediately after, post 2 hours and post 24 hours, blood samples were collected to examine hormone concentrations (cortisol and total testosterone) and cellular damage markers [creatine kinase (CK), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH)]. Moreover, the rating of perceived exertion (RPE) and recovery (RPR) scales were applied. Results Final lactate [La] values (control: 11.9 +/- 1.4 mmol/L, OHB: 10.2 +/- 1.4 mmol/L) and RPE [control: 14 (13-17 a.u.), OHB: 18 (17-20 a.u.)] were not significantly different following the training sessions. Furthermore, there was no difference between any time points for blood lactate and RPE in the two experimental conditions (P > 0.05). There was no effect of experimental conditions on cortisol (F-1,F-20 = 0.1, P = 0.793, eta(2) = 0.00, small), total testosterone (F-1,F-20 = 0.03, P = 0.877, eta(2) = 0.00, small), CK (F-1,F-20 = 0.1, P = 0.759, eta(2) = 0.01, small), AST (F-1,F-20 = 0.1, P = 0.761, eta(2) = 0.01, small), ALT (F-1,F-20 = 0.0, P = 0.845, eta(2) = 0.00, small) or LDH (F-1,F-20 = 0.7, P = 0.413, eta(2) = 0.03, small). However, there was a difference between the two experimental conditions in RPR with higher values at post 2 h and 24 h in OHB when compared to the control condition (P < 0.05). Conclusions Thus, it can be concluded that OHB exerts no influence on the recovery of hormonal status or cellular damage markers. Nonetheless, greater perceived recovery, potentially due to the placebo effect, was evident following the OHB condition.	[Magnani Branco, Braulio Henrique; da Silva Santos, Jonatas Ferreira; Franchini, Emerson] Univ Sao Paulo, Sports & Phys Educ Sch, Sao Paulo, Brazil; [Magnani Branco, Braulio Henrique; da Silva Santos, Jonatas Ferreira; Franchini, Emerson] Univ Sao Paulo, Combat Sports & Martial Arts Res Grp, Phys Educ & Sports Sch, Sao Paulo, Brazil; [Fukuda, David Hideyoshi] Univ Cent Florida, Orlando, FL 32816 USA; [Andreato, Leonardo Vidal] Santa Catarina State Univ, Florianopolis, SC, Brazil; [Del Conti Esteves, Joao Victor] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; State University System of Florida; University of Central Florida; Universidade do Estado de Santa Catarina; Universidade de Sao Paulo	Branco, BHM (corresponding author), Univ Sao Paulo, Sports & Phys Educ Sch, Sao Paulo, Brazil.; Branco, BHM (corresponding author), Univ Sao Paulo, Combat Sports & Martial Arts Res Grp, Phys Educ & Sports Sch, Sao Paulo, Brazil.	brauliomagnani@live.com	Esteves, João Victor/N-7866-2015; Fukuda, David/F-4507-2014; Franchini, Emerson/B-9119-2012; da Silva Santos, Jonatas Ferreira/O-6956-2019; Branco, Braulio/AAA-1747-2019; Magnani Branco, Braulio Henrique/B-8178-2017	Esteves, João Victor/0000-0001-8274-000X; Fukuda, David/0000-0002-4299-7764; Franchini, Emerson/0000-0002-0769-8398; da Silva Santos, Jonatas Ferreira/0000-0002-3309-4731; Magnani Branco, Braulio Henrique/0000-0002-4625-9128	Laboratory of Energy Determinants of Performance Sports (LADESP) of School of Physical Education and Sport, University of Sao Paulo, Sao Paulo, Brazil	Laboratory of Energy Determinants of Performance Sports (LADESP) of School of Physical Education and Sport, University of Sao Paulo, Sao Paulo, Brazil	Research was carried out with funds provided by the Laboratory of Energy Determinants of Performance Sports (LADESP) of School of Physical Education and Sport, University of Sao Paulo, Sao Paulo, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreato LV, 2015, J STRENGTH COND RES, V29, P2015, DOI 10.1519/JSC.0000000000000819; Babul S, 2003, CLIN J SPORT MED, V13, P138, DOI 10.1097/00042752-200305000-00003; Babul S, 2000, SPORTS MED, V30, P395, DOI 10.2165/00007256-200030060-00002; Barata P, 2011, THER ADV MUSCULOSKEL, V3, P111, DOI 10.1177/1759720X11399172; Barnett A, 2006, SPORTS MED, V36, P781, DOI 10.2165/00007256-200636090-00005; Bennett MH, 2005, COCHRANE DB SYST REV, V19, P1; Bennett MH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004609.pub3; Bishop PA, 2015, INT J EXERC SCI, V3, P297; Bleakley C, 2003, BRIT J SPORT MED, V37, P72; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Broatch JR, 2014, MED SCI SPORT EXER, V46, P2139, DOI 10.1249/MSS.0000000000000348; Brownlee KK, 2005, J SPORT SCI MED, V4, P76; Cohen J.E., 1988, STAT POWER ANAL BEHA; Santos WOC, 2012, J HUM SPORT EXERC, V7, P629, DOI 10.4100/jhse.2012.73.03; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Hai-peng Z, 1994, PATHOPHYSIOLOGY, V1, P91; Hayes LD, 2015, SPORTS MED, V45, P713, DOI 10.1007/s40279-015-0306-y; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Jones NB, 2012, STRENGTH COND J, V34, P60, DOI 10.1519/SSC.0b013e3182405476; Kim S., 2011, HEALTH-LONDON, V03, P432, DOI [DOI 10.4236/HEALTH.2011.37071, https://doi.org/10.4236/health.2011.37071]; Laurent CM, 2011, J STRENGTH COND RES, V25, P620, DOI 10.1519/JSC.0b013e3181c69ec6; Lund V, 1999, UNDERSEA HYPERBAR M, V26, P87; Mayer R, 2005, STRAHLENTHER ONKOL, V181, P113, DOI 10.1007/s00066-005-1277-y; Mortensen C.R., 2008, CURR ANAESTH CRIT CA, V19, P333, DOI DOI 10.1016/J.CACC.2008.07.007; Passavanti G, 2010, UROLOG J, V77, P52, DOI 10.1177/039156031007700109; Pinho Júnior E. A., 2014, Rev Andal Med Deporte, V7, P7; Reilly T, 2005, J SPORT SCI, V23, P619, DOI 10.1080/02640410400021302; Sheridan RL, 1999, J TRAUMA, V47, P426, DOI 10.1097/00005373-199908000-00045; Shimoda M, 2015, J STRENGTH COND RES, V29, P1648, DOI 10.1519/JSC.0000000000000809; Staples J, 1996, SPORTS MED, V22, P219, DOI 10.2165/00007256-199622040-00002; Tiidus PM, 2015, CURR REV MUSCULOSKE, V8, P162, DOI 10.1007/s12178-015-9261-3	31	18	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150517	10.1371/journal.pone.0150517	http://dx.doi.org/10.1371/journal.pone.0150517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959652	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300054
J	Yang, SN; Kong, WM; Hsue, CY; Fish, AF; Chen, YF; Guo, XH; Lou, QQ; Anderson, R				Yang, Shengnan; Kong, Weimin; Hsue, Cunyi; Fish, Anne F.; Chen, Yufeng; Guo, Xiaohui; Lou, Qingqing; Anderson, Robert			Knowledge of A1c Predicts Diabetes Self-Management and A1c Level among Chinese Patients with Type 2 Diabetes	PLOS ONE			English	Article							IMPROVES GLYCEMIC CONTROL; FEEDBACK; HBA(1C); CARE; VALUES; HBA1C	This study was to identify current A1c understanding status among Chinese patients with type 2 diabetes, assess if knowledge of A1c affects their diabetes self-management and their glycemic control and recognize the factors influencing knowledge of A1c among patients with type 2 diabetes. A multi-center, cross-sectional survey was conducted between April and July 2010 in 50 medical centers in the Mainland China. Participants were recruited from inpatients and outpatients who were admitted to or visited those medical centers. The survey included core questions about their demographic characteristics, diabetes self-management behavior, and A1c knowledge. Overall, of 5957 patients, the percentage of patients with good understanding was 25.3%. In the multivariable logistic regression model, the variables related to the knowledge of A1c status are presented. We discovered that patients with longer diabetes duration (OR = 1.05; 95% CI = 1.04-1.06) and having received diabetes education (OR = 1.80; 95% CI = 1.49-2.17) were overrepresented in the good understanding of A1c group. In addition, compared to no education level, higher education level was statistically associated with good understanding of A1c (P<0.001). The percentage of patients with good understanding varied from region to region (P<0.001), with Eastern being highest (OR = 1.54; 95% CI = 1.32-1.80), followed by Central (OR = 1.25; 95% CI = 1.02-1.53), when referring to Western. Only a minority of patients with type 2 diabetes in China understood their A1c value. The patients who had a good understanding of their A1c demonstrated significantly better diabetes self-management behavior and had lower A1c levels than those who did not.	[Yang, Shengnan; Lou, Qingqing] Nanjing Univ Chinese Med, Affiliated Hosp Integrated Tradit Chinese & Weste, Nanjing, Jiangsu, Peoples R China; [Yang, Shengnan; Kong, Weimin; Chen, Yufeng] Nanjing Univ Chinese Med, Coll Nursing, Nanjing, Jiangsu, Peoples R China; [Yang, Shengnan; Lou, Qingqing] Jiangsu Prov Acad Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China; [Hsue, Cunyi] Hangzhou 9 High Sch, Hangzhou, Zhejiang, Peoples R China; [Fish, Anne F.] Univ Missouri, Coll Nursing, ISP Fellowship Support Program, St Louis, MO 63121 USA; [Guo, Xiaohui] Peking Univ, Hosp 1, Dept Endocrinol, Beijing 100871, Peoples R China; [Anderson, Robert] Michigan Diabet Res & Training Ctr, Dept Med Educ & Senior Res Scientist, Ann Arbor, MI USA	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; University of Missouri System; University of Missouri Saint Louis; Peking University	Lou, QQ (corresponding author), Nanjing Univ Chinese Med, Affiliated Hosp Integrated Tradit Chinese & Weste, Nanjing, Jiangsu, Peoples R China.; Lou, QQ (corresponding author), Jiangsu Prov Acad Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China.; Guo, XH (corresponding author), Peking Univ, Hosp 1, Dept Endocrinol, Beijing 100871, Peoples R China.	guoxh@medmail.com.cn; lqq188@yahoo.com						American Diabetes Association, 2003, DOCT PAT DIAL MAY HE; Beard E, 2010, PATIENT EDUC COUNS, V80, P227, DOI 10.1016/j.pec.2009.11.008; Beckles GLA, 1998, DIABETES CARE, V21, P1432, DOI 10.2337/diacare.21.9.1432; Cagliero E, 1999, DIABETES CARE, V22, P1785, DOI 10.2337/diacare.22.11.1785; Chapin RB, 2003, J GEN INTERN MED, V18, P120, DOI 10.1046/j.1525-1497.2003.20367.x; Chrvala CA, 2016, PATIENT EDUC COUNS, V99, P926, DOI 10.1016/j.pec.2015.11.003; DUNN SM, 1990, SOC SCI MED, V31, P1135, DOI 10.1016/0277-9536(90)90235-K; Gopalan A, 2014, J GEN INTERN MED, V29, P996, DOI 10.1007/s11606-014-2810-4; Guo XH, 2012, CHINESE MED J-PEKING, V125, P4175, DOI 10.3760/cma.j.issn.0366-6999.2012.23.003; He XW, 2011, CHINESE NURSING MANA, V11, P10; Heisler M, 2005, DIABETES CARE, V28, P816, DOI 10.2337/diacare.28.4.816; Hu QH, 2007, J NURSING, V14, P3; International Diabetes Federatoin, 2013, IDF DIAB ATL, P29; Iqbal N, 2008, ANN CLIN BIOCHEM, V45, P504, DOI 10.1258/acb.2008.008034; Kahn CR, 2005, JOSLINS DIABETES MEL, P587; Lafata JE, 2002, J GEN INTERN MED, V17, P521, DOI 10.1046/j.1525-1497.2002.10901.x; LARSEN ML, 1990, NEW ENGL J MED, V323, P1021, DOI 10.1056/NEJM199010113231503; Lou QQ, 2011, PATIENT EDUC COUNS, V85, P336, DOI 10.1016/j.pec.2011.01.006; [莫永珍 Mo Yongzhen], 2012, [中华护理杂志, Chinese Journal of Nursing], V47, P141; NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602; Skeie S, 2001, CLIN CHEM, V47, P1212; Stolar M, 2010, AM J MED, V123, pS3, DOI 10.1016/j.amjmed.2009.12.004; Suzuki-Saito T, 2013, J DIABETES INVEST, V4, P206, DOI 10.1111/jdi.12002; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wei H., 2008, J SW U NAT, V10, P56; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Zhang Y, 2003, CHINESE J PUBLIC HLT, V19, P888	28	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150753	10.1371/journal.pone.0150753	http://dx.doi.org/10.1371/journal.pone.0150753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TF	26959422	Green Published, gold			2022-12-27	WOS:000371992300071
J	Vikmoen, O; Raastad, T; Seynnes, O; Bergstrom, K; Ellefsen, S; Ronnestad, BR				Vikmoen, Olav; Raastad, Truls; Seynnes, Olivier; Bergstrom, Kristoffer; Ellefsen, Stian; Ronnestad, Bent R.			Effects of Heavy Strength Training on Running Performance and Determinants of Running Performance in Female Endurance Athletes	PLOS ONE			English	Article							SKELETAL-MUSCLE ADAPTATIONS; LONG-DISTANCE RUNNERS; WHOLE-BODY VIBRATION; MECHANICAL-PROPERTIES; PATELLAR TENDON; CONCURRENT ENDURANCE; JUMP PERFORMANCE; OXYGEN-UPTAKE; ECONOMY; CYCLISTS	Purpose The purpose of the current study was to investigate the effects of adding strength training to normal endurance training on running performance and running economy in well-trained female athletes. We hypothesized that the added strength training would improve performance and running economy through altered stiffness of the muscle-tendon complex of leg extensors. Methods Nineteen female endurance athletes [maximal oxygen consumption (VO2max): 53 +/- 3 ml.kg(-1).min(-1), 5.8 h weekly endurance training] were randomly assigned to either normal endurance training (E, n = 8) or normal endurance training combined with strength training (E+S, n = 11). The strength training consisted of four leg exercises [3 x 4-10 repetition maximum (RM)], twice a week for 11 weeks. Muscle strength, 40 min all-out running distance, running performance determinants and patellar tendon stiffness were measured before and after the intervention. Results E + S increased 1RM in leg exercises (40 +/- 15%) and maximal jumping height in counter movement jump (6 +/- 6%) and squat jump (9 +/- 7%, p < 0.05). This was accompanied by increased muscle fiber cross sectional area of both fiber type I (13 +/- 7%) and fiber type II (31 +/- 20%) in m. vastus lateralis (p < 0.05), with no change in capillary density in m. vastus lateralis or the stiffness of the patellar tendon. Neither E + S nor E changed running economy, fractional utilization of VO2max or VO2max. There were also no change in running distance during a 40 min all-out running test in neither of the groups. Conclusion Adding heavy strength training to endurance training did not affect 40 min all-out running performance or running economy compared to endurance training only.	[Vikmoen, Olav; Ellefsen, Stian; Ronnestad, Bent R.] Lillehammer Univ Coll, Sect Sport Sci, Lillehammer, Norway; [Raastad, Truls; Seynnes, Olivier; Bergstrom, Kristoffer] Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway	Inland Norway University of Applied Sciences; Norwegian School of Sport Sciences	Vikmoen, O (corresponding author), Lillehammer Univ Coll, Sect Sport Sci, Lillehammer, Norway.	olav.vikmoen@hil.no	Raastad, Truls/AFP-1474-2022	Raastad, Truls/0000-0002-2567-3004; Seynnes, Olivier/0000-0002-1289-246X; Ronnestad, Bent/0000-0002-6907-1347	Regional Science Fund-Innlandet of Norway [203961]	Regional Science Fund-Innlandet of Norway	This work was supported by grant 203961 from the Regional Science Fund-Innlandet of Norway. (http://www.regionaleforskningsfond.no/prognett-innlandet/Forside/1253953746925). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2011, SCAND J MED SCI SPOR, V21, pE298, DOI 10.1111/j.1600-0838.2010.01283.x; Arampatzis A, 2006, J EXP BIOL, V209, P3345, DOI 10.1242/jeb.02340; Barnes KR, 2013, MED SCI SPORT EXER, V45, P2322, DOI 10.1249/MSS.0b013e31829af603; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Bell GJ, 2000, EUR J APPL PHYSIOL, V81, P418, DOI 10.1007/s004210050063; Bertuzzi R, 2013, INT J SPORTS MED, V34, P917, DOI 10.1055/s-0033-1333748; BRODAL P, 1977, AM J PHYSIOL, V232, pH705, DOI 10.1152/ajpheart.1977.232.6.H705; COSTILL DL, 1976, MED SCI SPORT EXER, V8, P96; Damasceno MV, 2015, EUR J APPL PHYSIOL, V115, P1513, DOI 10.1007/s00421-015-3130-z; Ferrauti A, 2010, J STRENGTH COND RES, V24, P2770, DOI 10.1519/JSC.0b013e3181d64e9c; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Francesca PM, 2012, J STRENGTH COND RES, DOI [10.1519/JSC.0b013e3182794485, DOI 10.1519/JSC.0B013E3182794485]; Guglielmo LGA, 2009, INT J SPORTS MED, V30, P27, DOI 10.1055/s-2008-1038792; HATHER BM, 1991, ACTA PHYSIOL SCAND, V143, P177, DOI 10.1111/j.1748-1716.1991.tb09219.x; Helland C, 2013, BRIT J SPORT MED, V47, P862, DOI 10.1136/bjsports-2013-092275; Hickson RC, 1988, APPL PHYSL, V65, P2285; Hill DW, 1996, MED SCI SPORT EXER, V28, P114, DOI 10.1097/00005768-199601000-00022; Hoff J, 2003, FOOTBALL SOCCER NEW, P37; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; INGJER F, 1978, EUR J APPL PHYSIOL O, V38, P291, DOI 10.1007/BF00423112; Jeukendrup A E, 2000, J Sci Med Sport, V3, P414, DOI 10.1016/S1440-2440(00)80008-0; Johnston RE, 1997, J STRENGTH COND RES, V11, P224; Kelly CM, 2008, J STRENGTH COND RES, V22, P396, DOI 10.1519/JSC.0b013e318163534a; Kongsgaard M, 2007, ACTA PHYSIOL, V191, P111, DOI 10.1111/j.1748-1716.2007.01714.x; KRAEMER WJ, 1995, J APPL PHYSIOL, V78, P976, DOI 10.1152/jappl.1995.78.3.976; Kubo K, 2006, J APPL BIOMECH, V22, P112, DOI 10.1123/jab.22.2.112; Kubo K, 2006, EUR J APPL PHYSIOL, V96, P305, DOI 10.1007/s00421-005-0087-3; Kubo K, 2001, J APPL PHYSIOL, V91, P26, DOI 10.1152/jappl.2001.91.1.26; Magnusson SP, 2007, INT J EXP PATHOL, V88, P237, DOI 10.1111/j.1365-2613.2007.00551.x; Mikkola J, 2007, INT J SPORTS MED, V28, P602, DOI 10.1055/s-2007-964849; Millet GP, 2002, MED SCI SPORT EXER, V34, P1351, DOI 10.1097/00005768-200208000-00018; Noakes TD, 1990, J SPORT SCI, V8, P35, DOI 10.1080/02640419008732129; Paavolainen L, 1999, J APPL PHYSIOL, V86, P1527; Reeves ND, 2003, J PHYSIOL-LONDON, V548, P971, DOI 10.1113/jphysiol.2002.035576; Roberts TJ, 2011, J EXP BIOL, V214, P353, DOI 10.1242/jeb.038588; Ronnestad BR, 2010, EUR J APPL PHYSIOL, V110, P1269, DOI 10.1007/s00421-010-1622-4; Ronnestad BR, 2010, EUR J APPL PHYSIOL, V108, P965, DOI 10.1007/s00421-009-1307-z; Ronnestad BR, 2008, J STRENGTH COND RES, V22, P773, DOI 10.1519/JSC.0b013e31816a5e86; Roschel H, 2015, J STRENGTH COND RES, V29, P2215, DOI 10.1519/JSC.0000000000000857; Saunders PU, 2006, J STRENGTH COND RES, V20, P947; Sedano S, 2013, J STRENGTH COND RES, V27, P2433, DOI 10.1519/JSC.0b013e318280cc26; Seynnes OR, 2009, J APPL PHYSIOL, V107, P523, DOI 10.1152/japplphysiol.00213.2009; SJOGAARD G, 1984, INT J SPORTS MED, V5, P250, DOI 10.1055/s-2008-1025915; Spurrs RW, 2003, EUR J APPL PHYSIOL, V89, P1, DOI 10.1007/s00421-002-0741-y; Taipale RS, 2010, INT J SPORTS MED, V31, P468, DOI 10.1055/s-0029-1243639; Tricoli V, 2005, J STRENGTH COND RES, V19, P433; Vikmoen O, 2016, SCAND J MED SCI SPOR, V26, P384, DOI 10.1111/sms.12468; WILSON GJ, 1993, MED SCI SPORT EXER, V25, P1279	49	27	29	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150799	10.1371/journal.pone.0150799	http://dx.doi.org/10.1371/journal.pone.0150799			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953893	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300051
J	Chen, HL; Chen, X; Tian, J; Yang, Y; Liu, ZX; Hao, XY; Wang, LX; Wang, SH; Liang, J; Zhang, LY; Yin, FX; Cheng, XZ				Chen, Honglin; Chen, Xin; Tian, Jing; Yang, Yong; Liu, Zhenxing; Hao, Xiyu; Wang, Lixia; Wang, Suhua; Liang, Jie; Zhang, Liya; Yin, Fengxiang; Cheng, Xuzhen			Development of Gene-Based SSR Markers in Rice Bean (Vigna umbellata L.) Based on Transcriptome Data	PLOS ONE			English	Article							MICROSATELLITE MARKERS; WILLD. OHWI; DIVERSITY; SEQUENCE; TRANSFERABILITY; GENERATION; ANGULARIS; CROSS	Rice bean (Vigna umbellata (Thunb.) Ohwi & Ohashi) is a warm season annual legume mainly grown in East Asia. Only scarce genomic resources are currently available for this legume crop species and no simple sequence repeat (SSR) markers have been specifically developed for rice bean yet. In this study, approximately 26 million high quality cDNA sequence reads were obtained from rice bean using Illumina paired-end sequencing technology and assembled into 71,929 unigenes with an average length of 986 bp. Of these unigenes, 38,840 (33.2%) showed significant similarity to proteins in the NCBI non-redundant protein and nucleotide sequence databases. Furthermore, 30,170 (76.3%) could be classified into gene ontology categories, 25,451 (64.4%) into Swiss-Prot categories and 21,982 (55.6%) into KOG database categories (E-value < 1.0E-5). A total of 9,301 (23.5%) were mapped onto 118 pathways using the Kyoto Encyclopedia of Genes and Genome (KEGG) pathway database. A total of 3,011 genic SSRs were identified as potential molecular markers. AG/CT (30.3%), AAG/CTT (8.1%) and AGAA/TTCT (20.0%) are the three main repeat motifs. A total of 300 SSR loci were randomly selected for validation by using PCR amplification. Of these loci, 23 primer pairs were polymorphic among 32 rice bean accessions. A UPGMA dendrogram revealed three major clusters among 32 rice bean accessions. The large number of SSR-containing sequences and genic SSRs in this study will be valuable for the construction of high-resolution genetic linkage maps, association or comparative mapping and genetic analyses of various Vigna species.	[Chen, Honglin; Wang, Lixia; Wang, Suhua; Cheng, Xuzhen] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China; [Chen, Xin] Jiangsu Acad Agr Sci, Inst Vegetable Crops, Nanjing 210014, Jiangsu, Peoples R China; [Tian, Jing] Hebei Acad Agr & Forestry Sci, Inst Cereal & Oil Crops, Shijiazhuang 050035, Hebei, Peoples R China; [Yang, Yong; Zhang, Liya] Anhui Acad Agr Sci, Crop Res Inst, Hefei 230031, Anhui, Peoples R China; [Liu, Zhenxing] Tangshan Acad Agr Sci, Tangshan 036001, Hebei, Peoples R China; [Hao, Xiyu; Liang, Jie; Yin, Fengxiang] Baicheng Acad Agr Sci, Baicheng 137000, Jilin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Jiangsu Academy of Agricultural Sciences; Hebei Academy of Agricultural & Forestry Sciences; Anhui Academy of Agricultural Sciences	Chen, HL; Cheng, XZ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China.	chenhonglin@caas.cn; chengxuzhen@caas.cn		Chen, Xin/0000-0002-8292-7699; Chen, Honglin/0000-0002-5737-9336	Agricultural Science and Technology Innovation Program (ASTIP) in CAAS; China Agriculture Research System from the Ministry of Agriculture of China [CARS-09]; Chinese Agricultural Academy of Sciences (CAAS) Agricultural Science and Technology Innovation Program (ASTIP)	Agricultural Science and Technology Innovation Program (ASTIP) in CAAS; China Agriculture Research System from the Ministry of Agriculture of China; Chinese Agricultural Academy of Sciences (CAAS) Agricultural Science and Technology Innovation Program (ASTIP)	This study was funded by the Agricultural Science and Technology Innovation Program (ASTIP) in CAAS and the China Agriculture Research System (CARS-09) from the Ministry of Agriculture of China.; This work was funded by the Chinese Agricultural Academy of Sciences (CAAS) Agricultural Science and Technology Innovation Program (ASTIP) to HLC and China Agriculture Research System (CARS-09).	Agarwal G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052443; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blair MW, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-100; Blair MW, 2011, BMC PLANT BIOL, P11; Cameron M, 2004, IEEE ACM T COMPUT BI, V1, P116, DOI 10.1109/TCBB.2004.32; Chankaew S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104990; Chen HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131939; Chen HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120273; Choudhary S, 2009, THEOR APPL GENET, V118, P591, DOI 10.1007/s00122-008-0923-z; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dubchak I, 2009, GENOME RES, V19, P682, DOI 10.1101/gr.081778.108; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Englen MD, 2000, LETT APPL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2672.2000.00841.x; Gong YM, 2011, AGR SCI CHINA, V10, P838, DOI 10.1016/S1671-2927(11)60069-2; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gupta SK, 2010, GENOME, V53, P508, DOI [10.1139/G10-028, 10.1139/g10-028]; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hiz MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092598; Huang DN, 2014, MOL ECOL RESOUR, V14, P569, DOI 10.1111/1755-0998.12197; Kaga A, 2000, THEOR APPL GENET, V100, P207, DOI 10.1007/s001220050028; Kang YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08069; Kang YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6443; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Muthusamy S, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue3-fulltext-8; Peterlongo P, 2010, LECT NOTES COMPUT SC, V6393, P147, DOI 10.1007/978-3-642-16321-0_14; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tian J, 2013, GENOME, V56, P717, DOI 10.1139/gen-2013-0118; Wang LX, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0259-8; Wang LX, 2012, J INTEGR AGR, V11, P1601, DOI 10.1016/S2095-3119(12)60163-4; Wang XW, 2004, THEOR APPL GENET, V109, P352, DOI 10.1007/s00122-004-1634-8; Blair MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101873; Xin DW, 2012, MOL BIOL REP, V39, P9047, DOI 10.1007/s11033-012-1776-8; Yoon MS, 2007, GENET RESOUR CROP EV, V54, P875, DOI 10.1007/s10722-006-9156-7; You FM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-59; Zhang GW, 2013, J ZHEJIANG UNIV-SC B, V14, P279, DOI 10.1631/jzus.B1200243; Zheng XF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-490	38	21	23	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0151040	10.1371/journal.pone.0151040	http://dx.doi.org/10.1371/journal.pone.0151040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950544	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100083
J	Erzinger, MM; Bovet, C; Hecht, KM; Senger, S; Winiker, P; Sobotzki, N; Cristea, S; Beerenwinkel, N; Shay, JW; Marra, G; Wollscheid, B; Sturla, SJ				Erzinger, Melanie M.; Bovet, Cedric; Hecht, Katrin M.; Senger, Sabine; Winiker, Pascale; Sobotzki, Nadine; Cristea, Simona; Beerenwinkel, Niko; Shay, Jerry W.; Marra, Giancarlo; Wollscheid, Bernd; Sturla, Shana J.			Sulforaphane Preconditioning Sensitizes Human Colon Cancer Cells towards the Bioreductive Anticancer Prodrug PR-104A	PLOS ONE			English	Article							KETO REDUCTASE 1C3; HUMAN TUMOR-CELLS; PHASE-I TRIAL; ANTITUMOR-ACTIVITY; MITOMYCIN-C; PRE-PRODRUG; EXPRESSION; ENZYMES; HYPOXIA; ISOTHIOCYANATES	The chemoprotective properties of sulforaphane (SF), derived from cruciferous vegetables, are widely acknowledged to arise from its potent induction of xenobiotic-metabolizing and antioxidant enzymes. However, much less is known about the impact of SF on the efficacy of cancer therapy through the modulation of drug-metabolizing enzymes. To identify proteins modulated by a low concentration of SF, we treated HT29 colon cancer cells with 2.5 mu M SF. Protein abundance changes were detected by stable isotope labeling of amino acids in cell culture. Among 18 proteins found to be significantly up-regulated, aldo-keto reductase 1C3 (AKR1C3), bioactivating the DNA cross-linking prodrug PR-104A, was further characterized. Preconditioning HT29 cells with SF reduced the EC50 of PR-104A 3.6-fold. The increase in PR-104A cytotoxicity was linked to AKR1C3 abundance and activity, both induced by SF in a dose-dependent manner. This effect was reproducible in a second colon cancer cell line, SW620, but not in other colon cancer cell lines where AKR1C3 abundance and activity were absent or barely detectable and could not be induced by SF. Interestingly, SF had no significant influence on PR-104A cytotoxicity in non-cancerous, immortalized human colonic epithelial cell lines expressing either low or high levels of AKR1C3. In conclusion, the enhanced response of PR-104A after preconditioning with SF was apparent only in cancer cells provided that AKR1C3 is expressed, while its expression in non-cancerous cells did not elicit such a response. Therefore, a subset of cancers may be susceptible to combined food-derived component and prodrug treatments with no harm to normal tissues.	[Erzinger, Melanie M.; Bovet, Cedric; Hecht, Katrin M.; Senger, Sabine; Winiker, Pascale; Wollscheid, Bernd; Sturla, Shana J.] ETH, Dept Hlth Sci & Technol, Zurich, Switzerland; [Sobotzki, Nadine; Wollscheid, Bernd] ETH, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland; [Cristea, Simona; Beerenwinkel, Niko] ETH, Dept Biosyst Sci & Engn, Basel, Switzerland; [Cristea, Simona; Beerenwinkel, Niko] SIB Swiss Inst Bioinformat, Basel, Switzerland; [Shay, Jerry W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Marra, Giancarlo] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland; [Wollscheid, Bernd] ETH, BioMed Prote Platform, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sturla, SJ (corresponding author), ETH, Dept Hlth Sci & Technol, Zurich, Switzerland.	sturlas@ethz.ch	Wollscheid, Bernd/E-8909-2010; Cristea, Simona/AAC-7421-2020	Wollscheid, Bernd/0000-0002-3923-1610; Bovet, Cedric/0000-0002-1600-3818	Swiss National Science Foundation [136247]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (136247), www.snf.ch.	Abou-Alfa GK, 2011, CANCER CHEMOTH PHARM, V68, P539, DOI 10.1007/s00280-011-1671-3; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agyeman AS, 2012, BREAST CANCER RES TR, V132, P175, DOI 10.1007/s10549-011-1536-9; Angeloni C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083283; Angeloni C, 2009, J AGR FOOD CHEM, V57, P5615, DOI 10.1021/jf900549c; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Begleiter A, 2004, BRIT J CANCER, V91, P1624, DOI 10.1038/sj.bjc.6602171; Bhamre S, 2009, PROSTATE, V69, P181, DOI 10.1002/pros.20869; Cornblatt BS, 2007, CARCINOGENESIS, V28, P1485, DOI 10.1093/carcin/bgm049; Di Pietro M, 2005, GASTROENTEROLOGY, V129, P1047, DOI 10.1053/j.gastro.2005.06.028; Efstathiou JA, 1999, P NATL ACAD SCI USA, V96, P2316, DOI 10.1073/pnas.96.5.2316; Erzinger MM, 2015, J BIOCHEM MOL TOXIC, V29, P10, DOI 10.1002/jbt.21601; Erzinger MM, 2011, CHIMIA, V65, P411, DOI 10.2533/chimia.2011.411; Fimognari C, 2004, BIOCHEM PHARMACOL, V68, P1133, DOI 10.1016/j.bcp.2004.03.044; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Gamet-Payrastre L, 1998, ANTI-CANCER DRUG, V9, P141, DOI 10.1097/00001813-199802000-00005; Gasper AV, 2007, J NUTR, V137, P1718, DOI 10.1093/jn/137.7.1718; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gross-Steinmeyer K, 2010, TOXICOL SCI, V116, P422, DOI 10.1093/toxsci/kfq135; Gu YC, 2010, DRUG METAB DISPOS, V38, P498, DOI 10.1124/dmd.109.030973; Gu YC, 2009, MOL CANCER THER, V8, P1714, DOI 10.1158/1535-7163.MCT-08-1209; Guise CP, 2010, CANCER RES, V70, P1573, DOI 10.1158/0008-5472.CAN-09-3237; Hu R, 2004, J PHARMACOL EXP THER, V310, P263, DOI 10.1124/jpet.103.064261; James D, 2012, NUTR REV, V70, P654, DOI 10.1111/j.1753-4887.2012.00532.x; Jameson MB, 2010, CANCER CHEMOTH PHARM, V65, P791, DOI 10.1007/s00280-009-1188-1; Jamieson SMF, 2014, BIOCHEM PHARMACOL, V88, P36, DOI 10.1016/j.bcp.2013.12.019; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Konwinski RR, 2004, TOXICOL SCI, V116, P422; Lee CH, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-67; Lin HK, 1997, MOL ENDOCRINOL, V11, P1971, DOI 10.1210/me.11.13.1971; Mandlekar S, 2006, CURR DRUG METAB, V7, P661, DOI 10.2174/138920006778017795; Mastrangelo L, 2008, CANCER RES, V68, P5487, DOI 10.1158/0008-5472.CAN-07-6171; McKeage MJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-496; McKeage MJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-432; Minarini A, 2014, EXPERT OPIN DRUG MET, V10, P25, DOI 10.1517/17425255.2013.843668; Nomura DK, 2010, NAT REV CANCER, V10, P630, DOI 10.1038/nrc2901; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pappa G, 2006, MUTAT RES-FUND MOL M, V599, P76, DOI 10.1016/j.mrfmmm.2006.01.007; Patterson AV, 2007, CLIN CANCER RES, V13, P3922, DOI 10.1158/1078-0432.CCR-07-0478; Pietsch KE, 2013, CHEM RES TOXICOL, V26, P146, DOI 10.1021/tx300430r; Pietsch KE, 2011, CHEM RES TOXICOL, V24, P2044, DOI 10.1021/tx200401u; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Scott O, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/503241; SHAO Y, 1995, LIPIDS, V30, P1035, DOI 10.1007/BF02536289; Singleton RS, 2009, CANCER RES, V69, P3884, DOI 10.1158/0008-5472.CAN-08-4023; Stornetta A, 2015, ANAL CHEM, V87, P11706, DOI 10.1021/acs.analchem.5b02759; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Traka M, 2005, J NUTR, V135, P1865, DOI 10.1093/jn/135.8.1865; Veeranki OL, 2013, BRIT J NUTR, V109, P25, DOI 10.1017/S0007114512000657; Wang X, 1999, BRIT J CANCER, V80, P1223, DOI 10.1038/sj.bjc.6690489; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Xia CZ, 2000, J BIOL CHEM, V275, P20942, DOI 10.1074/jbc.M002598200; Yee DJ, 2006, P NATL ACAD SCI USA, V103, P13304, DOI 10.1073/pnas.0604672103; Yu X, 2012, J PHARMACOL EXP THER, V343, P426, DOI 10.1124/jpet.112.195768; Zhang YS, 1996, ANAL BIOCHEM, V239, P160, DOI 10.1006/abio.1996.0311	58	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150219	10.1371/journal.pone.0150219	http://dx.doi.org/10.1371/journal.pone.0150219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950072	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000371990100025
J	Sattler, FA; Wagner, U; Christiansen, H				Sattler, Frank A.; Wagner, Ulrich; Christiansen, Hanna			Effects of Minority Stress, Group-Level Coping, and Social Support on Mental Health of German Gay Men	PLOS ONE			English	Article							SEXUAL ORIENTATION; PSYCHOLOGICAL DISTRESS; INTERNALIZED HOMONEGATIVITY; REJECTION SENSITIVITY; PSYCHIATRIC-DISORDERS; BISEXUAL POPULATIONS; DISCRIMINATION; CONCEALMENT; PREVALENCE; DISCLOSURE	Objective According to epidemiological studies, gay men are at a higher risk of mental disorders than heterosexual men. In the current study, the minority stress theory was investigated in German gay men: 1) it was hypothesized that minority stressors would positively predict mental health problems and that 2) group-level coping and social support variables would moderate these predictions negatively. Methods Data from 1,188 German self-identified gay men were collected online. The questionnaire included items about socio-demographics, minority stress (victimization, rejection sensitivity, and internalized homonegativity), group-level coping (disclosure of sexual orientation, homopositivity, gay affirmation, gay rights support, and gay rights activism), and social support (gay social support and non-gay social support). A moderated multiple regression was conducted. Results Minority stressors positively predicted mental health problems. Group-level coping did not interact with minority stressors, with the exception of disclosure and homopositivity interacting marginally with some minority stressors. Further, only two interactions were found for social support variables and minority stress, one of them marginal. Gay and non-gay social support inversely predicted mental health problems. In addition, disclosure and homopositivity marginally predicted mental health problems. Conclusions The findings imply that the minority stress theory should be modified. Disclosure does not have a relevant effect on mental health, while social support variables directly influence mental health of gay men. Group-level coping does not interact with minority stressors relevantly, and only one relevant interaction between social support and minority stress was found. Further longitudinal or experimental replication is needed before transferring the results to mental health interventions and prevention strategies for gay men.	[Sattler, Frank A.; Christiansen, Hanna] Univ Marburg, Dept Clin Child & Adolescent Psychol, Marburg, Germany; [Wagner, Ulrich] Univ Marburg, Dept Social Psychol, Marburg, Germany; [Wagner, Ulrich] Univ Marburg, Ctr Conflict Studies, Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg	Sattler, FA (corresponding author), Univ Marburg, Dept Clin Child & Adolescent Psychol, Marburg, Germany.	frank.sattler@uni-marburg.de		Sattler, Frank A./0000-0001-8974-445X				Acock A.C., 2018, GENTLE INTRO STATA, V6, P570; Cochran SD, 2000, AM J EPIDEMIOL, V151, P516; Cochran SD, 2000, AM J PUBLIC HEALTH, V90, P573, DOI 10.2105/AJPH.90.4.573; Cochran SD, 2003, J CONSULT CLIN PSYCH, V71, P53, DOI 10.1037/0022-006X.71.1.53; Cohen J.E., 1988, STAT POWER ANAL BEHA; Derogatis L.R, 1993, BRIEF SYMPTOM INVENT; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Ellis SJ, 2002, J HOMOSEXUAL, V44, P121, DOI 10.1300/J082v44n01_07; Feinstein BA, 2012, J CONSULT CLIN PSYCH, V80, P917, DOI 10.1037/a0029425; Fergusson DM, 1999, ARCH GEN PSYCHIAT, V56, P876, DOI 10.1001/archpsyc.56.10.876; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P571, DOI 10.1037/0022-3514.50.3.571; Fredriksen-Goldsen KI, 2013, AM J PUBLIC HEALTH, V103, P1802, DOI 10.2105/AJPH.2012.301110; Frisell T, 2010, PSYCHOL MED, V40, P315, DOI 10.1017/S0033291709005996; Goldberg AE, 2011, J COUNS PSYCHOL, V58, P139, DOI 10.1037/a0021684; Grossman AH, 2000, J GERONTOL B-PSYCHOL, V55, pP171, DOI 10.1093/geronb/55.3.P171; Hatzenbuehler ML, 2010, AM J PUBLIC HEALTH, V100, P452, DOI 10.2105/AJPH.2009.168815; Herek GM, 1992, HATE CRIMES CONFRONT, P270; Juster RP, 2013, PSYCHOSOM MED, V75, P103, DOI 10.1097/PSY.0b013e3182826881; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Kline P., 2000, HDB PSYCHOL TESTING; Lewis RJ, 2003, J SOC CLIN PSYCHOL, V22, P716, DOI 10.1521/jscp.22.6.716.22932; Mayfield W, 2001, J HOMOSEXUAL, V41, P53, DOI 10.1300/J082v41n02_04; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Morrison TG, 2007, J HOMOSEXUAL, V52, P63, DOI 10.1300/J082v52n03_04; Newcomb ME, 2010, CLIN PSYCHOL REV, V30, P1019, DOI 10.1016/j.cpr.2010.07.003; Pachankis JE, 2008, J CONSULT CLIN PSYCH, V76, P306, DOI 10.1037/0022-006X.76.2.306; PLODERL M, 2005, SEXUELLE ORIENTIERUN; Ploderl M., 2006, VERHALTENSTHERAPIE P, V38, P283; Proescholdbell RJ, 2006, J COMMUNITY PSYCHOL, V34, P9, DOI 10.1002/jcop.20080; Rostosky SS, 2009, J COUNS PSYCHOL, V56, P56, DOI 10.1037/a0013609; Sandfort TGM, 2001, ARCH GEN PSYCHIAT, V58, P85, DOI 10.1001/archpsyc.58.1.85; SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127; Schneider S, 2006, DIPS DSM 4 DIAGNOSTI; Schrimshaw EW, 2013, J CONSULT CLIN PSYCH, V81, P141, DOI 10.1037/a0031272; Sturmer S, 2004, PERS SOC PSYCHOL B, V30, P263, DOI 10.1177/0146167203256690; Szymanski DM, 2009, PSYCHOL WOMEN QUART, V33, P197, DOI 10.1111/j.1471-6402.2009.01489.x; Ullrich PM, 2003, J PSYCHOSOM RES, V54, P205, DOI 10.1016/S0022-3999(02)00481-6; Zakalik RA, 2006, J COUNS PSYCHOL, V53, P302, DOI 10.1037/0022-0167.53.3.302	39	27	28	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150562	10.1371/journal.pone.0150562	http://dx.doi.org/10.1371/journal.pone.0150562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG0FG	26943785	Green Published, Green Submitted, gold			2022-12-27	WOS:000371739400032
J	Farrell, MS; McCorvy, JD; Huang, XP; Urban, DJ; White, KL; Giguere, PM; Doak, AK; Bernstein, AI; Stout, KA; Park, SM; Rodriguiz, RM; Gray, BW; Hyatt, WS; Norwood, AP; Webster, KA; Gannon, BM; Miller, GW; Porter, JH; Shoichet, BK; Fantegrossi, WE; Wetsel, WC; Roth, BL				Farrell, Martilias S.; McCorvy, John D.; Huang, Xi-Ping; Urban, Daniel J.; White, Kate L.; Giguere, Patrick M.; Doak, Allison K.; Bernstein, Alison I.; Stout, Kristen A.; Park, Su Mi; Rodriguiz, Ramona M.; Gray, Bradley W.; Hyatt, William S.; Norwood, Andrew P.; Webster, Kevin A.; Gannon, Brenda M.; Miller, Gary W.; Porter, Joseph H.; Shoichet, Brian K.; Fantegrossi, William E.; Wetsel, William C.; Roth, Bryan L.			In Vitro and In Vivo Characterization of the Alkaloid Nuciferine	PLOS ONE			English	Article							DISCRIMINATIVE STIMULUS PROPERTIES; ATYPICAL ANTIPSYCHOTIC-DRUG; PROTEIN-COUPLED RECEPTORS; HIGH-THROUGHPUT SCREEN; COLLOIDAL AGGREGATION; C57BL/6 MICE; SEROTONIN RECEPTORS; CLOZAPINE; AGONIST; RATS	Rationale The sacred lotus (Nelumbo nucifera) contains many phytochemicals and has a history of human use. To determine which compounds may be responsible for reported psychotropic effects, we used in silico predictions of the identified phytochemicals. Nuciferine, an alkaloid component of Nelumbo nucifera and Nymphaea caerulea, had a predicted molecular profile similar to antipsychotic compounds. Our study characterizes nuciferine using in vitro and in vivo pharmacological assays. Methods Nuciferine was first characterized in silico using the similarity ensemble approach, and was followed by further characterization and validation using the Psychoactive Drug Screening Program of the National Institute of Mental Health. Nuciferine was then tested in vivo in the head-twitch response, pre-pulse inhibition, hyperlocomotor activity, and drug discrimination paradigms. Results Nuciferine shares a receptor profile similar to aripiprazole-like antipsychotic drugs. Nuciferine was an antagonist at 5-HT2A, 5-HT2C, and 5-HT2B, an inverse agonist at 5-HT7, a partial agonist at D-2, D-5 and 5-HT6, an agonist at 5-HT1A and D-4 receptors, and inhibited the dopamine transporter. In rodent models relevant to antipsychotic drug action, nuciferine blocked head-twitch responses and discriminative stimulus effects of a 5-HT2A agonist, substituted for clozapine discriminative stimulus, enhanced amphetamine induced locomotor activity, inhibited phencyclidine (PCP)-induced locomotor activity, and rescued PCP-induced disruption of prepulse inhibition without induction of catalepsy. Conclusions The molecular profile of nuciferine was similar but not identical to that shared with several approved antipsychotic drugs suggesting that nuciferine has atypical antipsychotic-like actions.	[Farrell, Martilias S.; McCorvy, John D.; Huang, Xi-Ping; Urban, Daniel J.; White, Kate L.; Giguere, Patrick M.; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC USA; [Roth, Bryan L.] Univ N Carolina, Sch Med, Program Neurosci, Chapel Hill, NC USA; [Roth, Bryan L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, Sch Med, Carolina Inst Dev Disabil, Chapel Hill, NC USA; [Roth, Bryan L.] Univ N Carolina, Sch Pharm, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Sch Med, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Chapel Hill, NC USA; [Gray, Bradley W.; Hyatt, William S.; Norwood, Andrew P.; Gannon, Brenda M.; Fantegrossi, William E.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Webster, Kevin A.; Porter, Joseph H.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Doak, Allison K.; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Bernstein, Alison I.; Stout, Kristen A.; Miller, Gary W.] Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Bernstein, Alison I.; Stout, Kristen A.] Emory Univ, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Park, Su Mi; Rodriguiz, Ramona M.; Wetsel, William C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC USA; [Park, Su Mi; Rodriguiz, Ramona M.; Wetsel, William C.] Duke Univ, Med Ctr, Dept Cell Biol, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC 27710 USA; [Park, Su Mi; Rodriguiz, Ramona M.; Wetsel, William C.] Duke Univ, Med Ctr, Dept Neurobiol, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Arkansas System; University of Arkansas Medical Sciences; Virginia Commonwealth University; University of California System; University of California San Francisco; Emory University; Rollins School Public Health; Emory University; Duke University; Duke University; Duke University	Farrell, MS (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA.	martilias_farrell@med.unc.edu	Roth, Bryan L/F-3928-2010; Bernstein, Alison I/H-9702-2019; Roth, Bryan/ABE-7032-2020	Bernstein, Alison I/0000-0002-5589-4318; Roth, Bryan/0000-0002-0561-6520; Stout, Kristen/0000-0002-3641-5326	National Institutes of Health [1F31MH091921]; National Institutes of Mental Health Psychoactive Drug Screening Program [RO1MH61887, U19MH82441]; Michael Hooker Chair in Pharmacology [P30 ES 019776, T32 ES 012870]; AIB; NIH [GM71630, GM71896]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870, P30ES019776, K99ES024570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071630, R01GM071896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441, U01MH104974, R01MH061887, F31MH091921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA022981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Mental Health Psychoactive Drug Screening Program; Michael Hooker Chair in Pharmacology; AIB; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by National Institutes of Health Grants #1F31MH091921 to MSF and RO1MH61887, U19MH82441, the National Institutes of Mental Health Psychoactive Drug Screening Program and the Michael Hooker Chair in Pharmacology to BLR; P30 ES 019776 and T32 ES 012870 to GWM and AIB, and and NIH GM71630 and GM71896 to BKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AI, 2009, J NEUROSCI, V29, P7124, DOI 10.1523/JNEUROSCI.1090-09.2009; Audinot V, 2001, NEUROPSYCHOPHARMACOL, V25, P410, DOI 10.1016/S0893-133X(01)00237-8; BAKSHI VP, 1994, J PHARMACOL EXP THER, V271, P787; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Bernstein AI, 2012, J NEUROSCI METH, V209, P357, DOI 10.1016/j.jneumeth.2012.06.002; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; BHATTACHARYA SK, 1978, PSYCHOPHARMACOLOGY, V59, P29, DOI 10.1007/BF00428026; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Burris KD, 2002, J PHARMACOL EXP THER, V302, P381, DOI 10.1124/jpet.102.033175; Colpaert FC, 1999, PHARMACOL BIOCHEM BE, V64, P337, DOI 10.1016/S0091-3057(99)00047-7; Colpaert FC, 2003, NAT REV DRUG DISCOV, V2, P315, DOI 10.1038/nrd1062; Compton AD, 2001, NEUROPHARMACOLOGY, V40, P289, DOI 10.1016/S0028-3908(00)00126-X; CORNE SJ, 1963, BRIT J PHARM CHEMOTH, V20, P106, DOI 10.1111/j.1476-5381.1963.tb01302.x; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; De Hert M, 2007, PSYCHIAT RES, V152, P165, DOI 10.1016/j.psychres.2006.07.012; Desmarais JE, 2012, J PSYCHOPHARMACOL, V26, P1167, DOI 10.1177/0269881112447988; Duan D, 2015, ACS CHEM BIOL, V10, P978, DOI 10.1021/cb5009487; EMBODEN WA, 1981, J ETHNOPHARMACOL, V3, P39, DOI 10.1016/0378-8741(81)90013-1; Etievant A, 2009, NEUROSCI LETT, V460, P82, DOI 10.1016/j.neulet.2009.05.035; EXTANCE K, 1981, PSYCHOPHARMACOLOGY, V73, P363, DOI 10.1007/BF00426467; Fantegrossi WE, 2004, PSYCHOPHARMACOLOGY, V173, P270, DOI 10.1007/s00213-003-1741-2; Fantegrossi WE, 2008, PHARMACOL BIOCHEM BE, V88, P358, DOI 10.1016/j.pbb.2007.09.007; Fantegrossi WE, 2009, J PHARMACOL EXP THER, V329, P1006, DOI 10.1124/jpet.109.150573; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Ferreira RS, 2010, J MED CHEM, V53, P4891, DOI 10.1021/jm100488w; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Gonzalez-Maeso J, 2009, TRENDS NEUROSCI, V32, P225, DOI 10.1016/j.tins.2008.12.005; Gu SY, 2014, J CHROMATOGR B, V961, P20, DOI 10.1016/j.jchromb.2014.04.038; Hert J, 2008, J CHEM INF MODEL, V48, P755, DOI 10.1021/ci8000259; Ishibashi T, 2010, J PHARMACOL EXP THER, V334, P171, DOI 10.1124/jpet.110.167346; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; KENAKIN T, 1990, DRUGS, V40, P666, DOI 10.2165/00003495-199040050-00003; KINROSSWRIGHT V, 1955, ANN NY ACAD SCI, V61, P174, DOI 10.1111/j.1749-6632.1955.tb42464.x; Krobert KA, 2002, BRIT J PHARMACOL, V135, P1563, DOI 10.1038/sj.bjp.0704588; Lin H, 2013, NAT METHODS, V10, P140, DOI [10.1038/NMETH.2324, 10.1038/nmeth.2324]; Lindsley CW, 2013, ACS CHEM NEUROSCI, V4, P905, DOI 10.1021/cn400107y; Liu HB, 2014, J CHEM INF MODEL, V54, P1050, DOI 10.1021/ci500004h; MACKO E, 1972, ARCH INT PHARMACOD T, V197, P261; Mahe C, 2004, EUR J PHARMACOL, V495, P97, DOI 10.1016/j.ejphar.2004.05.033; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Meltzer HY, 2013, J CLIN INVEST, V123, P4986, DOI 10.1172/JCI70678; MELTZER HY, 1989, J PHARMACOL EXP THER, V251, P238; Mukherjee PK, 2009, J PHARM PHARMACOL, V61, P407, DOI 10.1211/jpp/61.04.0001; Munusamy V, 2013, CHEM BIOL DRUG DES, V81, P250, DOI 10.1111/cbdd.12069; Newman-Tancredi A, 2011, PSYCHOPHARMACOLOGY, V216, P451, DOI 10.1007/s00213-011-2247-y; ORTMANN R, 1982, N-S ARCH PHARMACOL, V321, P265, DOI 10.1007/BF00498511; Owen SC, 2012, ACS CHEM BIOL, V7, P1429, DOI 10.1021/cb300189b; Peluso MJ, 2012, BRIT J PSYCHIAT, V200, P387, DOI 10.1192/bjp.bp.111.101485; PEROUTKA SJ, 1981, SCIENCE, V212, P827, DOI 10.1126/science.7221567; Philibin SD, 2009, PSYCHOPHARMACOLOGY, V203, P303, DOI 10.1007/s00213-008-1385-3; Philibin SD, 2005, PSYCHOPHARMACOLOGY, V180, P49, DOI 10.1007/s00213-005-2147-0; Porsolt RD, 2010, J PHARMACOL EXP THER, V333, P632, DOI 10.1124/jpet.110.166710; Porter JH, 2005, PSYCHOPHARMACOLOGY, V178, P67, DOI 10.1007/s00213-004-1985-5; Porter JH, 2008, BEHAV PHARMACOL, V19, P530, DOI 10.1097/FBP.0b013e32830cd84e; Prus AJ, 2006, BEHAV PHARMACOL, V17, P185, DOI 10.1097/01.fbp.0000197457.70774.91; ROTH BL, 1994, J PHARMACOL EXP THER, V268, P1403; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Sassano MF, 2013, J MED CHEM, V56, P2406, DOI 10.1021/jm301749y; Shahid M, 2009, J PSYCHOPHARMACOL, V23, P65, DOI 10.1177/0269881107082944; Shapiro DA, 2003, NEUROPSYCHOPHARMACOL, V28, P1400, DOI 10.1038/sj.npp.1300203; Shoichet BK, 2006, DRUG DISCOV TODAY, V11, P607, DOI 10.1016/j.drudis.2006.05.014; Sokoloff P., 2006, CNS & Neurological Disorders-Drug Targets, V5, P25, DOI 10.2174/187152706784111551; Tadori Y, 2005, EUR J PHARMACOL, V515, P10, DOI 10.1016/j.ejphar.2005.02.051; Terstappen GC, 2001, NEUROPHARMACOLOGY, V40, P772, DOI 10.1016/S0028-3908(01)00007-7; Thomas DR, 1998, BRIT J PHARMACOL, V124, P1300, DOI 10.1038/sj.bjp.0701946; Wiebelhaus JM, 2012, BEHAV PHARMACOL, V23, P262, DOI 10.1097/FBP.0b013e3283534332; Yadav PN, 2011, NEUROPSYCHOPHARMACOL, V36, P638, DOI 10.1038/npp.2010.195; Zhang JY, 2003, EUR J PHARMACOL, V472, P33, DOI 10.1016/S0014-2999(03)01855-7; Zheng GR, 2006, AAPS J, V8, pE682, DOI 10.1208/aapsj080478	74	19	21	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150602	10.1371/journal.pone.0150602	http://dx.doi.org/10.1371/journal.pone.0150602			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963248	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000044
J	Han, FP; Ren, LL; Zhang, XC; Li, ZB				Han, Fengpeng; Ren, Lulu; Zhang, Xingchang; Li, Zhanbin			The WEPP Model Application in a Small Watershed in the Loess Plateau	PLOS ONE			English	Article							SOIL-EROSION; NITROGEN LOSS; LAND-USE; CHINA; RUNOFF; ENVIRONMENT; PREDICTION; RUSLE; GIS	In the Loess Plateau, soil erosion has not only caused serious ecological and environmental problems but has also impacted downstream areas. Therefore, a model is needed to guide the comprehensive control of soil erosion. In this study, we introduced the WEPP model to simulate soil erosion both at the slope and watershed scales. Our analyses showed that: the simulated values at the slope scale were very close to the measured. However, both the runoff and soil erosion simulated values at the watershed scale were higher than the measured. At the slope scale, under different coverage, the simulated erosion was slightly higher than the measured. When the coverage is 40%, the simulated results of both runoff and erosion are the best. At the watershed scale, the actual annual runoff of the Liudaogou watershed is 83m(3); sediment content is 0.097 t/m(3), annual erosion sediment 8.057t and erosion intensity 0.288 t ha(-1) yr(-1). Both the simulated values of soil erosion and runoff are higher than the measured, especially the runoff. But the simulated erosion trend is relatively accurate after the farmland is returned to grassland. We concluded that the WEPP model can be used to establish a reasonable vegetation restoration model and guide the vegetation restoration of the Loess Plateau.	[Han, Fengpeng; Ren, Lulu; Zhang, Xingchang; Li, Zhanbin] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dry Land Farming Loess, Yangling, Shaanxi Provinc, Peoples R China; [Li, Zhanbin] Xian Univ Technol, Inst Water Resources & Hydroelect Engn, Xian, Shaanxi Provinc, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Xi'an University of Technology	Li, ZB (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dry Land Farming Loess, Yangling, Shaanxi Provinc, Peoples R China.; Li, ZB (corresponding author), Xian Univ Technol, Inst Water Resources & Hydroelect Engn, Xian, Shaanxi Provinc, Peoples R China.	zbli65@163.com			National Natural Science Foundation of China [41471437, 41101528]; China Clean Development Mechanism Fund [2012027-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Clean Development Mechanism Fund	The research was supported by the National Natural Science Foundation of China (No. 41471437, 41101528) and China Clean Development Mechanism Fund grant project (No. 2012027-1).	Alberts EE, 1995, USDA WATER EROSION P; Ashish P, 2008, J HYDROL, V348, P305; Bjorneberg DL, 1999, T ASAE, V42, P1733, DOI 10.13031/2013.13336; Castillo VM, 1997, SOIL SCI SOC AM J, V61, P1116, DOI 10.2136/sssaj1997.03615995006100040018x; Cochrane TA, 2003, T ASAE, V46, P1041, DOI 10.13031/2013.13966; Covert SA, 2005, T ASAE, V48, P1091, DOI 10.13031/2013.18519; Fang M, 2005, J WATER RESOURCES WA, V16, P41; Flanagan DC, 2000, T ASAE, V43, P573, DOI 10.13031/2013.2737; Fu BJ, 2004, LAND DEGRAD DEV, V15, P87, DOI 10.1002/ldr.572; Goodrich DC, 2012, T ASABE, V55, P1561; Han FP, 2010, GEODERMA, V154, P261, DOI 10.1016/j.geoderma.2009.10.011; Issa A, 2011, ENT MONITORING ASSES, V180, P537; Kang SZ, 2001, HYDROL PROCESS, V15, P977, DOI 10.1002/hyp.191; Liao C, 2005, T CSAE, VV1, P13; Liu L, 2010, PROCEDIA ENVIRON SCI, V2, P134, DOI 10.1016/j.proenv.2010.10.017; Mu X, 1993, MEMOIR NISWC ACAD SI, V18, P24; Mustafa A, 2014, ENVIRON EARTH SCI, V72, P2051; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Nearing MA, 1998, CATENA, V32, P15, DOI 10.1016/S0341-8162(97)00052-0; Nicks A.D., 1995, USDA WATER EROSION P; Pandey A, 2008, J HYDROL, V348, P305, DOI 10.1016/j.jhydrol.2007.10.010; Poesen J, 2003, CATENA, V50, P87, DOI 10.1016/S0341-8162(02)00146-7; RISSE LM, 1993, SOIL SCI SOC AM J, V57, P825, DOI 10.2136/sssaj1993.03615995005700030032x; Sun WY, 2013, J GEOGR SCI, V23, P1091, DOI 10.1007/s11442-013-1065-z; Tang Q, 2015, ENVIRON EARTH SCI, V73, P1715, DOI 10.1007/s12665-014-3523-z; Tiwari AK, 2000, T ASAE, V43, P1129; Wachal DJ, 2008, T ASABE, V51, P1977, DOI 10.13031/2013.25402; [王建勋 WANG Jianxun], 2007, [水土保持通报, Bulletin of Soil and Water Conservation], V27, P50; [叶俊道 Ye Jundao], 2012, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V26, P132; Yuan WP, 2014, REMOTE SENS LETT, V5, P221, DOI 10.1080/2150704X.2014.894655; Zhang QingWen, 2004, Transactions of the Chinese Society of Agricultural Engineering, V20, P35; Zhang XC, 2003, ACTA BOT SIN, V45, P1195; Zhao GJ, 2013, LAND DEGRAD DEV, V24, P499, DOI 10.1002/ldr.2246; ZHAO S, 2006, SCI SOIL WATER CONSE, V4, P5; Zheng FL, 2006, PEDOSPHERE, V16, P420, DOI 10.1016/S1002-0160(06)60071-4; [郑粉莉 Zheng Fenchi], 2004, [水土保持研究, Research of Soil and Water Conservation], V11, P1	36	13	14	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0148445	10.1371/journal.pone.0148445	http://dx.doi.org/10.1371/journal.pone.0148445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963704	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000004
J	Vargas-Straube, MJ; Camara, B; Tello, M; Montero-Silva, F; Cardenas, F; Seeger, M				Jose Vargas-Straube, Maria; Camara, Beatriz; Tello, Mario; Montero-Silva, Francisco; Cardenas, Franco; Seeger, Michael			Genetic and Functional Analysis of the Biosynthesis of a Non-Ribosomal Peptide Siderophore in Burkholderia xenovorans LB400	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR GENOME; HUMAN PATHOGENIC BACTERIA; SIGMA-FACTOR PVDS; SP STRAIN LB400; PSEUDOMONAS-AERUGINOSA; ADENYLATION DOMAINS; MALLEOBACTIN BIOSYNTHESIS; MYCOBACTERIUM-SMEGMATIS; ORNIBACTIN BIOSYNTHESIS; POLYKETIDE SYNTHASES	B. xenovorans LB400 is a model bacterium for the study of the metabolism of aromatic compounds. The aim of this study was the genomic and functional characterization of a nonribosomal peptide synthetase containing gene cluster that encodes a siderophore in B. xenovorans LB400. The mba gene cluster from strain LB400 encodes proteins involved in the biosynthesis and transport of a hydroxamate-type siderophore. Strain LB400 has a unique mba gene organization, although mba gene clusters have been observed in diverse Burkholderiales. Bioinformatic analysis revealed the presence of promoters in the mba gene cluster that strongly suggest regulation by the ferric uptake regulator protein (Fur) and by the alternative RNA polymerase extracytoplasmic function sigma factor MbaF. Reverse transcriptase PCR analyses showed the expression of iron-regulated transcriptional units mbaFGHIJKL, mbaN, mbaABCE, mbaO, mbaP and mbaD genes under iron limitation. Chrome azurol S (CAS) assay strongly suggests that strain LB400 synthesized a siderophore under iron limitation. Mass spectrometry ESI-MS and MALDI-TOF-MS analyses revealed that the siderophore is a non-ribosomal peptide, and forms an iron complex with a molecular mass of 676 Da. Based on bioinformatic prediction, CAS assay and MS analyses, we propose that the siderophore is L-N-delta-hydroxy-N-delta-formylOrn-D-beta-hydroxyAsp-L-Ser-L-N-delta-hydroxy-N-delta-formylOrn-1,4-diaminobutane that is closely related to malleobactin-type siderophores reported in B. thailandensis.	[Jose Vargas-Straube, Maria; Camara, Beatriz; Montero-Silva, Francisco; Cardenas, Franco; Seeger, Michael] Univ Tecn Federico Santa Maria, Lab Microbiol Mol & Biotecnol Ambiental, Dept Quim, Valparaiso, Chile; [Jose Vargas-Straube, Maria; Camara, Beatriz; Montero-Silva, Francisco; Cardenas, Franco; Seeger, Michael] Univ Tecn Federico Santa Maria, Ctr Nanotechnol & Syst Biol, Valparaiso, Chile; [Jose Vargas-Straube, Maria; Camara, Beatriz; Montero-Silva, Francisco; Cardenas, Franco; Seeger, Michael] Univ Tecn Federico Santa Maria, Ctr Biotechnol, Valparaiso, Chile; [Tello, Mario] Univ Santiago Chile, Dept Biol, Ctr Biotecnol Acuicola, Santiago, Chile	Universidad Tecnica Federico Santa Maria; Universidad Tecnica Federico Santa Maria; Universidad Tecnica Federico Santa Maria; Universidad de Santiago de Chile	Seeger, M (corresponding author), Univ Tecn Federico Santa Maria, Lab Microbiol Mol & Biotecnol Ambiental, Dept Quim, Valparaiso, Chile.; Seeger, M (corresponding author), Univ Tecn Federico Santa Maria, Ctr Nanotechnol & Syst Biol, Valparaiso, Chile.; Seeger, M (corresponding author), Univ Tecn Federico Santa Maria, Ctr Biotechnol, Valparaiso, Chile.	michael.seeger@usm.cl	Seeger, Michael/AFK-3436-2022; Tello, Mario/N-4198-2019; Silva, Francisco Montero/K-9066-2019	Tello, Mario/0000-0003-4573-6460; Silva, Francisco Montero/0000-0001-8367-5123; Camara, Beatriz/0000-0001-5227-7499	Conicyt; Mecesup [FSM0710, CD FSM1204, FSM710]; UTFSM; RIABIN; UTFSM-PIIC (FMS) fellowships; FONDECYT [1110992, 11121571, 1151174]; FDI Mecesup; USM [131562, 131342, 131109]	Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Mecesup; UTFSM; RIABIN; UTFSM-PIIC (FMS) fellowships; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FDI Mecesup; USM	The authors acknowledge Conicyt (MJV, FMS), Mecesup FSM0710 (FC), Mecesup CD FSM1204 (FMS), UTFSM (FC), RIABIN (FMS), and UTFSM-PIIC (FMS) fellowships. MS and BC acknowledge financial support by FONDECYT (1110992, 11121571 & 1151174) (http://www.fondecyt.cl), Mecesup (FSM710 & CD FSM1204) (www.mineduc.cl), FDI Mecesup (2012, 2013 & 2014) (www.mineduc.cl), and USM (131562, 131342 & 131109) (http://www.usm.cl) grants.	Agnoli K, 2006, J BACTERIOL, V188, P3631, DOI 10.1128/JB.188.10.3631-3644.2006; Alice AF, 2006, J BACTERIOL, V188, P1551, DOI 10.1128/JB.188.4.1551-1566.2006; Almodovar I, 2011, RAPID COMMUN MASS SP, V25, P370, DOI 10.1002/rcm.4868; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Bosello M, 2012, BIOCHEMISTRY-US, V51, P3059, DOI 10.1021/bi201837f; Brown SD, 2012, J BACTERIOL, V194, P5991, DOI 10.1128/JB.01243-12; Camara B, 2004, ENVIRON MICROBIOL, V6, P842, DOI 10.1111/j.1462-2920.2004.00630.x; Carrillo-Castaneda G, 2002, ADV ENVIRON RES, V6, P391, DOI 10.1016/S1093-0191(02)00054-0; Chaiharn M, 2009, WORLD J MICROB BIOT, V25, P1919, DOI 10.1007/s11274-009-0090-7; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Challis GL, 2000, FEMS MICROBIOL LETT, V187, P111, DOI 10.1111/j.1574-6968.2000.tb09145.x; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chirino B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075746; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; de los Santos-Villalobos S, 2012, WORLD J MICROB BIOT, V28, P2615, DOI 10.1007/s11274-012-1071-9; Denef VJ, 2004, APPL ENVIRON MICROB, V70, P4961, DOI 10.1128/AEM.70.8.4961-4970.2004; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Franke J, 2015, CHEM-EUR J, V21, P8010, DOI 10.1002/chem.201500757; Franke J, 2014, J AM CHEM SOC, V136, P5599, DOI 10.1021/ja501597w; Franke J, 2013, ANGEW CHEM INT EDIT, V52, P8271, DOI 10.1002/anie.201303196; Gaines JM, 2007, MICROBIOL-SGM, V153, P4219, DOI 10.1099/mic.0.2007/011338-0; Hamood AN, 1996, MOL MICROBIOL, V21, P97, DOI 10.1046/j.1365-2958.1996.6251337.x; Herbst DA, 2013, J BIOL CHEM, V288, P1991, DOI 10.1074/jbc.M112.420182; Jin CW, 2010, ANN BOT-LONDON, V105, P835, DOI 10.1093/aob/mcq071; Romero-Silva MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056038; Konz D, 1999, CHEM BIOL, V6, pR39, DOI 10.1016/S1074-5521(99)80002-7; Kvitko BH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001715; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Loper JE, 1999, APPL ENVIRON MICROB, V65, P5357; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; MARAHIEL MA, 1985, MOL GEN GENET, V201, P231, DOI 10.1007/BF00425664; Mathew A, 2014, MOL MICROBIOL, V91, P805, DOI 10.1111/mmi.12499; McMorran BJ, 1996, GENE, V176, P55, DOI 10.1016/0378-1119(96)00209-0; McMorran BJ, 2001, MICROBIOL-SGM, V147, P1517, DOI 10.1099/00221287-147-6-1517; Mendez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017583; MEYER JM, 1995, BIOMETALS, V8, P309, DOI 10.1007/BF00141604; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Ochsner UA, 1996, P NATL ACAD SCI USA, V93, P4409, DOI 10.1073/pnas.93.9.4409; Penyalver R, 2001, APPL ENVIRON MICROB, V67, P654, DOI 10.1128/AEM.67.2.654-664.2001; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Schmitt E, 1998, EMBO J, V17, P6819, DOI 10.1093/emboj/17.23.6819; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Seeger M, 1999, APPL ENVIRON MICROB, V65, P3614; SEEGER M, 1995, APPL ENVIRON MICROB, V61, P2654, DOI 10.1128/AEM.61.7.2654-2658.1995; SHARMAN GJ, 1995, BIOCHEM J, V305, P187, DOI 10.1042/bj3050187; Shim JH, 1999, BIOCHEMISTRY-US, V38, P10024, DOI 10.1021/bi9904609; Sokol PA, 1999, INFECT IMMUN, V67, P4443, DOI 10.1128/IAI.67.9.4443-4455.1999; Sokol PA, 2000, INFECT IMMUN, V68, P6554, DOI 10.1128/IAI.68.12.6554-6560.2000; Stachelhaus T, 1998, J BIOL CHEM, V273, P22773, DOI 10.1074/jbc.273.35.22773; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; STEPHAN H, 1993, BIOMETALS, V6, P93, DOI 10.1007/BF00140109; Stephan H, 1993, LIEBIGS ANN CHEM, V1993, P43; Suarez-Moreno ZR, 2012, MICROB ECOL, V63, P249, DOI 10.1007/s00248-011-9929-1; Thomas MS, 2007, BIOMETALS, V20, P431, DOI 10.1007/s10534-006-9065-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urtuvia V, 2014, INT J BIOL MACROMOL, V70, P208, DOI 10.1016/j.ijbiomac.2014.06.001; Vasil ML, 1998, J BACTERIOL, V180, P6784, DOI 10.1128/JB.180.24.6784-6788.1998; Whitby PW, 2006, J MED MICROBIOL, V55, P661, DOI 10.1099/jmm.0.46199-0; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8; Yu SW, 1998, J BACTERIOL, V180, P4676, DOI 10.1128/JB.180.17.4676-4685.1998	65	15	15	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151273	10.1371/journal.pone.0151273	http://dx.doi.org/10.1371/journal.pone.0151273			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963250	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000132
J	Nam, Y; Kong, Y; Reyes, B; Reljin, N; Chon, KH				Nam, Yunyoung; Kong, Youngsun; Reyes, Bersain; Reljin, Natasa; Chon, Ki H.			Monitoring of Heart and Breathing Rates Using Dual Cameras on a Smartphone	PLOS ONE			English	Article							RESPIRATORY RATE; PULMONARY-FUNCTION; CARDIAC-SURGERY; MOVEMENTS; PHOTOPLETHYSMOGRAPHY; NONCONTACT; MOTION; WOMEN	Some smartphones have the capability to process video streams from both the front-and rear-facing cameras simultaneously. This paper proposes a new monitoring method for simultaneous estimation of heart and breathing rates using dual cameras of a smartphone. The proposed approach estimates heart rates using a rear-facing camera, while at the same time breathing rates are estimated using a non-contact front-facing camera. For heart rate estimation, a simple application protocol is used to analyze the varying color signals of a fingertip placed in contact with the rear camera. The breathing rate is estimated from non-contact video recordings from both chest and abdominal motions. Reference breathing rates were measured by a respiration belt placed around the chest and abdomen of a subject; reference heart rates (HR) were determined using the standard electrocardiogram. An automated selection of either the chest or abdominal video signal was determined by choosing the signal with a greater autocorrelation value. The breathing rate was then determined by selecting the dominant peak in the power spectrum. To evaluate the performance of the proposed methods, data were collected from 11 healthy subjects. The breathing ranges spanned both low and high frequencies (6-60 breaths/min), and the results show that the average median errors from the reflectance imaging on the chest and the abdominal walls based on choosing the maximum spectral peak were 1.43% and 1.62%, respectively. Similarly, HR estimates were also found to be accurate.	[Nam, Yunyoung; Kong, Youngsun] Soonchunhyang Univ, Dept Dept Comp Sci & Engn, Asan, South Korea; [Reyes, Bersain; Reljin, Natasa; Chon, Ki H.] Univ Connecticut, Dept Biomed Engn, Storrs, CT USA	Soonchunhyang University; University of Connecticut	Chon, KH (corresponding author), Univ Connecticut, Dept Biomed Engn, Storrs, CT USA.	ki.chon@uconn.edu	Kong, Youngsun/AAG-2934-2019; Chon, Ki/W-5498-2019; Nam, Yunyoung/AAI-4536-2020	Kong, Youngsun/0000-0001-5409-3888; Nam, Yunyoung/0000-0002-3318-9394; Reljin, Natasa/0000-0001-8799-9379; Reyes, Bersain/0000-0001-6082-9767	Soonchunhyang University Research Fund; US Army Medical Research and Materiel Command (USAMRMC) [W81XWH-12-1-0541]	Soonchunhyang University Research Fund; US Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by the Soonchunhyang University Research Fund, and in part by the US Army Medical Research and Materiel Command (USAMRMC) under Grant No. W81XWH-12-1-0541. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolkhovsky JB, 2012, IEEE ENG MED BIO, P1610, DOI 10.1109/EMBC.2012.6346253; Bradski G., 2000, DR DOBBS J SOFTW TOO; CULHAM EG, 1994, SPINE, V19, P1250, DOI 10.1097/00007632-199405310-00010; FERRIGNO G, 1994, J APPL PHYSIOL, V77, P1224, DOI 10.1152/jappl.1994.77.3.1224; FIESELMANN JF, 1993, J GEN INTERN MED, V8, P354, DOI 10.1007/BF02600071; Gregoski MJ, 2012, INT J TELEMED APPL, V2012, DOI 10.1155/2012/696324; Hillman K, 2005, LANCET, V365, P2091; Jonathan E, 2010, PHYSIOL MEAS, V31, pN79, DOI 10.1088/0967-3334/31/11/N01; Jonathan E, 2011, J BIOPHOTONICS, V4, P293, DOI 10.1002/jbio.201000050; Kristjansdottir A, 2004, SCAND CARDIOVASC J, V38, P369, DOI 10.1080/14017430410016396; Kristjansdottir A, 2004, SCAND CARDIOVASC J, V38, P98, DOI 10.1080/14017430410028492; Lazaro J, 2015, PHYSIOL MEAS, V36, P2317, DOI 10.1088/0967-3334/36/11/2317; Lazaro J, 2014, 2014 8TH CONFERENCE OF THE EUROPEAN STUDY GROUP ON CARDIOVASCULAR OSCILLATIONS (ESGCO), P121, DOI 10.1109/ESGCO.2014.6847549; Lazaro J, 2013, MED BIOL ENG COMPUT, V51, P233, DOI 10.1007/s11517-012-0954-0; Leonard P, 2003, EMERG MED J, V20, P524, DOI 10.1136/emj.20.6.524; Leonard Paul, 2004, J Clin Monit Comput, V18, P309, DOI 10.1007/s10877-005-2697-z; Leonard PA, 2006, ACTA PAEDIATR, V95, P1124, DOI 10.1080/08035250600612280; Leong JCY, 1999, SPINE, V24, P1310, DOI 10.1097/00007632-199907010-00007; Nakajima K, 1996, MED ENG PHYS, V18, P365, DOI 10.1016/1350-4533(95)00066-6; Nam Y, 2014, ANN BIOMED ENG, V42, P885, DOI 10.1007/s10439-013-0944-x; Nilsson L, 2005, ACTA ANAESTH SCAND, V49, P1157, DOI 10.1111/j.1399-6576.2005.00721.x; Nilsson L, 2000, J CLIN MONIT COMPUT, V16, P309, DOI 10.1023/A:1011424732717; Pelegris P, 2010, IEEE ENG MED BIO, P5488, DOI 10.1109/IEMBS.2010.5626580; Poh MZ, 2011, IEEE T BIO-MED ENG, V58, P7, DOI 10.1109/TBME.2010.2086456; Ragnarsdottir M, 2006, RESPIRATION, V73, P48, DOI 10.1159/000087456; Ragnarsdottir M, 2004, SCAND CARDIOVASC J, V38, P46, DOI 10.1080/14017430310016658; Ragnarsdottir M, 2008, SPINE J, V8, P505, DOI 10.1016/j.spinee.2006.12.009; Scully CG, 2012, IEEE T BIO-MED ENG, V59, P303, DOI 10.1109/TBME.2011.2163157; Shao DD, 2014, IEEE T BIO-MED ENG, V61, P2760, DOI 10.1109/TBME.2014.2327024; Shelley Kirk H, 2006, J Clin Monit Comput, V20, P81, DOI 10.1007/s10877-006-9010-7; Subbe CP, 2003, ANAESTHESIA, V58, P797, DOI 10.1046/j.1365-2044.2003.03258.x; Sun Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3602852; Tarassenko L, 2014, PHYSIOL MEAS, V35, P807, DOI 10.1088/0967-3334/35/5/807; Tarrant SC, 1997, DYSPHAGIA, V12, P24, DOI 10.1007/PL00009515; Wu HY, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185561; Zhao F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071384	37	88	91	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151013	10.1371/journal.pone.0151013	http://dx.doi.org/10.1371/journal.pone.0151013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963390	Green Submitted, gold, Green Published			2022-12-27	WOS:000371993000089
J	Ochoa-Gonzalez, F; Cervantes-Villagrana, AR; Fernandez-Ruiz, JC; Nava-Ramirez, HS; Hernandez-Correa, AC; Enciso-Moreno, JA; Castaneda-Delgado, JE				Ochoa-Gonzalez, Fatima; Cervantes-Villagrana, Alberto R.; Fernandez-Ruiz, Julio C.; Nava-Ramirez, Hilda S.; Hernandez-Correa, Adriana C.; Enciso-Moreno, Jose A.; Castaneda-Delgado, Julio E.			Metformin Induces Cell Cycle Arrest, Reduced Proliferation, Wound Healing Impairment In Vivo and Is Associated to Clinical Outcomes in Diabetic Foot Ulcer Patients	PLOS ONE			English	Article							LOWER-EXTREMITY AMPUTATION; CANCER-RISK; GROWTH; VITRO; INHIBITION; MORTALITY; MTOR; DRUG; ENHANCEMENT; CISPLATIN	Background Several epidemiological studies in diabetic patients have demonstrated a protective effect of metformin to the development of several types of cancer. The underlying mechanisms of such phenomenon is related to the effect of metformin on cell proliferation among which, mTOR, AMPK and other targets have been identified. However, little is known about the role that metformin treatment have on other cell types such as keratinocytes and whether exposure to metformin of these cells might have serious repercussions in wound healing delay and in the development of complications in diabetic patients with foot ulcers or in their exacerbation. Material and Methods HaCaT Cells were exposed to various concentrations of metformin and cell viability was evaluated by a Resazurin assay; Proliferation was also evaluated with a colony formation assay and with CFSE dilution assay by flow cytometry. Cell cycle was also evaluated by flow cytometry by PI staining. An animal model of wound healing was used to evaluate the effect of metformin in wound closure. Also, an analysis of patients receiving metformin treatment was performed to determine the effect of metformin treatment on the outcome and wound area. Statistical analysis was performed on SPSS v.18 and GraphPad software v.5. Results Metformin treatment significantly reduces cell proliferation; colony formation and alterations of the cell cycle are observed also in the metformin treated cells, particularly in the S phase. There is a significant increase in the area of the wound of the metformin treated animals at different time points (P<0.05). There is also a significant increase in the size and wound area of the patients with diabetic foot ulcers at the time of hospitalization. A protective effect of metformin was observed for amputation, probably associated with the anti inflammatory effects reported of metformin. Conclusions Metformin treatment reduces cell proliferation and reduces wound healing in an animal model and affects clinical outcomes in diabetic foot ulcer patients. Chronic use of this drug should be further investigated to provide evidence of their security in association with DFU.	[Ochoa-Gonzalez, Fatima; Fernandez-Ruiz, Julio C.; Nava-Ramirez, Hilda S.; Enciso-Moreno, Jose A.; Castaneda-Delgado, Julio E.] Inst Mexicano Seguro Social, Unidad Invest Biomed Zacatecas, Zacatecas, Zac, Mexico; [Cervantes-Villagrana, Alberto R.; Hernandez-Correa, Adriana C.] Univ Autonoma Zacatecas, Unidad Acad Ciencias Quim, Area Ciencias Salud, Zacatecas, Mexico; [Ochoa-Gonzalez, Fatima] Univ Autonoma Zacatecas, Area Ciencias Salud, Zacatecas, Zac, Mexico	Instituto Mexicano del Seguro Social; Universidad Autonoma de Zacatecas; Universidad Autonoma de Zacatecas	Castaneda-Delgado, JE (corresponding author), Inst Mexicano Seguro Social, Unidad Invest Biomed Zacatecas, Zacatecas, Zac, Mexico.	julioenrique_castaeda@yahoo.com.mx	Delgado, Julio Enrique Castañeda/AAL-1946-2020	Delgado, Julio Enrique Castañeda/0000-0003-2124-2036; Fernandez-Ruiz, Julio Cesar/0000-0002-5490-6049; CERVANTES VILLAGRANA, ALBERTO RAFAEL/0000-0001-7344-353X	ARCV [PROMEP-UAZ-PTC-197]; Proyecto FOMIX-CONACYT [ZAC-2013C04224230, UAZ22301312]	ARCV; Proyecto FOMIX-CONACYT	The study was partially funded to ARCV for PROMEP-UAZ-PTC-197("Programa de mejoramiento del profesorado, Universidad Autonoma de Zacatecas", program for improvement of professorship, from the acronym in Spanish) for the animal experiments. For in vitro data and clinical data, no specific funding was received and materials and reagents were kindly donated by JAEM. FOG thanks Proyecto FOMIX-CONACYT #ZAC-2013C04224230 for the scholarship #UAZ22301312. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Berger E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/821761; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Cai XB, 2013, ONCOL REP, V30, P2449, DOI 10.3892/or.2013.2718; Castro-Rios A, 2014, ARCH MED RES, V45, P400, DOI 10.1016/j.arcmed.2014.05.002; Chen MJ, 2015, DIABETES-METAB RES, V31, P781, DOI 10.1002/dmrr.2761; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Eikawa S, 2015, P NATL ACAD SCI USA, V112, P1809, DOI 10.1073/pnas.1417636112; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gandini S, 2014, CANCER PREV RES, V7, P867, DOI 10.1158/1940-6207.CAPR-13-0424; Gandini S, 2013, J CLIN ONCOL, V31, P973, DOI 10.1200/JCO.2012.46.3596; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Lee CH, 2014, ACS APPL MATER INTER, V6, P3979, DOI 10.1021/am405329g; Lee SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135858; Lee WJ, 2012, J KOREAN MED SCI, V27, P255, DOI 10.3346/jkms.2012.27.3.255; Liu Y, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.25709; Luo QQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-517; Margolis DJ, 2013, MED CLIN N AM, V97, P791, DOI 10.1016/j.mcna.2013.03.008; Martins-Mendes D, 2014, J DIABETES COMPLICAT, V28, P632, DOI 10.1016/j.jdiacomp.2014.04.011; Matsuzaki S, 2015, BIOCHEMISTRY-US, V54, P2011, DOI 10.1021/bi501473h; Musa HG, 2012, DIABET FOOT ANKLE, V3, DOI 10.3402/dfa.v3i0.18980; Nair V, 2014, J BIOL CHEM, V289, P27692, DOI 10.1074/jbc.M114.592576; Ng CS, 2014, DIABETES RES CLIN PR, V105, P151, DOI 10.1016/j.diabres.2014.03.020; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Achar RAN, 2014, ACTA CIR BRAS, V29, P125, DOI 10.1590/S0102-86502014000200009; O'Reilly DJ, 2011, QUAL LIFE RES, V20, P939, DOI 10.1007/s11136-010-9828-9; Park J, 2014, HEALTH REP, V25, P12; Perez-Revuelta BI, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.175; Peyton KJ, 2012, J PHARMACOL EXP THER, V342, P827, DOI 10.1124/jpet.112.194712; Pickwell K, 2015, DIABETES CARE, V38, P852, DOI 10.2337/dc14-1598; Quattrini I, 2014, ONCOL REP, V31, P370, DOI 10.3892/or.2013.2862; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Bolanos RDR, 2010, REV PANAM SALUD PUBL, V28, P412, DOI 10.1590/S1020-49892010001200002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuler KM, 2015, CANCER MED-US, V4, P161, DOI 10.1002/cam4.353; Silvestri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136250; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Singhal A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009885; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Vazquez-Martin A, 2009, CELL CYCLE, V8, P88, DOI 10.4161/cc.8.1.7499; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wang ZS, 2015, ACTA CIR BRAS, V30, P617, DOI 10.1590/S0102-865020150090000006; Won SH, 2014, YONSEI MED J, V55, P1373, DOI 10.3349/ymj.2014.55.5.1373; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500	48	39	42	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150900	10.1371/journal.pone.0150900	http://dx.doi.org/10.1371/journal.pone.0150900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963096	Green Published, gold			2022-12-27	WOS:000371993000076
J	Ipina, EP; Dawson, SP				Perez Ipina, Emiliano; Ponce Dawson, Silvina			Fluctuations, Correlations and the Estimation of Concentrations inside Cells	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; GRADIENT; LIMITS	Information transmission in cells occurs quite accurately even when concentration changes are "read" by individual binding sites. In this paper we study ligand number and site occupancy fluctuations when ligands diffuse and react going beyond the analyses that focus on their asymptotic decay. In this way we show that, for immobile binding sites, fluctuations in the number of bound molecules decay on a relatively fast scale before the asymptotic behavior kicks in. This result can explain the observed co-existence of highly fluctuating instantaneous transcriptional activities with accumulated mRNA concentrations that have relatively small noise levels. We also show that the initial stages of the decay in the bound molecule number fluctuations have one or two characteristic timescales depending on the concentration of free molecules. This transition can explain the changes in enzyme activity observed at the single molecule level.	[Ponce Dawson, Silvina] Consejo Nacl Invest Cient & Tecn, FCEN UBA, Dept Fis, Ciudad Univ,Pabellon 1, RA-1428 Buenos Aires, DF, Argentina; Consejo Nacl Invest Cient & Tecn, IFIBA, Ciudad Univ,Pabellon 1, RA-1428 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Dawson, SP (corresponding author), Consejo Nacl Invest Cient & Tecn, FCEN UBA, Dept Fis, Ciudad Univ,Pabellon 1, RA-1428 Buenos Aires, DF, Argentina.	silvina@df.uba.ar		Perez Ipina, Emiliano/0000-0002-1664-0411	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina [PICT 2010-2767, PICT 2013-1301]; Universidad de Buenos Aires, Argentina, UBACyT [20020130100480BA]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina(ANPCyT); Universidad de Buenos Aires, Argentina, UBACyT(University of Buenos Aires)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina, PICT 2010-2767; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina, PICT 2013-1301; and Universidad de Buenos Aires, Argentina, UBACyT 20020130100480BA.	Abu-Arish A, 2010, BIOPHYS J, V99, pL33, DOI 10.1016/j.bpj.2010.05.031; AGMON N, 1990, J CHEM PHYS, V92, P5270, DOI 10.1063/1.458533; Berezhkovskii AM, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816105; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Bialek W, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.258101; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Gregor T, 2014, TRENDS GENET, V30, P364, DOI 10.1016/j.tig.2014.06.002; Kaizu K, 2014, BIOPHYS J, V106, P976, DOI 10.1016/j.bpj.2013.12.030; Krichevsky O, 2002, REP PROG PHYS, V65, P251, DOI 10.1088/0034-4885/65/2/203; Little SC, 2013, CELL, V154, P789, DOI 10.1016/j.cell.2013.07.025; Pando B, 2006, P NATL ACAD SCI USA, V103, P5338, DOI 10.1073/pnas.0509576103; Ipina EP, 2014, BIOPHYS J, V107, P2674, DOI 10.1016/j.bpj.2014.10.046; Ipina EP, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022706; Sigaut L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003629; Sigaut L, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051912	18	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151132	10.1371/journal.pone.0151132	http://dx.doi.org/10.1371/journal.pone.0151132			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26962863	Green Published, gold			2022-12-27	WOS:000371993000108
J	Sabilallah, M; Fontanaud, P; Linck, N; Boussadia, B; Peyroutou, R; Lasgouzes, T; Rassendren, FA; Marchi, N; Hirbec, HE				Sabilallah, Mounira; Fontanaud, Pierre; Linck, Nathalie; Boussadia, Badreddine; Peyroutou, Ronan; Lasgouzes, Thibault; Rassendren, Francois A.; Marchi, Nicola; Hirbec, Helene E.			Evidence for Status Epilepticus and Pro-Inflammatory Changes after Intranasal Kainic Acid Administration in Mice	PLOS ONE			English	Article							MICROGLIAL ACTIVATION; LOBE EPILEPSY; MODELS; SEIZURE	Kainic acid (KA) is routinely used to elicit status epilepticus (SE) and epileptogenesis. Among the available KA administration protocols, intranasal instillation (IN) remains understudied. Dosages of KA were instilled IN in mice. Racine Scale and Video-EEG were used to assess and quantify SE onset. Time spent in SE and spike activity was quantified for each animal and confirmed by power spectrum analysis. Immunohistochemistry and qPCR were performed to define brain inflammation occurring after SE, including activated microglial phenotypes. Long term video-EEG recording was also performed. Titration of IN KA showed that a dose of 30 mg/kg was associated with low mortality while eliciting SE. IN KA provoked at least one behavioral and electrographic SE in the majority of the mice (>90%). Behavioral and EEG SE were accompanied by a rapid and persistent microglial-astrocytic cell activation and hippocampal neurodegeneration. Specifically, microglial modifications involved both pro-(M1) and anti-inflammatory (M2) genes. Our initial long-term video-EEG exploration conducted using a small cohort of mice indicated the appearance of spike activity or SE. Our study demonstrated that induction of SE is attainable using IN KA in mice. Typical pro-inflammatory brain changes were observed in this model after SE, supporting disease pathophysiology. Our results are in favor of the further development of IN KA as a means to study seizure disorders. A possibility for tailoring this model to drug testing or to study mechanisms of disease is offered.	[Sabilallah, Mounira; Fontanaud, Pierre; Linck, Nathalie; Boussadia, Badreddine; Peyroutou, Ronan; Lasgouzes, Thibault; Rassendren, Francois A.; Marchi, Nicola; Hirbec, Helene E.] CNRS, UMR 5203, Inst Genom Fonct, Montpellier, France; [Sabilallah, Mounira; Fontanaud, Pierre; Linck, Nathalie; Boussadia, Badreddine; Peyroutou, Ronan; Lasgouzes, Thibault; Rassendren, Francois A.; Marchi, Nicola; Hirbec, Helene E.] INSERM, U1191, Montpellier, France; [Sabilallah, Mounira; Fontanaud, Pierre; Linck, Nathalie; Boussadia, Badreddine; Peyroutou, Ronan; Lasgouzes, Thibault; Rassendren, Francois A.; Marchi, Nicola; Hirbec, Helene E.] Univ Montpellier, UMR5203, F-34059 Montpellier, France; [Sabilallah, Mounira; Linck, Nathalie; Peyroutou, Ronan; Lasgouzes, Thibault; Rassendren, Francois A.; Hirbec, Helene E.] Labex ICST, Montpellier, France; [Fontanaud, Pierre] Plateforme Imagerie Petit Anim Montpellier, Biocampus, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	Marchi, N; Hirbec, HE (corresponding author), CNRS, UMR 5203, Inst Genom Fonct, Montpellier, France.; Marchi, N; Hirbec, HE (corresponding author), INSERM, U1191, Montpellier, France.; Marchi, N; Hirbec, HE (corresponding author), Univ Montpellier, UMR5203, F-34059 Montpellier, France.; Hirbec, HE (corresponding author), Labex ICST, Montpellier, France.	nicola.marchi@igf.cnrs.fr; helene.hirbec@igf.cnrs.fr	Marchi, Nicola/J-8607-2016; Rassendren, Francois/AAA-6190-2021; Hirbec, Helene/ABE-4188-2021	Marchi, Nicola/0000-0001-9124-0226; Hirbec, Helene/0000-0002-5593-5255; Rassendren, Francois/0000-0003-3320-2461; BOUSSADIA, Badreddine/0000-0001-6425-0496; Linck, Nathalie/0000-0002-2218-239X	Citizens United for Research in Epilepsy [332226]; Federation pour la recherche sur le cerveau (FRC); Fond Unique Interministeriel and Region Languedoc-Roussillon, DiaTrAl [110284]	Citizens United for Research in Epilepsy; Federation pour la recherche sur le cerveau (FRC); Fond Unique Interministeriel and Region Languedoc-Roussillon, DiaTrAl(Region Occitanie)	This work was supported by: 1. Citizens United for Research in Epilepsy, www.cureepilepsy.org, Grant No 332226 (NM); 2. Federation pour la recherche sur le cerveau (FRC), www.frc.asso.fr (NM); 3. Fond Unique Interministeriel and Region Languedoc-Roussillon, DiaTrAl, Grant No 110284 (FR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avignone E, 2008, J NEUROSCI, V28, P9133, DOI 10.1523/JNEUROSCI.1820-08.2008; BENARI Y, 1978, EUR J PHARMACOL, V52, P419, DOI 10.1016/0014-2999(78)90302-3; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chen ZG, 2002, BRAIN RES, V931, P135, DOI 10.1016/S0006-8993(02)02268-0; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Costantino HR, 2007, INT J PHARMACEUT, V337, P1, DOI 10.1016/j.ijpharm.2007.03.025; Depaulis A, 2015, REV NEUROL-FRANCE, V171, P217, DOI 10.1016/j.neurol.2015.01.558; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Dudek FE, 2006, MODELS OF SEIZURES AND EPILEPSY, P415, DOI 10.1016/B978-012088554-1/50036-0; Illum L, 2000, EUR J PHARM SCI, V11, P1, DOI 10.1016/S0928-0987(00)00087-7; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Legido A, 2014, SEMIN PEDIATR NEUROL, V21, P197, DOI 10.1016/j.spen.2014.10.001; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Marchi N, 2014, TRENDS NEUROSCI, V37, P55, DOI 10.1016/j.tins.2013.11.002; Marchi N, 2013, NEUROSCIENTIST, V19, P304, DOI 10.1177/1073858412462747; McKhann GM, 2003, NEUROSCIENCE, V122, P551, DOI 10.1016/S0306-4522(03)00562-1; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; OCALLAGHAN JP, 1995, NEUROCHEM INT, V26, P115, DOI 10.1016/0197-0186(94)00106-5; Parent J. M., 2012, JASPERS BASIC MECH E; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Sharma AK, 2007, TOXICOL PATHOL, V35, P984, DOI 10.1080/01926230701748305; Ulmann L, 2013, GLIA, V61, P1306, DOI 10.1002/glia.22516; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2011, EXP NEUROL; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Vyas Tushar K., 2005, Current Drug Delivery, V2, P165, DOI 10.2174/1567201053586047	28	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150793	10.1371/journal.pone.0150793	http://dx.doi.org/10.1371/journal.pone.0150793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963100	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000065
J	Yu, B; Yang, YT; Liu, H; Gong, M; Millard, RW; Wang, YG; Ashraf, M; Xu, MF				Yu, Bin; Yang, Yueting; Liu, Huan; Gong, Min; Millard, Ronald W.; Wang, Yi-Gang; Ashraf, Muhammad; Xu, Meifeng			Clusterin/Akt Up-Regulation Is Critical for GATA-4 Mediated Cytoprotection of Mesenchymal Stem Cells against Ischemia Injury	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CLUSTERIN/APOLIPOPROTEIN-J; SURVIVAL; PATHWAY; CARDIOMYOCYTES; RESISTANCE; APOPTOSIS; THERAPY; TRIAL; SIZE	Background Clusterin (Clu) is a stress-responding protein with multiple biological functions. Our preliminary microarray studies show that clusterin was prominently upregulated in mesenchymal stem cells (MSCs) overexpressing GATA-4 (MSCGATA-4). We hypothesized that the upregulation of clusterin is involved in overexpression of GATA-4 mediated cytoprotection. Methods MSCs harvested from bone marrow of rats were transduced with GATA-4. The expression of clusterin in MSCs was further confirmed by real-time PCR and western blotting. Simulation of ischemia was achieved by exposure of MSCs to a hypoxic environment. Lactate dehydrogenase (LDH) released from MSCs was served as a biomarker of cell injury and MTs uptake was used to estimate cell viability. Mitochondrial function was evaluated by measuring mitochondrial membrane potential (Delta psi m) and caspase 3/7 activity. Results (1) Clusterin expression was up-regulated in MSCGATA-4 compared to control MSCs transfected with empty-vector (MSC(Nul)l). MSCGATA-4 were tolerant to 72 h hypoxia exposure as shown by reduced LDH release and higher MTs uptake. This protection was abrogated by transfecting Clu-siRNA into MSCGATA-4. (2) Exogenous clusterin significantly decreased LDH release and increased MSC survival in hypoxic environment. Moreover, Delta psi m was maintained and caspase 3/7 activity was reduced by clusterin in a concentration-dependent manner. (3) p-Akt expression in MSCs was upregulated following pre-treatment with clusterin, with no change in total Akt. Moreover, cytoprotection mediated by clusterin was partially abrogated by Akt inhibitor LY294002. Conclusions Clusterin/Akt signaling pathway is involved in GATA-4 mediated cytoprotection against hypoxia stress. It is suggested that clusterin may be therapeutically exploited in MSC based therapy for cardiovascular diseases.	[Yu, Bin; Yang, Yueting; Liu, Huan; Gong, Min; Wang, Yi-Gang; Ashraf, Muhammad; Xu, Meifeng] Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH USA; [Millard, Ronald W.] Univ Cincinnati, Med Ctr, Dept Pharmacol & Cell Biophys, Cincinnati, OH USA; [Ashraf, Muhammad] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Xu, MF (corresponding author), Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH USA.	Meifeng.xu@uc.edu	Ashraf, Muhammad/ABB-3463-2021		National Institutes of Health [HL105176, HL114654]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091478, R01HL105176, R01HL114654, R01HL126516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grants HL105176 and HL114654 to MX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar H, 2008, J BIOL CHEM, V283, P12851, DOI 10.1074/jbc.M800403200; Cubedo J, 2011, J PROTEOME RES, V10, P211, DOI 10.1021/pr100805h; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de Jong R, 2014, CIRC-CARDIOVASC INTE, V7, P156, DOI 10.1161/CIRCINTERVENTIONS.113.001009; Jun HO, 2011, EXP MOL MED, V43, P53, DOI 10.3858/emm.2011.43.1.006; Kim JH, 2007, CURR EYE RES, V32, P693, DOI 10.1080/02713680701487871; Krijnen PAJ, 2005, AM J PHYSIOL-HEART C, V289, pH2193, DOI 10.1152/ajpheart.00355.2005; Li HX, 2011, CYTOTHERAPY, V13, P1057, DOI 10.3109/14653249.2011.597380; Li HX, 2010, AM J PHYSIOL-HEART C, V299, pH1772, DOI 10.1152/ajpheart.00557.2010; Li YX, 2007, BIOCHEM BIOPH RES CO, V357, P157, DOI 10.1016/j.bbrc.2007.03.109; Lourda M, 2007, INT J CANCER, V120, P611, DOI 10.1002/ijc.22327; Malecki Marek, 2013, Mol Cell Ther, V1; Martinez-Bujidos M, 2015, FASEB J, V29, P1688, DOI 10.1096/fj.14-264036; Matsushita K, 2016, ANDROLOGIA, V48, P11, DOI 10.1111/and.12404; Nguan CYC, 2014, AM J PHYSIOL-RENAL, V306, pF724, DOI 10.1152/ajprenal.00410.2013; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Pons J, 2009, J GENE MED, V11, P743, DOI 10.1002/jgm.1362; Rodrigo SF, 2013, J CARDIOVASC TRANSL, V6, P816, DOI 10.1007/s12265-013-9507-7; Sadat K, 2014, J NUCL CARDIOL, V21, P351, DOI 10.1007/s12350-013-9846-4; Schutt RC, 2015, CIRC RES, V116, P99, DOI 10.1161/CIRCRESAHA.116.304710; Song HB, 2013, ONCOL REP, V30, P2713, DOI 10.3892/or.2013.2764; Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079; Troyan MB, 1997, EXP CELL RES, V233, P274, DOI 10.1006/excr.1997.3570; van Dijk A, 2010, EUR J CLIN INVEST, V40, P893, DOI 10.1111/j.1365-2362.2010.02345.x; Wohrle J, 2013, CLIN RES CARDIOL, V102, P765, DOI 10.1007/s00392-013-0595-9; Xiu P, 2013, CANCER SCI, V104, P375, DOI 10.1111/cas.12088; Yu B, 2013, INT J BIOCHEM CELL B, V45, P2724, DOI 10.1016/j.biocel.2013.09.007	27	10	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151542	10.1371/journal.pone.0151542	http://dx.doi.org/10.1371/journal.pone.0151542			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26962868	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000163
J	Cho, KH; Park, EC; Nam, YS; Lee, SH; Nam, CM; Lee, SG				Cho, Kyoung Hee; Park, Eun-Cheol; Nam, Young Soon; Lee, Seon-Heui; Nam, Chung Mo; Lee, Sang Gyu			Impact of Market Competition on Continuity of Care and Hospital Admissions for Asthmatic Children: A Longitudinal Analysis of Nationwide Health Insurance Data 2009-2013	PLOS ONE			English	Article							AMBULATORY-CARE; ADULT PATIENTS; ADHERENCE; OUTCOMES	Background Ambulatory care-sensitive conditions, including asthma, can be managed with timely and effective outpatient care, thereby reducing the need for hospitalization. Objective This study assessed the relationship between market competition, continuity of care (COC), and hospital admissions in asthmatic children according to their health care provider. Methods A longitudinal design was employed with a 5-year follow-up period, between 2009 and 2013, under a Korean universal health insurance program. A total of 253 geographical regions were included in the analysis, according to data from the Korean Statistical Office. Data from 9,997 patients, aged <= 12 years, were included. We measured the COC over a 5-year period using the Usual Provider Continuity (UPC) index. Random intercept models were calculated to assess the temporal and multilevel relationship between market competition, COC, and hospital admission rate. Results Of the 9,997 patients, 243 (2.4%) were admitted to the hospital in 2009. In the multilevel regression analysis, as the Herfindahl-Hirschman Index increased by 1,000 points denoting decreased competitiveness), UPC scores also increased (beta = 0.001; p < 0.0001). In multilevel logistic regression analysis, the adjusted odds ratio (OR) for hospital admissions for individuals with lower COC scores (>= 2 ambulatory visits and a UPC index score of < 1) was 3.61 (95% CI: 2.98-4.38) relative to the reference group (>= 2 ambulatory visits and a UPC index score of 1). Conclusions Market competition appears to reduce COC; decreased COC was associated with a higher OR for hospital admissions.	[Cho, Kyoung Hee] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea; [Cho, Kyoung Hee; Park, Eun-Cheol; Lee, Sang Gyu] Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Nam, Young Soon] Hlth Insurance Review & Assessment Serv, Dept Qual Assessment, Wonju, South Korea; [Lee, Seon-Heui] Gachon Univ, Coll Nursing, Dept Nursing Sci, Songnam, South Korea; [Nam, Chung Mo] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Lee, Sang Gyu] Yonsei Univ, Grad Sch Publ Hlth, Seoul 120749, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Gachon University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, SG (corresponding author), Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea.; Lee, SG (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Seoul 120749, South Korea.	leevan@yuhs.ac	Park, Eun-Cheol/O-5644-2019	Park, Eun-Cheol/0000-0002-2306-5398; Nam, Chung Mo/0000-0003-0985-0928; Cho, Kyoung Hee/0000-0003-0753-1560; Lee, Sang Gyu/0000-0003-4847-2421				Agency for Healthcare Research and Quality, 2004, GUID PREV QUAL IND H; AL-Jahdali H, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-80; Atlas SJ, 2009, ANN INTERN MED, V150, P325, DOI 10.7326/0003-4819-150-5-200903030-00008; Besanko D., 2009, EC STRATEGY; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; Cabana MD, 2004, J FAM PRACTICE, V53, P974; Chen CC, 2012, BMC HEALTH SERV RES, V12, P405; den Exter AP, 2014, MED LAW REV, V22, P255, DOI 10.1093/medlaw/fwu009; Gleeson S, 2016, JAMA PEDIATR, V170, P259, DOI 10.1001/jamapediatrics.2015.3809; Health Insurance Review & Assessment Service, 2010, INTR INC SYST AMB PR; Hong JS, 2014, MED CARE, V52, P446, DOI 10.1097/MLR.0000000000000110; Hong JS, 2013, HEALTH POLICY, V109, P158, DOI 10.1016/j.healthpol.2012.09.009; Hong J, 2010, J KOREAN MED SCI, V25, P1754, DOI 10.3346/jkms.2010.25.12.1754; Hussey PS, 2014, JAMA INTER MED; Jeong HS, 2008, KOREAN J HLTH EC POL, V14, P151; Kim RY, 2011, INTRO NATL PATIENTS; Korea National Statistical Office, 2013, STAT ALL CAUS MORT 2; Korhonen K, 2009, WORLD J PEDIATR, V5, P177, DOI 10.1007/s12519-009-0034-1; Mainous AG, 1998, AM J PUBLIC HEALTH, V88, P1539, DOI 10.2105/AJPH.88.10.1539; Malcolm JC, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-303; 김재용, 2006, Diabetes and Metabolism Journal, V30, P377; Ministry of Helath & Welfare Health Insurance Review & Assessment Service, 2011, PROD DEV OECD HLTH C; Mooney G, 1994, KEY ISUUES HLTH EC; National Health Insurance Corporation, 2007, NAT HLTH INS PROGR K; Parchman ML, 2002, MED CARE, V40, P137, DOI 10.1097/00005650-200202000-00008; Pyun BY, 2007, J KOREAN MED ASSOC, V50, P1130, DOI 10.5124/jkma.2007.50.12.1130; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rust G, 2013, J ASTHMA, V50, P769, DOI 10.3109/02770903.2013.799687; Sharma G, 2010, ARCH INTERN MED, V170, P1664, DOI 10.1001/archinternmed.2010.345; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; The Korean Academy of Asthma AaCI, 2011, KOR ASTHM MAN GUID A; Uijen AA, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X649115; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413; Weiss LJ, 1996, AM J PUBLIC HEALTH, V86, P1742, DOI 10.2105/AJPH.86.12.1742; Wong HS, 2005, REV IND ORGAN, V26, P61, DOI 10.1007/s11151-004-6067-7	35	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150926	10.1371/journal.pone.0150926	http://dx.doi.org/10.1371/journal.pone.0150926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TF	26958850	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300086
J	Cooper, J; Kierans, C; Defres, S; Easton, A; Kneen, R; Solomon, T				Cooper, Jessie; Kierans, Ciara; Defres, Sylviane; Easton, Ava; Kneen, Rachel; Solomon, Tom			Diagnostic Pathways as Social and Participatory Practices: The Case of Herpes Simplex Encephalitis	PLOS ONE			English	Article							MANAGEMENT; HEALTH; CARE; TRAJECTORIES; MULTICENTER	Herpes simplex virus (HSV) encephalitis is a potentially devastating disease, with significant rates of mortality and co-morbidities. Although the prognosis for people with HSV encephalitis can be improved by prompt treatment with aciclovir, there are often delays involved in the diagnosis and treatment of the disease. In response, National Clinical Guidelines have been produced for the UK which make recommendations for improving the management of suspected viral encephalitis. However, little is currently known about the everyday experiences and processes involved in the diagnosis and care of HSV encephalitis. The reported study aimed to provide an account of the diagnosis and treatment of HSV encephalitis from the perspective of people who had been affected by the condition. Thirty narrative interviews were conducted with people who had been diagnosed with HSV encephalitis and their significant others. The narrative accounts reveal problems with gaining access to a diagnosis of encephalitis and shortfalls in care for the condition once in hospital. In response, individuals and their families work hard to obtain medical recognition for the problem and shape the processes of acute care. As a consequence, we argue that the diagnosis and management of HSV encephalitis needs to be considered as a participatory process, which is co-produced by health professionals, patients, and their families. The paper concludes by making recommendations for developing the current management guidelines by formalising the critical role of patients and their significant others in the identification, and treatment of, HSV encephalitis.	[Cooper, Jessie; Kierans, Ciara] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Defres, Sylviane; Easton, Ava; Kneen, Rachel; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Defres, Sylviane] Royal Liverpool & Broadgreen Univ Hosp Trust, Trop & Infect Dis Unit, Liverpool, Merseyside, England; [Easton, Ava] Encephalitis Soc, Malton, N Yorkshire, England; [Kneen, Rachel] Alder Hey Childrens NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England; [Solomon, Tom] Walton Ctr NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England; [Solomon, Tom] Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Walton Centre; University of Liverpool	Cooper, J (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England.	j.c.cooper@liverpool.ac.uk		Easton, Ava/0000-0002-1739-2915; Kierans, Ciara/0000-0001-7268-4438; Solomon, Tom/0000-0001-7266-6547	National Institute for Health Research under Programme Grants for Applied Research Programme [RP-PG-0108-10048]; National Institute for Health Research [12/205/28, IS-HPU-1112-10117, RP-PG-0108-10048, NF-SI-0514-10177] Funding Source: researchfish	National Institute for Health Research under Programme Grants for Applied Research Programme; National Institute for Health Research(National Institute for Health Research (NIHR))	This work received support from the National Institute for Health Research (www.nihr.ac.uk) under its Programme Grants for Applied Research Programme (grant reference number RP-PG-0108-10048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen D, 2004, SOCIOL HEALTH ILL, V26, P1008, DOI 10.1111/j.0141-9889.2004.00426.x; Atkin K, 2010, SOC SCI MED, V71, P386, DOI 10.1016/j.socscimed.2010.04.011; Bell DJ, 2009, CLIN MED, V9, P231, DOI 10.7861/clinmedicine.9-3-231; Berg M, 1997, SOC SCI MED, V44, P1081, DOI 10.1016/S0277-9536(96)00235-3; Bruner J. S., 1986, ACTUAL MINDS POSSIBL, DOI DOI 10.4159/9780674029019; Cetina Karin Knorr, 2009, EPISTEMIC CULTURES S, DOI 10.2307/j.ctvxw3q7f; Chataway J, 2004, QJM-INT J MED, V97, P325, DOI 10.1093/qjmed/hch058; Cooper Jessie., 2016, MORTALITY, V21, P1, DOI DOI 10.1080/13576275.2015.1021314; Davies Nicholas W S, 2012, Pract Neurol, V12, P206, DOI 10.1136/practneurol-2012-000297; Easton A, 2006, BR J NEUROSCI NURS, V2; Elbers JM, 2007, PEDIATRICS, V119, pE399, DOI 10.1542/peds.2006-1494; Farmer P, 1996, DAEDALUS, V125, P261; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Hannigan B, 2013, COMMUNITY MENT HLT J, V49, P380, DOI 10.1007/s10597-011-9467-9; HOGLE LF, 1995, SCI TECHNOL HUM VAL, V20, P482, DOI 10.1177/016224399502000405; Hokkanen L, 2007, NEUROPSYCHOL REHABIL, V17, P450, DOI 10.1080/09602010601137039; Jutel A., 2011, PUTTING NAME IT DIAG; Kelly C, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-145; Kennedy PGE, 2013, J NEUROVIROL, V19, P346, DOI 10.1007/s13365-013-0178-6; Kierans C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054380; Kneen R, 2012, J INFECTION, V64, P449, DOI 10.1016/j.jinf.2011.11.013; Labov W, 1972, LANGUAGE INNER CITY; Latour B., 1986, LAB LIFE CONSTRUCTIO; Matata Claire, 2013, Nurs Stand, V28, P49, DOI 10.7748/ns2013.12.28.15.49.e7852; McGrath N, 1997, J NEUROL NEUROSUR PS, V63, P321, DOI 10.1136/jnnp.63.3.321; Mesman J, 2008, UNCERTAINTY IN MEDICAL INNOVATION: EXPERIENCED PIONEERS IN NEONATAL CARE, P1, DOI 10.1057/9780230594920; Mishler E.G., 1986, NARRATIVE PSYCHOL ST, P233; Mishler EG, 1995, J NARRAT LIFE HIST, V5, P87, DOI 10.1075/jnlh.5.2.01mod; Mol Annemarie, 2002, BODY MULTIPLE ONTOLO, DOI DOI 10.1215/9780822384151; Molassiotis A, 2010, EUR J CANCER CARE, V19, P98, DOI 10.1111/j.1365-2354.2008.01020.x; Rapley T, 2008, SOCIOL HEALTH ILL, V30, P429, DOI 10.1111/j.1467-9566.2007.01064.x; Raschilas F, 2002, CLIN INFECT DIS, V35, P254, DOI 10.1086/341405; Ray S, 2015, J NEUROINFECT DIS, V6, P2; Riessman C.K., 2008, NARRATIVE METHODS HU, P21; Salander P, 1999, FAM PRACT, V16, P143, DOI 10.1093/fampra/16.2.143; Schatzki T.R., 2001, PRACTICE TURN CONT T, P10; Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014; Solomon Tom, 2007, Pract Neurol, V7, P288, DOI 10.1136/jnnp.2007.129098; Strauss AL., 1985, SOCIAL ORG MED WORK; Timmermans S, 2003, GOLD STANDARD CHALLE; Vora NM, 2014, NEUROLOGY, V82, P443, DOI 10.1212/WNL.0000000000000086; Wengraf Tom., 2001, QUALITATIVE RES INTE; WHITLEY RJ, 1986, NEW ENGL J MED, V314, P144, DOI 10.1056/NEJM198601163140303	43	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151145	10.1371/journal.pone.0151145	http://dx.doi.org/10.1371/journal.pone.0151145			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TF	26960197	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000371992300103
J	Fraser, CML; Seebacher, F; Lathlean, J; Coleman, RA				Fraser, Clarissa M. L.; Seebacher, Frank; Lathlean, Justin; Coleman, Ross A.			Facing the Heat: Does Desiccation and Thermal Stress Explain Patterns of Orientation in an Intertidal Invertebrate?	PLOS ONE			English	Article							CONTROLLING BODY-TEMPERATURE; THERMOREGULATORY BEHAVIOR; CELLANA-GRATA; SOLAR-RADIATION; ROCKY SHORES; LIMPET; GASTROPODS; RESPONSES; ECOLOGY; HABITAT	A key challenge for ecologists is to quantify, explain and predict the ecology and behaviour of animals from knowledge of their basic physiology. Compared to our knowledge of many other types of distribution and behaviour, and how these are linked to individual function, we have a poor level of understanding of the causal basis for orientation behaviours. Most explanations for patterns of animal orientation assume that animals will modify their exposure to environmental factors by altering their orientation. We used a keystone grazer on rocky shores, the limpet Cellana tramoserica, to test this idea. Manipulative experiments were done to evaluate whether orientation during emersion affected limpet desiccation or body temperature. Body temperature was determined from infrared thermography, a technique that minimises disturbance to the test organism. No causal relationships were found between orientation and (i) level of desiccation and (ii) their body temperature. These results add to the growing knowledge that responses to desiccation and thermal stress may be less important in modifying the behaviour of intertidal organisms than previously supposed and that thermoregulation does not always reflect patterns of animal orientation. Much of what we understand about orientation comes from studies of animals able to modify orientation over very short time scales. Our data suggests that for animals whose location is less flexible, orientation decisions may have less to do with responses to environmental factors and more to do with structural habitat properties or intrinsic individual attributes. Therefore we suggest future studies into processes affecting orientation must include organisms with differing levels of behavioural plasticity.	[Fraser, Clarissa M. L.; Coleman, Ross A.] Univ Sydney, Sch Biol Sci, Ctr Res Ecol Impacts Coastal Cities, Sydney, NSW 2006, Australia; [Seebacher, Frank] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Lathlean, Justin] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Lathlean, Justin] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Fraser, Clarissa M. L.] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	University of Sydney; University of Sydney; University of Wollongong; University of New South Wales Sydney; Academia Sinica - Taiwan	Fraser, CML (corresponding author), Univ Sydney, Sch Biol Sci, Ctr Res Ecol Impacts Coastal Cities, Sydney, NSW 2006, Australia.; Fraser, CML (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	cfra4174@uni.sydney.edu.au		Seebacher, Frank/0000-0002-2281-9311; Fraser, Clarissa/0000-0002-1129-5890	Malacological Society of Australasia	Malacological Society of Australasia	This work was supported by the Malacological Society of Australasia, http://www.malsocaus.org/, with a Research Grant Awarded to CMLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott D. P., 1956, Nautilus Philadelphia, V693, P79; BARTHOLO.GA, 1966, CONDOR, V68, P523, DOI 10.2307/1366261; Bohorquez-Alonso ML, 2011, AMPHIBIA-REPTILIA, V32, P93, DOI 10.1163/017353710X542994; Bortolotti GR, 2011, IBIS, V153, P134, DOI 10.1111/j.1474-919X.2010.01067.x; Branch G.M., 1981, Oceanography and Marine Biology an Annual Review, V19, P235; Brumm H, 2003, BEHAVIOUR, V140, P43, DOI 10.1163/156853903763999881; Chapman MG, 2000, J EXP MAR BIOL ECOL, V250, P77, DOI 10.1016/S0022-0981(00)00180-5; CHAPMAN MG, 1986, J EXP MAR BIOL ECOL, V103, P181, DOI 10.1016/0022-0981(86)90140-1; Chapperon C, 2011, FUNCT ECOL, V25, P1040, DOI 10.1111/j.1365-2435.2011.01859.x; CLAPPERTON JL, 1965, J AGR SCI-CAMBRIDGE, V64, P37, DOI 10.1017/S0021859600010455; Coelho JR, 2001, J THERM BIOL, V26, P109, DOI 10.1016/S0306-4565(00)00030-9; Coleman RA, 2010, J EXP MAR BIOL ECOL, V386, P113, DOI 10.1016/j.jembe.2010.02.011; Coleman RA, 2006, OECOLOGIA, V147, P556, DOI 10.1007/s00442-005-0296-9; COLMAN JOHN, 1933, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V18, P435; CRISP DJ, 1957, J ANIM ECOL, V26, P179, DOI 10.2307/1788; Denny MW, 2011, J EXP MAR BIOL ECOL, V400, P175, DOI 10.1016/j.jembe.2011.02.006; Denny MW, 2006, J EXP BIOL, V209, P2409, DOI 10.1242/jeb.02257; Denny MW, 2006, J EXP BIOL, V209, P2420, DOI 10.1242/jeb.02258; DREISIG H, 1995, OECOLOGIA, V101, P169, DOI 10.1007/BF00317280; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fraser CML, 2015, MAR ECOL PROG SER, V522, P145, DOI 10.3354/meps11132; Fraser CML, 2014, OECOLOGIA, V174, P67, DOI 10.1007/s00442-013-2743-3; Fraser CML, 2010, AQUAT BIOL, V11, P91, DOI 10.3354/ab00294; Fraser CML, 2014, ORIENTATION KEYSTONE; Fretter V., 1994, BRIT PROSOBRANCH MOL; GALLIEN WB, 1985, PAC SCI, V39, P383; GARRITY SD, 1984, ECOLOGY, V65, P559, DOI 10.2307/1941418; Harley CDG, 2008, MAR ECOL PROG SER, V371, P37, DOI 10.3354/meps07711; HAWKINS SJ, 1992, SYST ASSOC SPEC VOL, V46, P1; Helmuth B, 2002, INTEGR COMP BIOL, V42, P837, DOI 10.1093/icb/42.4.837; Helmuth BST, 2001, BIOL BULL-US, V201, P374, DOI 10.2307/1543615; HUEY RB, 1991, AM NAT, V137, pS91, DOI 10.1086/285141; HUMPHREYS WF, 1991, BEHAV ECOL SOCIOBIOL, V28, P47, DOI 10.1007/BF00172138; Kang CK, 2012, J EVOLUTION BIOL, V25, P1695, DOI 10.1111/j.1420-9101.2012.02557.x; Lactin DJ, 1998, CAN ENTOMOL, V130, P551, DOI 10.4039/Ent130551-5; Lang RC, 1998, HYDROBIOLOGIA, V378, P161, DOI 10.1023/A:1003258125962; Lathlean J, 2014, MAR ECOL PROG SER, V514, P263, DOI 10.3354/meps10995; Lathlean JA, 2012, LIMNOL OCEANOGR, V57, P1279, DOI 10.4319/lo.2012.57.5.1279; LUSTICK S, 1978, SCIENCE, V200, P81, DOI 10.1126/science.635577; MACLULICH JH, 1986, MAR ECOL PROG SER, V32, P91, DOI 10.3354/meps032091; Maloney SK, 2005, J COMP PHYSIOL A, V191, P1065, DOI 10.1007/s00359-005-0031-3; Marshall DJ, 2012, J EXP MAR BIOL ECOL, V430, P25, DOI 10.1016/j.jembe.2012.06.011; Marshall DJ, 2010, BIOL LETTERS, V6, P669, DOI 10.1098/rsbl.2010.0233; MARTIN J, 1995, CAN J ZOOL, V73, P1065, DOI 10.1139/z95-126; Miller LP, 2011, BIOL BULL-US, V220, P209, DOI 10.1086/BBLv220n3p209; Miller LP, 2009, FUNCT ECOL, V23, P756, DOI 10.1111/j.1365-2435.2009.01567.x; Morritt D, 2007, J EXP MAR BIOL ECOL, V352, P78, DOI 10.1016/j.jembe.2007.07.002; Munoz JLP, 2005, COMP BIOCHEM PHYS A, V142, P92, DOI 10.1016/j.cbpa.2005.08.002; Nakata K, 2010, P ROY SOC B-BIOL SCI, V277, P3019, DOI 10.1098/rspb.2010.0729; Olea PP, 2010, BEHAV ECOL SOCIOBIOL, V64, P927, DOI 10.1007/s00265-010-0908-1; ONEILL KM, 1992, J THERM BIOL, V17, P323, DOI 10.1016/0306-4565(92)90041-D; OTWAY NM, 1987, J EXP MAR BIOL ECOL, V105, P85, DOI 10.1016/S0022-0981(87)80031-X; Raffaelli D, 1996, INTERTIDAL ECOLOGY; RUTOWSKI RL, 1994, ANIM BEHAV, V48, P833, DOI 10.1006/anbe.1994.1307; Rutowski Ronald L., 1991, Journal of Research on the Lepidoptera, V30, P129; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; STEVENSON RD, 1985, AM NAT, V126, P362, DOI 10.1086/284423; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; UNDERWOOD AJ, 1983, OECOLOGIA, V56, P202, DOI 10.1007/BF00379692; UNDERWOOD AJ, 1978, OECOLOGIA, V33, P185, DOI 10.1007/BF00344847; VERMEIJ GJ, 1971, MAR BIOL, V10, P315, DOI 10.1007/BF00368091; Webster RJ, 2009, PHILOS T R SOC B, V364, P503, DOI 10.1098/rstb.2008.0215; WILLIAMS GA, 1995, MAR ECOL PROG SER, V124, P89, DOI 10.3354/meps124089; Williams GA, 2005, MAR ECOL PROG SER, V292, P213, DOI 10.3354/meps292213; Williams GA, 1999, J MAR BIOL ASSOC UK, V79, P881, DOI 10.1017/S0025315498001040; WOLCOTT TG, 1973, BIOL BULL, V145, P389, DOI 10.2307/1540048; Zschokke S, 2010, NATURWISSENSCHAFTEN, V97, P43, DOI 10.1007/s00114-009-0609-7	67	6	6	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150200	10.1371/journal.pone.0150200	http://dx.doi.org/10.1371/journal.pone.0150200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959815	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300037
J	Wagner, L; Ross, I; Foster, J; Hankamer, B				Wagner, Liam; Ross, Ian; Foster, John; Hankamer, Ben			Trading Off Global Fuel Supply, CO2 Emissions and Sustainable Development	PLOS ONE			English	Article							ENERGY-CONSUMPTION; ECONOMIC-GROWTH; CAUSALITY; RETURN; OUTPUT; NEXUS; EROI	The United Nations Conference on Climate Change (Paris 2015) reached an international agreement to keep the rise in global average temperature 'well below 2 degrees C' and to 'aim to limit the increase to 1.5 degrees C'. These reductions will have to be made in the face of rising global energy demand. Here a thoroughly validated dynamic econometric model (Eq 1) is used to forecast global energy demand growth (International Energy Agency and BP), which is driven by an increase of the global population (UN), energy use per person and real GDP (World Bank and Maddison). Even relatively conservative assumptions put a severe upward pressure on forecast global energy demand and highlight three areas of concern. First, is the potential for an exponential increase of fossil fuel consumption, if renewable energy systems are not rapidly scaled up. Second, implementation of internationally mandated CO2 emission controls are forecast to place serious constraints on fossil fuel use from similar to 2030 onward, raising energy security implications. Third is the challenge of maintaining the international 'pro-growth' strategy being used to meet poverty alleviation targets, while reducing CO2 emissions. Our findings place global economists and environmentalists on the same side as they indicate that the scale up of CO2 neutral renewable energy systems is not only important to protect against climate change, but to enhance global energy security by reducing our dependence of fossil fuels and to provide a sustainable basis for economic development and poverty alleviation. Very hard choices will have to be made to achieve 'sustainable development' goals.	[Wagner, Liam] Griffith Univ, Griffith Business Sch, Econ, Brisbane, Qld 4111, Australia; [Ross, Ian; Hankamer, Ben] Univ Queensland, IMB, Brisbane, Qld, Australia; [Foster, John] Univ Queensland, Sch Econ, Brisbane, Qld, Australia	Griffith University; University of Queensland; University of Queensland	Hankamer, B (corresponding author), Univ Queensland, IMB, Brisbane, Qld, Australia.	b.hankamer@imb.uq.edu.au	Hankamer, Ben D/C-9688-2015; Ross, Ian/A-8622-2011; Wagner, Liam/U-1803-2019; Wagner, Liam D/E-2948-2010	Hankamer, Ben D/0000-0001-9284-4929; Ross, Ian/0000-0002-2389-4292; Wagner, Liam D/0000-0003-1297-5801; Foster, John/0000-0002-2601-1539	Australian Research Council [DP0877147, LP0883380, DP1093287]; University of Queensland, Queensland government; Eisenhower Fellowship scheme	Australian Research Council(Australian Research Council); University of Queensland, Queensland government; Eisenhower Fellowship scheme	This work was supported by the Australian Research Council [DP0877147, LP0883380, and DP1093287], the University of Queensland, Queensland government. This work was also supported by the Eisenhower Fellowship scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang JB, 2007, ENERG POLICY, V35, P4772, DOI 10.1016/j.enpol.2007.03.032; Balcilar M, 2010, ENERG ECON, V32, P1398, DOI 10.1016/j.eneco.2010.05.015; Bentley RW, 2007, ENERG POLICY, V35, P6364, DOI 10.1016/j.enpol.2007.08.001; Bolt J., 2013, WP4 U GRON MADD PROJ; BP, 2013, STAT REV WORLD EN 20; BREUSCH TS, 1978, AUST ECON PAP, V17, P334, DOI 10.1111/j.1467-8454.1978.tb00635.x; Chiou-Wei SZ, 2008, ENERG ECON, V30, P3063, DOI 10.1016/j.eneco.2008.02.002; Chontanawat J, 2008, J POLICY MODEL, V30, P209, DOI 10.1016/j.jpolmod.2006.10.003; DeLong JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130547; DICKEY DA, 1981, ECONOMETRICA, V49, P1057, DOI 10.2307/1912517; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Dittrick P, 2008, OIL GAS J, V106, P20; DURBIN J, 1950, BIOMETRIKA, V37, P409, DOI 10.1093/biomet/37.3-4.409; Durbin J, 1951, TESTING SERIAL CORRE, P159; EIA, 2011, INT EN OUTL 2011; ENI, 2013, WORLD OIL GAS REV; Foster J, 2011, J ECON BEHAV ORGAN, V80, P88, DOI 10.1016/j.jebo.2011.02.013; Frondel M, 2014, Q REV ECON FINANC, V54, P208, DOI 10.1016/j.qref.2013.10.003; Garnaut Ross, 2008, GARNAUT CLIMATE CHAN; GODFREY LG, 1978, ECONOMETRICA, V46, P1293, DOI 10.2307/1913829; Grubler A, 1998, TECHNOLOGY GLOBAL CH; Hall CAS, 2009, ENERGIES, V2, P25, DOI 10.3390/en20100025; Heinberg R, 2010, NATURE, V468, P367, DOI 10.1038/468367a; Heun MK, 2012, ENERG POLICY, V40, P147, DOI 10.1016/j.enpol.2011.09.008; Huang BN, 2008, ECOL ECON, V67, P41, DOI 10.1016/j.ecolecon.2007.11.006; IEA, 2012, WORLD EN OUTL 2012; IEA, 2020, ENERGY TECHNOLOGY PE, DOI [10.1787/9789264109834-en, DOI 10.1787/9789264109834-EN]; Johansson TB, 2012, GLOBAL ENERGY ASSESS; Kalimeris P, 2014, J CLEAN PROD, V67, P1, DOI 10.1016/j.jclepro.2013.12.040; Kander A, 2014, ENERG ECON, V46, P56, DOI 10.1016/j.eneco.2014.08.025; King CW, 2011, SUSTAINABILITY-BASEL, V3, P1810, DOI 10.3390/su3101810; Kjarstad J, 2009, ENERG POLICY, V37, P441, DOI 10.1016/j.enpol.2008.09.056; Lal R, 2008, PHILOS T R SOC B, V363, P815, DOI 10.1098/rstb.2007.2185; Lefevre N, 2010, ENERG POLICY, V38, P1635, DOI 10.1016/j.enpol.2009.02.003; Lenton TM, 2010, CARBON MANAG, V1, P145, DOI 10.4155/CMT.10.12; Mackinnon JG, 1996, J APPL ECONOMET, V11, P601, DOI 10.1002/(SICI)1099-1255(199611)11:6<601::AID-JAE417>3.0.CO;2-T; MacKinnon JG, 2010, CRITICAL VALUES COIN; Magne B, 2014, CLIMATIC CHANGE, V123, P677, DOI 10.1007/s10584-013-1030-y; Mohr SH, 2010, ENERG POLICY, V38, P265, DOI 10.1016/j.enpol.2009.09.015; Mohr SH, 2009, FUEL, V88, P2059, DOI 10.1016/j.fuel.2009.01.032; Narayan PK, 2008, ENERG POLICY, V36, P910, DOI 10.1016/j.enpol.2007.10.017; OECD Nuclear Energy Agency, 2007, UR 2007 RES PROD DEM; Pascual C, 2010, ENERGY SECURITY: ECONOMICS, POLITICS, STRATEGIES, AND IMPLICATIONS, P1; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Rogelj J, 2011, NAT CLIM CHANGE, V1, P413, DOI 10.1038/NCLIMATE1258; Smil V., 2003, ENERGY CROSSROADS GL; Soytas U, 2006, J POLICY MODEL, V28, P739, DOI 10.1016/j.jpolmod.2006.02.003; Steinacher M, 2013, NATURE; Stern DI, 2013, ENERG ECON, V39, P135, DOI 10.1016/j.eneco.2013.05.007; Stern DI, 2011, ANN NY ACAD SCI, V1219, P26, DOI 10.1111/j.1749-6632.2010.05921.x; Stern DI, 2000, ENERG ECON, V22, P267, DOI 10.1016/S0140-9883(99)00028-6; Stern N. H., 2006, STERN REV EC CLIMATE; Stocker BD, 2013, NATURE CLIMATE CHANG; *UN DEP EC SOC AFF, 2004, WORLD POP 2300; UNFCC, 2010, CANC ACC; UNFCCC, 2009, COP ACC; World Bank, 2014, WORLD DEV IND 2014	58	49	49	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149406	10.1371/journal.pone.0149406	http://dx.doi.org/10.1371/journal.pone.0149406			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TF	26959977	gold, Green Published, Green Submitted			2022-12-27	WOS:000371992300011
J	Weinberger, AB; Iyer, H; Green, AE				Weinberger, Adam B.; Iyer, Hari; Green, Adam E.			Conscious Augmentation of Creative State Enhances "Real" Creativity in Open-Ended Analogical Reasoning	PLOS ONE			English	Article							LATENT SEMANTIC ANALYSIS; MENTAL ROTATIONS TEST; THRESHOLD HYPOTHESIS; THINKING; INTELLIGENCE; ORIGINALITY; INDUCTION; COGNITION; DISTANCE; SUPPORT	Humans have an impressive ability to augment their creative state (i.e., to consciously try and succeed at thinking more creatively). Though this "thinking cap" phenomenon is commonly experienced, the range of its potential has not been fully explored by creativity research, which has often focused instead on creativity as a trait. A key question concerns the extent to which conscious augmentation of state creativity can improve creative reasoning. Although artistic creativity is also of great interest, it is creative reasoning that frequently leads to innovative advances in science and industry. Here, we studied state creativity in analogical reasoning, a form of relational reasoning that spans the conceptual divide between intelligence and creativity and is a core mechanism for creative innovation. Participants performed a novel Analogy Finding Task paradigm in which they sought valid analogical connections in a matrix of word-pairs. An explicit creativity cue elicited formation of substantially more creative analogical connections (measured via latent semantic analysis). Critically, the increase in creative analogy formation was not due to a generally more liberal criterion for analogy formation (that is, it appeared to reflect "real" creativity rather than divergence at the expense of appropriateness). The use of an online sample provided evidence that state creativity augmentation can be successfully elicited by remote cuing in an online environment. Analysis of an intelligence measure provided preliminary indication that the influential "threshold hypothesis," which has been proposed to characterize the relationship between intelligence and trait creativity, may be extensible to the new domain of state creativity.	[Weinberger, Adam B.; Iyer, Hari; Green, Adam E.] Georgetown Univ, Dept Psychol, Washington, DC 20057 USA	Georgetown University	Green, AE (corresponding author), Georgetown Univ, Dept Psychol, Washington, DC 20057 USA.	aeg58@georgetown.edu		Weinberger, Adam/0000-0002-5115-1162	National Science Foundation [DRL-1420481]; John Templeton Foundation [51971]; Pymetrics	National Science Foundation(National Science Foundation (NSF)); John Templeton Foundation; Pymetrics	This research was supported by awards from the National Science Foundation (DRL-1420481; http://www.nsf.gov/), The John Templeton Foundation (#51971; www.templeton.org), and Pymetrics (pymetrics.com) to A. Green. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen I.E., 2007, ONLINE NATION 5 YEAR; [Anonymous], 2012, CAMBRIDGE HDB INTELL, DOI DOI 10.1017/CBO9780511977244.039; Barnett SM, 2002, PSYCHOL BULL, V128, P612, DOI 10.1037//0033-2909.128.4.612; Bowdle BF, 2005, PSYCHOL REV, V112, P193, DOI 10.1037/0033-295X.112.1.193; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Carless SA, 2000, EDUC PSYCHOL MEAS, V60, P592, DOI 10.1177/00131640021970745; Chan J, 2012, MEM COGNITION, V40, P1352, DOI 10.3758/s13421-012-0227-z; CHAND I, 1993, PERS INDIV DIFFER, V14, P155, DOI 10.1016/0191-8869(93)90185-6; Chen CS, 2005, J CREATIVE BEHAV, V39, P89, DOI 10.1002/j.2162-6057.2005.tb01252.x; Costello FJ, 2000, COGNITIVE SCI, V24, P299, DOI 10.1207/s15516709cog2402_4; Dahl DW, 2002, J MARKETING RES, V39, P47, DOI 10.1509/jmkr.39.1.47.18930; Dunbar K, 2001, TRENDS COGN SCI, V5, P334, DOI 10.1016/S1364-6613(00)01698-3; Forster E.A., 2009, P 31TH ANN C COGNITI, P602; GENTNER D, 1983, COGNITIVE SCI, V7, P155, DOI 10.1016/S0364-0213(83)80009-3; GICK ML, 1983, COGNITIVE PSYCHOL, V15, P1, DOI 10.1016/0010-0285(83)90002-6; GICK ML, 1980, COGNITIVE PSYCHOL, V12, P306, DOI 10.1016/0010-0285(80)90013-4; GILCHRIST MB, 1972, PSYCHOL REP, V31, P579, DOI 10.2466/pr0.1972.31.2.579; Green AE, 2015, HUM BRAIN MAPP, V36, P923, DOI 10.1002/hbm.22676; Green AE, 2012, INTELLIGENCE, V40, P598, DOI 10.1016/j.intell.2012.08.005; Green AE, 2012, J EXP PSYCHOL LEARN, V38, P264, DOI 10.1037/a0025764; Green AE, 2010, CEREB CORTEX, V20, P70, DOI 10.1093/cercor/bhp081; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; Guilford J.P., 1967, NATURE HUMAN INTELLI; HARRINGTON DM, 1975, J PERS, V43, P434, DOI 10.1111/j.1467-6494.1975.tb00715.x; Harrison KD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004487; Heemskerk I, 2014, J COMPUT ASSISTED LE, V30; Holyoak K.K.J., 1995, THAGARD MENTAL LEAPS; Howard-Jones PA, 2005, COGNITIVE BRAIN RES, V25, P240, DOI 10.1016/j.cogbrainres.2005.05.013; Hummel JE, 1997, PSYCHOL REV, V104, P427, DOI 10.1037/0033-295X.104.3.427; IBM, 2010, GLOB CHIEF EX OFF ST; Jackson D. N., 1998, MULTIDIMENSIONAL APT; Jauk E, 2013, INTELLIGENCE, V41, P212, DOI 10.1016/j.intell.2013.03.003; Karwowski M, 2013, THINK SKILLS CREAT, V8, P25, DOI 10.1016/j.tsc.2012.05.003; Kim H. K., 2005, J SECONDARY GIFTED E, V15, P57, DOI DOI 10.4219/JSGE-2005-473; Kupczynski L, 2012, INT J INSTR, V5, P81; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Niu WH, 2001, INT J PSYCHOL, V36, P225, DOI 10.1080/00207590143000036; NSF, 2011, EMP NAT DISC INN NSF; Nusbaum EC, 2014, PSYCHOL AESTHET CREA, V8, P423, DOI 10.1037/a0036549; O'Hara LA, 2000, CREATIVITY RES J, V13, P197; OZER DJ, 1987, J PERS SOC PSYCHOL, V53, P129, DOI 10.1037/0022-3514.53.1.129; Parsons TD, 2004, NEUROPSYCHOLOGIA, V42, P555, DOI 10.1016/j.neuropsychologia.2003.08.014; PETERS M, 1995, BRAIN COGNITION, V28, P39, DOI 10.1006/brcg.1995.1032; Prabhakaran R., 2013, BEHAV RES METHODS; Preckel F, 2006, PERS INDIV DIFFER, V40, P159, DOI 10.1016/j.paid.2005.06.022; Runco M.A., 1986, CREATIVE CHILD ADULT, V11, P212; RUNCO MA, 1995, EDUC PSYCHOL REV, V7, P243, DOI 10.1007/BF02213373; RUNCO MA, 1991, APPL COGNITIVE PSYCH, V5, P435, DOI 10.1002/acp.2350050505; Runco MA, 2012, CREATIVITY RES J, V24, P92, DOI 10.1080/10400419.2012.650092; Salkind NJ., 2007, ENCY MEASUREMENT STA, P640; Schunn C. D., 2006, FINAL REPORT NSF INN; STERNBERG RJ, 1977, PSYCHOL REV, V84, P353, DOI 10.1037/0033-295X.84.4.353; Torrance, 2008, TORRANCE TESTS CREAT; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599; Vendetti M, 2012, COGN AFFECT BEHAV NE, V12, P804, DOI 10.3758/s13415-012-0103-0; Vendetti MS, 2014, PSYCHOL SCI, V25, P928, DOI 10.1177/0956797613518079; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wolfe MBW, 2003, BEHAV RES METH INS C, V35, P22, DOI 10.3758/BF03195494	61	28	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150773	10.1371/journal.pone.0150773	http://dx.doi.org/10.1371/journal.pone.0150773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TF	26959821	Green Submitted, gold, Green Published			2022-12-27	WOS:000371992300073
J	Janjua, NZ; Kuo, M; Chong, M; Yu, A; Alvarez, M; Cook, D; Armour, R; Aiken, C; Li, KR; Rizi, SAM; Woods, R; Godfrey, D; Wong, J; Gilbert, M; Tyndall, MW; Krajden, M				Janjua, Naveed Zafar; Kuo, Margot; Chong, Mei; Yu, Amanda; Alvarez, Maria; Cook, Darrel; Armour, Rosemary; Aiken, Ciaran; Li, Karen; Rizi, Seyed Ali Mussavi; Woods, Ryan; Godfrey, David; Wong, Jason; Gilbert, Mark; Tyndall, Mark W.; Krajden, Mel			Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants	PLOS ONE			English	Article							NATIONAL DEATH INDEX; CLAIMS DATA; LINKAGE; IDENTIFIERS; REGISTRY; LINKING; POPULATION; SCOTLAND; IMPACT; CARE	Background The British Columbia (BC) Hepatitis Testers Cohort (BC-HTC) was established to assess and monitor hepatitis C (HCV) epidemiology, cost of illness and treatment effectiveness in BC, Canada. In this paper, we describe the cohort construction, data linkage process, linkage yields, and comparison of the characteristics of linked and unlinked individuals. Methods The BC-HTC includes all individuals tested for HCV and/or HIV or reported as a case of HCV, hepatitis B (HBV), HIV or active tuberculosis (TB) in BC linked with the provincial health insurance client roster, medical visits, hospitalizations, drug prescriptions, the cancer registry and mortality data using unique personal health numbers. The cohort includes data since inception (1990/1992) of each database until 2012/2013 with plans for annual updates. We computed linkage rates by year and compared the characteristics of linked and unlinked individuals. Results Of 2,656,323 unique individuals available in the laboratory and surveillance data, 1,427,917 (54%) were included in the final linked cohort, including about 1.15 million tested for HCV and about 1.02 million tested for HIV. The linkage rate was 86% for HCV tests, 89% for HCV cases, 95% for active TB cases, 48% for HIV tests and 36% for HIV cases. Linkage rates increased from 40% for HCV negatives and 70% for HCV positives in 1992 to similar to 90% after 2005. Linkage rates were lower for males, younger age at testing, and those with unknown residence location. Linkage rates for HCV testers co-infected with HIV, HBV or TB were very high (90-100%). Conclusion Linkage rates increased over time related to improvements in completeness of identifiers in laboratory, surveillance, and registry databases. Linkage rates were higher for HCV than HIV testers, those testing positive, older individuals, and females. Data from the cohort provide essential information to support the development of prevention, care and treatment initiatives for those infected with HCV.	[Janjua, Naveed Zafar; Kuo, Margot; Chong, Mei; Yu, Amanda; Alvarez, Maria; Cook, Darrel; Aiken, Ciaran; Wong, Jason; Gilbert, Mark; Tyndall, Mark W.; Krajden, Mel] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Janjua, Naveed Zafar; Wong, Jason; Gilbert, Mark; Tyndall, Mark W.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Armour, Rosemary; Li, Karen; Godfrey, David] British Columbia Minist Hlth, Victoria, BC, Canada; [Rizi, Seyed Ali Mussavi] Prov Hlth Serv Author, Performance Measurement & Reporting, Vancouver, BC, Canada; [Woods, Ryan] BC Canc Agcy, Vancouver, BC, Canada; [Gilbert, Mark] Ontario HIV Treatment Network, Toronto, ON, Canada; [Krajden, Mel] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Janjua, NZ (corresponding author), British Columbia Ctr Dis Control, Vancouver, BC, Canada.; Janjua, NZ (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	naveed.janjua@bccdc.ca	Alvarez, Maria/GZH-1345-2022; Zafar, Naveed/A-2712-2008	Zafar, Naveed/0000-0001-5681-719X; Tyndall, Mark/0000-0003-4450-5679; Woods, Ryan/0000-0002-9520-2128	BC Centre for Disease Control	BC Centre for Disease Control	This work was supported by BC Centre for Disease Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 1997, PAEDIATR PERINAT EP, V11, P78, DOI 10.1111/j.1365-3016.1997.tb00799.x; [Anonymous], 2014, ABBVIE COMPL LARG PH; [Anonymous], 2010, HIV LAB TEST RES HLT; [Anonymous], 2013, COMM DIS CONTR MAN; [Anonymous], 2009, COMM DIS CONTR MAN; [Anonymous], 2012, COMM DIS CONTR MAN; BCA. BC Cancer Agency Registry Data BC Cancer Agency, 2013, BC CANC AG REG DAT; BCMoH, 2013, DISCH ABSTR DAT HOSP; BCMoH, 2013, MED SERV PLAN MSP PA; BCMoH, 2013, PHARMANET; Bindman AB, 1998, JAMA-J AM MED ASSOC, V280, P1416, DOI 10.1001/jama.280.16.1416; Bohensky MA, 2011, ANAESTH INTENS CARE, V39, P202, DOI 10.1177/0310057X1103900208; BVSA, 2014, VIT STAT DEATHS; Chamberlayne R, 1998, CAN J PUBLIC HEALTH, V89, P270, DOI 10.1007/BF03403934; Dougan S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-7; El-Saadany S, 2002, CAN J PUBLIC HEALTH, V93, P439, DOI 10.1007/BF03405034; Fortenberry JD, 2002, AM J PUBLIC HEALTH, V92, P378, DOI 10.2105/AJPH.92.3.378; HIRANO D, 1994, AM J PUBLIC HEALTH, V84, P2008, DOI 10.2105/AJPH.84.12.2008; Hottes TS, 2012, ANONYMOUS HIV TESTIN; Kariminia A, 2005, AUST NZ J PUBL HEAL, V29, P572, DOI 10.1111/j.1467-842X.2005.tb00253.x; Kendall P, 2003, BR COLUMBIA MED J, V45, P120; Knox R, 2013, 1000 PILL HEPATITIS; Korzeniewski SJ, 2010, MATERN CHILD HLTH J, V14, P360, DOI 10.1007/s10995-009-0464-3; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Lawson EH, 2013, SURGERY, V153, P423, DOI 10.1016/j.surg.2012.08.065; McDonald SA, 2014, J VIRAL HEPATITIS, V21, P366, DOI 10.1111/jvh.12153; Nakhaee F, 2007, AUST NZ J PUBL HEAL, V31, P308, DOI 10.1111/j.1753-6405.2007.00076.x; Nosyk B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054416; Palmateer NE, 2007, J VIRAL HEPATITIS, V14, P870, DOI 10.1111/j.1365-2893.2007.00876.x; Rizi SAM, 2013, STUD HEALTH TECHNOL, V192, P861, DOI 10.3233/978-1-61499-289-9-861; Rossi I, 1998, AIDS CARE, V10, P89, DOI 10.1080/713612354; Sasse A, 2006, INT J STD AIDS, V17, P817, DOI 10.1258/095646206779307504; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Setoguchi S, 2014, CIRC-CARDIOVASC QUAL, V7, P475, DOI 10.1161/CIRCOUTCOMES.113.000294; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Trubnikov M, 2014, Can Commun Dis Rep, V40, P429	36	55	55	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150176	10.1371/journal.pone.0150176	http://dx.doi.org/10.1371/journal.pone.0150176			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SW	26954020	gold, Green Published, Green Submitted			2022-12-27	WOS:000371991300016
J	Lakshmipriya, T; Gopinath, SCB; Tang, TH				Lakshmipriya, Thangavel; Gopinath, Subash C. B.; Tang, Thean-Hock			Biotin-Streptavidin Competition Mediates Sensitive Detection of Biomolecules in Enzyme Linked Immunosorbent Assay	PLOS ONE			English	Article							SANDWICH ELISA PROCEDURE; HUMAN-FACTOR-IX; CRYSTAL-STRUCTURE; BINDING PROTEIN; RNA APTAMER; GUIDE; IDENTIFICATION; PURIFICATION; SENSORS; SYSTEM	Enzyme Linked Immunosorbent Assay (ELISA) is the gold standard assay for detecting and identifying biomolecules using antibodies as the probe. Improving ELISA is crucial for detecting disease-causing agents and facilitating diagnosis at the early stages of disease. Biotinylated antibody and streptavidin-conjugated horse radish peroxide (streptavidin-HRP) often are used with ELISA to enhance the detection of various kinds of targets. In the present study, we used a competition-based strategy in which we pre-mixed free biotin with streptavidin-HRP to generate high-performance system, as free biotin occupies some of the biotin binding sites on streptavidin, thereby providing more chances for streptavidin-HRP to bind with biotinylated antibody. ESAT-6, which is a protein secreted early during tuberculosis infection, was used as the model target. We found that 8 fM of free biotin mixed with streptavidin-HRP anchored the higher detection level of ESAT-6 by four-fold compared with detection without free biotin (only streptavidin-HRP), and the limit of detection of the new method was 250 pM. These results suggest that biotin-streptavidin competition can be used to improve the diagnosis of analytes in other types of sensors.	[Lakshmipriya, Thangavel; Tang, Thean-Hock] Univ Sains Malaysia, AMDI, Kepala Batas, Penang, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, INEE, Kangar, Perlis, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Sch Bioproc Engn, Arau, Perlis, Malaysia	Universiti Sains Malaysia; Universiti Malaysia Perlis; Universiti Malaysia Perlis	Lakshmipriya, T; Tang, TH (corresponding author), Univ Sains Malaysia, AMDI, Kepala Batas, Penang, Malaysia.	lakshmipriya50@gmail.com; tangth@amdi.usm.edu.my	Gopinath, Subash/D-2953-2015	Gopinath, Subash/0000-0002-8347-4687	Universiti Sains Malaysia	Universiti Sains Malaysia(Universiti Sains Malaysia)	T. Lakshmipriya was supported by a post-doctoral research fellowship from Universiti Sains Malaysia.	Anbu P, 2006, CAN J MICROBIOL, V52, P1060, DOI 10.1139/W06-067; Balakrishnan SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137891; Balakrishnan SR, 2016, BIOSENS BIOELECTRON, V84, P44, DOI 10.1016/j.bios.2015.10.075; Cauchon N, 2007, EUR J NUCL MED MOL I, V34, P247, DOI 10.1007/s00259-006-0199-y; Chen Y, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0786-2; Dixit CK, 2011, NAT PROTOC, V6, P439, DOI 10.1038/nprot.2011.304; Dixit CK, 2010, ANAL CHEM, V82, P7049, DOI 10.1021/ac101339q; Duan XX, 2012, NAT NANOTECHNOL, V7, P401, DOI [10.1038/nnano.2012.82, 10.1038/NNANO.2012.82]; Fujimaki M, 2010, OPT EXPRESS, V18, P15732, DOI 10.1364/OE.18.015732; Geluk A, 2002, INFECT IMMUN, V70, P2544, DOI 10.1128/IAI.70.5.2544-2548.2002; Gopinath SCB, 2007, ARCH VIROL, V152, P2137, DOI 10.1007/s00705-007-1014-1; Gopinath SCB, 2003, WORLD J MICROB BIOT, V19, P681, DOI 10.1023/A:1025119222925; Gopinath SCB, 2008, ANAL CHEM, V80, P6602, DOI 10.1021/ac800767s; Gopinath SCB, 2007, BIOCHEM J, V405, P351, DOI 10.1042/BJ20061737; Gopinath SCB, 2006, J BIOCHEM, V140, P667, DOI 10.1093/jb/mvj203; Gopinath SCB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081396; Gopinath SCB, 2012, J VIROL, V86, P6732, DOI 10.1128/JVI.00377-12; Gopinath SCB, 2012, SENSORS-BASEL, V12, P2136, DOI 10.3390/s120202136; Gopinath SCS, 2009, ANAL CHEM, V81, P4963, DOI 10.1021/ac802757z; Gopinath SCB, 2008, THROMB RES, V122, P838, DOI 10.1016/j.thromres.2007.10.022; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Guimaraes AJ, 2004, J MED MICROBIOL, V53, P509, DOI 10.1099/jmm.0.05469-0; Haarindraprasad R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132755; Kim S, 2010, TALANTA, V81, P1755, DOI 10.1016/j.talanta.2010.03.036; Kumarevel T, 2004, STRUCTURE, V12, P1269, DOI 10.1016/j.str.2004.05.005; Kumarevel T, 2008, J STRUCT BIOL, V161, P9, DOI 10.1016/j.jsb.2007.08.017; Lakshmipriya T, 2014, ANALYST, V139, P3977, DOI 10.1039/c4an00168k; Lakshmipriya T, 2013, LANGMUIR, V29, P15107, DOI 10.1021/la4027283; Lakshmipriya T, 2013, ANALYST, V138, P2863, DOI 10.1039/c3an00298e; Li XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053026; Lim KH, 2011, BIOCHEMISTRY-US, V50, P8682, DOI 10.1021/bi2010366; Liu QL, 2013, MOLECULES, V18, P12675, DOI 10.3390/molecules181012675; Nomura K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3855; Perumal V, 2016, BIOSENS BIOELECTRON, V78, P14, DOI 10.1016/j.bios.2015.10.083; Perumal V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12231; Poongodi GL, 2002, J BIOL CHEM, V277, P28200, DOI 10.1074/jbc.M202731200; Saha K, 2012, CHEM REV, V112, P2739, DOI 10.1021/cr2001178; Sakahara H, 1999, ADV DRUG DELIVER REV, V37, P89, DOI 10.1016/S0169-409X(98)00101-X; Sano T, 1997, P NATL ACAD SCI USA, V94, P6153, DOI 10.1073/pnas.94.12.6153; Toh SY, 2015, BIOSENS BIOELECTRON, V64, P392, DOI 10.1016/j.bios.2014.09.026; Tse J, 2015, ANAL BIOCHEM, V470, P34, DOI 10.1016/j.ab.2014.10.005; Vashist SK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04407; Vashist SK, 2013, BIOSENS BIOELECTRON, V40, P297, DOI 10.1016/j.bios.2012.07.067; Wilchek M, 2006, IMMUNOL LETT, V103, P27, DOI 10.1016/j.imlet.2005.10.022	44	63	63	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151153	10.1371/journal.pone.0151153	http://dx.doi.org/10.1371/journal.pone.0151153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954237	gold, Green Published, Green Submitted			2022-12-27	WOS:000371991300089
J	Tasaniyananda, N; Chaisri, U; Tungtrongchitr, A; Chaicumpa, W; Sookrung, N				Tasaniyananda, Natt; Chaisri, Urai; Tungtrongchitr, Anchalee; Chaicumpa, Wanpen; Sookrung, Nitat			Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine	PLOS ONE			English	Article							GRASS-POLLEN IMMUNOTHERAPY; NECROSIS-FACTOR-ALPHA; D-I; MONOCLONAL-ANTIBODIES; CELL RESPONSES; MESSENGER-RNA; NASAL-MUCOSA; TGF-BETA; IMMUNITY; TOLERANCE	Cats (Felis domesticus) are rich source of airborne allergens that prevailed in the environment and sensitized a number of people to allergy. In this study, a mouse model of allergic rhinitis caused by the cat allergens was developed for the first time and the model was used for testing therapeutic efficacy of a novel intranasal liposome-entrapped vaccines made of native Fel d 1 (major cat allergen) in comparison with the vaccine made of crude cat hair extract (cCE). BALB/c mice were sensitized with cCE mixed with alum intraperitoneally and intranasally. The allergic mice were treated with eight doses of either liposome (L)-entrapped native Fel d 1 (L-nFD1), L-cCE), or placebo on every alternate day. Vaccine efficacy evaluation was performed one day after provoking the treated mice with aerosolic cCE. All allergenized mice developed histological features of allergic rhinitis with rises of serum specific-IgE and Th2 cytokine gene expression. Serum IgE and intranasal mucus production of allergic mice reduced significantly after vaccination in comparison with the placebo mice. The vaccines also caused a shift of the Th2 response (reduction of Th2 cytokine expressions) towards the non-pathogenic responses: Th1 (down-regulation of the Th1 suppressive cytokine gene, IL-35) and Treg (up-regulation of IL-10 and TGF-beta). In conclusions, a mouse model of allergic rhinitis to cat allergens was successfully developed. The intranasal, liposome-adjuvanted vaccines, especially the refined single allergen formulation, assuaged the allergic manifestations in the modeled mice. The prototype vaccine is worthwhile testing further for clinical use in the pet allergic patients.	[Tasaniyananda, Natt] Mahidol Univ, Grad Program Immunol, Dept Immunol, Fac Med,Siriraj Hosp, Bangkok 10700, Thailand; [Tasaniyananda, Natt; Tungtrongchitr, Anchalee; Chaicumpa, Wanpen] Mahidol Univ, Dept Parasitol, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Chaisri, Urai] Mahidol Univ, Dept Trop Pathol, Fac Trop Med, Bangkok 10400, Thailand; [Sookrung, Nitat] Mahidol Univ, Dept Res & Dev, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Sookrung, N (corresponding author), Mahidol Univ, Dept Res & Dev, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand.	nitat.soo@mahidol.ac.th			National Research University (NRU) Project of the Office of Higher Education Commission, Ministry of Education, Thailand; Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand; NSTDA Chair Professor grant; National Science and Technology Development Agency (NSTDA); MRG grant of the Thailand Research Fund	National Research University (NRU) Project of the Office of Higher Education Commission, Ministry of Education, Thailand; Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand; NSTDA Chair Professor grant; National Science and Technology Development Agency (NSTDA); MRG grant of the Thailand Research Fund	This work was co-supported by grants from the National Research University (NRU) Project of the Office of Higher Education Commission, Ministry of Education, Thailand; the Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand; the NSTDA Chair Professor grant, the National Science and Technology Development Agency (NSTDA); and the MRG grant of the Thailand Research Fund to Nitat Sookrung.	Akbarzadeh A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-102; Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; ALVING CR, 1991, J IMMUNOL METHODS, V140, P1, DOI 10.1016/0022-1759(91)90120-5; Astry B, 2015, CYTOKINE, V74, P54, DOI 10.1016/j.cyto.2014.11.020; Badiee A, 2009, EXP PARASITOL, V121, P362, DOI 10.1016/j.exppara.2008.12.015; Ball T, 2009, ALLERGY, V64, P569, DOI 10.1111/j.1398-9995.2008.01910.x; Baraniuk J N, 2001, Curr Allergy Asthma Rep, V1, P207, DOI 10.1007/s11882-001-0007-5; Basomba A, 2002, J ALLERGY CLIN IMMUN, V109, P943, DOI 10.1067/mai.2002.124465; Boeuf P, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-5; Bollinger ME, 1996, J ALLERGY CLIN IMMUN, V97, P907, DOI 10.1016/S0091-6749(96)80064-9; Brewer JM, 1998, J IMMUNOL, V161, P4000; Brimnes J, 2007, CLIN EXP ALLERGY, V37, P488, DOI 10.1111/j.1365-2222.2006.02624.x; BRINER TJ, 1993, P NATL ACAD SCI USA, V90, P7608, DOI 10.1073/pnas.90.16.7608; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Bunnag C, 2009, ASIAN PAC J ALLERGY, V27, P79; CHAPMAN MD, 1988, J IMMUNOL, V140, P812; Cohn L, 1999, J IMMUNOL, V162, P6178; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Czarneski J, 2004, LEUKEMIA, V18, P597, DOI 10.1038/sj.leu.2403244; DEGROOT H, 1988, J ALLERGY CLIN IMMUN, V82, P778, DOI 10.1016/0091-6749(88)90079-6; Desmedt M, 1998, J IMMUNOL, V160, P5300; Durham SR, 1996, J ALLERGY CLIN IMMUN, V97, P1356, DOI 10.1016/S0091-6749(96)70205-1; Ebmeyer J, 2010, OTOL NEUROTOL, V31, P42, DOI 10.1097/MAO.0b013e3181b4e3e3; Focke M, 2010, CLIN EXP ALLERGY, V40, P385, DOI 10.1111/j.1365-2222.2009.03443.x; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; GREGORIADIS G, 1990, IMMUNOL TODAY, V11, P89, DOI 10.1016/0167-5699(90)90034-7; Grundstrom J, 2012, INT ARCH ALLERGY IMM, V157, P136, DOI 10.1159/000327546; Henriksen-Lacey M, 2010, J CONTROL RELEASE, V145, P102, DOI 10.1016/j.jconrel.2010.03.027; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Ishikawa Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-42; Iwasaki M, 2003, J ALLERGY CLIN IMMUN, V112, P134, DOI 10.1067/mai.2003.1554; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Lehmann J, 2001, J IMMUNOL, V167, P5304, DOI 10.4049/jimmunol.167.9.5304; MAGGI E, 1992, J IMMUNOL, V148, P2142; Martinez-Gomez JM, 2009, INT ARCH ALLERGY IMM, V150, P59, DOI 10.1159/000210381; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Meechan P, 2013, INT ARCH ALLERGY IMM, V161, P351, DOI 10.1159/000348314; Mo JH, 2011, ALLERGY, V66, P279, DOI 10.1111/j.1398-9995.2010.02476.x; MONTE PD, 1989, J IMMUNOL, V142, P1437; Neimert-Andersson T, 2008, ALLERGY, V63, P518, DOI 10.1111/j.1398-9995.2008.01644.x; Olivieri M, 2000, J INVEST ALLERG CLIN, V10, P300; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; Phipatanakul W, 2001, Curr Allergy Asthma Rep, V1, P461, DOI 10.1007/s11882-001-0034-2; ROGERS BL, 1993, MOL IMMUNOL, V30, P559, DOI 10.1016/0161-5890(93)90030-F; Ryang YS, 2007, PARASITOL RES, V101, P1103, DOI 10.1007/s00436-007-0591-y; Saarne T, 2011, ALLERGY, V66, P255, DOI 10.1111/j.1398-9995.2010.02468.x; Samsom JN, 2005, J IMMUNOL, V174, P5279, DOI 10.4049/jimmunol.174.9.5279; Schuetze N, 2005, INT IMMUNOL, V17, P649, DOI 10.1093/intimm/dxh247; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Sookrung N, 2008, ASIAN PAC J ALLERGY, V26, P143; Thomas PS, 2001, IMMUNOL CELL BIOL, V79, P132, DOI 10.1046/j.1440-1711.2001.00980.x; Treter S, 2000, CELL IMMUNOL, V206, P116, DOI 10.1006/cimm.2000.1739; Valenta R, 2012, J INTERN MED, V272, P144, DOI 10.1111/j.1365-2796.2012.02556.x; Valenta R, 2002, NAT REV IMMUNOL, V2, P446, DOI 10.1038/nri824; Vangasseri DP, 2006, MOL MEMBR BIOL, V23, P385, DOI 10.1080/09687860600790537; Wang M, 2013, CLIN EXP ALLERGY, V43, P956, DOI 10.1111/cea.12123; Williams Jesse W, 2012, J Allergy (Cairo), V2012, P236075, DOI 10.1155/2012/236075; Wilson DR, 2001, J ALLERGY CLIN IMMUN, V107, P971, DOI 10.1067/mai.2001.115483	59	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150463	10.1371/journal.pone.0150463	http://dx.doi.org/10.1371/journal.pone.0150463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954254	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300029
J	Ge, XC; Shi, XL; Shi, LM; Liu, JL; Stone, V; Kong, FX; Kitten, T; Xu, P				Ge, Xiuchun; Shi, Xiaoli; Shi, Limei; Liu, Jinlin; Stone, Victoria; Kong, Fanxiang; Kitten, Todd; Xu, Ping			Involvement of NADH Oxidase in Biofilm Formation in Streptococcus sanguinis	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; EXTRACELLULAR DNA; BACTERIAL BIOFILMS; AEROBIC GROWTH; MEMBRANE-FLUIDITY; BACILLUS-SUBTILIS; OXIDATIVE STRESS; EPITHELIAL-CELLS; MUTANS; VIRULENCE	Biofilms play important roles in microbial communities and are related to infectious diseases. Here, we report direct evidence that a bacterial nox gene encoding NADH oxidase is involved in biofilm formation. A dramatic reduction in biofilm formation was observed in a Streptococcus sanguinis nox mutant under anaerobic conditions without any decrease in growth. The membrane fluidity of the mutant bacterial cells was found to be decreased and the fatty acid composition altered, with increased palmitic acid and decreased stearic acid and vaccenic acid. Extracellular DNA of the mutant was reduced in abundance and bacterial competence was suppressed. Gene expression analysis in the mutant identified two genes with altered expression, gtfP and Idh, which were found to be related to biofilm formation through examination of their deletion mutants. NADH oxidase-related metabolic pathways were analyzed, further clarifying the function of this enzyme in biofilm formation.	[Ge, Xiuchun; Liu, Jinlin; Stone, Victoria; Kitten, Todd; Xu, Ping] Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Shi, Xiaoli; Shi, Limei; Kong, Fanxiang] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 21008, Jiangsu, Peoples R China; [Kitten, Todd; Xu, Ping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA	Virginia Commonwealth University; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Virginia Commonwealth University	Xu, P (corresponding author), Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Med Coll Virginia Campus, Richmond, VA 23298 USA.; Xu, P (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.	pxu@vcu.edu	Kitten, Todd/O-6531-2014	Kitten, Todd/0000-0001-6097-7583	National Institutes of Health, US [R01DE018138, R01DE023078, R56AI085195]; Chinese Academy of Science [KZZD-EW-TZ-08]; NIH-NINDS Center Core Grant [5 P30 NS047463]; NIH-NCI Cancer Center Support Grant [P30 CA016059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023078, R01DE018138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	National Institutes of Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Science(Chinese Academy of Sciences); NIH-NINDS Center Core Grant; NIH-NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the National Institutes of Health, US, grants R01DE018138, R01DE023078 (PX), and R56AI085195 (TK); and Chinese Academy of Science grant KZZD-EW-TZ-08 (FXK, PX). The confocal microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility supported, in part, by funding from NIH-NINDS Center Core Grant 5 P30 NS047463 and, in part, by funding from NIH-NCI Cancer Center Support Grant P30 CA016059. The funders have no role in study design, data collection and analysis, manuscript preparation and decision for publication.; We thank Lei Chen and Tara Nulton for their assistance and discussions. DNA sequencing was performed at the Nucleic Acids Research Core Facility, Virginia Commonwealth University, which is supported, in part, by funding from the NIH-NCI Cancer Center Support Grant (P30 CA016059). The confocal microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility supported, in part, by funding from NIH-NINDS Center Core Grant 5 P30 NS047463 and, in part, by funding from NIH-NCI Cancer Center Support Grant P30 CA016059. We also thank the Pathogen Functional Genomics Resource Center at JCVI for providing S. sanguinis spotted microarray slides.	Ahn SJ, 2008, INFECT IMMUN, V76, P4259, DOI 10.1128/IAI.00422-08; Argimon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056305; Aricha B, 2004, J BACTERIOL, V186, P4638, DOI 10.1128/JB.186.14.4638-4644.2004; Auzat I, 1999, MOL MICROBIOL, V34, P1018, DOI 10.1046/j.1365-2958.1999.01663.x; Baker JL, 2014, J BACTERIOL, V196, P2166, DOI 10.1128/JB.01542-14; Benamara H, 2011, BBA-BIOMEMBRANES, V1808, P98, DOI 10.1016/j.bbamem.2010.09.004; Berne C, 2010, MOL MICROBIOL, V77, P815, DOI 10.1111/j.1365-2958.2010.07267.x; Bitoun JP, 2016, MOL ORAL MICROBIOL, V31, P115, DOI 10.1111/omi.12114; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Boylan Julie A., 2008, V431, P213; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Coenye T, 2007, ANTIMICROB AGENTS CH, V51, P1541, DOI 10.1128/AAC.00999-06; Crump KE, 2014, MOL MICROBIOL, V92, P1243, DOI 10.1111/mmi.12625; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Derr AM, 2012, APPL ENVIRON MICROB, V78, P1215, DOI 10.1128/AEM.06890-11; Du LD, 2000, INFECT IMMUN, V68, P4834, DOI 10.1128/IAI.68.8.4834-4837.2000; Feldman-Salit A, 2013, J BIOL CHEM, V288, P21295, DOI 10.1074/jbc.M113.458265; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; Ge XC, 2008, INFECT IMMUN, V76, P2551, DOI 10.1128/IAI.00338-08; Ge XC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011666; Gutekunst H, 2004, INFECT IMMUN, V72, P3495, DOI 10.1128/IAI.72.6.3495-3504.2004; Heise T, 2006, P NATL ACAD SCI USA, V103, P3375, DOI 10.1073/pnas.0507749103; Higuchi M, 1999, J BACTERIOL, V181, P5940, DOI 10.1128/JB.181.19.5940-5947.1999; Kingston AW, 2011, MOL MICROBIOL, V81, P69, DOI 10.1111/j.1365-2958.2011.07679.x; Kjelleberg S, 2002, CURR OPIN MICROBIOL, V5, P254, DOI 10.1016/S1369-5274(02)00325-9; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Liao SM, 2014, J BACTERIOL, V196, P2355, DOI 10.1128/JB.01493-14; Liu Y, 2007, J BACTERIOL, V189, P1589, DOI 10.1128/JB.01151-06; Loo CY, 2004, J BACTERIOL, V186, P8193, DOI 10.1128/JB.186.24.8193-8206.2004; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; MUNRO C, 1991, INFECT IMMUN, V59, P2316, DOI 10.1128/IAI.59.7.2316-2323.1991; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Okshevsky M, 2015, CRIT REV MICROBIOL, V41, P341, DOI 10.3109/1040841X.2013.841639; Ooshima T, 2001, J DENT RES, V80, P1672, DOI 10.1177/00220345010800071401; Palmer RJ, 2001, INFECT IMMUN, V69, P5794, DOI 10.1128/IAI.69.9.5794-5804.2001; Park SE, 2012, INFECT IMMUN, V80, P3975, DOI 10.1128/IAI.00699-12; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rosenau A, 2007, INFECT IMMUN, V75, P1310, DOI 10.1128/IAI.00996-06; ROZES N, 1993, LETT APPL MICROBIOL, V17, P126, DOI 10.1111/j.1472-765X.1993.tb01440.x; Sakamoto T, 2002, CURR OPIN MICROBIOL, V5, P206, DOI 10.1016/S1369-5274(02)00306-5; Simionato MR, 2006, INFECT IMMUN, V74, P6419, DOI 10.1128/IAI.00639-06; Spellerberg B, 1999, INFECT IMMUN, V67, P871, DOI 10.1128/IAI.67.2.871-878.1999; Spoering AL, 2006, CURR OPIN MICROBIOL, V9, P133, DOI 10.1016/j.mib.2006.02.004; Suntharalingam P, 2005, TRENDS MICROBIOL, V13, P3, DOI 10.1016/j.tim.2004.11.009; Taniai H, 2008, J BACTERIOL, V190, P3572, DOI 10.1128/JB.01882-07; Turner LS, 2009, MICROBIOL-SGM, V155, P2573, DOI 10.1099/mic.0.024513-0; UEDA S, 1988, MOL MICROBIOL, V2, P135, DOI 10.1111/j.1365-2958.1988.tb00014.x; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Ward DE, 2001, EUR J BIOCHEM, V268, P5816, DOI 10.1046/j.0014-2956.2001.02526.x; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125; Yamamoto Y, 2006, MOL MICROBIOL, V62, P772, DOI 10.1111/j.1365-2958.2006.05406.x; Zafra O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048716	56	13	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0151142	10.1371/journal.pone.0151142	http://dx.doi.org/10.1371/journal.pone.0151142			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950587	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100092
J	Gu, CH; Tembrock, LR; Johnson, NG; Simmons, MP; Wu, ZQ				Gu, Cuihua; Tembrock, Luke R.; Johnson, Nels G.; Simmons, Mark P.; Wu, Zhiqiang			The Complete Plastid Genome of Lagerstroemia fauriei and Loss of rpl2 Intron from Lagerstroemia (Lythraceae)	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; CHLOROPLAST GENOME; GENETIC DIVERSITY; TANDEM REPEATS; SEQUENCES; ANGIOSPERMS; EVOLUTION; L.; TRANSFORMATION; PHYLOGENY	Lagerstroemia (crape myrtle) is an important plant genus used in ornamental horticulture in temperate regions worldwide. As such, numerous hybrids have been developed. However, DNA sequence resources and genome information for Lagerstroemia are limited, hindering evolutionary inferences regarding interspecific relationships. We report the complete plastid genome of Lagerstroemia fauriei. To our knowledge, this is the first reported whole plastid genome within Lythraceae. This genome is 152,440 bp in length with 38% GC content and consists of two single-copy regions separated by a pair of 25,793 bp inverted repeats. The large single copy and the small single copy regions span 83,921 bp and 16,933 bp, respectively. The genome contains 129 genes, including 17 located in each inverted repeat. Phylogenetic analysis of genera sampled from Geraniaceae, Myrtaceae, and Onagraceae corroborated the sister relationship between Lythraceae and Onagraceae. The plastid genomes of L. fauriei and several other Lythraceae species lack the rpl2 intron, which indicating an early loss of this intron within the Lythraceae lineage. The plastid genome of L. fauriei provides a much needed genetic resource for further phylogenetic research in Lagerstroemia and Lythraceae. Highly variable markers were identified for application in phylogenetic, barcoding and conservation genetic applications.	[Gu, Cuihua] Zhejiang Agr & Forestry Univ, Sch Landscape & Architecture, Hangzhou 311300, Peoples R China; [Gu, Cuihua; Tembrock, Luke R.; Simmons, Mark P.; Wu, Zhiqiang] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Johnson, Nels G.] Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA	Zhejiang A&F University; Colorado State University; University of Tennessee System; University of Tennessee Knoxville	Wu, ZQ (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	wu.zhiqiang.1020@gmail.com	Simmons, Mark Pitkin/F-7157-2013; , wuzhiqiang/C-7843-2017; Wu, Zhiqiang/CAG-6688-2022	Simmons, Mark Pitkin/0000-0003-3896-4633; , wuzhiqiang/0000-0002-4238-7317; Wu, Zhiqiang/0000-0002-4238-7317; Johnson, Nels/0000-0002-8500-0194	National Natural Science Fund [31300581]; Open Fund of the most important disciplines of Forestry, Zhejiang Agriculture and Forestry University [KF201322]; Lagerstroemia indica Breeding and Industrialization Development - Science Technology Department of Zhejiang Province [2012C12909-5]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Open Fund of the most important disciplines of Forestry, Zhejiang Agriculture and Forestry University; Lagerstroemia indica Breeding and Industrialization Development - Science Technology Department of Zhejiang Province	This study was supported by The National Natural Science Fund (NO. 31300581), Open Fund of the most important disciplines of Forestry, Zhejiang Agriculture and Forestry University (KF201322), and Lagerstroemia indica Breeding and Industrialization Development (NO. 2012C12909-5) sponsored by Science Technology Department of Zhejiang Province.	Asif H, 2013, TREE GENET GENOMES, V9, P867, DOI 10.1007/s11295-013-0604-1; Bailey CD, 1997, SYST BOT, V22, P133, DOI 10.2307/2419681; Bayly MJ, 2013, MOL PHYLOGENET EVOL, V69, P704, DOI 10.1016/j.ympev.2013.07.006; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cai M, 2011, SCI HORTIC-AMSTERDAM, V131, P88, DOI 10.1016/j.scienta.2011.09.031; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; CERUTTI H, 1995, MOL CELL BIOL, V15, P3003; Conti E, 1997, SYST BOT, V22, P629, DOI 10.2307/2419432; Curci PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120589; DAHLGREN R, 1984, ANN MO BOT GARD, V71, P633, DOI 10.2307/2399158; Day A, 2011, PLANT BIOTECHNOL J, V9, P540, DOI 10.1111/j.1467-7652.2011.00604.x; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; DOWNIE SR, 1991, EVOLUTION, V45, P1245, DOI [10.2307/2409731, 10.1111/j.1558-5646.1991.tb04390.x]; Doyle J. J., 1987, PHYTOCHEM B, P11; DUJON B, 1989, GENE, V82, P91, DOI 10.1016/0378-1119(89)90034-6; Egolf DR, 1978, LAGERSTROEMIA HDB CH; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; FURTADO C X, 1969, Gardens' Bulletin (Singapore), V24, P185; Gemayel R, 2012, GENES-BASEL, V3, P461, DOI 10.3390/genes3030461; George B, 2015, CURR GENET, V61, P665, DOI 10.1007/s00294-015-0495-9; Graham SA, 2005, INT J PLANT SCI, V166, P995, DOI 10.1086/432631; Grassi F, 2002, VITIS, V41, P157; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; Greiner S, 2008, NUCLEIC ACIDS RES, V36, P2366, DOI 10.1093/nar/gkn081; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; He D, 2012, GENET MOL RES, V11, P3522, DOI 10.4238/2012.September.26.9; He D, 2014, PLANT BREEDING, V133, P138, DOI 10.1111/pbr.12100; Hilu KW, 2008, MOL PHYLOGENET EVOL, V48, P1120, DOI 10.1016/j.ympev.2008.05.021; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Huang H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-151; Huang YL, 2002, INT J PLANT SCI, V163, P215, DOI 10.1086/338392; Ichikawa H, 2010, J ETHNOPHARMACOL, V128, P254, DOI 10.1016/j.jep.2009.12.033; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2008, MOL PHYLOGENET EVOL, V48, P1204, DOI 10.1016/j.ympev.2008.06.013; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Li JH, 2008, J SYST EVOL, V46, P341, DOI 10.3724/SP.J.1002.2008.08025; JOHNSON LAS, 1984, ANN MO BOT GARD, V71, P700, DOI 10.2307/2399159; KIM KJ, 1995, P NATL ACAD SCI USA, V92, P10379, DOI 10.1073/pnas.92.22.10379; Koehne E., 1883, PFLANZENGESCHICHTE P, V4, P252; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li Qiang, 2005, Yichuan, V27, P808; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Maliga P, 2004, ANNU REV PLANT BIOL, V55, P289, DOI 10.1146/annurev.arplant.55.031903.141633; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; O'Brien SJ, 1999, NATURE, V402, P365, DOI 10.1038/46450; Pal M, 1994, HOMOLOGOUS RECOMBINA; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Nguyen PAT, 2015, PLANTA, V242, P223, DOI 10.1007/s00425-015-2303-7; Pooler MR, 2003, HORTSCIENCE, V38, P256, DOI 10.21273/HORTSCI.38.2.256; Pounders C, 2007, HORTSCIENCE, V42, P1317, DOI 10.21273/HORTSCI.42.6.1317; Qin HN, 2007, FLORA CHINA, V13, P277; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; RUBINSZTEIN DC, 1995, NAT GENET, V10, P337, DOI 10.1038/ng0795-337; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Simmons MP, 2004, MOL PHYLOGENET EVOL, V31, P874, DOI 10.1016/j.ympev.2003.10.008; Soltis DE, 2013, TAXON, V62, P886, DOI 10.12705/625.13; SVAB Z, 1993, P NATL ACAD SCI USA, V90, P913, DOI 10.1073/pnas.90.3.913; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, P1, DOI DOI 10.1007/BF02198856; Sytsma Kenneth J., 1993, American Journal of Botany, V80, P79; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Unno T, 2004, J ETHNOPHARMACOL, V93, P391, DOI 10.1016/j.jep.2004.04.012; Voronova A, 2014, TREE GENET GENOMES, V10, P937, DOI 10.1007/s11295-014-0733-1; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Wang X, 2011, J AM SOC HORTIC SCI, V136, P116, DOI 10.21273/JASHS.136.2.116; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Wu ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118019; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang JB, 2014, MOL ECOL RESOUR, V14, P1024, DOI 10.1111/1755-0998.12251	82	22	22	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150752	10.1371/journal.pone.0150752	http://dx.doi.org/10.1371/journal.pone.0150752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950701	gold, Green Published, Green Submitted			2022-12-27	WOS:000371990100057
J	Ma, QL; Chen, CH; Deng, P; Zhu, G; Lin, M; Zhang, L; Xu, SC; He, MD; Lu, YH; Duan, WX; Pi, HF; Cao, ZW; Pei, LP; Li, M; Liu, C; Zhang, YW; Zhong, M; Zhou, Z; Yu, ZP				Ma, Qinlong; Chen, Chunhai; Deng, Ping; Zhu, Gang; Lin, Min; Zhang, Lei; Xu, Shangcheng; He, Mindi; Lu, Yonghui; Duan, Weixia; Pi, Huifeng; Cao, Zhengwang; Pei, Liping; Li, Min; Liu, Chuan; Zhang, Yanwen; Zhong, Min; Zhou, Zhou; Yu, Zhengping			Extremely Low-Frequency Electromagnetic Fields Promote In Vitro Neuronal Differentiation and Neurite Outgrowth of Embryonic Neural Stem Cells via Up-Regulating TRPC1	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; GATED CA2+ CHANNELS; MAGNETIC-FIELD; SELF-RENEWAL; SOX2 FUNCTIONS; EXPOSURE; GROWTH; PROLIFERATION; CALCIUM; MODULATION	Exposure to extremely low-frequency electromagnetic fields (ELF-EMFs) can enhance hippocampal neurogenesis in adult mice. However, little is focused on the effects of ELF-EMFs on embryonic neurogenesis. Here, we studied the potential effects of ELF-EMFs on embryonic neural stem cells (eNSCs). We exposed eNSCs to ELF-EMF (50 Hz, 1 mT) for 1, 2, and 3 days with 4 hours per day. We found that eNSC proliferation and maintenance were significantly enhanced after ELF-EMF exposure in proliferation medium. ELF-EMF exposure increased the ratio of differentiated neurons and promoted the neurite outgrowth of eNSC-derived neurons without influencing astrocyes differentiation and the cell apoptosis. In addition, the expression of the proneural genes, NeuroD and Ngn1, which are crucial for neuronal differentiation and neurite outgrowth, was increased after ELF-EMF exposure. Moreover, the expression of transient receptor potential canonical 1 (TRPC1) was significantly up-regulated accompanied by increased the peak amplitude of intracellular calcium level induced by ELF-EMF. Furthermore, silencing TRPC1 expression eliminated the up-regulation of the proneural genes and the promotion of neuronal differentiation and neurite outgrowth induced by ELF-EMF. These results suggest that ELF-EMF exposure promotes the neuronal differentiation and neurite outgrowth of eNSCs via up-regulation the expression of TRPC1 and proneural genes (NeuroD and Ngn1). These findings also provide new insights in understanding the effects of ELF-EMF exposure on embryonic brain development.	[Ma, Qinlong; Chen, Chunhai; Deng, Ping; Zhu, Gang; Lin, Min; Zhang, Lei; Xu, Shangcheng; He, Mindi; Lu, Yonghui; Duan, Weixia; Pi, Huifeng; Cao, Zhengwang; Pei, Liping; Li, Min; Liu, Chuan; Zhang, Yanwen; Zhong, Min; Zhou, Zhou; Yu, Zhengping] Third Mil Med Univ, Fac Prevent Med, Dept Occupat Hlth, Chongqing, Peoples R China; [Chen, Chunhai; Zhang, Lei; Xu, Shangcheng; He, Mindi; Lu, Yonghui; Pei, Liping; Zhang, Yanwen; Zhong, Min; Zhou, Zhou; Yu, Zhengping] Third Mil Med Univ, Key Lab Electromagnet Radiat Protect, Minist Educ China, Chongqing, Peoples R China	Army Medical University; Army Medical University; Ministry of Education, China	Zhou, Z; Yu, ZP (corresponding author), Third Mil Med Univ, Fac Prevent Med, Dept Occupat Hlth, Chongqing, Peoples R China.; Zhou, Z; Yu, ZP (corresponding author), Third Mil Med Univ, Key Lab Electromagnet Radiat Protect, Minist Educ China, Chongqing, Peoples R China.	lunazhou00@163.com; yuzping_tmmu@126.com	zhou, zhou/HCH-1084-2022	Chen, Chunhai/0000-0002-7549-213X	National Basic Research Program of China (National 973 Program) [2011CB503700]; National Natural Science Foundation of China [31170800, 31370832]	National Basic Research Program of China (National 973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (National 973 Program) (Grant No. 2011CB503700; Zhengping Yu; study design) and the National Natural Science Foundation of China (Grant No. 31170800; Lei Zhang; data collection and analysis) and the National Natural Science Foundation of China (No. 31370832; Chunhai Chen; study design; preparation of the manuscript).	Balassa T, 2013, INT J DEV NEUROSCI, V31, P724, DOI 10.1016/j.ijdevneu.2013.08.004; Barbier E, 1996, BIOELECTROMAGNETICS, V17, P303, DOI 10.1002/(SICI)1521-186X(1996)17:4<303::AID-BEM6>3.0.CO;2-7; Barzegar M, 2015, HIPPOCAMPUS, V25, P187, DOI 10.1002/hipo.22363; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Boisseau S, 2009, HISTOCHEM CELL BIOL, V131, P355, DOI 10.1007/s00418-008-0532-6; Britz O, 2006, CEREB CORTEX, V16, pI138, DOI 10.1093/cercor/bhj168; Buzanska L, 2009, STEM CELLS, V27, P2591, DOI 10.1002/stem.179; Canedo L, 2003, INT J DEV NEUROSCI, V21, P263, DOI 10.1016/S0736-5748(03)00054-6; Chen CH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05103; Chen CH, 2012, STEM CELLS DEV, V21, P2667, DOI 10.1089/scd.2012.0023; Chen CH, 2011, NEUROTOX RES, V20, P15, DOI 10.1007/s12640-010-9214-y; Cho MR, 1999, FASEB J, V13, P677, DOI 10.1096/fasebj.13.6.677; Cuccurazzu B, 2010, EXP NEUROL, V226, P173, DOI 10.1016/j.expneurol.2010.08.022; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fanelli C, 1999, FASEB J, V13, P95, DOI 10.1096/fasebj.13.1.95; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grassi C, 2004, CELL CALCIUM, V35, P307, DOI 10.1016/j.ceca.2003.09.001; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; He M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.60; Heo DK, 2012, CELL SIGNAL, V24, P899, DOI 10.1016/j.cellsig.2011.12.011; Imayoshi I, 2014, NEURON, V82, P9, DOI 10.1016/j.neuron.2014.03.018; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Kanemura Y, 2002, J NEUROSCI RES, V69, P869, DOI 10.1002/jnr.10377; KARABAKHTSIAN R, 1994, FEBS LETT, V349, P1, DOI 10.1016/0014-5793(94)00618-0; Lacy-Hulbert A, 1998, FASEB J, V12, P395, DOI 10.1096/fasebj.12.6.395; Leone L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00228; Leone L, 2014, MOL NEUROBIOL, V49, P1472, DOI 10.1007/s12035-014-8650-8; Lepski G, 2011, MOL CELL NEUROSCI, V47, P36, DOI 10.1016/j.mcn.2011.02.011; Li MQ, 2012, CELL CALCIUM, V51, P486, DOI 10.1016/j.ceca.2012.04.014; Lisi A, 2006, BIOELECTROMAGNETICS, V27, P641, DOI 10.1002/bem.20255; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma QL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090041; Macias MY, 2000, BIOELECTROMAGNETICS, V21, P272, DOI 10.1002/(SICI)1521-186X(200005)21:4<272::AID-BEM4>3.0.CO;2-5; Manikonda PK, 2007, NEUROSCI LETT, V413, P145, DOI 10.1016/j.neulet.2006.11.048; Morgado-Valle C, 1998, CELL TISSUE RES, V291, P217, DOI 10.1007/s004410050992; Mori H, 2006, J NEUROSCI RES, V84, P1682, DOI 10.1002/jnr.21082; Nikolova T, 2005, FASEB J, V19, P1686, DOI 10.1096/fj.04-3549fje; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Pla AF, 2005, J NEUROSCI, V25, P2687, DOI 10.1523/JNEUROSCI.0951-04.2005; Radio NM, 2008, NEUROTOXICOLOGY, V29, P361, DOI 10.1016/j.neuro.2008.02.011; Ryan BM, 1996, TERATOLOGY, V54, P73, DOI 10.1002/(SICI)1096-9926(199606)54:2<73::AID-TERA3>3.0.CO;2-5; Sato T, 2010, STEM CELLS, V28, P1660, DOI 10.1002/stem.488; Schuderer J, 2004, BIOELECTROMAGNETICS, V25, P582, DOI 10.1002/bem.20037; Sherafat MA, 2012, J MOL NEUROSCI, V48, P144, DOI 10.1007/s12031-012-9791-8; Shin HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010359; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tai YL, 2008, J CELL SCI, V121, P2301, DOI 10.1242/jcs.026906; Tazumi T, 2005, BEHAV BRAIN RES, V162, P153, DOI 10.1016/j.bbr.2005.03.006; WALLECZEK J, 1990, FEBS LETT, V271, P157, DOI 10.1016/0014-5793(90)80396-Z; Wolf FI, 2005, BBA-MOL CELL RES, V1743, P120, DOI 10.1016/j.bbamcr.2004.09.005; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Xu S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.7; Zhang Y, 2006, J BIOL PHYS, V32, P1, DOI 10.1007/s10867-006-6901-2; Zhou JL, 2002, BIOCHEM BIOPH RES CO, V296, P1013, DOI 10.1016/S0006-291X(02)02022-3	57	32	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150923	10.1371/journal.pone.0150923	http://dx.doi.org/10.1371/journal.pone.0150923			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950212	Green Submitted, Green Published, gold			2022-12-27	WOS:000371990100071
J	Kok, KY; Rajendran, P				Kok, Kai Yit; Rajendran, Parvathy			Differential-Evolution Control Parameter Optimization for Unmanned Aerial Vehicle Path Planning	PLOS ONE			English	Article							LITHIUM-ION BATTERY; COMPOSITE PLATES; UAV; ALGORITHM; ULTRACAPACITOR; IDENTIFICATION; SEARCH; DESIGN; MODELS; FILTER	The differential evolution algorithm has been widely applied on unmanned aerial vehicle (UAV) path planning. At present, four random tuning parameters exist for differential evolution algorithm, namely, population size, differential weight, crossover, and generation number. These tuning parameters are required, together with user setting on path and computational cost weightage. However, the optimum settings of these tuning parameters vary according to application. Instead of trial and error, this paper presents an optimization method of differential evolution algorithm for tuning the parameters of UAV path planning. The parameters that this research focuses on are population size, differential weight, crossover, and generation number. The developed algorithm enables the user to simply define the weightage desired between the path and computational cost to converge with the minimum generation required based on user requirement. In conclusion, the proposed optimization of tuning parameters in differential evolution algorithm for UAV path planning expedites and improves the final output path and computational cost.	[Kok, Kai Yit; Rajendran, Parvathy] Univ Sains Malaysia, Sch Aerosp Engn, Engn Campus,14300 Nibong Tebal, George Town, Malaysia	Universiti Sains Malaysia	Rajendran, P (corresponding author), Univ Sains Malaysia, Sch Aerosp Engn, Engn Campus,14300 Nibong Tebal, George Town, Malaysia.	aeparvathy@usm.my	Rajendran, Parvathy/C-6070-2016; Rajendran, Parvathy/M-5823-2019	Rajendran, Parvathy/0000-0002-7430-1389; Rajendran, Parvathy/0000-0002-7430-1389; kok, kai yit/0000-0002-4536-3281	Universiti Sains Malaysia [304/PAERO/60312047, 304/PHUMANITI/650718]	Universiti Sains Malaysia(Universiti Sains Malaysia)	This study was supported by Universiti Sains Malaysia; short term grant no. 304/PAERO/60312047 and MYLAB-KPM grant no. 304/PHUMANITI/650718. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard M, 2011, J FIELD ROBOT, V28, P914, DOI 10.1002/rob.20401; Besada-Portas E, 2013, INFORM SCIENCES, V238, P111, DOI 10.1016/j.ins.2013.02.022; Brest J, 2006, EV COMP 2006 CEC IEE, DOI [10.1109/CEC.2006.1688311, DOI 10.1109/CEC.2006.1688311]; Bry A, 2011, IEEE INT CONF ROBOT; Cayero J, 2014, AEROSP SCI TECHNOL, V39, P342, DOI 10.1016/j.ast.2014.09.022; Coifman B., 2006, IEE Proceedings Intelligent Transport Systems, V153, P11, DOI 10.1049/ip-its:20055014; Doherty P, 2007, LECT NOTES COMPUT SC, V4830, P1; Ergezer H, 2013, UNM AIRCR SYST ICUAS, DOI [10.1109/ICUAS.2013.6564676, DOI 10.1109/ICUAS.2013.6564676]; Fan QQ, 2015, EXPERT SYST APPL, V42, P1551, DOI 10.1016/j.eswa.2014.09.046; Fu YG, 2013, IEEE T SYST MAN CY-S, V43, P1451, DOI 10.1109/TSMC.2013.2248146; Gamperle R., 2002, ADV INTELL SYST FUZZ, V10, P293; Gao L, 2015, EXPERT SYST APPL, V42, P5976, DOI 10.1016/j.eswa.2015.03.016; Hrabar S., 2008, INT ROB SYST 2008 IR, DOI [10.1109/IROS.2008.4650775, DOI 10.1109/IR0S.2008.4650775]; Hu XS, 2011, J CENT SOUTH UNIV T, V18, P1525, DOI 10.1007/s11771-011-0869-1; Jun M, 2003, COOPERATIVE CONTROL, DOI [10.1007/978-1-4757-3758-5_6, DOI 10.1007/978-1-4757-3758-5_]; Khan A, 2014, KNOWL INF SYST, V43, P583; Kontogiannis SG, 2013, AEROSP SCI TECHNOL, V29, P339, DOI 10.1016/j.ast.2013.04.005; Kownacki C, 2015, AEROSP SCI TECHNOL, V41, P81, DOI 10.1016/j.ast.2014.12.008; Le-Anh L, 2015, COMPOS STRUCT, V127, P382, DOI 10.1016/j.compstruct.2015.02.069; Li ZR, 2010, MACH VISION APPL, V21, P677, DOI 10.1007/s00138-009-0206-y; Lin Y, UNM AIRCR SYST ICUAS, DOI [10.1109/ICUAS.2014.6842268, DOI 10.1109/ICUAS.2014.6842268]; Lin Y, 2015, ROB AUT ICRA 2015 IE, DOI [10.1109/ICRA.2015.7140098, DOI 10.1109/ICRA.2015.7140098]; Lin YC, 2012, IEEE INT CONF ROBOT, P3588, DOI 10.1109/ICRA.2012.6225112; Neri F, 2008, EV COMP 2008 CEC IEE, DOI [10.1109/CEC.2008.4631082, DOI 10.1109/CEC.2008.4631082]; Panagiotou P, 2014, AEROSP SCI TECHNOL, V39, P190, DOI 10.1016/j.ast.2014.09.006; Pettersson PO, 2006, J INTELL FUZZY SYST, V17, P395; Qin AK, 2009, IEEE T EVOLUT COMPUT, V13, P398, DOI 10.1109/TEVC.2008.927706; Qu Y, 2005, IND EL SOC 2005 IECO, DOI [10.1109/IECON.2005.1568876, DOI 10.1109/IEC0N.2005.1568876]; Rathinam S, 2007, P AMER CONTR CONF, P2035; Ro K, 2007, 45 AIAA AER SCI M EX, DOI [10.2514/6.2007-596, DOI 10.2514/6.2007-596]; Roque CMC, 2015, COMPOS STRUCT, V124, P317, DOI 10.1016/j.compstruct.2015.01.019; Scherer S, 2008, INT J ROBOT RES, V27, P549, DOI 10.1177/0278364908090949; Semsch E, 2009, 2009 IEEE/WIC/ACM INTERNATIONAL JOINT CONFERENCES ON WEB INTELLIGENCE (WI) AND INTELLIGENT AGENT TECHNOLOGIES (IAT), VOL 2, P82; Shanmugavel M., AIAA GUID NAV CONTR, DOI [10.2514/6.2006-6211, DOI 10.2514/6.2006-6211]; Storn R., 1995, ICSI TR, V1995, P12; Sun FC, 2011, ENERGY, V36, P3531, DOI 10.1016/j.energy.2011.03.059; Torres SP, 2015, INT J ELEC POWER, V68, P243, DOI 10.1016/j.ijepes.2014.12.016; Wang Y, 2011, IEEE T EVOLUT COMPUT, V15, P55, DOI 10.1109/TEVC.2010.2087271; Yi WC, 2015, APPL INTELL, V42, P642, DOI 10.1007/s10489-014-0620-3; Zhang L, 2015, J POWER SOURCES, V287, P129, DOI 10.1016/j.jpowsour.2015.04.043; Zhang L, 2015, J POWER SOURCES, V274, P899, DOI 10.1016/j.jpowsour.2014.10.170; Zhang L, 2014, ENERGIES, V7, P3204, DOI 10.3390/en7053204; Zielinski K, 2006, EV COMP 2006 CEC 200, P1857, DOI [10.1109/CEC.2006.1688533, DOI 10.1109/CEC.2006.1688533]	43	27	28	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150558	10.1371/journal.pone.0150558	http://dx.doi.org/10.1371/journal.pone.0150558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943630	gold, Green Submitted, Green Published			2022-12-27	WOS:000371739400031
J	Balmert, LC; Buchanich, JM; Pringle, JL; Williams, KE; Burke, DS; Marsh, GM				Balmert, Lauren C.; Buchanich, Jeanine M.; Pringle, Janice L.; Williams, Karl E.; Burke, Donald S.; Marsh, Gary M.			Patterns and Trends in Accidental Poisoning Deaths: Pennsylvania's Experience 1979-2014	PLOS ONE			English	Article							SUBSTANCE-ABUSE; UNITED-STATES; WOMEN	Introduction The purpose of this study was to examine county and state-level accidental poisoning mortality trends in Pennsylvania from 1979 to 2014. Methods Crude and age-adjusted death rates were formed for age group, race, sex, and county for accidental poisonings (ICD 10 codes X40-X49) from 1979 to 2014 for ages 15+ using the Mortality and Population Data System housed at the University of Pittsburgh. Rate ratios were calculated comparing rates from 1979 to 2014, overall and by sex, age group, and race. Joinpoint regression was used to detect statistically significant changes in trends of age-adjusted mortality rates. Results Rate ratios for accidental poisoning mortality in Pennsylvania increased more than 14-fold from 1979 to 2014. The largest rate ratios were among 35-44 year olds, females, and White adults. The highest accidental poisoning mortality rates were found in the counties of Southwestern Pennsylvania, those surrounding Philadelphia, and those in Northeast Pennsylvania near Scranton. Conclusions The patterns and locations of accidental poisoning mortality by race, sex, and age group provide direction for interventions and policy makers. In particular, this study found the highest rate ratios in PA among females, whites, and the age group 35-44.	[Balmert, Lauren C.; Buchanich, Jeanine M.; Marsh, Gary M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, 130 DeSoto St, Pittsburgh, PA 15261 USA; [Pringle, Janice L.] Univ Pittsburgh, Sch Pharm, 5607 Baum Blvd,Room 531, Pittsburgh, PA 15206 USA; [Williams, Karl E.] Off Med Examiner Allegheny Cty, 1520 Penn Ave, Pittsburgh, PA 15222 USA; [Burke, Donald S.] Univ Pittsburgh, Grad Sch Publ Hlth, 130 DeSoto St, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Balmert, LC (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, 130 DeSoto St, Pittsburgh, PA 15261 USA.	lab165@pitt.edu	Williams, Karl/Y-8279-2019	/0000-0002-5704-8094	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER; NIGMS NIH HHS [U54 GM088491] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baggett TP, 2013, JAMA INTERN MED, V173, P189, DOI 10.1001/jamainternmed.2013.1604; Bernstein L, 2015, WASHINGTON POST; Centers for Disease Control and Prevention, CDC WOND DAT US REST; Centers for Disease Control and Prevention,, 2000, GUID STAT IMPL ICD 1; Chen LH, 2015, MMWR-MORBID MORTAL W, V64, P32; Cicero TJ, 2014, JAMA PSYCHIAT, V71, P821, DOI 10.1001/jamapsychiatry.2014.366; Conners NA, 2003, AM J DRUG ALCOHOL AB, V29, P743, DOI 10.1081/ADA-120026258; Firger J, 2015, LACED HEROIN PROMPTS; Greenfield SF, 2010, PSYCHIAT CLIN N AM, V33, P339, DOI 10.1016/j.psc.2010.01.004; Hernandez-Avila CA, 2004, DRUG ALCOHOL DEPEN, V74, P265, DOI 10.1016/j.drugalcdep.2004.02.001; Joinpoint Regression Program, 2015, STAT METH APPL BRANC; Mack KA, 2013, MMWR-MORBID MORTAL W, V62, P537; Marsh G, 2004, MORTALITY POPULATION; Office of Applied Studies Substance Abuse and Mental Health Services Administration, 2012, RES 2012 NAT SURV DR; Office of Applied Studies Substance Abuse and Mental Health Services Administration, 2005, TREATM EP DAT SETS T; Pennsylvania Department of Drug and Alcohol Programs, 2015, NAL REV POL OFF OP O; Pennsylvania Office of the Governor, 2015, GOV WOLF DEP HLTH WE; Slavova S, 2015, PUBLIC HEALTH REP, V130, P339, DOI 10.1177/003335491513000411; StataCorp, 2014, STAT STAT SOFTW REL; US Census Bureau, 2010 CENS URB RUR CL; Warner M, 2014, TRENDS DRUG POISONIN	21	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151655	10.1371/journal.pone.0151655	http://dx.doi.org/10.1371/journal.pone.0151655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963396	Green Published, Green Accepted, gold			2022-12-27	WOS:000371993000166
J	Ide, M; Harris, M; Stevens, A; Sussams, R; Hopkins, V; Culliford, D; Fuller, J; Ibbett, P; Raybould, R; Thomas, R; Puenter, U; Teeling, J; Perry, VH; Holmes, C				Ide, Mark; Harris, Marina; Stevens, Annette; Sussams, Rebecca; Hopkins, Viv; Culliford, David; Fuller, James; Ibbett, Paul; Raybould, Rachel; Thomas, Rhodri; Puenter, Ursula; Teeling, Jessica; Perry, V. Hugh; Holmes, Clive			Periodontitis and Cognitive Decline in Alzheimer's Disease	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; TOOTH LOSS; INFLAMMATION; ASSOCIATION; DEMENTIA; HEALTH	Periodontitis is common in the elderly and may become more common in Alzheimer's disease because of a reduced ability to take care of oral hygiene as the disease progresses. Elevated antibodies to periodontal bacteria are associated with an increased systemic pro-inflammatory state. Elsewhere raised serum pro-inflammatory cytokines have been associated with an increased rate of cognitive decline in Alzheimer's disease. We hypothesized that periodontitis would be associated with increased dementia severity and a more rapid cognitive decline in Alzheimer's disease. We aimed to determine if periodontitis in Alzheimer's disease is associated with both increased dementia severity and cognitive decline, and an increased systemic pro inflammatory state. In a six month observational cohort study 60 community dwelling participants with mild to moderate Alzheimer's Disease were cognitively assessed and a blood sample taken for systemic inflammatory markers. Dental health was assessed by a dental hygienist, blind to cognitive outcomes. All assessments were repeated at six months. The presence of periodontitis at baseline was not related to baseline cognitive state but was associated with a six fold increase in the rate of cognitive decline as assessed by the ADAS-cog over a six month follow up period. Periodontitis at baseline was associated with a relative increase in the pro-inflammatory state over the six month follow up period. Our data showed that periodontitis is associated with an increase in cognitive decline in Alzheimer's Disease, independent to baseline cognitive state, which may be mediated through effects on systemic inflammation.	[Ide, Mark] Guys Hosp, Kings Coll London, Inst Dent, London SE1 9RT, England; [Harris, Marina; Sussams, Rebecca; Holmes, Clive] Univ Southampton, Fac Med, Clin Expt Sci, Southampton SO9 5NH, Hants, England; [Stevens, Annette; Sussams, Rebecca; Hopkins, Viv; Holmes, Clive] Moorgreen Hosp, Memory Assessment & Res Ctr, Southampton, Hants, England; [Culliford, David] Univ Southampton, Fac Hlth Sci, NIHR CLAHRC Wessex Methodol Hub, Southampton, Hants, England; [Fuller, James; Ibbett, Paul; Puenter, Ursula; Teeling, Jessica; Perry, V. Hugh] Univ Southampton, Ctr Biol Sci, Fac Nat & Environm Sci, Southampton, Hants, England; [Raybould, Rachel; Thomas, Rhodri] Cardiff Univ, MRC, Ctr Neuropsychiat Genet & Genom, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Southampton; University of Southampton; University of Southampton; University of Southampton; Cardiff University	Holmes, C (corresponding author), Univ Southampton, Fac Med, Clin Expt Sci, Southampton SO9 5NH, Hants, England.; Holmes, C (corresponding author), Moorgreen Hosp, Memory Assessment & Res Ctr, Southampton, Hants, England.	ch4@soton.ac.uk	Croucher, Rebecca/R-6006-2019; Perry, V. Hugh/Y-2935-2019	Teeling, Jessica/0000-0003-4004-7391; Ide, Mark/0000-0002-6511-7803; Holmes, Clive/0000-0003-1999-6912; HARRIS, MARINA/0000-0002-9084-1633	Dunhill Medical Trust [R190/0211]; Medical Research Council [1361541] Funding Source: researchfish; The Dunhill Medical Trust [R190/0211] Funding Source: researchfish; Fight for Sight [1421/22] Funding Source: researchfish	Dunhill Medical Trust(Dunhill Medical Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Dunhill Medical Trust(Dunhill Medical Trust); Fight for Sight	This study was funded by Dunhill Medical Trust [grant number R190/0211]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar JM, 2002, PERIODONTOL 2000, V29, P7, DOI 10.1034/j.1600-0757.2002.290101.x; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Farhad Shirin Zahra, 2014, Dent Res J (Isfahan), V11, P549; Geerts SO, 2002, J PERIODONTOL, V73, P73, DOI 10.1902/jop.2002.73.1.73; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Hatipoglu MG, 2011, GERODONTOLOGY, V28, P302, DOI 10.1111/j.1741-2358.2010.00401.x; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Ide M, 2004, J PERIODONTOL, V75, P420, DOI 10.1902/jop.2004.75.3.420; Kamer AR, 2015, NEUROBIOL AGING, V36, P627, DOI 10.1016/j.neurobiolaging.2014.10.038; Kamer AR, 2012, J ALZHEIMERS DIS, V28, P613, DOI 10.3233/JAD-2011-102004; Kamer AR, 2009, J NEUROIMMUNOL, V216, P92, DOI 10.1016/j.jneuroim.2009.08.013; Kubota T, 2014, ARCH ORAL BIOL, V59, P586, DOI 10.1016/j.archoralbio.2014.03.004; Leon AC, 2008, SCHIZOPHRENIA BULL, V34, P664, DOI 10.1093/schbul/sbn035; Martande SS, 2014, AM J ALZHEIMERS DIS, V29, P498, DOI 10.1177/1533317514549650; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Molloy D W, 1997, Int Psychogeriatr, V9 Suppl 1, P87, DOI 10.1017/S1041610297004754; Noble JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114959; Nunn J, 2000, BRIT DENT J, V189, P639, DOI 10.1038/sj.bdj.4800853a; Okamoto N, 2015, J ALZHEIMERS DIS, V44, P777, DOI 10.3233/JAD-141665; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Passoja A, 2010, J CLIN PERIODONTOL, V37, P881, DOI 10.1111/j.1600-051X.2010.01602.x; Rolim TD, 2014, ARQ NEURO-PSIQUIAT, V72, P919, DOI 10.1590/0004-282X20140140; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Stein PS, 2007, J AM DENT ASSOC, V138, P1314, DOI 10.14219/jada.archive.2007.0046; Stein PS, 2012, ALZHEIMERS DEMENT, V8, P196, DOI 10.1016/j.jalz.2011.04.006; Syrjala AMH, 2012, GERODONTOLOGY, V29, P36, DOI 10.1111/j.1741-2358.2010.00396.x	27	188	199	5	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151081	10.1371/journal.pone.0151081	http://dx.doi.org/10.1371/journal.pone.0151081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963387	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000371993000100
J	Moreno, JD; Lewis, TJ; Clancy, CE				Moreno, Jonathan D.; Lewis, Timothy J.; Clancy, Colleen E.			Parameterization for In-Silico Modeling of Ion Channel Interactions with Drugs	PLOS ONE			English	Article							CARDIAC SODIUM-CHANNEL; SINGLE-CHANNEL; NA+ CHANNELS; SIMPLEX-METHOD; INACTIVATION; FLECAINIDE; MUTATION; IDENTIFIABILITY; OPTIMIZATION; SIMULATION	Since the first Hodgkin and Huxley ion channel model was described in the 1950s, there has been an explosion in mathematical models to describe ion channel function. As experimental data has become richer, models have concomitantly been improved to better represent ion channel kinetic processes, although these improvements have generally resulted in more model complexity and an increase in the number of parameters necessary to populate the models. Models have also been developed to explicitly model drug interactions with ion channels. Recent models of drug-channel interactions account for the discrete kinetics of drug interaction with distinct ion channel state conformations, as it has become clear that such interactions underlie complex emergent kinetics such as use-dependent block. Here, we describe an approach for developing a model for ion channel drug interactions. The method describes the process of extracting rate constants from experimental electrophysiological function data to use as initial conditions for the model parameters. We then describe implementation of a parameter optimization method to refine the model rate constants describing ion channel drug kinetics. The algorithm takes advantage of readily available parallel computing tools to speed up the optimization. Finally, we describe some potential applications of the platform including the potential for gaining fundamental mechanistic insights into ion channel function and applications to in silico drug screening and development.	[Moreno, Jonathan D.] Washington Univ, Barnes Jewish Hosp, Dept Med, Div Cardiol, St Louis, MO USA; [Lewis, Timothy J.] Univ Calif Davis, Dept Math, Davis, CA 95616 USA; [Clancy, Colleen E.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	Barnes-Jewish Hospital; Washington University (WUSTL); University of California System; University of California Davis; University of California System; University of California Davis	Moreno, JD (corresponding author), Washington Univ, Barnes Jewish Hosp, Dept Med, Div Cardiol, St Louis, MO USA.	mail@jonathanmoreno.com			American Heart Association (GIAs) [10GRNT3880050, 13GRNT14370019]; Alfred P. Sloan Foundation; NIH NHLBI [1R01HL105242-01, R01 GM101928-01]; Mallinckrodt - Oliver Langenberg Physician Scientist Training Program at Washington University in St. Louis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL126273, R01HL128537, R01HL128170, R01HL105242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101928] Funding Source: NIH RePORTER	American Heart Association (GIAs); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Mallinckrodt - Oliver Langenberg Physician Scientist Training Program at Washington University in St. Louis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the American Heart Association (GIAs (10GRNT3880050, 13GRNT14370019), Western States Affiliate), the Alfred P. Sloan Foundation and the NIH NHLBI 1R01HL105242-01 and R01 GM101928-01 (to CEC), and the Mallinckrodt - Oliver Langenberg Physician Scientist Training Program at Washington University in St. Louis (JDM).	Abriel H, 2000, CIRCULATION, V102, P921; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; Balser JR, 1999, CARDIOVASC RES, V42, P327, DOI 10.1016/S0008-6363(99)00031-0; Balser JR, 2001, J MOL CELL CARDIOL, V33, P599, DOI 10.1006/jmcc.2000.1346; Baranauskas G, 2006, J NEUROSCI, V26, P671, DOI 10.1523/JNEUROSCI.2283-05.2006; BENNDORF K, 1989, BIOMED BIOCHIM ACTA, V48, P287; Bot CT, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00421; Clancy CE, 2003, CIRCULATION, V107, P2233, DOI 10.1161/01.CIR.0000069273.51375.BD; Clancy CE, 2002, CIRCULATION, V105, P1208, DOI 10.1161/hc1002.105183; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Colquhoun D, 2004, BIOPHYS J, V86, P3510, DOI 10.1529/biophysj.103.038679; COLQUHOUN D, 1981, PROC R SOC SER B-BIO, V211, P205, DOI 10.1098/rspb.1981.0003; Dokos S, 2004, PROG BIOPHYS MOL BIO, V85, P407, DOI 10.1016/j.pbiomolbio.2004.02.002; Fink M, 2009, PHILOS T R SOC A, V367, P2161, DOI 10.1098/rsta.2008.0301; Goldman L, 1995, BIOPHYS J, V69, P2369, DOI 10.1016/S0006-3495(95)80106-2; Groenendaal W, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004242; Guo TR, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/706195; Gurkiewicz M, 2007, PLOS COMPUT BIOL, V3, P1633, DOI 10.1371/journal.pcbi.0030169; Harmer A. R., 2008, Journal of Pharmacological and Toxicological Methods, V57, P30, DOI 10.1016/j.vascn.2007.09.002; HORN R, 1983, BIOPHYS J, V43, P207, DOI 10.1016/S0006-3495(83)84341-0; HORN R, 1984, J GEN PHYSIOL, V84, P505, DOI 10.1085/jgp.84.4.505; Hui BBCB, 2007, P ANN INT IEEE EMBS, P5307, DOI 10.1109/IEMBS.2007.4353539; Irvine LA, 1999, BIOPHYS J, V76, P1868, DOI 10.1016/S0006-3495(99)77346-7; Irvine LA, 1998, MODELS CARDIAC SODIU; KUO CC, 1994, NEURON, V12, P819, DOI 10.1016/0896-6273(94)90335-2; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lawrence JH, 1996, BIOPHYS J, V71, P1285, DOI 10.1016/S0006-3495(96)79329-3; LAWRENCE JH, 1991, J PHYSIOL-LONDON, V443, P629, DOI 10.1113/jphysiol.1991.sp018855; Liu HJ, 2003, J GEN PHYSIOL, V121, P199, DOI 10.1085/jgp.20028723; Liu HJ, 2002, J GEN PHYSIOL, V120, P39, DOI 10.1085/jgp.20028558; Liu SG, 1997, AM J PHYSIOL-HEART C, V272, pH2013, DOI 10.1152/ajpheart.1997.272.4.H2013; Lu HR, 2010, BRIT J PHARMACOL, V160, P60, DOI 10.1111/j.1476-5381.2010.00646.x; MAGLEBY KL, 1992, METHOD ENZYMOL, V207, P763; Menon V, 2009, P NATL ACAD SCI USA, V106, P16829, DOI 10.1073/pnas.0903766106; Mickus T, 1999, BIOPHYS J, V76, P846, DOI 10.1016/S0006-3495(99)77248-6; Milescu LS, 2005, BIOPHYS J, V88, P2494, DOI 10.1529/biophysj.104.053256; MITSUIYE T, 1993, J PHYSIOL-LONDON, V465, P245, DOI 10.1113/jphysiol.1993.sp019675; Moreno JD, 2013, CIRC RES, V113, pE50, DOI 10.1161/CIRCRESAHA.113.301971; Moreno JD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002588; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Ramos E, 2004, J PHYSIOL-LONDON, V560, P37, DOI 10.1113/jphysiol.2004.065003; Rudy Y, 2006, Q REV BIOPHYS, V39, P57, DOI 10.1017/S0033583506004227; Sarkar AX, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000914; SHELDON RS, 1989, CLIN CHEM, V35, P748; VANDENBERG CA, 1991, BIOPHYS J, V60, P1511, DOI 10.1016/S0006-3495(91)82186-5; Vecchietti S, 2006, MED BIOL ENG COMPUT, V44, P35, DOI 10.1007/s11517-005-0017-x; Yang PC, 2015, J PHYSIOL-LONDON, V593, P1429, DOI 10.1113/jphysiol.2014.279554; YUE DT, 1989, SCIENCE, V244, P349, DOI 10.1126/science.2540529; Zhu YJ, 2006, AM J PHYSIOL-HEART C, V291, pH29, DOI 10.1152/ajpheart.01317.2005	49	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150761	10.1371/journal.pone.0150761	http://dx.doi.org/10.1371/journal.pone.0150761			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963710	Green Published, gold			2022-12-27	WOS:000371993000059
J	Arnott, C; Punnia-Moorthy, G; Tan, J; Sadeghipour, S; Bursill, C; Patel, S				Arnott, Clare; Punnia-Moorthy, Gaya; Tan, Joanne; Sadeghipour, Sara; Bursill, Christina; Patel, Sanjay			The Vascular Endothelial Growth Factor Inhibitors Ranibizumab and Aflibercept Markedly Increase Expression of Atherosclerosis-Associated Inflammatory Mediators on Vascular Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; ARTERIAL THROMBOEMBOLIC EVENTS; RANDOMIZED CONTROLLED-TRIALS; MACULAR DEGENERATION; VEGF-TRAP; CARDIOVASCULAR SAFETY; BEVACIZUMAB; MECHANISMS; CHEMOKINES; THERAPY	Introduction Recent studies have suggested that the VEGF inhibitors, Ranibizumab and Aflibercept may be associated with an excess of cardiovascular events, potentially driven by increasing atheroma instability, leading to plaque rupture and clinical events. Inflammation plays a key role in the progression of atherosclerotic plaque and particularly conversion to an unstable phenotype. Here, we sought to assess the in vitro effects of these drugs on the expression of key inflammatory mediators on endothelial cells. Methods Human coronary artery endothelial cells were co-incubated for 16h with Ranibizumab (0.11nM) or Aflibercept (0.45nM), as determined by each drug's peak serum concentration (Cmax). Expression at protein (ELISA) and gene (RT-PCR) level of inflammatory chemokines CCL2, CCL5 and CXC3L1 as well as gene expression for the cell adhesion molecules VCAM-1, ICAM-1 and the key NF-kappa b protein p65 was assessed. VEGF-A protein levels were also determined. Results Both drugs significantly increased chemokine, cell adhesion molecule (CAM) and p65 expression, while decreasing VEGF-A protein secretion. At equivalent Cmax concentrations, Aflibercept was significantly more pro-inflammatory than Ranibizumab. Reduction of secreted VEGF-A levels significantly attenuated inflammatory effects of both drugs, whereas blockade of the VEGF-A receptor or silencing of VEGF-A gene synthesis alone had no effect, suggesting that binding of drug to secreted VEGF-A is crucial in promoting inflammation. Finally, blockade of Toll-like receptor 4 significantly reduced inflammatory effects of both drugs. Conclusion We demonstrated here, for the first time, that both drugs have potent pro-inflammatory effects, mediated via activation of Toll-like receptor 4 on the endothelial cell surface by drug bound to VEGF-A. Further studies are required to investigate whether these effects are also seen in vivo.	[Arnott, Clare; Patel, Sanjay] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia; [Arnott, Clare; Tan, Joanne; Sadeghipour, Sara; Bursill, Christina; Patel, Sanjay] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Punnia-Moorthy, Gaya; Tan, Joanne; Sadeghipour, Sara; Bursill, Christina; Patel, Sanjay] Heart Res Inst, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; Heart Research Institute	Patel, S (corresponding author), Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia.; Patel, S (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.; Patel, S (corresponding author), Heart Res Inst, Sydney, NSW, Australia.	Sanjay.Patel@sswahs.nsw.gov.au	Tan, Joanne Tsui Ming/Y-4423-2019; Tan, Ming-Jen/A-3862-2011	Tan, Joanne Tsui Ming/0000-0003-1875-4882; Punnia-Moorthy, Gaya/0000-0002-2251-370X; Tan, Ming-Jen/0000-0002-3583-1723; Bursill, Christina/0000-0002-0682-8760; Arnott, Clare/0000-0001-9370-9913	Educational Grant from Novartis Australia	Educational Grant from Novartis Australia	This study was supported by an Educational Grant from Novartis Australia (SP). URL:www.novartis.com.au. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 2005, RETINA-J RET VIT DIS, V25, P111, DOI 10.1097/00006982-200502000-00001; Avery RL, 2014, BRIT J OPHTHALMOL, V98, P1636, DOI 10.1136/bjophthalmol-2014-305252; Avery RL, 2014, BRIT J OPHTHALMOL, V98, P7, DOI 10.1136/bjophthalmol-2013-303844; Bhavsar PK, 2008, FASEB J, V22, P1807, DOI 10.1096/fj.07-094235; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Bressler NM, 2012, RETINA-J RET VIT DIS, V32, P1821, DOI 10.1097/IAE.0b013e31825db6ba; Bursi CA, 2004, CURR OPIN LIPIDOL, V15, P145, DOI [10.1097/00041433-200404000-00007, 10.1097/01.mol.0000124526.75650.13]; Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Campbell RJ, 2012, OPHTHALMOLOGY, V119, P1604, DOI 10.1016/j.ophtha.2012.05.028; Campochiaro PA, 2007, DRUG TODAY, V43, P529, DOI 10.1358/dot.2007.43.8.1120868; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; den Dekker WK, 2010, ATHEROSCLEROSIS, V209, P314, DOI 10.1016/j.atherosclerosis.2009.09.075; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Girardi F, 2010, ONCOLOGIST, V15, P683, DOI 10.1634/theoncologist.2009-0235; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Lim LS, 2011, AM J OPHTHALMOL, V152, P329, DOI 10.1016/j.ajo.2011.05.040; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Monaco C, 2004, CARDIOVASC RES, V61, P671, DOI 10.1016/j.cardiores.2003.11.038; Mones J, 2011, OPHTHALMOLOGICA, V225, P112, DOI 10.1159/000319906; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Patel S, 2008, INT J BIOCHEM CELL B, V40, P576, DOI 10.1016/j.biocel.2007.11.017; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Ranpura V, 2010, ACTA ONCOL, V49, P287, DOI 10.3109/02841860903524396; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rothen Michelle, 2005, Ophthalmol Clin North Am, V18, P561; Rudge JS, 2007, P NATL ACAD SCI USA, V104, P18363, DOI 10.1073/pnas.0708865104; Scappaticci FA, 2007, JNCI-J NATL CANCER I, V99, P1232, DOI 10.1093/jnci/djm086; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Stewart Michael W., 2011, Inflammation & Allergy Drug Targets, V10, P497; Verheul HMW, 2007, NAT REV CANCER, V7, P475, DOI 10.1038/nrc2152; Werts C, 2007, EUR J IMMUNOL, V37, P2499, DOI 10.1002/eji.200737069; Winnik S, 2013, INT J CARDIOL, V168, P2453, DOI 10.1016/j.ijcard.2013.03.010	36	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150688	10.1371/journal.pone.0150688	http://dx.doi.org/10.1371/journal.pone.0150688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959822	Green Published, gold			2022-12-27	WOS:000371992300064
J	Brehm, G; Hebert, PDN; Colwell, RK; Adams, MO; Bodner, F; Friedemann, K; Mockel, L; Fiedler, K				Brehm, Gunnar; Hebert, Paul D. N.; Colwell, Robert K.; Adams, Marc-Oliver; Bodner, Florian; Friedemann, Katrin; Moeckel, Lars; Fiedler, Konrad			Turning Up the Heat on a Hotspot: DNA Barcodes Reveal 80% More Species of Geometrid Moths along an Andean Elevational Gradient	PLOS ONE			English	Article							BETA-DIVERSITY; LEPIDOPTERA; TAXONOMY; MORPHOLOGY; RICHNESS; ALPHA	We sampled 14,603 geometrid moths along a forested elevational gradient from 1020-3021 m in the southern Ecuadorian Andes, and then employed DNA barcoding to refine decisions on species boundaries initially made by morphology. We compared the results with those from an earlier study on the same but slightly shorter gradient that relied solely on morphological criteria to discriminate species. The present analysis revealed 1857 putative species, an 80% increase in species richness from the earlier study that detected only 1010 species. Measures of species richness and diversity that are less dependent on sample size were more than twice as high as in the earlier study, even when analysis was restricted to an identical elevational range. The estimated total number of geometrid species (new dataset) in the sampled area is 2350. Species richness at single sites was 32-43% higher, and the beta diversity component rose by 43-51%. These impacts of DNA barcoding on measures of richness reflect its capacity to reveal cryptic species that were overlooked in the first study. The overall results confirmed unique diversity patterns reported in the first investigation. Species diversity was uniformly high along the gradient, declining only slightly above 2800 m. Species turnover also showed little variation along the gradient, reinforcing the lack of evidence for discrete faunal zones. By confirming these major biodiversity patterns, the present study establishes that incomplete species delineation does not necessarily conceal trends of biodiversity along ecological gradients, but it impedes determination of the true magnitude of diversity and species turnover.	[Brehm, Gunnar; Moeckel, Lars] Univ Jena, Inst Spezielle Zool & Evolut Biol Phyletischem Mu, Jena, Germany; [Hebert, Paul D. N.] Univ Guelph, Ctr Biodivers Genom, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Colwell, Robert K.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Colwell, Robert K.] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil; [Colwell, Robert K.] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA; [Adams, Marc-Oliver; Bodner, Florian; Fiedler, Konrad] Univ Vienna, Dept Bot & Biodivers Res, Vienna, Austria; [Friedemann, Katrin] Hess Landesmuseum Darmstadt, Abt Nat Geschichte Zool, Darmstadt, Germany	Friedrich Schiller University of Jena; University of Guelph; University of Connecticut; Universidade Federal de Goias; University of Colorado System; University of Colorado Boulder; University of Vienna	Brehm, G (corresponding author), Univ Jena, Inst Spezielle Zool & Evolut Biol Phyletischem Mu, Jena, Germany.	gunnar.brehm@uni-jena.de	Fiedler, Konrad/H-8788-2019	Fiedler, Konrad/0000-0002-4789-3753	Basler Stiftung fur biologische Forschung; Genome Canada through the Ontario Genomics Institute; Deutsche Forschungsgemeinschaft [FOR 816, FOR 402, Fi 547/10-1, Fi 547/10-2]; Synthesys [GB TAF1048]; CAPES Ciencia sem Fronteiras; Basler Stiftung fur biologische Forschung, Basel, Switzerland; Ontario Ministry of Research and Innovation; Faculty of Life Sciences (Univ. of Vienna); SYNTHESYS programme [GB-TAF1048]; CAPES Ciencia sem Fronteiras (Brazil)	Basler Stiftung fur biologische Forschung; Genome Canada through the Ontario Genomics Institute(Genome Canada); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Synthesys; CAPES Ciencia sem Fronteiras(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Basler Stiftung fur biologische Forschung, Basel, Switzerland; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Faculty of Life Sciences (Univ. of Vienna); SYNTHESYS programme; CAPES Ciencia sem Fronteiras (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by Basler Stiftung fur biologische Forschung: (http://www.moneyhouse.ch/u/basler_stiftung_fur_biologische_forschung_CH-270.7.000.069-8.htm); Genome Canada through the Ontario Genomics Institute: (http://www.ontariogenomics.ca/about-us/partners/genome-canada); Deutsche Forschungsgemeinschaft, FOR 816, FOR 402, Fi 547/10-1 and 10-2: (http://www.dfg.de/en); Synthesys, GB TAF1048: (http://www.synthesys.info); CAPES Ciencia sem Fronteiras: (http://www.cienciasemfronteiras.gov.br/web/csf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Scott Miller (Washington, D.C.) and an anonymous reviewer for helpful comments on our manuscript. Sequence analysis was enabled by funding from Genome Canada through the Ontario Genomics Institute in support of the International Barcode of Life Project and by the Basler Stiftung fur biologische Forschung, Basel, Switzerland. Additional sequence data for the genus Eois were generated by P. Strutzenberger (Dresden) and B. Gottsberger (Vienna). Data analysis was aided by the Barcode of Life Data System, which is supported by the Ontario Ministry of Research and Innovation. We thank the Ministerio del Medio Ambiente of Ecuador for issuing research permits, the Universidad Tecnica Particular de Loja for logistic support, and the foundation Nature and Culture International (Loja, Del Mar) for providing access to the Reserva Biologica San Francisco. Lisamarie Lehner (Vienna) and Yoko Matsumura (Kiel) kindly assisted with field work and with moth sampling and processing. Roman Link (Gottingen) and Shaun Levick (Jena) kindly helped produce the map of the study area. Support from DFG grants (FOR 816, FOR 402, Fi 547/10-1 and 10-2), through funds from the Faculty of Life Sciences (Univ. of Vienna), and the SYNTHESYS programme (GB-TAF1048) is acknowledged. RKC acknowledges support from CAPES Ciencia sem Fronteiras (Brazil).	Beck E., 2008, V198, P1; Beck J, 2010, METHODS ECOL EVOL, V1, P38, DOI 10.1111/j.2041-210X.2009.00003.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Binz H, 2014, ECOTROPICA, V20, P1; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Brehm G, 2005, J BIOGEOGR, V32, P1621, DOI 10.1111/j.1365-2699.2005.01304.x; Brehm G, 2004, J TROP ECOL, V20, P165, DOI 10.1017/S0266467403001184; Brehm G, 2003, ECOGRAPHY, V26, P456, DOI 10.1034/j.1600-0587.2003.03498.x; Brehm G, 2003, DIVERS DISTRIB, V9, P351, DOI 10.1046/j.1472-4642.2003.00023.x; Brehm G., 2002, THESIS; Brehm G, 2007, GLOBAL ECOL BIOGEOGR, V16, P205, DOI 10.1111/j.1466-8238.2006.00281.x; Brehm G, 2006, ENVIRON ENTOMOL, V35, P757, DOI 10.1603/0046-225X-35.3.757; Brehm G, 2015, ZOOKEYS, P131, DOI 10.3897/zookeys.537.6090; Brehm G, 2013, ECOGRAPHY, V36, P1247, DOI 10.1111/j.1600-0587.2013.00030.x; Brehm G, 2011, ANN ENTOMOL SOC AM, V104, P1091, DOI 10.1603/AN10050; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2010, PROGRAM USERS GUIDE; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; Colwell RK, 2013, ESTIMATES 9 1 STAT E; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; deWaard JR, 2007, METHODS MOL BIOL ENV, P275; Dinca V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12395; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Tapia-Armijos MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133701; Fernandez-Flores S, 2013, MOL ECOL RESOUR, V13, P1146, DOI 10.1111/1755-0998.12102; Gorley C.K., 2006, GETTING STARTED PRIM; Guo QF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03007; Hausmann A., 2001, GEOMETRID MOTHS EURO, V1, P1, DOI DOI 10.1007/978-1-4757-3423-2_; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hernandez-Triana LM, 2015, ZOOTAXA, V3936, P93, DOI 10.11646/zootaxa.3936.1.5; Herzog SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064963; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Holloway J. D., 2011, Malayan Nature Journal, V63, P1; Homeier J, 2010, BIOTROPICA, V42, P140, DOI 10.1111/j.1744-7429.2009.00547.x; Hortal J, 2015, ANN REV ECOL EVOL SY, V46; Hsieh T. C., 2013, INEXT ONLINE INTERPO; Huemer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115774; Janzen DH, 2012, INVERTEBR SYST, V26, P478, DOI 10.1071/IS12038; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kekkonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122481; Legendre P., 2012, NUMERICAL ECOLOGY, V3rd ed.; Longino JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104030; Pentinsaari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108651; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Rougerie R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101108; Schmidt BC, 2008, SYST ENTOMOL, V33, P613, DOI 10.1111/J.1365-3113.2008.00433.x; Seifert CL, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev098; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Speidel W, 2015, ZOOTAXA, V3999, P401, DOI 10.11646/zootaxa.3999.3.5; Strutzenberger P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049710; Strutzenberger P, 2011, INSECT SCI, V18, P349, DOI 10.1111/j.1744-7917.2010.01366.x; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; Thormann B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148268; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Voda R, 2015, ECOGRAPHY, V38, P405, DOI 10.1111/ecog.00762; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wilson JJ, 2010, ZOOKEYS, P41, DOI 10.3897/zookeys.46.406; Young MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048755	63	44	44	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150327	10.1371/journal.pone.0150327	http://dx.doi.org/10.1371/journal.pone.0150327			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959368	Green Published, gold			2022-12-27	WOS:000371992300043
J	Kayser, DN; Agthe, M; Maner, JK				Kayser, Daniela Niesta; Agthe, Maria; Maner, Jon K.			Strategic Sexual Signals: Women's Display versus Avoidance of the Color Red Depends on the Attractiveness of an Anticipated Interaction Partner	PLOS ONE			English	Article							ENHANCES MENS ATTRACTION; FACIAL ATTRACTIVENESS; CLOTHING COLOR; RECEPTIVITY; COMPETITION; EVOLUTION; HEALTH	The color red has special meaning in mating-relevant contexts. Wearing red can enhance perceptions of women's attractiveness and desirability as a potential romantic partner. Building on recent findings, the present study examined whether women's (N = 74) choice to display the color red is influenced by the attractiveness of an expected opposite-sex interaction partner. Results indicated that female participants who expected to interact with an attractive man displayed red (on clothing, accessories, and/or makeup) more often than a baseline consisting of women in a natural environment with no induced expectation. In contrast, when women expected to interact with an unattractive man, they eschewed red, displaying it less often than in the baseline condition. Findings are discussed with respect to evolutionary and cultural perspectives on mate evaluation and selection.	[Kayser, Daniela Niesta] Univ Potsdam, Dept Psychol, Potsdam, Germany; [Agthe, Maria] Univ Munich, Dept Psychol, Munich, Germany; [Maner, Jon K.] Northwestern Univ, JL Kellogg Grad Sch Management, Dept Management & Org, Evanston, IL USA	University of Potsdam; University of Munich; Northwestern University	Kayser, DN (corresponding author), Univ Potsdam, Dept Psychol, Potsdam, Germany.	niesta@uni-potsdam.de			German Research Foundation (DFG) [NI 1115/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The authors disclosed receipt of the following financial support for the research and authorship of this article: German Research Foundation (DFG; NI 1115/2-1).	Adam H, 2012, J EXP SOC PSYCHOL, V48, P918, DOI 10.1016/j.jesp.2012.02.008; Andersson Malte, 1994; Beall AT, 2013, PSYCHOL SCI, V24, P1837, DOI 10.1177/0956797613476045; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; BUSS DM, 1988, J PERS SOC PSYCHOL, V54, P616, DOI 10.1037/0022-3514.54.4.616; Crowley A. E., 1993, MARKET LETT, V4, P59, DOI [10.1007/BF00994188, DOI 10.1007/BF00994188]; Durante KM, 2011, J CONSUM RES, V37, P921, DOI 10.1086/656575; Eisenbruch AB, 2015, PSYCHOL SCI, V26, P1332, DOI 10.1177/0956797615586403; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; Elliot AJ, 2013, J EXP SOC PSYCHOL, V49, P599, DOI 10.1016/j.jesp.2012.10.001; Elliot AJ, 2013, J EXP SOC PSYCHOL, V49, P165, DOI 10.1016/j.jesp.2012.07.017; Elliot AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034607; Elliot AJ, 2010, J EXP PSYCHOL GEN, V139, P399, DOI 10.1037/a0019689; GANGESTAD SW, 1993, ETHOL SOCIOBIOL, V14, P89, DOI 10.1016/0162-3095(93)90009-7; Gangestad SW., 1997, EVOLUTIONARY SOCIAL, P169; Geary DC, 2005, PSYCHOL BULL, V131, P654, DOI 10.1037/0033-2909.131.5.654; Gueguen N, 2014, J HOSP TOUR RES, V38, P275, DOI 10.1177/1096348012442546; Gueguen N, 2013, COLOR RES APPL, V38, P309, DOI 10.1002/col.21718; Gueguen N, 2012, INT J HOSP MANAG, V31, P1333, DOI 10.1016/j.ijhm.2012.03.012; Gueguen N, 2012, J SOC PSYCHOL, V152, P261, DOI 10.1080/00224545.2011.605398; Gueguen N, 2012, COLOR RES APPL, V37, P76, DOI 10.1002/col.21757; Haselton MG, 2007, HORM BEHAV, V51, P40, DOI 10.1016/j.yhbeh.2006.07.007; Henderson JJA, 2003, EVOL HUM BEHAV, V24, P351, DOI 10.1016/S1090-5138(03)00036-9; Kayser DN, 2010, EUR J SOC PSYCHOL, V40, P901, DOI 10.1002/ejsp.757; Li NP, 2002, J PERS SOC PSYCHOL, V82, P947, DOI 10.1037//0022-3514.82.6.947; Lin HY, 2014, DISPLAYS, V35, P202, DOI 10.1016/j.displa.2014.05.009; Pazda AD, 2014, COLOR RES APPL, V39, P208, DOI 10.1002/col.21804; Pazda AD, 2012, J EXP SOC PSYCHOL, V48, P787, DOI 10.1016/j.jesp.2011.12.009; Powers C, 1999, EVOLUTION CULTURE, P92; Re DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017859; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Roberts SC, 2010, EVOL PSYCHOL-US, V8, P350, DOI 10.1177/147470491000800304; Ryan S, 2012, EVOL HUM BEHAV, V33, P639, DOI 10.1016/j.evolhumbehav.2012.04.001; Schwarz S, 2013, J EXP SOC PSYCHOL, V49, P161, DOI 10.1016/j.jesp.2012.08.004; Shackelford TK, 1999, EVOL HUM BEHAV, V20, P71, DOI 10.1016/S1090-5138(98)00036-1; THORNHILL R, 1993, HUM NATURE-INT BIOS, V4, P237, DOI 10.1007/BF02692201; Tracy JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088852; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tybur JM, 2009, J PERS SOC PSYCHOL, V97, P103, DOI 10.1037/a0015474; Weeden J, 2005, PSYCHOL BULL, V131, P635, DOI 10.1037/0033-2909.131.5.635; Young SG, 2015, EUR J SOC PSYCHOL, V45, P146, DOI 10.1002/ejsp.2098; Zebrowitz LA, 2004, J NONVERBAL BEHAV, V28, P167, DOI 10.1023/B:JONB.0000039648.30935.1b; Zebrowitz LA, 2003, PERS SOC PSYCHOL REV, V7, P194, DOI 10.1207/S15327957PSPR0703_01	43	11	11	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0148501	10.1371/journal.pone.0148501	http://dx.doi.org/10.1371/journal.pone.0148501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TF	26960135	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300003
J	Todd, A; Beling, P; Scherer, W				Todd, Andrew; Beling, Peter; Scherer, William			Crossed and Locked Quotes in a Multi-Market Simulation	PLOS ONE			English	Article							ZERO INTELLIGENCE; MODEL; NASDAQ; PRICE	Financial markets are often fragmented, introducing the possibility that quotes in identical securities may become crossed or locked. There are a number of theoretical explanations for the existence of crossed and locked quotes, including competition, simultaneous actions, inattentiveness, fee structure and market access. In this paper, we perform a simulation experiment designed to examine the effect of simple order routing procedures on the properties of a fragmented market consisting of a single security trading in two independent limit order books. The quotes in the two markets are connected solely by the routing decision of the market participants. We report on the health of the consolidated market as measured by the duration of crossed and locked states, as well as the spread and the volatility of transaction prices in the consolidated market. We aim to quantify exactly how the prevalence of order routing among a population of market participants affects properties of the consolidated market. Our model contributes to the zero-intelligence literature by treating order routing as an experimental variable. Additionally, we introduce a parsimonious heuristic for limit order routing, allowing us to study the effects of both market order routing and limit order routing. Our model refines intuition for the sometimes subtle relationships between the prevalence of order routing and various market measures. Our model also provides a benchmark for more complex agent-based models.	[Todd, Andrew; Beling, Peter; Scherer, William] Univ Virginia, Sch Engn & Appl Sci, Dept Syst & Informat Engn, Charlottesville, VA USA	University of Virginia	Todd, A (corresponding author), Univ Virginia, Sch Engn & Appl Sci, Dept Syst & Informat Engn, Charlottesville, VA USA.	aet6cd@virginia.edu						Abergel F, 2013, INT J THEOR APPL FIN, V16, DOI 10.1142/S0219024913500258; Aguilar L., 2015, US EQUITY MARKET STR; Banks HT, 2012, P SIMCRT 2011, P3; Bias B, 2014, BANKERS MARKETS INVE, V128, P5; Cao C, 2000, J FINANC, V55, P1339, DOI 10.1111/0022-1082.00249; Chen SH, 2012, J ECON DYN CONTROL, V36, P1, DOI 10.1016/j.jedc.2011.09.003; Cont R, 2010, OPER RES, V58, P549, DOI 10.1287/opre.1090.0780; Daniels MG, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.108102; Edmonds B, 2005, LECT NOTES COMPUT SC, V3415, P130; Farmer JD, 2005, P NATL ACAD SCI USA, V102, P2254, DOI 10.1073/pnas.0409157102; Garvey R., 2006, J ALTERN INVEST LOND, V9, P6; Gatheral J, 2010, FINANC STOCH, V14, P249, DOI 10.1007/s00780-009-0120-1; GODE DK, 1993, J POLIT ECON, V101, P119, DOI 10.1086/261868; Gould MD, 2013, QUANT FINANC, V13, P1709, DOI 10.1080/14697688.2013.803148; Hedstrom P, 2010, ANNU REV SOCIOL, V36, P49, DOI 10.1146/annurev.soc.012809.102632; Knuth D, 1997, SEMINUMERICAL ALGORI, V3; Ladley D, 2012, KNOWL ENG REV, V27, P273, DOI 10.1017/S0269888912000173; Lamont OA, 2003, J ECON PERSPECT, V17, P191, DOI 10.1257/089533003772034952; Law A., 2007, J AM STATAL ASS, V4th; Maslov S, 2000, PHYSICA A, V278, P571, DOI 10.1016/S0378-4371(00)00067-4; Mike S, 2008, J ECON DYN CONTROL, V32, P200, DOI 10.1016/j.jedc.2007.01.025; O'Hara M, 2015, J FINANC ECON, V116, P257, DOI 10.1016/j.jfineco.2015.01.003; Shkilko AV, 2008, J FINANC MARK, V11, P308, DOI 10.1016/j.finmar.2007.02.001; Smith E, 2003, QUANT FINANC, V3, P481, DOI 10.1088/1469-7688/3/6/307; Toth B, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021006; Way E., 2013, P 14 ACM C EL COMM, P855, DOI DOI 10.1145/2482540.2482577	26	0	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151096	10.1371/journal.pone.0151096	http://dx.doi.org/10.1371/journal.pone.0151096			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TF	26959416	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300098
J	Christiansen, DH; Frost, P; Frich, LH; Falla, D; Svendsen, SW				Christiansen, David Hoyrup; Frost, Poul; Frich, Lars Henrik; Falla, Deborah; Svendsen, Susanne Wulff			The Use of Physiotherapy among Patients with Subacromial Impingement Syndrome: Impact of Sex, Socio-Demographic and Clinical Factors	PLOS ONE			English	Article							ARTHROSCOPIC ACROMIOPLASTY; EXERCISE STRATEGY; FOLLOW-UP; SHOULDER; DECOMPRESSION; REGISTER; SURGERY; SATISFACTION; BENEFITS; COHORT	Background Physiotherapy with exercises is generally recommended in the treatment of patients with subacromial impingement syndrome (SIS). Objective We aimed to investigate the use of physiotherapy in patients with SIS in Danish hospital settings as part of initial non-surgical treatment and after SIS-related surgery and to evaluate to which extent sex, socio-demographic and clinical factors predict the use of physiotherapy. Methods Using national health registers, we identified 57,311 patients who had a first hospital contact with a diagnosis of ICD-10, groups M75.1-75.9, 1 July 2007 to 30 June 2011. Records of physiotherapy were extracted within 52 weeks after first contact (or until surgery), and for surgically treated patients within 26 weeks after surgery. Predictors of the use of physiotherapy after first contact and after surgery were analysed as time-to-event. Results Within 52 weeks after first contact, 43% of the patients had physiotherapy and 30% underwent surgery. Within 26 weeks after surgery, 80% had a record of physiotherapy. After first contact and after surgery, exercise was part of physiotherapy in 65% and 84% of the patients, respectively. A public hospital contact, physiotherapy before hospital contact, administrative region, female sex, a diagnosis of other or unspecified disorders (M75.8-M75.9), and surgical procedure predicted higher use of physiotherapy. Low education level predicted slightly lower use of physiotherapy after first contact, but not after surgery. Conclusion In patients with SIS in Danish hospital settings, physiotherapy was more often used after surgery than as part of initial non-surgical treatment. The use of physiotherapy was less common among men than women, whereas unequal use of physiotherapy in relation to education level was not noticeable. The use of physiotherapy with exercises in initial nonsurgical treatment was relatively limited.	[Christiansen, David Hoyrup; Svendsen, Susanne Wulff] Reg Hosp West Jutland, Danish Ramazzini Ctr, Dept Occupat Med, Univ Res Clin, Herning, Denmark; [Frost, Poul] Aarhus Univ Hosp, Aarhus Hosp, Danish Ramazzini Ctr, Dept Occupat Med, DK-8000 Aarhus, Denmark; [Frich, Lars Henrik] Odense Univ Hosp, Dept Orthoped, DK-5000 Odense, Denmark; [Falla, Deborah] Univ Hosp Gottingen, Ctr Anesthesiol Emergency & Intens Care Med, Gottingen, Germany; [Falla, Deborah] Univ Gottingen, Univ Med Ctr, Gottingen Bernstein Ctr Computat Neurosci BCCN, Inst Neurorehabil Syst,Bernstein Focus Neurotechn, Gottingen, Germany	Aarhus University; University of Southern Denmark; Odense University Hospital; University of Gottingen; University of Gottingen	Christiansen, DH (corresponding author), Reg Hosp West Jutland, Danish Ramazzini Ctr, Dept Occupat Med, Univ Res Clin, Herning, Denmark.	David.Christiansen@vest.rm.dk	Falla, Deborah/ABA-7734-2021; Christiansen, David Høyrup/ABE-7118-2021	Falla, Deborah/0000-0003-1689-6190; Christiansen, David Høyrup/0000-0001-7458-3921; Frich, Lars Henrik/0000-0002-0147-4211	Danish Agency for Science, Technology and Innovation grant [09-066985]; Danish Ramazzini Centre	Danish Agency for Science, Technology and Innovation grant; Danish Ramazzini Centre	This work was supported by The Danish Agency for Science, Technology and Innovation grant number 09-066985, http://ufm.dk/en?set_language=en&cl=en, and the Danish Ramazzini Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; Andersen NH, 1999, J SHOULDER ELB SURG, V8, P99, DOI 10.1016/S1058-2746(99)90000-9; Andersen PK, 2010, STAT METHODS MED RES, V19, P71, DOI 10.1177/0962280209105020; Biering K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049268; Braman JP, 2014, MED BIOL ENG COMPUT, V52, P211, DOI 10.1007/s11517-013-1074-1; Chaudhury S, 2010, NAT REV RHEUMATOL, V6, P217, DOI 10.1038/nrrheum.2010.25; Checroun A J, 1998, Bull Hosp Jt Dis, V57, P145; Danish Health and Medicines Authority, 2013, REC PREN CAR; de Witte PB, 2014, MED BIOL ENG COMPUT, V52, P221, DOI 10.1007/s11517-013-1075-0; Dickens VA, 2005, PHYSIOTHERAPY, V91, P159, DOI 10.1016/j.physio.2004.10.008; Green S, 1998, BRIT MED J, V316, P354, DOI 10.1136/bmj.316.7128.354; Hallgren HCB, 2014, BRIT J SPORT MED, V48, P1431, DOI 10.1136/bjsports-2013-093233; Hanratty CE, 2012, SEMIN ARTHRITIS RHEU, V42, P297, DOI 10.1016/j.semarthrit.2012.03.015; Hjollund NH, 2007, SCAND J PUBLIC HEALT, V35, P497, DOI 10.1080/14034940701271882; Holmgren T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e787; Holmgren T, 2012, J REHABIL MED, V44, P12, DOI 10.2340/16501977-0889; Jensen LD, 2011, SPINE, V36, pE791, DOI 10.1097/BRS.0b013e3181ef6243; Ketola S, 2009, J BONE JOINT SURG BR, V91B, P1326, DOI 10.1302/0301-620X.91B10.22094; Klintberg IH, 2011, J SHOULDER ELB SURG, V20, P598, DOI 10.1016/j.jse.2010.08.021; Klintberg IH, 2010, KNEE SURG SPORT TR A, V18, P394, DOI 10.1007/s00167-009-0963-1; Klintberg IH, 2008, CLIN REHABIL, V22, P951, DOI 10.1177/0269215508090771; Lewis JS, 2009, BRIT J SPORT MED, V43, P236, DOI 10.1136/bjsm.2008.052175; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Odenbring S, 2008, ARTHROSCOPY, V24, P1092, DOI 10.1016/j.arthro.2008.04.073; Rothman KJ, 2008, ANONYMOUS MODERN EPI, P481; Rudbeck M, 2013, J SHOULDER ELB SURG, V22, P1167, DOI 10.1016/j.jse.2012.12.003; Svendsen SW, 2012, SCAND J RHEUMATOL, V41, P59, DOI 10.3109/03009742.2011.595375; Ylinen J, 2013, EUR J PHYS REHAB MED, V49, P499	28	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151077	10.1371/journal.pone.0151077	http://dx.doi.org/10.1371/journal.pone.0151077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954692	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300082
J	Cruz, MP; Andrade, CMF; Silva, KO; de Souza, EP; Yatsuda, R; Marques, LM; David, JP; David, JM; Napimoga, MH; Clemente-Napimoga, JT				Cruz, Mariluze P.; Andrade, Cassya M. F.; Silva, Kelle O.; de Souza, Erika P.; Yatsuda, Regiane; Marques, Lucas M.; David, Juceni P.; David, Jorge M.; Napimoga, Marcelo H.; Clemente-Napimoga, Juliana T.			Antinoceptive and Anti-inflammatory Activities of the Ethanolic Extract, Fractions and Flavones Isolated from Mimosa tenuiflora (Willd.) Poir (Leguminosae)	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; FORMALIN TEST; INFLAMMATORY HYPERALGESIA; NEUTROPHIL RECRUITMENT; DRUG DEVELOPMENT; PAIN; ACTIVATION; MECHANISMS; CYTOKINE	The bark of Mimosa tenuiflora (Willd.) Poiret (Leguminosae family), popularly known as "jurema preta" in Brazil, is used by the population of Contendas of Sincora (Bahia State, Brazil) for the treatment of coughs and wound healing. Thus, the aim of this study was to evaluate the antinociceptive and anti-inflammatory activities of the bark ethanol extract (EEMT) and solvent soluble fractions (hexane-H, DCM-D, EtOAc-E and BuOH-B) of the extract in vivo. Additionally, we synthesized 5,7-dihidroxy-4'-methoxyflavanone (isosakuranetin) and isolated the compound sakuranetin, and both compounds were also tested. The anti-inflammatory and antinociceptive assays performed were: writhing test; nociception induced by intraplantar formalin injection; leukocyte recruitment to the peritoneal cavity; evaluation of vascular permeability (Evans blue test); and evaluation of mechanical hypernociception (von Frey test). Production of TNF-alpha, IL-10, myeloperoxidase and the expression of ICAM-1 were also evaluated. Statistical analysis was performed by one-way ANOVA followed by the Bonferroni post-test (n = 8), with P < 0.05. The EEMT showed antinociceptive activities in writhing test (100-200 mg/kg), in the second phase of the formalin test (50-200 mg/kg), and in mechanical hypernociception (100 mg/kg). EEMT showed an anti-inflammatory effect by reducing neutrophil migration to the peritoneal cavity and in the plantar tissue detected by the reduction of myeloperoxidase activity (100 mg/kg), reduction of IL-10 levels and expression of ICAM-1 in the peritoneal exudate and the mesentery (100 mg/kg), respectively. The four soluble EEMT fractions showed good results in tests for antinociceptive (H, D, E, B) and anti-inflammation (H, D, E). Only sakuranetin showed reduction of the writhing and neutrophil migration (200 mg/kg). Thus, the EEMT and soluble fractions of M. tenuiflora bark demonstrated great antinociceptive and anti-inflammatory activities, as also sakuranetin. More studies should be conducted to elucidate the mechanism of action of this compound. To the best of our knowledge, this is the first report on the antinociceptive activity of the M. tenuiflora fractions and the bioactive isolated compound sakuranetin in vivo.	[Cruz, Mariluze P.; Andrade, Cassya M. F.; Silva, Kelle O.; de Souza, Erika P.; Yatsuda, Regiane; Marques, Lucas M.] Univ Fed Bahia, Inst Multidisciplinar Saude, Vitoria Da Conquista, BA, Brazil; [David, Juceni P.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil; [Cruz, Mariluze P.; David, Jorge M.] Univ Fed Bahia, Inst Quim, Salvador, BA, Brazil; [Napimoga, Marcelo H.] Sao Leopoldo Mand Inst & Res Ctr, Lab Immunol & Mol Biol, Campinas, SP, Brazil; [Clemente-Napimoga, Juliana T.] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Faculdade Sao Leopoldo Mandic; Universidade de Sao Paulo; Universidade Estadual de Campinas	David, JM (corresponding author), Univ Fed Bahia, Inst Quim, Salvador, BA, Brazil.	jmdavid@ufba.br	Marques, Lucas M/L-2507-2018; Silva, Lucas/GQH-8201-2022; David, Jorge Mauricio/AAK-7022-2020; Napimoga, Marcelo/S-2434-2019; Yatsuda, Regiane/L-1926-2018; Clemente-Napimoga, Juliana T/E-5163-2013; David, Juceni/AAX-8782-2020; David, Jorge M/G-4550-2012	Marques, Lucas M/0000-0002-8276-8149; David, Jorge Mauricio/0000-0001-6375-9055; Napimoga, Marcelo/0000-0003-4472-365X; Yatsuda, Regiane/0000-0002-5018-9978; Clemente-Napimoga, Juliana T/0000-0003-1068-3039; David, Juceni/0000-0001-9405-2327; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [472605/2012-7]; Fundacao de Amparo a Pesquisa do Estado da Bahia-FAPESB [PET0055/2012]; CNPq; CAPES; PRONEM/FAPESB	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado da Bahia-FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PRONEM/FAPESB	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (472605/2012-7); Fundacao de Amparo a Pesquisa do Estado da Bahia-FAPESB (PET0055/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the CNPq, CAPES and PRONEM/FAPESB for grants and fellowships. We are indebted to Dr. Manuela P. Cardoso, who recorded the HRESI Mass spectra.	Alves PM, 2008, ARQ ODONTOL, V44, P53; ANTON R, 1993, J ETHNOPHARMACOL, V38, P153, DOI 10.1016/0378-8741(93)90010-3; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; Camargo-Ricalde S., 1994, CONTACTO, V5, P29; Camargo-Ricalde SL, 2000, REV BIOL TROP, V48, P939; Chen SM, 2008, CLIN EXP IMMUNOL, V153, P420, DOI 10.1111/j.1365-2249.2008.03707.x; Choi JH, 2012, J ETHNOPHARMACOL, V144, P379, DOI 10.1016/j.jep.2012.09.023; COLLIER HOJ, 1968, BRIT J PHARMACOL, V32, P295, DOI 10.1111/j.1476-5381.1968.tb00973.x; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x; Cunha TM, 2008, J LEUKOCYTE BIOL, V83, P824, DOI 10.1189/jlb.0907654; Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107; DeSmet PAGM, 1997, DRUGS, V54, P801, DOI 10.2165/00003495-199754060-00003; Duarte JC, 2008, 20 S PLANT MED BRAS, P248; Ehlers S, 2010, TRENDS IMMUNOL, V31, P184, DOI 10.1016/j.it.2010.02.003; FERREIRA SH, 1972, NATURE-NEW BIOL, V240, P200, DOI 10.1038/newbio240200a0; FERREIRA SH, 1993, BRIT J PHARMACOL, V110, P1227, DOI 10.1111/j.1476-5381.1993.tb13946.x; Ferreira SH, 1997, BRIT J PHARMACOL, V121, P883, DOI 10.1038/sj.bjp.0701211; Fine PG, 2009, PAIN MED, V10, pS79, DOI 10.1111/j.1526-4637.2009.00666.x; Gaujac A, 2013, MICROCHEM J, V109, P78, DOI 10.1016/j.microc.2012.03.033; GRETHER R, 1988, B SOC BOT MEX, V48, P151; Guilhon CC, 2011, J ETHNOPHARMACOL, V135, P406, DOI 10.1016/j.jep.2011.03.032; Guimaraes-Beelen PM, 2006, SMALL RUMINANT RES, V61, P35, DOI 10.1016/j.smallrumres.2005.01.007; Haridas V, 2001, P NATL ACAD SCI USA, V98, P11557, DOI 10.1073/pnas.191363498; HONOHAN T, 1976, J AGR FOOD CHEM, V24, P906, DOI 10.1021/jf60207a031; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; JIANG YL, 1991, PHYTOCHEMISTRY, V30, P2357, DOI 10.1016/0031-9422(91)83648-5; JIANG YL, 1991, J NAT PROD, V54, P1247, DOI 10.1021/np50077a002; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Khasar SG, 1999, J NEUROPHYSIOL, V81, P1104, DOI 10.1152/jn.1999.81.3.1104; Kim HP, 2004, J PHARMACOL SCI, V96, P229, DOI 10.1254/jphs.CRJ04003X; KOSTER R, 1959, FED PROC, V18, P412; Manson SC, 2009, RESP MED, V103, P975, DOI 10.1016/j.rmed.2009.01.003; Mazzon E, 2008, CLIN EXP IMMUNOL, V153, P136, DOI 10.1111/j.1365-2249.2008.03669.x; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Nakamura Y, 1998, CANCER RES, V58, P4832; Napimoga MH, 2007, INT IMMUNOPHARMACOL, V7, P824, DOI 10.1016/j.intimp.2007.02.001; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nunes BS, 2009, N-S ARCH PHARMACOL, V379, P609, DOI 10.1007/s00210-009-0397-9; Ohsaki A, 2006, CHEM PHARM BULL, V54, P1728, DOI 10.1248/cpb.54.1728; Bitencourt MAO, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/378235; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; POBER JS, 1987, J IMMUNOL, V138, P3319; Prasad AK, 2005, PURE APPL CHEM, V77, P25, DOI 10.1351/pac200577010025; Rivera-Arce E, 2007, J ETHNOPHARMACOL, V113, P400, DOI 10.1016/j.jep.2007.06.023; Rojewska E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138583; ROSLAND JH, 1990, PAIN, V42, P235, DOI 10.1016/0304-3959(90)91167-H; Ruiz PA, 2007, J NUTR, V137, P1208, DOI 10.1093/jn/137.5.1208; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; SHIBATA M, 1989, PAIN, V38, P347, DOI 10.1016/0304-3959(89)90222-4; Shu YZ, 1998, J NAT PROD, V61, P1053, DOI 10.1021/np9800102; Sjostrom J, 1999, ANAL METHODS WOOD CH; Souza GV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117501; Suleyman H, 2007, PHARMACOL REP, V59, P247; Szatmari S Z, 2003, Cochrane Database Syst Rev, pCD003119, DOI 10.1002/14651858.CD003119; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Toledo AC, 2013, BRIT J PHARMACOL, V168, P1736, DOI 10.1111/bph.12062; VACHER J, 1964, MED EXP, V11, P51; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Wagner JG, 2000, PHARMACOL REV, V52, P349; Wang Y, 2014, J ETHNOPHARMACOL, V151, P944, DOI 10.1016/j.jep.2013.12.003; Wei G, 2008, EUR J ORG CHEM, V2008, P3156, DOI 10.1002/ejoe.200800239; Xu JL, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0117801, 10.1371/journal.pone.0118099]; [No title captured]	66	30	32	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150839	10.1371/journal.pone.0150839	http://dx.doi.org/10.1371/journal.pone.0150839			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954375	Green Submitted, Green Published, gold			2022-12-27	WOS:000371991300054
J	Parraga, CA; Akbarinia, A				Parraga, C. Alejandro; Akbarinia, Arash			NICE: A Computational Solution to Close the Gap from Colour Perception to Colour Categorization	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; LOCATING BASIC COLORS; RIGHT VISUAL-FIELD; CONE INPUTS; CHROMATIC MECHANISMS; UNIQUE HUES; CARDINAL DIRECTIONS; STRIATE CORTEX; AREA V4; MODEL	The segmentation of visible electromagnetic radiation into chromatic categories by the human visual system has been extensively studied from a perceptual point of view, resulting in several colour appearance models. However, there is currently a void when it comes to relate these results to the physiological mechanisms that are known to shape the pre-cortical and cortical visual pathway. This work intends to begin to fill this void by proposing a new physiologically plausible model of colour categorization based on Neural Isoresponsive Colour Ellipsoids (NICE) in the cone-contrast space defined by the main directions of the visual signals entering the visual cortex. The model was adjusted to fit psychophysical measures that concentrate on the categorical boundaries and are consistent with the ellipsoidal isoresponse surfaces of visual cortical neurons. By revealing the shape of such categorical colour regions, our measures allow for a more precise and parsimonious description, connecting well-known early visual processing mechanisms to the less understood phenomenon of colour categorization. To test the feasibility of our method we applied it to exemplary images and a popular ground-truth chart obtaining labelling results that are better than those of current state-of-the-art algorithms.	[Parraga, C. Alejandro; Akbarinia, Arash] CVC, Barcelona, Spain; [Parraga, C. Alejandro; Akbarinia, Arash] Univ Autonoma Barcelona, Dept Ciencies Computac, E-08193 Barcelona, Spain	Centre de Visio per Computador (CVC); Autonomous University of Barcelona	Parraga, CA (corresponding author), CVC, Barcelona, Spain.; Parraga, CA (corresponding author), Univ Autonoma Barcelona, Dept Ciencies Computac, E-08193 Barcelona, Spain.	alejandro.parraga@cvc.uab.es	Parraga, C. Alejandro/D-2329-2011	Parraga, C. Alejandro/0000-0002-3809-241X	Spanish Secretaria de Estado de I+D+i project [TIN2013-41751-P, TIN2013-49982-EXP]	Spanish Secretaria de Estado de I+D+i project	CAP was funded by the Spanish Secretaria de Estado de I+D+i projects TIN2013-41751-P and TIN2013-49982-EXP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfken GB, 1985, MATH METHODS PHYS, Vxxii; Baronchelli A, 2010, P NATL ACAD SCI USA, V107, P2403, DOI 10.1073/pnas.0908533107; Benavente R, 2004, CGIV 2004: SECOND EUROPEAN CONFERENCE ON COLOR IN GRAPHICS, IMAGING, AND VISION - CONFERENCE PROCEEDINGS, P135; Benavente R, 2009, PERCEPTION, V38, P36; Benavente R, 2008, J OPT SOC AM A, V25, P2582, DOI 10.1364/JOSAA.25.002582; Berlin B, 1991, BASIC COLOR TERMS TH, Vxiii; BOYNTON RM, 1987, COLOR RES APPL, V12, P94, DOI 10.1002/col.5080120209; BOYNTON RM, 1986, COLOR RES APPL, V11, P244, DOI 10.1002/col.5080110405; Brainard D.H., 2003, SCI COLOR, V2, P191, DOI DOI 10.1016/B978-044451251-2/50006-4; Brainard DH, 2000, J OPT SOC AM A, V17, P607, DOI 10.1364/JOSAA.17.000607; Briggs F, 2014, NEW VISUAL NEUROSCIENCES, P315; Brouwer GJ, 2009, J NEUROSCI, V29, P13992, DOI 10.1523/JNEUROSCI.3577-09.2009; Brown RO, 1997, CURR BIOL, V7, P844, DOI 10.1016/S0960-9822(06)00372-1; BROWN WRJ, 1949, J OPT SOC AM, V39, P808, DOI 10.1364/JOSA.39.000808; BURNS SA, 1984, VISION RES, V24, P479, DOI 10.1016/0042-6989(84)90045-2; Cao DC, 2005, VISION RES, V45, P1929, DOI 10.1016/j.visres.2005.01.033; Carroll Joseph, 2002, J Vis, V2, P531, DOI 10.1167/2.8.1; Conway BR, 2007, NEURON, V56, P560, DOI 10.1016/j.neuron.2007.10.008; Conway BR, 2009, P NATL ACAD SCI USA, V106, P18034, DOI 10.1073/pnas.0810943106; Conway BR, 2001, J NEUROSCI, V21, P2768, DOI 10.1523/JNEUROSCI.21-08-02768.2001; Cropper Simon J, 2005, Behav Cogn Neurosci Rev, V4, P192, DOI 10.1177/1534582305285120; Cropper SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059945; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P4997, DOI 10.1073/pnas.97.9.4997; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P197, DOI 10.1113/jphysiol.1975.sp011087; DEREFELDT G, 1995, DISPLAYS, V16, P69, DOI 10.1016/0141-9382(95)91176-3; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DEVALOIS RL, 1993, VISION RES, V33, P1053, DOI 10.1016/0042-6989(93)90240-W; Dixon AC, 1908, MATH GAZ, V4, P228; Drivonikou GV, 2007, P NATL ACAD SCI USA, V104, P1097, DOI 10.1073/pnas.0610132104; Dubrovin B. A., 1984, MODERN GEOMETRY METH; Fairchild MD, 1998, COLOR APPEARANCE MOD, Vxvii; Franklin A, 2008, P NATL ACAD SCI USA, V105, P3221, DOI 10.1073/pnas.0712286105; Franklin A, 2005, J EXP CHILD PSYCHOL, V91, P227, DOI 10.1016/j.jecp.2005.03.003; Gescheider G. A., 1997, PSYCHOPHYSICS FUNDAM, P45; Gilbert AL, 2006, P NATL ACAD SCI USA, V103, P489, DOI 10.1073/pnas.0509868103; Goldstein H., 1980, CLASSICAL MECH, Vxiv; Guest S, 2000, VISION RES, V40, P723, DOI 10.1016/S0042-6989(99)00221-7; GUTH SL, 1991, J OPT SOC AM A, V8, P976, DOI 10.1364/JOSAA.8.000976; Hansen T, 2007, J VISION, V7, DOI 10.1167/7.4.2; Horwitz GD, 2007, J NEUROPHYSIOL, V97, P3070, DOI 10.1152/jn.00965.2006; Horwitz GD, 2012, NAT NEUROSCI, V15, P913, DOI 10.1038/nn.3105; INDOW T, 1988, PSYCHOL REV, V95, P456, DOI 10.1037/0033-295X.95.4.456; INDOW T, 1960, J EXP PSYCHOL, V59, P330, DOI 10.1037/h0044796; Johnson EN, 2004, J NEUROPHYSIOL, V91, P2501, DOI 10.1152/jn.01043.2003; JORDAN G, 1995, VISION RES, V35, P613, DOI 10.1016/0042-6989(94)00153-D; Kay P, 2003, P NATL ACAD SCI USA, V100, P9085, DOI 10.1073/pnas.1532837100; Kay P, 2006, TRENDS COGN SCI, V10, P51, DOI 10.1016/j.tics.2005.12.007; KRAUSKOPF J, 1982, VISION RES, V22, P1123, DOI 10.1016/0042-6989(82)90077-3; Kuehni RG, 2004, COLOR RES APPL, V29, P183, DOI 10.1002/col.20004; Kuehni RG, 2002, COLOR RES APPL, V27, P20, DOI 10.1002/col.10002; Kuehni RG, 2001, COLOR RES APPL, V26, P61, DOI 10.1002/1520-6378(200102)26:1<61::AID-COL6>3.0.CO;2-P; Lammens J, 1994, COMPUTATIONAL MODEL; LENNIE P, 1990, J NEUROSCI, V10, P649; Lindsey DT, 2010, PSYCHOL SCI, V21, P1208, DOI 10.1177/0956797610379861; Liu Q, 2009, NEUROSCI LETT, V454, P58, DOI 10.1016/j.neulet.2009.02.045; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LUTHER R, 1927, Z TECH PHYS, V8, P540; MACLAURY RE, 1992, CURR ANTHROPOL, V33, P137, DOI 10.1086/204049; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Maffi Luisa, 1997, COLOR CATEGORIES THO; Mathews J., 2004, NUMERICAL METHODS US, P430; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Menegaz G, 2007, EURASIP J ADV SIG PR, DOI 10.1155/2007/29125; Miyahara E, 1998, VISION RES, V38, P601, DOI 10.1016/S0042-6989(97)88334-4; Mojsilovic A, 2005, IEEE T IMAGE PROCESS, V14, P690, DOI 10.1109/TIP.2004.841201; MOLLON JD, 1989, J EXP BIOL, V146, P21; MOLLON JD, 1982, ANNU REV PSYCHOL, V33, P41, DOI 10.1146/annurev.ps.33.020182.000353; Moroney N, 2003, SPIE COLOR IMAGING; Namima T, 2014, J NEUROSCI, V34, P14934, DOI 10.1523/JNEUROSCI.2289-14.2014; Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8; Olkkonen M, 2009, J VISION, V9, DOI 10.1167/9.12.6; Otazu X, 2010, J VISION, V10, DOI 10.1167/10.12.5; Parkes LM, 2009, J VISION, V9, DOI 10.1167/9.1.1; Parraga A, 2007, PERCEPTION, V36, P198; Parraga CA, 2002, CURR BIOL, V12, P483, DOI 10.1016/S0960-9822(02)00718-2; Parraga CA, 2009, J IM SCI TEC, V53; Pointer MR, 1998, COLOR RES APPL, V23, P52, DOI 10.1002/(SICI)1520-6378(199802)23:1<52::AID-COL8>3.0.CO;2-2; POKORNY J, 1977, J OPT SOC AM, V67, P1196, DOI 10.1364/JOSA.67.001196; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Regier T, 2007, P NATL ACAD SCI USA, V104, P1436, DOI 10.1073/pnas.0610341104; Regier T, 2009, TRENDS COGN SCI, V13, P439, DOI 10.1016/j.tics.2009.07.001; Roca-Vila J, 2013, J VISION, V13, DOI 10.1167/13.4.3; Saunders BAC, 1997, BEHAV BRAIN SCI, V20, P167, DOI 10.1017/S0140525X97001428; SCHEFRIN BE, 1990, J OPT SOC AM A, V7, P305, DOI 10.1364/JOSAA.7.000305; Seaborn M, 2005, PATTERN RECOGN, V38, P165, DOI 10.1016/j.patcog.2004.05.001; Sharpe L.T., 1999, COLOR VISION GENES P, P3; Shepard R.N., 1992, ADAPTED MIND EVOLUTI, P495; Sherman SM, 2014, NEW VISUAL NEUROSCIENCES, P257; Siok WT, 2009, P NATL ACAD SCI USA, V106, P8140, DOI 10.1073/pnas.0903627106; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; Smith VC, 1996, COLOR RES APPL, V21, P375, DOI 10.1002/(SICI)1520-6378(199610)21:5<375::AID-COL6>3.0.CO;2-V; SMITH VC, 1976, VISION RES, V16, P1087, DOI 10.1016/0042-6989(76)90247-9; Smith VC, 1996, VISION RES, V36, P3087, DOI 10.1016/0042-6989(96)00035-1; STURGES J, 1995, COLOR RES APPL, V20, P364, DOI 10.1002/col.5080200605; Tailby C, 2008, J NEUROSCI, V28, P4078, DOI 10.1523/JNEUROSCI.5338-07.2008; Tailby C, 2008, J NEUROSCI, V28, P1131, DOI 10.1523/JNEUROSCI.4682-07.2008; van de Weijer J., 2007, IEEE C COMP VIS PATT; WALSH V, 1992, BEHAV BRAIN RES, V52, P81, DOI 10.1016/S0166-4328(05)80327-4; Wang Z, 2006, 3 EUR C COL GRAPH IM; WARE C, 1982, VISION RES, V22, P1353, DOI 10.1016/0042-6989(82)90225-5; Webster MA, 2000, J OPT SOC AM A, V17, P1545, DOI 10.1364/JOSAA.17.001545; WEBSTER MA, 1988, J OPT SOC AM A, V5, P1722, DOI 10.1364/JOSAA.5.001722; Webster MA, 2002, J OPT SOC AM A, V19, P1951, DOI 10.1364/JOSAA.19.001951; Webster MA, 1997, VISION RES, V37, P3283, DOI 10.1016/S0042-6989(97)00125-9; Webster MA, 2007, ANTHROPOLOGY OF COLOR: INTERDISCIPLINARY MULTILEVEL MODELING, P29; WERNER JS, 1993, J OPT SOC AM A, V10, P1509, DOI 10.1364/JOSAA.10.001509; Werner JS, 1996, PROG RETIN EYE RES, V15, P621, DOI 10.1016/1350-9462(96)00001-8; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; Witzel C, 2013, J VISION, V13, DOI 10.1167/13.7.1; Wuerger SM, 2005, VISION RES, V45, P3210, DOI 10.1016/j.visres.2005.06.016; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; Xiao YP, 2007, NEUROIMAGE, V35, P771, DOI 10.1016/j.neuroimage.2006.11.059; Xiao YP, 2003, NATURE, V421, P535, DOI 10.1038/nature01372; Xiao YP, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024994, DOI 10.1371/JORNAL.PONE.0024994]; Yendrikhovskij SN, 2001, COLOR RES APPL, V26, pS235, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL50>3.0.CO;2-O; Yokoi K, 2005, J OPT SOC AM A, V22, P2309, DOI 10.1364/JOSAA.22.002309; Yoshioka T, 1996, BEHAV BRAIN RES, V76, P51, DOI 10.1016/0166-4328(95)00183-2	117	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0149538	10.1371/journal.pone.0149538	http://dx.doi.org/10.1371/journal.pone.0149538			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954691	gold, Green Submitted, Green Published			2022-12-27	WOS:000371991300010
J	Wang, X; Xi, W; Toomey, S; Chiang, YC; Hasek, J; Laue, TM; Denis, CL				Wang, Xin; Xi, Wen; Toomey, Shaun; Chiang, Yueh-Chin; Hasek, Jiri; Laue, Thomas M.; Denis, Clyde L.			Stoichiometry and Change of the mRNA Closed-Loop Factors as Translating Ribosomes Transit from Initiation to Elongation	PLOS ONE			English	Article							DEADENYLATION IN-VIVO; SACCHAROMYCES-CEREVISIAE; POLY(A)-BINDING PROTEIN; FLUORESCENCE DETECTION; CCR4; YEAST; BINDING; EUKARYOTES; POLY(A); EIF4G	Protein synthesis is a highly efficient process and is under exacting control. Yet, the actual abundance of translation factors present in translating complexes and how these abundances change during the transit of a ribosome across an mRNA remains unknown. Using analytical ultracentrifugation with fluorescent detection we have determined the stoichiometry of the closed-loop translation factors for translating ribosomes. A variety of pools of translating polysomes and monosomes were identified, each containing different abundances of the closed-loop factors eIF4E, eIF4G, and PAB1 and that of the translational repressor, SBP1. We establish that closed-loop factors eIF4E/eIF4G dissociated both as ribosomes transited polyadenylated mRNA from initiation to elongation and as translation changed from the polysomal to monosomal state prior to cessation of translation. eIF4G was found to particularly dissociate from polyadenylated mRNA as polysomes moved to the monosomal state, suggesting an active role for translational repressors in this process. Consistent with this suggestion, translating complexes generally did not simultaneously contain eIF4E/eIF4G and SBP1, implying mutual exclusivity in such complexes. For substantially deadenylated mRNA, however, a second type of closed-loop structure was identified that contained just eIF4E and eIF4G. More than one eIF4G molecule per polysome appeared to be present in these complexes, supporting the importance of eIF4G interactions with the mRNA independent of PAB1. These latter closed-loop structures, which were particularly stable in polysomes, may be playing specific roles in both normal and disease states for specific mRNA that are deadenylated and/or lacking PAB1. These analyses establish a dynamic snapshot of molecular abundance changes during ribosomal transit across an mRNA in what are likely to be critical targets of regulation.	[Wang, Xin; Xi, Wen; Toomey, Shaun; Chiang, Yueh-Chin; Laue, Thomas M.; Denis, Clyde L.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Wang, Xin; Xi, Wen; Toomey, Shaun; Chiang, Yueh-Chin; Laue, Thomas M.; Denis, Clyde L.] Acad Sci Czech Republ, Inst Microbiol, Dept Mol Cellular & Biomed Sci, Videnska 1083, Prague, Czech Republic; [Hasek, Jiri] Acad Sci Czech Republ, Inst Microbiol, Lab Cell Reprod, Videnska 1083, Prague, Czech Republic	University System Of New Hampshire; University of New Hampshire; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Denis, CL (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.; Denis, CL (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Dept Mol Cellular & Biomed Sci, Videnska 1083, Prague, Czech Republic.	cldenis@unh.edu	Hasek, Jiri/H-2427-2014	Hasek, Jiri/0000-0001-6634-2386	National Institutes of Health, ARRA Initiative [GM82048, 106286]; New Hampshire Agricultural Experiment Station, United States Department of Agriculture Hatch Project [00589]; New Hampshire Agricultural Experiment Station [2622]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM082048, R15GM106286] Funding Source: NIH RePORTER	National Institutes of Health, ARRA Initiative; New Hampshire Agricultural Experiment Station, United States Department of Agriculture Hatch Project; New Hampshire Agricultural Experiment Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health GM82048, 106286, ARRA Initiative of 2009 (CLD); and New Hampshire Agricultural Experiment Station, United States Department of Agriculture Hatch Project 00589 (CLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We greatly appreciate the provision of GFP tagged proteins by R. Parker. Partial funding was provided by the New Hampshire Agricultural Experiment Station. This is Scientific Contribution Number 2622.	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Amrani N, 2008, NATURE, V453, P1276, DOI 10.1038/nature06974; Archer SK, 2015, RNA BIOL, V12, P248, DOI 10.1080/15476286.2015.1017242; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Baierlein C, 2010, RNA BIOL, V7, P548, DOI 10.4161/rna.7.5.12686; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Berset C, 2003, RNA, V9, P871, DOI 10.1261/rna.5380903; Castelli LM, 2011, MOL BIOL CELL, V22, P3379, DOI 10.1091/mbc.E11-02-0153; Castello A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007997; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Clarkson BK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009114; Costello J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0559-z; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Heyer EE, 2016, CELL, V164, P757, DOI 10.1016/j.cell.2016.01.003; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; Kaye NM, 2009, J BIOL CHEM, V284, P17742, DOI 10.1074/jbc.M109.009001; Lee D, 2010, J MOL BIOL, V399, P562, DOI 10.1016/j.jmb.2010.04.034; Ling J, 2002, MOL CELL BIOL, V22, P7853, DOI 10.1128/MCB.22.22.7853-7867.2002; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Merrick WC, 2010, J BIOL CHEM, V285, P21197, DOI 10.1074/jbc.R110.111476; Ohn T, 2007, NUCLEIC ACIDS RES, V35, P3002, DOI 10.1093/nar/gkm196; Park EH, 2011, EMBO J, V30, P302, DOI 10.1038/emboj.2010.312; Pavitt GD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-323; Rajyaguru P, 2012, MOL CELL, V45, P244, DOI 10.1016/j.molcel.2011.11.026; Richardson R, 2012, MOL GENET GENOMICS, V287, P711, DOI 10.1007/s00438-012-0709-5; Rivera CI, 2008, VIROLOGY, V375, P59, DOI 10.1016/j.virol.2008.02.002; Segal SP, 2006, MOL CELL BIOL, V26, P5120, DOI 10.1128/MCB.01913-05; Singh CR, 2014, MOL CELL BIOL, V34, P3978; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; van den Elzen AMG, 2014, EMBO J, V33, P265, DOI 10.1002/embj.201386123; Viswanathan P, 2004, J BIOL CHEM, V279, P23988, DOI 10.1074/jbc.M402803200; Viswanathan P, 2003, J BIOL CHEM, V278, P14949, DOI 10.1074/jbc.M211794200; von Moeller H, 2013, NUCLEIC ACIDS RES, V41, P7960, DOI 10.1093/nar/gkt558; Wang X, 2012, PROTEIN SCI, V21, P1253, DOI 10.1002/pro.2110; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Yanagiya A, 2009, MOL CELL BIOL, V29, P1661, DOI 10.1128/MCB.01187-08; Yao G, 2007, MOL CELL BIOL, V27, P6243, DOI 10.1128/MCB.00734-07; Zhang CX, 2014, PROTEIN SCI, V23, P1036, DOI 10.1002/pro.2490; Zhang CX, 2013, MOL GENET GENOMICS, V288, P401, DOI 10.1007/s00438-013-0759-3	44	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150616	10.1371/journal.pone.0150616	http://dx.doi.org/10.1371/journal.pone.0150616			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953568	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300036
J	Wasfi, R; Elkhatib, WF; Khairalla, AS				Wasfi, Reham; Elkhatib, Walid F.; Khairalla, Ahmed S.			Effects of Selected Egyptian Honeys on the Cellular Ultrastructure and the Gene Expression Profile of Escherichia coli	PLOS ONE			English	Article							MANUKA HONEY; ANTIBACTERIAL ACTIVITY; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; STAPHYLOCOCCUS-AUREUS; STRESS-RESPONSE; HIGH PREVALENCE; FLORAL SOURCES; WOUND CARE; INFECTIONS	The purpose of this study was to: (i) evaluate the antibacterial activities of three Egyptian honeys collected from different floral sources (namely, citrus, clover, and marjoram) against Escherichia coli; (ii) investigate the effects of these honeys on bacterial ultrastructure; and (iii) assess the anti-virulence potential of these honeys, by examining their impacts on the expression of eight selected genes (involved in biofilm formation, quorum sensing, and stress survival) in the test organism. The minimum inhibitory concentration (MIC) of the honey samples against E. coli ATCC 8739 were assessed by the broth microdilution assay in the presence and absence of catalase enzyme. Impacts of the honeys on the cellular ultrastructure and the expression profiles of the selected genes of E. coli were examined using transmission electron microscopy (TEM) and quantitative real-time polymerase chain reaction (qPCR) analysis, respectively. The susceptibility tests showed promising antibacterial activities of all the tested honeys against E. coli. This was supported by the TEM observations, which revealed "ghost" cells lacking DNA, in addition to cells with increased vacuoles, and/or with irregular shrunken cytoplasm. Among the tested honeys, marjoram exhibited the highest total antibacterial activity and the highest levels of peroxide-dependent activity. The qPCR analysis showed that all honey-treated cells share a similar overall pattern of gene expression, with a trend toward reduced expression of the virulence genes of interest. Our results indicate that some varieties of the Egyptian honey have the potential to be effective inhibitor and virulence modulator of E. coli via multiple molecular targets.	[Wasfi, Reham] October Univ Modern Sci & Arts MSA, Fac Pharm, Dept Microbiol & Immunol, Giza, Egypt; [Elkhatib, Walid F.] Ain Shams Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt; [Khairalla, Ahmed S.] Beni Suef Univ, Fac Pharm, Dept Microbiol & Immunol, Bani Suwayf, Egypt	Egyptian Knowledge Bank (EKB); Modern Sciences & Arts University (MSA); Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Beni Suef University	Khairalla, AS (corresponding author), Beni Suef Univ, Fac Pharm, Dept Microbiol & Immunol, Bani Suwayf, Egypt.	ahmedkhairalla@pharm.bsu.edu.eg	Elkhatib, Walid/AAT-2062-2021; Wasfi, Reham/M-8982-2017	Elkhatib, Walid/0000-0001-5815-3200; Wasfi, Reham/0000-0002-6747-5946; Khairalla, Ahmed/0000-0003-1204-1478				Abbas H. A., 2013, Asian Journal of Pharmaceutical Research, V3, P114; Abbas HA, 2014, ASIAN J APPL SCI, V2, P110; Abdelatif M, 2008, J Wound Care, V17, P108; Aboelsoud NH, 2010, J MED PLANTS RES, V4, P82; Abou-El-Kheir A, 1991, EGYPTIAN J FOOD SCI; Ahmer BMM, 2004, MOL MICROBIOL, V52, P933, DOI 10.1111/j.1365-2958.2004.04054.x; Al-Maaini RAS, 2011, HONEY ANTIMICROBIAL; Amal A. I. M., 2010, Annals of Agricultural Science (Cairo), V55, P221; Andreu V, 2015, MATERIALS, V8, P5154, DOI 10.3390/ma8085154; [Anonymous], 2009, OSTOMY WOUND MANAG, V55, P14; [Anonymous], 2014, AFRICAN J MICROBIOLO, DOI DOI 10.5897/ajmr2014.7110; Anthimidou E, 2013, J MED FOOD, V16, P42, DOI 10.1089/jmf.2012.0042; AOAC, 2007, OFFICIAL METHODS ANA, V18th; Badawy OFH, 2004, REV SCI TECH OIE, V23, P1011, DOI 10.20506/rst.23.3.1543; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Blair SE, 2009, EUR J CLIN MICROBIOL, V28, P1199, DOI 10.1007/s10096-009-0763-z; Bodei A, 1986, J AGR RES EGYPT; Boukraa L, 2007, J MED FOOD, V10, P712, DOI 10.1089/jmf.2006.256; Brudzynski K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00213; Cooper RA, 2002, J APPL MICROBIOL, V93, P857, DOI 10.1046/j.1365-2672.2002.01761.x; Cooper RA, 2001, EUR J CLIN MICROBIOL, V20, P758, DOI 10.1007/s100960100590; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Ejrnaes K, 2011, DAN MED BULL, V58; El Sohaimy S, 2015, ANN AGR SCI; El-Banby M, 1989, P 4 INT C AP TROP CL; El-Fadaly H., 1999, PAK J BIOL SCI, V2, P1; El-Kalyoubi M. H., 2013, Journal of Applied Sciences Research, V9, P5712; EL-Metwally AAE, 2015, FACTORS AFFECTING PH; El-Nagar KE, 2012, INT J CHEM, V4, P79; El-Sherbiny G, 1981, EGYPTIAN J FOOD SCI; Elbagoury E F, 1993, Egypt Dent J, V39, P381; Elbanna K., 2014, Asian Pacific Journal of Tropical Disease, V4, P194, DOI 10.1016/S2222-1808(14)60504-1; Ezzeddine NB, 2001, J ESSENT OIL RES, V13, P295, DOI 10.1080/10412905.2001.9699698; Farooqi A.A., 2010, CULTIVATION MED AROM; Hamdy AA, 2009, J EGYPT PUBLIC HEAL, V84, P245; Hamouda H. M., 2011, International Journal of Microbiological Research (IJMR), V2, P149; Hassanein SM, 2010, J AM SCI, V6, P301; Hegazi A., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P312; Hegazi A. G., 2011, Research Journal of Microbiology, V6, P488, DOI 10.3923/jm.2011.488.495; Henriques AF, 2011, EUR J CLIN MICROBIOL, V30, P167, DOI 10.1007/s10096-010-1065-1; Henriques AF, 2010, EUR J CLIN MICROBIOL, V29, P45, DOI 10.1007/s10096-009-0817-2; Ibrahim S.H., 1977, Agricultural Research Review (Cairo), V55, P125; Iftikhar F, 2010, PHYTOTHER RES, V24, P583, DOI 10.1002/ptr.2990; JARVIS WR, 1992, J ANTIMICROB CHEMOTH, V29, P19, DOI 10.1093/jac/29.suppl_A.19; Jenkins R, 2014, J ANTIMICROB CHEMOTH, V69, P603, DOI 10.1093/jac/dkt430; Jenkins R, 2011, J ANTIMICROB CHEMOTH, V66, P2536, DOI 10.1093/jac/dkr340; Johnson DW, 2005, J AM SOC NEPHROL, V16, P1456, DOI 10.1681/ASN.2004110997; Le TMV, 2009, J MED MICROBIOL, V58, P1585, DOI 10.1099/jmm.0.010033-0; Lee JH, 2011, BIOFOULING, V27, P1095, DOI 10.1080/08927014.2011.633704; Lemar KM, 2002, J APPL MICROBIOL, V93, P398, DOI 10.1046/j.1365-2672.2002.01707.x; Lotfy M, 2006, BRIT J BIOMED SCI, V63, P171, DOI 10.1080/09674845.2006.11732742; Lu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055898; Lund-Nielsen B, 2011, WOUND REPAIR REGEN, V19, P664, DOI 10.1111/j.1524-475X.2011.00735.x; Lusby PE, 2005, ARCH MED RES, V36, P464, DOI 10.1016/j.arcmed.2005.03.038; Majtan J, 2009, EPIDEMIOL MIKROBI IM, V58, P137; Mandal Manisha Deb, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P154, DOI 10.1016/S2221-1691(11)60016-6; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; Mishref A, 1989, 4 INT C AP TROP CLIM; Moghazy AM, 2010, DIABETES RES CLIN PR, V89, P276, DOI 10.1016/j.diabres.2010.05.021; Mohamed H, 2014, J DIABETES METAB, V5, DOI 10.4172/2155-6156.1000373; MOLAN PC, 1992, BEE WORLD, V73, P5, DOI 10.1080/0005772X.1992.11099109; Moreno PRH, 2013, CURR TOP MED CHEM, V13, P3040, DOI 10.2174/15680266113136660219; Mundo MA, 2004, INT J FOOD MICROBIOL, V97, P1, DOI 10.1016/j.ijfoodmicro.2004.03.025; Na-Bangchang Kesara, 2014, Trop Med Health, V42, P3, DOI 10.2149/tmh.2014-S01; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ng WJ, 2014, AFR J TRADIT COMPLEM, V11, P315, DOI 10.4314/ajtcam.v11i2.14; Nikpour Maryam, 2014, Oman Med J, V29, P255, DOI 10.5001/omj.2014.68; Nishino K, 2002, J BACTERIOL, V184, P2319, DOI 10.1128/JB.184.8.2319-2323.2002; NOUR ME, 1998, J AGR SCI MANSOURA U, V23, P1749; Ostrowska K, 2012, POSTEPY HIGIENY MEDY, V67, P1027; Owens CD, 2008, J HOSP INFECT, V70, P3, DOI 10.1016/S0195-6701(08)60017-1; Pecanac Marija, 2013, Med Pregl, V66, P263; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Quadri K. H. M., 1998, Journal of the American Society of Nephrology, V9, p180A; Roberts AEL, 2012, MICROBIOL-SGM, V158, P3005, DOI 10.1099/mic.0.062794-0; Shafik A, 2003, SCI AC CULT, V3, P27; Simon A, 2009, EVID-BASED COMPL ALT, V6, P165, DOI 10.1093/ecam/nem175; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Subrahmanyam M, 1998, BURNS, V24, P157, DOI 10.1016/S0305-4179(97)00113-7; TAHA E, 2012, J PLANT PROTEC PATHO, V3, P1211; Taha EA, 2010, J APICULT RES, V49, P202, DOI 10.3896/IBRA.1.49.2.10; Tan MK, 2012, EVIDENCE BASED COMPL, V2012; Tasleem Samiyah, 2013, J Ayub Med Coll Abbottabad, V25, P145; Tasleem Samiyah, 2011, J Ayub Med Coll Abbottabad, V23, P26; Tsukamoto N, 2013, CHEMOTHERAPY, V59, P379, DOI 10.1159/000361011; Uhlich GA, 2009, INFECT IMMUN, V77, P1543, DOI 10.1128/IAI.00949-08; Vandamme L, 2013, BURNS, V39, P1514, DOI 10.1016/j.burns.2013.06.014; Visavadia BG, 2008, BRIT J ORAL MAX SURG, V46, P55, DOI 10.1016/j.bjoms.2006.09.013; Wang A, 2013, PRIMARY CARE, V40, P687, DOI 10.1016/j.pop.2013.06.005; Wang R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00144; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Weber MM, 2010, MICROBIOL-SGM, V156, P139, DOI 10.1099/mic.0.031468-0; White-Ziegler CA, 2009, J BACTERIOL, V191, P1106, DOI 10.1128/JB.00599-08; Wu H, 2014, APPL MICROBIOL BIOT, V98, P10013, DOI 10.1007/s00253-014-6059-y; Zainol MI, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-129; Zampini IC, 2009, J ETHNOPHARMACOL, V124, P499, DOI 10.1016/j.jep.2009.05.011; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06; ZUMLA A, 1989, J ROY SOC MED, V82, P384, DOI 10.1177/014107688908200704	99	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150984	10.1371/journal.pone.0150984	http://dx.doi.org/10.1371/journal.pone.0150984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954570	Green Submitted, Green Published, gold			2022-12-27	WOS:000371991300068
J	Xing, F; Matsumiya, T; Hayakari, R; Yoshida, H; Kawaguchi, S; Takahashi, I; Nakaji, S; Imaizumi, T				Xing, Fei; Matsumiya, Tomoh; Hayakari, Ryo; Yoshida, Hidemi; Kawaguchi, Shogo; Takahashi, Ippei; Nakaji, Shigeyuki; Imaizumi, Tadaatsu			Alteration of Antiviral Signalling by Single Nucleotide Polymorphisms (SNPs) of Mitochondrial Antiviral Signalling Protein (MAVS)	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; INDUCIBLE GENE-I; DOUBLE-STRANDED-RNA; INNATE IMMUNE-RESPONSE; RIG-I; ADAPTER PROTEIN; ASSOCIATION; HELICASE; POPULATION; PHOSPHORYLATION	Genetic variation is associated with diseases. As a type of genetic variation occurring with certain regularity and frequency, the single nucleotide polymorphism (SNP) is attracting more and more attention because of its great value for research and real-life application. Mitochondrial antiviral signalling protein (MAVS) acts as a common adaptor molecule for retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), which can recognize foreign RNA, including viral RNA, leading to the induction of type I interferons (IFNs). Therefore, MAVS is thought to be a crucial molecule in antiviral innate immunity. We speculated that genetic variation of MAVS may result in susceptibility to infectious diseases. To assess the risk of viral infection based on MAVS variation, we tested the effects of twelve non-synonymous MAVS coding-region SNPs from the National Center for Biotechnology Information (NCBI) database that result in amino acid substitutions. We found that five of these SNPs exhibited functional alterations. Additionally, four resulted in an inhibitory immune response, and one had the opposite effect. In total, 1,032 human genomic samples obtained from a mass examination were genotyped at these five SNPs. However, no homozygous or heterozygous variation was detected. We hypothesized that these five SNPs are not present in the Japanese population and that such MAVS variations may result in serious immune diseases.	[Xing, Fei; Matsumiya, Tomoh; Hayakari, Ryo; Yoshida, Hidemi; Imaizumi, Tadaatsu] Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Vasc Biol, Hirosaki, Aomori, Japan; [Kawaguchi, Shogo] Hirosaki Univ, Grad Sch Med, Dept Gastroenterol & Hematol, Hirosaki, Aomori, Japan; [Takahashi, Ippei; Nakaji, Shigeyuki] Hirosaki Univ, Grad Sch Med, Dept Social Med, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University; Hirosaki University	Matsumiya, T (corresponding author), Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Vasc Biol, Hirosaki, Aomori, Japan.	tomo1027@hirosaki-u.ac.jp	KAWAGUCHI, Shogo/ADM-6097-2022; Matsumiya, Tomoh/ABA-5861-2021	KAWAGUCHI, Shogo/0000-0001-5599-1110; 	KAKENHI (Japan) [70711985, 26460567]; Hirosaki University Institutional Research Grant (Japan); Hirosaki University Institutional Research Grant for Young Scientists (Japan); Center of Innovation Science and Technology; Grants-in-Aid for Scientific Research [15K06766] Funding Source: KAKEN	KAKENHI (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hirosaki University Institutional Research Grant (Japan); Hirosaki University Institutional Research Grant for Young Scientists (Japan); Center of Innovation Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Young Scientists (B): KAKENHI (70711985 to FX, Japan), a Grant-in-Aid for Scientific Research (c): KAKENHI (26460567 to TM, Japan), a Hirosaki University Institutional Research Grant (to TI, Japan), and a Hirosaki University Institutional Research Grant for Young Scientists (to TM, Japan), and The Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program: Ministry of Education, Culture, Sports, Science and Technology ("Development of an innovative strategy for disease prediction and prevention by combining neuroscience research and analysis of "big health" data" to IT and SN, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by a Grant-in-Aid for Young Scientists (B): KAKENHI (70711985 to FX, Japan), a Grant-in-Aid for Scientific Research (c): KAKENHI (26460567 to TM, Japan), a Hirosaki University Institutional Research Grant (to TI, Japan), a Hirosaki University Institutional Research Grant for Young Scientists (to TM, Japan), and The Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program: Ministry of Education, Culture, Sports, Science and Technology ("Development of an innovative strategy for disease prediction and prevention by combining neuroscience research and analysis of "big health" data" to IT and SN, Japan).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Brubaker SW, 2014, CELL, V156, P800, DOI 10.1016/j.cell.2014.01.021; Clausen LN, 2014, J VIRAL HEPATITIS, V21, P578, DOI 10.1111/jvh.12188; Dempoya J, 2012, J VIROL, V86, P12760, DOI 10.1128/JVI.01881-12; Drahos J, 2009, J VIROL, V83, P11581, DOI 10.1128/JVI.01490-09; Hise AG, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003584; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hu JZ, 2010, J IMMUNOL, V185, P424, DOI 10.4049/jimmunol.0903291; Humphrey SJ, 2015, TRENDS ENDOCRIN MET, V26, P676, DOI 10.1016/j.tem.2015.09.013; Karamchandani-Patel G, 2011, ANN ALLERG ASTHMA IM, V107, P50, DOI 10.1016/j.anai.2011.03.009; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu XW, 2011, MOL BIOL REP, V38, P4583, DOI 10.1007/s11033-010-0590-4; Mandal RK, 2012, MOL BIOL REP, V39, P7263, DOI 10.1007/s11033-012-1556-5; Matsumiya T, 2011, ARCH IMMUNOL THER EX, V59, P41, DOI 10.1007/s00005-010-0107-9; Matsumiya T, 2010, CRIT REV IMMUNOL, V30, P489, DOI 10.1615/CritRevImmunol.v30.i6.10; Matsumiya T, 2009, J IMMUNOL, V182, P2717, DOI 10.4049/jimmunol.0802933; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Ovsyannikova IG, 2010, J INFECT DIS, V201, P207, DOI 10.1086/649588; Pothlichet J, 2011, EMBO MOL MED, V3, P142, DOI 10.1002/emmm.201000120; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Takeuchi F, 2011, CIRC J, V75, P911, DOI 10.1253/circj.CJ-10-0774; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Varzari A, 2014, J NEUROIMMUNOL, V277, P140, DOI 10.1016/j.jneuroim.2014.09.015; Vitour D, 2009, J BIOL CHEM, V284, P21797, DOI 10.1074/jbc.M109.018275; Wei CW, 2010, J IMMUNOL, V185, P1158, DOI 10.4049/jimmunol.0903874; Willie B, 2014, GENES IMMUN, V15, P569, DOI 10.1038/gene.2014.54; Xing F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045136; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zhang JH, 2014, GENE, V533, P385, DOI 10.1016/j.gene.2013.08.051	41	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151173	10.1371/journal.pone.0151173	http://dx.doi.org/10.1371/journal.pone.0151173			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954674	Green Published, gold			2022-12-27	WOS:000371991300093
J	Hilley, J; Truong, S; Olson, S; Morishige, D; Mullet, J				Hilley, Josie; Truong, Sandra; Olson, Sara; Morishige, Daryl; Mullet, John			Identification of Dw1, a Regulator of Sorghum Stem Internode Length	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; QUANTITATIVE TRAIT LOCI; PLANT HEIGHT; GENETIC MODEL; QTL; BIOMASS; ASSOCIATION; TRANSPORTER; POPULATION; COMPLEXITY	Sorghum is an important C4 grain and grass crop used for food, feed, forage, sugar, and biofuels. In its native Africa, sorghum landraces often grow to approximately 3-4 meters in height. Following introduction into the U.S., shorter, early flowering varieties were identified and used for production of grain. Quinby and Karper identified allelic variation at four loci designated Dw1-Dw4 that regulated plant height by altering the length of stem internodes. The current study used a map-based cloning strategy to identify the gene corresponding to Dw1. Hegari (Dw1dw2Dw3dw4) and 80M (dw1dw2Dw3dw4) were crossed and F-2 and HIF derived populations used for QTL mapping. Genetic analysis identified four QTL for internode length in this population, Dw1 on SBI-09, Dw2 on SBI-06, and QTL located on SBI-01 and SBI-07. The QTL on SBI-07 was similar to 3 Mbp upstream of Dw3 and interacted with Dw1. Dw1 was also found to contribute to the variation in stem weight in the population. Dw1 was fine mapped to an interval of similar to 33 kbp using HIFs segregating only for Dw1. A polymorphism in an exon of Sobic.009G229800 created a stop codon that truncated the encoded protein in 80M (dw1). This polymorphism was not present in Hegari (Dw1) and no other polymorphisms in the delimited Dw1 locus altered coding regions. The recessive dw1 allele found in 80M was traced to Dwarf Yellow Milo, the progenitor of grain sorghum genotypes identified as dw1. Dw1 encodes a putative membrane protein of unknown function that is highly conserved in plants.	[Hilley, Josie; Truong, Sandra; Olson, Sara; Morishige, Daryl; Mullet, John] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Mullet, J (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	jmullet@tamu.edu		Truong, Sandra/0000-0002-5561-139X	Perry Adkisson Chair in Agricultural Biology; Feedstock Genomics Program (NIFA) [2010-67009-21507]; Ceres, Inc.	Perry Adkisson Chair in Agricultural Biology; Feedstock Genomics Program (NIFA); Ceres, Inc.	This research was supported by the Perry Adkisson Chair in Agricultural Biology, the Feedstock Genomics Program (NIFA No. 2010-67009-21507), and Ceres, Inc.	[Anonymous], 1974, SORGHUM IMPROVEMENT; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Brown PJ, 2008, GENETICS, V180, P629, DOI 10.1534/genetics.108.092239; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; CASADY A. J., 1965, CROP SCI, V5, P385, DOI 10.2135/cropsci1965.0011183X000500050002x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Gill JR, 2014, BIOENERG RES, V7, P1026, DOI 10.1007/s12155-014-9445-5; GRAHAM D, 1966, CROP SCI, V6, P372, DOI 10.2135/cropsci1966.0011183X000600040024x; Higgins RH, 2014, G3-GENES GENOM GENET, V4, P1593, DOI 10.1534/g3.114.013318; Karper RE, 1932, AM NAT, V66, P511, DOI 10.1086/280457; Klein RR, 2008, CROP SCI, V48, pS12, DOI 10.2135/cropsci2007.06.0319tpg; Knoller AS, 2010, J EXP BOT, V61, P3689, DOI 10.1093/jxb/erq180; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li X, 2015, P NATL ACAD SCI USA, V112, P11823, DOI 10.1073/pnas.1509229112; Manichaikul A, 2009, GENETICS, V181, P1077, DOI 10.1534/genetics.108.094565; Mocoeur A, 2015, THEOR APPL GENET, V128, P1685, DOI 10.1007/s00122-015-2538-5; Monna L, 2002, DNA RES, V9, P11, DOI 10.1093/dnares/9.1.11; Morishige DT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-448; Morris GP, 2013, P NATL ACAD SCI USA, V110, P453, DOI 10.1073/pnas.1215985110; Mullet J, 2014, J EXP BOT, V65, P3479, DOI 10.1093/jxb/eru229; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Murray SC, 2008, CROP SCI, V48, P2165, DOI 10.2135/cropsci2008.01.0016; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Olson SN, 2012, BIOFUEL BIOPROD BIOR, V6, P640, DOI 10.1002/bbb.1357; Ordonio RL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05287; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; PEREIRA MG, 1995, THEOR APPL GENET, V90, P380, DOI 10.1007/BF00221980; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; QUINBY J. R., 1961, CROP SCI, V1, P8, DOI 10.2135/cropsci1961.0011183X000100010004x; QUINBY JR, 1954, AGRON J, V46, P211, DOI 10.2134/agronj1954.00021962004600050007x; Ritter KB, 2008, MOL BREEDING, V22, P367, DOI 10.1007/s11032-008-9182-6; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thurber CS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r68; Truong SK, 2015, GENETICS, V201, P1229, DOI 10.1534/genetics.115.178608; Tuinstra MR, 1997, THEOR APPL GENET, V95, P1005, DOI 10.1007/s001220050654; Wang S, 2012, WINDOWS QTL CARTOGRA; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	46	57	57	6	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151271	10.1371/journal.pone.0151271	http://dx.doi.org/10.1371/journal.pone.0151271			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963094	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000131
J	Tabet, F; Torres, LFC; Ong, KL; Shrestha, S; Choteau, SA; Barter, PJ; Clifton, P; Rye, KA				Tabet, Fatiha; Torres, Luisa F. Cuesta; Ong, Kwok Leung; Shrestha, Sudichhya; Choteau, Sebastien A.; Barter, Philip J.; Clifton, Peter; Rye, Kerry-Anne			High-Density Lipoprotein-Associated miR-223 Is Altered after Diet-Induced Weight Loss in Overweight and Obese Males	PLOS ONE			English	Article							MICRORNAS; EXPRESSION; PLASMA; CHOLESTEROL; SIGNATURE; RNAS	Background and Aims microRNAs (miRNAs) are small, endogenous non-coding RNAs that regulate metabolic processes, including obesity. The levels of circulating miRNAs are affected by metabolic changes in obesity, as well as in diet-induced weight loss. Circulating miRNAs are transported by high-density lipoproteins (HDL) but the regulation of HDL-associated miRNAs after diet-induced weight loss has not been studied. We aim to determine if HDL-associated miR-16, miR-17, miR-126, miR-222 and miR-223 levels are altered by diet-induced weight loss in overweight and obese males. Methods HDL were isolated from 47 subjects following 12 weeks weight loss comparing a high protein diet (HP, 30% of energy) with a normal protein diet (NP, 20% of energy). HDL-associated miRNAs (miR-16, miR-17, miR-126, miR-222 and miR-223) at baseline and after 12 weeks of weight loss were quantified by TaqMan miRNA assays. HDL particle sizes were determined by non-denaturing polyacrylamide gradient gel electrophoresis. Serum concentrations of human HDL constituents were measured immunoturbidometrically or enzymatically. Results miR-16, miR-17, miR-126, miR-222 and miR-223 were present on HDL from overweight and obese subjects at baseline and after 12 weeks of the HP and NP weight loss diets. The HP diet induced a significant decrease in HDL-associated miR-223 levels (p = 0.015), which positively correlated with changes in body weight (r = 0.488, p = 0.032). Changes in miR-223 levels were not associated to changes in HDL composition or size. Conclusion HDL-associated miR-223 levels are significantly decreased after HP diet-induced weight loss in overweight and obese males. This is the first study reporting changes in HDL-associated miRNA levels with diet-induced weight loss.	[Tabet, Fatiha; Torres, Luisa F. Cuesta; Ong, Kwok Leung; Shrestha, Sudichhya; Choteau, Sebastien A.; Barter, Philip J.; Rye, Kerry-Anne] Univ New S Wales, Sch Med Sci, Lipid Res Grp, Randwick, NSW, Australia; [Clifton, Peter] Univ S Australia, Sch Pharm & Med Sci, Div Hlth Sci, Adelaide, SA 5001, Australia	University of New South Wales Sydney; University of South Australia	Tabet, F (corresponding author), Univ New S Wales, Sch Med Sci, Lipid Res Grp, Randwick, NSW, Australia.	f.tabet@unsw.edu.au	Ong, Kwok Leung/B-9018-2009	Ong, Kwok Leung/0000-0001-7229-7614; Choteau, Sebastien/0000-0002-5128-7086	National Heat Foundation of Australian-Future Leader Fellowship [100090]; National Health and Medical Research Council of Australia [1037903]; National Heat Foundation of Australian [100090]	National Heat Foundation of Australian-Future Leader Fellowship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heat Foundation of Australian	Dr. Fatiha Tabet is supported by the National Heat Foundation of Australian-Future Leader Fellowship (Award ID 100090). This study was supported by the National Health and Medical Research Council of Australia (Grant 1037903).; We thank the Commonwealth Scientific and Industrial Research Organisation (CSIRO) Food and Nutrition Adelaide for providing access to the samples. We would like to thank A/Prof. Jennifer Keogh and Kristy Turner for facilitating the accessibility to the samples. Dr Fatiha Tabet is supported by the National Heat Foundation of Australian-Future Leader Fellowship (Award ID 100090). This study was supported by the National Health and Medical Research Council of Australia (Grant 1037903).	Arner E, 2012, DIABETES, V61, P1986, DOI 10.2337/db11-1508; Catalan V, 2011, J CLIN ENDOCR METAB, V96, P200, DOI 10.1210/jc.2010-0994; de Gonzalo-Calvo D, 2015, J APPL PHYSIOL, V119, P124, DOI 10.1152/japplphysiol.00077.2015; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Heneghan HM, 2011, J CLIN ENDOCR METAB, V96, pE846, DOI 10.1210/jc.2010-2701; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; IZZO C, 1981, CLIN CHEM, V27, P371; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Milagro FI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054319; Nielsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087308; Ogawa R, 2010, BIOCHEM BIOPH RES CO, V398, P723, DOI 10.1016/j.bbrc.2010.07.008; RAINWATER DL, 1992, J LIPID RES, V33, P1876; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2014, CLIN SCI, V126, P183, DOI 10.1042/CS20130203; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wen DZ, 2015, OBES RES CLIN PRACT, V9, P398, DOI 10.1016/j.orcp.2015.01.006; Wycherley TP, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.11; Xie HM, 2009, EXPERT OPIN THER TAR, V13, P1227, DOI 10.1517/14728220903190707; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357	23	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151061	10.1371/journal.pone.0151061	http://dx.doi.org/10.1371/journal.pone.0151061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26962854	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000371993000097
J	Yang, H; Wei, CL; Liu, HW; Wu, JL; Li, ZG; Zhang, L; Jian, JB; Li, YY; Tai, YL; Zhang, J; Zhang, ZZ; Jiang, CJ; Xia, T; Wan, XC				Yang, Hua; Wei, Chao-Ling; Liu, Hong-Wei; Wu, Jun-Lan; Li, Zheng-Guo; Zhang, Liang; Jian, Jian-Bo; Li, Ye-Yun; Tai, Yu-Ling; Zhang, Jing; Zhang, Zheng-Zhu; Jiang, Chang-Jun; Xia, Tao; Wan, Xiao-Chun			Genetic Divergence between Camellia sinensis and Its Wild Relatives Revealed via Genome-Wide SNPs from RAD Sequencing	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; INFERRING PHYLOGENY; GREEN TEA; IDENTIFICATION; DISCOVERY; MARKERS; CHLOROPLAST; DIVERSITY; TOOL; PHYLOGEOGRAPHY	Tea is one of the most popular beverages across the world and is made exclusively from cultivars of Camellia sinensis. Many wild relatives of the genus Camellia that are closely related to C. sinensis are native to Southwest China. In this study, we first identified the distinct genetic divergence between C. sinensis and its wild relatives and provided a glimpse into the artificial selection of tea plants at a genome-wide level by analyzing 15,444 genomic SNPs that were identified from 18 cultivated and wild tea accessions using a high-throughput genome-wide restriction site-associated DNA sequencing (RAD-Seq) approach. Six distinct clusters were detected by phylogeny inferrence and principal component and genetic structural analyses, and these clusters corresponded to six Camellia species/varieties. Genetic divergence apparently indicated that C. taliensis var. bangwei is a semi-wild or transient landrace occupying a phylogenetic position between those wild and cultivated tea plants. Cultivated accessions exhibited greater heterozygosity than wild accessions, with the exception of C. taliensis var. bangwei. Thirteen genes with non-synonymous SNPs exhibited strong selective signals that were suggestive of putative artificial selective footprints for tea plants during domestication. The genome-wide SNPs provide a fundamental data resource for assessing genetic relationships, characterizing complex traits, comparing heterozygosity and analyzing putatitve artificial selection in tea plants.	[Yang, Hua; Wei, Chao-Ling; Liu, Hong-Wei; Li, Zheng-Guo; Zhang, Liang; Li, Ye-Yun; Tai, Yu-Ling; Zhang, Jing; Zhang, Zheng-Zhu; Jiang, Chang-Jun; Xia, Tao; Wan, Xiao-Chun] Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Hefei 230036, Peoples R China; [Yang, Hua] Anhui Agr Univ, Sch Sci, Dept Appl Chem, Hefei 230036, Peoples R China; [Wu, Jun-Lan] Anhui Agr Univ, Sch Informat & Comp, Hefei 230036, Peoples R China; [Jian, Jian-Bo] BGI Shenzhen, Shenzhen 518083, Peoples R China	Anhui Agricultural University; Anhui Agricultural University; Anhui Agricultural University; Beijing Genomics Institute (BGI)	Wan, XC (corresponding author), Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Hefei 230036, Peoples R China.	xcwan@ahau.edu.cn	Zhang, Liang/F-7144-2015; Zhang, Liang/GWM-6088-2022; Li, Zhengguo/AAR-5191-2020	Zhang, Zhengzhu/0000-0003-1564-1428; Zhang, Liang/0000-0002-2279-2657	Major Project of the Chinese National Program for Fundamental Research and Development [2012CB722903]; Science and Technology Project of AnHui Province [13Z03012]; Tea Genome Project of AnHui Province, China; Program for Changjiang Scholars and Innovative Research Team in University [IRT1101]; National Natural Science Foundation of China [31300578]; Collegiate Natural Science Foundation of Anhui Province [KJ2013Z078]; Anhui Agricultural University [2014XKPY-34]; BGI-Shenzhen; Special Innovative Province Construction in Anhui Province [15czs08032]	Major Project of the Chinese National Program for Fundamental Research and Development; Science and Technology Project of AnHui Province; Tea Genome Project of AnHui Province, China; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collegiate Natural Science Foundation of Anhui Province; Anhui Agricultural University; BGI-Shenzhen; Special Innovative Province Construction in Anhui Province	This work received financial support from the Major Project of the Chinese National Program for Fundamental Research and Development (2012CB722903), the Science and Technology Project of AnHui Province (13Z03012) and the Tea Genome Project of AnHui Province, China grants to Xiao-Chun Wan, the Program for Changjiang Scholars and Innovative Research Team in University (IRT1101) grants to Zhengzhu Zhang, the National Natural Science Foundation of China (31300578), the Collegiate Natural Science Foundation of Anhui Province (KJ2013Z078), and the Academic backbone cultivation project of Anhui Agricultural University (2014XKPY-34) grants to Hua Yang. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BGI-Shenzhen provided support in the form of salaries for Jian-Bo Jian, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors are articulated in the 'author contributions' section.; We are very grateful to Dr. Ying Lu for constructive comments and assistance in revising the manuscript, Dr. Shancen Zhao for assistance with analyses of SNPs related to domestication, and four anonymous reviewers for insightful comments and suggestions. This work received financial support from the Major Project of the Chinese National Program for Fundamental Research and Development (2012CB722903), the Science and Technology Project of AnHui Province (13Z03012), the Special Innovative Province Construction in Anhui Province (15czs08032) and the Tea Genome Project of AnHui Province, China grants to Xiao-Chun Wan, the Program for Changjiang Scholars and Innovative Research Team in University (IRT1101) grants to Zhengzhu Zhang, the National Natural Science Foundation of China (31300578), the Collegiate Natural Science Foundation of Anhui Province (KJ2013Z078), and the Academic backbone cultivation project of Anhui Agricultural University (2014XKPY-34) grants to Hua Yang. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BGI-Shenzhen provided support in the form of salaries for JBJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these author are articulated in the 'author contributions' section.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Batley J, 2003, PLANT PHYSIOL, V132, P84, DOI 10.1104/pp.102.019422; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; CHANG HT, 1981, MONOGRAPHIC SERIES, V1, P1; Chen L, 2005, PLANT BREEDING, V124, P404, DOI 10.1111/j.1439-0523.2005.01100.x; Chen L, 2002, J HORTIC SCI BIOTECH, V77, P729, DOI 10.1080/14620316.2002.11511564; Chen LiAng, 2000, Journal of Tea Science, V20, P89; Chu ND, 2014, MOL ECOL, V23, P1863, DOI 10.1111/mec.12681; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Clark LV, 2015, J EXP BOT, V66, P4213, DOI 10.1093/jxb/eru511; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Deokar AA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-708; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Ellegren H, 2014, TRENDS ECOL EVOL, V29, P51, DOI 10.1016/j.tree.2013.09.008; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Fang WP, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.35; Fang Wei, 2010, Acta Botanica Yunnanica, V32, P1, DOI 10.3724/SP.J.1143.2010.00001; Fournier-Level A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-179; Greeff C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00209; HASIMOTO M, 1978, JPN J TROP AGR, V21, P93; Hipp A.L., 2013, INT OAK J, V24, P61; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Huang H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-151; Huang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064981; [季鹏章 JI Peng-zhang], 2009, [西南农业学报, Southwest China Journal of Agricultural Sciences], V22, P584; Jiang D, 2010, AGR SCI CHINA, V9, P179, DOI 10.1016/S1671-2927(09)60082-1; Li Bin, 1996, Journal of Tea Science, V16, P119; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Liu LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139840; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Liu Y, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-92; Ma JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128798; Mammadov JA, 2010, THEOR APPL GENET, V121, P577, DOI 10.1007/s00122-010-1331-8; McCouch SR, 2010, BREEDING SCI, V60, P524, DOI 10.1270/jsbbs.60.524; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Ming T. L., 2000, MONOGRAPH GENUS CAME; Ming T. L., 1992, THEA ACTA BOT YUNNAN, V14, P115; Mondal T.K., 2014, BREEDING BIOTECHNOLO, DOI [10.1007/978-81-322-1704-6, DOI 10.1007/978-81-322-1704-6]; Mondal TK, 2002, EUPHYTICA, V128, P307, DOI 10.1023/A:1021212419811; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Muraya MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132120; Nadeau NJ, 2013, MOL ECOL, V22, P814, DOI 10.1111/j.1365-294X.2012.05730.x; Nelson MR, 2004, GENOME RES, V14, P1664, DOI 10.1101/gr.2421604; Parchman TL, 2012, MOL ECOL, V21, P2991, DOI 10.1111/j.1365-294X.2012.05513.x; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pegadaraju V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-556; Ramirez M, 2005, PLANT PHYSIOL, V137, P1211, DOI 10.1104/pp.104.054999; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sharma RK, 2010, BIOCHEM GENET, V48, P549, DOI 10.1007/s10528-010-9338-z; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Simko I, 2006, GENETICS, V173, P2237, DOI 10.1534/genetics.106.060905; Singh R, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0224-6; Tai YL, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0574-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka J., 2006, CHAGYO KENKYU HOKOKU, V101, P1, DOI DOI 10.5979/CHA.2006.1; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Terol J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-423; Tian Min, 2008, Acta Horticulturae Sinica, V35, P1685; Truong HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037565; Wachira F, 2001, J HORTIC SCI BIOTECH, V76, P557; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; [王丽鸳 WANG Li-yuan], 2009, [茶叶科学, Journal of Tea Science], V29, P341; Wang XQ, 2013, MOL ECOL RESOUR, V13, P938, DOI 10.1111/1755-0998.12136; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073053; Yao MZ, 2012, TREE GENET GENOMES, V8, P205, DOI 10.1007/s11295-011-0433-z; Yu F., 1986, J TEA SCI, V6, P1; Yuan Y, 2015, INT J MOL SCI, V16, P521, DOI 10.3390/ijms16010521; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006; Zhai C, 2011, NEW PHYTOL, V189, P321, DOI 10.1111/j.1469-8137.2010.03462.x; Zhang CC, 2014, GENET MOL RES, V13, P5822, DOI 10.4238/2014.April.14.10; Zhang W, 2009, AUST SYST BOT, V22, P286, DOI 10.1071/SB08027; Zhou GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133161; Zhu YL, 2003, GENETICS, V163, P1123	84	45	52	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151424	10.1371/journal.pone.0151424	http://dx.doi.org/10.1371/journal.pone.0151424			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26962860	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000152
J	Allin, B; Aveyard, N; Campion-Smith, T; Floyd, E; Kimpton, J; Swarbrick, K; Williams, E; Knight, M				Allin, Benjamin; Aveyard, Nicholas; Campion-Smith, Timothy; Floyd, Eleanor; Kimpton, James; Swarbrick, Kate; Williams, Emma; Knight, Marian			What Evidence Underlies Clinical Practice in Paediatric Surgery? A Systematic Review Assessing Choice of Study Design	PLOS ONE			English	Review							IDEAL FRAMEWORK; TRIALS; STATE	Objective Identify every paediatric surgical article published in 1998 and every paediatric surgical article published in 2013, and determine which study designs were used and whether they were appropriate for robustly assessing interventions in surgical conditions. Methods A systematic review was conducted according to a pre-specified protocol (CRD42014007629), using EMBASE and Medline. Non-English language studies were excluded. Studies were included if meeting population criteria and either condition or intervention criteria. Population: Children under the age of 18, or adults who underwent intervention for a condition managed by paediatric surgeons when they were under 18 years of age. Condition: Onemanaged by general paediatric surgeons. Intervention: Used for treatment of a condition managed by general paediatric surgeons. Main Outcome Measure Studies were classified according to whether the IDEAL collaboration recommended their design for assessing surgical interventions or not. Change in proportions between 1998 and 2013 was calculated. Results 1581 paediatric surgical articles were published in 1998, and 3453 in 2013. The most commonly used design, accounting for 45% of studies in 1998 and 46.8% in 2013, was the retrospective case series. Only 1.8% of studies were RCTs in 1998, and 1.9% in 2013. Overall, in 1998, 9.8% of studies used a recommended design. In 2013, 11.9% used a recommended design (proportion increase 2.3%, 95% confidence interval 0.5% increase to 4% increase, p = 0.017). Conclusions and Relevance A low proportion of published paediatric surgical manuscripts utilise a design that is recommended for assessing surgical interventions. RCTs represent fewer than 1 in 50 studies. In 2013, 88.1% of studies used a less robust design, suggesting the need for a new way of approaching paediatric surgical research.	[Allin, Benjamin; Knight, Marian] Radcliffe Infirm, Natl Perinatal Epidemiol Unit, Oxford OX2 6HE, England; [Allin, Benjamin] Oxford Childrens Hosp, Dept Paediat Surg, Oxford, England; [Aveyard, Nicholas; Campion-Smith, Timothy; Kimpton, James] Univ Oxford, Sch Med, Oxford, England; [Floyd, Eleanor; Swarbrick, Kate; Williams, Emma] Royal Berkshire Hosp NHS Trust, Reading, Berks, England; [Swarbrick, Kate; Williams, Emma] Oxford Univ Hosp NHS Trust, Oxford, England	Radcliffe Infirmary; University of Oxford; University of Oxford; Royal Berkshire Hospital; Oxford University Hospitals NHS Foundation Trust	Allin, B (corresponding author), Radcliffe Infirm, Natl Perinatal Epidemiol Unit, Oxford OX2 6HE, England.; Allin, B (corresponding author), Oxford Childrens Hosp, Dept Paediat Surg, Oxford, England.	benjaminallin@doctors.org.uk	Knight, Marian/B-6225-2009	Knight, Marian/0000-0002-1984-4575; Williams, Emma/0000-0001-6480-468X; Kimpton, James/0000-0002-7890-6182; Aveyard, Nicholas/0000-0002-3519-7582; Kimpton, James/0000-0002-7303-6309	National Institute for Health Research (NIHR) Professorship; National Institute for Health Research (NIHR) Academic Clinical Fellowship; National Institute for Health Research (NIHR); National Institute for Health Research [ACF-2012-13-012, NIHR-RP-011-032] Funding Source: researchfish	National Institute for Health Research (NIHR) Professorship(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) Academic Clinical Fellowship(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Marian Knight is funded by a National Institute for Health Research (NIHR) Professorship. Benjamin Allin is partly funded by a National Institute for Health Research (NIHR) Academic Clinical Fellowship. This paper presents independent research partially funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Allin BSR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116908; Azzopardi D, 2016, LANCET NEUROL, V15, P145, DOI 10.1016/S1474-4422(15)00347-6; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Burge DM, 2013, BRIT J SURG, V100, P515, DOI 10.1002/bjs.9019; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Cook JA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2820; Costeloe K, 2016, LANCET, V387, P649, DOI 10.1016/S0140-6736(15)01027-2; Davies SC, 2013, ANN REPORT CHIEF MED; Ergina PL, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3011; Hardin WD, 1999, J PEDIATR SURG, V34, P908, DOI 10.1016/S0022-3468(99)90396-2; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; McCulloch P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3012; Moreton RBR, 2016, EYE, V30, P577, DOI 10.1038/eye.2015.280; Moss RL, 2001, J PEDIATR SURG, V36, P1182, DOI 10.1053/jpsu.2001.25749; Nair MC, 2016, INDOSS ASSA IN PRESS; Ostlie DJ, 2010, J PEDIATR SURG, V45, P1940, DOI 10.1016/j.jpedsurg.2010.05.008; Shribman S, 2012, NHS ATLAS VARIATION; Skarsgard ED, 2008, J PEDIATR SURG, V43, P30, DOI 10.1016/j.jpedsurg.2007.09.011; Stenson B, 2011, NEW ENGL J MED, V364, P1680, DOI 10.1056/NEJMc1101319; Zani-Ruttenstock E, 2015, PEDIATR SURG INT, V31, P53, DOI 10.1007/s00383-014-3624-5	20	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150864	10.1371/journal.pone.0150864	http://dx.doi.org/10.1371/journal.pone.0150864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959824	Green Submitted, gold, Green Published			2022-12-27	WOS:000371992300082
J	Duscharla, D; Bhumireddy, SR; Lakshetti, S; Pospisil, H; Murthy, PVLN; Walther, R; Sripadi, P; Ummanni, R				Duscharla, Divya; Bhumireddy, Sudarshana Reddy; Lakshetti, Sridhar; Pospisil, Heike; Murthy, P. V. L. N.; Walther, Reinhard; Sripadi, Prabhakar; Ummanni, Ramesh			Prostate Cancer Associated Lipid Signatures in Serum Studied by ESI-Tandem Mass Spectrometryas Potential New Biomarkers	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; PLASMA; RISK; GROWTH; PHOSPHOLIPIDS; EXTRACTION; EXPRESSION; PROFILES; ANTIGEN; OMEGA-3	Prostate cancer (PCa) is one amongst the most common cancersin western men. Incidence rate ofPCa is on the rise worldwide. The present study deals with theserum lipidome profiling of patients diagnosed with PCa to identify potential new biomarkers. We employed ESIMS/MS and GC-MS for identification of significantly altered lipids in cancer patient's serum compared to controls. Lipidomic data revealed 24 lipids are significantly altered in cancer patinet's serum (n = 18) compared to normal (n = 18) with no history of PCa. By using hierarchical clustering and principal component analysis (PCA) we could clearly separate cancer patients from control group. Correlation and partition analysis along with Formal Concept Analysis (FCA) have identified that PC (39:6) and FA (22:3) could classify samples with higher certainty. Both the lipids, PC (39:6) and FA (22:3) could influence the cataloging of patients with 100% sensitivity (all 18 control samples are classified correctly) and 77.7% specificity (of 18 tumor samples 4 samples are misclassified) with p-value of 1.612x10(-6) in Fischer's exact test. Further, we performed GC-MS to denote fatty acids altered in PCa patients and found that alpha-linolenic acid (ALA) levels are altered in PCa. We also performed an in vitro proliferation assay to determine the effect of ALA in survival of classical human PCa cell lines LNCaP and PC3. We hereby report that the altered lipids PC (39: 6) and FA (22: 3) offer a new set of biomarkers in addition to the existing diagnostic tests that could significantly improve sensitivity and specificity in PCa diagnosis.	[Duscharla, Divya; Ummanni, Ramesh] Indian Inst Chem Technol, Ctr Chem Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India; [Duscharla, Divya; Bhumireddy, Sudarshana Reddy; Sripadi, Prabhakar; Ummanni, Ramesh] Indian Inst Chem Technol, Ctr Acad Sci & Innovat Res, CSIR, Hyderabad 500007, Andhra Pradesh, India; [Bhumireddy, Sudarshana Reddy; Lakshetti, Sridhar; Sripadi, Prabhakar] Indian Inst Chem Technol, CSIR, Natl Ctr Mass Spectrometry, Hyderabad 500007, Andhra Pradesh, India; [Pospisil, Heike] Tech Univ, High Performance Comp Life Sci, Wildau, Germany; [Murthy, P. V. L. N.] Nizams Inst Med Sci, Dept Urol, Hyderabad, Andhra Pradesh, India; [Walther, Reinhard] Univ Greifswald, Dept Med Biochem & Mol Biol, Greifswald, Germany	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Nizam's Institute of Medical Sciences; Ernst Moritz Arndt Universitat Greifswald	Ummanni, R (corresponding author), Indian Inst Chem Technol, Ctr Chem Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India.; Ummanni, R (corresponding author), Indian Inst Chem Technol, Ctr Acad Sci & Innovat Res, CSIR, Hyderabad 500007, Andhra Pradesh, India.	ummanni@iict.res.in	Pospisil, Heike/G-7377-2016		Department of Biotechnology (DBT), Ministry of Science of Technology, India [6242-P-54/RGCB/PMD/DBT/RHUN/2015]; Council for Scientific and Industrial Research (CSIR), India	Department of Biotechnology (DBT), Ministry of Science of Technology, India; Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The project is supported by Department of Biotechnology (DBT), Ministry of Science of Technology, India. Grant No: 6242-P-54/RGCB/PMD/DBT/RHUN/2015. DD Acknowledges Council for Scientific and Industrial Research (CSIR), India for CSIR-JRF fellowship and AcSIR for registering as graduate student.	Andersson SO, 1996, INT J CANCER, V68, P716; Aronson WJ, 2011, CANCER PREV RES, V4, P2062, DOI 10.1158/1940-6207.CAPR-11-0298; Azrad M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053104; Bassett JK, 2013, INT J CANCER, V133, P1882, DOI 10.1002/ijc.28203; Bird SS, 2011, ANAL CHEM, V83, P940, DOI 10.1021/ac102598u; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Cequier-Sanchez E, 2008, J AGR FOOD CHEM, V56, P4297, DOI 10.1021/jf073471e; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Crowe FL, 2008, AM J CLIN NUTR, V88, P1353, DOI 10.3945/ajcn.2008.26369; De Stefani E, 2000, CANCER EPIDEM BIOMAR, V9, P335; DEVRIES CEE, 1992, ANTICANCER RES, V12, P1513; Dwivedi S, 2011, ASIAN PAC J CANCER P, V12, P1843; Ekroos K, 2010, CURR ATHEROSCLER REP, V12, P273, DOI 10.1007/s11883-010-0110-y; Everley PA, 2006, J PROTEOME RES, V5, P1224, DOI 10.1021/pr0504891; Gadomska H, 2005, EUR J OBSTET GYN R B, V120, P87, DOI 10.1016/j.ejogrb.2004.02.045; GANN PH, 1994, J NATL CANCER I, V86, P281, DOI 10.1093/jnci/86.4.281; Ghosh J, 1998, NUTRITION, V14, P48; Ghosh J, 1997, BIOCHEM BIOPH RES CO, V235, P418, DOI 10.1006/bbrc.1997.6799; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P1571, DOI 10.1093/jnci/85.19.1571; Gorke R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-126; Goyens PL, 2006, AM J CLIN NUTR, V84, P44, DOI 10.1093/ajcn/84.1.44; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han XL, 2003, J LIPID RES, V44, P1071, DOI 10.1194/jlr.R300004-JLR200; Harvei S, 1997, INT J CANCER, V71, P545, DOI 10.1002/(SICI)1097-0215(19970516)71:4<545::AID-IJC7>3.0.CO;2-U; Hayashi N, 2012, BJU INT, V109, P515, DOI 10.1111/j.1464-410X.2011.10358.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kerwin JL, 1996, J MASS SPECTROM, V31, P184, DOI 10.1002/(SICI)1096-9888(199602)31:2<184::AID-JMS283>3.0.CO;2-2; Lexander H, 2006, PROTEOMICS, V6, P4370, DOI 10.1002/pmic.200600148; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Meehan KL, 2002, PROSTATE, V50, P54, DOI 10.1002/pros.10032; Mehdi Kaytoue1 Se DSOKaAN, 2009, 2 FCA BASED METHODS, P251; Motameny S, 2008, LECT NOTES ARTIF INT, V4933, P229, DOI 10.1007/978-3-540-78137-0_17; Nilsson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011411; Ollero M, 2011, J LIPID RES, V52, P1011, DOI 10.1194/jlr.P013722; Pandalai PK, 1996, ANTICANCER RES, V16, P815; Pang J, 2010, J PROTEOME RES, V9, P216, DOI 10.1021/pr900953s; Patel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088841; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Polascik TJ, 1999, J UROLOGY, V162, P293, DOI 10.1016/S0022-5347(05)68543-6; Qadir MI, 2008, EUR J GYNAECOL ONCOL, V29, P158; Roberts F, 1989, CONCEPTUAL SCALING, P139; Rose DP, 1997, AM J CLIN NUTR, V66, P1513; ROSE DP, 1991, PROSTATE, V18, P243, DOI 10.1002/pros.2990180306; Sanchez-Avila N, 2009, J CHROMATOGR A, V1216, P6864, DOI 10.1016/j.chroma.2009.08.045; SCARDINO PT, 1989, UROL CLIN N AM, V16, P635; Shah FD, 2008, INTEGR CANCER THER, V7, P33, DOI 10.1177/1534735407313883; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Sterin M, 2004, BREAST CANCER RES TR, V87, P1, DOI 10.1023/B:BREA.0000041572.07837.ec; Szachowicz-Petelska B, 2007, MOL CELL BIOCHEM, V294, P237, DOI 10.1007/s11010-006-9264-x; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Ummanni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016833; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yamada K, 1998, INT J EPIDEMIOL, V27, P794, DOI 10.1093/ije/27.5.794; Zhou JR, 1997, AM J CLIN NUTR, V66, P1572; Zhou XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048889	59	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150253	10.1371/journal.pone.0150253	http://dx.doi.org/10.1371/journal.pone.0150253			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26958841	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300041
J	Baglioni, C; Nissen, C; Schweinoch, A; Riemann, D; Spiegelhalder, K; Berger, M; Weiller, C; Sterr, A				Baglioni, Chiara; Nissen, Christoph; Schweinoch, Adrian; Riemann, Dieter; Spiegelhalder, Kai; Berger, Mathias; Weiller, Cornelius; Sterr, Annette			Polysomnographic Characteristics of Sleep in Stroke: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							DAYTIME SLEEPINESS; MENTAL-HEALTH; INSOMNIA; APNEA; EEG; PERFORMANCE; MOVEMENTS; SYMPTOMS; DISEASE; QUALITY	Background Research on sleep after stroke has focused mainly on sleep disordered breathing. However, the extend to which sleep physiology is altered in stroke survivors, how these alterations compare to healthy volunteers, and how sleep changes might affect recovery as well as physical and mental health has yet to be fully researched. Motivated by the view that a deeper understanding of sleep in stroke is needed to account for its role in health and wellbeing as well as its relevance for recovery and rehabilitation, we conducted a systematic review and meta-analysis of polysomnographic studies comparing stroke to control populations. Method Medline and PsycInfo databases were searched using "stroke" and words capturing polysomnographic parameters as search terms. This yielded 1692 abstracts for screening, with 15 meeting the criteria for systematic review and 9 for meta-analysis. Prisma best practice guidelines were followed for the systematic review; the Comprehensive Meta-Analysis software was used for random effects modelling. Results The meta-analysis revealed that patients with stroke have poorer sleep than controls. Patients had lower sleep efficiency (mean 75% vs 84%), shorter total-sleep-time (309.4 vs 340.3 min) and more wake-after-sleep-onset (97.2 vs 53.8 min). Patients also spend more time in stage 1 (13% vs 10%) and less time in stage 2 sleep (36% vs 45%) and slow-wave-sleep (10% vs 12%). No group differences were identified for REM sleep. The systematic review revealed a strong bias towards studies in the early recovery phase of stroke, with no study reporting specifically on patients in the chronic state. Moreover, participants in the control groups included community samples as well as other patients groups. Conclusions These results indicate poorer sleep in patients with stroke than controls. While strongly suggestive in nature, the evidence base is limited and methodologically diverse, and hands a clear mandate for further research. A particular need regards polysomnographic studies in chronic community-dwelling patients compared to age-matched individuals.	[Baglioni, Chiara; Nissen, Christoph; Schweinoch, Adrian; Riemann, Dieter; Spiegelhalder, Kai; Berger, Mathias] Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Freiburg, Germany; [Weiller, Cornelius] Univ Med Ctr Freiburg, Dept Neurol, Freiburg, Germany; [Sterr, Annette] Univ Surrey, Sch Psychol, Guildford GU2 5XH, Surrey, England; [Sterr, Annette] Univ Sao Paulo, Dept Neurol, Sao Paulo, Brazil	University of Freiburg; University of Freiburg; University of Surrey; Universidade de Sao Paulo	Sterr, A (corresponding author), Univ Surrey, Sch Psychol, Guildford GU2 5XH, Surrey, England.; Sterr, A (corresponding author), Univ Sao Paulo, Dept Neurol, Sao Paulo, Brazil.	a.sterr@surrey.ac.uk	Riemann, Dieter/R-4013-2019; Nissen, Christoph/C-7642-2015; Baglioni, Chiara/AAC-2605-2019; Baglioni, Chiara/ABC-3423-2020; Spiegelhalder, Kai/B-7861-2019	Nissen, Christoph/0000-0001-9809-0275; Riemann, Dieter/0000-0002-1968-6220; Sterr, Annette/0000-0003-4490-985X	University of Freiburg; University of Surrey; Else Kroner Fresenius-Stiftung, Germany; Medical Research Council [G0200128] Funding Source: researchfish; MRC [G0200128] Funding Source: UKRI	University of Freiburg; University of Surrey; Else Kroner Fresenius-Stiftung, Germany; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded through in-house resources of the University of Freiburg (lab costs and salaries of all authors except A. Sterr) and University of Surrey (salary of A. Sterr). KS gratefully acknowledges the support from The Else Kroner Fresenius-Stiftung, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LM, 2013, BRIT J PSYCHIAT, V203, P453, DOI 10.1192/bjp.bp.113.128355; Arzt M, 2010, STROKE, V41, pE129, DOI 10.1161/STROKEAHA.109.566463; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bakken LN, 2014, J ADV NURS, V70, P639, DOI 10.1111/jan.12228; Bakken LN, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/936298; Bassetti C, 1999, SLEEP, V22, P217, DOI 10.1093/sleep/22.2.217; Bassetti Claudio L, 2011, Handb Clin Neurol, V99, P1051, DOI 10.1016/B978-0-444-52007-4.00021-7; Bassetti CL, 2001, SLEEP MED, V2, P185, DOI 10.1016/S1389-9457(00)00071-X; Bliwise DL, 2002, J GERIATR PSYCH NEUR, V15, P61, DOI 10.1177/089198870201500202; Dworzynski K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3615; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; GIUBILEI F, 1992, ACTA NEUROL SCAND, V86, P567, DOI 10.1111/j.1600-0404.1992.tb05488.x; Goldman SE, 2007, SLEEP, V30, P1317, DOI 10.1093/sleep/30.10.1317; Gottselig JM, 2002, BRAIN, V125, P373, DOI 10.1093/brain/awf021; Gruber R, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0500-x; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Hermann DM, 2009, NEUROLOGY, V73, P1313, DOI 10.1212/WNL.0b013e3181bd137c; Herron K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/794086; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; HUDGEL DW, 1993, CHEST, V104, P1503, DOI 10.1378/chest.104.5.1503; Lerdal A, 2009, J PAIN SYMPTOM MANAG, V38, P928, DOI 10.1016/j.jpainsymman.2009.04.028; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; McArdle N, 2003, STROKE, V34, P2916, DOI 10.1161/01.STR.0000103748.31609.4E; MOHSENIN V, 1995, ARCH PHYS MED REHAB, V76, P71, DOI 10.1016/S0003-9993(95)80046-8; Muller C, 2002, EUR NEUROL, V48, P164, DOI 10.1159/000065509; Neumann M, 2014, J NEUROL SCI, V340, P178, DOI 10.1016/j.jns.2014.03.024; Nissen C, 2011, J SLEEP RES, V20, P129, DOI 10.1111/j.1365-2869.2010.00872.x; Ohayon MM, 2013, ANN NEUROL, V73, P785, DOI 10.1002/ana.23818; Palagini L, 2011, SLEEP MED REV, V15, P179, DOI 10.1016/j.smrv.2010.07.003; Pierce CA, 2008, ORGAN RES METHODS, V11, P188, DOI 10.1177/1094428106296641; Pinto LR, 2000, ARQ NEURO-PSIQUIAT, V58, P239, DOI 10.1590/S0004-282X2000000200006; Reid KJ, 2006, AM J GERIAT PSYCHIAT, V14, P860, DOI 10.1097/01.JGP.0000206164.56404.ba; Roth T, 2007, J CLIN SLEEP MED, V3, pS7, DOI [10.5664/jcsm.26929, DOI 10.5664/JCSM.26929]; Santamaria J, 2000, SLEEP, V23, P333; Coelho FMS, 2010, J CLIN SLEEP MED, V6, P428; Sarasso S, 2014, NEUROREHAB NEURAL RE, V28, P129, DOI 10.1177/1545968313498651; Siccoli MM, 2008, EUR J NEUROL, V15, P565, DOI 10.1111/j.1468-1331.2008.02119.x; Siengsukon CF, 2009, NEUROSCI LETT, V451, P1, DOI 10.1016/j.neulet.2008.12.040; Sivertsen B, 2009, J PSYCHOSOM RES, V67, P109, DOI 10.1016/j.jpsychores.2009.05.001; Smagula SF, 2013, J GERONTOL B; SPIELMAN AJ, 1986, CLIN PSYCHOL REV, V6, P11, DOI 10.1016/0272-7358(86)90015-2; Spira AP, 2014, J GERONTOL B-PSYCHOL, V69, pS35, DOI 10.1093/geronb/gbu116; Sterr A, 2008, BRAIN INJURY, V22, P575, DOI 10.1080/02699050802189727; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; Terzoudi A, 2009, EUR NEUROL, V61, P16, DOI 10.1159/000165344; Vock J, 2002, J SLEEP RES, V11, P331, DOI 10.1046/j.1365-2869.2002.00316.x; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Wallace DM, 2012, INT J STROKE, V7, P231, DOI 10.1111/j.1747-4949.2011.00760.x; Yokoyama E, 1996, BRAIN TOPOGR, V8, P269, DOI 10.1007/BF01184783	49	31	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0148496	10.1371/journal.pone.0148496	http://dx.doi.org/10.1371/journal.pone.0148496			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26949966	gold, Green Submitted, Green Published			2022-12-27	WOS:000371990100006
J	Baranski, P; Pietrzak, P				Baranski, Przemyslaw; Pietrzak, Piotr			Computational Effective Fault Detection by Means of Signature Functions	PLOS ONE			English	Article							DIAGNOSIS; CIRCUITS; STATE	The paper presents a computationally effective method for fault detection. A system's responses are measured under healthy and ill conditions. These signals are used to calculate so-called signature functions that create a signal space. The current system's response is projected into this space. The signal location in this space easily allows to determine the fault. No classifier such as a neural network, hidden Markov models, etc. is required. The advantage of this proposed method is its efficiency, as computing projections amount to calculating dot products. Therefore, this method is suitable for real-time embedded systems due to its simplicity and undemanding processing capabilities which permit the use of low-cost hardware and allow rapid implementation. The approach performs well for systems that can be considered linear and stationary. The communication presents an application, whereby an industrial process of moulding is supervised. The machine is composed of forms (dies) whose alignment must be precisely set and maintained during the work. Typically, the process is stopped periodically to manually control the alignment. The applied algorithm allows on-line monitoring of the device by analysing the acceleration signal from a sensor mounted on a die. This enables to detect failures at an early stage thus prolonging the machine's life.	[Baranski, Przemyslaw] Lodz Univ Technol, Inst Elect, Wolczanska 211-215, Lodz, Poland; [Pietrzak, Piotr] Lodz Univ Technol, Dept Microelect & Comp Sci, Wolczanska 221-223, Lodz, Poland	Lodz University of Technology; Lodz University of Technology	Baranski, P (corresponding author), Lodz Univ Technol, Inst Elect, Wolczanska 211-215, Lodz, Poland.	przemyslaw.baranski@p.lodz.pl	Pietrzak, Piotr/R-1352-2019	Pietrzak, Piotr/0000-0003-1489-5274	Lodz University of Technology	Lodz University of Technology	The work was funded the by Lodz University of Technology grant: "Finansowanie dzialalnosci polegajacej na prowadzeniu badan naukowych lub prac rozwojowych oraz zadan z nimi zwiazanych, sluzacych rozwojowi mlodych naukowcow oraz uczestnikow studiow doktoranckich".	Bouthiba T., 2004, International Journal of Applied Mathematics and Computer Science, V14, P69; Brandt S., 1999, STAT COMPUTATIONAL M; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; Cui JA, 2010, METROL MEAS SYST, V17, P561; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Ge M, 2004, MECH SYST SIGNAL PR, V18, P391, DOI 10.1016/S0888-3270(03)00076-1; Ge M, 2008, IEEE T AUTOM SCI ENG, V5, P127, DOI 10.1109/TASE.2006.886833; Grzechca D, 2011, METROL MEAS SYST, V18, P555, DOI 10.2478/v10178-011-0054-8; Grzechca D, 2009, METROL MEAS SYST, V16, P583; Kuczynski A, 2009, METROL MEAS SYST, V16, P77; Lei YG, 2012, SENSORS-BASEL, V12, P2005, DOI 10.3390/s120202005; Liu ZK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125703; Majkowski A, 2014, METROL MEAS SYST, V21, P741, DOI 10.2478/mms-2014-0054; Nowicki A, 2012, INT J AP MAT COM-POL, V22, P939, DOI 10.2478/v10006-012-0070-1; Paynabar K, 2013, IIE TRANS, V45, P1235, DOI 10.1080/0740817X.2013.770187; Ruiz-Gonzalez R, 2014, SENSORS-BASEL, V14, P20713, DOI 10.3390/s141120713; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Tadeusiewicz M, 2011, METROL MEAS SYST, V18, P349, DOI 10.2478/v10178-011-0002-1; Tchakoua P, 2014, ENERGIES, V7, P2595, DOI 10.3390/en7042595; Tharrault Y, 2008, INT J APPL MATH COMP, V18, P429, DOI 10.2478/v10006-008-0038-3; Zhang CL, 2015, METROL MEAS SYST, V22, P251, DOI 10.1515/mms-2015-0025; Zhou C, 2015, ENTROPY-SWITZ, V17, P6379, DOI 10.3390/e17096379; Zhou SY, 2006, IEEE T AUTOM SCI ENG, V3, P60, DOI 10.1109/TASE.2005.859655	23	0	0	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150787	10.1371/journal.pone.0150787	http://dx.doi.org/10.1371/journal.pone.0150787			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26949942	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100060
J	Dedeoglu, B; Meijers, RWJ; Klepper, M; Hesselink, DA; Baan, CC; Litjens, NHR; Betjes, MGH				Dedeoglu, Burc; Meijers, Ruud W. J.; Klepper, Mariska; Hesselink, Dennis A.; Baan, Carla C.; Litjens, Nicolle H. R.; Betjes, Michiel G. H.			Loss of CD28 on Peripheral T Cells Decreases the Risk for Early Acute Rejection after Kidney Transplantation	PLOS ONE			English	Article							FLOW-CYTOMETRIC ANALYSIS; HEPATITIS-B VACCINATION; PANEL-REACTIVE ANTIBODY; FOLLOW-UP; DISEASE; LYMPHOCYTES; SUBSETS; MEMORY; GRAFT; CD8	Background End-stage renal disease patients have a dysfunctional, prematurely aged peripheral T-cell system. Here we hypothesized that the degree of premature T-cell ageing before kidney transplantation predicts the risk for early acute allograft rejection (EAR). Methods 222 living donor kidney transplant recipients were prospectively analyzed. EAR was defined as biopsy proven acute allograft rejection within 3 months after kidney transplantation. The differentiation status of circulating T cells, the relative telomere length and the number of CD31(+) naive T cells were determined as T-cell ageing parameters. Results Of the 222 patients analyzed, 30 (14%) developed an EAR. The donor age and the historical panel reactive antibody score were significantly higher (p = 0.024 and p = 0.039 respectively) and the number of related donor kidney transplantation was significantly lower (p = 0.018) in the EAR group. EAR-patients showed lower CD4(+)CD28null T-cell numbers (p<0.01) and the same trend was observed for CD8(+)CD28null T-cell numbers (p = 0.08). No differences regarding the other ageing parameters were found. A multivariate Cox regression analysis showed that higher CD4(+)CD28null T-cell numbers was associated with a lower risk for EAR (HR: 0.65, p = 0.028). In vitro, a significant lower percentage of alloreactive T cells was observed within CD28null T cells (p<0.001). Conclusion Immunological ageing-related expansion of highly differentiated CD28null T cells is associated with a lower risk for EAR.	[Dedeoglu, Burc; Meijers, Ruud W. J.; Klepper, Mariska; Hesselink, Dennis A.; Baan, Carla C.; Litjens, Nicolle H. R.; Betjes, Michiel G. H.] Erasmus MC, Dept Internal Med, Sect Nephrol & Transplantat, Rotterdam, South Holland, Netherlands	Erasmus University Rotterdam; Erasmus MC	Dedeoglu, B (corresponding author), Erasmus MC, Dept Internal Med, Sect Nephrol & Transplantat, Rotterdam, South Holland, Netherlands.	b.dedeoglu@erasmusmc.nl		Litjens, Nicolle/0000-0003-2504-1805; Betjes, Michiel/0000-0001-9435-6208; Baan, Carla/0000-0003-2274-2788	Dutch Kidney Foundation [KSPB.10.12]	Dutch Kidney Foundation	This study was funded by the Dutch Kidney Foundation (KSPB.10.12). Website: https://www.nierstichting.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263; Betjes MGH, 2008, KIDNEY INT, V74, P760, DOI 10.1038/ki.2008.301; Betjes MGH, 2013, J TRANSPLANT, V2013, DOI 10.1155/2013/841430; Betjes MGH, 2013, NAT REV NEPHROL, V9, P255, DOI 10.1038/nrneph.2013.44; Betjes MGH, 2012, TRANSPLANTATION, V94, P63, DOI 10.1097/TP.0b013e31825306ff; Betjes MGH, 2012, J NEPHROL, V25, P183, DOI 10.5301/jn.5000057; Betjes MGH, 2011, KIDNEY INT, V80, P209, DOI 10.1038/ki.2011.110; Betjes MGH, 2010, NEPHROL DIAL TRANSPL, V25, P3640, DOI 10.1093/ndt/gfq203; Boleslawski E, 2008, CLIN TRANSPLANT, V22, P494, DOI 10.1111/j.1399-0012.2008.00815.x; Bradley LM, 2005, TRENDS IMMUNOL, V26, P172, DOI 10.1016/j.it.2005.01.004; Dirks J, 2013, AM J TRANSPLANT, V13, P3132, DOI 10.1111/ajt.12480; Faravardeh A, 2013, TRANSPLANTATION, V96, P1089, DOI 10.1097/TP.0b013e3182a688e5; Franceschi C, 2000, VACCINE, V18, P1717, DOI 10.1016/S0264-410X(99)00513-7; GIRNDT M, 1995, AM J KIDNEY DIS, V26, P454, DOI 10.1016/0272-6386(95)90491-3; Heeger PS, 1999, J IMMUNOL, V163, P2267; Jimenez R, 2005, KIDNEY INT, V68, P11; Kato M, 2004, CLIN TRANSPLANT, V18, P242, DOI 10.1111/j.1399-0012.2004.00143.x; Koch S, 2008, IMMUN AGEING, V5, DOI [10.1186/1742-4933-5-6, 10.1186/1742-4933-5-11]; Kohler S, 2005, EUR J IMMUNOL, V35, P1987, DOI 10.1002/eji.200526181; Kruger S, 2001, AM J KIDNEY DIS, V38, P1264, DOI 10.1053/ajkd.2001.29223; Lee KW, 2004, TRANSPL P, V36, P2009, DOI 10.1016/j.transproceed.2004.08.137; Lim WH, 2015, TRANSPLANTATION, V99, P1043, DOI 10.1097/TP.0000000000000469; Litjens NHR, 2013, CLIN EXP IMMUNOL, V174, P179, DOI 10.1111/cei.12152; Litjens NHR, 2006, CLIN IMMUNOL, V118, P83, DOI 10.1016/j.clim.2005.09.007; Litjens NHR, 2008, J AM SOC NEPHROL, V19, P1483, DOI 10.1681/ASN.2007090971; Meijers RWJ, 2013, CLIN EXP IMMUNOL, V174, P424, DOI 10.1111/cei.12188; Meijers RWJ, 2014, TRANSPL INT, V27, P1272, DOI 10.1111/tri.12416; Meijers RWJ, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-19; Meijers Ruud Wj, 2014, World J Nephrol, V3, P268, DOI 10.5527/wjn.v3.i4.268; Nadareishvili ZG, 2004, NEUROLOGY, V63, P1446; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Nunes C, 2012, CLIN CANCER RES, V18, P678, DOI 10.1158/1078-0432.CCR-11-2630; Oetting WS, 2014, TRANSPLANTATION, V97, P325, DOI 10.1097/01.TP.0000436705.87898.88; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Stewart JH, 2009, NEPHROL DIAL TRANSPL, V24, P3225, DOI 10.1093/ndt/gfp331; Trzonkowski P, 2010, MECH AGEING DEV, V131, P96, DOI 10.1016/j.mad.2009.12.006; Vallejo AN, 2005, IMMUNOL REV, V205, P158, DOI 10.1111/j.0105-2896.2005.00256.x; van Leeuwen EMM, 2004, J IMMUNOL, V173, P1834, DOI 10.4049/jimmunol.173.3.1834; Vaziri ND, 2004, SEMIN NEPHROL, V24, P469, DOI 10.1016/j.semnephrol.2004.06.026; Verkade MA, 2004, KIDNEY INT, V66, P614, DOI 10.1111/j.1523-1755.2004.00781.x; Weinberger B, 2007, HUM IMMUNOL, V68, P86, DOI 10.1016/j.humimm.2006.10.019; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Weyand CM, 1998, MECH AGEING DEV, V102, P131, DOI 10.1016/S0047-6374(97)00161-9; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6; Yadav AK, 2011, NEPHROL DIAL TRANSPL, V26, P1689, DOI 10.1093/ndt/gfr010	47	30	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150826	10.1371/journal.pone.0150826	http://dx.doi.org/10.1371/journal.pone.0150826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950734	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100066
J	Brouwer, AF; Eisenberg, MC; Meza, R				Brouwer, Andrew F.; Eisenberg, Marisa C.; Meza, Rafael			Age Effects and Temporal Trends in HPV-Related and HPV-Unrelated Oral Cancer in the United States: A Multistage Carcinogenesis Modeling Analysis	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; COLORECTAL-CANCER; INCIDENCE CURVES; MORTALITY-RATES; COHORT MODELS; NECK-CANCER; PERIOD; LUNG; EPIDEMIOLOGY; PATTERNS	Differences in prognosis in HPV-positive and HPV-negative oral (oropharyngeal and oral cavity) squamous cell carcinomas (OSCCs) and increasing incidence of HPV-related cancers have spurred interest in demographic and temporal trends in OSCC incidence. We leverage multistage clonal expansion (MSCE) models coupled with age-period-cohort (APC) epidemiological models to analyze OSCC data in the SEER cancer registry (1973-2012). MSCE models are based on the initiation-promotion-malignant conversion paradigm in carcinogenesis and allow for interpretation of trends in terms of biological mechanisms. APC models seek to differentiate between the temporal effects of age, period, and birth cohort on cancer risk. Previous studies have looked at the effect of period and cohort on tumor initiation, and we extend this to compare model fits of period and cohort effects on each of tumor initiation, promotion, and malignant conversion rates. HPV-related, HPV-unrelated except oral tongue, and HPV-unrelated oral tongue sites are best described by placing period and cohort effects on the initiation rate. HPV-related and non-oral-tongue HPV-unrelated cancers have similar promotion rates, suggesting similar tumorigenesis dynamics once initiated. Estimates of promotion rates at oral tongue sites are lower, corresponding to a longer sojourn time; this finding is consistent with the hypothesis of an etiology distinct from HPV or alcohol and tobacco use. Finally, for the three subsite groups, men have higher initiation rates than women of the same race, and black people have higher promotion than white people of the same sex. These differences explain part of the racial and sex differences in OSCC incidence.	[Brouwer, Andrew F.; Eisenberg, Marisa C.; Meza, Rafael] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Meza, R (corresponding author), Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.	rmeza@umich.edu	Brouwer, Andrew/I-3951-2019	Brouwer, Andrew F./0000-0002-3779-5287	National Institutes for Health [U01CA182915]; University of Michigan MCubed Program; NIH [U01CA182915]; NATIONAL CANCER INSTITUTE [U01CA182915] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan MCubed Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes for Health Grant U01CA182915 (RM, ME, AB) (nih.gov) and University of Michigan MCubed Program (RM, ME, AB) (mcubed.umich.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grant U01CA182915 and the University of Michigan MCubed program.	Brouwer AF, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1314-0; Brown LM, 2011, CANCER CAUSE CONTROL, V22, P753, DOI 10.1007/s10552-011-9748-1; BROWN LM, 2012, J ONCOL, V2012, P49498, DOI DOI 10.1155/2012/649498; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406; Crump KS, 2005, RISK ANAL, V25, P921, DOI 10.1111/j.1539-6924.2005.00651.x; Dewanji A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002213; Gillison ML, 2012, VACCINE, V30, pF34, DOI 10.1016/j.vaccine.2012.05.070; Gravitt PE, 2013, J INFECT DIS, V207, P272, DOI 10.1093/infdis/jis660; Hazelton WD, 2006, J TOXICOL ENV HEAL A, V69, P1013, DOI 10.1080/00397910500360202; Heidenreich WF, 1997, RISK ANAL, V17, P391, DOI 10.1111/j.1539-6924.1997.tb00878.x; Holford TR, 2014, AM J PREV MED, V46, pE31, DOI 10.1016/j.amepre.2013.10.022; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; HOLFORD TR, 1983, BIOMETRICS, V39, P311, DOI 10.2307/2531004; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Jeon J, 2008, MATH BIOSCI, V213, P56, DOI 10.1016/j.mbs.2008.02.006; Jeon J, 2006, CANCER CAUSE CONTROL, V17, P971, DOI 10.1007/s10552-006-0037-3; Kerr WC, 2004, ADDICTION, V99, P1111, DOI 10.1111/j.1360-0443.2004.00820.x; Little MP, 2002, INT J RADIAT BIOL, V78, P49, DOI 10.1080/09553000110085797; Luebeck EG, 2008, CANCER EPIDEM BIOMAR, V17, P1360, DOI 10.1158/1055-9965.EPI-07-2878; Luebeck EG, 2013, CANCER RES, V73, P1086, DOI 10.1158/0008-5472.CAN-12-2198; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Luebeck G, GEN LIKELIHOOD EXPLO; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Meza R, 2005, MATH BIOSCI, V197, P188, DOI 10.1016/j.mbs.2005.06.003; Meza R, 2010, J DEV ORIG HLTH DIS, V1, P174, DOI 10.1017/S2040174410000218; Meza R, 2010, CANC RISK ASSESSMENT, P636; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Meza R, 2010, CANCER RES, V70, P5419, DOI 10.1158/0008-5472.CAN-09-4417; MOOLGAVKAR SH, 1981, J NATL CANCER I, V66, P1037, DOI 10.1093/jnci/66.6.1037; MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1; MOOLGAVKAR SH, 1990, RISK ANAL, V10, P323, DOI 10.1111/j.1539-6924.1990.tb01053.x; Moolgavkar SH, 2009, CANCER CAUSE CONTROL, V20, P935, DOI 10.1007/s10552-009-9328-9; Patel SC, 2011, J CLIN ONCOL, V29, P1488, DOI 10.1200/JCO.2010.31.7883; Saba NF, 2011, ONCOLOGY-BASEL, V81, P12, DOI 10.1159/000330807; Schollnberger H, 2010, CANCER RES, V70, P6797, DOI 10.1158/0008-5472.CAN-09-4392; Sturgis EM, 2004, SEMIN ONCOL, V31, P726, DOI 10.1053/j.seminoncol.2004.09.013	39	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151098	10.1371/journal.pone.0151098	http://dx.doi.org/10.1371/journal.pone.0151098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963717	Green Submitted, gold, Green Published			2022-12-27	WOS:000371993000103
J	Gilmour, JP; Underwood, JN; Howells, EJ; Gates, E; Heyward, AJ				Gilmour, James P.; Underwood, Jim N.; Howells, Emily J.; Gates, Emily; Heyward, Andrew J.			Biannual Spawning and Temporal Reproductive Isolation in Acropora Corals	PLOS ONE			English	Article							POPULATION-STRUCTURE; SCLERACTINIAN CORALS; SOLAR INSOLATION; REEF; PATTERNS; DIVERSITY; PACIFIC; SYSTEM; HYBRIDIZATION; BIOGEOGRAPHY	Coral spawning on the oceanic reef systems of north-western Australia was recently discovered during autumn and spring, but the degree to which species and particularly colonies participated in one or both of these spawnings was unknown. At the largest of the oceanic reef systems, the participation by colonies in the two discrete spawning events was investigated over three years in 13 species of Acropora corals (n = 1,855 colonies). Seven species spawned during both seasons; five only in autumn and one only in spring. The majority of tagged colonies (n = 218) spawned once a year in the same season, but five colonies from three species spawned during spring and autumn during a single year. Reproductive seasonality was not influenced by spatial variation in habitat conditions, or by Symbiodinium partners in the biannual spawner Acropora tenuis. Colonies of A. tenuis spawning during different seasons separated into two distinct yet cryptic groups, in a bayesian clustering analysis based on multiple microsatellite markers. These groups were associated with a major genetic divergence (G(ST)" = 0.469), despite evidence of mixed ancestry in a small proportion of individuals. Our results confirm that temporal reproductive isolation is a common feature of Acropora populations at Scott Reef and indicate that spawning season is a genetically determined trait in at least A. tenuis. This reproductive isolation may be punctuated occasionally by interbreeding between genetic groups following favourable environmental conditions, when autumn spawners undergo a second annual gametogenic cycle and spawn during spring.	[Gilmour, James P.; Underwood, Jim N.; Gates, Emily; Heyward, Andrew J.] Univ Western Australia, Oceans Inst, Australian Inst Marine Sci, Perth, WA 6009, Australia; [Howells, Emily J.] Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia; [Howells, Emily J.] New York Univ Abu Dhabi, Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates; [Gates, Emily] Univ Western Australia, Oceans Inst, Sch Plant Biol, Perth, WA 6009, Australia	Australian Institute of Marine Science; University of Western Australia; Australian Institute of Marine Science; University of Western Australia	Gilmour, JP (corresponding author), Univ Western Australia, Oceans Inst, Australian Inst Marine Sci, Perth, WA 6009, Australia.	j.gilmour@aims.gov.au		Howells, Emily/0000-0001-7732-2372	Woodside Energy Limited; Australian Federal Government, through the Australian Institute of Marine Science	Woodside Energy Limited; Australian Federal Government, through the Australian Institute of Marine Science	The authors acknowledge the financial support of Woodside Energy Limited, as operator of the Browse LNG Development Limited, and the Australian Federal Government, through the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock R, 1995, REPROD FERT DEVELOP, V7, P943, DOI 10.1071/RD9950943; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; BABCOCK RC, 1994, CORAL REEFS, V13, P161, DOI 10.1007/BF00301193; Baird AH, 2011, MAR BIOL, V158, P275, DOI 10.1007/s00227-010-1557-7; Baird AH, 2002, 9 INT COR REEF S BAL; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Bouwmeester J, 2015, CORAL REEFS, P1; Bowman DMJS, 2010, J BIOGEOGR, V37, P201, DOI 10.1111/j.1365-2699.2009.02210.x; CRESSWELL G, 1993, J GEOPHYS RES-OCEANS, V98, P14379, DOI 10.1029/93JC00317; DAI CF, 1990, MAR ECOL PROG SER, V60, P291, DOI 10.3354/meps060291; Dai CF, 2000, MAR ECOL PROG SER, V201, P179, DOI 10.3354/meps201179; Domingues CM, 2007, DEEP-SEA RES PT II, V54, P797, DOI 10.1016/j.dsr2.2006.10.003; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Gilmour JP, 2009, MAR BIOL, V156, P1297, DOI 10.1007/s00227-009-1171-8; Guest JR, 2005, INVERTEBR REPROD DEV, V48, P207, DOI 10.1080/07924259.2005.9652186; Guest JR, 2005, CORAL REEFS, V24, P112, DOI 10.1007/s00338-004-0433-7; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hayashibara T, 2002, CORAL REEFS, V21, P224; HEYWARD AJ, 1986, MAR BIOL, V90, P191, DOI 10.1007/BF00569127; HOLLOWAY PE, 1995, DEEP-SEA RES PT I, V42, P285, DOI 10.1016/0967-0637(95)00004-P; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jones AM, 2011, J MAR BIOL; Kopelman NM, 2015, MOL ECOL RESOUR; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2000, BIOL BULL, V199, P126, DOI 10.2307/1542872; Leuzinger S, 2003, OECOLOGIA, V136, P524, DOI 10.1007/s00442-003-1305-5; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Mangubhai S, 2007, CORAL REEFS, V26, P15, DOI 10.1007/s00338-006-0173-y; Mangubhai S, 2006, 10 INT COR REEF S OK, P106; Mangubhai S, 2009, MAR ECOL PROG SER, V374, P305, DOI 10.3354/meps07910; McKinney David, 2009, Records of the Western Australian Museum Supplement, V77, P105; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Ohki S, 2015, CORAL REEFS, V34, P1189, DOI 10.1007/s00338-015-1337-4; Oliver J.K., 1988, P803; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Penland L, 2004, CORAL REEFS, V23, P133, DOI 10.1007/s00338-003-0362-x; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Richards ZT, 2016, CONSERV GENET, V17, P577, DOI 10.1007/s10592-015-0807-0; Richards Zoe T., 2014, Records of the Western Australian Museum, P111, DOI 10.18195/issn.0313-122x.84.2014.111-132; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; RINKEVICH B, 1989, MAR BIOL, V101, P259, DOI 10.1007/BF00391465; Rosser NL, 2008, CORAL REEFS, V27, P345, DOI 10.1007/s00338-007-0335-6; Rosser NL, 2013, CORAL REEFS, V32, P455, DOI 10.1007/s00338-012-0986-9; Rosser NL, 2015, MOL ECOL, V24, P5006, DOI 10.1111/mec.13372; Schmidt-Roach S, 2013, CORAL REEFS, V32, P161, DOI 10.1007/s00338-012-0959-z; Schmidt-Roach S, 2014, ZOOL J LINN SOC-LOND, V170, P1, DOI 10.1111/zoj12092; Shlesinger Y, 1998, MAR BIOL, V132, P691, DOI 10.1007/s002270050433; SHLESINGER Y, 1985, SCIENCE, V228, P1333, DOI 10.1126/science.228.4705.1333; Silverstein RN, 2011, MAR ECOL PROG SER, V422, P63, DOI 10.3354/meps08934; SIMPSON C J, 1991, Journal of the Royal Society of Western Australia, V74, P85; Stobart B., 1992, P 7 INT COR REEF S, V1, P494; SZMANTFROELICH A, 1980, BIOL BULL, V158, P257, DOI 10.2307/1540935; Tang PC, 2010, ZOOL STUD, V49, P657; Todd PA, 2004, MAR ECOL PROG SER, V271, P167, DOI 10.3354/meps271167; Underwood JN, 2009, EVOL APPL, V2, P222, DOI 10.1111/j.1752-4571.2008.00065.x; Van Oppen MJH, 2007, MOL ECOL NOTES, V7, P436, DOI 10.1111/j.1471-8286.2006.01610.x; van Woesik R, 2006, ECOL LETT, V9, P390, DOI 10.1111/j.1461-0248.2006.00886.x; van Woesik R, 2010, P R SOC B, V277, P715, DOI 10.1098/rspb.2009.1524; Veron J. E., 2000, CORALS WORLD, V1; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585; Warner PA, 2015, MOL ECOL, V24, P2993, DOI 10.1111/mec.13225; Willis B. L., 1985, P 5 INT COR REEF C, V4, P343; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242; Willis BL, ANN REV ECOLOGY EVOL, P489; Wilson B, 2013, BIOGEOGRAPHY OF THE AUSTRALIAN NORTH WEST SHELF: ENVIRONMENTAL CHANGE AND LIFE'S RESPONSE, P1; Wilson JR, 2003, MAR ECOL PROG SER, V260, P115, DOI 10.3354/meps260115; Wolstenholme JK, 2004, MAR BIOL, V144, P567, DOI 10.1007/s00227-003-1209-2; Wolstenholme JK, 2003, CORAL REEFS, V22, P155, DOI 10.1007/s00338-003-0299-0	75	26	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150916	10.1371/journal.pone.0150916	http://dx.doi.org/10.1371/journal.pone.0150916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963249	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000077
J	Holmes, MA; Harrison, EM; Fisher, EA; Graham, EM; Parkhill, J; Foster, G; Paterson, GK				Holmes, Mark A.; Harrison, Ewan M.; Fisher, Elizabeth A.; Graham, Elizabeth M.; Parkhill, Julian; Foster, Geoffrey; Paterson, Gavin K.			Genomic Analysis of Companion Rabbit Staphylococcus aureus	PLOS ONE			English	Article							MECA HOMOLOG; RESISTANCE; MRSA; INFECTION; DIVERSITY	In addition to being an important human pathogen, Staphylococcus aureus is able to cause a variety of infections in numerous other host species. While the S. aureus strains causing infection in several of these hosts have been well characterised, this is not the case for companion rabbits (Oryctolagus cuniculus), where little data are available on S. aureus strains from this host. To address this deficiency we have performed antimicrobial susceptibility testing and genome sequencing on a collection of S. aureus isolates from companion rabbits. The findings show a diverse S. aureus population is able to cause infection in this host, and while antimicrobial resistance was uncommon, the isolates possess a range of known and putative virulence factors consistent with a diverse clinical presentation in companion rabbits including severe abscesses. We additionally show that companion rabbit isolates carry polymorphisms within dltB as described as underlying host-adaption of S. aureus to farmed rabbits. The availability of S. aureus genome sequences from companion rabbits provides an important aid to understanding the pathogenesis of disease in this host and in the clinical management and surveillance of these infections.	[Holmes, Mark A.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Harrison, Ewan M.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Fisher, Elizabeth A.; Paterson, Gavin K.] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull, Yorks, England; [Graham, Elizabeth M.] Univ Glasgow, Sch Vet Med, Glasgow, Lanark, Scotland; [Parkhill, Julian] Wellcome Trust Res Labs, Sanger Inst, Genome Campus, Hinxton, Cambs, England; [Foster, Geoffrey] Scottish Agr Coll Consulting Vet Serv, Inverness, Scotland	University of Cambridge; University of Cambridge; University of Hull; University of Glasgow; Wellcome Trust Sanger Institute	Paterson, GK (corresponding author), Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull, Yorks, England.	g.paterson@hull.ac.uk	Parkhill, Julian/G-4703-2011; Paterson, Gavin/V-6725-2019; Harrison, Ewan/I-5003-2013	Parkhill, Julian/0000-0002-7069-5958; Paterson, Gavin/0000-0002-1880-0095; Harrison, Ewan/0000-0003-2720-0507; Foster, Geoffrey/0000-0002-5527-758X	School of Biological, Biomedical and Environmental Sciences, University of Hull; Medical Research Council (MRC) [G1001787/1]; Wellcome Trust [098051]; MRC [G1001787] Funding Source: UKRI; Medical Research Council [G1001787] Funding Source: researchfish	School of Biological, Biomedical and Environmental Sciences, University of Hull; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported by internal funding from the School of Biological, Biomedical and Environmental Sciences, University of Hull (GKP), a Medical Research Council (MRC) Partnership Grant (G1001787/1) (MAH and JP), and the Wellcome Trust, Grant number 098051 (JP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besier S, 2003, MOL MICROBIOL, V47, P463, DOI 10.1046/j.1365-2958.2003.03307.x; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Harcourt-Brown F, 2001, TXB RABBIT MED; Harris SR, 2012, LANCET INFECT DIS, V9, P70268; Harrison EM, 2014, MBIO, V5, DOI 10.1128/mBio.00985-13; Harrison EM, 2013, EMBO MOL MED, V5, P509, DOI 10.1002/emmm.201202413; KAATZ GW, 1995, ANTIMICROB AGENTS CH, V39, P2650, DOI 10.1128/AAC.39.12.2650; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Leopold SR, 2014, J CLIN MICROBIOL, V52, P2365, DOI 10.1128/JCM.00262-14; Loncaric I, 2013, VET DERMATOL, V24, P370, DOI 10.1111/vde.12023; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; O'Neill AJ, 2002, J ANTIMICROB CHEMOTH, V50, P839, DOI 10.1093/jac/dkf248; O'Neill AJ, 2004, ANTIMICROB AGENTS CH, V48, P3594, DOI 10.1128/AAC.48.9.3594-3597.2004; Paterson GK, 2012, J ANTIMICROB CHEMOTH, V67, P2809, DOI 10.1093/jac/dks329; Paterson GK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7560; PFMA, PET FOOD MAN ASS PET; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rankin S, 2005, VET MICROBIOL, V108, P145, DOI 10.1016/j.vetmic.2005.02.013; Rich M, 2006, VET REC, V159, P535, DOI 10.1136/vr.159.16.535; Stanczak-Mrozek KI, 2015, J ANTIMICROB CHEMOTH, V70, P2191, DOI 10.1093/jac/dkv119; Truong-Bolduc QC, 2005, J BACTERIOL, V187, P2395, DOI 10.1128/JB.187.7.2395-2405.2005; Viana D, 2015, NAT GENET, V47, P361, DOI 10.1038/ng.3219; Vincze S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085656; Weese JS, 2010, ILAR J, V51, P233, DOI 10.1093/ilar.51.3.233; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	27	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151458	10.1371/journal.pone.0151458	http://dx.doi.org/10.1371/journal.pone.0151458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963381	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000371993000155
J	Lee, CC; Lo, Y; Ho, LJ; Lai, JH; Lien, SB; Lin, LC; Chen, CL; Chen, TC; Liu, FC; Huang, HS				Lee, Chia-Chung; Lo, Yang; Ho, Ling-Jun; Lai, Jenn-Haung; Lien, Shiu-Bii; Lin, Leou-Chyr; Chen, Chun-Liang; Chen, Tsung-Chih; Liu, Feng-Cheng; Huang, Hsu-Shan			A New Application of Parallel Synthesis Strategy for Discovery of Amide-Linked Small Molecules as Potent Chondroprotective Agents in TNF-alpha-Stimulated Chondrocytes	PLOS ONE			English	Article							OSTEOARTHRITIS IN-VIVO; NITRIC-OXIDE SYNTHASE; SELECTIVE-INHIBITION; DRUG DISCOVERY; MATRIX METALLOPROTEINASES; ARTICULAR CHONDROCYTES; CARTILAGE; OSTEOCLASTOGENESIS; PROGRESSION; MECHANISMS	As part of an effort to profile potential therapeutics for the treatment of inflammation-related diseases, a diversity of amide-linked small molecules was synthesized by using parallel synthesis strategy. Moreover, these new compounds were also evaluated for their inhibitory effects on nitric oxide (NO) by using tumor necrosis factor alpha (TNF-alpha)-induced inflammatory responses in chondrocytes. Among the tested compounds, N-(3-chloro-4-fluorophenyl)-2-hydroxybenzamide (HS-Ck) was the most potent inhibitor of NO production and inducible nitric oxide synthase (iNOS) expression in TNF-alpha-stimulated chondrocytes. In addition, our biological results indicated that HS-Ck might suppress the expression levels of iNOS and matrix metalloproteinases-13 (MMP-13) activities through downregulating the activation of nuclear factor kappa B (NF-kappa B) and signal transducer and activator of transcription 3 (STAT-3) transcriptional factors. Therefore, the parallel synthesis was successful used to develop a new class of potential anti-inflammatory agents as chondroprotective candidates for the treatment of osteoarthritis.	[Lee, Chia-Chung; Chen, Chun-Liang; Chen, Tsung-Chih; Huang, Hsu-Shan] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Lee, Chia-Chung; Lo, Yang; Chen, Chun-Liang; Chen, Tsung-Chih; Huang, Hsu-Shan] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan; [Lee, Chia-Chung; Liu, Feng-Cheng; Huang, Hsu-Shan] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Ho, Ling-Jun] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Lai, Jenn-Haung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taoyuan, Taiwan; [Lien, Shiu-Bii; Lin, Leou-Chyr] Natl Def Med Ctr, Triserv Gen Hosp, Dept Orthopaed, Taipei, Taiwan; [Liu, Feng-Cheng] Natl Def Med Ctr, Triserv Gen Hosp, Rheumatol Immunol Allergy, Taipei, Taiwan	Taipei Medical University; National Defense Medical Center; National Defense Medical Center; National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Huang, HS (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan.; Huang, HS (corresponding author), Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan.; Liu, FC; Huang, HS (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Liu, FC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Rheumatol Immunol Allergy, Taipei, Taiwan.	lfc10399@yahoo.com.tw; huanghs99@tmu.edu.tw		CHEN, Tsung-Chih/0000-0001-8256-6240; Huang, Hsu-Shan/0000-0001-8162-5608; Ho, Ling-Jun/0000-0003-3453-2913				Akao Y, 2003, BIOL PHARM BULL, V26, P1057, DOI 10.1248/bpb.26.1057; Aktas E, 2012, EUR J ORTHOP SURG TR, V22, P119, DOI 10.1007/s00590-011-0803-0; An M, 2001, J CHEM ECOL, V27, P383, DOI 10.1023/A:1005640708047; Baragi VM, 2009, ARTHRITIS RHEUM-US, V60, P2008, DOI 10.1002/art.24629; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Capkova K, 2007, BIOORG MED CHEM LETT, V17, P6463, DOI 10.1016/j.bmcl.2007.09.103; Cheng CP, 2012, J CLIN IMMUNOL, V32, P762, DOI 10.1007/s10875-012-9660-9; Cheng FF, 2011, FOOD RES INT, V44, P98, DOI 10.1016/j.foodres.2010.11.005; Felson DT, 2006, NEW ENGL J MED, V354, P841, DOI 10.1056/NEJMcp051726; Forsyth CB, 2002, ARTHRITIS RHEUM, V46, P2368, DOI 10.1002/art.10502; Geysen HM, 2003, NAT REV DRUG DISCOV, V2, P222, DOI 10.1038/nrd10335; Goldring M B, 2000, Curr Rheumatol Rep, V2, P459, DOI 10.1007/s11926-000-0021-y; Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16; Gooding OW, 2004, CURR OPIN CHEM BIOL, V8, P297, DOI 10.1016/j.cbpa.2004.04.009; Haseeb A, 2013, CLIN IMMUNOL, V146, P185, DOI 10.1016/j.clim.2012.12.011; Ho LJ, 2005, BIOCHEM PHARMACOL, V70, P200, DOI 10.1016/j.bcp.2005.04.039; Jungel A, 2010, ANN RHEUM DIS, V69, P898, DOI 10.1136/ard.2008.106021; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Kolb HC, 2003, DRUG DISCOV TODAY, V8, P1128, DOI 10.1016/S1359-6446(03)02933-7; Lane NE, 2007, NEW ENGL J MED, V357, P1413, DOI 10.1056/NEJMcp071112; Lee CC, 2015, BIOORGAN MED CHEM, V23, P4522, DOI 10.1016/j.bmc.2015.06.007; Lee CC, 2015, EUR J MED CHEM, V98, P115, DOI 10.1016/j.ejmech.2015.05.015; Li NG, 2011, CURR MED CHEM, V18, P977, DOI 10.2174/092986711794940905; Liacini A, 2003, EXP CELL RES, V288, P208, DOI 10.1016/S0014-4827(03)00180-0; Liou JT, 2014, EUR J PHARMACOL, V726, P124, DOI 10.1016/j.ejphar.2014.01.049; Liu FC, 2011, J CLIN IMMUNOL, V31, P1131, DOI 10.1007/s10875-011-9576-9; Liu FC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3127; Magnano MD, 2007, J RHEUMATOL, V34, P1323; Marcu KB, 2010, CURR DRUG TARGETS, V11, P599, DOI 10.2174/138945010791011938; Meszaros E, 2012, THER ADV CHRONIC DIS, V3, P219, DOI 10.1177/2040622312454157; Mort JS, 2001, ARTHRITIS RES, V3, P337, DOI 10.1186/ar325; Pan B, 2011, EUR J MED CHEM, V46, P819, DOI 10.1016/j.ejmech.2010.12.014; Pelletier JP, 2005, SEMIN ARTHRITIS RHEU, V34, P13, DOI 10.1016/j.semanthrit.2004.03.005; Pelletier JP, 2000, ARTHRITIS RHEUM-US, V43, P1290, DOI 10.1002/1529-0131(200006)43:6<1290::AID-ANR11>3.0.CO;2-R; Pelletier JP, 1998, ARTHRITIS RHEUM-US, V41, P1275, DOI 10.1002/1529-0131(199807)41:7<1275::AID-ART19>3.0.CO;2-T; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Sabatini M, 2005, ARTHRITIS RHEUM-US, V52, P171, DOI 10.1002/art.20900; Selway CN, 1996, BIOORGAN MED CHEM, V4, P645, DOI 10.1016/0968-0896(96)00058-2; Shah N, 2000, J COMB CHEM, V2, P453, DOI 10.1021/cc000011o; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yoshihara Y, 2000, ANN RHEUM DIS, V59, P455, DOI 10.1136/ard.59.6.455	45	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149317	10.1371/journal.pone.0149317	http://dx.doi.org/10.1371/journal.pone.0149317			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963090	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000010
J	Vermeulen, JF; van Hecke, W; Spliet, WGM; Hidalgo, JV; Fisch, P; Broekhuizen, R; Bovenschen, N				Vermeulen, Jeroen F.; van Hecke, Wim; Spliet, Wim G. M.; Hidalgo, Jose Villacorta; Fisch, Paul; Broekhuizen, Roel; Bovenschen, Niels			Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme Inhibitors	PLOS ONE			English	Article							DELTA-T-CELLS; PROTEASE INHIBITOR-9; IMMUNE ESCAPE; NK CELLS; MEDULLOBLASTOMA; APOPTOSIS; CHILDREN; SURVIVAL; IDENTIFICATION; RADIOTHERAPY	Background Central nervous system (CNS) primitive neuroectodermal tumors (PNETs) are malignant primary brain tumors that occur in young infants. Using current standard therapy, up to 80% of the children still dies from recurrent disease. Cellular immunotherapy might be key to improve overall survival. To achieve efficient killing of tumor cells, however, immunotherapy has to overcome cancer-associated strategies to evade the cytotoxic immune response. Whether CNS-PNETs can evade the immune response remains unknown. Methods We examined by immunohistochemistry the immune response and immune evasion strategies in pediatric CNS-PNETs. Results Here, we show that CD4(+), CD8(+),gamma delta-T-cells, and Tregs can infiltrate pediatric CNS-PNETs, although the activation status of cytotoxic cells is variable. Pediatric CNS-PNETs evade immune recognition by downregulating cell surface MHC-I and CD1d expression. Intriguingly, expression of SERPINB9, SERPINB1, and SERPINB4 is acquired during tumorigenesis in 29%, 29%, and 57% of the tumors, respectively. Conclusion We show for the first time that brain tumors express direct granzyme inhibitors (serpins) as a potential mechanism to overcome cellular cytotoxicity, which may have consequences for cellular immunotherapy.	[Vermeulen, Jeroen F.; van Hecke, Wim; Spliet, Wim G. M.; Broekhuizen, Roel; Bovenschen, Niels] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; [Bovenschen, Niels] Univ Med Ctr Utrecht, Lab Translat Immunol, NL-3584 CX Utrecht, Netherlands; [Hidalgo, Jose Villacorta; Fisch, Paul] Univ Med Ctr Freiburg, Inst Pathol, D-79106 Freiburg, Germany	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Freiburg	Bovenschen, N (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands.; Bovenschen, N (corresponding author), Univ Med Ctr Utrecht, Lab Translat Immunol, NL-3584 CX Utrecht, Netherlands.	n.bovenschen@umcutrecht.nl		Villacorta Hidalgo, Jose/0000-0002-5028-3999	Cancer Foundation Koppie-Au	Cancer Foundation Koppie-Au	This work was supported by a research grant from Cancer Foundation Koppie-Au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bladergroen BA, 2001, J IMMUNOL, V166, P3218, DOI 10.4049/jimmunol.166.5.3218; Bovenschen N, 2010, IMMUNOL REV, V235, P117, DOI 10.1111/j.0105-2896.2010.00889.x; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; De Braganca KC, 2013, CURR TREAT OPTION NE, V15, P593, DOI 10.1007/s11940-013-0255-4; de Koning PJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022645; Gao HS, 2015, BRAIN RES, V1600, P59, DOI 10.1016/j.brainres.2014.06.017; GEROSA MA, 1980, CHILD BRAIN, V6, P92; Igney FH, 2002, J LEUKOCYTE BIOL, V71, P907; Johnston DL, 2008, J NEURO-ONCOL, V86, P101, DOI 10.1007/s11060-007-9440-1; KUMMER JA, 1995, CLIN EXP IMMUNOL, V100, P164; Liu DF, 2013, CLIN IMMUNOL, V149, P55, DOI 10.1016/j.clim.2013.06.005; McGettrick AF, 2001, EUR J BIOCHEM, V268, P5868, DOI 10.1046/j.0014-2956.2001.02535.x; Medema JP, 2001, P NATL ACAD SCI USA, V98, P11515, DOI 10.1073/pnas.201398198; Murakami A, 2001, BRIT J CANCER, V84, P851, DOI 10.1054/bjoc.2000.1683; Packer RJ, 2013, NEURO-ONCOLOGY, V15, P97, DOI 10.1093/neuonc/nos267; Picard D, 2012, LANCET ONCOL, V13, P838, DOI 10.1016/S1470-2045(12)70257-7; Poli A, 2013, J IMMUNOL, V190, P5355, DOI 10.4049/jimmunol.1203401; Raffaghello L, 2007, CANCER RES, V67, P5471, DOI 10.1158/0008-5472.CAN-06-4735; Sapoznik S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/818214; Smoll NR, 2012, J CLIN NEUROSCI, V19, P1541, DOI 10.1016/j.jocn.2012.04.009; STAM NJ, 1990, INT IMMUNOL, V2, P113, DOI 10.1093/intimm/2.2.113; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Timmermann B, 2006, J CLIN ONCOL, V24, P1554, DOI 10.1200/JCO.2005.04.8074; Uldrich AP, 2013, NAT IMMUNOL, V14, P1137, DOI 10.1038/ni.2713; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; van Diest PJ, 2002, BMJ-BRIT MED J, V325, P648, DOI 10.1136/bmj.325.7365.648; van Houdt IS, 2005, CLIN CANCER RES, V11, P6400, DOI 10.1158/1078-0432.CCR-05-0306; VAQUERO J, 1989, J NEUROSURG, V70, P728, DOI 10.3171/jns.1989.70.5.0728; Wang L, 2013, J IMMUNOL, V190, P1319, DOI 10.4049/jimmunol.1202542	30	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151465	10.1371/journal.pone.0151465	http://dx.doi.org/10.1371/journal.pone.0151465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963506	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000156
J	Zavasnik-Bergant, T; Marusic, MB				Zavasnik-Bergant, Tina; Marusic, Martina Bergant			Exogenous Thyropin from p41 Invariant Chain Diminishes Cysteine Protease Activity and Affects IL-12 Secretion during Maturation of Human Dendritic Cells	PLOS ONE			English	Article							CLASS-II MOLECULES; COXIELLA-BURNETII; CATHEPSIN-L; CYSTATIN-F; COMPLEX; INHIBITORS; FRAGMENT; TICK; CD74; DIFFERENTIATION	Dendritic cells (DC) play a pivotal role as antigen presenting cells (APC) and their maturation is crucial for effectively eliciting an antigen-specific immune response. The p41 splice variant of MHC class II-associated chaperone, called invariant chain p41 Ii, contains an amino acid sequence, the p41 fragment, which is a thyropin-type inhibitor of proteolytic enzymes. The effects of exogenous p41 fragment and related thyropin inhibitors acting on human immune cells have not been reported yet. In this study we demonstrate that exogenous p41 fragment can enter the endocytic pathway of targeted human immature DC. Internalized p41 fragment has contributed to the total amount of the immunogold labelled p41 Ii-specific epitope, as quantified by transmission electron microscopy, in particular in late endocytic compartments with multivesicular morphology where antigen processing and binding to MHC II take place. In cell lysates of treated immature DC, diminished enzymatic activity of cysteine proteases has been confirmed. Internalized exogenous p41 fragment did not affect the perinuclear clustering of acidic cathepsin S-positive vesicles typical of mature DC. p41 fragment is shown to interfere with the nuclear translocation of NF-kappa B p65 subunit in LPS-stimulated DC. p41 fragment is also shown to reduce the secretion of interleukin-12 (IL-12/p70) during the subsequent maturation of treated DC. The inhibition of proteolytic activity of lysosomal cysteine proteases in immature DC and the diminished capability of DC to produce IL-12 upon their subsequent maturation support the immunomodulatory potential of the examined thyropin from p41 Ii.	[Zavasnik-Bergant, Tina] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana, Slovenia; [Marusic, Martina Bergant] Blood Transfus Ctr Slovenia, Tissue Typing Ctr, Ljubljana, Slovenia; [Marusic, Martina Bergant] Univ Nova Gorica, Ctr Biomed Sci & Engn, Nova Gorica, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Nova Gorica	Zavasnik-Bergant, T (corresponding author), Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana, Slovenia.	tina.zavasnik@ijs.si	Bergant, Martina/AAF-9623-2020		program (Proteolysis and its Regulation) [P1-0140]; Ministry of Education, Science and Sport of the Republic of Slovenia via the Slovenian Research Agency (ARRS); EMBO	program (Proteolysis and its Regulation); Ministry of Education, Science and Sport of the Republic of Slovenia via the Slovenian Research Agency (ARRS); EMBO(European Molecular Biology Organization (EMBO))	This work was supported by the program P1-0140 (Proteolysis and its Regulation, led by V. Turk and B. Turk) and financed by the Ministry of Education, Science and Sport of the Republic of Slovenia via the Slovenian Research Agency (ARRS). TZB acknowledges support from EMBO in the form of a short-term fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anatriello E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-450; Antonios D, 2010, J IMMUNOL, V185, P89, DOI 10.4049/jimmunol.0901992; ARUNACHALAM B, 1994, INT IMMUNOL, V6, P439, DOI 10.1093/intimm/6.3.439; Beare PA, 2008, CLIN VACCINE IMMUNOL, V15, P1771, DOI 10.1128/CVI.00300-08; Berger AC, 2009, J CELL SCI, V122, P1, DOI 10.1242/jcs.035089; Bevec T, 1996, J EXP MED, V183, P1331, DOI 10.1084/jem.183.4.1331; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Costantino CM, 2009, J IMMUNOL, V183, P945, DOI 10.4049/jimmunol.0900921; Creasy BM, 2011, CELL IMMUNOL, V267, P56, DOI 10.1016/j.cellimm.2010.11.004; CRESSWELL P, 1992, CURR OPIN IMMUNOL, V4, P87, DOI 10.1016/0952-7915(92)90131-W; Denzin LK, 2013, NAT STRUCT MOL BIOL, V20, P7, DOI 10.1038/nsmb.2484; Diaz-Martin V, 2013, J PROTEOMICS, V80, P216, DOI 10.1016/j.jprot.2013.01.015; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; Drutman SB, 2010, J IMMUNOL, V185, P2140, DOI 10.4049/jimmunol.1000642; Ebner S, 2001, J IMMUNOL, V166, P633, DOI 10.4049/jimmunol.166.1.633; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Fiebiger E, 2002, J EXP MED, V196, P1263, DOI 10.1084/jem.20020762; Fortin JS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00443; FREISEWINKEL IM, 1993, P NATL ACAD SCI USA, V90, P9703, DOI 10.1073/pnas.90.20.9703; Geisel J, 2014, J IMMUNOL, V192, P3530, DOI 10.4049/jimmunol.1300556; Ghigo E, 2009, ANN NY ACAD SCI, V1166, P55, DOI 10.1111/j.1749-6632.2009.04515.x; Gonzalez-Leal IJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003194; Gordon JR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00007; Gregers TF, 2003, INT IMMUNOL, V15, P1291, DOI 10.1093/intimm/dxg128; Gregers TF, 2003, EUR J IMMUNOL, V33, P277, DOI 10.1002/immu.200310001; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; Guncar G, 1999, EMBO J, V18, P793, DOI 10.1093/emboj/18.4.793; Hamilton G, 2008, EMBO J, V27, P499, DOI 10.1038/sj.emboj.7601979; Hamza T, 2010, INT J MOL SCI, V11, P789, DOI 10.3390/ijms11030789; Hiltbold EM, 2002, CURR OPIN IMMUNOL, V14, P30, DOI 10.1016/S0952-7915(01)00295-3; Johannessen M, 2013, MICROBIOL-SGM, V159, P2001, DOI 10.1099/mic.0.069369-0; JONES PP, 1979, MOL IMMUNOL, V16, P51, DOI 10.1016/0161-5890(79)90027-0; Jung JY, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-16; Jung M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116972; Kantyka T, 2010, BIOCHIMIE, V92, P1644, DOI 10.1016/j.biochi.2010.06.004; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Krummen M, 2010, J LEUKOCYTE BIOL, V88, P189, DOI 10.1189/jlb.0408228; Landsverk OJB, 2009, SCAND J IMMUNOL, V70, P184, DOI 10.1111/j.1365-3083.2009.02301.x; Landsverk OJB, 2012, J LEUKOCYTE BIOL, V91, P729, DOI 10.1189/jlb.0311150; Langerholc T, 2005, FEBS J, V272, P1535, DOI 10.1111/j.1742-4658.2005.04594.x; Lenarcic B, 1998, BIOL CHEM, V379, P105; Lennon-Dumenil AM, 2002, CURR OPIN IMMUNOL, V14, P15, DOI 10.1016/S0952-7915(01)00293-X; Lennon-Dumenil AM, 2001, EMBO J, V20, P4055, DOI 10.1093/emboj/20.15.4055; Lew-Tabor AE, 2010, VET PARASITOL, V167, P304, DOI 10.1016/j.vetpar.2009.09.033; Lundberg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052875; Magister S, 2013, J CANCER, V4, P45, DOI 10.7150/jca.5044; Mayhew TM, 2004, HISTOCHEM CELL BIOL, V122, P171, DOI 10.1007/s00418-004-0685-x; Mihelic M, 2008, J BIOL CHEM, V283, P14453, DOI 10.1074/jbc.M801283200; Mihelic M, 2007, BIOL CHEM, V388, P1123, DOI 10.1515/BC.2007.155; Nayak JV, 2006, J IMMUNOL, V177, P8493, DOI 10.4049/jimmunol.177.12.8493; Neefjes J, 1999, EUR J IMMUNOL, V29, P1421, DOI 10.1002/(SICI)1521-4141(199905)29:05<1421::AID-IMMU1421>3.3.CO;2-3; Obermajer N, 2008, J LEUKOCYTE BIOL, V84, P1306, DOI 10.1189/jlb.0508285; OGRINC T, 1993, FEBS LETT, V336, P555, DOI 10.1016/0014-5793(93)80875-U; OSULLIVAN DM, 1987, J EXP MED, V166, P444, DOI 10.1084/jem.166.2.444; Pezeshki AM, 2013, HUM IMMUNOL, V74, P1280, DOI 10.1016/j.humimm.2013.05.010; PIETERS J, 1991, J CELL BIOL, V115, P1213, DOI 10.1083/jcb.115.5.1213; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Polajnar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102500; Poreba M, 2014, AMINO ACIDS, V46, P931, DOI 10.1007/s00726-013-1654-2; Qiang Y, 2003, J IMMUNOL, V170, P1473, DOI 10.4049/jimmunol.170.3.1473; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Repnik U, 2008, IMMUNOBIOLOGY, V213, P51, DOI 10.1016/j.imbio.2007.06.005; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Sa-Nunes A, 2009, J IMMUNOL, V182, P7422, DOI 10.4049/jimmunol.0900075; Sanchez-Nino MD, 2013, CYTOKINE GROWTH F R, V24, P23, DOI 10.1016/j.cytogfr.2012.08.001; Santamaria ME, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-307; Santegoets SJAM, 2008, J LEUKOCYTE BIOL, V84, P1364, DOI 10.1189/jlb.0208092; Schwarz A, 2012, TICKS TICK-BORNE DIS, V3, P117, DOI 10.1016/j.ttbdis.2012.03.004; Shachar I, 2011, LEUKEMIA LYMPHOMA, V52, P1446, DOI 10.3109/10428194.2011.565437; Shannon JG, 2005, P NATL ACAD SCI USA, V102, P8722, DOI 10.1073/pnas.0501863102; Song JS, 2015, IMMUNOL LETT, V167, P41, DOI 10.1016/j.imlet.2015.07.002; Stang E, 1998, J IMMUNOL, V160, P4696; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Stoeckle C, 2012, J AUTOIMMUN, V38, P332, DOI 10.1016/j.jaut.2012.02.003; STRUBIN M, 1986, EMBO J, V5, P3483, DOI 10.1002/j.1460-2075.1986.tb04673.x; STRUBIN M, 1986, CELL, V47, P619, DOI 10.1016/0092-8674(86)90626-4; Stumptner P, 1997, EMBO J, V16, P5807, DOI 10.1038/sj.emboj.7590555; Tirloni L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094831; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; Watts C, 2012, BBA-PROTEINS PROTEOM, V1824, P14, DOI 10.1016/j.bbapap.2011.07.006; Wei XQ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/697340; Zavasnik-Bergant T, 2005, J LEUKOCYTE BIOL, V78, P122, DOI 10.1189/jlb.0804451; Zavasnik-Bergant T, 2008, FRONT BIOSCI-LANDMRK, V13, P4625, DOI 10.2741/3028; Zavasnik-Bergant V, 2004, IMMUNOLOGY, V112, P378, DOI 10.1111/j.1365-2567.2004.01879.x	85	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150815	10.1371/journal.pone.0150815	http://dx.doi.org/10.1371/journal.pone.0150815			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960148	gold, Green Submitted, Green Published			2022-12-27	WOS:000371992300075
J	Cardona, T				Cardona, Tanai			Origin of Bacteriochlorophyll a and the Early Diversification of Photosynthesis	PLOS ONE			English	Article							REACTION CENTERS; EVOLUTIONARY RELATIONSHIPS; PHYLUM ACIDOBACTERIA; CHLOROPHYLL; BACTERIA; LIFE; RECONSTRUCTION; CYANOBACTERIA; PROKARYOTES; PHYLOGENY	Photosynthesis originated in the domain Bacteria billions of years ago; however, the identity of the last common ancestor to all phototrophic bacteria remains undetermined and speculative. Here I present the evolution of BchF or 3-vinyl-bacteriochlorophyll hydratase, an enzyme exclusively found in bacteria capable of synthetizing bacteriochlorophyll a. I show that BchF exists in two forms originating from an early divergence, one found in the phylum Chlorobi, including its paralogue BchV, and a second form that was ancestral to the enzyme found in the remaining anoxygenic phototrophic bacteria. The phylogeny of BchF is consistent with bacteriochlorophyll a evolving in an ancestral phototrophic bacterium that lived before the radiation event that gave rise to the phylum Chloroflexi, Chlorobi, Acidobacteria, Proteobacteria, and Gemmatimonadetes, but only after the divergence of Type I and Type II reaction centers. Consequently, it is suggested that the lack of phototrophy in many groups of extant bacteria is a derived trait.	[Cardona, Tanai] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England	Imperial College London	Cardona, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	t.cardona@imperial.ac.uk	Cardona, Tanai/AAE-3011-2019	Cardona, Tanai/0000-0003-2076-4115	Imperial College London	Imperial College London(General Electric)	This work was funded by an Imperial College London Junior Research Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The financial support of an Imperial College London Junior Research Fellowship is gracefully acknowledged.	Battistuzzi FU, 2009, MOL BIOL EVOL, V26, P335, DOI 10.1093/molbev/msn247; BEANLAND TJ, 1990, J THEOR BIOL, V145, P535, DOI 10.1016/S0022-5193(05)80487-4; Blank CE, 2010, GEOBIOLOGY, V8, P1, DOI 10.1111/j.1472-4669.2009.00220.x; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Bryant DA, 2012, ADV PHOTOSYNTH RESP, V33, P47, DOI 10.1007/978-94-007-1533-2_3; Cardona T, 2015, PHOTOSYNTH RES, V126, P111, DOI 10.1007/s11120-014-0065-x; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; David LA, 2011, NATURE, V469, P93, DOI 10.1038/nature09649; Dutilh BE, 2008, MOL BIOL EVOL, V25, P1659, DOI 10.1093/molbev/msn115; Greening C, 2015, P NATL ACAD SCI USA, V112, P10497, DOI 10.1073/pnas.1508385112; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta RS, 2016, PHOTOSYNTH RES, V127, P201, DOI 10.1007/s11120-015-0177-y; Gupta RS, 2003, PHOTOSYNTH RES, V76, P173, DOI 10.1023/A:1024999314839; Harada J, 2015, MOL MICROBIOL, V98, P1184, DOI 10.1111/mmi.13208; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jun SR, 2010, P NATL ACAD SCI USA, V107, P133, DOI 10.1073/pnas.0913033107; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lockhart PJ, 1996, P NATL ACAD SCI USA, V93, P1930, DOI 10.1073/pnas.93.5.1930; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; NITSCHKE W, 1991, TRENDS BIOCHEM SCI, V16, P241, DOI 10.1016/0968-0004(91)90095-D; OLSON JM, 1981, BIOSYSTEMS, V14, P89, DOI 10.1016/0303-2647(81)90024-1; Quaiser A, 2003, MOL MICROBIOL, V50, P563, DOI 10.1046/j.1365-2958.2003.03707.x; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Sadekar S, 2006, MOL BIOL EVOL, V23, P2001, DOI 10.1093/molbev/msl079; Sanchez-Baracaldo P, 2015, SCI REP-UK, V5, DOI 10.1038/srep17418; Satoh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070290; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sousa FL, 2013, GENOME BIOL EVOL, V5, P200, DOI 10.1093/gbe/evs127; Tsukatani Y, 2013, BBA-BIOENERGETICS, V1827, P1200, DOI 10.1016/j.bbabio.2013.06.007; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Zeng YH, 2014, P NATL ACAD SCI USA, V111, P7795, DOI 10.1073/pnas.1400295111	34	14	14	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151250	10.1371/journal.pone.0151250	http://dx.doi.org/10.1371/journal.pone.0151250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953697	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300097
J	Ngo, CC; Massa, HM; Thornton, RB; Cripps, AW				Ngo, Chinh C.; Massa, Helen M.; Thornton, Ruth B.; Cripps, Allan W.			Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review	PLOS ONE			English	Review							NONTYPABLE HAEMOPHILUS-INFLUENZAE; PNEUMOCOCCAL CONJUGATE VACCINE; INDIGENOUS AUSTRALIAN CHILDREN; RESPIRATORY SYNCYTIAL VIRUS; COSTA-RICAN CHILDREN; STREPTOCOCCUS-PNEUMONIAE; ALLOIOCOCCUS-OTITIDIS; MORAXELLA-CATARRHALIS; PHID-CV; CLINICAL-EFFICACY	Background Otitis media (OM) is amongst the most common childhood diseases and is associated with multiple microbial pathogens within the middle ear. Global and temporal monitoring of predominant bacterial pathogens is important to inform new treatment strategies, vaccine development and to monitor the impact of vaccine implementation to improve progress toward global OM prevention. Methods A systematic review of published reports of microbiology of acute otitis media (AOM) and otitis media with effusion (OME) from January, 1970 to August 2014, was performed using PubMed databases. Results This review confirmed that Streptococcus pneumoniae and Haemophilus influenzae, remain the predominant bacterial pathogens, with S. pneumoniae the predominant bacterium in the majority reports from AOM patients. In contrast, H. influenzae was the predominant bacterium for patients experiencing chronic OME, recurrent AOM and AOM with treatment failure. This result was consistent, even where improved detection sensitivity from the use of polymerase chain reaction (PCR) rather than bacterial culture was conducted. On average, PCR analyses increased the frequency of detection of S. pneumoniae and H. influenzae 3.2 fold compared to culture, whilst Moraxella catarrhalis was 4.5 times more frequently identified by PCR. Molecular methods can also improve monitoring of regional changes in the serotypes and identification frequency of S. pneumoniae and H. influenzae over time or after vaccine implementation, such as after introduction of the 7-valent pneumococcal conjugate vaccine. Conclusions Globally, S. pneumoniae and H. influenzae remain the predominant otopathogens associated with OM as identified through bacterial culture; however, molecular methods continue to improve the frequency and accuracy of detection of individual serotypes. Ongoing monitoring with appropriate detection methods for OM pathogens can support development of improved vaccines to provide protection from the complex combination of otopathogens within the middle ear, ultimately aiming to reduce the risk of chronic and recurrent OM in vulnerable populations.	[Ngo, Chinh C.; Massa, Helen M.; Cripps, Allan W.] Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia; [Ngo, Chinh C.; Massa, Helen M.; Cripps, Allan W.] Griffith Univ, Menzies Hlth Inst Queensland, Mol Basis Dis, Gold Coast, Qld, Australia; [Thornton, Ruth B.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Thornton, Ruth B.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia	Griffith University; Griffith University; Menzies Health Institute Queensland; University of Western Australia; Telethon Kids Institute; University of Western Australia	Massa, HM (corresponding author), Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia.; Massa, HM (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Mol Basis Dis, Gold Coast, Qld, Australia.	h.massa@griffith.edu.au	Thornton, Ruth/GOP-2314-2022	Thornton, Ruth/0000-0001-9852-8310; Massa, Helen/0000-0002-2224-2276	Vietnam International Education Development, The Ministry of Education and Training (VIED-MOET); BrightSpark Foundation, Perth, Western Australia	Vietnam International Education Development, The Ministry of Education and Training (VIED-MOET); BrightSpark Foundation, Perth, Western Australia	The authors received no specific funding for this work. CNN acknowledges the Vietnam International Education Development, The Ministry of Education and Training (VIED-MOET) for a doctoral scholarship. RBT acknowledges the BrightSpark Foundation, Perth, Western Australia for a post-doctoral fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelnour A, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-52; Agrawal A, 2011, J CLIN MICROBIOL, V49, P3728, DOI 10.1128/JCM.05476-11; Aguilar L, 2009, INT J PEDIATR OTORHI, V73, P1407, DOI 10.1016/j.ijporl.2009.07.005; Akinjogunla OJ, 2011, J MICROB BIOTEC FOOD, V1, P333; Ako-Nai AK, 2002, J TROP PEDIATRICS, V48, P15, DOI 10.1093/tropej/48.1.15; Alonso M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054333; Aly BH, 2012, INDIAN J OTOLARYNGOL, V64, P51, DOI 10.1007/s12070-011-0161-6; Arguedas A, 2005, PEDIATR INFECT DIS J, V24, P631, DOI 10.1097/01.inf.0000168748.92510.45; Arguedas A, 2003, PEDIATR INFECT DIS J, V22, P1063, DOI 10.1097/01.inf.0000101189.81501.e9; Arguedas A, 1998, PEDIATR INFECT DIS J, V17, P680, DOI 10.1097/00006454-199808000-00004; Ashhurst-Smith C, 2014, INNATE IMMUN, V3; Ashhurst-Smith C, 2014, INNATE IMMUN, V20; Ashhurst-Smith C, 2007, FEMS IMMUNOL MED MIC, V51, P163, DOI 10.1111/j.1574-695X.2007.00297.x; Barkai G, 2009, PEDIATR INFECT DIS J, V28, P466, DOI 10.1097/INF.0b013e3181950c74; Ben-Shimol S, 2012, VACCINE, V30, P6600, DOI 10.1016/j.vaccine.2012.08.012; Beswich AJ, 1999, LANCET, V354, P386, DOI 10.1016/S0140-6736(98)09295-2; Block SL, 2002, PEDIATR INFECT DIS J, V21, P859, DOI 10.1097/00006454-200209000-00015; BLUESTONE CD, 1992, PEDIATR INFECT DIS J, V11, pS7, DOI 10.1097/00006454-199208001-00002; Broides A, 2009, CLIN INFECT DIS, V49, P1641, DOI 10.1086/647933; Bulut Y, 2007, EUR J PEDIATR, V166, P223, DOI 10.1007/s00431-006-0233-x; Casey JR, 2010, PEDIATR INFECT DIS J, V29, P304, DOI 10.1097/INF.0b013e3181c1bc48; Centers for Disease Control and Prevention, 2000, PREV PNEUM DIS INF Y; Chiu NC, 2012, J FORMOS MED ASSOC, V111, P536, DOI 10.1016/j.jfma.2011.07.015; Chonmaitree T, 2012, PEDIATR INFECT DIS J, V31, P325, DOI 10.1097/INF.0b013e318241afe4; COFFEY JD, 1967, ARCHIV OTOLARYNGOL, V86, P403; Commisso R, 2000, INT J PEDIATR OTORHI, V56, P23, DOI 10.1016/S0165-5876(00)00402-X; Couloigner V, 2012, PEDIATR INFECT DIS J, V31, P154, DOI 10.1097/INF.0b013e3182357c8d; Courter JD, 2010, ANN PHARMACOTHER, V44, P471, DOI 10.1345/aph.1M344; Cripps AW, 2006, EXPERT REV VACCINES, V5, P517, DOI 10.1586/14760584.5.4.517; Cripps AW, 2003, IMMUNOL CELL BIOL, V81, P46, DOI 10.1046/j.0818-9641.2002.01141.x; Dagan R, 2000, PEDIATR INFECT DIS J, V19, P95, DOI 10.1097/00006454-200002000-00002; Daniel M, 2012, INT J PEDIATR OTORHI, V76, P1416, DOI 10.1016/j.ijporl.2012.06.013; DAWSON VM, 1985, AUST J EXP BIOL MED, V63, P99, DOI 10.1038/icb.1985.12; Martinez ID, 2007, ACTA OTORRINOLAR ESP, V58, P408; delCastillo F, 1996, PEDIATR INFECT DIS J, V15, P541; DIAMOND C, 1989, J LARYNGOL OTOL, V103, P369, DOI 10.1017/S0022215100108989; Dicko A, 2013, HUM VACC IMMUNOTHER, V9, P382, DOI 10.4161/hv.22692; Dupont D, 2010, DIAGN MICR INFEC DIS, V68, P89, DOI 10.1016/j.diagmicrobio.2010.04.012; el-Shamy H A, 1993, J Egypt Public Health Assoc, V68, P495; Fenoll A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-239; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Gene A, 2004, ENFERM INFEC MICR CL, V22, P377, DOI 10.1157/13065523; Gibney KB, 2005, BMC PEDIATR, V5, P1; Giele C, 2007, VACCINE, V25, P2379, DOI 10.1016/j.vaccine.2006.09.004; Gok U, 2001, INT J PEDIATR OTORHI, V60, P49, DOI 10.1016/S0165-5876(01)00510-9; Gomes HD, 2009, EUROSURVEILLANCE, V14, P2; Gomez-Barreto D, 2011, SALUD PUBLICA MEXICO, V53, P207; Grevers G, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-312; Grubb MS, 2010, CLIN PEDIATR, V49, P727, DOI 10.1177/0009922810361365; Guevara S, 2012, VACCINE, V30, P3857, DOI 10.1016/j.vaccine.2012.04.010; Guven M, 2006, INT J PEDIATR OTORHI, V70, P915, DOI 10.1016/j.ijporl.2005.10.004; Guvenc MG, 2010, AURIS NASUS LARYNX, V37, P269, DOI 10.1016/j.anl.2009.09.002; Hamamoto Y, 2005, J LARYNGOL OTOL, V119, P862, DOI 10.1258/002221505774783476; Harimaya A, 2006, J CLIN MICROBIOL, V44, P946, DOI 10.1128/JCM.44.3.946-949.2006; Harimaya A, 2009, INT J PEDIATR OTORHI, V73, P677, DOI 10.1016/j.ijporl.2008.12.033; Heikkinen T, 1999, NEW ENGL J MED, V340, P260, DOI 10.1056/NEJM199901283400402; Hendolin PH, 1999, PEDIATR INFECT DIS J, V18, P860, DOI 10.1097/00006454-199910000-00005; Holder RC, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-87; Hsu KK, 2010, PEDIATR INFECT DIS J, V29, P289, DOI 10.1097/INF.0b013e3181c15471; Huebner RE, 2003, J LARYNGOL OTOL, V117, P169, DOI 10.1258/002221503321192430; Intakorn P, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-157; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Jefferies JMC, 2011, HUM VACCINES, V7, P1012, DOI 10.4161/hv.7.10.16794; Jero J, 1997, ACTA OTO-LARYNGOL, P22; Jones SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072794; Jung H, 2009, J INFECTION, V59, P308, DOI 10.1016/j.jinf.2009.08.013; Kalcioglu MT, 2002, MICROBIOLOGICA, V25, P31; KARMA PH, 1987, INT J PEDIATR OTORHI, V14, P141, DOI 10.1016/0165-5876(87)90025-5; Kaur R, 2010, PEDIATR INFECT DIS J, V29, P741, DOI 10.1097/INF.0b013e3181d9e639; Khoramrooz SS, 2012, AURIS NASUS LARYNX, V39, P369, DOI 10.1016/j.anl.2011.07.002; Kilpi T, 2001, PEDIATR INFECT DIS J, V20, P654, DOI 10.1097/00006454-200107000-00004; Kim CH, 2011, PEDIATR INFECT DIS J, V30, pE235, DOI 10.1097/INF.0b013e31822a8541; Kong K, 2009, MED J AUSTRALIA, V191, pS39; KURONO Y, 1988, ARCH OTOLARYNGOL, V114, P1262; Lagos RM, 2011, HUM VACCINES, V7, P511, DOI 10.4161/hv.7.5.14634; Leach AJ, 2007, PEDIATR INFECT DIS J, V26, pS4, DOI 10.1097/INF.0b013e318154b238; Lee LH, 2014, VACCINES-BASEL, V2, P112, DOI 10.3390/vaccines2010112; Leibovitz E, 2003, PEDIATR INFECT DIS J, V22, P943, DOI 10.1097/01.inf.0000095468.89866.14; Leibovitz E, 1998, PEDIATR INFECT DIS J, V17, P1126, DOI 10.1097/00006454-199812000-00005; Leskinen K, 2004, INT J PEDIATR OTORHI, V68, P51, DOI 10.1016/j.ijporl.2003.09.005; Leskinen K, 2002, INT J PEDIATR OTORHI, V66, P41, DOI 10.1016/S0165-5876(02)00186-6; Lim FS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-530; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Lua CY, 2012, VACCINE, V30, P2250, DOI 10.1016/j.vaccine.2011.10.070; Parra MM, 2011, VACCINE, V29, P5544, DOI 10.1016/j.vaccine.2011.04.128; MacLoughlin GJF, 1996, J ANTIMICROB CHEMOTH, V37, P565, DOI 10.1093/jac/37.3.565; Marsh RL, 2012, BMC EAR NOSE THROAT, V12, DOI 10.1186/1472-6815-12-11; Massa HM, 2009, MED J AUSTRALIA, V191, pS44; Matar GM, 1998, J CLIN MICROBIOL, V36, P1185, DOI 10.1128/JCM.36.5.1185-1188.1998; Mawas F, 2009, EXPERT REV VACCINES, V8, P77, DOI 10.1586/14760584.8.1.77; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P1738, DOI 10.1086/429908; Mills N, 2015, J PAEDIATR CHILD H, V51, P300, DOI 10.1111/jpc.12710; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mokaddas E, 2012, VACCINE, V30, pG37, DOI 10.1016/j.vaccine.2012.10.061; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Morris Peter S, 2009, Pediatr Clin North Am, V56, P1383, DOI 10.1016/j.pcl.2009.09.007; Murphy TF, 2005, EXPERT REV VACCINES, V4, P843, DOI 10.1586/14760584.4.6.843; Naranjo L, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-40; Nasser SC, 2011, J LARYNGOL OTOL, V125, P928, DOI 10.1017/S0022215111001587; Neumark T, 2011, SCAND J INFECT DIS, V43, P891, DOI 10.3109/00365548.2011.591820; Newall AT, 2011, VACCINE, V29, P8077, DOI 10.1016/j.vaccine.2011.08.050; Niittynen L, 2012, INT J PEDIATR OTORHI, V76, P465, DOI 10.1016/j.ijporl.2012.01.011; Oguz F, 2003, INT J PEDIATR OTORHI, V67, P43, DOI 10.1016/S0165-5876(02)00360-9; Palmu AAI, 2005, CLIN INFECT DIS, V40, P52, DOI 10.1086/426446; Palmu AAI, 2004, CLIN INFECT DIS, V38, P234, DOI 10.1086/380642; Park CW, 2004, J KOREAN MED SCI, V19, P735, DOI 10.3346/jkms.2004.19.5.735; Patel JA, 2007, VACCINE, V25, P1683, DOI 10.1016/j.vaccine.2006.10.045; Pereira M. Beatriz Rotta, 2004, J. Pediatr. (Rio J.), V80, P41, DOI 10.1590/S0021-75572004000100009; Pichichero ME, 2007, JAMA-J AM MED ASSOC, V298, P1772, DOI 10.1001/jama.298.15.1772; Polachek A, 2004, PEDIATR INFECT DIS J, V23, P406, DOI 10.1097/01.inf.0000122603.78338.bd; Porat N, 2010, PEDIATR INFECT DIS J, V29, P126, DOI 10.1097/INF.0b013e3181b78e6e; POST JC, 1995, JAMA-J AM MED ASSOC, V273, P1598, DOI 10.1001/jama.273.20.1598; Pumarola F, 2013, INT J PEDIATR OTORHI, V77, P1231, DOI 10.1016/j.ijporl.2013.04.002; Rodriguez WJ, 1999, PEDIATR INFECT DIS J, V18, P942, DOI 10.1097/00006454-199910000-00023; Rodriguez WJ, 1995, PEDIATR INFECT DIS J, V14, P1075, DOI 10.1097/00006454-199512000-00009; Roland PS, 2007, ENT-EAR NOSE THROAT, V86, P2, DOI 10.1177/014556130708611s02; Rosenblut A, 2006, ANN OTO RHINOL LARYN, V115, P186, DOI 10.1177/000348940611500305; Rosenblut A, 2001, PEDIATR INFECT DIS J, V20, P501, DOI 10.1097/00006454-200105000-00006; Rosenfeld RM, 2004, PEDIATRICS, V113, P1412, DOI 10.1542/peds.113.5.1412; Rovers MM, 2008, VACCINE, V26, pG2, DOI 10.1016/j.vaccine.2008.11.005; Ruiz-Palacios GM, 2011, HUM VACCINES, V7, P1137, DOI 10.4161/hv.7.11.17984; Ruohola A, 2006, CLIN INFECT DIS, V43, P1417, DOI 10.1086/509332; Sagai S, 2004, AURIS NASUS LARYNX, V31, P341, DOI 10.1016/j.anl.2004.07.005; Segal N, 2005, CLIN INFECT DIS, V41, P35, DOI 10.1086/430605; Seo E, 2010, ACM T EMBED COMPUT S, V10, DOI 10.1145/1880050.1880059; Shishegar M, 2011, IRAN J MED SCI, V36, P273; Sierra A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-4; Sih TM, 2001, ANN OTO RHINOL LARYN, V110, P662, DOI 10.1177/000348940111000712; SIPILA P, 1981, ACTA OTO-LARYNGOL, V92, P123, DOI 10.3109/00016488109133246; Smidt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064422; Smith-Vaughan HC, 2013, BMC EAR NOSE THROAT, V13, DOI 10.1186/1472-6815-13-12; Smith-Vaughan HC, 2014, CLIN VACCINE IMMUNOL, V21, P250, DOI 10.1128/CVI.00632-13; Somech I, 2011, VACCINE, V29, P4202, DOI 10.1016/j.vaccine.2011.03.103; SRIWARDHANA KB, 1989, J LARYNGOL OTOL, V103, P253, DOI 10.1017/S0022215100108631; Stamboulidis K, 2011, PEDIATR INFECT DIS J, V30, P551, DOI 10.1097/INF.0b013e31821038d9; Stol K, 2013, INT J PEDIATR OTORHI, V77, P488, DOI 10.1016/j.ijporl.2012.12.016; Stuart J, 2003, J PAEDIATR CHILD H, V39, P665, DOI 10.1046/j.1440-1754.2003.00247.x; SUGITA R, 1981, LARYNGOSCOPE, V91, P816; Suzuki A, 2005, PEDIATR INFECT DIS J, V24, P655, DOI 10.1097/01.inf.0000168755.01196.49; Thornton RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053837; Tomic V, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/s12941-014-0052-2; Ton TT, 2007, EXPERT REV VACCINES, V6, P949, DOI 10.1586/14760584.6.6.949; Tristram S, 2007, CLIN MICROBIOL REV, V20, P368, DOI 10.1128/CMR.00040-06; TRUJILLO H, 1989, PEDIATR INFECT DIS J, V8, P361, DOI 10.1097/00006454-198906000-00007; Tseng T-C, 2007, FU JEN J MED, V5, P1; Turner D, 2002, PEDIATR INFECT DIS J, V21, P669, DOI 10.1097/00006454-200207000-00013; Tyo KR, 2011, VACCINE, V29, P6686, DOI 10.1016/j.vaccine.2011.06.091; van den Bergh MR, 2011, PEDIATR INFECT DIS J, V30, pE170, DOI 10.1097/INF.0b013e31821a0614; Verduin CM, 2002, CLIN MICROBIOL REV, V15, P125, DOI 10.1128/CMR.15.1.125-144.2002; Walls T, 2011, NEW ZEAL MED J, V124, P6; Watson M, 2007, J MED MICROBIOL, V56, P819, DOI 10.1099/jmm.0.47057-0; Watson P, 1996, NEW ZEAL MED J, V109, P182; Weil-Olivier C, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-207; Wiertsema SP, 2011, VACCINE, V29, P5163, DOI 10.1016/j.vaccine.2011.05.035; Wilke MS, 2005, CURR OPIN MICROBIOL, V8, P525, DOI 10.1016/j.mib.2005.08.016; Yano H, 2009, ACTA OTO-LARYNGOL, V129, P19, DOI 10.1080/00016480802032777; Yano H, 2013, J CLIN MICROBIOL, V51, P3542, DOI 10.1128/JCM.01108-13	157	113	118	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150949	10.1371/journal.pone.0150949	http://dx.doi.org/10.1371/journal.pone.0150949			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953891	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300063
J	Patel, RV; Hamanishi, ET; Provart, NJ				Patel, Rohan V.; Hamanishi, Erin T.; Provart, Nicholas J.			A Human "eFP" Browser for Generating Gene Expression Anatograms	PLOS ONE			English	Article							DATABASE; MICROARRAY; CELLS	Transcriptomic studies help to further our understanding of gene function. Human transcriptomic studies tend to focus on a particular subset of tissue types or a particular disease state; however, it is possible to collate into a compendium multiple studies that have been profiled using the same expression analysis platform to provide an overview of gene expression levels in many different tissues or under different conditions. In order to increase the knowledge and understanding we gain from such studies, intuitive visualization of gene expression data in such a compendium can be useful. The Human eFP ("electronic Fluorescent Pictograph") Browser presented here is a tool for intuitive visualization of large human gene expression data sets on pictographic representations of the human body as gene expression "anatograms". Pictographic representations for new data sets may be generated easily. The Human eFP Browser can also serve as a portal to other gene-specific information through link-outs to various online resources.	[Patel, Rohan V.; Provart, Nicholas J.] Univ Toronto, Dept Cell & Syst Biol, 25 Willcocks St, Toronto, ON M5S 3B2, Canada; [Patel, Rohan V.; Provart, Nicholas J.] Univ Toronto, Ctr Anal Genome Evolut & Funct, 25 Willcocks St, Toronto, ON M5S 3B2, Canada; [Hamanishi, Erin T.] Univ Toronto Scarborough, Dept Biol Sci, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Scarborough	Provart, NJ (corresponding author), Univ Toronto, Dept Cell & Syst Biol, 25 Willcocks St, Toronto, ON M5S 3B2, Canada.; Provart, NJ (corresponding author), Univ Toronto, Ctr Anal Genome Evolut & Funct, 25 Willcocks St, Toronto, ON M5S 3B2, Canada.	nicholas.provart@utoronto.ca			University of Toronto Faculty of Arts and Science, Funds for Online Learning Initiative (FOIL) grant	University of Toronto Faculty of Arts and Science, Funds for Online Learning Initiative (FOIL) grant	A University of Toronto Faculty of Arts and Science, Funds for Online Learning Initiative (FOIL) grant for "An Upper Level Bioinformatic Methods Computer Laboratory Course as a MOOC" to NJP in part supported RVP while undertaking work described in this paper. The Human eFP Browser is used in the Bioinformatic Methods II course on Coursera.org that was created through this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors (NJP and ETH) received no specific funding for this work.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bao X, 2008, VIROLOGY, V374, P114, DOI 10.1016/j.virol.2007.12.024; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Ezkurdia I, 2014, SHRINKING HUMAN PROT; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Hiraoka N, 2011, GASTROENTEROLOGY, V140, P310, DOI 10.1053/j.gastro.2010.10.009; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Kalogeropoulos M, 2010, FASEB J, V24, P2893, DOI 10.1096/fj.09-148908; Karoly ED, 2007, ENVIRON HEALTH PERSP, V115, P535, DOI 10.1289/ehp.9556; Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009993; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Mutskov V, 2009, P NATL ACAD SCI USA, V106, P17419, DOI 10.1073/pnas.0909288106; Okamoto K, 2009, PHYSIOLOGY, V24, P357, DOI 10.1152/physiol.00029.2009; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Roe OD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006554; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Ware C., 2012, INFORM VISUALIZATION; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150982	10.1371/journal.pone.0150982	http://dx.doi.org/10.1371/journal.pone.0150982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954504	gold, Green Published, Green Submitted			2022-12-27	WOS:000371991300067
J	Dehghan, A; Bis, JC; White, CC; Smith, AV; Morrison, AC; Cupples, LA; Trompet, S; Chasman, DI; Lumley, T; Volker, U; Buckley, BM; Ding, JZ; Jensen, MK; Folsom, AR; Kritchevsky, SB; Girman, CJ; Ford, I; Dorr, M; Salomaa, V; Uitterlinden, AG; Eiriksdottir, G; Vasan, RS; Franceschini, N; Carty, CL; Virtamo, J; Demissie, S; Amouyel, P; Arveiler, D; Heckbert, SR; Ferrieres, J; Ducimetiere, P; Smith, NL; Wang, YA; Siscovick, DS; Rice, KM; Wiklund, PG; Taylor, KD; Evans, A; Kee, F; Rotter, JI; Karvanen, J; Kuulasmaa, K; Heiss, G; Kraft, P; Launer, LJ; Hofman, A; Markus, MRP; Rose, LM; Silander, K; Wagner, P; Benjamin, EJ; Lohman, K; Stott, DJ; Rivadeneira, F; Harris, TB; Levy, D; Liu, YM; Rimm, EB; Jukema, JW; Volzke, H; Ridker, PM; Blankenberg, S; Franco, OH; Gudnason, V; Psaty, BM; Boerwinkle, E; O'Donnell, CJ				Dehghan, Abbas; Bis, Joshua C.; White, Charles C.; Smith, Albert Vernon; Morrison, Alanna C.; Cupples, L. Adrienne; Trompet, Stella; Chasman, Daniel I.; Lumley, Thomas; Voelker, Uwe; Buckley, Brendan M.; Ding, Jingzhong; Jensen, Majken K.; Folsom, Aaron R.; Kritchevsky, Stephen B.; Girman, Cynthia J.; Ford, Ian; Doerr, Marcus; Salomaa, Veikko; Uitterlinden, Andre G.; Eiriksdottir, Gudny; Vasan, Ramachandran S.; Franceschini, Nora; Carty, Cara L.; Virtamo, Jarmo; Demissie, Serkalem; Amouyel, Philippe; Arveiler, Dominique; Heckbert, Susan R.; Ferrieres, Jean; Ducimetiere, Pierre; Smith, Nicholas L.; Wang, Ying A.; Siscovick, David S.; Rice, Kenneth M.; Wiklund, Per-Gunnar; Taylor, Kent D.; Evans, Alun; Kee, Frank; Rotter, Jerome I.; Karvanen, Juha; Kuulasmaa, Kari; Heiss, Gerardo; Kraft, Peter; Launer, Lenore J.; Hofman, Albert; Markus, Marcello R. P.; Rose, Lynda M.; Silander, Kaisa; Wagner, Peter; Benjamin, Emelia J.; Lohman, Kurt; Stott, David J.; Rivadeneira, Fernando; Harris, Tamara B.; Levy, Daniel; Liu, Yongmei; Rimm, Eric B.; Jukema, J. Wouter; Voelzke, Henry; Ridker, Paul M.; Blankenberg, Stefan; Franco, Oscar H.; Gudnason, Vilmundur; Psaty, Bruce M.; Boerwinkle, Eric; O'Donnell, Christopher J.			Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies: The CHARGE Consortium	PLOS ONE			English	Article							CHROMOSOME 9P21; RISK; DESIGN; SUSCEPTIBILITY; PREDICTION	Background Data are limited on genome-wide association studies (GWAS) for incident coronary heart disease (CHD). Moreover, it is not known whether genetic variants identified to date also associate with risk of CHD in a prospective setting. Methods We performed a two-stage GWAS analysis of incident myocardial infarction (MI) and CHD in a total of 64,297 individuals (including 3898 MI cases, 5465 CHD cases). SNPs that passed an arbitrary threshold of 5x10(-6) in Stage I were taken to Stage II for further discovery. Furthermore, in an analysis of prognosis, we studied whether known SNPs from former GWAS were associated with total mortality in individuals who experienced MI during follow-up. Results In Stage I 15 loci passed the threshold of 5x10(-6); 8 loci for MI and 8 loci for CHD, for which one locus overlapped and none were reported in previous GWAS meta-analyses. We took 60 SNPs representing these 15 loci to Stage II of discovery. Four SNPs near QKI showed nominally significant association with MI (p-value<8.8x10(-3)) and three exceeded the genome-wide significance threshold when Stage I and Stage II results were combined (top SNP rs6941513: p = 6.2x10(-9)). Despite excellent power, the 9p21 locus SNP (rs1333049) was only modestly associated with MI (HR = 1.09, p-value = 0.02) and marginally with CHD (HR = 1.06, p-value = 0.08). Among an inception cohort of those who experienced MI during follow-up, the risk allele of rs1333049 was associated with a decreased risk of subsequent mortality (HR = 0.90, p-value = 3.2x10(-3)). Conclusions QKI represents a novel locus that may serve as a predictor of incident CHD in prospective studies. The association of the 9p21 locus both with increased risk of first myocardial infarction and longer survival after MI highlights the importance of study design in investigating genetic determinants of complex disorders.	[Dehghan, Abbas; Uitterlinden, Andre G.; Hofman, Albert; Rivadeneira, Fernando; Franco, Oscar H.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Bis, Joshua C.; Heckbert, Susan R.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [White, Charles C.; Cupples, L. Adrienne; Demissie, Serkalem; Wang, Ying A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Smith, Albert Vernon; Eiriksdottir, Gudny; Gudnason, Vilmundur] Icelandic Heart Assoc, Kopavogur, Iceland; [Smith, Albert Vernon; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Morrison, Alanna C.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Morrison, Alanna C.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Cupples, L. Adrienne; Vasan, Ramachandran S.; Benjamin, Emelia J.; Levy, Daniel; O'Donnell, Christopher J.] Boston Univ, Framingham, MA USA; [Cupples, L. Adrienne; Vasan, Ramachandran S.; Benjamin, Emelia J.; Levy, Daniel; O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Trompet, Stella] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Chasman, Daniel I.; Rose, Lynda M.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Chasman, Daniel I.; Rose, Lynda M.; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA USA; [Lumley, Thomas; Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Voelker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Voelker, Uwe; Doerr, Marcus; Markus, Marcello R. P.; Voelzke, Henry] DZHK German Ctr Cardiovasc Res, Partner Site, Greifswald, Germany; [Buckley, Brendan M.] Univ Coll, Dept Pharmacol & Therapeut, Cork, Ireland; [Ding, Jingzhong] Wake Forest Univ, Dept Internal Med, Div Geriatr, Winston Salem, NC 27109 USA; [Jensen, Majken K.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Jensen, Majken K.; Rimm, Eric B.] Harvard Univ, Sch Med, Channing Div Network Med, Boston, MA USA; [Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Kritchevsky, Stephen B.] Wake Forest Sch Med, Sticht Ctr Aging, Winston Salem, NC USA; [Girman, Cynthia J.; Franceschini, Nora; Heiss, Gerardo] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Girman, Cynthia J.] Merck Sharp & Dohme Corp, Dept Epidemiol, Merck Res Labs, Whitehouse Stn, NJ USA; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Doerr, Marcus] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Salomaa, Veikko; Virtamo, Jarmo; Karvanen, Juha; Kuulasmaa, Kari; Silander, Kaisa; Wagner, Peter] Natl Inst Hlth & Welf, Helsinki, Finland; [Uitterlinden, Andre G.; Rivadeneira, Fernando] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Prevent Med, Boston, MA 02118 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA; [Carty, Cara L.] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Amouyel, Philippe] Inst Pasteur, Dept Epidemiol & Publ Hlth, F-59019 Lille, France; [Arveiler, Dominique] Univ Strasbourg, Dept Epidemiol & Publ Hlth, EA 3430, Strasbourg, France; [Heckbert, Susan R.; Smith, Nicholas L.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Heckbert, Susan R.; Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Ferrieres, Jean] Toulouse Univ Hosp, Dept Cardiol, Toulouse, France; [Ferrieres, Jean] Toulouse Univ Hosp, Dept Epidemiol, Toulouse, France; [Ducimetiere, Pierre] Natl Inst Hlth & Med Res, U258, Paris, France; [Smith, Nicholas L.] Seattle Epidemiol Res & Informat Ctr, Dept Vet Affairs, Off Res & Dev, Seattle, WA USA; [Wang, Ying A.] Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA USA; [Siscovick, David S.] New York Acad Med, New York, NY USA; [Wiklund, Per-Gunnar] Umea Univ Hosp, Dept Med, S-90185 Umea, Sweden; [Taylor, Kent D.; Rotter, Jerome I.] Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA USA; [Taylor, Kent D.; Rotter, Jerome I.] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90509 USA; [Evans, Alun; Kee, Frank] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth Res Northern Irela, Belfast, Antrim, North Ireland; [Karvanen, Juha] Univ Jyvaskyla, Dept Math & Stat, Jyvaskyla, Finland; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; [Markus, Marcello R. P.; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Silander, Kaisa; Wagner, Peter] Univ Helsinki, Inst Mol Med FIMM, Helsinki, Finland; [Lohman, Kurt; Liu, Yongmei] Wake Forest Sch Med, Dept Epidemiol & Prevent, Publ Hlth Sci, Winston Salem, NC 27157 USA; [Stott, David J.] Univ Glasgow, Fac Med, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Rivadeneira, Fernando] Netherlands Consortium Hlth Aging, Netherlands Genom Initiat, Leiden, Netherlands; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Blankenberg, Stefan] Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Boerwinkle, Eric] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [O'Donnell, Christopher J.] NHLBI, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA; [O'Donnell, Christopher J.] Boston Vet Adm Healthcare, Cardiol Sect, Dept Med, Boston, MA USA	Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; Boston University; Icelandic Heart Association; University of Iceland; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of Auckland; Greifswald Medical School; German Centre for Cardiovascular Research; University College Cork; Wake Forest University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; Merck & Company; University of Glasgow; Greifswald Medical School; Finland National Institute for Health & Welfare; Erasmus University Rotterdam; Erasmus MC; Boston University; Boston University; Boston University; Boston University; Fred Hutchinson Cancer Center; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Washington; University of Washington Seattle; Group Health Cooperative; CHU de Toulouse; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Novartis; New York Academy of Medicine; Umea University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Queens University Belfast; University of Jyvaskyla; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Greifswald Medical School; University of Helsinki; Wake Forest University; University of Glasgow; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Washington; University of Washington Seattle; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Dehghan, A (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands.; O'Donnell, CJ (corresponding author), Boston Univ, Framingham, MA USA.; O'Donnell, CJ (corresponding author), NHLBI, Framingham Heart Study, Framingham, MA USA.; O'Donnell, CJ (corresponding author), NHLBI, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA.; O'Donnell, CJ (corresponding author), Boston Vet Adm Healthcare, Cardiol Sect, Dept Med, Boston, MA USA.	a.dehghan@erasmusmc.nl; odonnellc@nhlbi.nih.gov	Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011; Ramachandran, Vasan/Y-2527-2019; Rivadeneira, Fernando/O-5385-2015; Ford, Ian/ABE-6145-2020; Kraft, Peter/GQH-8448-2022; Franco, Óscar H/ABE-2305-2020; Gudnason, Vilmundur/AAE-7126-2019; Levy, Daniel/ABF-6873-2021; Markus, Marcello Ricardo Paulista/H-7698-2019; Jukema, J. Wouter/ABD-6503-2021; Dörr, Marcus/F-1919-2010; Rotter, Jerome/AAY-6598-2021; Dehghan, Abbas/ABE-7377-2020; Smith, Albert Vernon/K-5150-2015; Dehghan, Abbas/B-9896-2008; Ferrieres, Jean/S-7993-2016	Benjamin, Emelia/0000-0003-4076-2336; Ramachandran, Vasan/0000-0001-7357-5970; Rivadeneira, Fernando/0000-0001-9435-9441; Franco, Óscar H/0000-0002-4606-4929; Gudnason, Vilmundur/0000-0001-5696-0084; Levy, Daniel/0000-0003-1843-8724; Markus, Marcello Ricardo Paulista/0000-0002-6234-4955; Jukema, J. Wouter/0000-0002-3246-8359; Dörr, Marcus/0000-0001-7471-475X; Amouyel, Philippe/0000-0001-9088-234X; Karvanen, Juha/0000-0001-5530-769X; Kuulasmaa, Kari/0000-0003-2165-1411; Smith, Albert Vernon/0000-0003-1942-5845; Jensen, Majken Karoline/0000-0003-4729-7545; Morrison, Alanna/0000-0001-6381-4296; Kraft, Peter/0000-0002-4472-8103; Volker, Uwe/0000-0002-5689-3448; Dehghan, Abbas/0000-0001-6403-016X; Cupples, L. Adrienne/0000-0003-0273-7965; Ferrieres, Jean/0000-0001-6144-1297; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Merck Sharp Dohme Corp.; Novartis Institutes for Biomedical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120393, T32HL007055, R01HL105756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006000] Funding Source: NIH RePORTER	Merck Sharp Dohme Corp.(Merck & Company); Novartis Institutes for Biomedical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	There were no current funding sources for this study. Merck Sharp & Dohme Corp. provided support in the form of salary for author Cynthia J. Girman, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. Novartis Institutes for Biomedical Research provided support in the form of salary for author Ying A. Wang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Chan K, 2013, J AM COLL CARDIOL, V61, P957, DOI 10.1016/j.jacc.2012.10.051; de Bruin RG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10846; de Vries PS, 2015, INT J EPIDEMIOL, V44, P682, DOI 10.1093/ije/dyv070; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gong Y, 2011, CIRC-CARDIOVASC GENE, V4, P169, DOI 10.1161/CIRCGENETICS.110.959296; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hill G, 2003, J CLIN EPIDEMIOL, V56, P293, DOI 10.1016/S0895-4356(02)00571-1; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; NEYMAN J, 1955, SCIENCE, V122, P401, DOI 10.1126/science.122.3166.401; O'Donnell CJ, 2011, NEW ENGL J MED, V365, P2098, DOI 10.1056/NEJMra1105239; Palomaki GE, 2010, JAMA-J AM MED ASSOC, V303, P648, DOI 10.1001/jama.2010.118; Patel RS, 2014, J AM COLL CARDIOL, V63, P2234, DOI 10.1016/j.jacc.2014.01.065; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Szpakowicz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104635; van der Veer E, 2013, CIRC RES; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wilson PWF, 2009, ENDOCRIN METAB CLIN, V38, P33, DOI 10.1016/j.ecl.2008.11.001	27	55	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0144997	10.1371/journal.pone.0144997	http://dx.doi.org/10.1371/journal.pone.0144997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950853	Green Published, Green Accepted, gold			2022-12-27	WOS:000371990100004
J	Goetz, JJ; Laboissonniere, LA; Wester, AK; Lynch, MR; Trimarchi, JM				Goetz, Jillian J.; Laboissonniere, Lauren A.; Wester, Andrea K.; Lynch, Madison R.; Trimarchi, Jeffrey M.			Polo-Like Kinase 3 Appears Dispensable for Normal Retinal Development Despite Robust Embryonic Expression	PLOS ONE			English	Article							CELL-FATE DETERMINATION; LARGE GENE LISTS; GANGLION-CELL; COMPETENCE STATE; MOUSE RETINA; MATH5; CYCLE; BIOINFORMATICS; PROGENITOR; PLK3	During retinogenesis seven different cell types are generated in distinct yet overlapping timepoints from a population of retinal progenitor cells. Previously, we performed single cell transcriptome analyses of retinal progenitor cells to identify candidate genes that may play roles in the generation of early-born retinal neurons. Based on its expression pattern in subsets of early retinal cells, polo-like kinase 3 (Plk3) was identified as one such candidate gene. Further characterization of Plk3 expression by in situ hybridization revealed that this gene is expressed as cells exit the cell cycle. We obtained a Plk3 deficient mouse and investigated changes in the retina's morphology and transcriptome through immunohistochemistry, in situ hybridization and gene expression profiling. These experiments have been performed initially on adult mice and subsequently extended throughout retinal development. Although morphological studies revealed no consistent changes in retinogenesis upon Plk3 loss, microarray profiling revealed potential candidate genes altered in Plk3-KO mice. Further studies will be necessary to understand the connection between these changes in gene expression and the loss of a protein kinase such as Plk3.	[Goetz, Jillian J.; Laboissonniere, Lauren A.; Wester, Andrea K.; Lynch, Madison R.; Trimarchi, Jeffrey M.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA; [Lynch, Madison R.] Ames High Sch, Ames, IA USA; [Goetz, Jillian J.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA	Iowa State University; Northwestern University; Feinberg School of Medicine	Trimarchi, JM (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA.	jtrimarc@iastate.edu	Laboissonniere, Lauren/U-9098-2019	Laboissonniere, Lauren/0000-0002-4260-5900; Trimarchi, Jeffrey/0000-0001-7923-1538	Iowa State University	Iowa State University	This work was funded by start-up funds provided by Iowa State University to JMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bagnoli P, 2003, HISTOL HISTOPATHOL, V18, P1219, DOI 10.14670/HH-18.1219; Bahassi ELM, 2004, ONCOGENE, V23, P2658, DOI 10.1038/sj.onc.1207425; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Bassett EA, 2012, DEV DYNAM, V241, P814, DOI 10.1002/dvdy.23762; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2012, DEV BIOL, V365, P395, DOI 10.1016/j.ydbio.2012.03.006; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Clapcote SJ, 2005, COMPARATIVE MED, V55, P310; Errijgers V, 2007, GENES BRAIN BEHAV, V6, P552, DOI 10.1111/j.1601-183X.2006.00282.x; Feng L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-36; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goetz JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110194; Goetz JJ, 2014, INT REV CEL MOL BIO, V308, P273, DOI 10.1016/B978-0-12-800097-7.00007-5; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iida M, 2009, J BIOCHEM, V146, P501, DOI 10.1093/jb/mvp092; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kruger M, 2002, MOL CELL BIOL, V22, P792, DOI 10.1128/MCB.22.3.792-800.2002; Le TT, 2006, DEV BIOL, V295, P764, DOI 10.1016/j.ydbio.2006.03.055; Liu Q, 2002, INVEST OPHTH VIS SCI, V43, P22; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Molday RS, 1989, PROG RET RES, V8, P173; Morrow EM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-2; Myer DL, 2011, MUTAT RES-FUND MOL M, V714, P1, DOI 10.1016/j.mrfmmm.2011.02.006; Myer DL, 2005, ONCOGENE, V24, P299, DOI 10.1038/sj.onc.1208278; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Seeburg DP, 2005, ONCOGENE, V24, P292, DOI 10.1038/sj.onc.1208277; Sidman RL, 1961, STRUCTURE EYE, P487; Skowronska-Krawczyk D, 2009, DEVELOPMENT, V136, P3767, DOI 10.1242/dev.033449; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Trimarchi JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001588; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wu FG, 2012, J COMP NEUROL, V520, P952, DOI 10.1002/cne.22741; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1; Zimmerman WC, 2007, CELL CYCLE, V6, P1314, DOI 10.4161/cc.6.11.4275; Zimmerman WC, 2007, P NATL ACAD SCI USA, V104, P1847, DOI 10.1073/pnas.0610856104	55	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150878	10.1371/journal.pone.0150878	http://dx.doi.org/10.1371/journal.pone.0150878			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26949938	Green Submitted, Green Published, gold			2022-12-27	WOS:000371990100069
J	Stamelos, VA; Fisher, N; Bamrah, H; Voisey, C; Price, JC; Farrell, WE; Redman, CW; Richardson, A				Stamelos, Vasileios A.; Fisher, Natalie; Bamrah, Harnoor; Voisey, Carolyn; Price, Joshua C.; Farrell, William E.; Redman, Charles W.; Richardson, Alan			The BH3 Mimetic Obatoclax Accumulates in Lysosomes and Causes Their Alkalinization	PLOS ONE			English	Article							CANCER CELLS; GX15-070; APOPTOSIS; INHIBITION; AUTOPHAGY; LAPATINIB; CYTOTOXICITY; COMBINATION; RESISTANCE; INDUCTION	Obatoclax belongs to a class of compounds known as BH3 mimetics which function as antagonists of Bcl-2 family apoptosis regulators. It has undergone extensive preclinical and clinical evaluation as a cancer therapeutic. Despite this, it is clear that obatoclax has additional pharmacological effects that contribute to its cytotoxic activity. It has been claimed that obatoclax, either alone or in combination with other molecularly targeted therapeutics, induces an autophagic form of cell death. In addition, obatoclax has been shown to inhibit lysosomal function, but the mechanism of this has not been elucidated. We have evaluated the mechanism of action of obatoclax in eight ovarian cancer cell lines. Consistent with its function as a BH3 mimetic, obatoclax induced apoptosis in three cell lines. However, in the remaining cell lines another form of cell death was evident because caspase activation and PARP cleavage were not observed. Obatoclax also failed to show synergy with carboplatin and paclitaxel, chemotherapeutic agents which we have previously shown to be synergistic with authentic Bcl-2 family antagonists. Obatoclax induced a profound accumulation of LC-3 but knockdown of Atg-5 or beclin had only minor effects on the activity of obatoclax in cell growth assays suggesting that the inhibition of lysosomal function rather than stimulation of autophagy may play a more prominent role in these cells. To evaluate how obatoclax inhibits lysosomal function, confocal microscopy studies were conducted which demonstrated that obatoclax, which contains two basic pyrrole groups, accumulates in lysosomes. Studies using pH sensitive dyes demonstrated that obatoclax induced lysosomal alkalinization. Furthermore, obatoclax was synergistic in cell growth/survival assays with bafilomycin and chloroquine, two other drugs which cause lysosomal alkalinization. These studies explain, for the first time, how obatoclax inhibits lysosomal function and suggest that lysosomal alkalinization contributes to the cytotoxic activity of obatoclax.	[Stamelos, Vasileios A.; Fisher, Natalie; Bamrah, Harnoor; Voisey, Carolyn; Price, Joshua C.; Farrell, William E.; Richardson, Alan] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England; [Voisey, Carolyn; Richardson, Alan] Keele Univ, Sch Pharm, Keele ST5 5BG, Staffs, England; [Stamelos, Vasileios A.; Redman, Charles W.] Univ Hosp North Midlands, Stoke On Trent, Staffs, England	Keele University; Keele University	Richardson, A (corresponding author), Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England.; Richardson, A (corresponding author), Keele Univ, Sch Pharm, Keele ST5 5BG, Staffs, England.	a.richardson1@keele.ac.uk	Richardson, Alan/I-4631-2015	Richardson, Alan/0000-0003-1825-3375	Medical Resarch Council [S1910 S060]; Keele University; North Staffordshire Medical Research Institute; University Hospital of North Midlands; University Hospital of North Midlands Cancer Research Fund	Medical Resarch Council; Keele University; North Staffordshire Medical Research Institute; University Hospital of North Midlands; University Hospital of North Midlands Cancer Research Fund	Funding provided by Medical Resarch Council, S1910 S060, http://www.mrc.ac.uk/, Keele University, No applicable grant number, https://www.keele.ac.uk/, North Staffordshire Medical Research Institute, No applicable grant number, http://nsmedicalinstitute.co.uk/ and University Hospital of North Midlands, No applicable grant number, http://www.uhnm.nhs.uk/Pages/Home.aspx.; This research was funded by the Medical Research Council (S1910 S060), Keele University, North Staffordshire Medical Institute, and the University Hospital of North Midlands Cancer Research Fund. The authors declare no conflicts of interest.	Andreu-Fernandez V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056881; Basit F, 2013, CELL DEATH DIFFER, V20, P1161, DOI 10.1038/cdd.2013.45; Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Brem EA, 2011, BRIT J HAEMATOL, V153, P599, DOI 10.1111/j.1365-2141.2011.08669.x; Chen KF, 2012, CANCER LETT, V321, P27, DOI 10.1016/j.canlet.2012.03.023; Chen SH, 2014, CANCER LETT, V348, P20, DOI 10.1016/j.canlet.2014.02.010; Chen SA, 2014, MOL CELL BIOL, V34, P3435, DOI 10.1128/MCB.01383-13; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cruickshanks N, 2012, MOL PHARMACOL, V82, P1217, DOI 10.1124/mol.112.081539; Cruickshanks N, 2012, MOL PHARMACOL, V81, P748, DOI 10.1124/mol.112.077586; de Grenu BD, 2011, CHEM-EUR J, V17, P14074, DOI 10.1002/chem.201101547; Espona-Fiedler M, 2012, BIOCHEM PHARMACOL, V83, P489, DOI 10.1016/j.bcp.2011.11.027; Fulda S, 2015, ONCOGENE, V34, P5105, DOI 10.1038/onc.2014.458; Goard CA, 2013, CORE EVID, V8, P15, DOI 10.2147/CE.S42568; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Heidari N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.53; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Koehler BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106571; Konopleva M, 2008, CANCER RES, V68, P3413, DOI 10.1158/0008-5472.CAN-07-1919; Liang LZ, 2015, ORAL DIS, V21, P470, DOI 10.1111/odi.12305; Martin AP, 2009, CANCER BIOL THER, V8, P2084; Martinez-Paniagua MA, 2011, CELL CYCLE, V10, P2792, DOI 10.4161/cc.10.16.16952; McCoy F, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.86; Moore VD, 2013, CANCER LETT, V332, P202, DOI 10.1016/j.canlet.2011.12.021; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Papireddy K, 2011, J MED CHEM, V54, P5296, DOI 10.1021/jm200543y; Petrini I, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.92; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Ruttgers A, 2006, BIOTECHNIQUES, V41, P469, DOI 10.2144/000112259; Schwartz-Roberts JL, 2013, MOL CANCER THER, V12, P448, DOI 10.1158/1535-7163.MCT-12-0617; Smoot RL, 2010, CANCER RES, V70, P1960, DOI 10.1158/0008-5472.CAN-09-3535; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Stamelos VA, 2013, GYNECOL ONCOL, V128, P377, DOI 10.1016/j.ygyno.2012.11.019; Stamelos Vasileios A, 2012, J Mol Signal, V7, P12, DOI 10.1186/1750-2187-7-12; Tang Y, 2012, MOL PHARMACOL, V81, P527, DOI 10.1124/mol.111.076851; Urtishak KA, 2013, BLOOD, V121, P2689, DOI 10.1182/blood-2012-04-425033; Vidot S, 2010, CELL SIGNAL, V22, P926, DOI 10.1016/j.cellsig.2010.01.017; von Schwarzenberg K, 2013, J BIOL CHEM, V288, P1385, DOI 10.1074/jbc.M112.412007; Wang G, 2014, ONCOL REP, V32, P2789, DOI 10.3892/or.2014.3525; Witham J, 2007, CLIN CANCER RES, V13, P7191, DOI 10.1158/1078-0432.CCR-07-0362; Yazbeck VY, 2014, ORAL ONCOL, V50, P120, DOI 10.1016/j.oraloncology.2013.10.013; Zhong DS, 2014, J CELL BIOCHEM, V115, P1624, DOI 10.1002/jcb.24829	43	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150696	10.1371/journal.pone.0150696	http://dx.doi.org/10.1371/journal.pone.0150696			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950068	Green Published, gold			2022-12-27	WOS:000371990100052
J	Wu, HC; Wang, XJ				Wu, Hongchen; Wang, Xinjun			ISBP: Understanding the Security Rule of Users' Information-Sharing Behaviors in Partnership	PLOS ONE			English	Article							ONLINE SOCIAL NETWORKS; PRIVACY; TRUSTWORTHINESS; SATISFACTION; INTENTION; FRIENDS	The rapid growth of social network data has given rise to high security awareness among users, especially when they exchange and share their personal information. However, because users have different feelings about sharing their information, they are often puzzled about who their partners for exchanging information can be and what information they can share. Is it possible to assist users in forming a partnership network in which they can exchange and share information with little worry? We propose a modified information sharing behavior prediction (ISBP) model that can help in understanding the underlying rules by which users share their information with partners in light of three common aspects: what types of items users are likely to share, what characteristics of users make them likely to share information, and what features of users' sharing behavior are easy to predict. This model is applied with machine learning techniques in WEKA to predict users' decisions pertaining to information sharing behavior and form them into trustable partnership networks by learning their features. In the experiment section, by using two real-life datasets consisting of citizens' sharing behavior, we identify the effect of highly sensitive requests on sharing behavior adjacent to individual variables: the younger participants' partners are more difficult to predict than those of the older participants, whereas the partners of people who are not computer majors are easier to predict than those of people who are computer majors. Based on these findings, we believe that it is necessary and feasible to offer users personalized suggestions on information sharing decisions, and this is pioneering work that could benefit college researchers focusing on user-centric strategies and website owners who want to collect more user information without raising their privacy awareness or losing their trustworthiness.	[Wu, Hongchen; Wang, Xinjun] Shandong Univ, Sch Comp Sci & Technol, Jinan 250100, Peoples R China	Shandong University	Wang, XJ (corresponding author), Shandong Univ, Sch Comp Sci & Technol, Jinan 250100, Peoples R China.	wxj@sdu.edu.cn			National Key Technologies RD Program [2012BAH54F04]; Natural Science Foundation of Shandong Province of China [ZR2013FQ009]; Shandong Province Independent Innovation Major Special Project [2013CXC30201]; China Scholarship Council (CSC) [201306220132]	National Key Technologies RD Program(National Key Technology R&D Program); Natural Science Foundation of Shandong Province of China(Natural Science Foundation of Shandong Province); Shandong Province Independent Innovation Major Special Project; China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by the National Key Technologies R&D Program (Grant No. 2012BAH54F04); the Natural Science Foundation of Shandong Province of China (Grant No. ZR2013FQ009); the Shandong Province Independent Innovation Major Special Project (Grant No. 2013CXC30201); and the author Hongchen Wu is thankful for financial support from the China Scholarship Council (CSC, File No. 201306220132).	Acquisti A, 2006, LECT NOTES COMPUT SC, V4258, P36; Acquisti A, 2015, SCIENCE, V347, P509, DOI 10.1126/science.aaa1465; Adler P S, 2013, ORGAN SCI, V12, P215; [Anonymous], [No title captured]; Beckman CM, 2004, ORGAN SCI, V15, P259, DOI 10.1287/orsc.1040.0065; Bock GW, 2005, MIS QUART, V29, P87, DOI 10.2307/25148669; Brandtzaeg PB, 2010, INT J HUM-COMPUT INT, V26, P1006, DOI 10.1080/10447318.2010.516719; Chen R, 2011, INFORM SYSTEMS FRONT, V15, P269; Chen XG, 2013, INT J INFORM MANAGE, V33, P917, DOI 10.1016/j.ijinfomgt.2013.08.010; Cheng Zhiyuan, 2011, ICWSM, P81; Chiaburu DS, 2008, J BUS ETHICS, V83, P453, DOI 10.1007/s10551-007-9631-x; Dietterich TG, 2000, MACH LEARN, V40, P139, DOI 10.1023/A:1007607513941; Ding S, 2014, KNOWL-BASED SYST, V56, P216, DOI 10.1016/j.knosys.2013.11.014; Ellison NB, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI 10.1111/j.1083-6101.2007.00367.x; Flach PA, 2004, MACH LEARN, V57, P233, DOI 10.1023/B:MACH.0000039778.69032.ab; Gao F, 2014, INT J COMPUT SCI ENG, V9, P347, DOI 10.1504/IJCSE.2014.060716; Gross J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127619; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Ji L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121105; Kobsa A, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P81, DOI 10.1145/2556288.2557102; Krasnova H, 2010, J INF TECHNOL, V25, P109, DOI 10.1057/jit.2010.6; Lindqvist J, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P2409; Liu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085236; Moussaid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084592; Rish I., 2001, IJCAI 2001 WORKSH EM, V3, P41; Shen CX, 2010, SCI CHINA INFORM SCI, V53, P405, DOI 10.1007/s11432-010-0069-x; Shiau WL, 2012, COMPUT HUM BEHAV, V28, P2431, DOI 10.1016/j.chb.2012.07.030; Shin DH, 2010, INTERACT COMPUT, V22, P428, DOI 10.1016/j.intcom.2010.05.001; Subramani MR, 2003, COMMUN ACM, V46, P300, DOI 10.1145/953460.953514; Tsai JY, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P2003; Wu Hequan, 2014, STAT BIOSCIENCES, P1; Zhang H., 2006, 2006 IEEE COMP SOC C, V2, P2126, DOI [DOI 10.1109/CVPR.2006.301, 10.1109/CVPR.2006.301]; Zhou ZM, 2012, J BUS RES, V65, P890, DOI 10.1016/j.jbusres.2011.06.034	33	1	1	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0151002	10.1371/journal.pone.0151002	http://dx.doi.org/10.1371/journal.pone.0151002			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SL	26950064	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100079
J	Jeon, H; Waku, T; Azami, T; Khoa, LTP; Yanagisawa, J; Takahashi, S; Ema, M				Jeon, Hyojung; Waku, Tsuyoshi; Azami, Takuya; Le Tran Phuc Khoa; Yanagisawa, Jun; Takahashi, Satoru; Ema, Masatsugu			Comprehensive Identification of Kruppel-Like Factor Family Members Contributing to the Self-Renewal of Mouse Embryonic Stem Cells and Cellular Reprogramming	PLOS ONE			English	Article							GROUND-STATE; ES CELLS; HUMAN FIBROBLASTS; IN-VITRO; PLURIPOTENCY; EPIBLAST; NANOG; DIFFERENTIATION; EXPRESSION; MAINTAINS	Pluripotency is maintained in mouse embryonic stem (ES) cells and is induced from somatic cells by the activation of appropriate transcriptional regulatory networks. Kruppel-like factor gene family members, such as Klf2, Klf4 and Klf5, have important roles in maintaining the undifferentiated state of mouse ES cells as well as in cellular reprogramming, yet it is not known whether other Klf family members exert self-renewal and reprogramming functions when overexpressed. In this study, we examined whether overexpression of any representative Klf family member, such as Klf1-Klf10, would be sufficient for the self-renewal of mouse ES cells. We found that only Klf2, Klf4, and Klf5 produced leukemia inhibitory factor (LIF)-independent self-renewal, although most KLF proteins, if not all, have the ability to occupy the regulatory regions of Nanog, a critical Klf target gene. We also examined whether overexpression of any of Klf1-Klf10 would be sufficient to convert epiblast stem cells into a naive pluripotent state and found that Klf5 had such reprogramming ability, in addition to Klf2 and Klf4. We also delineated the functional domains of the Klf2 protein for LIF-independent self-renewal and reprogramming. Interestingly, we found that both the N-terminal transcriptional activation and C-terminal zinc finger domains were indispensable for this activity. Taken together, our comprehensive analysis provides new insight into the contribution of Klf family members to mouse ES self-renewal and cellular reprogramming.	[Jeon, Hyojung; Azami, Takuya; Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Fac Med, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan; [Waku, Tsuyoshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Le Tran Phuc Khoa] Univ Tsukuba, Sch Integrat & Global Majors, Dept Anat & Embryol, Human Biol Program, 1-1-1 Tennodai, Ibaraki 3058575, Japan; [Yanagisawa, Jun] Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan; [Yanagisawa, Jun] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan; [Takahashi, Satoru] Univ Tsukuba, Int Inst Integrat Sleep Med, Life Sci Ctr, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan; [Takahashi, Satoru] Univ Tsukuba, Anim Resource Ctr, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan; [Ema, Masatsugu] Shiga Univ Med Sci, Dept Stem Cells & Human Dis Models, Res Ctr Anim Life Sci, Tsukinowa Cho, Otsu, Shiga 5202192, Japan; [Ema, Masatsugu] Japan Sci & Technol Agcy, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan	University of Tsukuba; University of Tokyo; University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; Shiga University of Medical Science; Japan Science & Technology Agency (JST)	Ema, M (corresponding author), Shiga Univ Med Sci, Res Ctr Anim Life Sci, Dept Stem Cells & Human Dis Models, Tsukinowa Cho, Otsu, Shiga 5202192, Japan.; Ema, M (corresponding author), Japan Sci & Technol Agcy, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.	mema@belle.shiga-med.ac.jp	Le, Khoa/AAL-2599-2020	Tran Phuc Le, Khoa/0000-0002-6076-3857; Azami, Takuya/0000-0002-3759-9710; Ema, Masatsugu/0000-0003-0645-6183	PRESTO, Japan Science and Technology Agency (JST)	PRESTO, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported in part by a grant from PRESTO, Japan Science and Technology Agency (JST) (to M.E.). This work was also supported by a Grant-in-Aid for JSPS Fellows (to T.A. and T.W.).	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gagliardi A, 2013, EMBO J, V32, P2231, DOI 10.1038/emboj.2013.161; Gillich A, 2012, CELL STEM CELL, V10, P425, DOI 10.1016/j.stem.2012.01.020; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hamilton WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060907; Honsho K, 2015, J REPROD DEVELOP, V61, P13, DOI 10.1262/jrd.2014-098; Ito I, 2013, J CLIN INVEST, V123, P4579, DOI 10.1172/JCI67804; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Posfai E, 2014, CURR TOP DEV BIOL, V107, P1, DOI 10.1016/B978-0-12-416022-4.00001-9; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang Y, 2011, EMBO REP, V12, P373, DOI 10.1038/embor.2011.11; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	38	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150715	10.1371/journal.pone.0150715	http://dx.doi.org/10.1371/journal.pone.0150715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943822	Green Published, gold, Green Submitted			2022-12-27	WOS:000371739400041
J	Chen, H; Arsovski, AA; Yu, KF; Wang, AM				Chen, Hui; Arsovski, Andrej Adam; Yu, Kangfu; Wang, Aiming			Genome-Wide Investigation Using sRNA-Seq, Degradome-Seq and Transcriptome-Seq Reveals Regulatory Networks of microRNAs and Their Target Genes in Soybean during Soybean mosaic virus Infection	PLOS ONE			English	Article							PARALLEL ANALYSIS; PARE LIBRARIES; MIRNA TARGETS; R1 PROTEIN; RESISTANCE; IDENTIFICATION; DEFENSE; CONSTRUCTION; TRANSLATION; VIRULENCE	MicroRNAs (miRNAs) play key roles in a variety of cellular processes through regulation of their target gene expression. Accumulated experimental evidence has demonstrated that infections by viruses are associated with the altered expression profile of miRNAs and their mRNA targets in the host. However, the regulatory network of miRNA-mRNA interactions during viral infection remains largely unknown. In this study, we performed small RNA (sRNA)-seq, degradome-seq and as well as a genome-wide transcriptome analysis to profile the global gene and miRNA expression in soybean following infections by three different Soybean mosaic virus (SMV) isolates, L (G2 strain), LRB (G2 strain) and G7 (G7 strain). sRNA-seq analyses revealed a total of 253 soybean miRNAs with a two-fold or greater change in abundance compared with the mock-inoculated control. 125 transcripts were identified as the potential cleavage targets of 105 miRNAs and validated by degradome-seq analyses. Genome-wide transcriptome analysis showed that total 2679 genes are differentially expressed in response to SMV infection including 71 genes predicted as involved in defense response. Finally, complex miRNA-mRNA regulatory networks were derived using the RNAseq, small RNAseq and degradome data. This work represents a comprehensive, global approach to examining virus-host interactions. Genes responsive to SMV infection are identified as are their potential miRNA regulators. Additionally, regulatory changes of the miRNAs themselves are described and the regulatory relationships were supported with degradome data. Taken together these data provide new insights into molecular SMV-soybean interactions and offer candidate miRNAs and their targets for further elucidation of the SMV infection process.	[Chen, Hui; Arsovski, Andrej Adam; Wang, Aiming] Agr & Agri Food Canada, 1391 Sandford ST, London, ON N5T 4T3, Canada; [Chen, Hui; Wang, Aiming] Univ Western Ontario, Dept Biol, 1151 Richmond ST N, London, ON N6A 5B7, Canada; [Yu, Kangfu] Agr & Agri Food Canada, Greenhouse & Proc Crops Res Ctr, 2585 Cty Rd 20, Harrow, ON N0R 1G0, Canada	Agriculture & Agri Food Canada; Western University (University of Western Ontario); Agriculture & Agri Food Canada	Wang, AM (corresponding author), Agr & Agri Food Canada, 1391 Sandford ST, London, ON N5T 4T3, Canada.; Wang, AM (corresponding author), Univ Western Ontario, Dept Biol, 1151 Richmond ST N, London, ON N6A 5B7, Canada.	Aiming.Wang@AGR.GC.CA	Chen, Hui/Y-4376-2019	Chen, Hui/0000-0001-6050-0873	AAFC Genomics R&D Initiative (GRDI); Natural Sciences and Engineering Research Council of Canada (NSERC); Grain Farmers Ontario (GFO)	AAFC Genomics R&D Initiative (GRDI); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Grain Farmers Ontario (GFO)	This work was supported in part by AAFC Genomics R&D Initiative (GRDI), the Natural Sciences and Engineering Research Council of Canada (NSERC), and Grain Farmers Ontario (GFO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2014, RICE, V7, DOI 10.1186/s12284-014-0009-2; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Babu M, 2008, J GEN VIROL, V89, P1069, DOI 10.1099/vir.0.83531-0; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bazzini AA, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-152; Chen H, 2015, VIROLOGY, V476, P395, DOI 10.1016/j.virol.2014.12.034; Chen J, 2004, PLANT CELL, V16, P1302, DOI 10.1105/tpc.018986; CHO EK, 1979, PHYTOPATHOLOGY, V69, P467, DOI 10.1094/Phyto-69-467; Chowda-Reddy RV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028342; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Dodds PN, 2010, SCIENCE, V330, P1486, DOI 10.1126/science.1200245; Du P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002176; Eggenberger AL, 2008, MOL PLANT MICROBE IN, V21, P931, DOI 10.1094/MPMI-21-7-0931; Folkes L, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks277; Gagarinova AG, 2008, VIRUS RES, V138, P50, DOI 10.1016/j.virusres.2008.08.010; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Gomez P, 2009, EUR J PLANT PATHOL, V125, P1, DOI 10.1007/s10658-009-9468-5; Gore MA, 2002, GENOME, V45, P592, DOI 10.1139/G02-009; Gunduz I, 2002, CROP SCI, V42, P90, DOI 10.2135/cropsci2002.0090; Hajimorad MR, 2003, VIROLOGY, V314, P497, DOI 10.1016/S0042-6822(03)00456-2; Hajimorad MR, 2001, MOL PLANT MICROBE IN, V14, P587, DOI 10.1094/MPMI.2001.14.5.587; Havelda Z, 2008, PLANT J, V55, P278, DOI 10.1111/j.1365-313X.2008.03501.x; Hayes AJ, 2000, CROP SCI, V40, P1434, DOI 10.2135/cropsci2000.4051434x; Jeong SC, 2002, CROP SCI, V42, P265, DOI 10.2135/cropsci2002.0265; Jones SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059270; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kohil D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108851; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Li EQ, 2014, TUMOR BIOL, V35, P7645, DOI 10.1007/s13277-014-2031-9; Lin CC, 2011, MOL CELL BIOL, V31, P2513, DOI 10.1128/MCB.01189-10; Liu Q, 2009, FEBS LETT, V583, P723, DOI 10.1016/j.febslet.2009.01.020; Llave C, 2011, METHODS MOL BIOL, V732, P187, DOI 10.1007/978-1-61779-083-6_14; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; Mallory AC, 2008, TRENDS PLANT SCI, V13, P359, DOI 10.1016/j.tplants.2008.03.007; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Noch E, 2012, MOL CANCER THER, V11, P14, DOI 10.1158/1535-7163.MCT-11-0517; Pradhan B, 2015, VIRUS RES, V195, P183, DOI 10.1016/j.virusres.2014.09.001; Ritte G, 2002, P NATL ACAD SCI USA, V99, P7166, DOI 10.1073/pnas.062053099; Romanel E, 2012, PLANT MOL BIOL, V80, P443, DOI 10.1007/s11103-012-9959-1; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shamimuzzaman M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-310; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Varallyay E, 2010, EMBO J, V29, P3507, DOI 10.1038/emboj.2010.215; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang AM, 2015, ANNU REV PHYTOPATHOL, V53, P45, DOI 10.1146/annurev-phyto-080614-120001; Wang AM, 2012, MOL PLANT PATHOL, V13, P795, DOI 10.1111/j.1364-3703.2012.00791.x; Wang Y, 2011, PLANT CELL, V23, P3185, DOI 10.1105/tpc.111.088013; Wang YN, 2014, PLANT CELL, V26, P4782, DOI 10.1105/tpc.114.131607; Wong J, 2014, PLANT J, V79, P928, DOI 10.1111/tpj.12590; Xia R, 2013, PLANT CELL, V25, P1555, DOI 10.1105/tpc.113.110957; Xu F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-66; Yamane K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098032; Yin XC, 2013, PLANTA, V237, P1213, DOI 10.1007/s00425-012-1835-3; Yin ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035765; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907; YU YG, 1994, PHYTOPATHOLOGY, V84, P60, DOI 10.1094/Phyto-84-60; Zhai JX, 2014, METHODS, V67, P84, DOI 10.1016/j.ymeth.2013.06.025; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zhao MX, 2015, PLANT CELL, V27, P546, DOI 10.1105/tpc.15.00048; Zheng C, 2005, CROP SCI, V45, P2503, DOI 10.2135/cropsci2005.0114	70	21	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150582	10.1371/journal.pone.0150582	http://dx.doi.org/10.1371/journal.pone.0150582			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963095	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000043
J	Choi, SY; Lee, K; Park, Y; Lee, SH; Jo, SH; Chung, S; Kim, KT				Choi, Se-Young; Lee, Keimin; Park, Yurim; Lee, Seung-Hyun; Jo, Su-Hyun; Chung, Sungkwon; Kim, Kyong-Tai			Non-Dioxin-Like Polychlorinated Biphenyls Inhibit G-Protein Coupled Receptor-Mediated Ca2+ Signaling by Blocking Store-Operated Ca2+ Entry	PLOS ONE			English	Article							CHOLINERGIC MUSCARINIC RECEPTORS; LONG-TERM POTENTIATION; DEVELOPMENTAL EXPOSURE; CALCIUM-ENTRY; HUMAN GABA(A); PCB MIXTURE; CELLS; RELEASE; CHANNEL; CONTRACTION	Polychlorinated biphenyls (PCBs) are ubiquitous pollutants which accumulate in the food chain. Recently, several molecular mechanisms by which non-dioxin-like (NDL) PCBs mediate neurodevelopmental and neurobehavioral toxicity have been elucidated. However, although the G-protein coupled receptor (GPCR) is a significant target for neurobehavioral disturbance, our understanding of the effects of PCBs on GPCR signaling remains unclear. In this study, we investigated the effects of NDL-PCBs on GPCR-mediated Ca2+ signaling in PC12 cells. We found that ortho-substituted 2,2', 6-trichlorinated biphenyl (PCB19) caused a rapid decline in the Ca2+ signaling of bradykinin, a typical Gq-and phospholipase C beta-coupled GPCR, without any effect on its inositol 1,4,5-trisphosphate production. PCB19 reduced thapsigargin-induced sustained cytosolic Ca2+ levels, suggesting that PCB19 inhibits SOCE. The abilities of other NDL-PCBs to inhibit store-operated Ca2+ entry (SOCE) were also examined and found to be of similar potencies to that of PCB19. PCB19 also showed a manner equivalent to that of known SOCE inhibitors. PCB19-mediated SOCE inhibition was confirmed by demonstrating the ability of PCB19 to inhibit the SOCE current and thapsigargin-induced Mn2+ influx. These results imply that one of the molecular mechanism by which NDL-PCBs cause neurobehavioral disturbances involves NDL-PCB-mediated inhibition of SOCE, thereby interfering with GPCR-mediated Ca2+ signaling.	[Choi, Se-Young; Lee, Keimin; Lee, Seung-Hyun] Seoul Natl Univ, Sch Dent, Dept Physiol, Dent Res Inst, Seoul, South Korea; [Choi, Se-Young; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Park, Yurim; Chung, Sungkwon] Sungkyunkwan Univ, Sch Med, Dept Physiol, Samsung Biomed Res Inst, Suwon, South Korea; [Jo, Su-Hyun] Kangwon Natl Univ, Sch Med, Dept Physiol, Chunchon, South Korea	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Sungkyunkwan University (SKKU); Kangwon National University	Kim, KT (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Div Integrat Biosci & Biotechnol, Pohang, South Korea.	ktk@postech.ac.kr	CHUNG, SUNGKWON/ABF-8293-2021	KIM, KYONG-TAI/0000-0001-7292-2627; Choi, Se-Young/0000-0001-7534-5167	National Research Foundation of Korea [2015048003, 2013R1A2A2A01014688, 2013M3C7A1044016]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (2015048003, 2013R1A2A2A01014688, 2013M3C7A1044016, http://www.nrf.re.kr/nrf_eng_cms/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann L, 2001, TOXICOL SCI, V61, P321, DOI 10.1093/toxsci/61.2.321; Bae J, 1999, J PHARMACOL EXP THER, V289, P1112; Boczek T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102352; Boix J, 2011, NEUROCHEM INT, V58, P69, DOI 10.1016/j.neuint.2010.10.014; Breivik K, 2002, SCI TOTAL ENVIRON, V290, P181, DOI 10.1016/S0048-9697(01)01075-0; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Choi SY, 2005, J NEUROSCI, V25, P11433, DOI 10.1523/JNEUROSCI.4084-05.2005; Choi SY, 2001, BRIT J PHARMACOL, V132, P411, DOI 10.1038/sj.bjp.0703840; Choi SY, 1999, J PHARMACOL EXP THER, V291, P107; CLARKSON TW, 1995, AM J CLIN NUTR, V61, p682S, DOI 10.1093/ajcn/61.3.682S; Coccini T, 2006, NEUROTOXICOLOGY, V27, P468, DOI 10.1016/j.neuro.2005.12.004; Cocco S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129481; Dewailly E, 1996, AM J PUBLIC HEALTH, V86, P1241, DOI 10.2105/AJPH.86.9.1241; ERIKSSON P, 1991, TOXICOLOGY, V69, P27, DOI 10.1016/0300-483X(91)90150-Y; Eriksson P, 2006, TOXICOL SCI, V94, P302, DOI 10.1093/toxsci/kfl109; Fangstrom B, 2005, ENV HLTH, V5, P4; Faroon O, 2000, TOXICOL IND HEALTH, V16, P307, DOI 10.1177/074823370001600708; Fernandes ECA, 2010, TOXICOL SCI, V118, P183, DOI 10.1093/toxsci/kfq257; Gilbert ME, 2000, TOXICOL SCI, V57, P102, DOI 10.1093/toxsci/57.1.102; Goto J, 2010, CELL CALCIUM, V47, P1, DOI 10.1016/j.ceca.2009.10.004; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grossman E, 2013, ENVIRON HEALTH PERSP, V121, pA86, DOI 10.1289/ehp.121-a86; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hendriks HS, 2010, TOXICOL SCI, V118, P635, DOI 10.1093/toxsci/kfq284; Hogan PG, 2015, CELL CALCIUM, V58, P357, DOI 10.1016/j.ceca.2015.07.001; Hussain RJ, 2000, ENVIRON HEALTH PERSP, V108, P827, DOI 10.2307/3434989; Inglefield JR, 2001, J PHARMACOL EXP THER, V297, P762; Jo SH, 2001, J CARDIOVASC PHARM, V38, P11, DOI 10.1097/00005344-200107000-00002; Kodavanti PRS, 2011, TOXICOL APPL PHARM, V256, P290, DOI 10.1016/j.taap.2011.07.005; Langeveld WT, 2012, TOXICOL SCI, V126, P487, DOI 10.1093/toxsci/kfr346; Lee H, 1997, J BIOL CHEM, V272, P21831, DOI 10.1074/jbc.272.35.21831; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Naveau E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091903; Neal AP, 2010, TOXICOL SCI, V116, P604, DOI 10.1093/toxsci/kfq139; Park MH, 2012, TOXICOL APPL PHARM, V262, P60, DOI 10.1016/j.taap.2012.04.019; Pessah IN, 2006, CHEM RES TOXICOL, V19, P92, DOI 10.1021/tx050196m; Pessah IN, 2010, PHARMACOL THERAPEUT, V125, P260, DOI 10.1016/j.pharmthera.2009.10.009; Putney JW, 2011, NEUROCHEM RES, V36, P1157, DOI 10.1007/s11064-010-0383-0; Rosado JA, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00325; Shafer TJ, 1996, TOXICOL APPL PHARM, V141, P448, DOI 10.1006/taap.1996.0311; Sirabella R, 2012, J NEUROCHEM, V122, P911, DOI 10.1111/j.1471-4159.2012.07838.x; Song SK, 1998, BIOCHEM PHARMACOL, V56, P561, DOI 10.1016/S0006-2952(97)00660-6; Thompson MA, 2009, CELL MOL NEUROBIOL, V29, P193, DOI 10.1007/s10571-008-9311-0; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Winneke G, 2002, TOXICOLOGY, V181, P161, DOI 10.1016/S0300-483X(02)00274-3; Winneke G, 1998, TOXICOL LETT, V103, P423, DOI 10.1016/S0378-4274(98)00334-8; Wong PW, 1996, MOL PHARMACOL, V49, P740; Wong PW, 1997, J BIOL CHEM, V272, P15145, DOI 10.1074/jbc.272.24.15145; Wong PW, 2001, J NEUROCHEM, V76, P450, DOI 10.1046/j.1471-4159.2001.00022.x; Yang J, 2011, EMBO J, V30, P165, DOI 10.1038/emboj.2010.286; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0	52	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150921	10.1371/journal.pone.0150921	http://dx.doi.org/10.1371/journal.pone.0150921			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963511	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000079
J	Coppage, AL; Heard, KR; DiMare, MT; Liu, YX; Wu, WG; Lai, JH; Bachovchin, WW				Coppage, Andrew L.; Heard, Kathryn R.; DiMare, Matthew T.; Liu, Yuxin; Wu, Wengen; Lai, Jack H.; Bachovchin, William W.			Human FGF-21 Is a Substrate of Fibroblast Activation Protein	PLOS ONE			English	Article							GROWTH-FACTOR 21; FGF21; IDENTIFICATION; OBESITY	FGF-21 is a key regulator of metabolism and potential drug candidate for the treatment of type II diabetes and other metabolic disorders. However, the half-life of active, circulating, human FGF-21 has recently been shown to be limited in mice and monkeys by a proteolytic cleavage between P171 and S172. Here, we show that fibroblast activation protein is the enzyme responsible for this proteolysis by demonstrating that purified FAP cleaves human FGF-21 at this site in vitro, and that an FAP-specific inhibitor, ARI-3099, blocks the activity in mouse, monkey and human plasma and prolongs the half-life of circulating human FGF-21 in mice. Mouse FGF-21, however, lacks the FAP cleavage site and is not cleaved by FAP. These findings indicate FAP may function in the regulation of metabolism and that FAP inhibitors may prove useful in the treatment of diabetes and metabolic disorders in humans, but pre-clinical proof of concept studies in rodents will be problematic.	[Coppage, Andrew L.; Heard, Kathryn R.; DiMare, Matthew T.; Liu, Yuxin; Wu, Wengen; Lai, Jack H.; Bachovchin, William W.] Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Heard, Kathryn R.; DiMare, Matthew T.; Liu, Yuxin; Wu, Wengen; Lai, Jack H.; Bachovchin, William W.] Arisaph Pharmaceut Inc, Boston, MA USA	Tufts University	Bachovchin, WW (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.; Bachovchin, WW (corresponding author), Arisaph Pharmaceut Inc, Boston, MA USA.	William.Bachovchin@tufts.edu	liu, yuxin/GRY-3592-2022; william.bachovchin@tufts.edu/AAA-3538-2022		Arisaph Pharmaceuticals; National Institutes of Health/National Cancer Institute [R01 CA163930]; National Science Foundation [IIP-1317741]; NATIONAL CANCER INSTITUTE [R01CA163930] Funding Source: NIH RePORTER	Arisaph Pharmaceuticals; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by Arisaph Pharmaceuticals: Sponsored Research Agreement [http://www.arisaph.com/]; National Institutes of Health/National Cancer Institute: R01 CA163930 [http://www.nih.gov/; http://www.cancer.gov/]; National Science Foundation: IIP-1317741 [http://www.nsf.gov/]. Arisaph Pharmaceuticals provided support in the form of salary for authors Kathryn R. Heard, Matthew T. DiMare, Yuxin Liu, Wengen Wu, Jack H. Lai and William W. Bachovchin, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Dunshee DR, 2016, J BIOL CHEM; Edosada CY, 2006, J BIOL CHEM, V281, P7437, DOI 10.1074/jbc.M511112200; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Ge X, 2011, J BIOL CHEM, V286, P34533, DOI 10.1074/jbc.M111.248591; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Gorrell M, 2012, NOVEL METABOLIC DIS; Hecht R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049345; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Huang CH, 2011, J BIOCHEM, V149, P685, DOI 10.1093/jb/mvr017; Jambunathan K, 2012, FEBS LETT, V586, P2507, DOI 10.1016/j.febslet.2012.06.015; Keane FM, 2014, FEBS OPEN BIO, V4, P43, DOI 10.1016/j.fob.2013.12.001; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058575; Kim HW, 2013, ENDOCRINOLOGY, V154, P3366, DOI 10.1210/en.2012-2276; Long YC, 2011, BBA-MOL BASIS DIS, V1812, P791, DOI 10.1016/j.bbadis.2011.04.002; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Poplawski SE, 2013, J MED CHEM, V56, P3467, DOI 10.1021/jm400351a; Popovici C, 2005, BIOESSAYS, V27, P849, DOI 10.1002/bies.20261; Stein S, 2009, DIABETES CARE, V32, P126, DOI 10.2337/dc08-1054; Veniant MM, 2012, ENDOCRINOLOGY, V153, P4192, DOI 10.1210/en.2012-1211; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zhang Y, 2011, MOL CELL ENDOCRINOL, V342, P41, DOI 10.1016/j.mce.2011.05.003; Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065; Zhen EY, 2015, BIOCH J	33	41	41	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151269	10.1371/journal.pone.0151269	http://dx.doi.org/10.1371/journal.pone.0151269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26962859	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000130
J	Kim, YW; Jeoung, JW; Kim, DW; Girard, MJA; Mari, JM; Park, KH; Kim, DM				Kim, Yong Woo; Jeoung, Jin Wook; Kim, Dai Woo; Girard, Michael J. A.; Mari, Jean Martial; Park, Ki Ho; Kim, Dong Myung			Clinical Assessment of Lamina Cribrosa Curvature in Eyes with Primary Open-Angle Glaucoma	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; CHOROIDAL THICKNESS; NERVE-HEAD; INTRAOCULAR-PRESSURE; DIURNAL-VARIATION; DISC COMPLIANCE; AXIAL LENGTH; DISPLACEMENT; DEPTH; ENHANCEMENT	Purpose Quantitative evaluation of lamina cribrosa (LC) posterior bowing in primary open-angle glaucoma (POAG) eyes using swept-source optical coherence tomography. Methods Patients with POAG (n = 123 eyes) and healthy individuals of a similar age (n = 92 eyes) were prospectively recruited. Anterior laminar insertion depth (ALID) was defined as the vertical distance between the anterior laminar insertion and a reference plane connecting the Bruch's membrane openings (BMO). The mean LC depth (mLCD) was approximated by dividing the area enclosed by the anterior LC, the BMO reference plane, and the two vertical lines for ALID measurement by the length between those two vertical lines. The LC curvature index was defined as the difference between the mLCD and the ALID. The factors influencing the LC curvature index were evaluated. Results The ALID and mLCD were significantly larger in POAG eyes than in healthy controls (P < 0.05). The LC curvature index was significantly larger in POAG eyes than in healthy controls on both the horizontal (85.8 +/- 34.1 vs. 68.2 +/- 32.3 mu m) and vertical meridians (49.8 +/- 38.5 vs. 32.2 +/- 31.1 mu m, all P < 0.001). Multivariate regression showed significant associations of greater disc area (P < 0.001), vertical C/D ratio (P < 0.001) and mLCD (P < 0.001), smaller rim area (P = 0.001), thinner average RNFLT (P < 0.001), and myopic refraction (P = 0.049) with increased LC curvature index. There was no difference in the LC curvature index between mild (MD > -6 dB) and moderate-to-advanced glaucoma (MD < -6 dB, P = 0.95). Conclusions LC posterior bowing was increased in POAG eyes, and was significantly associated with structural optic nerve head (ONH) changes but not with functional glaucoma severity. Quantitative evaluation of LC curvature can facilitate assessment of glaucomatous ONH change.	[Kim, Yong Woo] Armed Forces Busan Hosp, Dept Ophthalmol, Busan, South Korea; [Jeoung, Jin Wook; Park, Ki Ho; Kim, Dong Myung] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul Natl Univ Hosp, Seoul, South Korea; [Kim, Dai Woo] Kims Eye Hosp, Dept Ophthalmol, Seoul, South Korea; [Girard, Michael J. A.] Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore; [Girard, Michael J. A.] Singapore Eye Res Inst, Singapore, Singapore; [Mari, Jean Martial] Univ French Polynesia, Tahiti, France	Seoul National University (SNU); Seoul National University Hospital; National University of Singapore; National University of Singapore; Singapore National Eye Center	Jeoung, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul Natl Univ Hosp, Seoul, South Korea.	neuroprotect@gmail.com	Girard, Michael/F-9323-2015	Girard, Michael/0000-0003-4408-5918; Mari, Jean Martial/0000-0002-1169-6547	Korea Health Technology RAMP;D Project, Ministry of Health AMP; Welfare, Republic of Korea [A121615]; NUS Young Investigator Award [NUSYIA_FY13_P03, R-397-000-174-133]	Korea Health Technology RAMP;D Project, Ministry of Health AMP; Welfare, Republic of Korea; NUS Young Investigator Award	This work was supported by a grant of the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (grant number A121615). The funding organization had no role in the design or conduct of this research. This work was also supported by NUS Young Investigator Award (NUSYIA_FY13_P03, R-397-000-174-133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Burgoyne CF, 1995, OPHTHALMOLOGY, V102, P1790, DOI 10.1016/S0161-6420(95)30792-0; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 1995, OPHTHALMOLOGY, V102, P1800, DOI 10.1016/S0161-6420(95)30791-9; Chakraborty R, 2011, INVEST OPHTH VIS SCI, V52, P5121, DOI 10.1167/iovs.11-7364; Downs JC, 2011, EXP EYE RES, V93, P133, DOI 10.1016/j.exer.2010.08.004; Furlanetto RL, 2013, INVEST OPHTH VIS SCI, V54, P4836, DOI 10.1167/iovs.12-11530; Girard MJA, 2015, INVEST OPHTH VIS SCI, V56, P865, DOI 10.1167/iovs.14-14903; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P7738, DOI 10.1167/iovs.10-6925; Hoffmann EM, 2007, SURV OPHTHALMOL, V52, P32, DOI 10.1016/j.survophthal.2006.10.002; Johnstone J, 2014, INVEST OPHTH VIS SCI, V55, P2004, DOI 10.1167/iovs.13-12937; Jonas JB, 2005, EUR J OPHTHALMOL, V15, P41, DOI 10.1177/112067210501500107; Jung KI, 2014, INVEST OPHTH VIS SCI, V55, P7709, DOI 10.1167/iovs.14-13957; Kim TW, 2013, CURR EYE RES, V38, P903, DOI 10.3109/02713683.2013.800888; Kim YW, 2015, EYE, V29, P1368, DOI 10.1038/eye.2015.162; Lee EJ, 2015, OPHTHALMOLOGY, V122, P721, DOI 10.1016/j.ophtha.2014.10.007; Lee EJ, 2013, OPHTHALMOLOGY, V120, P553, DOI 10.1016/j.ophtha.2012.08.047; Lee EJ, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.034; Lee KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114935; Lee SW, 2014, RETINA-J RET VIT DIS, V34, P385, DOI 10.1097/IAE.0b013e3182993f29; Mari JM, 2013, INVEST OPHTH VIS SCI, V54, P2238, DOI 10.1167/iovs.12-11327; Park HYL, 2013, OPHTHALMOLOGY, V120, P745, DOI 10.1016/j.ophtha.2012.09.051; Park SC, 2015, INVEST OPHTH VIS SCI, V56, P2059, DOI 10.1167/iovs.14-15540; Park Sung Chul, 2013, J Glaucoma, V22 Suppl 5, pS29, DOI 10.1097/IJG.0b013e3182934a7b; Park SC, 2012, INVEST OPHTH VIS SCI, V53, P1610, DOI 10.1167/iovs.11-7577; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Reis ASC, 2012, INVEST OPHTH VIS SCI, V53, P5819, DOI 10.1167/iovs.12-9924; Ren RJ, 2014, INVEST OPHTH VIS SCI, V55, P1531, DOI 10.1167/iovs.13-13382; Sigal IA, 2014, BRIT J OPHTHALMOL, V98, P34, DOI 10.1136/bjophthalmol-2013-304751; Sigal IA, 2010, EXP EYE RES, V90, P70, DOI 10.1016/j.exer.2009.09.013; Sigal IA, 2009, EXP EYE RES, V88, P799, DOI 10.1016/j.exer.2009.02.003; Strouthidis NG, 2010, INVEST OPHTH VIS SCI, V51, P1464, DOI 10.1167/iovs.09-3984; Takayama K, 2013, INVEST OPHTH VIS SCI, V54, P4798, DOI 10.1167/iovs.13-11677; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Thakku SG, 2015, INVEST OPHTH VIS SCI, V56, P3604, DOI 10.1167/iovs.15-16707; Wu ZH, 2015, OPHTHALMOLOGY, V122, P1317, DOI 10.1016/j.ophtha.2015.02.035; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P4597, DOI 10.1167/iovs.07-0349; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P7109, DOI 10.1167/iovs.11-7448; Yoshikawa M, 2014, INVEST OPHTH VIS SCI, V55, P477, DOI 10.1167/iovs.13-11897	39	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150260	10.1371/journal.pone.0150260	http://dx.doi.org/10.1371/journal.pone.0150260			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963816	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000027
J	Geng, S; Shan, SR; Ma, HJ; Liu, BG				Geng, Sheng; Shan, Sharui; Ma, Hanjun; Liu, Benguo			Antioxidant Activity and alpha-Glucosidase Inhibitory Activities of the Polycondensate of Catechin with Glyoxylic Acid	PLOS ONE			English	Article							TEA EXTRACTS; COMPLICATIONS; ACETALDEHYDE; FLAVAN-3-OLS; FLAVONOIDS; AMYLASE; FRUITS	In order to investigate polymeric flavonoids, the polycondensate of catechin with glyoxylic acid (PCG) was prepared and its chemically antioxidant, cellular antioxidant (CAA) and alpha-glucosidase inhibitory activities were evaluated. The DPPH and ABTS radical scavenging activities and antiproliferative effect of PCG were lower than those of catechin, while PCG had higher CAA activity than catechin. In addition, PCG had very high alpha-glucosidase inhibitory activities (IC50 value, 2.59 mu g/mL) in comparison to catechin (IC50 value, 239.27 mu g/mL). Inhibition kinetics suggested that both PCG and catechin demonstrated a mixture of noncompetitive and anticompetitive inhibition. The enhanced CAA and alpha-glucosidase inhibitor activities of PCG could be due to catechin polymerization enhancing the binding capacity to the cellular membrane and enzymes.	[Geng, Sheng; Ma, Hanjun; Liu, Benguo] Henan Inst Sci & Technol, Sch Food Sci, Xinxiang 453003, Peoples R China; [Shan, Sharui] Affiliated Hosp 1, Sch Clin Med GDPD, Dept Rehabil, Guangzhou, Guangdong, Peoples R China	Henan Institute of Science & Technology	Liu, BG (corresponding author), Henan Inst Sci & Technol, Sch Food Sci, Xinxiang 453003, Peoples R China.	liubenguo@hist.edu.cn	Liu, Benguo/Q-2736-2016	Liu, Benguo/0000-0001-9992-9319; Geng, Sheng/0000-0002-1165-6764	National Natural Science Foundation of China [21166024]; Program for Innovative Research Team (in Science and Technology) in University of Henan Province [13IRTSTHN006, 16IRTSTHN007]; Program for Science & Technology Innovation Talents in Universities of Henan Province [14HASTIT019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team (in Science and Technology) in University of Henan Province; Program for Science & Technology Innovation Talents in Universities of Henan Province	BGL received the National Natural Science Foundation of China (21166024), the Program for Innovative Research Team (in Science and Technology) in University of Henan Province (no. 13IRTSTHN006 and 16IRTSTHN007) and the Program for Science & Technology Innovation Talents in Universities of Henan Province (14HASTIT019). BGL had role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Adisakwattana S, 2004, BIOORG MED CHEM LETT, V14, P2893, DOI 10.1016/j.bmcl.2004.03.037; Baratzadeh MH, 2013, INT J FOOD SCI TECH, V48, P1603, DOI 10.1111/ijfs.12130; Chen AY, 2013, FOOD CHEM, V138, P2099, DOI 10.1016/j.foodchem.2012.11.139; Chen YS, 2015, J AGR FOOD CHEM, V63, P169, DOI 10.1021/jf503700v; Chen YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108140; Chung JE, 2004, BIOMACROMOLECULES, V5, P113, DOI 10.1021/bm0342436; Clerici MTPS, 2011, FOOD RES INT, V44, P1658, DOI 10.1016/j.foodres.2011.04.020; Drinkine J, 2007, J AGR FOOD CHEM, V55, P6292, DOI 10.1021/jf070038w; Erlund I, 2004, NUTR RES, V24, P851, DOI 10.1016/j.nutres.2004.07.005; Frazier RA, 2010, J PHARMACEUT BIOMED, V51, P490, DOI 10.1016/j.jpba.2009.05.035; Fulcrand H, 1996, J CHROMATOGR A, V752, P85, DOI 10.1016/S0021-9673(96)00485-2; Jadhav SB, 2014, FOOD CHEM, V150, P9, DOI 10.1016/j.foodchem.2013.10.127; Kim YJ, 2004, BIOMACROMOLECULES, V5, P474, DOI 10.1021/bm034320x; Kim YJ, 2003, MACROMOL CHEM PHYSIC, V204, P1863, DOI 10.1002/macp.200350041; Li YQ, 2009, J AGR FOOD CHEM, V57, P11463, DOI 10.1021/jf903083h; Liu BG, 2012, FOOD CHEM, V134, P926, DOI 10.1016/j.foodchem.2012.02.207; Liu RH, 2005, J AGR FOOD CHEM, V53, P4311, DOI 10.1021/jf058070i; Oertel, 2015, CLIN NUTR EXPT, V3, DOI 10.1016/j.yclnex.2015.09.001; RoedigPenman A, 1997, J AGR FOOD CHEM, V45, P4267, DOI 10.1021/jf9705936; Sattar Z, 2012, SPECTROCHIM ACTA A, V97, P1089, DOI 10.1016/j.saa.2012.07.034; Shobana S, 2009, FOOD CHEM, V115, P1268, DOI 10.1016/j.foodchem.2009.01.042; Uyama H, 2007, MACROMOL BIOSCI, V7, P410, DOI 10.1002/mabi.200700005; Xiao HZ, 2015, FOOD RES INT, V76, P605, DOI 10.1016/j.foodres.2015.07.029; Yen GC, 1997, J AGR FOOD CHEM, V45, P30, DOI 10.1021/jf9603994; Yousefi A, 2015, INT J BIOL MACROMOL, V78, P46, DOI 10.1016/j.ijbiomac.2015.03.060; Yu ZY, 2015, CARBOHYD POLYM, V132, P180, DOI 10.1016/j.carbpol.2015.06.068; Zhang TT, 2012, EXPERT OPIN INV DRUG, V21, P1625, DOI 10.1517/13543784.2012.713937; Zhu KX, 2011, FOOD CHEM, V126, P1122, DOI 10.1016/j.foodchem.2010.11.144	28	19	20	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150412	10.1371/journal.pone.0150412	http://dx.doi.org/10.1371/journal.pone.0150412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960205	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300049
J	Smith, TAD; Phyu, SM				Smith, Tim A. D.; Phyu, Su M.			Metformin Decouples Phospholipid Metabolism in Breast Cancer Cells	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; ACTIVATED PROTEIN-KINASE; CHOLINE KINASE; GLUCOSE-TRANSPORT; LIPID-METABOLISM; PROSTATE-CANCER; RAT HEPATOCYTES; UP-REGULATION; PHOSPHATIDYLCHOLINE	Introduction The antidiabetic drug metformin, currently undergoing trials for cancer treatment, modulates lipid and glucose metabolism both crucial in phospholipid synthesis. Here the effect of treatment of breast tumour cells with metformin on phosphatidylcholine (PtdCho) metabolism which plays a key role in membrane synthesis and intracellular signalling has been examined. Methods MDA-MB-468, BT474 and SKBr3 breast cancer cell lines were treated with metformin and [H-3-methyl] choline and [C-14(U)]glucose incorporation and lipid accumulation determined in the presence and absence of lipase inhibitors. Activities of choline kinase (CK), CTP: phosphocholine cytidylyl transferase (CCT) and PtdCho-phospholipase C (PLC) were also measured. [H-3] Radiolabelled metabolites were determined using thin layer chromatography. Results Metformin-treated cells exhibited decreased formation of [H-3] phosphocholine but increased accumulation of [H-3]choline by PtdCho. CK and PLC activities were decreased and CCT activity increased by metformin-treatment. [C-14] incorporation into fatty acids was decreased and into glycerol was increased in breast cancer cells treated with metformin incubated with [C-14(U)]glucose. Conclusion This is the first study to show that treatment of breast cancer cells with metformin induces profound changes in phospholipid metabolism.	[Smith, Tim A. D.; Phyu, Su M.] Univ Aberdeen, Sch Med Med Sci & Nutr, Aberdeen, Scotland	University of Aberdeen	Smith, TAD (corresponding author), Univ Aberdeen, Sch Med Med Sci & Nutr, Aberdeen, Scotland.	t.smith@abdn.ac.uk		Smith, Tim/0000-0002-3945-630X	University of Aberdeen	University of Aberdeen	This work was funded by the University of Aberdeen.	Abalsamo L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3151; Al-Saeedi F, 2005, EUR J NUCL MED MOL I, V32, P660, DOI 10.1007/s00259-004-1707-6; Arlauckas SP, 2014, MOL CANCER THER, V13, P2149, DOI 10.1158/1535-7163.MCT-14-0085; Barbato DL, 2014, BBA-REV CANCER, V1845, P317, DOI 10.1016/j.bbcan.2014.02.003; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Cecchetti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136120; Cooper AC, 2015, J CANCER RES CLIN, V141, P1523, DOI 10.1007/s00432-015-1909-2; CORNELL R, 1989, J BIOL CHEM, V264, P9077; Cui Z, 2002, BBA-MOL CELL BIOL L, V1585, P87, DOI 10.1016/S1388-1981(02)00328-1; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Davis NM, 2014, ONCOTARGET, V5, P4603, DOI 10.18632/oncotarget.2209; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; Fleming IN, 2014, BREAST CANCER RES TR, V144, P241, DOI 10.1007/s10549-014-2858-1; Fryer LGD, 2000, DIABETES, V49, P1978, DOI 10.2337/diabetes.49.12.1978; Garg R, 2012, J BIOL CHEM, V287, P37570, DOI 10.1074/jbc.M112.398925; Glunde K, 2015, EXPERT REV MOL DIAGN, V15, P735, DOI 10.1586/14737159.2015.1039515; Goodwin PJ, 2012, J CLIN ONCOL, V30, P2812, DOI 10.1200/JCO.2012.42.3319; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hosotani K, 2003, J CHROMATOGR B, V791, P305, DOI 10.1016/S1570-0232(03)00233-2; Houweling M, 2002, BIOCHEM J, V362, P97, DOI 10.1042/0264-6021:3620097; Ide Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061204; JAMIL H, 1992, FASEB J, V6, pA496; Kim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119473; Kletzien RF, 1974, J BIOL CHEM, V249; Kobayashi H, 2015, BIOCHEM BIOPH RES CO, V467, P121, DOI 10.1016/j.bbrc.2015.09.106; Lacal JC, 2015, MOL CANCER THER, V14, P31, DOI 10.1158/1535-7163.MCT-14-0531; Lagutin K, 2014, LIPIDS, V49, P1133, DOI 10.1007/s11745-014-3946-z; Leach MO, 1998, NMR BIOMED, V11, P314, DOI 10.1002/(SICI)1099-1492(1998110)11:7<314::AID-NBM522>3.0.CO;2-Z; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Loubiere C, 2015, ONCOTARGET, V6, P15652, DOI 10.18632/oncotarget.3404; Mori N, 2015, NMR BIOMED, V28, P1697, DOI 10.1002/nbm.3429; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Ng MNP, 2004, BBA-MOL CELL BIOL L, V1686, P85, DOI 10.1016/j.bbalip.2004.09.001; Nimmagadda S, 2009, NEOPLASIA, V11, P477, DOI 10.1593/neo.81430; Podo F, 2007, CURR MED IMAGING, V3, P123, DOI 10.2174/157340507780619160; Queiroz EAIF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098207; Ramirez de Molina A, 2004, CANCER RES, V64, P6732, DOI 10.1158/0008-5472.CAN-04-0489; Rego DF, 2015, ORAL ONCOL, V51, P416, DOI 10.1016/j.oraloncology.2015.01.007; Ridgway ND, 2013, CRIT REV BIOCHEM MOL, V48, P20, DOI 10.3109/10409238.2012.735643; Ross J, 2008, MOL CANCER THER, V7, P2556, DOI 10.1158/1535-7163.MCT-08-0015; Sanchez-Lopez E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.453; Santolla MF, 2012, J BIOL CHEM, V287, P43234, DOI 10.1074/jbc.M112.417303; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; SMITH TAD, 1991, BRIT J CANCER, V64, P821, DOI 10.1038/bjc.1991.407; Smith TAD, 2013, CANCER CHEMOTH PHARM, V71, P473, DOI 10.1007/s00280-012-2032-6; Soo JSS, 2015, APOPTOSIS, V20, P1373, DOI 10.1007/s10495-015-1158-5; Sui XB, 2015, MOL PHARMACEUT, V12, P3783, DOI 10.1021/acs.molpharmaceut.5b00577; Tan HW, 2013, RENEW SUST ENERG REV, V27, P118, DOI 10.1016/j.rser.2013.06.035; Thompson AM, 2014, CLIN CANCER RES, V20, P2508, DOI 10.1158/1078-0432.CCR-13-0354; Thupari JN, 2001, BIOCHEM BIOPH RES CO, V285, P217, DOI 10.1006/bbrc.2001.5146; Tripathi A, 2014, BIOCHEM SOC T, V42, P1383, DOI 10.1042/BST20140187; Wahdan-Alaswad RS, 2014, HORM CANCER-US, V5, P374, DOI 10.1007/s12672-014-0188-8; Yoon S, 2007, J BIOL CHEM, V282, P26122, DOI 10.1074/jbc.M702854200; Zaidi N, 2013, PROG LIPID RES, V52, P585, DOI 10.1016/j.plipres.2013.08.005; Zakikhani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049513	55	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151179	10.1371/journal.pone.0151179	http://dx.doi.org/10.1371/journal.pone.0151179			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959405	Green Submitted, gold, Green Published			2022-12-27	WOS:000371992300107
J	Guichet, PO; Guelfi, S; Ripoll, C; Teigell, M; Sabourin, JC; Bauchet, L; Rigau, V; Rothhut, B; Hugnot, JP				Guichet, Pierre-Olivier; Guelfi, Sophie; Ripoll, Chantal; Teigell, Marisa; Sabourin, Jean-Charles; Bauchet, Luc; Rigau, Valerie; Rothhut, Bernard; Hugnot, Jean-Philippe			Asymmetric Distribution of GFAP in Glioma Multipotent Cells	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; NEURAL STEM-CELLS; INTERMEDIATE-FILAMENTS; MOLECULAR-CLONING; DIVISION; GLIOBLASTOMA; CANCER; EXPRESSION; VIMENTIN; FLIES	Asymmetric division (AD) is a fundamental mechanism whereby unequal inheritance of various cellular compounds during mitosis generates unequal fate in the two daughter cells. Unequal repartitions of transcription factors, receptors as well as mRNA have been abundantly described in AD. In contrast, the involvement of intermediate filaments in this process is still largely unknown. AD occurs in stem cells during development but was also recently observed in cancer stem cells. Here, we demonstrate the asymmetric distribution of the main astrocytic intermediate filament, namely the glial fibrillary acid protein (GFAP), in mitotic glioma multipotent cells isolated from glioblastoma (GBM), the most frequent type of brain tumor. Unequal mitotic repartition of GFAP was also observed in mice non-tumoral neural stem cells indicating that this process occurs across species and is not restricted to cancerous cells. Immunofluorescence and videomicroscopy were used to capture these rare and transient events. Considering the role of intermediate filaments in cytoplasm organization and cell signaling, we propose that asymmetric distribution of GFAP could possibly participate in the regulation of normal and cancerous neural stem cell fate.	[Guichet, Pierre-Olivier; Guelfi, Sophie; Ripoll, Chantal; Teigell, Marisa; Sabourin, Jean-Charles; Rothhut, Bernard; Hugnot, Jean-Philippe] Hop St Eloi, Inst Neurosci Montpellier, INSERM U1051, 80 Ave Augustin Fliche, F-34091 Montpellier 05, France; [Bauchet, Luc; Rigau, Valerie] CHU Montpellier, Hop Gui De Chaulliac, 80 Ave Augustin Fliche, F-34295 Montpellier, France; [Hugnot, Jean-Philippe] Univ Montpellier, Pl Eugene Bataillon, F-34095 Montpellier 5, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier	Hugnot, JP (corresponding author), Hop St Eloi, Inst Neurosci Montpellier, INSERM U1051, 80 Ave Augustin Fliche, F-34091 Montpellier 05, France.; Hugnot, JP (corresponding author), Univ Montpellier, Pl Eugene Bataillon, F-34095 Montpellier 5, France.	pierre-olivier.guichet@inserm.fr; hugnot@univ-montp2.fr		Guichet, Pierre-Olivier/0000-0003-0115-2199; Rothhut, Bernard/0000-0001-6467-8134	"Association pour la Recherche sur le Cancer" (ARC, France); "Association pour la Recherche contre les Tumeurs Cerebrales" (ARTC Sud, France); "l'Institut National pour la Recherche sur le Cancer" (INCA, France)	"Association pour la Recherche sur le Cancer" (ARC, France)(Fondation ARC pour la Recherche sur le Cancer); "Association pour la Recherche contre les Tumeurs Cerebrales" (ARTC Sud, France); "l'Institut National pour la Recherche sur le Cancer" (INCA, France)	This work was supported by the "Association pour la Recherche sur le Cancer" (ARC, France), the "Association pour la Recherche contre les Tumeurs Cerebrales" (ARTC Sud, France) and "l'Institut National pour la Recherche sur le Cancer" (INCA, France).; This work was supported by the "Association pour la Recherche sur le Cancer" (ARC, France), the "Association pour la Recherche contre les Tumeurs Cerebrales" (ARTC Sud, France) and "l'Institut National pour la Recherche sur le Cancer" (INCA, France). We thank Dr. D. Pham Dinh (Paris, France) for kindly providing all hGFAP-EGFP constructions. RIO and RHEM Montpellier facilities were used for this work. This work has benefited from the facilities and expertise of the CCBH-M Collection (glioma collection) of the University Hospital of Montpellier-France (www.chu-montpellier.fr)	BONGCAMRUDLOFF E, 1991, CANCER RES, V51, P1553; Bu PC, 2013, CELL STEM CELL, V12, P602, DOI 10.1016/j.stem.2013.03.002; Buchman JJ, 2007, NAT REV NEUROSCI, V8, P89, DOI 10.1038/nrn2058; Cusulin C, 2015, STEM CELL REP, V5, P1, DOI 10.1016/j.stemcr.2015.05.010; Deleyrolle L, 2006, STEM CELLS, V24, P748, DOI 10.1634/stemcells.2005-0138; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Gao YS, 1998, J BIOL CHEM, V273, P33825, DOI 10.1074/jbc.273.50.33825; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Guichet PO, 2013, GLIA, V61, P225, DOI 10.1002/glia.22429; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; JAGADHA V, 1986, CAN J NEUROL SCI, V13, P307; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Knoblich JA, 1997, CURR OPIN CELL BIOL, V9, P833, DOI 10.1016/S0955-0674(97)80085-3; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lathia JD, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.80; Li R, 2013, DEV CELL, V25, P439, DOI 10.1016/j.devcel.2013.05.003; Lu BW, 1998, CURR OPIN GENET DEV, V8, P392, DOI 10.1016/S0959-437X(98)80108-1; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Minin AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1453, DOI 10.1134/S0006297908130063; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nekrasova OE, 2011, MOL BIOL CELL, V22, P2282, DOI 10.1091/mbc.E10-09-0766; Noatynska A, 2012, J CELL BIOL, V199, P1025, DOI 10.1083/jcb.201209015; Ogrodnik M, 2014, P NATL ACAD SCI USA, V111, P8049, DOI 10.1073/pnas.1324035111; Ouellet J, 2012, J CELL BIOL, V196, P305, DOI 10.1083/jcb.201102078; Palmer E, 2004, COMP FUNCT GENOM, V5, P342, DOI 10.1002/cfg.405; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; REIFENBERGER G, 1987, ACTA NEUROPATHOL, V74, P105, DOI 10.1007/BF00692841; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Sabourin JC, 2009, STEM CELLS, V27, P2722, DOI 10.1002/stem.226; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sawaishi Y, 2009, BRAIN DEV-JPN, V31, P493, DOI 10.1016/j.braindev.2009.03.006; Singh SK, 2003, CANCER RES, V63, P5821; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707; van den Berge SA, 2010, AGING CELL, V9, P313, DOI 10.1111/j.1474-9726.2010.00556.x; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wilhelmsson U, 2012, STEM CELLS, V30, P2320, DOI 10.1002/stem.1196	47	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151274	10.1371/journal.pone.0151274	http://dx.doi.org/10.1371/journal.pone.0151274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953813	gold, Green Published			2022-12-27	WOS:000371991300098
J	Margraf, J; Lavallee, K; Zhang, XC; Schneider, S				Margraf, Juergen; Lavallee, Kristen; Zhang, XiaoChi; Schneider, Silvia			Social Rhythm and Mental Health: A Cross-Cultural Comparison	PLOS ONE			English	Article							ANXIETY STRESS SCALES; BIPOLAR SPECTRUM DISORDERS; LIFE EVENTS; DEPRESSIVE SYMPTOMS; CIRCADIAN-RHYTHMS; SLEEP QUALITY; METRIC SRM; PERSONALITY; REGULARITY; THERAPY	Background Social rhythm refers to the regularity with which one engages in social activities throughout the week, and has established links with bipolar disorder, as well as some links with depression and anxiety. The aim of the present study is to examine social rhythm and its relationship to various aspects of health, including physical health, negative mental health, and positive mental health. Method Questionnaire data were obtained from a large-scale multi-national sample of 8095 representative participants from the U.S., Russia, and Germany. Results Results indicated that social rhythm irregularity is related to increased reporting of health problems, depression, anxiety, and stress. In contrast, greater regularity is related to better overall health state, life satisfaction, and positive mental health. The effects are generally small in size, but hold even when controlling for gender, marital status, education, income, country, and social support. Further, social rhythm means differ across Russia, the U.S., and Germany. Relationships with mental health are present in all three countries, but differ in magnitude. Conclusions Social rhythm irregularity is related to mental health in Russia, the U.S., and Germany.	[Margraf, Juergen; Lavallee, Kristen; Zhang, XiaoChi; Schneider, Silvia] Ruhr Univ Bochum, Clin Child & Adolescent Psychol, Bochum, Germany; [Lavallee, Kristen] Univ Basel, Inst Psychol, Div Dev & Personal Psychol, Basel, Switzerland	Ruhr University Bochum; University of Basel	Margraf, J (corresponding author), Ruhr Univ Bochum, Clin Child & Adolescent Psychol, Bochum, Germany.	juergen.margraf@rub.de	Margraf, Jürgen/A-6873-2008; Schneider, Silvia/C-5229-2015	Margraf, Jürgen/0000-0001-5207-7016; Schneider, Silvia/0000-0003-0698-8411	Alexander von Humboldt-Foundation	Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation)	This study was supported by Alexander von Humboldt Professorship awarded to Jurgen Margraf by the Alexander von Humboldt-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Alexander von Humboldt Professorship awarded to Jurgen Margraf by the Alexander von Humboldt-Foundation. We appreciate the contribution of the participants in this study, as well as Angela Bieda, Julia Brailovskaia, Pia Schofeld, and Julia Velten for their assistance in data collection and management. Dr. Margraf, Dr. Lavallee, Mrs. Zhang, and Dr. Schneider have no conflicts of interest to disclose.	Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Bieda A, HAPPINESS I IN PRESS; Bobak M, 2006, BRIT J PSYCHIAT, V188, P359, DOI 10.1192/bjp.188.4.359; Boland EM, 2012, J AFFECT DISORDERS, V139, P264, DOI 10.1016/j.jad.2012.01.038; Brooks R, 1996, HLTH POLICY, V37; Brown LF, 1996, PSYCHIAT RES, V62, P161, DOI 10.1016/0165-1781(96)02914-9; Bullock B, 2011, J AFFECT DISORDERS, V135, P384, DOI 10.1016/j.jad.2011.06.006; Chang GH, 2003, BIPOLAR DISORD S, P39; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eaton NR, 2012, J ABNORM PSYCHOL, V121, P282, DOI 10.1037/a0024780; EHLERS CL, 1988, ARCH GEN PSYCHIAT, V45, P948; Frank E, 2000, BIOL PSYCHIAT, V48, P593, DOI 10.1016/S0006-3223(00)00969-0; Frank E, 2005, ARCH GEN PSYCHIAT, V62, P996, DOI 10.1001/archpsyc.62.9.996; Frank E., 1994, BEHAV THERAPIST, V17, P143; Frank E., 2005, TREATING BIPOLAR DIS; Gay C, 2009, ENCEPHALE, V35, pS72, DOI 10.1016/S0013-7006(09)75538-1; Goodwin RD, 2006, J HEALTH PSYCHOL, V11, P643, DOI 10.1177/1359105306066610; Gorwood P., 2012, MEDICOGRAPHICA, V34, P289; Grandin LD, 2006, CLIN PSYCHOL REV, V26, P679, DOI 10.1016/j.cpr.2006.07.001; Greiner Wolfgang, 2003, Eur J Health Econ, V4, P222, DOI 10.1007/s10198-003-0182-5; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; IBM Corp, 2012, IBM SPSS STAT MAC VE; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Lieverse R, 2013, AM J GERIAT PSYCHIAT, V21, P1144, DOI 10.1016/j.jagp.2013.01.052; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lukat Justina, 2016, BMC Psychol, V4, P8, DOI 10.1186/s40359-016-0111-x; Maercker A, 2015, INT J CLIN HLTH PSYC, V15, P8, DOI 10.1016/j.ijchp.2014.06.001; Malkoff-Schwartz S, 2000, PSYCHOL MED, V30, P1005, DOI 10.1017/S0033291799002706; Margraf J., BOCHUM OPTIMIS UNPUB; Meyer TD, 2006, PSYCHIAT RES, V141, P103, DOI 10.1016/j.psychres.2005.07.023; Miklowitz DJ, 2007, AM J PSYCHIAT, V164, P1340, DOI 10.1176/appi.ajp.2007.07020311; Miklowitz DJ, 2007, ARCH GEN PSYCHIAT, V64, P419, DOI 10.1001/archpsyc.64.4.419; MONK TH, 1991, PSYCHIAT RES, V36, P195, DOI 10.1016/0165-1781(91)90131-8; MONK TH, 1990, J NERV MENT DIS, V178, P120, DOI 10.1097/00005053-199002000-00007; Monk TH, 2002, J SLEEP RES, V11, P183, DOI 10.1046/j.1365-2869.2002.00300.x; MONK TH, 1994, J SLEEP RES, V3, P196, DOI 10.1111/j.1365-2869.1994.tb00132.x; Nusslock R., 2012, CASEBOOK INTERPERSON, P103; PRIGERSON HG, 1994, PSYCHIAT RES, V51, P33, DOI 10.1016/0165-1781(94)90045-0; Schimitt R, 2013, BIOL RHYTHM RES, V44, P403, DOI 10.1080/09291016.2012.692256; Schimitt Regina L., 2012, J. bras. psiquiatr., V61, P89; Scholten S, UNIVERSAL ASSE UNPUB; SHEAR MK, 1994, ANXIETY, V1, P90; Shen GH, 2008, BIPOLAR DISORD, V10, P520, DOI 10.1111/j.1399-5618.2008.00583.x; Simon GE, 2002, PSYCHOL MED, V32, P585, DOI 10.1017/S0033291702005457; Smith SS, 2012, INT J SOC PSYCHIATR, V58, P166, DOI 10.1177/0020764010387551; Sylvia LG, 2009, BEHAV THER, V40, P131, DOI 10.1016/j.beth.2008.04.003; SZUBA MP, 1992, PSYCHIAT RES, V42, P221, DOI 10.1016/0165-1781(92)90114-I; Thase ME, 2002, HANDBOOK OF DEPRESSION, P192; The Euroqol Group, 2013, EQ 5D 3L US GUID; Tonetti L, 2009, CHRONOBIOL INT, V26, P337, DOI 10.1080/07420520902750995; van Tienoven TP, 2014, BEHAV SCI-BASEL, V4, P265, DOI 10.3390/bs4030265; Velten Julia, 2014, BMC Psychol, V2, P58, DOI 10.1186/s40359-014-0055-y; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zhang X-C, 2014, MODELLIERUNG M UNPUB	56	42	46	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150312	10.1371/journal.pone.0150312	http://dx.doi.org/10.1371/journal.pone.0150312			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SW	26954568	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300020
J	Mhanna, C; Marquardt, TL; Li, ZM				Mhanna, Christiane; Marquardt, Tamara L.; Li, Zong-Ming			Adaptation of the Transverse Carpal Ligament Associated with Repetitive Hand Use in Pianists	PLOS ONE			English	Article							TUNNEL-SYNDROME; RELEASE; THICKNESS; MOTION; THENAR; ARCH	The transverse carpal ligament (TCL) plays a critical role in carpal tunnel biomechanics through interactions with its surrounding tissues. The purpose of this study was to investigate the in vivo adaptations of the TCL's mechanical properties in response to repetitive hand use in pianists using acoustic radiation force impulse (ARFI) imaging. It was hypothesized that pianists, in comparison to non-pianists, would have a stiffer TCL as indicated by an increased acoustic shear wave velocity (SWV). ARFI imagining was performed for 10 female pianists and 10 female non-pianists. The median SWV values of the TCL were determined for the entire TCL, as well as for its radial and ulnar portions, rTCL and uTCL, respectively. The TCL SWV was significantly increased in pianists relative to non-pianists (p < 0.05). Additionally, the increased SWV was location dependent for both pianist and non-pianist groups (p < 0.05), with the rTCL having a significantly greater SWV than the uTCL. Between groups, the rTCL SWV of pianists was 22.2% greater than that of the non-pianists (p < 0.001). This localized increase of TCL SWV, i.e. stiffening, may be primarily attributable to focal biomechanical interactions that occur at the radial TCL aspect where the thenar muscles are anchored. Progressive stiffening of the TCL may become constraining to the carpal tunnel, leading to median nerve compression in the tunnel. TCL maladaptation helps explain why populations who repeatedly use their hands are at an increased risk of developing musculoskeletal pathologies, e.g. carpal tunnel syndrome.	[Mhanna, Christiane; Marquardt, Tamara L.; Li, Zong-Ming] Cleveland Clin, Dept Biomed Engn, Hand Res Lab, Cleveland, OH 44106 USA; [Li, Zong-Ming] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44106 USA; [Li, Zong-Ming] Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Li, ZM (corresponding author), Cleveland Clin, Dept Biomed Engn, Hand Res Lab, Cleveland, OH 44106 USA.; Li, ZM (corresponding author), Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44106 USA.; Li, ZM (corresponding author), Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44106 USA.	liz4@ccf.org			National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R21AR064957]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR064957] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number R21AR064957 (Awardee: ZML). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brooks JJ, 2003, CLIN BIOMECH, V18, P685, DOI 10.1016/S0268-0033(03)00052-4; Fuss F K, 1996, Clin Anat, V9, P100, DOI 10.1002/(SICI)1098-2353(1996)9:2<100::AID-CA2>3.0.CO;2-L; HOCHBERG FH, 1983, JAMA-J AM MED ASSOC, V249, P1869; JOHN V, 1983, AM J NEURORADIOL, V4, P770; KIRITSIS PG, 1995, J HAND SURG-AM, V20A, P173, DOI 10.1016/S0363-5023(05)80003-6; KLINE SC, 1992, J BONE JOINT SURG AM, V74A, P1478, DOI 10.2106/00004623-199274100-00006; Kung J, 2005, J HAND SURG-BRIT EUR, V30B, P475, DOI 10.1016/j.jhsb.2005.04.019; Mackinnon SE, 1997, J HAND SURG-AM, V22A, P2, DOI 10.1016/S0363-5023(05)80174-1; Miyamoto H, 2013, J HAND SURG-ASIAN-PA, V18, P209, DOI 10.1142/S0218810413500251; Moore JS, 2002, AM J IND MED, V41, P353, DOI 10.1002/ajim.10037; Nightingale K, 2002, ULTRASOUND MED BIOL, V28, P227, DOI 10.1016/S0301-5629(01)00499-9; Parry CBW, 2003, HAND CLIN, V19, P317; RICHMAN JA, 1989, J HAND SURG-AM, V14A, P852, DOI 10.1016/S0363-5023(89)80089-9; Sakai N, 2006, J HAND SURG-AM, V31A, P830, DOI 10.1016/j.jhsa.2006.02.009; Shen ZLL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068569; Shen ZLL, 2013, J APPL PHYSIOL, V114, P225, DOI 10.1152/japplphysiol.01273.2012; Shen ZLL, 2012, ULTRASOUND MED BIOL, V38, P982, DOI 10.1016/j.ultrasmedbio.2012.02.021; SILVERSTEIN BA, 1987, AM J IND MED, V11, P343, DOI 10.1002/ajim.4700110310; Sucher BM, 2009, J AM OSTEOPATH ASSOC, V109, P641, DOI 10.7556/jaoa.2009.109.12.641; Szabo RM, 1998, CLIN ORTHOP RELAT R, P78; Tengrootenhuysen M, 2009, ACTA ORTHOP BELG, V75, P467; WOO SLY, 1982, BIORHEOLOGY, V19, P397; Xiu KH, 2010, CLIN BIOMECH, V25, P776, DOI 10.1016/j.clinbiomech.2010.05.011; Zheng YP, 2006, ULTRASONICS, V44, pE313, DOI 10.1016/j.ultras.2006.06.018	24	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150174	10.1371/journal.pone.0150174	http://dx.doi.org/10.1371/journal.pone.0150174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953892	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300015
J	Ouyang, FB; Chen, YC; Zhao, YH; Dang, G; Liang, JH; Zeng, JS				Ouyang, Fubing; Chen, Yicong; Zhao, Yuhui; Dang, Ge; Liang, Jiahui; Zeng, Jinsheng			Selection of Patients and Anesthetic Types for Endovascular Treatment in Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							BASILAR ARTERY-OCCLUSION; INTRAVENOUS T-PA; EARLY CT SCORE; COMPUTED-TOMOGRAPHY; INTERVENTIONAL MANAGEMENT; MECHANICAL THROMBECTOMY; INTRAARTERIAL TREATMENT; GENERAL-ANESTHESIA; THROMBOLYSIS; THERAPY	Background and Purpose Recent randomized controlled trials have demonstrated consistent effectiveness of endovascular treatment (EVT) for acute ischemic stroke, leading to update on stroke management guidelines. We conducted this meta-analysis to assess the efficacy and safety of EVT overall and in subgroups stratified by age, baseline stroke severity, brain imaging feature, and anesthetic type. Methods Published randomized controlled trials comparing EVT and standard medical care alone were evaluated. The measured outcomes were 90-day functional independence (modified Rankin Scale <= 2), all-cause mortality, and symptomatic intracranial hemorrhage. Results Nine trials enrolling 2476 patients were included (1338 EVT, 1138 standard medical care alone). For patients with large vessel occlusions confirmed by noninvasive vessel imaging, EVT yielded improved functional outcome (pooled odds ratio [OR], 2.02; 95% confidence interval [CI], 1.64-2.50), lower mortality (OR, 0.75; 95% CI, 0.58-0.97), and similar symptomatic intracranial hemorrhage rate (OR, 1.12; 95% CI, 0.72-1.76) compared with standard medical care. A higher proportion of functional independence was seen in patients with terminus intracranial artery occlusion (+/- M1) (OR, 3.16; 95% CI, 1.64-6.06), baseline Alberta Stroke Program Early CT score of 8-10 (OR, 2.11; 95% CI, 1.25-3.57) and age <= 70 years (OR, 3.01; 95% CI, 1.73-5.24). EVT performed under conscious sedation had better functional outcomes (OR, 2.08; 95% CI, 1.47-2.96) without increased risk of symptomatic intracranial hemorrhage or short-term mortality compared with general anesthesia. Conclusions Vessel-imaging proven large vessel occlusion, a favorable scan, and younger age are useful predictors to identify anterior circulation stroke patients who may benefit from EVT. Conscious sedation is feasible and safe in EVT based on available data. However, firm conclusion on the choice of anesthetic types should be drawn from more appropriate randomized controlled trials.	[Zeng, Jinsheng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China; Sun Yat Sen Univ, Affiliated Hosp 1, Stroke Ctr, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zeng, JS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China.	zengjs@pub.guangzhou.gd.cn			Natural Science Foundation of China [8120090]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (No. 8120090). URL: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Chebl A, 2015, STROKE, V46, P2142, DOI 10.1161/STROKEAHA.115.008761; Abou-Chebl A, 2014, STROKE, V45, P1396, DOI 10.1161/STROKEAHA.113.003698; Bal S, 2015, INT J STROKE, V10, P55, DOI 10.1111/j.1747-4949.2012.00859.x; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Berkhemer OA, INT STROK C 2015; Bhatia R, 2010, STROKE, V41, P2254, DOI 10.1161/STROKEAHA.110.592535; Bracard S, 2015, INT J STROKE, V10, P31; Brinjikji W, 2015, AM J NEURORADIOL, V36, P525, DOI 10.3174/ajnr.A4159; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BCV, 2015, LANCET NEUROL, V14, P846, DOI 10.1016/S1474-4422(15)00140-4; Castonguay AC, 2014, STROKE, V45, P3631, DOI 10.1161/STROKEAHA.114.006487; Ciccone A, 2010, J NEUROINTERV SURG, V2, P74, DOI 10.1136/jnis.2009.001388; Ciccone A, 2013, NEW ENGL J MED, V368, P904, DOI 10.1056/NEJMoa1213701; Demchuk AM, 2005, STROKE, V36, P2110, DOI 10.1161/01.STR.0000181116.15426.58; Demchuk AM, 2014, RADIOLOGY, V273, P202, DOI 10.1148/radiol.14132649; Dorn F, 2015, J STROKE CEREBROVASC, V24, P1465, DOI 10.1016/j.jstrokecerebrovasdis.2015.04.013; Dzialowski I, 2006, STROKE, V37, P973, DOI 10.1161/01.STR.0000206215.62441.56; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Falk-Delgado A, 2015, J NEUROINTERV SURG; Fischer U, 2005, STROKE, V36, P2121, DOI 10.1161/01.STR.0000182099.04994.fc; Flores A, 2015, J NEUROINTERV SURG, V7, P234, DOI 10.1136/neurintsurg-2014-011100; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2011, STROKE, V42, P93, DOI 10.1161/STROKEAHA.110.594481; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hill MD, 2003, STROKE, V34, P1925, DOI 10.1161/01.STR.0000082483.37127.D0; Hill MD, 2014, STROKE, V45, P444, DOI 10.1161/STROKEAHA.113.003580; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Khatri P, 2015, STROKE, V46, P1727, DOI 10.1161/STROKEAHA.115.008782; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Lindsberg PJ, 2006, STROKE, V37, P922, DOI 10.1161/01.STR.0000202582.29510.6b; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Menon BK, 2015, STROKE, V46, P1453, DOI 10.1161/STROKEAHA.115.009160; Mocco J, 2015, INT J STROKE, V10, P10; Morais LT, 2013, J NEUROINTERV SURG, V5, P13, DOI 10.1136/neurintsurg-2013-010733; Nakajima M, 2004, AM J NEURORADIOL, V25, P238; Powers WJ, 2015, STROKE, DOI DOI 10.1161/STR.0000000000000074; Qureshi Adnan I, 2014, J Vasc Interv Neurol, V7, P56; Rubiera M, 2006, STROKE, V37, P2301, DOI 10.1161/01.STR.0000237070.80133.1d; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Schonewille WJ, 2009, LANCET NEUROL, V8, P724, DOI 10.1016/S1474-4422(09)70173-5; Soize S, 2013, AM J NEURORADIOL, V34, P360, DOI 10.3174/ajnr.A3200; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sun X, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1553; Talke PO, 2014, STROKE, V45, pE138, DOI 10.1161/STROKEAHA.113.003412; van den Berg LA, 2015, STROKE, V46, P1257, DOI 10.1161/STROKEAHA.115.008699; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Yoo AJ, 2014, STROKE, V45, P746, DOI 10.1161/STROKEAHA.113.004260	50	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151210	10.1371/journal.pone.0151210	http://dx.doi.org/10.1371/journal.pone.0151210			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953574	Green Submitted, gold, Green Published			2022-12-27	WOS:000371991300096
J	van der Zee, A; Roorda, L; Bosman, G; Ossewaarde, JM				van der Zee, Anneke; Roorda, Lieuwe; Bosman, Gerda; Ossewaarde, Jacobus M.			Molecular Diagnosis of Urinary Tract Infections by Semi-Quantitative Detection of Uropathogens in a Routine Clinical Hospital Setting	PLOS ONE			English	Article							DIFFERENTIATION; BACTERIA	Background The objective of our study was the development of a semi-quantitative real-time PCR to detect uropathogens. Two multiplex PCR reactions were designed to detect Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter spp., Proteus mirabilis, Enterococcus faecalis, and Pseudomonas aeruginosa. 16S based PCR was performed in parallel to detect Gram-positive and Gram-negative bacteria. Firstly to identify non-targeted agents of infection in the same urine specimen, and secondly to quantify background flora. The method was evaluated in comparison with standard bacterial culture, and a commercial PCR kit for detection of uropathogens. Findings Analysis with a known panel of 116 clinical isolates yielded a PCR specificity of 100%. Analysis of urine specimens from 211 patients revealed a high correlation of PCR Cq values with both culture positivity and quantity. Concordance between PCR and culture was 98% when both methods yielded results. PCR was found to be more sensitive than culture. With a cut-off Cq value of 33, the negative predictive value of PCR was 94%. The 16S PCR confirmed most results. One specimen was positive by 16S PCR suggesting another cause of infection not detected by the specific PCR assays. Conclusion We conclude that it is feasible to detect and identify uropathogens by multiplex real-time PCR assay.	[van der Zee, Anneke; Roorda, Lieuwe; Bosman, Gerda; Ossewaarde, Jacobus M.] Maasstad Hosp, Med Microbiol & Mol Diagnost Unit, Rotterdam, Netherlands; [Ossewaarde, Jacobus M.] Erasmus MC, Rotterdam, Netherlands	Maasstad Hospital; Erasmus University Rotterdam; Erasmus MC	van der Zee, A (corresponding author), Maasstad Hosp, Med Microbiol & Mol Diagnost Unit, Rotterdam, Netherlands.	zeea@maasstadziekenhuis.nl						[Anonymous], 2013, SWAB GUID ANT THER C; [Anonymous], 2008, INFECTIEZIEKTEN B, V19; Antao EM, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-22; Chung A, 2010, AUST FAM PHYSICIAN, V39, P295; Giesen LGM, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-78; Hansen WLJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061439; Hansen WLJ, 2010, J CLIN MICROBIOL, V48, P4432, DOI 10.1128/JCM.00562-10; Hinata Nobuyuki, 2004, Mol Diagn, V8, P179, DOI 10.2165/00066982-200408030-00006; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Kaclikova E, 2005, CURR MICROBIOL, V51, P229, DOI 10.1007/s00284-005-4528-3; Klaschik S, 2002, J CLIN MICROBIOL, V40, P4304, DOI 10.1128/JCM.40.11.4304-4307.2002; Kohling HL, 2012, J MED MICROBIOL, V61, P339, DOI 10.1099/jmm.0.032284-0; Lehmann LE, 2010, BJU INT, V106, P114, DOI 10.1111/j.1464-410X.2009.09017.x; McKechnie ML, 2011, J MED MICROBIOL, V17; Najar M S, 2009, Indian J Nephrol, V19, P129, DOI 10.4103/0971-4065.59333; Ronald Allan Ross, 1996, MICROBIOLOGY GENITOU; Schmiemann G, 2010, DTSCH ARZTEBL INT, V107, P361, DOI 10.3238/arztebl.2010.0361; Shigemura K, 2005, CLIN EXP MED, V4, P196, DOI 10.1007/s10238-004-0056-x; Verest LFHM, 2000, BRIT J GEN PRACT, V50, P309; Wagenlehner FME, 2009, CURR OPIN UROL, V19, P368, DOI 10.1097/MOU.0b013e32832ae18c	20	25	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150755	10.1371/journal.pone.0150755	http://dx.doi.org/10.1371/journal.pone.0150755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954694	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300047
J	Hasbun, R; Garcia, MN; Kellaway, J; Baker, L; Salazar, L; Woods, SP; Murray, KO				Hasbun, Rodrigo; Garcia, Melissa N.; Kellaway, Judianne; Baker, Laura; Salazar, Lucrecia; Woods, Steven Paul; Murray, Kristy O.			West Nile Virus Retinopathy and Associations with Long Term Neurological and Neurocognitive Sequelae	PLOS ONE			English	Article							INFECTION; CHORIORETINITIS; RETINITIS; FEATURES; OUTCOMES; RISK	West Nile virus (WNV) has emerged as an important vector-borne pathogen in North America, with more than 3 million estimated to have been infected. Retinopathy from WNV infection has been previously reported in acute cases, though those prior reports did not evaluate the risk of retinopathy based on clinical severity of neurologic disease. The purpose of this cross-sectional study was to perform comprehensive ophthalmological and neurological examinations on 111 patients with a history of West Nile virus infection and describe the ocular manifestations. Out of 111 patients, 27 (24%) had evidence for West Nile virus associated retinopathy (WNVR); this observation was higher (49%) in those patients who initially presented with encephalitis. Individuals with WNVR had more frequent involvement of the macula and peripheral involvement compared to those patients without WNVR (p < 0.05). WNVR was also associated with a greater likelihood of abnormal reflexes on neurological exam, poorer learning, greater dependence in activities of daily living, and lower quality of life (p < 0.05). WNVR was seen more frequently in elderly patients (age > 60 years), and was associated with higher rates of diabetes mellitus and a history of encephalitis (p < 0.05). A multivariable logistic regression revealed that only a history of encephalitis was independently associated with WNVR [Adjusted Odds Ratio = 4.9 (1.8-13.2); p = 0.001]. Our study found that WNVR occurs in one fourth of patients with a history of WNV infection and is more frequently observed in those with apparent severe neurological sequelae (e.g., encephalitis). The clinical relevance of WNVR was supported by its associations with dependence in activities of daily living and lower quality of life. This unique evaluation of WNV patients included fundoscopic examinations and their associations with neurologic impairment. Our findings can be used during ophthalmological consultation for the evaluation, treatment and rehabilitation phases of care for WNV patients.	[Hasbun, Rodrigo; Salazar, Lucrecia] Univ Texas Hlth Sci Ctr Houston, Sch Med, Infect Dis Sect, Houston, TX 77030 USA; [Garcia, Melissa N.; Murray, Kristy O.] Baylor Coll Med, Dept Pediat, Natl Sch Trop Med, Sect Pediat Trop Med, Houston, TX 77030 USA; [Kellaway, Judianne] Univ Texas Hlth Sci Ctr Houston, Sch Med, Ruiz Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA; [Baker, Laura] Robert Cizik Eye Clin, Houston, TX USA; [Woods, Steven Paul] Univ Houston, Dept Psychol, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston	Murray, KO (corresponding author), Baylor Coll Med, Dept Pediat, Natl Sch Trop Med, Sect Pediat Trop Med, Houston, TX 77030 USA.	kmurray@bcm.edu			Gillson Longenbaugh Foundation; National Institutes of Health/National Institute for Allergy and Infectious Diseases (NIH/NIAID) [1R01AI091816-01]; National Eye Institute Vision Core Grant [P30EY010608]; Research to Prevent Blindness; Hermann Eye Fund; National Center for Research Resources [NIH-1 K23 RR018929-01A2]; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR018929] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY010608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091816] Funding Source: NIH RePORTER	Gillson Longenbaugh Foundation; National Institutes of Health/National Institute for Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Eye Institute Vision Core Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Hermann Eye Fund; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Gillson Longenbaugh Foundation and the National Institutes of Health/National Institute for Allergy and Infectious Diseases (NIH/NIAID 1R01AI091816-01), National Eye Institute Vision Core Grant (P30EY010608), a Challenge Grant to The University of Texas Medical School from Research to Prevent Blindness, and the Hermann Eye Fund, and National Center for Research Resources (NIH-1 K23 RR018929-01A2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abroug F, 2006, MAYO CLIN PROC, V81, P12, DOI 10.4065/81.1.12; Afshar AR, 2012, ARCH OPHTHALMOL-CHIC, V130, P396, DOI 10.1001/archopthalmol.2011.1630; Chan CK, 2006, OPHTHALMOLOGY, V113, P1539, DOI 10.1016/j.ophtha.2006.04.021; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Garcia MN, 2014, VIRAL IMMUNOL, V27, P327, DOI 10.1089/vim.2014.0035; Huybrechts KF, 2007, CURR MED RES OPIN, V23, P1627, DOI 10.1185/030079907X210444; Khairallah M, 2007, EYE, V21, P952, DOI 10.1038/sj.eye.6702355; Khairallah M, 2004, OPHTHALMOLOGY, V111, P2065, DOI 10.1016/j.ophtha.2004.03.032; Khairallah M, 2007, OCUL IMMUNOL INFLAMM, V15, P435, DOI 10.1080/09273940701798488; Khairallah M, 2006, RETINA-J RET VIT DIS, V26, P358, DOI 10.1097/00006982-200603000-00019; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037; Lippa SM, 2013, BRAIN INJURY, V27, P689, DOI 10.3109/02699052.2013.771793; Murray K, 2006, EPIDEMIOL INFECT, V134, P1325, DOI 10.1017/S0950268806006339; Murray KO, 2008, VECTOR-BORNE ZOONOT, V8, P167, DOI 10.1089/vbz.2007.0109; Murray KO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102953; Murray KO, 2013, AM J TROP MED HYG, V89, P996, DOI 10.4269/ajtmh.13-0232; Nolan MS, 2012, J CLIN PSYCHOL, V68, P801, DOI 10.1002/jclp.21871; Ramanuj PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103496; Sejvar JJ, 2007, CLIN INFECT DIS, V44, P1617, DOI 10.1086/518281; Shafer AB, 2006, J CLIN PSYCHOL, V62, P123, DOI 10.1002/jclp.20213; Shukla J, 2012, INT J INFECT DIS, V16, pE53, DOI 10.1016/j.ijid.2011.09.020; Sivakumar RR, 2013, OPHTHALMOLOGY, V120, P1820, DOI 10.1016/j.ophtha.2013.02.006	23	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0148898	10.1371/journal.pone.0148898	http://dx.doi.org/10.1371/journal.pone.0148898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950214	Green Submitted, gold, Green Published			2022-12-27	WOS:000371990100008
J	Regan, E; Sibley, RC; Cenik, BK; Silva, A; Girard, L; Minna, JD; Dellinger, MT				Regan, Erin; Sibley, Robert C.; Cenik, Bercin Kutluk; Silva, Asitha; Girard, Luc; Minna, John D.; Dellinger, Michael T.			Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines	PLOS ONE			English	Article							GROWTH-FACTOR-C; LYMPH-NODE METASTASIS; VEGF-C; TUMOR LYMPHANGIOGENESIS; UP-REGULATION; MOUSE MODEL; PROMOTES; CARCINOMA; ANGIOGENESIS; INHIBITOR	It is well established that lung tumors induce the formation of lymphatic vessels. However, the molecular mechanisms controlling tumor lymphangiogenesis in lung cancer have not been fully delineated. In the present study, we identify a panel of non-small cell lung cancer (NSCLC) cell lines that induce lymphangiogenesis and use genome-wide mRNA expression to characterize the molecular mechanisms regulating tumor lymphangiogenesis. We show that Calu-1, H1993, HCC461, HCC827, and H2122 NSCLC cell lines formtumors that induce lymphangiogenesis whereas Calu-3, H1155, H1975, and H2073 NSCLC cell lines form tumors that do not induce lymphangiogenesis. By analyzing genome-wide mRNA expression data, we identify a 17-gene expression signature that distinguishes lymphangiogenic from non-lymphangiogenic NSCLC cell lines. Importantly, VEGF-C is the only lymphatic growth factor in this expression signature and is approximately 50-fold higher in the lymphangiogenic group than in the non-lymphangiogenic group. We show that forced expression of VEGF-C by H1975 cells induces lymphangiogenesis and that knockdown of VEGF-C in H1993 cells inhibits lymphangiogenesis. Additionally, we demonstrate that the triple angiokinase inhibitor, nintedanib (small molecule that blocks all FGFRs, PDGFRs, and VEGFRs), suppresses tumor lymphangiogenesis in H1993 tumors. Together, these data suggest that VEGF-C is the dominant driver of tumor lymphangiogenesis in NSCLC and reveal a specific therapy that could potentially block tumor lymphangiogenesis in NSCLC patients.	[Regan, Erin; Sibley, Robert C.; Cenik, Bercin Kutluk; Silva, Asitha; Girard, Luc; Minna, John D.; Dellinger, Michael T.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Girard, Luc; Minna, John D.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Dellinger, Michael T.] Univ Texas SW Med Ctr Dallas, Div Surg Oncol, Dept Surg, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Dellinger, MT (corresponding author), Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA.; Dellinger, MT (corresponding author), Univ Texas SW Med Ctr Dallas, Div Surg Oncol, Dept Surg, Dallas, TX 75390 USA.	michael.dellinger@utsouthwestern.edu		Sibley, Robert/0000-0001-5075-5071; Dellinger, Michael/0000-0002-3315-4239	Department of Surgery at UT Southwestern Medical Center; NCI SPORE [P50CA70907]; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098040] Funding Source: NIH RePORTER	Department of Surgery at UT Southwestern Medical Center; NCI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by start-up funds from the Department of Surgery at UT Southwestern Medical Center to MTD and by a career development award from the NCI SPORE P50CA70907 to MTD. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bill R, 2015, CLIN CANCER RES, V21, P4856, DOI 10.1158/1078-0432.CCR-14-3036; Burton JB, 2008, CANCER RES, V68, P7828, DOI 10.1158/0008-5472.CAN-08-1488; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; Cao RH, 2006, BLOOD, V107, P3531, DOI 10.1182/blood-2005-06-2538; Cenik BK, 2013, MOL CANCER THER, V12, P992, DOI 10.1158/1535-7163.MCT-12-0995; Chen ZT, 2005, CANCER RES, V65, P9004, DOI 10.1158/0008-5472.CAN-05-0885; Cong B, 2009, THORAC CARDIOV SURG, V57, P291, DOI 10.1055/s-0029-1185625; Du Q, 2014, CANCER SCI, V105, P1261, DOI 10.1111/cas.12504; Fagiani E, 2011, CANCER RES, V71, P5717, DOI 10.1158/0008-5472.CAN-10-4635; Feng YK, 2010, ANAT REC, V293, P802, DOI 10.1002/ar.21096; Guo BL, 2009, ANAT REC, V292, P633, DOI 10.1002/ar.20893; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Hoshida T, 2006, CANCER RES, V66, P8065, DOI 10.1158/0008-5472.CAN-06-1392; Kadota K, 2008, EUR J CANCER, V44, P1057, DOI 10.1016/j.ejca.2008.03.012; Karpanen T, 2001, CANCER RES, V61, P1786; Karpinich NO, 2013, FASEB J, V27, P590, DOI 10.1096/fj.12-214080; Kobayashi S, 2007, CANCER SCI, V98, P726, DOI 10.1111/j.1349-7006.2007.00439.x; Larrieu-Lahargue F, 2010, BLOOD, V115, P5418, DOI 10.1182/blood-2009-11-252338; Luangdilok S, 2011, EUR J CANCER, V47, P520, DOI 10.1016/j.ejca.2010.10.009; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Mattila MMT, 2002, INT J CANCER, V98, P946, DOI 10.1002/ijc.10283; Modi S, 2000, ONCOGENE, V19, P4632, DOI 10.1038/sj.onc.1203815; Mountain CF, 1997, CHEST, V111, P1718, DOI 10.1378/chest.111.6.1718; Oda M, 1998, LUNG CANCER-J IASLC, V22, P23, DOI 10.1016/S0169-5002(98)00070-1; Phelps RM, 1996, J CELL BIOCHEM, P32; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2; Shi YZ, 2013, ANTICANCER RES, V33, P409; Shibata MA, 2013, ANTICANCER RES, V33, P4237; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Skobe M, 2001, AM J PATHOL, V159, P893, DOI 10.1016/S0002-9440(10)61765-8; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Sun JG, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-21; Tsai PW, 2003, J BIOL CHEM, V278, P5750, DOI 10.1074/jbc.M204863200; Wong SY, 2005, CANCER RES, V65, P9789, DOI 10.1158/0008-5472.CAN-05-0901; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yanai Y, 2001, J EXP CLIN CANC RES, V20, P419; Yang F, 2011, CANCER RES, V71, P5512, DOI 10.1158/0008-5472.CAN-10-2614; Yao JB, 2013, TUMOR BIOL, V34, P1493, DOI 10.1007/s13277-013-0674-6; Yao LC, 2014, CIRC RES, V114, P806, DOI 10.1161/CIRCRESAHA.114.303119	43	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150963	10.1371/journal.pone.0150963	http://dx.doi.org/10.1371/journal.pone.0150963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950548	Green Published, gold			2022-12-27	WOS:000371990100074
J	Salari, V; Scholkmann, F; Bokkon, I; Shahbazi, F; Tuszynski, J				Salari, Vahid; Scholkmann, Felix; Bokkon, Istvan; Shahbazi, Farhad; Tuszynski, Jack			The Physical Mechanism for Retinal Discrete Dark Noise: Thermal Activation or Cellular Ultraweak Photon Emission?	PLOS ONE			English	Article							OUTER SEGMENTS; ISOMERIZATION DYNAMICS; ROD PHOTORECEPTORS; VISUAL PIGMENTS; LIGHT-EMISSION; L-GLUTAMATE; IN-VIVO; RHODOPSIN; BRAIN; CHROMOPHORE	For several decades the physical mechanism underlying discrete dark noise of photoreceptors in the eye has remained highly controversial and poorly understood. It is known that the Arrhenius equation, which is based on the Boltzmann distribution for thermal activation, can model only a part (e.g. half of the activation energy) of the retinal dark noise experimentally observed for vertebrate rod and cone pigments. Using the Hinshelwood distribution instead of the Boltzmann distribution in the Arrhenius equation has been proposed as a solution to the problem. Here, we show that the using the Hinshelwood distribution does not solve the problem completely. As the discrete components of noise are indistinguishable in shape and duration from those produced by real photon induced photoisomerization, the retinal discrete dark noise is most likely due to 'internal photons' inside cells and not due to thermal activation of visual pigments. Indeed, all living cells exhibit spontaneous ultraweak photon emission (UPE), mainly in the optical wavelength range, i.e., 350-700 nm. We show here that the retinal discrete dark noise has a similar rate as UPE and therefore dark noise is most likely due to spontaneous cellular UPE and not due to thermal activation.	[Salari, Vahid; Shahbazi, Farhad] Isfahan Univ Technol, Dept Phys, Esfahan 8415683111, Iran; [Salari, Vahid; Shahbazi, Farhad] Inst Res Fundamental Sci IPM, Sch Phys, Tehran 193955531, Iran; [Scholkmann, Felix] Univ Zurich, Univ Zurich Hosp, Dept Neonatol, Biomed Opt Res Lab, CH-8091 Zurich, Switzerland; [Scholkmann, Felix] Res Off Complex Phys & Biol Syst ROCoS, CH-8038 Zurich, Switzerland; [Bokkon, Istvan] Vis Res Inst, 25 Rita St, Lowell, MA 01854 USA; [Bokkon, Istvan] Natl Ctr Spinal Disorders, Psychoszomat OutPatient Dept, H-1126 Budapest, Hungary; [Tuszynski, Jack] Univ Alberta, Dept Phys, Edmonton, AB T6G 2J1, Canada	Isfahan University of Technology; University of Zurich; University Zurich Hospital; University of Alberta	Tuszynski, J (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB T6G 2J1, Canada.	jackt@ualberta.ca	Shahbazi, Farhad/Q-5471-2019; Tuszynski, Jack/AAA-2073-2020	Tuszynski, Jack/0000-0001-9976-0429; Scholkmann, Felix/0000-0002-1748-4852; Salari, Vahid/0000-0001-7908-0696				Ala-Laurila P, 2004, BIOPHYS J, V86, P3653, DOI 10.1529/biophysj.103.035626; Ala-Laurila P, 2007, J PHYSIOL-LONDON, V585, P57, DOI 10.1113/jphysiol.2007.142935; BARLOW RB, 1993, NATURE, V366, P64, DOI 10.1038/366064a0; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Bokkon I, 2016, REV NEUROSC; Bokkon I, 2009, J PHOTOCH PHOTOBIO B, V96, P255, DOI 10.1016/j.jphotobiol.2009.07.002; Brady S., 2006, BASIC NEUROCHEMISTRY; Campos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044191; Catala A, 2006, INT J BIOCHEM CELL B, V38, P1482, DOI 10.1016/j.biocel.2006.02.010; Cifra M, 2014, J PHOTOCH PHOTOBIO B, V139, P2, DOI 10.1016/j.jphotobiol.2014.02.009; COOPER A, 1979, NATURE, V282, P531, DOI 10.1038/282531a0; Csaszar N, 2016, REV NEUROSC; Dartnall H. J. A., 1965, Vision Research, V5, P81, DOI 10.1016/0042-6989(65)90057-X; DEVARAJ B, 1991, PHOTOCHEM PHOTOBIOL, V54, P289, DOI 10.1111/j.1751-1097.1991.tb02018.x; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Fu YB, 2008, NAT NEUROSCI, V11, P565, DOI 10.1038/nn.2110; Gozem S, 2012, SCIENCE, V337, P1225, DOI 10.1126/science.1220461; GRAYMORE C, 1960, Br J Ophthalmol, V44, P363, DOI 10.1136/bjo.44.6.363; HILL RW, 1977, J AM STAT ASSOC, V72, P828; Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028; ISOSHIMA T, 1995, REV SCI INSTRUM, V66, P2922, DOI 10.1063/1.1145578; Ives JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087401; Johns Hopkins Medical Institutions, 2011, SCIENCEDAILY NE 0609; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; Kim JE, 2003, BIOPHYS J, V84, P2492, DOI 10.1016/S0006-3495(03)75054-1; Kobayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105700; Kobayashi M, 1998, PHYS REV E, V57, P2129, DOI 10.1103/PhysRevE.57.2129; Kobayashi M, 2000, APPL OPTICS, V39, P183, DOI 10.1364/AO.39.000183; Kobayashi M, 1999, NEUROSCI RES, V34, P103, DOI 10.1016/S0168-0102(99)00040-1; Kobayashi M, 1999, J NEUROSCI METH, V93, P163, DOI 10.1016/S0165-0270(99)00140-5; Levenberg K., 1944, J APPL MATH, V2, P164; Lin SW, 1998, J PHYS CHEM B, V102, P2787, DOI 10.1021/jp972752u; LOPPNOW GR, 1988, BIOPHYS J, V54, P35, DOI 10.1016/S0006-3495(88)82928-X; Lorenz-Fonfria VA, 2010, J AM CHEM SOC, V132, P5693, DOI 10.1021/ja907756e; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Nakano M., 2005, J BIOLUMIN CHEMILUM, V4, P231, DOI DOI 10.1002/BI0.1170040133; NIELSEN JC, 1986, INVEST OPHTH VIS SCI, V27, P261; Paro FM, 2003, J APPL PHYSIOL, V94, P271, DOI 10.1152/japplphysiol.00291.2002; Planck M, 1901, ANN PHYS-BERLIN, V4, P553; Pospisil P, 2014, J PHOTOCH PHOTOBIO B, V139, P11, DOI 10.1016/j.jphotobiol.2014.02.008; Prasad A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01211; Prasad A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022345; Reichl L. E., 1998, MODERN COURSE STAT P; SCOTT RQ, 1991, FEBS LETT, V285, P97, DOI 10.1016/0014-5793(91)80733-J; SLAWINSKI J, 1988, EXPERIENTIA, V44, P559; Steele RH, 2003, ARCH BIOCHEM BIOPHYS, V411, P1, DOI 10.1016/S0003-9861(02)00459-9; STGEORGE RCC, 1952, J GEN PHYSIOL, V35, P495, DOI 10.1085/jgp.35.3.495; Takeda M, 2004, CANCER SCI, V95, P656, DOI 10.1111/j.1349-7006.2004.tb03325.x; Tang RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085643; van Wijk E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084579; Wang C, 2011, BRAIN RES, V1369, P1, DOI 10.1016/j.brainres.2010.10.077; WIEDMANN TS, 1988, BIOCHEMISTRY-US, V27, P6469, DOI 10.1021/bi00417a041; YOSHIMATSU H, 1993, BRAIN RES, V601, P121, DOI 10.1016/0006-8993(93)91702-T; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7	56	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0148336	10.1371/journal.pone.0148336	http://dx.doi.org/10.1371/journal.pone.0148336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950936	Green Published, gold, Green Accepted			2022-12-27	WOS:000371990100005
J	Wakarchuk, WW; Brochu, D; Foote, S; Robotham, A; Saxena, H; Erak, T; Kelly, J				Wakarchuk, Warren W.; Brochu, Denis; Foote, Simon; Robotham, Anna; Saxena, Hirak; Erak, Tamara; Kelly, John			Proteomic Analysis of the Secretome of Cellulomonas fimi ATCC 484 and Cellulomonas flavigena ATCC 482	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELLULASES; GENES; ENDOGLUCANASE; PURIFICATION; ORGANIZATION; HYDROLYSIS; XYLANASES; BACTERIUM; BIOMASS	The bacteria in the genus Cellulomonas are known for their ability to degrade plant cell wall biomass. Cellulomonas fimi ATCC 484 and C. flavigena ATCC 482 have been the subject of much research into secreted cellulases and hemicellulases. Recently the genome sequences of both C. fimi ATCC 484 and C. flavigena ATCC 482 were published, and a genome comparison has revealed their full spectrum of possible carbohydrate-active enzymes (CAZymes). Using mass spectrometry, we have compared the proteins secreted by C. fimi and C. flavigena during growth on the soluble cellulose substrate, carboxymethylcellulose (CMC), as well as a soluble xylan fraction. Many known C. fimi CAZymes were detected, which validated our analysis, as were a number of new CAZymes and other proteins that, though identified in the genome, have not previously been observed in the secretome of either organism. Our data also shows that many of these are co-expressed on growth of either CMC or xylan. This analysis provides a new perspective on Cellulomonas enzymes and provides many new CAZyme targets for characterization.	[Wakarchuk, Warren W.; Saxena, Hirak; Erak, Tamara] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada; [Brochu, Denis; Foote, Simon; Robotham, Anna; Kelly, John] Natl Res Council Canada, Human Hlth Therapeut Program, Ottawa, ON, Canada	Toronto Metropolitan University; National Research Council Canada	Wakarchuk, WW (corresponding author), Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada.	wwakarchuk@ryerson.ca	Wakarchuk, Warren/AAO-2774-2020; Wakarchuk, Warren/Q-9514-2017	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Robotham, Anna/0000-0002-6464-736X	Natural Sciences Engineering Research Council Discovery grant [NSERC 385796-2011]	Natural Sciences Engineering Research Council Discovery grant	This work was funded by Natural Sciences Engineering Research Council Discovery grant to W. Wakarchuk NSERC 385796-2011.	Adav SS, 2012, J PROTEOMICS, V75, P3694, DOI 10.1016/j.jprot.2012.04.031; BEGUIN P, 1977, J GEN MICROBIOL, V101, P191, DOI 10.1099/00221287-101-2-191; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Christopherson MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053954; CLARKE JH, 1991, FEMS MICROBIOL LETT, V83, P305, DOI [10.1016/0378-1097(91)90493-T, 10.1111/j.1574-6968.1991.tb04481.x]; Espitia C, 2010, MOL BIOSYST, V6, P775, DOI 10.1039/b916394h; Fincher G, GH3 CAZYMES JULY 4; Gao J, 2014, J BACTERIOL, V196, P4103, DOI 10.1128/JB.02194-14; GILKES NR, 1984, J GEN MICROBIOL, V130, P1377; Gonzalez-Zamnorano M, 2009, J PROTEOME RES, V8, P721, DOI 10.1021/pr800756a; HAN YW, 1968, APPL MICROBIOL, V16, P1140, DOI 10.1128/AEM.16.8.1140-1145.1968; Hekmat O, 2005, J BIOL CHEM, V280, P35126, DOI 10.1074/jbc.M508434200; Hekmat O, 2007, CHEMBIOCHEM, V8, P2125, DOI 10.1002/cbic.200700481; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Kataeva IA, 2002, APPL ENVIRON MICROB, V68, P4292, DOI 10.1128/AEM.68.9.4292-4300.2002; KOLIOS G, 1991, BIOTECHNOL APPL BIOC, V14, P365; LANGSFORD ML, 1984, J GEN MICROBIOL, V130, P1367; MEINKE A, 1991, J BACTERIOL, V173, P308, DOI 10.1128/jb.173.1.308-314.1991; MEINKE A, 1994, MOL MICROBIOL, V12, P413, DOI 10.1111/j.1365-2958.1994.tb01030.x; Mejia-Castillo T, 2008, BIOTECHNOL LETT, V30, P681, DOI 10.1007/s10529-007-9589-x; MOSER B, 1989, APPL ENVIRON MICROB, V55, P2480, DOI 10.1128/AEM.55.10.2480-2487.1989; Nataf Y, 2010, P NATL ACAD SCI USA, V107, P18646, DOI 10.1073/pnas.1012175107; Perez-Avalos O, 2008, CURR MICROBIOL, V57, P39, DOI 10.1007/s00284-008-9149-1; Sanchez-Herrera LM, 2007, APPL MICROBIOL BIOT, V77, P589, DOI 10.1007/s00253-007-1190-7; Sandercock LE, 1996, FEMS MICROBIOL LETT, V143, P7, DOI 10.1016/0378-1097(96)00297-2; SHEN H, 1994, BIOCHEM BIOPH RES CO, V199, P1223, DOI 10.1006/bbrc.1994.1361; Takasuka TE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01030; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; VanderVen BC, 2005, SCIENCE, V309, P941, DOI 10.1126/science.1114347; WHITTLE DJ, 1982, GENE, V17, P139, DOI 10.1016/0378-1119(82)90066-X	30	15	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0151186	10.1371/journal.pone.0151186	http://dx.doi.org/10.1371/journal.pone.0151186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950732	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100093
J	Yang, CC				Yang, Ching-Ching			Characterization of Scattered X-Ray Photons in Dental Cone-Beam Computed Tomography	PLOS ONE			English	Article							CT; RADIOLOGY; SIMULATION; NECK; HEAD; CBCT	Purpose Scatter is a very important artifact causing factor in dental cone-beam CT (CBCT), which has a major influence on the detectability of details within images. This work aimed to improve the image quality of dental CBCT through scatter correction. Methods Scatter was estimated in the projection domain from the low frequency component of the difference between the raw CBCT projection and the projection obtained by extrapolating the model fitted to the raw projections acquired with 2 different sizes of axial field-of-view (FOV). The function for curve fitting was optimized by using Monte Carlo simulation. To validate the proposed method, an anthropomorphic phantom and a water-filled cylindrical phantom with rod inserts simulating different tissue materials were scanned using 120 kVp, 5 mA and 9-second scanning time covering an axial FOV of 4 cm and 13 cm. The detectability of the CT image was evaluated by calculating the contrast-to-noise ratio (CNR). Results Beam hardening and cupping artifacts were observed in CBCT images without scatter correction, especially in those acquired with 13 cm FOV. These artifacts were reduced in CBCT images corrected by the proposed method, demonstrating its efficacy on scatter correction. After scatter correction, the image quality of CBCT was improved in terms of target detectability which was quantified as the CNR for rod inserts in the cylindrical phantom. Conclusions Hopefully the calculations performed in this work can provide a route to reach a high level of diagnostic image quality for CBCT imaging used in oral and maxillofacial structures whilst ensuring patient dose as low as reasonably achievable, which may ultimately make CBCT scan a reliable and safe tool in clinical practice.	[Yang, Ching-Ching] Tzu Chi Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Hualien, Taiwan	Tzu Chi University of Science & Technology	Yang, CC (corresponding author), Tzu Chi Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Hualien, Taiwan.	cyang@tcust.edu.tw		Yang, Ching-Ching/0000-0002-9420-3102				Chen Y, 2009, MED PHYS, V36, P857, DOI 10.1118/1.3077122; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Graham SA, 2007, MED PHYS, V34, P2691, DOI 10.1118/1.2740466; Jan S, 2004, PHYS MED BIOL, V49, P4543, DOI 10.1088/0031-9155/49/19/007; Loubele M, 2009, EUR J RADIOL, V71, P461, DOI 10.1016/j.ejrad.2008.06.002; Ludlow JB, 2011, DENTOMAXILLOFAC RAD, V40, P115, DOI 10.1259/dmfr/31708191; Ludlow JB, 2008, ORAL SURG ORAL MED O, V106, P106, DOI 10.1016/j.tripleo.2008.03.018; Maher KP, 1997, CONTEMP PHYS, V38, P131, DOI 10.1080/001075197182469; Matteson SR, 1996, CRIT REV ORAL BIOL M, V7, P346, DOI 10.1177/10454411960070040401; McCollough CH, 2009, RADIOL CLIN N AM, V47, P27, DOI 10.1016/j.rcl.2008.10.006; Miracle AC, 2009, AM J NEURORADIOL, V30, P1088, DOI 10.3174/ajnr.A1653; Monsour PA, 2008, AUST DENT J, V53, pS11, DOI 10.1111/j.1834-7819.2008.00037.x; Niu TY, 2010, MED PHYS, V37, P5395, DOI 10.1118/1.3483260; Ouyang T, 2010, ORAL MAXIL SURG CLIN, V22, P107, DOI 10.1016/j.coms.2009.10.002; Pauwels R, 2012, EUR J RADIOL, V81, P267, DOI 10.1016/j.ejrad.2010.11.028; Saavedra-Abril JA, 2010, RADIOGRAPHICS, V30, P1975, DOI 10.1148/rg.307105026; Scarfe William C, 2008, Dent Clin North Am, V52, P707, DOI 10.1016/j.cden.2008.05.005; Schauer DA, 2009, HEALTH PHYS, V97, P1, DOI 10.1097/01.HP.0000356672.44380.b7; Siewerdsen JH, 2001, MED PHYS, V28, P220, DOI 10.1118/1.1339879; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Theodorakou C, 2012, BRIT J RADIOL, V85, P153, DOI 10.1259/bjr/19389412; Xu J, 2012, MED PHYS, V39, P4932, DOI 10.1118/1.4736805	22	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0149904	10.1371/journal.pone.0149904	http://dx.doi.org/10.1371/journal.pone.0149904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950435	Green Submitted, gold, Green Published			2022-12-27	WOS:000371990100019
J	Dunham, Y; Lieberman, ES; Snell, SA				Dunham, Yarrow; Lieberman, Evan S.; Snell, Steven A.			Does Stigmatized Social Risk Lead to Denialism? Results from a Survey Experiment on Race, Risk Perception, and Health Policy in the United States	PLOS ONE			English	Article							PSYCHOLOGY; POLITICS; SCIENCE; GENDER; SELF; HIV	In this article, we report findings from an original survey experiment investigating the effects of different framings of disease threats on individual risk perceptions and policy priorities. We analyze responses from 1,946 white and African-American participants in a self-administered, web-based survey in the United States. We sought to investigate the effects of: 1) frames emphasizing disparities in the racial prevalence of disease and 2) frames emphasizing non-normative (blameworthy or stigmatized) behavioral risk factors. We find some evidence that when treated with the first frame, African-Americans are more likely to report higher risk of infection (compared to an African-American control group and to whites receiving the same treatment); and that whites are more likely to report trust in government data (compared to a White control group and to African-Americans receiving the same treatment). Notwithstanding, we find no support for our hypotheses concerning the interactive effects of providing both frames, which was a central motivation for our study. We argue that this may be due to very large differences in risk perception at baseline (which generate limits on possible treatment effects) and the fact that in the context of American race relations, it may not be possible to fully differentiate racialized and stigmatized frames.	[Dunham, Yarrow] Yale Univ, Dept Psychol, New Haven, CT USA; [Lieberman, Evan S.] MIT, Dept Polit Sci, Cambridge, MA 02139 USA; [Snell, Steven A.] Duke Univ, Social Sci Res Inst, Durham, NC USA	Yale University; Massachusetts Institute of Technology (MIT); Duke University	Lieberman, ES (corresponding author), MIT, Dept Polit Sci, Cambridge, MA 02139 USA.	evanlieb@mit.edu		Lieberman, Evan/0000-0001-9242-5687	Center for Health and Wellbeing, Princeton University; Princeton's Center for Health and Wellbeing	Center for Health and Wellbeing, Princeton University(Princeton University); Princeton's Center for Health and Wellbeing	This work was supported by Center for Health and Wellbeing, Princeton University (no grant number, http://www.princeton.edu/chw/). EL and YD received this funding (at the time, EL was a faculty member, YD was visiting faculty at Princeton, and SS was a doctoral student). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge research assistance from Jessica Grody; helpful comments on the research design from Tali Mendelburg, Betsy Paluck, and participants in the Press Research in Experimental Social Science seminar; and financial support from Princeton's Center for Health and Wellbeing.	Berinsky AJ, 2014, AM J POLIT SCI, V58, P739, DOI 10.1111/ajps.12081; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Blumberg SJ, 2000, HEALTH EDUC BEHAV, V27, P780, DOI 10.1177/109019810002700611; Brandon DM, 2014, BEHAV RES ACCOUNT, V26, P1, DOI 10.2308/bria-50651; Brewer MB, 2007, AM PSYCHOL, V62, P728, DOI 10.1037/0003-066X.62.8.728; Douglas M, 2005, RISK BLAME ESSAYS CU; Druckman JN, 2001, POLIT BEHAV, V23, P225, DOI 10.1023/A:1015006907312; Dunham Y, 2011, J EXP SOC PSYCHOL, V47, P668, DOI 10.1016/j.jesp.2011.01.003; Ellemers N, 2002, ANNU REV PSYCHOL, V53, P161, DOI 10.1146/annurev.psych.53.100901.135228; Fitzgerald J, 1998, MICHIGAN PANEL STUDY; Higgins MJ, 2013, WORKING PAPER; Horiuchi Y, 2007, AM J POLIT SCI, V51, P669, DOI 10.1111/j.1540-5907.2007.00274.x; Kahan D. M., 2007, J EMPIR LEGAL STUD, V4, P465, DOI DOI 10.1111/J.1740-1461.2007.00097.X; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Lieberman ES, 2007, COMP POLIT STUD, V40, P1407, DOI 10.1177/0010414007306862; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Moore RT, 2012, POLIT ANAL, V20, P460, DOI 10.1093/pan/mps025; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Rosoff H, 2012, RISK ANAL, V32, P729, DOI 10.1111/j.1539-6924.2012.01769.x; Slovic P, 2004, RISK ANAL RISK FEELI; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Tajfel H., 2001, EXPT INTERGROUP DISC, P178; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683	27	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0147219	10.1371/journal.pone.0147219	http://dx.doi.org/10.1371/journal.pone.0147219			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TL	26963380	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000001
J	Paulus, A; Rohr, M; Dotsch, R; Wentura, D				Paulus, Andrea; Rohr, Michaela; Dotsch, Ron; Wentura, Dirk			Positive Feeling, Negative Meaning: Visualizing the Mental Representations of In-Group and Out-Group Smiles	PLOS ONE			English	Article							FACIAL EXPRESSIONS; SOCIAL CATEGORIZATION; EMOTIONAL-REACTIONS; FACES; VALIDATION; ENJOYMENT; ATTITUDES; RESPONSES; DISPLAYS; DUCHENNE	Even though smiles are seen as universal facial expressions, research shows that there exist various kinds of smiles (i.e., affiliative smiles, dominant smiles). Accordingly, we suggest that there also exist various mental representations of smiles. Which representation is employed in cognition may depend on social factors, such as the smiling person's group membership: Since in-group members are typically seen as more benevolent than outgroup members, in-group smiles should be associated with more benevolent social meaning than those conveyed by out-group members. We visualized in-group and out-group smiles with reverse correlation image classification. These visualizations indicated that mental representations of in-group smiles indeed express more benevolent social meaning than those of out-group smiles. The affective meaning of these visualized smiles was not influenced by group membership. Importantly, the effect occurred even though participants were not instructed to attend to the nature of the smile, pointing to an automatic association between group membership and intention.	[Paulus, Andrea; Rohr, Michaela; Wentura, Dirk] Univ Saarland, D-66123 Saarbrucken, Germany; [Dotsch, Ron] Univ Utrecht, Utrecht, Netherlands; [Dotsch, Ron] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Saarland University; Utrecht University; Radboud University Nijmegen	Paulus, A (corresponding author), Univ Saarland, D-66123 Saarbrucken, Germany.	a.paulus@mx.uni-saarland.de			Deutsche Forschungsgemeinschaft (DFG) [WE 2284/9-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The research reported in this article was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG; http://www.dfg.de/en/) to Dirk Wentura (WE 2284/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambadar Z, 2009, J NONVERBAL BEHAV, V33, P17, DOI 10.1007/s10919-008-0059-5; Bernstein MJ, 2008, PSYCHOL SCI, V19, P981, DOI 10.1111/j.1467-9280.2008.02187.x; Bernstein MJ, 2010, J EXP SOC PSYCHOL, V46, P196, DOI 10.1016/j.jesp.2009.08.010; Bijlstra G, 2010, J EXP SOC PSYCHOL, V46, P657, DOI 10.1016/j.jesp.2010.03.006; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; DIJKER AJM, 1987, EUR J SOC PSYCHOL, V17, P305, DOI 10.1002/ejsp.2420170306; Dotsch R, 2008, PSYCHOL SCI, V19, P978, DOI 10.1111/j.1467-9280.2008.02186.x; Dotsch R, 2012, SOC PSYCHOL PERS SCI, V3, P562, DOI 10.1177/1948550611430272; Dotsch R, 2011, J PERS SOC PSYCHOL, V100, P999, DOI 10.1037/a0023026; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; EKMAN P, 1982, J NONVERBAL BEHAV, V6, P238, DOI 10.1007/BF00987191; Ekman P., 2005, WHAT FACE REVEALS; Ekman P., 2001, TELLING LIES CLUES D, V3rd; Ekman P., 2002, FACIAL ACTION CODING; Ekman P., 2002, FACIAL ACTION CODING, P40; Ekman Paul, 1972, NEBRASKA S MOTIVATIO, V19, P207, DOI DOI 10.1037/0022-3514.53.4.712; Epstude K, 2009, EMOTION, V9, P1, DOI 10.1037/a0014148; Escher M. C., 1992, THE GRAPHIC WORK; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; FRANK MG, 1993, J PERS SOC PSYCHOL, V64, P83, DOI 10.1037/0022-3514.64.1.83; Fridlund A, 2002, EMPIRICAL REFLECTION; Fridlund A.J., 1994, HUMAN FACIAL EXPRESS; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 1996, PSYCHOPHYSIOLOGY, V33, P175, DOI 10.1111/j.1469-8986.1996.tb02121.x; Hassin RR, 2013, EMOT REV, V5, P60, DOI 10.1177/1754073912451331; Hess U., 2002, EMPIRICAL REFLECTION, P187; Hugenberg K, 2005, EMOTION, V5, P267, DOI 10.1037/1528-3542.5.3.267; Hugenberg K, 2006, SOC COGNITION, V24, P516, DOI 10.1521/soco.2006.24.5.516; Imhoff R, 2011, PSYCHOL SCI, V22, P1583, DOI 10.1177/0956797611419675; Izard C.E., 1971, FACE EMOTION; Jack RE, 2012, P NATL ACAD SCI USA, V109, P7241, DOI 10.1073/pnas.1200155109; Jack RE, 2012, J EXP PSYCHOL GEN, V141, P19, DOI 10.1037/a0023463; Johnston L, 2010, BRIT J SOC PSYCHOL, V49, P107, DOI 10.1348/014466609X412476; Karremans JC, 2011, COGNITION, V121, P422, DOI 10.1016/j.cognition.2011.07.008; KELTNER D, 1995, J PERS SOC PSYCHOL, V68, P441, DOI 10.1037/0022-3514.68.3.441; Krumhuber EG, 2009, EMOTION, V9, P807, DOI 10.1037/a0017844; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Lundqvist D., 1998, AVERAGED KAROLINSKA; Mangini MC, 2004, COGNITIVE SCI, V28, P209, DOI 10.1016/j.cogsci.2003.11.004; Maringer M, 2011, EMOTION, V11, P181, DOI 10.1037/a0022596; Marsh AA, 2005, EMOTION, V5, P119, DOI 10.1037/1528-3542.5.1.119; Miles L, 2007, J NONVERBAL BEHAV, V31, P259, DOI 10.1007/s10919-007-0036-4; Niedenthal PM, 2010, BEHAV BRAIN SCI, V33, P417, DOI 10.1017/S0140525X10000865; Otten S, 1999, EUR J SOC PSYCHOL, V29, P1049, DOI 10.1002/(SICI)1099-0992(199912)29:8<1049::AID-EJSP985>3.0.CO;2-Q; Park B, 2005, PERS SOC PSYCHOL REV, V9, P108, DOI 10.1207/s15327957pspr0902_2; Paulus A., 2012, VALIDATION SAA UNPUB; Paulus A, 2014, COGNITION EMOTION, V28, P656, DOI 10.1080/02699931.2013.849659; Philippot P, 2007, STUD EMO SO, P69, DOI 10.1017/CBO9780511499838.005; Ratner KG, 2014, J PERS SOC PSYCHOL, V106, P897, DOI 10.1037/a0036498; Russell J. A., 1997, PSYCHOL FACIAL EXPRE, P295, DOI [10.1017/CBO9780511659911.015, DOI 10.1017/CBO9780511659911.015, 10.1017/cbo9780511659911.015]; Surakka V, 1998, INT J PSYCHOPHYSIOL, V29, P23, DOI 10.1016/S0167-8760(97)00088-3; Tabachnick B. G., 2013, USING MULTIVARIATE S; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Thibault P, 2006, J EXP SOC PSYCHOL, V42, P676, DOI 10.1016/j.jesp.2005.10.006; Todorov A, 2011, SOC PERSONAL PSYCHOL, V5, P775, DOI 10.1111/j.1751-9004.2011.00389.x; Tskhay KO, 2015, EMOTION, V15, P812, DOI 10.1037/emo0000077; van der Schalk J, 2011, EMOTION, V11, P907, DOI 10.1037/a0023853; van der Schalk J, 2011, EMOTION, V11, P286, DOI 10.1037/a0022582; Wilkowski BM, 2010, J PERS SOC PSYCHOL, V98, P201, DOI 10.1037/a0017992; Young SG, 2010, J PERS SOC PSYCHOL, V99, P964, DOI 10.1037/a0020400	61	16	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151230	10.1371/journal.pone.0151230	http://dx.doi.org/10.1371/journal.pone.0151230			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TL	26963621	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000124
J	Potgieser, ARE; de Jong, BM				Potgieser, Adriaan R. E.; de Jong, Bauke M.			Visuomotor Dissociation in Cerebral Scaling of Size	PLOS ONE			English	Article							LATERAL OCCIPITAL COMPLEX; POSTERIOR PARIETAL CORTEX; STIMULUS-DRIVEN ATTENTION; MEDIAL FRONTAL-CORTEX; EVENT-RELATED FMRI; MENTAL ROTATION; PREMOTOR CORTEX; MOTOR SYSTEM; COGNITIVE CONTROL; ANTERIOR INSULA	Estimating size and distance is crucial in effective visuomotor control. The concept of an internal coordinate system implies that visual and motor size parameters are scaled onto a common template. To dissociate perceptual and motor components in such scaling, we performed an fMRI experiment in which 16 right-handed subjects copied geometric figures while the result of drawing remained out of sight. Either the size of the example figure varied while maintaining a constant size of drawing (visual incongruity) or the size of the examples remained constant while subjects were instructed to make changes in size (motor incongruity). These incongruent were compared to congruent conditions. Statistical Parametric Mapping (SPM8) revealed brain activations related to size incongruity in the dorsolateral prefrontal and inferior parietal cortex, pre-SMA / anterior cingulate and anterior insula, dominant in the right hemisphere. This pattern represented simultaneous use of a 'resized' virtual template and actual picture information requiring spatial working memory, early-stage attention shifting and inhibitory control. Activations were strongest in motor incongruity while right pre-dorsal premotor activation specifically occurred in this condition. Visual incongruity additionally relied on a ventral visual pathway. Left ventral premotor activation occurred in all variably sized drawing while constant visuomotor size, compared to congruent size variation, uniquely activated the lateral occipital cortex additional to superior parietal regions. These results highlight size as a fundamental parameter in both general hand movement and movement guided by objects perceived in the context of surrounding 3D space.	[Potgieser, Adriaan R. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, Groningen, Netherlands; [Potgieser, Adriaan R. E.; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands; [de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	de Jong, BM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands.; de Jong, BM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	b.m.de.jong@umcg.nl		de Jong, Bauke M./0000-0002-6568-5739	University of Groningen	University of Groningen	This work was supported by the Unrestricted JSM grant of the University of Groningen. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Beudel M, 2009, CEREB CORTEX, V19, P2361, DOI 10.1093/cercor/bhn254; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; BONDA E, 1995, P NATL ACAD SCI USA, V92, P11180, DOI 10.1073/pnas.92.24.11180; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Buxbaum LJ, 2006, BRAIN RES, V1117, P175, DOI 10.1016/j.brainres.2006.08.010; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Cieslik EC, 2010, J NEUROPHYSIOL, V104, P1472, DOI 10.1152/jn.00261.2010; Clavagnier S, 2007, NEUROSCIENTIST, V13, P22, DOI 10.1177/1073858406295688; COHEN L, 1994, J NEUROL NEUROSUR PS, V57, P73, DOI 10.1136/jnnp.57.1.73; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; DAY RH, 1972, SCIENCE, V175, P1335, DOI 10.1126/science.175.4028.1335; de Jong BM, 2002, CEREB CORTEX, V12, P1213, DOI 10.1093/cercor/12.11.1213; de Jong BM, 1999, COGNITIVE BRAIN RES, V8, P45, DOI 10.1016/S0926-6410(99)00005-1; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Frassinetti F, 1999, BRAIN, V122, P339, DOI 10.1093/brain/122.2.339; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Geyer S, 2000, ANAT EMBRYOL, V202, P443, DOI 10.1007/s004290000127; Glover S, 2004, BEHAV BRAIN SCI, V27, P3; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Gregory RL, 2008, SPATIAL VISION, V21, P407, DOI 10.1163/156856808784532509; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grinband J, 2006, NEURON, V49, P757, DOI 10.1016/j.neuron.2006.01.032; Han SW, 2014, J NEUROSCI, V34, P6958, DOI 10.1523/JNEUROSCI.4975-13.2014; Hanakawa T, 2011, NEUROSCI RES, V70, P144, DOI 10.1016/j.neures.2011.02.010; Harpaz NK, 2014, NEURON, V81, P452, DOI 10.1016/j.neuron.2013.10.058; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; Hester R, 2004, CEREB CORTEX, V14, P986, DOI 10.1093/cercor/bhh059; Hu Y, 2000, J COGNITIVE NEUROSCI, V12, P856, DOI 10.1162/089892900562462; Ikkai A, 2011, NEUROPSYCHOLOGIA, V49, P1428, DOI 10.1016/j.neuropsychologia.2010.12.020; Iwamura Y, 1998, CURR OPIN NEUROBIOL, V8, P522, DOI 10.1016/S0959-4388(98)80041-X; JEANNEROD M, 1986, BEHAV BRAIN RES, V19, P99, DOI 10.1016/0166-4328(86)90008-2; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; Kassubek J, 1999, NEUROPSYCHOLOGIA, V37, P1327, DOI 10.1016/S0028-3932(99)00041-X; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Konen CS, 2008, NAT NEUROSCI, V11, P224, DOI 10.1038/nn2036; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Kourtzi Z, 2003, CEREB CORTEX, V13, P911, DOI 10.1093/cercor/13.9.911; Kourtzi Z, 2011, ANNU REV NEUROSCI, V34, P45, DOI 10.1146/annurev-neuro-060909-153218; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Langner R, 2011, CEREB CORTEX, V21, P2850, DOI 10.1093/cercor/bhr083; Matelli M, 2001, NEUROIMAGE, V14, pS27, DOI 10.1006/nimg.2001.0835; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ondo WG, 2007, MOVEMENT DISORD, V22, P2130, DOI 10.1002/mds.21733; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Plewan T, 2012, J COGNITIVE NEUROSCI, V24, P2015, DOI 10.1162/jocn_a_00258; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Roberts B, 2005, PERCEPTION, V34, P847, DOI 10.1068/p5273; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Shukla AW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000628; Stanley J, 2007, NEUROIMAGE, V34, P290, DOI 10.1016/j.neuroimage.2006.08.043; Sterzer P, 2010, BRAIN STRUCT FUNCT, V214, P611, DOI 10.1007/s00429-010-0252-2; Vingerhoets G, 2002, NEUROIMAGE, V17, P1623, DOI 10.1006/nimg.2002.1290; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Wen XT, 2013, J NEUROSCI, V33, P6444, DOI 10.1523/JNEUROSCI.4939-12.2013; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25	81	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151484	10.1371/journal.pone.0151484	http://dx.doi.org/10.1371/journal.pone.0151484			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963705	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000158
J	Zhu, YN; Shao, ZX; Jing, J; Ma, J; Chen, YJ; Li, XH; Yang, WH; Guo, L; Jin, Y				Zhu, Yanna; Shao, Zixian; Jing, Jin; Ma, Jun; Chen, Yajun; Li, Xiuhong; Yang, Wenhan; Guo, Li; Jin, Yu			Body Mass Index Is Better than Other Anthropometric Indices for Identifying Dyslipidemia in Chinese Children with Obesity	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; WAIST CIRCUMFERENCE; BLOOD-PRESSURE; HIP RATIO; ADOLESCENTS; CHILDHOOD; PUBERTY; PREVALENCE; PREDICTORS; OVERWEIGHT	Background Body mass index (BMI), waist circumference (WC), and waist-to-hip ratio (WHR) are used in screening and predicting obesity in adults. However, the best identifier of metabolic complications in children with obesity remains unclear. This study evaluated lipid profile distribution and investigated the best anthropometric parameter in association with lipid disorders in children with obesity. Methods A total of 2243 school children aged 7-17 years were enrolled in Guangzhou, China, in 2014. The anthropometric indices and lipid profiles were measured. Dyslipidemia was defined according to the US Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. The association between anthropometry (BMI, WC, and WHR) and lipid profile values was examined using chi-square analysis and discriminant function analysis. Information about demography, physical activity, and dietary intake was provided by the participant children and their parents. Results Children aged 10-14 and 15-17 years old generally had higher triglyceride values but lower median concentration of total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol compared with children aged 7-9 years old (all P < 0.001). These lipid parameters fluctuated in children aged 10-14 years old. The combination of age groups, BMI, WC and WHR achieved 65.1% accuracy in determining dyslipidemic disorders. BMI correctly identified 77% of the total dyslipidemic disorders in obese children, which was higher than that by WHR (70.8%) (P < 0.05). Conclusion The distribution of lipid profiles in Chinese children differed between younger and older age groups, and the tendency of these lipid levels remarkably fluctuated during 10 to 14 years old. BMI had better practical utility in identifying dyslipidemia among school-aged children with obesity compared with other anthropometric measures.	[Zhu, Yanna; Shao, Zixian; Jing, Jin; Chen, Yajun; Li, Xiuhong; Yang, Wenhan; Guo, Li; Jin, Yu] Sun Yat Sen Univ, Global Hlth Inst, Sch Publ Hlth, Dept Maternal & Child Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Jun] Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing, Peoples R China	Sun Yat Sen University; Peking University	Jin, Y (corresponding author), Sun Yat Sen Univ, Global Hlth Inst, Sch Publ Hlth, Dept Maternal & Child Hlth, Guangzhou 510275, Guangdong, Peoples R China.	jinyu@mail.sysu.edu.cn	Li, xiuhong/AHA-9848-2022	Li, xiuhong/0000-0001-8084-9706	National Natural Science Foundation of China [81302424]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20130171120056]; Ministry of Health of China [201202010]; Fundamental Research Funds for the Central Universities in Sun Yat-sen University [15ykpy09]; Guangdong Provincial Natural Science Foundation [2015A030313175]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Ministry of Health of China; Fundamental Research Funds for the Central Universities in Sun Yat-sen University; Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by National Natural Science Foundation of China, Award Number 81302424 (Recipient: Yanna Zhu); Specialized Research Fund for the Doctoral Program of Higher Education of China, Award Number 20130171120056 (Recipient: Yanna Zhu); Special Research Grant for Non-profit Public Service of the Ministry of Health of China, Award Number 201202010 (Recipient: Jun Ma); The Fundamental Research Funds for the Central Universities in Sun Yat-sen University, Award Number 15ykpy09; (Recipient: Yanna Zhu); and Guangdong Provincial Natural Science Foundation, Award Number 2015A030313175 (Recipient: Yanna Zhu).	Al-Okbi SY, 2014, J MED FOOD, V17, P764, DOI 10.1089/jmf.2013.0033; [Anonymous], 2007, ZHONGHUA XIN XUE GUA, V35, P390, DOI DOI 10.3760/J.ISSN:0253-3758.2007.05.003; Yanez SB, 2015, NUTR HOSP, V31, P2079, DOI 10.3305/nh.2015.31.5.8672; Burgos MS, 2013, ARQ BRAS CARDIOL, V101, P288, DOI 10.5935/abc.20130169; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Cheng CH, 2010, NUTR RES, V30, P585, DOI 10.1016/j.nutres.2010.08.007; Colmenares A, 2014, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2014-5; Coronelli CLS, 2003, REV SAUDE PUBL, V37, P24, DOI 10.1590/S0034-89102003000100006; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; Alcântara Neto Osvaldo Dário de, 2012, Rev. bras. epidemiol., V15, P335, DOI 10.1590/S1415-790X2012000200011; DESPRES JP, 1995, INT J OBESITY, V19, pS76; Dietz WH, 1998, PEDIATRICS, V101, P518; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Freedman DS, 2008, INT J OBESITY, V32, P749, DOI 10.1038/sj.ijo.0803798; Freedman DS, 2009, PEDIATRICS, V123, P750, DOI 10.1542/peds.2008-1284; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Mascarenhas LPG, 2015, J PEDIATR ENDOCR MET, V28, P125, DOI 10.1515/jpem-2013-0450; Jennings A, 2012, OBESITY, V20, P1462, DOI 10.1038/oby.2012.72; Ji CY, 2010, BIOMED ENVIRON SCI, V23, P12, DOI 10.1016/S0895-3988(10)60026-8; Kit BK, 2015, JAMA PEDIATR, V169, P272, DOI 10.1001/jamapediatrics.2014.3216; Lam BCC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122985; Matikainen N, 2012, CURR CARDIOL REP, V14, P721, DOI 10.1007/s11886-012-0309-3; Nobre LN, 2013, J PEDIAT-BRAZIL, V89, P462, DOI 10.1016/j.jped.2013.02.020; Pierce MB, 2010, ANN EPIDEMIOL, V20, P676, DOI 10.1016/j.annepidem.2010.05.015; Ribas SA, 2012, NUTR HOSP, V27, P1228, DOI 10.3305/nh.2012.27.4.5798; Working Group on obesity in China (WGOC), 2004, ZHONGHUA LIU XING BI, V25, P97; Yip PM, 2006, CLIN BIOCHEM, V39, P978, DOI 10.1016/j.clinbiochem.2006.06.012; Zhu Jian-Fang, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P1005; Zhu YN, 2014, J CLIN ENDOCR METAB, V99, P561, DOI 10.1210/jc.2013-2845	30	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149392	10.1371/journal.pone.0149392	http://dx.doi.org/10.1371/journal.pone.0149392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963377	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000012
J	Grosman, L; Goren-Inbar, N				Grosman, Leore; Goren-Inbar, Naama			Landscape Alteration by Pre-Pottery Neolithic Communities in the Southern Levant - The Kaizer Hilltop Quarry, Israel	PLOS ONE			English	Article							BIFACIAL TOOLS; RAW-MATERIAL; EXTRACTION; JORDAN	This study focuses on Kaizer Hill, a quarry site located in the vicinity of the city of Modiin where remains of a single prehistoric cultural entity assigned to the Pre-Pottery Neolithic A were discovered. A systematic survey revealed that large-scale quarrying activities have left damage markings on the bedrock of the Hilltop and its slopes. We aim to present here our findings from the Hilltop, which are concerned with the human impact on rock surfaces and the lithic artifacts retrieved during the survey. It is evident that the Pre-Pottery Neolithic A inhabitants of the area changed their landscape forever, "stripping" the caliche surface and penetrating it in search of flint bedded in the bedrock.	[Grosman, Leore; Goren-Inbar, Naama] Hebrew Univ Jerusalem, Inst Archaeol, IL-91905 Jerusalem, Israel	Hebrew University of Jerusalem	Grosman, L (corresponding author), Hebrew Univ Jerusalem, Inst Archaeol, IL-91905 Jerusalem, Israel.	leore.grosman@mail.huji.ac.il	Grosman, Leore/GRJ-0792-2022; Grosman, Leore/C-7010-2014	Grosman, Leore/0000-0002-6976-6202; Grosman, Leore/0000-0002-6976-6202	Ruth Amiran Foundation; Institute of Archaeology, The Hebrew University	Ruth Amiran Foundation; Institute of Archaeology, The Hebrew University	The project was supported by the Ruth Amiran Foundation, Institute of Archaeology, The Hebrew University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Blades B., 2009, LITHIC MAT PALEOLITH, P174; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2006, AXE AGE ACHEULIAN TO; Bar-Yosef O., 1980, PALEORIENT, V6, P201; Barkai R, 2002, ANTIQUITY, V76, P672, DOI 10.1017/S0003598X00091110; Barkai R, 2001, TOOLS REDEFINING PPN, P73; Bostyn F, 1997, SILICEOUS ROCKS CULT, P271; Brenet M, 2011, APPROCHE EXPT; Crowfoot-Payne J, 1983, EXCAVATIONS JERICHO, P622; Ekshtain R, 2014, QUATERN INT, V331, P248, DOI 10.1016/j.quaint.2013.07.025; Finlayson B, 2011, P NATL ACAD SCI USA, V108, P8183, DOI 10.1073/pnas.1017642108; Garfinkel Y., 2006, PREPOTTERY NEOLITHIC; Gopher A, 2014, QUATERN INT, V331, P95, DOI 10.1016/j.quaint.2013.08.025; Grosman L., 2010, NEW STUDIES ARCHAEOL, P40; Grosman L., 2013, ARCHAEOLOGICAL SERIE, P622, DOI DOI 10.2307/J.CTV8BT33H.41; Grosman L, 2007, CURR ANTHROPOL, V48, P732, DOI 10.1086/520966; Grosman L, 2011, J HUM EVOL, V60, P398, DOI 10.1016/j.jhevol.2010.02.004; Herzlinger G, 2013, STONE TOOLS TRANSITI; Inbar M., 2011, PALEORIENT, V37, P107; Kuijt I., 2000, LIFE NEOLITHIC FARMI, P19, DOI DOI 10.1007/0-306-47166-3_2; Lechevallier M, 1994, MEMOIRES TRAVAUX CTR, V8, P141; Lighton R, 1989, P PREHIST SOC, V55, P135; Liphschitz N, 2001, ISRAEL EXPLOR J, V51, P36; Marder O, 2007, PALEORIENT, V32, P79; Nadel D., 2010, EURASIAN PREHISTORY, V7, P61; Shaham D, 2010, J ARCHAEOL SCI, V37, P2010, DOI 10.1016/j.jas.2010.03.006; Taute W, 1994, STUDIES EARLY NEAR E, V1, P495; van den Brink ECM, 2004, EVALUATION ASSESSMEN; van den Brink ECM, 2008, ISRAEL EXPLOR J, V58, P1; Vardi J, 2015, ARCHAEOMETRY, V57, P20, DOI 10.1111/arcm.12131; Yerkes RW, 2003, J ARCHAEOL SCI, V30, P1051, DOI 10.1016/S0305-4403(03)00007-4; Zbenovich VG, 2006, ATIQOT, V51, P1; Zbinovich V., 1999, MODIIN PROJECT FLINT; Zbinovich V., 1999, MODIIN PROJECT SALVA	35	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150395	10.1371/journal.pone.0150395	http://dx.doi.org/10.1371/journal.pone.0150395			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DG3TF	26960156	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300048
J	Haiman, CA; Patel, YM; Stram, DO; Carmella, SG; Chen, ML; Wilkens, LR; Le Marchand, L; Hecht, SS				Haiman, Christopher A.; Patel, Yesha M.; Stram, Daniel O.; Carmella, Steven G.; Chen, Menglan; Wilkens, Lynne R.; Le Marchand, Loic; Hecht, Stephen S.			Benzene Uptake and Glutathione S-transferase T1 Status as Determinants of S-Phenylmercapturic Acid in Cigarette Smokers in the Multiethnic Cohort	PLOS ONE			English	Article							LUNG-CANCER RISK; OCCUPATIONAL-EXPOSURE; ETHNIC-DIFFERENCES; AFRICAN-AMERICANS; JAPANESE MEN; LOS-ANGELES; BIOMARKERS; SMOKING; TOBACCO; POLYMORPHISMS	Research from the Multiethnic Cohort (MEC) demonstrated that, for the same quantity of cigarette smoking, African Americans and Native Hawaiians have a higher lung cancer risk than Whites, while Latinos and Japanese Americans are less susceptible. We collected urine samples from 2,239 cigarette smokers from five different ethnic groups in the MEC and analyzed each sample for S-phenylmercapturic acid (SPMA), a specific biomarker of benzene uptake. African Americans had significantly higher (geometric mean [SE] 3.69 [0.2], p<0.005) SPMA/ml urine than Whites (2.67 [0.13]) while Japanese Americans had significantly lower levels than Whites (1.65 [0.07], p<0.005). SPMA levels in Native Hawaiians and Latinos were not significantly different from those of Whites. We also conducted a genome-wide association study in search of genetic risk factors related to benzene exposure. The glutathione S-transferase T1 (GSTT1) deletion explained between 14.2-31.6%(p = 5.4x10(-157)) and the GSTM1 deletion explained between 0.2%-2.4% of the variance (p = 1.1x10(-9)) of SPMA levels in these populations. Ethnic differences in levels of SPMA remained strong even after controlling for the effects of these two deletions. These results demonstrate the powerful effect of GSTT1 status on SPMA levels in urine and show that uptake of benzene in African American, White, and Japanese American cigarette smokers is consistent with their lung cancer risk in the MEC. While benzene is not generally considered a cause of lung cancer, its metabolite SPMA could be a biomarker for other volatile lung carcinogens in cigarette smoke.	[Haiman, Christopher A.; Patel, Yesha M.; Stram, Daniel O.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90032 USA; [Haiman, Christopher A.; Patel, Yesha M.; Stram, Daniel O.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90032 USA; [Carmella, Steven G.; Chen, Menglan; Hecht, Stephen S.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55105 USA; [Wilkens, Lynne R.; Le Marchand, Loic] Univ Hawaii, Program Epidemiol, Canc Res Ctr Hawaii, Honolulu, HI 96813 USA	University of Southern California; University of Southern California; University of Minnesota System; University of Minnesota Twin Cities; Cancer Research Center of Hawaii; University of Hawaii System	Hecht, SS (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55105 USA.	hecht002@umn.edu			National Institutes of Health [5P01CA138338-05, 5U01CA164973-02]; NATIONAL CANCER INSTITUTE [P30CA071789, P01CA138338, U01CA164973, P30CA077598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health [5P01CA138338-05 to S.S.H., 5U01CA164973-02 to L.L.M.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avogbe PH, 2005, CARCINOGENESIS, V26, P613, DOI 10.1093/carcin/bgh353; Blot WJ, 2011, JNCI-J NATL CANCER I, V103, P810, DOI 10.1093/jnci/djr102; Burns D M, 2008, Tob Control, V17, P132, DOI 10.1136/tc.2007.024158; Camella SG, 2013, CHEM RES TOXICOL, V26, P1209, DOI 10.1021/tx400121n; Carmella SG, 2013, J CHROMATOGR B, V935, P36, DOI 10.1016/j.jchromb.2013.07.004; Carmella SG, 2009, CHEM RES TOXICOL, V22, P734, DOI 10.1021/tx800479s; Carpenter CL, 2009, NUTR CANCER, V61, P492, DOI 10.1080/01635580902752270; Carrieri M, 2012, TOXICOL LETT, V213, P63, DOI 10.1016/j.toxlet.2011.11.031; Chen B, 2010, LUNG CANCER, V70, P247, DOI 10.1016/j.lungcan.2010.03.011; Chen LS, 2012, GENET EPIDEMIOL, V36, P340, DOI 10.1002/gepi.21627; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dougherty D, 2008, TOXICOL LETT, V182, P7, DOI 10.1016/j.toxlet.2008.09.008; Egner PA, 2014, CANCER PREV RES, V7, P813, DOI 10.1158/1940-6207.CAPR-14-0103; Fowles J, 2003, TOB CONTROL, V12, P424, DOI 10.1136/tc.12.4.424; Gadgeel SM, 2001, CHEST, V120, P55, DOI 10.1378/chest.120.1.55; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; HARRIS RE, 1993, INT J EPIDEMIOL, V22, P592, DOI 10.1093/ije/22.4.592; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; Hecht SS, 2002, CARCINOGENESIS, V23, P907, DOI 10.1093/carcin/23.6.907; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hecht SS, 2010, CHEM RES TOXICOL, V23, P1001, DOI 10.1021/tx100056m; HINDS MW, 1981, INT J CANCER, V27, P297, DOI 10.1002/ijc.2910270307; Hoet P, 2009, INT ARCH OCC ENV HEA, V82, P985, DOI 10.1007/s00420-008-0381-6; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; IARC, 2012, IARC MON EV CARC RIS, V100F, P249; IARC (International Agency for Research on Cancer), 2012, IARC MON EV CARC R F, V100F-26, P309; Kim S, 2007, PHARMACOGENET GENOM, V17, P789, DOI 10.1097/FPC.0b013e3280128f77; Kiyohara Chikako, 2010, Cancers (Basel), V2, P1813, DOI 10.3390/cancers2041813; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; LEMARCHAND L, 1992, CANCER EPIDEM BIOMAR, V1, P103; Lin LC, 2008, CANCER EPIDEM BIOMAR, V17, P1460, DOI 10.1158/1055-9965.EPI-08-0160; Manini P, 2010, TOXICOL LETT, V193, P229, DOI 10.1016/j.toxlet.2010.01.013; Mansi A, 2012, TOXICOL LETT, V213, P57, DOI 10.1016/j.toxlet.2011.02.001; McHale CM, 2012, CARCINOGENESIS, V33, P240, DOI 10.1093/carcin/bgr297; Monks TJ, 2010, CHEM-BIOL INTERACT, V184, P201, DOI 10.1016/j.cbi.2009.12.025; Murphy SE, 2014, CARCINOGENESIS, V35, P2526, DOI 10.1093/carcin/bgu191; National Toxicology Program, 1986, Natl Toxicol Program Tech Rep Ser, V289, P1; National Toxicology Program, 2011, 12 US DEP HLTH HUM S; NELSON HH, 1995, CARCINOGENESIS, V16, P1243, DOI 10.1093/carcin/16.5.1243; Park SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124841; Park SL, 2015, CANCER EPIDEM BIOMAR, V24, P561, DOI 10.1158/1055-9965.EPI-14-1054; Patel YM, 2015, CANCER EPIDEM BIOMAR, V24, P119, DOI 10.1158/1055-9965.EPI-14-0815; Qu QS, 2005, CHEM-BIOL INTERACT, V153, P85, DOI 10.1016/j.cbi.2005.03.012; Roemer E, 2004, TOXICOLOGY, V195, P31, DOI 10.1016/j.tox.2003.08.006; Scheepers PTJ, 2002, TOXICOL LETT, V134, P305, DOI 10.1016/S0378-4274(02)00195-9; Schwartz AG, 1997, CANCER, V79, P45, DOI 10.1002/(SICI)1097-0142(19970101)79:1<45::AID-CNCR7>3.0.CO;2-L; Sobue T, 2002, INT J CANCER, V99, P245, DOI 10.1002/ijc.10308; Sorensen M, 2004, CANCER EPIDEM BIOMAR, V13, P1729; Stellman SD, 2001, CANCER EPIDEM BIOMAR, V10, P1193; Truong T, 2010, CARCINOGENESIS, V31, P625, DOI 10.1093/carcin/bgq001; Wallace L, 1996, ENVIRON HEALTH PERSP, V104, P1129, DOI 10.2307/3433152; Wang JZ, 2011, BIOMARKERS, V16, P144, DOI 10.3109/1354750X.2010.536257; Williams PRD, 2014, J TOXICOL ENV HEAL B, V17, P259, DOI 10.1080/10937404.2014.924452; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zarth AT, 2015, CHEM-BIOL INTERACT, V242, P390, DOI 10.1016/j.cbi.2015.11.005; Zhan P, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-99	57	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150641	10.1371/journal.pone.0150641	http://dx.doi.org/10.1371/journal.pone.0150641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959369	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300061
J	Oshida, K; Waxman, DJ; Corton, JC				Oshida, Keiyu; Waxman, David J.; Corton, J. Christopher			Chemical and Hormonal Effects on STAT5b-Dependent Sexual Dimorphism of the Liver Transcriptome	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; GROWTH-HORMONE; GENE-EXPRESSION; SIGNAL TRANSDUCER; NONALCOHOLIC STEATOHEPATITIS; GLUCOCORTICOID-RECEPTOR; HEPATIC STEATOSIS; THYROID-HORMONE; BETA-OXIDATION; DNA-BINDING	The growth hormone (GH)-activated transcription factor signal transducer and activator of transcription 5b (STAT5b) is a key regulator of sexually dimorphic gene expression in the liver. Suppression of hepatic STAT5b signaling is associated with lipid metabolic dysfunction leading to steatosis and liver cancer. In the companion publication, a STAT5b biomarker gene set was identified and used in a rank-based test to predict both increases and decreases in liver STAT5b activation status/function with high (>= 97%) accuracy. Here, this computational approach was used to identify chemicals and hormones that activate (masculinize) or suppress (feminize) STAT5b function in a large, annotated mouse liver and primary hepatocyte gene expression compendium. Exposure to dihydrotestosterone and thyroid hormone caused liver masculinization, whereas glucocorticoids, fibroblast growth factor 15, and angiotensin II caused liver feminization. In mouse models of diabetes and obesity, liver feminization was consistently observed and was at least partially reversed by leptin or resveratrol exposure. Chemical-induced feminization of male mouse liver gene expression profiles was a relatively frequent phenomenon: of 156 gene expression biosets from chemically-treated male mice, 29% showed feminization of liver STAT5b function, while < 1% showed masculinization. Most (93%) of the biosets that exhibited feminization of male liver were also associated with activation of one or more xenobiotic-responsive receptors, most commonly constitutive activated receptor (CAR) or peroxisome proliferator-activated receptor alpha (PPARa). Feminization was consistently associated with increased expression of peroxisome proliferator-activated receptor gamma (Pparg) but not other lipogenic transcription factors linked to steatosis. GH-activated STAT5b signaling in mouse liver is thus commonly altered by diverse chemicals, and provides a linkage between chemical exposure and dysregulated gene expression associated with adverse effects on the liver.	[Oshida, Keiyu; Corton, J. Christopher] US EPA, Integrated Syst Toxicol Div, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA; [Waxman, David J.] Boston Univ, Div Cell & Mol Biol, Dept Biol & Bioinformat Program, Boston, MA 02215 USA; [Oshida, Keiyu] Toray Industries Ltd, Kamakura, Kanagawa, Japan	United States Environmental Protection Agency; Boston University; Toray Industries, Inc.	Corton, JC (corresponding author), US EPA, Integrated Syst Toxicol Div, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	corton.chris@epa.gov		Waxman, David/0000-0001-7982-9206	U.S. Environmental Protection Agency; National Institutes of Health (NIH) [ES024421, DK33765]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033765, R56DK033765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024421] Funding Source: NIH RePORTER	U.S. Environmental Protection Agency(United States Environmental Protection Agency); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The information in this document has been funded in part by the U.S. Environmental Protection Agency, and by National Institutes of Health (NIH) grants ES024421 and DK33765 (to DJW).	Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; Barclay JL, 2011, ENDOCRINOLOGY, V152, P181, DOI 10.1210/en.2010-0537; Bianchi M, 2000, P NATL ACAD SCI USA, V97, P9573, DOI 10.1073/pnas.160099797; Bijland S, 2011, TOXICOL SCI, V123, P290, DOI 10.1093/toxsci/kfr142; Carvalheira JBC, 2003, BIOL CHEM, V384, P151, DOI 10.1515/BC.2003.016; Chia DJ, 2014, MOL ENDOCRINOL, V28, P1012, DOI 10.1210/me.2014-1099; Cho HY, 2014, J CELL PHYSIOL, V229, P561, DOI 10.1002/jcp.24478; Choi HK, 1999, ENDOCRINOLOGY, V140, P5126, DOI 10.1210/en.140.11.5126; Choi HK, 2000, GROWTH HORM IGF RES, V10, P1, DOI 10.1016/S1096-6374(00)80002-7; Clodfelter KH, 2007, PHYSIOL GENOMICS, V31, P63, DOI 10.1152/physiolgenomics.00055.2007; Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489; Corton JC, 2014, CRIT REV TOXICOL, V44, P1, DOI 10.3109/10408444.2013.835784; Corton JC, 1998, MOL PHARMACOL, V54, P463, DOI 10.1124/mol.54.3.463; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; DANNAN GA, 1986, J BIOL CHEM, V261, P728; DAVIES RR, 1984, CLIN ENDOCRINOL, V21, P477, DOI 10.1111/j.1365-2265.1984.tb03235.x; EAGON PK, 1994, INT J CANCER, V58, P736, DOI 10.1002/ijc.2910580519; Fan LQ, 2004, TOXICOLOGY, V203, P41, DOI 10.1016/j.tox.2004.05.013; Favre-Young H, 2000, MOL ENDOCRINOL, V14, P1411, DOI 10.1210/me.14.9.1411; Frank SJ, 2001, GROWTH HORM IGF RES, V11, P201, DOI 10.1054/ghir.2001.0237; Geter DR, 2014, TOXICOL SCI, V138, P425, DOI 10.1093/toxsci/kfu014; Gong Y, 2007, J BIOL CHEM, V282, P31019, DOI 10.1074/jbc.M702838200; Greenhill Claire, 2014, Nat Rev Endocrinol, V10, P511, DOI 10.1038/nrendo.2014.104; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Han M, 2009, FEBS J, V276, P1720, DOI 10.1111/j.1742-4658.2009.06902.x; HARTMAN ML, 1993, HORM RES, V40, P37, DOI 10.1159/000183766; He JH, 2013, MOL CELL BIOL, V33, P2047, DOI 10.1128/MCB.01658-12; Hedbacker K, 2010, CELL METAB, V11, P11, DOI 10.1016/j.cmet.2009.11.007; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Herrington J, 2001, TRENDS ENDOCRIN MET, V12, P252, DOI 10.1016/S1043-2760(01)00423-4; Holloway MG, 2006, MOL ENDOCRINOL, V20, P647, DOI 10.1210/me.2005-0328; Ishii T, 2006, J PHARMACOL SCI, V101, P250, DOI 10.1254/jphs.FP0060414; Jiang MX, 2013, DRUG METAB REV, V45, P156, DOI 10.3109/03602532.2012.743561; Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Landry D, 2013, REPROD BIOL, V13, P1, DOI 10.1016/j.repbio.2012.12.001; Laubner K, 2005, DIABETES, V54, P3410, DOI 10.2337/diabetes.54.12.3410; Lee JY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001639; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Lu H, 2011, TOXICOL APPL PHARM, V256, P122, DOI 10.1016/j.taap.2011.07.019; Maran RRM, 2003, ARCH ANDROLOGY, V49, P375, DOI 10.1080/01485010390204968; McWhinney CD, 1998, J MOL CELL CARDIOL, V30, P751, DOI 10.1006/jmcc.1998.0639; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Mueller KM, 2011, HEPATOLOGY, V54, P1398, DOI 10.1002/hep.24509; Ocaranza P, 2014, GROWTH HORM IGF RES, V24, P42, DOI 10.1016/j.ghir.2014.01.001; Oshida K, 2015, PLOS ONE IN PRESS; Oshida K, 2015, TOXICOLOGY, V336, P99, DOI 10.1016/j.tox.2015.07.005; Oshida Keiyu, 2015, Nucl Recept Signal, V13, pe002, DOI 10.1621/nrs.13002; Oshida K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0112655; Paukku K, 2004, CYTOKINE GROWTH F R, V15, P435, DOI 10.1016/j.cytogfr.2004.09.001; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pery ARR, 2013, SCI TOTAL ENVIRON, V456, P307, DOI 10.1016/j.scitotenv.2013.03.099; Potthoff MJ, 2011, CELL METAB, V13, P729, DOI 10.1016/j.cmet.2011.03.019; Pruniau VPEG, 2013, HEPATOLOGY, V58, P2209, DOI 10.1002/hep.26483; Shipley JM, 2004, TOXICOL APPL PHARM, V199, P275, DOI 10.1016/j.taap.2003.12.020; Sos BC, 2011, J CLIN INVEST, V121, P1412, DOI 10.1172/JCI42894; Stauber AJ, 2005, MOL PHARMACOL, V67, P681, DOI 10.1124/mol.104.007278; Stoecklin E, 1997, MOL CELL BIOL, V17, P6708, DOI 10.1128/MCB.17.11.6708; Tailleux A, 2012, BBA-MOL CELL BIOL L, V1821, P809, DOI 10.1016/j.bbalip.2011.10.016; Takahashi Y, 2007, GASTROENTEROLOGY, V132, P938, DOI 10.1053/j.gastro.2006.12.024; Tannenbaum GS, 2001, ENDOCRINOLOGY, V142, P4599, DOI 10.1210/en.142.11.4599; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Thomas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063308; Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Vidarsdottir S, 2006, J CLIN ENDOCR METAB, V91, P3482, DOI 10.1210/jc.2006-0368; Wan HT, 2012, BBA-GEN SUBJECTS, V1820, P1092, DOI 10.1016/j.bbagen.2012.03.010; Wauthier Valerie, 2010, Mol Endocrinol, V24, P667, DOI 10.1210/me.2009-0454; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; WAXMAN DJ, 1988, BIOCHEM PHARMACOL, V37, P71, DOI 10.1016/0006-2952(88)90756-3; WAXMAN DJ, 1995, J BIOL CHEM, V270, P13262, DOI 10.1074/jbc.270.22.13262; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Yu JH, 2012, HEPATOLOGY, V56, P2375, DOI 10.1002/hep.25900; Zhou YC, 1999, J BIOL CHEM, V274, P29874, DOI 10.1074/jbc.274.42.29874; Zhou YC, 2002, TOXICOL APPL PHARM, V182, P1, DOI 10.1006/taap.2002.9426; Zhu JZ, 2015, DIGEST DIS SCI, V60, P3194, DOI 10.1007/s10620-015-3728-3	79	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150284	10.1371/journal.pone.0150284	http://dx.doi.org/10.1371/journal.pone.0150284			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959237	Green Published, gold			2022-12-27	WOS:000371992300042
J	Rosas, PC; Nagaraja, GM; Kaur, P; Panossian, A; Wickman, G; Garcia, LR; Al-Khamis, FA; Asea, AAA				Rosas, Paola C.; Nagaraja, Ganachari M.; Kaur, Punit; Panossian, Alexander; Wickman, Georg; Garcia, L. Rene; Al-Khamis, Fahd A.; Asea, Alexzander A. A.			Hsp72 (HSPA1A) Prevents Human Islet Amyloid Polypeptide Aggregation and Toxicity: A New Approach for Type 2 Diabetes Treatment	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; PANCREATIC BETA-CELLS; C-ELEGANS; MOLECULAR CHAPERONES; PARKINSONS-DISEASE; GENE-TRANSFER; HUMAN-IAPP; PROTEINS; PROTEOSTASIS; MODEL	Type 2 diabetes is a growing public health concern and accounts for approximately 90% of all the cases of diabetes. Besides insulin resistance, type 2 diabetes is characterized by a deficit in beta-cell mass as a result of misfolded human islet amyloid polypeptide (h-IAPP) which forms toxic aggregates that destroy pancreatic beta-cells. Heat shock proteins (HSP) play an important role in combating the unwanted self-association of unfolded proteins. We hypothesized that Hsp72 (HSPA1A) prevents h-IAPP aggregation and toxicity. In this study, we demonstrated that thermal stress significantly up-regulates the intracellular expression of Hsp72, and prevents h-IAPP toxicity against pancreatic beta-cells. Moreover, Hsp72 (HSPA1A) overexpression in pancreatic beta-cells ameliorates h-IAPP toxicity. To test the hypothesis that Hsp72 (HSPA1A) prevents aggregation and fibril formation, we established a novel C. elegans model that expresses the highly amyloidogenic human pro-IAPP (h-proIAPP) that is implicated in amyloid formation and beta-cell toxicity. We demonstrated that h-proIAPP expression in body-wall muscles, pharynx and neurons adversely affects C. elegans development. In addition, we demonstrated that h-proIAPP forms insoluble aggregates and that the co-expression of h-Hsp72 in our h-proIAPP C. elegans model, increases h-proIAPP solubility. Furthermore, treatment of transgenic h-proIAPP C. elegans with ADAPT-232, known to induce the expression and release of Hsp72 (HSPA1A), significantly improved the growth retardation phenotype of transgenic worms. Taken together, this study identifies Hsp72 (HSPA1A) as a potential treatment to prevent beta-cell mass decline in type 2 diabetic patients and establishes for the first time a novel in vivo model that can be used to select compounds that attenuate h-proIAPP aggregation and toxicity.	[Rosas, Paola C.; Nagaraja, Ganachari M.] Scott & White Hosp, Div Invest Pathol, Temple, TX USA; [Rosas, Paola C.; Nagaraja, Ganachari M.] Texas A&M Hlth Sci Ctr, Coll Med, Temple, TX USA; [Kaur, Punit] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [Kaur, Punit] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Panossian, Alexander; Wickman, Georg] Swedish Herbal Inst, Dept Res, Askloster, Sweden; [Garcia, L. Rene] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Garcia, L. Rene] Texas A&M Univ, Howard Hughes Med Inst, College Stn, TX USA; [Al-Khamis, Fahd A.; Asea, Alexzander A. A.] Univ Dammam, Inst Res & Med Consultancies, Dept Neurosci Res, Dammam, Saudi Arabia; [Al-Khamis, Fahd A.; Asea, Alexzander A. A.] Univ Dammam, Sci Res, Dammam, Saudi Arabia; [Rosas, Paola C.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Med Physiol, Temple, TX USA; [Nagaraja, Ganachari M.] Cent Texas Vet Hlth Care Syst, Div Infect Dis, Temple, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Morehouse School of Medicine; University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; Howard Hughes Medical Institute; Texas A&M University System; Texas A&M University College Station; Imam Abdulrahman Bin Faisal University; Imam Abdulrahman Bin Faisal University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Asea, AAA (corresponding author), Univ Dammam, Inst Res & Med Consultancies, Dept Neurosci Res, Dammam, Saudi Arabia.; Asea, AAA (corresponding author), Univ Dammam, Sci Res, Dammam, Saudi Arabia.	aaasea@uod.edu.sa	Asea, Alexzander/X-6432-2019; Panossian, Alexander/AAK-8720-2021; Panossian, Alexander George/AAB-8052-2022	Panossian, Alexander/0000-0002-8467-4525; Panossian, Alexander George/0000-0002-8467-4525; Rosas, Paola C./0000-0002-8131-310X	US National Institutes of Health [RO1CA91889]; Texas A&M Health Science Center College of Medicine; Central Texas Veterans Health Administration; Endowment from the Cain Foundation; University of Dammam; NATIONAL CANCER INSTITUTE [R01CA091889] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas A&M Health Science Center College of Medicine; Central Texas Veterans Health Administration; Endowment from the Cain Foundation; University of Dammam; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by institutional support from Scott & White Memorial Hospital and Clinic (to GMN, PK, and AAAA), the US National Institutes of Health grant RO1CA91889 (to AAAA), Texas A&M Health Science Center College of Medicine (to AAAA), the Central Texas Veterans Health Administration (to AAAA), an Endowment from the Cain Foundation (to AAAA) and the University of Dammam (to AAAA). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bai YJ, 2011, J NAT MED-TOKYO, V65, P417, DOI 10.1007/s11418-011-0509-y; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Campbell RK, 2009, J AM PHARM ASSOC, V49, pS10, DOI 10.1331/JAPhA.2009.09076; Chien V, 2010, BIOCHEM J, V432, P113, DOI 10.1042/BJ20100434; Daval M, 2010, AMYLOID, V17, P118, DOI 10.3109/13506129.2010.530008; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Fonte V, 2002, P NATL ACAD SCI USA, V99, P9439, DOI 10.1073/pnas.152313999; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; HODGKIN J, 1979, GENETICS, V91, P67; Hou X, 1999, DIABETOLOGIA, V42, P188, DOI 10.1007/s001250051138; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Jacob TC, 2003, J NEUROSCI, V23, P2122; Jafari M, 2007, REJUV RES, V10, P587, DOI 10.1089/rej.2007.0560; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Krampert M, 2000, CHEM BIOL, V7, P855, DOI 10.1016/S1074-5521(00)00034-X; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Massie MR, 2003, CELL STRESS CHAPERON, V8, P1, DOI 10.1379/1466-1268(2003)8<1:ETTMIS>2.0.CO;2; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Panossian A, 2009, PHYTOMEDICINE, V16, P617, DOI 10.1016/j.phymed.2008.12.003; Paulsson JF, 2006, DIABETOLOGIA, V49, P1237, DOI 10.1007/s00125-006-0206-7; Paulsson JF, 2005, DIABETES, V54, P2117, DOI 10.2337/diabetes.54.7.2117; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; Rivera JF, 2011, CELL DEATH DIFFER, V18, P415, DOI 10.1038/cdd.2010.111; Roodveldt C, 2009, EMBO J, V28, P3758, DOI 10.1038/emboj.2009.298; SCHNABEL H, 1990, SCIENCE, V250, P686, DOI 10.1126/science.250.4981.686; Schultz SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020221; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wiegant FAC, 2009, BIOGERONTOLOGY, V10, P27, DOI 10.1007/s10522-008-9151-9; Zheng XY, 2010, ACTA DIABETOL, V47, P265, DOI 10.1007/s00592-010-0201-9	41	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149409	10.1371/journal.pone.0149409	http://dx.doi.org/10.1371/journal.pone.0149409			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960140	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300012
J	Lima, MP; Longatto, A; Osorio, FL				Lima, Manuela Polidoro; Longatto-Filho, Adhemar; Osorio, Flavia L.			Predictor Variables and Screening Protocol for Depressive and Anxiety Disorders in Cancer Outpatients	PLOS ONE			English	Article							BREAST-CANCER; DISTRESS; HEALTH; WOMEN; ASSOCIATION; MORBIDITY; VALIDITY; ROLES	Background Cancer patients are at increased risk of persistent depressive and anxiety symptoms and disorders compared to the general population. However, these issues are not always identified, which may worsen the prognosis and increase morbidity and mortality. Therefore, the objectives of this study are to identify predictor variables (demographic and clinical) for the development of mood and anxiety disorders in cancer outpatients and to propose a probabilistic screening protocol considering these variables and certain standardized screening instruments. Methods A total of 1,385 adults, of both genders, receiving outpatient cancer care were evaluated using a questionnaire and screening instruments. Thereafter, 400 of these subjects responded to the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID-IV) by telephone to confirm or rule out the presence of a Current Major Depressive Episode (CMDE) or Anxiety Disorder (AD). Results Of the patients surveyed, 64% met the criteria for CMDE and 41% for AD. Female gender was found to be a risk factor for both disorders, and the presence of previous psychiatric history and marital status (divorced and widowed) were risk factors for anxiety disorders. When scoring above the recommended cutoff score, the screening instruments also indicated a risk of the studied disorders. Based on these findings, a screening protocol and nomograms were created for the quantification, combination and probabilistic estimate of risk, with accuracy indicators >0.68. Conclusion The prevalence rates for the disorders under study are extremely high in cancer patients. The use of the proposed protocol and nomogram can facilitate rapid and wide screening, thus refining triage and supporting the establishment of criteria for referral to mental health professionals, so that patients can be properly diagnosed and treated.	[Lima, Manuela Polidoro; Longatto-Filho, Adhemar; Osorio, Flavia L.] Canc Hosp Barretos, Pio XII Fdn, Barretos, Brazil; [Longatto-Filho, Adhemar] Univ Sao Paulo, Sch Med, Lab Med Invest LIM 14, Sao Paulo, Brazil; [Longatto-Filho, Adhemar] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Longatto-Filho, Adhemar] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Osorio, Flavia L.] Univ Sao Paulo, Med Sch Ribeirao Preto, Sao Paulo, Brazil	Hospital de Cancer de Barretos; Universidade de Sao Paulo; Universidade do Minho; Universidade de Sao Paulo	Osorio, FL (corresponding author), Canc Hosp Barretos, Pio XII Fdn, Barretos, Brazil.; Osorio, FL (corresponding author), Univ Sao Paulo, Med Sch Ribeirao Preto, Sao Paulo, Brazil.	flaliosorio@ig.com.br	LIMA, MANUELA POLIDORO/O-1444-2019; Longatto-Filho, Adhemar/N-3397-2019; Osório, Flávia L./H-6079-2012; Osório, Flávia L./T-5001-2019; Lima, Manuela Polidoro/F-3175-2017; longatto-filho, adhemar/D-7039-2013	LIMA, MANUELA POLIDORO/0000-0002-9366-7829; Longatto-Filho, Adhemar/0000-0002-5779-9752; Lima, Manuela Polidoro/0000-0002-9366-7829; longatto-filho, adhemar/0000-0002-5779-9752; L. Osorio, Flavia/0000-0003-1396-555X				Al-Ghazal SK, 1999, EUR J SURG ONCOL, V25, P571, DOI 10.1053/ejso.1999.0708; Amaro Terezinha Aparecida Carvalho, 2006, Arq. Bras. Oftalmol., V69, P889, DOI 10.1590/S0004-27492006000600019; Andrade LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031879; [Anonymous], 1999, Oncology (Williston Park), V13, P113; Aube J, 2000, DEV PSYCHOPATHOL, V12, P633, DOI 10.1017/S0954579400004053; Boing AF, 2012, REV SAUDE PUBL, V46, P617, DOI 10.1590/S0034-89102012005000044; Bottino SMB, 2009, REV PSIQ CLIN-BRAZIL, V36, P109, DOI 10.1590/S0101-60832009000900007; Bultz BD, 2011, PSYCHO-ONCOLOGY, V20, P569, DOI 10.1002/pon.1986; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; Carlson LE, 2012, J CLIN ONCOL, V30, P1160, DOI 10.1200/JCO.2011.39.5509; Coyne JC, 2007, PSYCHOL BULL, V133, P367, DOI 10.1037/0033-2909.133.3.367; de Andrade Ana Carla Alves, 2005, Rev Gaucha Enferm, V26, P57; Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008; First M. B., 1997, STRUCTURED CLIN INTE; Goebel S, 2011, SUPPORT CARE CANCER, V19, P1797, DOI 10.1007/s00520-010-1021-8; Grady-Weliky TA, 2002, COMORBIDITY ITS IMPL, P295; Jacobsen PB, 2008, CA-CANCER J CLIN, V58, P214, DOI 10.3322/CA.2008.0003; Keller M, 2004, ANN ONCOL, V15, P1243, DOI 10.1093/annonc/mdh318; Kendler KS, 1996, BRIT J PSYCHIAT, V168, P68, DOI 10.1192/S0007125000298437; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kissane DW, 2004, AUST NZ J PSYCHIAT, V38, P320, DOI 10.1080/j.1440-1614.2004.01358.x; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lazenby M, 2014, PALLIAT SUPPORT CARE, V12, P63, DOI 10.1017/S1478951513000394; Lima MP, 2014, J ONCOL, V2014, DOI 10.1155/2014/350262; Martire LM, 2000, PSYCHOL AGING, V15, P148, DOI 10.1037/0882-7974.15.1.148; McCarter K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008277; Moreno AL, 2015, TEMAS PSICO IN PRESS; Norbeck JS., 2001, NURS RES, V34, P223; Osorio FL, 2015, PSYCHIAT RES; Osorio FD, 2009, PERSPECT PSYCHIATR C, V45, P216, DOI 10.1111/j.1744-6163.2009.00224.x; Pandey Manoj, 2006, World J Surg Oncol, V4, P68, DOI 10.1186/1477-7819-4-68; Pasquini M, 2006, DEPRESS ANXIETY, V23, P441, DOI 10.1002/da.20198; Pereira Furtado J, 2005, REV LATINOAM PSICOPA; Pirl WF, 2014, CANCER-AM CANCER SOC, V120, P2946, DOI 10.1002/cncr.28750; Qiu JY, 2012, PSYCHO-ONCOLOGY, V21, P1331, DOI 10.1002/pon.2075; R Core Team, 2013, R LANG ENV STAT COMP; Raison CL, 2003, BIOL PSYCHIAT, V54, P283, DOI 10.1016/S0006-3223(03)00413-X; Ramasubbu R, 2003, CAN J PSYCHIAT, V48, P250, DOI 10.1177/070674370304800409; Recklitis CJ, 2016, CANCER-AM CANCER SOC, V122, P296, DOI 10.1002/cncr.29736; Redmond G, 1997, INT J FERTIL WOMEN M, V42, P67; Romeiro FB, 2000, REV PSICOLOGIA SAUDE, V4, P27; Roy-Byrne PP, 2008, GEN HOSP PSYCHIAT, V30, P208, DOI 10.1016/j.genhosppsych.2007.12.006; Rundell JR, 2002, AM PSYCHIAT PRESS TX; Silberg J, 2001, BRIT J PSYCHIAT, V179, P116, DOI 10.1192/bjp.179.2.116; Spencer R, 2010, CANCER-AM CANCER SOC, V116, P1810, DOI 10.1002/cncr.24954; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Thalen-Lindstrom A, 2013, ACTA ONCOL, V52, P118, DOI 10.3109/0284186X.2012.707785; Vodermaier A, 2009, JNCI-J NATL CANCER I, V101, P1464, DOI 10.1093/jnci/djp336; Wagner LI, 2013, J NATL COMPR CANC NE, V11, P214, DOI 10.6004/jnccn.2013.0028	50	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0149421	10.1371/journal.pone.0149421	http://dx.doi.org/10.1371/journal.pone.0149421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SW	26954671	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300009
J	Pasma, JH; Engelhart, D; Maier, AB; Aarts, RGKM; van Gerven, JMA; Arendzen, JH; Schouten, AC; Meskers, CGM; van der Kooij, H				Pasma, Jantsje H.; Engelhart, Denise; Maier, Andrea B.; Aarts, Ronald G. K. M.; van Gerven, Joop M. A.; Arendzen, J. Hans; Schouten, Alfred C.; Meskers, Carel G. M.; van der Kooij, Herman			Reliability of System Identification Techniques to Assess Standing Balance in Healthy Elderly	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; SENSORY ORGANIZATION TEST; HUMAN POSTURAL CONTROL; OLDER-ADULTS; PROPRIOCEPTIVE INFORMATION; PRESSURE MEASURES; YOUNG ADULTS; EPIDEMIOLOGY; DISORDERS; POSITION	Objectives System identification techniques have the potential to assess the contribution of the underlying systems involved in standing balance by applying well-known disturbances. We investigated the reliability of standing balance parameters obtained with multivariate closed loop system identification techniques. Methods In twelve healthy elderly balance tests were performed twice a day during three days. Body sway was measured during two minutes of standing with eyes closed and the Balance test Room (BalRoom) was used to apply four disturbances simultaneously: two sensory disturbances, to the proprioceptive and the visual system, and two mechanical disturbances applied at the leg and trunk segment. Using system identification techniques, sensitivity functions of the sensory disturbances and the neuromuscular controller were estimated. Based on the generalizability theory (G theory), systematic errors and sources of variability were assessed using linear mixed models and reliability was assessed by computing indexes of dependability (ID), standard error of measurement (SEM) and minimal detectable change (MDC). Results A systematic error was found between the first and second trial in the sensitivity functions. No systematic error was found in the neuromuscular controller and body sway. The reliability of 15 of 25 parameters and body sway were moderate to excellent when the results of two trials on three days were averaged. To reach an excellent reliability on one day in 7 out of 25 parameters, it was predicted that at least seven trials must be averaged. Conclusion This study shows that system identification techniques are a promising method to assess the underlying systems involved in standing balance in elderly. However, most of the parameters do not appear to be reliable unless a large number of trials are collected across multiple days. To reach an excellent reliability in one third of the parameters, a training session for participants is needed and at least seven trials of two minutes must be performed on one day.	[Pasma, Jantsje H.; Arendzen, J. Hans] Leiden Univ, Med Ctr, Dept Rehabil Med, Leiden, Netherlands; [Pasma, Jantsje H.; Schouten, Alfred C.; van der Kooij, Herman] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands; [Engelhart, Denise; Schouten, Alfred C.; van der Kooij, Herman] Univ Twente, Inst Biomed Technol & Tech Med MIRA, Dept Biomech Engn, POB 217, NL-7500 AE Enschede, Netherlands; [Maier, Andrea B.] Univ Melbourne, Royal Melbourne Hosp, Dept Med & Aged Care, Melbourne, Vic 3050, Australia; [Maier, Andrea B.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands; [Aarts, Ronald G. K. M.] Univ Twente, Dept Mech Automat & Mechatron, POB 217, NL-7500 AE Enschede, Netherlands; [van Gerven, Joop M. A.] Ctr Human Drug Res, Leiden, Netherlands; [Meskers, Carel G. M.] Vrije Univ Amsterdam, Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Delft University of Technology; University of Twente; Royal Melbourne Hospital; University of Melbourne; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Pasma, JH (corresponding author), Leiden Univ, Med Ctr, Dept Rehabil Med, Leiden, Netherlands.; Pasma, JH (corresponding author), Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands.	j.h.pasma@tudelft.nl	Aarts, Ronald/AFQ-4816-2022; Maier, Andrea/W-7060-2019; Maier, Andrea B./Q-5548-2019; Schouten, Alfred C./AAH-3560-2019	Aarts, Ronald/0000-0002-7304-0535; Maier, Andrea/0000-0001-7206-1724; Schouten, Alfred C./0000-0003-3149-6726; Meskers, Carel/0000-0002-5056-5611; Pasma, Jantsje/0000-0002-8769-1021	Dutch Technology Foundation STW, Netherlands Organization for Scientific Research (NWO) [10737]; Ministry of Economic Affairs; EU FP7 grant [610454]	Dutch Technology Foundation STW, Netherlands Organization for Scientific Research (NWO)(Technologiestichting STWNetherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs; EU FP7 grant	This research (BalRoom; project number 10737) is supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO) and which is partly funded by the Ministry of Economic Affairs, and by the seventh framework program EMBalance (EU FP7 grant number 610454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research (BalRoom; project number 10737) is supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO) and which is partly funded by the Ministry of Economic Affairs, and by the seventh framework program EMBalance (EU FP7 grant number 610454).	Ageberg E, 2003, BMC MUSCULOSKELET DI, V4, DOI 10.1186/1471-2474-4-14; Asslander L, 2015, HUM MOVEMENT SCI, V41, P147, DOI 10.1016/j.humov.2015.02.010; Asslander L, 2014, J NEUROPHYSIOL, V111, P1852, DOI 10.1152/jn.00669.2013; Boonstra TA, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-23; Cenciarini M, 2010, IEEE T BIO-MED ENG, V57, P267, DOI 10.1109/TBME.2009.2031874; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Engelhart D, 2014, IEEE T NEURAL SYST R; Engelhart D, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2013.09.009; Fleiss JL., 1986, DESIGN ANAL CLIN EXP; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORDSMITH CD, 1995, ARCH PHYS MED REHAB, V76, P77, DOI 10.1016/S0003-9993(95)80047-6; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hendershot BD, 2012, J BIOMECH, V45, P2019, DOI 10.1016/j.jbiomech.2012.05.026; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; Jonsson R, 2004, J VESTIBUL RES-EQUIL, V14, P47; Keating Jennifer, 1998, Aust J Physiother, V44, P5; Konrad HR, 1999, LARYNGOSCOPE, V109, P1454, DOI 10.1097/00005537-199909000-00019; Lariviere C, 2015, J BIOMECH, V48, P254, DOI 10.1016/j.jbiomech.2014.11.036; Lin HW, 2012, LARYNGOSCOPE, V122, P1858, DOI 10.1002/lary.23376; MANCHESTER D, 1989, J GERONTOL, V44, pM118; Moghadam M, 2011, GAIT POSTURE, V33, P651, DOI 10.1016/j.gaitpost.2011.02.016; Muir SW, 2010, J CLIN EPIDEMIOL, V63, P389, DOI 10.1016/j.jclinepi.2009.06.010; Pasma JH, 2015, J NEUROPHYSIOL, V114, P3220, DOI 10.1152/jn.00414.2015; Pasma JH, 2014, NEUROSCIENCE, V267, P157, DOI 10.1016/j.neuroscience.2014.02.030; Pasma JH, 2012, J NEUROPHYSIOL, V108, P1138, DOI 10.1152/jn.01008.2011; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Popovich JM, 2015, J BIOMECH, V48, P549, DOI 10.1016/j.jbiomech.2014.11.023; Reeves NP, 2014, J BIOMECH, V47, P44, DOI 10.1016/j.jbiomech.2013.10.018; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Santos BR, 2008, GAIT POSTURE, V27, P408, DOI 10.1016/j.gaitpost.2007.05.008; Schouten AC, 2011, IEEE T NEUR SYS REH, V19, P660, DOI 10.1109/TNSRE.2011.2163644; Shavelson R. J., 1991, GEN THEORY; Sturnieks DL, 2008, NEUROPHYSIOL CLIN, V38, P467, DOI 10.1016/j.neucli.2008.09.001; van der Kooij H, 2005, J NEUROSCI METH, V145, P175, DOI 10.1016/j.jneumeth.2005.01.003; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WINTER DA, 1990, MED PROG TECHNOL, V16, P31; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151012	10.1371/journal.pone.0151012	http://dx.doi.org/10.1371/journal.pone.0151012			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953694	gold, Green Published			2022-12-27	WOS:000371991300073
J	Peng, SB; Zhang, XY; Paul, D; Kays, LM; Ye, M; Vaillancourt, P; Dowless, M; Stancato, LF; Stewart, J; Uhlik, MT; Long, HY; Chu, SY; Obungu, VH				Peng, Sheng-Bin; Zhang, Xiaoyi; Paul, Donald; Kays, Lisa M.; Ye, Ming; Vaillancourt, Peter; Dowless, Michele; Stancato, Louis F.; Stewart, Julie; Uhlik, Mark T.; Long, Haiyan; Chu, Shaoyou; Obungu, Victor H.			Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; TUMOR-GROWTH; TARGETING CXCR4; CELLS; ANTAGONIST; EXPRESSION; CANCER; ANGIOGENESIS; MOBILIZATION; SENSITIVITY	SDF-1 and CXCR4 are a chemokine and chemokine receptor pair playing critical roles in tumorigenesis. Overexpression of CXCR4 is a hallmark of many hematological malignancies including acute myeloid leukemia, chronic lymphocytic leukemia and non-Hodgkin's lymphoma, and generally correlates with a poor prognosis. In this study, we developed a humanized anti-CXCR4 monoclonal antibody, LY2624587 as a potent CXCR4 antagonist that was advanced into clinical study for cancer. LY2624587 blocked SDF-1 binding to CXCR4 with an IC50 of 0.26 nM, and inhibited SDF-1-induced GTP binding with a K-b of 0.66 nM. In human lymphoma U937 and leukemia CCRF-CEM cells expressing endogenous CXCR4, LY2624587 inhibited SDF-1-induced cell migration with IC50 values of 3.7 and 0.26 nM, respectively. This antibody also inhibited CXCR4 and SDF-1 mediated cell signaling including activation of MAPK and AKT in tumor cells expressing CXCR4. Bifocal microscopic and flow cytometry analyses revealed that LY2624587 mediated receptor internalization and caused CXCR4 down-regulation on the cell surface. In human hematologic cancer cells, LY2624587 caused dose dependent apoptosis in vitro and in vivo. In mouse xenograft models developed with human leukemia and lymphoma cells expressing high levels of CXCR4, LY2624587 exhibited dose-dependent tumor growth inhibition and provided significant survival benefit in a disseminated lymphoma model. Collectively, we have demonstrated that CXCR4 inhibition by LY2624587 has the potential for the treatment of human hematological malignancies.	[Peng, Sheng-Bin; Zhang, Xiaoyi; Paul, Donald; Kays, Lisa M.; Ye, Ming; Vaillancourt, Peter; Dowless, Michele; Stancato, Louis F.; Stewart, Julie; Uhlik, Mark T.; Long, Haiyan; Chu, Shaoyou; Obungu, Victor H.] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly	Peng, SB (corresponding author), Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA.	Peng_sheng-bin@lilly.com			Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	Eli Lilly and Company provided support in the form of salaries for authors [SBP, XZ, DP, LMK, MY, PV, MD, LFS, JS, MTU, HL, SC, and VHO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Beider K, 2013, CLIN CANCER RES, V19, P3495, DOI 10.1158/1078-0432.CCR-12-3015; Bertolini F, 2002, CANCER RES, V62, P3106; Brault L, 2014, LEUKEMIA, V28, P566, DOI 10.1038/leu.2013.201; Broxmeyer HE, 2003, J LEUKOCYTE BIOL, V73, P630, DOI 10.1189/jlb.1002495; Cho BS, 2015, BLOOD, V126, P222, DOI 10.1182/blood-2015-02-628677; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Debnath B, 2013, THERANOSTICS, V3, P47, DOI 10.7150/thno.5376; DeLapp NW, 1999, J PHARMACOL EXP THER, V289, P946; DiPersio JF, 2009, BLOOD, V113, P5720, DOI 10.1182/blood-2008-08-174946; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Falcon BL, 2013, DRUG DISCOV TODAY, V18, P510, DOI 10.1016/j.drudis.2012.08.008; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Kim JM, 2011, ENDOCRINOLOGY, V152, P536, DOI 10.1210/en.2010-0642; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Ko SY, 2014, LEUKEMIA RES, V38, P65, DOI 10.1016/j.leukres.2013.10.016; Kuhne MR, 2013, CLIN CANCER RES, V19, P357, DOI 10.1158/1078-0432.CCR-12-2333; Kwong J, 2009, MOL CANCER THER, V8, P1893, DOI 10.1158/1535-7163.MCT-08-0966; Labrosse B, 1998, J VIROL, V72, P6381, DOI 10.1128/JVI.72.8.6381-6388.1998; Li MZ, 2009, SEMIN CANCER BIOL, V19, P111, DOI 10.1016/j.semcancer.2008.11.001; Micallef IN, 2009, BIOL BLOOD MARROW TR, V15, P1578, DOI 10.1016/j.bbmt.2009.08.005; Mo W, 2013, CELL, V152, P1077, DOI 10.1016/j.cell.2013.01.053; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; O'Callaghan K, 2012, BLOOD, V119, P1717, DOI 10.1182/blood-2011-04-347518; Oishi S, 2012, ORG BIOMOL CHEM, V10, P5720, DOI 10.1039/c2ob25107h; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Peled A, 2014, CLIN CANCER RES, V20, P469, DOI 10.1158/1078-0432.CCR-13-1302; Peng SB, 2005, MOL CANCER RES, V3, P227; Peng SB, 2015, MOL CANCER THER, V14, P480, DOI 10.1158/1535-7163.MCT-14-0850; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Tavernier-Tardy E, 2009, LEUKEMIA RES, V33, P764, DOI 10.1016/j.leukres.2008.10.014; Uy GL, 2012, BLOOD, V119, P3917, DOI 10.1182/blood-2011-10-383406; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; Yu T, 2012, MOL THER, V20, P398, DOI 10.1038/mt.2011.257; Zeng A, 2009, BLOOD, V113, P6215, DOI [10.1182/blood-2008-05-158311, DOI 10.1182/BL00D-2008-05-158311]; Zhang Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.137; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200	40	40	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150585	10.1371/journal.pone.0150585	http://dx.doi.org/10.1371/journal.pone.0150585			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954567	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300032
J	Kasahara, K; Shirota, M; Kinoshita, K				Kasahara, Kota; Shirota, Matsuyuki; Kinoshita, Kengo			Ion Concentration- and Voltage-Dependent Push and Pull Mechanisms of Potassium Channel Ion Conduction	PLOS ONE			English	Article							CONSTANT ELECTRIC-FIELD; MOLECULAR-DYNAMICS; K+ CHANNELS; PERMEATION THEORY; CRYSTAL-STRUCTURE; KCSA CHANNEL; SELECTIVITY; ENERGETICS; PERMEABILITY; SIMULATION	The mechanism of ion conduction by potassium channels is one of the central issues in physiology. In particular, it is still unclear how the ion concentration and the membrane voltage drive ion conduction. We have investigated the dynamics of the ion conduction processes in the Kv1.2 pore domain, by molecular dynamics (MD) simulations with several different voltages and ion concentrations. By focusing on the detailed ion movements through the pore including selectivity filter (SF) and cavity, we found two major conduction mechanisms, called the III-IV-III and III-II-III mechanisms, and the balance between the ion concentration and the voltage determines the mechanism preference. In the III-IV-III mechanism, the outermost ion in the pore is pushed out by a new ion coming from the intracellular fluid, and four-ion states were transiently observed. In the III-II-III mechanism, the outermost ion is pulled out first, without pushing by incoming ions. Increases in the ion concentration and voltage accelerated ion conductions, but their mechanisms were different. The increase in the ion concentrations facilitated the III-IV-III conductions, while the higher voltages increased the III-II-III conductions, indicating that the pore domain of potassium channels permeates ions by using two different driving forces: a push by intracellular ions and a pull by voltage.	[Kasahara, Kota; Shirota, Matsuyuki; Kinoshita, Kengo] Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, 6-3-09 Aramaki Aza Aoba, Sendai, Miyagi 9808597, Japan; [Shirota, Matsuyuki; Kinoshita, Kengo] Tohoku Univ, Tohoku Med Megabank Org, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808573, Japan; [Shirota, Matsuyuki] Tohoku Univ, Grad Sch Med, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan; [Kinoshita, Kengo] Tohoku Univ, Inst Dev Aging & Canc, Aoba Ku, 4-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan; [Kasahara, Kota] Osaka Univ, Inst Prot Res, 3-2 Yamada Oka, Suita, Osaka 5650871, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Osaka University	Kinoshita, K (corresponding author), Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, 6-3-09 Aramaki Aza Aoba, Sendai, Miyagi 9808597, Japan.; Kinoshita, K (corresponding author), Tohoku Univ, Tohoku Med Megabank Org, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808573, Japan.; Kinoshita, K (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Aoba Ku, 4-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	kengo@ecei.tohoku.ac.jp	Kinoshita, Kengo/E-9688-2011	Kinoshita, Kengo/0000-0003-3453-2171; Kasahara, Kota/0000-0003-0207-6271	Japan Society for Promotion of Science	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Kengo Kinoshita is funded by Japan Society for Promotion of Science (https://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCAYAGA C, 1989, BIOPHYS J, V55, P367, DOI 10.1016/S0006-3495(89)82814-0; Allen TW, 2006, BIOPHYS CHEM, V124, P251, DOI 10.1016/j.bpc.2006.04.015; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Berneche S, 2000, BIOPHYS J, V78, P2900, DOI 10.1016/S0006-3495(00)76831-7; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1145/1188455.1188544; Capener CE, 2002, HUM MOL GENET, V11, P2425, DOI 10.1093/hmg/11.20.2425; Diaz-Franulic I, 2015, J GEN PHYSIOL, V146, P133, DOI 10.1085/jgp.201411353; Domene C, 2009, J MOL BIOL, V389, P637, DOI 10.1016/j.jmb.2009.04.038; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Egwolf B, 2010, J MOL BIOL, V401, P831, DOI 10.1016/j.jmb.2010.07.006; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Furini S, 2011, BIOPHYS J, V101, P1623, DOI 10.1016/j.bpj.2011.08.035; Furini S, 2011, J MOL BIOL, V409, P867, DOI 10.1016/j.jmb.2011.04.043; Furini S, 2009, P NATL ACAD SCI USA, V106, P16074, DOI 10.1073/pnas.0903226106; Gumbart J, 2012, BBA-BIOMEMBRANES, V1818, P294, DOI 10.1016/j.bbamem.2011.09.030; HEGINBOTHAM L, 1993, BIOPHYS J, V65, P2089, DOI 10.1016/S0006-3495(93)81244-X; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HILLE B, 1973, J GEN PHYSIOL, V61, P669, DOI 10.1085/jgp.61.6.669; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; Jensen MO, 2013, J GEN PHYSIOL, V141, P619, DOI 10.1085/jgp.201210820; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Kasahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056342; Khalili-Araghi F, 2006, BIOPHYS J, V91, pL2, DOI 10.1529/biophysj.106.091926; Kopfer DA, 2014, SCIENCE, V346, P352, DOI 10.1126/science.1254840; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Nelson PH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3580562; Nelson PH, 2003, J CHEM PHYS, V119, P6981, DOI 10.1063/1.1604112; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Paparoditis E, 2002, CR MATH, V335, P959, DOI 10.1016/S1631-073X(02)02578-5; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Roux B, 2008, BIOPHYS J, V95, P4205, DOI 10.1529/biophysj.108.136499; Roux B, 2011, J GEN PHYSIOL, V137, P415, DOI 10.1085/jgp.201010577; Sack JT, 2015, J GEN PHYSIOL, V146, P123, DOI 10.1085/jgp.201511469; Shaw DE, 2007, CONF PROC INT SYMP C, P1, DOI 10.1145/1273440.1250664; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865	44	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150716	10.1371/journal.pone.0150716	http://dx.doi.org/10.1371/journal.pone.0150716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950215	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100053
J	Leino, T; Ollgren, J; Stromberg, N; Elonsalo, U				Leino, Tuija; Ollgren, Jukka; Stromberg, Nina; Elonsalo, Ulpu			Evaluation of the Intussusception Risk after Pentavalent Rotavirus Vaccination in Finnish Infants	PLOS ONE			English	Article							NATIONAL IMMUNIZATION PROGRAM; AVAILABLE EVIDENCE; US INFANTS; SAFETY; VACCINES; SURVEILLANCE; CHILDREN; FINLAND; GASTROENTERITIS; INFECTIONS	Background An association between rotavirus immunisation and intussusception (IS) has been suggested with present rotavirus vaccines in post-licensure studies. In Finland, rotavirus vaccination programme was implemented in September 2009 using a 2, 3, and 5 months schedule with the pentavalent rotavirus vaccine. By the end of 2013, it is estimated that 719 000 rotavirus vaccine doses have been given in the national programme of which 240 000 were first doses. Nationwide register allows us to evaluate the association between rotavirus vaccination and IS. Methods and Materials Cases of IS diagnosed during 1999-2013 were identified from National Hospital Discharge Register. All cases under 250 days of age diagnosed during 2009-2013 were confirmed by reviewing medical charts. Self-controlled case-series method was used to assess the risk of IS during 1-21 days compared to 22-42 days post vaccination. Findings In register data the relative incidence of IS at 2 months of age between the post and pre vaccination era was 9.1 (95% CI 2.0-84.3). We identified 22 verified cases with date of admission less than 43 days after any of the three rotavirus vaccine doses. The incidence of IS in the risk period after the 1st dose relative to the control period was 2.0 (95% CI 0.5-8.4; p = 0.34.) Number of excess IS cases per 100 000 first vaccine doses was therefore estimated to be 1.04 (95% CI 0.0-2.5), i.e. one additional IS case per 96 000 first doses of rotavirus vaccine (95% CI 54 600 to infinity). There was no risk detected after 2nd and 3rd doses. Conclusion The finding is in line with the recent published estimates. The benefits of rotavirus immunisation programme outweigh possible small risks of intussusception.	[Leino, Tuija; Stromberg, Nina; Elonsalo, Ulpu] Natl Inst Hlth & Welf THL, Dept Hlth Protect, Helsinki, Finland; [Ollgren, Jukka] Natl Inst Hlth & Welf THL, Dept Infect Dis, Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Leino, T (corresponding author), Natl Inst Hlth & Welf THL, Dept Hlth Protect, Helsinki, Finland.	tuija.leino@thl.fi			National Institute for Health and Welfare	National Institute for Health and Welfare	All authors are employees of the National Institute for Health and Welfare and received funding in the form of salaries.	Bines JE, 2004, VACCINE, V22, P569, DOI 10.1016/j.vaccine.2003.09.016; Buttery JP, 2011, VACCINE, V29, P3061, DOI 10.1016/j.vaccine.2011.01.088; Carlin JB, 2013, CLIN INFECT DIS, V57, P1427, DOI 10.1093/cid/cit520; Farrington CP, 2004, VACCINE, V22, P2064, DOI 10.1016/j.vaccine.2004.01.017; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; Glanz JM, 2006, J CLIN EPIDEMIOL, V59, P808, DOI 10.1016/j.jclinepi.2005.11.012; Haber P, 2013, PEDIATRICS, V131, P1042, DOI 10.1542/peds.2012-2554; Hemming M, 2013, EUR J PEDIATR, V172, P739, DOI 10.1007/s00431-013-1945-3; Jiang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068482; Johnson B, 2010, J PEDIATR GASTR NUTR, V51, P458, DOI 10.1097/MPG.0b013e3181d3273f; Lappalainen S, 2012, ACTA PAEDIATR, V101, P663, DOI 10.1111/j.1651-2227.2012.02616.x; Leino T, 2012, VACCINE, V31, P176, DOI 10.1016/j.vaccine.2012.10.068; Loughlin J, 2012, PEDIATR INFECT DIS J, V31, P292, DOI 10.1097/INF.0b013e3182421390; Moser CA, 2001, J INFECT DIS, V183, P1108, DOI 10.1086/319294; Murphy BR, 2003, J INFECT DIS, V187, P1301, DOI 10.1086/367895; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Nylund CM, 2010, J PEDIATR-US, V156, P761, DOI 10.1016/j.jpeds.2009.11.026; Patel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952; Patel MM, 2009, EXPERT REV VACCINES, V8, P1555, DOI 10.1586/ERV.09.106; Payne DC, 2015, CLIN INFECT DIS, V60, P163, DOI 10.1093/cid/ciu746; Velazquez FR, 2012, PEDIATR INFECT DIS J, V31, P736, DOI 10.1097/INF.0b013e318253add3; Rha B, 2014, EXPERT REV VACCINES, V13, P1339, DOI 10.1586/14760584.2014.942223; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Shui IM, 2012, JAMA-J AM MED ASSOC, V307, P598, DOI 10.1001/jama.2012.97; Simonsen L, 2001, LANCET, V358, P1224, DOI 10.1016/S0140-6736(01)06346-2; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Tate JE, 2012, VACCINE, V30, pA179, DOI 10.1016/j.vaccine.2011.08.110; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2013, PEDIATR INFECT DIS J, V32, P1365, DOI 10.1097/INF.0000000000000086; Weintraub ES, 2014, NEW ENGL J MED, V370, P513, DOI 10.1056/NEJMoa1311738; Yih WK, 2014, NEW ENGL J MED, V370, P503, DOI 10.1056/NEJMoa1303164	32	15	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0144812	10.1371/journal.pone.0144812	http://dx.doi.org/10.1371/journal.pone.0144812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950702	Green Published, gold			2022-12-27	WOS:000371990100003
J	Kanouchi, H; Kakimoto, T; Nakano, H; Suzuki, M; Nakai, Y; Shiozaki, K; Akikoka, K; Otomaru, K; Nagano, M; Matsumoto, M				Kanouchi, Hiroaki; Kakimoto, Toshiaki; Nakano, Hideya; Suzuki, Masahiro; Nakai, Yuji; Shiozaki, Kazuhiro; Akikoka, Kohei; Otomaru, Konosuke; Nagano, Masanobu; Matsumoto, Mitsuharu			The Brewed Rice Vinegar Kurozu Increases HSPA1A Expression and Ameliorates Cognitive Dysfunction in Aged P8 Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; UNPOLISHED RICE; SAMP8 MOUSE; MODEL	Kurozu is a traditional Japanese rice vinegar. During fermentation and aging of the Kurozu liquid in an earthenware jar over 1 year, a solid residue called Kurozu Moromi is produced. In the present study, we evaluated whether concentrated Kurozu or Kurozu Moromi could ameliorate cognitive dysfunction in the senescence-accelerated P8 mouse. Senescence-accelerated P8 mice were fed 0.25%(w/w) concentrated Kurozu or 0.5% (w/w) Kurozu Moromi for 4 or 25 weeks. Kurozu suppressed cognitive dysfunction and amyloid accumulation in the brain, while Kurozu Moromi showed a tendency to ameliorate cognitive dysfunction, but the effect was not significant. We hypothesize that concentrated Kurozu has an antioxidant effect; however, the level of lipid peroxidation in the brain did not differ in senescence-accelerated P8 mice. DNA microarray analysis indicated that concentrated Kurozu increased HSPA1A mRNA expression, a protein that prevents protein misfolding and aggregation. The increase in HSPA1A expression by Kurozu was confirmed using quantitative real-time PCR and immunoblotting methods. The suppression of amyloid accumulation by concentrated Kurozu may be associated with HSPA1A induction. However, concentrated Kurozu could not increase HSPA1A expression in mouse primary neurons, suggesting it may not directly affect neurons.	[Kanouchi, Hiroaki; Kakimoto, Toshiaki; Nakano, Hideya; Suzuki, Masahiro] Kagoshima Univ, Dept Vet Pathobiol, Joint Fac Vet Med, Kagoshima 890, Japan; [Nakai, Yuji] Hirosaki Univ, Inst Food Sci, Aomori, Japan; [Shiozaki, Kazuhiro] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan; [Akikoka, Kohei] Kagoshima Univ, Dept Vet Histopathol, Joint Fac Vet Med, Kagoshima 890, Japan; [Otomaru, Konosuke] Kagoshima Univ, Ctr Vet Clin, Joint Fac Vet Med, Kagoshima 890, Japan; [Nagano, Masanobu] Sakamoto Kurozu Inc, Uenosono Cho, Kagoshima, Japan; [Matsumoto, Mitsuharu] Kagoshima Univ, Dept Vet Anat, Joint Fac Vet Med, Kagoshima 890, Japan	Kagoshima University; Hirosaki University; Kagoshima University; Kagoshima University; Kagoshima University; Kagoshima University	Kanouchi, H (corresponding author), Kagoshima Univ, Dept Vet Pathobiol, Joint Fac Vet Med, Kagoshima 890, Japan.	kano@agri.kagoshima-u.ac.jp	KANOUCHI, Hiroaki/T-8916-2019; NAKAI, Yuji/G-3433-2014	KANOUCHI, Hiroaki/0000-0002-1023-1502; NAKAI, Yuji/0000-0002-2458-3875				Moneim AEA, 2015, CURR ALZHEIMER RES, V12, P335, DOI 10.2174/1567205012666150325182702; Bobkova NV, 2014, J ALZHEIMERS DIS, V38, P425, DOI 10.3233/JAD-130779; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chang X, 2015, EXP CELL RES, V334, P136, DOI 10.1016/j.yexcr.2015.04.004; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gang BZ, 2011, BRAIN RES, V1389, P183, DOI 10.1016/j.brainres.2011.03.039; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Ikeda A, 2015, J FOOD PROCESS PRES, V39, P107, DOI 10.1111/jfpp.12210; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Leak RK, 2014, J CELL COMMUN SIGNAL, V8, P293, DOI 10.1007/s12079-014-0243-9; Markowska AL, 1998, PHYSIOL BEHAV, V64, P15, DOI 10.1016/S0031-9384(98)00011-0; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nanda K, 2004, J EXP CLIN CANC RES, V23, P69; Nishidai S, 2000, BIOSCI BIOTECH BIOCH, V64, P1909, DOI 10.1271/bbb.64.1909; Pallas M., 2012, ISRN CELL BIOL; Rege SD, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00218; Repalli J, 2015, DRUG DES DEV THER, V9, P321, DOI 10.2147/DDDT.S72165; ROY AK, 1983, J BIOL CHEM, V258, P123; Shizuma T, 2011, DIGEST DIS SCI, V56, P1387, DOI 10.1007/s10620-010-1432-x; Suyama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029483; Zheng JD, 2009, J NEUROL SCI, V287, P188, DOI 10.1016/j.jns.2009.07.027	21	8	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150796	10.1371/journal.pone.0150796	http://dx.doi.org/10.1371/journal.pone.0150796			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943920	Green Published, Green Submitted, gold			2022-12-27	WOS:000371739400051
J	Thornley, TB; Agarwal, KA; Kyriazis, P; Ma, LZ; Chipashvili, V; Aker, JE; Korniotis, S; Csizmadia, E; Strom, TB; Koulmanda, M				Thornley, Thomas B.; Agarwal, Krishna A.; Kyriazis, Periklis; Ma, Lingzhi; Chipashvili, Vaja; Aker, Jonathan E.; Korniotis, Sarantis; Csizmadia, Eva; Strom, Terry B.; Koulmanda, Maria			Contrasting Roles of Islet Resident Immunoregulatory Macrophages and Dendritic Cells in Experimental Autoimmune Type 1 Diabetes	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; REGULATORY T-CELLS; TISSUE MACROPHAGES; NOD MICE; B-CELLS; MONOCYTES; TOLERANCE; IMMUNITY; RECEPTOR; DISTINCT	The innate immune system critically shapes diabetogenic adaptive immunity during type 1 diabetes (T1D) pathogenesis. While the role of tissue-infiltrating monocyte-derived macrophages in T1D is well established, the role of their tissue-resident counterparts remains undefined. We now demonstrate that islet resident macrophages (IRMs) from non-autoimmune mice have an immunoregulatory phenotype and powerfully induce FoxP3+ Tregs in vitro. The immunoregulatory phenotype and function of IRMs is compromised by TLR4 activation in vitro. Moreover, as T1D approaches in NOD mice, the immunoregulatory phenotype of IRMs is diminished as is their relative abundance compared to immunostimulatory DCs. Our findings suggest that maintenance of IRM abundance and their immunoregulatory phenotype may constitute a novel therapeutic strategy to prevent and/or cure T1D.	[Thornley, Thomas B.; Agarwal, Krishna A.; Kyriazis, Periklis; Ma, Lingzhi; Chipashvili, Vaja; Aker, Jonathan E.; Korniotis, Sarantis; Strom, Terry B.; Koulmanda, Maria] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Thornley, Thomas B.; Agarwal, Krishna A.; Kyriazis, Periklis; Ma, Lingzhi; Chipashvili, Vaja; Aker, Jonathan E.; Korniotis, Sarantis; Csizmadia, Eva; Strom, Terry B.; Koulmanda, Maria] Beth Israel Deaconess Med Ctr, Transplant Inst, Boston, MA 02215 USA; [Csizmadia, Eva; Strom, Terry B.; Koulmanda, Maria] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Strom, TB; Koulmanda, M (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA.; Strom, TB; Koulmanda, M (corresponding author), Beth Israel Deaconess Med Ctr, Transplant Inst, Boston, MA 02215 USA.; Strom, TB; Koulmanda, M (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston, MA 02215 USA.	tstrom@bidmc.harvard.edu; mkoulman@bidmc.harvard.edu	Agarwal, Krishna/I-8357-2019	Agarwal, Krishna/0000-0001-5787-070X	National Institute of Diabetes and Digest and Kidney Diseases [R01-DK096138]; National Heart, Lung and Blood Institute [T32-HL007893]; Juvenile Diabetes Research Foundation [3-2010-792]; American Diabetes Association [1-13-BS-096]; NIH T32 training grant [5T32DK007199-37]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096138, T32DK007199] Funding Source: NIH RePORTER	National Institute of Diabetes and Digest and Kidney Diseases; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institute of Diabetes and Digest and Kidney Diseases (www.niddk.nih.gov) grant number R01-DK096138 (T.B.S., and M.K.), National Heart, Lung and Blood Institute (www.nhlbi.nih.gov) training grant number T32-HL007893 (T.B.T.), Juvenile Diabetes Research Foundation (www.jdrf.org) fellowship award number 3-2010-792 (T.B.T.), American Diabetes Association (www.diabetes.org) grant number 1-13-BS-096 (M.K.), and NIH T32 training grant number 5T32DK007199-37 (P.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Calderon B, 2015, J EXP MED, V212, P1497, DOI 10.1084/jem.20150496; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Ferris ST, 2014, IMMUNITY, V41, P657, DOI 10.1016/j.immuni.2014.09.012; Fiorina P, 2008, DIABETES, V57, P3013, DOI 10.2337/db08-0420; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gonzalez A, 1997, IMMUNITY, V7, P873, DOI 10.1016/S1074-7613(00)80405-7; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Guleria I, 2007, CLIN IMMUNOL, V125, P16, DOI 10.1016/j.clim.2007.05.013; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Ito T, 2004, J IMMUNOL, V172, P3628, DOI 10.4049/jimmunol.172.6.3628; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Judkowski V, 2001, J IMMUNOL, V166, P908, DOI 10.4049/jimmunol.166.2.908; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Kleffel S, 2015, DIABETES, V64, P158, DOI 10.2337/db13-1639; Koulmanda M, 2007, P NATL ACAD SCI USA, V104, P13074, DOI 10.1073/pnas.0705863104; Martinez-Pomares L, 2012, TRENDS IMMUNOL, V33, P66, DOI 10.1016/j.it.2011.11.001; Meyers AJ, 2010, J MOL MED, V88, P1221, DOI 10.1007/s00109-010-0666-6; Montandon R, 2013, P NATL ACAD SCI USA, V110, pE2199, DOI 10.1073/pnas.1222446110; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; PROCHAZKA M, 1992, DIABETES, V41, P98, DOI 10.2337/diabetes.41.1.98; Riella LV, 2013, AM J PATHOL, V182, P2204, DOI 10.1016/j.ajpath.2013.02.014; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Sauer AV, 2012, BLOOD, V119, P1428, DOI 10.1182/blood-2011-07-366781; SERREZE DV, 1993, J IMMUNOL, V150, P2534; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; Thornley TB, 2006, J IMMUNOL, V176, P1561, DOI 10.4049/jimmunol.176.3.1561; Thornley TB, 2014, J CLIN INVEST, V124, P3443, DOI 10.1172/JCI73527; Triantafilou K, 2004, J VIROL, V78, P11313, DOI 10.1128/JVI.78.20.11313-11320.2004; Viksman MY, 2002, CLIN IMMUNOL, V104, P77, DOI 10.1006/clim.2002.5233; Yui MA, 1996, MAMM GENOME, V7, P331, DOI 10.1007/s003359900097; Zhang S, 2010, INT J CLIN EXP PATHO, V3, P24; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zipris D, 2008, CURR OPIN ENDOCRINOL, V15, P326, DOI 10.1097/MED.0b013e3283073a46	35	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150792	10.1371/journal.pone.0150792	http://dx.doi.org/10.1371/journal.pone.0150792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943809	gold, Green Published, Green Submitted			2022-12-27	WOS:000371739400050
J	Amador, A; Wang, YJ; Banerjee, S; Kameneka, TM; Solt, LA; Burris, TP				Amador, Ariadna; Wang, Yongjun; Banerjee, Subhashis; Kameneka, Theodore M.; Solt, Laura A.; Burris, Thomas P.			Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression	PLOS ONE			English	Article							LATERAL HYPOTHALAMIC SYNDROME; HYPOCRETIN OREXIN; CIRCADIAN CLOCK; HUMAN NARCOLEPSY; OREXIN/HYPOCRETIN NEURONS; BODY-WEIGHT; ALPHA; MICE; METABOLISM; BEHAVIOR	The nuclear receptors REV-ERB alpha and REV-ERB beta are transcription factors that play pivotal roles in the regulation of the circadian rhythm and various metabolic processes. The circadian rhythm is an endogenous mechanism, which generates entrainable biological changes that follow a 24-hour period. It regulates a number of physiological processes, including sleep/wakeful cycles and feeding behaviors. We recently demonstrated that REV-ERB-specific small molecules affect sleep and anxiety. The orexinergic system also plays a significant role in mammalian physiology and behavior, including the regulation of sleep and food intake. Importantly, orexin genes are expressed in a circadian manner. Given these overlaps in function and circadian expression, we wanted to determine whether the REV-ERBs might regulate orexin. We found that acute in vivo modulation of REV-ERB activity, with the REV-ERB-specific synthetic ligand SR9009, affects the circadian expression of orexinergic genes in mice. Long term dosing with SR9009 also suppresses orexinergic gene expression in mice. Finally, REV-ERB beta-deficient mice present with increased orexinergic transcripts. These data suggest that the REV-ERBs may be involved in the repression of orexinergic gene expression.	[Amador, Ariadna; Kameneka, Theodore M.; Solt, Laura A.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Wang, Yongjun; Banerjee, Subhashis; Burris, Thomas P.] St Louis Univ, Dept Physiol & Pharmacol, St Louis, MO 63103 USA	Scripps Research Institute; Saint Louis University	Burris, TP (corresponding author), St Louis Univ, Dept Physiol & Pharmacol, St Louis, MO 63103 USA.	burristp@slu.edu	Burris, Thomas/B-3886-2016	Burris, Thomas/0000-0003-2922-4449	National Institute of Mental Health [MH09342]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (MH09342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annerbrink K, 2011, PSYCHIAT GENET, V21, P85, DOI 10.1097/YPG.0b013e328341a3db; ASCHOFF J, 1965, SCIENCE, V148, P1427, DOI 10.1126/science.148.3676.1427; ASCHOFF J, 1969, AEROSPACE MED, V40, P844; Aston-Jones G, 2010, BRAIN RES, V1314, P74, DOI 10.1016/j.brainres.2009.09.106; Banerjee S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6759; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bernardis LL, 1996, NEUROSCI BIOBEHAV R, V20, P189, DOI 10.1016/0149-7634(95)00015-1; BERNARDIS LL, 1993, NEUROSCI BIOBEHAV R, V17, P141, DOI 10.1016/S0149-7634(05)80149-6; Boutrel B, 2010, BRAIN RES, V1314, P103, DOI 10.1016/j.brainres.2009.11.054; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Burdakov D, 2005, J CELL MOL MED, V9, P795, DOI 10.1111/j.1582-4934.2005.tb00380.x; Burdakov D, 2004, NEUROSCIENTIST, V10, P286, DOI 10.1177/1073858404263597; Chang GQ, 2004, ENDOCRINOLOGY, V145, P3904, DOI 10.1210/en.2003-1582; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; DANGUIR J, 1980, BRAIN RES, V185, P305, DOI 10.1016/0006-8993(80)91070-7; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Deng BS, 2007, J APPL PHYSIOL, V103, P1772, DOI 10.1152/japplphysiol.00075.2007; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Hungs M, 2001, GENOME RES, V11, P531, DOI 10.1101/gr.GR-1610R; Jager J, 2014, MOL ENDOCRINOL, V28, P490, DOI 10.1210/me.2013-1351; Karnani MM, 2011, NEURON, V72, P616, DOI 10.1016/j.neuron.2011.08.027; Kukkonen JP, 2013, AM J PHYSIOL-CELL PH, V304, pC2, DOI 10.1152/ajpcell.00227.2012; Kuwaki T, 2008, RESP PHYSIOL NEUROBI, V164, P204, DOI 10.1016/j.resp.2008.03.011; LEVITT DR, 1975, P NATL ACAD SCI USA, V72, P2819, DOI 10.1073/pnas.72.7.2819; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; MITSUI A, 1986, NATURE, V323, P720, DOI 10.1038/323720a0; Nishino S, 2001, ANN NEUROL, V50, P381, DOI 10.1002/ana.1130; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Perna G, 2011, EXPERT OPIN EMERG DR, V16, P631, DOI 10.1517/14728214.2011.628313; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 1998, CELL, V92, pU29; Scammell TE, 2000, J NEUROSCI, V20, P8620, DOI 10.1523/JNEUROSCI.20-22-08620.2000; Sellayah D, 2011, CELL METAB, V14, P478, DOI 10.1016/j.cmet.2011.08.010; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; STAL LJ, 1985, ARCH MICROBIOL, V143, P67, DOI 10.1007/BF00414770; Tanaka S, 2012, VITAM HORM, V89, P75, DOI 10.1016/B978-0-12-394623-2.00005-6; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thompson JL, 2011, BEHAV BRAIN RES, V217, P446, DOI 10.1016/j.bbr.2010.09.028; Thorpe AJ, 2005, AM J PHYSIOL-REG I, V289, pR367, DOI 10.1152/ajpregu.00737.2004; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Tsujino N, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00028; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Williams Rhiannan H., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000823; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Wu T, 2010, CHRONOBIOL INT, V27, P1, DOI 10.3109/07420520903398625; Yamanaka A, 1999, BRAIN RES, V849, P248, DOI 10.1016/S0006-8993(99)01905-8; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yawata S, 2012, P NATL ACAD SCI USA, V109, P12764, DOI 10.1073/pnas.1210797109; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zhang W, 2005, NEUROSCI LETT, V385, P131, DOI 10.1016/j.neulet.2005.05.032; Zhang YX, 2015, SCIENCE, V348, P1488, DOI 10.1126/science.aab3021	69	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151014	10.1371/journal.pone.0151014	http://dx.doi.org/10.1371/journal.pone.0151014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963516	gold, Green Submitted, Green Published			2022-12-27	WOS:000371993000090
J	Gonzalez-Sistal, A; Baltasar-Sanchez, A; Menendez, P; Arias, JI; Ruibal, A				Gonzalez-Sistal, Angel; Baltasar-Sanchez, Alicia; Menendez, Primitiva; Ignacio Arias, Jose; Ruibal, Alvaro			Breastfeeding and Immunohistochemical Expression of ki-67, p53 and BCL2 in Infiltrating Lobular Breast Carcinoma	PLOS ONE			English	Article							RISK-FACTORS; CANCER; ASSOCIATION; PARITY; SUBTYPES; THERAPY; INDEX; BIRTH; GRADE; KI67	Background/Aim Invasive lobular breast carcinoma is the second most common type of breast cancer after invasive ductal carcinoma. According to the American Cancer Society, more than 180,000 women in the United States find out they have invasive breast cancer each year. Personal history of breast cancer and certain changes in the breast are correlated with an increased breast cancer risk. The aim of this work was to analyze breastfeeding in patients with infiltrating lobular breast carcinoma, in relation with: 1) clinicopathological parameters, 2) hormonal receptors and 3) tissue-based tumor markers Materials and Methods The study included 80 women with ILC, 46 of which had breastfeed their children. Analyzed parameters were: age, tumor size, axillary lymph node (N), distant metastasis (M), histological grade (HG), estrogen receptor (ER), progesterone receptor (PR), androgen receptor (AR), Ki-67, p53 and BCL2 Results ILC of non-lactating women showed a larger (p = 0.009), lymph node involvement (p = 0.051) and distant metastasis (p = 0.060). They were also more proliferative tumors measured by Ki-67 (p = 0.053). Breastfeeding history did not influence the subsequent behavior of the tumor regardless of histological subtype Conclusion Lactation seems to influence the biological characteristics of ILC defining a subgroup with more tumor size, axillary lymph node involvement, distant metastasis and higher proliferation measured by ki-67 expression.	[Gonzalez-Sistal, Angel; Baltasar-Sanchez, Alicia] Univ Barcelona, Fac Med, Dept Physiol Sci 2, Barcelona 7, Spain; [Menendez, Primitiva] Univ Oviedo, Hosp Cent Asturias, Pathol Serv, E-33080 Oviedo, Spain; [Ignacio Arias, Jose] Hosp Monte Naranco, Surg Serv, Oviedo, Spain; [Ruibal, Alvaro] Complejo Hosp Univ, Nucl Med Serv, Fac Med, IDIS,Fdn Tejerina, Madrid, Spain	University of Barcelona; Central University Hospital Asturias; University of Oviedo	Gonzalez-Sistal, A (corresponding author), Univ Barcelona, Fac Med, Dept Physiol Sci 2, Barcelona 7, Spain.	angelgonzalez@ub.edu	Bujan, Pablo Menendez/W-3736-2017	Bujan, Pablo Menendez/0000-0001-9372-1007				Albrektsen G, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-226; Aleskandarany MA, 2011, BREAST CANCER RES TR, V127, P591, DOI 10.1007/s10549-010-1028-3; Brouckaert O, 2013, ANN ONCOL, V24, P47, DOI 10.1093/annonc/mds238; Costarelli Vassiliki, 2010, Nurs Stand, V24, P35; Engels CC, 2014, BRIT J CANCER, V111, P532, DOI 10.1038/bjc.2014.338; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Gonzalez-Sistal A, 2014, ANTICANCER RES, V34, P269; Huo D, 2008, BRIT J CANCER, V98, P992, DOI 10.1038/sj.bjc.6604275; Loof-Johanson M, 2011, BREAST, V20, P170, DOI 10.1016/j.breast.2010.08.007; Lord SJ, 2008, CANCER EPIDEM BIOMAR, V17, P1723, DOI 10.1158/1055-9965.EPI-07-2824; Lyons TR, 2009, J MAMMARY GLAND BIOL, V14, P87, DOI 10.1007/s10911-009-9119-7; Niikura N, 2014, CLIN BREAST CANCER, V14, P323, DOI 10.1016/j.clbc.2013.12.013; Phipps AI, 2008, CANCER-AM CANCER SOC, V113, P1521, DOI 10.1002/cncr.23786; Rakha EA, 2008, EUR J CANCER, V44, P73, DOI 10.1016/j.ejca.2007.10.009; Rossi L, 2015, BRIT J CANCER, V113, P996, DOI 10.1038/bjc.2015.239; Sotgia F, 2009, AM J PATHOL, V174, P613, DOI 10.2353/ajpath.2009.080653; Sotgia F, 2009, AM J PATHOL, V174, P746, DOI 10.2353/ajpath.2009.080658; Travis RC, 2010, LANCET, V375, P2143, DOI 10.1016/S0140-6736(10)60636-8; Turkoz FP, 2013, BREAST, V22, P344, DOI 10.1016/j.breast.2012.08.005; Wiesner FG, 2009, BREAST, V18, P135, DOI 10.1016/j.breast.2009.02.009; Yang L, 2008, J WOMENS HEALTH, V17, P1635, DOI 10.1089/jwh.2008.0917; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	22	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151093	10.1371/journal.pone.0151093	http://dx.doi.org/10.1371/journal.pone.0151093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963620	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000102
J	Haase, N; Golic, M; Herse, F; Rugor, J; Linz, D; Solano, ME; Muller, DN; Dechend, R				Haase, Nadine; Golic, Michaela; Herse, Florian; Rugor, Julianna; Linz, Dominik; Solano, Maria Emilia; Mueller, Dominik N.; Dechend, Ralf			Relaxin Treatment in an Ang-II-Based Transgenic Preeclamptic-Rat Model	PLOS ONE			English	Article							ENDOVASCULAR TROPHOBLAST INVASION; RENAL VASODILATION; EMERGING ROLE; PREGNANCY; IMPLANTATION; KINASE; RENIN; CELLS; TERM	Relaxin is a peptide related to pregnancy that induces nitric oxide-related and gelatinase-related effects, allowing vasodilation and pregnancy-related adjustments permitting parturition to occur. Relaxin controls the hemodynamic and renovascular adaptive changes that occur during pregnancy. Interest has evolved regarding relaxin and a therapeutic principle in preeclampsia and heart failure. Preeclampsia is a pregnancy disorder, featuring hypertension, proteinuria and placental anomalies. We investigated relaxin in an established transgenic rat model of preeclampsia, where the phenotype is induced by angiotensin (Ang)-II production in mid pregnancy. We gave recombinant relaxin to preeclamtic rats at day 9 of gestation. Hypertension and proteinuria was not ameliorated after relaxin administration. Intrauterine growth retardation of the fetus was unaltered by relaxin. Heart-rate responses and relaxin levels documented drug effects. In this Ang-II-based model of preeclampsia, we could not show a salubrious effect on preeclampsia.	[Haase, Nadine; Golic, Michaela; Herse, Florian; Rugor, Julianna; Mueller, Dominik N.; Dechend, Ralf] Max Delbruck Ctr Mol Med Helmholtz & Charite Med, Expt & Clin Res Ctr, Berlin, Germany; [Linz, Dominik] Univ Klinikum Saarlandes, Innere Med Klin 3, Kardiol Angiol & Internist Intens Med, Homburg, Germany; [Solano, Maria Emilia] Univ Med Ctr Hamburg Eppendorf, Lab Expt Fetomaternal Med, Dept Obstet & Fetal Med, Hamburg, Germany; [Dechend, Ralf] HELIOS Klin, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Universitatsklinikum des Saarlandes; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helios Kliniken	Dechend, R (corresponding author), Max Delbruck Ctr Mol Med Helmholtz & Charite Med, Expt & Clin Res Ctr, Berlin, Germany.; Dechend, R (corresponding author), HELIOS Klin, Berlin, Germany.	ralf.dechend@charite.de	Linz, Dominik/J-2558-2019; Solano, María/ABF-8950-2020	Linz, Dominik/0000-0003-4893-0824; Herse, Florian/0000-0002-9305-8134; Haase, Nadine/0000-0003-0727-1738; Muller, Dominik N/0000-0003-3650-5644; Golic, Michaela/0000-0003-3030-2678	Novartis; Deutsche Forschungsgemeinschaft (DFG) [DE631/9-1, HE6249/1-2]; German Centre for Cardiovascular Research (DZHK)	Novartis(Novartis); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Centre for Cardiovascular Research (DZHK)	The work was funded by grant in aid by Novartis. The Deutsche Forschungsgemeinschaft (DFG) supported R. Dechend (DE631/9-1), F. Herse (HE6249/1-2), and D.N. Muller. http://www.dfg.de/. The German Centre for Cardiovascular Research (DZHK) supported D.N. Muller. http://dzhk.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Anand-Ivell R, 2014, MOL CELL ENDOCRINOL, V382, P472, DOI 10.1016/j.mce.2013.08.010; Becker GJ, 2001, KIDNEY INT, V59, P1184, DOI 10.1046/j.1523-1755.2001.0590031184.x; BECKSTEAD JH, 1995, J HISTOCHEM CYTOCHEM, V43, P345, DOI 10.1177/43.3.7868864; Bohlender J, 2000, J AM SOC NEPHROL, V11, P2056, DOI 10.1681/ASN.V11112056; Bryant-Greenwood GD, 2009, PLACENTA, V30, P599, DOI 10.1016/j.placenta.2009.04.009; Conrad KP, 2014, AM J PHYSIOL-RENAL, V306, pF1121, DOI 10.1152/ajprenal.00042.2014; Conrad KP, 2011, AM J PHYSIOL-REG I, V301, pR267, DOI 10.1152/ajpregu.00156.2011; Conrad KP, 2011, SEMIN NEPHROL, V31, P15, DOI 10.1016/j.semnephrol.2010.10.003; Conrad KP, 2010, HYPERTENSION, V56, P2, DOI 10.1161/HYPERTENSIONAHA.109.133926; Conrad KP, 2004, ENDOCRINOLOGY, V145, P3289, DOI 10.1210/en.2003-1612; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; Danielson LA, 2003, J APPL PHYSIOL, V95, P1509, DOI 10.1152/japplphysiol.00545.2003; Dechend R, 2005, HYPERTENSION, V45, P742, DOI 10.1161/01.HYP.0000154785.50570.63; Farrell B, 2007, LANCET, V369, P13, DOI 10.1016/S0140-6736(07)60010-5; Geusens N, 2008, PLACENTA, V29, P614, DOI 10.1016/j.placenta.2008.04.005; Geusens N, 2010, PLACENTA, V31, P320, DOI 10.1016/j.placenta.2010.01.011; Goldsmith LT, 2004, P NATL ACAD SCI USA, V101, P4685, DOI 10.1073/pnas.0400776101; Granot I, 2012, REPRODUCTION, V144, P661, DOI 10.1530/REP-12-0217; Haase N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093743; Hering L, 2010, HYPERTENSION, V56, P311, DOI 10.1161/HYPERTENSIONAHA.110.150961; Jeyabalan A, 2007, ADV EXP MED BIOL, V612, P65; Kristiansson P, 2001, HUM REPROD, V16, P13, DOI 10.1093/humrep/16.1.13; Lafayette RA, 2011, CLIN NEPHROL, V75, P226, DOI 10.5414/CNP75226; Lodhi RSZ, 2013, GYNECOL ENDOCRINOL, V29, P1051, DOI 10.3109/09513590.2013.829444; McGuane JT, 2011, ENDOCRINOLOGY, V152, P2786, DOI 10.1210/en.2010-1126; Novak J, 2001, J CLIN INVEST, V107, P1469, DOI 10.1172/JCI11975; Piccinni MP, 1999, EUR J IMMUNOL, V29, P2241, DOI 10.1002/(SICI)1521-4141(199907)29:07<2241::AID-IMMU2241>3.0.CO;2-E; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Roberts JM, 2005, HYPERTENSION, V46, P1243, DOI 10.1161/01.HYP.0000188408.49896.c5; Samuel CS, 2009, CURR OPIN NEPHROL HY, V18, P9, DOI 10.1097/MNH.0b013e32831b7096; Segal MS, 2012, BLOOD, V119, P629, DOI 10.1182/blood-2011-04-346007; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; Smith MC, 2006, FERTIL STERIL, V86, P253, DOI 10.1016/j.fertnstert.2005.11.070; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stewart DR, 1999, HUM REPROD, V14, P338, DOI 10.1093/humrep/14.2.338; SZLACHTER BN, 1982, OBSTET GYNECOL, V59, P167; Takimoto E, 1996, SCIENCE, V274, P995, DOI 10.1126/science.274.5289.995; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Thadhani R, 2011, CIRCULATION, V124, P940, DOI 10.1161/CIRCULATIONAHA.111.034793; Unemori E, 2009, ANN NY ACAD SCI, V1160, P381, DOI 10.1111/j.1749-6632.2009.03838.x; Verlohren S, 2008, HYPERTENSION, V51, P547, DOI 10.1161/HYPERTENSIONAHA.107.103176; Verlohren S, 2010, HYPERTENSION, V56, P304, DOI 10.1161/HYPERTENSIONAHA.110.153163	44	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150743	10.1371/journal.pone.0150743	http://dx.doi.org/10.1371/journal.pone.0150743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963382	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000371993000056
J	Howe, GA; Xiao, B; Zhao, HJ; Al-Zahrani, KN; Hasim, MS; Villeneuve, J; Sekhon, HS; Goss, GD; Sabourin, LA; Dimitroulakos, J; Addison, CL				Howe, Grant A.; Xiao, Bin; Zhao, Huijun; Al-Zahrani, Khalid N.; Hasim, Mohamed S.; Villeneuve, James; Sekhon, Harmanjatinder S.; Goss, Glenwood D.; Sabourin, Luc A.; Dimitroulakos, Jim; Addison, Christina L.			Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EGFR INHIBITORS; ACQUIRED-RESISTANCE; CLINICAL-RESPONSE; MUTATIONS; GEFITINIB; FAK; ADENOCARCINOMAS; SENSITIVITY; ACTIVATION	Blockade of epidermal growth factor receptor (EGFR) activity has been a primary therapeutic target for non-small cell lung cancers (NSCLC). As patients with wild-type EGFR have demonstrated only modest benefit from EGFR tyrosine kinase inhibitors (TKIs), there is a need for additional therapeutic approaches in patients with wild-type EGFR. As a key component of downstream integrin signalling and known receptor cross-talk with EGFR, we hypothesized that targeting focal adhesion kinase (FAK) activity, which has also been shown to correlate with aggressive stage in NSCLC, would lead to enhanced activity of EGFR TKIs. As such, EGFR TKI-resistant NSCLC cells (A549, H1299, H1975) were treated with the EGFR TKI erlotinib and FAK inhibitors (PF-573,228 or PF-562,271) both as single agents and in combination. We determined cell viability, apoptosis and 3-dimensional growth in vitro and assessed tumor growth in vivo. Treatment of EGFR TKI-resistant NSCLC cells with FAK inhibitor alone effectively inhibited cell viability in all cell lines tested; however, its use in combination with the EGFR TKI erlotinib was more effective at reducing cell viability than either treatment alone when tested in both 2-and 3-dimensional assays in vitro, with enhanced benefit seen in A549 cells. This increased efficacy may be due in part to the observed inhibition of Akt phosphorylation when the drugs were used in combination, where again A549 cells demonstrated the most inhibition following treatment with the drug combination. Combining erlotinib with FAK inhibitor was also potent in vivo as evidenced by reduced tumor growth in the A549 mouse xenograft model. We further ascertained that the enhanced sensitivity was irrespective of the LKB1 mutational status. In summary, we demonstrate the effectiveness of combining erlotinib and FAK inhibitors for use in known EGFR wild-type, EGFR TKI resistant cells, with the potential that a subset of cell types, which includes A549, could be particularly sensitive to this combination treatment. As such, further evaluation of this combination therapy is warranted and could prove to be an effective therapeutic approach for patients with inherent EGFR TKI-resistant NSCLC.	[Howe, Grant A.; Xiao, Bin; Zhao, Huijun; Al-Zahrani, Khalid N.; Hasim, Mohamed S.; Villeneuve, James; Sabourin, Luc A.; Dimitroulakos, Jim; Addison, Christina L.] Ottawa Hosp Res Inst, Canc Therapeut Program, Ottawa, ON, Canada; [Al-Zahrani, Khalid N.; Sabourin, Luc A.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Hasim, Mohamed S.; Dimitroulakos, Jim; Addison, Christina L.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Villeneuve, James] Univ Ottawa, Dept Surg, Ottawa, ON, Canada; [Sekhon, Harmanjatinder S.] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Goss, Glenwood D.; Dimitroulakos, Jim; Addison, Christina L.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa	Addison, CL (corresponding author), Ottawa Hosp Res Inst, Canc Therapeut Program, Ottawa, ON, Canada.; Addison, CL (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Addison, CL (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON, Canada.	caddison@ohri.ca	Dimitroulakos, Jim/AAK-3398-2020	Hasim, Mohamed Shaad/0000-0002-0275-3378	Lung Cancer Research Foundation	Lung Cancer Research Foundation	This work was supported by a grant to CLA from the Lung Cancer Research Foundation (http://www.lungcancerresearchfoundation.org). The funders had no role in the study design, data collection or analysis, decision to publish or the preparation of this manuscript.	Al-Zahrani KN, 2014, DEV DYNAM, V243, P640, DOI 10.1002/dvdy.24106; Amann J, 2005, CANCER RES, V65, P226; Bagi CM, 2009, CANCER BIOL THER, V8, P856, DOI 10.4161/cbt.8.9.8246; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bianco R, 2008, BRIT J CANCER, V98, P923, DOI 10.1038/sj.bjc.6604269; Cabrita MA, 2011, MOL ONCOL, V5, P517, DOI 10.1016/j.molonc.2011.10.004; Calvo E, 2006, J CLIN ONCOL, V24, P2158, DOI 10.1200/JCO.2006.06.5961; Carelli S, 2006, LUNG CANCER, V53, P263, DOI 10.1016/j.lungcan.2006.06.001; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Ettinger DS, 2006, ONCOLOGIST, V11, P358, DOI 10.1634/theoncologist.11-4-358; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Friess T, 2005, CLIN CANCER RES, V11, P5300, DOI 10.1158/1078-0432.CCR-04-2642; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Golubovskaya VM, 2010, ANTI-CANCER AGENT ME, V10, P735; Hiscox S, 2011, BREAST CANCER RES TR, V125, P659, DOI 10.1007/s10549-010-0857-4; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Honeywell DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070515; Ju LX, 2010, J CELL BIOCHEM, V111, P1565, DOI 10.1002/jcb.22888; Kline ER, 2013, J BIOL CHEM, V288, P17663, DOI 10.1074/jbc.M112.444620; Konstantinidou G, 2013, CANCER DISCOV, V3, P444, DOI 10.1158/2159-8290.CD-12-0388; Li C, 2013, CANCER GENE THER, V20, P101, DOI 10.1038/cgt.2012.91; Lu HB, 2013, MOL CANCER THER, V12, P2864, DOI 10.1158/1535-7163.MCT-13-0233; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mahoney CL, 2009, BRIT J CANCER, V100, P370, DOI 10.1038/sj.bjc.6604886; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Mukohara T, 2005, JNCI-J NATL CANCER I, V97, P1185, DOI 10.1093/jnci/dji238; Murray S, 2006, LUNG CANCER, V52, P225, DOI 10.1016/j.lungcan.2005.12.015; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2005, J CLIN ONCOL, V23, P2556, DOI 10.1200/JCO.2005.07.799; Pino MS, 2006, CANCER RES, V66, P3802, DOI 10.1158/0008-5472.CAN-05-3753; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Schultze A, 2010, INVEST NEW DRUG, V28, P825, DOI 10.1007/s10637-009-9326-5; Schultze A, 2010, EXPERT OPIN INV DRUG, V19, P777, DOI 10.1517/13543784.2010.489548; Schwock J, 2010, EXPERT OPIN THER TAR, V14, P77, DOI 10.1517/14728220903460340; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Suda K, 2012, CANCER METAST REV, V31, P807, DOI 10.1007/s10555-012-9391-7; Tracy S, 2004, CANCER RES, V64, P7241, DOI 10.1158/0008-5472.CAN-04-1905; van Nimwegen MJ, 2005, CANCER RES, V65, P4698, DOI 10.1158/0008-5472.CAN-04-4126; Yoon H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088587; Yu X, 2000, J CELL SCI, V113, P2139; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924	52	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150567	10.1371/journal.pone.0150567	http://dx.doi.org/10.1371/journal.pone.0150567			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26962872	Green Published, gold			2022-12-27	WOS:000371993000042
J	Krishnan, R; Menon, RR; Tanaka, N; Busse, HJ; Krishnamurthi, S; Rameshkumar, N				Krishnan, Ramya; Menon, Rahul Ravikumar; Tanaka, Naoto; Busse, Hans-Juergen; Krishnamurthi, Srinivasan; Rameshkumar, Natarajan			Arthrobacter pokkalii sp nov, a Novel Plant Associated Actinobacterium with Plant Beneficial Properties, Isolated from Saline Tolerant Pokkali Rice, Kerala, India	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; AD-HOC-COMMITTEE; PSEUDOMONAS-FLUORESCENS; DEOXYRIBONUCLEIC-ACID; PHYLOGENETIC ANALYSIS; SPECIES DEFINITION; BIOFILM FORMATION; ACC DEAMINASE; SOIL; RHIZOSPHERE	A novel yellow colony-forming bacterium, strain P3B162(T) was isolated from the pokkali rice rhizosphere from Kerala, India, as part of a project study aimed at isolating plant growth beneficial rhizobacteria from saline tolerant pokkali rice and functionally evaluate their abilities to promote plant growth under saline conditions. The novel strain P3B162(T) possesses plant growth beneficial traits such as positive growth on 1-aminocyclopropane-1-carboxylic acid (ACC), production of indole acetic acid (IAA) and siderophore. In addition, it also showed important phenotypic characters such as ability to form biofilm and utilization of various components of plant root exudates (sugars, amino acids and organic acids), clearly indicating its lifestyle as a plant rhizosphere associated bacterium. Taxonomically, the novel strain P3B162(T) was affiliated to the genus Arthrobacter based on the collective results of phenotypic, genotypic and chemotaxonomic analyses. Moreover, molecular analysis using 16S rRNA gene showed Arthrobacter globiformis NBRC 12137(T), Arthrobacter pascens DSM 20545(T) and Arthrobacter liuii DSXY97(3)T as the closely related phylogenetic neighbours, showing more than 98% 16S rRNA similarity values, whereas the recA gene analysis displayed Arthrobacter liuii JCM 19864(T) as the nearest neighbour with 94.7% sequence similarity and only 91.7% to Arthrobacter globiformis LMG 3813(T) and 88.7% to Arthrobacter pascens LMG 16255(T). However, the DNA-DNA hybridization values between strain P3B162(T), Arthrobacter globiformis LMG 3813(T), Arthrobacter pascens LMG 16255(T) and Arthrobacter liuii JCM 19864(T) was below 50%. In addition, the novel strain P3B162(T) can be distinguished from its closely related type strains by several phenotypic characters such as colony pigment, tolerance to NaCl, motility, reduction of nitrate, hydrolysis of DNA, acid from sucrose, cell wall sugars and cell wall peptidoglycan structure. In conclusion, the combined results of this study support the classification of strain P3B162(T) as a novel Arthrobacter species and we propose Arthrobacter pokkalii sp.nov.as its name. The type strain is P3B162(T) (= KCTC 29498(T) = MTCC 12358(T)).	[Krishnan, Ramya; Menon, Rahul Ravikumar; Rameshkumar, Natarajan] CSIR, Natl Inst Interdisciplinary Sci & Technol, Dept Biotechnol, Thiruvananthapuram 695019, Kerala, India; [Tanaka, Naoto] Tokyo Univ Agr, NODAI Culture Collect Ctr, Setagaya Ku, 1-1-1 Sakuragaoka, Tokyo 1568502, Japan; [Busse, Hans-Juergen] Vet Univ Vienna, Inst Microbiol, A-1210 Vienna, Austria; [Krishnamurthi, Srinivasan] CSIR, Inst Microbial Technol, Microbial Type Culture Collect & Gene Bank MTCC, Sec 39A, Chandigarh 160036, India; [Krishnan, Ramya; Rameshkumar, Natarajan] Acad Sci & Innovat Res AcSIR, New Delhi 110001, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST); Tokyo University of Agriculture; University of Veterinary Medicine Vienna; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Academy of Scientific & Innovative Research (AcSIR)	Rameshkumar, N (corresponding author), CSIR, Natl Inst Interdisciplinary Sci & Technol, Dept Biotechnol, Thiruvananthapuram 695019, Kerala, India.; Rameshkumar, N (corresponding author), Acad Sci & Innovat Res AcSIR, New Delhi 110001, India.	rameshkumar@niist.res.in		Natatajan, Ramesh Kumar/0000-0003-1241-8933; Krishnan, Ramya/0000-0003-2180-2814	Council of Scientific and Industrial research (CSIR), Government of India [BSC0117]; Council of Scientific and Industrial Research	Council of Scientific and Industrial research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was carried out with financial support from the Council of Scientific and Industrial research (CSIR) supported project (BSC0117), Government of India, to NRK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Dr. Rudiger Pukall (DSMZ) for kindly providing the three type strains of Arthrobacter; DSM 24664<SUP>T</SUP>, DSM 25586<SUP>T</SUP> and DSM 25587<SUP>T</SUP>, Dr. Elke Lang for helping biomass generation for cell wall analysis. RK acknowledge the Council of Scientific and Industrial Research for providing the junior research fellowship.	Altenburger P, 1996, J BIOTECHNOL, V47, P39, DOI 10.1016/0168-1656(96)01376-4; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Busse H. J., 2012, BERGEYS MANUAL SYSTE, V5, P578; Carmen B, 2011, ABIOTIC STRESS IN PLANTS - MECHANISMS AND ADAPTATIONS, P143; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; CONN HJ, 1947, J BACTERIOL, V54, P291, DOI 10.1128/JB.54.3.291-303.1947; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224, DOI 10.1099/00207713-39-3-224; Francis I, 2010, ENVIRON MICROBIOL, V12, P1, DOI 10.1111/j.1462-2920.2009.01989.x; Glick BR, 2014, MICROBIOL RES, V169, P30, DOI 10.1016/j.micres.2013.09.009; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Hontzeas N, 2005, APPL ENVIRON MICROB, V71, P7556, DOI 10.1128/AEM.71.11.7556-7558.2005; Huang Z, 2015, INT J SYST EVOL MICR, V65, P365, DOI 10.1099/ijs.0.069492-0; Jaeger CH, 1999, APPL ENVIRON MICROB, V65, P2685; Kampfer P, 2012, ENVIRON MICROBIOL, V14, P291, DOI 10.1111/j.1462-2920.2011.02615.x; Kageyama A, 2008, INT J SYST EVOL MICR, V58, P53, DOI 10.1099/ijs.0.64875-0; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P250, DOI 10.1094/MPMI-19-0250; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kim TU, 2012, J MICROBIOL, V50, P50, DOI 10.1007/s12275-012-1417-x; KOCH C, 1995, INT J SYST BACTERIOL, V45, P837, DOI 10.1099/00207713-45-4-837; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kravchenko LV, 2004, MICROBIOLOGY+, V73, P156, DOI 10.1023/B:MICI.0000023982.76684.9d; Kuiper I, 2001, MOL PLANT MICROBE IN, V14, P1096, DOI 10.1094/MPMI.2001.14.9.1096; Kumar NR, 2007, INT J SYST EVOL MICR, V57, P2241, DOI 10.1099/ijs.0.65017-0; Kwok AYC, 1999, INT J SYST BACTERIOL, V49, P1181, DOI 10.1099/00207713-49-3-1181; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lugtenberg BJJ, 1999, ENVIRON MICROBIOL, V1, P439, DOI 10.1046/j.1462-2920.1999.00054.x; Marasco R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048479; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; McGrath KC, 2010, APPL ENVIRON MICROB, V76, P7161, DOI 10.1128/AEM.03108-09; Mikkonen TP, 2004, INT J SYST EVOL MICR, V54, P753, DOI 10.1099/ijs.0.02839-0; Noiraud N, 2001, PLANT CELL, V13, P695, DOI 10.1105/tpc.13.3.695; Onofre-Lemus J, 2009, APPL ENVIRON MICROB, V75, P6581, DOI 10.1128/AEM.01240-09; Owen R. J., 1979, IDENTIFICATION METHO, P217; Park Y, 2014, INT J SYST EVOL MICR, V64, P3069, DOI 10.1099/ijs.0.064550-0; Parte AC, 2014, NUCLEIC ACIDS RES, V42, pD613, DOI 10.1093/nar/gkt1111; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Qin S, 2014, PLANT SOIL, V374, P753, DOI 10.1007/s11104-013-1918-3; Rainey PB, 1999, ENVIRON MICROBIOL, V1, P243, DOI 10.1046/j.1462-2920.1999.00040.x; Rameshkumar N, 2014, INT J SYST EVOL MICR, V64, P545, DOI 10.1099/ijs.0.053512-0; Rameshkumar N, 2009, FEMS MICROBIOL ECOL, V67, P455, DOI 10.1111/j.1574-6941.2008.00638.x; Ramey BE, 2004, CURR OPIN MICROBIOL, V7, P602, DOI 10.1016/j.mib.2004.10.014; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Ruppel S, 2013, FUNCT PLANT BIOL, V40, P940, DOI 10.1071/FP12355; SantaCruz-Calvo L, 2013, INT J SYST EVOL MICR, V63, P4174, DOI 10.1099/ijs.0.052902-0; Sarkar S, 2008, FEMS MICROBIOL LETT, V282, P160, DOI 10.1111/j.1574-6968.2008.01080.x; Sasser M, 1990, IDENTIFICATION BACTE; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schumann P, 2011, METHOD MICROBIOL, V38, P101, DOI 10.1016/B978-0-12-387730-7.00005-X; Schumann P, 2009, INT J SYST EVOL MICR, V59, P1823, DOI 10.1099/ijs.0.012971-0; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Shen XM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-271; Shi SJ, 2011, FEMS MICROBIOL ECOL, V77, P600, DOI 10.1111/j.1574-6941.2011.01150.x; Silby MW, 2004, J BACTERIOL, V186, P7411, DOI 10.1128/JB.186.21.7411-7419.2004; Smibert R.M., 1994, METHODS GEN MOL BACT, p[617, 620, 622]; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Stevenson F. J., 1985, Humic substances in soil, sediment and water: geochemistry, isolation and characterization., P13; Stolz A, 2007, INT J SYST EVOL MICR, V57, P572, DOI 10.1099/ijs.0.64761-0; Sziderics AH, 2007, CAN J MICROBIOL, V53, P1195, DOI 10.1139/W07-082; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timmusk S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096086; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; TINDALL BJ, 1990, SYST APPL MICROBIOL, V13, P128, DOI 10.1016/S0723-2020(11)80158-X; Tiwari S, 2011, BIOL FERT SOILS, V47, P907, DOI 10.1007/s00374-011-0598-5; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; van Waasbergen LG, 2000, APPL ENVIRON MICROB, V66, P3454, DOI 10.1128/AEM.66.8.3454-3463.2000; Hoang VA, 2014, INT J SYST EVOL MICR, V64, P420, DOI 10.1099/ijs.0.053967-0; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Yamamoto S, 1996, INT J SYST BACTERIOL, V46, P506, DOI 10.1099/00207713-46-2-506; Yu XY, 2014, INT J SYST IN PRESS; Zhang J, 2012, INT J SYST EVOL MICR, V62, P2731, DOI 10.1099/ijs.0.036889-0	79	22	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150322	10.1371/journal.pone.0150322	http://dx.doi.org/10.1371/journal.pone.0150322			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963092	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000032
J	Sun, QQ; Nie, SS; Wang, LX; Yang, F; Meng, ZM; Xiao, HY; Xiang, B; Li, XJ; Fu, XH; Wang, S				Sun, Qianqian; Nie, Shuangshuang; Wang, Lingxiao; Yang, Fan; Meng, Zhangming; Xiao, Hengyi; Xiang, Bing; Li, Xiujun; Fu, Xianghui; Wang, Shuang			Factors that Affect Pancreatic Islet Cell Autophagy in Adult Rats: Evaluation of a Calorie-Restricted Diet and a High-Fat Diet	PLOS ONE			English	Article							BETA-CELLS; GLUCOSE-TOLERANCE; IN-VIVO; APOPTOSIS; INSULIN; DEATH; CANCER; HOMEOSTASIS; LC3B; MICE	Aging may be a risk factor for type 2 diabetes in the elderly. Dietary intervention can affect glucose tolerance in adults, which may be due to body composition and islet cell autophagy. The aim of this study was to determine the effects of various dietary interventions on islet cell autophagy. Pancreatic tissue and blood samples were collected from Sprague Dawley rats (14-16 months old, n = 15 for each group) that received a normal diet (ND), a high-fat diet (HFD), or a calorie-restricted diet (CRD). The body weight (BW), visceral fat, serum lipid levels, fasting serum glucose, insulin levels, and beta/alpha cell area were determined in 14-16-(0-w), 16-18-(8-w), and 18-20(16-w)-month-old rats. Pancreatic islet autophagy (LC3B and LAMP2), AP (Acid Phosphatase) and apoptosis (apoptosis index, AI (TUNEL assay) and cleaved caspase-3) were detected using immunohistochemistry, ELISA and western blot. At 16 weeks, the expressions of LC3B, LAMP2 and AP markedly increased in both the HFD (P<0.01) and CRD (P<0.05) groups; however, an increase in the AI (P<0.05), cleaved caspase-3 and Beclin1 expression and a decrease in the expressions of BCL2 and BCLXL (P<0.05) were observed in only the HFD group. FFA, triglyceride levels, HOMA-IR, insulin levels and glucagon levels were significantly increased in the HFD group but decreased in the CRD group at 16 weeks (P<0.05). The degree of islet cell autophagy was potentially regulated by the levels of FFA and islet cell insulin and glucagon, which may have been due to the effects of Beclin1/BCL2.	[Sun, Qianqian; Nie, Shuangshuang; Wang, Lingxiao; Yang, Fan; Meng, Zhangming; Wang, Shuang] Sichuan Univ, Ctr Gerontol & Geriatr, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China; [Xiao, Hengyi] Sichuan Univ, West China Hosp, West China Med Sch, Lab Aging Res, Chengdu 610064, Sichuan Provinc, Peoples R China; [Xiang, Bing] Sichuan Univ, West China Hosp, Dept Hematol, Chengdu 610064, Sichuan Provinc, Peoples R China; [Li, Xiujun] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610064, Sichuan Provinc, Peoples R China; [Fu, Xianghui] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Sichuan Provinc, Peoples R China; [Fu, Xianghui] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610064, Sichuan Provinc, Peoples R China; [Fu, Xianghui] Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University	Wang, S (corresponding author), Sichuan Univ, Ctr Gerontol & Geriatr, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China.	wangs0211@hotmail.com	wang, xl/Y-8251-2019; wang, xiao/HGB-7081-2022; Wang, Xin/GYU-1129-2022; Wang, Xin/AAN-8435-2021; li, xiu/GXV-1745-2022	wang, xiao/0000-0002-4088-3341; Wang, Xin/0000-0002-4457-7376; Fu, Xianghui/0000-0001-9808-3892	Science and Technology of Sichuan Province of China [2013FZ0054]	Science and Technology of Sichuan Province of China	Funding for this work came from the Science and Technology of Sichuan Province of China (2013FZ0054). The funder played an important role in the study design, data collection and analysis.	Button RW, 2015, NEUROSCI BULL, V31, P382, DOI 10.1007/s12264-015-1528-y; Chen S, 2013, CLIN CANCER RES, V19, P6853, DOI 10.1158/1078-0432.CCR-13-1617; Chu KY, 2015, DIABETOLOGIA, V58, P2074, DOI 10.1007/s00125-015-3665-x; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Giansanti V, 2011, APOPTOSIS, V16, P321, DOI 10.1007/s10495-011-0589-x; Guo JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5420; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Hilderink J, 2015, J CELL MOL MED, V19, P1836, DOI 10.1111/jcmm.12555; Hur KY, 2010, DIABETES OBES METAB, V12, P20, DOI 10.1111/j.1463-1326.2010.01278.x; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Keku TO, 2005, CANCER EPIDEM BIOMAR, V14, P2076, DOI 10.1158/1055-9965.EPI-05-0239; Lalaoui N, 2015, SEMIN CELL DEV BIOL, V39, P63, DOI 10.1016/j.semcdb.2015.02.003; Lee MS, 2014, TRENDS ENDOCRIN MET, V25, P620, DOI 10.1016/j.tem.2014.08.005; Lerman-Garber I, 2010, REV INVEST CLIN, V62, P312; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li MM, 2015, APOPTOSIS, V20, P769, DOI 10.1007/s10495-015-1110-8; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Maruyama Y, 2014, BIOCHEM BIOPH RES CO, V446, P309, DOI 10.1016/j.bbrc.2014.02.093; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Qi ZF, 2015, TRANSL STROKE RES, V6, P198, DOI 10.1007/s12975-015-0393-y; Shimizu S, 2014, INT J MOL SCI, V15, P3145, DOI 10.3390/ijms15023145; Su ZY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0321-5; Tessari P, 2013, DIABETES, V62, P2699, DOI 10.2337/db12-1127; Wang S, 2013, CLIN INVEST MED, V36, pE72; Weiss EP, 2006, AM J CLIN NUTR, V84, P1033; Xing BH, 2015, J PHYSIOL BIOCHEM, V71, P649, DOI 10.1007/s13105-015-0430-z; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Young ARJ, 2010, CURR OPIN CELL BIOL, V22, P234, DOI 10.1016/j.ceb.2009.12.005	30	15	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151104	10.1371/journal.pone.0151104	http://dx.doi.org/10.1371/journal.pone.0151104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963814	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000104
J	Alamidi, DF; Kindvall, SSI; Cristinacce, PLH; McGrath, DM; Young, SS; Naish, JH; Waterton, JC; Wollmer, P; Diaz, S; Olsson, M; Hockings, PD; Lagerstrand, KM; Parker, GJM; Olsson, LE				Alamidi, Daniel F.; Kindvall, Simon S. I.; Cristinacce, Penny L. Hubbard; McGrath, Deirdre M.; Young, Simon S.; Naish, Josephine H.; Waterton, John C.; Wollmer, Per; Diaz, Sandra; Olsson, Marita; Hockings, Paul D.; Lagerstrand, Kerstin M.; Parker, Geoffrey J. M.; Olsson, Lars E.			T-1 Relaxation Time in Lungs of Asymptomatic Smokers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COPD; QUANTIFICATION; EMPHYSEMA; SMOKING; HEALTH; MRI; T1	Purpose Interest in using T-1 as a potential MRI biomarker of chronic obstructive pulmonary disease (COPD) has recently increased. Since tobacco smoking is the major risk factor for development of COPD, the aim for this study was to examine whether tobacco smoking, pack-years (PY), influenced T-1 of the lung parenchyma in asymptomatic current smokers. Materials and Methods Lung T-1 measurements from 35 subjects, 23 never smokers and 12 current smokers were retrospectively analyzed from an institutional review board approved study. All 35 subjects underwent pulmonary function test (PFT) measurements and lung T-1, with similar T-1 measurement protocols. A backward linear model of T-1 as a function of FEV1, FVC, weight, height, age and PY was tested. Results A significant correlation between lung T-1 and PY was found with a negative slope of -3.2 ms/year (95% confidence interval [CI] [-5.8, -0.6], p = 0.02), when adjusted for age and height. Lung T-1 shortens with ageing among all subjects, -4.0 ms/year (95% CI [-6.3, -1.7], p = 0.001), and among the never smokers, -3.7 ms/ year (95% CI [-6.0, -1.3], p = 0.003). Conclusions A correlation between lung T1 and PY when adjusted for both age and height was found, and T-1 of the lung shortens with ageing. Accordingly, PY and age can be significant confounding factors when T-1 is used as a biomarker in lung MRI studies that must be taken into account to detect underlying patterns of disease.	[Alamidi, Daniel F.; Lagerstrand, Kerstin M.] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Radiat Phys, Gothenburg, Sweden; [Kindvall, Simon S. I.; Olsson, Lars E.] Lund Univ, Dept Med Phys, Translat Sci, Malmo, Sweden; [Cristinacce, Penny L. Hubbard; McGrath, Deirdre M.; Naish, Josephine H.; Waterton, John C.; Parker, Geoffrey J. M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Imaging Sci, Manchester, Lancs, England; [Cristinacce, Penny L. Hubbard; McGrath, Deirdre M.; Naish, Josephine H.; Waterton, John C.; Parker, Geoffrey J. M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Biomed Imaging Inst, Manchester, Lancs, England; [Young, Simon S.] AstraZeneca R&D, Alderley Pk, Cheshire, England; [Wollmer, Per; Diaz, Sandra] Lund Univ, Dept Translat Med, Malmo, Sweden; [Olsson, Marita] AstraZeneca R&D, Molndal, Sweden; [Hockings, Paul D.] Chalmers Univ Technol, Medtech West, S-41296 Gothenburg, Sweden; [Hockings, Paul D.] Antaros Med, BioVenture Hub, Molndal, Sweden; [Parker, Geoffrey J. M.] Bioxydyn Ltd, Manchester, Lancs, England	University of Gothenburg; Lund University; University of Manchester; University of Manchester; AstraZeneca; Lund University; AstraZeneca; Chalmers University of Technology	Alamidi, DF (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Radiat Phys, Gothenburg, Sweden.	daniel.alamidi@gu.se	Parker, Geoff/Y-6269-2019; Hockings, Paul D/AAM-7950-2020; Waterton, John Charles/A-8565-2008; Wollmer, Per/S-5895-2019	Parker, Geoff/0000-0003-2934-2234; Hockings, Paul D/0000-0002-7154-9047; Waterton, John Charles/0000-0002-7734-2290; Kindvall, Simon/0000-0003-2176-7529; Diaz Ruiz, Sandra/0000-0003-2016-4195; Olsson, Lars E./0000-0001-6090-6697; McGrath, Deirdre/0000-0002-0823-8932; Young, Simon/0000-0003-4331-7596	AstraZeneca and Allmanna Sjukhusets i Malmo stiftelse for bekampande av Cancer	AstraZeneca and Allmanna Sjukhusets i Malmo stiftelse for bekampande av Cancer	This work was supported by AstraZeneca and Allmanna Sjukhusets i Malmo stiftelse for bekampande av Cancer. The funders provided support in the form of salaries for authors DFA, SSIK, SSY, and MO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agusti A, 2014, THORAX, V69, P857, DOI 10.1136/thoraxjnl-2014-205507; Alamidi FD, 2015, J CHRONIC OBSTRUCTIV, V2555, P1, DOI DOI 10.3109/15412555.2015.10488; [Anonymous], 2008, WORLD HLTH STAT 2008; Barnes PJ, 2003, THORAX, V58, P803, DOI 10.1136/thorax.58.9.803; BERGIN C, 1986, AM REV RESPIR DIS, V133, P541; Biederer J, 2012, INSIGHTS IMAG, P1; BOTTOMLEY PA, 1987, MED PHYS, V14, P1, DOI 10.1118/1.596111; Dasenbrook EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073286; DEICHMANN R, 1992, J MAGN RESON, V96, P608, DOI 10.1016/0022-2364(92)90347-A; Deninger AJ, 1999, J MAGN RESON, V141, P207, DOI 10.1006/jmre.1999.1902; Edelman RR, 1996, NAT MED, V2, P1236, DOI 10.1038/nm1196-1236; Fain SB, 2006, RADIOLOGY, V239, P875, DOI 10.1148/radiol.2393050111; Gerhardsson de Verdier Maria, 2008, Proc Am Thorac Soc, V5, P800, DOI 10.1513/pats.200806-058TH; Hamedani H, 2014, RADIOLOGY; Hanrahan JP, 1996, AM J RESP CRIT CARE, V153, P861, DOI 10.1164/ajrccm.153.2.8564146; Jakob PM, 2001, J MAGN RESON IMAGING, V14, P795, DOI 10.1002/jmri.10024; Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x; Jogi J, 2011, EUR J NUCL MED MOL I, V38, P1344, DOI 10.1007/s00259-011-1757-5; KILBURN KH, 1984, ENVIRON HEALTH PERSP, V55, P97, DOI 10.2307/3429695; Lynch DA, 2008, CLIN CHEST MED, V29, P165, DOI 10.1016/j.ccm.2007.11.008; Mai VM, 1999, MAGNET RESON MED, V41, P866, DOI 10.1002/(SICI)1522-2594(199905)41:5<866::AID-MRM2>3.0.CO;2-D; Mannino DM, 2006, EUR RESPIR J, V27, P627, DOI 10.1183/09031936.06.00024605; Marsh S, 2006, EUR RESPIR J, V28, P883, DOI 10.1183/09031936.06.00074806; Meinel FG, 2013, EUR J RADIOL, V82, P1565, DOI 10.1016/j.ejrad.2013.04.019; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morgan AR, 2014, EUR J RADIOL, V83, P2093, DOI 10.1016/j.ejrad.2014.08.004; Naish JH, 2005, MAGNET RESON MED, V54, P464, DOI 10.1002/mrm.20570; Stadler A, 2008, MAGN RESON MED, V59, P96, DOI 10.1002/mrm.21446; Stadler A, 2007, INT J BIOMED IMAGING, V2007, DOI 10.1155/2007/23624; Swanney MP, 2008, THORAX, V63, P1046, DOI 10.1136/thx.2008.098483; Triphan SMF, 2015, J MAGN RESON IMAGING, V42, P610, DOI 10.1002/jmri.24840; Wild JM, 2012, INSIGHTS IMAGING, V3, P345, DOI 10.1007/s13244-012-0176-x; Zhang W-J, 2015, RADIOLOGY	33	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149760	10.1371/journal.pone.0149760	http://dx.doi.org/10.1371/journal.pone.0149760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26958856	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300023
J	Chen, XH; Li, M; Jiang, HL; Li, YM; Mo, JR; Lin, PY; Graham, CA; Rainer, TH				Chen, Xiaohui; Li, Min; Jiang, Huilin; Li, Yunmei; Mo, Junrong; Lin, Peiyi; Graham, Colin A.; Rainer, Timothy H.			STEMI Outcomes in Guangzhou and Hong Kong: Two-Centre Retrospective Interregional Study	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY ANGIOPLASTY; FASTING GLUCOSE; HEALTH-CARE; REPERFUSION; MANAGEMENT; GUIDELINES; CHINA; DELAY	Background and Objectives Healthcare systems are organized very differently in Hong Kong (HK) and Guangzhou (GZ). This study compared managements of the emergency departments (ED) and one-year mortalities of ST-segment elevation myocardial infarction (STEMI) patients in two teaching hospitals in Guangzhou and Hong Kong. Methods Retrospective observational study of STEMI mortalities and treatments in the Prince of Wales Hospital (PWH) and the Second Affiliated Hospital of Guangzhou Medical University (AHGZMU), was conducted between January and December 2010. The primary outcome was one-year all cause mortality. Results Univariate analysis of 76 cases from PWH and 111 cases from AHGZMU showed similar clinical characteristics, except for lower proportions of males (74% vs 92%, P = 0.002), hyperlipidemia (5% vs 25%, P<0.001), and Killip class I (56% vs 91%; P<0.001) in AHGZMU. The onset-to-door time of STEMI patients in AHGZMU was longer than in PWH (median 205 min [(IQR: 95-432) vs 120 min (IQR: 55-225), P = 0.001]. In AHGZMU, 85 (77%) patients received primary percutaneous coronary intervention (PPCI) as the main reperfusion treatment, whereas 18 (24%) received PPCI and 51 (67%) patients received thrombolytic therapy in PWH. Overall the one-year mortality in AHGZMU was 20%, whilst in PWH it was 14% (P = 0.436). The standardized one-year all-cause mortality ratios for AHGZMU and PWH were comparable (18.7 vs. 18.2%, P = 0894). Independent predictors of one-year mortality included older age (>67 years) and hyperglycemia (>10 mmol/L). Aged over 65 years, presence of anterior wall infarct, body weight <= 65 kg, SBP <100 mmHg at ED and glucose level >10 mmol/L were the independent predictors of in-hospital MACE. Conclusion There was no statistically significant difference between the standardized one-year all-cause mortalities of STEMI patients in the setting mainly using thrombolysis with shorter door-to-treatment time and the setting mainly using PCI with longer door-to-treatment time. Aged over 67 years and glucose level over 10 mmol/L were the independent predictors of one-year mortality. Older age, presence of anterior wall infarct, lower body weight, lower SBP at ED and hyperglycemia were the independent predictors of in-hospital MACE.	[Chen, Xiaohui; Li, Min; Jiang, Huilin; Li, Yunmei; Mo, Junrong; Lin, Peiyi] Guangzhou Med Univ, Affiliated Hosp 2, Emergency Dept, Guangzhou, Guangdong, Peoples R China; [Jiang, Huilin; Li, Yunmei; Mo, Junrong; Graham, Colin A.; Rainer, Timothy H.] Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, Hong Kong, Hong Kong, Peoples R China	Guangzhou Medical University; Chinese University of Hong Kong	Rainer, TH (corresponding author), Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, Hong Kong, Hong Kong, Peoples R China.	thrainer@cuhk.edu.hk	Graham, Colin A/B-4535-2013; Rainer, Timothy/I-2591-2013	Graham, Colin A/0000-0002-4381-7470; Rainer, Timothy/0000-0003-3355-3237	Bureau of Science and Information Technology of Guangzhou Municipality [2013J4500009]; Key Medical Disciplines and Specialties Program of Guangzhou	Bureau of Science and Information Technology of Guangzhou Municipality; Key Medical Disciplines and Specialties Program of Guangzhou	This research study was supported by the Bureau of Science and Information Technology of Guangzhou Municipality (Grant No. 2013J4500009) and the Key Medical Disciplines and Specialties Program of Guangzhou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasa M, 2010, AM HEART J, V160, P322, DOI 10.1016/j.ahj.2010.05.008; Alexander KP, 2007, CIRCULATION, V115, P2570, DOI 10.1161/CIRCULATIONAHA.107.182616; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Bonnefoy E, 2009, EUR HEART J, V30, P1598, DOI 10.1093/eurheartj/ehp156; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Chen ZM, 2009, CVD PREV CONTROL, V4, P9; DeGeare VS, 2001, AM J CARDIOL, V87, P1035, DOI 10.1016/S0002-9149(01)01457-6; Department of Health, 2012, OR HLTH SURV 2011; Duan Tianbing, 2014, Zhonghua Xin Xue Guan Bing Za Zhi, V42, P641; Fitzner KA, 2000, HEALTH POLICY, V53, P147, DOI 10.1016/S0168-8510(00)00090-7; Grines CL, 1996, NEW ENGL J MED, V335, P1313; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hoebers LP, 2012, AM J CARDIOL, V109, P53, DOI 10.1016/j.amjcard.2011.07.067; Horne R, 2000, HEART, V83, P388, DOI 10.1136/heart.83.4.388; Hu DY, 2003, CHIN J GEN PRACT, V2, P75, DOI DOI 10.3760/CMA.J.ISSN.1671-7368.2003.02.005; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V60, P1; Kosiborod M, 2010, CIRCULATION, V122, P2736, DOI 10.1161/CIRCULATIONAHA.109.913368; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; McGinn AP, 2005, AM HEART J, V150, P392, DOI 10.1016/j.ahj.2005.03.064; MEIJER A, 1993, CIRCULATION, V87, P1524, DOI 10.1161/01.CIR.87.5.1524; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Pollack CV, 2008, ANN EMERG MED, V51, P591, DOI 10.1016/j.annemergmed.2007.09.004; Porter A, 2008, AM HEART J, V155, P284, DOI 10.1016/j.ahj.2007.10.010; Ranasinghe I, 2014, CIRC-CARDIOVASC QUAL, V7, P209, DOI 10.1161/CIRCOUTCOMES.113.000527; SIMES RJ, 1995, CIRCULATION, V91, P1923, DOI 10.1161/01.CIR.91.7.1923; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Suleiman M, 2005, CIRCULATION, V111, P754, DOI 10.1161/01.CIR.0000155235.48601.2A; Taylor David McD, 2005, Emerg Med Australas, V17, P204; Timoteo AT, 2011, REV PORT CARDIOL, V30, P897, DOI 10.1016/j.repc.2011.09.013; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; World Health Organization, 2011, CARD DIS; Wu KL, 2012, HONG KONG MED J, V18, P276; Xun YW, 2010, CHINESE MED J-PEKING, V123, P800, DOI 10.3760/cma.j.issn.0366-6999.2010.07.007; Yu Li-tian, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P593; Zhao D, 2000, CHIN J CARDIOL, V27, P14	36	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149981	10.1371/journal.pone.0149981	http://dx.doi.org/10.1371/journal.pone.0149981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959984	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300029
J	Fanelli, D; Lariviere, V				Fanelli, Daniele; Lariviere, Vincent			Researchers' Individual Publication Rate Has Not Increased in a Century	PLOS ONE			English	Article							ACADEMIC LIFE; PUBLISH; CONSEQUENCES; METRICS; PERISH	Debates over the pros and cons of a "publish or perish" philosophy have inflamed academia for at least half a century. Growing concerns, in particular, are expressed for policies that reward "quantity" at the expense of "quality," because these might prompt scientists to unduly multiply their publications by fractioning ("salami slicing"), duplicating, rushing, simplifying, or even fabricating their results. To assess the reasonableness of these concerns, we analyzed publication patterns of over 40,000 researchers that, between the years 1900 and 2013, have published two or more papers within 15 years, in any of the disciplines covered by the Web of Science. The total number of papers published by researchers during their early career period (first fifteen years) has increased in recent decades, but so has their average number of co-authors. If we take the latter factor into account, by measuring productivity fractionally or by only counting papers published as first author, we observe no increase in productivity throughout the century. Even after the 1980s, adjusted productivity has not increased for most disciplines and countries. These results are robust to methodological choices and are actually conservative with respect to the hypothesis that publication rates are growing. Therefore, the widespread belief that pressures to publish are causing the scientific literature to be flooded with salami-sliced, trivial, incomplete, duplicated, plagiarized and false results is likely to be incorrect or at least exaggerated.	[Fanelli, Daniele] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, 1070 Arastradero Rd, Palo Alto, CA 94304 USA; [Lariviere, Vincent] Univ Montreal, Ecole Bibliothecon & Sci Informat, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Lariviere, Vincent] Univ Quebec, OST CIRST, CP 8888,Succ Ctr Ville, Montreal, PQ H3C 3P8, Canada	Stanford University; Universite de Montreal; University of Quebec; University of Quebec Montreal	Fanelli, D (corresponding author), Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, 1070 Arastradero Rd, Palo Alto, CA 94304 USA.	email@danielefanelli.com	Lariviere, Vincent/AAF-3179-2019	Fanelli, Daniele/0000-0003-1780-1958				[Anonymous], 2015, PROTOCOL RES ASSESSM; Bertamini M, 2012, PERSPECT PSYCHOL SCI, V7, P67, DOI 10.1177/1745691611429353; Buela-Casal G, 2014, EUR J PSYCHOL APPL L, V6, P91, DOI 10.1016/j.ejpal.2014.06.005; De Rond M, 2005, J MANAGE INQUIRY, V14, P321, DOI 10.1177/1056492605276850; Debackere K, 2004, SCIENTOMETRICS, V59, P253, DOI 10.1023/B:SCIE.0000018532.70146.02; Fanelli D, 2013, PLOS ONE IN PRESS; Fanelli D., 2010, PLOS ONE, V5; Fanelli D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127556; Fanelli D, 2013, P NATL ACAD SCI USA, V110, P15031, DOI 10.1073/pnas.1302997110; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Franzoni C, 2011, SCIENCE, V333, P702, DOI 10.1126/science.1197286; Fronczak P, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.026103; Garfield E, 1996, SCIENTIST, V10, P11; Gingras Y., 2010, PHYS PERSPECTIVE, V12; Hayer CA, 2013, FISHERIES, V38, P352, DOI 10.1080/03632415.2013.813845; Hicks D, 2015, NATURE, V520, P429, DOI 10.1038/520429a; Jose-Alain S, SCI TRANSL MED, V3, P84, DOI [10.1126/scitranslmed.3002249, DOI 10.1126/SCITRANSLMED.3002249]; Kaushal SS, 2013, BIOSCIENCE, V63, P155, DOI 10.1525/bio.2013.63.3.3; Miller AN, 2011, CAREER DEV INT, V16, P422, DOI 10.1108/13620431111167751; Munafo MR, 2008, PSYCHOL MED, V38, P1213, DOI 10.1017/S003329170800353X; Papatheodorou SI, 2008, J CLIN EPIDEMIOL, V61, P546, DOI 10.1016/j.jclinepi.2007.07.017; Pautasso M, 2012, SUSTAINABILITY-BASEL, V4, P3234, DOI 10.3390/su4123234; Pautasso M, 2010, SCIENTOMETRICS, V85, P193, DOI 10.1007/s11192-010-0233-5; Pontille D., 2004, SIGNATURE SCI SOCIOL; Siegel D, 2010, SCIENCE, V329, P1466, DOI 10.1126/science.329.5998.1466-a; Statzner B, 2010, FRESHWATER BIOL, V55, P2639, DOI 10.1111/j.1365-2427.2010.02484.x; Tijdink JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073381; van Dalen HP, 2012, J AM SOC INF SCI TEC, V63, P1282, DOI 10.1002/asi.22636; Ware JJ, 2015, ADDICTION, V110, P4, DOI 10.1111/add.12673; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	30	78	80	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149504	10.1371/journal.pone.0149504	http://dx.doi.org/10.1371/journal.pone.0149504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TF	26960191	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300013
J	Gendall, P; Hoek, J; Edwards, R; Glantz, S				Gendall, Philip; Hoek, Janet; Edwards, Richard; Glantz, Stanton			Effect of Exposure to Smoking in Movies on Young Adult Smoking in New Zealand	PLOS ONE			English	Article							TOBACCO USE; ADOLESCENT SMOKING; CONTEMPORARY MOVIES; VIEWING SMOKING; YOUTH SMOKING; INITIATION; FILMS; ASSOCIATION; PROMOTION; ATTITUDES	Onscreen Smoking Is a Form of Tobacco Marketing Tobacco advertising has been prohibited in New Zealand since 1990, and the government has set a goal of becoming a smokefree nation by 2025. However, tobacco marketing persists indirectly through smoking in motion pictures, and there is strong evidence that exposure to onscreen smoking causes young people to start smoking. We investigated the relationship between exposure to smoking in movies and youth smoking initiation among New Zealand young adults. Data from an online survey of 419 smokers and non-smokers aged 18 to 25 were used to estimate respondents' exposure to smoking occurrences in 50 randomly-selected movies from the 423 US top box office movies released between 2008 and 2012. Analyses involved calculating movie smoking exposure (MSE) for each respondent, using logistic regression to analyse the relationship between MSE and current smoking behaviour, and estimating the attributable fraction due to smoking in movies. Effect of Smoking in Movies on New Zealand Youth Exposure to smoking occurrences in movies was associated with current smoking status. After allowing for the influence of family, friends and co-workers, age and rebelliousness, respondents' likelihood of smoking increased by 11% for every 100-incident increase in exposure to smoking incidents, (aOR1.11; p<.05). The estimated attributable fraction due to smoking in movies was 54%; this risk could be substantially reduced by eliminating smoking from movies currently rated as appropriate for youth. We conclude that exposure to smoking in movies remains a potent risk factor associated with smoking among young adults, even in a progressive tobacco control setting such as New Zealand. Harmonising the age of legal tobacco purchase (18) with the age at which it is legal to view smoking in movies would support New Zealand's smokefree 2025 goal.	[Gendall, Philip; Hoek, Janet] Univ Otago, Dept Mkt, Dunedin, New Zealand; [Edwards, Richard] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Glantz, Stanton] Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA	University of Otago; University of Otago; University of California System; University of California San Francisco	Gendall, P (corresponding author), Univ Otago, Dept Mkt, Dunedin, New Zealand.	Philip.gendall@otago.ac.nz	Edwards, Richard/O-4771-2017; Hoek, Janet/A-5186-2010	Edwards, Richard/0000-0003-2264-9823; Hoek, Janet/0000-0003-4362-1539	National Institutes of Health [CA077026]; NATIONAL CANCER INSTITUTE [R01CA077026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was internally funded from the second author's research account. No external funding was received. However, the analysis of smoking in movies at The Dartmouth Media Lab at the Geisel School of Medicine was funded by the following grant: National Institutes of Health CA077026.; The authors received no specific funding for this work. The data on on-screen occurrences of smoking in movies was provided by the Dartmouth Media Lab at the Geisel School of Medicine; their data collection was funded by the National Institutes of Health grant CA077026. We also acknowledge the assistance of Danielle Ramo and Giuseppe Cavaleri from the Center for Tobacco Control Research and Education in setting up our online survey.	Allem JP, 2015, AM J HEALTH BEHAV, V39, P794, DOI 10.5993/AJHB.39.6.7; [Anonymous], 2009, STAT STAT SOFTW REL; Bandura Albert, 1977, SOCIAL LEARNING THEO; Charlesworth A, 2005, PEDIATRICS, V116, P1516, DOI 10.1542/peds.2005-0141; Dalton MA, 2003, LANCET, V362, P281, DOI 10.1016/S0140-6736(03)13970-0; Dalton MA, 2002, PREV MED, V34, P516, DOI 10.1006/pmed.2002.1013; Dalton MA, 2009, PEDIATRICS, V123, pE551, DOI 10.1542/peds.2008-2102; DiFranza JR, 2006, PEDIATRICS, V117, pE1237, DOI 10.1542/peds.2005-1817; Distefan JM, 2004, AM J PUBLIC HEALTH, V94, P1239, DOI 10.2105/AJPH.94.7.1239; Edwards R, 2013, AUST NZ J PUBL HEAL, V37, P516, DOI 10.1111/1753-6405.12105; Fischer P, 2011, PSYCHOL BULL, V137, P367, DOI 10.1037/a0022267; Glantz S., 2012, ATTRIBUTABLE RISK SM; Gray RJ, 2016, TOB CONTROL, V25, P46, DOI 10.1136/tobaccocontrol-2014-051793; Hanewinkel R, 2007, AM J PREV MED, V32, P466, DOI 10.1016/j.amepre.2007.02.025; HAZAN AR, 1994, AM J PUBLIC HEALTH, V84, P998, DOI 10.2105/AJPH.84.6.998; Henriksen L, 2012, TOB CONTROL, V21, P147, DOI 10.1136/tobaccocontrol-2011-050416; Hoek J, 2012, QUAL HEALTH RES, V22, P630, DOI 10.1177/1049732311431070; Hunt K, 2009, HEALTH EDUC RES, V24, P22, DOI 10.1093/her/cym082; Laugesen M, 2007, PREV MED, V45, P454, DOI 10.1016/j.ypmed.2007.07.025; McCool JP, 2005, J ADOLESCENT HEALTH, V36, P475, DOI 10.1016/j.jadohealth.2004.03.006; Millett C, 2010, THORAX, V65, P377, DOI 10.1136/thx.2009.133108; Morgenstern M, 2013, AM J PREV MED, V44, P339, DOI 10.1016/j.amepre.2012.11.037; Morgenstern M, 2011, THORAX, V66, P875, DOI 10.1136/thoraxjnl-2011-200489; New Zealand Government, 2011, GOV FIN RESP REP MAO; Pennay DW, 2009, PROFILING MOBILE PHO; Sargent JD, 2012, PEDIATRICS, V130, P228, DOI 10.1542/peds.2011-1787; Sargent JD, 2008, COMMUN METHODS MEAS, V2, P134, DOI 10.1080/19312450802063404; Sargent JD, 2001, BRIT MED J, V323, P1394, DOI 10.1136/bmj.323.7326.1394; Sargent JD, 2002, AM J PREV MED, V22, P137, DOI 10.1016/S0749-3797(01)00434-2; Song AV, 2007, AM J PREV MED, V33, P396, DOI 10.1016/j.amepre.2007.07.026; Statistics New Zealand, 2013, CENS QUICKSTATS NAT; Tickle JJ, 2001, TOB CONTROL, V10, P16, DOI 10.1136/tc.10.1.16; Titus-Ernstoff L, 2008, PEDIATRICS, V121, P15, DOI 10.1542/peds.2007-0051; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Wellman RJ, 2006, ARCH PEDIAT ADOL MED, V160, P1285, DOI 10.1001/archpedi.160.12.1285; Wills TA, 2008, PSYCHOL ADDICT BEHAV, V22, P269, DOI 10.1037/0893-164X.22.2.269; World Health Organization, 2011, SMOK FREE MOV EV ACT; World Health Organization, 2003, WHO FRAM CONV TOB CO	39	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0148692	10.1371/journal.pone.0148692	http://dx.doi.org/10.1371/journal.pone.0148692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TF	26960189	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300004
J	Gul, R; Park, DR; Shawl, AI; Im, SY; Nam, TS; Lee, SH; Ko, JK; Jang, KY; Kim, D; Kim, UH				Gul, Rukhsana; Park, Dae-Ryoung; Shawl, Asif Iqbal; Im, Soo-Yeul; Nam, Tae-Sik; Lee, Sun-Hwa; Ko, Jae-Ki; Jang, Kyu Yoon; Kim, Donghee; Kim, Uh-Hyun			Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) and Cyclic ADP-Ribose (cADPR) Mediate Ca2+ Signaling in Cardiac Hypertrophy Induced by beta-Adrenergic Stimulation	PLOS ONE			English	Article							ANGIOTENSIN-II; HEART; CALCIUM; CYCLASE; CD38; POLYMORPHISMS; CONTRACTION; MECHANISMS; GENERATION; PATHWAYS	Ca2+ signaling plays a fundamental role in cardiac hypertrophic remodeling, but the underlying mechanisms remain poorly understood. We investigated the role of Ca2+-mobilizing second messengers, NAADP and cADPR, in the cardiac hypertrophy induced by beta-adrenergic stimulation by isoproterenol. Isoproterenol induced an initial Ca2+ transients followed by sustained Ca2+ rises. Inhibition of the cADPR pathway with 8-Br-cADPR abolished only the sustained Ca2+ increase, whereas inhibition of the NAADP pathway with bafilomycin-A1 abolished both rapid and sustained phases of the isoproterenol-mediated signal, indicating that the Ca2+ signal is mediated by a sequential action of NAADP and cADPR. The sequential production of NAADP and cADPR was confirmed biochemically. The isoproterenolmediated Ca2+ increase and cADPR production, but not NAADP production, were markedly reduced in cardiomyocytes obtained from CD38 knockout mice. CD38 knockout mice were rescued from chronic isoproterenol infusion-induced myocardial hypertrophy, interstitial fibrosis, and decrease in fractional shortening and ejection fraction. Thus, our findings indicate that beta-adrenergic stimulation contributes to the development of maladaptive cardiac hypertrophy via Ca2+ signaling mediated by NAADP-synthesizing enzyme and CD38 that produce NAADP and cADPR, respectively.	[Gul, Rukhsana; Park, Dae-Ryoung; Shawl, Asif Iqbal; Im, Soo-Yeul; Nam, Tae-Sik; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561756, South Korea; [Gul, Rukhsana; Park, Dae-Ryoung; Shawl, Asif Iqbal; Im, Soo-Yeul; Nam, Tae-Sik; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Natl Creat Res Lab Signaling Network Ca2, Jeonju 561756, South Korea; [Lee, Sun-Hwa; Ko, Jae-Ki] Chonbuk Natl Univ, Sch Med, Dept Internal Med, Jeonju 561756, South Korea; [Jang, Kyu Yoon] Chonbuk Natl Univ, Sch Med, Dept Pathol, Jeonju 561756, South Korea; [Ko, Jae-Ki; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Inst Cardiovasc Res, Jeonju 561756, South Korea; [Kim, Donghee] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Physiol & Biophys, N Chicago, IL USA; [Gul, Rukhsana] King Saud Univ, Coll Med, Obes Res Ctr, Riyadh 11461, Saudi Arabia	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Chicago Medical School; Rosalind Franklin University Medical & Science; King Saud University	Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561756, South Korea.; Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Natl Creat Res Lab Signaling Network Ca2, Jeonju 561756, South Korea.; Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Inst Cardiovasc Res, Jeonju 561756, South Korea.	uhkim@chonbuk.ac.kr	Gul, Rukhsana/ABG-8259-2020; lee, sun hwa/R-1431-2019	Gul, Rukhsana/0000-0003-0454-864X; lee, sun hwa/0000-0001-9752-9717; Kim, Uh-Hyun/0000-0003-3304-7190	National Research Foundation of Korea (NRF) [2012R1A3A2026453]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This work was funded by grant number 2012R1A3A2026453 from the National Research Foundation of Korea (NRF): http://www.nrf.re.kr.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; BAKER KM, 1990, AM J PHYSIOL, V259, pH324, DOI 10.1152/ajpheart.1990.259.2.H324; BAKER KM, 1992, ANNU REV PHYSIOL, V54, P227, DOI 10.1146/annurev.physiol.54.1.227; Berridge MJ, 2006, BIOCHEM SOC T, V34, P228, DOI 10.1042/BST0340228; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Chemaly ER, 2013, HEART, V99, P992, DOI 10.1136/heartjnl-2012-302970; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; da Silva CP, 2000, BBA-MOL CELL RES, V1498, P122, DOI 10.1016/S0167-4889(00)00089-6; Dangel V, 1996, CIRCULATION, V94, P3303; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; Frey N, 2000, NAT MED, V6, P1221, DOI 10.1038/81321; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gul R, 2008, AM J PHYSIOL-HEART C, V295, pH77, DOI 10.1152/ajpheart.01355.2007; Gul R, 2009, CARDIOVASC RES, V81, P582, DOI 10.1093/cvr/cvn232; Hajjar RJ, 2002, NEW ENGL J MED, V347, P1196, DOI 10.1056/NEJMe020105; Higashida H, 1999, J BIOL CHEM, V274, P33348, DOI 10.1074/jbc.274.47.33348; Higashida H, 2000, BIOCHEM J, V352, P197, DOI 10.1042/0264-6021:3520197; Kang J, 2012, J BIOL CHEM, V287, P14502, DOI 10.1074/jbc.M111.329003; Kim BJ, 2008, DIABETES, V57, P868, DOI 10.2337/db07-0443; Kim SY, 2009, AM J PHYSIOL-RENAL, V296, pF291, DOI 10.1152/ajprenal.90381.2008; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Lorell BH, 2000, CIRCULATION, V102, P470; Lou Q, 2012, ADV EXP MED BIOL, V740, P1145, DOI 10.1007/978-94-007-2888-2_52; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Molkentin JD, 2006, J CLIN INVEST, V116, P623, DOI 10.1172/JCI27824; Morisco C, 2001, J MOL CELL CARDIOL, V33, P561, DOI 10.1006/jmcc.2000.1332; Nam TS, 2006, EXP MOL MED, V38, P718, DOI 10.1038/emm.2006.84; Naylor LH, 2008, SPORTS MED, V38, P69, DOI 10.2165/00007256-200838010-00006; Nebel M, 2013, J BIOL CHEM, V288, P16017, DOI 10.1074/jbc.M112.441246; Park KH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001595; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Rah SY, 2010, J BIOL CHEM, V285, P21877, DOI 10.1074/jbc.M109.066290; Scheuer J, 1999, AM J CARDIOL, V83, p70H; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; Wilson HL, 1998, BIOCHEM J, V331, P837, DOI 10.1042/bj3310837; Xie GH, 2005, BIOCHEM BIOPH RES CO, V330, P1290, DOI 10.1016/j.bbrc.2005.03.114	42	29	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149125	10.1371/journal.pone.0149125	http://dx.doi.org/10.1371/journal.pone.0149125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959359	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300007
J	Kwon, SB; Kim, MJ; Yang, JM; Lee, HP; Hong, JT; Jeong, HS; Kim, ES; Yoon, DY				Kwon, Sae-Bom; Kim, Min-Je; Yang, Jin Mo; Lee, Hee-Pom; Hong, Jin Tae; Jeong, Heon-Sang; Kim, Eun Suk; Yoon, Do-Young			Cudrania tricuspidata Stem Extract Induces Apoptosis via the Extrinsic Pathway in SiHa Cervical Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; CHLOROGENIC ACID; CARCINOMA CELLS; EXPRESSION; RECEPTOR; PROLIFERATION; MITOCHONDRIA; INHIBITION; ACTIVATION; WORLDWIDE	The focus of this study is the anti-cancer effects of Cudrania tricuspidata stem (CTS) extract on cervical cancer cells. The effect of CTS on cell viability was investigated in HPV-positive cervical cancer cells and HaCaT human normal keratinocytes. CTS showed significant dose-dependent cytotoxic effects in cervical cancer cells. However, there was no cytotoxic effect of CTS on HaCaT keratinocytes at concentrations of 0.125-0.5 mg/mL. Based on this cytotoxic effect, we demonstrated that CTS induced apoptosis by down-regulating the E6 and E7 viral oncogenes. Apoptosis was detected by DAPI staining, annexin V-FITC/PI staining, cell cycle analysis, western blotting, RT-PCR, and JC-1 staining in SiHa cervical cancer cells. The mRNA expression levels of extrinsic pathway molecules such as Fas, death receptor 5 (DR5), and TNF-related apoptosis-inducing ligand (TRAIL) were increased by CTS. Furthermore, CTS treatment activated caspase-3/caspase-8 and cleavage of poly (ADP-ribose) polymerase (PARP). However, the mitochondrial membrane potential and expression levels of intrinsic pathway molecules such as Bcl-2, Bcl-xL, Bax, and cytochrome C were not modulated by CTS. Taken together, these results indicate that CTS induced apoptosis by activating the extrinsic pathway, but not the intrinsic pathway, in SiHa cervical cancer cells. These results suggest that CTS can be used as a modulating agent in cervical cancer.	[Kwon, Sae-Bom; Kim, Min-Je; Yang, Jin Mo; Yoon, Do-Young] Konkuk Univ, Bio Mol Informat Ctr, Dept Biosci & Biotechnol, Seoul, South Korea; [Yang, Jin Mo] Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA; [Lee, Hee-Pom; Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm, Med Res Ctr, Osong, Chungbuk, South Korea; [Jeong, Heon-Sang] Chungbuk Natl Univ, Agr Life & Environm Sci, Cheongju, Chungbuk, South Korea; [Kim, Eun Suk] Chungcheongbukdo Bio CS, Osong, Chungbuk, South Korea	Konkuk University; University of Minnesota System; University of Minnesota Twin Cities; Chungbuk National University; Chungbuk National University	Yoon, DY (corresponding author), Konkuk Univ, Bio Mol Informat Ctr, Dept Biosci & Biotechnol, Seoul, South Korea.	ydy4218@konkuk.ac.kr			National Research Foundation of Korea (NRF) [2015R1A2A2A09001137]; Priority Research Centers Program [2012-0006686]; Pharma Teksol; Chungcheongbukdo Bio CS	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Priority Research Centers Program; Pharma Teksol(Dexcel Pharma); Chungcheongbukdo Bio CS	This research was supported by the basic program (2015R1A2A2A09001137) of the National Research Foundation of Korea (NRF), http://www.nrf.re.kr/nrf_eng_cms. D.Y. Yoon was supported partially by the Priority Research Centers Program (2012-0006686). The authors are grateful to Pharma Teksol and Chungcheongbukdo Bio CS for their intellectual and financial support of this project. There was no additional external funding received for this study.; This research was supported by the basic program (2015R1A2A2A09001137) of the National Research Foundation of Korea (NRF). (http://www.nrf.re.kr/nrf_eng_cms). D.Y. Yoon was supported partially by the Priority Research Centres Program (2012-0006686). The authors are grateful to PharmaTeksol and Chungcheongbukdo Bio CS for their intellectual and financial support of this project. There was no additional external funding received for this study.	Algeciras-Schimnich A, 2003, P NATL ACAD SCI USA, V100, P11445, DOI 10.1073/pnas.2034995100; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bak Y, 2013, MOL BIOL REP, V40, P4507, DOI 10.1007/s11033-013-2544-0; Banjerdpongchai R, 2016, TUMOR BIOL, V37, P227, DOI 10.1007/s13277-015-3774-7; Belkaid A, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-7; Bouzaiene NN, 2015, EUR J PHARMACOL, V766, P99, DOI [10.1016/j.etphar.2015.09.044, 10.1016/j.ejphar.2015.09.044]; Bufalo MC, 2013, J ETHNOPHARMACOL, V149, P84, DOI 10.1016/j.jep.2013.06.004; Burgos-Moron E, 2012, J AGR FOOD CHEM, V60, P7384, DOI 10.1021/jf300999e; Chen LX, 2016, J CHROMATOGR A, V1428, P134, DOI 10.1016/j.chroma.2015.10.037; Cho EJ, 2003, AM J CHINESE MED, V31, P907, DOI 10.1142/S0192415X03001648; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Denny L, 2012, DISCOV MED, V14, P125; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hengartner MO, 2001, CELL, V104, P325, DOI 10.1016/S0092-8674(01)00219-7; Jiang M, 2002, ONCOGENE, V21, P6041, DOI 10.1038/sj.onc.1205878; Jin CY, 2011, MOL NUTR FOOD RES, V55, P300, DOI 10.1002/mnfr.201000024; Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728; Kang DG, 2002, LIFE SCI, V70, P2599, DOI 10.1016/S0024-3205(02)01547-3; Kim MS, 2013, CELL BIOL TOXICOL, V29, P259, DOI 10.1007/s10565-013-9251-4; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Le MQ, 2015, BIOCHIMIE, V119, P52, DOI 10.1016/j.biochi.2015.10.006; Lee BW, 2005, J NAT PROD, V68, P456, DOI 10.1021/np030481a; Munagala R, 2015, CANCER LETT, V356, P536, DOI 10.1016/j.canlet.2014.09.037; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; MUNGER K, 1992, CANCER SURV, V12, P197; Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718; Pan MH, 2008, CHEM SOC REV, V37, P2558, DOI 10.1039/b801558a; Park JH, 2008, FOOD CHEM TOXICOL, V46, P3684, DOI 10.1016/j.fct.2008.09.056; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Rosendahl AH, 2015, CLIN CANCER RES, V21, P1877, DOI 10.1158/1078-0432.CCR-14-1748; Schneider P, 2000, Pharm Acta Helv, V74, P281, DOI 10.1016/S0031-6865(99)00038-2; Vidya Priyadarsini R, 2010, Eur J Pharmacol, V649, P84, DOI 10.1016/j.ejphar.2010.09.020; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yan Y, 2015, ANTI-CANCER DRUG, V26, P540, DOI 10.1097/CAD.0000000000000218; YEE C, 1985, AM J PATHOL, V119, P361; Yuan SJ, 2010, STRUCTURE, V18, P571, DOI 10.1016/j.str.2010.04.001	40	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150235	10.1371/journal.pone.0150235	http://dx.doi.org/10.1371/journal.pone.0150235			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960190	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300040
J	Lee, HS; Choi, EJ; Lee, KS; Kim, HR; Na, BR; Kwon, MS; Jeong, GS; Choi, HG; Choi, EY; Jun, CD				Lee, Hyun-Su; Choi, Eun-Ju; Lee, Kyung-Sik; Kim, Hye-Ran; Na, Bo-Ra; Kwon, Min-Sung; Jeong, Gil-Saeng; Choi, Hyun Gyu; Choi, Eun Young; Jun, Chang-Duk			Oral Administration of p-Hydroxycinnamic Acid Attenuates Atopic Dermatitis by Downregulating Th1 and Th2 Cytokine Production and Keratinocyte Activation	PLOS ONE			English	Article							KINASE-C-THETA; T-CELL-ACTIVATION; PHENOLIC-COMPOUNDS; IN-VITRO; MODEL; MICE	Atopic dermatitis (AD) is a complex disease that is caused by various factors, including environmental change, genetic defects, and immune imbalance. We previously showed that p-hydroxycinnamic acid (HCA) isolated from the roots of Curcuma longa inhibits T-cell activation without inducing cell death. Here, we demonstrated that oral administration of HCA in a mouse model of ear AD attenuates the following local and systemic AD manifestations: ear thickening, immune-cell infiltration, production of AD-promoting immunoregulatory cytokines in ear tissues, increased spleen and draining lymph node size and weight, increased pro-inflammatory cytokine production by draining lymph nodes, and elevated serum immunoglobulin production. HCA treatment of CD4(+) T cells in vitro suppressed their proliferation and differentiation into Th1 or Th2 and their Thl and Th2 cytokine production. HCA treatment of keratinocytes lowered their production of the pro-inflammatory cytokines that drive either Th1 or Th2 responses in AD. Thus, HCA may be of therapeutic potential for AD as it acts by suppressing keratinocyte activation and downregulating T-cell differentiation and cytokine production.	[Lee, Hyun-Su; Lee, Kyung-Sik; Kim, Hye-Ran; Na, Bo-Ra; Kwon, Min-Sung; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Sch Life Sci, Immune Synapse Res Ctr, Gwangju, South Korea; [Lee, Hyun-Su; Lee, Kyung-Sik; Kim, Hye-Ran; Na, Bo-Ra; Kwon, Min-Sung; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Gwangju, South Korea; [Choi, Eun-Ju] Konkuk Univ, Div Sport Sci, Coll Nat Sci, Chungju, South Korea; [Jeong, Gil-Saeng] Keimyung Univ, Coll Pharm, Daegu, South Korea; [Choi, Hyun Gyu] Yeungnam Univ, Coll Pharm, Gyongsan, South Korea; [Choi, Eun Young] Univ Ulsan, Coll Med, Dept Biomed Sci, Seoul, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Konkuk University; Keimyung University; Yeungnam University; University of Ulsan	Jun, CD (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Immune Synapse Res Ctr, Gwangju, South Korea.; Jun, CD (corresponding author), Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Gwangju, South Korea.; Choi, EY (corresponding author), Univ Ulsan, Coll Med, Dept Biomed Sci, Seoul, South Korea.	choieun@ulsan.ac.kr; cdjun@gist.ac.kr			Creative Research Initiative Program [2015R1A3A2066253]; Basic Science Program through the National Research Foundation (NRF) grants - Ministry of Science, ICT & Future Planning (MSIP) [2015R1A2A1A15052658]; Basic Science Program through the National Research Foundation (NRF) grants - Ministry of Education (MOE), Korea [2013R1A6A3A04064259]; Bio Imaging Research Center at GIST	Creative Research Initiative Program; Basic Science Program through the National Research Foundation (NRF) grants - Ministry of Science, ICT & Future Planning (MSIP); Basic Science Program through the National Research Foundation (NRF) grants - Ministry of Education (MOE), Korea; Bio Imaging Research Center at GIST	This work was supported by the Creative Research Initiative Program (2015R1A3A2066253), and the Basic Science Program (2015R1A2A1A15052658) through the National Research Foundation (NRF) grants funded by the Ministry of Science, ICT & Future Planning (MSIP), the Basic Science Program (2013R1A6A3A04064259) through the National Research Foundation (NRF) grants funded by the Ministry of Education (MOE), Korea, and Bio Imaging Research Center at GIST.	Akber U, 2015, INT IMMUNOPHARMACOL, V25, P130, DOI 10.1016/j.intimp.2015.01.020; Akdis Mubeccel, 2002, Curr Allergy Asthma Rep, V2, P1, DOI 10.1007/s11882-002-0029-7; Bernard Francois-Xavier, 2012, J Allergy (Cairo), V2012, P718725, DOI 10.1155/2012/718725; Cardador-Martinez A, 2002, FOOD ADDIT CONTAM, V19, P62, DOI 10.1080/02652030110062110; Caux C, 2000, SPRINGER SEMIN IMMUN, V22, P345, DOI 10.1007/s002810000053; Cho JY, 1998, BIOSCI BIOTECH BIOCH, V62, P2273, DOI 10.1271/bbb.62.2273; Choi EJ, 2011, J ETHNOPHARMACOL, V137, P802, DOI 10.1016/j.jep.2011.06.043; D'Ambrosio D, 1998, J IMMUNOL, V161, P5111; Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139; Darlenski R, 2014, CLIN DERMATOL, V32, P409, DOI 10.1016/j.clindermatol.2013.11.007; Grammatikos AP, 2008, ANN MED, V40, P482, DOI 10.1080/07853890802082096; Kawakami T, 2009, CURR OPIN IMMUNOL, V21, P666, DOI 10.1016/j.coi.2009.09.006; Kim JA, 2008, NAT PROD COMMUN, V3, P1655; Kim SH, 2006, TOXICOL SCI, V91, P123, DOI 10.1093/toxsci/kfj063; Laske N, 2004, PEDIAT ALLERG IMM-UK, V15, P86, DOI 10.1046/j.0905-6157.2003.00106.x; Lee HS, 2012, INT IMMUNOPHARMACOL, V12, P131, DOI 10.1016/j.intimp.2011.11.001; Lee LS, 2013, MOLECULES, V18, P12548, DOI 10.3390/molecules181012548; Lee TY, 2009, CANCER IMMUNOL IMMUN, V58, P1783, DOI 10.1007/s00262-009-0689-4; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Matsumoto M, 1999, J IMMUNOL, V162, P1056; Natalija Novak, 2003, J ALLERGY CLIN IMMUN, V112, pS128, DOI DOI 10.1016/j.jaci.2003.09.032; Ou SY, 2004, J SCI FOOD AGR, V84, P1261, DOI 10.1002/jsfa.1873; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Puupponen-Pimia R, 2001, J APPL MICROBIOL, V90, P494, DOI 10.1046/j.1365-2672.2001.01271.x; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Sergent T, 2010, CHEM-BIOL INTERACT, V188, P659, DOI 10.1016/j.cbi.2010.08.007; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Wang HQ, 1999, J CELL SCI, V112, P3497	31	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150952	10.1371/journal.pone.0150952	http://dx.doi.org/10.1371/journal.pone.0150952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959360	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300088
J	Shringarpure, KS; Isaakidis, P; Sagili, KD; Baxi, RK; Das, M; Daftary, A				Shringarpure, Kalpita S.; Isaakidis, Petros; Sagili, Karuna D.; Baxi, R. K.; Das, Mrinalini; Daftary, Amrita			"When Treatment Is More Challenging than the Disease": A Qualitative Study of MDR-TB Patient Retention	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; TREATMENT OUTCOMES; EXPERIENCES; INDIA; CARE	Background One-fifth of the patients on multidrug-resistant tuberculosis treatment at the Drug-Resistant-TB (DR-TB) Site in Gujarat are lost-to-follow-up(LFU). Objective To understand patients' and providers' perspectives on reasons for LFU and their suggestions to improve retention-in-care. Design Qualitative study conducted between December 2013-March 2014, including in-depth interviews with LFU patients and DOT-providers, and a focus group discussion with DR-TB site supervisors. A thematic-network analysis approach was utilised. Results Three sub-themes emerged: (i) Struggle with prolonged treatment; (ii) Strive against stigma and toward support; (iii) Divergent perceptions and practices. Daily injections, pill burden, DOT, migratory work, social problems, prior TB treatment, and adverse drugs effects were reported as major barriers to treatment adherence and retention-in-care by patients and providers. Some providers felt that despite their best efforts, LFU patients remain. Patient movements between private practitioners and traditional healers further influenced LFU. Conclusion The study points to a need for repeated patient counselling and education, improved coordination between various tiers of providers engaged in DR-TB care, collaboration between the public, private and traditional practitioners, and promotion of social and economic support to help patients adhere to MDR-TB treatment and avoid LFU.	[Shringarpure, Kalpita S.; Baxi, R. K.] Coll Med, Dept Prevent Social Med, Baroda, Gujarat, India; [Isaakidis, Petros] Medecins Sans Frontieres, Operat Res Unit, Bombay, Maharashtra, India; [Sagili, Karuna D.] The Union, South East Asia Off, New Delhi, India; [Das, Mrinalini] Medecins Sans Frontieres, Operat Res Unit, Delhi, India; [Daftary, Amrita] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada; [Daftary, Amrita] Univ Kwazulu Natal, Nelson R Mandela Sch Med, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Daftary, Amrita] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	McGill University; University of Kwazulu Natal; University of Toronto	Shringarpure, KS (corresponding author), Coll Med, Dept Prevent Social Med, Baroda, Gujarat, India.	kshringarpure@gmail.com	Daftary, Amrita/AAC-5022-2022	Daftary, Amrita/0000-0003-2275-3540; Isaakidis, Petros/0000-0002-7881-1554	American People through the United States Agency for International Development (USAID); State RNTCP Cell, Gandhinagar	American People through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); State RNTCP Cell, Gandhinagar	Funding for the operational research course was made possible by the support of the American People through the United States Agency for International Development (USAID). Funding for the project was made possible through support of the State RNTCP Cell, Gandhinagar. Funders had no role in study design, data collection, analysis and interpretation of data, decision to publish or preparation of the manuscript. The contents of this paper do not necessarily reflect the views of USAID, the United States Government, International Union Against Tuberculosis and Lung Disease (The Union) or the State RNTCP cell, Gujarat.	Tomas BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082440; [Anonymous], GLOB TUB REP; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; Baral SC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-46; Bell CA, 2011, INT J TUBERC LUNG D, V15, P1005, DOI 10.5588/ijtld.10.0294; Cavanaugh JS, 2012, INT J TUBERC LUNG D, V16, P1069, DOI 10.5588/ijtld.11.0696; Chiang CY, 2010, RESPIROLOGY, V15, P413, DOI 10.1111/j.1440-1843.2010.01738.x; Christodoulou M, 2011, LANCET INFECT DIS, V11, P663, DOI 10.1016/S1473-3099(11)70228-6; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Courtwright A, PUBLIC HLTH REP S4, V125, P34; Deshmukh RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135802; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Furin J, 2014, INT J TUBERC LUNG D, V18, P1479, DOI 10.5588/ijtld.14.0277; Government of India, 2014, TB IND 2014 REV NAT; Holtz T, 2006, TUBERC, V10, P649; Isaakidis P, 2013, TROP MED INT HEALTH, V18, P1128, DOI 10.1111/tmi.12146; Jeon DS, 2011, J KOREAN MED SCI, V26, P33, DOI 10.3346/jkms.2011.26.1.33; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kielmann K, 2014, GLOB PUBLIC HEALTH, V9, P975, DOI 10.1080/17441692.2014.941898; Mistry N, 2012, OPER RES HEALTH CARE, V1, P45, DOI 10.1016/j.orhc.2012.06.001; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Sanchez-Padilla E, 2014, INT J TUBERC LUNG D, V18, P160, DOI 10.5588/ijtld.13.0369; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Sharma Raman, 2014, Acta Med Iran, V52, P448; Shringarpure KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132543; Singla R, 2009, INT J TUBERC LUNG D, V13, P976; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Zammarchi L, 2014, MEDITERR J HEMATOL I, V6, DOI 10.4084/MJHID.2014.043	31	42	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150849	10.1371/journal.pone.0150849	http://dx.doi.org/10.1371/journal.pone.0150849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959366	Green Published, gold			2022-12-27	WOS:000371992300079
J	Ueda, I; Kakeda, S; Watanabe, K; Yoshimura, R; Kishi, T; Abe, O; Ide, S; Moriya, J; Katsuki, A; Hori, H; Iwata, N; Nakamura, J; Korogi, Y				Ueda, Issei; Kakeda, Shingo; Watanabe, Keita; Yoshimura, Reiji; Kishi, Taro; Abe, Osamu; Ide, Satoru; Moriya, Junji; Katsuki, Asuka; Hori, Hikaru; Iwata, Nakao; Nakamura, Jun; Korogi, Yukunori			Relationship between G1287A of the NET Gene Polymorphisms and Brain Volume in Major Depressive Disorder: A Voxel-Based MRI Study	PLOS ONE			English	Article							NOREPINEPHRINE TRANSPORTER GENE; ANTIDEPRESSANT RESPONSE; POSTSTROKE DEPRESSION; INTRACRANIAL VOLUME; LESION LOCATION; BDNF; ABNORMALITIES; ASSOCIATION; SEROTONIN; DOPAMINE	Background Earlier studies implicated norepinephrine transporter (NET) gene (SLC6A2) polymorphisms in the etiology of major depressive disorder (MDD). Recently, two single nucleotide SLC6A2 polymorphisms, G1287A in exon 9 and T-182C in the promoter region, were found to be associated with MDD in different populations. We investigated the relationship between the brain volume and these two polymorphisms of the SLC6A2 in MDD patients. Methods We obtained 3D high-resolution T1-weighted images of 30 first-episode MDD patients and 48 age- and sex-matched healthy subjects (HS). All were divided into 4 groups based on polymorphism of either the G1287A or the T-182C genotype. VBM analysis examined the effects of diagnosis, genotype, and genotype-diagnosis interactions. Results Diagnosis effects on the brain morphology were found in the left superior temporal cortex. No significant genotype effects were found in the T-182C and the G1287A. A significant genotype (G1287A)-diagnosis interaction was found in the left dorsolateral prefrontal cortex. No significant genotype (T-182C)-diagnosis interaction effects were observed in any brain region. Conclusions In MDD patients there seems to be a relationship between the volume of the dorsolateral prefrontal cortex and polymorphism of the SLC6A2 G1287A gene.	[Ueda, Issei; Kakeda, Shingo; Watanabe, Keita; Ide, Satoru; Moriya, Junji; Korogi, Yukunori] Univ Occupat & Environm Hlth, Dept Radiol, Kitakyushu, Fukuoka 807, Japan; [Yoshimura, Reiji; Katsuki, Asuka; Hori, Hikaru; Nakamura, Jun] Univ Occupat & Environm Hlth, Dept Psychiat, Kitakyushu, Fukuoka 807, Japan; [Kishi, Taro; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan; [Abe, Osamu] Nihon Univ, Sch Med, Dept Radiol, Tokyo, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Fujita Health University; Nihon University	Watanabe, K (corresponding author), Univ Occupat & Environm Hlth, Dept Radiol, Kitakyushu, Fukuoka 807, Japan.	sapient@med.uoeh-u.ac.jp	Hori, Hikaru/S-9838-2019; Ide, Satoru/AAJ-6850-2021; Hori, Hikaru/AFG-2767-2022	Watanabe, Keita/0000-0001-9592-8802; IWATA, Nakao/0000-0003-3189-6076; Abe, Osamu/0000-0002-1180-2629	Grants-in-Aid for Scientific Research [25461858] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Benmansour S, 2004, BIOL PSYCHIAT, V55, P313, DOI 10.1016/S0006-3223(03)00676-0; Berridge CW, 2011, BIOL PSYCHIAT, V69, pE101, DOI 10.1016/j.biopsych.2010.06.023; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Borgkvist A, 2012, INT J NEUROPSYCHOPH, V15, P531, DOI 10.1017/S1461145711000812; Cardoner N, 2013, DEPRESS ANXIETY, V30, P225, DOI 10.1002/da.22025; Chen MJ, 2007, CELL SIGNAL, V19, P114, DOI 10.1016/j.cellsig.2006.05.028; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; EASTWOOD MR, 1989, BRIT J PSYCHIAT, V154, P195, DOI 10.1192/bjp.154.2.195; First MB., 1997, USERS GUIDE STRUCTUR; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hahn MK, 2008, GENES BRAIN BEHAV, V7, P487, DOI 10.1111/j.1601-183X.2007.00384.x; Harmer CJ, 2003, AM J PSYCHIAT, V160, P990, DOI 10.1176/appi.ajp.160.5.990; Ide S, 2015, PSYCHIAT RES-NEUROIM, V233, P120, DOI 10.1016/j.pscychresns.2015.05.016; Inoue K, 2004, NEUROPSYCHOBIOLOGY, V50, P301, DOI 10.1159/000080957; Ito K, 2014, MICROBIOL IMMUNOL, V58, P467, DOI 10.1111/1348-0421.12173; Jeannotte AM, 2009, NEUROSCI LETT, V467, P86, DOI 10.1016/j.neulet.2009.10.010; Jonsson EG, 1998, PSYCHIAT RES, V79, P1, DOI 10.1016/S0165-1781(98)00027-4; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kim CH, 1999, J BIOL CHEM, V274, P6507, DOI 10.1074/jbc.274.10.6507; Kim H, 2006, JAMA-J AM MED ASSOC, V296, P1609, DOI 10.1001/jama.296.13.1609; Klimek V, 1997, J NEUROSCI, V17, P8451; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Linner L, 2001, J PHARMACOL EXP THER, V297, P540; Malone IB, 2015, NEUROIMAGE, V104, P366, DOI 10.1016/j.neuroimage.2014.09.034; Meyer J, 1998, J NEURAL TRANSM, V105, P1341, DOI 10.1007/s007020050136; Molendijk ML, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.72; Nordenskjold R, 2013, NEUROIMAGE, V83, P355, DOI 10.1016/j.neuroimage.2013.06.068; Owen D, 1999, PSYCHIAT RES, V87, P1, DOI 10.1016/S0165-1781(99)00050-5; Owens MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P3201, DOI 10.1038/npp.2008.47; Pan CC, 2009, INT J GERIATR PSYCH, V24, P847, DOI 10.1002/gps.2206; ROBINSON RG, 1984, BRAIN, V107, P81, DOI 10.1093/brain/107.1.81; Shah PJ, 2002, BRIT J PSYCHIAT, V180, P434, DOI 10.1192/bjp.180.5.434; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Takahashi T, 2010, PROG NEURO-PSYCHOPH, V34, P98, DOI 10.1016/j.pnpbp.2009.10.005; Tully K, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-15; Vaishnavi SN, 2004, BIOL PSYCHIAT, V55, P320, DOI 10.1016/j.biopsych.2003.07.006; Vataja R, 2004, J NEUROPSYCH CLIN N, V16, P156, DOI 10.1176/appi.neuropsych.16.2.156; Wang YM, 1999, BIOL PSYCHIAT, V46, P1124, DOI 10.1016/S0006-3223(99)00245-0; Watanabe K, 2015, PSYCHIAT RES-NEUROIM, V233, P481, DOI 10.1016/j.pscychresns.2015.07.024; Wei N, 2015, J NEUROL, V262, P81, DOI 10.1007/s00415-014-7534-1; Xu Y, 2009, PSYCHIAT RES, V168, P213, DOI 10.1016/j.psychres.2009.03.015; Yamashita M, 2006, NEUROPSYCHOPHARMACOL, V31, P2132, DOI 10.1038/sj.npp.1301009; Yoshida K, 2004, AM J PSYCHIAT, V161, P1575, DOI 10.1176/appi.ajp.161.9.1575; Zill P, 2002, NEUROPSYCHOPHARMACOL, V26, P489, DOI 10.1016/S0893-133X(01)00386-4	49	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150712	10.1371/journal.pone.0150712	http://dx.doi.org/10.1371/journal.pone.0150712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960194	gold, Green Published, Green Submitted			2022-12-27	WOS:000371992300067
J	Wang, L; Haccou, P; Lu, BR				Wang, Lei; Haccou, Patsy; Lu, Bao-Rong			High-Resolution Gene Flow Model for Assessing Environmental Impacts of Transgene Escape Based on Biological Parameters and Wind Speed	PLOS ONE			English	Article							RICE ORYZA-SATIVA; EXPERIMENTAL FIELD CONDITIONS; LONG-DISTANCE DISPERSAL; TRITICUM-AESTIVUM L.; CULTIVATED RICE; POLLEN-DISPERSAL; SEED DISPERSAL; BRASSICA-NAPUS; HERBICIDE RESISTANCE; OILSEED RAPE	Environmental impacts caused by transgene flow from genetically engineered (GE) crops to their wild relatives mediated by pollination are longstanding biosafety concerns worldwide. Mathematical modeling provides a useful tool for estimating frequencies of pollen-mediated gene flow (PMGF) that are critical for assessing such environmental impacts. However, most PMGF models are impractical for this purpose because their parameterization requires actual data from field experiments. In addition, most of these models are usually too general and ignored the important biological characteristics of concerned plant species; and therefore cannot provide accurate prediction for PMGF frequencies. It is necessary to develop more accurate PMGF models based on biological and climatic parameters that can be easily measured in situ. Here, we present a quasi-mechanistic PMGF model that only requires the input of biological and wind speed parameters without actual data from field experiments. Validation of the quasi-mechanistic model based on five sets of published data from field experiments showed significant correlations between the model-simulated and field experimental- generated PMGF frequencies. These results suggest accurate prediction for PMGF frequencies using this model, provided that the necessary biological parameters and wind speed data are available. This model can largely facilitate the assessment and management of environmental impacts caused by transgene flow, such as determining transgene flow frequencies at a particular spatial distance, and establishing spatial isolation between a GE crop and its coexisting non-GE counterparts and wild relatives.	[Wang, Lei; Lu, Bao-Rong] Fudan Univ, Dept Ecol & Evolutionary Biol, Minist Educ, Key Lab Biodivers & Ecol Engn, Handan Rd 220, Shanghai 200433, Peoples R China; [Haccou, Patsy] Leiden Univ Coll The Hague, POB 13228, NL-2501 EE The Hague, Netherlands	Fudan University	Lu, BR (corresponding author), Fudan Univ, Dept Ecol & Evolutionary Biol, Minist Educ, Key Lab Biodivers & Ecol Engn, Handan Rd 220, Shanghai 200433, Peoples R China.	brlu@fudan.edu.cn	Lu, Bao-Rong/C-3130-2009; Haccou, Patsy/L-5416-2013	Lu, Bao-Rong/0000-0002-0214-2390; Haccou, Patsy/0000-0002-0602-3866	Natural Science Foundation of China [31330014, 31271683]; National Program of Development of Transgenic New Species of China [2011ZX08011-006]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program of Development of Transgenic New Species of China	This work is supported by the Natural Science Foundation of China (31330014, 31271683) and National Program of Development of Transgenic New Species of China (2011ZX08011-006). The authors declare no conflict of interest for this work.	Andersen NS, 2005, MOL ECOL, V14, P1391, DOI 10.1111/j.1365-294X.2005.02490.x; Arriola PE, 1996, AM J BOT, V83, P1153, DOI 10.2307/2446198; Aylor DE, 2002, J AEROSOL SCI, V33, P1601, DOI 10.1016/S0021-8502(02)00105-2; Baker J, 2003, TRANSGENIC RES, V12, P731, DOI 10.1023/B:TRAG.0000005147.04075.62; Beckie HJ, 2008, PLANT SCI, V175, P615, DOI 10.1016/j.plantsci.2008.05.021; Capurro MA, 2014, POTATO RES, V57, P111, DOI 10.1007/s11540-014-9255-3; Capurro MA, 2013, HEREDITAS, V150, P60, DOI 10.1111/j.1601-5223.2013.00018.x; Chaturvedi M, 1998, GRANA, V37, P79, DOI 10.1080/00173139809362647; Chauhan Y. S., 1987, Cruciferae Newsletter, P44; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Chhikara R. S., 1989, INVERSE GAUSSIAN DIS; De Storme N, 2013, PLANT REPROD, V26, P65, DOI 10.1007/s00497-012-0209-0; Devos Y, 2009, AGRON SUSTAIN DEV, V29, P11, DOI 10.1051/agro:2008051; Devos Yann, 2005, Environmental Biosafety Research, V4, P71, DOI 10.1051/ebr:2005013; DIGIOVANNI F, 1989, GRANA, V28, P129, DOI 10.1080/00173138909429964; Duffin KI, 2008, VEG HIST ARCHAEOBOT, V17, P507, DOI 10.1007/s00334-007-0101-2; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Ellstrand NC, 2003, PHILOS T R SOC B, V358, P1163, DOI 10.1098/rstb.2003.1299; Ellstrand NC, 2007, J HERED, V98, P183, DOI 10.1093/jhered/esm002; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Ellstrand NC, 2013, ANNU REV ECOL EVOL S, V44, P325, DOI 10.1146/annurev-ecolsys-110512-135840; Felber F, 2007, ADV BIOCHEM ENG BIOT, V107, P173, DOI 10.1007/10_2007_050; Ford CS, 2006, P R SOC B, V273, P3111, DOI 10.1098/rspb.2006.3686; Giddings G, 2000, THEOR APPL GENET, V100, P971, DOI 10.1007/s001220051378; GOSS JA, 1968, BOT REV, V34, P333, DOI 10.1007/BF02985391; Guadagnuolo R, 2001, THEOR APPL GENET, V103, P1, DOI 10.1007/s001220100636; Gustafson DI, 2005, CROP SCI, V45, P1286, DOI 10.2135/cropsci2004.0137; Hanson BD, 2005, CROP SCI, V45, P1610, DOI 10.2135/cropsci2004.0443; Hucl P, 2001, CROP SCI, V41, P1348, DOI 10.2135/cropsci2001.4141348x; Jackson ST, 1999, BOT REV, V65, P39, DOI 10.1007/BF02856557; Jia SR, 2007, TRANSGENIC RES, V16, P491, DOI 10.1007/s11248-006-9037-z; Jiang WM, 1993, INTRO AIR POLLUTION, P53; Katul GG, 2005, AM NAT, V166, P368, DOI 10.1086/432589; Klein EK, 2003, ECOL MONOGR, V73, P131, DOI 10.1890/0012-9615(2003)073[0131:CPDQMM]2.0.CO;2; Krato C, 2012, WEED RES, V52, P187, DOI 10.1111/j.1365-3180.2012.00907.x; Kuroda Y, 2008, CROP SCI, V48, P1071, DOI 10.2135/cropsci2007.09.0496; LABANA K S, 1984, Genetica Agraria, V38, P131; Langhof M, 2010, CROP SCI, V50, P1496, DOI 10.2135/cropsci2009.11.0641; Lavigne C, 1998, THEOR APPL GENET, V96, P886, DOI 10.1007/s001220050816; Lemmon EW, 2004, INT J THERMOPHYS, V25, P21, DOI 10.1023/B:IJOT.0000022327.04529.f3; Loos C, 2003, J THEOR BIOL, V225, P241, DOI 10.1016/S0022-5193(03)00243-1; Loureiro I, 2012, TRANSGENIC RES, V21, P1329, DOI 10.1007/s11248-012-9619-x; Lu BR, 2005, BIOSCIENCE, V55, P669, DOI 10.1641/0006-3568(2005)055[0669:GFFGMR]2.0.CO;2; Luna S, 2001, CROP SCI, V41, P1551, DOI 10.2135/cropsci2001.4151551x; MANASSE RS, 1992, ECOL APPL, V2, P431, DOI 10.2307/1941878; Matus-Cadiz MA, 2004, CROP SCI, V44, P718, DOI 10.2135/cropsci2004.0718; Messeguer J, 2003, PLANT CELL TISS ORG, V73, P201, DOI 10.1023/A:1023007606621; Messeguer J, 2001, THEOR APPL GENET, V103, P1151, DOI 10.1007/s001220100713; Messeguer J, 2006, PLANT BIOTECHNOL J, V4, P633, DOI 10.1111/j.1467-7652.2006.00207.x; Oka H. I., 1988, Origin of cultivated rice.; RAKOW G, 1987, CAN J PLANT SCI, V67, P147, DOI 10.4141/cjps87-017; Rong J, 2005, NEW PHYTOL, V168, P559, DOI 10.1111/j.1469-8137.2005.01539.x; Rong J, 2004, NEW PHYTOL, V163, P439, DOI 10.1111/j.1469-8137.2004.01100.x; Rong J, 2010, PLANT BIOTECHNOL J, V8, P452, DOI 10.1111/j.1467-7652.2009.00488.x; Saeglitz C, 2003, MOL ECOL, V9, P2035; Seguin-Swartz G, 2013, CAN J PLANT SCI, V93, P1083, DOI [10.4141/CJPS2013-129, 10.4141/cjps2013-129]; Snall T, 2007, OIKOS, V116, P1037, DOI 10.1111/j.2007.0030-1299.15604.x; Song Z. P., 2001, International Rice Research Notes, V26, P31; Song ZP, 2004, BIODIVERS CONSERV, V13, P579, DOI 10.1023/B:BIOC.0000009491.24573.1d; Song ZP, 2003, NEW PHYTOL, V157, P657, DOI 10.1046/j.1469-8137.2003.00699.x; Soons MB, 2004, ECOLOGY, V85, P3056, DOI 10.1890/03-0522; Tackenberg O, 2003, PLANT BIOLOGY, V5, P451, DOI 10.1055/s-2003-44789; Tackenberg O, 2003, ECOL MONOGR, V73, P173, DOI 10.1890/0012-9615(2003)073[0173:MLDOPD]2.0.CO;2; Waines JG, 2003, CROP SCI, V43, P451, DOI 10.2135/cropsci2003.0451; Wang F, 2006, PLANT BIOTECHNOL J, V4, P667, DOI 10.1111/j.1467-7652.2006.00210.x; Weekes R, 2005, TRANSGENIC RES, V14, P749, DOI 10.1007/s11248-005-0943-2; Yao KM, 2008, NEW PHYTOL, V180, P217, DOI 10.1111/j.1469-8137.2008.02555.x; Yoshimura Yasuyuki, 2006, Environmental Biosafety Research, V5, P169, DOI 10.1051/ebr:2007003; Zhang BH, 2005, MOL BIOTECHNOL, V31, P11, DOI 10.1385/MB:31:1:011; Zhang K, 2011, J AGR SCI-CAMBRIDGE, V149, P205, DOI 10.1017/S0021859610000602	71	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149563	10.1371/journal.pone.0149563	http://dx.doi.org/10.1371/journal.pone.0149563			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959240	gold, Green Published, Green Submitted			2022-12-27	WOS:000371992300015
J	Zheng, JD; Huo, XX; Huai, Y; Xiao, L; Jiang, H; Klena, J; Greene, CM; Xing, XS; Huang, JG; Liu, SL; Peng, YX; Yang, H; Luo, J; Peng, ZB; Liu, LL; Chen, MY; Chen, H; Zhang, YZ; Huang, DQ; Guan, XH; Feng, LZ; Zhan, FX; Hu, DJ; Varma, JK; Yu, HJ				Zheng, Jiandong; Huo, Xixiang; Huai, Yang; Xiao, Lin; Jiang, Hui; Klena, John; Greene, Carolyn M.; Xing, Xuesen; Huang, Jigui; Liu, Shali; Peng, Youxing; Yang, Hui; Luo, Jun; Peng, Zhibin; Liu, Linlin; Chen, Maoyi; Chen, Hui; Zhang, Yuzhi; Huang, Danqin; Guan, Xuhua; Feng, Luzhao; Zhan, Faxian; Hu, Dale J.; Varma, Jay K.; Yu, Hongjie			Epidemiology, Seasonality and Treatment of Hospitalized Adults and Adolescents with Influenza in Jingzhou, China, 2010-2012	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY SYNCYTIAL VIRUS; NEURAMINIDASE INHIBITORS; PRIMARY-CARE; RISK-FACTORS; INFECTION; MORTALITY; CORTICOSTEROIDS; VACCINATION; ILLNESS	Background After the 2009 influenza A (H1 N1) pandemic, we conducted hospital-based severe acute respiratory infection (SARI) surveillance in one central Chinese city to assess disease burden attributable to influenza among adults and adolescents. Methods We defined an adult SARI case as a hospitalized patient aged >= 15 years with temperature >= 38.0 degrees C and at least one of the following: cough, sore throat, tachypnea, difficulty breathing, abnormal breath sounds on auscultation, sputum production, hemoptysis, chest pain, or chest radiograph consistent with pneumonia. For each enrolled SARI case-patient, we completed a standardized case report form, and collected a nasopharyngeal swab within 24 hours of admission. Specimens were tested for influenza viruses by real-time reverse transcription polymerase chain reaction (rRT-PCR). We analyzed data from adult SARI cases in four hospitals in Jingzhou, China from April 2010 to April 2012. Results Of 1,790 adult SARI patients enrolled, 40% were aged >= 65 years old. The median duration of hospitalization was 9 days. Nearly all were prescribed antibiotics during theirhospitalization, less than 1% were prescribed oseltamivir, and 28% were prescribed corticosteroids. Only 0.1% reported receiving influenza vaccination in the past year. Of 1,704 samples tested, 16% were positive for influenza. Influenza activity in all age groups showed winter-spring and summer peaks. Influenza-positive patients had a longer duration from illness onset to hospitalization and a shorter duration from hospital admission to discharge or death compared to influenza negative SARI patients. Conclusions There is substantial burden of influenza-associated SARI hospitalizations in Jingzhou, China, especially among older adults. More effective promotion of annual seasonal influenza vaccination and timely oseltamivir treatment among high risk groups may improve influenza prevention and control in China.	[Zheng, Jiandong; Jiang, Hui; Peng, Zhibin; Feng, Luzhao; Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Div Infect Dis, Beijing, Peoples R China; [Huo, Xixiang; Xing, Xuesen; Liu, Linlin; Chen, Hui; Huang, Danqin; Guan, Xuhua; Zhan, Faxian] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Huai, Yang; Klena, John; Greene, Carolyn M.; Zhang, Yuzhi; Hu, Dale J.; Varma, Jay K.] Ctr Dis Control & Prevent, Ctr Global Hlth, China US Collaborat Program Emerging & Reemerging, Beijing, Peoples R China; [Xiao, Lin; Huang, Jigui; Chen, Maoyi] Jingzhou Ctr Dis Control & Prevent, Jingzhou, Peoples R China; [Klena, John; Hu, Dale J.; Varma, Jay K.] Ctr Dis Control & Prevent, Global Dis Detect Branch, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA; [Greene, Carolyn M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Liu, Shali] Jingzhou Cent Hosp, Jingzhou, Peoples R China; [Peng, Youxing] Jingzhou First Peoples Hosp, Jingzhou, Peoples R China; [Yang, Hui] Jingzhou Second Peoples Hosp, Jingzhou, Peoples R China; [Luo, Jun] Jingzhou Maternal & Childrens Hosp, Jingzhou, Peoples R China; [Hu, Dale J.] NIAID, Vaccine Res Program, Div Aids, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yu, HJ (corresponding author), Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Div Infect Dis, Beijing, Peoples R China.	yuhj@chinacdc.cn	Yu, Hongjie/GZK-5351-2022		Cooperative Agreement Number [5U2GGH000018]; Centers for Disease Control and Prevention	Cooperative Agreement Number; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by the Cooperative Agreement Number, 5U2GGH000018, funded by the Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention or the Department of Health and Human Services.	Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Costelloe Ceire, 2010, BMJ, V340, pc2096, DOI 10.1136/bmj.c2096; Cowling BJ, 2014, VACCINE, V32, P5278, DOI 10.1016/j.vaccine.2014.07.084; Delabre RM, 2015, INFLUENZA OTHER RESP, V9, P43, DOI 10.1111/irv.12294; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Feng Luzhao, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P1295; Feng LZ, 2012, B WORLD HEALTH ORGAN, V90, P279, DOI 10.2471/BLT.11.096958; Feng LZ, 2010, VACCINE, V28, P6778, DOI 10.1016/j.vaccine.2010.07.064; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Garcia-Vidal C, 2007, EUR RESPIR J, V30, P951, DOI 10.1183/09031936.00027607; Guo KJ, 2014, BONE JOINT J, V96B, P259, DOI 10.1302/0301-620X.96B2.31935; Han K, 2011, CLIN INFECT DIS, V53, P326, DOI 10.1093/cid/cir398; Lapidus N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060127; Lee N, 2015, EUR RESPIR J, V45, P1642, DOI 10.1183/09031936.00169714; Mak DB, 2015, AUST NZ J OBSTET GYN, V55, P131, DOI 10.1111/ajo.12292; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; National Health and Family Planning Commission of the People's Republic of China, NOT REL HOSP SEV AC; Nessler K, 2014, VACCINE, V32, P7122, DOI 10.1016/j.vaccine.2014.10.026; Nicholson KG, 1996, EPIDEMIOL INFECT, V116, P51, DOI 10.1017/S0950268800058957; Nicoli EJ, 2013, J INFECTION, V66, P512, DOI 10.1016/j.jinf.2013.02.007; Nie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047926; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Peng ZB, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0884-1; Shu YL, 2010, EMERG INFECT DIS, V16, P725, DOI 10.3201/eid1604.091578; Siempos II, 2008, J ANTIMICROB CHEMOTH, V62, P661, DOI 10.1093/jac/dkn283; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; The Chinese Center for Disease Control and Prevention, TECHN GUID NAT INFL; Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88; United States Center for Disease Control and Prevention, PEOPL HIGH RISK DEV; World Health Organization, WHO GLOB EP SURV STA; World Health Organization, 2011, WHO GLOB TECHN CONS; Yang P, 2014, VACCINE, V32, P5285, DOI 10.1016/j.vaccine.2014.07.083; Yu H, 2012, INFLUENZA OTHER RESP, V8, P53, DOI DOI 10.1111/IRV.12205; Yu Hongjie, 2008, PLoS One, V3, pe2985, DOI 10.1371/journal.pone.0002985; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144; Yu HJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4779; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X; Zhang Y, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0764-5	38	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150713	10.1371/journal.pone.0150713	http://dx.doi.org/10.1371/journal.pone.0150713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26958855	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300068
J	Fairhall, EA; Charles, MA; Probert, PME; Wallace, K; Gibb, J; Ravindan, C; Soloman, M; Wright, MC				Fairhall, Emma A.; Charles, Michelle A.; Probert, Philip M. E.; Wallace, Karen; Gibb, Jennifer; Ravindan, Chandni; Soloman, Martin; Wright, Matthew C.			Pancreatic B-13 Cell Trans-Differentiation to Hepatocytes Is Dependent on Epigenetic-Regulated Changes in Gene Expression	PLOS ONE			English	Article							HUMAN-GLUCOCORTICOID-RECEPTOR; FUNCTIONAL HEPATOCYTES; PROGENITOR; INHIBITION; TOXICOLOGY; THERAPY; LIVER	The proliferative B-13 pancreatic cell line is unique in its ability to generate functional hepatocyte-like (B-13/H) cells in response to exposure to glucocorticoid. In these studies, quantitatively comparable hepatic levels of liver-specific and liver-enriched transcription factor and hepatocyte defining mRNA transcripts were expressed after 10-14 days continuous treatment with glucocorticoid. This conversion in phenotype was associated with increased Gr-alpha mRNA expression and translation of a functional N-terminally truncated variant protein that localized to the nucleus in B-13/H cells. A short (6 hours) pulse exposure to glucocorticoid was also sufficient to transiently activate the Gr and irreversibly drive near identical conversion to B-13/H cells. Examination of epigenetic-related mechanisms demonstrated that B-13 DNA was rapidly methylated and de-methylated over the initial 2 days in response to both continuous or pulse exposure with glucocorticoid. DNA methylation and glucocorticoid-dependent conversion to an hepatic B-13/H phenotype was blocked by the methylation inhibitor, 5-azacytidine. Conversion to an hepatic B-13/H phenotype was also blocked by histone deacetylase inhibitors. Previous experiments have identified N-terminal Sgk1 variant proteins as pivotal to the mechanism(s) associated with pancreatic-hepatic differentiation. Both continuous and pulse exposure to DEX was sufficient to result in a near-similar robust transcriptional increase in Sgk1c mRNA expression from undetectable levels in B-13 cells. Notably, expression of Sgk1c mRNA remained constitutive 14 days later; including after pulse exposure to glucocorticoid and this induction was inhibited by 5-azacytidine or by histone deacetylase inhibitors. These data therefore suggest that exposing B-13 cells to glucocorticoid results in a Gr-dependent pulse in DNA methylation and likely other epigenetic changes such as histone modifications that leads to constitutive expression of Sgk1c and irreversible reprogramming of B-13 cells into B-13/H cells. Understanding and application of these mechanism(s) may enhance the functionality of stem cell-derived hepatocytes generated in vitro.	[Fairhall, Emma A.; Charles, Michelle A.; Probert, Philip M. E.; Wallace, Karen; Gibb, Jennifer; Ravindan, Chandni; Soloman, Martin; Wright, Matthew C.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wallace, Karen] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland	Newcastle University - UK; University of Aberdeen	Wright, MC (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	M.C.Wright@ncl.ac.uk	Ravindan, Chandni/O-2923-2017	Ravindan, Chandni/0000-0002-4097-2117; Wright, Matthew/0000-0003-3167-6743	MRC (Medical Research Council); European Union [287596]; National Institute for Health Research [HPRU-2012-10076]; National Centre for the Replacement [NC/K500471/1] Funding Source: researchfish	MRC (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); National Centre for the Replacement	This work was supported by an MRC (Medical Research Council) ITTP PhD studentship (to EAF). The research leading to these results has also received funding from the European Union's Seventh Framework ProGramme (FP7/2007-2013) under Grant agreement no. 287596 (see also http://www.D-LIVER.eu/) and the National Institute for Health Research (HPRU-2012-10076).	Axon A, 2012, TOXICOLOGY, V298, P40, DOI 10.1016/j.tox.2012.04.014; BECKER FF, 1970, BIOCHEM PHARMACOL, V19, P1457, DOI 10.1016/0006-2952(70)90061-4; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Fairhall EA, 2013, TOXICOL RES-UK, V2, P308, DOI 10.1039/c3tx50030f; Fairhall EA, 2013, TOXICOL RES-UK, V2, P80, DOI 10.1039/c2tx20061a; Gadalla KKE, 2011, BIOCHEM J, V439, P1, DOI 10.1042/BJ20110648; KONISHI N, 1990, TOXICOL APPL PHARM, V104, P149, DOI 10.1016/0041-008X(90)90290-B; Lewis-Tuffin LJ, 2006, ANN NY ACAD SCI, V1069, P1, DOI 10.1196/annals.1351.001; Mann DA, 2015, EXPERT OPIN DRUG MET, V11, P1, DOI 10.1517/17425255.2015.981523; Marek CJ, 2003, BIOCHEM J, V370, P763, DOI 10.1042/BJ20021545; Mashima H, 1996, ENDOCRINOLOGY, V137, P3969, DOI 10.1210/en.137.9.3969; Probert PM, 2016, TOXICOL LETT, V243, P98, DOI 10.1016/j.toxlet.2015.12.010; Probert PME, 2015, TOXICOL RES-UK, V4, P203, DOI 10.1039/c4tx00214h; Probert PME, 2014, TOXICOL SCI, V137, P350, DOI 10.1093/toxsci/kft258; REDDY JK, 1984, J CELL BIOL, V98, P2082, DOI 10.1083/jcb.98.6.2082; RIGGS MG, 1977, NATURE, V268, P462, DOI 10.1038/268462a0; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Thaler R, 2012, EPIGENETICS-US, V7, P635, DOI 10.4161/epi.20163; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Wallace K, 2011, J CELL SCI, V124, P405, DOI 10.1242/jcs.077503; Wallace K, 2010, TOXICOLOGY, V278, P277, DOI 10.1016/j.tox.2010.05.008; Wallace K, 2010, AM J PATHOL, V177, P1225, DOI 10.2353/ajpath.2010.100107; Wallace K, 2010, J CELL SCI, V123, P2102, DOI 10.1242/jcs.070722; Wallace K, 2009, J STEROID BIOCHEM, V116, P76, DOI 10.1016/j.jsbmb.2009.05.002; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006	26	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150959	10.1371/journal.pone.0150959	http://dx.doi.org/10.1371/journal.pone.0150959			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954030	Green Published, gold			2022-12-27	WOS:000371991300064
J	Kim, D; Kim, TH; Wu, G; Park, BK; Ha, JH; Kim, YS; Lee, K; Lee, Y; Kwon, HJ				Kim, Dongbum; Kim, Te Ha; Wu, Guang; Park, Byoung Kwon; Ha, Ji-Hee; Kim, Yong-Sung; Lee, Keunwook; Lee, Younghee; Kwon, Hyung-Joo			Extracellular Release of CD11b by TLR9 Stimulation in Macrophages	PLOS ONE			English	Article							CPG-DNA STIMULATION; BACTERIAL-DNA; GENE-EXPRESSION; IMMUNE CELLS; ACTIVATION; OLIGODEOXYNUCLEOTIDE; EXOSOMES; MOTIFS; ANTIBODY	CpG-DNA upregulates the expression of pro-inflammatory cytokines, chemokines and cell surface markers. Investigators have shown that CD11b (integrin alpha M) regulates TLR-triggered inflammatory responses in the macrophages and dendritic cells. Therefore, we aimed to identify the effects of CpG-DNA on the expression of CD11b in macrophages. There was no significant change in surface expression of CD11b after CpG-DNA stimulation. However, CD11b was released into culture supernatants after stimulation with phosphorothioate-backbone modified CpG-DNA such as PS-ODN CpG-DNA 1826(S). In contrast, MB-ODN 4531 and non-CpG-DNA control (regardless of backbone type and liposome-encapsulation) failed to induce release of CD11b. Therefore, the context of the CpG-DNA sequence and phosphorothioate backbone modification may regulate the effects of CpG-DNA on CD11b release. Based on inhibitor studies, CD11b release is mediated by p38 MAP kinase activation, but not by the PI3K and NF-kappa B activation. CD11b release is mediated by lysosomal degradation and by vacuolar acidification in response to CpG-DNA stimulation. The amount of CD11b in the exosome precipitant was significantly increased by CpG-DNA stimulation in vivo and in vitro depending on TLR9. Our observations perhaps give more insight into understanding of the mechanisms involved in CpG-DNA-induced immunomodulation in the innate immunity.	[Kim, Dongbum; Wu, Guang; Park, Byoung Kwon; Kwon, Hyung-Joo] Hallym Univ, Coll Med, Ctr Med Sci Res, Chunchon, South Korea; [Kim, Te Ha; Kwon, Hyung-Joo] Hallym Univ, Dept Microbiol, Coll Med, Chunchon, South Korea; [Ha, Ji-Hee; Kim, Yong-Sung] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Lee, Keunwook] Hallym Univ, Coll Nat Sci, Dept Biomed Sci, Chunchon, South Korea; [Lee, Younghee] Chungbuk Natl Univ, Coll Nat Sci, Dept Biochem, Cheongju, South Korea	Hallym University; Hallym University; Ajou University; Hallym University; Chungbuk National University	Kwon, HJ (corresponding author), Hallym Univ, Coll Med, Ctr Med Sci Res, Chunchon, South Korea.; Kwon, HJ (corresponding author), Hallym Univ, Dept Microbiol, Coll Med, Chunchon, South Korea.	hjookwon@hallym.ac.kr		Kim, Yong-Sung/0000-0003-2673-1509	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning in the Republic of Korea [NRF-2013R1A6A3A01061155, 2013R1A2A2A03067981, 2014M3C1A3051473, 2014M3A9D5A01073841, 2015R1A2A2A01007209]; Hallym Research Fund [HRF-201505-012]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning in the Republic of Korea; Hallym Research Fund	This research was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning in the Republic of Korea (NRF-2013R1A6A3A01061155, 2013R1A2A2A03067981, 2014M3C1A3051473, 2014M3A9D5A01073841, 2015R1A2A2A01007209), and a grant from the Hallym Research Fund (HRF-201505-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Anand Paras K, 2010, Commun Integr Biol, V3, P405, DOI 10.4161/cib.3.5.12474; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Deng GM, 1999, NAT MED, V5, P702, DOI 10.1038/9554; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; FAN ST, 1991, J CLIN INVEST, V87, P50, DOI 10.1172/JCI115000; Fernandez-Calotti PX, 2003, SCAND J IMMUNOL, V57, P35, DOI 10.1046/j.1365-3083.2003.01187.x; Greening DW, 2015, SEMIN CELL DEV BIOL, V40, P72, DOI 10.1016/j.semcdb.2015.02.009; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Kim D, 2013, J KOREAN SOC APPL BI, V56, P553, DOI 10.1007/s13765-013-3171-0; Kim D, 2011, BMB REP, V44, P607, DOI 10.5483/BMBRep.2011.44.9.607; Kim D, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-29; Kim D, 2009, BIOCHEM BIOPH RES CO, V379, P362, DOI 10.1016/j.bbrc.2008.12.063; Kim SH, 2007, J IMMUNOL, V179, P2235, DOI 10.4049/jimmunol.179.4.2235; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kinashi T, 2007, ADV IMMUNOL, V93, P185, DOI 10.1016/S0065-2776(06)93005-3; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kwon HJ, 2003, BIOCHEM BIOPH RES CO, V308, P608, DOI 10.1016/S0006-291X(03)01434-7; Kwon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033121; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Lee KW, 2006, MOL IMMUNOL, V43, P2107, DOI 10.1016/j.molimm.2005.12.004; Lee KW, 2005, CELL MOL LIFE SCI, V62, P188, DOI 10.1007/s00018-004-4399-y; Lee KW, 2004, MOL IMMUNOL, V41, P955, DOI 10.1016/j.molimm.2004.06.022; Lefort CT, 2009, J IMMUNOL, V183, P6460, DOI 10.4049/jimmunol.0900983; Liang H, 1996, J CLIN INVEST, V98, P1119, DOI 10.1172/JCI118894; Ling GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4039; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Monteith DK, 1997, ANTI-CANCER DRUG DES, V12, P421; Park MC, 2013, BMB REP, V46, P448, DOI 10.5483/BMBRep.2013.46.9.023; Ridder K, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1008371; Ross GD, 2002, IMMUNOL RES, V25, P219, DOI 10.1385/IR:25:3:219; Saegusa K, 2007, MOL IMMUNOL, V44, P1323, DOI 10.1016/j.molimm.2006.05.008; Salama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106153; Singh PP, 2012, J IMMUNOL, V189, P777, DOI 10.4049/jimmunol.1103638; Skogberg G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067554; Sohn WJ, 2006, MOL IMMUNOL, V43, P1163, DOI 10.1016/j.molimm.2005.07.020; Sparwasser T, 1999, J IMMUNOL, V162, P2368; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	42	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150677	10.1371/journal.pone.0150677	http://dx.doi.org/10.1371/journal.pone.0150677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954233	Green Submitted, Green Published, gold			2022-12-27	WOS:000371991300041
J	Li, SH; Geng, J; Xu, XF; Huang, XX; Leng, D; Jiang, DY; Liang, JR; Wang, C; Jiang, DH; Dai, HP				Li, Shuhong; Geng, Jing; Xu, Xuefeng; Huang, Xiaoxi; Leng, Dong; Jiang, Dingyuan; Liang, Jiurong; Wang, Chen; Jiang, Dianhua; Dai, Huaping			miR-130b-3p Modulates Epithelial-Mesenchymal Crosstalk in Lung Fibrosis by Targeting IGF-1	PLOS ONE			English	Article							GROWTH-FACTOR-I; CELL-FIBROBLAST INTERACTIONS; INDUCED PULMONARY-FIBROSIS; REGULATORY NETWORKS; EXPRESSION; INJURY; REPAIR; LOCALIZATION; INDUCTION; PROLIFERATION	Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and usually lethal fibrotic lung disease with largely unknown etiology and pathogenesis. Evidence suggests microRNAs (miRNA) contribute to pathogenesis of IPF. In this study, we sought to identify miRNA expression signatures and determine the role of miR-130b-3p in lung fibrosis. The miRNA expression profile of the lungs from patients with IPF and normal donors was determined by Affymetrix microarray, and transcriptome with Affymetrix array. The functions and signal pathways as well as miRNA-mRNA networks were established by bioinformatics analysis. Luciferase assays and ELISA were used to confirm the miRNA target gene. The effect of miRNA-transfected epithelium on fibroblast activities was assessed using a co-culture system. The fibroblast activities were determined by qRT-PCR, western blotting, Transwell and BrdU assays. Seven miRNAs were significantly decreased in IPF lungs, with miR-130b-3p being the highest in the miRNA-mRNA network. Insulin-like growth factor (IGF-1) was a target gene of miR-130b-3p in the epithelium. miR-130b-3p inhibition in the epithelium induced collagen I expression and enhanced the proliferation and migration ability of fibroblast in co-culture systems, which mimicked the functions of exogenous IGF-1 on fibroblasts. Neutralizing IGF-1 with an antibody significantly reduced the modulatory effects of miR-130b-3p inhibitor-transfected epithelium on the activation of fibroblasts. Our results show that miR-130b- 3p was downregulated in IPF lungs. miR-130b-3p downregulation contributed to the activation of fibroblasts and the dysregulated epithelial-mesenchymal crosstalk by promoting IGF-1 secretion from lung epithelium, suggesting a key regulatory role for this miRNA in preventing lung fibrosis.	[Li, Shuhong; Geng, Jing; Xu, Xuefeng; Jiang, Dingyuan; Jiang, Dianhua; Dai, Huaping] Capital Med Univ, Dept Resp & Crit Care Med, Beijing Key Lab Resp & Pulm Circulat Disorders, Beijing Chao Yang Hosp,Beijing Inst Resp Med, Beijing 100020, Peoples R China; [Xu, Xuefeng; Wang, Chen] Beijing Hosp, Natl Clin Res Ctr Resp Med, Beijing 100730, Peoples R China; [Huang, Xiaoxi] Capital Med Univ, Dept Med Res, Beijing Chao Yang Hosp, Beijing 100020, Peoples R China; [Leng, Dong] Capital Med Univ, Beijing Chao Yang Hosp, Clin Lab, Beijing 100020, Peoples R China; [Liang, Jiurong; Jiang, Dianhua] Cedars Sinai Med Ctr, Dept Med, Div Pulm, Los Angeles, CA 90048 USA; [Liang, Jiurong; Jiang, Dianhua] Cedars Sinai Med Ctr, Womens Guild Lung Inst, Los Angeles, CA 90048 USA; [Wang, Chen; Dai, Huaping] China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Beijing 100029, Peoples R China	Capital Medical University; Beijing Hospital; Capital Medical University; Capital Medical University; Cedars Sinai Medical Center; Cedars Sinai Medical Center; China-Japan Friendship Hospital	Jiang, DH; Dai, HP (corresponding author), Capital Med Univ, Dept Resp & Crit Care Med, Beijing Key Lab Resp & Pulm Circulat Disorders, Beijing Chao Yang Hosp,Beijing Inst Resp Med, Beijing 100020, Peoples R China.; Jiang, DH (corresponding author), Cedars Sinai Med Ctr, Dept Med, Div Pulm, Los Angeles, CA 90048 USA.; Jiang, DH (corresponding author), Cedars Sinai Med Ctr, Womens Guild Lung Inst, Los Angeles, CA 90048 USA.; Dai, HP (corresponding author), China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Beijing 100029, Peoples R China.	dianhua.jiang@cshs.org; daihuaping@ccmu.edu.cn	Liang, Carol Jiurong/AAI-4963-2021; Jiang, Dianhua/B-1421-2009	Liang, Jiurong/0000-0001-5179-5016; Jiang, Dianhua/0000-0002-4508-3829	Key Program of National Natural Science Foundation of China [81430001]; key Program of Beijing Municipal Natural Science Foundation [7131008]; NIH [R01 HL122068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122068] Funding Source: NIH RePORTER	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key Program of Beijing Municipal Natural Science Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Key Program of National Natural Science Foundation of China (No. 81430001), the key Program of Beijing Municipal Natural Science Foundation (No. 7131008), and NIH R01 HL122068 to DJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1988, AM J PATHOL, V130, P377; ADAMSON IYR, 1990, AM J PATHOL, V137, P385; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BOWDEN DH, 1994, EXP LUNG RES, V20, P251, DOI 10.3109/01902149409064386; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Chetty A, 2006, PEDIATR RES, V60, P389, DOI 10.1203/01.pdr.0000238257.15502.f4; Choi JE, 2009, AM J RESP CRIT CARE, V179, P212, DOI 10.1164/rccm.200802-228OC; Cool CD, 2006, AM J RESP CRIT CARE, V174, P654, DOI 10.1164/rccm.200602-205OC; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; EL Ghalbzouri A, 2004, WOUND REPAIR REGEN, V12, P359, DOI 10.1111/j.1067-1927.2004.012306.x; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Enright AJ, 2004, GENOME BIOL, V5; Hardie WD, 2009, AM J PATHOL, V175, P3, DOI 10.2353/ajpath.2009.081170; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; HOMMA S, 1995, AM J RESP CRIT CARE, V152, P2084, DOI 10.1164/ajrccm.152.6.8520779; Honeyman L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-16; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kodama T, 2011, J CLIN INVEST, V121, P3343, DOI 10.1172/JCI44957; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Krein PM, 2002, CHEST, V122, p289S, DOI 10.1378/chest.122.6_suppl.289S; Krein PM, 2003, AM J RESP CRIT CARE, V167, P83, DOI 10.1164/rccm.2201012; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Milosevic J, 2012, AM J RESP CELL MOL, V47, P879, DOI 10.1165/rcmb.2011-0377OC; Mitra R, 2014, RNA, V20, P1356, DOI 10.1261/rna.042754.113; Morishima Y, 2001, AM J RESP CELL MOL, V24, P1; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Noble PW, 2005, AM J RESP CELL MOL, V33, P113, DOI 10.1165/rcmb.F301; Pan LH, 2001, EUR RESPIR J, V17, P1220, DOI 10.1183/09031936.01.00074101; Pan TL, 2001, AM J RESP CELL MOL, V25, P353, DOI 10.1165/ajrcmb.25.3.4004; Pandit KV, 2015, BIOCHEM CELL BIOL, V93, P129, DOI 10.1139/bcb-2014-0101; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718; Prasad S, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-7; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Selman M, 2004, SARCOIDOSIS VASC DIF, V21, P165; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Uh ST, 1998, AM J RESP CRIT CARE, V158, P1626, DOI 10.1164/ajrccm.158.5.9804025; van Almen GC, 2011, AGING CELL, V10, P769, DOI 10.1111/j.1474-9726.2011.00714.x; Waghray M, 2005, FASEB J, V19, P854, DOI 10.1096/fj.04-2882fje; Wang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070725, 10.1371/journal.pone.0060462, 10.1371/journal.pone.0077273, 10.1371/journal.pone.0081882]; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xie T, 2012, J IMMUNOL, V188, P2437, DOI 10.4049/jimmunol.1101070; Xie T, 2011, PHYSIOL GENOMICS, V43, P479, DOI 10.1152/physiolgenomics.00222.2010; Xu LJ, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0244-8; Xu XF, 2013, EXP BIOL MED, V238, P1082, DOI 10.1177/1535370213498976; Yang SZ, 2012, AM J PATHOL, V180, P484, DOI 10.1016/j.ajpath.2011.10.005; Zhang CX, 2008, PHYSIOL GENOMICS, V33, P139, DOI 10.1152/physiolgenomics.00034.2008; Zhang HA, 2010, J ETHNOPHARMACOL, V131, P165, DOI 10.1016/j.jep.2010.06.022	55	37	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150418	10.1371/journal.pone.0150418	http://dx.doi.org/10.1371/journal.pone.0150418			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953888	Green Published, gold			2022-12-27	WOS:000371991300027
J	Martins, JR; Bitondi, MMG				Martins, Juliana Ramos; Gentile Bitondi, Marcia Maria			The HEX 110 Hexamerin Is a Cytoplasmic and Nucleolar Protein in the Ovaries of Apis mellifera	PLOS ONE			English	Article							RNA-BINDING SITES; HONEY-BEE; FAT-BODY; DROSOPHILA-MELANOGASTER; STORAGE PROTEINS; SUBNUCLEAR LOCALIZATION; ARTHROPOD HEMOCYANINS; PROTEOMIC ANALYSIS; CALLIPHORA-VICINA; CELL-METABOLISM	Hexamerins are insect storage proteins abundantly secreted by the larval fat body into the haemolymph. The canonical role of hexamerins consists of serving as an amino acid reserve for development toward the adult stage. However, in Apis mellifera, immunofluorescence assays coupled to confocal laser-scanning microscopy, and high-throughput sequencing, have recently shown the presence of hexamerins in other organs than the fat body. These findings have led us to study these proteins with the expectation of uncovering additional functions in insect development. We show here that a honeybee hexamerin, HEX 110, localizes in the cytoplasm and nucleus of ovarian cells. In the nucleus of somatic and germline cells, HEX 110 colocalized with a nucleolar protein, fibrillarin, suggesting a structural or even regulatory function in the nucleolus. RNase A provoked the loss of HEX 110 signals in the ovarioles, indicating that the subcellular localization depends on RNA. This was reinforced by incubating ovaries with pyronin Y, a RNA-specific dye. Together, the colocalization with fibrillarin and pyronin Y, and the sensitivity to RNase, highlight unprecedented roles for HEX110 in the nucleolus, the nuclear structure harbouring the gene cluster involved in ribosomal RNA production. However, the similar patterns of HEX 110 foci distribution in the active and inactive ovaries of queens and workers preclude its association with the functional status of these organs.	[Martins, Juliana Ramos] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, BR-14049 Ribeirao Preto, SP, Brazil; [Gentile Bitondi, Marcia Maria] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Martins, JR (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, BR-14049 Ribeirao Preto, SP, Brazil.; Bitondi, MMG (corresponding author), Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.	julianarmartins@usp.br; mmgbit@usp.br	Martins, Juliana Ramos/AAD-4694-2021; Martins, Juliana Ramos/F-6726-2012; Bitondi, Marcia MG/E-8014-2012	Martins, Juliana Ramos/0000-0002-7185-6477; Bitondi, Marcia MG/0000-0002-5619-6378	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 2011/03171-5, 2012/16040-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support was provided by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2011/03171-5), which also provided a fellowship to JRM (2012/16040-9).	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Andrews LM, 2013, METHODS APPL FLUORES, V1, DOI 10.1088/2050-6120/1/1/015001; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Begna D, 2012, J PROTEOME RES, V11, P1317, DOI 10.1021/pr200974a; BEINTEMA JJ, 1994, MOL BIOL EVOL, V11, P493; Bishop GH, 1923, J MORPHOL, V37, P533, DOI 10.1002/jmor.1050370304; Bishop GH, 1922, J MORPHOL, V36, P567, DOI 10.1002/jmor.1050360404; Bitondi MMG, 2006, ARCH INSECT BIOCHEM, V63, P57, DOI 10.1002/arch.20142; Burmester T, 1998, J MOL EVOL, V47, P93, DOI 10.1007/PL00006366; Burmester T, 2002, J COMP PHYSIOL B, V172, P95, DOI 10.1007/s00360-001-0247-7; Burmester T, 1999, EUR J BIOCHEM, V262, P49, DOI 10.1046/j.1432-1327.1999.00315.x; Cardinale S, 2007, MOL BIOL CELL, V18, P1282, DOI 10.1091/mbc.E06-09-0846; Chamousset D, 2010, MOL BIOL CELL, V21, P4212, DOI 10.1091/mbc.E10-04-0287; Cooper GM., 2007, CELL MOL APPROACH; Cristino AS, 2010, INSECT MOL BIOL, V19, P137, DOI 10.1111/j.1365-2583.2009.00970.x; Cruz-Landim C, 2009, ABELHAS MORFOLOGIA F; Danty E, 1998, INSECT BIOCHEM MOLEC, V28, P387, DOI 10.1016/S0965-1748(98)00011-3; Fong KW, 2013, J CELL BIOL, V203, P149, DOI 10.1083/jcb.201303145; Guidugli KR, 2005, ARCH INSECT BIOCHEM, V59, P211, DOI 10.1002/arch.20061; Guidugli-Lazzarini KR, 2008, J INSECT PHYSIOL, V54, P1138, DOI 10.1016/j.jinsphys.2008.04.021; Hernandez LG, 2012, J PROTEOME RES, V11, P1485, DOI 10.1021/pr2007818; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; Hunt JH, 2003, J INSECT PHYSIOL, V49, P785, DOI 10.1016/S0022-1910(03)00115-X; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Kumar M, 2011, J MOL RECOGNIT, V24, P303, DOI 10.1002/jmr.1061; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVENBOOK L, 1984, INSECT BIOCHEM, V14, P77, DOI 10.1016/0020-1790(84)90086-6; Levenbook L., 1985, P307; LOCKE M, 1968, J CELL BIOL, V36, P453, DOI 10.1083/jcb.36.3.453; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Martins JR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-23; Martins Juliana Ramos, 2012, Insects, V3, P1039, DOI 10.3390/insects3041039; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nezis IP, 2000, EUR J CELL BIOL, V79, P610, DOI 10.1078/0171-9335-00088; Niu D, 2014, INSECT MOL BIOL, V23, P668, DOI 10.1111/imb.12114; OCHS RL, 1985, BIOL CELL, V54, P123, DOI 10.1111/j.1768-322X.1985.tb00387.x; PAGE RE, 1988, BEHAV ECOL SOCIOBIOL, V23, P117, DOI 10.1007/BF00299895; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Ronai I, 2015, J INSECT PHYSIOL, V81, P36, DOI 10.1016/j.jinsphys.2015.06.014; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; SCHIMMANG T, 1989, EMBO J, V8, P4015, DOI 10.1002/j.1460-2075.1989.tb08584.x; Seehuus SC, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.5201; Seehuus SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069870; SEKERIS CE, 1977, INSECT BIOCHEM, V7, P5, DOI 10.1016/0020-1790(77)90049-X; Shen HB, 2007, PROTEIN ENG DES SEL, V20, P561, DOI 10.1093/protein/gzm057; Snodgrass RE, 1956, ANATOMY HONEY BEE GR, P217; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Walia RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097725; Walia RR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-89; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang RW, 2007, FEBS LETT, V581, P3164, DOI 10.1016/j.febslet.2007.05.082; Wang ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047954; WHEELER DE, 1995, J INSECT PHYSIOL, V41, P885, DOI 10.1016/0022-1910(95)00028-S; Wilson MJ, 2011, EVOL DEV, V13, P127, DOI 10.1111/j.1525-142X.2011.00463.x; WOLFE J, 1977, EUR J BIOCHEM, V79, P47, DOI 10.1111/j.1432-1033.1977.tb11782.x; WYATT GR, 1978, ANNU REV BIOCHEM, V47, P779, DOI 10.1146/annurev.bi.47.070178.004023; Zalewska M, 2009, BBA-BIOMEMBRANES, V1788, P1695, DOI 10.1016/j.bbamem.2009.04.022	64	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151035	10.1371/journal.pone.0151035	http://dx.doi.org/10.1371/journal.pone.0151035			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954256	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300077
J	Sonoki, S; Shao, HM; Morita, Y; Minami, K; Shoji, J; Hori, M; Miyashita, K				Sonoki, Shiori; Shao, Huamei; Morita, Yuka; Minami, Kenji; Shoji, Jun; Hori, Masakazu; Miyashita, Kazushi			Using Acoustics to Determine Eelgrass Bed Distribution and to Assess the Seasonal Variation of Ecosystem Service	PLOS ONE			English	Article							SETO INLAND SEA; SEAGRASS; JAPAN	Eelgrass beds are an important source of primary production in coastal ecosystems. Understanding seasonal variation in the abundance and distribution of eelgrass is important for conservation, and the objectives of this study were to 1) monitor seasonal variation in eelgrass beds using an acoustic monitoring method (Quantitative echo sounder) and 2) broadly quantify the carbon circulation function. We obtained acoustic data of eelgrass beds in coastal areas north and east of Ikunojima Island. Surveys were conducted nine times over the 3-year period from 2011 to 2013 in order to monitor seasonal variation. Acoustic data were obtained and used to estimate the spatial distribution of eelgrass by geostatistical methods. To determine supporting services, we determined carbon sink and carbon fixation by eelgrass beds using data from the National Research Institute of Fisheries and Environment of Inland Sea (2011). The height and distribution of eelgrass beds were at a maximum in May and at a minimum in November of each year. Distribution trends were different between the north and east areas. Supporting services showed the same patterns throughout the year. The area of distribution was considered to be coincident with the life history of eelgrass. Distribution differed by area and changed yearly due to the effects of bottom characteristics and wind direction. Quantifying the supporting services of eelgrass beds was shown to be useful for managing the conservation of coastal ecosystems.	[Sonoki, Shiori; Shao, Huamei] Hokkaido Univ, Grad Sch Environm Sci, 20-5 Benten Cho, Hakodate, Hokkaido, Japan; [Morita, Yuka] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Inst East China Sea Res, 1551-7 Taira Cho, Nagasaki, Nagasaki, Japan; [Minami, Kenji] Hokkaido Univ, Grad Sch Fisheries Sci, 3-3-1 Minato Cho, Hakodate, Hokkaido, Japan; [Shoji, Jun] Hiroshima Univ, Ctr Field Sci Seto Inland Sea, 5-8-1 Minato Cho, Takehara City, Hiroshima, Japan; [Hori, Masakazu] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Maruishi 2-17-5, Hatsukaichi City, Hiroshima, Japan; [Miyashita, Kazushi] Hokkaido Univ, Field Sci Ctr Northern Biosphere, 20-5 Benten Cho, Hakodate, Hokkaido, Japan	Hokkaido University; Nagasaki University; Hokkaido University; Hiroshima University; Japan Fisheries Research & Education Agency (FRA); Hokkaido University	Sonoki, S (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, 20-5 Benten Cho, Hakodate, Hokkaido, Japan.	white-honey-lotus@ees.hokudai.ac.jp	Miyashita, Kazush/D-6757-2012	HORI, Masakazu/0000-0002-4677-9377; Shoji, Jun/0000-0003-2293-5707	Kakenhi [23380108]; Environment Research and Technology Development Fund [4E-1102]; Grants-in-Aid for Scientific Research [24405012] Funding Source: KAKEN	Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Environment Research and Technology Development Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by Kakenhi (23380108) and Environment Research and Technology Development Fund (4E-1102).	Abe M, 2004, NIPPON SUISAN GAKK, V70, P523, DOI 10.2331/suisan.70.523; ADAMS SM, 1976, J EXP MAR BIOL ECOL, V22, P269, DOI 10.1016/0022-0981(76)90007-1; [Anonymous], 2005, EC HUM WELL BEING SY; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; DENNISON WC, 1982, OECOLOGIA, V55, P137, DOI 10.1007/BF00384478; Duarte CM, 2000, J EXP MAR BIOL ECOL, V250, P117, DOI 10.1016/S0022-0981(00)00194-5; Fisheries Agency, 2008, FISH WHIT BOOK 2008; Fisheries Research Agency, 2011, ANN REP PROJ JAP FIS, P117; FORTUIN L, 1970, J ACOUST SOC AM, V47, P1209, DOI 10.1121/1.1912022; Hashimoto S, 2009, P GRADUATE SCH BIOSP, V48, P63; Hemming M. A., 2000, SEAGRASS ECOLOGY; Hirai Kotaro, 2009, Biosphere Science, V48, P1; Hiraoka K, 2005, J JAPAN SOC WATER EN, V28, P257; Kamimura Y., 2009, AQUACULTURE SCI, V57, P233; Kohsaka H., 1998, J DEP GEOGRAPHY COLL, P27; Komatsu T, 2002, FISHERIES SCI, V68, P580, DOI 10.2331/fishsci.68.sup1_580; Koshikawa Y, 2009, J JPN SOC CIV ENG B, V65, P1076; Mikami A., 2003, OTSUCHI MARINE SCI, V28, P72; Minami K, 2012, NIPPON SUISAN GAKK, V78, P171, DOI 10.2331/suisan.78.171; Miyamoto Y, 2007, LAGUNA, V14, P9; Nagelkerken I, 2000, ESTUAR COAST SHELF S, V51, P31, DOI 10.1006/ecss.2000.0617; Ona E, 1996, ICES J MAR SCI, V53, P677, DOI 10.1006/jmsc.1996.0087; Oomori Y., 2000, AQUABIOLOGY, V131, P524; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Shoji T, 2007, J GEOTHERM RES SOC J, P183; Simmonds J., 2005, FISHERIES ACOUSTICS, V2nd edn; Terawaki Toshinobu, 2002, Bulletin of Fisheries Research Agency, P25; Ueta Y, 2003, FISHERIES ENG, V31, P189; Watanabe M, 2000, AQUABIOLOGY, V131, P533; Yamakita T., 2005, JPN J CONSERV ECOL, V10, P129; Yoshida Goro, 2011, Bulletin of Fisheries Research Agency, P1	31	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150890	10.1371/journal.pone.0150890	http://dx.doi.org/10.1371/journal.pone.0150890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954673	gold, Green Published			2022-12-27	WOS:000371991300057
J	Wei, JC; Dobnikar, J; Curk, T; Song, F				Wei, Jiachen; Dobnikar, Jure; Curk, Tine; Song, Fan			The Effect of Attractive Interactions and Macromolecular Crowding on Crystallins Association	PLOS ONE			English	Article							GAMMA-CRYSTALLINS; EYE LENS; PROTEIN INTERACTIONS; CATARACT; MODEL	In living systems proteins are typically found in crowded environments where their effective interactions strongly depend on the surrounding medium. Yet, their association and dissociation needs to be robustly controlled in order to enable biological function. Uncontrolled protein aggregation often causes disease. For instance, cataract is caused by the clustering of lens proteins, i.e., crystallins, resulting in enhanced light scattering and impaired vision or blindness. To investigate the molecular origins of cataract formation and to design efficient treatments, a better understanding of crystallin association in macromolecular crowded environment is needed. Here we present a theoretical study of simple coarse grained colloidal models to characterize the general features of how the association equilibrium of proteins depends on the magnitude of intermolecular attraction. By comparing the analytic results to the available experimental data on the osmotic pressure in crystallin solutions, we identify the effective parameters regimes applicable to crystallins. Moreover, the combination of two models allows us to predict that the number of binding sites on crystallin is small, i.e. one to three per protein, which is different from previous estimates. We further observe that the crowding factor is sensitive to the size asymmetry between the reactants and crowding agents, the shape of the protein clusters, and to small variations of intermolecular attraction. Our work may provide general guidelines on how to steer the protein interactions in order to control their association.	[Wei, Jiachen; Song, Fan] Chinese Acad Sci, Inst Mech, State Key Lab Nonlinear Mech LNM, Beijing 100190, Peoples R China; [Dobnikar, Jure] Beijing Univ Chem Technol, Int Res Ctr Soft Matter, Beijing 100029, Peoples R China; [Curk, Tine] Univ Cambridge, Univ Chem Lab, Lensfield Rd, Cambridge CB2 1EW, England	Chinese Academy of Sciences; Institute of Mechanics, CAS; Beijing University of Chemical Technology; University of Cambridge	Song, F (corresponding author), Chinese Acad Sci, Inst Mech, State Key Lab Nonlinear Mech LNM, Beijing 100190, Peoples R China.	songf@lnm.imech.ac.cn	Dobnikar, Jure/C-8765-2011	Dobnikar, Jure/0000-0002-1169-6619; Curk, Tine/0000-0002-2167-5336	National Natural Science Foundation of China [11232013, 11472285]; Fundamental Research Funds for the Central Universities of P. R. China [buctrc201422]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of P. R. China	This work was supported by the National Natural Science Foundation of China (Grant No. 11232013 and No. 11472285) and the Fundamental Research Funds for the Central Universities of P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundations of China ( Grants No. 11232013 and No. 11472285) and the Fundamental Research Funds for the Central Universities of P. R. China under the project buctrc201422.	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Banerjee PR, 2011, P NATL ACAD SCI USA, V108, P574, DOI 10.1073/pnas.1014653107; Batra J, 2009, PROTEINS, V77, P133, DOI 10.1002/prot.22425; Benedek GB, 1997, INVEST OPHTH VIS SCI, V38, P1911; BETTELHEIM FA, 1983, BIOPHYS J, V41, P29, DOI 10.1016/S0006-3495(83)84402-6; Bhattacharya Apratim, 2013, Biophys Rev, V5, P99, DOI 10.1007/s12551-013-0111-5; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; BOUBLIK T, 1986, MOL PHYS, V59, P371, DOI 10.1080/00268978600102131; CARNAHAN NF, 1969, J CHEM PHYS, V51, P635, DOI 10.1063/1.1672048; Das P, 2011, P NATL ACAD SCI USA, V108, P10514, DOI 10.1073/pnas.1019152108; Das P, 2010, PROTEIN SCI, V19, P131, DOI 10.1002/pro.296; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Dorsaz N, 2011, SOFT MATTER, V7, P1763, DOI 10.1039/c0sm00156b; Duda Y, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3089702; Fang H, 2015, J ETHNOPHARMACOL, V172, P238, DOI 10.1016/j.jep.2015.06.034; Grey AC, 2008, MOL VIS, V14, P171; GUTTMAN HJ, 1995, BIOPHYS J, V68, P835, DOI 10.1016/S0006-3495(95)80260-2; Keenan J, 2008, MOL VIS, V14, P1245; Kim JS, 2011, J PHYS CHEM B, V115, P347, DOI 10.1021/jp107123y; Kim YC, 2014, J PHYS CHEM B, V118, P12621, DOI 10.1021/jp508046y; Kim YC, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.208102; Kim YC, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3516589; Liu CW, 1996, P NATL ACAD SCI USA, V93, P377, DOI 10.1073/pnas.93.1.377; Liu Z, 2008, BIOPHYS J, V94, P3629, DOI 10.1529/biophysj.107.117465; McManus JJ, 2007, P NATL ACAD SCI USA, V104, P16856, DOI 10.1073/pnas.0707412104; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Minton AP, 2013, BIOPOLYMERS, V99, P239, DOI 10.1002/bip.22163; Minton AP, 1998, METHOD ENZYMOL, V295, P127; Pellicane G, 2004, J PHYS CHEM B, V108, P7538, DOI 10.1021/jp048651v; REISS H, 1959, J CHEM PHYS, V31, P369, DOI 10.1063/1.1730361; Rosen J, 2011, J PHYS CHEM B, V115, P2683, DOI 10.1021/jp200625k; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Stradner A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.198103; Takemoto L, 2008, EXP EYE RES, V87, P496, DOI 10.1016/j.exer.2008.08.018; Tanford C., 1961, PHYS CHEM MACROMOLEC; TARDIEU A, 1992, EUR BIOPHYS J BIOPHY, V21, P1, DOI 10.1007/BF00195438; VERETOUT F, 1989, EUR BIOPHYS J BIOPHY, V17, P61, DOI 10.1007/BF00257103; Zhao HY, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046004	39	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151159	10.1371/journal.pone.0151159	http://dx.doi.org/10.1371/journal.pone.0151159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954357	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300090
J	Verhaag, EM; Buist-Homan, M; Koehorst, M; Groen, AK; Moshage, H; Faber, KN				Verhaag, Esther M.; Buist-Homan, Manon; Koehorst, Martijn; Groen, Albert K.; Moshage, Han; Faber, Klaas Nico			Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity	PLOS ONE			English	Article							ISOLATED RAT HEPATOCYTES; FARNESOID-X-RECEPTOR; SALT EXPORT PUMP; REPERFUSION INJURY; INDUCED APOPTOSIS; OBSTRUCTIVE CHOLESTASIS; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; ACTIVATION; FXR	Introduction Cholestasis is characterized by accumulation of bile acids and inflammation, causing hepatocellular damage. Still, liver damage markers are highest in acute cholestasis and drop when this condition becomes chronic, indicating that hepatocytes adapt towards the hostile environment. This may be explained by a hormetic response in hepatocytes that limits cell death during cholestasis. Aim To investigate the mechanisms that underlie the hormetic response that protect hepatocytes against experimental cholestatic conditions. Methods HepG2.rNtcp cells were preconditioned (24 h) with sub-apoptotic concentrations (0.1-50 mu M) of various bile acids, the superoxide donor menadione, TNF-alpha or the Farsenoid X Receptor agonist GW4064, followed by a challenge with the apoptosis-inducing bile acid glycochenodeoxycholic acid (GCDCA; 200 mu M for 4 h), menadione (50 mu M, 6 h) or cytokine mixture (CM; 6 h). Levels of apoptotic and necrotic cell death, mRNA expression of the bile salt export pump (ABCB11) and bile acid sensors, as well as intracellular GCDCA levels were analyzed. Results Preconditioning with the pro-apoptotic bile acids GCDCA, taurocholic acid, or the protective bile acids (tauro) ursodeoxycholic acid reduced GCDCA-induced caspase-3/7 activity in HepG2.rNtcp cells. Bile acid preconditioning did not induce significant levels of necrosis in GCDCA-challenged HepG2.rNtcp cells. In contrast, preconditioning with cholic acid, menadione or TNF-alpha potentiated GCDCA-induced apoptosis. GCDCA preconditioning specifically reduced GCDCA-induced cell death and not CM-or menadione-induced apoptosis. The hormetic effect of GCDCA preconditioning was concentration-and time-dependent. GCDCA-, CDCA-and GW4064-preconditioning enhanced ABCB11 mRNA levels, but in contrast to the bile acids, GW4064 did not significantly reduce GCDCA-induced caspase-3/7 activity. The GCDCA challenge strongly increased intracellular levels of this bile acid, which was not lowered by GCDCA-preconditioning. Conclusions Sub-toxic concentrations of bile acids in the range that occur under normal physiological conditions protect HepG2.rNtcp cells against GCDCA-induced apoptosis, which is independent of FXR-controlled changes in bile acid transport.	[Verhaag, Esther M.; Buist-Homan, Manon; Moshage, Han; Faber, Klaas Nico] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Ctr Liver Digest & Metab Dis, Groningen, Netherlands; [Buist-Homan, Manon; Koehorst, Martijn; Groen, Albert K.; Moshage, Han; Faber, Klaas Nico] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Lab Med, Groningen, Netherlands; [Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, NL-9700 AB Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Faber, KN (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Ctr Liver Digest & Metab Dis, Groningen, Netherlands.; Faber, KN (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Lab Med, Groningen, Netherlands.	K.N.Faber@umcg.nl		Moshage, Han/0000-0002-4764-0246; Koehorst, Martijn/0000-0001-6219-0901				Alchera E, 2010, WORLD J GASTROENTERO, V16, P6058, DOI 10.3748/wjg.v16.i48.6058; Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Beuers U, 2015, J HEPATOL, V62, pS25, DOI 10.1016/j.jhep.2015.02.023; BILLINGTON D, 1980, BIOCHEM J, V188, P321, DOI 10.1042/bj1880321; BOTLA R, 1995, J PHARMACOL EXP THER, V272, P930; Carini R, 2003, GASTROENTEROLOGY, V125, P1480, DOI 10.1016/j.gastro.2003.05.005; Conde de la Rosa L, 2006, J HEPATOL, V44, P918, DOI 10.1016/j.jhep.2005.07.034; Conde de la Rosa L, 2015, PHARM RES PERSPECT, V3, P2052; Copple BL, 2010, SEMIN LIVER DIS, V30, P195, DOI 10.1055/s-0030-1253228; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Dijkstra G, 2004, J PATHOL, V204, P296, DOI 10.1002/path.1656; Dunning S, 2013, BBA-MOL BASIS DIS, V1832, P2027, DOI 10.1016/j.bbadis.2013.07.008; Fiorucci S, 2014, EXPERT OPIN THER TAR, V18, P1449, DOI 10.1517/14728222.2014.956087; Fischer S, 1996, CLIN CHIM ACTA, V251, P173, DOI 10.1016/0009-8981(96)06305-X; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; Gumpricht E, 2000, TOXICOL APPL PHARM, V164, P102, DOI 10.1006/taap.2000.8894; Hofmann AF, 1999, NEWS PHYSIOL SCI, V14, P24, DOI 10.1152/physiologyonline.1999.14.1.24; Karimian G, 2013, BBA-MOL BASIS DIS, V1832, P1922, DOI 10.1016/j.bbadis.2013.06.011; KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305; Kullak-Ublick GA, 2000, CYTOTECHNOLOGY, V34, pB1, DOI 10.1023/A:1008152729133; Losada DM, 2014, ACTA CIR BRAS, V29, P61, DOI 10.1590/S0102-8650201400140012; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Meier PJ, 1995, AM J PHYSIOL-GASTR L, V269, pG801, DOI 10.1152/ajpgi.1995.269.6.G801; Palmeira CM, 2004, TOXICOLOGY, V203, P1, DOI 10.1016/j.tox.2004.06.001; Pellicoro A, 2007, ALIMENT PHARM THERAP, V26, P149, DOI 10.1111/j.1365-2036.2007.03522.x; Plass JRM, 2002, HEPATOLOGY, V35, P589, DOI 10.1053/jhep.2002.31724; POPPER H, 1968, ANNU REV MED, V19, P39, DOI 10.1146/annurev.me.19.020168.000351; Qureshi WA, 1999, DIGEST DIS, V17, P49, DOI 10.1159/000016903; Rembacz KP, 2010, HEPATOLOGY, V52, P2167, DOI 10.1002/hep.23954; Rudic JS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000551.pub3; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; Schoemaker MH, 2003, J HEPATOL, V39, P153, DOI 10.1016/S0168-8278(03)00214-9; SKREDE S, 1978, CLIN CHEM, V24, P1095; Sokol RJ, 2006, J PEDIATR GASTR NUTR, V43, pS4, DOI 10.1097/01.mpg.0000226384.71859.16; Sokol TJ, 2005, J PEDIATR GASTR NUTR, V41, P235, DOI 10.1097/01.MPG.0000170600.80640.88; Suyavaran A, 2015, INFLAMM RES, V64, P71, DOI 10.1007/s00011-014-0785-6; Vaquero J, 2013, BIOCHEM PHARMACOL, V86, P926, DOI 10.1016/j.bcp.2013.07.022; Vaquero J, 2013, BBA-MOL CELL RES, V1833, P2212, DOI 10.1016/j.bbamcr.2013.05.006; Wenniger LMD, 2010, DIGEST LIVER DIS, V42, P409, DOI 10.1016/j.dld.2010.03.015; Woolbright BL, 2015, TOXICOL APPL PHARM, V283, P168, DOI 10.1016/j.taap.2015.01.015; Woudenberg-Vrenken TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071773; Yin DP, 1998, TRANSPLANTATION, V66, P152, DOI 10.1097/00007890-199807270-00002; Zhang RJ, 2014, J HEPATOL, V61, P1048, DOI 10.1016/j.jhep.2014.06.020	45	9	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0149782	10.1371/journal.pone.0149782	http://dx.doi.org/10.1371/journal.pone.0149782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950211	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100017
J	Guerrero, M; Crisafulli, E; Liapikou, A; Huerta, A; Gabarrus, A; Chetta, A; Soler, N; Torres, A				Guerrero, Monica; Crisafulli, Ernesto; Liapikou, Adamantia; Huerta, Arturo; Gabarrus, Albert; Chetta, Alfredo; Soler, Nestor; Torres, Antoni			Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION DECLINE; HOSPITALIZATION; PREDICTORS	Background and Objective Twenty per cent of chronic obstructive pulmonary disease (COPD) patients are readmitted for acute exacerbation (AECOPD) within 30 days of discharge. The prognostic significance of early readmission is not fully understood. The objective of our study was to estimate the mortality risk associated with readmission for acute exacerbation within 30 days of discharge in COPD patients. Methods The cohort (n = 378) was divided into patients readmitted (n = 68) and not readmitted (n = 310) within 30 days of discharge. Clinical, laboratory, microbiological, and severity data were evaluated at admission and during hospital stay, and mortality data were recorded at four time points during follow-up: 30 days, 6 months, 1 year and 3 years. Results Patients readmitted within 30 days had poorer lung function, worse dyspnea perception and higher clinical severity. Two or more prior AECOPD (HR, 2.47; 95% CI, 1.51-4.05) was the only variable independently associated with 30-day readmission. The mortality risk during the follow-up period showed a progressive increase in patients readmitted within 30 days in comparison to patients not readmitted; moreover, 30-day readmission was an independent risk factor for mortality at 1 year (HR, 2.48; 95% CI, 1.10-5.59). In patients readmitted within 30 days, the estimated absolute increase in the mortality risk was 4% at 30 days (number needed to harm NNH, 25), 17% at 6-months (NNH, 6), 19% at 1-year (NNH, 6) and 24% at 3 years ( NNH, 5). Conclusion In conclusion a readmission for AECOPD within 30 days is associated with a progressive increased long-term risk of death.	[Guerrero, Monica; Huerta, Arturo; Gabarrus, Albert; Soler, Nestor; Torres, Antoni] Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed Agusti Pi & Sunyer IDIBAPS, Resp Dept,Clin Inst Resp ICR,CIBERES, Barcelona, Spain; [Crisafulli, Ernesto; Chetta, Alfredo] Univ Parma, Dept Clin & Expt Med, Resp Dis & Lung Funct Unit, I-43100 Parma, Italy; [Liapikou, Adamantia] Sotiria Hosp, Resp Dept 6, Athens, Greece	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Parma; University Hospital of Parma	Torres, A (corresponding author), Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed Agusti Pi & Sunyer IDIBAPS, Resp Dept,Clin Inst Resp ICR,CIBERES, Barcelona, Spain.	ATORRES@clinic.ub.es	Torres, Antoni/H-6128-2017; Huerta, Arturo/T-9954-2019; Lliapikou, Adamadia/H-8512-2019; Crisafulli, Ernesto/AAB-9595-2019	Torres, Antoni/0000-0002-8643-2167; Huerta, Arturo/0000-0002-6191-4143; Crisafulli, Ernesto/0000-0001-7298-7084; Gabarrus, Albert/0000-0003-3492-1310; Chetta, Alfredo/0000-0002-0416-5334; Soler, Nestor/0000-0003-4371-3994				Almagro P, 2014, CHEST, V145, P972, DOI 10.1378/chest.13-1328; Blasi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101228; Celli BR, 2007, EUR RESPIR J, V29, P1224, DOI 10.1183/09031936.00109906; Citrome L, 2013, INT J CLIN PRACT, V67, P407, DOI 10.1111/ijcp.12142; Collett D, 1994, MODELLING SURVIVAL D; Crisafulli E., 2015, CLIN PULMONARY MED, V22, P172, DOI DOI 10.1097/CPM.0000000000000090; Crisafulli E, 2015, COPD, V12, P306, DOI 10.3109/15412555.2014.933954; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Garcia-Aymerich J, 2011, THORAX, V66, P585, DOI 10.1136/thx.2010.152876; Groenewegen KH, 2003, CHEST, V124, P459, DOI 10.1378/chest.124.2.459; Hurst JR, 2006, AM J RESP CRIT CARE, V174, P867, DOI 10.1164/rccm.200604-506OC; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Hurst JR, 2009, AM J RESP CRIT CARE, V179, P369, DOI 10.1164/rccm.200807-1067OC; Makris D, 2007, RESP MED, V101, P1305, DOI 10.1016/j.rmed.2006.10.012; MIKE V, 1982, STAT MED RES METHODS; Prieto-Centurion Valentin, 2014, Ann Am Thorac Soc, V11, P417, DOI 10.1513/AnnalsATS.201308-254OC; Sethi S, 2008, AM J RESP CRIT CARE, V177, P491, DOI 10.1164/rccm.200708-1234OC; Shah T, 2015, CHEST, V147, P1219, DOI 10.1378/chest.14-2181; Sharif Roozbeh, 2014, Ann Am Thorac Soc, V11, P685, DOI 10.1513/AnnalsATS.201310-358OC; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Steer J, 2012, THORAX, V67, P117, DOI 10.1136/thoraxjnl-2011-200332; Suissa S, 2012, THORAX, V67, P957, DOI 10.1136/thoraxjnl-2011-201518; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wedzicha JA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-181	24	63	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150737	10.1371/journal.pone.0150737	http://dx.doi.org/10.1371/journal.pone.0150737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943928	Green Published, Green Submitted, gold			2022-12-27	WOS:000371739400042
J	Liu, X; Liao, S; Xu, ZW; Zhu, L; Yang, F; Guo, WZ				Liu, Xiao; Liao, Shan; Xu, Zhiwen; Zhu, Ling; Yang, Fan; Guo, Wanzhu			Identification and Analysis of the Porcine MicroRNA in Porcine Cytomegalovirus-Infected Macrophages Using Deep Sequencing	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; EXPRESSED MICRORNAS; CELL PROLIFERATION; XENOTRANSPLANTATION; DIFFERENTIATION; RECOGNITION; PROGRESS; VIRUS	Porcine cytomegalovirus (PCMV; genus Cytomegalovirus, subfamily Betaherpesvirinae, family Herpesviridae) is an immunosuppressive virus that mainly inhibits the immune function of T lymphocytes and macrophages, which has caused substantial damage in the farming industry. In this study, we obtained the miRNA expression profiles of PCMV-infected porcine macrophages via high-throughput sequencing. The comprehensive analysis of miRNA profiles showed that 239 miRNA database-annotated and 355 novel pig-encoded miRNAs were detected. Of these, 130 miRNAs showed significant differential expression between the PCMV-infected and uninfected porcine macrophages. The 10 differentially expressed pig-encoded miRNAs were further determined by stem-loop reverse-transcription polymerase chain reaction, and the results were consistent with the high-throughput sequencing. Gene Ontology analysis of the target genes of miRNAs in PCMV-infected porcine macrophages showed that the differentially expressed miRNAs are mainly involved in immune and metabolic processes. This is the first report of the miRNA transcriptome in porcine macrophages and an analysis of the miRNA regulatory mechanisms during PCMV infection. Further research into the regulatory mechanisms of miRNAs during immunosuppressive viral infections should contribute to the treatment and prevention of immunosuppressive viruses.	[Liu, Xiao; Liao, Shan; Xu, Zhiwen; Zhu, Ling; Yang, Fan; Guo, Wanzhu] Sichuan Agr Univ, Coll Vet Med, Anim Biotechnol Ctr, Yaan 625014, Peoples R China; [Liu, Xiao] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Liver, Boston, MA 02114 USA; [Liu, Xiao] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Div,Dept Med, Boston, MA 02114 USA; [Xu, Zhiwen] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth, Yaan 625014, Peoples R China	Sichuan Agricultural University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Xu, ZW (corresponding author), Sichuan Agr Univ, Coll Vet Med, Anim Biotechnol Ctr, Yaan 625014, Peoples R China.; Xu, ZW (corresponding author), Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth, Yaan 625014, Peoples R China.	abtcxzw@126.com	YANG, FAN/F-2603-2015	YANG, FAN/0000-0002-0355-3044	Program for Changjiang Scholars and Innovative Research Team in University [IRT13083]; Program for Sichuan Youth Science and Technology and Innovation Research Team [2013TD0015]; China Scholarship Council (CSC); Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for Sichuan Youth Science and Technology and Innovation Research Team; China Scholarship Council (CSC)(China Scholarship Council); Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University	This study was supported by the Program for Changjiang Scholars and Innovative Research Team in University (project no: IRT13083), Program for Sichuan Youth Science and Technology and Innovation Research Team (project no: 2013TD0015), China Scholarship Council (CSC), and by the Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, NUCLEIC ACIDS RES; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cai YH, 2015, INT J MOL SCI, V16, P2204, DOI 10.3390/ijms16012204; Chan EK, 2012, ANN RHEUM DIS; Chen ZQ, 2010, ADV CIV ENG, V2010, DOI 10.1155/2010/215295; Clark DA, 2003, XENOTRANSPLANTATION, V10, P142, DOI 10.1034/j.1399-3089.2003.01128.x; Cullen BR, 2013, NAT IMMUNOL, V14, P205, DOI 10.1038/ni.2537; Dong HF, 2013, CHEM REV, V113, P6207, DOI 10.1021/cr300362f; Fehniger TA, 2010, GENOME RES, V20, P1590, DOI 10.1101/gr.107995.110; Fishman JA, 2004, AM J TRANSPLANT, V4, P1383, DOI 10.1111/j.1600-6143.2004.00542.x; Fryer JFL, 2001, J CLIN MICROBIOL, V39, P1155, DOI 10.1128/JCM.39.3.1155-1156.2001; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Gu WW, 2014, VIROLOGY, V460, P165, DOI 10.1016/j.virol.2014.05.014; Guerau-de-Arellano M, 2012, J NEUROIMMUNOL, V248, P32, DOI 10.1016/j.jneuroim.2011.10.006; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang S, 2011, BRIT J CANCER, V104, P235, DOI 10.1038/sj.bjc.6606010; Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lee CS, 2007, J VIROL METHODS, V139, P39, DOI 10.1016/j.jviromet.2006.09.003; Lee HM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00178; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li X, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/431476; Linsen SEV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-249; Liu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113921; Liu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064648; Lu C, 2011, METHODS MOL BIOL, V729, P141, DOI 10.1007/978-1-61779-065-2_9; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mueller NJ, 2004, TRANSPLANTATION, V78, P1449, DOI 10.1097/01.TP.0000141361.68446.1F; Nobuta K, 2010, METHODS MOL BIOL, V592, P89, DOI 10.1007/978-1-60327-005-2_7; Rebane A, 2014, J ALLERGY CLIN IMMUN, V134, P836, DOI 10.1016/j.jaci.2014.05.022; Roy S, 2011, PHYSIOL GENOMICS, V43, P557, DOI 10.1152/physiolgenomics.00160.2010; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Scobie L, 2010, XENOTRANSPLANTATION, V17, P118, DOI 10.1111/j.1399-3089.2010.00573_19.x; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shenoy A, 2014, NAT REV MOL CELL BIO, V15, P565, DOI 10.1038/nrm3854; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Whitteker JL, 2008, TRANSPLANTATION, V86, P155, DOI 10.1097/TP.0b013e31817d4823; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988	45	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150971	10.1371/journal.pone.0150971	http://dx.doi.org/10.1371/journal.pone.0150971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943793	gold, Green Published, Green Submitted			2022-12-27	WOS:000371739400068
J	Simpson, K; Johnson, CN; Carver, S				Simpson, Kellie; Johnson, Christopher N.; Carver, Scott			Sarcoptes scabiei: The Mange Mite with Mighty Effects on the Common Wombat (Vombatus ursinus)	PLOS ONE			English	Article							DOGS NYCTEREUTES-PROCYONOIDES; TRADE-OFFS; ECOLOGICAL IMMUNOLOGY; LASIORHINUS-LATIFRONS; PARASITE; BEHAVIOR; MARSUPIALIA; INFECTION; DIGESTION; PATHOLOGY	Parasitism has both direct and indirect effects on hosts. Indirect effects (such as behavioural changes) may be common, although are often poorly described. This study examined sarcoptic mange (caused by the mite Sarcoptes scabiei) in the common wombat (Vombatus ursinus), a species that shows severe symptoms of infection and often causes mortality. Wombats showed alterations to above ground behaviours associated with mange. Infected wombats were shown to be active outside of the burrow for longer than healthy individuals. Additionally, they spent more time scratching and drinking, and less time walking as a proportion of time spent above ground when compared with healthy individuals. They did not spend a higher proportion of time feeding, but did have a slower feeding rate and were in poorer body condition. Thermal images showed that wombats with mange lost considerably more heat to the environment due to a diminished insulation layer. Infection status did not have an effect on burrow emergence time, although this was strongly dependent on maximum daily temperature. This study, through the most detailed behavioural observations of wombats to date, contributes to a broader understanding of how mange affects wombat health and abundance, and also to our understanding of the evolution of host responses to this parasite. Despite being globally dispersed and impacting over 100 species with diverse intrinsic host traits, the effects of mange on hosts are relatively poorly understood, and it is possible that similar effects of this disease are conserved in other host species. The indirect effects that we observed may extend to other pathogen types.	[Simpson, Kellie; Johnson, Christopher N.; Carver, Scott] Univ Tasmania, Sch Biol Sci, Sandy Bay, Australia; [Simpson, Kellie] Dept Pk Primary Ind Water & Environm, Hobart, Tas, Australia	University of Tasmania	Simpson, K (corresponding author), Univ Tasmania, Sch Biol Sci, Sandy Bay, Australia.; Simpson, K (corresponding author), Dept Pk Primary Ind Water & Environm, Hobart, Tas, Australia.	kellie.simpson@dpipwe.tas.gov.au	Johnson, Christopher/J-7894-2014; Carver, Scott/J-7654-2014	Johnson, Christopher/0000-0002-9719-3771; Carver, Scott/0000-0002-3579-7588				Barber I, 2000, REV FISH BIOL FISHER, V10, P131, DOI 10.1023/A:1016658224470; BARBOZA PS, 1993, PHYSIOL ZOOL, V66, P983, DOI 10.1086/physzool.66.6.30163750; BARBOZA PS, 1992, J COMP PHYSIOL B, V162, P561; BARBOZA PS, 1992, J COMP PHYSIOL B, V162, P552; Bize P, 2010, EVOL BIOL, V37, P169, DOI 10.1007/s11692-010-9092-5; BOOTH DT, 1993, P ROY SOC B-BIOL SCI, V253, P125, DOI 10.1098/rspb.1993.0091; Borchard P, 2008, WILDLIFE RES, V35, P760, DOI 10.1071/WR08071; Borchard P, 2012, MAMM BIOL, V77, P244, DOI 10.1016/j.mambio.2012.04.004; Evans M, 2003, OECOLOGIA, V137, P171, DOI 10.1007/s00442-003-1322-4; Evans MC, 2006, WILDLIFE RES, V33, P321, DOI 10.1071/WR05047; Evans MC, 2008, WILDLIFE RES, V35, P455, DOI 10.1071/WR07067; Giorgi MS, 2001, P ROY SOC B-BIOL SCI, V268, P2071, DOI 10.1098/rspb.2001.1686; GRAY D. F., 1937, Australian Veterinary Journal, V13, P154, DOI 10.1111/j.1751-0813.1937.tb04110.x; Hartley M, 2005, EUR J WILDLIFE RES, V51, P117, DOI 10.1007/s10344-005-0080-5; Hogan LA, 2011, AUST J ZOOL, V59, P35, DOI 10.1071/ZO11006; Holz PH, 2011, AUST VET J, V89, P458, DOI 10.1111/j.1751-0813.2011.00830.x; Johnson CN, 1998, WOMBATS, P34; Kido N, 2013, VET PARASITOL, V191, P102, DOI 10.1016/j.vetpar.2012.07.026; Kido N, 2011, PARASITOL INT, V60, P425, DOI 10.1016/j.parint.2011.06.023; Lefevre T, 2008, TRENDS PARASITOL, V24, P435, DOI 10.1016/j.pt.2008.06.006; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Martin RW, 1998, AUST VET J, V76, P411, DOI 10.1111/j.1751-0813.1998.tb12391.x; McLelland DJ, 2005, AUST VET J, V83, P744, DOI 10.1111/j.1751-0813.2005.tb11585.x; Moore J, 2002, PARASITES BEHAV ANIM; Moore J, 2013, J EXP BIOL, V216, P11, DOI 10.1242/jeb.074088; Nimmervoll H, 2013, J WILDLIFE DIS, V49, P91, DOI 10.7589/2010-11-316; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; OBENDORF DL, 1983, J WILDLIFE DIS, V19, P123, DOI 10.7589/0090-3558-19.2.123; Oleaga A, 2011, VET PARASITOL, V181, P255, DOI 10.1016/j.vetpar.2011.04.036; Orlofske SA, 2013, COMP BIOCHEM PHYS A, V164, P529, DOI 10.1016/j.cbpa.2012.12.013; PENCE DB, 1983, J PARASITOL, V69, P1100, DOI 10.2307/3280873; Pence DB, 2002, REV SCI TECH OIE, V21, P385, DOI 10.20506/rst.21.2.1335; Rasero R, 2010, BIOL CONSERV, V143, P1269, DOI 10.1016/j.biocon.2010.03.001; Raveh A, 2011, ECOL LETT, V14, P47, DOI 10.1111/j.1461-0248.2010.01549.x; Ruykys L, 2009, AUST J ZOOL, V57, P129, DOI 10.1071/ZO09010; Serieys LEK, 2015, EVOL APPL, V8, P75, DOI 10.1111/eva.12226; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shelley DP, 2002, CAN FIELD NAT, V116, P648; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Skerratt LF, 1998, AUST VET J, V76, P408, DOI 10.1111/j.1751-0813.1998.tb12389.x; Skerratt LF, 1999, J WILDLIFE DIS, V35, P633, DOI 10.7589/0090-3558-35.4.633; Skerratt LF, 2004, AUST J ZOOL, V52, P303, DOI 10.1071/ZO02061; Skerratt LF, 2004, AUST J ZOOL, V52, P331, DOI 10.1071/ZO02062; Skerratt LF, 2003, J WILDLIFE DIS, V39, P179, DOI 10.7589/0090-3558-39.1.179; Skerratt LF, 2003, J WILDLIFE DIS, V39, P193, DOI 10.7589/0090-3558-39.1.193; Tasmanian Parks and Wildlife Service (PWS), 2000, NAR NAT PARK HAWL BE; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Triggs B, 2009, WOMBATS; Walsh PT, 2013, ANIM BEHAV, V86, P559, DOI 10.1016/j.anbehav.2013.06.011; Wu P, 1996, BIOMATERIALS, V17, P1373, DOI 10.1016/0142-9612(96)87277-2; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	52	25	25	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0149749	10.1371/journal.pone.0149749	http://dx.doi.org/10.1371/journal.pone.0149749			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943790	Green Published, gold, Green Submitted			2022-12-27	WOS:000371739400005
J	Zarroug, IMA; Hashim, K; Elaagip, AH; Samy, AM; Frah, EA; ElMubarak, WA; Mohamed, HA; Deran, TCM; Aziz, N; Higazi, TB				Zarroug, Isam M. A.; Hashim, Kamal; Elaagip, Arwa H.; Samy, Abdallah M.; Frah, Ehab A.; ElMubarak, Wigdan A.; Mohamed, Hanan A.; Deran, Tong Chor M.; Aziz, Nabil; Higazi, Tarig B.			Seasonal Variation in Biting Rates of Simulium damnosum sensu lato, Vector of Onchocerca volvulus, in Two Sudanese Foci	PLOS ONE			English	Article							ABU-HAMED FOCUS; NORTHERN SUDAN; BLACK FLIES; TRANSMISSION; DIPTERA; NIGERIA; DYNAMICS; COMPLEX; POPULATION; DISEASE	Background The abundance of onchocerciasis vectors affects the epidemiology of disease in Sudan, therefore, studies of vector dynamics are crucial for onchocerciasis control/elimination programs. This study aims to compare the relative abundance, monthly biting-rates (MBR) and hourly-based distribution of onchocerciasis vectors in Abu-Hamed and Galabat foci. These seasonally-based factors can be used to structure vector control efforts to reduce fly-biting rates as a component of onchocerciasis elimination programs. Methods A cross-sectional study was conducted in four endemic villages in Abu-Hamed and Galabat foci during two non-consecutive years (2007-2008 and 2009-2010). Both adults and aquatic stages of the potential onchocerciasis vector Simulium damnosum sensu lato were collected following standard procedures during wet and dry seasons. Adult flies were collected using human landing capture for 5 days/month. The data was recorded on handheld data collection sheets to calculate the relative abundance, MBR, and hourly-based distribution associated with climatic factors. The data analysis was carried out using ANOVA and Spearman rank correlation tests. Results Data on vector surveillance revealed higher relative abundance of S. damnosum s.l. in Abu-Hamed (39,934 flies) than Galabat (8,202 flies). In Abu-Hamed, vector populations increased in January-April then declined in June-July until they disappeared in August-October. Highest black fly density and MBR were found in March 2007 (N = 9,444, MBR = 58,552.8 bites/person/month), and March 2010 (N = 2,603, MBR = 16,138.6 bites/person/month) while none of flies were collected in August-October (MBR = 0 bites/person/month). In Galabat, vectors increased in September-December, then decreased in February-June. The highest vector density and MBR were recorded in September 2007 (N = 1,138, MBR = 6,828 bites/person/month) and September 2010 (N = 1,163, MBR = 6,978 bites/person/ month), whereas, none appeared in collection from April to June. There was a significant difference in mean monthly density of S. damnosum s.l. across the two foci in 2007-2008 (df = 3, F = 3.91, P = 0.011). Minimum temperature showed significant correlation with adult flies counts in four areas sampled; the adult counts were increased in Nady village (r(s) = 0.799) and were decreased in Kalasecal (r(s) = -0.676), Gumaiza (r(s) = -0.585), and Hilat Khateir (r(s) = -0.496). Maximum temperature showed positive correlation with black fly counts only in Galabat focus. Precipitation was significantly correlated with adult flies counts in Nady village, Abu-Hamed, but no significance was found in the rest of the sampled villages in both foci. Hourly-based distribution of black flies showed a unimodal pattern in Abu-Hamed with one peak (10:00-18:00), while a bimodal pattern with two peaks (07:00-10:00) and (14:00-18:00) was exhibited in Galabat. Conclusion Transmission of onchocerciasis in both foci showed marked differences in seasonality, which may be attributed to ecology, microclimate and proximity of breeding sites to collection sites. The seasonal shifts between the two foci might be related to variations in climate zones. This information on black fly vector seasonality, ecology, distribution and biting activity has obvious implications in monitoring transmission levels to guide the national and regional onchocerciasis elimination programs in Sudan.	[Zarroug, Isam M. A.; ElMubarak, Wigdan A.; Mohamed, Hanan A.] Fed Minist Hlth, Natl Programme Prevent Blindness, Onchocerciasis Control Eliminat Programme, Khartoum, Sudan; [Hashim, Kamal; Deran, Tong Chor M.] Fed Minist Hlth, Natl Programme Prevent Blindness, Khartoum, Sudan; [Elaagip, Arwa H.] Univ Khartoum, Fac Med Lab Sci, Dept Parasitol & Med Entomol, Khartoum, Sudan; [Samy, Abdallah M.] Ain Shams Univ, Fac Sci, Dept Entomol, Cairo, Egypt; [Frah, Ehab A.] Natl Res Ctr, Res Inst Trop Med, Biostat & Data Anal Unit, Khartoum, Sudan; [Aziz, Nabil] Carter Ctr, Khartoum, Sudan; [Higazi, Tarig B.] Ohio Univ, Dept Biol Sci, Zanesville, OH USA	University of Khartoum; Egyptian Knowledge Bank (EKB); Ain Shams University; University System of Ohio; Ohio University	Zarroug, IMA (corresponding author), Fed Minist Hlth, Natl Programme Prevent Blindness, Onchocerciasis Control Eliminat Programme, Khartoum, Sudan.	imazarroug@gmail.com	Frah, Ehab Ahmed/D-5078-2013; Mostafa, Hanan/AAE-7372-2021; Samy, Abdallah/B-4375-2010	Frah, Ehab Ahmed/0000-0002-4947-7374; Samy, Abdallah/0000-0003-3978-1134				Adeleke M. A., 2011, Journal of Public Health and Epidemiology, V3, P162; Adeleke MA, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-93; Baker R. H. A., 1985, Sudan Medical Journal, V21, P19; BAKER RHA, 1986, TROP MED PARASITOL, V37, P341; CHEKE RA, 1992, T ROY SOC TROP MED H, V86, P67, DOI 10.1016/0035-9203(92)90445-I; Daszak P, 2013, P NATL ACAD SCI USA, V110, P3681, DOI 10.1073/pnas.1201243109; Davies J, 1991, WHOVBC91992; DAVIES JB, 1988, MED VET ENTOMOL, V2, P357, DOI 10.1111/j.1365-2915.1988.tb00209.x; DE MEILLON B, 1957, Bull World Health Organ, V16, P509; FREDEEN FJH, 1991, J MED ENTOMOL, V28, P831, DOI 10.1093/jmedent/28.6.831; Freeman P, 1953, SIMULIIDAE ETHIOPIAN, P1; GHALIB HW, 1987, ANN TROP MED PARASIT, V81, P405, DOI 10.1080/00034983.1987.11812138; Higazi TB, 2013, AM J TROP MED HYG, V89, P51, DOI 10.4269/ajtmh.13-0112; Higazi TB, 2011, AM J TROP MED HYG, V84, P753, DOI 10.4269/ajtmh.2011.11-0009; Higazi TB, 2000, J MED ENTOMOL, V37, P547, DOI 10.1603/0022-2585-37.4.547; Higazi TB, 2001, EXP PARASITOL, V97, P24, DOI 10.1006/expr.2000.4589; Ibeh O, 2007, J BIOMEDICAL INVESTI, V5, P27; Ikpeama CA, 2007, INT WLD J SCITECH, V3, P1; Lindblade KA, 2007, AM J TROP MED HYG, V77, P334, DOI 10.4269/ajtmh.2007.77.334; Maegga BTA, 2011, ACTA TROP, V117, P86, DOI 10.1016/j.actatropica.2010.10.003; Marr J, 1977, WHOVBC77657; Minitab, 2010, MIN 17 STAT COMP SOF; Oluwole AS, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-55; Opara K. N., 2008, Journal of Vector Borne Diseases, V45, P225; Opara KN, 2005, AM J TROP MED HYG, V73, P371, DOI 10.4269/ajtmh.2005.73.371; Opoku AA, 2006, WEST AFR J APPL ECOL, V9, DOI [10.4314/wajae.v9i1.45689, DOI 10.4314/WAJAE.V9I1.45689]; Post RJ, 2007, TROP MED INT HEALTH, V12, P1342, DOI 10.1111/j.1365-3156.2007.01921.x; RENZ A, 1987, ANN TROP MED PARASIT, V81, P229, DOI 10.1080/00034983.1987.11812116; Roberts DM, 1996, MED VET ENTOMOL, V10, P137, DOI 10.1111/j.1365-2915.1996.tb00719.x; Sam-Wobo SO, 2013, INT J TROP INSECT SC, V33, P2, DOI 10.1017/S1742758412000434; TRAVIS BV, 1979, REV BIOL TROP, V27, P135; Walsh J., 1983, VECTOR MANAGEMENT TR, P93; WALSH JF, 1978, T ROY SOC TROP MED H, V72, P675, DOI 10.1016/0035-9203(78)90039-1; WILLIAMS JF, 1985, T ROY SOC TROP MED H, V79, P464, DOI 10.1016/0035-9203(85)90066-5; World Health Organization, 2001, VER EL HUM ONCH CRIT; Zarroug I. M. A., 2013, Journal of Public Health and Epidemiology, V5, P83; Zarroug IMA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-168	37	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150309	10.1371/journal.pone.0150309	http://dx.doi.org/10.1371/journal.pone.0150309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943668	Green Published, gold, Green Submitted			2022-12-27	WOS:000371739400022
J	Schafferer, S; Khurana, R; Refolo, V; Venezia, S; Sturm, E; Piatti, P; Hechenberger, C; Hackl, H; Kessler, R; Willi, M; Gstir, R; Krogsdam, A; Lusser, A; Poewe, W; Wenning, GK; Huttenhofer, A; Stefanova, N				Schafferer, Simon; Khurana, Rimpi; Refolo, Violetta; Venezia, Serena; Sturm, Edith; Piatti, Paolo; Hechenberger, Clara; Hackl, Hubert; Kessler, Roman; Willi, Michaela; Gstir, Ronald; Krogsdam, Anne; Lusser, Alexandra; Poewe, Werner; Wenning, Gregor K.; Huettenhofer, Alexander; Stefanova, Nadia			Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications	PLOS ONE			English	Article							GLIAL CYTOPLASMIC INCLUSIONS; ALPHA-SYNUCLEIN INCLUSIONS; MICROGLIAL ACTIVATION; PARKINSONS-DISEASE; POSTTRANSCRIPTIONAL REGULATION; MYELOPEROXIDASE INHIBITION; R PACKAGE; EXPRESSION; NEUROPATHOLOGY; DEGENERATION	Multiple system atrophy (MSA) is a fatal rapidly progressive alpha-synucleinopathy, characterized by alpha-synuclein accumulation in oligodendrocytes. It is accepted that the pathological alpha-synuclein accumulation in the brain of MSA patients plays a leading role in the disease process, but little is known about the events in the early stages of the disease. In this study we aimed to define potential roles of the miRNA-mRNA regulatory network in the early premotor stages of the disease, i.e., downstream of alpha-synuclein accumulation in oligodendroglia, as assessed in a transgenic mouse model of MSA. We investigated the expression patterns of miRNAs and their mRNA targets in substantia nigra (SN) and striatum, two brain regions that undergo neurodegeneration at a later stage in the MSA model, by microarray and RNA-seq analysis, respectively. Analysis was performed at a time point when alpha-synuclein accumulation was already present in oligodendrocytes at neuropathological examination, but no neuronal loss nor deficits of motor function had yet occurred. Our data provide a first evidence for the leading role of gene dysregulation associated with deficits in immune and inflammatory responses in the very early, non-symptomatic disease stages of MSA. While dysfunctional homeostasis and oxidative stress were prominent in SN in the early stages of MSA, in striatum differential gene expression in the non-symptomatic phase was linked to oligodendroglial dysfunction, disturbed protein handling, lipid metabolism, transmembrane transport and altered cell death control, respectively. A large number of putative miRNA-mRNAs interaction partners were identified in relation to the control of these processes in the MSA model. Our results support the role of early changes in the miRNAmRNA regulatory network in the pathogenesis of MSA preceding the clinical onset of the disease. The findings thus contribute to understanding the disease process and are likely to pave the way towards identifying disease biomarkers for early diagnosis of MSA.	[Schafferer, Simon; Khurana, Rimpi; Kessler, Roman; Gstir, Ronald; Huettenhofer, Alexander] Med Univ Innsbruck, Bioctr, Div Genom & RNom, Innrain 80-82, A-6020 Innsbruck, Austria; [Refolo, Violetta; Venezia, Serena; Sturm, Edith; Wenning, Gregor K.; Stefanova, Nadia] Med Univ Innsbruck, Dept Neurol, Div Neurobiol, Innrain 66-G2, A-6020 Innsbruck, Austria; [Piatti, Paolo; Hechenberger, Clara; Lusser, Alexandra] Med Univ Innsbruck, Bioctr, Div Mol Biol, Innrain 80-82, A-6020 Innsbruck, Austria; [Hackl, Hubert; Willi, Michaela; Krogsdam, Anne] Med Univ Innsbruck, Bioctr, Div Bioinformat, Innrain 80-82, A-6020 Innsbruck, Austria; [Poewe, Werner] Med Univ Innsbruck, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Huttenhofer, A (corresponding author), Med Univ Innsbruck, Bioctr, Div Genom & RNom, Innrain 80-82, A-6020 Innsbruck, Austria.; Stefanova, N (corresponding author), Med Univ Innsbruck, Dept Neurol, Div Neurobiol, Innrain 66-G2, A-6020 Innsbruck, Austria.	alexander.huettenhofer@i-med.ac.at; nadia.stefanova@i-med.ac.at	Refolo, Violetta/S-6612-2019; Refolo, Violetta/L-3598-2019; Stefanova, Nadia/ABF-5664-2020; Hackl, Hubert/B-3168-2018; Khurana, Rimpi/J-5050-2019; Krogsdam, Anne/AAM-7278-2020	Stefanova, Nadia/0000-0001-8188-639X; Hackl, Hubert/0000-0003-4055-3841; Wenning, Gregor/0000-0001-9077-1666; Piatti, Paolo/0000-0002-4863-5887; Lusser, Alexandra/0000-0002-2226-9081; Khurana, Rimpi/0000-0002-0493-6266; Krogsdam, Anne/0000-0002-5478-0511; Willi, Michaela/0000-0002-2248-1998	Austrian Science Fund (FWF) [F4404, F4408, F4411, F4414, W1206-08, P25161]; Austrian Science Fund (FWF) [P 25161] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The study was supported by grants of the Austrian Science Fund (FWF) (http://www.fwf.ac.at/en/): F4404 (to GKW); F4408 (to AL); F4411 (to AH); F4414 (to NS); W1206-08 (to NS); and P25161 (to NS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Ahmed Z, 2012, NEUROPATH APPL NEURO, V38, P4, DOI 10.1111/j.1365-2990.2011.01234.x; Ahmed Z, 2013, BRAIN PATHOL, V23, P263, DOI 10.1111/j.1750-3639.2012.00637.x; Amende Ivo, 2005, J Neuroeng Rehabil, V2, P20, DOI 10.1186/1743-0003-2-20; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Asi YT, 2014, GLIA, V62, P964, DOI 10.1002/glia.22653; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Britschgi M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-220; Brock GN, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-1; Cabeza-Arvelaiz Y, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-83; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Cheng D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017299; Chiba Y, 2012, NEUROPATH APPL NEURO, V38, P559, DOI 10.1111/j.1365-2990.2011.01229.x; Cooper AJL, 2001, MENT RETARD DEV D R, V7, P280, DOI 10.1002/mrdd.1039; Djelloul M, 2015, STEM CELL REP, V5, P174, DOI 10.1016/j.stemcr.2015.07.002; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dodel R, 2010, MOVEMENT DISORD, V25, P97, DOI 10.1002/mds.22732; Don AS, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0150-6; Dupuis JP, 2014, REV NEUROSCIENCE, V25, P741, DOI 10.1515/revneuro-2014-0024; Dweep H, 2014, METHODS MOL BIOL, V1182, P289, DOI 10.1007/978-1-4939-1062-5_25; Elvin SJ, 2004, NATURE, V430, P417, DOI 10.1038/nature02822; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fanciulli A, 2015, NEW ENGL J MED, V372, P249, DOI 10.1056/NEJMra1311488; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; Fellner L, 2011, ACTA NEUROPATHOL, V121, P675, DOI 10.1007/s00401-011-0833-z; Fernagut PO, 2004, EXP NEUROL, V185, P47, DOI 10.1016/j.expneurol.2003.09.014; Fernandez-Santiago R, 2015, ANN NEUROL, V77, P895, DOI 10.1002/ana.24384; Ferrer I, 2011, J ALZHEIMERS DIS, V23, P537, DOI 10.3233/JAD-2010-101485; Frigerio CS, 2013, NEUROLOGY, V81, P2103, DOI 10.1212/01.wnl.0000437306.37850.22; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerhard A, 2003, NEUROLOGY, V61, P686, DOI 10.1212/01.WNL.0000078192.95645.E6; Ghorayeb I, 2000, MOVEMENT DISORD, V15, P531, DOI 10.1002/1531-8257(200005)15:3<531::AID-MDS1017>3.0.CO;2-C; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Halliday GM, 2011, ACTA NEUROPATHOL, V122, P187, DOI 10.1007/s00401-011-0852-9; Hasegawa T, 2013, NEUROL CLIN NEUROSCI, V1, P189, DOI 10.1111/ncn3.57; Heijnen HF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004371; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Ishizawa K, 2004, J NEUROPATH EXP NEUR, V63, P43, DOI 10.1093/jnen/63.1.43; Jackson WS, 2014, DIS MODEL MECH, V7, P21, DOI 10.1242/dmm.012146; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kaindlstorfer C, 2015, NEUROTOX RES, V28, P185, DOI 10.1007/s12640-015-9547-7; Kale A, 2015, CELL DEATH DIFFER, V22, P1300, DOI 10.1038/cdd.2014.218; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kawamoto Y, 2007, BRAIN RES, V1136, P219, DOI 10.1016/j.brainres.2006.12.049; Kocerha J, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-46; Kong L, 2008, CELL RES, V18, P745, DOI 10.1038/cr.2008.65; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee ST, 2015, MOL NEUROBIOL, V51, P180, DOI 10.1007/s12035-014-8788-4; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Loher P, 2012, BIOINFORMATICS, V28, P3322, DOI 10.1093/bioinformatics/bts615; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Martin M, 2011, EMBNET J, V17; Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332; Miki Y, 2011, NEUROPATHOLOGY, V31, P561, DOI 10.1111/j.1440-1789.2011.01200.x; Mills JD, 2015, NEUROGENETICS, V16, P107, DOI 10.1007/s10048-014-0430-0; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Pati S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/503162; Prusiner SB, 2015, P NATL ACAD SCI US; Reyes CC, 2014, CURR BIOL, V24, P1263, DOI 10.1016/j.cub.2014.04.021; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Rother S, 2011, BIOCHIMIE, V93, P1905, DOI 10.1016/j.biochi.2011.07.032; Ruiperez V, 2010, PROG LIPID RES, V49, P420, DOI 10.1016/j.plipres.2010.05.004; Sanchez-Guajardo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008784; Santa-Maria I, 2015, J CLIN INVEST, V125, P681, DOI 10.1172/JCI78421; Schelshorn DW, 2009, J CEREBR BLOOD F MET, V29, P585, DOI 10.1038/jcbfm.2008.152; Serafin A, 2015, NEUROLOGY, V84, P645, DOI 10.1212/WNL.0000000000001258; Simon D, 2010, HUM MOL GENET, V19, P2015, DOI 10.1093/hmg/ddq083; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song YJC, 2007, AM J PATHOL, V171, P1291, DOI 10.2353/ajpath.2007.070201; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Stefanova N, 2005, AM J PATHOL, V166, P869, DOI 10.1016/S0002-9440(10)62307-3; Stefanova N, 2014, AGE RELATED ANAL STR, pS32; Stefanova N, 2013, PROGR MSA LIKE MOTOR, pS359; Stefanova N, 2007, MOVEMENT DISORD, V22, P2196, DOI 10.1002/mds.21671; Stefanova N, 2015, CLIN AUTON RES, V25, P9, DOI 10.1007/s10286-014-0266-6; Stefanova N, 2012, ACTA NEUROPATHOL, V124, P51, DOI 10.1007/s00401-012-0977-5; Stefanova N, 2012, NEUROTOX RES, V21, P393, DOI 10.1007/s12640-011-9294-3; Stefanova N, 2011, AM J PATHOL, V179, P954, DOI 10.1016/j.ajpath.2011.04.013; Stefanova N, 2009, LANCET NEUROL, V8, P1172, DOI 10.1016/S1474-4422(09)70288-1; Stemberger S, 2010, EXP NEUROL, V224, P459, DOI 10.1016/j.expneurol.2010.05.008; Sturm Edith, 2014, Exp Neurobiol, V23, P277, DOI 10.5607/en.2014.23.4.277; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takeda A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/19365; Ubhi K, 2014, EUR J NEUROSCI, V39, P1026, DOI 10.1111/ejn.12444; Uryu K, 2006, AM J PATHOL, V168, P947, DOI 10.2353/ajpath.2006.050770; Vallelunga A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00156; Vasu MM, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-40; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Wang XC, 2015, ORAL ONCOL, V51, P674, DOI 10.1016/j.oraloncology.2015.04.010; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Wenning GK, 2008, ANN NEUROL, V64, P239, DOI 10.1002/ana.21465; Wille A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00313; Wong Joanna H, 2014, Exp Neurobiol, V23, P337, DOI 10.5607/en.2014.23.4.337; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	101	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150705	10.1371/journal.pone.0150705	http://dx.doi.org/10.1371/journal.pone.0150705			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26962858	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000053
J	Guisoni, N; Monteoliva, D; Diambra, L				Guisoni, N.; Monteoliva, D.; Diambra, L.			Promoters Architecture-Based Mechanism for Noise-Induced Oscillations in a Single-Gene Circuit	PLOS ONE			English	Article							STOCHASTIC-OSCILLATIONS; DELAY; AMPLIFICATION; FLUCTUATIONS; EXPRESSION	It is well known that single-gene circuits with negative feedback loop can lead to oscillatory gene expression when they operate with time delay. In order to generate these oscillations many processes can contribute to properly timing such delay. Here we show that the time delay coming from the transitions between internal states of the cis-regulatory system (CRS) can drive sustained oscillations in an auto-repressive single-gene circuit operating in a small volume like a cell. We found that the cooperative binding of repressor molecules is not mandatory for a oscillatory behavior if there are enough binding sites in the CRS. These oscillations depend on an adequate balance between the CRS kinetic, and the synthesis/degradation rates of repressor molecules. This finding suggest that the multi-site CRS architecture can play a key role for oscillatory behavior of gene expression. Finally, our results can also help to synthetic biologists on the design of the promoters architecture for new genetic oscillatory circuits.	[Guisoni, N.] Univ Nacl La Plata, Inst Fis Liquidos & Sistemas Biol, RA-1900 La Plata, Buenos Aires, Argentina; [Monteoliva, D.] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Fis, RA-1900 La Plata, Buenos Aires, Argentina; [Diambra, L.] Univ Nacl La Plata, Ctr Reg Estudios Genom, RA-1900 La Plata, Buenos Aires, Argentina	National University of La Plata; National University of La Plata; National University of La Plata	Diambra, L (corresponding author), Univ Nacl La Plata, Ctr Reg Estudios Genom, RA-1900 La Plata, Buenos Aires, Argentina.	ldiambra@gmail.com	L, Diambra/F-6319-2015; Guisoni, Nara/AAV-8107-2020	L, Diambra/0000-0001-8052-4880; Guisoni, Nara/0000-0002-2025-7765				Bessho Y, 2003, CURR OPIN GENET DEV, V13, P379, DOI 10.1016/S0959-437X(03)00083-2; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Biancalani T, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.208101; Biancalani T, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046215; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Cantini L, 2014, J MATH BIOL, V69, P1585, DOI 10.1007/s00285-013-0743-x; Cantini L, 2014, J THEOR BIOL, V349, P92, DOI 10.1016/j.jtbi.2014.01.035; de Figueiredo JCB, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051905; Diambra L, 2015, ACS SYNTH BIOL, V4, P177, DOI 10.1021/sb500233u; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Erban R, 07041908V2 ARXIV; Galla T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021909; Gonze D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069573; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; GRIFFITH JS, 1968, J THEOR BIOL, V20, P209, DOI 10.1016/0022-5193(68)90190-2; Grima R, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.042124; Grima R, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3702848; Grima R, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3625958; Gutierrez PS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011914; Gutierrez PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044812; Hanisch A, 2013, DEVELOPMENT, V140, P444, DOI 10.1242/dev.077230; Hoyle NP, 2013, P NATL ACAD SCI USA, V110, pE4316, DOI 10.1073/pnas.1308811110; Kim J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.119; Leloup JC, 1999, J BIOL RHYTHM, V14, P433, DOI 10.1177/074873099129000948; Lengye IM, 2014, PAP PHYS-LA PLATA, V6, DOI 10.4279/PIP.060012; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Lipshtat A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.188101; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Mather W, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.068105; McKane AJ, 2007, J STAT PHYS, V128, P165, DOI 10.1007/s10955-006-9221-9; McKane AJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.218102; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; Murugan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104328; Ramaswamy R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00154; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Takashima Y, 2011, P NATL ACAD SCI USA, V108, P3300, DOI 10.1073/pnas.1014418108; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Thomas P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S4-S5; Thomas P, 2013, J THEOR BIOL, V335, P222, DOI 10.1016/j.jtbi.2013.06.021; Toner DLK, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4788979; Wang JK, 2014, BIOPHYS J, V107, P2403, DOI 10.1016/j.bpj.2014.09.042	43	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151086	10.1371/journal.pone.0151086	http://dx.doi.org/10.1371/journal.pone.0151086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26958852	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300095
J	Jacobs, RL; Bradley, BJ				Jacobs, Rachel L.; Bradley, Brenda J.			Considering the Influence of Nonadaptive Evolution on Primate Color Vision	PLOS ONE			English	Article							WHITE-FACED CAPUCHINS; NEW-WORLD; OPSIN GENE; POPULATION-STRUCTURE; TRICHROMATIC VISION; PHOTOPIGMENT POLYMORPHISM; COMPUTER-PROGRAM; LEMUR; BOTTLENECKS; SELECTION	Color vision in primates is variable across species, and it represents a rare trait in which the genetic mechanisms underlying phenotypic variation are fairly well-understood. Research on primate color vision has largely focused on adaptive explanations for observed variation, but it remains unclear why some species have trichromatic or polymorphic color vision while others are red-green color blind. Lemurs, in particular, are highly variable. While some species are polymorphic, many closely-related species are strictly dichromatic. We provide the first characterization of color vision in a wild population of red-bellied lemurs (Eulemur rubriventer, Ranomafana National Park, Madagascar) with a sample size (87 individuals; N-X chromosomes = 134) large enough to detect even rare variants (0.95 probability of detection at >= 3% frequency). By sequencing exon 5 of the X-linked opsin gene we identified opsin spectral sensitivity based on known diagnostic sites and found this population to be dichromatic and monomorphic for a long wavelength allele. Apparent fixation of this long allele is in contrast to previously published accounts of Eulemur species, which exhibit either polymorphic color vision or only the medium wavelength opsin. This unexpected result may represent loss of color vision variation, which could occur through selective processes and/or genetic drift (e. g., genetic bottleneck). To indirectly assess the latter scenario, we genotyped 55 adult red-bellied lemurs at seven variable microsatellite loci and used heterozygosity excess and M-ratio tests to assess if this population may have experienced a recent genetic bottleneck. Results of heterozygosity excess but not M-ratio tests suggest a bottleneck might have occurred in this red-bellied lemur population. Therefore, while selection may also play a role, the unique color vision observed in this population might have been influenced by a recent genetic bottleneck. These results emphasize the need to consider adaptive and nonadaptive mechanisms of color vision evolution in primates.	[Jacobs, Rachel L.; Bradley, Brenda J.] George Washington Univ, Ctr Adv Study Human Paleobiol, Dept Anthropol, Washington, DC USA; [Jacobs, Rachel L.] SUNY Stony Brook, Interdept Doctoral Program Anthropol Sci, Stony Brook, NY 11794 USA; [Jacobs, Rachel L.] Ctr ValBio Res Stn, Ranomafana, Fianarantsoa, Madagascar	George Washington University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Jacobs, RL (corresponding author), George Washington Univ, Ctr Adv Study Human Paleobiol, Dept Anthropol, Washington, DC USA.; Jacobs, RL (corresponding author), SUNY Stony Brook, Interdept Doctoral Program Anthropol Sci, Stony Brook, NY 11794 USA.; Jacobs, RL (corresponding author), Ctr ValBio Res Stn, Ranomafana, Fianarantsoa, Madagascar.	rachel_jacobs@email.gwu.edu			National Science Foundation (DDIG) [BCS 1232535]; Leakey Foundation; Wenner-Gren Foundation; RW Primate Fund, Yale University; George Washington University; Interdepartmental Doctoral Program in Anthropological Sciences at Stony Brook University	National Science Foundation (DDIG)(National Science Foundation (NSF)); Leakey Foundation; Wenner-Gren Foundation; RW Primate Fund, Yale University; George Washington University; Interdepartmental Doctoral Program in Anthropological Sciences at Stony Brook University	This research was funded in part by the National Science Foundation (DDIG, BCS 1232535), The Leakey Foundation, The Wenner-Gren Foundation, the RW Primate Fund, Yale University, The George Washington University and the Interdepartmental Doctoral Program in Anthropological Sciences at Stony Brook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasaad S, 2011, MAMM BIOL, V76, P722, DOI 10.1016/j.mambio.2011.01.011; Pessoa DMA, 2014, AM J PRIMATOL, V76, P721, DOI 10.1002/ajp.22264; Andriantompohavana R, 2007, MOL ECOL NOTES, V7, P1162, DOI 10.1111/j.1471-8286.2007.01815.x; Baden AL, 2011, THESIS STONY BROOK U; Bradley Brenda J., 2000, Conservation Genetics, V1, P289, DOI 10.1023/A:1011514007741; Brenneman RA, 2012, ORYX, V46, P298, DOI 10.1017/S0030605311000159; Broquet T, 2010, CONSERV BIOL, V24, P1596, DOI 10.1111/j.1523-1739.2010.01556.x; Bunce JA, 2011, INT J PRIMATOL, V32, P1058, DOI 10.1007/s10764-011-9522-y; Busch JD, 2007, MOL ECOL, V16, P2450, DOI 10.1111/j.1365-294X.2007.03283.x; Caine NG, 2010, BIOL LETTERS, V6, P36, DOI 10.1098/rsbl.2009.0591; Chikhi L, 2010, GENETICS, V186, P983, DOI 10.1534/genetics.110.118661; Cornuet JM, 1996, GENETICS, V144, P2001; Craul M, 2009, BIOL CONSERV, V142, P2862, DOI 10.1016/j.biocon.2009.05.026; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; Dulai KS, 1999, GENOME RES, V9, P629; Durham DL, 2003, THESIS U CALIFORNIA; Fredsted T, 2007, BEHAV ECOL SOCIOBIOL, V61, P943, DOI 10.1007/s00265-006-0323-9; Funk WC, 2010, CONSERV GENET, V11, P1013, DOI 10.1007/s10592-009-9946-5; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Galov A, 2011, MAMM BIOL, V76, P339, DOI 10.1016/j.mambio.2010.07.002; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Heesy CP, 2001, J HUM EVOL, V40, P111, DOI 10.1006/jhev.2000.0447; Hiramatsu C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003356; Hiramatsu C, 2009, ANIM BEHAV, V77, P1421, DOI 10.1016/j.anbehav.2009.02.012; Hiwatashi T, 2010, MOL BIOL EVOL, V27, P453, DOI 10.1093/molbev/msp262; Hundertmark KJ, 2010, CONSERV GENET, V11, P139, DOI 10.1007/s10592-009-0013-z; Irwin MT, 2005, ORYX, V39, P204, DOI 10.1017/S0030605305000451; Jacobs GH, 2003, AM J PHYS ANTHROPOL, V122, P66, DOI 10.1002/ajpa.10309; JACOBS GH, 1993, VISION RES, V33, P269, DOI 10.1016/0042-6989(93)90083-9; Jacobs GH, 2002, VISION RES, V42, P11, DOI 10.1016/S0042-6989(01)00264-4; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; JACOBS GH, 1987, P NATL ACAD SCI USA, V84, P2545, DOI 10.1073/pnas.84.8.2545; Jacobs GH, 2003, NORMAL DEFECTIVE COL, P14; Kainz PM, 1998, VISION RES, V38, P3315, DOI 10.1016/S0042-6989(98)00078-9; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kawamura Shoji, 2012, P93; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Lawler RR, 2011, POPUL ECOL, V53, P229, DOI 10.1007/s10144-010-0206-9; Leonhardt SD, 2009, BEHAV ECOL, V20, P1, DOI 10.1093/beheco/arn106; Lucas PW, 1998, FOLIA PRIMATOL, V69, P139, DOI 10.1159/000021576; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Markolf M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-70; Marshall JCJ, 2009, CONSERV GENET, V10, P465, DOI 10.1007/s10592-008-9624-z; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Melin AD, 2008, BEHAV ECOL SOCIOBIOL, V62, P659, DOI 10.1007/s00265-007-0490-3; Melin AD, 2007, ANIM BEHAV, V73, P205, DOI 10.1016/j.anbehav.2006.07.003; Melin AD, 2016, MOL BIOL EVOL, V33, P1029, DOI 10.1093/molbev/msv346; Melin AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0189; Melin AD, 2009, INT J PRIMATOL, V30, P753, DOI 10.1007/s10764-009-9383-9; Merenlender AM, 1993, THESIS U ROCHESTER; Mittermeier R, 2008, INT J PRIMATOL, V29, P1607, DOI 10.1007/s10764-008-9317-y; MOLLON JD, 1989, J EXP BIOL, V146, P21; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; MORGAN MJ, 1992, P ROY SOC B-BIOL SCI, V248, P291, DOI 10.1098/rspb.1992.0074; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; Olivieri GL, 2008, BIOL CONSERV, V141, P1257, DOI 10.1016/j.biocon.2008.02.025; Osorio D, 1998, J OPT SOC AM A, V15, P16, DOI 10.1364/JOSAA.15.000016; Osorio D, 2004, AM NAT, V164, P696, DOI 10.1086/425332; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Overdorff Deborah J., 2006, P235, DOI 10.1007/978-0-387-34586-4_11; OVERDORFF DJ, 1993, LEMUR SOCIAL SYSTEMS AND THEIR ECOLOGICAL BASIS, P167; Overdorff DJ, 1991, THESIS DUKE U; Parga JA, 2012, AM J PHYS ANTHROPOL, V147, P21, DOI 10.1002/ajpa.21603; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pope LC, 2000, MOL ECOL, V9, P2041, DOI 10.1046/j.1365-294X.2000.01110.x; Ranaivoarisoa Jean Freddy, 2010, Open Conservation Biology Journal, V4, P1; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saito A, 2005, AM J PRIMATOL, V67, P425, DOI 10.1002/ajp.20197; Smith AC, 2012, ANIM BEHAV, V83, P479, DOI 10.1016/j.anbehav.2011.11.023; Snyder-Mackler N, 2015, PREPRINT; Spear SF, 2006, CONSERV GENET, V7, P605, DOI 10.1007/s10592-005-9095-4; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Storz JF, 2002, EVOLUTION, V56, P154; Sumner P, 2000, J EXP BIOL, V203, P1963; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tan Y, 1999, NATURE, V402, P36, DOI 10.1038/46947; Tecot SR, 2008, THESIS U TEXAS AUSTI; Valenta K, 2016, FUNCT ECOL, V30, P932, DOI 10.1111/1365-2435.12575; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veilleux CC, 2014, INT J PRIMATOL, V35, P88, DOI 10.1007/s10764-013-9708-6; Veilleux CC, 2013, MOL BIOL EVOL, V30, P1420, DOI 10.1093/molbev/mst058; Veilleux CC, 2009, AM J PRIMATOL, V71, P86, DOI 10.1002/ajp.20621; Villesen Palle, 2006, BMC Ecology, V6, P8, DOI 10.1186/1472-6785-6-8; Vogel ER, 2007, BEHAV ECOL, V18, P292, DOI 10.1093/beheco/arl082; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WILLIAMS AJ, 1992, EMBO J, V11, P2039, DOI 10.1002/j.1460-2075.1992.tb05261.x; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5; Wright Patricia C., 2012, P67; Wright Patricia C., 1992, Evolutionary Anthropology, V1, P25, DOI 10.1002/evan.1360010108	96	11	11	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149664	10.1371/journal.pone.0149664	http://dx.doi.org/10.1371/journal.pone.0149664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959829	gold, Green Published, Green Submitted			2022-12-27	WOS:000371992300019
J	Meyer, FW; Vogel, N; Diele, K; Kunzmann, A; Uthicke, S; Wild, C				Meyer, Friedrich W.; Vogel, Nikolas; Diele, Karen; Kunzmann, Andreas; Uthicke, Sven; Wild, Christian			Effects of High Dissolved Inorganic and Organic Carbon Availability on the Physiology of the Hard Coral Acropora millepora from the Great Barrier Reef	PLOS ONE			English	Article							OCEAN ACIDIFICATION; BENTHIC FORAMINIFERA; REDUCED CALCIFICATION; LIGHT AVAILABILITY; MICROBIAL ACTIVITY; WATER-QUALITY; OXYGEN; ALGAL; PHOTOSYNTHESIS; SEDIMENTS	Coral reefs are facing major global and local threats due to climate change-induced increases in dissolved inorganic carbon (DIC) and because of land-derived increases in organic and inorganic nutrients. Recent research revealed that high availability of labile dissolved organic carbon (DOC) negatively affects scleractinian corals. Studies on the interplay of these factors, however, are lacking, but urgently needed to understand coral reef functioning under present and near future conditions. This experimental study investigated the individual and combined effects of ambient and high DIC (pCO(2) 403 mu atm/pH(Total) 8.2 and 996 mu atm/pH(Total) 7.8) and DOC (added as Glucose 0 and 294 mu mol L-1, background DOC concentration of 83 mu mol L-1) availability on the physiology (net and gross photosynthesis, respiration, dark and light calcification, and growth) of the scleractinian coral Acropora millepora (Ehrenberg, 1834) from the Great Barrier Reef over a 16 day interval. High DIC availability did not affect photosynthesis, respiration and light calcification, but significantly reduced dark calcification and growth by 50 and 23%, respectively. High DOC availability reduced net and gross photosynthesis by 51% and 39%, respectively, but did not affect respiration. DOC addition did not influence calcification, but significantly increased growth by 42%. Combination of high DIC and high DOC availability did not affect photosynthesis, light calcification, respiration or growth, but significantly decreased dark calcification when compared to both controls and DIC treatments. On the ecosystem level, high DIC concentrations may lead to reduced accretion and growth of reefs dominated by Acropora that under elevated DOC concentrations will likely exhibit reduced primary production rates, ultimately leading to loss of hard substrate and reef erosion. It is therefore important to consider the potential impacts of elevated DOC and DIC simultaneously to assess real world scenarios, as multiple rather than single factors influence key physiological processes in coral reefs.	[Meyer, Friedrich W.; Kunzmann, Andreas; Wild, Christian] Leibniz Ctr Trop Marine Ecol ZMT, Dept Ecol, Bremen, Germany; [Meyer, Friedrich W.; Vogel, Nikolas; Wild, Christian] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany; [Vogel, Nikolas; Uthicke, Sven] Australian Inst Marine Sci, Townsville, Qld, Australia; [Diele, Karen] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland; [Diele, Karen] St Abbs Marine Stn, St Abbs, Scotland	Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen; Australian Institute of Marine Science; Edinburgh Napier University	Meyer, FW (corresponding author), Leibniz Ctr Trop Marine Ecol ZMT, Dept Ecol, Bremen, Germany.; Meyer, FW (corresponding author), Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany.	friedrich.meyer@hotmail.de	Kunzmann, Andreas/O-1345-2013; Uthicke, Sven/F-1810-2010; Kunzmann, Andreas/O-5459-2019	Kunzmann, Andreas/0000-0002-9500-4332; Uthicke, Sven/0000-0002-3476-6595; Kunzmann, Andreas/0000-0002-9500-4332	German Leibniz Association (WGL); Australian Government's National Environmental Research Program; Australian Research Council Discovery Grant; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; Open Access fund of the Leibniz Association	German Leibniz Association (WGL); Australian Government's National Environmental Research Program(Australian Government); Australian Research Council Discovery Grant(Australian Research Council); MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; Open Access fund of the Leibniz Association	The study was conducted with the support from the German Leibniz Association (WGL; http://www.leibniz-gemeinschaft.de/en/home/), the Australian Government's National Environmental Research Program (http://www.environment.gov.au/science/nerp) and an Australian Research Council Discovery Grant to SU (http://www.arc.gov.au/ncgp/dp/dp_default.htm). KD received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) and its support is gratefully acknowledged. MASTS is funded by the Scottish Funding Council [grant number HR09011 to KD] and contributing institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The publication of this article was funded by the Open Access fund of the Leibniz Association.	Abbasi T, 2011, CRIT REV ENV SCI TEC, V41, P1601, DOI 10.1080/10643389.2010.481579; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Alongi DM, 2005, MAR POLLUT BULL, V51, P239, DOI 10.1016/j.marpolbul.2004.10.033; Andersson AJ, 2007, AQUAT GEOCHEM, V13, P237, DOI 10.1007/s10498-007-9018-8; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Borell EM, 2008, OECOLOGIA, V157, P593, DOI 10.1007/s00442-008-1102-2; BYTHELL JC, 1990, MAR ECOL PROG SER, V68, P65, DOI 10.3354/meps068065; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; CHISHOLM JRM, 1991, LIMNOL OCEANOGR, V36, P1232, DOI 10.4319/lo.1991.36.6.1232; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; Colombo-Pallotta MF, 2010, CORAL REEFS, V29, P899, DOI 10.1007/s00338-010-0638-x; Crook ED, 2013, P NATL ACAD SCI USA, V110, P11044, DOI 10.1073/pnas.1301589110; Daniel MHB, 2002, WATER AIR SOIL POLL, V136, P189, DOI 10.1023/A:1015287708170; de Putron SJ, 2011, CORAL REEFS, V30, P321, DOI 10.1007/s00338-010-0697-z; DeVantier LM, 2006, CORAL REEFS, V25, P329, DOI 10.1007/s00338-006-0115-8; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dlugokencky E, 2013, TRENDS ATMOSPHERIC; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Dove SG, 2013, P NATL ACAD SCI USA, V110, P15342, DOI 10.1073/pnas.1302701110; Dunne RP, 2010, CORAL REEFS, V29, P145, DOI 10.1007/s00338-009-0569-6; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabricius KE, 2004, ECOL APPL, V14, P1448, DOI 10.1890/03-5320; Ford P, 2005, MAR POLLUT BULL, V51, P119, DOI 10.1016/j.marpolbul.2004.10.019; Furnas M, 2011, CONT SHELF RES, V31, P1967, DOI 10.1016/j.csr.2011.09.007; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Gregg AK, 2013, PEERJ, V1, DOI 10.7717/peerj.107; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Haas A, 2009, J EXP MAR BIOL ECOL, V380, P99, DOI 10.1016/j.jembe.2009.09.005; Haas AF, 2013, PEERJ, V1, DOI 10.7717/peerj.108; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Haas AF, 2010, AQUAT BIOL, V10, P131, DOI 10.3354/ab00271; Hauri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012685; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; IPCC, 2001, 3 ASSESSMENT REPORT; Jokiel P, 1978, CORAL GROWTH BUOYANT; Joo M., 2012, MARINE POLLUTION B, V65, P150, DOI DOI 10.1016/J.MARP0LBUL.2012.01.002; Kaczmarsky L, 2011, CORAL REEFS, V30, P253, DOI 10.1007/s00338-010-0686-2; Kaniewska P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034659; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Leuzinger S, 2003, OECOLOGIA, V136, P524, DOI 10.1007/s00442-003-1305-5; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; Meehl G. A., 2007, IPCC CLIMATE CHANGE, P747; Meron D, 2011, ISME J, V5, P51, DOI 10.1038/ismej.2010.102; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Mueller B, 2014, B MAR SCI, V90, P875, DOI 10.5343/bms.2013.1062; Nakamura M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014521; Naumann MS, 2009, CORAL REEFS, V28, P109, DOI 10.1007/s00338-008-0459-3; Nelson CE, 2013, ISME J, V7, P962, DOI 10.1038/ismej.2012.161; Nusch E.A., 1980, ARCH HYDROBIOLOGIE B, V14, P14; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Rasheed M, 2006, CHEM ECOL, V22, P13, DOI 10.1080/02757540500456823; Retallack GJ, 2001, NATURE, V411, P287, DOI 10.1038/35077041; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Robbins L, 2010, 20101280 US GEOL SUR, V7, DOI DOI 10.1007/978-3-642-52335-9_1; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Schaffelke B, 2008, WATER QUALITY ECOSYS; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Schmidt C, 2011, LIMNOL OCEANOGR, V56, P1587, DOI 10.4319/lo.2011.56.5.1587; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; Shaw EC, 2013, GLOBAL CHANGE BIOL, V19, P1632, DOI 10.1111/gcb.12154; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Solomon S, 2007, CLIM CHANG 2007 CONT; Uthicke S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01769; Uthicke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109092; Uthicke S, 2012, GLOBAL CHANGE BIOL, V18, P2781, DOI 10.1111/j.1365-2486.2012.02715.x; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Veron John E.N., 2011, Diversity, V3, P262; Vogel N, 2015, MAR ECOL PROG SER, V521, P49, DOI 10.3354/meps11088; Vogel N, 2012, J EXP MAR BIOL ECOL, V424, P15, DOI 10.1016/j.jembe.2012.05.008; Weber M, 2012, P NATL ACAD SCI USA, V109, pE1558, DOI 10.1073/pnas.1100715109; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; Wild C, 2010, MAR ECOL PROG SER, V411, P61, DOI 10.3354/meps08653; Wild C, 2009, AQUAT BIOL, V6, P133, DOI 10.3354/ab00181; Witt V, 2011, ENVIRON MICROBIOL, V13, P2976, DOI 10.1111/j.1462-2920.2011.02571.x; Wittmann AC, 2013, NAT CLIM CHANGE, V3, P995, DOI 10.1038/NCLIMATE1982; Zeebe RE, 2001, CO2 SEAWATER EQUILIE	85	3	4	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149598	10.1371/journal.pone.0149598	http://dx.doi.org/10.1371/journal.pone.0149598			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959499	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300017
J	Baldwin, AS; Baker, DH; Hess, RF				Baldwin, Alex S.; Baker, Daniel H.; Hess, Robert F.			What Do Contrast Threshold Equivalent Noise Studies Actually Measure? Noise vs. Nonlinearity in Different Masking Paradigms	PLOS ONE			English	Article							SAMPLING EFFICIENCY; PHYSICAL LIMITS; HUMAN EYE; SENSITIVITY; DISCRIMINATION; VISION; MODEL; SUMMATION; SIGNAL; NORMALIZATION	The internal noise present in a linear system can be quantified by the equivalent noise method. By measuring the effect that applying external noise to the system's input has on its output one can estimate the variance of this internal noise. By applying this simple "linear amplifier" model to the human visual system, one can entirely explain an observer's detection performance by a combination of the internal noise variance and their efficiency relative to an ideal observer. Studies using this method rely on two crucial factors: firstly that the external noise in their stimuli behaves like the visual system's internal noise in the dimension of interest, and secondly that the assumptions underlying their model are correct (e.g. linearity). Here we explore the effects of these two factors while applying the equivalent noise method to investigate the contrast sensitivity function (CSF). We compare the results at 0.5 and 6 c/deg from the equivalent noise method against those we would expect based on pedestal masking data collected from the same observers. We find that the loss of sensitivity with increasing spatial frequency results from changes in the saturation constant of the gain control nonlinearity, and that this only masquerades as a change in internal noise under the equivalent noise method. Part of the effect we find can be attributed to the optical transfer function of the eye. The remainder can be explained by either changes in effective input gain, divisive suppression, or a combination of the two. Given these effects the efficiency of our observers approaches the ideal level. We show the importance of considering these factors in equivalent noise studies.	[Baldwin, Alex S.; Hess, Robert F.] McGill Univ, Dept Ophthalmol, McGill Vis Res, Montreal, PQ H3A 2T5, Canada; [Baker, Daniel H.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	McGill University; University of York - UK	Baldwin, AS (corresponding author), McGill Univ, Dept Ophthalmol, McGill Vis Res, Montreal, PQ H3A 2T5, Canada.	alexsbaldwin@googlemail.com	Baker, Daniel H/A-1674-2009	Baker, Daniel H/0000-0002-0161-443X; Baldwin, Alex/0000-0002-3830-6254	Natural Sciences and Engineering Research Council [46528-11]; Canadian Institutes of Health Research [MT108-18]; Wellcome Trust [105624]; NSERC [46528-11]; CIHR [MT 108-18]; Wellcome Trust through the Centre for Chronic Diseases and Disorders (C2D2) at the University of York [105624]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); Wellcome Trust through the Centre for Chronic Diseases and Disorders (C2D2) at the University of York(Wellcome Trust)	This work was supported by Natural Sciences and Engineering Research Council, http://www.nserc-crsng.gc.ca, #46528-11 (RFH); Canadian Institutes of Health Research, www.cihr-irsc.gc.ca, #MT108-18 (RFH); and Wellcome Trust, www.wellcome.ac.uk, #105624 (DHB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by an NSERC grant (#46528-11) and a CIHR grant (#MT 108-18) awarded to RFH, with additional funding from the Wellcome Trust (#105624) through the Centre for Chronic Diseases and Disorders (C2D2) at the University of York. We would like to thank Bosco Tjan, three anonymous reviewers, and the editor Zhong- Lin Lu for their helpful comments and suggestions. An early version of this work was presented in poster form at VSS 2014 [80].	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allard R, 2013, J VISION, V13, DOI 10.1167/13.10.25; Allard R, 2013, VISION RES, V92, P47, DOI 10.1016/j.visres.2013.09.004; [Anonymous], 2014, R LANG ENV STAT COMP; Baker DH, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00763; Baker DH, 2013, J VISION, V13, DOI 10.1167/13.10.26; Baker DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069536; Baker DH, 2012, J VISION, V12, DOI 10.1167/12.10.20; Baker DH, 2011, J VISION, V11, DOI 10.1167/11.14.14; Baldwin AS, 2012, J VISION, V12, DOI 10.1167/12.11.23; Baldwin AS, 2013, PATTERN INTEGRATION, P210; Baldwin AS, 2014, J VISION, V14, P1421, DOI [10.1167/14.10.1421, DOI 10.1167/14.10.1421]; BANKS MS, 1987, VISION RES, V27, P1915, DOI 10.1016/0042-6989(87)90057-5; BARLOW HB, 1956, J OPT SOC AM, V46, P634, DOI 10.1364/JOSA.46.000634; Bennett PJ, 1999, J OPT SOC AM A, V16, P654, DOI 10.1364/JOSAA.16.000654; Bird CM, 2002, J OPT SOC AM A, V19, P1267, DOI 10.1364/JOSAA.19.001267; BIRDSALL TG, 1960, J ACOUST SOC AM, V32, P1038, DOI 10.1121/1.1908274; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Brouwer GJ, 2011, J NEUROPHYSIOL, V106, P2108, DOI 10.1152/jn.00540.2011; BURGESS AE, 1988, J OPT SOC AM A, V5, P617, DOI 10.1364/JOSAA.5.000617; Burnham KP, 2002, MODEL SELECTION MULT, P66; BURTON GJ, 1981, BIOL CYBERN, V40, P27, DOI 10.1007/BF00326678; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; CAMPBELL FW, 1965, J PHYSIOL-LONDON, V181, P576, DOI 10.1113/jphysiol.1965.sp007784; CANNON MW, 1991, VISION RES, V31, P983, DOI 10.1016/S0042-6989(05)80001-X; Chen GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086045; Christensen BK, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00401; COHN TE, 1976, J OPT SOC AM, V66, P1426, DOI 10.1364/JOSA.66.001426; CORSO JF, 1963, PSYCHOL BULL, V60, P356, DOI 10.1037/h0040633; Dakin SC, 2001, J OPT SOC AM A, V18, P1016, DOI 10.1364/JOSAA.18.001016; Dao DY, 2006, J VISION, V6, P739, DOI 10.1167/6.7.6; De Valois R. L., 1990, SPATIAL VISION, P94; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; Foley JM, 2007, VISION RES, V47, P85, DOI 10.1016/j.visres.2006.09.005; Garcia-Perez MA, 1998, VISION RES, V38, P1861, DOI 10.1016/S0042-6989(97)00340-4; GEISLER WS, 1984, J OPT SOC AM A, V1, P775, DOI 10.1364/JOSAA.1.000775; Georgeson MA, 2004, PERCEPTION, V33, P754; Gorea A, 2001, NAT NEUROSCI, V4, P1146, DOI 10.1038/nn741; Goris RLT, 2013, PSYCHOL REV, V120, P472, DOI 10.1037/a0033136; Goris RLT, 2008, J VISION, V8, DOI 10.1167/8.15.17; Green DM, 1966, SIGNAL DETECTION THE; GREGORY RL, 1955, NATURE, V176, P1272, DOI 10.1038/1761272a0; Guirao A, 1999, INVEST OPHTH VIS SCI, V40, P203; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hess RF, 2008, J VISION, V8, DOI 10.1167/8.1.19; Hoaglin D.C., 1983, UNDERSTANDING ROBUST; Hou F, 2014, J VISION, V14, DOI 10.1167/14.13.9; KERSTEN D, 1984, VISION RES, V24, P1977, DOI 10.1016/0042-6989(84)90033-6; KERSTEN D, 1988, CLIN VISION SCI, V2, P143; Kingdom F, 2009, PALAMEDES MATLAB ROU; Kingdom F., 2010, GOODNESS OF FIT PSYC, P226; Kingdom FAA, 2015, J VISION, V15, DOI 10.1167/15.5.1; Klein SA, 2009, J OPT SOC AM A, V26, pB110, DOI 10.1364/JOSAA.26.00B110; LASLEY DJ, 1981, VISION RES, V21, P273, DOI 10.1016/0042-6989(81)90121-8; LEGGE GE, 1987, J OPT SOC AM A, V4, P391, DOI 10.1364/JOSAA.4.000391; LEGGE GE, 1980, J OPT SOC AM, V70, P1458, DOI 10.1364/JOSA.70.001458; Levi DM, 2008, J VISION, V8, DOI 10.1167/8.4.1; Lu ZL, 2008, PSYCHOL REV, V115, P44, DOI 10.1037/0033-295X.115.1.44; Lu ZL, 1999, J OPT SOC AM A, V16, P764, DOI 10.1364/JOSAA.16.000764; May KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074815; McAnany JJ, 2013, INVEST OPHTH VIS SCI, V54, P3857, DOI 10.1167/iovs.13-11789; McAnany JJ, 2010, VISION RES, V50, P1957, DOI 10.1016/j.visres.2010.07.006; Meese TS, 2006, J VISION, V6, P1224, DOI 10.1167/6.11.7; Meese TS, 2007, P R SOC B, V274, P2891, DOI 10.1098/rspb.2007.0957; Meese TS, 2013, I-PERCEPTION, V4, P1, DOI 10.1068/i0556; Meese TS, 2012, J VISION, V12, DOI 10.1167/12.11.9; Meese TS, 2010, J VISION, V10, DOI 10.1167/10.8.14; Meese TS, 2009, J VISION, V9, DOI 10.1167/9.4.7; Morgan M, 2008, J VISION, V8, DOI 10.1167/8.11.9; NAGARAJA NS, 1964, J OPT SOC AM, V54, P950, DOI 10.1364/JOSA.54.000950; NAVARRO R, 1993, J OPT SOC AM A, V10, P201, DOI 10.1364/JOSAA.10.000201; Neri P, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/016014; Pardhan S, 2004, J OPT SOC AM A, V21, P169, DOI 10.1364/JOSAA.21.000169; Pelli D.G, 1981, EFFECTS VISUAL NOISE; Pelli DG, 1999, J OPT SOC AM A, V16, P647, DOI 10.1364/JOSAA.16.000647; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Pelli DG, 2004, J VISION, V4, P904, DOI 10.1167/4.10.6; Pelli DG, 1991, COMPUTATIONAL MODELS, P147; POINTER JS, 1989, VISION RES, V29, P1133, DOI 10.1016/0042-6989(89)90061-8; ROSE A, 1948, J OPT SOC AM, V38, P196, DOI 10.1364/JOSA.38.000196; Speranza F, 2001, PSYCHOL AGING, V16, P281, DOI 10.1037/0882-7974.16.2.281; SWETS JA, 1961, SCIENCE, V134, P168, DOI 10.1126/science.134.3473.168; Tolhurst DJ, 1997, VISUAL NEUROSCI, V14, P293, DOI 10.1017/S0952523800011433; Tukey, 1970, EXPLORATORY DATA ANA; Watson AB, 2013, J VISION, V13, DOI 10.1167/13.6.18; Xu P, 2006, VISION RES, V46, P3748, DOI 10.1016/j.visres.2006.06.013	88	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150942	10.1371/journal.pone.0150942	http://dx.doi.org/10.1371/journal.pone.0150942			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953796	Green Published, Green Accepted, gold			2022-12-27	WOS:000371991300062
J	Flaudias, V; Picot, MC; Lopez-Castroman, J; Llorca, PM; Schmitt, A; Perriot, J; Georgescu, V; Courtet, P; Quantin, X; Guillaume, S				Flaudias, Valentin; Picot, Marie Christine; Lopez-Castroman, Jorge; Llorca, Pierre-Michel; Schmitt, Audrey; Perriot, Jean; Georgescu, Vera; Courtet, Philippe; Quantin, Xavier; Guillaume, Sebastien			Executive Functions in Tobacco Dependence: Importance of Inhibitory Capacities	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; RESPONSE-INHIBITION; SMOKING-CESSATION; NICOTINE DEPENDENCE; WORKING-MEMORY; CIGARETTE-SMOKING; ATTENTIONAL BIAS; SMOKERS; IMPULSIVITY; BRAIN	Background Executive functions are linked to tobacco dependence and craving. In this cross-sectional study, we assessed the impact of three executive functions: updating, inhibition and shifting processes on tobacco craving and dependence. Method 134 tobacco consumers were included in this study: 81 moderately (Fagerstrom score <7) and 53 heavily dependent (Fagerstrom score >7). Dependence was assessed with the Fagerstrom test and craving with the tobacco craving questionnaire (TCQ 12). We used the Stroop test and the Hayling test to measure inhibition, the Trail Making Test to measure shifting processes and the n-back test to measure updating processes. A multivariate logistic model was used to assess which variables explained best the level of nicotine dependence. Results Inhibition (p = 0.002) and updating (p = 0.014) processes, but not shifting processes, were associated with higher tobacco dependence. Inhibition capacity had a significant effect on the nicotine dependence level independently of age, education, time since last cigarette, intellectual quotient, craving, updating and shifting process. Conclusions Nicotine dependence level seems better explained by inhibition capacities than by craving and updating effects. The capacity to inhibit our behaviours is a good predictor of the severity of tobacco dependence. Our results suggest a prefrontal cortex dysfunction affecting the inhibitory capacities of heavy tobacco dependent smokers. Further studies are needed to investigate the application of these findings in the treatment of tobacco dependence.	[Flaudias, Valentin; Llorca, Pierre-Michel; Schmitt, Audrey] Clermont Univ, Univ DAuvergne, EA NPsy Sydo, BP 10448, F-63000 Clermont Ferrand, France; [Flaudias, Valentin; Llorca, Pierre-Michel; Schmitt, Audrey] CHU Clermont Ferrand, Pole Psychiat B, F-63001 Clermont Ferrand, France; [Picot, Marie Christine; Georgescu, Vera] CHU Montpellier, DIM, Montpellier, France; [Lopez-Castroman, Jorge] CHRU Nimes, Dept Psychiat, INSERM U1061, Nimes, France; [Perriot, Jean] Univ DAuvergne, Dispensaire Emile Roux, Clermont Ferrand, France; [Courtet, Philippe; Guillaume, Sebastien] CHRU Montpellier, Dept Emergency Psychiat & Post Acute Care, INSERM U1061, Montpellier, France; [Quantin, Xavier] CHU Montpellier, Dept Resp Dis, Lab Epsylon, Montpellier, France	CHU Clermont Ferrand; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Nimes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Flaudias, V (corresponding author), Clermont Univ, Univ DAuvergne, EA NPsy Sydo, BP 10448, F-63000 Clermont Ferrand, France.; Flaudias, V (corresponding author), CHU Clermont Ferrand, Pole Psychiat B, F-63001 Clermont Ferrand, France.	vflaudias@chu-clermontferrand.fr	Castroman, Lopez/A-6192-2014; Fond, Guillaume/D-7646-2011; PICOT, Marie-Christine/AAK-4802-2020; Flaudias, Valentin/O-9865-2014	Castroman, Lopez/0000-0003-0618-0690; Fond, Guillaume/0000-0003-3249-2030; 	CHU Montpellier [PHRC UF 8269]	CHU Montpellier	This study received financial support from CHU Montpellier (PHRC UF 8269, clinical trial.gouv NCT01554436). CHU Montpellier had no further role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Baddeley A. D, 2001, PRINCIPLES FRONTAL L, P246; Barch DM, 2003, BIOL PSYCHIAT, V53, P376, DOI 10.1016/S0006-3223(02)01674-8; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Berlin I, 2010, NICOTINE TOB RES, V12, P500, DOI 10.1093/ntr/ntq039; Billieux J, 2010, DRUG ALCOHOL DEPEN, V112, P164, DOI 10.1016/j.drugalcdep.2010.06.006; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; CRAIG TJ, 1977, J STUD ALCOHOL, V38, P1434, DOI 10.15288/jsa.1977.38.1434; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; Dinn WM, 2004, ADDICT BEHAV, V29, P107, DOI 10.1016/j.addbeh.2003.07.001; Etter JF, 1999, ADDICTION, V94, P269, DOI 10.1046/j.1360-0443.1999.94226910.x; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fadardi JS, 2009, DRUG ALCOHOL DEPEN, V101, P137, DOI 10.1016/j.drugalcdep.2008.11.015; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Fecteau S, 2010, SUBST USE MISUSE, V45, P1766, DOI 10.3109/10826084.2010.482434; Fernandez E, 2006, NICOTINE TOB RES, V8, P29, DOI 10.1080/14622200500264432; Fernandez-Serrano MJ, 2011, NEUROSCI BIOBEHAV R, V35, P377, DOI 10.1016/j.neubiorev.2010.04.008; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Fond G, 2013, J AFFECT DISORDERS, V149, P418, DOI 10.1016/j.jad.2012.11.066; Fregni F, 2008, J CLIN PSYCHIAT, V69, P32, DOI 10.4088/JCP.v69n0105; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Heishman SJ, 2010, PSYCHOPHARMACOLOGY, V210, P453, DOI 10.1007/s00213-010-1848-1; Hidiroglu C, 2015, BIPOLAR DISORD, V17, P781, DOI 10.1111/bdi.12335; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Hugues J., 2006, KAPLAN SADOCKS COMPR, P1257; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kandel D, 1997, DRUG ALCOHOL DEPEN, V44, P11, DOI 10.1016/S0376-8716(96)01315-4; Killen JD, 1997, EXP CLIN PSYCHOPHARM, V5, P137, DOI 10.1037/1064-1297.5.2.137; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Krishnan-Sarin S, 2007, DRUG ALCOHOL DEPEN, V88, P79, DOI 10.1016/j.drugalcdep.2006.09.006; Lawrence NS, 2002, NEURON, V36, P539, DOI 10.1016/S0896-6273(02)01004-8; Li XB, 2013, BIOL PSYCHIAT, V73, P714, DOI 10.1016/j.biopsych.2013.01.003; Lubman DI, 2004, ADDICTION, V99, P1491, DOI 10.1111/j.1360-0443.2004.00808.x; Mackinnon A, 1999, INT J METH PSYCH RES, V8, P27, DOI DOI 10.1002/MPR.54; McBride D, 2006, NEUROPSYCHOPHARMACOL, V31, P2728, DOI 10.1038/sj.npp.1301075; McNamee RL, 2008, ALCOHOL CLIN EXP RES, V32, P405, DOI 10.1111/j.1530-0277.2007.00604.x; Meil W, 2012, SUBSTANCE DEPENDENCE; Mendrek A, 2006, ADDICT BEHAV, V31, P833, DOI 10.1016/j.addbeh.2005.06.009; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monterosso JR, 2005, DRUG ALCOHOL DEPEN, V79, P273, DOI 10.1016/j.drugalcdep.2005.02.002; Nathaniel-James DA, 2002, NEUROIMAGE, V16, P1094, DOI 10.1006/nimg.2002.1167; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Nigg JT, 2006, J AM ACAD CHILD PSY, V45, P468, DOI 10.1097/01.chi.0000199028.76452.a9; Nigg JT, 2004, J ABNORM PSYCHOL, V113, P302, DOI 10.1037/0021-843X.113.2.302; Odlaug BL, 2014, J PSYCHIATR RES, V59, P167, DOI 10.1016/j.jpsychires.2014.08.010; Pattij T, 2013, CURR OPIN NEUROBIOL, V23, P700, DOI 10.1016/j.conb.2013.01.023; Pauli-Pott U, 2014, J CHILD PSYCHOL PSYC, V55, P1117, DOI 10.1111/jcpp.12230; PELLET J, 1987, ANN MED-PSYCHOL, V145, P170; Reynolds B, 2007, EXP CLIN PSYCHOPHARM, V15, P264, DOI 10.1037/1064-1297.15.3.264; Sacco KA, 2004, J PSYCHOPHARMACOL, V18, P457, DOI 10.1177/0269881104047273; SCOTT WA, 1962, SOCIOMETRY, V25, P405, DOI 10.2307/2785779; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Stein EA, 1998, AM J PSYCHIAT, V155, P1009, DOI 10.1176/ajp.155.8.1009; STROOP JR, 1992, J EXP PSYCHOL GEN, V121, P15; Underner M, 2012, REV MAL RESPIR, V29, P462, DOI 10.1016/j.rmr.2011.09.051; Vickers D, 1996, J CLIN PSYCHOL, V52, P651, DOI 10.1002/(SICI)1097-4679(199611)52:6<651::AID-JCLP7>3.0.CO;2-N; Wagner M, 2013, ADDICT BIOL, V18, P752, DOI 10.1111/j.1369-1600.2011.00429.x; Wegmann L, 2012, ADDICT BEHAV, V37, P463, DOI 10.1016/j.addbeh.2011.12.008; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilson SJ, 2013, ADDICT BEHAV, V38, P1812, DOI 10.1016/j.addbeh.2012.11.004; Yakir A, 2007, EUR NEUROPSYCHOPHARM, V17, P339, DOI 10.1016/j.euroneuro.2006.09.004	64	19	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150940	10.1371/journal.pone.0150940	http://dx.doi.org/10.1371/journal.pone.0150940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953688	gold, Green Published, Green Submitted			2022-12-27	WOS:000371991300061
J	Fujita, T; Nagayama, H; Sato, A; Yamamoto, Y; Yamane, K; Otsuki, K; Tsuchiya, K; Tozato, F				Fujita, Takaaki; Nagayama, Hirofumi; Sato, Atsushi; Yamamoto, Yuichi; Yamane, Kazuhiro; Otsuki, Koji; Tsuchiya, Kenji; Tozato, Fusae			Hierarchy of Dysfunction Related to Dressing Performance in Stroke Patients: A Path Analysis Study	PLOS ONE			English	Article							MUSCLE STRENGTH; BALANCE; DISABILITY; LIMB; IMPAIRMENTS; ABILITY; MOTOR	Previous reports indicated that various dysfunctions caused by stroke affect the level of independence in dressing. These dysfunctions can be hierarchical, and these effects on dressing performance can be complicated in stroke patients. However, there are no published reports focusing on the hierarchical structure of the relationships between the activities of daily living and balance function, motor and sensory functions of the affected lower limb, strength of the abdominal muscles and knee extension on the unaffected side, and visuospatial deficits. The purpose of this study was to elucidate the hierarchical and causal relationships between dressing performance and these dysfunctions in stroke patients. This retrospective study included 104 first-time stroke patients. The causal relationship between the dressing performance and age, time post stroke, balance function, motor and sensory functions of the affected lower limb, strength of the abdominal muscles and knee extension on the unaffected side, and visuospatial deficits were examined using path analysis. A hypothetical path model was created based on previous studies, and the goodness of fit between the data and model were verified. A modified path model was created that achieved an almost perfect fit to the data. Balance function and abdominal muscle strength have direct effects on dressing performance, with standardized direct effect estimates of 0.78 and 0.15, respectively. Age, motor and sensory functions of the affected lower limb, and strength of abdominal muscle and knee extension on the unaffected side have indirect effects on dressing by influencing balance function. Our results suggest that dressing performance depends strongly on balance function, and it is mainly influenced by the motor function of the affected lower limb.	[Fujita, Takaaki] Tohoku Fukushi Univ, Fac Hlth Sci, Dept Rehabil, Sendai, Miyagi, Japan; [Fujita, Takaaki; Tsuchiya, Kenji; Tozato, Fusae] Gunma Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Maebashi, Gunma, Japan; [Nagayama, Hirofumi] Kanagawa Univ Human Serv, Fac Hlth & Welf, Dept Rehabil, Yokosuka, Kanagawa, Japan; [Sato, Atsushi] Yachiyo Rehabil Coll, Dept Phys Therapy, Yachiyo, Chiba, Japan; [Yamamoto, Yuichi; Yamane, Kazuhiro; Otsuki, Koji] Northern Fukushima Med Ctr, Dept Rehabil, Date, Fukushima, Japan; [Tsuchiya, Kenji] Gunma Chuo Hosp, Japan Community Healthcare Org, Dept Rehabil, Maebashi, Gunma, Japan	Gunma University	Fujita, T (corresponding author), Tohoku Fukushi Univ, Fac Hlth Sci, Dept Rehabil, Sendai, Miyagi, Japan.; Fujita, T (corresponding author), Gunma Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Maebashi, Gunma, Japan.	t-fujita@tfu-mail.tfu.ac.jp	Nagayama, Hirofumi/AAF-1364-2020	Nagayama, Hirofumi/0000-0002-1763-1330; Fujita, Takaaki/0000-0002-9009-8325	Japan Society for the Promotion of Science [26893250]; Uniform Data System for Medical Rehabilitation (UDSMR)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uniform Data System for Medical Rehabilitation (UDSMR)	This work was supported by the Japan Society for the Promotion of Science (grant Number 26893250), https://www.jsps.go.jp/english/index.html (TF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The use of the FIM (R) instrument to collect data for this research study was authorized and conducted in accordance with the term of a special purpose license granted to the licensee by the Uniform Data System for Medical Rehabilitation (UDSMR). Licensee has not been trained by UDSMR in the use of the FIM (R) instrument, and the patient data collected during the course of this research study has not been submitted to or processed by UDSMR. No implication is intended that such data has been or will be subjected to UDSMR's standard data processing procedures or that it is otherwise comparable to data processed by UDSMR.	[Anonymous], 1990, GUID UN DAT SET MED; [Anonymous], NIG J HLTH BIOMED SC; BERG K, 1995, SCAND J REHABIL MED, V27, P27; BERG K, 1989, Physiotherapy Canada, V41, P304; Bohannon R., 1995, CLIN REHABIL, V9, P47, DOI DOI 10.1177/026921559500900107; Bonan IV, 2007, J NEUROL NEUROSUR PS, V78, P49, DOI 10.1136/jnnp.2006.087791; Chino N, 1994, JPN J REHABIL MED, V31, P119, DOI DOI 10.2490/JJRM1963.31.119; Domen K, 1995, JPN J REHABIL MED, V32, P113, DOI DOI 10.2490/jjrm1963.32.113; Edmans JA, 1990, BRIT J OCCUPATIONAL, V53, P139; Fricke J, 1993, AUST OCCUP THER J, V40, P7; Fujita T, AM J OCCUP IN PRESS, P70; Fujita T, 2015, J PHYS THER SCI, V27, P3771, DOI 10.1589/jpts.27.3771; Fujita T, 2015, J PHYS THER SCI, V27, P815, DOI 10.1589/jpts.27.815; Hodges PW, 1997, ERGONOMICS, V40, P1220, DOI 10.1080/001401397187469; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; Karatas M, 2004, AM J PHYS MED REHAB, V83, P81, DOI 10.1097/01.PHM.0000107486.99756.C7; Lee H, 2015, J PHYS THER SCI, V27, P1, DOI 10.1589/jpts.27.1; Liao CF, 2015, J PHYS THER SCI, V27, P2201, DOI 10.1589/jpts.27.2201; Mercier L, 2001, STROKE, V32, P2602, DOI 10.1161/hs1101.098154; Nijboer TCW, 2014, NEUROREPORT, V25, P1381, DOI 10.1097/WNR.0000000000000277; Saito Y, 2012, SAGYOURYOUHOU, V31, P134; SEGAL ME, 1994, STROKE, V25, P2391, DOI 10.1161/01.STR.25.12.2391; Sonoda S, 1995, JPN J REHABIL MED, V32, P123; Tokuno CD, 2013, SCAND J MED SCI SPOR, V23, P349, DOI 10.1111/j.1600-0838.2011.01394.x; Tyson SF, 2013, TOP STROKE REHABIL, V20, P441, DOI 10.1310/tsr2005-441; Tyson SF, 2006, PHYS THER, V86, P30, DOI 10.1093/ptj/86.1.30; Usuda S, 1998, J PHYS THER SCI, V10, P53, DOI DOI 10.1589/jpts.10.53; WALKER MF, 1991, J NEUROL NEUROSUR PS, V54, P699, DOI 10.1136/jnnp.54.8.699; Wee SK, 2015, PHYS THER, V95, P1163, DOI 10.2522/ptj.20140487; Yanase Y, 2010, J JPN PHYS THER ASS, V37, P397	30	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151162	10.1371/journal.pone.0151162	http://dx.doi.org/10.1371/journal.pone.0151162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954499	Green Published, gold			2022-12-27	WOS:000371991300091
J	Lo, WC; Cheng, PW; Wang, CT; Shueng, PW; Hsieh, CH; Chang, YL; Liao, LJ				Lo, Wu-Chia; Cheng, Po-Wen; Wang, Chi-Te; Shueng, Pei-Wei; Hsieh, Chen-Hsi; Chang, Yih-Leong; Liao, Li-Jen			The Effect of Radiotherapy on Ultrasound-Guided Fine Needle Aspiration Biopsy and the Ultrasound Characteristics of Neck Lymph Nodes in Oral Cancer Patients after Primary Treatment	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; SQUAMOUS-CELL CARCINOMA; NASOPHARYNGEAL CARCINOMA; DIAGNOSTIC-VALUE; REAL-TIME; HEAD; CYTOLOGY; THERAPY; METAANALYSIS; METASTASIS	Objectives To investigate the effect of radiotherapy (RT) on ultrasound-guided fine needle aspiration (USgFNA) and sonographic characteristics in the assessment of cervical lymph nodes (LNs) in oral squamous cell carcinoma (OSCC) patients after primary treatment. Materials and Methods 88 treated OSCC patients underwent 111 USgFNAs of the neck LNs after US evaluation. Among them, 48 USgFNAs were performed on 40 patients following RT and 63 USgFNAs on 48 patients without previous RT. The results of USgFNA and the US characteristics were compared between these two groups. Results USgFNA had a sensitivity of 88.0%, specificity of 91.4%, positive predictive value (PPV) of 88.0%, negative predictive value (NPV) of 91.4% and accuracy of 90.0% in patients without previous RT, and a sensitivity of 97.1%, specificity of 83.3%, PPV of 94.3%, NPV of 90.9% and accuracy of 93.5% in those with previous neck RT. The ranges of the short-axis and long-axis length were 13.3 +/- 8.0 mm (mean +/- SD) versus 17.8 +/- 9.1 mm, and 18.6 +/- 9.0 mm versus 24.4 +/- 10.9 mm for recurrent LNs from patients with, versus without, previous RT (both ps < 0.05), respectively. 76.5% (26/34) of the recurrent nodes after RT and 48%(12/25) of the recurrent nodes without previous RT exhibited an irregular margin (p < 0.05). Additionally, irradiated recurrent LNs had a significantly decreased percentage of discernable calcification compared with non-irradiated recurrent nodes (48% versus 20.6%, p < 0.05). Conclusions RT had influence on sonographic characteristics but no influence on USgFNA in diagnosing recurrent LNs in treated OSCC patients.	[Lo, Wu-Chia; Chang, Yih-Leong] Natl Taiwan Univ, Coll Med, Dept & Grad Inst Pathol, Taipei 10764, Taiwan; [Lo, Wu-Chia; Cheng, Po-Wen; Wang, Chi-Te; Liao, Li-Jen] Far Eastern Mem Hosp, Dept Otolaryngol, Taipei, Taiwan; [Lo, Wu-Chia; Cheng, Po-Wen] Oriental Inst Technol, Taipei, Taiwan; [Shueng, Pei-Wei; Hsieh, Chen-Hsi] Far Eastern Mem Hosp, Dept Radiol, Div Radiat Oncol, Taipei, Taiwan	National Taiwan University; Far Eastern Memorial Hospital; Asia Eastern University of Science & Technology; Far Eastern Memorial Hospital	Chang, YL (corresponding author), Natl Taiwan Univ, Coll Med, Dept & Grad Inst Pathol, Taipei 10764, Taiwan.; Liao, LJ (corresponding author), Far Eastern Mem Hosp, Dept Otolaryngol, Taipei, Taiwan.	ipohdamu@gmail.com; liaolj@ntu.edu.tw		CHANG, YIH-LEONG/0000-0001-5309-0554	Far Eastern Memorial Hospital [FEMH-2015-C-012, FEMH-2014-C-027]	Far Eastern Memorial Hospital	This work was supported by grants from Far Eastern Memorial Hospital (FEMH-2015-C-012 and FEMH-2014-C-027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 1999, J LARYNGOL OTOL, V113, P993, DOI 10.1017/S0022215100145797; Ahuja A, 1996, CLIN RADIOL, V51, P698, DOI 10.1016/S0009-9260(96)80241-8; Ahuja AT, 2008, CANCER IMAGING, V8, P48, DOI 10.1102/1470-7330.2008.0006; Brown JJ, 1998, OTOLARYNG CLIN N AM, V31, P785, DOI 10.1016/S0030-6665(05)70087-6; Bude RO, 1996, RADIOLOGY, V200, P21, DOI 10.1148/radiology.200.1.8657912; Chan JYW, 2013, LARYNGOSCOPE, V123, P134, DOI 10.1002/lary.23373; Chan RCL, 2012, LARYNGOSCOPE, V122, P1779, DOI 10.1002/lary.23380; Chen TC, 2013, ORAL ONCOL, V49, P367, DOI 10.1016/j.oraloncology.2012.10.006; Chen TC, 2011, ANN SURG ONCOL, V18, P497, DOI 10.1245/s10434-010-1294-7; Cheung TT, 2014, LIVER INT, V34, pE136, DOI 10.1111/liv.12474; de Bondt RBJ, 2007, EUR J RADIOL, V64, P266, DOI 10.1016/j.ejrad.2007.02.037; de Bree R, 2009, ORAL ONCOL, P84, DOI 10.1016/j.oos.2009.06.169; Flach GB, 2013, ORAL ONCOL, V49, P157, DOI 10.1016/j.oraloncology.2012.08.006; Furukawa MK, 2010, INT J CLIN ONCOL, V15, P23, DOI 10.1007/s10147-009-0017-1; Hundt W, 2007, AM J ROENTGENOL, V189, P726, DOI 10.2214/AJR.07.2371; Kuru TH, 2015, ONCOL RES TREAT, V38, P634, DOI 10.1159/000441600; Liao LJ, 2010, HEAD NECK-J SCI SPEC, V32, P594, DOI 10.1002/hed.21225; Liao LJ, 2012, BMC CANCER, P12; Lo WC, 2013, EUR RADIOL, V23, P2351, DOI 10.1007/s00330-013-2861-7; Nasuti JF, 2002, DIAGN CYTOPATHOL, V27, P1, DOI 10.1002/dc.10065; Nishimura G, 2012, ANTICANCER RES, V32, P595; Novoa E, 2012, HEAD NECK-J SCI SPEC, V34, P1497, DOI 10.1002/hed.21821; Oh KS, 2014, COLLOID SURFACE B, V119, P137, DOI 10.1016/j.colsurfb.2014.05.007; Pillsbury HC, 1997, LARYNGOSCOPE, V107, P1294, DOI 10.1097/00005537-199710000-00004; Poff JA, 2008, RADIOLOGY, V248, P485, DOI 10.1148/radiol.2482071674; Robitschek J, 2010, OTOLARYNG HEAD NECK, V142, P306, DOI 10.1016/j.otohns.2009.11.011; Sargeran K, 2008, BRIT J ORAL MAX SURG, V46, P187, DOI 10.1016/j.bjoms.2007.11.004; Seemann KM, 2015, J CONTROL RELEASE, V197, P131, DOI 10.1016/j.jconrel.2014.11.007; Tandon S, 2008, HEAD NECK-J SCI SPEC, V30, P1246, DOI 10.1002/hed.20849; Toh ST, 2007, HEAD NECK-J SCI SPEC, V29, P370, DOI 10.1002/hed.20526; Viguer JM, 2005, DIAGN CYTOPATHOL, V32, P233, DOI 10.1002/dc.20216; Zhang ML, 2015, J ULTRAS MED, V34, P435, DOI 10.7863/ultra.34.3.435; Zhou YF, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/205325	33	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0149346	10.1371/journal.pone.0149346	http://dx.doi.org/10.1371/journal.pone.0149346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954569	gold, Green Published, Green Submitted			2022-12-27	WOS:000371991300008
J	Niessner, C; Gross, JC; Denzau, S; Peichl, L; Fleissner, G; Wiltschko, W; Wiltschko, R				Niessner, Christine; Gross, Julia Christina; Denzau, Susanne; Peichl, Leo; Fleissner, Gerta; Wiltschko, Wolfgang; Wiltschko, Roswitha			Seasonally Changing Cryptochrome 1b Expression in the Retinal Ganglion Cells of a Migrating Passerine Bird	PLOS ONE			English	Article							BLUE-LIGHT; MAGNETIC ORIENTATION; MAGNETORECEPTION; FIELD; PHOTORECEPTOR; CHICKENS; PLANTS; NEUN	Cryptochromes, blue-light absorbing proteins involved in the circadian clock, have been proposed to be the receptor molecules of the avian magnetic compass. In birds, several cryptochromes occur: Cryptochrome 2, Cryptochrome 4 and two splice products of Cryptochrome 1, Cry1a and Cry1b. With an antibody not distinguishing between the two splice products, Cryptochrome 1 had been detected in the retinal ganglion cells of garden warblers during migration. A recent study located Cry1a in the outer segments of UV/V-cones in the retina of domestic chickens and European robins, another migratory species. Here we report the presence of cryptochrome 1b (eCry1b) in retinal ganglion cells and displaced ganglion cells of European Robins, Erithacus rubecula. Immuno-histochemistry at the light microscopic and electron microscopic level showed eCry1b in the cell plasma, free in the cytosol as well as bound to membranes. This is supported by immuno-blotting. However, this applies only to robins in the migratory state. After the end of the migratory phase, the amount of eCry1b was markedly reduced and hardly detectable. In robins, the amount of eCry1b in the retinal ganglion cells varies with season: it appears to be strongly expressed only during the migratory period when the birds show nocturnal migratory restlessness. Since the avian magnetic compass does not seem to be restricted to the migratory phase, this seasonal variation makes a role of eCry1b in magnetoreception rather unlikely. Rather, it could be involved in physiological processes controlling migratory restlessness and thus enabling birds to perform their nocturnal flights.	[Niessner, Christine; Gross, Julia Christina; Denzau, Susanne; Fleissner, Gerta; Wiltschko, Wolfgang; Wiltschko, Roswitha] Goethe Univ Frankfurt, Fachbereich Biowissensch, Max von Laue Str 13, D-60438 Frankfurt, Germany; [Gross, Julia Christina] Univ Med Gottingen, Haematol & Oncol & Dev Biochem, Justus von Liebig Weg 11, D-37077 Gottingen, Germany; [Peichl, Leo] Max Planck Inst Brain Res, Max von Laue Str 4, D-60438 Frankfurt, Germany; [Niessner, Christine] Univ Munich, Dept Earth & Environm Sci, Theresienstr 41-IV, D-80333 Munich, Germany	Goethe University Frankfurt; University of Gottingen; Max Planck Society; University of Munich	Niessner, C (corresponding author), Goethe Univ Frankfurt, Fachbereich Biowissensch, Max von Laue Str 13, D-60438 Frankfurt, Germany.; Niessner, C (corresponding author), Univ Munich, Dept Earth & Environm Sci, Theresienstr 41-IV, D-80333 Munich, Germany.	c.niessner@bio.uni-frankfurt.de	Gross, Julia Christina/AAN-5730-2020	Gross, Julia Christina/0000-0002-8939-5664; Peichl, Leo/0000-0002-8141-0911	Deutsche Forschungsgemeinschaft; Alfons und Gertrud Kassel Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alfons und Gertrud Kassel Stiftung	Funded by Deutsche Forschungsgemeinschaft (Grant to RW) and Alfons und Gertrud Kassel Stiftung (Scholarship of CN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey MJ, 2002, FEBS LETT, V513, P169, DOI 10.1016/S0014-5793(02)02276-7; Bolte P, 2016, PLOS ONE IN PRESS; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Cassone VM, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00032; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Denzau Susanne, 2013, Commun Integr Biol, V6, pe27096, DOI 10.4161/cib.27096; Freire R, 2005, CURR BIOL, V15, pR620, DOI 10.1016/j.cub.2005.08.017; Fusani L, 2014, J EXP BIOL, V217, P918, DOI 10.1242/jeb.096479; Haque R, 2002, NEUROREPORT, V13, P2247, DOI 10.1097/00001756-200212030-00016; Helfer G, 2006, CHRONOBIOL INT, V23, P113, DOI 10.1080/07420520500521871; Henbest KB, 2004, J AM CHEM SOC, V126, P8102, DOI 10.1021/ja048220q; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; Keary N, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-25; KEETON WT, 1971, P NATL ACAD SCI USA, V68, P102, DOI 10.1073/pnas.68.1.102; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106; Liedvogel M, 2010, J R SOC INTERFACE, V7, pS147, DOI 10.1098/rsif.2009.0411.focus; Lind D, 2005, J NEUROSCI RES, V79, P295, DOI 10.1002/jnr.20354; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Niessner C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0638; Niessner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020091; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2001, ORIENTATION NAVIGATI; SASSOEPOGNETTO M, 1994, J NEUROSCI, V14, P5131; SEMM P, 1986, J COMP PHYSIOL A, V159, P619, DOI 10.1007/BF00612035; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Voss J, 2007, NEUROREPORT, V18, P1053, DOI 10.1097/WNR.0b013e32818b2a21; WALCOTT C, 1974, SCIENCE, V184, P180, DOI 10.1126/science.184.4133.180; Watari R, 2012, J BIOL CHEM, V287, P42634, DOI 10.1074/jbc.M112.395731; Wiltschko R, 2013, J PHYSIOL-PARIS, V107, P137, DOI 10.1016/j.jphysparis.2012.03.003; Wiltschko R, 2011, J EXP BIOL, V214, P3096, DOI 10.1242/jeb.059212; Wiltschko W, 2007, J EXP BIOL, V210, P2300, DOI 10.1242/jeb.004853	34	30	30	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150377	10.1371/journal.pone.0150377	http://dx.doi.org/10.1371/journal.pone.0150377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953690	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300025
J	Visser, WE; Bombardieri, CR; Zevenbergen, C; Barnhoorn, S; Ottaviani, A; van der Pluijm, I; Brandt, R; Kaptein, E; van Heerebeek, R; van Toor, H; Garinis, GA; Peeters, RP; Medici, M; van Ham, W; Vermeij, WP; de Waard, MC; de Krijger, RR; Boelen, A; Kwakkel, J; Kopchick, JJ; List, EO; Melis, JPM; Darras, VM; Dolle, MET; van der Horst, GTJ; Hoeijmakers, JHJ; Visser, TJ				Visser, W. Edward; Bombardieri, Cintia R.; Zevenbergen, Chantal; Barnhoorn, Sander; Ottaviani, Alexandre; van der Pluijm, Ingrid; Brandt, Renata; Kaptein, Ellen; van Heerebeek, Ramona; van Toor, Hans; Garinis, George A.; Peeters, Robin P.; Medici, Marco; van Ham, Willy; Vermeij, Wilbert P.; de Waard, Monique C.; de Krijger, Ronald R.; Boelen, Anita; Kwakkel, Joan; Kopchick, John J.; List, Edward O.; Melis, Joost P. M.; Darras, Veerle M.; Dolle, Martijn E. T.; van der Horst, Gijsbertus T. J.; Hoeijmakers, Jan H. J.; Visser, Theo J.			Tissue-Specific Suppression of Thyroid Hormone Signaling in Various Mouse Models of Aging	PLOS ONE			English	Article							III IODOTHYRONINE DEIODINASE; GROWTH-HORMONE; DNA-DAMAGE; MOLECULAR-BASIS; DWARF MICE; EXPRESSION; GENE; RESTRICTION; METABOLISM; DISEASE	DNA damage contributes to the process of aging, as underscored by premature aging syndromes caused by defective DNA repair. Thyroid state changes during aging, but underlying mechanisms remain elusive. Since thyroid hormone (TH) is a key regulator of metabolism, changes in TH signaling have widespread effects. Here, we reveal a significant common transcriptomic signature in livers from hypothyroid mice, DNA repair-deficient mice with severe (Csb(m/m)/Xpa(-/-)) or intermediate (Ercc1(-/Delta-7)) progeria and naturally aged mice. A strong induction of TH-inactivating deiodinase D3 and decrease of TH-activating D1 activities are observed in Csb(m/m)/Xpa(-/-) livers. Similar findings are noticed in Ercc1(-/Delta-7), in naturally aged animals and in wild-type mice exposed to a chronic subtoxic dose of DNA-damaging agents. In contrast, TH signaling in muscle, heart and brain appears unaltered. These data show a strong suppression of TH signaling in specific peripheral organs in premature and normal aging, probably lowering metabolism, while other tissues appear to preserve metabolism. D3-mediated TH inactivation is unexpected, given its expression mainly in fetal tissues. Our studies highlight the importance of DNA damage as the underlying mechanism of changes in thyroid state. Tissue-specific regulation of deiodinase activities, ensuring diminished TH signaling, may contribute importantly to the protective metabolic response in aging.	[Visser, W. Edward; Zevenbergen, Chantal; Kaptein, Ellen; van Heerebeek, Ramona; van Toor, Hans; Peeters, Robin P.; Medici, Marco; Visser, Theo J.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Bombardieri, Cintia R.; Barnhoorn, Sander; Ottaviani, Alexandre; van der Pluijm, Ingrid; Brandt, Renata; Garinis, George A.; Vermeij, Wilbert P.; de Waard, Monique C.; van der Horst, Gijsbertus T. J.; Hoeijmakers, Jan H. J.] Erasmus MC, Canc Genom Ctr, MGC Dept Genet, Rotterdam, Netherlands; [Ottaviani, Alexandre] INSERM UNS, Fac Med, Inst Res Canc & Aging, Nice IRCAN,UMR CNRS U1081 7284, 28 Ave Valombrose, Nice, France; [van Ham, Willy; Darras, Veerle M.] KULeuven, Dept Biol, Lab Comparat Endocrinol, Leuven, Belgium; [de Krijger, Ronald R.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Boelen, Anita; Kwakkel, Joan] Acad Med Ctr, Dept Endocrinol & Metab, Amsterdam, Netherlands; [Kopchick, John J.; List, Edward O.] Ohio Univ, Edison Biotechnol Inst, Dept Biomed Sci, Athens, OH 45701 USA; [Melis, Joost P. M.] Leiden Univ, Med Ctr, Dept Toxicogenet, Leiden, Netherlands; [Dolle, Martijn E. T.] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect Res, Bilthoven, Netherlands; [van der Pluijm, Ingrid] Erasmus MC, Dept Vasc Surg, Rotterdam, Netherlands; [Garinis, George A.] FORTH, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece; [de Waard, Monique C.] Vrije Univ Amsterdam Med Ctr, Dept Intens Care, Amsterdam, Netherlands; [de Krijger, Ronald R.] Reinier Graaf Gasthuis, Dept Pathol, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; KU Leuven; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; University System of Ohio; Ohio University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; Foundation for Research & Technology - Hellas (FORTH); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Reinier de Graaf Hospital	Visser, WE (corresponding author), Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.	w.e.visser@erasmusmc.nl	Garinis, George A./B-2943-2012; van der Horst, Gijsbertus TJ/E-3661-2015; List, Ed/AAG-7094-2019; Medici, Marco/U-2777-2018; Hoeijmakers, Jan/AAX-6972-2021; de Krijger, Ronald/J-2564-2019; Visser, W. Edward/C-4062-2015	Garinis, George A./0000-0002-3200-5004; van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Visser, W. Edward/0000-0002-5248-863X; Brandt, Renata M. C./0000-0003-0514-5623; Peeters, Robin/0000-0001-7732-9371; Ottaviani, Alexandre/0000-0002-1564-0735; Vermeij, Wilbert/0000-0002-9690-1385	European commission [FP7-Health-2008-200880, LSHG-CT-2005-512113, LSHG-CT-2007-036894]; National Institutes of Health (NIH)/National Institute of Ageing (NIA) [1PO1 AG-17242-02]; NIEHS [1UO1 ES011044]; Royal Academy of Arts and Sciences of the Netherlands; European Research Council; European Community [HEALTH-F2-2010-259893]; Erasmus University; American Thyroid Association; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	European commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health (NIH)/National Institute of Ageing (NIA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Royal Academy of Arts and Sciences of the Netherlands; European Research Council(European Research Council (ERC)European Commission); European Community(European Commission); Erasmus University; American Thyroid Association; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the European commission FP7 Markage (FP7-Health-2008-200880), DNA Repair (LSHG-CT-2005-512113) and LifeSpan (LSHG-CT-2007-036894), National Institutes of Health (NIH)/National Institute of Ageing (NIA; 1PO1 AG-17242-02), NIEHS (1UO1 ES011044), and the Royal Academy of Arts and Sciences of the Netherlands (academia professorship to JHJH) and a European Research Council Advanced Grant DamAge to JHJH. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. HEALTH-F2-2010-259893. WEV is supported by an Erasmus University Fellowship and a Research fellowship from the American Thyroid Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge financial support of the European commission FP7 Markage (FP7-Health-2008- 200880), DNA Repair (LSHG-CT-2005-512113) and LifeSpan (LSHG-CT-2007-036894), National Institute of Health (NIH)/National Institute of Ageing (NIA) (1PO1 AG-17242-02), NIEHS (1UO1 ES011044), and the Royal Academy of Arts and Sciences of the Netherlands (academia professorship to JHJH) and a European Research Council Advanced Grant DamAge to JHJH. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. HEALTH-F2-2010-259893. WEV is supported by an Erasmus University Fellowship and a Research fellowship from the American Thyroid Association.	Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Atzmon G, 2009, J CLIN ENDOCR METAB, V94, P4768, DOI 10.1210/jc.2009-0808; Bartke A, 2003, NEUROENDOCRINOLOGY, V78, P210, DOI 10.1159/000073704; Boelen A, 2011, ENDOCR REV, V32, P670, DOI 10.1210/er.2011-0007; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Chen JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004950; Chipchase MD, 2003, HEPATOLOGY, V38, P958, DOI 10.1053/jhep.2003.50421; DARRAS VM, 1992, FEBS LETT, V310, P5, DOI 10.1016/0014-5793(92)81133-7; DEESCOBAR GM, 1994, ENDOCRINOLOGY, V134, P2410; Dentice M, 2007, P NATL ACAD SCI USA, V104, P14466, DOI 10.1073/pnas.0706754104; Dewil E, 1999, LIFE SCI, V64, P1359, DOI 10.1016/S0024-3205(99)00082-X; Dolle MET, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7219; Dong H, 2007, ENDOCRINOLOGY, V148, P3932, DOI 10.1210/en.2007-0452; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Friedrichsen S, 2003, ENDOCRINOLOGY, V144, P777, DOI 10.1210/en.2002-220715; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Garinis GA, 2009, NAT CELL BIOL, V11, P604, DOI 10.1038/ncb1866; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Huang SA, 2008, NAT CLIN PRACT ENDOC, V4, P148, DOI 10.1038/ncpendmet0727; Kester MHA, 2009, ENDOCRINOLOGY, V150, P540, DOI 10.1210/en.2008-0344; Kirkwood T, 2006, NATURE, V444, P1015, DOI 10.1038/4441015a; Lawrence NJ, 2008, DNA REPAIR, V7, P281, DOI 10.1016/j.dnarep.2007.10.005; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; MARIOTTI S, 1995, ENDOCR REV, V16, P686, DOI 10.1210/er.16.6.686; MCGRANE MM, 1988, J BIOL CHEM, V263, P11443; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Oliveros J.C., 2007, VENNY INTERACTIVE TO; OOKA H, 1983, MECH AGEING DEV, V22, P113, DOI 10.1016/0047-6374(83)90104-5; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P3202, DOI 10.1210/jc.2002-022013; Ronning B, 2009, J EXP BIOL, V212, P3060, DOI 10.1242/jeb.029835; Rozing MP, 2010, J GERONTOL A-BIOL, V65, P365, DOI 10.1093/gerona/glp200; Schermer B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-559; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Selfridge J, 2001, NUCLEIC ACIDS RES, V29, P4541, DOI 10.1093/nar/29.22.4541; Simonides WS, 2008, J CLIN INVEST, V118, P975, DOI 10.1172/JCI32824; Simonsick EM, 2009, ARCH INTERN MED, V169, P2011, DOI 10.1001/archinternmed.2009.392; TORNELL J, 1991, INT J CANCER, V49, P114, DOI 10.1002/ijc.2910490121; van de Ven Marieke, 2006, PLoS Genet, V2, pe192, DOI 10.1371/journal.pgen.0020192; van den Beld AW, 2005, J CLIN ENDOCR METAB, V90, P6403, DOI 10.1210/jc.2005-0872; Van der Geyten S, 1999, GEN COMP ENDOCR, V116, P272, DOI 10.1006/gcen.1999.7368; Van der Geyten S, 1999, MOL CELL ENDOCRINOL, V147, P49, DOI 10.1016/S0303-7207(98)00218-4; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; van Zeijl CJJ, 2010, MOL CELL ENDOCRINOL, V321, P231, DOI 10.1016/j.mce.2010.03.002; Vergara M, 2004, J GERONTOL A-BIOL, V59, P1244, DOI 10.1093/gerona/59.12.1244; Visser WE, 2011, MOL ENDOCRINOL, V25, P1, DOI 10.1210/me.2010-0095; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Zavacki AM, 2005, ENDOCRINOLOGY, V146, P1568, DOI 10.1210/en.2004-1392; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	56	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0149941	10.1371/journal.pone.0149941	http://dx.doi.org/10.1371/journal.pone.0149941			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953569	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300012
J	Aldasoro, M; Guerra-Ojeda, S; Aguirre-Rueda, D; Mauricio, MD; Vila, JM; Marchio, P; Iradi, A; Aldasoro, C; Jorda, A; Obrador, E; Valles, SL				Aldasoro, Martin; Guerra-Ojeda, Sol; Aguirre-Rueda, Diana; Mauricio, Ma Dolores; Vila, Jose Ma; Marchio, Patricia; Iradi, Antonio; Aldasoro, Constanza; Jorda, Adrian; Obrador, Elena; Valles, Soraya L.			Effects of Ranolazine on Astrocytes and Neurons in Primary Culture	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; ISCHEMIA-REPERFUSION INJURY; LATE SODIUM CURRENT; PPAR-GAMMA; ANTIANGINAL DRUG; INFLAMMATORY RESPONSES; CHRONIC ANGINA; BRAIN-INJURY; IN-VITRO; ROLES	Ranolazine (Rn) is an antianginal agent used for the treatment of chronic angina pectoris when angina is not adequately controlled by other drugs. Rn also acts in the central nervous system and it has been proposed for the treatment of pain and epileptic disorders. Under the hypothesis that ranolazine could act as a neuroprotective drug, we studied its effects on astrocytes and neurons in primary culture. We incubated rat astrocytes and neurons in primary cultures for 24 hours with Rn (10(-7), 10(-6) and 10(-5) M). Cell viability and proliferation were measured using trypan blue exclusion assay, MTT conversion assay and LDH release assay. Apoptosis was determined by Caspase 3 activity assay. The effects of Rn on proinflammatory mediators IL-beta and TNF-alpha was determined by ELISA technique, and protein expression levels of Smac/Diablo, PPAR-gamma, Mn-SOD and Cu/Zn-SOD by western blot technique. In cultured astrocytes, Rn significantly increased cell viability and proliferation at any concentration tested, and decreased LDH leakage, Smac/Diablo expression and Caspase 3 activity indicating less cell death. Rn also increased anti-inflammatory PPAR-gamma protein expression and reduced pro-inflammatory proteins IL-1 beta and TNF alpha levels. Furthermore, antioxidant proteins Cu/Zn-SOD and Mn-SOD significantly increased after Rn addition in cultured astrocytes. Conversely, Rn did not exert any effect on cultured neurons. In conclusion, Rn could act as a neuroprotective drug in the central nervous system by promoting astrocyte viability, preventing necrosis and apoptosis, inhibiting inflammatory phenomena and inducing anti-inflammatory and antioxidant agents.	[Aldasoro, Martin; Guerra-Ojeda, Sol; Aguirre-Rueda, Diana; Mauricio, Ma Dolores; Vila, Jose Ma; Marchio, Patricia; Iradi, Antonio; Aldasoro, Constanza; Jorda, Adrian; Obrador, Elena; Valles, Soraya L.] Univ Valencia, Sch Med, Dept Physiol, E-46003 Valencia, Spain	University of Valencia	Valles, SL (corresponding author), Univ Valencia, Sch Med, Dept Physiol, E-46003 Valencia, Spain.	lilian.valles@uv.es	Guerra, Solanye/AAX-2891-2021; Mauricio, Maria D/AAN-7412-2020; Valles, Soraya L./H-9320-2019; Guerra, Solanye/GXH-1600-2022; ALDASORO, MARTIN/AAB-3344-2019; OBRADOR, ELENA/H-4069-2015	Mauricio, Maria D/0000-0002-7695-2898; Valles, Soraya L./0000-0003-4861-4266; ALDASORO, MARTIN/0000-0001-6630-0493; OBRADOR, ELENA/0000-0002-5934-5543; Aguirre Rueda, Diana/0000-0003-1166-5780; Aldasoro, Constanza/0000-0003-0641-8558; Guerra, Solanye/0000-0003-3018-4683; Vila Salinas/0000-0001-8589-9307; Jorda, Adrian/0000-0001-6093-0013; Estan Capell, Nuria/0000-0001-8768-3139; Aguirre Rueda, Diana/0000-0003-2019-0457	generalitat valenciana grant	generalitat valenciana grant(Center for Forestry Research & Experimentation (CIEF))	Funded by generalitat valenciana grant 2007.	Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; Aguirre-Rueda D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122843; Aguirre-Rueda D, 2015, INT J MED SCI, V12, P48, DOI 10.7150/ijms.10035; Aldakkak M, 2011, PHARMACOL RES, V64, P381, DOI 10.1016/j.phrs.2011.06.018; Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Belardinelli L, 2006, HEART, V92, P6, DOI 10.1136/hrt.2005.078790; Belfiore A, 2009, PPAR RES, V2009, DOI 10.1155/2009/830501; Black JA, 2007, ANN NEUROL, V62, P21, DOI 10.1002/ana.21172; Black JA, 2013, NEURON, V80, P280, DOI 10.1016/j.neuron.2013.09.012; Black JA, 2009, GLIA, V57, P1072, DOI 10.1002/glia.20830; Block L, 2013, EUR J NEUROSCI, V38, P3669, DOI 10.1111/ejn.12364; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Chaitman BR, 2006, CIRCULATION, V113, P2462, DOI 10.1161/CIRCULATIONAHA.105.597500; Chaitman BR, 2004, J AM COLL CARDIOL, V43, P1375, DOI 10.1016/j.jacc.2003.11.045; Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Chen BS, 2009, J PHARMACOL SCI, V110, P295, DOI 10.1254/jphs.09018FP; Chen YC, 2012, MOL NEUROBIOL, V46, P114, DOI 10.1007/s12035-012-8259-8; Choi SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092325; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; Cummins TR, 2007, PAIN, V131, P243, DOI 10.1016/j.pain.2007.07.026; Deshmukh SH, 2009, CORONARY ARTERY DIS, V20, P343, DOI 10.1097/MCA.0b013e32832a198b; Ding GL, 2007, CARDIOVASC RES, V76, P269, DOI 10.1016/j.cardiores.2007.06.027; Du C, 2000, CELL, V86, P147; Forshammar J, 2013, BRAIN RES, V1539, P34, DOI 10.1016/j.brainres.2013.09.052; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fuller S, 2010, MUTAT RES-FUND MOL M, V690, P40, DOI 10.1016/j.mrfmmm.2009.08.016; Gadicherla AK, 2012, BBA-BIOENERGETICS, V1817, P419, DOI 10.1016/j.bbabio.2011.11.021; Genolet Raphael, 2004, Current Drug Targets - Inflammation and Allergy, V3, P361, DOI 10.2174/1568010042634578; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gould HJ, 2009, BEHAV PHARMACOL, V20, P755, DOI 10.1097/FBP.0b013e3283323c90; Gu WW, 2016, NEUROSCIENCE, V316, P26, DOI 10.1016/j.neuroscience.2015.11.052; Hatton JL, 2008, PPAR RES, V2008, DOI 10.1155/2008/159415; Heneka MT, 2007, NAT CLIN PRACT NEURO, V3, P496, DOI 10.1038/ncpneuro0586; Hu SM, 2012, MOL ENDOCRINOL, V26, P977, DOI 10.1210/me.2011-1253; Huang XJ, 2014, J NEUROTRAUM, V31, P346, DOI 10.1089/neu.2013.2899; Inoue I, 2001, METABOLISM, V50, P3, DOI 10.1053/meta.2001.19415; Cuartero MI, 2013, STROKE, V44, P3498, DOI 10.1161/STROKEAHA.113.002470; Jung GY, 2013, GLIA, V61, P1807, DOI 10.1002/glia.22559; Kahlig KM, 2010, BRIT J PHARMACOL, V161, P1414, DOI 10.1111/j.1476-5381.2010.00976.x; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Knott C, 2000, MOL CELL NEUROSCI, V16, P724, DOI 10.1006/mcne.2000.0914; Kooijman E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090584; Lei BP, 2001, ANESTHESIOLOGY, V95, P445, DOI 10.1097/00000542-200108000-00029; Liberatore GT, 1999, NAT MED, V5, P1403; Liu X, 1996, CELL, V86, P33; Luo YM, 2006, J NEUROCHEM, V97, P435, DOI 10.1111/j.1471-4159.2006.03758.x; Ma JH, 2014, J CARDIOVASC PHARM, V64, P60, DOI 10.1097/FJC.0000000000000090; McCormack JG, 1996, CIRCULATION, V93, P135, DOI 10.1161/01.CIR.93.1.135; Morrow DA, 2009, CIRCULATION, V119, P2032, DOI 10.1161/CIRCULATIONAHA.107.763912; Ning Y, 2011, J PHARMACOL EXP THER, V337, P50, DOI 10.1124/jpet.110.176396; Norenberg M, 1996, THEROLE GLIA NEUROTO, P93; Pappalardo LW, 2014, GLIA, V62, P1162, DOI 10.1002/glia.22671; Park YY, 2013, J NEUROPHYSIOL, V109, P1378, DOI 10.1152/jn.00435.2012; Peters CH, 2013, BRIT J PHARMACOL, V169, P704, DOI 10.1111/bph.12150; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Ronicke R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003236; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; Schram G, 2004, BRIT J PHARMACOL, V142, P1300, DOI 10.1038/sj.bjp.0705879; Shryock JC, 2008, BRIT J PHARMACOL, V153, P1128, DOI 10.1038/sj.bjp.0707522; Siddiqui MAA, 2006, DRUGS, V66, P693, DOI 10.2165/00003495-200666050-00010; Skaper SD, 2007, ANN NY ACAD SCI, V1122, P23, DOI 10.1196/annals.1403.002; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Song YSJ, 2009, AM J PHYSIOL-HEART C, V297, P1254; Sossalla S, 2012, PHARMACOL THERAPEUT, V133, P311, DOI 10.1016/j.pharmthera.2011.11.003; Sundararajan S, 2004, DRUG NEWS PERSPECT, V17, P229, DOI 10.1358/dnp.2004.17.4.829049; Valles SL, 2008, AGING CELL, V7, P112, DOI 10.1111/j.1474-9726.2007.00356.x; Valles SL, 2010, BRAIN RES, V1312, P138, DOI 10.1016/j.brainres.2009.11.044; Wan HY, 2008, BIOMED PHARMACOTHER, V62, P466, DOI 10.1016/j.biopha.2007.10.012; Wang HM, 2010, J ALZHEIMERS DIS, V20, P1189, DOI 10.3233/JAD-2010-091336; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Xing DG, 2014, ONCOL REP, V31, P2692, DOI 10.3892/or.2014.3143; Xu C, 2016, CELL MOL LIFE SCI, V73, P327, DOI 10.1007/s00018-015-2067-z; Yang P, 2008, J NEUROSCI, V28, P2231, DOI 10.1523/JNEUROSCI.3574-07.2008; Yoo HY, 1999, GENE, V234, P87, DOI 10.1016/S0378-1119(99)00176-6; Zacharowski K, 2001, EUR J PHARMACOL, V418, P105, DOI 10.1016/S0014-2999(01)00920-7; Zaza A, 2008, PHARMACOL THERAPEUT, V119, P326, DOI 10.1016/j.pharmthera.2008.06.001; Zhang R, 2014, BRAIN RES, V1583, P23, DOI 10.1016/j.brainres.2014.08.016; Zhao XR, 2009, J NEUROSCI, V29, P6186, DOI 10.1523/JNEUROSCI.5857-08.2009	85	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150619	10.1371/journal.pone.0150619	http://dx.doi.org/10.1371/journal.pone.0150619			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950436	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100046
J	Beckstead, J; Meyer, SE; Ishizuka, TS; McEvoy, KM; Coleman, CE				Beckstead, Julie; Meyer, Susan E.; Ishizuka, Toby S.; McEvoy, Kelsey M.; Coleman, Craig E.			Lack of Host Specialization on Winter Annual Grasses in the Fungal Seed Bank Pathogen Pyrenophora semeniperda	PLOS ONE			English	Article							WESTERN NORTH-AMERICA; BROMUS-TECTORUM; RED-QUEEN; POPULATION; RANGE; SPECIFICITY; GERMINATION; MORTALITY; DYNAMICS; GENETICS	Generalist plant pathogens may have wide host ranges, but many exhibit varying degrees of host specialization, with multiple pathogen races that have narrower host ranges. These races are often genetically distinct, with each race causing highest disease incidence on its host of origin. We examined host specialization in the seed pathogen Pyrenophora semeniperda by reciprocally inoculating pathogen strains from Bromus tectorum and from four other winter annual grass weeds (Bromus diandrus, Bromus rubens, Bromus arvensis and Taeniatherum caput-medusae) onto dormant seeds of B. tectorum and each alternate host. We found that host species varied in resistance and pathogen strains varied in aggressiveness, but there was no evidence for host specialization. Most variation in aggressiveness was among strains within populations and was expressed similarly on both hosts, resulting in a positive correlation between strain-level disease incidence on B. tectorum and on the alternate host. In spite of this lack of host specialization, we detected weak but significant population genetic structure as a function of host species using two neutral marker systems that yielded similar results. This genetic structure is most likely due to founder effects, as the pathogen is known to be dispersed with host seeds. All host species were highly susceptible to their own pathogen races. Tolerance to infection (i.e., the ability to germinate even when infected and thereby avoid seed mortality) increased as a function of seed germination rate, which in turn increased as dormancy was lost. Pyrenophora semeniperda apparently does not require host specialization to fully exploit these winter annual grass species, which share many life history features that make them ideal hosts for this pathogen.	[Beckstead, Julie; Ishizuka, Toby S.; McEvoy, Kelsey M.] Gonzaga Univ, Dept Biol, Spokane, WA 99258 USA; [Meyer, Susan E.] USDA, Shrub Sci Lab, Forest Serv, Rocky Mt Res Stn, Provo, UT 84606 USA; [Coleman, Craig E.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA	Gonzaga University; United States Department of Agriculture (USDA); United States Forest Service; Brigham Young University	Meyer, SE (corresponding author), USDA, Shrub Sci Lab, Forest Serv, Rocky Mt Res Stn, Provo, UT 84606 USA.	semeyer@xmission.com			Joint Fire Sciences Program [JFSP-2011-S-2-6]	Joint Fire Sciences Program	Joint Fire Sciences Program: www.firescience.gov/ (JFSP-2011-S-2-6; S.E.M., J.B.). Howard Hughes Medical Institute Undergraduate Science Education Program: http://www.hhmi.org/programs/science-education-research-training (J.B.). Claire and Robert McDonald Work Award Program at Gonzaga University (J.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PS, 2010, C P SEED EC 3 JUN 20, VIII; Augspurger CK, 2007, BIOTROPICA, V39, P702, DOI 10.1111/j.1744-7429.2007.00326.x; BASKIN JM, 1981, J RANGE MANAGE, V34, P369, DOI 10.2307/3897906; Beckstead J, 1996, CAN J BOT, V74, P875, DOI 10.1139/b96-109; Beckstead J, 2007, ANN BOT-LONDON, V99, P907, DOI 10.1093/aob/mcm028; Beckstead J, 2014, PLANT ECOL, V215, P427, DOI 10.1007/s11258-014-0313-3; Beckstead J, 2010, J ECOL, V98, P168, DOI 10.1111/j.1365-2745.2009.01599.x; Boedo C, 2012, PLANT PATHOL, V61, P63, DOI 10.1111/j.1365-3059.2011.02494.x; Boose D, 2011, MYCOLOGIA, V103, P85, DOI 10.3852/09-310; Campbell MA, 2003, PLANT PATHOL, V52, P448, DOI 10.1046/j.1365-3059.2003.00872.x; Carlsson-Graner U, 2006, OIKOS, V112, P174, DOI 10.1111/j.0030-1299.2006.13292.x; CRUTE IR, 1997, GENE FOR GENE RELATI; Dybdahl MF, 2003, TRENDS ECOL EVOL, V18, P523, DOI 10.1016/S0169-5347(03)00223-4; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finch H, 2013, SEED SCI RES, V23, P57, DOI 10.1017/S0960258512000244; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Glass NL, 2000, ANNU REV GENET, V34, P165, DOI 10.1146/annurev.genet.34.1.165; HARRADINE AR, 1986, WEED RES, V26, P173, DOI 10.1111/j.1365-3180.1986.tb00693.x; Hawkins KK, THESIS B YOUNG U; Kawecki TJ, 1998, AM NAT, V152, P635, DOI 10.1086/286195; Kluger CG, 2008, J TROP ECOL, V24, P351, DOI 10.1017/S0266467408005026; Kniskern JM, 2011, EVOLUTION, V65, P818, DOI 10.1111/j.1558-5646.2010.01157.x; Konno M, 2011, J ECOL, V99, P1394, DOI 10.1111/j.1365-2745.2011.01869.x; Leger RJS, 2000, APPL ENVIRON MICROB, V66, P320, DOI 10.1128/AEM.66.1.320-324.2000; Medd RW, 2003, AUSTRALAS PLANT PATH, V32, P539, DOI 10.1071/AP03059; Meyer SE, 2015, PLANT PATHOL; Meyer SE, 2014, OECOLOGIA, V174, P1401, DOI 10.1007/s00442-013-2868-4; Meyer SE, 2010, NEW PHYTOL, V187, P209, DOI 10.1111/j.1469-8137.2010.03255.x; Meyer SE, 2008, CAN J PLANT PATHOL, V30, P525, DOI 10.1080/07060660809507552; Ooi Mark, 2004, Ecological Management & Restoration, V5, P141, DOI 10.1111/j.1442-8903.2004.201-6.x; Pringle EG, 2007, PLANT ECOL, V193, P211, DOI 10.1007/s11258-006-9259-4; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; Soliai MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087045; Stewart TE, 2009, PLANT DIS, V93, P1351, DOI 10.1094/PDIS-93-12-1351B; VanderPutten WH, 1997, ECOLOGY, V78, P1785, DOI 10.1890/0012-9658(1997)078[1785:HSBPMA]2.0.CO;2; Verhoeven KJF, 2009, ECOL LETT, V12, P107, DOI 10.1111/j.1461-0248.2008.01248.x; Yonow T, 2004, PHYTOPATHOLOGY, V94, P805, DOI 10.1094/PHYTO.2004.94.8.805; Young J.A., 1992, WEST N AM NATURALIST, V52, P245	39	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0151058	10.1371/journal.pone.0151058	http://dx.doi.org/10.1371/journal.pone.0151058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950931	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100086
J	Fanosie, A; Gelaw, B; Tessema, B; Tesfay, W; Admasu, A; Yitayew, G				Fanosie, Alemu; Gelaw, Baye; Tessema, Belay; Tesfay, Wogahta; Admasu, Aschalew; Yitayew, Gashaw			Mycobacterium tuberculosis Complex and HIV Co-Infection among Extrapulmonary Tuberculosis Suspected Cases at the University of Gondar Hospital, Northwestern Ethiopia	PLOS ONE			English	Article							EXTRA-PULMONARY TUBERCULOSIS; RISK-FACTORS; BOVIS; MALNUTRITION; DIAGNOSIS	Background Extrapulmonary Tuberculosis (EPTB) and Human Immunodeficiency Virus (HIV) infection are interrelated as a result of immune depression. The aim of this study was to determine the prevalence of Mycobacterium tuberculosis complex isolates and the burden of HIV co-infection among EPTB suspected patients. Method An institution based cross-sectional study was conducted among EPTB suspected patients at the University of Gondar Hospital. Socio-demographic characteristics and other clinical data were collected using a pretested questionnaire. GeneXpert MTB/RIF assay was performed to diagnosis Mycobacterium tuberculosis complex and Rifampicin resistance. All samples were also investigated by cytology and culture. The HIV statuses of all patients were screened initially by KHB, and all positive cases were further re-tested by STAT-pack. Data was analyzed using SPSS version 20 computer software and a P-value of < 0.05 was taken as statistically significant. Results A total of 141 extrapulmonary suspected patients were enrolled in this study. The overall prevalence of culture confirmed extrapulmonary tuberculosis infection was 29.8%, but the GeneXpert result showed a 26.2% prevalence of Mycobacterium tuberculosis complex infection. The 78.4% prevalence of extrapulmonary tuberculosis infection was found to be higher among the adult population. The prevalence of HIV infection among EPTB suspected patients was 14.1%, while it was 32.4% among GeneXpert-confirmed extrapulmonary TB cases (12/37). Tuberculosis lymphadenitis was the predominant (78.4%) type of EPTB infection followed by tuberculosis cold abscess (10.7%). Adult hood, previous history of contact with known pulmonary tuberculosis patients, and HIV co-infection showed a statistically significant association with extrapulmonary tuberculosis infection (P<0.013). Conclusion The prevalence of culture confirmed-EPTB infection was high, and a higher EPTB-HIV co-infection was also observed.	[Fanosie, Alemu; Gelaw, Baye; Tessema, Belay] Univ Gondar UOG, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, POB 196, Gondar, Ethiopia; [Tesfay, Wogahta] Univ Gondar UOG, Coll Med & Hlth Sci, Sch Med, POB 196, Gondar, Ethiopia; [Admasu, Aschalew; Yitayew, Gashaw] Bahir Dar Reg Hlth & Res Lab Ctr, Bahir Dar, Ethiopia	University of Gondar; University of Gondar	Gelaw, B (corresponding author), Univ Gondar UOG, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, POB 196, Gondar, Ethiopia.	tedybayegelaw@gmail.com	Tes, Bel/L-3858-2019					Agonafir M, 2010, INT J TUBERC LUNG D, V14, P1259; [Anonymous], IMPR DIAGN TREATM SM, DOI DOI 10.1186/s12879-016-1967-3; [Anonymous], 2015, J CLINDIAGN RES, V9, pEE01; ANTONY SJ, 1995, J NATL MED ASSOC, V87, P187; Berg S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0846-7; Bhaskaram P., 1995, Journal of Nutritional Immunology, V3, P71; Biadglegne F, 2014, INDIAN J MED RES, V140, P116; Cailhol J, 2005, J CLIN EPIDEMIOL, V58, P1066, DOI 10.1016/j.jclinepi.2005.02.023; Causse M, 2011, J CLIN MICROBIOL, V49, P3065, DOI 10.1128/JCM.00491-11; Cegielski J, INT J TUBERC LUNG DI, V8, P286; Chakravorty S, 2005, J CLIN MICROBIOL, V43, P4357, DOI 10.1128/JCM.43.9.4357-4362.2005; Cicero R, 2009, EUR J CLIN MICROBIOL, V28, P455, DOI 10.1007/s10096-008-0649-5; Clinical and Laboratory Standards Institute: CLSI Guidelines, 2008, LAB DET ID MYC APPR; DANDAPAT MC, 1990, BRIT J SURG, V77, P911, DOI 10.1002/bjs.1800770823; Davies PDO, 2008, INT J TUBERC LUNG D, V12, P1226; Davies PD, 2008, CLIN TUBERCULOSIS; Denkinger C. M., 2014, EUR RESP J; Deribew A, 2011, ETHIOPIAN MED J, V6; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Durr S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002399; FARER LS, 1979, AM J EPIDEMIOL, V109, P205, DOI 10.1093/oxfordjournals.aje.a112675; Ferreira-e-Silva WT, 2009, NEUROIMMUNOMODULAT, V16, P219, DOI 10.1159/000212382; Ghariani A, 2015, INT J MYCOBACT, V4, P270, DOI 10.1016/j.ijmyco.2015.05.011; Golden MP, 2005, AM FAM PHYSICIAN, V72, P1761; GRANGE JM, 1994, VET MICROBIOL, V40, P137, DOI 10.1016/0378-1135(94)90052-3; Gunal S, 2011, BMC PUBLIC HEALTH, V11, P154; Hemal AK., 2001, GENITOURINARY TUBERC; Hussain W, 2004, TAJ, V17, P16; Iwnetu R, 2009, SCAND J INFECT DIS, V41, P462, DOI 10.1080/00365540902897697; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Kamenju P., 2011, Tanzania Journal of Health Research, V13, P25; Kipp AM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-107; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Lin JN, 2009, INT J TUBERC LUNG D, V13, P620; Luma N, 2013, ANN TROPICAL MED PUB, V6, P100; Macallan DC, 1999, DIAGN MICR INFEC DIS, V34, P153, DOI 10.1016/S0732-8893(99)00007-3; Mesfin M. M., 2005, Ethiopian Journal of Health Development, V19, P13; Ministry of Health of Ethiopia, 2012, GUID CLIN PROGR MAN; Noertjojo K, 2002, INT J TUBERC LUNG D, V6, P879; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; SMALL PM, 1991, NEW ENGL J MED, V324, P289, DOI 10.1056/NEJM199101313240503; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Sulaiman A, 2010, COMPREHENSIVE CYTOL, V16, P707; Tadesse M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137471; Ukwaja Kingsley, 2011, Pan Afr Med J, V9, P12; Vadwai V, 2011, J CLIN MICROBIOL, V49, P25; WHO, 2014, GLOB TUB REP; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2014, GLOB TUB REP; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644; Yassin MA, 2006, INT J TUBERC LUNG D, V10, P1166; Zenebe Yohannes, 2013, BMC Res Notes, V6, P21, DOI 10.1186/1756-0500-6-21	53	15	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150646	10.1371/journal.pone.0150646	http://dx.doi.org/10.1371/journal.pone.0150646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950547	Green Published, gold			2022-12-27	WOS:000371990100047
J	Pilloux, L; LeRoy, D; Brunel, C; Roger, T; Greub, G				Pilloux, Ludovic; LeRoy, Didier; Brunel, Christophe; Roger, Thierry; Greub, Gilbert			Mouse Model of Respiratory Tract Infection Induced by Waddlia chondrophila	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ADVERSE PREGNANCY OUTCOMES; ABORTED BOVINE FETUS; CHLAMYDIA-PNEUMONIAE; INTRACELLULAR BACTERIA; HUMAN MACROPHAGES; PARACHLAMYDIA; PATHOGENS; AGENTS	Waddlia chondrophila, an obligate intracellular bacterium belonging to the Chlamydiales order, is considered as an emerging pathogen. Some clinical studies highlighted a possible role of W. chondrophila in bronchiolitis, pneumonia and miscarriage. This pathogenic potential is further supported by the ability of W. chondrophila to infect and replicate within human pneumocytes, macrophages and endometrial cells. Considering that W. chondrophila might be a causative agent of respiratory tract infection, we developed a mouse model of respiratory tract infection to get insight into the pathogenesis of W. chondrophila. Following intranasal inoculation of 2 x 10(8) W. chondrophila, mice lost up to 40% of their body weight, and succumbed rapidly from infection with a death rate reaching 50% at day 4 post-inoculation. Bacterial loads, estimated by qPCR, increased from day 0 to day 3 post-infection and decreased thereafter in surviving mice. Bacterial growth was confirmed by detecting dividing bacteria using electron microscopy, and living bacteria were isolated from lungs 14 days post-infection. Immunohistochemistry and histopathology of infected lungs revealed the presence of bacteria associated with pneumonia characterized by an important multifocal inflammation. The high inflammatory score in the lungs was associated with the presence of pro-inflammatory cytokines in both serum and lungs at day 3 post-infection. This animal model supports the role of W. chondrophila as an agent of respiratory tract infection, and will help understanding the pathogenesis of this strict intracellular bacterium.	[Pilloux, Ludovic; Greub, Gilbert] Univ Hosp Ctr, Inst Microbiol, Ctr Res Intracellular Bacteria, Lausanne, Switzerland; [Pilloux, Ludovic; LeRoy, Didier; Brunel, Christophe; Roger, Thierry; Greub, Gilbert] Univ Lausanne, Lausanne, Switzerland; [LeRoy, Didier; Roger, Thierry] Univ Hosp Ctr, Infect Dis Serv, Dept Med, Lausanne, Switzerland; [Brunel, Christophe] Univ Hosp Ctr, Inst Pathol, Lausanne, Switzerland	University of Lausanne	Greub, G (corresponding author), Univ Hosp Ctr, Inst Microbiol, Ctr Res Intracellular Bacteria, Lausanne, Switzerland.; Greub, G (corresponding author), Univ Lausanne, Lausanne, Switzerland.	gilbert.greub@chuv.ch	Roger, Thierry/G-2007-2012; Greub, Gilbert GG/K-5804-2017; Pilloux, Ludovic/A-3297-2015	Roger, Thierry/0000-0002-9358-0109; Greub, Gilbert GG/0000-0001-9529-3317; LE ROY, Didier/0000-0001-8954-5442; Pilloux, Ludovic/0000-0002-2133-1891	Swiss National Science Foundation [141050, 138488, 149511]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	GG is supported by the Swiss National Science Foundation grant no 141050 that covers the salary of LP. TR is supported by the Swiss National Science Foundation grant no 138488 and no 149511. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Swiss National Science Foundation (141050 to GG and 138488 and 149511 to TR). We thank C. Loussert and J. Daraspe (ElectronMicroscopy Facility, Lausanne) for assisting with electron microscopy analysis, J. C. Stehle (Mouse Pathology Facility, Lausanne) for histology and immunohistochemistry staining, S. Aeby and J. Gyger (CHUV, Lausanne) for technical help, and A. Croxatto (CHUV, Lausanne) for fruitful discussions.	Baud D, 2011, CLIN MICROBIOL INFEC, V17, P1312, DOI 10.1111/j.1469-0691.2011.03604.x; Baud D, 2007, EMERG INFECT DIS, V13, P1239, DOI 10.3201/eid1308.070315; Baud D, 2008, CURR OPIN INFECT DIS, V21, P70, DOI 10.1097/QCO.0b013e3282f3e6a5; Baud D, 2014, EMERG INFECT DIS, V20, P460, DOI 10.3201/eid2003.131019; Bertelli C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010890; Blumer S, 2011, VET MICROBIOL, V152, P385, DOI 10.1016/j.vetmic.2011.05.024; Bochud PY, 2001, MEDICINE, V80, P75, DOI 10.1097/00005792-200103000-00001; Casson N, 2008, MICROB PATHOGENESIS, V45, P92, DOI 10.1016/j.micpath.2008.04.003; Codony F, 2012, MICROBES ENVIRON, V27, P529, DOI 10.1264/jsme2.ME12048; Corsarol D, 2006, CLIN MICROBIOL REV, V19, P283, DOI 10.1128/CMR.19.2.283-297.2006; Costa SF, 2001, INT J ANTIMICROB AG, V17, P147, DOI 10.1016/S0924-8579(00)00316-2; Croxatto A, 2010, MICROBIOL-SGM, V156, P340, DOI 10.1099/mic.0.034546-0; Diederen BMW, 2008, J INFECTION, V56, P1, DOI 10.1016/j.jinf.2007.09.010; DILBECK PM, 1990, J CLIN MICROBIOL, V28, P814, DOI 10.1128/JCM.28.4.814-816.1990; Dilbeck-Robertson P, 2003, J VET DIAGN INVEST, V15, P568, DOI 10.1177/104063870301500609; Echols RM, 2008, CLIN INFECT DIS, V47, pS166, DOI 10.1086/591399; Friedman MG, 2006, J CLIN PATHOL, V59, P331, DOI 10.1136/jcp.2004.025601; Fujitani S, 2011, CHEST, V139, P909, DOI 10.1378/chest.10-0166; Goy G, 2009, EUR J CLIN MICROBIOL, V28, P1483, DOI 10.1007/s10096-009-0804-7; Goy G, 2008, MICROBES INFECT, V10, P556, DOI 10.1016/j.micinf.2008.02.003; Greub G, 2002, EMERG INFECT DIS, V8, P625; Haider S, 2008, FEMS MICROBIOL LETT, V281, P198, DOI 10.1111/j.1574-6968.2008.01099.x; Hammerschlag MR, 2000, EUR RESPIR J, V16, P1001, DOI 10.1183/09031936.00.16510010; Henning K, 2002, NEOSPORA CANINUM WAD, P1; Jacquier N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4578; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; Jupelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077447; Kahane S, 1998, J INFECT DIS, V177, P1425, DOI 10.1086/517830; Kebbi-Beghdadi C, 2011, MICROBES INFECT, V13, P566, DOI 10.1016/j.micinf.2011.01.020; Lamoth F, 2010, FEMS MICROBIOL REV, V34, P260, DOI 10.1111/j.1574-6976.2009.00207.x; Mizgerd JP, 2008, AM J PHYSIOL-LUNG C, V294, pL387, DOI 10.1152/ajplung.00330.2007; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Mpiga P, 2006, MICROBIOL RES, V161, P9, DOI 10.1016/j.micres.2005.04.004; ROWBOTHAM TJ, 1983, J CLIN PATHOL, V36, P978, DOI 10.1136/jcp.36.9.978; Rurangirwa FR, 1999, INT J SYST BACTERIOL, V49, P577, DOI 10.1099/00207713-49-2-577; Rusconi B, 2013, ANTON LEEUW INT J G, V104, P521, DOI 10.1007/s10482-013-9999-9; Shimada K, 2012, MICROBES INFECT, V14, P1301, DOI 10.1016/j.micinf.2012.08.004; Shimada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021477; Torres A, 2014, EUR J CLIN MICROBIOL, V33, P1065, DOI 10.1007/s10096-014-2067-1; Welte T, 2004, INFECTION, V32, P234, DOI 10.1007/s15010-004-3107-z; YANG ZP, 1993, INFECT IMMUN, V61, P2037, DOI 10.1128/IAI.61.5.2037-2040.1993	41	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150909	10.1371/journal.pone.0150909	http://dx.doi.org/10.1371/journal.pone.0150909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950066	gold, Green Published, Green Submitted			2022-12-27	WOS:000371990100070
J	Prechl, J; Papp, K; Herincs, Z; Peterfy, H; Lorand, V; Szittner, Z; Estonba, A; Rovero, P; Paolini, I; del Amo, J; Uribarri, M; Alcaro, MC; Ruiz-Larranaga, O; Migliorini, P; Czirjak, L				Prechl, Jozsef; Papp, Krisztian; Herincs, Zoltan; Peterfy, Hajna; Lorand, Veronika; Szittner, Zoltan; Estonba, Andone; Rovero, Paolo; Paolini, Ilaria; del Amo, Jokin; Uribarri, Maria; Alcaro, Maria Claudia; Ruiz-Larranaga, Otsanda; Migliorini, Paola; Czirjak, Laszlo			Serological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium	PLOS ONE			English	Article							CIRCULATING IMMUNE-COMPLEXES; ANTI-DSDNA ANTIBODIES; C-REACTIVE PROTEIN; CLASSIFICATION CRITERIA; DISEASE-ACTIVITY; DNA ANTIBODIES; C1Q; ITGAM; AUTOIMMUNITY; ASSOCIATION	Systemic lupus erythematosus is a chronic autoimmune disease with multifactorial ethiopathogenesis. The complement system is involved in both the early and late stages of disease development and organ damage. To better understand autoantibody mediated complement consumption we examined ex vivo immune complex formation on autoantigen arrays. We recruited patients with SLE (n = 211), with other systemic autoimmune diseases (n = 65) and non-autoimmune control subjects (n = 149). Standard clinical and laboratory data were collected and serum complement levels were determined. The genotype of SNP rs1143679 in the ITGAM gene was also determined. Ex vivo formation of immune complexes, with respect to IgM, IgG, complement C4 and C3 binding, was examined using a functional immunoassay on autoantigen microarray comprising nucleic acids, proteins and lipids. Complement consumption of nucleic acids increased upon binding of IgM and IgG even when serum complement levels were decreased due to consumption in SLE patients. A negative correlation between serum complement levels and ex vivo complement deposition on nucleic acid autoantigens is demonstrated. On the contrary, complement deposition on tested protein and lipid autoantigens showed positive correlation with C4 levels. Genetic analysis revealed that the non-synonymous variant rs1143679 in complement receptor type 3 is associated with an increased production of anti-dsDNA IgG antibodies. Notwithstanding, homozygous carriers of the previously reported susceptible allele (AA) had lower levels of dsDNA specific IgM among SLE patients. Both the non-synonymous variant rs1143679 and the high ratio of nucleic acid specific IgG/IgM were associated with multiple organ involvement. In summary, secondary complement deficiency in SLE does not impair opsonization of nucleic-acid-containing autoantigens but does affect other antigens and potentially other complement dependent processes. Dysfunction of the receptor recognizing complement opsonized immune complexes promotes the development of class-switched autoantibodies targeting nucleic acids.	[Prechl, Jozsef; Herincs, Zoltan; Peterfy, Hajna] Diagnosticum Zrt, Budapest, Hungary; [Prechl, Jozsef; Papp, Krisztian; Szittner, Zoltan] Eotvos Lorand Univ, MTA ELTE Immunol Res Grp, Budapest, Hungary; [Lorand, Veronika; Czirjak, Laszlo] Univ Pecs, Ctr Clin, Dept Rheumatol & Immunol, Pecs, Hungary; [Estonba, Andone; Ruiz-Larranaga, Otsanda] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Bilbao, Spain; [Rovero, Paolo] Univ Florence, Dept NeuroFarBa, Florence, Italy; [Paolini, Ilaria; Alcaro, Maria Claudia] Toscana Biomarkers, Siena, Italy; [del Amo, Jokin; Uribarri, Maria] Progenika Biopharma SA, Derio, Bizkaia, Spain; [Migliorini, Paola] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy	Eotvos Lorand University; University of Pecs; University of Basque Country; University of Florence; Grifols; University of Pisa	Prechl, J (corresponding author), Diagnosticum Zrt, Budapest, Hungary.; Prechl, J (corresponding author), Eotvos Lorand Univ, MTA ELTE Immunol Res Grp, Budapest, Hungary.	jprechl@diagnosticum.com	Rovero, Paolo/AAB-6775-2022; Migliorini, Paola/P-6176-2015; DEL AMO VALERO, JULIA/M-7020-2015; Prechl, Jozsef/B-2094-2009	Rovero, Paolo/0000-0001-9577-5228; Migliorini, Paola/0000-0001-6433-4964; DEL AMO VALERO, JULIA/0000-0002-3104-540X; Ruiz-Larranaga, Otsanda/0000-0002-4087-8518; Prechl, Jozsef/0000-0003-3859-4353; Papp, Krisztian/0000-0003-0619-8233; Estonba, Andone/0000-0003-2851-5201; Herincs, Zoltan/0000-0001-9743-1891	European Union [314971 (GAPAID-314971)]; National Research, Development and Innovation Office - NKFIH [K109683]; Diagnosticum Zrt; Toscana Biomarkers; Progenika	European Union(European Commission); National Research, Development and Innovation Office - NKFIH; Diagnosticum Zrt; Toscana Biomarkers; Progenika	This work was funded by European Union grant FP7/2007-2013 grant agreement no 314971 (GAPAID-314971, FP7-SME2012, http://cordis.europa.eu/project/rcn/105440_en.html). Support from the National Research, Development and Innovation Office - NKFIH to JP, grant number K109683 is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Diagnosticum Zrt, Toscana Biomarkers and Progenika provided support in the form of salaries for authors JP, ZH, HP, IP, MCA, JDA and MU, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrejevic S, 2013, CLIN RHEUMATOL, V32, P1619, DOI 10.1007/s10067-013-2330-3; BENCIVELLI W, 1992, CLIN EXP RHEUMATOL, V10, P549; Bossi F, 2014, P NATL ACAD SCI USA, V111, P4209, DOI 10.1073/pnas.1311968111; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; DAVIS P, 1977, CLIN EXP IMMUNOL, V28, P226; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fagerholm SC, 2013, LUPUS, V22, P657, DOI 10.1177/0961203313491851; Forger F, 2004, LUPUS, V13, P36, DOI 10.1191/0961203304lu485oa; Johnson SR, 2012, ARTHRIT CARE RES, V64, P358, DOI 10.1002/acr.20684; Kidmose RT, 2012, P NATL ACAD SCI USA, V109, P15425, DOI 10.1073/pnas.1208031109; Kim-Howard X, 2010, ANN RHEUM DIS, V69, P1329, DOI 10.1136/ard.2009.120543; Korb LC, 1997, J IMMUNOL, V158, P4525; Leffler J, 2014, ANN RHEUM DIS, V73, P1601, DOI 10.1136/annrheumdis-2014-205287; MacPherson M, 2011, J BIOL CHEM, V286, P17303, DOI 10.1074/jbc.M110.182998; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Papp K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044824; Papp K, 2008, J IMMUNOL, V181, P8162, DOI 10.4049/jimmunol.181.11.8162; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Pickering M C, 2000, Adv Immunol, V76, P227; Prechl Jozsef, 2015, F1000Res, V4, P24, DOI 10.12688/f1000research.6075.2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Putterman C, 2014, LUPUS SCI MED, V1, DOI 10.1136/lupus-2014-000056; Rhodes B, 2012, ANN RHEUM DIS, V71, P2028, DOI 10.1136/annrheumdis-2012-201390; ROBEY FA, 1985, J EXP MED, V161, P1344, DOI 10.1084/jem.161.6.1344; Sontheimer RD, 2005, J INVEST DERMATOL, V125, P14, DOI 10.1111/j.0022-202X.2005.23673.x; Stokol T, 2004, J EXP MED, V200, P835, DOI 10.1084/jem.20040501; VANSCHRAVENDIJK MR, 1982, MOL IMMUNOL, V19, P1179, DOI 10.1016/0161-5890(82)90328-5; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Williams WM, 1996, LUPUS, V5, P576, DOI 10.1177/096120339600500604; Witte T, 1998, RHEUMATOL INT, V18, P85, DOI 10.1007/s002960050063	33	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150685	10.1371/journal.pone.0150685	http://dx.doi.org/10.1371/journal.pone.0150685			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950932	Green Submitted, Green Published, gold			2022-12-27	WOS:000371990100050
J	Saha, MR; Dey, P; Begum, S; De, B; Chaudhuri, TK; De Sarker, D; Das, AP; Sen, A				Saha, Manas Ranjan; Dey, Priyankar; Begum, Sainiara; De, Bratati; Chaudhuri, Tapas Kr.; De Sarker, Dilip; Das, Abhaya Prasad; Sen, Arnab			Effect of Acacia catechu (L.f.) Willd. on Oxidative Stress with Possible Implications in Alleviating Selected Cognitive Disorders	PLOS ONE			English	Article							RADICAL SCAVENGING ACTIVITY; ANTIOXIDANT ACTIVITIES; BIOLOGICAL-ACTIVITIES; HYDROGEN-PEROXIDE; DEMENTIA; SUPEROXIDE; PREVALENCE; EXTRACTS; PEROXYNITRITE; PROTECTION	In human body, several categories of degenerative processes are largely determined by free radicals originating in cell. Free radicals are also known to have correlated with a variety of cognitive disorders (CDs) resulting in neuronal injury and eventually to death. Alzheimer's disease (AD) and Parkinson's disease (PD) are such kind of killer CDs that occur due to dysfunction of cholinergic and dopaminergic neurons. Plant parts of Ginkgo biloba, Bacopa monnieri etc. are being used for the treatment of cognitive disorders in several countries. The present study was aimed to explore the detailed antioxidant and anti-cholinesterase activity of Acaciacatechu leaf (ACL) over CDs. Gas chromatography-Mass spectroscopy (GC-MS) analysis and Nuclear Magnetic Resonance (NMR) were employed to identify the bioactive components present in ACL. Furthermore, the extract was evaluated to check the cytotoxic effects of ACL on normal cells. Amongst several antioxidant assays, DPPH assay, hydroxyl radical, nitric oxide radical and hypochlorous acid inhibitory activities were found to be greater in ACL than that of the respective standards while other assays exhibited a moderate or at per inhibitory activity with standards. Total phenolic and flavonoid content were also found to be present in decent amount. In addition, we found, a greater acetylcholinesterase (AChE) inhibitory activity of ACL when compared to other medicinally important plants, indicating its positive effect over CDs. Forty one bioactive components were explored through GC-MS. Of these, gallic acid, epicatechin, catechin, isoquercitrin etc. were found, which are potent antioxidant and a few of them have anti-neurodegenerative properties. Eventually, ACL was found to be nontoxic and safer to consume. Further studies with animal or human model however, would determine its efficacy as a potential anti-schizophrenic drug.	[Saha, Manas Ranjan; Sen, Arnab] Univ N Bengal, Dept Bot, Mol Cytogenet Lab, Siliguri 734013, India; [Dey, Priyankar; Chaudhuri, Tapas Kr.] Univ N Bengal, Dept Zool, Cellular Immunol Lab, Siliguri 734013, India; [Begum, Sainiara; De, Bratati] Univ Calcutta, Dept Bot, Phytochem & Pharmacognosy Res Lab, 35 Ballygunge Circular Rd, Kolkata 700019, India; [De Sarker, Dilip] Raiganj Univ, Dept Bot, Raiganj 733134, India; [Das, Abhaya Prasad] Univ N Bengal, Dept Bot, Taxon & Envioronmental Biol Lab, Siliguri 734013, India	University of North Bengal; University of North Bengal; University of Calcutta; University of North Bengal	Sen, A (corresponding author), Univ N Bengal, Dept Bot, Mol Cytogenet Lab, Siliguri 734013, India.	senarnab_nbu@hotmail.com	Dey, Priyankar/AAG-5125-2022; Dey, Priyankar/AFE-4921-2022; Das, A P/AGK-7697-2022	Dey, Priyankar/0000-0002-9513-425X; Dey, Priyankar/0000-0002-9513-425X; BEGUM, SAINIARA/0000-0001-6581-6869				Abrahim NN, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-220; [Anonymous], 1964, QUANTITATIVE ANAL DR, DOI DOI 10.1016/j.foodchem.2005.06.040; [Anonymous], 2013, GLOB J BOT SCI; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; ARUOMA OI, 1987, BIOCHEM J, V248, P973, DOI 10.1042/bj2480973; Bailly F, 2000, FEBS LETT, V486, P19, DOI 10.1016/S0014-5793(00)02234-1; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; BECKMAN JS, 1994, METHOD ENZYMOL, V233, P229; Berr C, 2005, EUR NEUROPSYCHOPHARM, V15, P463, DOI 10.1016/j.euroneuro.2005.04.003; Beydoun MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-643; Biradar S. M., 2012, Journal of Pharmacology and Toxicology, V7, P231; Brodal P., 2004, CENTRAL NERVOUS SYST; Chang ST, 2001, J AGR FOOD CHEM, V49, P3420, DOI 10.1021/jf0100907; Chattipakorn S, 2007, J ETHNOPHARMACOL, V110, P61, DOI 10.1016/j.jep.2006.09.007; Chaudhuri D, 2012, ASIAN J PHARM CLIN R, V5, P193, DOI DOI 10.1186/0717-6287-47-24; Chew YL, 2009, FOOD CHEM, V116, P13, DOI 10.1016/j.foodchem.2009.01.091; Chinta SJ, 2005, INT J BIOCHEM CELL B, V37, P942, DOI 10.1016/j.biocel.2004.09.009; Chirino Yolanda I., 2004, BMC Pharmacology, V4, P20, DOI 10.1186/1471-2210-4-20; Das A, 2002, PHARMACOL BIOCHEM BE, V73, P893, DOI 10.1016/S0091-3057(02)00940-1; DESESSO JM, 1994, TERATOLOGY, V49, P248, DOI 10.1002/tera.1420490404; Dey P, 2015, CYTOTECHNOLOGY, P1; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; Fontana M, 2001, BIOCHEM PHARMACOL, V61, P1253, DOI 10.1016/S0006-2952(01)00565-2; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Gimenez-Garzo C, 2015, ANTIOXID REDOX SIGN, V22, P871, DOI 10.1089/ars.2014.6240; Goyal AK, 2011, FUNCT PLANT BIOL, V38, P697, DOI 10.1071/FP11016; Haro-Vicente JF, 2006, FOOD CHEM, V98, P639, DOI 10.1016/j.foodchem.2005.06.040; Hou WC, 2005, J ETHNOPHARMACOL, V100, P216, DOI 10.1016/j.jep.2005.03.017; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Khare C.P., 2007, INDIAN MED PLANTS, V1, DOI [10.1007/978-0-387-70638-2_1383, DOI 10.1007/978-0-387-70638-2_1383, 10.1007/978-0-387-70638-2]; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Kirtikar KR, 1975, INDIA MED PLANTS, V2; Kizil G, 2008, PHARM BIOL, V46, P231, DOI 10.1080/13880200701739363; Kulma A, 2007, PLANT SCI, V172, P433, DOI 10.1016/j.plantsci.2006.10.013; Kumar D. S., 2010, International Journal of PharmTech Research, V2, P2063; KUNCHANDY E, 1990, INT J PHARM, V58, P237, DOI 10.1016/0378-5173(90)90201-E; Lakshmi T., 2011, International Journal of Phytomedicine, V3, P579; Li Xingcui, 2010, Zhongguo Zhong Yao Za Zhi, V35, P1425; Long LH, 1999, BIOCHEM BIOPH RES CO, V262, P605, DOI 10.1006/bbrc.1999.1263; Mathew M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086804; Mohan S. C., 2012, Journal of Chemical and Pharmaceutical Research, V4, P197; Mukherjee PK, 2007, PHYTOTHER RES, V21, P1142, DOI 10.1002/ptr.2224; Mustafa RA, 2010, J FOOD SCI, V75, pC28, DOI 10.1111/j.1750-3841.2009.01401.x; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Pereira DM, 2010, PHYTOMEDICINE, V17, P646, DOI 10.1016/j.phymed.2009.10.008; Peterhans E, 1997, J NUTR, V127, pS962, DOI 10.1093/jn/127.5.962S; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Ramakrishna H., 2012, ASIAN J PLANT SCI RE, V2, P30; Rathee JS, 2006, J AGR FOOD CHEM, V54, P9046, DOI 10.1021/jf061679e; Shyur L.-F., 2005, INT J APPL SCI ENG, V3, P195; Silverstein RM, 2005, PROTON NMR SPECTROME, P127; Singh R. P., 2004, J IND ACAD CLIN MED, V5, P218; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Sullivan RJ, 2000, BRIT J PSYCHIAT, V177, P174, DOI 10.1192/bjp.177.2.174; Sun J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032021; Tripathi AK, 2006, PHYTOCHEM ANALYSIS, V17, P394, DOI 10.1002/pca.936; Trivedi J K, 2006, Indian J Psychiatry, V48, P10, DOI 10.4103/0019-5545.31613; Valcic S, 2000, CHEM RES TOXICOL, V13, P801, DOI 10.1021/tx000080k; Vellosa J. C. R., 2011, Ecletica Quimica, V36, P7, DOI 10.1590/S0100-46702011000200001; Yen GC, 2002, FOOD CHEM, V79, P307, DOI 10.1016/S0308-8146(02)00145-0; Zhao CY, 2005, BBA-GEN SUBJECTS, V1723, P114, DOI 10.1016/j.bbagen.2005.02.004; Zia-Ul-Haq M, 2014, MOLECULES, V19, P10998, DOI 10.3390/molecules190810998; Zia-Ul-Haq M, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-23	65	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150574	10.1371/journal.pone.0150574	http://dx.doi.org/10.1371/journal.pone.0150574			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26949964	Green Submitted, Green Published, gold			2022-12-27	WOS:000371990100042
J	Valencia, A; Wang, HC; Soto, A; Aristizabal, M; Arboleda, JW; Eyun, SI; Noriega, DD; Siegfried, B				Valencia, Arnubio; Wang, Haichuan; Soto, Alberto; Aristizabal, Manuel; Arboleda, Jorge W.; Eyun, Seong-Il; Noriega, Daniel D.; Siegfried, Blair			Pyrosequencing the Midgut Transcriptome of the Banana Weevil Cosmopolites sordidus (Germar) (Coleoptera: Curculionidae) Reveals Multiple Protease-Like Transcripts	PLOS ONE			English	Article							BROWN PLANTHOPPER; LARVAL MIDGUT; ENZYMES; GENOME; BEETLE; GENE; RESISTANCE; EXPRESSION; EVOLUTION; RESPONSES	The banana weevil Cosmopolites sordidus is an important and serious insect pest in most banana and plantain-growing areas of the world. In spite of the economic importance of this insect pest very little genomic and transcriptomic information exists for this species. In the present study, we characterized the midgut transcriptome of C. sordidus using massive 454-pyrosequencing. We generated over 590,000 sequencing reads that assembled into 30,840 contigs with more than 400 bp, representing a significant expansion of existing sequences available for this insect pest. Among them, 16,427 contigs contained one or more GO terms. In addition, 15,263 contigs were assigned an EC number. In-depth transcriptome analysis identified genes potentially involved in insecticide resistance, peritrophic membrane biosynthesis, immunity-related function and defense against pathogens, and Bacillus thuringiensis toxins binding proteins as well as multiple enzymes involved with protein digestion. This transcriptome will provide a valuable resource for understanding larval physiology and for identifying novel target sites and management approaches for this important insect pest.	[Valencia, Arnubio; Soto, Alberto; Aristizabal, Manuel] Univ Caldas, Dept Prod Agr, Manizales, Colombia; [Wang, Haichuan] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA; [Arboleda, Jorge W.] Univ Atlantico, Barranquilla, Colombia; [Eyun, Seong-Il] Univ Nebraska, Ctr Biotechnol, Lincoln, NE 68588 USA; [Noriega, Daniel D.] Univ Caldas, Programa Biol, Manizales, Colombia; [Siegfried, Blair] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	Universidad de Caldas; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Universidad de Caldas; State University System of Florida; University of Florida	Valencia, A (corresponding author), Univ Caldas, Dept Prod Agr, Manizales, Colombia.	arnubio.valencia@ucaldas.edu.co	Grossi-de-Sa, Maria Fatima/N-7856-2017; Eyun, Seong-il/Q-8872-2019	Eyun, Seong-il/0000-0003-4687-1066; Valencia-Jimenez, Arnubio/0000-0003-3328-2932	Universidad de Caldas (Manizales, Colombia) [1659114]; National Bank for Reconstruction and Development (BIRF) [FP44842-242-2015]; Entomology Department at the University of Nebraska (Lincoln, USA)	Universidad de Caldas (Manizales, Colombia); National Bank for Reconstruction and Development (BIRF); Entomology Department at the University of Nebraska (Lincoln, USA)	Funding came from the Universidad de Caldas (Manizales, Colombia) grant # 1659114 and from the National Bank for Reconstruction and Development (BIRF) (Contract No. FP44842-242-2015) administered by Colombian National Fund for Science, Technology and Innovation, Francisco Jose de Caldas-COLCIENCIAS.; The authors thank the Universidad de Caldas (Manizales, Colombia) and the Entomology Department at the University of Nebraska (Lincoln, USA) for support of this research. Authors also thank the Colombian National Fund for Science, Technology and Innovation, Francisco Jose de Caldas-COLCIENCIAS (Colombia).	Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; COLLINS PJ, 1991, CROP PROT, V10, P215, DOI 10.1016/0261-2194(91)90046-T; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Eyun SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094052; Forgain R, 2002, STUDIES BANANA BORER; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gill M, 2002, INSECT MOL BIOL, V11, P619, DOI 10.1046/j.1365-2583.2002.00373.x; Gold C.S., 2000, BANANA WEEVIL COSMOP; Gold Clifford S., 2002, Integrated Pest Management Reviews, V6, P79, DOI 10.1023/A:1023330900707; Gold CS, 1999, RECENT ADV BANANA WE; Gold CS, 1991, FARMER PERCEPTIONS B; Hlavica P, 2011, J INORG BIOCHEM, V105, P1354, DOI 10.1016/j.jinorgbio.2011.05.003; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Jaworski DC, 2010, INSECT MOL BIOL, V19, P617, DOI 10.1111/j.1365-2583.2010.01037.x; Joanitti G.A., 2006, CURR ENZYM INHIB, V2, P199, DOI [10.2174/157340806777934801, DOI 10.2174/157340806777934801]; Johnson KS, 2000, COMP COMP BIOCH PH A, P10; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kiggundu A, 2003, EUPHYTICA, V133, P267, DOI 10.1023/A:1025725124849; Kiggundu A., 2000, HOST PLANT INTERACTI; Lopes RB, 2011, B INSECTOL, V64, P201; MASOUD SA, 1993, PLANT MOL BIOL, V21, P655, DOI 10.1007/BF00014548; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; MURDOCK LL, 1987, COMP BIOCHEM PHYS B, V87, P783, DOI 10.1016/0305-0491(87)90388-9; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Onwueme IC, 1991, TECHNICAL CTR AGR RU; Pantoja A, 2006, ANN ENTOMOL SOC AM, V99, P875, DOI 10.1603/0013-8746(2006)99[875:ROIAAT]2.0.CO;2; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Peng X, 2011, INSECT MOL BIOL, V20, P745, DOI 10.1111/j.1365-2583.2011.01104.x; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Reddy GVP, 2009, J CHEM ECOL, V35, P111, DOI 10.1007/s10886-008-9580-6; Reeck GR, 1997, PROTEINASE INHIBITOR, P157; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sengooba T., SURVEY BANANA PEST P; Seshu-Reddy KV, 1993, BREEDING BANANA PLAN, P143; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; THIE NMR, 1990, INSECT BIOCHEM, V20, P313, DOI 10.1016/0020-1790(90)90049-Z; Tinzaara W, 2005, J APPL ENTOMOL, V129, P265, DOI 10.1111/j.1439-0418.2005.00962.x; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Waterhouse D. F., 1987, Biological control: Pacific prospects.; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Xie W, 2012, INT J BIOL SCI, V8, P1142, DOI 10.7150/ijbs.4588; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zou Z, 2008, INSECT BIOCHEM MOLEC, V38, P677, DOI 10.1016/j.ibmb.2008.03.009	50	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0151001	10.1371/journal.pone.0151001	http://dx.doi.org/10.1371/journal.pone.0151001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26949943	Green Published, gold			2022-12-27	WOS:000371990100078
J	Xia, T; Li, YJ; Sun, DL; Zhuo, T; Fan, XJ; Zou, HS				Xia, Tian; Li, Yanjiao; Sun, Dongling; Zhuo, Tao; Fan, Xiaojing; Zou, Huasong			Identification of an Extracellular Endoglucanase That Is Required for Full Virulence in Xanthomonas citri subsp citri	PLOS ONE			English	Article							AXONOPODIS PV. CITRI; OUTER-MEMBRANE PROTEIN; ERWINIA-CAROTOVORA; SECRETION SYSTEM; II SECRETION; RSMB RNA; ENZYMES; GENE; PATHOGENICITY; CHRYSANTHEMI	Xanthomonas citri subsp. citri causes citrus canker disease, which is characterized by the formation of water-soaked lesions, white or yellow spongy pustules and brown corky canker. In this work, we report the contribution of extracellular endoglucanase to canker development during infection. The ectopic expression of nine putative cellulases in Escherichia coli indicated that two endoglucanases, BglC3 and EngXCA, show carboxymethyl cellulase activity. Both bglC3 and engXCA genes were transcribed in X. citri subsp. citri, however, only BglC3 protein was detected outside the cell in western blot analysis. The deletion of bglC3 gene resulted in complete loss of extracellular carboxymethyl cellulase activity and delayed the onset of canker symptoms in both infiltration- and wound-inoculation assays. When growing in plant tissue, the cell density of bglC3 mutant was lower than that of the wild type. Our data demonstrated that BglC3 is an extracellular endoglucanase required for the full virulence of X. citri subsp. citri.	[Xia, Tian; Li, Yanjiao; Sun, Dongling; Zhuo, Tao; Fan, Xiaojing; Zou, Huasong] Fujian Agr & Forestry Univ, Coll Plant Protect, Fujian Prov Key Lab Plant Virol, Fuzhou 350002, Peoples R China	Fujian Agriculture & Forestry University	Zou, HS (corresponding author), Fujian Agr & Forestry Univ, Coll Plant Protect, Fujian Prov Key Lab Plant Virol, Fuzhou 350002, Peoples R China.	hszou@fafu.edu.cn	Zou, Huasong/GLN-3569-2022	Zou, Huasong/0000-0001-5758-1975	National Natural Science Foundation of China [31171832]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31171832) to HZ. The funder had no role in the study design, data analysis, decision to publish, or preparation of the manuscript.	Baptista JC, 2010, GENET MOL BIOL, V33, P146, DOI 10.1590/S1415-47572009005000110; BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201, DOI 10.1146/annurev.py.32.090194.001221; BATEMAN DF, 1966, ANNU REV PHYTOPATHOL, V14, P119; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; COLLMER A, 1986, ANNU REV PHYTOPATHOL, V24, P383, DOI 10.1146/annurev.py.24.090186.002123; Cui Y, 2001, MOL PLANT MICROBE IN, V14, P516, DOI 10.1094/MPMI.2001.14.4.516; Dunger G, 2005, PLANT PATHOL, V54, P781, DOI 10.1111/j.1365-3059.2005.01284.x; Dunger G, 2012, MOL PLANT PATHOL, V13, P865, DOI 10.1111/j.1364-3703.2012.00797.x; Guo J, 2015, J INTEGR AGR, V14, P1338, DOI 10.1016/S2095-3119(14)60965-5; Hu J, 2007, FEMS MICROBIOL LETT, V269, P273, DOI 10.1111/j.1574-6968.2007.00638.x; Hu NT, 1998, MICROBIOL-SGM, V144, P1479, DOI 10.1099/00221287-144-6-1479; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Li JY, 2011, MOL PLANT PATHOL, V12, P381, DOI 10.1111/j.1364-3703.2010.00681.x; MAE A, 1995, MOL GEN GENET, V247, P17, DOI 10.1007/BF00425817; Matsumoto H, 2003, MOL PLANT MICROBE IN, V16, P226, DOI 10.1094/MPMI.2003.16.3.226; Mukherjee A, 2000, ENVIRON MICROBIOL, V2, P203, DOI 10.1046/j.1462-2920.2000.00093.x; PEROMBELON MCM, 1980, ANNU REV PHYTOPATHOL, V18, P361, DOI 10.1146/annurev.py.18.090180.002045; PY B, 1991, FEMS MICROBIOL LETT, V79, P315, DOI [10.1016/0378-1097(91)90105-J, 10.1111/j.1574-6968.1991.tb04548.x]; ROBERTS DP, 1988, J BACTERIOL, V170, P1445, DOI 10.1128/jb.170.4.1445-1451.1988; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Schroter K, 2001, APPL MICROBIOL BIOT, V55, P727, DOI 10.1007/s002530100654; Sgro GG, 2012, MOL PLANT PATHOL, V13, P1047, DOI 10.1111/j.1364-3703.2012.00814.x; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Song X, 2015, J MICROBIOL, V53, P330, DOI 10.1007/s12275-015-4589-3; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Thowthampitak J, 2008, PHYTOPATHOLOGY, V98, P1252, DOI 10.1094/PHYTO-98-12-1252; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Xue XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093205; Yan Q, 2012, MOL PLANT MICROBE IN, V25, P69, DOI 10.1094/MPMI-05-11-0121; Zou HS, 2012, MICROBIOL-SGM, V158, P2372, DOI 10.1099/mic.0.059964-0	32	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0151017	10.1371/journal.pone.0151017	http://dx.doi.org/10.1371/journal.pone.0151017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950296	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100081
J	Burmistrova, DA; Tillib, SV; Shcheblyakov, DV; Dolzhikova, IV; Shcherbinin, DN; Zubkova, OV; Ivanova, TI; Tukhvatulin, AI; Shmarov, MM; Logunov, DY; Naroditsky, BS; Gintsburg, AL				Burmistrova, Daria A.; Tillib, Sergey V.; Shcheblyakov, Dmitry V.; Dolzhikova, Inna V.; Shcherbinin, Dmitry N.; Zubkova, Olga V.; Ivanova, Tatiana I.; Tukhvatulin, Amir I.; Shmarov, Maxim M.; Logunov, Denis Y.; Naroditsky, Boris S.; Gintsburg, Aleksandr L.			Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis	PLOS ONE			English	Article							SINGLE-DOMAIN ANTIBODIES; PROSTATE-CANCER; CHLAMYDIA-TRACHOMATIS; RECEPTOR FCRN; IMMUNITY; TRACT; IGG; THERAPEUTICS; UREAPLASMA; DISEASES	Developing pathogen-specific recombinant antibody fragments (especially nanobodies) is a very promising strategy for the treatment of infectious disease. Nanobodies have great potential for gene therapy application due to their single-gene nature. Historically, Mycoplasma hominis has not been considered pathogenic bacteria due to the lack of acute infection and partially due to multiple studies demonstrating high frequency of isolation of M. hominis samples from asymptomatic patients. However, recent studies on the role of latent M. hominis infection in oncologic transformation, especially prostate cancer, and reports that M. hominis infects Trichomonas and confers antibiotic resistance to Trichomonas, have generated new interest in this field. In the present study we have generated specific nanobody against M. hominis (aMh), for which the identified target is the ABC-transporter substrate-binding protein. aMh exhibits specific antibacterial action against M. hominis. In an attempt to improve the therapeutic properties, we have developed the adenoviral vector-based gene therapy approach for passive immunization with nanobodies against M. hominis. For better penetration into the mucous layer of the genital tract, we fused aMh with the Fc-fragment of IgG. Application of this comprehensive approach with a single systemic administration of recombinant adenovirus expressing aMh-Fc demonstrated both prophylactic and therapeutic effects in a mouse model of genital M. hominis infection.	[Burmistrova, Daria A.; Shcheblyakov, Dmitry V.; Naroditsky, Boris S.] Gamaleya Res Ctr Epidemiol & Microbiol, Dept Immunobiotechnol, Moscow, Russia; [Tillib, Sergey V.; Ivanova, Tatiana I.] Inst Gene Biol, Dept Mol Biotechnol, Moscow, Russia; [Dolzhikova, Inna V.; Tukhvatulin, Amir I.; Logunov, Denis Y.] Gamaleya Res Ctr Epidemiol & Microbiol, Dept Cellular Microbiol, Moscow, Russia; [Shcherbinin, Dmitry N.; Zubkova, Olga V.; Shmarov, Maxim M.] Gamaleya Res Ctr Epidemiol & Microbiol, Dept Mol Biotechnol, Moscow, Russia; [Gintsburg, Aleksandr L.] Gamaleya Res Ctr Epidemiol & Microbiol, Moscow, Russia	Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS	Burmistrova, DA; Shcheblyakov, DV (corresponding author), Gamaleya Res Ctr Epidemiol & Microbiol, Dept Immunobiotechnol, Moscow, Russia.	darya_burmistrova@yahoo.com; sdmitryv@yahoo.com	Ivanova, Tatiana Ilinichna/B-9020-2011; Shmarov, Maxim M/D-8662-2014; Dolzhikova, Inna/E-8295-2014; Tillib, Sergei/I-4115-2013; Tukhvatulin, Amir/E-8183-2014; Zubkova, Olga/E-4168-2014; Tillib, Sergei/AAT-2293-2020; Logunov, Denis/E-8300-2014	Ivanova, Tatiana Ilinichna/0000-0002-4283-464X; Dolzhikova, Inna/0000-0003-2548-6142; Tillib, Sergei/0000-0002-7172-8731; Tukhvatulin, Amir/0000-0001-8506-2339; Zubkova, Olga/0000-0001-7893-8419; Tillib, Sergei/0000-0002-7172-8731; Gintsburg, Alexander/0000-0003-1769-5059; Egorova, Daria/0000-0003-3562-9880; Shmarov, Maxim/0000-0002-5268-1296; Dmitrii, Shcherbinin/0000-0002-8518-1669; Logunov, Denis/0000-0003-4035-6581; Naroditsky, Boris/0000-0001-5522-8238	Russian Science Foundation [15-14-00081]; Ministry of Education and Science of Russia [Mkappa-4765.2015.7, MK-3077.2014.7, MK-4765.2015.7]	Russian Science Foundation(Russian Science Foundation (RSF)); Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation)	This study was supported in part by a grant from Russian Science Foundation (No 15-14-00081 to S.V.T.) and in part by grants from Ministry of Education and Science of Russia (No M kappa-4765.2015.7 to D.V.S. and No MK-3077.2014.7 to A.I.T.).; The authors thank I.V. Rakovskaya (Gamaleya Research Center of Epidemiology and Microbiology, Russian Ministry of Health, Moscow, Russia) and V.N. Lazarev (Institute of Physicochemical Medicine, Russian Ministry of Health, Moscow, Russia) for their support and contributions. This study was supported in part by a grant from Russian Science Foundation (No 15-14-00081 to S.V.T.) and in part by grants from Ministry of Education and Science of Russia (No MK-4765.2015.7 to D.V.S. and No MK-3077.2014.7 to A.I.T.).	Ahuja S, 2015, STRUCTURE, V23, P713, DOI 10.1016/j.str.2015.01.020; Bakema JE, 2015, J IMMUNOL, V194, P1856, DOI 10.4049/jimmunol.1303126; Barykova YA, 2011, ONCOTARGET, V2, P289; Caini S, 2014, CANCER EPIDEMIOL, V38, P329, DOI 10.1016/j.canep.2014.06.002; Camara B, 2007, EXP CLIN TRANSPLANT, V5, P708; Casadevall A, 2012, NAT IMMUNOL, V13, P21, DOI 10.1038/ni.2184; Challa DK, 2014, CURR TOP MICROBIOL, V382, P249, DOI 10.1007/978-3-319-07911-0_12; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Crasson Rhazi, 2015, ENZYMATIC FUNCTIONAL; De Meyer T, 2014, TRENDS BIOTECHNOL, V32, P263, DOI 10.1016/j.tibtech.2014.03.001; Degrange S, 2008, ANTIMICROB AGENTS CH, V52, P742, DOI 10.1128/AAC.00960-07; Flouzat-Lachaniette CH, 2013, EUR SPINE J, V22, pS394, DOI 10.1007/s00586-012-2511-9; Garcia C, 2007, INTENS CARE MED, V33, P143, DOI 10.1007/s00134-006-0435-8; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Hoefman S, 2015, ANTIBODIES, V4, P141, DOI 10.3390/antib4030141; Hofherr SE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017076, 10.1371/journal.pone.0023376]; Kahraman S, 2010, MOL IMAGING BIOL, V12, P278, DOI 10.1007/s11307-009-0260-x; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kennedy KJ, 2009, J CLIN MICROBIOL, V47, P3050, DOI 10.1128/JCM.02203-08; Kijanka M, 2015, NANOMEDICINE-UK, V10, P161, DOI 10.2217/nnm.14.178; Krijnen Matthijs R, 2006, Eur Spine J, V15 Suppl 5, P599; Kuo TT, 2011, MABS-AUSTIN, V3, P422, DOI 10.4161/mabs.3.5.16983; Kuo TT, 2010, J CLIN IMMUNOL, V30, P777, DOI 10.1007/s10875-010-9468-4; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Luz DE, 2012, MOL ORAL MICROBIOL, V27, P172, DOI 10.1111/j.2041-1014.2012.00641.x; Majhen D, 2014, HUM GENE THER, V25, P301, DOI 10.1089/hum.2013.235; Meng DY, 2014, BRAZ J MICROBIOL, V45, P239, DOI 10.1590/S1517-83822014000100034; Miranda C, 2005, EUR J CLIN MICROBIOL, V24, P334, DOI 10.1007/s10096-005-1326-6; Moldoveanu Z, 2005, J IMMUNOL, V175, P4127, DOI 10.4049/jimmunol.175.6.4127; Mukherjee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106422; Murtha AP, 2014, OBSTET GYN CLIN N AM, V41, P615, DOI 10.1016/j.ogc.2014.08.010; Naz RK, 2012, J REPROD IMMUNOL, V93, P1, DOI 10.1016/j.jri.2011.09.005; Obishakin E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115893; Oleksiewicz MB, 2012, ARCH BIOCHEM BIOPHYS, V526, P124, DOI 10.1016/j.abb.2012.06.001; Olsen AW, 2015, J INFECT DIS, V212, P978, DOI 10.1093/infdis/jiv137; Ouzounova-Raykova V, 2015, APMIS, V123, P586, DOI 10.1111/apm.12391; Pain C, 2015, BIOCHIMIE, V111, P82, DOI 10.1016/j.biochi.2015.01.012; Parvege MM, 2014, DRUG TARGET INSIGHT, V8, P51, DOI 10.4137/DTI.S19728; Rechnitzer H, 2011, MICROBIOL-SGM, V157, P760, DOI 10.1099/mic.0.043208-0; Saerens D, 2004, J BIOL CHEM, V279, P51965, DOI 10.1074/jbc.M409292200; Sfanos KS, 2011, ONCOTARGET, V2, P281; Sheoran AS, 2015, INFECT IMMUN, V83, P286, DOI 10.1128/IAI.02360-14; Shkarupeta MM, 2004, B EXP BIOL MED+, V137, P53, DOI 10.1023/B:BEBM.0000024386.33789.0f; Siontorou CG, 2013, INT J NANOMED, V8, P4215, DOI 10.2147/IJN.S39428; Sobouti B, 2014, IRAN J MICROBIOL, V6, P219; Tillib SV, 2014, J CHROMATOGR B, V949, P48, DOI 10.1016/j.jchromb.2013.12.034; Tillib SV, 2011, MOL BIOL+, V45, P66, DOI 10.1134/S0026893311010134; Tillib SV, 2013, ANTIVIR RES, V97, P245, DOI 10.1016/j.antiviral.2012.12.014; Tutykhina IL, 2013, ANTIVIR RES, V97, P318, DOI 10.1016/j.antiviral.2012.12.021; Vincke C, 2012, METHOD MOL BIOL, P15; Wang Y, 2014, J DRUG TARGET, V22, P269, DOI 10.3109/1061186X.2013.875030; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Wium M, 2015, GENE, V558, P31, DOI 10.1016/j.gene.2014.12.036	53	10	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150958	10.1371/journal.pone.0150958	http://dx.doi.org/10.1371/journal.pone.0150958			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26962869	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000086
J	Manzano-Szalai, K; Pali-Scholl, I; Krishnamurthy, D; Stremnitzer, C; Flaschberger, I; Jensen-Jarolim, E				Manzano-Szalai, Krisztina; Pali-Schoell, Isabella; Krishnamurthy, Durga; Stremnitzer, Caroline; Flaschberger, Ingo; Jensen-Jarolim, Erika			Anaphylaxis Imaging: Non-Invasive Measurement of Surface Body Temperature and Physical Activity in Small Animals	PLOS ONE			English	Article							FOOD ALLERGY; BALB/C MICE; MOUSE MODEL; MAST-CELLS; SENSITIZATION; PREVALENCE; SEVERITY; PROTEINS; IGE	In highly sensitized patients, the encounter with a specific allergen from food, insect stings or medications may rapidly induce systemic anaphylaxis with potentially lethal symptoms. Countless animal models of anaphylaxis, most often in BALB/c mice, were established to understand the pathophysiology and to prove the safety of different treatments. The most common symptoms during anaphylactic shock are drop of body temperature and reduced physical activity. To refine, improve and objectify the currently applied manual monitoring methods, we developed an imaging method for the automated, non-invasive measurement of the whole-body surface temperature and, at the same time, of the horizontal and vertical movement activity of small animals. We tested the anaphylaxis imaging in three in vivo allergy mouse models for i) milk allergy, ii) peanut allergy and iii) egg allergy. These proof-of-principle experiments suggest that the imaging technology represents a reliable non-invasive method for the objective monitoring of small animals during anaphylaxis over time. We propose that the method will be useful for monitoring diseases associated with both, changes in body temperature and in physical behaviour.	[Manzano-Szalai, Krisztina; Pali-Schoell, Isabella; Jensen-Jarolim, Erika] Univ Vet Med Vienna, Messerli Res Inst, Comparat Med, Vienna, Austria; [Manzano-Szalai, Krisztina; Pali-Schoell, Isabella; Jensen-Jarolim, Erika] Med Univ Vienna, Vienna, Austria; [Manzano-Szalai, Krisztina; Pali-Schoell, Isabella; Jensen-Jarolim, Erika] Univ Vienna, Vienna, Austria; [Manzano-Szalai, Krisztina; Pali-Schoell, Isabella; Krishnamurthy, Durga; Stremnitzer, Caroline; Jensen-Jarolim, Erika] Med Univ Vienna, Inst Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Flaschberger, Ingo] Crossip Commun GmbH, Vienna, Austria	University of Veterinary Medicine Vienna; Medical University of Vienna; University of Vienna; Medical University of Vienna	Jensen-Jarolim, E (corresponding author), Univ Vet Med Vienna, Messerli Res Inst, Comparat Med, Vienna, Austria.; Jensen-Jarolim, E (corresponding author), Med Univ Vienna, Vienna, Austria.; Jensen-Jarolim, E (corresponding author), Univ Vienna, Vienna, Austria.	erika.jensen-jarolim@meduniwien.ac.at	Jensen-Jarolim, Erika/C-5120-2018	Jensen-Jarolim, Erika/0000-0003-4019-5765	Biomedical International R+D GmbH, Vienna, Austria; Austrian Science Fund [Sonderforschungsbereich SFB-Special Research Area F4606-B19, SFB F4606-B28, W1205-B09]; Austrian Research Agency FFG (project Nano Health) [819721]	Biomedical International R+D GmbH, Vienna, Austria; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Research Agency FFG (project Nano Health)	The study was financed by Biomedical International R+D GmbH, Vienna, Austria, and in part supported by the Austrian Science Fund (grants Sonderforschungsbereich SFB-Special Research Area F4606-B19, SFB F4606-B28 and W1205-B09 to EJJ), and by the Austrian Research Agency FFG (project Nano Health 819721 to IPS). The design of imaging cage prototypes was done in collaboration with the Austrian Institute of Technology (AIT), and with promotion by the Austrian Research Promotion Agency FFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. IF was employed by Crossip Communications during the course of the study. Crossip Communications provided support in the form of salary for author IF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Brown SGA, 2004, J ALLERGY CLIN IMMUN, V114, P371, DOI 10.1016/j.jaci.2004.04.029; Brown SGA, 2013, J ALLERGY CLIN IMMUN, V132, P1141, DOI 10.1016/j.jaci.2013.06.015; Diesner SC, 2008, IMMUNOL LETT, V121, P45, DOI 10.1016/j.imlet.2008.08.006; Diesner SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126279; Diesner SC, 2012, IMMUNOL LETT, V141, P210, DOI 10.1016/j.imlet.2011.10.006; Finkelman FD, 2010, CURR OPIN IMMUNOL, V22, P783, DOI 10.1016/j.coi.2010.10.005; Greenberger Paul A, 2012, Allergy Asthma Proc, V33 Suppl 1, P80, DOI 10.2500/aap.2012.33.3557; Jensen-Jarolim E, 2013, patent, Patent No. [US 14/204,570, 14204570]; Jensen-Jarolim E, 2013, patent, Patent No. [EP13158620.8, 131586208]; Krishnamurthy D, 2012, CLIN EXP ALLERGY, V42, P1119, DOI 10.1111/j.1365-2222.2012.04012.x; Kulikov AV, 2010, ILAR J, V51, pE11, DOI 10.1093/ilar.51.2.E11; Li XM, 1999, J ALLERGY CLIN IMMUN, V103, P206, DOI 10.1016/S0091-6749(99)70492-6; Ma L, 2014, J ALLERGY CLIN IMMUN, V133, P1075, DOI 10.1016/j.jaci.2013.10.029; Maaswinkel H, 2013, JOVE-J VIS EXP, DOI 10.3791/50681; Manzano-Szalai K, 2014, VIRAL IMMUNOL, V27, P438, DOI 10.1089/vim.2014.0059; Nwaru BI, 2014, ALLERGY, V69, P992, DOI 10.1111/all.12423; Ogawa Y, 2007, IMMUNOL ALLERGY CLIN, V27, P249, DOI 10.1016/j.iac.2007.03.013; Oka T, 2013, J ALLERGY CLIN IMMUN, V132, P922, DOI 10.1016/j.jaci.2013.05.004; Pali-Scholl I, 2013, EUR J PHARM BIOPHARM, V85, P656, DOI 10.1016/j.ejpb.2013.03.003; Reber LL, 2013, J ALLERGY CLIN IMMUN, V132, P881, DOI 10.1016/j.jaci.2013.06.008; Roth-Walter F, 2008, ALLERGY, V63, P882, DOI 10.1111/j.1398-9995.2008.01673.x; Scholl I, 2007, FASEB J, V21, P1264, DOI 10.1096/fj.06-7223com; Scholl L, 2005, AM J CLIN NUTR, V81, P154; Sheikh A, 2008, J ROY SOC MED, V101, P139, DOI 10.1258/jrsm.2008.070306; Simons FER, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0080-1; Simons FER, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f602; Starkl P, 2012, CLIN EXP ALLERGY, V42, P1801, DOI 10.1111/cea.12031; Torabi A, 2008, LECT NOTES COMPUT SC, V5358, P1081, DOI 10.1007/978-3-540-89639-5_103; Tornqvist E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101638; Untersmayr E, 2003, J ALLERGY CLIN IMMUN, V112, P616, DOI [10.1016/S0091-6749(03)01719-6, 10.1016/mai.2003.1681]	30	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150819	10.1371/journal.pone.0150819	http://dx.doi.org/10.1371/journal.pone.0150819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963393	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000067
J	Podder, PK; Paul, M; Murshed, M				Podder, Pallab Kanti; Paul, Manoranjan; Murshed, Manzur			Fast Mode Decision in the HEVC Video Coding Standard by Exploiting Region with Dominated Motion and Saliency Features	PLOS ONE			English	Article							CU SIZE DECISION; ALGORITHM; COMPLEXITY; ENCODERS; BLOCK	The emerging High Efficiency Video Coding (HEVC) standard introduces a number of innovative and powerful coding tools to acquire better compression efficiency compared to its predecessor H.264. The encoding time complexities have also increased multiple times that is not suitable for realtime video coding applications. To address this limitation, this paper employs a novel coding strategy to reduce the time complexity in HEVC encoder by efficient selection of appropriate block-partitioning modes based on human visual features (HVF). The HVF in the proposed technique comprise with human visual attention modelling- based saliency feature and phase correlation-based motion features. The features are innovatively combined through a fusion process by developing a content-based adaptive weighted cost function to determine the region with dominated motion/saliency (RDMS)based binary pattern for the current block. The generated binary pattern is then compared with a codebook of predefined binary pattern templates aligned to the HEVC recommended block-paritioning to estimate a subset of inter-prediction modes. Without exhaustive exploration of all modes available in the HEVC standard, only the selected subset of modes are motion estimated and motion compensated for a particular coding unit. The experimental evaluation reveals that the proposed technique notably down-scales the average computational time of the latest HEVC reference encoder by 34% while providing similar rate-distortion (RD) performance for a wide range of video sequences.	[Podder, Pallab Kanti; Paul, Manoranjan] Charles Sturt Univ, Sch Comp & Math, Bathurst, NSW 2795, Australia; [Murshed, Manzur] Federat Univ, Sch Informat Technol, Churchill, Vic, Australia	Charles Sturt University; Federation University Australia	Podder, PK (corresponding author), Charles Sturt Univ, Sch Comp & Math, Bathurst, NSW 2795, Australia.	ppodder@csu.edu.au	Paul, Manoranjan/AAD-4047-2021	Paul, Manoranjan/0000-0001-6870-5056; Murshed, Manzur/0000-0001-7079-9717	Australian Research Council [DP130103670]	Australian Research Council(Australian Research Council)	This work was supported in part by the Australian Research Council under Discovery Projects Grant DP130103670.	Ahn S, 2015, IEEE T CIRC SYST VID, V25, P422, DOI 10.1109/TCSVT.2014.2360031; Assembly IR, 2003, METH SUBJ ASS QUAL T; Bjontegaard G., 2001, VCEG M33 CALCULATION; Bossen F, 2012, IEEE T CIRC SYST VID, V22, P1685, DOI 10.1109/TCSVT.2012.2221255; Bross B., 2012, ITUTSG16 WP3; Cassa MB, 2012, 2012 PICTURE CODING SYMPOSIUM (PCS), P493, DOI 10.1109/PCS.2012.6213262; Correa G, 2011, IEEE T CONSUM ELECTR, V57, P1866, DOI 10.1109/TCE.2011.6131165; Harel J., 2006, GRAPH BASED VISUAL S, P545; Hou X, 2014, FAST CODING UNIT PAR, P7; Jie Leng, 2011, 2011 International Conference on Multimedia and Signal Processing (CMSP), P56, DOI 10.1109/CMSP.2011.167; Lee A, 2013, EFFICIENT INTERPREDI, P502; Lee H, EALRY SKIP MODE DECI; Li ZC, 2011, IMAGE VISION COMPUT, V29, P1, DOI 10.1016/j.imavis.2010.07.001; Lim K, R FAST PU SKIP SPLIT; Liu Z, 2014, IEEE T CIRC SYST VID, V24, P1522, DOI 10.1109/TCSVT.2014.2308642; Liu Z, 2009, IEEE T CIRC SYST VID, V19, P128, DOI 10.1109/TCSVT.2008.2005804; Lu Y., 2013, REAL TIME CPU BASED; Pan ZQ, 2014, IEEE T BROADCAST, V60, P405, DOI 10.1109/TBC.2014.2321682; Paul M, 2011, IEEE T IMAGE PROCESS, V20, P461, DOI 10.1109/TIP.2010.2063436; Paul M, 2010, IEEE T IMAGE PROCESS, V19, P691, DOI 10.1109/TIP.2009.2033406; Paul M, 2009, IEEE T MULTIMEDIA, V11, P581, DOI 10.1109/TMM.2009.2017610; Shen LQ, 2015, SIGNAL PROCESS-IMAGE, V32, P121, DOI 10.1016/j.image.2015.01.008; Shen LQ, 2014, IEEE T CIRC SYST VID, V24, P1709, DOI 10.1109/TCSVT.2014.2313892; Shen LQ, 2014, IEEE T IMAGE PROCESS, V23, P4232, DOI 10.1109/TIP.2014.2341927; Shen LQ, 2013, IEEE T CONSUM ELECTR, V59, P207, DOI 10.1109/TCE.2013.6490261; Shen LQ, 2013, MULTIMED TOOLS APPL, V63, P709, DOI 10.1007/s11042-011-0893-z; Shen LQ, 2013, IEEE T MULTIMEDIA, V15, P465, DOI 10.1109/TMM.2012.2231060; Shi Y.Q., 1999, IMAGE VIDEO COMPRESS; Tan HL, 2012, INT CONF ACOUST SPEE, P825, DOI 10.1109/ICASSP.2012.6288011; Vanne J, 2014, IEEE T CIRC SYST VID, V24, P1579, DOI 10.1109/TCSVT.2014.2308453; Wiegand T, 2003, IEEE T CIRC SYST VID, V13, P560, DOI 10.1109/TCSVT.2003.815165; Zeng HQ, 2009, IEEE T CIRC SYST VID, V19, P491, DOI 10.1109/TCSVT.2009.2014014	32	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150673	10.1371/journal.pone.0150673	http://dx.doi.org/10.1371/journal.pone.0150673			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963813	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000049
J	Hungate, BA; Kearns, DN; Ogle, K; Caron, M; Marks, JC; Rogg, HW				Hungate, Bruce A.; Kearns, Diana N.; Ogle, Kiona; Caron, Melanie; Marks, Jane C.; Rogg, Helmuth W.			Hydrogen Isotopes as a Sentinel of Biological Invasion by the Japanese Beetle, Popillia japonica (Newman)	PLOS ONE			English	Article							STABLE-ISOTOPES; BAYESIAN-ANALYSIS; NORTH-AMERICA; NATAL ORIGINS; BODY-WATER; OXYGEN; MIGRATION; MODULARIZATION; FRACTIONATION; ESTABLISHMENT	Invasive species alter ecosystems, threaten native and endangered species, and have negative economic impacts. Knowing where invading individuals are from and when they arrive to a new site can guide management. Here, we evaluated how well the stable hydrogen isotope composition (delta H-2) records the recent origin and time since arrival of specimens of the invasive Japanese beetle (Popillia japonica Newman) captured near the Portland International Airport (Oregon, U.S.A.). The delta H-2 of Japanese beetle specimens collected from sites across the contiguous U.S.A. reflected the delta H-2 of local precipitation, a relationship similar to that documented for other organisms, and one confirming the utility of delta H-2 as a geographic fingerprint. Within weeks after experimental relocation to a new isotopic environment, the delta H-2 of beetles changed linearly with time, demonstrating the potential for delta H-2 to also mark the timing of arrival to a new location. We used a hierarchical Bayesian model to estimate the recent geographical origin and timing of arrival of each specimen based on its delta H-2 value. The geographic resolution was broad, with values consistent with multiple regions of origin in the eastern U.S.A., slightly favoring the southeastern U.S.A. as the more likely source. Beetles trapped from 2007-2010 had arrived 30 or more days prior to trapping, whereas the median time since arrival declined to 3-7 days for beetles trapped from 2012-2014. This reduction in the time between arrival and trapping at the Portland International Airport supports the efficacy of trapping and spraying to prevent establishment. More generally, our analysis shows how stable isotopes can serve as sentinels of biological invasions, verifying the efficacy of control measures, or, alternatively, indicating when those measures show signs of failure.	[Hungate, Bruce A.; Ogle, Kiona; Caron, Melanie; Marks, Jane C.] No Arizona Univ, Ctr Ecosyst Sci & Soc, Colorado Plateau Stable Isotope Lab, Flagstaff, AZ 86011 USA; [Hungate, Bruce A.; Ogle, Kiona; Caron, Melanie; Marks, Jane C.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Kearns, Diana N.; Rogg, Helmuth W.] Oregon Dept Agr, Plant Div, Salem, OR 97301 USA; [Ogle, Kiona] No Arizona Univ, Informat & Comp Program, Flagstaff, AZ 86011 USA	Northern Arizona University; Northern Arizona University; Northern Arizona University	Hungate, BA (corresponding author), No Arizona Univ, Ctr Ecosyst Sci & Soc, Colorado Plateau Stable Isotope Lab, Flagstaff, AZ 86011 USA.; Hungate, BA (corresponding author), No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA.	bruce.hungate@nau.edu			Oregon State Department of Agriculture; Northern Arizona University Technology Research Initiative Fund	Oregon State Department of Agriculture; Northern Arizona University Technology Research Initiative Fund	This research was supported by the Oregon State Department of Agriculture and the Northern Arizona University Technology Research Initiative Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aketarawong N, 2014, BMC GENETICS, V15; [Anonymous], 1963, JAPANESE BEETLE US H; Aranda C, 2006, MED VET ENTOMOL, V20, P150, DOI 10.1111/j.1365-2915.2006.00605.x; Baerwald EF, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00380.1; Barrow LM, 2008, PHYSIOL BIOCHEM ZOOL, V81, P688, DOI 10.1086/588172; Bethke JA, 2014, INSECT HOT TOPICS JA; Bodey T.W., 2011, Occasional Papers of the IUCN Species Survival Commission, V42, P148; Bowen GJ, 2014, METHODS ECOL EVOL, V5, P201, DOI 10.1111/2041-210X.12147; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Bowen GJ, 2015, ONLINE ISOTOPES PREC; Brattstrom O, 2010, ECOGRAPHY, V33, P720, DOI 10.1111/j.1600-0587.2009.05748.x; Bridge ES, 2014, ECOL INDIC, V45, P266, DOI 10.1016/j.ecolind.2014.04.027; Bullock S, 2013, QUARRANTINE NAME JAP; Byers JE, 2002, CONSERV BIOL, V16, P630, DOI 10.1046/j.1523-1739.2002.01057.x; CAREY JR, 1991, SCIENCE, V253, P1369, DOI 10.1126/science.1896848; Casella G., 2002, STAT INFERENCE, V2nd; Castrovillo P., 2014, JAPANESE BEETLE IDAH; Cooper M, 1998, US DOMESTIC NATL JAP; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Dalthorp D, 1999, ENVIRON ENTOMOL, V28, P255, DOI 10.1093/ee/28.2.255; DELLAPORTAS P, 1995, BIOMETRICS, V51, P1085, DOI 10.2307/2533007; Federal Aviation Administration, 2013, PASS BOARD ENPL ALL; Flockhart DTT, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1087; Forbes KJ, 2011, ECOL ENTOMOL, V36, P396, DOI 10.1111/j.1365-2311.2011.01268.x; Grocke DR, 2011, TOP GEOBIOL, V34, P105, DOI 10.1007/978-90-481-9684-5_5; Hamilton RM, 2007, ENVIRON ENTOMOL, V36, P287, DOI 10.1603/0046-225X(2007)36[287:DADOJB]2.0.CO;2; Hammons DL, 2009, P NATL ACAD SCI USA, V106, P3686, DOI 10.1073/pnas.0811097106; Hobson KA, 2004, CONDOR, V106, P732, DOI 10.1650/7631; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hobson KA, 2015, ECOL EVOL, V5, P799, DOI 10.1002/ece3.1383; Hobson KA, 2014, J FIELD ORNITHOL, V85, P237, DOI 10.1111/jofo.12065; Hobson KA, 2012, METHODS ECOL EVOL, V3, P766, DOI 10.1111/j.2041-210X.2012.00202.x; Hodgson E, 2010, JAPANESE BEETLE POPI; Holder PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092384; Liebhold Andrew M., 2006, American Entomologist, V52, P48; Liu F, 2009, BAYESIAN ANAL, V4, P119, DOI 10.1214/09-BA404; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Niziolek OK, 2013, INSECT SCI, V20, P513, DOI 10.1111/j.1744-7917.2012.01515.x; Ogle K, 2015, J GEOPHYS RES-BIOGEO, V120, P221, DOI 10.1002/2014JG002794; Ogle K, 2013, BAYESIAN ANAL, V8, P133, DOI 10.1214/13-BA806; Podlesak DW, 2008, GEOCHIM COSMOCHIM AC, V72, P19, DOI 10.1016/j.gca.2007.10.003; Podlesak DW, 2012, ISOT ENVIRON HEALT S, V48, P259, DOI 10.1080/10256016.2012.644283; Poland TM, 2006, J FOREST, V104, P118; Portland Co, 2016, PDX AV STAT; POTTER DA, 1991, ANNU REV ENTOMOL, V36, P383, DOI 10.1146/annurev.en.36.010191.002123; Potter DA, 2002, ANNU REV ENTOMOL, V47, P175, DOI 10.1146/annurev.ento.47.091201.145153; Raymond L, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00075.1; Ruiz G.M., 2003, INVASIVE SPECIES VEC, P457; Shanklin D, 2013, COMMON QUESTIONS JAP; Tiddens Paul Thomas, 2006, Arboriculture & Urban Forestry, V32, P108; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; USDA, 2010, JAP BEETL PROGR MAN, P124; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Virgilio M, 2010, MOL ECOL, V19, P2713, DOI 10.1111/j.1365-294X.2010.04662.x; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; YAKIR D, 1990, PLANT PHYSIOL, V93, P325, DOI 10.1104/pp.93.1.325	58	9	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149599	10.1371/journal.pone.0149599	http://dx.doi.org/10.1371/journal.pone.0149599			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959686	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300018
J	Lueza, B; Mauguen, A; Pignon, JP; Rivero-Arias, O; Bonastre, J				Lueza, Beranger; Mauguen, Audrey; Pignon, Jean-Pierre; Rivero-Arias, Oliver; Bonastre, Julia		MAR-LC Collaborative Grp	Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study	PLOS ONE			English	Article							LUNG-CANCER; CLINICAL-TRIALS; RADIOTHERAPY; OUTCOMES	Objective In economic evaluation, a commonly used outcome measure for the treatment effect is the between-arm difference in restricted mean survival time (rmstD). This study illustrates how different survival analysis methods can be used to estimate the rmstD for economic evaluation using individual patient data (IPD) meta-analysis. Our aim was to study if/how the choice of a method impacts on cost-effectiveness results. Methods We used IPD from the Meta-Analysis of Radiotherapy in Lung Cancer concerning 2,000 patients with locally advanced non-small cell lung cancer, included in ten trials. We considered methods either used in the field of meta-analysis or in economic evaluation but never applied to assess the rmstD for economic evaluation using IPD meta-analysis. Methods were classified into two approaches. With the first approach, the rmstD is estimated directly as the area between the two pooled survival curves. With the second approach, the rmstD is based on the aggregation of the rmstDs estimated in each trial. Results The average incremental cost-effectiveness ratio (ICER) and acceptability curves were sensitive to the method used to estimate the rmstD. The estimated rmstDs ranged from 1.7 month to 2.5 months, and mean ICERs ranged from (sic) 24,299 to (sic) 34,934 per life-year gained depending on the chosen method. At a ceiling ratio of (sic) 25,000 per life year-gained, the probability of the experimental treatment being cost-effective ranged from 31% to 68%. Conclusions This case study suggests that the method chosen to estimate the rmstD from IPD metaanalysis is likely to influence the results of cost-effectiveness analyses.	[Lueza, Beranger; Mauguen, Audrey; Pignon, Jean-Pierre; Bonastre, Julia] Inst Gustave Roussy, Serv Biostat & Epidemiol, Villejuif, France; [Lueza, Beranger; Pignon, Jean-Pierre; Bonastre, Julia] Univ Paris 11, Univ Paris Saclay, CESP, INSERM U1018, Villejuif, France; [Lueza, Beranger; Mauguen, Audrey; Pignon, Jean-Pierre] Inst Gustave Roussy, Ligue Natl Canc Meta Anal Plateform, Villejuif, France; [Rivero-Arias, Oliver] Univ Oxford, Natl Perinatal Epidemiol Unit, Nuffield Dept Populat Hlth, Oxford, England; [Rivero-Arias, Oliver] Red Invest Serv Salud Enfermedades Cron REDISSEC, Madrid, Spain	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; University of Oxford	Lueza, B (corresponding author), Inst Gustave Roussy, Serv Biostat & Epidemiol, Villejuif, France.; Lueza, B (corresponding author), Univ Paris 11, Univ Paris Saclay, CESP, INSERM U1018, Villejuif, France.; Lueza, B (corresponding author), Inst Gustave Roussy, Ligue Natl Canc Meta Anal Plateform, Villejuif, France.	beranger.lueza@gustaveroussy.fr		Baumann, Michael/0000-0002-9340-974X; Zajusz, Aleksander/0000-0002-2696-3150; Mauguen, Audrey/0000-0003-3236-6093; Rivero-Arias, Oliver/0000-0003-2233-6544; PIGNON, Jean-Pierre/0000-0003-2047-1582; Dahlberg, Suzanne/0000-0001-5139-831X; Lueza, Beranger/0000-0001-8399-4458; bonastre, julia/0000-0001-9884-0072	ITMO Cancer; IReSP (French Public Health Research Institute) as part of the French "Plan Cancer"; French "Programme Hospitalier de Recherche Clinique"; French "Ligue Nationale Contre le Cancer"	ITMO Cancer; IReSP (French Public Health Research Institute) as part of the French "Plan Cancer"; French "Programme Hospitalier de Recherche Clinique"; French "Ligue Nationale Contre le Cancer"(Ligue nationale contre le cancer)	This work was supported by ITMO Cancer and IReSP (French Public Health Research Institute) as part of the French "Plan Cancer 2009-2013", by the French "Programme Hospitalier de Recherche Clinique", and by the French "Ligue Nationale Contre le Cancer". The funding sources had no role in study design, data collection, data analysis, data interpretation, or manuscript writing.	Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Anell A, 2000, HEALTH POLICY, V51, P87, DOI 10.1016/S0168-8510(00)00058-0; Bower P, 2003, BMJ-BRIT MED J, V326, P1; Braud AC, 2003, PHARMACOECONOMICS, V21, P671, DOI 10.2165/00019053-200321090-00005; Buyse M, 2000, ONCOLOGY-NY, V14, P437; Connock M, 2011, PHARMACOECONOMICS, V29, P827, DOI 10.2165/11585940-000000000-00000; Debray TPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060650; DurandZaleski I, 1997, JNCI-J NATL CANCER I, V89, P790, DOI 10.1093/jnci/89.11.790; *EARL BREAST CANC, 1990, TREATM EARL BREAST C, V1; Earle CC, 2000, MED DECIS MAKING, V20, P104, DOI 10.1177/0272989X0002000113; Gong Q, 2012, PHARM STAT, V11, P135, DOI 10.1002/pst.514; Gray A., 2011, APPL METHODS COST EF; Guyot P, 2011, VALUE HEALTH, V14, P640, DOI 10.1016/j.jval.2011.01.008; Hawkins N, 2012, HEALTH ECON, V21, P742, DOI 10.1002/hec.1741; Jackson CH, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1269; Jansen JP, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-61; Lamb KE, 2015, PHARM STAT, V14, P409, DOI 10.1002/pst.1700; Latimer NR, 2013, MED DECIS MAKING, V33, P743, DOI 10.1177/0272989X12472398; Martin P, 2003, B CANCER, V90, P969; Mauguen A, 2012, J CLIN ONCOL, V30, P2788, DOI 10.1200/JCO.2012.41.6677; Messori A, 1999, PHARMACOECONOMICS, V16, P153, DOI 10.2165/00019053-199916020-00004; Orsi C, 2007, BONE MARROW TRANSPL, V40, P643, DOI 10.1038/sj.bmt.1705790; Pignon JP, 2001, LANCET ONCOL, V2, P475, DOI 10.1016/S1470-2045(01)00453-3; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Ramaekers BLT, 2013, J THORAC ONCOL, V8, P1295, DOI 10.1097/JTO.0b013e31829f6c55; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Royston P, 2011, STAT MED, V30, P2409, DOI 10.1002/sim.4274; Saint S, 1999, PHARMACOECONOMICS, V15, P1, DOI 10.2165/00019053-199915010-00001; Smith CT, 2007, CLIN TRIALS, V4, P621, DOI 10.1177/1740774507085276; Stewart GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046042; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Teljeur C, 2014, INT J TECHNOL ASSESS, V30, P44, DOI 10.1017/S0266462313000676; Wei YH, 2015, STAT MED, V34, P2881, DOI 10.1002/sim.6556; Whitehead A., 2002, METAANALYSIS CONTROL	34	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150032	10.1371/journal.pone.0150032	http://dx.doi.org/10.1371/journal.pone.0150032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960150	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300030
J	Mimet, A; Pellissier, V; Houet, T; Julliard, R; Simon, L				Mimet, Anne; Pellissier, Vincent; Houet, Thomas; Julliard, Romain; Simon, Laurent			A Holistic Landscape Description Reveals That Landscape Configuration Changes More over Time than Composition: Implications for Landscape Ecology Studies	PLOS ONE			English	Article							BIRD COMMUNITIES; PREDICTORS; RESPONSES	Background Space-for-time substitution-that is, the assumption that spatial variations of a system can explain and predict the effect of temporal variations-is widely used in ecology. However, it is questionable whether it can validly be used to explain changes in biodiversity over time in response to land-cover changes. Hypothesis Here, we hypothesize that different temporal vs spatial trajectories of landscape composition and configuration may limit space-for-time substitution in landscape ecology. Land-cover conversion changes not just the surface areas given over to particular types of land cover, but also affects isolation, patch size and heterogeneity. This means that a small change in land cover over time may have only minor repercussions on landscape composition but potentially major consequences for landscape configuration. Methods Using land-cover maps of the Paris region for 1982 and 2003, we made a holistic description of the landscape disentangling landscape composition from configuration. After controlling for spatial variations, we analyzed and compared the amplitudes of changes in landscape composition and configuration over time. Results For comparable spatial variations, landscape configuration varied more than twice as much as composition over time. Temporal changes in composition and configuration were not always spatially matched. Significance The fact that landscape composition and configuration do not vary equally in space and time calls into question the use of space-for-time substitution in landscape ecology studies. The instability of landscapes over time appears to be attributable to configurational changes in the main. This may go some way to explaining why the landscape variables that account for changes over time in biodiversity are not the same ones that account for the spatial distribution of biodiversity.	[Mimet, Anne; Simon, Laurent] UMR 7533 CNRS Paris 1 Paris 7 Paris 8 Paris 10, Lab Social Dynam & Space Recomposit LADYSS, 2 Rue Valette, FR-75005 Paris, France; [Mimet, Anne; Pellissier, Vincent; Julliard, Romain] UMR 7204 MNHN CNRS UPCM, Ctr Conservat Sci CESCO, 55 Rue Buffon, FR-75005 Paris, France; [Houet, Thomas] UMR 5602 CNRS UTM, Geog Environm GEODE, 5 Allee A Machado, FR-31058 Toulouse 1, France; [Pellissier, Vincent] Aarhus Univ, Dept Biosci, Sect Ecoinformat & Biodivers, Ny Munkegade 114-116, DK-8000 Aarhus, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Aarhus University	Mimet, A (corresponding author), UMR 7533 CNRS Paris 1 Paris 7 Paris 8 Paris 10, Lab Social Dynam & Space Recomposit LADYSS, 2 Rue Valette, FR-75005 Paris, France.; Mimet, A (corresponding author), UMR 7204 MNHN CNRS UPCM, Ctr Conservat Sci CESCO, 55 Rue Buffon, FR-75005 Paris, France.	anne.mimet@gmail.com		Houet, Thomas/0000-0001-5890-6145	Atlas dynamique de la biodiversite en Seine-et-Marne	Atlas dynamique de la biodiversite en Seine-et-Marne	The study was funded by the Atlas dynamique de la biodiversite en Seine-et-Marne. LS and RJ received the funding.	Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Birch CPD, 2007, ECOL MODEL, V206, P347, DOI 10.1016/j.ecolmodel.2007.03.041; Bonthoux S, 2013, OECOLOGIA, V172, P563, DOI 10.1007/s00442-012-2498-2; Boulinier T, 2001, ECOLOGY, V82, P1159, DOI 10.1890/0012-9658(2001)082[1159:FFABCD]2.0.CO;2; Burgi M, 2004, LANDSCAPE ECOL, V19, P857, DOI 10.1007/s10980-004-0245-8; Caprio E, 2009, BIODIVERS CONSERV, V18, P1287, DOI 10.1007/s10531-008-9478-1; Cushman SA, 2007, MULTIVARIATE LANDSCA, P119; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Feranec J, 2010, APPL GEOGR, V30, P19, DOI 10.1016/j.apgeog.2009.07.003; Filippi-Codaccioni O, 2009, ACTA OECOL, V35, P705, DOI 10.1016/j.actao.2009.07.003; Fischer J, 2006, OIKOS, V112, P473, DOI 10.1111/j.0030-1299.2006.14148.x; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Griffith JA, 2000, LANDSCAPE URBAN PLAN, V52, P45, DOI 10.1016/S0169-2046(00)00112-2; Hanski I, 2001, NATURWISSENSCHAFTEN, V88, P372, DOI 10.1007/s001140100246; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Houet T, 2010, LANDSCAPE ECOL, V25, P163, DOI 10.1007/s10980-009-9417-x; Houet T, 2010, LANDSCAPE ECOL, V25, P249, DOI 10.1007/s10980-009-9362-8; Hu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043894; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Kratz TK, 2003, BIOSCIENCE, V53, P57, DOI 10.1641/0006-3568(2003)053[0057:EVISAT]2.0.CO;2; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Li BL, 2000, LANDSCAPE URBAN PLAN, V50, P27, DOI 10.1016/S0169-2046(00)00078-5; LI H, 1995, OIKOS, V73, P280, DOI 10.2307/3545921; Lindenmayer DB., 2007, MANAGING DESIGNING L; Long JA, 2010, APPL GEOGR, V30, P426, DOI 10.1016/j.apgeog.2009.12.002; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Mimet A, 2014, ECOL INDIC, V36, P19, DOI 10.1016/j.ecolind.2013.06.029; Mimet A, 2013, METHODS ECOL EVOL, V4, P453, DOI 10.1111/2041-210x.12024; Molnar Z, 1998, PHYTOCOENOLOGIA, V28, P1; Pellissier V, 2012, LANDSCAPE URBAN PLAN, V104, P181, DOI 10.1016/j.landurbplan.2011.10.011; PICKETT S T A, 1989, P110; Price B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074333; Proulx R, 2010, LANDSCAPE ECOL, V25, P1479, DOI 10.1007/s10980-010-9523-9; Radford JQ, 2007, J APPL ECOL, V44, P737, DOI 10.1111/j.1365-2664.2007.01327.x; Ricklefs RE, 2011, PHILOS T R SOC B, V366, P2438, DOI 10.1098/rstb.2011.0066; RIITTERS KH, 1995, LANDSCAPE ECOL, V10, P23, DOI 10.1007/BF00158551; Sanderson FJ, 2009, AGR ECOSYST ENVIRON, V129, P37, DOI 10.1016/j.agee.2008.07.001; Schindler S, 2008, ECOL INDIC, V8, P502, DOI 10.1016/j.ecolind.2007.06.001; Sirami C, 2009, LANDSCAPE ECOL, V24, P893, DOI 10.1007/s10980-009-9365-5; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Strayer D, 1986, LONGTERM ECOLOGICAL, P574; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Wang XL, 2011, LANDSCAPE ECOL, V26, P723, DOI 10.1007/s10980-011-9601-7; Wretenberg J, 2010, BIOL CONSERV, V143, P375, DOI 10.1016/j.biocon.2009.11.001; Wu JG, 2002, LANDSCAPE ECOL, V17, P355, DOI 10.1023/A:1020561630963; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	51	9	10	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150111	10.1371/journal.pone.0150111	http://dx.doi.org/10.1371/journal.pone.0150111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959363	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300034
J	Raman, R; Sarkar, S				Raman, Rajani; Sarkar, Sandip			Predictive Coding: A Possible Explanation of Filling-In at the Blind Spot	PLOS ONE			English	Article							RECEPTIVE-FIELD PROPERTIES; RESPONSE PROPERTIES; NEURAL RESPONSES; VISUAL-CORTEX; MACAQUE V1; PERCEPTION; COMPLETION; DYNAMICS; FEEDBACK; STIMULI	Filling-in at the blind spot is a perceptual phenomenon in which the visual system fills the informational void, which arises due to the absence of retinal input corresponding to the optic disc, with surrounding visual attributes. It is known that during filling-in, nonlinear neural responses are observed in the early visual area that correlates with the perception, but the knowledge of underlying neural mechanism for filling-in at the blind spot is far from complete. In this work, we attempted to present a fresh perspective on the computational mechanism of filling-in process in the framework of hierarchical predictive coding, which provides a functional explanation for a range of neural responses in the cortex. We simulated a three-level hierarchical network and observe its response while stimulating the network with different bar stimulus across the blind spot. We find that the predictive-estimator neurons that represent blind spot in primary visual cortex exhibit elevated non-linear response when the bar stimulated both sides of the blind spot. Using generative model, we also show that these responses represent the filling-in completion. All these results are consistent with the finding of psychophysical and physiological studies. In this study, we also demonstrate that the tolerance in filling-in qualitatively matches with the experimental findings related to non-aligned bars. We discuss this phenomenon in the predictive coding paradigm and show that all our results could be explained by taking into account the efficient coding of natural images along with feedback and feed-forward connections that allow priors and predictions to co-evolve to arrive at the best prediction. These results suggest that the filling-in process could be a manifestation of the general computational principle of hierarchical predictive coding of natural images.	[Raman, Rajani; Sarkar, Sandip] Saha Inst Nucl Phys, Appl Nucl Phys Div, Kolkata, India	Saha Institute of Nuclear Physics	Raman, R (corresponding author), Saha Inst Nucl Phys, Appl Nucl Phys Div, Kolkata, India.	rajani.raman@saha.ac.in		, Rajani Raman/0000-0001-5222-2156	Department of Atomic Energy, Govt. of India	Department of Atomic Energy, Govt. of India(Department of Atomic Energy (DAE))	This work was supported by Department of Atomic Energy, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araragi Y, 2008, VISION RES, V48, P618, DOI 10.1016/j.visres.2007.12.001; Araragi Y, 2011, EXP BRAIN RES, V212, P529, DOI 10.1007/s00221-011-2758-0; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; Ballard DH, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00254; Boerlin M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003258; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; DAYAN P, 1995, NEURAL COMPUT, V7, P889, DOI 10.1162/neco.1995.7.5.889; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FIORANI M, 1992, P NATL ACAD SCI USA, V89, P8547, DOI 10.1073/pnas.89.18.8547; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; GERRITS HJM, 1969, VISION RES, V9, P439, DOI 10.1016/0042-6989(69)90092-3; Grossberg S, 1997, TRENDS NEUROSCI, V20, P106, DOI 10.1016/S0166-2236(96)01002-8; Grossberg S, 1999, VISION RES, V39, P3796, DOI 10.1016/S0042-6989(99)00095-4; GROSSBERG S, 1985, PSYCHOL REV, V92, P173, DOI 10.1037/0033-295X.92.2.173; Hohwy J, 2008, COGNITION, V108, P687, DOI 10.1016/j.cognition.2008.05.010; Hosoya H, 2012, NEURAL COMPUT, V24, P2119, DOI 10.1162/NECO_a_00310; Huang YP, 2011, WIRES COGN SCI, V2, P580, DOI 10.1002/wcs.142; Jehee JFM, 2006, J PHYSIOL-PARIS, V100, P125, DOI 10.1016/j.jphysparis.2006.09.011; Jehee JFM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000373; Komatsu H, 2006, NAT REV NEUROSCI, V7, P220, DOI 10.1038/nrn1869; Komatsu H, 2000, J NEUROSCI, V20, P9310; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Matsumoto M, 2005, J NEUROPHYSIOL, V93, P2374, DOI 10.1152/jn.00811.2004; Mumford D., 1994, LARGE SCALE THEORIES; Neumann H, 1999, BIOL CYBERN, V81, P425, DOI 10.1007/s004220050573; Neumann H, 2001, BIOL CYBERN, V85, P355, DOI 10.1007/s004220100258; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; RAMACHANDRAN VS, 1992, SCI AM, V266, P86, DOI 10.1038/scientificamerican0592-86; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rao RPN, 2002, NEU INF PRO, P297; Satoh S, 2008, NEURAL NETWORKS, V21, P1261, DOI 10.1016/j.neunet.2008.05.001; Spratling MW, 2008, VISION RES, V48, P1391, DOI 10.1016/j.visres.2008.03.009; Spratling MW, 2012, BIOL CYBERN, V106, P37, DOI 10.1007/s00422-012-0477-7; Spratling MW, 2010, J NEUROSCI, V30, P3531, DOI 10.1523/JNEUROSCI.4911-09.2010	36	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151194	10.1371/journal.pone.0151194	http://dx.doi.org/10.1371/journal.pone.0151194			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959812	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300109
J	He, SK; Zheng, XL; Zeng, D; Luo, C; Zhang, Z				He, Saike; Zheng, Xiaolong; Zeng, Daniel; Luo, Chuan; Zhang, Zhu			Exploring Entrainment Patterns of Human Emotion in Social Media	PLOS ONE			English	Article								Emotion entrainment, which is generally defined as the synchronous convergence of human emotions, performs many important social functions. However, what the specific mechanisms of emotion entrainment are beyond in-person interactions, and how human emotions evolve under different entrainment patterns in large-scale social communities, are still unknown. In this paper, we aim to examine the massive emotion entrainment patterns and understand the underlying mechanisms in the context of social media. As modeling emotion dynamics on a large scale is often challenging, we elaborate a pragmatic framework to characterize and quantify the entrainment phenomenon. By applying this framework on the datasets from two large-scale social media platforms, we find that the emotions of online users entrain through social networks. We further uncover that online users often form their relations via dual entrainment, while maintain it through single entrainment. Remarkably, the emotions of online users are more convergent in nonreciprocal entrainment. Building on these findings, we develop an entrainment augmented model for emotion prediction. Experimental results suggest that entrainment patterns inform emotion proximity in dyads, and encoding their associations promotes emotion prediction. This work can further help us to understand the underlying dynamic process of large-scale online interactions and make more reasonable decisions regarding emergency situations, epidemic diseases, and political campaigns in cyberspace.	[He, Saike; Zheng, Xiaolong; Zeng, Daniel; Luo, Chuan; Zhang, Zhu] Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing 100190, Peoples R China; [Zeng, Daniel] Univ Arizona, Dept Management Informat Syst, Tucson, AZ 85721 USA	Chinese Academy of Sciences; Institute of Automation, CAS; University of Arizona	Zheng, XL (corresponding author), Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing 100190, Peoples R China.	xiaolong.zheng@ia.ac.cn			National Natural Science Foundation of China [71402177, 71472175, 71025001, 61175040, 71103180]; National Institutes of Health (NIH) of the United States of America [1R01DA037378-01]; Ministry of Health [2013ZX10004218, 2012ZX10004801]; National Institutes of Health (NIH) of USA [1R01DA037378-01]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037378] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH) of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ministry of Health; National Institutes of Health (NIH) of USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the following grants: the National Natural Science Foundation of China under Grant Nos. 71402177, 71472175, 71025001, 61175040, and 71103180; the National Institutes of Health (NIH) of the United States of America under Grant No. 1R01DA037378-01; and the Ministry of Health under Grant No. 2013ZX10004218 and 2012ZX10004801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Bo Xu, Changliang Li, Guanhua Tian and Hongwei Hao for useful discussions. This work was supported in part by the following grants: the National Natural Science Foundation of China under Grant Nos. 71402177, 71472175, and 71103180; the National Institutes of Health (NIH) of USA under Grant No. 1R01DA037378-01; and the Ministry of Health under Grant No. 2013ZX10004218.	Agarwal Shatam, 2008, Pac Symp Biocomput, P402; Ancona D, 1996, ENTRAINMENT; Bastiaansen J, 2011, MIRROR IMAGES, P21; BEMMAOR AC, 1994, INT SER QUANT MARKET, P201; Berger AL, 1996, COMPUT LINGUIST, V22, P39; Bjarnason T, 1998, J SCI STUD RELIG, V37, P742, DOI 10.2307/1388154; Bortz B, 2012, P 3 INT WORKSH SOC B; Brown P. F., 1992, Computational Linguistics, V18, P467; Burke M, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1909; Chmiel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022207; Choy M, 2012, IEEE SYSTEMS J; Cristian Danescu-Niculescu-Mizil, 2012, P 21 INT C WORLD WID, P699, DOI DOI 10.1145/2187836.2187931; Danescu-Niculescu-Mizil C., 2013, P 22 INT C WORLD WID, P307, DOI DOI 10.1145/2488388.2488416; Danescu-Niculescu-Mizil Cristian, 2011, P INT C WORLD WIDE W, P745, DOI [10.1145/1963405.1963509, DOI 10.1145/1963405.1963509]; Darcy O, 2015, GOP CONGRESSMAN WHY; Davis M, 1982, HUMAN SCIENCES PR; De Boer PT, 2005, ANN OPER RES, V134, P19, DOI 10.1007/s10479-005-5724-z; De Choudhury M, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P3563, DOI 10.1145/2556288.2557197; Dezecache G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067371; Eisenberg N., 2014, HDB MORAL BEHAV DEV, VVol. 2, P63, DOI DOI 10.1017/9781316271698.007; Flach B, 2000, LECT NOTES COMPUT SC, V1876, P462; Fu G, 2010, P 23 INT C COMP LING, P312; Garas A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00402; HARALICK RM, 1979, IEEE T PATTERN ANAL, V1, P173, DOI 10.1109/TPAMI.1979.4766903; Hatfield E, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P19; Hawk S, 2010, J PERS SOC PSYCHOL, V32, P145; He S, 2015, DECIS SUPPORT SYST, V81, P1; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Hildebrand F. B, 1987, INTRO NUMERICAL ANAL; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Hoffman M. L., 1984, EMOTIONS COGNITIONS; Hoffman ML., 2008, HDB EMOTIONS, P440; Hume D, ORG BEHAV, P258; Jiang L., 2011, P 49 ANN M ASS COMPU, V1, P151; Kessler H., 2012, COLING, P569; Kohli P, 2009, INT J COMPUT VISION, V82, P302, DOI 10.1007/s11263-008-0202-0; Kramer A. D., 2014, P NATL ACAD SCI USA; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Lampe C, 2008, CSCW: 2008 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, CONFERENCE PROCEEDINGS, P721; Lee C. -c., 2011, P INT, P3101; Lee CC, 2014, COMPUT SPEECH LANG, V28, P518, DOI 10.1016/j.csl.2012.06.006; Lee CC, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P1955; Leon Simone, 2010, WSEAS Transactions on Systems, V9, P594; Leshed G., 2006, P C HUM FACT COMP SY, P1019, DOI [10.1145/1125451.1125646, DOI 10.1145/1125451.1125646]; Li X, 2010, EXPLOITING EMOTIONS, P136; Liang Y, 2016, INT SOC WORK, V59, P760, DOI 10.1177/0020872814531303; Mackie DM, 2008, SOC PERSONAL PSYCHOL, V2, P1866, DOI 10.1111/j.1751-9004.2008.00130.x; Mariev S., 2013, P IEEE INT C AUT FAC, P1; Markov AA, 1953, THEORY ALGORITHMS; Martinez E, 2011, COORDINATION ORG I N, P114; McCallum A., 1998, P AAAI 98 WORKSH LEA, P41; Metallinou A, 2012, INT CONF ACOUST SPEE, P2401, DOI 10.1109/ICASSP.2012.6288399; Miles LK, 2009, J EXP SOC PSYCHOL, V45, P585, DOI 10.1016/j.jesp.2009.02.002; Mishne G, 2005, P ACM SIGRI 2005 WOR; Nenkova Ani, 2008, P 46 ANN M ASS COMP, P169, DOI DOI 10.3115/1557690.1557737; Oh O, 2013, MIS QUART, V37, P407, DOI 10.25300/MISQ/2013/37.2.05; Park J, 1991, NEURAL COMPUT, V3, P246, DOI 10.1162/neco.1991.3.2.246; Pasek J, 2006, COMMUN RES, V33, P115, DOI 10.1177/0093650206287073; Pempek TA, 2009, J APPL DEV PSYCHOL, V30, P227, DOI 10.1016/j.appdev.2008.12.010; Qu Y., 2011, P ACM 2011 C COMP SU, P25, DOI DOI 10.1145/1958824.1958830; Reidsma D, 2010, 2010 INTERNATIONAL CONFERENCE ON CYBERWORLDS (CW 2010), P67, DOI 10.1109/CW.2010.21; Roberts SGB, 2011, PERS RELATIONSHIP, V18, P439, DOI 10.1111/j.1475-6811.2010.01310.x; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; Saike He, 2011, Intelligence and Security Informatics. Proceedings Pacific Asia Workshop, PAISI 2011, P36, DOI 10.1007/978-3-642-22039-5_4; Salathe M, 2013, EPJ DATA SCI, V2, DOI 10.1140/epjds16; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Sato W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057889; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Sia CL, 2002, INFORM SYST RES, V13, P70, DOI 10.1287/isre.13.1.70.92; Subrahmanyam K, 2008, J APPL DEV PSYCHOL, V29, P420, DOI 10.1016/j.appdev.2008.07.003; THAMM R, 1992, SOCIOL PERSPECT, V35, P649, DOI 10.2307/1389303; Tumasjan A., 2010, P 4 INT AAAI C WEBLO, V4, P178, DOI DOI 10.1074/JBC.M501708200; Vakali A, 2012, WORLD WID WEB C; Van den Bulte C, 2001, AM J SOCIOL, V106, P1409, DOI 10.1086/320819; Varni G., 2008, P 8 IEEE INT C AUT F, P1; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; von Scheve C, 2013, EMOT REV, V5, P406, DOI 10.1177/1754073913484170; Wang F, 2012, COLING, P1311; WARNER RM, 1987, J NONVERBAL BEHAV, V11, P57, DOI 10.1007/BF00990958; Wasserman T, 2011, TOYOTA USED SOCIAL M; Watson D., 2000, MOOD TEMPERAMENT; Weisbuch M, 2009, J EXP SOC PSYCHOL, V45, P573, DOI 10.1016/j.jesp.2008.12.009; Wilson T, 2005, P C HUM LANG TECHN E, P347, DOI DOI 10.3115/1220575.1220619; Xinpo Lou, 2013, Chinese Lexical Semantics. 14th Workshop, CLSW 2013. Revised Selected Papers: LNCS 8229, P466, DOI 10.1007/978-3-642-45185-0_49; Zhang J., 2013, P 23 INT JOINT C ART, P2761, DOI 10.5555/2540128.2540526; Zhao J., 2012, P 18 ACM SIGKDD INT, P1528, DOI DOI 10.1145/2339530.2339772	88	19	19	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150630	10.1371/journal.pone.0150630	http://dx.doi.org/10.1371/journal.pone.0150630			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SW	26953692	Green Submitted, gold, Green Published			2022-12-27	WOS:000371991300037
J	Patole, SK; Rao, SC; Keil, AD; Nathan, EA; Doherty, DA; Simmer, KN				Patole, Sanjay K.; Rao, Shripada C.; Keil, Anthony D.; Nathan, Elizabeth A.; Doherty, Dorota A.; Simmer, Karen N.			Benefits of Bifidobacterium breve M-16V Supplementation in Preterm Neonates - A Retrospective Cohort Study	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; PREVENTING NECROTIZING ENTEROCOLITIS; UPDATED METAANALYSIS; PROBIOTICS; MORTALITY; CARE	Background Systematic reviews of randomised controlled trials report that probiotics reduce the risk of necrotising enterocolitis (NEC) in preterm neonates. Aim To determine whether routine probiotic supplementation (RPS) to preterm neonates would reduce the incidence of NEC. Methods The incidence of NEC >= Stage II and all-cause mortality was compared for an equal period of 24 months 'before' (Epoch 1) and 'after' (Epoch 2) RPS with Bifidobacterium breve M-16V in neonates <34 weeks. Multivariate logistic regression analysis was conducted to adjust for relevant confounders. Results A total of 1755 neonates (Epoch I vs. II: 835 vs. 920) with comparable gestation and birth weights were admitted. There was a significant reduction in NEC >= Stage II: 3% vs. 1%, adjusted odds ratio (aOR) = 0.43 (95% CI: 0.21-0.87); 'NEC >= Stage II or all-cause mortality': 9% vs. 5%, aOR = 0.53 (95% CI: 0.32-0.88); but not all-cause mortality alone: 7% vs. 4%, aOR = 0.58 (95% CI: 0.31-1.06) in Epoch II. The benefits in neonates <28 weeks did not reach statistical significance: NEC >= Stage II: 6% vs. 3%, aOR 0.51 (95% CI: 0.20-1.27), 'NEC >= Stage II or all-cause mortality', 21% vs. 14%, aOR = 0.59 (95% CI: 0.29-1.18); all-cause mortality: 17% vs. 11%, aOR = 0.63 (95% CI: 0.28-1.41). There was no probiotic sepsis. Conclusion RPS with Bifidobacterium breve M-16V was associated with decreased NEC >= Stage II and 'NEC >= Stage II or all- cause mortality' in neonates <34 weeks. Large sample size is required to assess the potential benefits of RPS in neonates <28 weeks.	[Patole, Sanjay K.; Simmer, Karen N.] King Edward Mem Hosp Women, Dept Neonatal Paediat, Perth, WA, Australia; [Rao, Shripada C.] Princess Margaret Hosp Children, Dept Neonatal Paediat, Perth, WA, Australia; [Keil, Anthony D.] PathWest Lab Med Western Australia, Perth, WA, Australia; [Nathan, Elizabeth A.; Doherty, Dorota A.] King Edward Mem Hosp Women, Women & Infants Res Fdn, Perth, WA, Australia; [Nathan, Elizabeth A.; Doherty, Dorota A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Patole, Sanjay K.; Simmer, Karen N.] Univ Western Australia, Ctr Neonatal Res & Educ, Perth, WA, Australia	King Edward Memorial Hospital; University of Western Australia; University of Western Australia; King Edward Memorial Hospital; University of Western Australia; University of Western Australia; University of Western Australia	Patole, SK (corresponding author), King Edward Mem Hosp Women, Dept Neonatal Paediat, Perth, WA, Australia.; Patole, SK (corresponding author), Univ Western Australia, Ctr Neonatal Res & Educ, Perth, WA, Australia.	sanjay.patole@health.wa.gov.au		Simmer, Karen/0000-0003-4777-9069				Afrazi A, 2014, J BIOL CHEM, V289, P9584, DOI 10.1074/jbc.M113.526517; AlFaleh K, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005496.pub4; Barclay AR, 2007, J PEDIATR GASTR NUTR, V45, P569, DOI 10.1097/MPG.0b013e3181344694; Beattie LM, 2010, PEDIATRICS, V126, pE742, DOI 10.1542/peds.2010-1949C; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bernardo WM, 2013, J PEDIAT-BRAZIL, V89, P18, DOI 10.1016/j.jped.2013.02.004; Choi Young Youn, 2014, Korean J Pediatr, V57, P505, DOI 10.3345/kjp.2014.57.12.505; Costeloe K, 2016, LANCET, V387, P649, DOI 10.1016/S0140-6736(15)01027-2; Costeloe KL, 2004, PEDIATR RES, V55, p494A; Deshpande G, 2010, PEDIATRICS, V125, P921, DOI 10.1542/peds.2009-1301; Flidel-Rimon O, 2006, ACTA PAEDIATR, V95, P1341, DOI 10.1080/08035250600719713; Food and Agriculture Organization of the United Nations and World Health Organization, 2001, REP JOINT FAO WHO EX; Ganguli K, 2011, J CLIN GASTROENTEROL, V45, pS133, DOI 10.1097/MCG.0b013e318228b799; Garland SM, 2010, PEDIATRICS, V126, pE741, DOI 10.1542/peds.2010-1949B; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Guthmann F, 2010, KLIN PADIATR, V222, P284, DOI 10.1055/s-0030-1254113; Hartel C, 2014, J PEDIATR-US, V165, P285, DOI 10.1016/j.jpeds.2014.04.029; Hickey L, 2014, J HOSP INFECT, V88, P226, DOI 10.1016/j.jhin.2014.09.006; Janvier A, 2014, J PEDIATR-US, V164, P980, DOI 10.1016/j.jpeds.2013.11.025; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Kitajima H, 1997, ARCH DIS CHILD-FETAL, V76, pF101, DOI 10.1136/fn.76.2.F101; Meng D, 2015, PEDIATR RES, V77, P416, DOI 10.1038/pr.2014.207; Mihatsch WA, 2012, CLIN NUTR, V31, P6, DOI 10.1016/j.clnu.2011.09.004; Modi N, 2014, NEONATOLOGY, V105, P71, DOI [10.1159/000354909, 10.1159/000360650]; Nanthakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017776; Neu J, 2014, CLIN PERINATOL, V41, P967, DOI 10.1016/j.clp.2014.08.014; Neu J, 2014, WORLD REV NUTR DIET, V110, P253, DOI 10.1159/000358474; Olsen R, 2016, NEONATOLOGY, V109, P105, DOI 10.1159/000441274; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Patole S. K., 2005, Archives of Disease in Childhood Fetal and Neonatal Edition, V90, pF147, DOI 10.1136/adc.2004.059741; Patole S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089511; Repa A, 2015, PEDIATR RES, V77, P381, DOI 10.1038/pr.2014.192; Rowland I, 2010, GUT MICROBES, V1, P436, DOI 10.4161/gmic.1.6.13610; Salminen S., 2001, Scandinavian Journal of Nutrition/Naringsforskning, V45, P8; Satoh Y, 2007, INT J PROBIOT PREBIO, V2, P149; Saunders ME, IS IT TIME CONSIDER; Schulzke SM, 2007, ARCH PEDIAT ADOL MED, V161, P583, DOI 10.1001/archpedi.161.6.583; Shlomai NO, 2014, NEONATOLOGY, V105, P64, DOI 10.1159/000354891; Soll RF, 2010, PEDIATRICS, V125, P1071, DOI 10.1542/peds.2010-0643; Tanner SM, 2015, AM J PATHOL, V185, P4, DOI 10.1016/j.ajpath.2014.08.028; Terrin G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/543765; Therapeutic Goods Administration (TGA Canberra), AUTH PRESCR PATHW; UAUY RD, 1991, J PEDIATR-US, V119, P630, DOI 10.1016/S0022-3476(05)82418-7; Vandenplas Y, 2012, J PEDIATR GASTR NUTR, V54, P4, DOI 10.1097/MPG.0b013e3182333de3; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Wang QZ, 2012, J PEDIATR SURG, V47, P241, DOI 10.1016/j.jpedsurg.2011.09.064; Yang Y, 2014, BRAZ J MED BIOL RES, V47, P804, DOI 10.1590/1414-431X20143857; Zhou W, 2014, J PEDIATR SURG, V49, P1057, DOI 10.1016/j.jpedsurg.2014.02.078	48	53	55	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150775	10.1371/journal.pone.0150775	http://dx.doi.org/10.1371/journal.pone.0150775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953798	gold, Green Submitted, Green Published			2022-12-27	WOS:000371991300050
J	Vizzini, S; Signa, G; Mazzola, A				Vizzini, Salvatrice; Signa, Geraldina; Mazzola, Antonio			Guano-Derived Nutrient Subsidies Drive Food Web Structure in Coastal Ponds	PLOS ONE			English	Article							STABLE-ISOTOPES; TROPHIC POSITION; NITROGEN; MARINE; CARBON; RATIOS; WATER; CONTAMINATION; TERRESTRIAL; ASSEMBLAGES	A stable isotope study was carried out seasonally in three coastal ponds (Marinello system, Italy) affected by different gull guano input to investigate the effect of nutrient subsidies on food web structure and dynamics. A marked N-15 enrichment occurred in the pond receiving the highest guano input, indicating that gull-derived fertilization (guanotrophication) had a strong localised effect and flowed across trophic levels. The main food web response to guanotrophication was an overall erosion of the benthic pathway in favour of the planktonic. Subsidized primary consumers, mostly deposit feeders, switched their diet according to organic matter source availability. Secondary consumers and, in particular, fish from the guanotrophic pond, acted as couplers of planktonic and benthic pathways and showed an omnivorous trophic behaviour. Food web structure showed substantial variability among ponds and a marked seasonality in the subsidized one: an overall simplification was evident only in summer when guano input maximises its trophic effects, while higher trophic diversity and complexity resulted when guano input was low to moderate.	[Vizzini, Salvatrice; Signa, Geraldina; Mazzola, Antonio] Univ Palermo, Dept Earth & Marine Sci, CoNISMa, Via Archirafi 18, I-90123 Palermo, Italy	CoNISMa; University of Palermo	Vizzini, S (corresponding author), Univ Palermo, Dept Earth & Marine Sci, CoNISMa, Via Archirafi 18, I-90123 Palermo, Italy.	salvatrice.vizzini@unipa.it	Signa, Geraldina/AAQ-9090-2020; Signa, Geraldina/G-3357-2017	Signa, Geraldina/0000-0003-2171-3299; Signa, Geraldina/0000-0003-2171-3299	Italian Ministry of Education, University and Research (PRIN); Italian Ministry of Education, University and Research (Flagship Project RITMARE - Italian Research for the Sea); University of Palermo	Italian Ministry of Education, University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Education, University and Research (Flagship Project RITMARE - Italian Research for the Sea); University of Palermo	This work was supported by the Italian Ministry of Education, University and Research (PRIN 2008 and Flagship Project RITMARE - Italian Research for the Sea) and University of Palermo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WB, 1999, OECOLOGIA, V118, P324, DOI 10.1007/s004420050733; Anderson WB, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P82; Blais JM, 2005, SCIENCE, V309, P445, DOI 10.1126/science.1112658; Carlier A, 2008, J SEA RES, V60, P287, DOI 10.1016/j.seares.2008.10.006; Carstensen J, 2007, LIMNOL OCEANOGR, V52, P370, DOI 10.4319/lo.2007.52.1.0370; Choy ES, 2010, SCI TOTAL ENVIRON, V408, P1858, DOI 10.1016/j.scitotenv.2010.01.014; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Doi H, 2006, BASIC APPL ECOL, V7, P159, DOI 10.1016/j.baae.2005.04.011; Dreier A, 2012, FEMS MICROBIOL ECOL, V81, P480, DOI 10.1111/j.1574-6941.2012.01374.x; Elliott M, 2007, FISH FISH, V8, P241, DOI 10.1111/j.1467-2679.2007.00253.x; Erwin RM, 1996, COLON WATERBIRD, V19, P1, DOI 10.2307/1521941; Faria LD, 2010, ECOL COMPLEX, V7, P107, DOI 10.1016/j.ecocom.2009.08.003; Fry B., 1989, STABLE ISOTOPES ECOL, P196, DOI [DOI 10.1007/978-1-4612-3498-2, DOI 10.1007/978-1-4612-3498-2_12]; Gagnon K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061284; Genkai-Kato M, 2012, ECOLOGY, V93, P619, DOI 10.1890/10-2126.1; Hagerthey SE, 2002, MAR ECOL PROG SER, V245, P47, DOI 10.3354/meps245047; Harding JS, 2004, FRESHWATER BIOL, V49, P576, DOI 10.1111/j.1365-2427.2004.01210.x; Huxel GR, 1998, AM NAT, V152, P460, DOI 10.1086/286182; Huxel GR, 2002, ECOL RES, V17, P419, DOI 10.1046/j.1440-1703.2002.00501.x; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jumars PA, 2015, ANNU REV MAR SCI, V7, P497, DOI 10.1146/annurev-marine-010814-020007; Kolb GS, 2010, MAR ECOL PROG SER, V417, P287, DOI 10.3354/meps08791; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Mancinelli G, 2013, ESTUAR COAST SHELF S, V135, P77, DOI 10.1016/j.ecss.2013.04.004; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; MIZUTANI H, 1988, ECOLOGY, V69, P340, DOI 10.2307/1940432; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Payne LX, 2006, OIKOS, V115, P69; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Sebastian-Gonzalez E, 2012, J LIMNOL, V71, P191, DOI 10.4081/jlimnol.2012.e20; Signa G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117544; Signa G, 2013, MAR POLLUT BULL, V74, P237, DOI 10.1016/j.marpolbul.2013.06.051; Signa G, 2013, MAR ECOL PROG SER, V479, P13, DOI 10.3354/meps10210; Signa G, 2012, ESTUAR COAST SHELF S, V111, P27, DOI 10.1016/j.ecss.2012.06.008; Stapp P, 1999, NATURE, V401, P467, DOI 10.1038/46769; Vander Zanden MJ, 2007, OIKOS, V116, P1378, DOI 10.1111/j.2007.0030-1299.16036.x; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; Vizzini S, 2005, HYDROBIOLOGIA, V550, P73, DOI 10.1007/s10750-005-4364-2; Vizzini S, 2006, SCI TOTAL ENVIRON, V368, P723, DOI 10.1016/j.scitotenv.2006.02.001; Wainright SC, 1998, MAR BIOL, V131, P63, DOI 10.1007/s002270050297	44	22	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151018	10.1371/journal.pone.0151018	http://dx.doi.org/10.1371/journal.pone.0151018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953794	Green Submitted, Green Published, gold			2022-12-27	WOS:000371991300074
J	Isnard, V; Taffou, M; Viaud-Delmon, I; Suied, C				Isnard, Vincent; Taffou, Marine; Viaud-Delmon, Isabelle; Suied, Clara			Auditory Sketches: Very Sparse Representations of Sounds Are Still Recognizable	PLOS ONE			English	Article							RECOGNITION; IDENTIFICATION	Sounds in our environment like voices, animal calls or musical instruments are easily recognized by human listeners. Understanding the key features underlying this robust sound recognition is an important question in auditory science. Here, we studied the recognition by human listeners of new classes of sounds: acoustic and auditory sketches, sounds that are severely impoverished but still recognizable. Starting from a time-frequency representation, a sketch is obtained by keeping only sparse elements of the original signal, here, by means of a simple peak-picking algorithm. Two time-frequency representations were compared: a biologically grounded one, the auditory spectrogram, which simulates peripheral auditory filtering, and a simple acoustic spectrogram, based on a Fourier transform. Three degrees of sparsity were also investigated. Listeners were asked to recognize the category to which a sketch sound belongs: singing voices, bird calls, musical instruments, and vehicle engine noises. Results showed that, with the exception of voice sounds, very sparse representations of sounds (10 features, or energy peaks, per second) could be recognized above chance. No clear differences could be observed between the acoustic and the auditory sketches. For the voice sounds, however, a completely different pattern of results emerged, with at-chance or even below-chance recognition performances, suggesting that the important features of the voice, whatever they are, were removed by the sketch process. Overall, these perceptual results were well correlated with a model of auditory distances, based on spectro-temporal excitation patterns (STEPs). This study confirms the potential of these new classes of sounds, acoustic and auditory sketches, to study sound recognition.	[Isnard, Vincent; Taffou, Marine; Viaud-Delmon, Isabelle] Univ Paris 06, Sorbonne Univ, CNRS, IRCAM,STMS,Espaces Acoust & Cognitifs, Paris, France; [Isnard, Vincent; Suied, Clara] Inst Rech Biomed Armees, Dept Act & Cognit Situat Operat, Bretigny Sur Orge, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Isnard, V (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS, IRCAM,STMS,Espaces Acoust & Cognitifs, Paris, France.; Isnard, V; Suied, C (corresponding author), Inst Rech Biomed Armees, Dept Act & Cognit Situat Operat, Bretigny Sur Orge, France.	vincent.isnard@ircam.fr; clara.suied@irba.fr		Viaud-Delmon, Isabelle/0000-0002-8664-3941	French program DEFISENS from the CNRS MI, project Supple-Sens;  [DGA-PDH-1-SMO-3-0808]	French program DEFISENS from the CNRS MI, project Supple-Sens; 	This study was supported by project DGA-PDH-1-SMO-3-0808 and French program DEFISENS from the CNRS MI, project Supple-Sens.	Agus TR, 2012, J ACOUST SOC AM, V131, P4124, DOI 10.1121/1.3701865; Altmann CF, 2007, CEREB CORTEX, V17, P2601, DOI 10.1093/cercor/bhl167; [Anonymous], J PHYS, DOI DOI 10.1051/JP4:19945134; BALLAS JA, 1993, J EXP PSYCHOL HUMAN, V19, P250, DOI 10.1037/0096-1523.19.2.250; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 2006, PHILOS T R SOC B, V361, P2091, DOI 10.1098/rstb.2006.1933; Boersma P., 2015, PRAAT; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; De Lucia M, 2010, J NEUROSCI, V30, P11210, DOI 10.1523/JNEUROSCI.2239-10.2010; DeCarlo LT, 2012, J MATH PSYCHOL, V56, P196, DOI 10.1016/j.jmp.2012.02.004; Elliott TM, 2013, J ACOUST SOC AM, V133, P389, DOI 10.1121/1.4770244; Felsen G, 2005, NAT NEUROSCI, V8, P1643, DOI 10.1038/nn1608; Giordano BL, 2013, CEREB CORTEX, V23, P2025, DOI 10.1093/cercor/bhs162; GREY JM, 1977, J ACOUST SOC AM, V61, P1270, DOI 10.1121/1.381428; Gygi B, 2004, J ACOUST SOC AM, V115, P1252, DOI 10.1121/1.1635840; Hromadka T, 2009, CURR OPIN NEUROBIOL, V19, P430, DOI 10.1016/j.conb.2009.07.009; Leaver AM, 2010, J NEUROSCI, V30, P7604, DOI 10.1523/JNEUROSCI.0296-10.2010; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; LIBERMAN AM, 1989, SCIENCE, V243, P489, DOI 10.1126/science.2643163; Macmillan NA, 2005, DETECTION THEORY USE; MCADAMS S, 1995, PSYCHOL RES-PSYCH FO, V58, P177, DOI 10.1007/BF00419633; Moerel M, 2012, J NEUROSCI, V32, P14205, DOI 10.1523/JNEUROSCI.1388-12.2012; Moore BCJ, 2003, J PHONETICS, V31, P563, DOI 10.1016/S0095-4470(03)00011-1; Patil K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002759; Plumbley MD, 2010, P IEEE, V98, P995, DOI 10.1109/JPROC.2009.2030345; REMEZ RE, 1981, SCIENCE, V212, P947, DOI 10.1126/science.7233191; ROBINSON K, 1995, MUSIC PERCEPT, V13, P1; ROBINSON K, 1995, J ACOUST SOC AM, V98, P1858, DOI 10.1121/1.414405; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Santoro R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003412; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Staeren N, 2009, CURR BIOL, V19, P498, DOI 10.1016/j.cub.2009.01.066; Suied C, 2014, J ACOUST SOC AM, V135, P1380, DOI 10.1121/1.4863659; Suied C, 2013, LECT NOTES COMPUT SC, V7900, P154, DOI 10.1007/978-3-642-41248-6_9; Suied C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005256; YANG XW, 1992, IEEE T INFORM THEORY, V38, P824, DOI 10.1109/18.119739	37	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150313	10.1371/journal.pone.0150313	http://dx.doi.org/10.1371/journal.pone.0150313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950589	Green Submitted, Green Published, gold			2022-12-27	WOS:000371990100029
J	Zoubrinetzky, R; Collet, G; Serniclaes, W; Nguyen-Morel, MA; Valdois, S				Zoubrinetzky, Rachel; Collet, Gregory; Serniclaes, Willy; Nguyen-Morel, Marie-Ange; Valdois, Sylviane			Relationships between Categorical Perception of Phonemes, Phoneme Awareness, and Visual Attention Span in Developmental Dyslexia	PLOS ONE			English	Article							SPEECH-PERCEPTION; ALLOPHONIC MODE; PHONOLOGICAL AWARENESS; READING DISABILITIES; FMRI EVIDENCE; CHILDREN; DEFICITS; DISCRIMINATION; ADULTS; PERFORMANCE	We tested the hypothesis that the categorical perception deficit of speech sounds in developmental dyslexia is related to phoneme awareness skills, whereas a visual attention (VA) span deficit constitutes an independent deficit. Phoneme awareness tasks, VA span tasks and categorical perception tasks of phoneme identification and discrimination using a d/t voicing continuum were administered to 63 dyslexic children and 63 control children matched on chronological age. Results showed significant differences in categorical perception between the dyslexic and control children. Significant correlations were found between categorical perception skills, phoneme awareness and reading. Although VA span correlated with reading, no significant correlations were found between either categorical perception or phoneme awareness and VA span. Mediation analyses performed on the whole dyslexic sample suggested that the effect of categorical perception on reading might be mediated by phoneme awareness. This relationship was independent of the participants' VA span abilities. Two groups of dyslexic children with a single phoneme awareness or a single VA span deficit were then identified. The phonologically impaired group showed lower categorical perception skills than the control group but categorical perception was similar in the VA span impaired dyslexic and control children. The overall findings suggest that the link between categorical perception, phoneme awareness and reading is independent from VA span skills. These findings provide new insights on the heterogeneity of developmental dyslexia. They suggest that phonological processes and VA span independently affect reading acquisition.	[Zoubrinetzky, Rachel; Nguyen-Morel, Marie-Ange; Valdois, Sylviane] CHU Grenoble, Ctr Referent Troubles Langage & Apprentissages, Pole Couple Enfant, F-38043 Grenoble, France; [Collet, Gregory; Serniclaes, Willy] Univ Libre Bruxelles, Ctr Rech Cognit & Neurosci, Unite Rech Neurosci Cognit, Brussels, Belgium; [Serniclaes, Willy] CNRS, Lab Psychol Percept, UMR 8242, Paris, France; [Serniclaes, Willy] Univ Paris 05, Paris, France; [Valdois, Sylviane] CNRS, Lab Psychol & NeuroCognit, UMR 5105, F-38000 Grenoble, France; [Zoubrinetzky, Rachel; Valdois, Sylviane] Univ Grenoble Alpes, LPNC, CS 40700, F-38058 Grenoble, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Zoubrinetzky, R (corresponding author), CHU Grenoble, Ctr Referent Troubles Langage & Apprentissages, Pole Couple Enfant, F-38043 Grenoble, France.; Zoubrinetzky, R (corresponding author), Univ Grenoble Alpes, LPNC, CS 40700, F-38058 Grenoble, France.	rachel.zoubri@gmail.com		Collet, Gregory/0000-0002-7378-0074; SERNICLAES, WILLY/0000-0002-2047-0718	French National Research Agency (ANR), "Investissements d'Avenir" program [ANR-10-LABX-0083]; ANR "Ortholearn" grant [ANR-12-BSH2-0013]; Interuniversity Attraction Poles, Belspo ("Mechanisms of conscious and unconscious learning") [IAP7/33]	French National Research Agency (ANR), "Investissements d'Avenir" program(French National Research Agency (ANR)); ANR "Ortholearn" grant(French National Research Agency (ANR)); Interuniversity Attraction Poles, Belspo ("Mechanisms of conscious and unconscious learning")	This work was supported by public grants overseen by the French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (reference: ANR-10-LABX-0083), by the ANR "Ortholearn" grant (ANR-12-BSH2-0013), and by an Interuniversity Attraction Poles grant IAP7/33, Belspo ("Mechanisms of conscious and unconscious learning"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard A, 1998, Q J EXP PSYCHOL-A, V51, P153, DOI 10.1080/713755750; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Boets B, 2008, BRAIN LANG, V106, P29, DOI 10.1016/j.bandl.2007.12.004; Boets B, 2010, BRIT J DEV PSYCHOL, V28, P5, DOI 10.1348/026151010X485223; Bogliotti C, 2008, J EXP CHILD PSYCHOL, V101, P137, DOI 10.1016/j.jecp.2008.03.006; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; Bosse ML, 2009, J RES READ, V32, P230, DOI 10.1111/j.1467-9817.2008.01387.x; Breier JI, 2001, J EXP CHILD PSYCHOL, V80, P245, DOI 10.1006/jecp.2001.2630; Carre R., 2004, PROGRAM SYNTFORMVOY; Castles A, 2004, COGNITION, V91, P77, DOI 10.1016/S0010-0277(03)00164-1; Cestnick L, 1999, COGNITION, V71, P231, DOI 10.1016/S0010-0277(99)00023-2; Collet G, 2012, RES DEV DISABIL, V33, P1805, DOI 10.1016/j.ridd.2012.05.003; Dubois M, 2010, CORTEX, V46, P717, DOI 10.1016/j.cortex.2009.11.002; Facoetti A, 2004, TRENDS IN DYSLEXIA RESEARCH, P35; Facoetti A, 2010, J COGNITIVE NEUROSCI, V22, P1011, DOI 10.1162/jocn.2009.21232; Germano GD, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01169; GODFREY JJ, 1981, J EXP CHILD PSYCHOL, V32, P401, DOI 10.1016/0022-0965(81)90105-3; Goswami U, 2015, NAT REV NEUROSCI, V16, P43, DOI 10.1038/nrn3836; Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; Hoonhorst I, 2011, SPEECH COMMUN, V53, P417, DOI 10.1016/j.specom.2010.11.005; Hoonhorst I, 2009, J EXP CHILD PSYCHOL, V104, P353, DOI 10.1016/j.jecp.2009.07.005; Horlyck S, 2012, SCI STUD READ, V16, P218, DOI 10.1080/10888438.2010.546460; HURFORD DP, 1990, J LEARN DISABIL, V23, P564, DOI 10.1177/002221949002300906; HURFORD DP, 1991, BEHAV RES METH INSTR, V23, P319, DOI 10.3758/BF03203386; Jacquier-Roux M, 2010, BALE BATTERIE ANAL L; Jacquier-Roux M., 2002, ODEDYS OUTIL DEPISTA; Joanisse MF, 2000, J EXP CHILD PSYCHOL, V77, P30, DOI 10.1006/jecp.1999.2553; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Lachmann T, 2005, INT J PSYCHOPHYSIOL, V56, P105, DOI 10.1016/j.ijpsycho.2004.11.005; Lallier M, 2013, COGNITION, V126, P121, DOI 10.1016/j.cognition.2012.09.008; Lallier M, 2010, NEUROPSYCHOLOGIA, V48, P4125, DOI 10.1016/j.neuropsychologia.2010.09.027; Lallier M, 2010, CORTEX, V46, P231, DOI 10.1016/j.cortex.2009.03.014; Lallier M, 2009, BRAIN RES, V1302, P132, DOI 10.1016/j.brainres.2009.07.037; Lefavrais P, 1965, TEST DE LALOUETTE; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; Lobier M, 2015, NAT REV NEUROSCI, V16, P225, DOI 10.1038/nrn3836-c1; Lobier M, 2012, NEUROPSYCHOLOGIA, V50, P2195, DOI 10.1016/j.neuropsychologia.2012.05.023; Lobier M, 2012, CORTEX, V48, P768, DOI 10.1016/j.cortex.2011.09.003; Lobier MA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00479; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Manis FR, 1997, J EXP CHILD PSYCHOL, V66, P211, DOI 10.1006/jecp.1997.2383; MASTERSON J, 1995, COGN NEUROPSYCHOL, V12, P233, DOI 10.1080/02643299508251997; MCBRIDECHANG C, 1995, J EDUC PSYCHOL, V87, P179, DOI 10.1037/0022-0663.87.2.179; McBrideChang C, 1996, CHILD DEV, V67, P1836, DOI 10.1111/j.1467-8624.1996.tb01831.x; Medina V, 2010, J PHONETICS, V38, P493, DOI 10.1016/j.wocn.2010.06.002; Melby-Lervag M, 2012, PSYCHOL BULL, V138, P322, DOI 10.1037/a0026744; Mody M, 1997, J EXP CHILD PSYCHOL, V64, P199, DOI 10.1006/jecp.1996.2343; Mousty P., 1994, EVALUER TROUBLES LEC, P127; Noordenbos MW, 2012, RES DEV DISABIL, V33, P1469, DOI 10.1016/j.ridd.2012.03.021; Noordenbos MW, 2015, SCI STUD READ, V19, P340, DOI 10.1080/10888438.2015.1052455; Noordenbos MW, 2013, CLIN NEUROPHYSIOL, V124, P1151, DOI 10.1016/j.clinph.2012.12.044; Paul I, 2006, EUR J NEUROSCI, V24, P2945, DOI 10.1111/j.1460-9568.2006.05153.x; Peyrin C, 2012, BRAIN LANG, V120, P381, DOI 10.1016/j.bandl.2011.12.015; Peyrin C, 2011, BRAIN LANG, V118, P128, DOI 10.1016/j.bandl.2010.06.005; POLLACK I, 1971, PSYCHON SCI, V24, P299; Ramus F, 2012, COGN NEUROPSYCHOL, V29, P104, DOI 10.1080/02643294.2012.677420; Raven J. C., 1998, PROGR MATRICES STAND; REED MA, 1989, J EXP CHILD PSYCHOL, V48, P270, DOI 10.1016/0022-0965(89)90006-4; Reilhac C, 2013, NEUROPSYCHOLOGIA, V51, P601, DOI 10.1016/j.neuropsychologia.2012.12.010; Renvall H, 2002, J COGNITIVE NEUROSCI, V14, P757, DOI 10.1162/08989290260138654; Serniclaes W, 2001, J SPEECH LANG HEAR R, V44, P384, DOI 10.1044/1092-4388(2001/032); Serniclaes W, 2015, ROUTLEDGE HDB COMMUN; Serniclaes WI, 2004, J EXP CHILD PSYCHOL, V87, P336, DOI 10.1016/j.jecp.2004.02.001; Snowling M J, 2001, Dyslexia, V7, P37; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Stein John, 2014, Curr Dev Disord Rep, V1, P267; Valdois S., 2003, READ WRIT, V16, P541, DOI DOI 10.1023/A:1025501406971; Valdois S, 2014, CORTEX, V53, P120, DOI 10.1016/j.cortex.2013.11.006; Valdois S, 2011, CORTEX, V47, P1197, DOI 10.1016/j.cortex.2011.05.011; van den Boer M, 2015, LEARN INDIVID DIFFER, V39, P141, DOI 10.1016/j.lindif.2015.03.017; van den Boer M, 2013, SCI STUD READ, V17, P243, DOI 10.1080/10888438.2012.683222; Vandermosten M, 2011, RES DEV DISABIL, V32, P593, DOI 10.1016/j.ridd.2010.12.015; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; Wechsler D., 2005, WISC 4 ECHELLE INTEL; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3; WERKER JF, 1987, CAN J PSYCHOL, V41, P48, DOI 10.1037/h0084150; Witton C, 1998, CURR BIOL, V8, P791, DOI 10.1016/S0960-9822(98)70320-3; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x; Zoubrinetzky R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099337	79	29	30	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0151015	10.1371/journal.pone.0151015	http://dx.doi.org/10.1371/journal.pone.0151015			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SL	26950210	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100080
J	Bhardwaj, M; van den Berg, R; Ma, WJ; Josic, K				Bhardwaj, Manisha; van den Berg, Ronald; Ma, Wei Ji; Josic, Kresimir			Do People Take Stimulus Correlations into Account in Visual Search?	PLOS ONE			English	Article							MEMORY; STATISTICS; VARIABILITY; ORIENTATION; BEHAVIOR; IMAGES; MODELS; BIAS	In laboratory visual search experiments, distractors are often statistically independent of each other. However, stimuli in more naturalistic settings are often correlated and rarely independent. Here, we examine whether human observers take stimulus correlations into account in orientation target detection. We find that they do, although probably not optimally. In particular, it seems that low distractor correlations are overestimated. Our results might contribute to bridging the gap between artificial and natural visual search tasks.	[Bhardwaj, Manisha; Josic, Kresimir] Univ Houston, Dept Math, Houston, TX 77204 USA; [van den Berg, Ronald; Ma, Wei Ji] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [van den Berg, Ronald] Uppsala Univ, Dept Psychol, Uppsala, Sweden; [Ma, Wei Ji] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Ma, Wei Ji] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Josic, Kresimir] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Houston System; University of Houston; Baylor College of Medicine; Uppsala University; New York University; New York University; University of Houston System; University of Houston	Josic, K (corresponding author), Univ Houston, Dept Math, Houston, TX 77204 USA.; Josic, K (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	josic@math.uh.edu	Bhardwaj, Manisha/S-6996-2019	Bhardwaj, Manisha/0000-0003-2366-2675; Ma, Wei Ji/0000-0002-9835-9083; van den Berg, Ronald/0000-0001-7353-5960	National Eye Institute [R01EY020958]; Army Research Office [W911NF-12-1-0262]; NSF [DMS-1122094]; NATIONAL EYE INSTITUTE [P30EY013079, R01EY020958] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Army Research Office; NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	W.J.M. is supported by award number R01EY020958 from the National Eye Institute and award number W911NF-12-1-0262 from the Army Research Office. K.J. is supported by NSF award DMS-1122094.	Baldassi S, 2000, VISION RES, V40, P1293, DOI 10.1016/S0042-6989(00)00029-8; Baldassi S, 2006, PLOS BIOL, V4, P387, DOI 10.1371/journal.pbio.0040056; Beck JM, 2012, NEURON, V74, P30, DOI 10.1016/j.neuron.2012.03.016; Brady TF, 2013, PSYCHOL REV, V120, P85, DOI 10.1037/a0030779; Brady TF, 2011, PSYCHOL SCI, V22, P384, DOI 10.1177/0956797610397956; Busey T, 2008, J EXP PSYCHOL HUMAN, V34, P790, DOI 10.1037/0096-1523.34.4.790; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Fougnie D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2237; Geisler WS, 2009, VISUAL NEUROSCI, V26, P109, DOI 10.1017/S0952523808080875; Genewein T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004369; Green CS, 2010, P NATL ACAD SCI USA, V107, P16401, DOI 10.1073/pnas.1001709107; Green DM, 1966, SIGNAL DETECTION THE; KAREEV Y, 1995, PSYCHOL REV, V102, P490, DOI 10.1037/0033-295X.102.3.490; Keshvari S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002927; Keshvari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040216; KOOPMAN BO, 1956, OPER RES, V4, P503, DOI 10.1287/opre.4.5.503; Kwon OS, 2013, P NATL ACAD SCI USA, V110, pE1064, DOI 10.1073/pnas.1214869110; Ma WJ, 2015, VISION RES, V116, P179, DOI 10.1016/j.visres.2014.12.019; Ma WJ, 2011, NAT NEUROSCI, V14, P783, DOI 10.1038/nn.2814; Mazyar H, 2013, J VISION, V13, DOI 10.1167/13.5.8; Mazyar H, 2012, J VISION, V12, DOI 10.1167/12.6.10; NOLTE LW, 1967, J ACOUST SOC AM, V41, P497, DOI 10.1121/1.1910360; Orhan AE, 2014, ATTEN PERCEPT PSYCHO; Orhan AE, 2013, CURRENT DIR IN PRESS; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; Peterson WW, 1954, IRE T PGIT, V4, P171, DOI DOI 10.1109/TIT.1954.1057460; Pitkow X, 2010, J VISION, V10, DOI 10.1167/10.14.42; Rosenholtz R, 2001, J EXP PSYCHOL HUMAN, V27, P985, DOI 10.1037//0096-1523.27.4.985; van den Berg R, 2014, PSYCHOL REV, V121, P124, DOI 10.1037/a0035234; van den Berg R, 2012, P NATL ACAD SCI USA, V109, P8780, DOI 10.1073/pnas.1117465109; Verghese P, 2001, NEURON, V31, P523, DOI 10.1016/S0896-6273(01)00392-0; Yule GU, 1902, BIOMETRIKA, V2, P121	33	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149402	10.1371/journal.pone.0149402	http://dx.doi.org/10.1371/journal.pone.0149402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TL	26963498	Green Published, gold			2022-12-27	WOS:000371993000013
J	Csakyova, V; Szecsenyi-Nagy, A; Csosz, A; Nagy, M; Fusek, G; Lango, P; Bauer, M; Mende, BG; Makovicky, P; Bauerova, M				Csakyova, Veronika; Szecsenyi-Nagy, Anna; Csosz, Aranka; Nagy, Melinda; Fusek, Gabriel; Lango, Peter; Bauer, Miroslav; Mende, Balazs Gusztav; Makovicky, Pavol; Bauerova, Maria			Maternal Genetic Composition of a Medieval Population from a Hungarian-Slavic Contact Zone in Central Europe	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; ANCIENT; INSIGHTS; EASTERN	The genetic composition of the medieval populations of Central Europe has been poorly investigated to date. In particular, the region of modern-day Slovakia is a blank spot in archaeogenetic research. This paper reports the study of mitochondrial DNA (mtDNA) in ancient samples from the 9th-12th centuries originating from the cemeteries discovered in Nitra-Sindolka and Cakajovce, located in western Slovakia (Central Europe). This geographical region is interesting to study because its medieval multi-ethnic population lived in the so-called contact zone of the territory of the Great Moravian and later Hungarian state formations. We described 16 different mtDNA haplotypes in 19 individuals, which belong to the most widespread European mtDNA haplogroups: H, J, T, U and R0. Using comparative statistical and population genetic analyses, we showed the differentiation of the European gene pool in the medieval period. We also demonstrated the heterogeneous genetic characteristics of the investigated population and its affinity to the populations of modern Europe.	[Csakyova, Veronika; Bauer, Miroslav; Bauerova, Maria] Constantine Philosopher Univ Nitra, Fac Nat Sci, Dept Bot & Genet, Nitra, Slovakia; [Szecsenyi-Nagy, Anna; Csosz, Aranka; Mende, Balazs Gusztav] Hungarian Acad Sci, Inst Archaeol, Res Ctr Humanities, Lab Archaeogenet, Budapest, Hungary; [Nagy, Melinda; Makovicky, Pavol] J Selye Univ Komarno, Fac Educ, Dept Biol, Komarno, Slovakia; [Fusek, Gabriel] Slovak Acad Sci, Inst Archaeol, Nitra, Slovakia; [Lango, Peter] Hungarian Acad Sci, Res Ctr Humanities, Inst Archaeol, Budapest, Hungary; [Bauer, Miroslav] NAFC, Res Inst Anim Prod, Nitra, Slovakia	Constantine the Philosopher University in Nitra; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for the Humanities; J. Selye University; Slovak Academy of Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for the Humanities; Slovak Agricultural Research Center	Csakyova, V (corresponding author), Constantine Philosopher Univ Nitra, Fac Nat Sci, Dept Bot & Genet, Nitra, Slovakia.	veronika.csakyova@ukf.sk	Fusek, Gabriel/Z-2185-2019; Bauerová, Mária/AAC-4455-2020; Nagy, Melinda/A-5702-2010; Bauer, Miroslav/AAC-2769-2020	Fusek, Gabriel/0000-0002-6665-1987; Nagy, Melinda/0000-0001-7127-3055; Bauer, Miroslav/0000-0002-5497-2900; Szecsenyi-Nagy, Anna/0000-0003-2095-738X; Bauerova, Maria/0000-0003-4803-3410	Ministry of Education, Science, Research and Sport of the Slovak Republic; Slovak Academy of Sciences [VEGA 1/0897/12]; project of University Grant Agency of the Constantine the Philosopher University in Nitra UGA [VIII/5/2015]	Ministry of Education, Science, Research and Sport of the Slovak Republic; Slovak Academy of Sciences(Slovak Academy of Sciences); project of University Grant Agency of the Constantine the Philosopher University in Nitra UGA	This research was realized in cooperation with the Constantine the Philosopher University in Nitra, the Institute of Archaeology, Research Centre for the Humanities, Hungarian Academy of Sciences, the Institute of Archaeology of the Slovak Academy of Sciences, and the University of Janos Selye in Komarno, in realizing the national grant of the Ministry of Education, Science, Research and Sport of the Slovak Republic and Slovak Academy of Sciences (Vedecka grantova agentura Ministerstva skolstva, vedy, vyskumu a sportu Slovenskej republiky a Slovenskej akademie vied) VEGA 1/0897/12, "Archaeogenetic research of contact zone from the 10th century in Slovakia" (MaB) and later supported also by the project of University Grant Agency of the Constantine the Philosopher University in Nitra UGA VIII/5/2015 (VC). The grants funded the research but had no role in study desing data collection and analysis. URLs: https://www.minedu.sk/rozpis-dotacii-na-nove-a-pokracujuce-projekty-vegana-rok-2012/; https://www.ukf.sk/projekty/univerzitnagrantova-agentura.	Alt KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110793; Alzualde A, 2006, AM J PHYS ANTHROPOL, V130, P394, DOI 10.1002/ajpa.20375; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 2012, LANG ENV STAT COMP; Barford P. M., 2001, EARLY SLAVS CULTURE; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fulton TL, 2012, METHODS MOL BIOL, V840, P111, DOI 10.1007/978-1-61779-516-9_15; Fusek G, 2012, ARCHAOLOGIE FRUHEN U, P89; Fusek Gabriel, 2008, KULTURWANDEL MITTELE, P645; Giesler J., 1981, PRAEHIST Z, V56, P3, DOI [10.1515/prhz.1981.56.1.3, DOI 10.1515/PRHZ.1981.56.1.3]; Guimaraes S, 2009, MOL BIOL EVOL, V26, P2157, DOI 10.1093/molbev/msp126; Helgason A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000343; Hervella M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034417; Juras A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110839; Kalmar T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e67; Krzewinska M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0384; Lango P, 2005, VARIA ARCHAEOLOGICA, P175; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Melchior L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011898; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pericic M, 2005, CROAT MED J, V46, P502; Pinhasi R, 2012, TRENDS GENET, V28, P496, DOI 10.1016/j.tig.2012.06.006; Rejholcova M., 1995, FONTES, V15; Rejholcova M, 1982, SLOV ARCHEOLOGIA, VXXX-1, P199; Relethford J., 2012, HUMAN POPULATION GEN; Rock AW, 2013, FORENSIC SCI INT-GEN, V7, P601, DOI 10.1016/j.fsigen.2013.07.005; Shapiro B, 2012, METHODS MOL BIOL, V840, P1, DOI 10.1007/978-1-61779-516-9; SLATKIN M, 1995, GENETICS, V139, P457; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Sussex R, 2011, THE SLAVIC LANGUAGES; Szecsenyi-Nagy A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0339; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tomory G, 2007, AM J PHYS ANTHROPOL, V134, P354, DOI 10.1002/ajpa.20677; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Toth Sandor Laszlo, 2005, RES PREHISTORY HUNGA, P45; Vai S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116801; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813	43	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151206	10.1371/journal.pone.0151206	http://dx.doi.org/10.1371/journal.pone.0151206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DG3TL	26963389	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000122
J	Goto, H; Shimada, H; Horak, MJ; Ahmad, A; Baltazar, BM; Perez, T; McPherson, MA; Stojsin, D; Shimono, A; Ohsawa, R				Goto, Hidetoshi; Shimada, Hiroshi; Horak, Michael J.; Ahmad, Aqeel; Baltazar, Baltazar M.; Perez, Tim; McPherson, Marc A.; Stojsin, Duska; Shimono, Ayako; Ohsawa, Ryo			Characterization of Natural and Simulated Herbivory on Wild Soybean (Glycine soja Seib. et Zucc.) for Use in Ecological Risk Assessment of Insect Protected Soybean	PLOS ONE			English	Article							GENETICALLY-MODIFIED CROPS; PROBLEM FORMULATION; MON 89788; DEFOLIATION; TOLERANCE; CULTIVARS; YIELD	Insect-protected soybean (Glycine max (L.) Merr.) was developed to protect against foliage feeding by certain Lepidopteran insects. The assessment of potential consequences of transgene introgression from soybean to wild soybean (Glycine soja Seib. et Zucc.) is required as one aspect of the environmental risk assessment (ERA) in Japan. A potential hazard of insect-protected soybean may be hypothesized as transfer of a trait by gene flow to wild soybean and subsequent reduction in foliage feeding by Lepidopteran insects that result in increased weediness of wild soybean in Japan. To assess this potential hazard two studies were conducted. A three-year survey of wild soybean populations in Japan was conducted to establish basic information on foliage damage caused by different herbivores. When assessed across all populations and years within each prefecture, the total foliage from different herbivores was <= 30%, with the lowest levels of defoliation (< 2%) caused by Lepidopteran insects. A separate experiment using five levels of simulated defoliation (0%, 10%, 25%, 50% and 100%) was conducted to assess the impact on pod and seed production and time to maturity of wild soybean. The results indicated that there was no decrease in wild soybean plants pod or seed number or time to maturity at defoliation rates up to 50%. The results from these experiments indicate that wild soybean is not limited by lepidopteran feeding and has an ability to compensate for defoliation levels observed in nature. Therefore, the potential hazard to wild soybean from the importation of insect-protected soybean for food and feed into Japan is negligible.	[Goto, Hidetoshi] Monsanto Japan Ltd, Chuo Ku, 2-5-18 Kyobashi, Tokyo 1040031, Japan; [Shimada, Hiroshi] Monsanto Japan Ltd, Kawachi Res Farm, 4475-2 Manaita Aza Dotemukai, Kawachi, Ibaraki 3001331, Japan; [Horak, Michael J.; Ahmad, Aqeel; Baltazar, Baltazar M.; Perez, Tim; McPherson, Marc A.; Stojsin, Duska] Monsanto Co, 800 N Lindbergh Blvd, St Louis, MO 63167 USA; [Shimono, Ayako] Toho Univ, Fac Sci, 2-2-1 Miyata, Funabashi, Chiba 2748510, Japan; [Ohsawa, Ryo] Univ Tsukuba, Grad Sch Life & Environm Sci, Lab Plant Breeding, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058572, Japan	Monsanto; Toho University; University of Tsukuba	Goto, H (corresponding author), Monsanto Japan Ltd, Chuo Ku, 2-5-18 Kyobashi, Tokyo 1040031, Japan.	hidetoshi.goto@monsanto.com	Shimono, Ayako/AAH-9085-2020		Monsanto Japan Limited; Monsanto Company	Monsanto Japan Limited; Monsanto Company	The funder provided support in the form of salaries for authors: HG and HS are employed by Monsanto Japan Limited, and MH, AA, BB, TP, MP, and DS are employed by Monsanto Company, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersson HC, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1879; Asano T., 1995, SEEDS FRUITS SEEDLIN, P62; Bernardi O, 2012, PEST MANAG SCI, V68, P1083, DOI 10.1002/ps.3271; CRAWLEY MJ, 1993, NATURE, V363, P620, DOI 10.1038/363620a0; Egli DB, 1998, SEED BIOL YIELD GRAI, P38; FEHR WR, 1977, CROP SCI, V17, P913, DOI 10.2135/cropsci1977.0011183X001700060024x; FUKUI J, 1978, Journal of the Faculty of Agriculture Iwate University, V14, P71; Haile FJ, 1998, AGRON J, V90, P344, DOI 10.2134/agronj1998.00021962009000030006x; Haile FJ, 1998, AGRON J, V90, P353, DOI 10.2134/agronj1998.00021962009000030007x; Hajika M, 2003, ANN REPORT EXPLORATI, V19, P7; HAUSER PT, 2013, FUNCTIONAL ECOLOGY, V0027, P00623, DOI DOI 10.1111/1365-2435.12053; Hokanson K, 1999, WORKSH EC EFF PEST R; Horak MJ, 2015, TRANSGENIC RES, V24, P213, DOI 10.1007/s11248-014-9839-3; Hunt T., 2010, DECISION MAKING GUID; James C., 2013, ISAAA BRIEF, V46; Japan Meteoroligical Agency, 2016, MET OBS DAT 2016; Kikuchi Atsushi, 2013, Proceedings of the Kansai Plant Protection Society, V55, P129; Kono Y, 2004, ANN REPORT EXPLORATI, V20, P11; Kuroda Y, 2008, CROP SCI, V48, P1071, DOI 10.2135/cropsci2007.09.0496; Lu Bao-Rong, 2004, Plant Species Biology, V19, P115, DOI 10.1111/j.1442-1984.2004.00108.x; Matsuo K, 2014, DEV BIOL DOCUMENT WI, V517, P478; Ministry of Agriculture Forestry and Fisheries, FOOD BAL SHEET FY201; Ministry of Finance, 2013, TRAD STAT JAP 2013; Mizuguti A, 2009, WEED BIOL MANAG, V9, P93, DOI 10.1111/j.1445-6664.2008.00324.x; MOE, 2014, JAP BIOS CLEAR HOUS; Nakayama Yuichiro, 2002, Weed Biology and Management, V2, P25, DOI 10.1046/j.1445-6664.2002.00043.x; Nickson TE, 2008, PLANT PHYSIOL, V147, P494, DOI 10.1104/pp.108.118422; Numata M., 1975, PICTORIAL BOOK WEED, P107; OECD, 2000, SER HARM REG OV BIOT, V15; *OECD, 1993, SAF CONS BIOT SCAL U; Ohashi H., 1999, WILD FLOWERS JAPAN H, P186; Pedersen P, 2009, SOYBEAN GROWTH DEV; Prado JR, 2014, ANNU REV PLANT BIOL, V65, P769, DOI 10.1146/annurev-arplant-050213-040039; Quijano A, 2011, FIELD CROP RES, V120, P151, DOI 10.1016/j.fcr.2010.09.009; Raybould Alan, 2006, Environmental Biosafety Research, V5, P119, DOI 10.1051/ebr:2007004; Rice M., 2002, INTEGRATED CROP MANA; Saruta M, 2009, ANN REPORT EXPLORATI, V25, P13; Saruta M, 2007, ANN REPORT EXPLORATI, V23, P1; SAS, 2002, SAS SOFTW REL 9 2 TS; SAS, 2014, SAS SOFTW REL 9 4; Shapiro CA, 1985, SOYBEAN YIELD LOSS D; Singer JW, 2004, AGRON J, V96, P1382, DOI 10.2134/agronj2004.1382; Takahashi M, 1996, KYUSHU AGR RES, V58, P51; Tilman David, 1997, P239; Tomooka N, 2009, ANN REPORT EXPLORATI, V25, P1; TRUMBLE JT, 1993, ANNU REV ENTOMOL, V38, P93, DOI 10.1146/annurev.en.38.010193.000521; WELTER SC, 1993, ECOL APPL, V3, P271, DOI 10.2307/1941830; Willson HR., 1989, 22 OH STAT U; Wolt JD, 2010, TRANSGENIC RES, V19, P425, DOI 10.1007/s11248-009-9321-9; Yamada T, 2012, ANN REPORT EXPLORATI, V28, P43; Yamada T, 2008, ANN REPORT EXPLORATI, V24, P1; Yasuda K, 2014, GENOMICS AGR INNOVAT; Yasuda Koji, 2012, Japan Heterocerists' Journal, V263, P333	53	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151237	10.1371/journal.pone.0151237	http://dx.doi.org/10.1371/journal.pone.0151237			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963815	Green Published, gold			2022-12-27	WOS:000371993000126
J	Grill, P; Tuckova, J				Grill, Pavel; Tuckova, Jana			Speech Databases of Typical Children and Children with SLI	PLOS ONE			English	Article							LANGUAGE IMPAIRMENT; WORKING-MEMORY; SHORT-TERM	The extent of research on children's speech in general and on disordered speech specifically is very limited. In this article, we describe the process of creating databases of children's speech and the possibilities for using such databases, which have been created by the LANNA research group in the Faculty of Electrical Engineering at Czech Technical University in Prague. These databases have been principally compiled for medical research but also for use in other areas, such as linguistics. Two databases were recorded: one for healthy children's speech (recorded in kindergarten and in the first level of elementary school) and the other for pathological speech of children with a Specific Language Impairment (recorded at a surgery of speech and language therapists and at the hospital). Both databases were sub-divided according to specific demands of medical research. Their utilization can be exoteric, specifically for linguistic research and pedagogical use as well as for studies of speech-signal processing.	[Grill, Pavel; Tuckova, Jana] Czech Tech Univ, Dept Circuit Theory, Fac Elect Engn, CR-16635 Prague, Czech Republic	Czech Technical University Prague	Grill, P (corresponding author), Czech Tech Univ, Dept Circuit Theory, Fac Elect Engn, CR-16635 Prague, Czech Republic.	grillpavel@gmail.com	Grill, Pavel/T-9292-2019		research IGA MZ [CRNT11443-5/2010]; IGA MZ CR-NR [8287-3/2005]	research IGA MZ; IGA MZ CR-NR	The work has been supported by research IGA MZ CRNT11443-5/2010 "Computer analysis of speech expression, EEG records and MR tractography in children with developmental dysphasia" and IGA MZ CR-NR 8287-3/2005 "Computer Analyses of Speech and Overnight EEG in Children."	Archibald LMD, 2006, INT J LANG COMM DIS, V41, P675, DOI 10.1080/13682820500442602; Bishop DVM, 2006, GENES BRAIN BEHAV, V5, P158, DOI 10.1111/j.1601-183X.2005.00148.x; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; Bishop DVM, 2014, PSYCHOL PRESS CLASS, P1; Bockova B, 2011, PODPORA ZAKU SE SPEC; Bolom V., 2008, DIGITAL TECHNOLOGIES, V1; CLAHSEN H, 1989, LINGUISTICS, V27, P897, DOI 10.1515/ling.1989.27.5.897; Eyben F., 2010, ACM MULTIMEDIA MM, P1459, DOI DOI 10.1145/1873951.1874246; Gopnik M, 1997, EVOLUTION SOCIAL BEH, V88; Grela B, 2013, HDB PSYCHOLINGUISTIC; Grill P, 2011, IEEE WORKSH EL CONTR; Grill P, 2009, TECHNICAL COMPUTING, P32; Grill P, 2010, DIGITAL TECHNOLOGIES; Grill P, 2012, BIODAT 2012, V1, P32; Grill P, 2011, TBMI VSB, P98; hang Y, 1994, P 5 AUSTR INT C SPEE, V2, P820; Kim H, DYSARTHRIC SPEECH DA; Klein L T, 2013, LANGUAGES LINGUISTIC; Knobloch H., 1980, MANUAL DEV DIAGNOSIS; Kohnert K, 2009, BRAIN LANG, V109, P101, DOI 10.1016/j.bandl.2008.01.009; Komarek V, 2011, 9 EPNS C MAY 2011 DU; Leonard L.B., 1998, CHILDREN SPECIFIC LA; Miller J D, 1996, CREATION 2 CHILDRENS, DOI [10.1109/ICASSP.1996.543254, DOI 10.1109/ICASSP.1996.543254]; Montgomery JW, 2010, AM J SPEECH-LANG PAT, V19, P78, DOI 10.1044/1058-0360(2009/09-0028); PALKOVA Z, 1994, PHONETICS PHONOLOGIC; Psutka J, 2006, WE TALK CZECH COMPUT; Saz O., 2010, ALBORADA I3A CORPUS; Saz O, 2008, WORKSH CHILD COMP IN; Swierkoszova J, 1990, SPECIFIC LEARNING DI; Thorndike R L, 1995, STANFORD BINET INTEL; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Tuckova J, 2008, NEUROENDOCRINOLOGY L, V29; Tuckova J, 2009, APPL ARTIFICIAL NEUR; Tuckova J, 2009, SELECTED APPL ARTIFI; van Weerdenburg M, 2011, J COMMUN DISORD, V44, P392, DOI 10.1016/j.jcomdis.2010.12.002; Vavrina J., 2012, LEKAR TECHNIKA, V42, P85; Vesanto J., 2000, SOM TOOLBOX MATLAB 5, V57, P60; Vranova M, 2011, AKL C TAB CZECH REP; Zetocha P, 2007, ECMS 2007 DOCT SCH 8; Zwitserlood R L M, 2014, LANGUAGE GROWTH DUTC	40	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150365	10.1371/journal.pone.0150365	http://dx.doi.org/10.1371/journal.pone.0150365			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TL	26963508	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000035
J	Noguchi, N; Inoue, S; Shimanoe, C; Shibayama, K; Shinchi, K				Noguchi, Norihito; Inoue, Satoshi; Shimanoe, Chisato; Shibayama, Kaoru; Shinchi, Koichi			Factors Associated with Nursing Activities in Humanitarian Aid and Disaster Relief	PLOS ONE			English	Article							HEALTH NURSES; PUBLIC-HEALTH; PREPAREDNESS; COMPETENCE; EARTHQUAKE; JAPAN	Background Although nurses play an important role in humanitarian aid and disaster relief (HA/DR), little is known about the nursing activities that are performed in HA/DR. We aimed to clarify the nursing activities performed by Japanese nurses in HA/DR and to examine the factors associated with the frequency of nursing activities. Methods A self-administered questionnaire survey was completed by 147 nurses with HA/DR experience. The survey extracted information on demographic characteristics, past experience (e.g., disaster medical training experience, HA/DR experience), circumstances surrounding their dispatched to HA/DR (e.g., team size, disaster type, post-disaster phase, mission term), and the frequency of nursing activities performed under HA/DR. The frequency of nursing activities was rated on a 5-point Likert scale. Evaluation of nursing activities was conducted based on the "nursing activity score", which represents the frequency of each nursing activity. Factors related to the nursing activity score were evaluated by multiple logistic regression analysis. Results Nurses were involved in 27 nursing activities in HA/DR, 10 of which were performed frequently. On analysis, factors significantly associated with nursing activity score were nursing license as a registered nurse (OR 7.79, 95% CI 2.95-20.57), two or more experiences with disaster medical training (OR 2.90 95%, CI 1.12-7.49) and a post-disaster phase of three weeks or longer (OR 8.77, 95% CI 2.59-29.67). Conclusions These results will contribute to the design of evidence-based disaster medical training that improves the quality of nursing activities.	[Noguchi, Norihito; Shinchi, Koichi] Saga Univ, Fac Med, Dept Community & Int Hlth Nursing, Saga 840, Japan; [Inoue, Satoshi] Saga Univ, Fac Med, Dept Emergency Med, Div Trauma Surg & Surg Crit Care, Saga 840, Japan; [Shimanoe, Chisato] Saga Univ, Fac Med, Dept Prevent Med, Saga 840, Japan; [Shibayama, Kaoru] Saga Ken Med Ctr Koseikan, Dept Nursing, Saga, Japan	Saga University; Saga University; Saga University	Noguchi, N (corresponding author), Saga Univ, Fac Med, Dept Community & Int Hlth Nursing, Saga 840, Japan.	13624019@edu.cc.saga-u.ac.jp		Shimanoe, Chisato/0000-0002-3561-9538; Shinchi, Koichi/0000-0003-2367-7607	Grants-in-Aid for Scientific Research [16K11946] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Asari Y, 2000, Prehosp Disaster Med, V15, P9; Baack S, 2013, J NURS SCHOLARSHIP, V45, P281, DOI 10.1111/jnu.12029; Bar-Tal D., 1976, PROSOCIAL BEHAV; Farfel A, 2011, EUR J PEDIATR, V170, P519, DOI 10.1007/s00431-011-1423-8; Fukuyama Y, 2006, J INT HLTH, V21, P169; Gary Klein, 1999, SOURCES POWER PEOPLE, P17; Glow SD, 2013, PREHOSP DISASTER MED, V28, P334, DOI 10.1017/S1049023X13000423; International Council of Nurses World Health Organization, 2009, ICN FRAM DIS NURS CO; Japan Ministry of Defense, 2014, DEF JAP 2014; Japanese Nursing Association, NURS IN JAP; Kako M, 2014, PREHOSP DISASTER MED, V29, P275, DOI 10.1017/S1049023X14000405; Kako M, 2012, PREHOSP DISASTER MED, V27, P178, DOI 10.1017/S1049023X12000520; Kondo Hisayoshi, 2002, Prehosp Disaster Med, V17, P126; Leaning J, 2013, NEW ENGL J MED, V369, P1836, DOI 10.1056/NEJMra1109877; Lim GH, 2013, PREHOSP DISASTER MED, V28, P353, DOI [10.1017/S1049023X1300349X, 10.1017/s1049023x1300349x]; LYNN MR, 1986, NURS RES, V35, P382; McLaughlin DE, 2005, PREPARING NURSES DIS, P55; Mohebbi HA, 2008, PREHOSP DISASTER MED, V23, P510, DOI 10.1017/S1049023X00006336; Morey Timothy E, 2013, Anesthesiol Clin, V31, P107, DOI 10.1016/j.anclin.2012.10.003; Nickerson JW, 2012, PREHOSP DISASTER MED, V27, P184, DOI 10.1017/S1049023X12000556; Ottem P, 2000, Nurs BC, V32, P19; Pesiridis T, 2015, NURSE EDUC PRACT, V15, P63, DOI 10.1016/j.nepr.2014.02.001; Putra A., 2011, NURSING MEDIA J NURS, V1, P169, DOI DOI 10.14710/NMJN.V1I2.971; Ranse J, 2015, ISSUES MENT HEALTH N, V36, P391, DOI 10.3109/01612840.2015.1017062; Redmond AD, 2011, PREHOSP DISASTER MED, V26, P449, DOI 10.1017/S1049023X12000088; Ripoll Gallardo A, 2015, DISASTER MED PUBLIC, V5, P1; Sakashita R., 2014, HLTH EMERGENCY DISAS, V1, P19; Silenas R, 2008, TEACH LEARN MED, V20, P62, DOI 10.1080/10401330701798311; The United Nations office for Disaster Risk Reduction, DIS STAT; Veenema TG, 2015, INT EMERG NURS, V23, P225, DOI 10.1016/j.ienj.2015.01.004; Verma Sarita, 2006, J Allied Health, V35, P109; Waltz CF., 2010, MEASUREMENT NURSING; Weiner E, 2005, NURS EDUC PERSPECT, V26, P334; WHO, 2013, CLASS MIN STAND FOR; Yamamoto A, 2013, JPN J NURS SCI, V10, P162, DOI 10.1111/jjns.12042; Yan YE, 2015, INT NURSING REV, V18; Yin HH, 2011, J ADV NURS, V67, P2231, DOI 10.1111/j.1365-2648.2011.05699.x; Yokoyama Y, 2014, PUBLIC HEALTH NURS, V31, P537, DOI 10.1111/phn.12141; Zhou WJ, 2015, NURSE EDUC PRACT, V15, P75, DOI 10.1016/j.nepr.2014.06.011	39	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151170	10.1371/journal.pone.0151170	http://dx.doi.org/10.1371/journal.pone.0151170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959351	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300106
J	Nymo, IH; Arias, MA; Pardo, J; Alvarez, MP; Alcaraz, A; Godfroid, J; de Bagues, MPJ				Nymo, Ingebjorg H.; Arias, Maykel A.; Pardo, Julian; Pilar Alvarez, Maria; Alcaraz, Ana; Godfroid, Jacques; Jimenez de Baguees, Mara Pilar			Marine Mammal Brucella Reference Strains Are Attenuated in a BALB/c Mouse Model	PLOS ONE			English	Article							HARBOR SEALS; INFECTION; ABORTUS; MICE; PINNIPEDIALIS; IMMUNE; CETI; RESPONSES; EMPHASIS; VIRULENT	Brucellosis is a zoonosis of worldwide distribution with numerous animal host species. Since the novel isolation of Brucella spp. from marine mammals in 1994 the bacteria have been isolated from various marine mammal hosts. The marine mammal reference strains Brucella pinnipedialis 12890 (harbour seal, Phoca vitulina) and Brucella ceti 12891 (harbour porpoise, Phocoena phocoena) were included in genus Brucella in 2007, however, their pathogenicity in the mouse model is pending. Herein this is evaluated in BALB/c mice with Brucella suis 1330 as a control. Both marine mammal strains were attenuated, however, B. ceti was present at higher levels than B. pinnipedialis in blood, spleen and liver throughout the infection, in addition B. suis and B. ceti were isolated from brains and faeces at times with high levels of bacteraemia. In B. suis-infected mice serum cytokines peaked at day 7. In B. pinnipedialis-infected mice, levels were similar, but peaked predominantly at day 3 and an earlier peak in spleen weight likewise implied an earlier response. The inflammatory response induced pathology in the spleen and liver. In B. ceti-infected mice, most serum cytokine levels were comparable to those in uninfected mice, consistent with a limited inflammatory response, which also was indicated by restricted spleen and liver pathology. Specific immune responses against all three strains were detected in vitro after stimulation of splenocytes from infected mice with the homologous heat-killed brucellae. Antibody responses in vivo were also induced by the three brucellae. The immunological pattern of B. ceti in combination with persistence in organs and limited pathology has heretofore not been described for other brucellae. These two marine mammal wildtype strains show an attenuated pattern in BALB/c mice only previously described for Brucella neotomea.	[Nymo, Ingebjorg H.; Godfroid, Jacques] Univ Tromso UiT, Arctic Univ Norway, Arctic Infect Biol, Fac Biosci Fisheries & Econ, Tromso, Norway; [Arias, Maykel A.; Pilar Alvarez, Maria; Jimenez de Baguees, Mara Pilar] Univ Zaragoza, Unidad Tecnol Prod & Sanidad Anim, Ctr Invest & Tecnol Agroalimentaria, Inst Agroalimentario Aragon, Zaragoza, Spain; [Arias, Maykel A.; Pardo, Julian] Univ Zaragoza, Cell Immun Canc Inflammat & Infect Grp, Dept Biochem & Mol & Cell Biol, Biomed Res Ctr Aragon CIBA,IIS Aragon, Zaragoza, Spain; [Pilar Alvarez, Maria] Gobierno Aragon, Lab Agroalimentario, Zaragoza, Spain; [Alcaraz, Ana] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA USA	UiT The Arctic University of Tromso; University of Zaragoza; University of Zaragoza; Western University of Health Sciences	Nymo, IH (corresponding author), Univ Tromso UiT, Arctic Univ Norway, Arctic Infect Biol, Fac Biosci Fisheries & Econ, Tromso, Norway.	ingebjorg.h.nymo@uit.no	Cabrero, Maykel Arias/AAB-1436-2020; Pardo, Julián/K-6764-2014; Godfroid, Jacques/HCI-7835-2022; Godfroid, Jacques/U-3524-2017	Pardo, Julián/0000-0003-0154-0730; Godfroid, Jacques/0000-0002-0782-7858; Nymo, Ingebjorg Helena/0000-0002-4844-8344; Jimenez de Bagues, Maria Pilar/0000-0002-5490-5177	National Institute for Agricultural and Food Research and Technology (INIA) and agrifood research in Spain [RTA 2013-00065-C02-01]; European Social Fund [SAF2014-54763-C2]	National Institute for Agricultural and Food Research and Technology (INIA) and agrifood research in Spain; European Social Fund(European Social Fund (ESF))	This work was supported by the grants RTA 2013-00065-C02-01 from The National Institute for Agricultural and Food Research and Technology (INIA) and agrifood research in Spain (MPJdB) and SAF2014-54763-C2 from the European Social Fund (JP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A., 2010, CELL MOL IMMUNOL, V6th ed., P267; Abbasi A, 2010, IEEE ICC; Arias MA, 2014, CELL REP, V8, P419, DOI 10.1016/j.celrep.2014.06.012; Baldi Pablo C, 2013, Recent Pat Antiinfect Drug Discov, V8, P18; Baldwin CL, 2002, VET MICROBIOL, V90, P367, DOI 10.1016/S0378-1135(02)00222-5; Baldwin CL, 2010, BRUCELLA MOL CELLULA, P341; Barnes LG, 2002, ENCY MARINE MAMMALS, P204; Berta A., 2002, ENCY MARINE MAMMALS, P903; Bingham J, 2008, NEW ZEAL VET J, V56, P10, DOI 10.1080/00480169.2008.36798; Brandao APMS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/589494; CORBEL MJ, 1975, INT J SYST BACTERIOL, V25, P83, DOI 10.1099/00207713-25-1-83; Corbel MJ., 2005, BERGEYS MANUAL SYSTE, V2, P370; ELZER PH, 1994, IMMUNOLOGY, V82, P651; EWALT DR, 1994, J VET DIAGN INVEST, V6, P448, DOI 10.1177/104063879400600408; Fairless AH, 2012, BEHAV BRAIN RES, V228, P299, DOI 10.1016/j.bbr.2011.12.001; Flecknell P, 2002, ALTEX-ALTERN TIEREXP, V19, P73; Foster G, 2002, VET MICROBIOL, V90, P563, DOI 10.1016/S0378-1135(02)00236-5; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Foster G, 2015, J WILDLIFE DIS, V51, P868, DOI 10.7589/2014-04-112; Grillo MJ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-29; Gu WP, 2013, INFECT IMMUN, V81, P4392, DOI 10.1128/IAI.00856-13; Gul HC, 2009, INT J INFECT DIS, V13, pE339, DOI 10.1016/j.ijid.2009.02.015; Guzman-Verri C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00003; Hernandez-Mora G, 2013, REV SCI TECH OIE, V32, P89; HONG CB, 1991, VET PATHOL, V28, P492, DOI 10.1177/030098589102800605; Hovelsrud GK, 2008, ECOL APPL, V18, pS135, DOI 10.1890/06-0843.1; Izadjoo MJ, 2004, INFECT IMMUN, V72, P4031, DOI 10.1128/IAI.72.7.4031-4039.2004; de Bagues MPJ, 2014, J INFECT DIS, V210, P467, DOI 10.1093/infdis/jiu102; Lambourn D, 2013, J WILDLIFE DIS, V49, P802, DOI 10.7589/2012-05-137; Larsen AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084861; Larsen AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070186; Maquart M, 2009, MICROBES INFECT, V11, P361, DOI 10.1016/j.micinf.2008.12.012; McDonald WL, 2006, J CLIN MICROBIOL, V44, P4363, DOI 10.1128/JCM.00680-06; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Moustafa DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014112; Nymo IH, 2013, THESIS NORWEGIAN SCH; Nymo IH, 2014, COMP IMMUNOL MICROB, V37, P195, DOI 10.1016/j.cimid.2014.01.005; Nymo IH, 2013, DIS AQUAT ORGAN, V106, P187, DOI 10.3354/dao02659; Nymo IH, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-93; Perrett LL, 2004, SMALL RUMINANT RES, V51, P221, DOI 10.1016/S0921-4488(03)00233-5; Pulzova L, 2009, FEMS IMMUNOL MED MIC, V57, P203, DOI 10.1111/j.1574-695X.2009.00594.x; Radostits OM., 2000, VET MED TXB DIS CATT, V9th, P867; Rajashekara G, 2005, CELL MICROBIOL, V7, P1459, DOI 10.1111/j.1462-5822.2005.00570.x; Rhyan JC, 2001, J VET DIAGN INVEST, V13, P379, DOI 10.1177/104063870101300502; ROSS HM, 1994, VET REC, V134, P359, DOI 10.1136/vr.134.14.359-b; Sathiyaseelan J, 2006, CELL IMMUNOL, V243, P1, DOI 10.1016/j.cellimm.2006.10.003; Scholz HC, 2008, INT J SYST EVOL MICR, V58, P375, DOI 10.1099/ijs.0.65356-0; Scholz HC, 2010, INT J SYST EVOL MICR, V60, P801, DOI 10.1099/ijs.0.011148-0; Sidor I, 2008, P BRUC 2008 INT RES; Sidor IF, 2013, J VET DIAGN INVEST, V25, P72, DOI 10.1177/1040638712470945; Sohn AH, 2003, EMERG INFECT DIS, V9, P485, DOI 10.3201/eid0904.020576; STEVENS MG, 1994, INFECT IMMUN, V62, P3206, DOI 10.1128/IAI.62.8.3206-3212.1994; Trinchieri, 2005, ANNU REV IMMUNOL, V13, P251; Verger JM, 1988, TECHNIQUES BRUCELLOS; von Bargen K, 2012, FEMS MICROBIOL REV, V36, P533, DOI 10.1111/j.1574-6976.2012.00334.x; Whatmore AM, 2008, EMERG INFECT DIS, V14, P517, DOI 10.3201/eid1403.070829; Whatmore AM, 2014, INT J SYST EVOL MICR, V64, P4120, DOI 10.1099/ijs.0.065482-0; Zarnke RL, 2006, J WILDLIFE DIS, V42, P290, DOI 10.7589/0090-3558-42.2.290; Zhan YF, 1996, INFECT IMMUN, V64, P2782, DOI 10.1128/IAI.64.7.2782-2786.1996	59	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150432	10.1371/journal.pone.0150432	http://dx.doi.org/10.1371/journal.pone.0150432			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959235	gold, Green Published, Green Submitted			2022-12-27	WOS:000371992300051
J	Shi, J; Sharif, S; Ruijtenbeek, R; Pieters, RJ				Shi, Jie; Sharif, Suhela; Ruijtenbeek, Rob; Pieters, Roland J.			Activity Based High-Throughput Screening for Novel O-GlcNAc Transferase Substrates Using a Dynamic Peptide Microarray	PLOS ONE			English	Article							LINKED N-ACETYLGLUCOSAMINE; MASS-SPECTROMETRY; GLCNACYLATION; CANCER; DISCOVERY; DISEASE; PHOSPHORYLATION; IDENTIFICATION; SPECIFICITY; INHIBITORS	O-GlcNAcylation is a reversible and dynamic protein post-translational modification in mammalian cells. The O-GlcNAc cycle is catalyzed by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). O-GlcNAcylation plays important role in many vital cellular events including transcription, cell cycle regulation, stress response and protein degradation, and altered O-GlcNAcylation has long been implicated in cancer, diabetes and neurodegenerative diseases. Recently, numerous approaches have been developed to identify OGT substrates and study their function, but there is still a strong demand for highly efficient techniques. Here we demonstrated the utility of the peptide microarray approach to discover novel OGT substrates and study its specificity. Interestingly, the protein RBL-2, which is a key regulator of entry into cell division and may function as a tumor suppressor, was identified as a substrate for three isoforms of OGT. Using peptide Ala scanning, we found Ser 420 is one possible O-GlcNAc site in RBL-2. Moreover, substitution of Ser 420, on its own, inhibited OGT activity, raising the possibility of mechanism-based development for selective OGT inhibitors. This approach will prove useful for both discovery of novel OGT substrates and studying OGT specificity.	[Shi, Jie; Sharif, Suhela; Ruijtenbeek, Rob; Pieters, Roland J.] Univ Utrecht, Dept Med Chem & Chem Biol, Utrecht, Netherlands; [Ruijtenbeek, Rob] PamGene Int BV, sHertogenbosch, Netherlands	Utrecht University; PamGene International BV	Pieters, RJ (corresponding author), Univ Utrecht, Dept Med Chem & Chem Biol, Utrecht, Netherlands.	r.j.pieters@uu.nl	Pieters, Roland J/A-9254-2008	Pieters, Roland J/0000-0003-4723-3584	China Scholarship Council [201306180061]; PamGene International BV	China Scholarship Council(China Scholarship Council); PamGene International BV(PamGene International BV)	This work was supported by a scholarship (file No. 201306180061) to JS from the China Scholarship Council (http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript. RR is employed by the commercial company "PamGene International BV". PamGene International BV provided support in the form of salary for the author RR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author RR is articulated in the "author contributions" section.	Aarts JMMJG, 2013, CHEM RES TOXICOL, V26, P336, DOI 10.1021/tx300463b; Anderson JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139267; Bagella L, 2007, ONCOGENE, V26, P1829, DOI 10.1038/sj.onc.1209987; Baldi A, 1997, CLIN CANCER RES, V3, P1691; Banerjee PS, 2013, CHEM SOC REV, V42, P4345, DOI 10.1039/c2cs35412h; Brister MA, 2014, J AM CHEM SOC, V136, P3803, DOI 10.1021/ja407156m; Chuh KN, 2014, J AM CHEM SOC, V136, P12283, DOI 10.1021/ja504063c; Copeland RJ, 2013, PROTEOM CLIN APPL, V7, P597, DOI 10.1002/prca.201300001; Deng RP, 2014, PROTEOMICS, V14, P1020, DOI 10.1002/pmic.201300144; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Dias WB, 2012, BIOCHEM BIOPH RES CO, V422, P224, DOI 10.1016/j.bbrc.2012.04.124; Eldar-Finkelman H, 2009, CURR PHARM DESIGN, V15, P2463, DOI 10.2174/138161209788682253; Folkvord S, 2010, INT J RADIAT ONCOL, V78, P555, DOI 10.1016/j.ijrobp.2010.04.036; Genovese C, 2006, ONCOGENE, V25, P5201, DOI 10.1038/sj.onc.1209652; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hilhorst R, 2009, ANAL BIOCHEM, V387, P150, DOI 10.1016/j.ab.2009.01.022; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Jochmann R, 2014, BBA-PROTEINS PROTEOM, V1844, P416, DOI 10.1016/j.bbapap.2013.12.002; Kim EJ, 2014, BIOCONJUGATE CHEM, V25, P1025, DOI 10.1021/bc5001774; Kim Eun Ju, 2013, Methods Mol Biol, V1022, P129, DOI 10.1007/978-1-62703-465-4_11; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lee VMY, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006437; Lemeer S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000581; Liu XY, 2014, FASEB J, V28, P3362, DOI 10.1096/fj.13-246850; Ma ZY, 2013, AMINO ACIDS, V45, P719, DOI 10.1007/s00726-013-1543-8; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Maury JJP, 2014, ANAL CHEM, V86, P395, DOI 10.1021/ac401821d; Ortiz-Meoz RF, 2014, J AM CHEM SOC, V136, P4845, DOI 10.1021/ja500451w; Pathak S, 2015, NAT STRUCT MOL BIOL, V22, P744, DOI 10.1038/nsmb.3063; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sikkema AH, 2009, CANCER RES, V69, P5987, DOI 10.1158/0008-5472.CAN-08-3660; Vocadlo DJ, 2012, CURR OPIN CHEM BIOL, V16, P488, DOI 10.1016/j.cbpa.2012.10.021; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Wells L, 2011, AMINO ACIDS, V40, P877, DOI 10.1007/s00726-010-0709-x; Wu HY, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S16-S1; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]; Zhang H, 2012, SEMIN CELL DEV BIOL, V23, P872, DOI 10.1016/j.semcdb.2012.05.009; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351	42	19	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151085	10.1371/journal.pone.0151085	http://dx.doi.org/10.1371/journal.pone.0151085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960196	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300094
J	Zhu, JW; Khalil, SM; Mitchell, RD; Bissinger, BW; Egekwu, N; Sonenshine, DE; Roe, RM				Zhu, Jiwei; Khalil, Sayed M.; Mitchell, Robert D.; Bissinger, Brooke W.; Egekwu, Noble; Sonenshine, Daniel E.; Roe, R. Michael			Mevalonate-Farnesal Biosynthesis in Ticks: Comparative Synganglion Transcriptomics and a New Perspective	PLOS ONE			English	Article							AMERICAN DOG TICK; JUVENILE-HORMONE BIOSYNTHESIS; DERMACENTOR-VARIABILIS ACARI; ACID-O-METHYLTRANSFERASE; METHYL FARNESOATE; CORPORA ALLATA; VITELLOGENIN SYNTHESIS; REPRODUCTION; 20-HYDROXYECDYSONE; METAMORPHOSIS	Juvenile hormone (JH) controls the growth, development, metamorphosis, and reproduction of insects. For many years, the general assumption has been that JH regulates tick and other acarine development and reproduction the same as in insects. Although researchers have not been able to find the common insect JHs in hard and soft tick species and JH applications appear to have no effect on tick development, it is difficult to prove the negative or to determine whether precursors to JH are made in ticks. The tick synganglion contains regions which are homologous to the corpora allata, the biosynthetic source for JH in insects. Next-gen sequencing of the tick synganglion transcriptome was conducted separately in adults of the American dog tick, Dermacentor variabilis, the deer tick, Ixodes scapularis, and the relapsing fever tick, Ornithodoros turicata as a new approach to determine whether ticks can make JH or a JH precursor. All of the enzymes that make up the mevalonate pathway from acetyl-CoA to farnesyl diphosphate (acetoacetyl-CoA thiolase, HMG-S, HMG-R, mevalonate kinase, phosphomevalonate kinase, diphosphomevalonate decarboxylase, and farnesyl diphosphate synthase) were found in at least one of the ticks studied but most were found in all three species. Sequence analysis of the last enzyme in the mevalonate pathway, farnesyl diphosphate synthase, demonstrated conservation of the seven prenyltransferase regions and the aspartate rich motifs within those regions typical of this enzyme. In the JH branch from farnesyl diphosphate to JH III, we found a putative farnesol oxidase used for the conversion of farnesol to farnesal in the synganglion transcriptome of I. scapularis and D. variabilis. Methyltransferases (MTs) that add a methyl group to farnesoic acid to make methyl farnesoate were present in all of the ticks studied with similarities as high as 36% at the amino acid level to insect JH acid methyltransferase (JHAMT). However, when the tick MTs were compared to the known insect JHAMTs from several insect species at the amino acid level, the former lacked the farnesoic acid binding motif typical in insects. The P450s shown in insects to add the C10,11 epoxide to methyl farnesoate, are in the CYP15 family; this family was absent in our tick transcriptomes and in the I. scapularis genome, the only tick genome available. These data suggest that ticks do not synthesize JH III but have the mevalonate pathway and may produce a JH III precursor.	[Zhu, Jiwei; Khalil, Sayed M.; Mitchell, Robert D.; Bissinger, Brooke W.; Roe, R. Michael] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Egekwu, Noble; Sonenshine, Daniel E.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA	University of North Carolina; North Carolina State University; Old Dominion University	Roe, RM (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	Michael_roe@ncsu.edu	Khalil, Sayed/AAJ-5597-2020; Mitchell, Robert/S-1726-2019; Sonenshine, Daniel/AAF-3625-2020	Khalil, Sayed/0000-0003-4433-4953; Mitchell, Bobby/0000-0001-6011-960X; Noble, Noble/0000-0002-8380-6792; Roe, Richard/0000-0002-6386-0994	National Science Foundation [IOS-0949194]; NIH [R21AI096268, 1R21AI096268]; NCSU Agricultural Research Foundation; NSF [IOS-0949194]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI096268] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCSU Agricultural Research Foundation; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the laboratories of RMR and DES was provided by grants from the National Science Foundation (IOS-0949194) and NIH (R21AI096268). RMR received a grant from the NCSU Agricultural Research Foundation to fund JZ in part. JZ also was supported by a teaching assistantship from the Department of Entomology at NCSU.; The authors thank Jennifer Schaff and Nigel Deighton and Ms. Megan Ulmer from the NC State Genome Sciences Laboratory (GSL) at North Carolina State University, Raleigh, NC, USA for their assistance with transcriptome sequencing via the Illumina platform and the Roche 454 pyrosequencing system. We want to thank Mr. Anirudh Dhammi for providing photographs of adult male and female American dog ticks. This work was funded by grants to RMR and DES from NIH (1R21AI096268) and NSF (IOS-0949194), a grant to RMR from the NCSU Agricultural Research Foundation, and a teaching assistantship from the Department of Entomology at NCSU to JZ.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen S.O., 1985, COMPREHENSIVE INSECT, V3, P59, DOI 10.1016/0020-711X(85)90033-3; Anderson JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-552; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Cane D. E., 1999, COMPREHENSIVE NATURA, V2, P1; CHANG ES, 1993, AM ZOOL, V33, P324; CHANG ES, 1993, ANNU REV ENTOMOL, V38, P161, DOI 10.1146/annurev.en.38.010193.001113; CHARMANTIER G, 1991, J CRUSTACEAN BIOL, V11, P481, DOI 10.2307/1548517; Cheng DJ, 2014, GENET MOL BIOL, V37, P444, DOI [10.1590/S1415-47572014005000006, 10.1590/S1415-47572014000300018]; CHINZEI Y, 1991, J MED ENTOMOL, V28, P506, DOI 10.1093/jmedent/28.4.506; CLARK AJ, 1959, J BIOL CHEM, V234, P2578; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CONNAT JL, 1983, INT J INVER REP DEV, V6, P285, DOI 10.1080/01651269.1983.10510054; Deborah MT, 2007, INSECT BIOCHEM MOLEC, V37, P363, DOI 10.1016/j.ibmb.2007.01.004; Defelipe LA, 2011, INSECT BIOCHEM MOLEC, V41, P228, DOI 10.1016/j.ibmb.2010.12.008; Donohue KV, 2010, INSECT BIOCHEM MOLEC, V40, P79, DOI 10.1016/j.ibmb.2009.12.014; Egekwu N, 2015, INSECT MOL IN PRESS; Egekwu N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102667; FEYEREISEN R, 1981, EUR J BIOCHEM, V118, P231; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Friesen KJ, 2002, J INSECT PHYSIOL, V48, P773, DOI 10.1016/S0022-1910(02)00107-5; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Gulia-Nuss M, 2015, NATURE COMM IN PRESS; HALLICK RB, 1977, NUCLEIC ACIDS RES, V4, P3055, DOI 10.1093/nar/4.9.3055; HAMMOCK BD, 1975, LIFE SCI, V17, P323, DOI 10.1016/0024-3205(75)90479-8; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Homola E, 1997, COMP BIOCHEM PHYS B, V117, P347, DOI 10.1016/S0305-0491(96)00337-9; Huang XQ, 1996, GENOMICS, V33, P21, DOI 10.1006/geno.1996.0155; Khalil SMS, 2011, J INSECT PHYSIOL, V57, P400, DOI 10.1016/j.jinsphys.2010.12.008; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; Klowden MJ, 1997, ARCH INSECT BIOCHEM, V35, P491, DOI 10.1002/(SICI)1520-6327(1997)35:4<491::AID-ARCH10>3.3.CO;2-5; KOYAMA T, 1993, J BIOCHEM-TOKYO, V113, P355, DOI 10.1093/oxfordjournals.jbchem.a124051; LAUFER H, 1993, AM ZOOL, V33, P365; Li YP, 2003, INSECT BIOCHEM MOLEC, V33, P1307, DOI 10.1016/j.ibmb.2003.07.003; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Marchal E, 2011, INSECT BIOCHEM MOLEC, V41, P219, DOI 10.1016/j.ibmb.2010.12.007; Margulies M, 2005, NATURE; Mayoral JG, 2009, P NATL ACAD SCI USA, V106, P21091, DOI 10.1073/pnas.0909938106; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; Nagaraju GPC, 2007, AQUACULTURE, V272, P39, DOI 10.1016/j.aquaculture.2007.05.014; Neese PA, 2000, J INSECT PHYSIOL, V46, P477, DOI 10.1016/S0022-1910(99)00134-1; Niwa R, 2008, INSECT BIOCHEM MOLEC, V38, P714, DOI 10.1016/j.ibmb.2008.04.003; Noriega FG, 2006, INSECT BIOCHEM MOLEC, V36, P366, DOI 10.1016/j.ibmb.2006.01.013; OLIVER JH, 1985, J MED ENTOMOL, V22, P281, DOI 10.1093/jmedent/22.3.281; Pennisi E, 2015, SCIENCE, V347, P220, DOI 10.1126/science.347.6219.220; POUND JM, 1979, SCIENCE, V206, P355, DOI 10.1126/science.206.4416.355; PRATT GE, 1975, EXPERIENTIA, V31, P120, DOI 10.1007/BF01924713; Reibstein D, 1976, ENZYMATIC SYNTHESIS, P131; Roe R.M., 2013, BIOL TICKS, V1, P416; Roe RM, 2008, FRONT BIOSCI-LANDMRK, V13, P7250, DOI 10.2741/3226; Roe RM, 2014, BIOL TICKS; Sankhon N, 1999, J INSECT PHYSIOL, V45, P755, DOI 10.1016/S0022-1910(99)00054-2; Santos AC, 2004, CURR BIOL, V14, pR578, DOI 10.1016/j.cub.2004.07.018; Sen SE, 2007, INSECT BIOCHEM MOLEC, V37, P1198, DOI 10.1016/j.ibmb.2007.07.011; Seybold SJ, 2003, ANNU REV ENTOMOL, V48, P425, DOI 10.1146/annurev.ento.48.091801.112645; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Sonenshine D. E., 1993, ECOLOGY NIDICOLOUS T, V2; Sonenshine DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024711; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR D, 1991, INSECT BIOCHEM, V21, P723, DOI 10.1016/0020-1790(91)90113-S; Terrapon N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4636; Thompson DM, 2005, J INSECT PHYSIOL, V51, P1105, DOI 10.1016/j.jinsphys.2005.05.011; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WEAVER RJ, 1980, INSECT BIOCHEM, V10, P245, DOI 10.1016/0020-1790(80)90019-0; Zhu XX, 2001, EXP APPL ACAROL, V25, P1005, DOI 10.1023/A:1020664211999	70	20	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0141084	10.1371/journal.pone.0141084	http://dx.doi.org/10.1371/journal.pone.0141084			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959814	Green Published, gold			2022-12-27	WOS:000371992300001
J	Athey, TBT; Teatero, S; Takamatsu, D; Wasserscheid, J; Dewar, K; Gottschalk, M; Fittipaldi, N				Athey, Taryn B. T.; Teatero, Sarah; Takamatsu, Daisuke; Wasserscheid, Jessica; Dewar, Ken; Gottschalk, Marcelo; Fittipaldi, Nahuel			Population Structure and Antimicrobial Resistance Profiles of Streptococcus suis Serotype 2 Sequence Type 25 Strains	PLOS ONE			English	Article							FLUOROQUINOLONE RESISTANCE; CONJUGATIVE ELEMENTS; DISEASED PIGS; VIRULENCE; PATHOGEN; ALIGNMENT; GENE; SUSCEPTIBILITY; IDENTIFICATION; RECOMBINATION	Strains of serotype 2 Streptococcus suis are responsible for swine and human infections. Different serotype 2 genetic backgrounds have been defined using multilocus sequence typing (MLST). However, little is known about the genetic diversity within each MLST sequence type (ST). Here, we used whole-genome sequencing to test the hypothesis that S. suis serotype 2 strains of the ST25 lineage are genetically heterogeneous. We evaluated 51 serotype 2 ST25 S. suis strains isolated from diseased pigs and humans in Canada, the United States of America, and Thailand. Whole-genome sequencing revealed numerous large-scale rearrangements in the ST25 genome, compared to the genomes of ST1 and ST28 S. suis strains, which result, among other changes, in disruption of a pilus island locus. We report that recombination and lateral gene transfer contribute to ST25 genetic diversity. Phylogenetic analysis identified two main and distinct Thai and North American clades grouping most strains investigated. These clades also possessed distinct patterns of antimicrobial resistance genes, which correlated with acquisition of different integrative and conjugative elements (ICEs). Some of these ICEs were found to be integrated at a recombination hot spot, previously identified as the site of integration of the 89K pathogenicity island in serotype 2 ST7 S. suis strains. Our results highlight the limitations of MLST for phylogenetic analysis of S. suis, and the importance of lateral gene transfer and recombination as drivers of diversity in this swine pathogen and zoonotic agent.	[Athey, Taryn B. T.; Teatero, Sarah; Fittipaldi, Nahuel] Publ Hlth Ontario, Toronto, ON, Canada; [Takamatsu, Daisuke] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki 305, Japan; [Takamatsu, Daisuke] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Wasserscheid, Jessica; Dewar, Ken] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Wasserscheid, Jessica; Dewar, Ken] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Gottschalk, Marcelo] Univ Montreal, Fac Med Vet, Grp Rech Malad Infect Porc, St Hyacinthe, PQ J2S 7C6, Canada; [Fittipaldi, Nahuel] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Gifu University; McGill University; Universite de Montreal; University of Toronto	Fittipaldi, N (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.; Fittipaldi, N (corresponding author), Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	nahuel.fittipaldi@oahpp.ca	Gottschalk, Marcelo/I-8116-2012	Fittipaldi, Nahuel/0000-0001-9553-3798	Public Health Ontario [PIF 2014-005]	Public Health Ontario	This work was supported by Public Health Ontario through internal grant PIF 2014-005 to NF.; We are grateful to Serge Messier and Sonia Lacouture (University of Montreal) for help with phenotypic antimicrobial characterization of S. suis, and bacterial strain collection, respectively. We thank Aimin Li and the staff at Public Health Ontario Genome Core facility, and Dax Torti, University of Toronto Donnelly Centre, for Illumina sequencing of the S. suis ST25 strains. We thank Genevieve Geneau and Alfredo Staffa and other staff at the McGill University and Genome Quebec Innovation Centre for PacBio sequencing. This work was supported by Public Health Ontario through internal grant PIF 2014-005 to NF.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; [Anonymous], 2010, R LANG ENV STAT COMP; Escudero JA, 2007, ANTIMICROB AGENTS CH, V51, P777, DOI 10.1128/AAC.00972-06; Athey TBT, 2016, J CLIN MICROBIOL, V54, P83, DOI 10.1128/JCM.02201-15; Athey TBT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137760; Berthelot-Herault F, 2005, CAN J VET RES, V69, P236; Brochet M, 2008, J BACTERIOL, V190, P6913, DOI 10.1128/JB.00824-08; Callens BF, 2013, MICROB DRUG RESIST, V19, P146, DOI 10.1089/mdr.2012.0131; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Clinical and Laboratory Standards Institute, 2020, M100 CLSI, V30th; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 2000, GENOME BIOL, V1; Fittipaldi N, 2008, INFECT IMMUN, V76, P3587, DOI 10.1128/IAI.01568-07; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fittipaldi N, 2011, EMERG INFECT DIS, V17, P2239, DOI 10.3201/eid1712.110609; Fittipaldi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008426; GOTTSCHALK M, 1989, J CLIN MICROBIOL, V27, P2633, DOI 10.1128/JCM.27.12.2633-2636.1989; Gottschalk M, 2011, DIS SWINE, P841; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Gottschalk M, 2013, VET MICROBIOL, V162, P819, DOI 10.1016/j.vetmic.2012.10.028; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; GOTTSCHALK MG, 1995, MICROBIOL-SGM, V141, P189, DOI 10.1099/00221287-141-1-189; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Haenni M, 2010, APPL ENVIRON MICROB, V76, P7957, DOI 10.1128/AEM.00805-10; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Hughes D, 2000, GENOME BIOL, V1; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Lee WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090581; Li M, 2011, MOL MICROBIOL, V79, P1670, DOI 10.1111/j.1365-2958.2011.07553.x; Marini E, 2015, VET MICROBIOL, V178, P99, DOI 10.1016/j.vetmic.2015.04.013; Marttinen P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-421; Maruyama F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-358; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Nusbaum C, 2009, NAT METHODS, V6, P67, DOI [10.1038/NMETH.1286, 10.1038/nmeth.1286]; Okura M, 2011, J BACTERIOL, V193, P822, DOI 10.1128/JB.01555-09; Palmieri C, 2012, ANTIMICROB AGENTS CH, V56, P4697, DOI 10.1128/AAC.00629-12; Palmieri C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00235; Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-7-405, 10.1186/gb-2013-14-6-405]; Rui P, 2012, J ANIM VET ADV, V11, P719; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Silva LMG, 2006, VET MICROBIOL, V115, P117, DOI 10.1016/j.vetmic.2005.12.013; SMITH HE, 1993, INFECT IMMUN, V61, P3318, DOI 10.1128/IAI.61.8.3318-3326.1993; Sonnhammer ELL, 2015, NUCLEIC ACIDS RES, V43, pD234, DOI 10.1093/nar/gku1203; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Takamatsu D, 2008, EMERG INFECT DIS, V14, P181, DOI 10.3201/eid1401.070568; Takamatsu D, 2009, VET MICROBIOL, V138, P132, DOI 10.1016/j.vetmic.2009.02.013; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Weinert LA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7740; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Wisselink HJ, 2006, VET MICROBIOL, V113, P73, DOI 10.1016/j.vetmic.2005.10.035; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Yao J, 2014, BIOSCI TRENDS, V8, P84, DOI 10.5582/bst.8.84; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194	63	23	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150908	10.1371/journal.pone.0150908	http://dx.doi.org/10.1371/journal.pone.0150908			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954687	gold, Green Published, Green Submitted			2022-12-27	WOS:000371991300058
J	del Amo, E; Esteva, C; Hernandez-Bou, S; Galles, C; Navarro, M; Sauca, G; Diaz, A; Gassiot, P; Marti, C; Larrosa, N; Ciruela, P; Jane, M; Sa-Leao, R; Munoz-Almagro, C				del Amo, Eva; Esteva, Cristina; Hernandez-Bou, Susanna; Galles, Carmen; Navarro, Marian; Sauca, Goretti; Diaz, Alvaro; Gassiot, Paula; Marti, Carmina; Larrosa, Nieves; Ciruela, Pilar; Jane, Mireia; Sa-Leao, Raquel; Munoz-Almagro, Carmen		Catalan Study Grp Invasive Pneumoc	Serotypes and Clonal Diversity of Streptococcus pneumoniae Causing Invasive Disease in the Era of PCV13 in Catalonia, Spain	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; IMMUNIZATION PLAN; CHILDREN; IMPACT; IDENTIFICATION; EPIDEMIOLOGY; EMERGENCE	The aim of this study was to study the serotypes and clonal diversity of pneumococci causing invasive pneumococcal disease in Catalonia, Spain, in the era of 13-valent pneumococcal conjugate vaccine (PCV13). In our region, this vaccine is only available in the private market and it is estimated a PCV13 vaccine coverage around 55% in children. A total of 1551 pneumococcal invasive isolates received between 2010 and 2013 in the Molecular Microbiology Department at Hospital Sant Joan de Deu, Barcelona, were included. Fifty-two serotypes and 249 clonal types-defined by MLST-were identified. The most common serotypes were serotype 1 (n = 182; 11.7%), 3 (n = 145; 9.3%), 19A (n = 137; 8.8%) and 7F (n = 122; 7.9%). Serotype 14 was the third most frequent serotype in children < 2 years (15 of 159 isolates). PCV7 serotypes maintained their proportion along the period of study, 16.6% in 2010 to 13.4% in 2013, whereas there was a significant proportional decrease in PCV13 serotypes, 65.3% in 2010 to 48.9% in 2013 (p<0.01). This decrease was mainly attributable to serotypes 19A and 7F. Serotype 12F achieved the third position in 2013 (n = 22, 6.4%). The most frequent clonal types found were ST306 (n = 154, 9.9%), ST191 (n = 111, 7.2%), ST989 (n = 85, 5.5%) and ST180 (n = 80, 5.2%). Despite their decrease, PCV13 serotypes continue to be a major cause of disease in Spain. These results emphasize the need for complete PCV13 vaccination.	[del Amo, Eva; Esteva, Cristina; Munoz-Almagro, Carmen] Hosp St Joan de Deu, Dept Mol Microbiol, Esplugas de Llobregat, Spain; [Hernandez-Bou, Susanna] Hosp St Joan de Deu, Dept Paediat, Esplugas de Llobregat, Spain; [Hernandez-Bou, Susanna] Univ Barcelona, Esplugas de Llobregat, Spain; [Galles, Carmen] Hosp St Jaume, Dept Microbiol, Calella, Spain; [Navarro, Marian] Hosp Vic, Dept Microbiol, Vic, Spain; [Sauca, Goretti] Hosp Mataro, Dept Microbiol, Mataro, Spain; [Diaz, Alvaro] Hosp Nens, Dept Microbiol, Barcelona, Spain; [Gassiot, Paula] Hosp Figueres, Dept Microbiol, Figueres, Spain; [Marti, Carmina] Hosp Gen Granollers, Dept Microbiol, Granollers, Spain; [Larrosa, Nieves] Hosp Valle De Hebron, Dept Microbiol, Barcelona, Spain; [Ciruela, Pilar; Jane, Mireia] Govt Catalonia, Publ Hlth Agcy, Barcelona, Spain; [Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Mol Microbiol Human Pathogens, P-2780156 Oeiras, Portugal	University of Barcelona; Hospital Universitari Vall d'Hebron; Public Health Agency of Barcelona; Universidade Nova de Lisboa	Munoz-Almagro, C (corresponding author), Hosp St Joan de Deu, Dept Mol Microbiol, Esplugas de Llobregat, Spain.	cma@hsjdbcn.org	Larrosa, María Nieves/C-5004-2014; Muñoz-Almagro, Carmen/N-7248-2015; Sá-Leão, Raquel/A-9341-2011; Garcia-Garcia, Juan José/J-5295-2014	Larrosa, María Nieves/0000-0001-8808-0233; Muñoz-Almagro, Carmen/0000-0001-5586-404X; Sá-Leão, Raquel/0000-0001-9804-827X; Garcia-Garcia, Juan José/0000-0002-3483-528X; Gimenez, Montserrat/0000-0001-8841-810X; Esteva Afonso, Cristina/0000-0001-7133-4540	FEDER; Ministry of Science and Innovation; Institute of Health Carlos III; Projects of Research on Health (FIS project) [PI13/01729]; Godia Foundation; Sant Joan de Deu Foundation; Instituto de Salud Carlos III [PFIS0100]	FEDER(European Commission); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Institute of Health Carlos III(Instituto de Salud Carlos III); Projects of Research on Health (FIS project); Godia Foundation; Sant Joan de Deu Foundation; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by FEDER and the Ministry of Science and Innovation, Institute of Health Carlos III, Projects of Research on Health (FIS project number PI13/01729), Godia Foundation and Sant Joan de Deu Foundation. EdA was the recipient of a fellowship from Instituto de Salud Carlos III (PFIS0100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2010, J CLIN MICROBIOL, V48, P101, DOI 10.1128/JCM.00665-09; [Anonymous], MANUAL VACUNAS LINEA; [Anonymous], 2013, CLIN BREAKP; [Anonymous], 2013, EUROPEAN PUBLIC ASSE; Antonio M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-81; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Ardanuy C, 2009, J ANTIMICROB CHEMOTH, V64, P507, DOI 10.1093/jac/dkp210; AUSTRIAN R, 1976, MT SINAI J MED, V43, P699; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Ben-Shimol S, 2012, VACCINE, V30, P6600, DOI 10.1016/j.vaccine.2012.08.012; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Browall S, 2014, J INFECT DIS, V209, P377, DOI 10.1093/infdis/jit481; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; del Amo E, 2015, EUR J CLIN MICROBIOL, V34, P705, DOI 10.1007/s10096-014-2280-y; del Amo E, 2014, CLIN MICROBIOL INFEC, V20, P684, DOI 10.1111/1469-0691.12422; Dinleyici EC, 2008, EXPERT REV VACCINES, V7, P1367, DOI 10.1586/14760584.7.9.1367; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gabarrot GG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112337; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; Jauneikaite E, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.37; Jefferies JMC, 2004, J CLIN MICROBIOL, V42, P5681, DOI 10.1128/JCM.42.12.5681-5688.2004; Lepoutre A, 2015, VACCINE, V33, P359, DOI 10.1016/j.vaccine.2014.11.011; Louie M, 1999, J INFECT DIS, V179, P892, DOI 10.1086/314664; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Metcalf BJ, 2015, CLIN MICROBIOL INFEC; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Moraga-Llop F, 2015, PEDIAT INFECT DIS J; Munoz-Almagro C, 2014, CLIN MICROBIOL INFEC, V20, pO745, DOI 10.1111/1469-0691.12615; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Munoz-Almagro C, 2011, J INFECTION, V63, P151, DOI 10.1016/j.jinf.2011.06.002; Overweg K, 2000, J CLIN MICROBIOL, V38, P4548, DOI 10.1128/JCM.38.12.4548-4553.2000; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Regev-Yochay G, 2015, VACCINE, V33, P1135, DOI 10.1016/j.vaccine.2015.01.030; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Selva L, 2012, EUR J CLIN MICROBIOL, V31, P1487, DOI 10.1007/s10096-011-1468-7; Selva L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041587; Selva L, 2012, J CLIN MICROBIOL, V50, P3451, DOI 10.1128/JCM.01368-12; Servei Catala de la Salut, INF REG CON MIN BAS; Setchanova LP, 2015, MICROB DRUG RESIST, V21, P35, DOI 10.1089/mdr.2014.0076; Sjostrom K, 2007, P NATL ACAD SCI USA, V104, P12907, DOI 10.1073/pnas.0705589104; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; van der Linden M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131494; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; World Health Organization, 2007, WKLY EPIDEMIOL REC, V82, P93	46	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151125	10.1371/journal.pone.0151125	http://dx.doi.org/10.1371/journal.pone.0151125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953887	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300087
J	Vaughn, VL; Gross, DC				Vaughn, Vanessa L.; Gross, Dennis C.			Characterization of salA, syrF, and syrG Genes and Attendant Regulatory Networks Involved in Plant Pathogenesis by Pseudomonas syringae pv. syringae B728a	PLOS ONE			English	Article							QUORUM-SENSING SYSTEM; TRANSCRIPTIONAL ACTIVATOR; SYRINGOPEPTIN PRODUCTION; RESPONSE REGULATOR; LEAF SURFACES; DNA-BINDING; LUXR GENE; VIRULENCE; BIOSYNTHESIS; SYRINGOMYCIN	Pseudomonas syringae pv. syringae B728a, causal agent of brown spot on bean, is an economically important plant pathogen that utilizes extracellular signaling to initiate a lifestyle change from an epiphyte to a pathogen. LuxR regulatory proteins play an important role in the transcriptional regulation of a variety of biological processes involving two-component signaling, quorum sensing, and secondary metabolism. Analysis of the B728a genome identified 24 LuxR-like proteins, three of which are encoded by salA, syrF, and syrG located adjacent to the syringomycin gene cluster. The LuxR-like proteins encoded by these three genes exhibit a domain architecture that places them in a subfamily of LuxR-like proteins associated with regulation of secondary metabolism in B728a. Deletion mutants of salA, syrF, and syrG failed to produce syringomycin and displayed reduction of virulence on bean. The transcriptional start sites of salA, syrG, and syrF were located 63, 235, and 498 bp upstream of the start codons, respectively, using primer extension analysis. The predicted -10/-35 promoter regions of syrF and syrG were confirmed using site-directed mutagenesis and GFP reporters that showed conserved promoter sequences around the -35 promoter region. Overexpression analysis and GFP reporters identified SyrG as an upstream transcriptional activator of syrF, where both SyrG and SyrF activate promoters of syringomycin biosynthesis genes. This study shows that syrG and syrF encode important transcriptional regulators of syringomycin biosynthesis genes.	[Vaughn, Vanessa L.; Gross, Dennis C.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Gross, DC (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.	d-gross@tamu.edu			Texas A&M AgriLife Research project [TEX0-1-8832]; Texas A&M University Online Access to Knowledge Fund (OAKFund); Office of the Vice President for Research	Texas A&M AgriLife Research project; Texas A&M University Online Access to Knowledge Fund (OAKFund); Office of the Vice President for Research	This work was supported by Texas A&M AgriLife Research project no vertical bar TEX0-1-8832. The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge Fund (OAKFund), supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaras B, 2013, MICROBIOL-SGM, V159, P230, DOI 10.1099/mic.0.061614-0; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; CHOI SH, 1992, J BACTERIOL, V174, P4064, DOI 10.1128/jb.174.12.4064-4069.1992; Danot O, 2001, P NATL ACAD SCI USA, V98, P435, DOI 10.1073/pnas.98.2.435; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ducros VMA, 2001, J MOL BIOL, V306, P759, DOI 10.1006/jmbi.2001.4443; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Finney AH, 2002, J BACTERIOL, V184, P4520, DOI 10.1128/JB.184.16.4520-4528.2002; GAMBELLO MJ, 1991, J BACTERIOL, V173, P3000, DOI 10.1128/JB.173.9.3000-3009.1991; Greenwald JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034804; Greenwald JW, 2011, THESIS TEXAS A M U C; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; He WQ, 2008, ARCH MICROBIOL, V189, P501, DOI 10.1007/s00203-007-0346-2; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Hussain MBBM, 2008, J BACTERIOL, V190, P1045, DOI 10.1128/JB.01472-07; Hutchison ML, 1997, MOL PLANT MICROBE IN, V10, P347, DOI 10.1094/MPMI.1997.10.3.347; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; KAPLAN HB, 1987, P NATL ACAD SCI USA, V84, P6639, DOI 10.1073/pnas.84.19.6639; KING EO, 1954, J LAB CLIN MED, V44, P301; Kitten T, 1998, MOL MICROBIOL, V28, P917, DOI 10.1046/j.1365-2958.1998.00842.x; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; LEONG SA, 1982, J BIOL CHEM, V257, P8724; Lu SE, 2005, MOL PLANT MICROBE IN, V18, P324, DOI 10.1094/MPMI-18-0324; Lu SE, 2002, FEMS MICROBIOL LETT, V210, P115, DOI 10.1111/j.1574-6968.2002.tb11169.x; Lu SE, 2002, MOL PLANT MICROBE IN, V15, P43, DOI 10.1094/MPMI.2002.15.1.43; Marco ML, 2005, ENVIRON MICROBIOL, V7, P1379, DOI 10.1111/j.1462-2920.2005.00825.x; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Monier JM, 2004, APPL ENVIRON MICROB, V70, P346, DOI 10.1128/AEM.70.1.346-355.2004; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PIPER KR, 1993, NATURE, V362, P448, DOI 10.1038/362448a0; Quinones B, 2005, MOL PLANT MICROBE IN, V18, P682, DOI 10.1094/MPMI-18-0682; Ramel C, 2012, MOL PLANT MICROBE IN, V25, P1198, DOI 10.1094/MPMI-03-12-0070-R; Ravindran A, 2015, MICROBIOLOGYOPEN, V4, P553, DOI 10.1002/mbo3.261; Records AR, 2010, J BACTERIOL, V192, P3584, DOI 10.1128/JB.00114-10; Saha S, 2013, MOL PLANT MICROBE IN, V26, P1123, DOI 10.1094/MPMI-04-13-0090-CR; Sawahel W, 1993, DEV ELECTROTRANSFORM, P261; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scholz-Schroeder BK, 2003, MOL PLANT MICROBE IN, V16, P271, DOI 10.1094/MPMI.2003.16.4.271; Scholz-Schroeder BK, 2001, MOL PLANT MICROBE IN, V14, P336, DOI 10.1094/MPMI.2001.14.3.336; Selin C, 2012, MICROBIOL-SGM, V158, P896, DOI 10.1099/mic.0.054254-0; SHADEL GS, 1992, J BIOL CHEM, V267, P7696; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Thakur PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058846; VIDAVER AK, 1967, APPL MICROBIOL, V15, P1523, DOI 10.1128/AEM.15.6.1523-1524.1967; Wang N, 2006, J BACTERIOL, V188, P3290, DOI 10.1128/JB.188.9.3290-3298.2006; Wang N, 2006, J BACTERIOL, V188, P160, DOI 10.1128/JB.188.1.160-168.2006; Welch M, 2000, EMBO J, V19, P631, DOI 10.1093/emboj/19.4.631; Wilson DJ, 2001, J BACTERIOL, V183, P3468, DOI 10.1128/JB.183.11.3468-3475.2001; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Yang MH, 2009, J BACTERIOL, V191, P434, DOI 10.1128/JB.01247-08; Yu XL, 2014, MBIO, V5, DOI 10.1128/mBio.01683-14; Yu XL, 2013, P NATL ACAD SCI USA, V110, pE425, DOI 10.1073/pnas.1221892110; Zhang JH, 2003, BIOCHEMISTRY-US, V42, P2552, DOI 10.1021/bi0272205	56	10	12	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150234	10.1371/journal.pone.0150234	http://dx.doi.org/10.1371/journal.pone.0150234			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954255	Green Submitted, Green Published, gold			2022-12-27	WOS:000371991300017
J	Zhong, XX; Feng, DD; Yu, H; Kong, LF; Li, Q				Zhong, Xiaoxiao; Feng, Dandan; Yu, Hong; Kong, Lingfeng; Li, Qi			Genetic Variation and Breeding Signature in Mass Selection Lines of the Pacific Oyster (Crassostrea gigas) Assessed by SNP Markers	PLOS ONE			English	Article							POPULATION-STRUCTURE; MICROSATELLITE LOCI; ATLANTIC SALMON; WILD; VARIABILITY; POLYMORPHISM; ASSOCIATION; DIVERSITY; MORTALITY; THUNBERG	In breeding industries, a challenging problem is how to keep genetic diversity over generations. To investigate genetic variation and identify breeding signatures in mass selected lines of Pacific oyster (Crassostrea gigas), three sixth-generation selected lines and four wild populations were assessed using 103 single nucleotide polymorphism (SNP) markers. The genetic diversity data indicated that the selected lines exhibited a significant reduction in the observed heterozygosity and observed number of alleles per locus compared with the wild populations (P <= 0.05), indicating the selected lines tended to lose genetic diversity contrasted with the wild populations. The unweighted pair-group method with arithmetic mean (UPGMA) analysis showed that the wild populations and selected lines were not separated into two groups. Using four outlier tests, a total of 17 loci were found under selection at two levels. The global outlier detection suggested that 4 common outlier loci were subject to selection using both the hierarchical island model and Bayesian likelihood approaches. At regional level, 3 SNPs were detected as outlier using at least two outlier tests and one outlier SNP (CgSNP309) was overlapped in the two wild-selected population comparisons. The candidate outlier SNPs provide valuable resources for future association studies in C. gigas.	[Zhong, Xiaoxiao; Feng, Dandan; Yu, Hong; Kong, Lingfeng; Li, Qi] Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao, Peoples R China	Ocean University of China	Li, Q (corresponding author), Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao, Peoples R China.	qili66@ouc.edu.cn	Kong, Lingfeng/AAJ-3402-2021; Kong, Lingfeng/AAG-2473-2019; Feng, Dandan/X-7524-2019; Zhong, Xiaoxiao/HGU-6374-2022	Kong, Lingfeng/0000-0001-5263-1697; 	National High Technology Research and Development Program [2012AA10A405-6]; National Natural Science Foundation of China [31372524]; Seed Improvement Project of Shandong Province	National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Seed Improvement Project of Shandong Province	This study was supported by grants from the National High Technology Research and Development Program (2012AA10A405-6), National Natural Science Foundation of China (31372524), and Seed Improvement Project of Shandong Province.; We wish to thank Qi Li for his help on the project designment and comments on previous drafts of this manuscript. We also thank Hong Yu, Lingfeng Kong and Dandan Feng to help us accomplish this project. This work was supported by the National High Technology Research and Development Program, National Natural Science Foundation of China, and Seed Improvement Project of Shandong Province.	ALLENDORF FW, 1980, T AM FISH SOC, V109, P537, DOI 10.1577/1548-8659(1980)109&lt;537:LOGVIA&gt;2.0.CO;2; [Anonymous], 1999, POPGENE VERSION 1 3; Chistiakov DA, 2006, AQUACULTURE, V255, P1, DOI 10.1016/j.aquaculture.2005.11.031; Clifford SL, 1998, J FISH BIOL, V52, P118, DOI 10.1111/j.1095-8649.1998.tb01557.x; Cong RH, 2014, BIOCHEM SYST ECOL, V54, P144, DOI 10.1016/j.bse.2014.02.003; Cruz P, 2004, MAR BIOTECHNOL, V6, P157, DOI 10.1007/s10126-003-0017-5; Degremont L, 2010, AQUACULTURE, V299, P21, DOI 10.1016/j.aquaculture.2009.11.017; DILLON RT, 1987, AQUACULTURE, V60, P99, DOI 10.1016/0044-8486(87)90301-2; DOF, 2013, CHIN FISH STAT YB; Dundon WG, 2011, AQUACULTURE, V314, P49, DOI 10.1016/j.aquaculture.2011.02.005; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fisher, 1958, GENETICAL THEORY NAT; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HEDGECOCK D, 1990, AQUACULTURE, V88, P21, DOI 10.1016/0044-8486(90)90316-F; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jiang Q, 2013, GENES GENOM, V35, P641, DOI 10.1007/s13258-013-0114-4; Kane NC, 2007, GENETICS, V175, P1823, DOI 10.1534/genetics.106.067728; Kauer MO, 2003, GENETICS, V165, P1137; Kohlmann K, 2005, AQUACULTURE, V247, P253, DOI 10.1016/j.aquaculture.2005.02.024; Kong LF, 2007, AQUACULTURE, V271, P152, DOI 10.1016/j.aquaculture.2007.06.007; Langdon C, 2003, AQUACULTURE, V220, P227, DOI 10.1016/S0044-8486(02)00621-X; LEBERG PL, 1992, EVOLUTION, V46, P477, DOI 10.1111/j.1558-5646.1992.tb02053.x; Li MH, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-32; Li Q, 2004, AQUACULTURE, V235, P207, DOI 10.1016/j.aquaculture.2003.12.018; Li Q, 2002, J SHELLFISH RES, V21, P811; Li Q, 2007, AQUACULTURE, V269, P211, DOI 10.1016/j.aquaculture.2007.04.017; Li Q, 2011, FISHERIES SCI, V77, P643, DOI 10.1007/s12562-011-0369-0; Liu FL, 2012, AQUACULTURE, V358, P139, DOI 10.1016/j.aquaculture.2012.06.022; Liu YG, 2015, CONSERV GENET RESOUR, V7, P659, DOI 10.1007/s12686-015-0471-1; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nguyen MT, 2010, AQUACULTURE, V301, P7, DOI 10.1016/j.aquaculture.2010.02.001; Ni LH, 2011, MAR ECOL-EVOL PERSP, V32, P488, DOI 10.1111/j.1439-0485.2011.00436.x; Norris AT, 1999, AQUACULTURE, V180, P247, DOI 10.1016/S0044-8486(99)00212-4; Prasertlux S, 2010, AQUACULTURE, V308, pS83, DOI 10.1016/j.aquaculture.2010.06.038; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Roberge C, 2006, MOL ECOL, V15, P9, DOI 10.1111/j.1365-294X.2005.02807.x; Sauvage C, 2009, MOL ECOL RESOUR, V9, P853, DOI 10.1111/j.1755-0998.2009.02525.x; Sauvage C, 2010, GENETICS, V185, P105, DOI 10.1534/genetics.110.115071; Schlotterer C, 2005, NOVEL TEST STAT IDEN; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Suquet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093486; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Tymchuk W, 2009, GEN COMP ENDOCR, V164, P175, DOI 10.1016/j.ygcen.2009.05.015; Vasemagi A, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/628204; Wang LL, 2007, AQUACULTURE, V271, P252, DOI 10.1016/j.aquaculture.2007.06.020; Wang Y, 2008, ANIM GENET, V39, P287, DOI 10.1111/j.1365-2052.2008.01701.x; Ward RD, 2000, AQUAC RES, V31, P35, DOI 10.1046/j.1365-2109.2000.00388.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Xiao J, 2010, MAR BIOL, V157, P1767, DOI 10.1007/s00227-010-1449-x; Yu ZN, 2004, MAR BIOTECHNOL, V6, P575, DOI 10.1007/s10126-004-3600-5; Zhong XX, 2014, AQUACULT INT, V22, P1877, DOI 10.1007/s10499-014-9789-z; Zhong XX, 2013, J WORLD AQUACULT SOC, V44, P455, DOI 10.1111/jwas.12044	59	10	10	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150868	10.1371/journal.pone.0150868	http://dx.doi.org/10.1371/journal.pone.0150868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954577	Green Published, gold			2022-12-27	WOS:000371991300056
J	Kalatzis, PG; Bastias, R; Kokkari, C; Katharios, P				Kalatzis, Panos G.; Bastias, Roberto; Kokkari, Constantina; Katharios, Pantelis			Isolation and Characterization of Two Lytic Bacteriophages, phi St2 and phi Grn1; Phage Therapy Application for Biological Control of Vibrio alginolyticus in Aquaculture Live Feeds	PLOS ONE			English	Article							FISH PATHOGEN; SEA BREAM; MACROBRACHIUM-ROSENBERGII; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; HATCHERY; ANGUILLARUM; BACTERIA; LARVAE; IDENTIFICATION	Bacterial infections are a serious problem in aquaculture since they can result in massive mortalities in farmed fish and invertebrates. Vibriosis is one of the most common diseases in marine aquaculture hatcheries and its causative agents are bacteria of the genus Vibrio mostly entering larval rearing water through live feeds, such as Artemia and rotifers. The pathogenic Vibrio alginolyticus strain V1, isolated during a vibriosis outbreak in cultured seabream, Sparus aurata, was used as host to isolate and characterize the two novel bacteriophages phi St2 and phi Grn1 for phage therapy application. In vitro cell lysis experiments were performed against the bacterial host V. alginolyticus strain V1 but also against 12 presumptive Vibrio strains originating from live prey Artemia salina cultures indicating the strong lytic efficacy of the 2 phages. In vivo administration of the phage cocktail, phi St2 and phi Grn1, at MOI = 100 directly on live prey A. salina cultures, led to a 93% decrease of presumptive Vibrio population after 4 h of treatment. Current study suggests that administration of phi St2 and phi Grn1 to live preys could selectively reduce Vibrio load in fish hatcheries. Innovative and environmental friendly solutions against bacterial diseases are more than necessary and phage therapy is one of them.	[Kalatzis, Panos G.; Bastias, Roberto; Kokkari, Constantina; Katharios, Pantelis] Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion 71003, Crete, Greece; [Kalatzis, Panos G.] Univ Copenhagen, Marine Biol Sect, Helsingor, Denmark; [Bastias, Roberto] Pontificia Univ Catolica Valparaiso, Inst Biol, Valparaiso, Chile	Hellenic Centre for Marine Research; University of Copenhagen; Pontificia Universidad Catolica de Valparaiso	Katharios, P (corresponding author), Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion 71003, Crete, Greece.	katharios@hcmr.gr	Bastías, Roberto/AAW-7522-2021; Katharios, Pantelis/G-8886-2011; Bastias, Roberto/A-4500-2014; KALATZIS, PANAGIOTIS/J-1233-2019	Bastías, Roberto/0000-0003-4819-6148; Katharios, Pantelis/0000-0001-9905-5068; Bastias, Roberto/0000-0003-4819-6148; KALATZIS, PANAGIOTIS/0000-0003-3029-783X	European Social Fund; Greek National Strategic Reference Framework FISHPHAGE project [131]; European Union, FP7 Marie Curie, IRSES, AQUAPHAGE project [269175]; PROAQUA project (Danish Committee for Strategic Research in Health, Food and Welfare); Greek National Funds	European Social Fund(European Social Fund (ESF)); Greek National Strategic Reference Framework FISHPHAGE project; European Union, FP7 Marie Curie, IRSES, AQUAPHAGE project; PROAQUA project (Danish Committee for Strategic Research in Health, Food and Welfare); Greek National Funds(Greek Ministry of Development-GSRT)	The current study was funded by the Greek National Strategic Reference Framework 2007-2013 (co-funded by European Social Fund and Greek National Funds) FISHPHAGE project 131, www.gsrt.gr, by the European Union, FP7 Marie Curie, IRSES 2010, AQUAPHAGE project 269175, http://ec.europa.eu/research/index.cfm and by PROAQUA project (Danish Committee for Strategic Research in Health, Food and Welfare). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon ST, 2001, APPL ENVIRON MICROB, V67, P4233, DOI 10.1128/AEM.67.9.4233-4241.2001; Abedon Stephen T, 2011, Bacteriophage, V1, P46, DOI 10.4161/bact.1.1.13980; Akayli T, 2008, ISR J AQUACULT-BAMID, V60, P89; Akinbowale OL, 2006, J APPL MICROBIOL, V100, P1103, DOI 10.1111/j.1365-2672.2006.02812.x; Athanassopoulou F, 1999, J FISH DIS, V22, P215, DOI 10.1046/j.1365-2761.1999.00151.x; Austin B., 2012, BACTERIAL FISH PATHO, DOI [10. 1007/978-94-007-4884-2, DOI 10.1007/978-94-007-4884-2]; Balcazar JL, 2010, ANTON LEEUW INT J G, V97, P207, DOI 10.1007/s10482-009-9398-4; Balebona MC, 1998, APPL ENVIRON MICROB, V64, P4269; Castillo D, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00729-15; Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/FMB.13.47, 10.2217/fmb.13.47]; COLORNI A, 1981, AQUACULTURE, V23, P257, DOI 10.1016/0044-8486(81)90019-3; Comeau AM, 2006, ENVIRON MICROBIOL, V8, P1164, DOI 10.1111/j.1462-2920.2006.01006.x; Crothers-Stomps C, 2010, J APPL MICROBIOL, V108, P1744, DOI 10.1111/j.1365-2672.2009.04578.x; Dhont J, 2013, WOODHEAD PUBL FOOD S, P157, DOI 10.1533/9780857097460.1.157; Di Pinto A, 2005, J FOOD PROTECT, V68, P150, DOI 10.4315/0362-028X-68.1.150; Golkar Z, 2014, J INFECT DEV COUNTR, V8, P129, DOI 10.3855/jidc.3573; Goulden EF, 2013, WOODHEAD PUBL FOOD S, P246, DOI 10.1533/9780857097460.1.246; Goulden EF, 2012, APPL ENVIRON MICROB, V78, P2841, DOI 10.1128/AEM.07274-11; Guerrero-Ferreira RC, 2011, P NATL ACAD SCI USA, V108, P9963, DOI 10.1073/pnas.1012388108; Heuer OE, 2009, CLIN INFECT DIS, V49, P1248, DOI 10.1086/605667; Higuera G, 2013, AQUACULTURE, V392, P128, DOI 10.1016/j.aquaculture.2013.02.013; Hoffmann M, 2012, LETT APPL MICROBIOL, V54, P160, DOI 10.1111/j.1472-765X.2011.03183.x; Hoj L, 2009, AQUACULTURE, V293, P278, DOI 10.1016/j.aquaculture.2009.04.024; Holmfeldt K, 2007, APPL ENVIRON MICROB, V73, P6730, DOI 10.1128/AEM.01399-07; Hong GE, 2007, FEMS MICROBIOL LETT, V269, P201, DOI 10.1111/j.1574-6968.2006.00618.x; Jayaprakash NS, 2006, AQUAC RES, V37, P351, DOI 10.1111/j.1365-2109.2006.01432.x; Jensen EC, 1998, APPL ENVIRON MICROB, V64, P575; Jensen MA, 2006, P NATL ACAD SCI USA, V103, P4652, DOI 10.1073/pnas.0600166103; Karunasagar I, 2007, AQUACULTURE, V268, P288, DOI 10.1016/j.aquaculture.2007.04.049; Kennedy B, 2006, AQUACULTURE, V261, P1156, DOI 10.1016/j.aquaculture.2006.09.015; Kong WD, 2015, ANTON LEEUW INT J G, V107, P1197, DOI 10.1007/s10482-015-0411-9; Kutter Elizabeth, 2009, V501, P141, DOI 10.1007/978-1-60327-164-6_14; Lee DY, 2008, YONSEI MED J, V49, P329, DOI 10.3349/ymj.2008.49.2.329; Lee KK, 1996, CURR MICROBIOL, V32, P229, DOI 10.1007/s002849900041; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; Lin Y, 2012, BIO MED CENT GENOMIC; Lin YR, 2012, ARCH VIROL, V157, P917, DOI 10.1007/s00705-012-1244-8; Loc-Carrillo Catherine, 2011, Bacteriophage, V1, P111; Lomeli-Ortega CO, 2014, AQUACULTURE, V434, P208, DOI 10.1016/j.aquaculture.2014.08.018; LOPES CM, 1993, CLIN INFECT DIS, V17, P299, DOI 10.1093/clinids/17.2.299; Martinez-Diaz SF, 2013, AQUACULTURE, V400, P120, DOI 10.1016/j.aquaculture.2013.03.007; Martins ML, 2010, BRAZ J BIOL, V70, P205, DOI 10.1590/S1519-69842010000100028; Mateus L, 2014, AQUACULTURE, V424, P167, DOI 10.1016/j.aquaculture.2014.01.001; Meaden S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00358; MIYAMOTO Y, 1961, JPN J MICROBIOL, V5, P477, DOI 10.1111/j.1348-0421.1961.tb00225.x; MOINEAU S, 1993, APPL ENVIRON MICROB, V59, P197, DOI 10.1128/AEM.59.1.197-202.1993; MUNRO PD, 1993, FISH FARMING TECHNOLOGY, P85; Mustapha S, 2013, INDIAN J SCI TECHNOL, V2, P302; Nakai T, 2002, RES MICROBIOL, V153, P13, DOI 10.1016/S0923-2508(01)01280-3; Olafsen JA, 2001, AQUACULTURE, V200, P223, DOI 10.1016/S0044-8486(01)00702-5; Oliveira J, 2012, AQUACULT INT, V20, P879, DOI 10.1007/s10499-012-9515-7; Pang L, 2006, LETT APPL MICROBIOL, V43, P249, DOI 10.1111/j.1472-765X.2006.01962.x; 허용주, 2012, [JOURNAL OF FISH PATHOLOGY, 한국어병학회지], V25, P165, DOI 10.7847/jfp.2012.25.3.165; Park SC, 2000, APPL ENVIRON MICROB, V66, P1416, DOI 10.1128/AEM.66.4.1416-1422.2000; Patil JR, 2014, DIS AQUAT ORGAN, V112, P113, DOI 10.3354/dao02806; Perreten V, 2005, FRONTIERS IN ANTIMICROBIAL RESISTANCE: A TRIBUTE TO STUART B. LEVY, P446; Phumkhachorn P, 2010, AFR J MICROBIOL RES, V4, P1794; Planas M, 2005, AQUACULTURE, V250, P232, DOI 10.1016/j.aquaculture.2005.04.050; Prol-Garcia MJ, 2010, AQUACULTURE, V302, P26, DOI 10.1016/j.aquaculture.2010.02.004; Rakhuba DV, 2010, POL J MICROBIOL, V59, P145, DOI 10.33073/pjm-2010-023; Reid HI, 2009, AQUACULTURE, V288, P36, DOI 10.1016/j.aquaculture.2008.11.022; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Sails AD, 1998, J MED MICROBIOL, V47, P123, DOI 10.1099/00222615-47-2-123; Scheftel JM, 2006, JOURNEES FRANCOPHONE; SCHIEWE MH, 1981, CURR MICROBIOL, V6, P343, DOI 10.1007/BF01567009; Schulze AD, 2006, AQUACULTURE, V256, P50, DOI 10.1016/j.aquaculture.2006.02.008; Shivu MM, 2007, ENVIRON MICROBIOL, V9, P322, DOI 10.1111/j.1462-2920.2006.01140.x; Silva YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114197; SKJERMO J, 1993, HYDROBIOLOGIA, V255, P185, DOI 10.1007/BF00025838; Snoussi M, 2006, ANN MICROBIOL, V56, P289, DOI 10.1007/BF03175020; Sonia GAS, 2012, INDIAN J GEO-MAR SCI, V41, P348; Sorum H, 2002, INT J FOOD MICROBIOL, V78, P43, DOI 10.1016/S0168-1605(02)00241-6; Sulakvelidze A., 2011, EUR IND PHARM, V45, P14; Talpur AD, 2011, RES J APPL SCI, V6, P116, DOI [10.3923/rjasci.2011.116.127, DOI 10.3923/RJASCI.2011.116.127]; Tan DM, 2014, APPL ENVIRON MICROB, V80, P3128, DOI 10.1128/AEM.03544-13; Tanji Y, 2005, J BIOSCI BIOENG, V100, P280, DOI 10.1263/jbb.100.280; Thomson R, 2005, J APPL MICROBIOL, V99, P243, DOI 10.1111/j.1365-2672.2005.02602.x; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Torrecillas S, 2012, J FISH DIS, V35, P591, DOI 10.1111/j.1365-2761.2012.01384.x; Urbanczyk H, 2013, INT J SYST EVOL MICR, V63, P2742, DOI 10.1099/ijs.0.051110-0; Varvarigos P, 2007, EUR AQ FISH PATH 13, pO; Villamil L, 2003, AQUACULTURE, V219, P43, DOI 10.1016/S0044-8486(02)00515-X; Vinod MG, 2006, AQUACULTURE, V255, P117, DOI 10.1016/j.aquaculture.2005.12.003; Zorrilla I, 2003, AQUACULTURE, V218, P11, DOI 10.1016/S0044-8486(02)00309-5	84	69	73	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0151101	10.1371/journal.pone.0151101	http://dx.doi.org/10.1371/journal.pone.0151101			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950336	gold, Green Published, Green Submitted			2022-12-27	WOS:000371990100090
J	Meng, S; Su, L; Li, YM; Wang, YJ; Zhang, CX; Zhao, Z				Meng, Sen; Su, Li; Li, Yiming; Wang, Yinjuan; Zhang, Chunxia; Zhao, Zhong			Nitrate and Ammonium Contribute to the Distinct Nitrogen Metabolism of Populus simonii during Moderate Salt Stress	PLOS ONE			English	Article							REDUCTASE-ACTIVITY; TRANSPORTER GENES; SALINITY; TOLERANCE; GROWTH; PLANTS; EXPRESSION; ROOTS; TRANSLOCATION; ASSIMILATION	Soil salinity is a major abiotic stressor affecting plant growth. Salinity affects nitrification and ammonification in the soil, however, limited information is available on the influence of different N sources on N metabolism during salt stress. To understand the N metabolism changes in response to different N sources during moderate salt stress, we investigated N uptake, assimilation and the transcript abundance of associated genes in Populus simonii seedlings treated with moderate salt stress (75mM NaCl) under hydroponic culture conditions with nitrate (NO3-) or ammonium (NH4+). Salt stress negatively affected plant growth in both NH4+-fed and NO3--fed plants. Both NH4+ uptake and the total N concentration were significantly increased in the roots of the NH4+-fed plants during salt stress. However, the NO3- uptake and nitrate reductase (NR) and nitrite reductase (NiR) activity primarily depended on the NO3- supply and was not influenced by salt stress. Salt stress decreased glutamine synthetase (GS) and glutamate synthase (GOGAT) activity in the roots and leaves. Most genes associated with NO3- uptake, reduction and N metabolism were down-regulated or remained unchanged; while two NH4+ transporter genes closely associated with NH4+ uptake (AMT1;2 and AMT1;6) were up-regulated in response to salt stress in the NH4+-fed plants. The accumulation of different amino acid compounds was observed in the NH4+- and NO3--fed plants during salt treatment. The results suggested that N metabolism in P. simonii plants exposed to salt enhanced salt resistance in the plants that were fed with NO3- instead of NH4+ as the sole N source.	[Meng, Sen; Su, Li; Li, Yiming; Wang, Yinjuan; Zhang, Chunxia; Zhao, Zhong] Northwest A&F Univ, Coll Forestry, Minist Educ, Key Lab Environm & Ecol Western China, Yangling 712100, Shaanxi, Peoples R China; [Meng, Sen; Zhang, Chunxia; Zhao, Zhong] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China	Zhang, CX; Zhao, Z (corresponding author), Northwest A&F Univ, Coll Forestry, Minist Educ, Key Lab Environm & Ecol Western China, Yangling 712100, Shaanxi, Peoples R China.; Zhang, CX; Zhao, Z (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China.	czhang2012@163.com; zhaozh@nwsuaf.edu.cn		Zhang, Chunxia/0000-0001-9142-7402	State Key Basic Research Development Program (973 Program) [2012CB416902]	State Key Basic Research Development Program (973 Program)(National Basic Research Program of China)	This research was supported by the State Key Basic Research Development Program (973 Program, grant No. 2012CB416902), http://www.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El Baki GK, 2000, PLANT CELL ENVIRON, V23, P515, DOI 10.1046/j.1365-3040.2000.00568.x; Alber A, 2012, TREES-STRUCT FUNCT, V26, P1403, DOI 10.1007/s00468-012-0700-0; Anuradha S, 2003, PLANT GROWTH REGUL, V40, P29, DOI 10.1023/A:1023080720374; ASHRAF M, 1994, CRIT REV PLANT SCI, V13, P17, DOI 10.1080/713608051; Bai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072126; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Castro-Rodriguez V, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-119; Coleman HD, 2012, PLANT BIOTECHNOL J, V10, P883, DOI 10.1111/j.1467-7652.2012.00714.x; Cooke JEK, 2005, NEW PHYTOL, V167, P19, DOI 10.1111/j.1469-8137.2005.01451.x; Ding L, 2015, PLANT SCI, V234, P14, DOI 10.1016/j.plantsci.2015.01.016; Dluzniewska P, 2007, NEW PHYTOL, V173, P279, DOI 10.1111/j.1469-8137.2006.01908.x; Ehlting B, 2007, PLANT CELL ENVIRON, V30, P796, DOI 10.1111/j.1365-3040.2007.01668.x; ENGELS C, 1993, J EXP BOT, V44, P1695, DOI 10.1093/jxb/44.11.1695; Gessler A, 1998, NEW PHYTOL, V138, P275, DOI 10.1046/j.1469-8137.1998.00107.x; HAWKINS HJ, 1993, NEW PHYTOL, V124, P161, DOI 10.1111/j.1469-8137.1993.tb03806.x; Hessini K, 2013, PLANT SOIL, V370, P163, DOI 10.1007/s11104-013-1616-1; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hoagland D.R., 1950, 347 CAL AGR EXP STAT; Kalcsits LA, 2015, PLANT CELL ENVIRONME, P12614; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Liu X, 2015, J S CHINA AGR U; Luo J, 2013, J EXPT BOT; Mansour MMF, 2000, BIOL PLANTARUM, V43, P491, DOI 10.1023/A:1002873531707; Min X, 1999, PLANT CELL ENVIRON, V22, P821, DOI 10.1046/j.1365-3040.1999.00450.x; Min X, 1998, PLANT CELL ENVIRON, V21, P1039, DOI 10.1046/j.1365-3040.1998.00340.x; Min XJ, 2000, PLANT CELL ENVIRON, V23, P321, DOI 10.1046/j.1365-3040.2000.00546.x; Mitsuya S, 2000, J PLANT PHYSIOL, V157, P661, DOI 10.1016/S0176-1617(00)80009-7; Nasraoui HA, 2013, B ENVIRON CONTAM TOX, V91, P711, DOI 10.1007/s00128-013-1120-6; Natali S, 2009, PLANT SOIL, V314, P197, DOI 10.1007/s11104-008-9718-x; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Parida AK, 2004, J PLANT PHYSIOL, V161, P921, DOI 10.1016/j.jplph.2003.11.006; Plett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015289; Popova OV, 2003, PLANT MOL BIOL, V52, P569, DOI 10.1023/A:1024802101057; Selle A, 2005, NEW PHYTOL, V168, P697, DOI 10.1111/j.1469-8137.2005.01535.x; Silveira JAG, 2001, ENVIRON EXP BOT, V46, P171, DOI 10.1016/S0098-8472(01)00095-8; SINGH RP, 1986, PHYSIOL PLANTARUM, V66, P413, DOI 10.1111/j.1399-3054.1986.tb05944.x; Singh SK, 2000, BIOL PLANTARUM, V43, P283, DOI 10.1023/A:1002720714781; SPEER M, 1994, PLANT CELL ENVIRON, V17, P1215, DOI 10.1111/j.1365-3040.1994.tb02019.x; Tang ZH, 2011, J PLANT NUTR SOIL SC, V174, P135, DOI 10.1002/jpln.200900354; TULLY RE, 1979, PLANT PHYSIOL, V63, P518, DOI 10.1104/pp.63.3.518; Wang H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-194; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Yamamoto S, 2014, SOILS LOESS PLATEAU, P35; Zhang CX, 2014, TREES-STRUCT FUNCT, V28, P1813, DOI 10.1007/s00468-014-1088-9	45	29	33	6	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150354	10.1371/journal.pone.0150354	http://dx.doi.org/10.1371/journal.pone.0150354			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950941	gold, Green Published, Green Submitted			2022-12-27	WOS:000371990100032
J	Breu, T; Bader, C; Messerli, P; Heinimann, A; Rist, S; Eckert, S				Breu, Thomas; Bader, Christoph; Messerli, Peter; Heinimann, Andreas; Rist, Stephan; Eckert, Sandra			Large-Scale Land Acquisition and Its Effects on the Water Balance in Investor and Host Countries	PLOS ONE			English	Article							GLOBAL LAND; BIOFUELS; DEALS	This study examines the validity of the assumption that international large-scale land acquisition (LSLA) is motivated by the desire to secure control over water resources, which is commonly referred to as 'water grabbing'. This assumption was repeatedly expressed in recent years, ascribing the said motivation to the Gulf States in particular. However, it must be considered of hypothetical nature, as the few global studies conducted so far focused primarily on the effects of LSLA on host countries or on trade in virtual water. In this study, we analyse the effects of 475 intended or concluded land deals recorded in the Land Matrix database on the water balance in both host and investor countries. We also examine how these effects relate to water stress and how they contribute to global trade in virtual water. The analysis shows that implementation of the LSLAs in our sample would result in global water savings based on virtual water trade. At the level of individual LSLA host countries, however, water use intensity would increase, particularly in 15 sub-Saharan states. From an investor country perspective, the analysis reveals that countries often suspected of using LSLA to relieve pressure on their domestic water resources-such as China, India, and all Gulf States except Saudi Arabia-invest in agricultural activities abroad that are less water-intensive compared to their average domestic crop production. Conversely, large investor countries such as the United States, Saudi Arabia, Singapore, and Japan are disproportionately externalizing crop water consumption through their international land investments. Statistical analyses also show that host countries with abundant water resources are not per se favoured targets of LSLA. Indeed, further analysis reveals that land investments originating in water-stressed countries have only a weak tendency to target areas with a smaller water risk.	[Breu, Thomas; Bader, Christoph; Messerli, Peter; Heinimann, Andreas; Rist, Stephan; Eckert, Sandra] Univ Bern, Ctr Dev & Environm, Bern, Switzerland; [Bader, Christoph; Heinimann, Andreas; Rist, Stephan] Univ Bern, Inst Geog, Bern, Switzerland	University of Bern; University of Bern	Breu, T (corresponding author), Univ Bern, Ctr Dev & Environm, Bern, Switzerland.	thomas.breu@cde.unibe.ch	Bader, Christoph/AAG-8312-2020	Bader, Christoph/0000-0002-8991-353X; Messerli, Peter/0000-0002-0286-6348; Heinimann, Andreas/0000-0001-8905-8169	Swiss National Centre of Competence in Research (NCCR) North-South - Swiss National Science Foundation (SNSF) [51NF40-128817]; Swiss Agency for Development and Cooperation (SDC); Centre for Development and Environment (CDE) of the University of Bern, Switzerland; Swiss Programme for Research on Global Issues for Development (r4d programme); International Land Coalition's Land Matrix Project	Swiss National Centre of Competence in Research (NCCR) North-South - Swiss National Science Foundation (SNSF); Swiss Agency for Development and Cooperation (SDC); Centre for Development and Environment (CDE) of the University of Bern, Switzerland; Swiss Programme for Research on Global Issues for Development (r4d programme); International Land Coalition's Land Matrix Project	The authors acknowledge support from the Swiss National Centre of Competence in Research (NCCR) North-South, co-funded by the Swiss National Science Foundation (SNSF) (grant 51NF40-128817), the Swiss Agency for Development and Cooperation (SDC), and the Centre for Development and Environment (CDE) of the University of Bern, Switzerland. Furthermore, this research has benefitted from collaboration with and support from the Swiss Programme for Research on Global Issues for Development (r4d programme) and the International Land Coalition's Land Matrix Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche J, 2011, FOOD POLICY, V36, pS3, DOI 10.1016/j.foodpol.2010.11.013; Anseeuw W., 2012, TRANSNATIONAL LAND D; Anseeuw W, 2013, J PEASANT STUD, V40, P521, DOI 10.1080/03066150.2013.803071; Borras SM, 2011, J PEASANT STUD, V38, P209, DOI 10.1080/03066150.2011.559005; Breu T, 2011, GEOGRAPHICA BERNEN G, P427; Carr JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055825; de Fraiture C, 2008, WATER POLICY, V10, P67, DOI 10.2166/wp.2008.054; FAO, 2014, FAOSTAT ON LIN DAT; FAO, 2013, FAOSTAT ON LIN DAT; FAO, 2014, AQUASTAT INF SYST WA; Gerbens-Leenes W, 2009, P NATL ACAD SCI USA, V106, pE113, DOI 10.1073/pnas.0909624106; Hering JG, 2015, SCIENCE, V349, P479, DOI 10.1126/science.aac5902; Hoff H, 2009, CURR OPIN ENV SUST, V1, P141, DOI 10.1016/j.cosust.2009.10.001; Jagerskog A, 2012, LAND ACQUISITIONS WI; Jongschaap REE, 2009, P NATL ACAD SCI USA, V106, pE92, DOI 10.1073/pnas.0907272106; Kundzewiczs ZW, 2007, CLIMATE CHANGE 2007, P173, DOI DOI 10.1007/S11269-006-3091-4; Mann H, 2010, 8 UN, P8; Mehta L., 2012, INTRO SPECIAL ISSUE; Mekonnen MM, 2012, WATER RESOUR MANAG, V26, P3725, DOI 10.1007/s11269-012-0099-9; Mekonnen M. M., 2011, NATL WATER FOOTPRINT, V2; Mekonnen M.M., 2011, 50 UNESCOIHE; Merian Research CRBM, 2010, VULT LAND GRABB, P46; Messerli P, 2014, APPL GEOGR, V53, P449, DOI 10.1016/j.apgeog.2014.07.005; Millenium Ecosystem Assessment RM, 2005, EC HUM WELL BEING SY; Mirza H, 2014, PRACTICE RESPONSIBLE, P80; Multsch S, 2013, GEOSCIENTIFIC MODEL, V6, P645, DOI [10.5194/gmdd-6-645-2013, DOI 10.5194/GMDD-6-645-2013]; Odorico PD, 2010, GEOPHYS RES LETT, V37; Rulli MC, 2013, GEOPHYS RES LETT, V40, P6130, DOI 10.1002/2013GL058281; Rulli MC, 2013, P NATL ACAD SCI USA, V110, P892, DOI 10.1073/pnas.1213163110; Smaller C, 2014, IISD GUIDE NEGOTIATI; Smaller C, 2009, THIRST DISTANT LANDS, P26; UNESCO, 2006, WAT SHAR RESP WORLD; UNW-DPAC, 2011, WAT AGR GREEN EC; Van Oel PR, 2010, 46 UNESCOIHE; Vermeulen S, 2010, J PEASANT STUD, V37, P899, DOI 10.1080/03066150.2010.512463; Woertz E, 2013, GLOBALIZATIONS, V10, P87, DOI 10.1080/14747731.2013.760932; Woodhouse P., 2012, Water Alternatives, V5, P208; Woodhouse P., 2011, IS WATER HIDDEN AGEN; World Economic Forum, 2015, GLOB RISKS 2015; *WORLD WAT ASS PRO, 2009, 3 UNESCO WORLD WAT A	40	38	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150901	10.1371/journal.pone.0150901	http://dx.doi.org/10.1371/journal.pone.0150901			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG0FG	26943794	Green Submitted, Green Published, gold			2022-12-27	WOS:000371739400059
J	Gu, YL; Wang, YF; Zhou, Q; Bowman, L; Mao, GC; Zou, BB; Xu, J; Liu, Y; Liu, K; Zhao, JS; Ding, M				Gu, Yuanliang; Wang, Yafei; Zhou, Qi; Bowman, Linda; Mao, Guochuan; Zou, Baobo; Xu, Jin; Liu, Yu; Liu, Kui; Zhao, Jinshun; Ding, Min			Inhibition of Nickel Nanoparticles-Induced Toxicity by Epigallocatechin-3-Gallate in JB6 Cells May Be through Down-Regulation of the MAPK Signaling Pathways	PLOS ONE			English	Article							PHOSPHATASE-MEDIATED CROSSTALK; ACTIVATION; APOPTOSIS; EXPOSURE; AP-1; MECHANISMS; MODEL; EGCG	With the rapid development in nanotechnology, nickel nanoparticles (Ni NPs) have emerged in the application of nanomedicine in recent years. However, the potential adverse health effects of Ni NPs are unclear. In this study, we examined the inhibition effects of epigallocatechin-3-gallate (EGCG) on the toxicity induced by Ni NPs in mouse epidermal cell line (JB6 cell). MTT assay showed that Ni NPs induced cytotoxicity in a dose-dependent manner while EGCG exerted a certain inhibition on the toxicity. Additionally, EGCG could reduce the apoptotic cell number and the level of reactive oxygen species (ROS) in JB6 cells induced by Ni NPs. Furthermore, we observed that EGCG could down-regulate Ni NPs-induced activator protein-1 (AP-1) and nuclear factor-kappa B (NF-kappa B) activation in JB6 cells, which has been shown to play pivotal roles in tumor initiation, promotion and progression. Western blot indicated that EGCG could alleviate the toxicity of Ni NPs through regulating protein changes in MAPK signaling pathways. In summary, our results suggest that careful evaluation on the potential health effects of Ni NPs is necessary before being widely used in the field of nanomedicine. Inhibition of EGCG on Ni NPs-induced cytotoxicity in JB6 cells may be through the MAPK signaling pathways suggesting that EGCG might be useful in preventing the toxicity of Ni NPs.	[Gu, Yuanliang; Wang, Yafei; Zhou, Qi; Mao, Guochuan; Zou, Baobo; Xu, Jin; Liu, Yu; Zhao, Jinshun] Ningbo Univ, Sch Med, Dept Preventat Med, Zhejiang Prov Key Lab Pathol & Physiol Technol, Ningbo 315211, Zhejiang, Peoples R China; [Bowman, Linda; Zhao, Jinshun; Ding, Min] NIOSH, Toxicol & Mol Biol Branch, Hlth Effects Lab Div, Morgantown, WV 26505 USA; [Liu, Kui] Zhejiang Prov Ctr Dis Control & Prevent, Dept Sci Res & Informat Management, Hangzhou, Zhejiang, Peoples R China	Ningbo University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Zhejiang Provincial Center for Disease Control & Prevention	Zhao, JS (corresponding author), Ningbo Univ, Sch Med, Dept Preventat Med, Zhejiang Prov Key Lab Pathol & Physiol Technol, Ningbo 315211, Zhejiang, Peoples R China.; Zhao, JS (corresponding author), NIOSH, Toxicol & Mol Biol Branch, Hlth Effects Lab Div, Morgantown, WV 26505 USA.; Liu, K (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Sci Res & Informat Management, Hangzhou, Zhejiang, Peoples R China.	kliu@cdc.zj.cn; zhaojinshun@nbu.edu.cn			National Nature Science Foundation of China [81273111]; Ningbo Scientific Project [2012C5019]; Science Technology Department of Zhejiang Province [2015C33148, 2015C37117]; Scientific Innovation Team Project of Ningbo [2011B82014]; K.C. Wong Education Foundation, Hong Kong	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ningbo Scientific Project; Science Technology Department of Zhejiang Province; Scientific Innovation Team Project of Ningbo; K.C. Wong Education Foundation, Hong Kong	This work was partly supported by the National Nature Science Foundation of China (Grant No. 81273111), the Ningbo Scientific Project (Grant No. 2012C5019), the Science Technology Department of Zhejiang Province (2015C33148 and 2015C37117) and the Scientific Innovation Team Project of Ningbo (No. 2011B82014). The authors also gratefully acknowledge the support of K.C. Wong Education Foundation, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad J, 2015, ENVIRON TOXICOL, V30, P137, DOI 10.1002/tox.21879; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Cameron Keyuna S., 2011, Reviews on Environmental Health, V26, P81, DOI 10.1515/REVEH.2011.012; Egger L, 2007, CELL DEATH DIFFER, V14, P1172, DOI 10.1038/sj.cdd.4402125; Elwood PC, 2009, LANCET, V373, P1301, DOI 10.1016/S0140-6736(09)60243-9; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fang MZ, 2003, CANCER RES, V63, P7563; Hansen T, 2006, J R SOC INTERFACE, V3, P767, DOI 10.1098/rsif.2006.0145; Jiang XH, 2001, ONCOGENE, V20, P8009, DOI 10.1038/sj.onc.1204981; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KIM J, 2015, PLOS GENET, V11, P38590, DOI DOI 10.1371/; Kucera O, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/476180; Kuo PL, 2003, J BIOMED SCI, V10, P219, DOI 10.1159/000068711; LIAO SS, 1995, CANCER LETT, V96, P239, DOI 10.1016/0304-3835(95)03948-V; Magaye R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092418; Nielsen NH, 1999, BRIT J DERMATOL, V141, P676; Park S, 2007, INHAL TOXICOL, V19, P59, DOI 10.1080/08958370701493282; Permenter MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027730; Phillips JI, 2010, AM J IND MED, V53, P763, DOI 10.1002/ajim.20855; Pietruska JR, 2011, TOXICOL SCI, V124, P138, DOI 10.1093/toxsci/kfr206; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Qiu Qiang, 2007, Yaoxue Xuebao, V42, P132; Scuri M, 2010, J TOXICOL ENV HEAL A, V73, P1353, DOI 10.1080/15287394.2010.497436; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tsang WP, 2010, J NUTR BIOCHEM, V21, P140, DOI 10.1016/j.jnutbio.2008.12.003; Wang H.-H., 2011, J NANOMATER, V2011, P1, DOI [DOI 10.1007/S11010-010-0600-9, DOI 10.1007/S11105-010-]; Wang Z, 2006, INVEST OPHTH VIS SCI, V47, P5267, DOI 10.1167/iovs.06-0642; YAO KS, 1994, MOL CELL BIOL, V14, P5997, DOI 10.1128/MCB.14.9.5997; Ye T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119543; Zhang QW, 1998, J TOXICOL ENV HEAL A, V53, P423; Zhang X, 2015, J HUAZHONG U SCI-MED, V35, P378, DOI 10.1007/s11596-015-1441-2; Zhang Y, 2007, J MED POSTGRADUATES, V20, P199; Zhao JS, 2009, J ENVIRON PATHOL TOX, V28, P177, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i3.10; Zhao Jinshun, 2009, Journal of Nanobiotechnology, V7, P2, DOI 10.1186/1477-3155-7-2; Zhou H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S11-S3	40	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150954	10.1371/journal.pone.0150954	http://dx.doi.org/10.1371/journal.pone.0150954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943640	Green Published, Green Submitted, gold			2022-12-27	WOS:000371739400067
J	Benzecry, SG; Alexandre, MA; Vitor-Silva, S; Salinas, JL; de Melo, GC; Marinho, HA; Paes, AT; de Siqueira, AM; Monteiro, WM; Lacerda, MVG; Leite, HP				Benzecry, Silvana Gomes; Alexandre, Marcia Almeida; Vitor-Silva, Sheila; Salinas, Jorge Luis; de Melo, Gisely Cardoso; Marinho, Helyde Albuquerque; Paes, Angela Tavares; de Siqueira, Andre Machado; Monteiro, Wuelton Marcelo; Guimaraes Lacerda, Marcus Vinicius; Leite, Heitor Pons			Micronutrient Deficiencies and Plasmodium vivax Malaria among Children in the Brazilian Amazon	PLOS ONE			English	Article							VITAMIN-A; ZINC SUPPLEMENTATION; NUTRITIONAL-STATUS; PRESCHOOL-CHILDREN; IRON-DEFICIENCY; YOUNG-CHILDREN; DIETARY IRON; FALCIPARUM; INFLAMMATION; MORBIDITY	Background There is a growing body of evidence linking micronutrient deficiencies and malaria incidence arising mostly from P. falciparum endemic areas. We assessed the impact of micronutrient deficiencies on malaria incidence and vice versa in the Brazilian state of Amazonas. Methodology/Principal Findings We evaluated children <10 years old living in rural communities in the state of Amazonas, Brazil, from May 2010 to May 2011. All children were assessed for sociodemographic, anthropometric and laboratory parameters, including vitamin A, beta-carotene, zinc and iron serum levels at the beginning of the study (May 2010) and one year later (May 2011). Children were followed in between using passive surveillance for detection of symptomatic malaria. Those living in the study area at the completion of the observation period were reassessed for micronutrient levels. Univariate Cox-proportional Hazards models were used to assess whether micronutrient deficiencies had an impact on time to first P. vivax malaria episode. We included 95 children median age 4.8 years (interquartile range [IQR]: 2.3-6.6), mostly males (60.0%) and with high maternal illiteracy (72.6%). Vitamin A deficiencies were found in 36% of children, beta-carotene deficiency in 63%, zinc deficiency in 61% and iron deficiency in 51%. Most children (80%) had at least one intestinal parasite. During follow-up, 16 cases of vivax malaria were diagnosed amongst 13 individuals. Micronutrient deficiencies were not associated with increased malaria incidence: vitamin A deficiency [Hazard ratio (HR): 1.51; P-value: 0.45]; beta-carotene [HR: 0.47; P-value: 0.19];zinc [HR: 1.41; P-value: 0.57] and iron [HR: 2.31; P-value: 0.16]). Upon reevaluation, children with al least one episode of malaria did not present significant changes in micronutrient levels. Conclusion Micronutrient serum levels were not associated with a higher malaria incidence nor the malaria episode influenced micronutrient levels. Future studies targeting larger populations to assess micronutrients levels in P. vivax endemic areas are warranted in order to validate these results.	[Benzecry, Silvana Gomes; Alexandre, Marcia Almeida; Vitor-Silva, Sheila; de Melo, Gisely Cardoso; de Siqueira, Andre Machado; Monteiro, Wuelton Marcelo; Guimaraes Lacerda, Marcus Vinicius] Univ Estado Amazonas, Escola Super Ciencias Saude, Manaus, Amazonas, Brazil; [Alexandre, Marcia Almeida; Vitor-Silva, Sheila; de Melo, Gisely Cardoso; de Siqueira, Andre Machado; Monteiro, Wuelton Marcelo; Guimaraes Lacerda, Marcus Vinicius] Fundacao Med Trop Dr Heitor Vieira Dourado, Gerencia Maleria, Manaus, Amazonas, Brazil; [Salinas, Jorge Luis] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Marinho, Helyde Albuquerque] Inst Nacl de Pesquisas da Amazonia, Lab Nutr, Manaus, Amazonas, Brazil; [Paes, Angela Tavares] Univ Fed Sao Paulo, Appl Stat, Sao Paulo, Brazil; [de Siqueira, Andre Machado] Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil; [Guimaraes Lacerda, Marcus Vinicius] Fundacao Oswaldo Cruz, Inst Pesquisas Leonidas & Maria Deane, Manaus, Amazonas, Brazil; [Leite, Heitor Pons] Univ Fed Sao Paulo, Dept Pediat, Discipline Nutr & Metab, Sao Paulo, Brazil	Universidade do Estado do Amazonas; Emory University; Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Sao Paulo (UNIFESP); Fundacao Oswaldo Cruz; Universidade Federal de Sao Paulo (UNIFESP)	Lacerda, MVG (corresponding author), Univ Estado Amazonas, Escola Super Ciencias Saude, Manaus, Amazonas, Brazil.; Lacerda, MVG (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, Gerencia Maleria, Manaus, Amazonas, Brazil.; Lacerda, MVG (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisas Leonidas & Maria Deane, Manaus, Amazonas, Brazil.; Leite, HP (corresponding author), Univ Fed Sao Paulo, Dept Pediat, Discipline Nutr & Metab, Sao Paulo, Brazil.	marcuslacerda.br@gmail.com; heitorpons@gmail.com	melo, gisely/GZK-5350-2022; Salinas, Jorge/ABC-7735-2021; Siqueira, Andre M/G-1340-2010; Leite, Heitor Pons/F-9178-2013	Salinas, Jorge/0000-0002-9193-820X; Siqueira, Andre M/0000-0003-2208-0294; Leite, Heitor Pons/0000-0001-8260-7559; Paes, Angela/0000-0002-7405-3442	CNPq; FAPEAM (Fundacao de Amparo a Pesquisa do Estado do Amazonas); Fundacio Cellex [483758/2009-4, G64334048/2007]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEAM (Fundacao de Amparo a Pesquisa do Estado do Amazonas); Fundacio Cellex(Foundation CELLEX)	This study was funded by CNPq, FAPEAM (Fundacao de Amparo a Pesquisa do Estado do Amazonas) and Fundacio Cellex (grant 483758/2009-4; G64334048/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amare B, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/598605; [Anonymous], 2001, IRON DEFICIENCY ANAE; [Anonymous], 2009, WHO CHILD GROWTH STA; Alexandre MAA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003743; ARIF A J, 1987, Indian Journal of Malariology, V24, P59; Athuman M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010767.pub2; Augusto RA, 2015, PUBLIC HEALTH NUTR, V18, P927, DOI 10.1017/S1368980014001244; BATES CJ, 1993, BRIT J NUTR, V69, P243, DOI 10.1079/BJN19930026; Battistini TRB, 2010, NUTRITION, V26, P612, DOI 10.1016/j.nut.2009.06.024; Brazilian Ministry of Health, 2004, ANTHR MEAS WEIGH; Brazilian Ministry of Health, 2013, SIT EP MAL BRAS 2000; Brazilian Ministry of Health, 2009, PESQ NAC DEM SAUD CR; Bresnahan KA, 2014, EXP BIOL MED, V239, P45, DOI 10.1177/1535370213510661; dos Santos-Valente EC, 2012, J INVEST ALLERG CLIN, V22, P427; CARDOSO MA, 1993, BRAZ J MED BIOL RES, V26, P1297; Cobayashi F, 2014, PUBLIC HEALTH NUTR, V17, P551, DOI 10.1017/S1368980013000190; Das BS, 1996, AM J CLIN NUTR, V64, P94, DOI 10.1093/ajcn/64.1.94; DAVIS TME, 1994, CLIN SCI, V87, P505, DOI 10.1042/cs0870505; Desvignes L, 2015, J CLIN INVEST, V125, P2347, DOI 10.1172/JCI80273; Duggan C, 2005, J NUTR, V135, P802; Faust E.C., 1939, Journal of Parasitology Urbana, V25, P241, DOI 10.2307/3272508; Foote SJ, 1997, NAT GENET, V17, P380, DOI 10.1038/ng1297-380; Frosch AEP, 2014, AM J CLIN NUTR, V100, P968, DOI 10.3945/ajcn.114.087114; Gillis J, 2014, ANTIVIR THER, V19, P309, DOI 10.3851/IMP2724; Glinz D, 2015, AM J CLIN NUTR, V101, P462, DOI 10.3945/ajcn.114.090175; HARVEY PWJ, 1985, INFECT IMMUN, V50, P932, DOI 10.1128/IAI.50.3.932-934.1985; Jonker FAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042670; Kaufmann SHE, 2013, CURR OPIN IMMUNOL, V25, P441, DOI 10.1016/j.coi.2013.05.005; KRISHNAN S, 1976, J NUTR, V106, P784, DOI 10.1093/jn/106.6.784; LUTZ Adolpho, 1919, Memorias do Instituto Oswaldo Cruz, V11, P121, DOI 10.1590/S0074-02761919000100006; Macedo RS, 2010, REV DIGITAL BUENOS A, V14, P1; Uscategui RM, 2009, BIOMEDICA, V29, P270, DOI 10.7705/biomedica.v29i2.29; Manning L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001972; Marinho HA, 2002, ACTA AMAZON, V33, P263; Mayo-Wilson E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009384.pub2; Mfonkeu JBP, 2010, BRIT J NUTR, V104, P886, DOI 10.1017/S0007114510001510; Muller O, 2001, BMJ-BRIT MED J, V322, P1567, DOI 10.1136/bmj.322.7302.1567; Murrieta R. S. S., 1998, REV ANTROPOLOGIA U S, V41, P97, DOI DOI 10.1590/S0034-77011998000100004; Murrieta RS, 2001, REV ANTROPOL, V2, P44; Mwanga-Amumpaire J, 2012, AFR HEALTH SCI, V12, P90, DOI 10.4314/ahs.v12i2.3; Nasi M, 2014, IMMUNOL LETT, V161, P184, DOI 10.1016/j.imlet.2014.01.008; Nyakeriga AM, 2004, AM J CLIN NUTR, V80, P1604, DOI 10.1093/ajcn/80.6.1604; Okebe JU, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006589.pub3; Olofin IO, 2014, JAIDS-J ACQ IMM DEF, V67, pS173, DOI 10.1097/QAI.0000000000000375; Ramalho Rejane Andréa, 2002, Rev Panam Salud Publica, V12, P117, DOI 10.1590/S1020-49892002000800007; Richard SA, 2006, AM J TROP MED HYG, V75, P126, DOI 10.4269/ajtmh.2006.75.1.0750126; Rodrigues AG, 2001, HORIZ ANTROPOL, V16, P131; Roos Albert, 1946, JOUR NUTRITION, V32, P473; Sandstrom B, 1997, EUR J CLIN NUTR, V51, pS17; Santos Hosana Gonçalves dos, 2005, Rev. Bras. Cienc. Farm., V41, P205, DOI 10.1590/S1516-93322005000200008; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Sazawal S, 2007, LANCET, V369, P927, DOI 10.1016/S0140-6736(07)60452-8; Sazawal Sunil, 2014, Malar Res Treat, V2014, P625905, DOI 10.1155/2014/625905; Shankar AH, 1999, LANCET, V354, P203, DOI 10.1016/S0140-6736(98)08293-2; Shankar AH, 2000, AM J TROP MED HYG, V62, P663, DOI 10.4269/ajtmh.2000.62.663; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; TANNER M, 1987, ACTA TROP, V44, P137; Tavares Bruno Mendes, 2012, Rev. paul. pediatr., V30, P42; Vitamin A, 1993, LANCET, V342, P7, DOI DOI 10.1016/0140-6736(93)91879-Q; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; WHITEHOUSE RC, 1982, CLIN CHEM, V28, P475; Womack JA, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001035; World Health Organization, 1995, 854 WHO, V854; World Health Organization, 2007, CHILD GROWTH STAND; World Health Organization, 2014, 2013 WORLD MAL REP; World Health Organization, 2006, MICR DIAGN MAL; Yang Hong, 2008, BMC Pediatr, V8, P19, DOI 10.1186/1471-2431-8-19; Yuyama LKO, 1996, ARCH LATINOAM NUTR, V46, P216; Zlotkin S, 2013, JAMA-J AM MED ASSOC, V310, P938, DOI 10.1001/jama.2013.277129	69	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151019	10.1371/journal.pone.0151019	http://dx.doi.org/10.1371/journal.pone.0151019			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963624	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000091
J	Bracamontes, JR; Akk, G; Steinbach, JH				Bracamontes, John R.; Akk, Gustav; Steinbach, Joe Henry			Introduced Amino Terminal Epitopes Can Reduce Surface Expression of Neuronal Nicotinic Receptors	PLOS ONE			English	Article							CYS-LOOP RECEPTOR; ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; A RECEPTORS; ALPHA-HELIX; STOICHIOMETRY; SUBUNITS; DOMAIN; PHARMACOLOGY; TRAFFICKING	Epitopes accessible on the surface of intact cells are extremely valuable in studies of membrane proteins, allowing quantification and determination of the distribution of proteins as well as identification of cells expressing large numbers of proteins. However for many membrane proteins there are no suitable antibodies to native sequences, due to lack of availability, low affinity or lack of specificity. In these cases the use of an introduced epitope at specific sites in the protein of interest can often provide a suitable tool for studies. However, the introduction of the epitope sequence has the potential to affect protein expression, the assembly of multisubunit proteins or transport to the surface membrane. We find that surface expression of heteromeric neuronal nicotinic receptors containing the alpha 4 and beta 4 subunits can be affected by introduced epitopes when inserted near the amino terminus of a subunit. The FLAG epitope greatly reduces surface expression when introduced into either alpha 4 or beta 4 subunits, the V5 epitope has little effect when placed in either, while the Myc epitope reduces expression more when inserted into beta 4 than alpha 4. These results indicate that the extreme amino terminal region is important for assembly of these receptors, and demonstrate that some widely used introduced epitopes may severely reduce surface expression.	[Bracamontes, John R.; Akk, Gustav; Steinbach, Joe Henry] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Akk, Gustav; Steinbach, Joe Henry] Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Steinbach, JH (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.; Steinbach, JH (corresponding author), Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO USA.	jhs@morpheus.wustl.edu	Akk, Gustav/CAG-1703-2022		National Institute of Neurological Disorders and Stroke [NS22356]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022356] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke (grant NS22356). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk G, 2008, MOL PHARMACOL, V74, P614, DOI 10.1124/mol.108.048520; Bar-Lev DD, 2011, J BIOL CHEM, V286, P43830, DOI 10.1074/jbc.M111.282715; Bracamontes JR, 2008, J BIOL CHEM, V283, P26128, DOI 10.1074/jbc.M801292200; Bracamontes JR, 2014, MOL PHARMACOL, V86, P20, DOI 10.1124/mol.114.092791; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Castillo M, 2009, J NEUROCHEM, V108, P1399, DOI 10.1111/j.1471-4159.2009.05924.x; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Criado M, 2010, J NEUROCHEM, V112, P103, DOI 10.1111/j.1471-4159.2009.06439.x; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Gurba KN, 2012, J BIOL CHEM, V287, P12083, DOI 10.1074/jbc.M111.332528; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Jin XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144631; Kittler JT, 2000, MOL CELL NEUROSCI, V16, P440, DOI 10.1006/mcne.2000.0882; KOPTA C, 1994, J NEUROSCI, V14, P3922; Li P, 2011, MOL PHARMACOL, V80, P818, DOI 10.1124/mol.111.073841; Li P, 2010, BRIT J PHARMACOL, V160, P1906, DOI 10.1111/j.1476-5381.2010.00761.x; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; PENG X, 1994, MOL PHARMACOL, V46, P523; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; Steinbach JH, 2001, J PHYSIOL-LONDON, V537, P715; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tsetlin V, 2011, J NEUROCHEM, V116, P734, DOI 10.1111/j.1471-4159.2010.07060.x; Ueno S, 1996, MOL PHARMACOL, V50, P931; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Wagoner KR, 2010, J BIOL CHEM, V285, P14187, DOI 10.1074/jbc.M110.104257; Wong LW, 2015, J NEUROCHEM, V134, P819, DOI 10.1111/jnc.13175; Wong LW, 2014, ACS CHEM NEUROSCI, V5, P1266, DOI 10.1021/cn500220t; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	31	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151071	10.1371/journal.pone.0151071	http://dx.doi.org/10.1371/journal.pone.0151071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963253	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000099
J	Khajah, MA; Fateel, MM; Ananthalakshmi, KV; Luqmani, YA				Khajah, Maitham A.; Fateel, Maryam M.; Ananthalakshmi, Kethireddy V.; Luqmani, Yunus A.			Anti-Inflammatory Action of Angiotensin 1-7 in Experimental Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; I-CONVERTING-ENZYME; ULCERATIVE-COLITIS; CROHNS-DISEASE; INTESTINAL INFLAMMATION; COLONIC INFLAMMATION; SIGNAL-TRANSDUCTION; MESSENGER-RNA; MAP KINASES; RECEPTOR	Background There is evidence to support a role for angiotensin (Ang) 1-7 in reducing the activity of inflammatory signaling molecules such as MAPK, PKC and SRC. Enhanced angiotensin converting enzyme 2 (ACE2) expression has been observed in patients with inflammatory bowel disease (IBD) suggesting a role in its pathogenesis, prompting this study. Methods The colonic expression/activity profile of ACE2, Ang 1-7, MAS1-receptor (MAS1-R), MAPK family and Akt were determined by western blot and immunofluorescence. The effect of either exogenous administration of Ang 1-7 or pharmacological inhibition of its function (by A779 treatment) was determined using the mouse dextran sulfate sodium model. Results Enhanced colonic expression of ACE2, Ang1-7 and MAS1-R was observed post-colitis induction. Daily Ang 1-7 treatment (0.01-0.06 mg/kg) resulted in significant amelioration of DSS-induced colitis. In contrast, daily administration of A779 significantly worsened features of colitis. Colitis-associated phosphorylation of p38, ERK1/2 and Akt was reduced by Ang 1-7 treatment. Conclusion Our results indicate important anti-inflammatory actions of Ang 1-7 in the pathogenesis of IBD, which may provide a future therapeutic strategy to control the disease progression.	[Khajah, Maitham A.; Fateel, Maryam M.; Ananthalakshmi, Kethireddy V.; Luqmani, Yunus A.] Kuwait Univ, Fac Pharm, POB 24923, Safat 13110, Kuwait	Kuwait University	Khajah, MA (corresponding author), Kuwait Univ, Fac Pharm, POB 24923, Safat 13110, Kuwait.	maitham@hsc.edu.kw	Khajah, Maitham/AAZ-8841-2020		Kuwait University [PT02/12]; Research Unit for Genomics, Proteomics and Cellomics Studies (OMICS), Kuwait University [SRUL02/13]	Kuwait University; Research Unit for Genomics, Proteomics and Cellomics Studies (OMICS), Kuwait University	This work was supported by Kuwait University Research Sector grant PT02/12. Parts of this work were supported by grant SRUL02/13 to the Research Unit for Genomics, Proteomics and Cellomics Studies (OMICS), Kuwait University.	Al-Shamali A, 2011, SCAND J GASTROENTERO, V46, P20, DOI 10.3109/00365521.2010.521890; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Beck PL, 2007, GASTROENTEROLOGY, V132, P1778, DOI 10.1053/j.gastro.2007.01.032; Byrnes JJ, 2009, INFLAMM RES, V58, P819, DOI 10.1007/s00011-009-0053-3; da Silveira KD, 2010, J IMMUNOL, V185, P5569, DOI 10.4049/jimmunol.1000314; Dong Bo, 2009, Zhonghua Xinxueguanbing Zazhi, V37, P622, DOI 10.3760/cma.j.issn.0253-3758.2009.07.014; El-Hashim AZ, 2012, BRIT J PHARMACOL, V2012, P1476, DOI DOI 10.1111/J.1476-5381.2012.01905.X; Ferrario CM, 2002, J HYPERTENS, V20, P805, DOI 10.1097/00004872-200205000-00004; Ferrario CM, 1997, HYPERTENSION, V30, P535, DOI 10.1161/01.HYP.30.3.535; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Garg M, 2015, J RENIN-ANGIO-ALDO S, V16, P559, DOI 10.1177/1470320314521086; Geara Abdallah S, 2009, Transplant Rev (Orlando), V23, P151, DOI 10.1016/j.trre.2009.04.002; Gembardt F, 2005, PEPTIDES, V26, P1270, DOI 10.1016/j.peptides.2005.01.009; Gironacci MM, 2011, HYPERTENSION, V58, P176, DOI 10.1161/HYPERTENSIONAHA.111.173344; Gironacci MM, 2002, BIOCHEM PHARMACOL, V63, P507, DOI 10.1016/S0006-2952(01)00920-0; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Huang XL, 2011, INFLAMM RES, V60, P727, DOI 10.1007/s00011-011-0325-6; Inokuchi Y, 2005, GUT, V54, P349, DOI 10.1136/gut.2003.036343; Iwai M, 2009, HYPERTENS RES, V32, P533, DOI 10.1038/hr.2009.74; Iyer SN, 1998, HYPERTENSION, V31, P356, DOI 10.1161/01.HYP.31.1.356; Iyer SN, 1998, HYPERTENSION, V31, P699, DOI 10.1161/01.HYP.31.2.699; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; Jahovic N, 2005, REGUL PEPTIDES, V130, P67, DOI 10.1016/j.regpep.2005.03.009; Jin X., 2015, INFLAMMATION, P3; Katada K, 2008, INFLAMM RES, V57, P84, DOI 10.1007/s00011-007-7098-y; Kim I, 2009, PHARM RES-DORDR, V26, P415, DOI 10.1007/s11095-008-9758-1; Koga H, 2008, SURGERY, V144, P259, DOI 10.1016/j.surg.2008.03.043; Kucharewicz I, 2002, J PHYSIOL PHARMACOL, V53, P533; Li L, 2013, J INFLAMM, V10, P1476; Liu L, 2009, INT IMMUNOPHARMACOL, V9, P1568, DOI 10.1016/j.intimp.2009.09.013; Luque M, 1996, J HYPERTENS, V14, P799, DOI 10.1097/00004872-199606000-00017; Matsuda T, 2001, AM J GASTROENTEROL, V96, P2705; Mizushima T, 2009, AM J PHYSIOL-GASTR L, V298, P25; Muthalif MM, 1998, J PHARMACOL EXP THER, V284, P388; Okawada M, 2011, DIGEST DIS SCI, V56, P2553, DOI 10.1007/s10620-011-1651-9; Peng XD, 2010, J PHARMACOL EXP THER, V332, P46, DOI 10.1124/jpet.109.153494; Rebas E, 2006, BIOCHEM BIOPH RES CO, V347, P581, DOI 10.1016/j.bbrc.2006.06.109; Reudelhuber TL, 2005, CURR OPIN NEPHROL HY, V14, P155, DOI 10.1097/00041552-200503000-00011; Saibeni S, 2007, EUR J GASTROEN HEPAT, V19, P976, DOI 10.1097/MEG.0b013e3282efa3fc; Santiago OI, 2008, REGUL PEPTIDES, V146, P250, DOI 10.1016/j.regpep.2007.10.004; Santos RAS, 2007, CURR OPIN NEPHROL HY, V16, P122, DOI 10.1097/MNH.0b013e328031f362; SOMMER H, 1986, ENZYME, V35, P181, DOI 10.1159/000469341; Spencer AU, 2007, DIGEST DIS SCI, V52, P1060, DOI 10.1007/s10620-006-9124-2; Su Z, 2006, KIDNEY INT, V69, P2212, DOI 10.1038/sj.ki.5001509; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, P10; Thoreson R, 2007, SURG CLIN N AM, V87, P575, DOI 10.1016/j.suc.2007.03.001; van Meeteren ME, 2000, SCAND J GASTROENTERO, V35, P517; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Wang Y, 2010, CIRC-HEART FAIL, V3, P286, DOI 10.1161/CIRCHEARTFAILURE.109.905968; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Zeng A, 2015, DRUG DELIV, V27, P1; Zhu ZM, 2002, J CARDIOVASC PHARM, V40, P693, DOI 10.1097/00005344-200211000-00007	56	66	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150861	10.1371/journal.pone.0150861	http://dx.doi.org/10.1371/journal.pone.0150861			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963721	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000070
J	Silkstone, G; Wilson, MT				Silkstone, Gary; Wilson, Michael T.			A Further Investigation of the Effects of Extremely Low Frequency Magnetic Fields on Alkaline Phosphatase and Acetylcholinesterase	PLOS ONE			English	Article							MECHANISM	Using a custom build spectrophotometer equipped with Helmholtz coils and designed to study the effects of magnetic fields on enzyme reactions in real-time we have investigated the influence of fields, from 100 mu T to 10 mT and at a variety of field frequencies, on the membrane bound enzymes alkaline phosphatase and acetylcholinesterase. We have also employed other methods to apply a magnetic field, e.g. Biostim. In contrast to earlier reports we have been unable to detect any field effects on these enzymes under any field/frequency regime. We discuss possible reasons for the discrepancy between this and earlier work and note the particularly complex influence of small temperature changes that may confound analysis.	[Silkstone, Gary; Wilson, Michael T.] Univ Essex, Sch Biol, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England	University of Essex	Silkstone, G (corresponding author), Univ Essex, Sch Biol, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	silkgi@essex.ac.uk			"Electromagnetic Field Research Trust" (EMF Research Trust) [XLE51 1123718]; EMF Biological Trust	"Electromagnetic Field Research Trust" (EMF Research Trust); EMF Biological Trust	This study was funded by the "Electromagnetic Field Research Trust" (EMF Research Trust) grant code number XLE51 1123718.; We would like to thank the EMF Biological Trust for their support.	Ball P, 2011, NATURE, V474, P272, DOI 10.1038/474272a; Barnes FS, 2005, IEEE T MAGN, V41, P4219, DOI 10.1109/TMAG.2005.855480; Buchachenko AL, 2008, J AM CHEM SOC, V130, P12868, DOI 10.1021/ja804819k; Caseli L, 2005, LANGMUIR, V21, P4090, DOI 10.1021/la047292s; Crotty D, 2012, P NATL ACAD SCI USA, V109, P1437, DOI 10.1073/pnas.1117840108; Fenk CJ, 2007, J CHEM EDUC, V84, P1676, DOI 10.1021/ed084p1676; GAFFNEY BJ, 1974, CHEM PHYS LETT, V24, P310, DOI 10.1016/0009-2614(74)85266-8; Hamdy HA, 2013, J INVEST BIOCH, V3, P133, DOI [10.5455/jib.20130716075920, DOI 10.5455/JIB.20130716075920]; Havas M., 2000, ELECTROMAGNETIC ENV, V253, P535; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, P101, DOI 10.1002/bem.2250130710; Kobayashi A, 1995, ADV CHEM SER, V250, P367; Labes MM, 1966, LETT NATURE, V11, DOI [10.1038/211968a0, DOI 10.1038/211968A0]; Morelli A, 2005, ARCH BIOCHEM BIOPHYS, V441, P191, DOI 10.1016/j.abb.2005.07.011; Muller P, 2011, J BIOL CHEM, V286, P21033, DOI 10.1074/jbc.M111.228940; Orchard A.F., 2003, MAGNETOCHEMISTRY; Polk C, 1996, HDB BIOL EFFECTS ELE, P159; Ravera S, 2010, BIOELECTROMAGNETICS, V31, P270, DOI 10.1002/bem.20563; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Rodgers C.T., 2008, PNAS, V106, P353; Rosen AD., 2010, PIERS ONLINE, V6, P133, DOI [10.2529/PIERS090529114533, DOI 10.2529/PIERS090529114533]; Rosen D, 1994, BBA-BIOMEMBRANES, V1193, P62; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Solov'yov IA, 2012, J AM CHEM SOC, V134, P18046, DOI 10.1021/ja3074819; Solov'yov IA, 2012, J PHYS CHEM B, V116, P1089, DOI 10.1021/jp209508y; STEGEMANN S, 1993, RADIAT ENVIRON BIOPH, V32, P65, DOI 10.1007/BF01213132; Wiltschko W, 1996, J EXP BIOL, V199, P29	26	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0148369	10.1371/journal.pone.0148369	http://dx.doi.org/10.1371/journal.pone.0148369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963611	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000003
J	Yan, YF; Zhang, LS; Yan, XZ				Yan, Yifei; Zhang, Lisong; Yan, Xiangzhen			Push Force Analysis of Anchor Block of the Oil and Gas Pipeline in a Single-Slope Tunnel Based on the Energy Balance Method	PLOS ONE			English	Article								In this paper, a single-slope tunnel pipeline was analysed considering the effects of vertical earth pressure, horizontal soil pressure, inner pressure, thermal expansion force and pipeline-soil friction. The concept of stagnation point for the pipeline was proposed. Considering the deformation compatibility condition of the pipeline elbow, the push force of anchor blocks of a single-slope tunnel pipeline was derived based on an energy method. Then, the theoretical formula for this force is thus generated. Using the analytical equation, the push force of the anchor block of an X80 large-diameter pipeline from the West-East Gas Transmission Project was determined. Meanwhile, to verify the results of the analytical method, and the finite element method, four categories of finite element codes were introduced to calculate the push force, including CAESARII, ANSYS, AutoPIPE and ALGOR. The results show that the analytical results agree well with the numerical results, and the maximum relative error is only 4.1%. Therefore, the results obtained with the analytical method can satisfy engineering requirements.	[Yan, Yifei] China Univ Petr, Coll Mech & Elect Engn, Qingdao 266580, Peoples R China; [Zhang, Lisong; Yan, Xiangzhen] China Univ Petr, Coll Pipeline & Civil Engn, Qingdao 266580, Peoples R China	China University of Petroleum; China University of Petroleum	Zhang, LS (corresponding author), China Univ Petr, Coll Pipeline & Civil Engn, Qingdao 266580, Peoples R China.	lisongzhang1982@163.com						Al-Gahtani HJ, 2009, PRACT PERIOD STRUCT, V14, P190, DOI 10.1061/(ASCE)1084-0680(2009)14:4(190); An X M., 1998, J CHINA U PETROLEUM, V31, P521; Deng DM, 1999, J OIL GAS STORAGE TR, V18, P7; Dong QL., 1997, J HENAN U, P33; Hobbs RE, 1981, J CONSTRUCTIONAL STE, P4; Irsyam M, 2007, J INDONESIAN OIL GAS, P13; Lan HT, 2015, J PIPELINE SYST ENG, V6, DOI 10.1061/(ASCE)PS.1949-1204.0000128; Lee L.N.H., 1984, SOILDYNAM EARTHQ ENG, V3, P168, DOI DOI 10.1016/0261-7277(84)90032-9; Luo W D., 1999, J CHINA U PETROLEUM, V23, P60; Narasimha R. S., 1997, MAR GEORESOUR GEOTEC, V15, P95; OLeary P.M., 1985, INT J SOIL DYN EARTH, V4, P151, DOI 10.1016/0261-7277(85)90009-9; Palmer AC, 2000, J PETROL TECHNOL, V1, P1283; Rao SN, 2006, APPL OCEAN RES, V28, P103, DOI 10.1016/j.apor.2006.08.001; Tong X. H., 1989, J U PET CHINA, V13, P51; Wang YJ, 1998, J SHEN YANG ARCHITEC, V14, P11; Xia ZF., 2003, TAIYUAN SCI TECHNOLO, V21, P36; Zhang YU, 2003, J DALIAN U TECHNOLOG, V43, P465	17	1	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150964	10.1371/journal.pone.0150964	http://dx.doi.org/10.1371/journal.pone.0150964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963097	gold, Green Submitted, Green Published			2022-12-27	WOS:000371993000087
J	Langhans, SD; Lienert, J				Langhans, Simone D.; Lienert, Judit			Four Common Simplifications of Multi-Criteria Decision Analysis do not hold for River Rehabilitation	PLOS ONE			English	Article							EXPERT KNOWLEDGE; UTILITY-THEORY; MANAGEMENT; ELICITATION; UNCERTAINTY; FRAMEWORK; ECOLOGY; SUPPORT; SYSTEM; BIASES	River rehabilitation aims at alleviating negative effects of human impacts such as loss of biodiversity and reduction of ecosystem services. Such interventions entail difficult trade-offs between different ecological and often socio-economic objectives. Multi-Criteria Decision Analysis (MCDA) is a very suitable approach that helps assessing the current ecological state and prioritizing river rehabilitation measures in a standardized way, based on stakeholder or expert preferences. Applications of MCDA in river rehabilitation projects are often simplified, i.e. using a limited number of objectives and indicators, assuming linear value functions, aggregating individual indicator assessments additively, and/or assuming risk neutrality of experts. Here, we demonstrate an implementation of MCDA expert preference assessments to river rehabilitation and provide ample material for other applications. To test whether the above simplifications reflect common expert opinion, we carried out very detailed interviews with five river ecologists and a hydraulic engineer. We defined essential objectives and measurable quality indicators (attributes), elicited the experts' preferences for objectives on a standardized scale (value functions) and their risk attitude, and identified suitable aggregation methods. The experts recommended an extensive objectives hierarchy including between 54 and 93 essential objectives and between 37 to 61 essential attributes. For 81% of these, they defined non-linear value functions and in 76% recommended multiplicative aggregation. The experts were risk averse or risk prone (but never risk neutral), depending on the current ecological state of the river, and the experts' personal importance of objectives. We conclude that the four commonly applied simplifications clearly do not reflect the opinion of river rehabilitation experts. The optimal level of model complexity, however, remains highly case-study specific depending on data and resource availability, the context, and the complexity of the decision problem.	[Langhans, Simone D.; Lienert, Judit] Swiss Fed Inst Aquat Sci & Technol, Eawag, Duebendorf, Switzerland; [Langhans, Simone D.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Langhans, SD (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Eawag, Duebendorf, Switzerland.; Langhans, SD (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany.	langhans@igb-berlin.de	Langhans, Simone D/A-5314-2019; Lienert, Judit/B-1138-2013	Lienert, Judit/0000-0003-1925-3895; Langhans, Simone Daniela/0000-0001-9581-3183	Leibniz Association; Alexander von Humboldt-Foundation	Leibniz Association; Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation)	The publication of this article was funded by the Open Access Fund of the Leibniz Association. Simone D. Langhans was supported by the Alexander von Humboldt-Foundation through a fellowship for experienced researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananda J, 2005, ECOL ECON, V55, P408, DOI 10.1016/j.ecolecon.2004.12.015; Ananda J, 2009, ECOL ECON, V68, P2535, DOI 10.1016/j.ecolecon.2009.05.010; [Anonymous], [No title captured]; [Anonymous], 2011, EXP EL TASK FORC WHI; [Anonymous], [No title captured]; Aspinall W, 2010, NATURE, V463, P294, DOI 10.1038/463294a; Bates B.C., 2008, TECHNICAL PAPER INTE, DOI DOI 10.1016/S0960-9822(97)70976-X; Belton V., 2003, MULTIPLE CRITERIA DE; Bortz J., 2009, FORSCHUNGSMETHODEN E; Bundi U, 2000, HYDROBIOLOGIA, V422, P477, DOI 10.1023/A:1017071427716; Choy SL, 2009, ECOLOGY, V90, P265, DOI 10.1890/07-1886.1; Clemen R.T, 2001, MAKING HARD DECISION; Clemen RT, 1999, RISK ANAL, V19, P187, DOI 10.1023/A:1006917509560; Collares-Pereira MJ, 2004, FISHERIES MANAG ECOL, V11, P303, DOI 10.1111/j.1365-2400.2004.00392.x; Corsair HJ, 2009, GROUP DECIS NEGOT, V18, P387, DOI 10.1007/s10726-008-9148-4; Cunningham R, 2012, GLASS HALF FULL HALF; DELFORCE RJ, 1985, AUST J AGR ECON, V29, P179, DOI 10.1111/j.1467-8489.1985.tb00443.x; DUCKSTEIN L, 1994, J WATER RES PLAN MAN, V120, P546, DOI 10.1061/(ASCE)0733-9496(1994)120:4(546); DYER JS, 1982, MANAGE SCI, V28, P875, DOI 10.1287/mnsc.28.8.875; DYER JS, 1979, OPER RES, V27, P810, DOI 10.1287/opre.27.4.810; Eisenfuhr F, 2010, RATIONAL DECISION MAKING, P1, DOI 10.1007/978-3-642-02851-9; Fazey I, 2006, ENVIRON CONSERV, V33, P1, DOI 10.1017/S037689290600275X; Gregory R., 2012, STRUCTURED DECISION, DOI [DOI 10.1002/9781444398557, 10.1002/9781444398557]; Hamalainen RP, 2013, EUR J OPER RES, V228, P623, DOI 10.1016/j.ejor.2013.02.001; Hamalainen RP, 2008, ECOL ECON, V68, P556, DOI 10.1016/j.ecolecon.2008.05.025; Hering D, 2010, SCI TOTAL ENVIRON, V408, P4007, DOI 10.1016/j.scitotenv.2010.05.031; Hermans C, 2007, J ENVIRON MANAGE, V84, P534, DOI 10.1016/j.jenvman.2006.07.013; Hostmann M, 2005, LARGE RIVERS, V15, P491, DOI DOI 10.1127/LR/15/2003/491; Hostmann M, 2005, J MULTI-CRITERIA DEC, V13, P91, DOI 10.1002/mcda.375; Huang IB, 2011, SCI TOTAL ENVIRON, V409, P3578, DOI 10.1016/j.scitotenv.2011.06.022; KBOB, 2016, EMPF HON ARCH ING SC; Keeney R.L., 1976, DECISIONS MULTIPLE O; Keeney RL, 2013, DECIS ANAL, V10, P103, DOI 10.1287/deca.2013.0265; KEENEY RL, 1977, WATER RESOUR RES, V13, P705, DOI 10.1029/WR013i004p00705; Keisler Jeffrey, 2014, Environment Systems & Decisions, V34, P369, DOI 10.1007/s10669-014-9515-4; Kim SH, 1999, EUR J OPER RES, V116, P498, DOI 10.1016/S0377-2217(98)00040-X; Kuhnert PM, 2010, ECOL LETT, V13, P900, DOI 10.1111/j.1461-0248.2010.01477.x; Langhans SD, 2014, ECOL INDIC, V45, P494, DOI 10.1016/j.ecolind.2014.05.014; Langhans SD, 2014, J ENVIRON MANAGE, V132, P296, DOI 10.1016/j.jenvman.2013.11.021; Langhans SD, 2013, ECOL INDIC, V32, P264, DOI 10.1016/j.ecolind.2013.03.027; Lienert J, 2013, J ENVIRON MANAGE, V125, P134, DOI 10.1016/j.jenvman.2013.03.052; Lienert J, 2011, ENVIRON SCI TECHNOL, V45, P3848, DOI 10.1021/es1031294; Linkov I, 2011, MULTICRITERIA DECISI; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; McBride MF, 2012, METHODS ECOL EVOL, V3, P906, DOI 10.1111/j.2041-210X.2012.00221.x; Montibeller G, 2015, RISK ANAL, V35, P1230, DOI 10.1111/risa.12360; Morgan MG, 2014, P NATL ACAD SCI USA, V111, P7176, DOI 10.1073/pnas.1319946111; Morton A, 2009, J OPER RES SOC, V60, P268, DOI 10.1057/palgrave.jors.2602550; O'Hagan A., 2006, UNCERTAIN JUDGEMENTS; Oppenheimer M, 2007, SCIENCE, V317, P1505, DOI 10.1126/science.1144831; Palmer MA, 2005, J APPL ECOL, V42, P208, DOI 10.1111/j.1365-2664.2005.01004.x; Peter A, 1987, THESIS ETH ZURICH; Prato T, 2003, ECOL ECON, V45, P297, DOI 10.1016/S0921-8009(03)00077-6; Raju KS, 2007, WATER RESOUR MANAG, V21, P717, DOI 10.1007/s11269-006-9060-0; Raju KS, 1999, EUR J OPER RES, V112, P479, DOI 10.1016/S0377-2217(98)00007-1; Regan HM, 2002, ECOL APPL, V12, P618, DOI 10.2307/3060967; Reichert P, 2007, ENVIRON MODELL SOFTW, V22, P188, DOI 10.1016/j.envsoft.2005.07.017; Reichert P, 2015, D5 4 RISKS UNCERTAIN; Reichert P, 2015, J ENVIRON MANAGE, V154, P316, DOI 10.1016/j.jenvman.2015.01.053; Roni P, 2008, N AM J FISH MANAGE, V28, P856, DOI 10.1577/M06-169.1; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Scholten L, 2015, EUR J OPER RES, V242, P243, DOI 10.1016/j.ejor.2014.09.044; Schuwirth N, 2012, EUR J OPER RES, V220, P472, DOI 10.1016/j.ejor.2012.01.055; Strager MP, P ESRI INT US C; SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529; Sutherland WJ, 2006, J APPL ECOL, V43, P599, DOI 10.1111/j.1365-2664.2006.01182.x; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; USEPA, 2003, DEV WAT QUA IN PRESS; WEBER M, 1988, MANAGE SCI, V34, P431, DOI 10.1287/mnsc.34.4.431; Woolsey S, 2007, FRESHWATER BIOL, V52, P752, DOI 10.1111/j.1365-2427.2007.01740.x	70	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150695	10.1371/journal.pone.0150695	http://dx.doi.org/10.1371/journal.pone.0150695			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954353	Green Submitted, Green Published, gold			2022-12-27	WOS:000371991300042
J	Pomidor, BJ; Makedonska, J; Slice, DE				Pomidor, Benjamin J.; Makedonska, Jana; Slice, Dennis E.			A Landmark-Free Method for Three-Dimensional Shape Analysis	PLOS ONE			English	Article								Background The tools and techniques used in morphometrics have always aimed to transform the physical shape of an object into a concise set of numerical data for mathematical analysis. The advent of landmark-based morphometrics opened new avenues of research, but these methods are not without drawbacks. The time investment required of trained individuals to accurately landmark a data set is significant, and the reliance on readily-identifiable physical features can hamper research efforts. This is especially true of those investigating smooth or featureless surfaces. Methods In this paper, we present a new method to perform this transformation for data obtained from high-resolution scanning technology. This method uses surface scans, instead of landmarks, to calculate a shape difference metric analogous to Procrustes distance and perform superimposition. This is accomplished by building upon and extending the Iterative Closest Point algorithm. We also explore some new ways this data can be used; for example, we can calculate an averaged surface directly and visualize point-wise shape information over this surface. Finally, we briefly demonstrate this method on a set of primate skulls and compare the results of the new methodology with traditional geometric morphometric analysis.	[Pomidor, Benjamin J.; Slice, Dennis E.] Florida State Univ, Dept Comp Sci, Tallahassee, FL 32306 USA; [Makedonska, Jana] SUNY Albany, Dept Anthropol, Albany, NY 12222 USA; [Slice, Dennis E.] Univ Vienna, Dept Anthropol, Vienna, Austria	State University System of Florida; Florida State University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Vienna	Slice, DE (corresponding author), Florida State Univ, Dept Comp Sci, Tallahassee, FL 32306 USA.; Slice, DE (corresponding author), Univ Vienna, Dept Anthropol, Vienna, Austria.	dslice@fsu.edu			US Army Natick Soldier Research, Development, and Engineering Center [W911QY-12-2-0004]; InfoSciTex Corporation [5004-S001]	US Army Natick Soldier Research, Development, and Engineering Center; InfoSciTex Corporation	This work was supported, in part, by awards W911QY-12-2-0004 from the US Army Natick Soldier Research, Development, and Engineering Center and 5004-S001 from InfoSciTex Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; CHEN Y, 1991, 1991 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-3, P2724, DOI 10.1109/ROBOT.1991.132043; Cignoni P., 2012, MESHLAB; Developers CM, 2012, APACHE COMMONS MATH; Developers N, 2012, DEV N NEXTENGINE; Godin G., 1994, Proceedings of the SPIE - The International Society for Optical Engineering, V2350, P279, DOI 10.1117/12.189139; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Mitra N.J., 2004, P 2004 EUR ACM SIGGR, P22, DOI DOI 10.1145/1057432.1057435; Pettinger D., 2010, 2010 Ninth International Conference on Machine Learning and Applications (ICMLA 2010), P319, DOI 10.1109/ICMLA.2010.46; Rohlf FJ, 2009, NYSYSPC NUMERICAL TA; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Simon D., 1996, THESIS CARNEGIE MELL; Toldo R, 2010, 5 INT S 3D DAT PROC; Wiley DF, 2005, IEEE VISUALIZATION 2005, PROCEEDINGS, P431	15	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150368	10.1371/journal.pone.0150368	http://dx.doi.org/10.1371/journal.pone.0150368			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953573	gold, Green Submitted, Green Published			2022-12-27	WOS:000371991300024
J	Shen, Y; McMackin, MZ; Shan, YX; Raetz, A; David, S; Cortopassi, G				Shen, Yan; McMackin, Marissa Z.; Shan, Yuxi; Raetz, Alan; David, Sheila; Cortopassi, Gino			Frataxin Deficiency Promotes Excess Microglial DNA Damage and Inflammation that Is Rescued by PJ34	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; POLY(ADP-RIBOSE) POLYMERASE; FRIEDREICHS-ATAXIA; OXIDATIVE DAMAGE; REPAIR; PARP; MECHANISMS; INHIBITOR; NUCLEAR; CELL	An inherited deficiency in the frataxin protein causes neurodegeneration of the dorsal root ganglia and Friedreich's ataxia (FA). Frataxin deficiency leads to oxidative stress and inflammatory changes in cell and animal models; however, the cause of the inflammatory changes, and especially what causes brain microglial activation is unclear. Here we investigated: 1) the mechanism by which frataxin deficiency activates microglia, 2) whether a brain-localized inflammatory stimulus provokes a greater microglial response in FA animal models, and 3) whether an anti-inflammatory treatment improves their condition. Intracerebroventricular administration of LPS induced higher amounts of microglial activation in the FA mouse model vs controls. We also observed an increase in oxidative damage in the form of 8-oxoguanine (8-oxo-G) and the DNA repair proteins MUTYH and PARP-1 in cerebellar microglia of FA mutant mice. We hypothesized that frataxin deficiency increases DNA damage and DNA repair genes specifically in microglia, activating them. siRNA-mediated frataxin knockdown in microglial BV2 cells clearly elevated DNA damage and the expression of DNA repair genes MUTYH and PARP-1. Frataxin knockdown also induced a higher level of PARP-1 in MEF cells, and this was suppressed in MUTYH-/- knockout cells. Administration of the PARP-1 inhibitor PJ34 attenuated the microglial activation induced by intracerebroventricular injection of LPS. The combined administration of LPS and angiotensin II provoke an even stronger activation of microglia and neurobehavioral impairment. PJ34 treatment attenuated the neurobehavioral impairments in FA mice. These results suggest that the DNA repair proteins MUTYH and PARP-1 may form a pathway regulating microglial activation initiated by DNA damage, and inhibition of microglial PARP-1 induction could be an important therapeutic target in Friedreich's ataxia.	[Shen, Yan; McMackin, Marissa Z.; Shan, Yuxi; Cortopassi, Gino] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA; [Raetz, Alan; David, Sheila] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Cortopassi, G (corresponding author), Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA.	gcortopassi@ucdavis.edu		Raetz, Alan/0000-0003-2039-3692	NIH [NS077777, EY012245, AG025532]; NATIONAL CANCER INSTITUTE [R01CA067985] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by NIH grants NS077777, EY012245 and AG025532 to G.A.C. Funding to pay the Open Access publication charges for this article was provided by the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by NIH grants NS077777, EY012245 and AG025532 to G.A.C. Funding to pay the Open Access publication charges for this article was provided by the NIH.	Abdelkarim GE, 2001, INT J MOL MED, V7, P255; Antolin AA, 2012, ACS CHEM BIOL, V7, P1962, DOI 10.1021/cb300317y; Ba XQ, 2011, AM J PATHOL, V178, P946, DOI 10.1016/j.ajpath.2010.12.004; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; Danielyan L, 2010, REJUV RES, V13, P195, DOI 10.1089/rej.2009.0944; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; DZAU VJ, 1988, CIRCULATION, V77, P4; FINOCCHIARO G, 1988, NEUROLOGY, V38, P1292, DOI 10.1212/WNL.38.8.1292; Fortini P, 2003, MUTAT RES-FUND MOL M, V531, P127, DOI 10.1016/j.mrfmmm.2003.07.004; Gonzalez-Cabo P, 2013, J NEUROCHEM, V126, P53, DOI 10.1111/jnc.12303; Grammatopoulos TN, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-1; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Haugen AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000812; Hayashi G, 2014, HUM MOL GENET, V23, P6838, DOI 10.1093/hmg/ddu407; Ilg W, 2007, BRAIN, V130, P786, DOI 10.1093/brain/awl376; Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349; Ko HL, 2012, BIOMOLECULES, V2, P524, DOI 10.3390/biom2040524; Krokan HE, 1997, BIOCHEM J, V325, P1; Lanz TV, 2010, J CLIN INVEST, V120, P2782, DOI 10.1172/JCI41709; Lefevre S, 2012, HUM MOL GENET, V21, P4060, DOI 10.1093/hmg/dds230; Lu CY, 2007, ARCH BIOCHEM BIOPHYS, V457, P111, DOI 10.1016/j.abb.2006.09.010; Lu CY, 2009, BBA-MOL BASIS DIS, V1792, P1052, DOI 10.1016/j.bbadis.2009.07.011; Madison DL, 2011, DNA REPAIR, V10, P1003, DOI 10.1016/j.dnarep.2011.07.006; Marmolino D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010025; Martinez-Zamudio RI, 2014, BRAIN BEHAV, V4, P552, DOI 10.1002/brb3.239; Miranda CJ, 2002, FEBS LETT, V512, P291, DOI 10.1016/S0014-5793(02)02251-2; Miyoshi M, 2008, EUR J NEUROSCI, V27, P343, DOI 10.1111/j.1460-9568.2007.06014.x; Oka S, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.35; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; PEACH MJ, 1977, PHYSIOL REV, V57, P313, DOI 10.1152/physrev.1977.57.2.313; PENTLAND B, 1983, J NEUROL NEUROSUR PS, V46, P1138, DOI 10.1136/jnnp.46.12.1138; Perring S, 2007, PHYSIOL MEAS, V28, P697, DOI 10.1088/0967-3334/28/6/008; Puccio H, 2000, HUM MOL GENET, V9, P887, DOI 10.1093/hmg/9.6.887; Santos R, 2010, ANTIOXID REDOX SIGN, V13, P651, DOI 10.1089/ars.2009.3015; Schulz J., 2000, NEUROLOGY, V55, P3; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; Scott GS, 2004, J PHARMACOL EXP THER, V310, P1053, DOI 10.1124/jpet.103.063214; Sheng ZJ, 2012, J CLIN INVEST, V122, P4344, DOI 10.1172/JCI65053; Shimura-Miura H, 1999, ANN NEUROL, V46, P920, DOI 10.1002/1531-8249(199912)46:6<920::AID-ANA17>3.0.CO;2-R; Slupska MM, 1996, J BACTERIOL, V178, P3885, DOI 10.1128/jb.178.13.3885-3892.1996; Soriano FG, 2001, NAT MED, V7, P108, DOI 10.1038/83241; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Villar-Cheda B, 2012, NEUROBIOL DIS, V47, P268, DOI 10.1016/j.nbd.2012.04.010; Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005	51	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151026	10.1371/journal.pone.0151026	http://dx.doi.org/10.1371/journal.pone.0151026			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954031	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300076
J	Zaworski, P; von Herrmann, KM; Taylor, S; Sunshine, SS; McCarthy, K; Risher, N; Newcomb, T; Weetall, M; Prior, TW; Swoboda, KJ; Chen, KS; Paushkin, S				Zaworski, Phillip; von Herrmann, Katharine M.; Taylor, Shannon; Sunshine, Sara S.; McCarthy, Kathleen; Risher, Nicole; Newcomb, Tara; Weetall, Marla; Prior, Thomas W.; Swoboda, Kathryn J.; Chen, Karen S.; Paushkin, Sergey			SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; NATURAL-HISTORY; SURVIVAL	Spinal muscular atrophy (SMA) is caused by defects in the survival motor neuron 1 (SMN1) gene that encodes survival motor neuron (SMN) protein. The majority of therapeutic approaches currently in clinical development for SMA aim to increase SMN protein expression and there is a need for sensitive methods able to quantify increases in SMN protein levels in accessible tissues. We have developed a sensitive electrochemiluminescence (ECL)-based immunoassay for measuring SMN protein in whole blood with a minimum volume requirement of 5 mu L. The SMN-ECL immunoassay enables accurate measurement of SMN in whole blood and other tissues. Using the assay, we measured SMN protein in whole blood from SMA patients and healthy controls and found that SMN protein levels were associated with SMN2 copy number and were greater in SMA patients with 4 copies, relative to those with 2 and 3 copies. SMN protein levels did not vary significantly in healthy individuals over a four-week period and were not affected by circadian rhythms. Almost half of the SMN protein was found in platelets. We show that SMN protein levels in C/C-allele mice, which model a mild form of SMA, were high in neonatal stage, decreased in the first few weeks after birth, and then remained stable throughout the adult stage. Importantly, SMN protein levels in the CNS correlated with SMN levels measured in whole blood of the C/C-allele mice. These findings have implications for the measurement of SMN protein induction in whole blood in response to SMN-upregulating therapy.	[Zaworski, Phillip; Taylor, Shannon] PharmOptima, Portage, MI USA; [von Herrmann, Katharine M.; Sunshine, Sara S.; McCarthy, Kathleen; Chen, Karen S.; Paushkin, Sergey] Spinal Muscular Atrophy Fdn, New York, NY USA; [Risher, Nicole; Weetall, Marla] PTC Therapeut, South Plainfield, NJ USA; [Newcomb, Tara; Swoboda, Kathryn J.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Prior, Thomas W.] Ohio State Univ, Wexner Med Ctr, Dept Mol Pathol, Columbus, OH 43210 USA; [von Herrmann, Katharine M.] Geisel Sch Med Dartmouth, Hanover, NH USA; [McCarthy, Kathleen] F Hoffmann La Roche Ltd, CH-4070 Basel, Switzerland; [Swoboda, Kathryn J.] Massachusetts Gen Hosp, Dept Neurol, Ctr Human Genet Res, Boston, MA 02114 USA	Utah System of Higher Education; University of Utah; University System of Ohio; Ohio State University; Dartmouth College; Roche Holding; Harvard University; Massachusetts General Hospital	Paushkin, S (corresponding author), Spinal Muscular Atrophy Fdn, New York, NY USA.	spaushkin@smafoundation.org		Swoboda, Kathryn/0000-0002-4593-6342	SMA Foundation; National Institutes of Health [R01-HD69045]; PTC Therapeutics; PharmOptima; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069045] Funding Source: NIH RePORTER	SMA Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PTC Therapeutics; PharmOptima; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was funded by the SMA Foundation. Work at University of Utah was supported in part by National Institutes of Health grant R01-HD69045 to KJS. PTC Therapeutics provided support in the form of salaries to NR and MW and PharmOptima provided support in the form of salaries for PZ and ST, but neither PTC Therapeutics or PharmOptima had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bricceno KV, 2014, HUM MOL GENET, V23, P4745, DOI 10.1093/hmg/ddu189; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Chang HC, 2004, NEUROCHEM INT, V45, P1107, DOI 10.1016/j.neuint.2004.04.005; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Crawford TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033572; Czech C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139950; Darras BT., 2015, NEUROMUSCULAR DISORD; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Finkel RS, 2014, NEUROLOGY, V83, P810, DOI 10.1212/WNL.0000000000000741; Kariya S, 2014, J CLIN INVEST, V124, P785, DOI 10.1172/JCI72017; Kobayashi DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050763; Kobayashi DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024269; Kolb SJ, 2016, ANN CLIN TRANSL NEUR, V3, P132, DOI 10.1002/acn3.283; Kolb SJ, 2015, NEUROL CLIN, V33, P831, DOI 10.1016/j.ncl.2015.07.004; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Mutsaers CA, 2011, HUM MOL GENET, V20, P4334, DOI 10.1093/hmg/ddr360; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Osborne M, 2012, HUM MOL GENET, V21, P4431, DOI 10.1093/hmg/dds285; Palacino J, 2015, NAT CHEM BIOL, V11, P511, DOI [10.1038/NCHEMBIO.1837, 10.1038/nchembio.1837]; Piepers S, 2008, J NEUROL, V255, P1400, DOI 10.1007/s00415-008-0929-0; Prior TW, 2009, AM J HUM GENET, V85, P408, DOI 10.1016/j.ajhg.2009.08.002; Rigo F, 2012, J CELL BIOL, V199, P21, DOI 10.1083/jcb.201207087; Shafey D, 2005, EXP CELL RES, V311, P49, DOI 10.1016/j.yexcr.2005.08.019; Steinkellner H, 2015, ASSAY DRUG DEV TECHN, V13, P167, DOI 10.1089/adt.2015.635; Tisdale S, 2015, J NEUROSCI, V35, P8691, DOI 10.1523/JNEUROSCI.0417-15.2015; Tiziano FD, 2013, EUR J HUM GENET, V21, P630, DOI 10.1038/ejhg.2012.233; US Department of Health and Human Services FDA, 2013, GUID IND BIOAN METH; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025; Zerres K, 1997, J NEUROL SCI, V146, P67, DOI 10.1016/S0022-510X(96)00284-5	33	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150640	10.1371/journal.pone.0150640	http://dx.doi.org/10.1371/journal.pone.0150640			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953792	Green Submitted, Green Published, gold			2022-12-27	WOS:000371991300038
J	Jones, DS; Rowe, CG; Chen, B; Reiter, K; Rausch, KM; Narum, DL; Wu, YM; Duffy, PE				Jones, David S.; Rowe, Christopher G.; Chen, Beth; Reiter, Karine; Rausch, Kelly M.; Narum, David L.; Wu, Yimin; Duffy, Patrick E.			A Method for Producing Protein Nanoparticles with Applications in Vaccines	PLOS ONE			English	Article							MALARIA VACCINE; IN-VITRO; ANTIBODY; PEPTIDE; CARRIER; IMMUNOGENICITY; EXPRESSION; PROTECTION; CANDIDATE; RATIOS	A practical method is described for synthesizing conjugated protein nanoparticles using thioether (thiol-maleimide) cross-linking chemistry. This method fills the need for a reliable and reproducible synthesis of protein conjugate vaccines for preclinical studies, which can be adapted to produce comparable material for clinical studies. The described method appears to be generally applicable to the production of nanoparticles from a variety of soluble proteins having different structural features. Examples presented include single-component particles of the malarial antigens AMA1, CSP and Pfs25, and two component particles comprised of those antigens covalently cross-linked with the immunogenic carrier protein EPA (a detoxified form of exotoxin A from Pseudomonas aeruginosa). The average molar masses (Mw) of particles in the different preparations ranged from 487 kDa to 3,420 kDa, with hydrodynamic radii (Rh) ranging from 12.1 nm to 38.3 nm. The antigenic properties and secondary structures of the proteins within the particles appear to be largely intact, with no significant changes seen in their far UV circular dichroism spectra, or in their ability to bind conformation-dependent monoclonal antibodies. Mice vaccinated with mixed particles of Pfs25 or CSP and EPA generated significantly greater antigen-specific antibody levels compared with mice vaccinated with the respective unmodified monomeric antigens, validating the potential of antigen-EPA nanoparticles as vaccines.	[Jones, David S.; Rowe, Christopher G.; Chen, Beth; Reiter, Karine; Rausch, Kelly M.; Narum, David L.; Wu, Yimin; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jones, DS (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA.	dsj123@aol.com		Narum, David/0000-0003-3041-5402	Division of Intramural Research (DIR) of NIAID, NIH; Malaria Vaccine Initiative (MVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001008, ZIAAI001009] Funding Source: NIH RePORTER	Division of Intramural Research (DIR) of NIAID, NIH; Malaria Vaccine Initiative (MVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research (DIR) of NIAID, NIH. A portion was funded by the Malaria Vaccine Initiative (MVI).	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Ellis RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046094; Fahmy TM, 2008, NANOMEDICINE-UK, V3, P343, DOI 10.2217/17435889.3.3.343; Finn A, 2004, BRIT MED BULL, V70, P1, DOI 10.1093/bmb/ldh021; Fu TM, 2009, VACCINE, V27, P1440, DOI 10.1016/j.vaccine.2008.12.034; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Herrera R, 2015, INFECT IMMUN, V83, P3771, DOI 10.1128/IAI.02676-14; Kaba SA, 2009, J IMMUNOL, V183, P7268, DOI 10.4049/jimmunol.0901957; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Knuf M, 2011, VACCINE, V29, P4881, DOI 10.1016/j.vaccine.2011.04.053; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kubler-Kielb J, 2007, P NATL ACAD SCI USA, V104, P293, DOI 10.1073/pnas.0609885104; Kubler-Kielb J, 2010, P NATL ACAD SCI USA, V107, P1172, DOI 10.1073/pnas.0913374107; LEANZA WJ, 1992, BIOCONJUGATE CHEM, V3, P514, DOI 10.1021/bc00018a009; Li CH, 2011, J PHARM SCI-US, V100, P4642, DOI 10.1002/jps.22695; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Pedersen MK, 2006, J IMMUNOL METHODS, V311, P198, DOI 10.1016/j.jim.2006.02.008; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Qian F, 2007, VACCINE, V25, P3923, DOI 10.1016/j.vaccine.2007.02.073; Qian F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036996; Qian F, 2009, MICROBES INFECT, V11, P408, DOI 10.1016/j.micinf.2008.12.009; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Salvador A, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/181646; Shimp RL, 2013, VACCINE, V31, P2954, DOI 10.1016/j.vaccine.2013.04.034; Shin IS, 2007, BIOCONJUGATE CHEM, V18, P821, DOI 10.1021/bc0603485; SHULER KR, 1992, J IMMUNOL METHODS, V156, P137, DOI 10.1016/0022-1759(92)90020-T; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Tsai CW, 2006, J BIOTECHNOL, V121, P458, DOI 10.1016/j.jbiotec.2005.08.025; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103	29	16	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0138761	10.1371/journal.pone.0138761	http://dx.doi.org/10.1371/journal.pone.0138761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950441	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100001
J	Li, SL; Yuan, YH; Wang, TJ; Xu, W; Li, MZ; Mai, KS; Ai, QH				Li, Songlin; Yuan, Yuhui; Wang, Tianjiao; Xu, Wei; Li, Mingzhu; Mai, Kangsen; Ai, Qinghui			Molecular Cloning, Functional Characterization and Nutritional Regulation of the Putative Elongase Elovl5 in the Orange-Spotted Grouper (Epinephelus coioides)	PLOS ONE			English	Article							FATTY ACYL DESATURASE; BASS DICENTRARCHUS-LABRAX; GENE-EXPRESSION; SEA-BASS; DELTA-6 DESATURASE; ACID SYNTHESIS; GROWTH-PERFORMANCE; LIPID DEPOSITION; MARINE FISH; FADS2	The enzymes involved in the biosynthesis of long-chain polyunsaturated fatty acids (LC-PUFAs) are widely studied in fish species, as fish are the main source of n-3 LC-PUFAs for human beings. In the present study, a putative gene for elovl5, which encodes a key enzyme involved in LC-PUFA synthesis, was cloned and functionally characterized, and its transcription in response to dietary n-3 LC-PUFA exposure was investigated. Moreover, cell transfection and luciferase assays were used to explore the mechanism underlying the regulation of elovl5. The full-length cDNA of elovl5 was 1242 bp (excluding the polyA tail), including an 885 bp coding region encoding a 295 amino acid protein that possesses all of the characteristic features of elovl proteins. Functional characterization of heterologously expressed grouper Elovl5 indicated that it effectively elongates both C18 (18:2n-6, 18:3n-3, 18:3n-6 and 18:4n-3) and C20 (20:4n-6 and C20:5n-3) PUFAs, but not the C22 substrates. The expression of elovl5 was significantly affected by dietary n-3 LC-PUFA exposure: a high n-3 LC-PUFA level repressed the expression of elovl5 by slightly down-regulating the expression of sterol regulatory element-binding protein (SREBP)-1 and liver X receptor (LXR) alpha, which are major regulators of hepatic lipid metabolism. Promoter studies showed that grouper elovl5 reporter activity was induced by over-expression of LXR alpha but not SREBP-1. This finding suggests that elovl5 is a direct target of LXR alpha, which is involved in the biosynthesis of PUFAs via transcriptional regulation of elovl5. These findings may contribute to a further understanding of the mechanism underlying the regulation of LC-PUFA biosynthesis in marine fish species.	[Li, Songlin; Yuan, Yuhui; Wang, Tianjiao; Xu, Wei; Li, Mingzhu; Mai, Kangsen; Ai, Qinghui] Ocean Univ China, Minist Agr, Key Lab Aquaculture Nutr & Feed, Qingdao 266003, Peoples R China; [Li, Songlin; Yuan, Yuhui; Wang, Tianjiao; Xu, Wei; Li, Mingzhu; Mai, Kangsen; Ai, Qinghui] Ocean Univ China, Minist Educ China, Key Lab Mariculture, Qingdao 266003, Peoples R China; [Li, Songlin; Yuan, Yuhui; Wang, Tianjiao; Xu, Wei; Li, Mingzhu; Mai, Kangsen; Ai, Qinghui] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries & Aquaculture, Qingdao, Peoples R China	Ministry of Agriculture & Rural Affairs; Ocean University of China; Ministry of Education, China; Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Ai, QH (corresponding author), Ocean Univ China, Minist Agr, Key Lab Aquaculture Nutr & Feed, Qingdao 266003, Peoples R China.; Ai, QH (corresponding author), Ocean Univ China, Minist Educ China, Key Lab Mariculture, Qingdao 266003, Peoples R China.; Ai, QH (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries & Aquaculture, Qingdao, Peoples R China.	qhai@ouc.edu.cn			National Science-technology Support Plan Project [2011BAD13B08, 2011BAD13B01]; National Natural Science Foundation of China [31172425]; National Basic Research Program of China (973 Program) [2014CB138600]	National Science-technology Support Plan Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was financially supported by the National Science-technology Support Plan Projects (2011BAD13B08 and 2011BAD13B01), National Natural Science Foundation of China (31172425) and the National Basic Research Program of China (973 Program) (2014CB138600). The funders' websites are http://www.most.gov.cn/index.htm, http://www.nsfc.gov.cn/ and http://www.most.gov.cn/index.htm, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaba M, 2004, MAR BIOTECHNOL, V6, P251, DOI 10.1007/s10126-003-0029-1; Ai QH, 2008, AQUACULT NUTR, V14, DOI 10.1111/j.1365-2095.2007.00557.x; Alimuddin, 2008, AQUACULTURE, V282, P13, DOI 10.1016/j.aquaculture.2008.06.033; Calder PC, 2007, PROSTAG LEUKOTR ESS, V77, P327, DOI 10.1016/j.plefa.2007.10.015; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Geay F, 2010, COMP BIOCHEM PHYS B, V156, P237, DOI 10.1016/j.cbpb.2010.03.008; Geay F, 2012, MAR GENOM, V5, P7, DOI 10.1016/j.margen.2011.08.003; Ghioni C, 1999, BBA-MOL CELL BIOL L, V1437, P170, DOI 10.1016/S1388-1981(99)00010-4; Gregory MK, 2010, COMP BIOCHEM PHYS B, V155, P178, DOI 10.1016/j.cbpb.2009.11.002; Hastings N, 2004, MAR BIOTECHNOL, V6, P463, DOI 10.1007/s10126-004-3002-8; Hastings N, 2001, P NATL ACAD SCI USA, V98, P14304, DOI 10.1073/pnas.251516598; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Howell G, 2009, BBA-MOL CELL BIOL L, V1791, P1190, DOI 10.1016/j.bbalip.2009.08.008; Izquierdo MS, 2003, AQUACULT NUTR, V9, P397, DOI 10.1046/j.1365-2095.2003.00270.x; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Kuah MK, 2015, BBA-MOL CELL BIOL L, V1851, P248, DOI 10.1016/j.bbalip.2014.12.012; Lewis MJ, 2013, AQUACULTURE, V412, P215, DOI 10.1016/j.aquaculture.2013.07.024; Li MZ, 2013, AQUACULTURE, V416, P48, DOI 10.1016/j.aquaculture.2013.08.030; Li SL, 2016, AQUAC RES, V47, P2481, DOI 10.1111/are.12697; Li SL, 2014, AQUACULTURE, V434, P212, DOI 10.1016/j.aquaculture.2014.08.009; Lin HZ, 2007, AQUAC RES, V38, P1605, DOI 10.1111/j.1365-2109.2007.01811.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; Millamena OM, 2002, AQUACULTURE, V204, P75, DOI 10.1016/S0044-8486(01)00629-9; Minghetti M, 2011, BBA-MOL CELL BIOL L, V1811, P194, DOI 10.1016/j.bbalip.2010.12.008; Monroig O, 2011, AVANCES NUTR ACUICOL, V11, P257; Monroig O, 2012, AQUACULTURE, V350, P63, DOI 10.1016/j.aquaculture.2012.04.017; Monroig O, 2011, COMP BIOCHEM PHYS B, V159, P206, DOI 10.1016/j.cbpb.2011.04.007; Morais S, 2015, BBA-MOL CELL BIOL L, V1851, P588, DOI 10.1016/j.bbalip.2015.01.014; Morais S, 2011, AQUACULTURE, V313, P129, DOI 10.1016/j.aquaculture.2011.01.031; Nakamura MT, 2001, LIPIDS, V36, P961, DOI 10.1007/s11745-001-0806-5; Nugent A. P., 2004, Nutrition Bulletin, V29, P36, DOI 10.1111/j.1467-3010.2004.00403.x; Peng M, 2014, AQUACULTURE, V433, P442, DOI 10.1016/j.aquaculture.2014.07.005; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Qin Y, 2009, BBA-MOL CELL BIOL L, V1791, P140, DOI 10.1016/j.bbalip.2008.12.003; Ren HT, 2012, COMP BIOCHEM PHYS B, V163, P184, DOI 10.1016/j.cbpb.2012.05.016; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sargent John R., 2002, P181; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Tocher DR, 2006, LIPIDS, V41, P1003, DOI 10.1007/s11745-006-5051-4; Tocher DR, 2015, AQUACULTURE, V449, P94, DOI 10.1016/j.aquaculture.2015.01.010; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Torrejon C, 2007, PROSTAG LEUKOTR ESS, V77, P319, DOI 10.1016/j.plefa.2007.10.014; Tvrdik P, 2000, J CELL BIOL, V149, P707, DOI 10.1083/jcb.149.3.707; Wang SQ, 2014, AQUACULTURE, V434, P57, DOI 10.1016/j.aquaculture.2014.07.016; Yamamoto Y, 2010, FISHERIES SCI, V76, P463, DOI 10.1007/s12562-010-0227-5; Zheng XZ, 2009, COMP BIOCHEM PHYS B, V154, P255, DOI 10.1016/j.cbpb.2009.06.010; Zheng XZ, 2009, AQUACULTURE, V290, P122, DOI 10.1016/j.aquaculture.2009.02.010; Zuo RT, 2016, AQUAC RES, V47, P2393, DOI 10.1111/are.12686; Zuo RT, 2013, BRIT J NUTR, V110, P1220, DOI 10.1017/S0007114513000378	56	24	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150544	10.1371/journal.pone.0150544	http://dx.doi.org/10.1371/journal.pone.0150544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950699	Green Submitted, Green Published, gold			2022-12-27	WOS:000371990100039
J	Hackler, L; Ozsvari, B; Gyuris, M; Sipos, P; Fabian, G; Molnar, E; Marton, A; Farago, N; Mihaly, J; Nagy, LI; Szenasi, T; Diron, A; Parducz, A; Kanizsai, I; Puskas, LG				Hackler, Laszlo, Jr.; Ozsvari, Bela; Gyuris, Mario; Sipos, Peter; Fabian, Gabriella; Molnar, Eszter; Marton, Annamaria; Farago, Nora; Mihaly, Jozsef; Nagy, Lajos Istvan; Szenasi, Tibor; Diron, Andrea; Parducz, Arpad; Kanizsai, Ivan; Puskas, Laszlo G.			The Curcumin Analog C-150, Influencing NF-kappa B, UPR and Akt/Notch Pathways Has Potent Anticancer Activity In Vitro and In Vivo	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HUMAN GLIOMA-CELLS; SIGNALING PATHWAY; EXPRESSION CHANGES; DOWN-REGULATION; CANCER-CELLS; APOPTOSIS; AGENTS; GROWTH	C-150 a Mannich-type curcumin derivative, exhibited pronounced cytotoxic effects against eight glioma cell lines at micromolar concentrations. Inhibition of cell proliferation by C-150 was mediated by affecting multiple targets as confirmed at transcription and protein level. C-150 effectively reduced the transcription activation of NFkB, inhibited PKC-alpha which are constitutively over-expressed in glioblastoma. The effects of C-150 on the Akt/Notch signaling were also demonstrated in a Drosophila tumorigenesis model. C-150 reduced the number of tumors in Drosophila with similar efficacy to mitoxantrone. In an in vivo orthotopic glioma model, C-150 significantly increased the median survival of treated nude rats compared to control animals. The multi-target action of C-150, and its preliminary in vivo efficacy would render this curcumin analogue as a potent clinical candidate against glioblastoma.	[Hackler, Laszlo, Jr.; Ozsvari, Bela; Gyuris, Mario; Farago, Nora; Nagy, Lajos Istvan; Diron, Andrea; Kanizsai, Ivan; Puskas, Laszlo G.] AVIDIN Ltd, Szeged, Hungary; [Sipos, Peter] Univ Szeged, Dept Pharmaceut Technol, Szeged, Hungary; [Fabian, Gabriella; Molnar, Eszter] AVICOR Ltd, Szeged, Hungary; [Marton, Annamaria] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Farago, Nora; Mihaly, Jozsef; Szenasi, Tibor; Puskas, Laszlo G.] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary; [Parducz, Arpad] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary	Szeged University; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Academy of Sciences; Hungarian Biological Research Center	Puskas, LG (corresponding author), AVIDIN Ltd, Szeged, Hungary.; Puskas, LG (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary.	laszlo@avidinbiotech.com		Fabian, Gabriella/0000-0002-2323-4948; Mihaly, Jozsef/0000-0003-3399-2424; Szenasi, Tibor/0000-0002-8405-0798	EU [HEALH-F2-2008-20166]; Pfizer Hungary Award [TAMOP-4.2.2.A-11/1/KONV-2012-0035]; OTKA grant [K82039, TAMOP -4.2.2.A-11/1/KONV-2012-0035]; Hungarian Brain Research Program [KTIA-NAP_13-2014-0007]; AVIDIN Ltd.; AVICOR Ltd.;  [GOP-1.1.1-11-2011-0003]	EU(European Commission); Pfizer Hungary Award; OTKA grant(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Brain Research Program; AVIDIN Ltd.; AVICOR Ltd.; 	This work was supported by the following grant: GOP-1.1.1-11-2011-0003 (Gazdasagfejlesztesi Operativ Program, Development Operational Programme). Research in the laboratory of J. M. was supported by an EU FP7 grant HEALH-F2-2008-20166, the Pfizer Hungary Award, OTKA grant K82039, TAMOP -4.2.2.A-11/1/KONV-2012-0035 and the Hungarian Brain Research Program (KTIA-NAP_13-2014-0007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AVIDIN Ltd. and AVICOR Ltd. provided support in the form of salaries for authors LH, BO, MG, NF, LIN, AD, IK, LGP, GF and EM but did not have any additional role in the study design, data collection and analysis, decision to publish, or in the preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.r This work was supported by the following grant: GOP-1.1.1-11-2011-0003. J.M. was supported by a the Pfizer Hungary Award, TAMOP-4.2.2.A-11/1/KONV-2012-0035, an EU FP7 grant HEALH-F2-2008-20166, OTKA grant K82039, and the Hungarian Brain Research Program (KTIA-NAP_13-2014-0007).	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Agrawal DK, 2010, MED RES REV, V30, P818, DOI 10.1002/med.20188; Alm K., 2013, HOLOGRAPHY BASIC PRI, P335, DOI DOI 10.5772/54505; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Ansari SA, 2001, EXP CELL RES, V265, P221, DOI 10.1006/excr.2001.5168; Antal O, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-142; Baska F, 2014, CURR MED CHEM, V21, P1938, DOI 10.2174/0929867321666140304152606; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Catala A, 2007, J PINEAL RES, V42, P43, DOI 10.1111/j.1600-079X.2006.00354.x; Choi BH, 2008, CANCER RES, V68, P1369, DOI 10.1158/0008-5472.CAN-07-5222; DAS UN, 1995, CANCER LETT, V94, P147, DOI 10.1016/0304-3835(95)03844-M; Dhandapani KM, 2007, J NEUROCHEM, V102, P522, DOI 10.1111/j.1471-4159.2007.04633.x; Eder K, 2009, BIOCHEM BIOPH RES CO, V389, P46, DOI 10.1016/j.bbrc.2009.08.082; Farago N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-173; Fresco P, 2010, CURR PHARM DESIGN, V16, P114, DOI 10.2174/138161210789941856; Fujiwara Y, 2011, CANCER SCI, V102, P206, DOI 10.1111/j.1349-7006.2010.01772.x; Gyuris M., 2013, WO Patent, Patent No. [WO2013/041895A1, 2013041895, WO2013041895A1]; Hanauske AR, 2004, CURR PHARM DESIGN, V10, P1923, DOI 10.2174/1381612043384376; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hegedus B, 2006, BIOPHYS J, V91, P2708, DOI 10.1529/biophysj.105.077834; Johnson SM, 2009, ANTICANCER RES, V29, P3185; Li YG, 2012, FEBS J, V279, P2247, DOI 10.1111/j.1742-4658.2012.08607.x; Lin L, 2006, J MED CHEM, V49, P3963, DOI 10.1021/jm051043z; Liu H, 2010, EYE, V24, P137, DOI 10.1038/eye.2009.20; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Madacsi R, 2013, MED CHEM, V9, P911, DOI 10.2174/1573406411309070004; McDowell KA, 2011, CURR PHARM DESIGN, V17, P2411; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Molder A, 2008, J MICROSC-OXFORD, V232, P240, DOI 10.1111/j.1365-2818.2008.02095.x; Nagy LI, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/968981; O'Sullivan-Coyne G, 2009, BRIT J CANCER, V101, P1585, DOI 10.1038/sj.bjc.6605308; Pae HO, 2007, BIOCHEM BIOPH RES CO, V353, P1040, DOI 10.1016/j.bbrc.2006.12.133; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Perry MC, 2010, MOL NUTR FOOD RES, V54, P1192, DOI 10.1002/mnfr.200900277; Purkayastha S, 2009, BRAIN RES, V1266, P130, DOI 10.1016/j.brainres.2009.01.066; Qiu X, 2010, J MED CHEM, V53, P8260, DOI 10.1021/jm1004545; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Schiborr C, 2014, MOL NUTR FOOD RES, V58, P516, DOI 10.1002/mnfr.201300724; Schonthal AH, 2011, CURR PHARM DESIGN, V17, P2428; Scott DW, 2007, J CELL BIOCHEM, V101, P307, DOI 10.1002/jcb.21179; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Singh Sarvjeet, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P259, DOI 10.2174/187152006776930918; Sukumari-Ramesh S, 2011, INT J DEV NEUROSCI, V29, P701, DOI 10.1016/j.ijdevneu.2011.06.002; Sung BK, 2012, NUTR CANCER, V64, P173, DOI 10.1080/01635581.2012.630551; Wang Y, 2011, J MED CHEM, V54, P3768, DOI 10.1021/jm200017g; Wang ZW, 2006, CANCER-AM CANCER SOC, V106, P2503, DOI 10.1002/cncr.21904; Weaver KD, 2003, J NEURO-ONCOL, V61, P187, DOI 10.1023/A:1022554824129; Weissenberger J, 2010, CLIN CANCER RES, V16, P5781, DOI 10.1158/1078-0432.CCR-10-0446; Woo JH, 2003, CARCINOGENESIS, V24, P1199, DOI 10.1093/carcin/bgg082; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zhang Q, 2011, BIOORG MED CHEM LETT, V21, P1010, DOI 10.1016/j.bmcl.2010.12.020; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	56	37	37	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0149832	10.1371/journal.pone.0149832	http://dx.doi.org/10.1371/journal.pone.0149832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943907	Green Published, Green Submitted, gold			2022-12-27	WOS:000371739400006
J	Song, JC; Xue, GX; Kang, YN				Song, Jiancai; Xue, Guixiang; Kang, Yanan			A Novel Method for Optimum Global Positioning System Satellite Selection Based on a Modified Genetic Algorithm	PLOS ONE			English	Article							GPS GDOP CLASSIFICATION	In this paper, a novel method for selecting a navigation satellite subset for a global positioning system (GPS) based on a genetic algorithm is presented. This approach is based on minimizing the factors in the geometric dilution of precision (GDOP) using a modified genetic algorithm (MGA) with an elite conservation strategy, adaptive selection, adaptive mutation, and a hybrid genetic algorithm that can select a subset of the satellites represented by specific numbers in the interval (4 similar to n) while maintaining position accuracy. A comprehensive simulation demonstrates that the MGA-based satellite selection method effectively selects the correct number of optimal satellite subsets using receiver autonomous integrity monitoring (RAIM) or fault detection and exclusion (FDE). This method is more adaptable and flexible for GPS receivers, particularly for those used in handset equipment and mobile phones.	[Song, Jiancai] Tianjin Univ, Sch Elect Informat Engn, Tianjin 300072, Peoples R China; [Xue, Guixiang] Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China; [Kang, Yanan] Shijiazhuang Tiedao Univ, Sch Comp Sci & Engn, Shijiazhuang, Hebei, Peoples R China	Tianjin University; Tianjin University; Shijiazhuang Tiedao University	Xue, GX (corresponding author), Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China.	xueguixiang_tju@163.com			National Science Foundation of China [61471262]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China under Grant of No. 61471262.	Azami H, 2014, INT J ELECTRON, V101, P1300, DOI 10.1080/00207217.2013.832390; Azarbad M, 2014, APPL SOFT COMPUT, V25, P285, DOI 10.1016/j.asoc.2014.09.022; Benson K, 2000, IEEE C EVOL COMPUTAT, P1543, DOI 10.1109/CEC.2000.870838; Carl Meyer D., 2000, MATRIX ANAL APPL LIN; Chaffee J, 1994, POS LOC NAV S 1994 I, P11; Dai XM, 2011, IEEE T COMMUN, V59, P1253, DOI 10.1109/TCOMM.2011.031611.070610; Doong SH, 2009, GPS SOLUT, V13, P183, DOI 10.1007/s10291-008-0111-2; Jwo DJ, 2007, GPS SOLUT, V11, P51, DOI 10.1007/s10291-006-0030-z; Lin TY, 2012, IEEE T VEH TECHNOL, V61, P2256, DOI 10.1109/TVT.2012.2191166; Liu M, 2011, EXPERT SYST APPL, V38, P9248, DOI 10.1016/j.eswa.2011.01.136; Liu M, 2009, I NAVIG SAT DIV INT, P2061; MOK E, 1994, J NAVIGATION, V47, P383, DOI 10.1017/S0373463300012327; Mosavi MR, 2009, IEEE ASME INT C ADV, P245, DOI 10.1109/AIM.2009.5230008; Otero A, 2006, 2006 INTERNATIONAL SYMPOSIUM ON EVOLVING FUZZY SYSTEMS, PROCEEDINGS, P300, DOI 10.1109/ISEFS.2006.251158; Ozgun O, 2003, IEEE T ANTENN PROPAG, V51, P1947, DOI 10.1109/TAP.2003.814732; Phatak MS, 2001, IEEE T AERO ELEC SYS, V37, P751, DOI 10.1109/7.937488; Sharp I, 2009, IEEE T VEH TECHNOL, V58, P3371, DOI 10.1109/TVT.2009.2017270; SIMON D, 1995, NEUROCOMPUTING, V7, P247, DOI 10.1016/0925-2312(94)00024-M; Wu CH, 2007, IEEE GEOSCI REMOTE S, V4, P297, DOI 10.1109/LGRS.2007.894164; Wu CH, 2011, IEEE T INSTRUM MEAS, V60, P137, DOI 10.1109/TIM.2010.2049228; Yarlagadda R, 2000, IEE P-RADAR SON NAV, V147, P259, DOI 10.1049/ip-rsn:20000554; Zhang MY, 2009, IEEE J-STSP, V3, P740, DOI 10.1109/JSTSP.2009.2028381; Zhang Miaoyan, 2008, POS LOC NAV S 2008, P5; Zheng ZY, 2004, CHINESE ASTRON ASTR, V28, P80, DOI 10.1016/j.chinastron.2004.01.009	24	12	13	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150005	10.1371/journal.pone.0150005	http://dx.doi.org/10.1371/journal.pone.0150005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943638	gold, Green Published, Green Submitted			2022-12-27	WOS:000371739400012
J	Malinska, H; Oliyarnyk, O; Skop, V; Silhavy, J; Landa, V; Zidek, V; Mlejnek, P; Simakova, M; Strnad, H; Kazdova, L; Pravenec, M				Malinska, Hana; Oliyarnyk, Olena; Skop, Vojtech; Silhavy, Jan; Landa, Vladimir; Zidek, Vaclav; Mlejnek, Petr; Simakova, Miroslava; Strnad, Hynek; Kazdova, Ludmila; Pravenec, Michal			Effects of Metformin on Tissue Oxidative and Dicarbonyl Stress in Transgenic Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein	PLOS ONE			English	Article							FALSE DISCOVERY RATE; METHYLGLYOXAL; GLYCATION; INFLAMMATION; METABOLISM	Inflammation and oxidative and dicarbonyl stress play important roles in the pathogenesis of type 2 diabetes. Metformin is the first-line drug of choice for the treatment of type 2 diabetes because it effectively suppresses gluconeogenesis in the liver. However, its "pleiotropic" effects remain controversial. In the current study, we tested the effects of metformin on inflammation, oxidative and dicarbonyl stress in an animal model of inflammation and metabolic syndrome, using spontaneously hypertensive rats that transgenically express human C-reactive protein (SHR-CRP). We treated 8-month-old male transgenic SHR-CRP rats with metformin (5 mg/kg/day) mixed as part of a standard diet for 4 weeks. A corresponding untreated control group of male transgenic SHR-CRP rats were fed a standard diet without metformin. In a similar fashion, we studied a group of nontransgenic SHR treated with metformin and an untreated group of nontransgenic SHR controls. In each group, we studied 6 animals. Parameters of glucose and lipid metabolism and oxidative and dicarbonyl stress were measured using standard methods. Gene expression profiles were determined using Affymetrix GeneChip Arrays. Statistical significance was evaluated by two-way ANOVA. In the SHR-CRP transgenic strain, we found that metformin treatment decreased circulating levels of inflammatory response marker IL-6, TNF alpha and MCP-1 while levels of human CRP remained unchanged. Metformin significantly reduced oxidative stress (levels of conjugated dienes and TBARS) and dicarbonyl stress (levels of methylglyoxal) in left ventricles, but not in kidneys. No significant effects of metformin on oxidative and dicarbonyl stress were observed in SHR controls. In addition, metformin treatment reduced adipose tissue lipolysis associated with human CRP. Possible molecular mechanisms of metformin action-studied by gene expression profiling in the liver-revealed deregulated genes from inflammatory and insulin signaling, AMP-activated protein kinase (AMPK) signaling and gluconeogenesis pathways. It can be concluded that in the presence of high levels of human CRP, metformin protects against inflammation and oxidative and dicarbonyl stress in the heart, but not in the kidney. Accordingly, these cardioprotective effects of metformin might be especially effective in diabetic patients with high levels of CRP.	[Malinska, Hana; Oliyarnyk, Olena; Skop, Vojtech; Kazdova, Ludmila] Inst Clin & Expt Med, Ctr Med Expt, Prague, Czech Republic; [Silhavy, Jan; Landa, Vladimir; Zidek, Vaclav; Mlejnek, Petr; Simakova, Miroslava; Pravenec, Michal] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; [Strnad, Hynek] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Pravenec, M (corresponding author), Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic.	pravenec@biomed.cas.cz	Silhavy, Jan/B-5292-2014; Simakova, Miroslava/B-7493-2012; Simakova, Miroslava/R-5367-2019; Mlejnek, Petr/C-2305-2012; Pravenec, Michal/B-1666-2012; Oliyarnyk, Olena/Q-6380-2019; Strnad, Hynek/B-7361-2008	Silhavy, Jan/0000-0001-8042-5890; Simakova, Miroslava/0000-0003-1468-5832; Mlejnek, Petr/0000-0002-4218-8983; Pravenec, Michal/0000-0001-9197-5871; Strnad, Hynek/0000-0002-0141-8340; Oliyarnyk, Olena/0000-0002-4912-6187; Skop, Vojtech/0000-0002-4685-4429	Czech Science Foundation [14-36804G]; Ministry of Education, Youth and Sports of the Czech Republic within the ERC CZ program [LL1204]; Ministry of Health of the Czech Republic [NT 14325-3/2013]; European Regional Development Fund (ERDF), Operational Program Prague - Competitiveness (OPPC) Biomodels [CZ.2.16/3.1.00/24017]; MH CZ-DRO ("Institute for Clinical and Experimental Medicine-IKEM") [IN 00023001]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic within the ERC CZ program; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); European Regional Development Fund (ERDF), Operational Program Prague - Competitiveness (OPPC) Biomodels; MH CZ-DRO ("Institute for Clinical and Experimental Medicine-IKEM")	This work was supported by grants 14-36804G from the Czech Science Foundation, LL1204 (within the ERC CZ program) from the Ministry of Education, Youth and Sports of the Czech Republic and grant NT 14325-3/2013 from the Ministry of Health of the Czech Republic and supported by the European Regional Development Fund (ERDF), Operational Program Prague - Competitiveness (OPPC) Biomodels CZ.2.16/3.1.00/24017 project for MP. LK was supported by MH CZ-DRO ("Institute for Clinical and Experimental Medicine-IKEM, IN 00023001"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal NK, 2014, WORLD J DIABETES, V5, P697, DOI 10.4239/wjd.v5.i5.697; Barnea M, 2012, BBA-MOL BASIS DIS, V1822, P1796, DOI 10.1016/j.bbadis.2012.08.005; Beisswenger PJ, 2012, AMINO ACIDS, V42, P1171, DOI 10.1007/s00726-010-0784-z; Benes J, 2011, CLIN SCI, V121, P29, DOI 10.1042/CS20100527; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Fleming T, 2012, DIABETOLOGIA, V55, P1151, DOI 10.1007/s00125-012-2452-1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Kahn SE, 2010, DIABETES CARE, V33, P177, DOI 10.2337/dc09-1661; Kender Z, 2014, EXP CLIN ENDOCR DIAB, V122, P316, DOI 10.1055/s-0034-1371818; Leverve XM, 2003, DIABETES METAB, V29, pS88; Loomba R, 2014, HEPATOLOGY, V60, P1818, DOI 10.1002/hep.27314; Maruthur NM, 2014, DIABETES CARE, V37, P876, DOI 10.2337/dc13-1276; Matafome P, 2012, ARCH PHYSIOL BIOCHEM, V118, P58, DOI 10.3109/13813455.2012.658065; Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052; Pravenec M, 2011, HYPERTENSION, V57, P731, DOI 10.1161/HYPERTENSIONAHA.110.164350; Pruski M, 2009, DIABETES CARE, V32, P1421, DOI 10.2337/dc08-2335; Rabbani N, 2015, BIOCHEM BIOPH RES CO, V458, P221, DOI 10.1016/j.bbrc.2015.01.140; Ruggiero-Lopez D, 1999, BIOCHEM PHARMACOL, V58, P1765, DOI 10.1016/S0006-2952(99)00263-4; Saisho Y, 2015, ENDOCR METAB IMMUNE, V15, P196, DOI 10.2174/1871530315666150316124019; Sena CM, 2012, PHARMACOL RES, V65, P497, DOI 10.1016/j.phrs.2012.03.004; Silhavy J, 2014, CARDIOVASC THER, V32, P59, DOI 10.1111/1755-5922.12061; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Tikellis C, 2014, DIABETES, V63, P3915, DOI 10.2337/db13-0932	27	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150924	10.1371/journal.pone.0150924	http://dx.doi.org/10.1371/journal.pone.0150924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963617	gold, Green Submitted, Green Published			2022-12-27	WOS:000371993000080
J	Chen, XG; Luo, YJ; Zhou, YF; Lu, M				Chen, Xiangang; Luo, Yunjian; Zhou, Yongfeng; Lu, Mei			Carbon Sequestration Potential in Stands under the Grain for Green Program in Southwest China	PLOS ONE			English	Article							SOIL CARBON; AFFORESTATION; LAND; PLANTATIONS; BIOMASS; PATTERN	The Grain for Green Program (GGP) is the largest afforestation and reforestation project in China in the early part of this century. To assess carbon sequestration in stands under the GGP in Southwest China, the carbon stocks and their annual changes in the GGP stands in the region were estimated based on the following information: (1) collected data on the annually planted area of each tree species under the GGP in Southwest China from 1999 to 2010; (2) development of empirical growth curves and corresponding carbon estimation models for each species growing in the GPP stands; and (3) parameters associated with the stands such as wood density, biomass expansion factor, carbon fraction and the change rate of soil organic carbon content. Two forest management scenarios were examined: scenario A, with no harvesting, and scenario B, with logging at the customary rotation followed by replanting. The results showed that by the years 2020, 2030, 2040, 2050 and 2060, the expected carbon storage of the GGP stands in Southwest China is 139.58 TgC, 177.50-207.55 TgC, 196.86-259.65 TgC, 240.45-290.62 TgC and 203.22-310.03 TgC (T = 10(12)), respectively. For the same years, the expected annual change in carbon stocks is 7.96 TgCyr(-1), -7.95-5.95 TgCyr(-1), -0.10-4.67 TgCyr(-1), 4.31-2.24 TgCyr(-1) and -0.02-1.75 TgCyr(-1), respectively. This indicates that the stands significantly contribute to forest carbon sinks in this region. In 2060, the estimated carbon stocks in the seven major species of GGP stands in Southwest China are 4.16-13.01 TgC for Pinus armandii, 6.30-15.01 TgC for Pinus massoniana, 11.51-13.44 TgC for Ctyptomeria fortunei, 15.94-24.13 TgC for Cunninghamia lanceolata, 28.05 TgC for Cupressus spp., 5.32-15.63 TgC for Populus deltoides and 5.87-14.09 TgC for Eucalyptus spp. The carbon stocks in these seven species account for 36.8%-41.4% of the total carbon stocks in all GGP stands over the next 50 years.	[Chen, Xiangang; Zhou, Yongfeng; Lu, Mei] Southwest Forestry Univ, Sch Environm Sci & Engn, Kunming, Yunnan, Peoples R China; [Luo, Yunjian] Yangzhou Univ, Dept Ecol, Sch Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China	Southwest Forestry University - China; Yangzhou University	Chen, XG (corresponding author), Southwest Forestry Univ, Sch Environm Sci & Engn, Kunming, Yunnan, Peoples R China.	chenxg1958@aliyun.com	Luo, Yunjian/C-5366-2019	Luo, Yunjian/0000-0002-7358-5797	National Natural Science Foundation of China [41263008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by the National Natural Science Foundation of China (Project No.41263008) [http://www.nsfc.gov.cn/publish/porta10/default.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Xue-shuang, 2008, Shengtaixue Zazhi, V27, P1647; Bateman IJ, 2000, J ENVIRON MANAGE, V60, P301, DOI 10.1006/jema.2000.0388; Chang RY, 2011, ENVIRON MANAGE, V48, P1158, DOI 10.1007/s00267-011-9682-8; Chen JJ, 2002, PRACTICAL MANUAL FOR, P174; Chen XG, 2009, FOREST ECOL MANAG, V258, P199, DOI 10.1016/j.foreco.2008.07.010; Cheng JZ, 2015, AGR FOREST METEOROL, V203, P88, DOI 10.1016/j.agrformet.2015.01.004; Dong X, 2014, ADV MAT RES, V864-867, P2444; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Garten CT, 2002, BIOMASS BIOENERG, V23, P93, DOI 10.1016/S0961-9534(02)00033-8; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Huang CD, 2008, ACTA ECOLOGICA SINIC, V28, P967; Institute of Forest Ecology Environment and Protection CAF ( IFEEP ), 2004, CHECKL REP LAND US C, P30; IPCC, 2022, SPECIAL REPORT CLIM; IPCC, 2004, IPCC GOOD PRACT LULU; Lazams M, 2001, PROJECT BASELINES BO; LI J, 2006, J ZHEJIANG FOREST SC, V26, P2; Li SD., 2004, RES GRAIN GREEN CHIN; Li ZhengCai, 2004, Journal of Zhejiang Forestry College, V21, P382; Liu D, 2014, LANDSCAPE ECOL, V29, P1675, DOI 10.1007/s10980-014-0081-4; Niu XZ, 2006, FOREST ECOL MANAG, V223, P415, DOI 10.1016/j.foreco.2005.12.044; Paul EA, 2003, SOIL SCI SOC AM J, V67, P1620, DOI 10.2136/sssaj2003.1620; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Paul KL, 2003, FOREST ECOL MANAG, V177, P485, DOI 10.1016/S0378-1127(02)00454-1; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Potter CS, 1999, SCIENCE, V283, P1815; Research Group of China Forestry Sustainable Development Strategy (RGCFSDS), 2002, RES CHIN FOR SUST DE, P135; SFAPRC, 2001, COMP NAT TECHN STAND; SFAPRC, 2009, TH7 NAT FOR IN UNPUB; SFAPRC, 1999, TH5 NAT FOR IN UNPUB; SFAPRC, 2004, TH6 NAT FOR IN UNPUB; SKOG KE, 2000, RMRSGTR59 USDA FOR S; Song X, 2014, SELECTED AREAS COMMU, P1; State Council of the People's Republic of China (SCPRC), 2002, REG GRAIN GREEN OFF; State Forestry Administration of the PRC (SFAPRC), 1994, TH4 NAT FOR IN UNPUB; Tian Xiu-ling, 2011, Yingyong Shengtai Xuebao, V22, P287; *UNFCCC, 2003, MOD PROC AFF REF PRO; UNFCCC, 2001, MARR ACC MARR DECL V; Wang ChunMei, 2007, Journal of Beijing Forestry University, V29, P112; Willems S., 2000, FRAMEWORK BASELINE G; Zhang K, 2010, LAND DEGRAD DEV, V21, P13, DOI 10.1002/ldr.954; Zhao FZ, 2013, SOIL SCI, V178, P550, DOI 10.1097/SS.0000000000000018; [赵敏 Zhao Min], 2004, [地理科学, Scientia Geographica Sinica], V24, P50; Zhou D, 2014, ECOLOGICAL INDICATOR, P88	45	6	7	5	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150992	10.1371/journal.pone.0150992	http://dx.doi.org/10.1371/journal.pone.0150992			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959645	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300090
J	Drolez, A; Vandenhaute, E; Julien, S; Gosselet, F; Burchell, J; Cecchelli, R; Delannoy, P; Dehouck, MP; Mysiorek, C				Drolez, Aurore; Vandenhaute, Elodie; Julien, Sylvain; Gosselet, Fabien; Burchell, Joy; Cecchelli, Romeo; Delannoy, Philippe; Dehouck, Marie-Pierre; Mysiorek, Caroline			Selection of a Relevant In Vitro Blood-Brain Barrier Model to Investigate Pro-Metastatic Features of Human Breast Cancer Cell Lines	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; APOPTOSIS	Around 7-17% of metastatic breast cancer patients will develop brain metastases, associated with a poor prognosis. To reach the brain parenchyma, cancer cells need to cross the highly restrictive endothelium of the Blood-Brain Barrier (BBB). As treatments for brain metastases are mostly inefficient, preventing cancer cells to reach the brain could provide a relevant and important strategy. For that purpose an in vitro approach is required to identify cellular and molecular interaction mechanisms between breast cancer cells and BBB endothelium, notably at the early steps of the interaction. However, while numerous studies are performed with in vitro models, the heterogeneity and the quality of BBB models used is a limitation to the extrapolation of the obtained results to in vivo context, showing that the choice of a model that fulfills the biological BBB characteristics is essential. Therefore, we compared pre-established and currently used in vitro models from different origins (bovine, mice, human) in order to define the most appropriate tool to study interactions between breast cancer cells and the BBB. On each model, the BBB properties and the adhesion capacities of breast cancer cell lines were evaluated. As endothelial cells represent the physical restriction site of the BBB, all the models consisted of endothelial cells from animal or human origins. Among these models, only the in vitro BBB model derived from human stem cells both displayed BBB properties and allowed measurement of meaningful different interaction capacities of the cancer cell lines. Importantly, the measured adhesion and transmigration were found to be in accordance with the cancer cell lines molecular sub-types. In addition, at a molecular level, the inhibition of ganglioside biosynthesis highlights the potential role of glycosylation in breast cancer cells adhesion capacities.	[Drolez, Aurore; Vandenhaute, Elodie; Gosselet, Fabien; Cecchelli, Romeo; Dehouck, Marie-Pierre; Mysiorek, Caroline] Univ Artois, EA2465, LBHE, F-62307 Lens, France; [Julien, Sylvain; Delannoy, Philippe] Univ Lille, Struct & Funct Glycobiol Unit, UMR CNRS 8576, Villeneuve Dascq, France; [Julien, Sylvain] Univ Lille, Cell Plast & Canc, U908, INSERM, Villeneuve Dascq, France; [Burchell, Joy] Kings Coll London, Res Oncol, London SE1 9RT, England	Universite d'Artois; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; University of London; King's College London	Mysiorek, C (corresponding author), Univ Artois, EA2465, LBHE, F-62307 Lens, France.	Caroline.mysiorek@univ-artois.fr	Gosselet, Fabien/U-8427-2019	Gosselet, Fabien/0000-0002-0481-5026; Mysiorek, Caroline/0000-0003-2338-8821; Delannoy, Philippe/0000-0001-6467-7553; Burchell, Joy/0000-0003-0413-3823	Conseil regional du Nord-Pas-de-Calais	Conseil regional du Nord-Pas-de-Calais(Region Hauts-de-FranceRegion Ile-de-France)	This study is granted by the 'Conseil regional du Nord-Pas-de-Calais' (Fellowship to A. Drolez and E. Vandenhaute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africa LD, 2015, J NEGAT RESULTS BIOM, V14, DOI 10.1186/s12952-015-0031-y; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; BOOHER J, 1972, Neurobiology (Copenhagen), V2, P97; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cazet A, 2009, BIOL CHEM, V390, P601, DOI 10.1515/BC.2009.054; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Cecchelli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099733; Chu JE, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/209748; Coisne C, 2005, LAB INVEST, V85, P734, DOI 10.1038/labinvest.3700281; Daphu I, 2013, CLIN EXP METASTAS, V30, P695, DOI 10.1007/s10585-013-9566-9; Dehghani L, 2013, INT J PREVENTIVE MED, V4, pS205; DEHOUCK MP, 1992, J NEUROCHEM, V58, P1790, DOI 10.1111/j.1471-4159.1992.tb10055.x; DEHOUCK MP, 1990, J NEUROCHEM, V54, P1798, DOI 10.1111/j.1471-4159.1990.tb01236.x; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Descamps L, 2003, GLIA, V42, P46, DOI 10.1002/glia.10205; Dittmar MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038260; Elodie Vandenhaute, 2016, LAB INVEST IN PRESS; Gachet J, 2011, B CANCER, V98, P357, DOI 10.1684/bdc.2011.1339; Hatiboglu MA, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.308; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Jeong JJ, 2012, INT J ONCOL, V41, P1358, DOI 10.3892/ijo.2012.1582; Kim IS, 2010, BIOCHEM BIOPH RES CO, V394, P443, DOI 10.1016/j.bbrc.2010.03.070; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kuntz M, 2015, J ALZHEIMERS DIS, V48, P849, DOI 10.3233/JAD-150469; Man S, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/384982; MERESSE S, 1989, J NEUROCHEM, V53, P1363, DOI 10.1111/j.1471-4159.1989.tb08526.x; Munzone E, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.309; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Pedroso DCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016114; Rhoo KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108487; Rizzo A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/476069; SIFLINGERBIRNBOIM A, 1987, J CELL PHYSIOL, V132, P111, DOI 10.1002/jcp.1041320115; Vandenhaute E, 2011, CURR NEUROVASC RES, V8, P258, DOI 10.2174/156720211798121016; Wilhelm I, 2011, ACTA NEUROBIOL EXP, V71, P113	36	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151155	10.1371/journal.pone.0151155	http://dx.doi.org/10.1371/journal.pone.0151155			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26958843	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300104
J	Wang, O; Liang, GX; McAllister, TA; Plastow, G; Stanford, K; Selinger, B; Guan, LL				Wang, Ou; Liang, Guanxiang; McAllister, Tim A.; Plastow, Graham; Stanford, Kim; Selinger, Brent; Guan, Le Luo			Comparative Transcriptomic Analysis of Rectal Tissue from Beef Steers Revealed Reduced Host Immunity in Escherichia coli O157:H7 Super-Shedders	PLOS ONE			English	Article							B-LYMPHOCYTES; EXPRESSION ANALYSIS; GENE-EXPRESSION; DENDRITIC CELLS; FOLLICLE FORMATION; LYMPH-NODES; IN-VIVO; RESPONSES; CATTLE; COLONIZATION	Super-shedder cattle are a major disseminator of E. coli O157:H7 into the environment, and the terminal rectum has been proposed as the primary E. coli O157:H7 colonization site. This study aimed to identify host factors that are associated with the super-shedding process by comparing transcriptomic profiles in rectal tissue collected from 5 super-shedder cattle and 4 non-shedder cattle using RNA-Seq. In total, 17,859 +/- 354 genes and 399 +/- 16 miRNAs were detected, and 11,773 genes were expressed in all animals. Fifty-eight differentially expressed (DE) genes (false discovery rate < 0.05) including 11 up-regulated and 47 down-regulated (log 2 (fold change) ranged from -5.5 to 4.2), and 2 up-regulated DE miRNAs (log 2 (fold change) = 2.1 and 2.5, respectively) were identified in super-shedders compared to non-shedders. Functional analysis of DE genes revealed that 31 down-regulated genes were potentially associated with reduced innate and adaptive immune functions in super-shedders, including 13 lymphocytes membrane receptors, 3 transcription factors and 5 cytokines, suggesting the decreased key host immune functions in the rectal tissue of super-shedders, including decreased quantity and migration of immune cells such as lymphocytes, neutrophils and dendritic cells. The up-regulation of bta-miR-29d-3p and the down regulation of its predicted target gene, regulator of G-protein signaling 13, suggested a potential regulatory role of this miRNA in decreased migration of lymphocytes in super-shedders. Based on these findings, the rectal tissue of super-shedders may inherently exhibit less effective innate and adaptive immune protection. Further study is required to confirm if such effect on host immunity is due to the nature of the host itself or due to actions mediated by E. coli O157: H7.	[Wang, Ou; Liang, Guanxiang; Plastow, Graham; Guan, Le Luo] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Stanford, Kim] Alberta Agr & Forestry, Lethbridge, AB, Canada; [Selinger, Brent] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada	University of Alberta; Agriculture & Agri Food Canada; University of Lethbridge	Guan, LL (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	lguan@ualberta.ca	Liang, Guanxiang/CAG-8838-2022; Liang, Guanxiang/C-7108-2018; McAllister, Tim A./R-9201-2017	Liang, Guanxiang/0000-0002-7367-2516; Plastow, Graham/0000-0002-3774-3110; McAllister, Tim A./0000-0002-8266-6513	Alberta Innovates Bio Solutions [FSC-12-017]	Alberta Innovates Bio Solutions	This work was supported by Alberta Innovates Bio Solutions (http://bio.albertainnovates.ca; Project Number: FSC-12-017) to TAM, GP, KS, BS, and LLG.; We would like to thank K. D. Munns for sampling fecal samples and identifying super-shedder cattle. We also would like to thank financial support provided by Alberta Innovates Bio Solutions (Project Number: FSC-12-017).	Arnold V, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-122; Baines D, 2008, CAN J MICROBIOL, V54, P984, DOI 10.1139/W08-090; Barleben A, 2010, SURG CLIN N AM, V90, P1, DOI 10.1016/j.suc.2009.09.001; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beer S, 2005, MOL CELL BIOL, V25, P9646, DOI 10.1128/MCB.25.21.9646-9660.2005; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; BORREGO F, 1993, EUR J IMMUNOL, V23, P1039, DOI 10.1002/eji.1830230509; Bottomly D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017820; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Bowman EP, 2000, J EXP MED, V191, P1303, DOI 10.1084/jem.191.8.1303; Brading AF, 2006, PROG BRAIN RES, V152, P345, DOI 10.1016/S0079-6123(05)52023-5; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Comerford L, 2005, IMMUNOL LETT, V96, P163, DOI 10.1016/j.imlet.2004.08.018; Corbishley A, 2014, INFECT IMMUN, V82, P5117, DOI 10.1128/IAI.02462-14; Dong ZJ, 2012, IMMUNITY, V36, P974, DOI 10.1016/j.immuni.2012.03.023; Dorn T, 2007, BLOOD, V109, P2346, DOI 10.1182/BLOOD-2006-04-019034; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Gannon VPJ, 1997, J CLIN MICROBIOL, V35, P656, DOI 10.1128/JCM.35.3.656-662.1997; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hoffman MA, 2006, CLIN VACCINE IMMUNOL, V13, P1322, DOI 10.1128/CVI.00205-06; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang IY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060139; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karnell JL, 2014, J IMMUNOL, V192, P1480, DOI 10.4049/jimmunol.1301361; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kroll J, 2005, MOL CELL BIOL, V25, P8531, DOI 10.1128/MCB.25.19.8531-8540.2005; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Malmuthuge N, 2012, VET IMMUNOL IMMUNOP, V146, P18, DOI 10.1016/j.vetimm.2012.01.010; McDonald KG, 2005, J IMMUNOL, V174, P5720, DOI 10.4049/jimmunol.174.9.5720; Menge C, 2003, EXP BIOL MED, V228, P377, DOI 10.1177/153537020322800408; Menge C, 2015, INNATE IMMUN-LONDON, V21, P655, DOI 10.1177/1753425915581215; Munns KD, 2015, FOODBORNE PATHOG DIS, V12, P89, DOI 10.1089/fpd.2014.1829; Munns KD, 2014, FOODBORNE PATHOG DIS, V11, P329, DOI 10.1089/fpd.2013.1621; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nagira M, 1998, EUR J IMMUNOL, V28, P1516, DOI 10.1002/(SICI)1521-4141(199805)28:05<1516::AID-IMMU1516>3.0.CO;2-J; Nart P, 2008, INFECT IMMUN, V76, P5366, DOI 10.1128/IAI.01223-07; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Nielsen PJ, 1996, EUR J IMMUNOL, V26, P3214, DOI 10.1002/eji.1830261255; Omisakin F, 2003, APPL ENVIRON MICROB, V69, P2444, DOI 10.1128/AEM.69.5.2444-2447.2003; Poe JC, 2004, NAT IMMUNOL, V5, P1078, DOI 10.1038/ni1121; Rekawiecki R, 2012, REPROD BIOL, V12, P362, DOI 10.1016/j.repbio.2012.10.010; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rueda A, 2015, NUCLEIC ACIDS RES, V43, pW467, DOI 10.1093/nar/gkv555; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Saeki H, 2000, EUR J IMMUNOL, V30, P2808, DOI 10.1002/1521-4141(200010)30:10<2808::AID-IMMU2808>3.0.CO;2-K; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Shao ZF, 2014, J BIOL CHEM, V289, P27146, DOI 10.1074/jbc.M114.572172; Sheridan Brian S, 2010, Curr Gastroenterol Rep, V12, P513, DOI 10.1007/s11894-010-0148-6; Shi GX, 2002, J IMMUNOL, V169, P2507, DOI 10.4049/jimmunol.169.5.2507; Simeoni L, 2005, MOL CELL BIOL, V25, P7557, DOI 10.1128/MCB.25.17.7557-7568.2005; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Sodha SV, 2015, EPIDEMIOL INFECT, V143, P267, DOI 10.1017/S0950268814000880; Sozzani S, 1998, J IMMUNOL, V161, P1083; Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Uchida J, 2004, INT IMMUNOL, V16, P119, DOI 10.1093/intimm/dxh009; Walle KV, 2013, VET IMMUNOL IMMUNOP, V152, P109, DOI 10.1016/j.vetimm.2012.09.028; Wolf MJ, 2010, ONCOGENE, V29, P5006, DOI 10.1038/onc.2010.260; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098115; Zhang ZX, 2010, J IMMUNOL, V185, P967, DOI 10.4049/jimmunol.0903245; Zhou YM, 2010, P NATL ACAD SCI USA, V107, P7904, DOI 10.1073/pnas.0908441107; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	69	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151284	10.1371/journal.pone.0151284	http://dx.doi.org/10.1371/journal.pone.0151284			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959367	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300115
J	Weissmuller, S; Kronhart, S; Kreuz, D; Schnierle, B; Kalinke, U; Kirberg, J; Hanschmann, KM; Waibler, Z				Weissmueller, Sabrina; Kronhart, Stefanie; Kreuz, Dorothea; Schnierle, Barbara; Kalinke, Ulrich; Kirberg, Joerg; Hanschmann, Kay-Martin; Waibler, Zoe			TGN1412 Induces Lymphopenia and Human Cytokine Release in a Humanized Mouse Model	PLOS ONE			English	Article							REGULATORY T-CELLS; MONOCLONAL-ANTIBODY TGN1412; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; CD28 SUPERAGONIST TGN1412; IN-VITRO; OKT3; TRIAL; ACTIVATION; MICE	Therapeutic monoclonal antibodies (mAbs) such as the superagonistic, CD28-specific antibody TGN1412, or OKT3, an anti-CD3 mAb, can cause severe adverse events including cytokine release syndrome. A predictive model for mAb-mediated adverse effects, for which no previous knowledge on severe adverse events to be expected or on molecular mechanisms underlying is prerequisite, is not available yet. We used a humanized mouse model of human peripheral blood mononuclear cell-reconstituted NOD-RAG1(-/-)A beta H-/--LADQ((tg+or tg-))IL-2R gamma c(-/-) mice to evaluate its predictive value for preclinical testing of mAbs. 2-6 hours after TGN1412 treatment, mice showed a loss of human CD45(+) cells from the peripheral blood and loss of only human T cells after OKT3 injection, reminiscent of effects observed in mAb-treated humans. Moreover, upon OKT3 injection we detected selective CD3 downmodulation on T cells, a typical effect of OKT3. Importantly, we detected release of human cytokines in humanized mice upon both OKT3 and TGN1412 application. Finally, humanized mice showed severe signs of illness, a rapid drop of body temperature, and succumbed to antibody application 2-6 hours after administration. Hence, the humanized mouse model used here reproduces several effects and adverse events induced in humans upon application of the therapeutic mAbs OKT3 and TGN1412.	[Weissmueller, Sabrina; Kronhart, Stefanie; Waibler, Zoe] Paul Ehrlich Inst, Jr Res Grp Novel Vaccinat Strategies & Early Immu, Langen, Germany; [Kreuz, Dorothea; Kirberg, Joerg] Paul Ehrlich Inst, Div Immunol, Langen, Germany; [Schnierle, Barbara] Paul Ehrlich Inst, Div Virol, Langen, Germany; [Kalinke, Ulrich] Hannover Med Sch MHH & Helmholtz Ctr Infect Res H, Ctr Expt & Clin Infect Res, TWINCORE, Inst Expt Infect Res, Hannover, Germany; [Hanschmann, Kay-Martin] Paul Ehrlich Inst, Div Biostat, Langen, Germany	Paul Ehrlich Institute; Paul Ehrlich Institute; Paul Ehrlich Institute; Helmholtz Association; Helmholtz-Center for Infection Research; Paul Ehrlich Institute	Waibler, Z (corresponding author), Paul Ehrlich Inst, Jr Res Grp Novel Vaccinat Strategies & Early Immu, Langen, Germany.	zoe.waibler@pei.de	Schnierle, Barbara/AAG-8108-2019	Kalinke, Ulrich/0000-0003-0503-9564; Schnierle, Barbara/0000-0001-9563-4564	Paul-Ehrlich-Institut	Paul-Ehrlich-Institut	The authors received no specific funding for this work. Funding of the work was obtained from the Paul-Ehrlich-Institut only.	ABRAMOWICZ D, 1989, TRANSPLANTATION, V47, P606, DOI 10.1097/00007890-198904000-00008; Bartholomaeus P, 2014, J IMMUNOL, V192, P2091, DOI 10.4049/jimmunol.1302461; Beyersdorf N, 2005, J EXP MED, V202, P445, DOI 10.1084/jem.20051060; Blum KS, 2007, IMMUNOL LETT, V108, P45, DOI 10.1016/j.imlet.2006.10.009; Buchner SM, 2013, CLIN EXP IMMUNOL, V173, P355, DOI 10.1111/cei.12121; Bugelski PJ, 2009, EXPERT REV CLIN IMMU, V5, P499, DOI [10.1586/eci.09.31, 10.1586/ECI.09.31]; CHATENOUD L, 1982, EUR J IMMUNOL, V12, P979, DOI 10.1002/eji.1830121116; CHATENOUD L, 1990, TRANSPLANTATION, V49, P697, DOI 10.1097/00007890-199004000-00009; Chatenoud L, 2003, NAT REV IMMUNOL, V3, P123, DOI 10.1038/nri1000; Eastwood D, 2010, BRIT J PHARMACOL, V161, P512, DOI 10.1111/j.1476-5381.2010.00922.x; HENELL KR, 1991, TRANSPLANT P, V23, P1070; HENELL KR, 1993, TRANSPLANT P, V25, P83; Horvath C, 2012, NAT REV IMMUNOL, V12, DOI [10.1038/nri3192-c1, 10.1038/nri3302]; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hunig T, 2007, ADV IMMUNOL, V95, P111, DOI 10.1016/S0065-2776(07)95004-X; Hunig T, 2012, NAT REV IMMUNOL, V12, P317, DOI 10.1038/nri3192; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; Legrand N, 2006, BLOOD, V108, P238, DOI 10.1182/blood-2006-01-0190; Lin CH, 2003, EUR J IMMUNOL, V33, P626, DOI 10.1002/eji.200323570; Malcolm SL, 2012, J IMMUNOL METHODS, V384, P33, DOI 10.1016/j.jim.2012.07.001; Muller N, 2008, J CLIN INVEST, V118, P1405, DOI 10.1172/JCI32698; NORMAN DJ, 1995, THER DRUG MONIT, V17, P615, DOI 10.1097/00007691-199512000-00012; Perrin PJ, 1999, J IMMUNOL, V163, P1704; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Romer PS, 2011, BLOOD, V118, P6772, DOI 10.1182/blood-2010-12-319780; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; SIEGEL SA, 1995, CYTOKINE, V7, P15, DOI 10.1006/cyto.1995.1003; Smit-McBride Z, 1998, J VIROL, V72, P6646, DOI 10.1128/JVI.72.8.6646-6656.1998; Smith JA, 1997, CURR OPIN IMMUNOL, V9, P648, DOI 10.1016/S0952-7915(97)80044-1; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tabares P, 2014, EUR J IMMUNOL, V44, P1225, DOI 10.1002/eji.201343967; TARYLEHMANN M, 1994, J EXP MED, V180, P1817, DOI 10.1084/jem.180.5.1817; TeGenero AG, TGN1412 INV MED PROD; TeGenero AG, INVESTIGATORS BROCHU; TERRELL TG, 1993, INT REV EXP PATHOL, V34, P73; The BMJ, 2021, GUID BMJ PAT PUBL RE; Vudattu NK, 2014, HUMANIZED MICE MODEL; Waibler Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001708; Waid TH, 1997, TRANSPLANTATION, V64, P274, DOI 10.1097/00007890-199707270-00017; Waldron-Lynch F, 2012, ANAL HUMAN BIOL MOUS; Weissmuller S, 2012, BLOOD, V119, P6268, DOI 10.1182/blood-2011-12-401083; Zaiss MM, 2010, J IMMUNOL, V184, P7238, DOI 10.4049/jimmunol.0903841	43	22	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149093	10.1371/journal.pone.0149093	http://dx.doi.org/10.1371/journal.pone.0149093			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959227	gold, Green Published, Green Submitted			2022-12-27	WOS:000371992300006
J	Campbell, SC; Wisniewski, PJ; Noji, M; McGuinness, LR; Haggblom, MM; Lightfoot, SA; Joseph, LB; Kerkhof, LJ				Campbell, Sara C.; Wisniewski, Paul J.; Noji, Michael; McGuinness, Lora R.; Haeggblom, Max M.; Lightfoot, Stanley A.; Joseph, Laurie B.; Kerkhof, Lee J.			The Effect of Diet and Exercise on Intestinal Integrity and Microbial Diversity in Mice	PLOS ONE			English	Article							GUT HORMONE-LEVELS; INDUCED OBESITY; PHYSICAL-EXERCISE; AEROBIC EXERCISE; ACYLATED GHRELIN; ENERGY-INTAKE; PEPTIDE YY; MECHANISMS; RESISTANCE; INCREASES	Background The gut microbiota is now known to play an important role contributing to inflammatory-based chronic diseases. This study examined intestinal integrity/inflammation and the gut microbial communities in sedentary and exercising mice presented with a normal or high-fat diet. Methods Thirty-six, 6-week old C57BL/6NTac male mice were fed a normal or high-fat diet for 12-weeks and randomly assigned to exercise or sedentary groups. After 12 weeks animals were sacrificed and duodenum/ileum tissues were fixed for immunohistochemistry for occludin, E-cadherin, and cyclooxygenase-2 (COX-2). The bacterial communities were assayed in fecal samples using terminal restriction fragment length polymorphism (TRFLP) analysis and pyrosequencing of 16S rRNA gene amplicons. Results Lean sedentary (LS) mice presented normal histologic villi while obese sedentary (OS) mice had similar villi height with more than twice the width of the LS animals. Both lean (LX) and obese exercise (OX) mice duodenum and ileum were histologically normal. COX-2 expression was the greatest in the OS group, followed by LS, LX and OX. The TRFLP and pyrosequencing indicated that members of the Clostridiales order were predominant in all diet groups. Specific phylotypes were observed with exercise, including Faecalibacterium prausnitzi, Clostridium spp., and Allobaculum spp. Conclusion These data suggest that exercise has a strong influence on gut integrity and host microbiome which points to the necessity for more mechanistic studies of the interactions between specific bacteria in the gut and its host.	[Campbell, Sara C.; Wisniewski, Paul J.; Noji, Michael] Rutgers State Univ, Dept Exercise Sci & Sports Studies, New Brunswick, NJ 08901 USA; [McGuinness, Lora R.; Kerkhof, Lee J.] Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Haeggblom, Max M.] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08901 USA; [Joseph, Laurie B.] Rutgers State Univ, Dept Pharmacol & Toxicol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Campbell, SC (corresponding author), Rutgers State Univ, Dept Exercise Sci & Sports Studies, New Brunswick, NJ 08901 USA.	saracamp@rci.rutgers.edu	Haggblom, Max M/E-7597-2010	Haggblom, Max M/0000-0001-6307-7863; Kerkhof, Lee/0000-0001-9107-8695; Noji, Michael/0000-0002-6996-5367	National Institutes of Health CounterACT Program through the National Institute of Arthritis and Musculoskeletal and Skin Diseases [U54AR055073]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR055073] Funding Source: NIH RePORTER	National Institutes of Health CounterACT Program through the National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was also supported in part by the National Institutes of Health CounterACT Program through the National Institute of Arthritis and Musculoskeletal and Skin Diseases (award U54AR055073). This funding only supported histochemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional funds for these experiments came from start-up funds given to SCC. Undergraduate research funds awarded to PJW, MN.	AVANISSAGHAJANI E, 1994, BIOTECHNIQUES, V17, P144; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084; Broom DR, 2007, J APPL PHYSIOL, V102, P2165, DOI 10.1152/japplphysiol.00759.2006; Broom DR, 2009, AM J PHYSIOL-REG I, V296, pR29, DOI 10.1152/ajpregu.90706.2008; Cabrele C, 2000, J PEPT SCI, V6, P97, DOI 10.1002/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO;2-E; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, CURR OPIN CLIN NUTR, V10, P729, DOI 10.1097/MCO.0b013e3282efdebb; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Clarke SF, 2014, GUT, V63, P1913, DOI 10.1136/gutjnl-2013-306541; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; de Oliveira EP, 2009, CURR OPIN CLIN NUTR, V12, P533, DOI 10.1097/MCO.0b013e32832e6776; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Douglass JD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00025; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fei N, 2013, ISME J, V7, P880, DOI 10.1038/ismej.2012.153; Gill JMR, 2003, J NUTR BIOCHEM, V14, P122, DOI 10.1016/S0955-2863(02)00275-9; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gummesson A, 2011, OBESITY, V19, P2280, DOI 10.1038/oby.2011.251; Guo Y, 2006, OBESITY, V14, P1562, DOI 10.1038/oby.2006.180; Hamilton MK, 2015, AM J PHYSIOL-GASTR L, V308, pG840, DOI 10.1152/ajpgi.00029.2015; Hoffman-Goetz L, 2009, BRAIN BEHAV IMMUN, V23, P498, DOI 10.1016/j.bbi.2009.01.015; Hood L, 2012, SCIENCE, V336, P1209, DOI 10.1126/science.1225475; Hudlicka O, 2006, MICROCIRCULATION, V13, P249, DOI 10.1080/10739680600556951; HURLEY BF, 1986, J APPL PHYSIOL, V60, P562, DOI 10.1152/jappl.1986.60.2.562; Khan MT, 2012, ANTIOXID REDOX SIGN, V17, P1433, DOI 10.1089/ars.2012.4701; Klare P, 2015, DIGESTION, V91, P239, DOI 10.1159/000371795; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liang GH, 2014, CURR OPIN PHARMACOL, V19, P84, DOI 10.1016/j.coph.2014.07.017; Marchesi JR, 2015, GUT; MARTIN WH, 1993, AM J PHYSIOL, V265, pE708, DOI 10.1152/ajpendo.1993.265.5.E708; Martins C, 2007, J ENDOCRINOL, V193, P251, DOI 10.1677/JOE-06-0030; Matsumoto M, 2008, BIOSCI BIOTECH BIOCH, V72, P572, DOI 10.1271/bbb.70474; Mauer J, 2015, TRENDS IMMUNOL, V36, P92, DOI 10.1016/j.it.2014.12.008; McGuinness LM, 2006, ENVIRON SCI TECHNOL, V40, P509, DOI 10.1021/es050900l; Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050; Nathan I, 2013, GASTROENTEROL NURS, V36, P437, DOI 10.1097/SGA.0000000000000005; Naylor LH, 2011, AM J PHYSIOL-HEART C, V300, pH664, DOI 10.1152/ajpheart.00985.2010; Packer N, 2012, CAN J AGING, V31, P161, DOI 10.1017/S0714980812000104; Pedersen BK, 2001, CURR OPIN HEMATOL, V8, P137, DOI 10.1097/00062752-200105000-00002; Peluso I, 2016, HUM IMMUNOL, V77, P47, DOI 10.1016/j.humimm.2015.10.008; Plaisance EP, 2014, J NUTR METAB, V2014, DOI 10.1155/2014/902065; Pond C.M., 1998, FATS LIFE; Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Stensel D, 2010, ANN NUTR METAB, V57, P36, DOI 10.1159/000322702; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ueda SY, 2009, J ENDOCRINOL, V203, P357, DOI 10.1677/JOE-09-0190; Ueda S, 2009, J ENDOCRINOL, V201, P151, DOI 10.1677/JOE-08-0500; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Zuhl M, 2014, BRIT J SPORT MED, V48, P980, DOI 10.1136/bjsports-2012-091585	58	136	152	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150502	10.1371/journal.pone.0150502	http://dx.doi.org/10.1371/journal.pone.0150502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954359	gold, Green Published, Green Submitted			2022-12-27	WOS:000371991300030
J	Le Gouez, M; Alvarez, L; Rousseau, V; Hubert, P; Abadie, V; Lapillonne, A; Kermorvant-Duchemin, E				Le Gouez, Morgane; Alvarez, Luis; Rousseau, Veronique; Hubert, Philippe; Abadie, Veronique; Lapillonne, Alexandre; Kermorvant-Duchemin, Elsa			Posttraumatic Stress Reactions in Parents of Children Esophageal Atresia	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; PRENATAL-DIAGNOSIS; PREMATURE BIRTH; DISORDER; MOTHERS; SYMPTOMS; INFANTS; DISEASE; GENDER; IMPACT	Objective The aim of this study was to investigate psychological stress in parents of children with esophageal atresia and to explore factors associated with the development of Posttraumatic Stress disorder (PTSD). Design Self-report questionnaires were administered to parents of children with EA. Domains included: (1) sociodemographic data, current personal difficulties, assessment scales for the quality of life and for the global health status of the child (2) French-validated versions of the Perinatal Posttraumatic Stress disorder Questionnaire and of the State-Trait Anxiety Inventory. Associations between PTSD and severity of the neonatal course, presence of severe sequelae at 2 years of age, and quality of life and global health status of children according to their parents' perception were studied. Setting A Tertiary care University Hospital Results Among 64 eligible families, 54 parents of 38 children (59%) participated to the study. PTSD was present in 32 (59%) parents; mothers were more frequently affected than fathers (69 vs 46%, p = 0.03). Four mothers (8%) had severe anxiety. PTSD was neither associated with neonatal severity nor with severe sequelae at 2 years. Parents with PTSD rated their child's quality of life and global health status significantly lower (7.5 vs 8.6; p = 0.01 and 7.4 vs 8.3; p = 0.02 respectively). Conclusions PTSD is frequent in parents of children with esophageal atresia, independently of neonatal severity and presence of severe sequelae at 2 years of age. Our results highlight the need for a long-term psychological support of families.	[Le Gouez, Morgane; Abadie, Veronique] Hop Univ Necker Enfants Malad, AP HP, Serv Pediat Gen, Paris, France; [Le Gouez, Morgane; Hubert, Philippe; Abadie, Veronique; Lapillonne, Alexandre; Kermorvant-Duchemin, Elsa] Univ Paris 05, Fac Med, Paris, France; [Alvarez, Luis] Hop Univ Necker Enfants Malad, AP HP, CPDPN, Paris, France; [Rousseau, Veronique] Hop Univ Necker Enfants Malad, AP HP, Serv Chirurg Pediat, Paris, France; [Hubert, Philippe] Hop Univ Necker Enfants Malad, AP HP, Serv Reanimat Pediat, Paris, France; [Lapillonne, Alexandre; Kermorvant-Duchemin, Elsa] Hop Univ Necker Enfants Malad, AP HP, Serv Neonatol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Kermorvant-Duchemin, E (corresponding author), Univ Paris 05, Fac Med, Paris, France.; Kermorvant-Duchemin, E (corresponding author), Hop Univ Necker Enfants Malad, AP HP, Serv Neonatol, Paris, France.	elsa.kermorvant@aphp.fr						Affleck G, 1991, Child Health Care, V20, P6, DOI 10.1207/s15326888chc2001_2; Bakker A, 2010, J PEDIATR PSYCHOL, V35, P656, DOI 10.1093/jpepsy/jsp090; Balluffi Andrew, 2004, Pediatr Crit Care Med, V5, P547, DOI 10.1097/01.PCC.0000137354.19807.44; Brett J, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000023; Bronner MB, 2008, ACTA PAEDIATR, V97, P181, DOI 10.1111/j.1651-2227.2007.00600.x; Brosig CL, 2007, J PERINATOL, V27, P687, DOI 10.1038/sj.jp.7211807; Caplan A, 2013, DIS ESOPHAGUS, V26, P392, DOI 10.1111/dote.12056; Castilloux J, 2010, J PEDIATR-US, V156, P755, DOI 10.1016/j.jpeds.2009.11.038; Colville G, 2012, INTENS CARE MED, V38, P1523, DOI 10.1007/s00134-012-2612-2; Crawford J, 2011, AUST PSYCHOL, V46, P3, DOI 10.1111/j.1742-9544.2010.00003.x; Dunn MJ, 2012, HEALTH PSYCHOL, V31, P176, DOI 10.1037/a0025545; Forcada-Guex M, 2011, EARLY HUM DEV, V87, P21, DOI 10.1016/j.earlhumdev.2010.09.006; Garel M, 2007, CHILD CARE HLTH DEV, V33, P137, DOI 10.1111/j.1365-2214.2006.00663.x; GAUTHIER J, 1993, CAN J BEHAV SCI, V25, P559, DOI 10.1037/h0078881; Jotzo M, 2005, PEDIATRICS, V115, P915, DOI 10.1542/peds.2004-0370; Kazak AE, 2004, J PEDIATR PSYCHOL, V29, P211, DOI 10.1093/jpepsy/jsh022; Legrand C, 2012, ARCH DIS CHILD, V97, P808, DOI 10.1136/archdischild-2012-301730; Linzer M, 1996, AM J MED, V101, P526, DOI 10.1016/S0002-9343(96)00275-6; Muller-Nix C, 2004, EARLY HUM DEV, V79, P145, DOI 10.1016/j.earlhumdev.2004.05.002; Nagata SI, 2008, J PEDIATR SURG, V43, P1480, DOI 10.1016/j.jpedsurg.2007.12.055; Nelson LP, 2012, PEDIATR CRIT CARE ME, V13, P338, DOI 10.1097/PCC.0b013e3182196a8f; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Pedersen RN, 2012, ARCH DIS CHILD, V97, P227, DOI 10.1136/archdischild-2011-300597; Pierrehumbert B, 2004, ANN MED-PSYCHOL, V162, P711, DOI 10.1016/j.amp.2003.10.017; Pierrehumbert B, 2003, ARCH DIS CHILD-FETAL, V88, pF400, DOI 10.1136/fn.88.5.F400; Rintala RJ, 2011, J PEDIATR GASTR NUTR, V52, pS35, DOI 10.1097/MPG.0b013e318212808e; Rychik J, 2013, J PEDIATR-US, V162, P302, DOI 10.1016/j.jpeds.2012.07.023; Shaw RJ, 2013, PEDIATRICS, V132, pE886, DOI 10.1542/peds.2013-1331; Shaw RJ, 2009, PSYCHOSOMATICS, V50, P131, DOI 10.1176/appi.psy.50.2.131; Skreden M, 2010, AM J MED GENET A, V152A, P2193, DOI 10.1002/ajmg.a.33605; Spear ML, 2002, AM J PERINAT, V19, P205, DOI 10.1055/s-2002-28484	31	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150760	10.1371/journal.pone.0150760	http://dx.doi.org/10.1371/journal.pone.0150760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SW	26953589	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300048
J	Oh, J; Choi, CH; Park, MK; Kim, BK; Hwang, K; Lee, SH; Hong, SG; Nasir, A; Cho, WS; Kim, KM				Oh, Jeongsu; Choi, Chi-Hwan; Park, Min-Kyu; Kim, Byung Kwon; Hwang, Kyuin; Lee, Sang-Heon; Hong, Soon Gyu; Nasir, Arshan; Cho, Wan-Sup; Kim, Kyung Mo			CLUSTOM-CLOUD: In-Memory Data Grid-Based Software for Clustering 16S rRNA Sequence Data in the Cloud Environment	PLOS ONE			English	Article							ESTIMATING SPECIES RICHNESS; DIVERSITY; PROGRAM; READS	High-throughput sequencing can produce hundreds of thousands of 16S rRNA sequence reads corresponding to different organisms present in the environmental samples. Typically, analysis of microbial diversity in bioinformatics starts from pre-processing followed by clustering 16S rRNA reads into relatively fewer operational taxonomic units (OTUs). The OTUs are reliable indicators of microbial diversity and greatly accelerate the downstream analysis time. However, existing hierarchical clustering algorithms that are generally more accurate than greedy heuristic algorithms struggle with large sequence datasets. To keep pace with the rapid rise in sequencing data, we present CLUSTOM-CLOUD, which is the first distributed sequence clustering program based on In-Memory Data Grid (IMDG) technology-a distributed data structure to store all data in the main memory of multiple computing nodes. The IMDG technology helps CLUSTOM-CLOUD to enhance both its capability of handling larger datasets and its computational scalability better than its ancestor, CLUSTOM, while maintaining high accuracy. Clustering speed of CLUSTOM-CLOUD was evaluated on published 16S rRNA human microbiome sequence datasets using the small laboratory cluster (10 nodes) and under the Amazon EC2 cloud-computing environments. Under the laboratory environment, it required only similar to 3 hours to process dataset of size 200 K reads regardless of the complexity of the human microbiome data. In turn, one million reads were processed in approximately 20, 14, and 11 hours when utilizing 20, 30, and 40 nodes on the Amazon EC2 cloud-computing environment. The running time evaluation indicates that CLUSTOM-CLOUD can handle much larger sequence datasets than CLUSTOM and is also a scalable distributed processing system. The comparative accuracy test using 16S rRNA pyrosequences of a mock community shows that CLUSTOM-CLOUD achieves higher accuracy than DOTUR, mothur, ESPRIT-Tree, UCLUST and Swarm. CLUSTOM-CLOUD is written in JAVA and is freely available at http://clustomcloud.kopri.re.kr.	[Oh, Jeongsu; Lee, Sang-Heon; Kim, Kyung Mo] Korea Res Inst Biosci & Biotechnol, Microbial Resource Ctr, Taejon, South Korea; [Choi, Chi-Hwan] Chungbuk Natl Univ, Dept Bioinformat Technol, Cheongju, South Korea; [Park, Min-Kyu] Chungbuk Natl Univ, Dept Business Data Convergence, Cheongju, South Korea; [Kim, Byung Kwon] Korea Res Inst Biosci & Biotechnol, BioNano Hlth Guard Res Ctr, Taejon, South Korea; [Hwang, Kyuin; Hong, Soon Gyu] Korea Polar Res Inst, Div Polar Life Sci, Inchon, South Korea; [Nasir, Arshan] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Cho, Wan-Sup] Chungbuk Natl Univ, Dept Management Informat Syst, BK Plus Team, Cheongju, South Korea; [Kim, Kyung Mo] Univ Sci & Technol, Dept Bioinformat, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University; Chungbuk National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); COMSATS University Islamabad (CUI); Chungbuk National University	Kim, KM (corresponding author), Korea Res Inst Biosci & Biotechnol, Microbial Resource Ctr, Taejon, South Korea.; Cho, WS (corresponding author), Chungbuk Natl Univ, Dept Management Informat Syst, BK Plus Team, Cheongju, South Korea.; Kim, KM (corresponding author), Univ Sci & Technol, Dept Bioinformat, Taejon, South Korea.	wscho@chungbuk.ac.kr; kmkim@kribb.re.kr	Nasir, Arshan/O-4111-2018	Nasir, Arshan/0000-0001-7200-0788; Kim, Kyung Mo/0000-0001-5125-5079	KRIBB; KOPRI [PE15020]	KRIBB; KOPRI(Korea Polar Research Institute of Marine Research Placement (KOPRI))	This material is based upon work supported by the KRIBB (http://www.kribb.re.kr) Research Initiative Program (to KMK) and by KOPRI (http://www.kopri.re.kr) research program under Grant No. PE15020 (to SGH). The funders had no role in studying design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barney B., 2012, MESSAGE PASSING INTE; Barney B., 2010, INTRO PARALLEL COMPU; Chen W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070837; Dean J, 2008, COMMUN ACM, V51, P107, DOI 10.1145/1327452.1327492; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ekanayake J, 2008, ESCIENCE 2008 ESCIEN; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hwang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062623; Johns M., 2013, GETTING STARTED HAZE; Kang S.-H., 2013, INT J CONTROL AUTOM, V6, P201; Lagana A, 2000, COMPUT PHYS COMMUN, V128, P295, DOI 10.1016/S0010-4655(99)00516-0; Lee KH, 2011, SIGMOD REC, V40, P11, DOI 10.1145/2094114.2094118; Li B, 2011, P 2011 ACM SIGMOD IN; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Mahe F, 2014, PEERJ, V2, DOI 10.7717/peerj.593; Mann S., LOOK OUT BIG DATA IN; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Oh J, 2012, J MICROBIOL, V50, P766, DOI 10.1007/s12275-012-2494-6; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Taylor RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S1; Tuomisto H, 2010, OECOLOGIA, V164, P853, DOI 10.1007/s00442-010-1812-0; Winkler MKH, 2013, APPL MICROBIOL BIOT, V97, P7447, DOI 10.1007/s00253-012-4472-7; Wittkop T, 2010, NAT METHODS, V7, P419, DOI 10.1038/nmeth0610-419; Zhan AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096928	30	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151064	10.1371/journal.pone.0151064	http://dx.doi.org/10.1371/journal.pone.0151064			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954507	gold, Green Published			2022-12-27	WOS:000371991300079
J	Clark, CJ; Ali, SM; Zaydfudim, V; Jacob, AK; Nagorney, DM				Clark, Clancy J.; Ali, Shahzad M.; Zaydfudim, Victor; Jacob, Adam K.; Nagorney, David M.			Safety of an Enhanced Recovery Pathway for Patients Undergoing Open Hepatic Resection	PLOS ONE			English	Article							FAST-TRACK PROGRAM; LENGTH-OF-STAY; SURGERY; REHABILITATION; CARE; IMPLEMENTATION; EXPERIENCE; COST	Background Enhanced recovery pathways (ERP) have not been widely implemented for hepatic surgery. The aim of this study was to evaluate the safety of an ERP for patients undergoing open hepatic resection. Methods A single-surgeon, retrospective observational cohort study was performed comparing the clinical outcomes of patients undergoing open hepatic resection treated before and after implementation of an ERP. Morbidity, mortality, and length of hospital stay (LOS) were compared between pre-ERP and ERP groups. Results 126 patients (pre-ERP n = 73, ERP n = 53) were identified for the study. Patient characteristics and operative details were similar between groups. Overall complication rate was similar between pre-ERP and ERP groups (37% vs. 28%, p = 0.343). Before and after pathway implementation, the median LOS was similar, 5 (IQR 4-7) vs. 5 (IQR 4-6) days, p = 0.708. After adjusting for age, type of liver resection, and ASA, the ERP group had no increased risk of major complication (OR 0.38, 95% CI 0.14-1.02, p = 0.055) or LOS greater than 5 days (OR 1.21, 95% CI 0.56-2.62, p = 0.627). Conclusions Routine use of a multimodal ERP is safe and is not associated with increased postoperative morbidity after open hepatic resection.	[Clark, Clancy J.] Wake Forest Baptist Hlth, Dept Gen Surg, Winston Salem, NC USA; [Ali, Shahzad M.; Nagorney, David M.] Mayo Clin, Div Gastroenterol & Gen Surg, Rochester, MN USA; [Zaydfudim, Victor] Univ Virginia, Dept Gen Surg, Charlottesville, VA USA; [Jacob, Adam K.] Mayo Clin, Dept Anesthesiol, Rochester, MN USA	Wake Forest University; Wake Forest Baptist Medical Center; Mayo Clinic; University of Virginia; Mayo Clinic	Clark, CJ (corresponding author), Wake Forest Baptist Hlth, Dept Gen Surg, Winston Salem, NC USA.	cjclark@wakehealth.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001421] Funding Source: NIH RePORTER; NCATS NIH HHS [KL2 TR001421] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Balcom JH, 2001, ARCH SURG-CHICAGO, V136, P391, DOI 10.1001/archsurg.136.4.391; Basse L, 2004, DIS COLON RECTUM, V47, P271, DOI 10.1007/s10350-003-0055-0; Bradshaw BGG, 1998, J AM COLL SURGEONS, V186, P501, DOI 10.1016/S1072-7515(98)00078-7; Delaney CP, 2003, DIS COLON RECTUM, V46, P851, DOI 10.1007/s10350-004-6672-4; Delaney CP, 2001, BRIT J SURG, V88, P1533, DOI 10.1046/j.0007-1323.2001.01905.x; Hall TC, 2012, ANN ROY COLL SURG, V94, P318, DOI 10.1308/003588412X13171221592410; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hirao M, 2005, WORLD J SURG, V29, P853, DOI 10.1007/s00268-005-7760-x; Kennedy EP, 2007, J AM COLL SURGEONS, V204, P917, DOI 10.1016/j.jamcollsurg.2007.01.057; Kennedy EP, 2009, J GASTROINTEST SURG, V13, P938, DOI 10.1007/s11605-009-0803-0; Nguyen KT, 2011, ARCH SURG-CHICAGO, V146, P348, DOI 10.1001/archsurg.2010.248; Koea Jonathan B, 2009, HPB Surg, V2009, P271986, DOI 10.1155/2009/271986; Lemmens L, 2009, DIGEST SURG, V26, P91, DOI 10.1159/000206142; Lin DX, 2011, CELL BIOCHEM BIOPHYS, V61, P413, DOI 10.1007/s12013-011-9203-7; MacKay G, 2008, SCOT MED J, V53, P22, DOI 10.1258/rsmsmj.53.2.22; Melbert RB, 2002, J GASTROINTEST SURG, V6, P745, DOI 10.1016/S1091-255X(02)00038-0; Porter GA, 2000, ANN SURG ONCOL, V7, P484, DOI 10.1007/s10434-000-0484-0; Raue W, 2004, SURG ENDOSC, V18, P1463, DOI 10.1007/s00464-003-9238-y; Schultz NA, 2013, BRIT J SURG, V100, P138, DOI 10.1002/bjs.8996; Spelt L, 2011, HPB, V13, P833, DOI 10.1111/j.1477-2574.2011.00391.x; Stephen AE, 2003, SURGERY, V133, P277, DOI 10.1067/msy.2003.19; Stoot JH, 2009, HPB, V11, P140, DOI 10.1111/j.1477-2574.2009.00025.x; Strasberg SM, 2005, J HEPATO-BILIARY-PAN, V12, P351, DOI 10.1007/s00534-005-0999-7; Strasberg SM, 2009, ANN SURG, V250, P177, DOI 10.1097/SLA.0b013e3181afde41; Tsikitis VL, 2010, SURG ENDOSC, V24, P1911, DOI 10.1007/s00464-009-0871-y; van Dam RM, 2008, BRIT J SURG, V95, P969, DOI 10.1002/bjs.6227; Wong-Lun-Hing EM, 2012, HPB, V14, P818, DOI 10.1111/j.1477-2574.2012.00546.x	27	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150782	10.1371/journal.pone.0150782	http://dx.doi.org/10.1371/journal.pone.0150782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950852	Green Submitted, Green Published, gold			2022-12-27	WOS:000371990100058
J	Mallma, P; Garcia, P; Carcamo, C; Torres-Rueda, S; Peeling, R; Mabey, D; Terris-Prestholt, F				Mallma, Patricia; Garcia, Patricia; Carcamo, Cesar; Torres-Rueda, Sergio; Peeling, Rosanna; Mabey, David; Terris-Prestholt, Fern			Rapid Syphilis Testing Is Cost-Effective Even in Low-Prevalence Settings: The CISNE-PERU Experience	PLOS ONE			English	Article								Studies have addressed cost-effectiveness of syphilis testing of pregnant women in high-prevalence settings. This study compares costs of rapid syphilis testing (RST) with laboratory-based rapid plasma reagin (RPR) tests in low-prevalence settings in Peru. The RST was introduced in a tertiary-level maternity hospital and in the Ventanilla Network of primary health centers, where syphilis prevalence is approximately 1%. The costs per woman tested and treated with RST at the hospital were $2.70 and $369 respectively compared with $3.60 and $740 for RPR. For the Ventanilla Network the costs per woman tested and treated with RST were $3.19 and $295 respectively compared with $5.55 and $1454 for RPR. The cost per DALY averted using RST was $46 vs. $109 for RPR. RST showed lower costs compared to the WHO standard costs per DALY ($64). Findings suggest syphilis screening with RST is cost-effective in low-prevalence settings.	[Mallma, Patricia; Garcia, Patricia; Carcamo, Cesar] Univ Peruana Cayetano Heredia, Sch Publ Hlth, STD HIV Unit, Epidemiol, Lima, Peru; [Torres-Rueda, Sergio; Peeling, Rosanna; Mabey, David; Terris-Prestholt, Fern] London Sch Hyg & Trop Med, London WC1, England	Universidad Peruana Cayetano Heredia; University of London; London School of Hygiene & Tropical Medicine	Garcia, P (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth, STD HIV Unit, Epidemiol, Lima, Peru.	patricia.garcia@upch.pe		Terris-Prestholt, Fern/0000-0003-1693-5196	Bill & Melinda Gates Foundation [47697]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Financial support for this study was provided by the Bill & Melinda Gates Foundation through a grant (#47697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blandford JM, 2007, SEX TRANSM DIS, V34, pS61, DOI 10.1097/01.olq.0000258314.20752.5f; Garcia PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066905; Genc M, 2000, SEX TRANSM INFECT, V76, P73, DOI 10.1136/sti.76.2.73; Jafari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054695; Kahn JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087510; Kamb ML, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/312798; Kuznik A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001545; Larson BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113868; Levin CE, 2007, SEX TRANSM DIS, V34, pS47, DOI 10.1097/01.olq.0000245986.62775.b6; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; (PAHO) PAHO, 2013, 2012 PROGR REP EL MO; Rydzak CE, 2008, SEX TRANSM DIS, V35, P775, DOI 10.1097/OLQ.0b013e318176196d; Schackman BR, 2007, PLOS MED, V4, P937, DOI 10.1371/journal.pmed.0040183; Stoner BP, 2008, SEX TRANSM DIS, V35, P785, DOI 10.1097/OLQ.0b013e31818638ee; Sweeney S, 2014, HEALTH POLICY PLANN, V29, P633, DOI 10.1093/heapol/czt049; Terris-Prestholt F, 2003, SEX TRANSM INFECT, V79, P375, DOI 10.1136/sti.79.5.375; Terris-Prestholt F, 2015, INT J GYNAECOL OBSTE; Tucker JD, 2010, LANCET INFECT DIS, V10, P381, DOI 10.1016/S1473-3099(10)70092-X; Vickerman P, 2006, SEX TRANSM INFECT, V82, pV38, DOI 10.1136/sti.2006.021824; World Health Organization, 2012, INV CAS EL MOTH TO C	20	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0149568	10.1371/journal.pone.0149568	http://dx.doi.org/10.1371/journal.pone.0149568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26949941	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000371990100015
J	Park, YH; Shin, SH; Byun, SW; Kim, JY				Park, Yun Hwi; Shin, Seung-Ho; Byun, Sung Wan; Kim, Ju Yeon			Age- and Gender-Related Mean Hearing Threshold in a Highly-Screened Population: The Korean National Health and Nutrition Examination Survey 2010-2012	PLOS ONE			English	Article							SEX-DIFFERENCES; PREVALENCE; AUDIOMETRY	Background In evaluating hearing disability in medicolegal work, the apportionment of age-and gender-related sensorineural hearing loss should be considered as a prior factor, especially for the elderly. However, in the literature written in the English language no studies have reported on the age-and gender-related mean hearing threshold for the South Korean population. Objective This study aimed to identify the mean hearing thresholds in the South Korean population to establish reference data and to identify the age- and gender-related characteristics. Methods This study is based on the Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012, which was conducted by the Korean government, the data of which was disclosed to the public. A total of 15,606 participants (unweighted) representing 33,011,778 Koreans (weighted) with normal tympanic membrane and no history of regular or occupational noise exposure were selected and analyzed in this study. The relationship between the hearing threshold level and frequency, age, and gender was investigated and analyzed in a highly-screened population by considering the sample weights of a complex survey design. Results A gender ratio difference was found between the unweighted and the weighted designs: male: female, 41.0%:59.0%(unweighted, participants) vs. 47.2%:52.8% (weighted, representing population). As age increased, the hearing threshold increased for all frequencies. Hearing thresholds of 3 kHz, 4 kHz, and 6 kHz showed a statistical difference between both genders for people older than 30, with the 4 kHz frequency showing the largest difference. This paper presents details about the mean hearing threshold based on age and gender. Conclusions The data from KNHANES 2010-2012 showed gender differences at hearing thresholds of 3 kHz, 4 kHz, and 6 kHz in a highly-screened population. The most significant gender difference in relation to hearing threshold was observed at 4 kHz. The hearing thresholds at all of the tested frequencies worsened with increasing age. The mean hearing thresholds suggested in this study will be useful for the formulation of healthcare-related hearing policies and used as reference data for disability ratings for hearing loss due to various causes.	[Park, Yun Hwi; Shin, Seung-Ho; Byun, Sung Wan; Kim, Ju Yeon] Ewha Womans Univ, Sch Med, Dept Otorhinolaryngol, Seoul, South Korea	Ewha Womans University	Shin, SH; Byun, SW (corresponding author), Ewha Womans Univ, Sch Med, Dept Otorhinolaryngol, Seoul, South Korea.	drshinsh@gmail.com; byunsw66@gmail.com			Ewha Womans University Research Grant	Ewha Womans University Research Grant	The work was supported by the Ewha Womans University Research Grant of 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid O., 2007, Eastern Mediterranean Health Journal, V13, P1170; Bahng J, 2015, J AUDIOL OTOL, V19, P91, DOI 10.7874/jao.2015.19.2.91; Baraldi Giovana dos Santos, 2007, Braz J Otorhinolaryngol, V73, P58; Ciorba A, 2011, J LARYNGOL OTOL, V125, P776, DOI 10.1017/S0022215111001101; CORSO JF, 1963, ARCHIV OTOLARYNGOL, V77, P385; Hoffman HJ, 2010, EAR HEARING, V31, P725, DOI 10.1097/AUD.0b013e3181e9770e; Joo YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131247; Jun HJ, 2015, LARYNGOSCOPE, V125, P690, DOI 10.1002/lary.24913; Kang TS, 2015, J EXPO SCI ENV EPID, V25, P106, DOI 10.1038/jes.2014.72; KELL RL, 1970, INT AUDIOL, V9, P334; Kim HN, 2000, J KOREAN MED SCI, V15, P580, DOI 10.3346/jkms.2000.15.5.580; Kim MG, 2009, YONSEI MED J, V50, P771, DOI 10.3349/ymj.2009.50.6.771; Kim S, 2010, CLIN EXP OTORHINOLAR, V3, P27, DOI 10.3342/ceo.2010.3.1.27; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; Korea Centers for Disease Control and Prevention, 2009, GUID EV 4 KOR NAT HL, P19; Looker Anne C, 2012, NCHS Data Brief, P1; Mahomed F, 2013, EAR HEARING, V34, P745, DOI 10.1097/01.aud.0000436255.53747.a4; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P186, DOI 10.1016/S0194-5998(95)70103-6; MOSCICKI EK, 1985, EAR HEARING, V6, P184, DOI 10.1097/00003446-198507000-00003; Oh IH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116161; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Schlauch RS, 2012, AM J AUDIOL, V21, P106, DOI 10.1044/1059-0889(2012/11-0012); Swanepoel D, 2010, TELEMED J E-HEALTH, V16, P557, DOI 10.1089/tmj.2009.0143	23	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150783	10.1371/journal.pone.0150783	http://dx.doi.org/10.1371/journal.pone.0150783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950935	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100059
J	Gonzalez-Chica, DA; Mnisi, Z; Avery, J; Duszynski, K; Doust, J; Tideman, P; Murphy, A; Burgess, J; Beilby, J; Stocks, N				Gonzalez-Chica, David Alejandro; Mnisi, Zandile; Avery, Jodie; Duszynski, Katherine; Doust, Jenny; Tideman, Philip; Murphy, Andrew; Burgess, Jacquii; Beilby, Justin; Stocks, Nigel			Effect of Health Literacy on Quality of Life amongst Patients with Ischaemic Heart Disease in Australian General Practice	PLOS ONE			English	Article							FAILURE; PREDICTORS; IMPACT; CARE; COMMUNICATION; VALIDATION; QUESTIONS; EDUCATION; OUTCOMES; STROKE	Background Appropriate understanding of health information by patients with cardiovascular disease (CVD) is fundamental for better management of risk factors and improved morbidity, which can also benefit their quality of life. Objectives To assess the relationship between health literacy and health-related quality of life (HRQoL) in patients with ischaemic heart disease (IHD), and to investigate the role of socio-demographic and clinical variables as possible confounders. Methods Cross-sectional study of patients with IHD recruited from a stratified sample of general practices in two Australian states (Queensland and South Australia) between 2007 and 2009. Health literacy was measured using a validated questionnaire and classified as inadequate, marginal, or adequate. Physical and mental components of HRQoL were assessed using the Medical Outcomes Study Short Form (SF12) questionnaire. Analyses were adjusted for confounders (sociodemographic variables, clinical history of IHD, number of CVD comorbidities, and CVD risk factors) using multiple linear regression. Results A total sample of 587 patients with IHD (mean age 72.0 +/- 8.4 years) was evaluated: 76.8% males, 84.2% retired or pensioner, and 51.4% with up to secondary educational level. Health literacy showed a mean of 39.6 +/- 6.7 points, with 14.3% (95% CI 11.8-17.3) classified as inadequate. Scores of the physical component of HRQoL were 39.6 (95% CI 37.1-42.1), 42.1 (95% CI 40.8-43.3) and 44.8 (95% CI 43.3-46.2) for inadequate, marginal, and adequate health literacy, respectively (p-value for trend = 0.001). This association persisted after adjustment for confounders. Health literacy was not associated with the mental component of HRQoL (p-value = 0.482). Advanced age, lower educational level, disadvantaged socioeconomic position, and a larger number of CVD comorbidities adversely affected both, health literacy and HRQoL. Conclusion Inadequate health literacy is a contributing factor to poor physical functioning in patients with IHD. Increasing health literacy may improve HRQoL and reduce the impact of IHD among patients with this chronic CVD.	[Gonzalez-Chica, David Alejandro; Mnisi, Zandile; Stocks, Nigel] Univ Adelaide, Sch Med, NHMRC Ctr Res Excellence Reduce Inequal Heart Dis, Discipline Gen Practice, Adelaide, SA, Australia; [Avery, Jodie] Univ Adelaide, Sch Med, Populat Res & Outcome Studies, Discipline Med, Adelaide, SA, Australia; [Duszynski, Katherine] Univ Adelaide, Sch Med, Discipline Paediat, Adelaide, SA, Australia; [Doust, Jenny] Bond Univ, Fac Hlth Sci & Med, Robina, Qld, Australia; [Tideman, Philip] Flinders Univ S Australia, Dept Cardiovasc Med, Adelaide, SA 5001, Australia; [Murphy, Andrew] Natl Univ Ireland, Dept Gen Practice, Galway, Ireland; [Burgess, Jacquii] Univ Queensland, Child Hlth Res Ctr, Ctr Childrens Burns & Trauma Res, Brisbane, Qld, Australia; [Beilby, Justin] Torrens Univ Australia, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide; Bond University; Flinders University South Australia; Ollscoil na Gaillimhe-University of Galway; University of Queensland; Torrens University Australia	Gonzalez-Chica, DA (corresponding author), Univ Adelaide, Sch Med, NHMRC Ctr Res Excellence Reduce Inequal Heart Dis, Discipline Gen Practice, Adelaide, SA, Australia.	david.gonzalez@adelaide.edu.au	Doust, Jenny/AGI-8773-2022; Avery, Jodie/A-2860-2012; Beilby, Justin/M-5147-2019; Gonzalez-Chica, David/L-5316-2019; Duszynski, Katherine/G-3152-2011	Doust, Jenny/0000-0002-4024-9308; Avery, Jodie/0000-0002-8857-9162; Gonzalez-Chica, David/0000-0002-7153-2878; Duszynski, Katherine/0000-0003-3532-7233; Stocks, Nigel/0000-0002-9018-0361; Murphy, Andrew/0000-0001-5549-8246	National health and Medical Research Council - General Practice Clinical Research Program [349574]	National health and Medical Research Council - General Practice Clinical Research Program	Thiw work was supported by National health and Medical Research Council - General Practice Clinical Research Program - Grant No. 349574. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboumatar HJ, 2013, J GEN INTERN MED, V28, P1469, DOI 10.1007/s11606-013-2466-5; Adams RJ, 2009, MED J AUSTRALIA, V191, P530, DOI 10.5694/j.1326-5377.2009.tb03304.x; [Anonymous], 2011, Cent Eur J Public Health, V19, P138; Australian Bureau of Statistics, 2011, CENS POP HOUS SOC EC; Australian commission on safety and quality in health care, 2015, NAT STAT HLTH LIT TA; Australian Institute of Health and Welfare, 2014, CARD DIAB CHRON KIDN, V2; AVERY J, 2003, QUALITY LIFE S AUSTR; Baker DW, 2005, J CARD FAIL, V11, P405, DOI 10.1016/j.cardfail.2005.03.010; Barber MN, 2009, HEALTH PROMOT INT, V24, P252, DOI 10.1093/heapro/dap022; Begg SJ, 2014, AUST HEALTH REV, V38, P1, DOI 10.1071/AH13114; Berkman N D, 2004, Evid Rep Technol Assess (Summ), P1; Bosworth HB, 2004, AGING MENT HEALTH, V8, P83, DOI 10.1080/13607860310001613374; Brett Tom, 2006, Aust Fam Physician, V35, P157; Campbell DJ, 2014, MED J AUSTRALIA, V200, P146, DOI [10.5694/mja13.10924, 10.5694/mja13.11084]; Campbell NC, 2004, HEART, V90, P29, DOI 10.1136/hrt.2004.037606; Campbell NC, 2004, HEART, V90, piv9; Carlson B, 2013, J CARDIOVASC NURS, V28, P206, DOI 10.1097/JCN.0b013e31824987a8; Chew LD, 2004, FAM MED, V36, P588; Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5; Cigolle CT, 2007, ANN INTERN MED, V147, P156, DOI 10.7326/0003-4819-147-3-200708070-00004; deBoer AGEM, 1997, HEALTH POLICY, V42, P101, DOI 10.1016/S0168-8510(97)00062-6; Evangelista LS, 2010, J CARD FAIL, V16, P9, DOI 10.1016/j.cardfail.2009.10.026; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gott M, 2006, AGE AGEING, V35, P172, DOI 10.1093/ageing/afj040; Gray J, 2000, BMJ-BRIT MED J, V321, P548, DOI 10.1136/bmj.321.7260.548; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Heo S, 2008, AM J CRIT CARE, V17, P124; Hong E, 2015, J PHYS THER SCI, V27, P2521, DOI 10.1589/jpts.27.2521; Howard DH, 2005, AM J MED, V118, P371, DOI 10.1016/j.amjmed.2005.01.010; Iqbal J, 2010, EUR J HEART FAIL, V12, P1002, DOI 10.1093/eurjhf/hfq114; Juenger J, 2002, HEART, V87, P235, DOI 10.1136/heart.87.3.235; Ludt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029334; Macabasco-O'Connell A, 2011, J GEN INTERN MED, V26, P979, DOI 10.1007/s11606-011-1668-y; Marathe J., 2014, HEART LUNG CIRC, V23, pE12; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Nesbitt T, 2014, CIRC-HEART FAIL, V7, P882, DOI 10.1161/CIRCHEARTFAILURE.113.000577; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Parker R, 2010, J HEALTH COMMUN, V15, P20, DOI 10.1080/10810730.2010.501094; Peerson A, 2009, HEALTH PROMOT INT, V24, P285, DOI 10.1093/heapro/dap014; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sabate E, 2003, 9241545992 WHO; Stocks NP, 2004, MED J AUSTRALIA, V180, P229, DOI 10.5694/j.1326-5377.2004.tb05891.x; van der Heide I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1180; Wang CL, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0190-5; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE, 2001, QUAL LIFE RES, V10, P405, DOI 10.1023/A:1012588218728; Weiner SD, 2010, J THROMB THROMBOLYS, V29, P8, DOI 10.1007/s11239-009-0381-8; Westlake Cheryl, 2013, Curr Heart Fail Rep, V10, P232, DOI 10.1007/s11897-013-0147-7; Zhang XH, 2009, VALUE HEALTH, V12, pS106, DOI 10.1111/j.1524-4733.2009.00640.x	49	49	49	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0151079	10.1371/journal.pone.0151079	http://dx.doi.org/10.1371/journal.pone.0151079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG0FG	26943925	Green Published, gold			2022-12-27	WOS:000371739400078
J	Legge, GE; Gage, R; Baek, Y; Bochsler, TM				Legge, Gordon E.; Gage, Rachel; Baek, Yihwa; Bochsler, Tiana M.			Indoor Spatial Updating with Reduced Visual Information	PLOS ONE			English	Article							FIELD-OF-VIEW; PATH-INTEGRATION; DISTANCE; VISION; REAL; PERCEPTION; LOCOMOTION; REPRESENTATIONS; NAVIGATION; MOBILITY	Purpose Spatial updating refers to the ability to keep track of position and orientation while moving through an environment. People with impaired vision may be less accurate in spatial updating with adverse consequences for indoor navigation. In this study, we asked how artificial restrictions on visual acuity and field size affect spatial updating, and also judgments of the size of rooms. Methods Normally sighted young adults were tested with artificial restriction of acuity in Mild Blur (Snellen 20/135) and Severe Blur (Snellen 20/900) conditions, and a Narrow Field (8 degrees) condition. The subjects estimated the dimensions of seven rectangular rooms with and without these visual restrictions. They were also guided along three-segment paths in the rooms. At the end of each path, they were asked to estimate the distance and direction to the starting location. In Experiment 1, the subjects walked along the path. In Experiment 2, they were pushed in a wheelchair to determine if reduced proprioceptive input would result in poorer spatial updating. Results With unrestricted vision, mean Weber fractions for room-size estimates were near 20%. Severe Blur but not Mild Blur yielded larger errors in room-size judgments. The Narrow Field was associated with increased error, but less than with Severe Blur. There was no effect of visual restriction on estimates of distance back to the starting location, and only Severe Blur yielded larger errors in the direction estimates. Contrary to expectation, the wheelchair subjects did not exhibit poorer updating performance than the walking subjects, nor did they show greater dependence on visual condition. Discussion If our results generalize to people with low vision, severe deficits in acuity or field will adversely affect the ability to judge the size of indoor spaces, but updating of position and orientation may be less affected by visual impairment.	[Legge, Gordon E.; Gage, Rachel; Baek, Yihwa; Bochsler, Tiana M.] Univ Minnesota, Dept Psychol, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Legge, GE (corresponding author), Univ Minnesota, Dept Psychol, St Paul, MN USA.	legge@umn.edu		Legge, Gordon/0000-0002-3742-1680	National Institutes of Health [EY017835]; University of Minnesota Doctoral Dissertation Fellowship; NATIONAL EYE INSTITUTE [R01EY017835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Doctoral Dissertation Fellowship(University of Minnesota System); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by a National Institutes of Health grant EY017835 to Gordon E. Legge and a University of Minnesota Doctoral Dissertation Fellowship to Tiana M. Bochsler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GL, 2004, PERCEPT PSYCHOPHYS, V66, P170, DOI 10.3758/BF03194870; Arthur JC, 2007, EXP BRAIN RES, V183, P557, DOI 10.1007/s00221-007-1075-0; Arthur JC, 2012, SEEING PERCEIVING, V25, P155, DOI 10.1163/187847612X629928; Black A., 1997, CLIN EXP OPTOM, V80, P1, DOI [10.1111/j.1444-0938.1997.tb04841.x, DOI 10.1111/J.1444-0938.1997.TB04841.X]; Bochsler TM, 2013, INVEST OPHTH VIS SCI, V54, P288, DOI 10.1167/iovs.12-10461; Bochsler TM, 2012, OPTOMETRY VISION SCI, V89, pE1299, DOI 10.1097/OPX.0b013e318264f2bd; Campos JL, 2010, EUR J NEUROSCI, V31, P1889, DOI 10.1111/j.1460-9568.2010.07212.x; Chance SS, 1998, PRESENCE-TELEOP VIRT, V7, P168, DOI 10.1162/105474698565659; Creem-Regehr SH, 2005, PERCEPTION, V34, P191, DOI 10.1068/p5144; Fortenbaugh FC, 2008, INVEST OPHTH VIS SCI, V49, P2765, DOI 10.1167/iovs.07-1021; Geuss MN, 2012, J EXP PSYCHOL HUMAN, V38, P1242, DOI 10.1037/a0027524; Gibson JJ, 1950, PERCEPTION VISUAL WO; Hassan SE, 2007, VISION RES, V47, P2115, DOI 10.1016/j.visres.2007.03.012; Huisingh C, 2015, INVEST OPHTH VIS SCI, V56, P132, DOI 10.1167/iovs.14-15194; JOHNSON CA, 1983, ARCH OPHTHALMOL-CHIC, V101, P371; Kalia AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072170; Kallie CS, 2012, INVEST OPHTH VIS SCI, V53, P7997, DOI 10.1167/iovs.12-10013; Klatzky RL, 1998, PSYCHOL SCI, V9, P293, DOI 10.1111/1467-9280.00058; Kuyk T, 1998, OPTOMETRY VISION SCI, V75, P538, DOI 10.1097/00006324-199807000-00023; Legge GE, 2010, J VISION, V10, DOI 10.1167/10.11.8; Loomis JM, 1999, WAYFINDING BEHAVIOR, P125; LOOMIS JM, 1993, J EXP PSYCHOL GEN, V122, P73, DOI 10.1037/0096-3445.122.1.73; LOOMIS JM, 1992, J EXP PSYCHOL HUMAN, V18, P906, DOI 10.1037/0096-1523.18.4.906; Loomis JM, 2001, OPTOMETRY VISION SCI, V78, P282, DOI 10.1097/00006324-200105000-00011; Mittelstaedt ML, 2001, EXP BRAIN RES, V139, P318, DOI 10.1007/s002210100735; Odell NV, 2008, J AAPOS, V12, P555, DOI 10.1016/j.jaapos.2008.04.012; Ooi TL, 2001, NATURE, V414, P197, DOI 10.1038/35102562; Peruch P, 1997, PERCEPTION, V26, P301, DOI 10.1068/p260301; Philbeck J, 2008, PERCEPTION, V37, P511, DOI 10.1068/p5839; Philbeck JW, 2001, J EXP PSYCHOL HUMAN, V27, P141, DOI 10.1037/0096-1523.27.1.141; Pinheiro J, 2015, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Core Team, 2021, R LANGUAGE ENV STAT; Rand KM, 2015, J EXP PSYCHOL HUMAN, V41, P649, DOI 10.1037/xhp0000040; Rand KM, 2011, PERCEPTION, V40, P143, DOI 10.1068/p6843; Redlick FP, 2001, VISION RES, V41, P213, DOI 10.1016/S0042-6989(00)00243-1; RIESER JJ, 1990, PERCEPTION, V19, P675, DOI 10.1068/p190675; Siegle JH, 2009, EXP BRAIN RES, V195, P429, DOI 10.1007/s00221-009-1805-6; Tarampi MR, 2010, ATTEN PERCEPT PSYCHO, V72, P23, DOI 10.3758/APP.72.1.23; Tcheang L, 2011, P NATL ACAD SCI USA, V108, P1152, DOI 10.1073/pnas.1011843108; Therrien ME, 2010, PERCEPTION, V39, P1043, DOI 10.1068/p5991; Wang RXF, 2000, COGNITION, V77, P215, DOI 10.1016/S0010-0277(00)00105-0; WOOD JM, 1992, OPHTHAL PHYSL OPT, V12, P291, DOI 10.1111/j.1475-1313.1992.tb00400.x; Wu B, 2004, NATURE, V428, P73, DOI 10.1038/nature02350; Yamamoto N, 2013, MEM COGNITION, V41, P109, DOI 10.3758/s13421-012-0240-2	45	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150708	10.1371/journal.pone.0150708	http://dx.doi.org/10.1371/journal.pone.0150708			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943674	Green Submitted, Green Published, gold			2022-12-27	WOS:000371739400040
J	Grone, BP; Marchese, M; Hamling, KR; Kumar, MG; Krasniak, CS; Sicca, F; Santorelli, FM; Patel, M; Baraban, SC				Grone, Brian P.; Marchese, Maria; Hamling, Kyla R.; Kumar, Maneesh G.; Krasniak, Christopher S.; Sicca, Federico; Santorelli, Filippo M.; Patel, Manisha; Baraban, Scott C.			Epilepsy, Behavioral Abnormalities, and Physiological Comorbidities in Syntaxin-Binding Protein 1 (STXBP1) Mutant Zebrafish	PLOS ONE			English	Article							WHOLE-GENOME DUPLICATION; DE-NOVO MUTATIONS; OHTAHARA-SYNDROME; LARVAL ZEBRAFISH; SYNAPTIC VESICLE; DRAVET SYNDROME; WEST SYNDROME; TELEOST FISH; SPOTTED GAR; DANIO-RERIO	Mutations in the synaptic machinery gene syntaxin-binding protein 1, STXBP1 (also known as MUNC18-1), are linked to childhood epilepsies and other neurodevelopmental disorders. Zebrafish STXBP1 homologs (stxbp1a and stxbp1b) have highly conserved sequence and are prominently expressed in the larval zebrafish brain. To understand the functions of stxbp1a and stxbp1b, we generated loss-of-function mutations using CRISPR/Cas9 gene editing and studied brain electrical activity, behavior, development, heart physiology, metabolism, and survival in larval zebrafish. Homozygous stxbp1a mutants exhibited a profound lack of movement, low electrical brain activity, low heart rate, decreased glucose and mitochondrial metabolism, and early fatality compared to controls. On the other hand, homozygous stxbp1b mutants had spontaneous electrographic seizures, and reduced locomotor activity response to a movement-inducing "dark-flash" visual stimulus, despite showing normal metabolism, heart rate, survival, and baseline locomotor activity. Our findings in these newly generated mutant lines of zebrafish suggest that zebrafish recapitulate clinical phenotypes associated with human syntaxin-binding protein 1 mutations.	[Grone, Brian P.; Hamling, Kyla R.; Krasniak, Christopher S.; Baraban, Scott C.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Marchese, Maria; Sicca, Federico; Santorelli, Filippo M.] IRCCS Stella Maris, Mol Med Lab, Pisa, Italy; [Marchese, Maria; Sicca, Federico; Santorelli, Filippo M.] IRCCS Stella Maris, Clin Neurophysiol Lab, Pisa, Italy; [Kumar, Maneesh G.; Patel, Manisha] Univ Colorado, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO USA; [Krasniak, Christopher S.] Colby Coll, Dept Biol, Waterville, ME 04901 USA	University of California System; University of California San Francisco; IRCCS Fondazione Stella Maris; IRCCS Fondazione Stella Maris; University of Colorado System; University of Colorado Anschutz Medical Campus; Colby College	Grone, BP (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA.	brian.grone@ucsf.edu	marchese, maria/J-8703-2014; Santorelli, Filippo M/ABE-5124-2020; Sicca, Federico/J-7768-2016	marchese, maria/0000-0002-0194-0702; Santorelli, Filippo M/0000-0002-1359-9062; Sicca, Federico/0000-0002-4917-5253; Baraban, Scott/0000-0003-1975-9781; Krasniak, Christopher/0000-0001-8852-6805; Hamling, Kyla/0000-0001-5408-9256	National Institutes of Neurological Disorders and Stroke [5R01NS079214, R01NS039587, R01NS086423]; Telethon Italy [GGP11188]; Fondazione Cassa di Risparmio di Lucca [567-2014]; LGS Foundation; NIH [5R01NS079214, R01NS039587, R01NS086423]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079214, R01NS096976, R01NS039587, R01NS086423] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon Italy(Fondazione Telethon); Fondazione Cassa di Risparmio di Lucca; LGS Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was financially supported by grants from: National Institutes of Neurological Disorders and Stroke 5R01NS079214 (S.B.), R01NS039587 and R01NS086423 (M.P.); Telethon Italy (http://www.telethon.it/en; Grant GGP11188) and the Fondazione Cassa di Risparmio di Lucca (Grant 567-2014) (F.S. and F.M.S.); and the LGS Foundation (B.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Matthew Dinday for technical assistance and Aliesha Griffin and MacKenzie Howard for helpful comments on an earlier version of the manuscript. This study was supported by grants from NIH 5R01NS079214 (S.B.), R01NS039587 and R01NS086423 (M.P.), and from the LGS Foundation (B.G.). The financial support of Telethon Italy (http://www.telethon.it/en; Grant no. GGP11188), and the Fondazione Cassa di Risparmio di Lucca (Grant 567-2014) are gratefully acknowledged.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Arjona FJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004267; BAKER BI, 1975, GEN COMP ENDOCR, V25, P147, DOI 10.1016/0016-6480(75)90185-9; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2007, EPILEPSIA, V48, P1151, DOI 10.1111/j.1528-1167.2007.01075.x; Baraban SC, 2013, JOVE-J VIS EXP, DOI 10.3791/50104; Baraban SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3410; Barcia G, 2013, EUR J MED GENET, V56, P683, DOI 10.1016/j.ejmg.2013.09.013; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Carvill GL, 2014, NEUROLOGY, V82, P1245, DOI 10.1212/WNL.0000000000000291; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Deprez L, 2010, NEUROLOGY, V75, P1159, DOI 10.1212/WNL.0b013e3181f4d7bf; Dreosti E, 2014, CURR BIOL, V24, P440, DOI 10.1016/j.cub.2014.01.016; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; EISEN JS, 1993, DEV BIOL, V159, P50, DOI 10.1006/dbio.1993.1220; Elbaz I, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00009; Elrod MG, 2015, J DEV BEHAV PEDIATR, V36, P166, DOI 10.1097/DBP.0000000000000140; Force A, 1999, GENETICS, V151, P1531; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; Grone BP, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00365; Grone BP, 2015, J COMP NEUROL, V523, P1125, DOI 10.1002/cne.23729; Haesemeyer M, 2015, CURR OPIN NEUROBIOL, V30, P122, DOI 10.1016/j.conb.2014.12.002; Hager T, 2014, BEHAV BRAIN RES, V260, P44, DOI 10.1016/j.bbr.2013.11.033; Hamdan FF, 2011, EUR J HUM GENET, V19, P607, DOI 10.1038/ejhg.2010.183; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hogben L, 1931, P R SOC LOND B-CONTA, V108, P10, DOI 10.1098/rspb.1931.0020; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Hunt RF, 2012, EXP NEUROL, V237, P199, DOI 10.1016/j.expneurol.2012.06.013; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jansen K, 2012, EPILEPSY RES, V102, P167, DOI 10.1016/j.eplepsyres.2012.05.010; Kassahn KS, 2009, GENOME RES, V19, P1404, DOI 10.1101/gr.086827.108; Keogh MJ, 2015, NEUROGENETICS, V16, P65, DOI 10.1007/s10048-014-0431-z; Kerr M, 2011, EPILEPTIC DISORD, V13, pS15, DOI 10.1684/epd.2011.0409; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; LAAKSO ML, 1993, J NEUROL, V240, P410, DOI 10.1007/BF00867353; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan DW, 2006, PIGM CELL RES, V19, P206, DOI 10.1111/j.1600-0749.2006.00307.x; Lynch M, 2000, GENETICS, V154, P459; MACDONALD RL, 1977, NATURE, V267, P720, DOI 10.1038/267720a0; Mahmood F, 2013, DIS MODEL MECH, V6, P652, DOI 10.1242/dmm.009480; Mann KD, 2010, AM J PHYSIOL-REG I, V298, pR1288, DOI 10.1152/ajpregu.00302.2009; McCammon JM, 2015, DIS MODEL MECH, V8, P647, DOI 10.1242/dmm.019620; Milh M, 2011, EPILEPSIA, V52, P1828, DOI 10.1111/j.1528-1167.2011.03181.x; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Novak AE, 2006, DEV DYNAM, V235, P1962, DOI 10.1002/dvdy.20811; Ohtahara S, 2006, EPILEPSY RES, V70, pS58, DOI 10.1016/j.eplepsyres.2005.11.021; Otsuka M, 2010, EPILEPSIA, V51, P2449, DOI 10.1111/j.1528-1167.2010.02767.x; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Patten SA, 2014, DIS MODEL MECH, V7, P799, DOI 10.1242/dmm.015719; Pelster B, 1996, CIRC RES, V79, P358, DOI 10.1161/01.RES.79.2.358; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramirez IBR, 2012, HUM MOL GENET, V21, P1744, DOI 10.1093/hmg/ddr608; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Schubert J, 2014, NAT GENET, V46, P1327, DOI 10.1038/ng.3130; Schwerte T, 2006, J EXP BIOL, V209, P1093, DOI 10.1242/jeb.02117; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Teng Y, 2010, HUM MOL GENET, V19, P4409, DOI 10.1093/hmg/ddq364; Tso WWY, 2014, PEDIATR NEUROL, V50, P177, DOI 10.1016/j.pediatrneurol.2013.10.006; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wolman MA, 2011, P NATL ACAD SCI USA, V108, P15468, DOI 10.1073/pnas.1107156108; Woods IG, 2014, J NEUROSCI, V34, P3142, DOI 10.1523/JNEUROSCI.3529-13.2014; Yamamoto T, 2016, BRAIN DEV-JPN, V38, P280, DOI 10.1016/j.braindev.2015.09.004; Zhang C, 2010, P NATL ACAD SCI USA, V107, P20164, DOI 10.1073/pnas.1014941107; Zhang XC, 2014, AM J HUM GENET, V94, P547, DOI 10.1016/j.ajhg.2014.03.003; Zhdanova IV, 2006, ZEBRAFISH, V3, P215, DOI 10.1089/zeb.2006.3.215	80	61	62	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151148	10.1371/journal.pone.0151148	http://dx.doi.org/10.1371/journal.pone.0151148			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963117	Green Submitted, gold, Green Published			2022-12-27	WOS:000371993000109
J	Masquillier, C; Wouters, E; Mortelmans, D; van Wyk, B; Hausler, H; Van Damme, W				Masquillier, Caroline; Wouters, Edwin; Mortelmans, Dimitri; van Wyk, Brian; Hausler, Harry; Van Damme, Wim			HIV/AIDS Competent Households: Interaction between a Health-Enabling Environment and Community-Based Treatment Adherence Support for People Living with HIV/AIDS in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; HIV-INFECTION; PROMOTION; STIGMA; TUBERCULOSIS; CONTEXTS; WORKERS; CARE; INTERVENTIONS; MANAGEMENT	In the context of severe human resource shortages in HIV care, task-shifting and especially community-based support are increasingly being cited as potential means of providing durable care to chronic HIV patients. Socio-ecological theory clearly stipulates that-in all social interventions-the interrelatedness and interdependency between individuals and their immediate social contexts should be taken into account. People living with HIV/AIDS (PLWHA) seldom live in isolation, yet community-based interventions for supporting chronic HIV patients have largely ignored the social contexts in which they are implemented. Research is thus required to investigate such community-based support within its context. The aim of this study is to address this research gap by examining the way in which HIV/AIDS competence in the household hampers or facilitates community-based treatment adherence support. The data was analyzed carefully in accordance with the Grounded Theory procedures, using Nvivo 10. More specifically, we analyzed field notes from participatory observations conducted during 48 community-based treatment adherence support sessions in townships on the outskirts of Cape Town, transcripts of 32 audio-recorded in-depth interviews with PLWHA and transcripts of 4 focus group discussions with 36 community health workers (CHWs). Despite the fact that the CHWs try to present themselves as not being openly associated with HIV/AIDS services, results show that the presence of a CHW is often seen as a marker of the disease. Depending on the HIV/AIDS competence in the household, this association can challenge the patient's hybrid identity management and his/her attempt to regulate the interference of the household in the disease management. The results deepen our understanding of how the degree of HIV/AIDS competence present in a PLWHA's household affects the manner in which the CHW can perform his or her job and the associated benefits for the patient and his/her household members. In this respect, a household with a high level of HIV/AIDS competence will be more receptive to treatment adherence support, as the patient is more likely to allow interaction between the CHW and the household. In contrast, in a household which exhibits limited characteristics of HIV/AIDS competence, interaction with the treatment adherence supporter may be difficult in the beginning. In such a situation, visits from the CHW threaten the hybrid identity management. If the CHW handles this situation cautiously and the patient-acting as a gate keeper-allows interaction, the CHW may be able to help the household develop towards HIV/AIDS competence. This would have a more added value compared to a household which was more HIV/AIDS competent from the outset. This study indicates that pre-existing dynamics in a patient's social environment, such as the HIV/AIDS competence of the household, should be taken into account when designing community-based treatment adherence programs in order to provide long-term quality care, treatment and support in the context of human resource shortages.	[Masquillier, Caroline; Wouters, Edwin; Mortelmans, Dimitri] Univ Antwerp, Res Ctr Longitudinal & Life Course Studies CELLO, B-2020 Antwerp, Belgium; [Wouters, Edwin] Univ Free State, Ctr Hlth Syst Res & Dev, Bloemfontein, South Africa; [van Wyk, Brian] Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa; [Hausler, Harry] TB HIV Care Assoc, Cape Town, South Africa; [Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	University of Antwerp; University of the Free State; University of the Western Cape; Institute of Tropical Medicine (ITM)	Masquillier, C (corresponding author), Univ Antwerp, Res Ctr Longitudinal & Life Course Studies CELLO, B-2020 Antwerp, Belgium.	caroline.masquillier@uantwerpen.be	Wouters, Edwin/AAE-1649-2021; Mortelmans, Dimitri/B-3860-2010; Van Damme, Wim/F-7404-2011	Wouters, Edwin/0000-0003-2268-3829; Mortelmans, Dimitri/0000-0003-3285-8223; Van Damme, Wim/0000-0002-6344-3007; Masquillier, Caroline/0000-0003-1748-5967	University of Antwerp	University of Antwerp	This work was funded by University Research Fund of the University of Antwerp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDS2031 Social Drivers Working Group, 2010, REV AIDS RESP BUILD; Angrosino M., 2007, DOING ETHNOGRAPHIC O; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Bogart LM, 2008, AIDS BEHAV, V12, P244, DOI 10.1007/s10461-007-9231-x; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Campbell C, 2007, AM J COMMUN PSYCHOL, V39, P347, DOI 10.1007/s10464-007-9116-1; Campbell C, 2006, J COMMUNITY APPL SOC, V16, P411, DOI 10.1002/casp.901; Campbell C, 2012, AIDS BEHAV, V16, P847, DOI 10.1007/s10461-011-9966-2; Celletti F, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000366082.68321.d6; Ciambrone D, 2006, WOMEN HEALTH, V44, P61, DOI 10.1300/J013v44n04_04; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Daftary A, 2012, SOC SCI MED, V74, P1512, DOI 10.1016/j.socscimed.2012.01.027; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Ferlander S, 2007, ACTA SOCIOL, V50, P115, DOI 10.1177/0001699307077654; Gardner EM, 2014, LANCET INFECT DIS, V14, P5, DOI 10.1016/S1473-3099(13)70272-X; Garner P, 2007, B WORLD HEALTH ORGAN, V85, P404, DOI 10.2471/BLT.06.035568; Gausset Q, 2012, SOCIAL SCI MED; Gilson L, 2014, HLTH RES POLICY SYST, V12, DOI DOI 10.1186; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Golden SD, 2012, HEALTH EDUC BEHAV, V39, P364, DOI 10.1177/1090198111418634; Grey M, 2006, NURS OUTLOOK, V54, P278, DOI 10.1016/j.outlook.2006.06.004; Gusdal AK, 2011, AIDS CARE, V23, P657, DOI 10.1080/09540121.2010.532531; HAYS RB, 1993, AIDS, V7, P425, DOI 10.1097/00002030-199303000-00019; Holzemer WL, 2007, J ADV NURS, V58, P541, DOI 10.1111/j.1365-2648.2007.04244.x; Kok MC, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0001-3; Lamboray J. L., 2001, Journal of International Development, V13, P513, DOI 10.1002/jid.800; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; Makoae LN, 2009, AIDS CARE, V21, P1357, DOI 10.1080/09540120902862576; Manaliyo J.C., 2009, TOURISM MULTILINGUAL; Masquillier C, 2015, INT J ENV RES PUB HE, V12, P3264, DOI 10.3390/ijerph120303264; McLaren L, 2005, J EPIDEMIOL COMMUN H, V59, P6, DOI 10.1136/jech.2003.018044; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; McNairy ML, 2012, AIDS, V26, P1735, DOI 10.1097/QAD.0b013e328355d67b; Mdege ND, 2012, HLTH POLICY PLANNING; Mortelmans D., 2013, HDB KWALITATIEVE OND; Munoz M, 2011, AIDS BEHAV, V15, P1454, DOI 10.1007/s10461-010-9697-9; Mwai GW, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18586; Nhamo M, 2010, AIDS CARE, V22, P1662, DOI 10.1080/09540121.2010.521544; Niehof A, 2011, INT J CONSUM STUD, V35, P488, DOI 10.1111/j.1470-6431.2011.01026.x; Nombo C, 2007, AIDS MEETS POVERTY I; Nullis-Kapp C., 2005, AFRICA IS WORST HIT; Odendaal WA, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-18; Ogden J., 2004, EXPANDING CARE CONTI; Remien RH, 2013, AIDS BEHAV, V17, P1979, DOI 10.1007/s10461-013-0438-8; Richard L, 2011, ANNU REV PUBL HEALTH, V32, P307, DOI 10.1146/annurev-publhealth-031210-101141; RodriguezGarcia R, 2013, DIR DEV, P1; Root R, 2013, J INT AIDS SOC, P1; Russell S, 2010, SOC SCI MED, V70, P375, DOI 10.1016/j.socscimed.2009.10.039; Sallis JF, 2008, HLTH BEHAV HLTH ED, P465, DOI DOI 10.7326/0003-4819-116-4-350_; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Simoni JM, 2011, AIDS BEHAV, V15, P376, DOI 10.1007/s10461-010-9836-3; Spire B, 2002, SOC SCI MED, V54, P1481, DOI 10.1016/S0277-9536(01)00125-3; Standing H, 2008, SOC SCI MED, V66, P2096, DOI 10.1016/j.socscimed.2008.01.046; Stokols D, 1996, AM J HEALTH PROMOT, V10, P282, DOI 10.4278/0890-1171-10.4.282; Wakefield SEL, 2005, SOC SCI MED, V60, P2819, DOI 10.1016/j.socscimed.2004.11.012; Waller MA, 2001, AM J ORTHOPSYCHIAT, V71, P290, DOI 10.1037/0002-9432.71.3.290; Weihs K, 2002, FAM SYST HLTH J COLL, V20, P7, DOI DOI 10.1037/H0089481; WHO, 2013, CONS ARV GUID 2013; Wools-Kaloustian KK, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-22; World Health Organization, PSYCH SUPP 2013; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE; Wouters E, 2009, AIDS CARE, V21, P411, DOI 10.1080/09540120802242077; Wouters E, 2012, SOC THEOR HEALTH, V10, P368, DOI 10.1057/sth.2012.12; Wouters E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-194; Wouters E, 2009, SOC SCI MED, V69, P1177, DOI 10.1016/j.socscimed.2009.07.034; Zachariah R, 2006, T ROY SOC TROP MED H, V100, P167, DOI 10.1016/j.trstmh.2005.07.008	68	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151379	10.1371/journal.pone.0151379	http://dx.doi.org/10.1371/journal.pone.0151379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TL	26963257	Green Published, gold			2022-12-27	WOS:000371993000143
J	Nel, A; Bekker, LG; Bukusi, E; Hellstrom, E; Kotze, P; Louw, C; Martinson, F; Masenga, G; Montgomery, E; Ndaba, N; van der Straten, A; van Niekerk, N; Woodsong, C				Nel, Annalene; Bekker, Linda-Gail; Bukusi, Elizabeth; Hellstroem, Elizabeth; Kotze, Philip; Louw, Cheryl; Martinson, Francis; Masenga, Gileard; Montgomery, Elizabeth; Ndaba, Nelisiwe; van der Straten, Ariane; van Niekerk, Neliette; Woodsong, Cynthia			Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa	PLOS ONE			English	Article							HEALTHY	Background This was the first microbicide trial conducted in Africa to evaluate an antiretroviral-containing vaginal ring as an HIV prevention technology for women. Objectives The trial assessed and compared the safety, acceptability and adherence to product use of a 4-weekly administered vaginal ring containing the antiretroviral microbicide, dapivirine, with a matching placebo ring among women from four countries in sub-Saharan Africa. Methods 280 Healthy, sexually active, HIV-negative women, aged 18 to 40 years were enrolled with 140 women randomised to a dapivirine vaginal ring (25 mg) and 140 women to a matching placebo ring, inserted 4-weekly and used over a 12-week period. Safety was evaluated by pelvic examination, colposcopy, clinical laboratory assessments, and adverse events. Blood samples for determination of plasma concentrations of dapivirine were collected at Weeks 0, 4 and 12. Residual dapivirine levels in returned rings from dapivirine ring users were determined post-trial. Participant acceptability and adherence to ring use were assessed by self-reports. Results No safety concerns or clinically relevant differences were observed between the dapivirine and placebo ring groups. Plasma dapivirine concentrations immediately prior to ring removal were similar after removal of the first and third ring, suggesting consistent ring use over the 12-week period. No clear relationship was observed between the residual amount of dapivirine in used rings and corresponding plasma concentrations. Self-reported adherence to daily use of the vaginal rings over the 12-week trial period was very high. At the end of the trial, 96% of participants reported that the ring was usually comfortable to wear, and 97% reported that they would be willing to use it in the future if proven effective. Conclusions The dapivirine vaginal ring has a favourable safety and acceptability profile. If proven safe and effective in large-scale trials, it will be an important component of combination HIV prevention approaches for women.	[Nel, Annalene; van Niekerk, Neliette; Woodsong, Cynthia] Int Partnership Microbicides, Silver Spring, MD USA; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Fdn, ZA-7925 Cape Town, South Africa; [Bukusi, Elizabeth] Kenya Govt Med Res Ctr, Kisumu, Kenya; [Hellstroem, Elizabeth] Be Part Yoluntu Ctr, Paarl, South Africa; [Kotze, Philip] Qhakaza Mbokodo Res Clin, Ladysmith, South Africa; [Louw, Cheryl] Madibeng Ctr Res, Brits, South Africa; [Martinson, Francis] Univ North Carolina Project, Lilongwe, Malawi; [Masenga, Gileard] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Montgomery, Elizabeth; van der Straten, Ariane] RTI Int, San Francisco, CA USA; [Ndaba, Nelisiwe] Maternal Adolescent & Child Hlth, Edendale, South Africa	University of Cape Town; Kenya Medical Research Institute; Kilimanjaro Christian Medical Centre; Research Triangle Institute	van Niekerk, N (corresponding author), Int Partnership Microbicides, Silver Spring, MD USA.	nvanniekerk@ipmglobal.org.za	Bekker, Linda-Gail/AAZ-8929-2020	Montgomery, Elizabeth/0000-0002-5477-4445; kotze, Paulo Gustavo/0000-0002-2053-5315; van der Straten, Ariane/0000-0001-8536-648X; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Kotze, Philip/0000-0003-1346-7833	International Partnership for Microbicides (IPM); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	International Partnership for Microbicides (IPM); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This clinical trial was funded by the International Partnership for Microbicides (IPM) (a not-for-profit public-private partnership).	Boyd P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125682; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Lachin J. M., 2000, WILEY SER PROB STAT; Lyndgaard LB, 2014, J RAMAN SPECTROSC, V45, P149, DOI 10.1002/jrs.4433; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Montgomery ET, 2012, AIDS BEHAV, V16, P1787, DOI 10.1007/s10461-012-0248-4; Nel A, 2011, CROI 2011; Nel A. M., 2014, Journal of AIDS and Clinical Research, V5, P355; Nel AM, 2014, HIV R4P POST P15 09; Nel AM, 2015, C RETR OPP INF CROI; Nel A, 2014, AIDS, V28, P1479, DOI 10.1097/QAD.0000000000000280; Nel AA, 2009, AIDS, V23, P1531, DOI 10.1097/QAD.0b013e32832c413d; Rees Helen, 2015, C RETR OPP INF 2015; Tolley EE, 2010, AIDS BEHAV, V14, P1124, DOI 10.1007/s10461-009-9635-x; UNAIDS, 2012, TOG WE WILL END AIDS; UNAIDS, 2014, PROGR REP GLOB PLAN; van der Straten A, 2012, AIDS BEHAV, V16, P1775, DOI 10.1007/s10461-012-0215-0; van der Straten A, 2013, CURR HIV-AIDS REP, V10, P89, DOI 10.1007/s11904-012-0141-9; Woodsong C, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.1.18505, 10.7448/IAS.17.3.19158]	20	75	75	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0147743	10.1371/journal.pone.0147743	http://dx.doi.org/10.1371/journal.pone.0147743			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963505	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000002
J	Sorber, R; Teper, Y; Abisoye-Ogunniyan, A; Waterfall, JJ; Davis, S; Killian, JK; Pineda, M; Ray, S; McCord, MR; Pflicke, H; Burkett, SS; Meltzer, PS; Rudloff, U				Sorber, Rebecca; Teper, Yaroslav; Abisoye-Ogunniyan, Abisola; Waterfall, Joshua J.; Davis, Sean; Killian, J. Keith; Pineda, Marbin; Ray, Satyajit; McCord, Matt R.; Pflicke, Holger; Burkett, Sandra Sczerba; Meltzer, Paul S.; Rudloff, Udo			Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G>A) in Axon Guidance Receptor Plexin A1 as Enhancer of Proliferation and Invasion	PLOS ONE			English	Article							DRUG-SENSITIVITY; PLUS GEMCITABINE; CLINICAL-TRIALS; ADENOCARCINOMA; PATHWAYS; CELLS; METASTASIS; MELANOMA; TARGETS; GENES	The genetic profile of human pancreatic cancers harbors considerable heterogeneity, which suggests a possible explanation for the pronounced inefficacy of single therapies in this disease. This observation has led to a belief that custom therapies based on individual tumor profiles are necessary to more effectively treat pancreatic cancer. It has recently been discovered that axon guidance genes are affected by somatic structural variants in up to 25% of human pancreatic cancers. Thus far, however, some of these mutations have only been correlated to survival probability and no function has been assigned to these observed axon guidance gene mutations in pancreatic cancer. In this study we established three novel pancreatic cancer cell lines and performed whole genome sequencing to discover novel mutations in axon guidance genes that may contribute to the cancer phenotype of these cells. We discovered, among other novel somatic variants in axon guidance pathway genes, a novel mutation in the PLXNA1 receptor (c.2587G>A) in newly established cell line SB.06 that mediates oncogenic cues of increased invasion and proliferation in SB.06 cells and increased invasion in 293T cells upon stimulation with the receptor's natural ligand semaphorin 3A compared to wild type PLXNA1 cells. Mutant PLXNA1 signaling was associated with increased Rho-GTPase and p42/p44 MAPK signaling activity and cytoskeletal expansion, but not changes in E-cadherin, vimentin, or metalloproteinase 9 expression levels. Pharmacologic inhibition of the Rho-GTPase family member CDC42 selectively abrogated PLXNA1 c.2587G>A-mediated increased invasion. These findings provide in-vitro confirmation that somatic mutations in axon guidance genes can provide oncogenic gain-of-function signals and may contribute to pancreatic cancer progression.	[Sorber, Rebecca; Teper, Yaroslav; Abisoye-Ogunniyan, Abisola; McCord, Matt R.; Pflicke, Holger; Rudloff, Udo] NCI, Thorac & GI Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Waterfall, Joshua J.; Davis, Sean; Killian, J. Keith; Pineda, Marbin; Meltzer, Paul S.] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [Ray, Satyajit] NCI, Surg Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Burkett, Sandra Sczerba] NCI, Mol Cytogenet Sect, MCGP, Ctr Canc Res,NIH, Frederick, MD 20892 USA; [Abisoye-Ogunniyan, Abisola] Tuskegee Univ, Dept Biol, Tuskegee, AL 36088 USA; [Abisoye-Ogunniyan, Abisola] Tuskegee Univ, Ctr Canc Res, Tuskegee, AL 36088 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tuskegee University; Tuskegee University	Rudloff, U (corresponding author), NCI, Thorac & GI Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	rudloffu@mail.nih.gov	Davis, Sean/AAD-1801-2021	Davis, Sean/0000-0002-8991-6458; Rudloff, Udo/0000-0003-2137-9040; Waterfall, Joshua/0000-0002-3762-5050; Burkett, Sandra/0000-0002-5476-4028; Abisoye-Ogunniyan, Abisola/0000-0002-8646-9031	NIH; Pfizer Inc; Doris Duke Charitable Foundation; Newport Foundation; American Association for Dental Research; Howard Hughes Medical Institute; Colgate-Palmolive Company; NATIONAL CANCER INSTITUTE [ZIABC011267, ZIABC011091] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Inc(Pfizer); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Newport Foundation; American Association for Dental Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Colgate-Palmolive Company; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was made possible through the National Institutes of Health (NIH) Medical Research Scholars Program, a public-private partnership supported jointly by the NIH and generous contributions to the Foundation for the NIH from Pfizer Inc, The Doris Duke Charitable Foundation, The Newport Foundation, The American Association for Dental Research, The Howard Hughes Medical Institute, and the Colgate-Palmolive Company, as well as other private donors. For a complete list, please visit the Foundation website at: http://fnih.org/work/education-training-0/medical-research-scholars-program.	Aci-Seche S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097779; Ahmed A, 2007, ADV EXP MED BIOL, V600, P24; Association WM, 1964, WMA DECL HELS ETH PR; Bachelder RE, 2003, CANCER RES, V63, P5230; Bagci T, 2009, ONCOGENE, V28, P3537, DOI 10.1038/onc.2009.204; Balakrishnan A, 2009, HUM MUTAT, V30, P1167, DOI 10.1002/humu.21017; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell DW, 2010, J PATHOL, V220, P231, DOI 10.1002/path.2645; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Catalano A, 2009, CANCER RES, V69, P1485, DOI 10.1158/0008-5472.CAN-08-3659; Chantrill LA, 2015, CLIN CANCER RES, V21, P2029, DOI 10.1158/1078-0432.CCR-15-0426; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Friesland A, 2013, P NATL ACAD SCI USA, V110, P1261, DOI 10.1073/pnas.1116051110; Gabrovska PN, 2011, GENE, V489, P63, DOI 10.1016/j.gene.2011.08.024; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gohrig A, 2014, CANCER RES, V74, P1529, DOI 10.1158/0008-5472.CAN-13-1012; Goshima Y, 2012, EXPERT OPIN THER TAR, V16, P933, DOI 10.1517/14728222.2012.710201; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Jaffee EM, 1998, CANCER J SCI AM, V4, P194; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma JM, 2013, JNCI-J NATL CANCER I, V105, P1694, DOI 10.1093/jnci/djt292; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Mueller MW, 2007, INT J CANCER, V121, P2421, DOI 10.1002/ijc.22949; Murphy SJ, 2013, GASTROENTEROLOGY, V145, P1098, DOI 10.1053/j.gastro.2013.07.049; Neufeld G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006718; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Ray S, 2012, J CANCER, V3, P196, DOI 10.7150/jca.4484; Ruckert F, 2012, J SURG RES, V172, P29, DOI 10.1016/j.jss.2011.04.021; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Tian TV, 2014, ONCOGENE, V33, P2204, DOI 10.1038/onc.2013.176; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Walia V, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00976.x; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	42	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149833	10.1371/journal.pone.0149833	http://dx.doi.org/10.1371/journal.pone.0149833			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26962861	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000020
J	Chan, BKK; Chen, HN; Dando, PR; Southward, AJ; Southward, EC				Chan, Benny K. K.; Chen, H. -N.; Dando, P. R.; Southward, A. J.; Southward, E. C.			Biodiversity and Biogeography of Chthamalid Barnacles from the North-Eastern Pacific (Crustacea Cirripedia)	PLOS ONE			English	Article							INTERTIDAL BARNACLES; MITOCHONDRIAL-DNA; VERTICAL ZONATION; ACORN BARNACLE; RECRUITMENT; STELLATUS; SPECIATION; COMMUNITY; LARVAL; GULF	The biogeography and ecology of the species of Chthamalus present on the west coast of America are described, using data from 51 localities from Alaska to Panama, together with their zonation on the shore with respect to that of other barnacles. The species present were C. dalli, Pilsbry 1916, C. fissus, Darwin, 1854, C. anisopoma Pilsbry 1916 and four species in the C. panamensis complex. The latter are C. panamensis Pilsbry, 1916, C. hedgecocki, Pitombo & Burton, 2007, C. alani nom. nov. (formerly C. southwardorum Pitombo & Burton, 2007) and C. newmani sp. nov.). These four species were initially separated by enzyme electrophoresis. They could only be partially separated by DNA bar coding but may be separated using morphological characters.	[Chan, Benny K. K.] Acad Sinica, Biodivers Res Ctr, 128 Sect 2,Acad Rd, Taipei 115, Taiwan; [Chen, H. -N.] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10617, Taiwan; [Dando, P. R.; Southward, A. J.; Southward, E. C.] Marine Biol Assoc United Kingdom Lab, Citadel Hill, Plymouth PL 2PB, Devon, England	Academia Sinica - Taiwan; National Taiwan University; Marine Biological Association United Kingdom	Chan, BKK (corresponding author), Acad Sinica, Biodivers Res Ctr, 128 Sect 2,Acad Rd, Taipei 115, Taiwan.	chankk@gate.sinica.edu.tw		Chan, Benny/0000-0001-9479-024X; Dando, Paul/0000-0002-1291-5414	Marine Biological Association of the United Kingdom through the Natural Environment Research Council; Ministry of Science and Technology, Taiwan	Marine Biological Association of the United Kingdom through the Natural Environment Research Council; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	PRD, AJS and ECS were funded by the Marine Biological Association of the United Kingdom through a grant-in-aid from the Natural Environment Research Council. BKKC is funded by the Ministry of Science and Technology, Taiwan. No sponsors or funders contributed to the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sibaja-Cordero JA, 2008, REV BIOL TROP, V56, P171; Bakus G.J., 1975, Atoll Res Bull, VNo. 179, P1; BARNES H, 1965, J ANIM ECOL, V34, P391, DOI 10.2307/2656; Burrows MT, 1999, J MAR BIOL ASSOC UK, V79, P93, DOI 10.1017/S0025315498000101; Burrows MT, 1988, COMP BIOL CHTHAMALUS; Cantera JR, 1999, HYDROBIOLOGIA, V413, P17, DOI 10.1023/A:1003890826741; Carlton JT, 2011, INVAD NAT SPRING SER, V6, P159, DOI 10.1007/978-94-007-0591-3_5; Chan BKK, 2008, J ZOOL, V275, P294, DOI 10.1111/j.1469-7998.2008.00441.x; Chan BKK, 2008, B MAR SCI, V83, P315; Chan BKK, 2007, ZOOL SCR, V36, P79, DOI 10.1111/j.1463-6409.2007.00260.x; Chen YY, 2012, ZOOKEYS, P43, DOI 10.3897/zookeys.214.3291; CRISP DJ, 1981, J MAR BIOL ASSOC UK, V61, P359, DOI 10.1017/S0025315400047007; DANDO PR, 1980, J MAR BIOL ASSOC UK, V60, P787, DOI 10.1017/S0025315400040455; DANDO PR, 1979, J MAR BIOL ASSOC UK, V59, P307, DOI 10.1017/S0025315400042612; Dando PR, 1980, 2ND INT C SYST EV BI, P415; Dando PR, 1987, BARNACLE BIOL, V5; Darwin CR, 1854, BALANIDAE SESSILE CI, V2; Deng QME, 2010, MAR BIOL, V157, P1989, DOI 10.1007/s00227-010-1468-7; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fiedler PC, 2006, PROG OCEANOGR, V69, P143, DOI 10.1016/j.pocean.2006.03.008; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Godwin LS, 2003, BIOFOULING, V19, P123, DOI 10.1080/0892701031000061750; Goldstein MC, 2014, MAR BIOL, V161, P1441, DOI 10.1007/s00227-014-2432-8; HEDGECOCK D, 1979, MAR BIOL, V54, P207; Henry Dora Priaulx, 1943, PROC U S NATION MUS, V93, P367; Henry DP, 1960, U WASHINGTON PUBLICA, V4, P135; Henry DP, 1942, U WASHINGTON PUBLICA, V4, P1; Jarrett JN, 2009, J CRUSTACEAN BIOL, V29, P329, DOI 10.1651/08-3119.1; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; KOLOSVARY G. v., 1941, ZOOL ANZ, V133, P67; Ladah LB, 2005, MAR ECOL PROG SER, V302, P177, DOI 10.3354/meps302177; Laguna J., 1985, THESIS U CALIFORNIA; LAGUNA JE, 1990, B MAR SCI, V46, P406; LIVELY CM, 1987, OECOLOGIA, V74, P304, DOI 10.1007/BF00379374; Lozano-Cortes DF, 2013, MAR BIODIVERS, V43, P463, DOI 10.1007/s12526-013-0175-2; MENGE BA, 1986, OECOLOGIA, V71, P75, DOI 10.1007/BF00377324; Meyers MK, 2013, REV BIOL TROP, V61, P75; MILLER KM, 1989, J CRUSTACEAN BIOL, V9, P242, DOI 10.2307/1548504; Mokady O, 2000, J EXP MAR BIOL ECOL, V243, P295, DOI 10.1016/S0022-0981(99)00124-0; Morgan SG, 2011, LIMNOL OCEANOGR, V56, P161, DOI 10.4319/lo.2011.56.1.0161; Needles LA, 2013, BIOL INVASIONS, V15, P1231, DOI 10.1007/s10530-012-0362-2; NEI M, 1971, AM NAT, V105, P385, DOI 10.1086/282732; Nilsson-Cantell CA, 1921, ZOOL BIDR UPPS, V7, P75; O'Riordan RM, 2010, J EXP MAR BIOL ECOL, V392, P46, DOI 10.1016/j.jembe.2010.04.010; Pagenkopp-Lohan K, 2013, RICHNESS EXTENT COND; Pilsbry HA, US NATL MUSEUM B, V93, P1; Pitombo F. B, 2002, CONTRIBUTIONS STUDY, V1, P97; Pitombo FB, 2007, ZOOTAXA, P1; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; QUESADA H, 1995, P ROY SOC B-BIOL SCI, V262, P51, DOI 10.1098/rspb.1995.0175; RAIMONDI PT, 1988, J EXP MAR BIOL ECOL, V123, P253, DOI 10.1016/0022-0981(88)90046-9; REIMER AA, 1976, MAR BIOL, V35, P225, DOI 10.1007/BF00396871; Romero-Centeno R, 2003, J CLIMATE, V16, P2628, DOI 10.1175/1520-0442(2003)016<2628:IOTWCA>2.0.CO;2; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; Sibaja-Cordero JA, 2008, REV BIOL TROP, V56, P91, DOI DOI 10.15517/RBT.V56I4.27208; Sibaja-Cordero JA, 2006, REV BIOL TROP, V54, P49; SOUTHWARD AJ, 1976, J MAR BIOL ASSOC UK, V56, P1007, DOI 10.1017/S0025315400021044; Southward AJ, 2005, ADV MAR BIOL, V47, P1; SOUTHWARD AJ, 1983, BIOL J LINN SOC, V20, P59, DOI 10.1111/j.1095-8312.1983.tb01589.x; Southward AJ, 2003, J MAR BIOL ASSOC UK, V83, P797, DOI 10.1017/S0025315403007835h; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Southward AJ, 1998, MAR ECOL PROG SER, V165, P119, DOI 10.3354/meps165119; Southward AJ, 1977, ASPECTS ECOLOGY BIOG, P427; Southward Alan J., 1995, Crustacean Issues, V10, P1; SUTHERLAND JP, 1990, ECOLOGY, V71, P955, DOI 10.2307/1937365; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wares JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005567; Wares JP, 2005, J MAR BIOL ASSOC UK, V85, P327, DOI 10.1017/S0025315405011227h; Wares JP, 2001, MOL PHYLOGENET EVOL, V18, P104, DOI 10.1006/mpev.2000.0857; Wu NM, 1982, DISTRIBUTION SPECIES; Zabin CJ, 2013, MAR ECOL-EVOL PERSP, V34, P131, DOI 10.1111/maec.12007; Zardus JD, 2005, MOL ECOL, V14, P3719, DOI 10.1111/j.1365-294X.2005.02701.x	72	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149556	10.1371/journal.pone.0149556	http://dx.doi.org/10.1371/journal.pone.0149556			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26958842	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000371992300014
J	Dey, A; Samanta, MK; Gayen, S; Sen, SK; Maiti, MK				Dey, Avishek; Samanta, Milan Kumar; Gayen, Srimonta; Sen, Soumitra K.; Maiti, Mrinal K.			Enhanced Gene Expression Rather than Natural Polymorphism in Coding Sequence of the OsbZIP23 Determines Drought Tolerance and Yield Improvement in Rice Genotypes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; SALT STRESS TOLERANCE; ABSCISIC-ACID; BZIP FACTOR; PROMOTER; COLD; ABA; OVEREXPRESSION; REGULATOR; INTERACTS	Drought is one of the major limiting factors for productivity of crops including rice (Oryza sativa L.). Understanding the role of allelic variations of key regulatory genes involved in stress-tolerance is essential for developing an effective strategy to combat drought. The bZIP transcription factors play a crucial role in abiotic-stress adaptation in plants via abscisic acid (ABA) signaling pathway. The present study aimed to search for allelic polymorphism in the OsbZIP23 gene across selected drought-tolerant and drought-sensitive rice genotypes, and to characterize the new allele through overexpression (OE) and gene-silencing (RNAi). Analyses of the coding DNA sequence (CDS) of the cloned OsbZIP23 gene revealed single nucleotide polymorphism at four places and a 15-nucleotide deletion at one place. The single-copy OsbZIP23 gene is expressed at relatively higher level in leaf tissues of drought-tolerant genotypes, and its abundance is more in reproductive stage. Cloning and sequence analyses of the OsbZIP23-promoter from drought-tolerant O. rufipogon and drought-sensitive IR20 cultivar showed variation in the number of stress-responsive cis-elements and a 35-nucleotide deletion at 5'-UTR in IR20. Analysis of the GFP reporter gene function revealed that the promoter activity of O. rufipogon is comparatively higher than that of IR20. The overexpression of any of the two polymorphic forms (1083 bp and 1068 bp CDS) of OsbZIP23 improved drought tolerance and yield-related traits significantly by retaining higher content of cellular water, soluble sugar and proline; and exhibited decrease in membrane lipid peroxidation in comparison to RNAi lines and non-transgenic plants. The OE lines showed higher expression of target genes-OsRab16B, OsRab21 and OsLEA3-1 and increased ABA sensitivity; indicating that OsbZIP23 is a positive transcriptional-regulator of the ABA-signaling pathway. Taken together, the present study concludes that the enhanced gene expression rather than natural polymorphism in coding sequence of OsbZIP23 is accountable for improved drought tolerance and yield performance in rice genotypes.	[Dey, Avishek; Samanta, Milan Kumar; Gayen, Srimonta; Sen, Soumitra K.; Maiti, Mrinal K.] Indian Inst Technol, Adv Technol Dev Ctr, Adv Lab Plant Genet Engn, Kharagpur 721302, W Bengal, India; [Maiti, Mrinal K.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Sen, SK; Maiti, MK (corresponding author), Indian Inst Technol, Adv Technol Dev Ctr, Adv Lab Plant Genet Engn, Kharagpur 721302, W Bengal, India.; Maiti, MK (corresponding author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.	soumitra@hijli.iitkgp.ernet.in; maitimk@hijli.iitkgp.ernet.in	Samanta, Milan/GPC-8507-2022	Samanta, Milan/0000-0002-0199-8170; GAYEN, SRIMONTA/0000-0002-8395-7283; Maiti, Mrinal/0000-0001-7803-4356	Department of Science and Technology, Government of India; Indian Council of Agricultural Research, Government of India [NAIP-PAR-C4/C/30033]	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Indian Council of Agricultural Research, Government of India(Indian Council of Agricultural Research (ICAR))	Avishek acknowledges Department of Science and Technology, Government of India for providing INSPIRE Fellowship during his research tenure. Financial support (NAIP-PAR-C4/C/30033) from Indian Council of Agricultural Research, Government of India is acknowledged.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Baryla A, 2000, ENVIRON POLLUT, V109, P131, DOI 10.1016/S0269-7491(99)00232-8; Bhattacharyya J, 2012, PLANT CELL REP, V31, P271, DOI 10.1007/s00299-011-1161-4; Bhunia RK, 2014, PLANT MOL BIOL, V86, P351, DOI 10.1007/s11103-014-0233-6; Bouman BAM, 2005, AGR WATER MANAGE, V74, P87, DOI 10.1016/j.agwat.2004.11.007; Challam C, 2015, J GENET, V94, P231, DOI 10.1007/s12041-015-0507-z; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dai SH, 2004, P NATL ACAD SCI USA, V101, P687, DOI 10.1073/pnas.0307687100; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Gao Y, 2015, PLANT MOL BIOL, V87, P413, DOI 10.1007/s11103-015-0288-z; Gomez-Porras JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-260; Hieno A, 2014, NUCLEIC ACIDS RES, V42, pD1188, DOI 10.1093/nar/gkt1027; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Hobo T, 1999, P NATL ACAD SCI USA, V96, P15348, DOI 10.1073/pnas.96.26.15348; Hossain MA, 2010, J PLANT PHYSIOL, V167, P1512, DOI 10.1016/j.jplph.2010.05.008; Hu W, 2013, PLANT CELL ENVIRON, V36, P1449, DOI 10.1111/pce.12074; HURST HC, 1994, PROTEIN PROFILE, V1, P123; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kim S, 2004, PLANT J, V40, P75, DOI 10.1111/j.1365-313X.2004.02192.x; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kumar GR, 2010, BIOTECHNOL ADV, V28, P451, DOI 10.1016/j.biotechadv.2010.02.007; Kumari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079011; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Liu CT, 2012, PLANTA, V235, P1157, DOI 10.1007/s00425-011-1564-z; Liu JJ, 2013, PLANT PHYSIOL BIOCH, V73, P114, DOI 10.1016/j.plaphy.2013.09.006; Liu Y, 2007, BIOCHEM J, V405, P243, DOI 10.1042/BJ20061375; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Mukherjee K, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-18; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; Parida SK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-426; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shimizu H, 2005, PLANT CELL PHYSIOL, V46, P1623, DOI 10.1093/pcp/pci178; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Tang N, 2012, PLANT PHYSIOL, V158, P1755, DOI 10.1104/pp.111.190389; Tao Z, 2011, J EXP BOT, V62, P4863, DOI 10.1093/jxb/err144; TIWARI V, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0131567; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei SY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-133; Xia XJ, 2014, PLANT CELL ENVIRON, V37, P2036, DOI 10.1111/pce.12275; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yamamoto YY, 2007, NUCLEIC ACIDS RES, V35, P6219, DOI 10.1093/nar/gkm685; Yang SJ, 2010, MOL PLANT, V3, P469, DOI 10.1093/mp/ssq016; Yang X, 2011, PLANT PHYSIOL, V156, P1397, DOI 10.1104/pp.111.173427; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Yue B, 2006, GENETICS, V172, P1213, DOI 10.1534/genetics.105.045062; Zhang L, 2011, J EXP BOT, V62, P4229, DOI 10.1093/jxb/err131; Zhang Z.J., 2013, BIOPROTOC, V3, pe817, DOI [10.21769/BioProtoc.817, DOI 10.21769/BIOPROTOC.817]; Zou MJ, 2008, PLANT MOL BIOL, V66, P675, DOI 10.1007/s11103-008-9298-4	57	25	26	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150763	10.1371/journal.pone.0150763	http://dx.doi.org/10.1371/journal.pone.0150763			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959651	Green Published, gold			2022-12-27	WOS:000371992300072
J	Martinez-Pizarro, A; Desviat, LR; Ugarte, M; Perez, B; Richard, E				Martinez-Pizarro, Ainhoa; Desviat, Lourdes R.; Ugarte, Magdalena; Perez, Belen; Richard, Eva			Endoplasmic Reticulum Stress and Autophagy in Homocystinuria Patients with Remethylation Defects	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; METHYLENETETRAHYDROFOLATE REDUCTASE; OXIDATIVE STRESS; MICE DEFICIENT; HOMOCYSTEINE; GENE; ER; FIBROBLASTS; APOPTOSIS; HERP	Proper function of endoplasmic reticulum (ER) and mitochondria is crucial for cellular homeostasis, and dysfunction at either site as well as perturbation of mitochondria-associated ER membranes (MAMs) have been linked to neurodegenerative and metabolic diseases. Previously, we have observed an increase in ROS and apoptosis levels in patientderived fibroblasts with remethylation disorders causing homocystinuria. Here we show increased mRNA and protein levels of Herp, Grp78, IP(3)R1, pPERK, ATF4, CHOP, asparagine synthase and GADD45 in patient-derived fibroblasts suggesting ER stress and calcium perturbations in homocystinuria. In addition, overexpressed MAM-associated proteins (Grp75, sigma-1R and Mfn2) were found in these cells that could result in mitochondrial calcium overload and oxidative stress increase. Our results also show an activation of autophagy process and a substantial degradation of altered mitochondria by mitophagy in patientderived fibroblasts. Moreover, we have observed that autophagy was partially abolished by antioxidants suggesting that ROS participate in this process that may have a protective role. Our findings argue that alterations in Ca2+ homeostasis and autophagy may contribute to the development of this metabolic disorder and suggest a therapeutic potential in homocystinuria for agents that stabilize calcium homeostasis and/or restore the proper function of ER-mitochondria communications.	[Richard, Eva] Univ Autonoma Madrid, Ctr Biol Mol SO UAM CSIC, Ctr Diagnost Enfermedades Mol, Campus Cantoblanco, E-28049 Madrid, Spain; IDIPaz, Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Richard, E (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol SO UAM CSIC, Ctr Diagnost Enfermedades Mol, Campus Cantoblanco, E-28049 Madrid, Spain.	erichard@cbm.csic.es	DESVIAT, LOURDES R/L-3055-2013	DESVIAT, LOURDES R/0000-0003-0492-3323; Richard Rodriguez, Eva Maria/0000-0001-9711-1417	Ministerio de Ciencia e Innovacion [SAF2010-15284]; Ministerio de Economia y Competividad: Instituto de Salud Carlos III [PI13/01239]; MITOLAB [S2010/BMD-2402]; Ministerio de Economia y Competividad [SAF2013-43005-R]; Institutional grant from Fundacion Ramon Areces	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competividad: Instituto de Salud Carlos III; MITOLAB; Ministerio de Economia y Competividad(Spanish Government); Institutional grant from Fundacion Ramon Areces	This work was funded by the Ministerio de Ciencia e Innovacion (SAF2010-15284 to ER), Ministerio de Economia y Competividad: Instituto de Salud Carlos III (PI13/01239 to BP), MITOLAB (S2010/BMD-2402 to BP), Ministerio de Economia y Competividad (SAF2013-43005-R to ER and LRD), and an Institutional grant from Fundacion Ramon Areces to the Centro de Biologia Molecular "Severo Ochoa". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Arnaudeau S, 2002, J BIOL CHEM, V277, P46696, DOI 10.1074/jbc.M202395200; Barbosa-Tessmann IP, 1999, J BIOL CHEM, V274, P31139, DOI 10.1074/jbc.274.44.31139; Belal C, 2012, HUM MOL GENET, V21, P963, DOI 10.1093/hmg/ddr502; BITTLES AH, 1974, J MED GENET, V11, P121, DOI 10.1136/jmg.11.2.121; Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Chen ZT, 2005, INT J DEV NEUROSCI, V23, P465, DOI 10.1016/j.ijdevneu.2005.05.007; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dickhout JG, 2012, J BIOL CHEM, V287, P7603, DOI 10.1074/jbc.M111.304576; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; Formichi P, 2009, J CELL PHYSIOL, V219, P494, DOI 10.1002/jcp.21695; FOWLER B, 1982, BIOCHIM BIOPHYS ACTA, V721, P201, DOI 10.1016/0167-4889(82)90069-6; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221; Ghandour H, 2004, J NUTR, V134, P2975, DOI 10.1093/jn/134.11.2975; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Han CC, 2013, CELL SIGNAL, V25, P144, DOI 10.1016/j.cellsig.2012.09.023; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Jadavji NM, 2014, BIOCHEM J, V461, P205, DOI 10.1042/BJ20131568; Jadavji NM, 2012, MOL GENET METAB, V106, P149, DOI 10.1016/j.ymgme.2012.03.020; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lawrance AK, 2011, J INHERIT METAB DIS, V34, P147, DOI 10.1007/s10545-010-9127-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maclean KN, 2012, J BIOL CHEM, V287, P31994, DOI 10.1074/jbc.M112.355172; Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015; Martinez-Vicente M, 2015, SEMIN CELL DEV BIOL, V40, P115, DOI 10.1016/j.semcdb.2015.03.005; Mendes MIS, 2014, J INHERIT METAB DIS, V37, P245, DOI 10.1007/s10545-013-9647-6; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Pasquali-Ronchetti I, 2006, J PATHOL, V208, P54, DOI 10.1002/path.1867; Richard E, 2013, J CELL BIOCHEM, V114, P183, DOI 10.1002/jcb.24316; Richard E, 2009, HUM MUTAT, V30, P1558, DOI 10.1002/humu.21107; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Rodriguez-Hernandez A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174; Shang J, 2002, GLYCOBIOLOGY, V12, P307, DOI 10.1093/glycob/12.5.307; Slodzinski H, 2009, CLIN NEUROPATHOL, V28, P333, DOI 10.2379/NPX08162; Strauss KA, 2007, MOL GENET METAB, V91, P165, DOI 10.1016/j.ymgme.2007.02.012; Voets AM, 2012, BBA-MOL BASIS DIS, V1822, P1161, DOI 10.1016/j.bbadis.2011.10.009; Watkins D, 2011, AM J MED GENET C, V157C, P33, DOI 10.1002/ajmg.c.30288; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zou CG, 2005, ANTIOXID REDOX SIGN, V7, P547, DOI 10.1089/ars.2005.7.547	47	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150357	10.1371/journal.pone.0150357	http://dx.doi.org/10.1371/journal.pone.0150357			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959487	Green Published, gold			2022-12-27	WOS:000371992300044
J	Mesher, D; Stanford, E; White, J; Findlow, J; Warrington, R; Das, S; Pebody, R; Borrow, R; Soldan, K				Mesher, David; Stanford, Elaine; White, Joanne; Findlow, Jamie; Warrington, Rosalind; Das, Sukamal; Pebody, Richard; Borrow, Ray; Soldan, Kate			HPV Serology Testing Confirms High HPV Immunisation Coverage in England	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; WOMEN; ANTIBODIES; VACCINE; IMMUNOGENICITY; INFECTION; ASSAY	Background Reported human papillomavirus (HPV) vaccination coverage in England is high, particularly in girls offered routine immunisation at age 12 years. Serological surveillance can be used to validate reported coverage and explore variations within it and changes in serological markers over time. Methods Residual serum specimens collected from females aged 15-19 years in 2010-2011 were tested for anti-HPV16 and HPV18 IgG by ELISA. Based on these results, females were classified as follows: seronegative, probable natural infection, probable vaccine-induced seropositivity, or possible natural infection/possible vaccine-induced seropositivity. The proportion of females with vaccine-induced seropositivity was compared to the reported vaccination coverage. Results Of 2146 specimens tested, 1380 (64%) were seropositive for both types HPV16 and HPV18 and 159 (7.4%) positive for only one HPV type. The IgG concentrations were far higher for those positive for both HPV types than those positive for only one HPV type. 1320 (62%) females were considered to have probable vaccine-induced seropositivity. Among vaccine-induced seropositives, antibody concentrations declined with increasing age at vaccination and increasing time since vaccination. Conclusions The proportion of females with vaccine-induced seropositivity was closest to the reported 3-dose coverage in those offered the vaccination at younger ages, with a greater discrepancy in the older females. This suggests either some under-reporting of immunisations of older females and/or that partial vaccination (i.e. one- or two-doses) has provided high antibody responses in 13-17 year olds.	[Mesher, David; Soldan, Kate] Publ Hlth England, Ctr Infect Dis Surveillance & Control, HIV & STI Dept, London, England; [Stanford, Elaine; Findlow, Jamie; Warrington, Rosalind; Borrow, Ray] Manchester Royal Infirm, Publ Hlth England, Vaccine Evaluat Unit, Oxford Rd, Manchester M13 9WL, Lancs, England; [White, Joanne; Das, Sukamal] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Immunisat Hepatitis & Blood Safety Dept, London, England; [Pebody, Richard] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Dept Resp Dis, London, England	Public Health England; Public Health England; University of Manchester; Public Health England; Public Health England	Mesher, D (corresponding author), Publ Hlth England, Ctr Infect Dis Surveillance & Control, HIV & STI Dept, London, England.	david.mesher@phe.gov.uk		Mesher, David/0000-0001-9163-6757; Soldan, Kate/0000-0002-0361-3174; Pebody, Richard/0000-0002-9069-2885	Public Health England	Public Health England	This work was supported by Public Health England.; We thank Georgia Kennedy for performing laboratory analyses. We also thank Simon Beddows for his comments on this paper. We are grateful to GSK (GlaxoSmithKline Biologicals S.A., Rixensart, Belgium) who kindly supplied the HPV-VLPs and transferred the assay, and critical reagents for its performance. All authors were supported by Public Health England.	Carter JJ, 1996, J INFECT DIS, V174, P927, DOI 10.1093/infdis/174.5.927; Carter JJ, 2000, J INFECT DIS, V181, P1911, DOI 10.1086/315498; Department of Health Health Protection Agency, ANN HPV VACC UPT ENG; Department of Health & Health Protection Agency, ANN HPV VACC COV ENG; Desai S, 2011, SEX TRANSM DIS, V38, P622, DOI 10.1097/OLQ.0b013e31820bc880; Dessy FJ, 2008, HUM VACCINES, V4, P425, DOI 10.4161/hv.4.6.6912; Einstein MH, 2011, HUM VACCINES, V7, P1359, DOI 10.4161/hv.7.12.18282; Harper DM, 2006, LANCET, P367; KIRNBAUER R, 1994, JNCI-J NATL CANCER I, V86, P494, DOI 10.1093/jnci/86.7.494; Osborne K, 2000, INT J EPIDEMIOL, V29, P362, DOI 10.1093/ije/29.2.362; Public Health England, 2013, ANN HPV VACC COV ENG; Romanowski B, 2014, HUM VACC IMMUNOTHER, V10, P1155, DOI 10.4161/hv.28022; Roteli-Martins CM, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.18865; Schwarz TF, 2014, PEDIAT INFECT DIS J; Viscidi RP, 1997, CLIN DIAGN LAB IMMUN, V4, P122, DOI 10.1128/CDLI.4.2.122-126.1997	15	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150107	10.1371/journal.pone.0150107	http://dx.doi.org/10.1371/journal.pone.0150107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959232	Green Published, gold			2022-12-27	WOS:000371992300033
J	Prax, M; Mechler, L; Weidenmaier, C; Bertram, R				Prax, Marcel; Mechler, Lukas; Weidenmaier, Christopher; Bertram, Ralph			Glucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus Persisters	PLOS ONE			English	Article							METHICILLIN-RESISTANT; ENTEROCOCCUS-FAECALIS; BACTERICIDAL ACTIVITY; IN-VIVO; MECHANISMS; VANCOMYCIN; INFECTIONS; INDUCTION; TOLERANCE; CELLS	Treatment of Staphylococcus aureus in stationary growth phase with high doses of the antibiotic daptomycin (DAP) eradicates the vast majority of the culture and leaves persister cells behind. Despite resting in a drug-tolerant and dormant state, persister cells exhibit metabolic activity which might be exploited for their elimination. We here report that the addition of glucose to S. aureus persisters treated with DAP increased killing by up to fivefold within one hour. This glucose-DAP effect also occurred with strains less sensitive to the drug. The underlying mechanism is independent of the proton motive force and was not observed with non-metabolizable 2-deoxy-glucose. Our results are consistent with two hypotheses on the glucose-DAP interplay. The first is based upon glucose-induced carbohydrate transport proteins that may influence DAP and the second suggests that glucose may trigger the release or activity of cell-lytic proteins to augment DAP's mode of action.	[Prax, Marcel; Mechler, Lukas; Bertram, Ralph] Univ Tubingen, Lehrbereich Mikrobielle Genet, Interfak Inst Mikrobiol & Infekt Med, Morgenstelle 28, D-72076 Tubingen, Germany; [Prax, Marcel] Paul Ehrlich Inst, Mikrobiol Sicherheit, Paul Ehrlich Str 51-59, D-63225 Langen, Germany; [Weidenmaier, Christopher] Univ Tubingen, Interfak Inst Mikrobiol & Infekt Med Med Mikrobio, Elfriede Aulhorn Str 6, D-72076 Tubingen, Germany; [Bertram, Ralph] Paracelsus Med Univ, Klinikum Nurnberg Med Sch GmbH, Res Dept, Nurnberg, Germany	Eberhard Karls University of Tubingen; Paul Ehrlich Institute; Eberhard Karls University of Tubingen	Bertram, R (corresponding author), Univ Tubingen, Lehrbereich Mikrobielle Genet, Interfak Inst Mikrobiol & Infekt Med, Morgenstelle 28, D-72076 Tubingen, Germany.; Bertram, R (corresponding author), Paracelsus Med Univ, Klinikum Nurnberg Med Sch GmbH, Res Dept, Nurnberg, Germany.	ralph.bertram@pmu.ac.at		Weidenmaier, Christopher/0000-0003-4107-739X	Deutsche Forschungsgemeinschaft [BE4038/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grant BE4038/2 within the priority programme 1316 "host adapted metabolism of bacterial pathogens" of the Deutsche Forschungsgemeinschaft (www.dfg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Amato SM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00070; Amato SM, 2013, MOL CELL, V50, P475, DOI 10.1016/j.molcel.2013.04.002; Babra C, 2013, J BASIC MICROBIOL; Balaban NQ, 2013, NAT REV MICROBIOL, V11, P587, DOI 10.1038/nrmicro3076; Barraud N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084220; Bayer AS, 2013, ANN NY ACAD SCI, V1277, P139, DOI 10.1111/j.1749-6632.2012.06819.x; Bayles KW, 2014, NAT REV MICROBIOL, V12, P63, DOI 10.1038/nrmicro3136; Berti AD, 2012, ANTIMICROB AGENTS CH, V56, P5046, DOI 10.1128/AAC.00502-12; Bertsche U, 2011, ANTIMICROB AGENTS CH, V55, P3922, DOI 10.1128/AAC.01226-10; BIERBAUM G, 1985, ARCH MICROBIOL, V141, P249, DOI 10.1007/BF00408067; Bokinsky G, 2013, J BACTERIOL, V195, P3173, DOI 10.1128/JB.02210-12; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Casadesus J, 2013, J BIOL CHEM, V288, P13929, DOI 10.1074/jbc.R113.472274; CAVARI BZ, 1967, BIOCHEM J, V103, P601, DOI 10.1042/bj1030601; Cohen NR, 2013, CELL HOST MICROBE, V13, P632, DOI 10.1016/j.chom.2013.05.009; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Cotroneo N, 2008, ANTIMICROB AGENTS CH, V52, P2223, DOI 10.1128/AAC.01410-07; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dortet L, 2013, INT J INFECT DIS, V17, pE1076, DOI 10.1016/j.ijid.2013.02.019; Endimiani A, 2011, ANTIMICROB AGENTS CH, V55, P1684, DOI 10.1128/AAC.01308-10; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Fischer A, 2011, J ANTIMICROB CHEMOTH, V66, P1696, DOI 10.1093/jac/dkr195; French GL, 2006, J ANTIMICROB CHEMOTH, V58, P1107, DOI 10.1093/jac/dkl393; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Fuchs PC, 2002, J ANTIMICROB CHEMOTH, V49, P467, DOI 10.1093/jac/49.3.467; Gasch O, 2013, ANTIMICROB AGENTS CH; Gasch O, 2013, J ANTIMICROB CHEMOTH; Gotz F, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P5, DOI 10.1007/0-387-30744-3_1; Gould IM, 2009, INT J ANTIMICROB AG, V34, pS8, DOI 10.1016/S0924-8579(09)70542-4; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; GUSTAFSON JE, 1992, ANTIMICROB AGENTS CH, V36, P566, DOI 10.1128/AAC.36.3.566; HANBERGER H, 1991, ANTIMICROB AGENTS CH, V35, P1710, DOI 10.1128/AAC.35.9.1710; Hayden MK, 2005, J CLIN MICROBIOL, V43, P5285, DOI 10.1128/JCM.43.10.5285-5287.2005; Helaine S, 2014, TRENDS MICROBIOL, V22, P417, DOI 10.1016/j.tim.2014.03.008; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Humphries RM, 2013, CLIN MICROBIOL REV, V26, P759, DOI 10.1128/CMR.00030-13; Humphries RM, 2012, ANTIMICROB AGENTS CH, V56, P6051, DOI 10.1128/AAC.01318-12; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Jahreis K, 2008, FEMS MICROBIOL REV, V32, P891, DOI 10.1111/j.1574-6976.2008.00125.x; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kullar R, 2011, ANTIMICROB AGENTS CH, V55, P3505, DOI 10.1128/AAC.01741-10; Kwan BW, 2013, ANTIMICROB AGENTS CH, V57, P1468, DOI 10.1128/AAC.02135-12; Lechner S, 2012, J MOL MICROB BIOTECH, V22, P235, DOI 10.1159/000342449; Lechnera S, 2014, INT J MED MICROBIOL, V304, P931, DOI 10.1016/j.ijmm.2014.05.008; Leung V, 2012, J BACTERIOL, V194, P2265, DOI 10.1128/JB.06707-11; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mariani PG, 2006, J ANTIMICROB CHEMOTH, V58, P481, DOI 10.1093/jac/dkl256; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; Mechler L, 2015, ANTIMICROB AGENTS CH, V59, P5366, DOI 10.1128/AAC.00643-15; Moore CL, 2012, CLIN INFECT DIS, V54, P51, DOI 10.1093/cid/cir764; MOY JA, 1990, J AM ACAD DERMATOL, V22, P893, DOI 10.1016/0190-9622(90)70120-7; Muraih JK, 2011, BBA-BIOMEMBRANES, V1808, P1154, DOI 10.1016/j.bbamem.2011.01.001; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P4398, DOI 10.1128/AAC.00372-13; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P3230, DOI 10.1128/AAC.00243-13; Paczia N, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-122; Pascoe B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085998; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028316; Que YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080140; Rice KC, 2005, J BACTERIOL, V187, P813, DOI 10.1128/JB.187.3.813-821.2005; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Skiest DJ, 2006, J CLIN MICROBIOL, V44, P655, DOI 10.1128/JCM.44.2.655-656.2006; Somerville GA, 2003, INFECT IMMUN, V71, P4724, DOI 10.1128/IAI.71.8.4724-4732.2003; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058469; Steenbergen JN, 2005, J ANTIMICROB CHEMOTH, V55, P283, DOI 10.1093/jac/dkh546; Stulke J, 1997, MOL MICROBIOL, V25, P65, DOI 10.1046/j.1365-2958.1997.4351797.x; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; VANDERAUWERA P, 1989, ANTIMICROB AGENTS CH, V33, P1783, DOI 10.1128/AAC.33.10.1783; WALE LJ, 1989, J MED MICROBIOL, V30, P45, DOI 10.1099/00222615-30-1-45; Werth BJ, 2013, ANTIMICROB AGENTS CH, V57, P66, DOI 10.1128/AAC.01586-12; WICK AN, 1957, J BIOL CHEM, V224, P963; Wood TK, 2013, APPL ENVIRON MICROB, V79, P7116, DOI 10.1128/AEM.02636-13; Yang SJ, 2005, J BACTERIOL, V187, P5893, DOI 10.1128/JB.187.17.5893-5900.2005	78	31	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150907	10.1371/journal.pone.0150907	http://dx.doi.org/10.1371/journal.pone.0150907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960193	Green Published, gold			2022-12-27	WOS:000371992300085
J	Scherer, R; Jansen, M; Nilsen, T; Areepattamannil, S; Marsh, HW				Scherer, Ronny; Jansen, Malte; Nilsen, Trude; Areepattamannil, Shaljan; Marsh, Herbert W.			The Quest for Comparability: Studying the Invariance of the Teachers' Sense of Self-Efficacy (TSES) Measure across Countries	PLOS ONE			English	Article							GOODNESS-OF-FIT; TEACHING EFFECTIVENESS; INSTRUCTIONAL QUALITY; TESTING MEASUREMENT; JOB-SATISFACTION; BELIEFS; CLASSROOM; STUDENTS; VALIDITY; INDEXES	Teachers' self-efficacy is an important motivational construct that is positively related to a variety of outcomes for both the teachers and their students. This study addresses challenges associated with the commonly used 'Teachers' Sense of Self-Efficacy (TSES)' measure across countries and provides a synergism between substantive research on teachers' self-efficacy and the novel methodological approach of exploratory structural equation modeling (ESEM). These challenges include adequately representing the conceptual overlap between the facets of self-efficacy in a measurement model (cross-loadings) and comparing means and factor structures across countries (measurement invariance). On the basis of the OECD Teaching and Learning International Survey (TALIS) 2013 data set comprising 32 countries (N = 164,687), we investigate the effects of cross-loadings in the TSES measurement model on the results of measurement invariance testing and the estimation of relations to external constructs (i.e., working experience, job satisfaction). To further test the robustness of our results, we replicate the 32-countries analyses for three selected sub-groups of countries (i.e., Nordic, East and South-East Asian, and Anglo-Saxon country clusters). For each of the TALIS 2013 participating countries, we found that the factor structure of the self-efficacymeasure is better represented by ESEMthan by confirmatory factor analysis (CFA) models that do not allow for cross-loadings. For both ESEM and CFA, only metric invariance could be achieved. Nevertheless, invariance levels beyondmetric invariance are better achieved with ESEM within selected country clusters. Moreover, the existence of cross-loadings did not affect the relations between the dimensions of teachers' self-efficacy and external constructs. Overall, this study shows that a conceptual overlap between the facets of self-efficacy exists and can be well-represented by ESEM. We further argue for the cross-cultural generalizability of the corresponding measurement model.	[Scherer, Ronny] Univ Oslo, Fac Educ Sci, Ctr Educ Measurement Univ Oslo CEMO, Oslo, Norway; [Jansen, Malte] German Inst Int Educ Res DIPF, Berlin, Germany; [Nilsen, Trude] Univ Oslo, Fac Educ Sci, Dept Teacher Educ & Sch Res, Oslo, Norway; [Areepattamannil, Shaljan] Emirates Coll Adv Educ, Abu Dhabi, U Arab Emirates; [Marsh, Herbert W.] Australian Catholic Univ, Fac Hlth Sci, Inst Posit Psychol & Educ, Sydney, NSW, Australia; [Marsh, Herbert W.] King Saud Univ, Riad, Saudi Arabia; [Marsh, Herbert W.] Univ Oxford, Dept Educ, Oxford, England	University of Oslo; German Institute for International Educational Research; University of Oslo; Australian Catholic University; King Saud University; University of Oxford	Nilsen, T (corresponding author), Univ Oslo, Fac Educ Sci, Dept Teacher Educ & Sch Res, Oslo, Norway.	trude.nilsen@ils.uio.no	Areepattamannil, Shaljan/AAF-5830-2020; Marsh, Herbert W/B-3134-2017; Areepattamannil, Shaljan/AAF-2171-2020	Marsh, Herbert W/0000-0002-1078-9717; Areepattamannil, Shaljan/0000-0003-3289-7804; Scherer, Ronny/0000-0003-3630-0710; Jansen, Malte/0000-0001-7081-6505				Akiba M., 2007, EDUC RESEARCHER, V36, P369, DOI [10.3102/0013189X07308739, DOI 10.3102/0013189X07308739]; [Anonymous], 2014, TALIS 2013 TECHN REP, DOI DOI 10.1787/9789264196261-EN; [Anonymous], 2014, ACTION TEACHER ED, DOI [10.1080/01626620.2014.948228, DOI 10.1080/01626620.2014.948228, DOI 10.1080/01626620.2014.948228STANDARDS]; Antikainen A., 2006, SCAND J EDUC RES, V50, P229, DOI DOI 10.1080/00313830600743258; Arora, 2012, TIMSS 2011 INT RESUL; Asparouhov T, 2005, STRUCT EQU MODELING, V12, P411, DOI 10.1207/s15328007sem1203_4; Asparouhov T., 2010, MPLUS TECHNICAL APPE; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Avanzi L, 2013, TEACH TEACH EDUC, V31, P69, DOI 10.1016/j.tate.2013.01.002; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Baumert J, 2010, AM EDUC RES J, V47, P133, DOI 10.3102/0002831209345157; Blomeke S., 2014, INT PERSPECTIVES TEA, P19, DOI [10.1007/978-94-007-6437-8_2, DOI 10.1007/978-94-007-6437-8_2]; Bong M, 2003, EDUC PSYCHOL REV, V15, P1, DOI 10.1023/A:1021302408382; Borsboom D, 2004, PSYCHOL REV, V111, P1061, DOI 10.1037/0033-295x.111.4.1061; Brouwers A, 2000, TEACH TEACH EDUC, V16, P239, DOI 10.1016/S0742-051X(99)00057-8; Bulle N, 2011, COMP EDUC, V47, P503, DOI 10.1080/03050068.2011.555117; BYRNE BM, 1989, PSYCHOL BULL, V105, P456, DOI 10.1037/0033-2909.105.3.456; Caprara GV, 2006, J SCHOOL PSYCHOL, V44, P473, DOI 10.1016/j.jsp.2006.09.001; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Creemers B. P. M., 2008, DYNAMICS ED EFFECTIV; Dellinger AB, 2008, TEACH TEACH EDUC, V24, P751, DOI 10.1016/j.tate.2007.02.010; Desa D., 2014, EVALUATING MEASUREME; Duffin LC, 2012, TEACH TEACH EDUC, V28, P827, DOI 10.1016/j.tate.2012.03.004; Duncan GJ, 2014, DEV PSYCHOL, V50, P2417, DOI 10.1037/a0037996; Enders C. K., 2010, APPL MISSING DATA AN; Evers WJG, 2002, BRIT J EDUC PSYCHOL, V72, P227, DOI 10.1348/000709902158865; Fauth B, 2014, LEARN INSTR, V29, P1, DOI 10.1016/j.learninstruc.2013.07.001; Fives H, 2010, J EXP EDUC, V78, P118, DOI 10.1080/00220970903224461; Guo Y, 2014, TEACH TEACH EDUC, V39, P12, DOI 10.1016/j.tate.2013.11.005; Hattie JAC, 2009, VISIBLE LEARNING: A SYNTHESIS OF OVER 800 META-ANALYSES RELATING TO ACHIEVEMENT, P1; Ho IT, 2004, TEACH TEACH EDUC, V20, P313, DOI 10.1016/j.tate.2003.09.009; Holzberger D, 2014, CONTEMP EDUC PSYCHOL, V39, P100, DOI 10.1016/j.cedpsych.2014.02.001; Holzberger D, 2013, J EDUC PSYCHOL, V105, P774, DOI 10.1037/a0032198; Jansen M, 2015, CONTEMP EDUC PSYCHOL, V41, P13, DOI 10.1016/j.cedpsych.2014.11.002; Khojasteh J, 2015, STRUCT EQU MODELING, V22, P531, DOI 10.1080/10705511.2014.937791; Klassen RM, 2014, EDUC RES REV-NETH, V12, P59, DOI 10.1016/j.edurev.2014.06.001; Klassen R, 2011, EDUC PSYCHOL REV, V23, P21, DOI 10.1007/s10648-010-9141-8; Klassen RM, 2010, J EDUC PSYCHOL, V102, P741, DOI 10.1037/a0019237; Klassen RM, 2009, CONTEMP EDUC PSYCHOL, V34, P67, DOI 10.1016/j.cedpsych.2008.08.001; Klieme E., 2009, PYTHAGORAS STUDY, P137; Kunter M, 2008, LEARN INSTR, V18, P468, DOI 10.1016/j.learninstruc.2008.06.008; Kunter M, 2013, J EDUC PSYCHOL, V105, P805, DOI 10.1037/a0032583; Li YB, 2013, J YOUTH ADOLESCENCE, V42, P20, DOI 10.1007/s10964-012-9857-5; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Malinen OP, 2013, TEACH TEACH EDUC, V33, P34, DOI 10.1016/j.tate.2013.02.004; Marsh HW, 2007, CONTEMP EDUC PSYCHOL, V32, P151, DOI 10.1016/j.cedpsych.2006.10.008; Marsh HW, 2014, ANNU REV CLIN PSYCHO, V10, P85, DOI 10.1146/annurev-clinpsy-032813-153700; Marsh HW, 2009, STRUCT EQU MODELING, V16, P439, DOI 10.1080/10705510903008220; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; Marsh HW, 2005, MULTIVAR APPL SER, P275; Matsumoto D., 2001, MANY FACES PSYCHOL R, P98; McDonald RP, 1999, TEST THEORY UNIFIED; MESSICK S, 1995, AM PSYCHOL, V50, P741, DOI 10.1037/0003-066X.50.9.741; Millsap RE, 2011, STAT APPROACHES MEAS; Muthen B, 1998, MPLUS; Muthen B, 2012, PSYCHOL METHODS, V17, P313, DOI 10.1037/a0026802; Nusche D, 2011, OECD REV EVALUATION; O'Neill SC, 2011, EDUC PSYCHOL-UK, V31, P261, DOI 10.1080/01443410.2010.545344; OECD, 2014, TALIS 2013 RES; OECD, 2013, PISA 2012 RES READ L, V3; Oettingen G., 1995, SELF EFFICACY CHANGI, P149, DOI DOI 10.1017/CBO9780511527692; Olafsson RF, 2014, NO LIGHTS TIMSS PIRL, P85; Pekrun R, 2012, HANDBOOK OF RESEARCH ON STUDENT ENGAGEMENT, P259, DOI 10.1007/978-1-4614-2018-7_12; Perry KE, 2007, J SCHOOL PSYCHOL, V45, P269, DOI 10.1016/j.jsp.2007.02.005; Pfitzner-Eden F, 2014, Z PADAGOG PSYCHOL, V28, P83, DOI 10.1024/1010-0652/a000125; Reynolds D., 2002, J CLASSROOM INTERACT, V37, P3; Rhemtulla M, 2012, PSYCHOL METHODS, V17, P354, DOI 10.1037/a0029315; Rutkowski L, 2014, EDUC PSYCHOL MEAS, V74, P31, DOI 10.1177/0013164413498257; Ryan AM, 2015, CONTEMP EDUC PSYCHOL, V41, P147, DOI 10.1016/j.cedpsych.2015.01.002; Satorra A, 2010, PSYCHOMETRIKA, V75, P243, DOI 10.1007/S11336-009-9135-Y; Segall MH, 1998, AM PSYCHOL, V53, P1101, DOI 10.1037/0003-066X.53.10.1101; Seidel T, 2007, REV EDUC RES, V77, P454, DOI 10.3102/0034654307310317; Skaalvik EM, 2007, J EDUC PSYCHOL, V99, P611, DOI 10.1037/0022-0663.99.3.611; Skaalvik EM, 2010, TEACH TEACH EDUC, V26, P1059, DOI 10.1016/j.tate.2009.11.001; Steinmetz H, 2009, QUAL QUANT, V43, P599, DOI 10.1007/s11135-007-9143-x; Sue S, 1999, AM PSYCHOL, V54, P1070, DOI 10.1037/0003-066X.54.12.1070; Tschannen-Moran M, 2001, TEACH TEACH EDUC, V17, P783, DOI 10.1016/S0742-051X(01)00036-1; Tschannen-Moran M, 2007, TEACH TEACH EDUC, V23, P944, DOI 10.1016/j.tate.2006.05.003; Tschannen-Moran M, 2011, TEACH TEACH EDUC, V27, P751, DOI 10.1016/j.tate.2010.12.005; van de Vijver FJR, 2013, CONTRIBUTIONS INT PS, P761; Vieluf S, 2013, TEACH TEACH EDUC, V35, P92, DOI 10.1016/j.tate.2013.05.006; Vieluf S, 2011, EXPERTISE IN MATHEMATICS INSTRUCTION: AN INTERNATIONAL PERSPECTIVE, P295, DOI 10.1007/978-1-4419-7707-6_14; Wagner W, 2013, LEARN INSTR, V28, P1, DOI 10.1016/j.learninstruc.2013.03.003; Woolfolk Hoy A., 2006, SELF EFFICACY BELIEF, P117	85	19	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150829	10.1371/journal.pone.0150829	http://dx.doi.org/10.1371/journal.pone.0150829			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TF	26959236	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300078
J	Shapira, S; Novack, L; Bar-Dayan, Y; Aharonson-Daniel, L				Shapira, Stav; Novack, Lena; Bar-Dayan, Yaron; Aharonson-Daniel, Limor			An Integrated and Interdisciplinary Model for Predicting the Risk of Injury and Death in Future Earthquakes	PLOS ONE			English	Article							VULNERABILITY; CRASH	Background A comprehensive technique for earthquake-related casualty estimation remains an unmet challenge. This study aims to integrate risk factors related to characteristics of the exposed population and to the built environment in order to improve communities' preparedness and response capabilities and to mitigate future consequences. Methods An innovative model was formulated based on a widely used loss estimation model (HAZUS) by integrating four human-related risk factors (age, gender, physical disability and socioeconomic status) that were identified through a systematic review and meta-analysis of epidemiological data. The common effect measures of these factors were calculated and entered to the existing model's algorithm using logistic regression equations. Sensitivity analysis was performed by conducting a casualty estimation simulation in a high-vulnerability risk area in Israel. Results the integrated model outcomes indicated an increase in the total number of casualties compared with the prediction of the traditional model; with regard to specific injury levels an increase was demonstrated in the number of expected fatalities and in the severely and moderately injured, and a decrease was noted in the lightly injured. Urban areas with higher populations at risk rates were found more vulnerable in this regard. Conclusion The proposed model offers a novel approach that allows quantification of the combined impact of human-related and structural factors on the results of earthquake casualty modelling. Investing efforts in reducing human vulnerability and increasing resilience prior to an occurrence of an earthquake could lead to a possible decrease in the expected number of casualties.	[Shapira, Stav; Bar-Dayan, Yaron; Aharonson-Daniel, Limor] Ben Gurion Univ Negev, PREPARED Ctr Emergency Response Res, IL-84105 Beer Sheva, Israel; [Shapira, Stav; Bar-Dayan, Yaron; Aharonson-Daniel, Limor] Ben Gurion Univ Negev, Fac Hlth Sci, Leon & Mathilde Recanati Sch Community Hlth Profe, Fac Hlth Sci, Beer Sheva, Israel; [Novack, Lena] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Publ Hlth, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University	Shapira, S (corresponding author), Ben Gurion Univ Negev, PREPARED Ctr Emergency Response Res, IL-84105 Beer Sheva, Israel.; Shapira, S (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Leon & Mathilde Recanati Sch Community Hlth Profe, Fac Hlth Sci, Beer Sheva, Israel.	stavshap@post.bgu.ac.il	Aharonson-Daniel, Limor/F-1998-2012; NOVACK, LENA/AAH-8343-2021	Aharonson-Daniel, Limor/0000-0003-4585-6892; NOVACK, LENA/0000-0003-3748-2632; Shapira, Stav/0000-0001-6258-4935				Aharonson-Daniel L, 2003, INJURY PREV, V9, P156, DOI 10.1136/ip.9.2.156; Alexander David, 2013, PLoS Curr, V5, pe50585b8e6efd1, DOI 10.1371/50585b8e6efd1; [Anonymous], LARG DEADL EARTHQ YE; Applied Technology Council, 1985, ATC13; Boruff BJ, 2005, J COASTAL RES, V21, P932, DOI 10.2112/04-0172.1; Chou YJ, 2004, AM J EPIDEMIOL, V160, P688, DOI 10.1093/aje/kwh270; Cutter S., 2006, HAZARDS VULNERABILIT, P115; Dong ZH, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.03.007; Doocy S, 2013, PLOS CURR, V5; Doocy S, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-5; Doocy Shannon, 2009, Am J Disaster Med, V4, P15; Eguchi RT, 2008, RISK GOV SOC, V14, P135, DOI 10.1007/978-3-540-71158-2_6; FEMA, 2003, HAZUS MH MR4 TECHN M; Finch C, 2010, POPUL ENVIRON, V31, P179, DOI 10.1007/s11111-009-0099-8; Guha-Sapir D., 2015, INT DIS DAT; Hao K, 2014, INT J CARDIOL, V177, P569, DOI 10.1016/j.ijcard.2014.08.127; Harlan SL, 2013, ENVIRON HEALTH PERSP, V121, P197, DOI 10.1289/ehp.1104625; Jaiswal K, 2010, EARTHQ SPECTRA, V26, P1017, DOI 10.1193/1.3480331; Jones AP, 2003, ACCIDENT ANAL PREV, V35, P59, DOI 10.1016/S0001-4575(01)00086-0; KIM K, 1995, ACCIDENT ANAL PREV, V27, P469, DOI 10.1016/0001-4575(95)00001-G; Kircher C. A., 2006, Natural Hazards Review, V7, P45, DOI 10.1061/(ASCE)1527-6988(2006)7:2(45); Lenguerrand E, 2006, ACCIDENT ANAL PREV, V38, P43, DOI 10.1016/j.aap.2005.06.021; Levi T, 2015, NAT HAZARDS, V75, P365, DOI 10.1007/s11069-014-1325-y; Liang NJ, 2001, ANN EMERG MED, V38, P549, DOI 10.1067/mem.2001.118999; Masozera M, 2007, ECOL ECON, V63, P299, DOI 10.1016/j.ecolecon.2006.06.013; Noriega GR, 2012, NAT HAZARDS, V64, P1341, DOI 10.1007/s11069-012-0301-7; Osaki Y, 2001, AM J EPIDEMIOL, V153, P153, DOI 10.1093/aje/153.2.153; Peek-Asa C, 2003, INJ PREV, V9, P62, DOI 10.1136/ip.9.1.62; Porter K., 2008, 14 WORLD C EARTHQUAK, V12, P17; Remo JWF, 2012, NAT HAZARDS, V63, P1055, DOI 10.1007/s11069-012-0206-5; ROCES MC, 1992, B WORLD HEALTH ORGAN, V70, P509; Shapira S, 2015, NAT HAZARDS, V78, P1447, DOI 10.1007/s11069-015-1780-0; Shoaf KI, 1998, DISASTERS, V22, P218, DOI 10.1111/1467-7717.00088; So E., 2011, HUMAN CASUALTIES EAR, P231; Sutton AJAK, 2000, METHODS METAANALYSIS; UN-United Nations, 2015, SEND FRAM DIS RISK R; Wei HH, 2014, 4 INT C BUILD RES SA	37	7	7	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151111	10.1371/journal.pone.0151111	http://dx.doi.org/10.1371/journal.pone.0151111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959647	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300099
J	Courtney, R; Browning, S; Seymour, J				Courtney, Robert; Browning, Sally; Seymour, Jamie			Early Life History of the 'Irukandji' Jellyfish Carukia barnesi	PLOS ONE			English	Article							MORBAKKA-VIRULENTA KISHINOUYE; CARYBDEA-MARSUPIALIS LINNAEUS; AUSTRALIAN BOX JELLYFISH; CNIDARIA CUBOZOA; TRIPEDALIA-CYSTOPHORA; METAMORPHOSIS; MORPHOLOGY; WATERS; CYCLE	Adult medusae of Carukia barnesi were collected near Double Island, North Queensland Australia. From 73 specimens, 8 males and 15 females spawned under laboratory conditions. These gametes were artificially mixed which resulted in fertilized eggs. Post fertilization, most eggs developed to an encapsulated planula stage and then paused for between six days and six months prior to hatching as ciliated planulae. The paused stage planulae were negatively buoyant and adhered to substrate. The first planula was produced six days post fertilization, lacked larval ocelli, remained stationary, or moved very slowly for two days prior to metamorphosis into primary polyps. Mature polyps reproduced through asexual reproduction via lateral budding producing ciliated swimming polyps, which in turn settled and developed into secondary polyps. Medusae production for this species was in the form of monodisc strobilation, which left behind polyps able to continue asexual reproduction.	[Courtney, Robert; Browning, Sally; Seymour, Jamie] James Cook Univ, Australian Inst Trop Hlth & Med, Div Trop Hlth & Med, Cairns, Qld, Australia	James Cook University	Courtney, R (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Div Trop Hlth & Med, Cairns, Qld, Australia.	Robert.Courtney@my.jcu.edu.au		Courtney, Robert/0000-0002-3914-1551	APA Scholarship	APA Scholarship	This project was funded through an APA Scholarship: https://www.education.gov.au/australian-postgraduate-awards to RC.	Arai M.N.A.., 1997, FUNCTIONAL BIOL SCYP; Arneson A. C., 1976, COELENTERATE ECOLOGY, P227, DOI [10.1007/978-1-4757-9724-4_24, DOI 10.1007/978-1-4757-9724-4_24]; Bentlage B, 2012, J NAT HIST, V46, P2595, DOI 10.1080/00222933.2012.717645; Carrette T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084377; Carrette TJ, 2012, DIVING HYPERB MED, V42, P214; Chaousis S, 2014, TOXICON, V80, P17, DOI 10.1016/j.toxicon.2014.01.007; Chiaverano LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077039; Coates MM, 2003, INTEGR COMP BIOL, V43, P542, DOI 10.1093/icb/43.4.542; Courtney R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124256; Courtney R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069369; Crow Gerald L., 2015, Bishop Museum Bulletins in Zoology, V9, P93; Cutress C. E., 1973, P ASS ISLAND MARINE, V9, P25; Fischer AB, 2004, HYDROBIOLOGIA, V530, P331, DOI 10.1007/s10750-004-2658-4; Garm A, 2007, J COMP PHYSIOL A, V193, P547, DOI 10.1007/s00359-007-0211-4; Gordon M, 2004, HYDROBIOLOGIA, V530, P339, DOI 10.1007/s10750-004-2655-7; Gordon MR, 2009, HYDROBIOLOGIA, V616, P87, DOI 10.1007/s10750-008-9594-7; Gordon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031277; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P171, DOI 10.1007/BF00026459; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P181, DOI 10.1007/BF00026460; Jacups SP, 2010, ECOHEALTH, V7, P14, DOI 10.1007/s10393-010-0306-1; Kingsford MJ, 2012, HYDROBIOLOGIA, V690, P257, DOI 10.1007/s10750-012-1041-0; Kinsey BE, 1988, MORE BARNES BOX JELL, P109; Klein SG, 2014, GLOBAL CHANGE BIOL, V20, P28, DOI 10.1111/gcb.12408; Lewis C, 2005, MAR BIOL, V147, P477, DOI 10.1007/s00227-005-1602-0; Lewis C, 2013, ZOOTAXA, V 3737, P473, DOI 10.11646/zootaxa.3737.4.8; Little M, 2003, ANAESTH INTENS CARE, V31, P642, DOI 10.1177/0310057X0303100605; Nickson CP, 2009, ANN EMERG MED, V54, P395, DOI 10.1016/j.annemergmed.2009.03.022; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; Nordstrom K, 2003, P ROYAL SOC LONDON B, V35; Pereira P, 2010, CLIN TOXICOL, V48, P390, DOI 10.3109/15563651003662675; Seymour JE, 2004, MED J AUSTRALIA, V181, P707, DOI 10.5694/j.1326-5377.2004.tb06529.x; SOUTHCOTT R. V., 1967, AUST J ZOOL, V15, P651, DOI 10.1071/ZO9670651; Stangl K, 2002, VIE MILIEU, V52, P131; Straehler-Pohl I, 2005, MAR BIOL, V147, P1271, DOI 10.1007/s00227-005-0031-4; Straehler-Pohl I, 2011, ZOOTAXA, P36; Thomas C S, 2001, Hawaii Med J, V60, P205; Toshino S, 2015, EVOL DEV, V17, P231, DOI 10.1111/ede.12127; Toshino Sho, 2014, Plankton & Benthos Research, V9, P32; Toshino Sho, 2013, Plankton & Benthos Research, V8, P1; Underwood AH, 2007, TOXICON, V49, P1073, DOI 10.1016/j.toxicon.2007.01.014; WERNER B, 1971, NATURE, V232, P582, DOI 10.1038/232582a0; Williamson J.A., 1996, VENOMOUS POISONOUS M; Yamaguchi M., 1980, P11; YAMASU T, 1976, CELL TISSUE RES, V170, P325, DOI 10.1007/BF00219415	44	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151197	10.1371/journal.pone.0151197	http://dx.doi.org/10.1371/journal.pone.0151197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954781	Green Published, Green Accepted, gold			2022-12-27	WOS:000371991300095
J	Goddard, A; Leisewitz, AL; Kjelgaard-Hansen, M; Kristensen, AT; Schoeman, JP				Goddard, Amelia; Leisewitz, Andrew L.; Kjelgaard-Hansen, Mads; Kristensen, Annemarie T.; Schoeman, Johan P.			Excessive Pro-Inflammatory Serum Cytokine Concentrations in Virulent Canine Babesiosis	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; C-REACTIVE PROTEIN; MONOCYTE CHEMOATTRACTANT PROTEIN-1; CHEMOTACTIC PROTEIN-1; RESPIRATORY-DISTRESS; RESPONSE SYNDROME; IMMUNE-RESPONSES; HEMOLYTIC-ANEMIA; SEVERE SEPSIS; PLASMA-LEVELS	Babesia rossi infection causes a severe inflammatory response in the dog, which is the result of the balance between pro-and anti-inflammatory cytokine secretion. The aim of this study was to determine whether changes in cytokine concentrations were present in dogs with babesiosis and whether it was associated with disease outcome. Ninety-seven dogs naturally infected with B. rossi were studied and fifteen healthy dogs were included as controls. Diagnosis of babesiosis was confirmed by polymerase chain reaction and reverse line blot. Blood samples were collected from the jugular vein at admission, prior to any treatment. Cytokine concentrations were assessed using a canine-specific multiplex assay on an automated analyser. Serum concentrations of interleukin (IL)-2, IL-6, IL-8, IL-10, IL-18, granulocyte-macrophage colony stimulating factor (GM-CSF) and monocyte chemotactic protein-1 (MCP-1) were measured. Twelve of the Babesia-infected dogs died (12%) and 85 survived (88%). Babesia-infected dogs were also divided into those that presented within 48 hours from displaying clinical signs, and those that presented more than 48 hours after displaying clinical signs. Cytokine concentrations were compared between the different groups using the Mann-Whitney U test. IL-10 and MCP-1 concentrations were significantly elevated for the Babesia-infected dogs compared to the healthy controls. In contrast, the IL-8 concentration was significantly decreased in the Babesia-infected dogs compared to the controls. Concentrations of IL-6 and MCP-1 were significantly increased in the non-survivors compared to the survivors. Concentrations for IL-2, IL-6, IL-18 and GM-CSF were significantly higher in those cases that presented during the more acute stage of the disease. These findings suggest that a mixed cytokine response is present in dogs with babesiosis caused by B. rossi, and that an excessive pro-inflammatory response may result in a poor outcome.	[Goddard, Amelia; Leisewitz, Andrew L.; Schoeman, Johan P.] Univ Pretoria, Fac Vet Sci, Dept Compan Anim Clin Studies, ZA-0002 Pretoria, South Africa; [Kjelgaard-Hansen, Mads; Kristensen, Annemarie T.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Copenhagen, Denmark; [Kjelgaard-Hansen, Mads] Novo Nordisk AS, Copenhagen, Denmark	University of Pretoria; University of Copenhagen; Novo Nordisk	Goddard, A (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Compan Anim Clin Studies, ZA-0002 Pretoria, South Africa.	amelia.goddard@up.ac.za	Schoeman, Johan/J-6765-2013	Schoeman, Johan/0000-0002-5057-311X; Goddard, Amelia/0000-0002-8415-4802; Kristensen, Annemarie T./0000-0003-3391-4928; Leisewitz, Andrew/0000-0001-8432-9425	Research Development Fund of the University of Pretoria; South African Veterinary Foundation; National Research Foundation	Research Development Fund of the University of Pretoria; South African Veterinary Foundation; National Research Foundation	This work was supported by Research Development Fund of the University of Pretoria (AG)-www.up.ac.za; South African Veterinary Foundation (AG)-www.savf.org.za; and National Research Foundation (JPS)-www.nrf.ac.za.	Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Awandare GA, 2006, J INFECT DIS, V194, P1438, DOI 10.1086/508547; Bazzocchi C, 2003, VET PARASITOL, V117, P73, DOI 10.1016/j.vetpar.2003.07.013; Blackwell TS, 1996, BRIT J ANAESTH, V77, P110, DOI 10.1093/bja/77.1.110; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Brown AL, 2015, EXP PARASITOL, V157, P185, DOI 10.1016/j.exppara.2015.08.002; BURGMANN H, 1995, CLIN IMMUNOL IMMUNOP, V76, P32, DOI 10.1006/clin.1995.1084; Carrigan SD, 2004, CLIN CHEM, V50, P1301, DOI 10.1373/clinchem.2004.032144; Christensen M, 2012, VET J, V194, P332, DOI 10.1016/j.tvjl.2012.05.007; Clark IA, 1998, ANN TROP MED PARASIT, V92, P483, DOI 10.1080/00034989859456; Cox-Singh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020541; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; DeClue AE, 2012, J VET INTERN MED, V26, P624, DOI 10.1111/j.1939-1676.2012.00895.x; Deroost K, 2013, AM J RESP CELL MOL, V48, P589, DOI 10.1165/rcmb.2012-0450OC; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; do Rosario APF, 2012, INT J PARASITOL, V42, P549, DOI 10.1016/j.ijpara.2012.03.010; Duffy AL, 2010, VET CLIN PATH, V39, P302, DOI 10.1111/j.1939-165X.2010.00228.x; Dvir E, 2012, VET PARASITOL, V190, P185, DOI 10.1016/j.vetpar.2012.06.007; Fagiolo E, 2002, AUTOIMMUNITY, V35, P39, DOI 10.1080/08916930290005891; Fransson BA, 2007, J VET EMERG CRIT CAR, V17, P373, DOI 10.1111/j.1476-4431.2006.00203.x; GIMBRONE MA, 1989, SCIENCE, V246, P1601, DOI 10.1126/science.2688092; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; HACK CE, 1989, BLOOD, V74, P1704; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Ioannidis LJ, 2014, PARASITOLOGY, V141, P602, DOI 10.1017/S0031182013001984; JACOBSON LS, 1994, J S AFR VET ASSOC, V65, P134; Kjelgaard-Hansen M, 2011, J VET INTERN MED, V25, P76, DOI 10.1111/j.1939-1676.2010.0642.x; Kjelgaard-Hansen M, 2003, VET CLIN PATH, V32, P81, DOI 10.1111/j.1939-165X.2003.tb00319.x; Kjelgaard-Hansen M, 2010, VET CLIN PATH, V39, P402, DOI 10.1111/j.1939-165X.2010.00276.x; Koster LS, 2009, J S AFR VET ASSOC, V80, P87; Krause PJ, 2007, TRENDS PARASITOL, V23, P605, DOI 10.1016/j.pt.2007.09.005; Loisa P, 2003, ACTA ANAESTH SCAND, V47, P319, DOI 10.1034/j.1399-6576.2003.00004.x; Lourembam SD, 2013, CYTOKINE, V64, P503, DOI 10.1016/j.cyto.2013.08.007; Malaguarnera L, 2002, PARASITE IMMUNOL, V24, P489, DOI 10.1046/j.1365-3024.2002.00485.x; Malaguarnera L, 2002, LANCET INFECT DIS, V2, P472, DOI 10.1016/S1473-3099(02)00344-4; Martin-Vaquero P, 2014, J VET INTERN MED, V28, P1268, DOI 10.1111/jvim.12388; Matijatko V, 2007, VET PARASITOL, V144, P242, DOI 10.1016/j.vetpar.2006.10.004; Matjila PT, 2008, VET PARASITOL, V155, P152, DOI 10.1016/j.vetpar.2008.04.012; Mirghani HA, 2011, J TROP PEDIATRICS, V57, P392, DOI 10.1093/tropej/fmq109; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Fernandes AAM, 2008, CLIN VACCINE IMMUNOL, V15, P650, DOI 10.1128/CVI.00475-07; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Nielsen LN, 2013, VET J, V198, P424, DOI 10.1016/j.tvjl.2013.07.030; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; Noone C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-5; Paim FC, 2013, KOREAN J PARASITOL, V51, P133, DOI 10.3347/kjp.2013.51.1.133; Perry JA, 2011, VET COMP ONCOL, V9, P55, DOI 10.1111/j.1476-5829.2010.00235.x; Rau S, 2007, VET CLIN PATH, V36, P253, DOI 10.1111/j.1939-165X.2007.tb00220.x; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; Schetters TPM, 2009, VET PARASITOL, V162, P7, DOI 10.1016/j.vetpar.2009.02.012; Schoeman JP, 2009, ONDERSTEPOORT J VET, V76, P59; Schoeman JP, 2007, VET PARASITOL, V148, P75, DOI 10.1016/j.vetpar.2007.06.010; Tanaka T, 2012, INT J BIOL SCI, V8, P1227, DOI 10.7150/ijbs.4666; van Dissel JT, 1998, LANCET, V351, P950, DOI 10.1016/S0140-6736(05)60606-X; VANZEE KJ, 1991, J IMMUNOL, V146, P3478; Welzl C, 2001, J S AFR VET ASSOC, V72, P158; Wiinberg B, 2005, J VET INTERN MED, V19, P4, DOI 10.1892/0891-6640(2005)19&lt;4:QAOIAI&gt;2.0.CO;2; Zois NE, 2012, VET J, V192, P106, DOI 10.1016/j.tvjl.2011.05.009; Zygner W, 2015, VET PARASITOL, V211, P23, DOI 10.1016/j.vetpar.2015.04.023; Zygner W, 2014, PARASITOL RES, V113, P1499, DOI 10.1007/s00436-014-3792-1	61	42	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150113	10.1371/journal.pone.0150113	http://dx.doi.org/10.1371/journal.pone.0150113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953797	Green Submitted, gold, Green Published			2022-12-27	WOS:000371991300014
J	Hu, XS; Pu, K; Feng, XQ; Wen, SM; Fu, X; Guo, CH; He, WW				Hu, Xingsheng; Pu, Ke; Feng, Xuqin; Wen, Shimin; Fu, Xi; Guo, Cuihua; He, Wenwu			Role of Gemcitabine and Pemetrexed as Maintenance Therapy in Advanced NSCLC: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							CELL LUNG-CANCER; PACLITAXEL PLUS CARBOPLATIN; PHASE-III; SUPPORTIVE CARE; INDUCTION CHEMOTHERAPY; 2ND-LINE TREATMENT; COST-EFFECTIVENESS; CISPLATIN; BEVACIZUMAB; ERLOTINIB	Background Gemcitabine and pemetrexed have been used as maintenance therapy. However, few systematic reviews and meta-analyses have assessed their effects in the newest studies. This systematic review and meta-analysis were conducted to assess the role of gemcitabine and pemetrexed in the maintenance treatment of non-small-cell lung carcinoma (NSCLC). Methods We performed a literature search using PubMed, EMBASE and Cochrane library databases from their inceptions to September 16, 2015. We also searched the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), and National Comprehensive Cancer Network (NCCN) databases from 2008 to 2015. Two authors independently extracted the data. The Cochrane Collaboration's risk of bias graph was used to assess the risk of bias. The GRADE system was used to assess the grading of evidence, and a meta-analysis was conducted using Stata 11.0 software. Results Eleven randomized controlled trial (RCT) studies were collected. Ten studies were included in the meta-analysis and divided into the following 4 groups: gemcitabine vs. best supportive care (BSC)/observation, pemetrexed vs. BSC/placebo, pemetrexed + bevacizumab vs. bevacizumab and pemetrexed vs. bevacizumab. Gemcitabine exhibited significantly improved progression-free survival (PFS) compared with BSC (hazard ratio (HR) = 0.62, p = 0.000). Pemetrexed exhibited significantly improved PFS (HR = 0.54, p = 0.000) and OS (HR = 0.75, p = 0.000) compared with BSC. Pemetrexed + bevacizumab almost exhibited significantly improved PFS (HR = 0.71, p = 0.051) compared with bevacizumab. Pemetrexed exhibited no improvement in PFS or overall survival (OS) compared with bevacizumab. Regarding the grade, the GRADE system indicated that the gemcitabine group was "MODERATE", the pemetrexed group was "HIGH", and both the pemetrexed + bevacizumab vs. bevacizumab groups and pemetrexed vs. B groups were "LOW". Conclusions Gemcitabine or pemetrexed compared with BSC/observation/placebo significantly improved PFS or OS. Whether pemetrexed + bevacizumab compared with bevacizumab alone significantly improves PFS requires further investigation.	[Hu, Xingsheng; Feng, Xuqin; Wen, Shimin; Fu, Xi; Guo, Cuihua] North Sichuan Med Coll, Clin Coll 2, Nanchong Cent Hosp, Dept Oncol, Nanchong, Peoples R China; [Pu, Ke] DaZhou Coll Chinese Med, Dazhou, Peoples R China; [He, Wenwu] Nanchong Cent Hosp, Dept Cardiothorac Surg, Nanchong, Peoples R China	North Sichuan Medical University; North Sichuan Medical University	He, WW (corresponding author), Nanchong Cent Hosp, Dept Cardiothorac Surg, Nanchong, Peoples R China.	137666745@qq.com						Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Barlesi F, 2014, ANN ONCOL, V25, P1044, DOI 10.1093/annonc/mdu098; Barlesi F, 2013, J CLIN ONCOL, V31, P3004, DOI 10.1200/JCO.2012.42.3749; Behera M, 2012, LUNG CANCER, V77, P331, DOI 10.1016/j.lungcan.2012.03.019; Belani CP, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.7506; Brodowicz T, 2006, LUNG CANCER, V52, P155, DOI 10.1016/j.lungcan.2006.01.006; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Correale P, 2009, CANCER BIOL THER, V8, P497, DOI 10.4161/cbt.8.6.7593; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Emanuel E, 2012, NEW ENGL J MED, V367, P949, DOI 10.1056/NEJMsb1205901; Galetta D, 2015, CLIN LUNG CANCER, V16, P262, DOI 10.1016/j.cllc.2014.12.002; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karayama M, 2013, CANCER CHEMOTH PHARM, V72, P445, DOI 10.1007/s00280-013-2218-6; Learn PA, 2010, J THORAC ONCOL, V5, P1111, DOI 10.1097/JTO.0b013e3181e7c425; Lee CP, 2009, VALUE HEALTH, V12, P80, DOI 10.1111/j.1524-4733.2008.00401.x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Matter-Walstra K, 2012, VALUE HEALTH, V15, P65, DOI 10.1016/j.jval.2011.08.1737; Mubarak N, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-423; Patel JD, 2013, J CLIN ONCOL, V31, P4349, DOI 10.1200/JCO.2012.47.9626; Paz-Ares LG, 2011, J CLIN ONCOL, V29, p18s; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Paz-Ares LG, 2013, J CLIN ONCOL, V31, P2895, DOI 10.1200/JCO.2012.47.1102; Perol M, 2010, ANN ONCOL, V21, P124; Perol M, 2012, J CLIN ONCOL, V30, P3516, DOI 10.1200/JCO.2011.39.9782; Qi WX, 2012, CURR MED RES OPIN, V28, P643, DOI 10.1185/03007995.2012.675880; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Schuiiemann HJ, 2009, GRADE HDB GRADING QU; Socinski MA, 2002, J CLIN ONCOL, V20, P1335, DOI 10.1200/JCO.20.5.1335; Soon YY, 2009, J CLIN ONCOL, V27, P3277, DOI 10.1200/JCO.2008.19.4522; Zhang XJ, 2011, CHEST, V140, P117, DOI 10.1378/chest.10-2745; Zinner RG, 2015, J THORAC ONCOL, V10, P134, DOI 10.1097/JTO.0000000000000366	33	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0149247	10.1371/journal.pone.0149247	http://dx.doi.org/10.1371/journal.pone.0149247			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954503	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300007
J	Kawaguchi, H; Shimada, H; Kodaka, F; Suzuki, M; Shinotoh, H; Hirano, S; Kershaw, J; Inoue, Y; Nakamura, M; Sasai, T; Kobayashi, M; Suhara, T; Ito, H				Kawaguchi, Hiroshi; Shimada, Hitoshi; Kodaka, Fumitoshi; Suzuki, Masayuki; Shinotoh, Hitoshi; Hirano, Shigeki; Kershaw, Jeff; Inoue, Yuichi; Nakamura, Masaki; Sasai, Taeko; Kobayashi, Mina; Suhara, Tetsuya; Ito, Hiroshi			Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density	PLOS ONE			English	Article							HUMAN SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; HUMAN BRAIN; HUMAN MIDBRAIN; TISSUE; AGE; DEGENERATION; POSTMORTEM; EMISSION; SYSTEM	The loss of dopaminergic (DA) neurons in the substantia nigra (SN) is a major pathophysiological feature of patients with Parkinson's disease (PD). As nigral DA neurons contain both neuromelanin (NM) and dopamine transporter (DAT), decreased intensities in both NM-sensitive MRI and DAT PET reflect decreased DA neuronal density. This study demonstrates that a more specific metric for the nigral DA neuronal density can be derived with multimodal MRI and PET. Participants were 11 clinically diagnosed PD patients and 10 age and gender matched healthy controls (HCs). Two quantities, the NM-related index (R-NM) and the binding potential of the radiotracer [F-18] FE-PE2I to DAT (BPND) in SN, were measured for each subject using MRI and PET, respectively. Principal component analysis (PCA) was applied to the multimodal data set to estimate principal components. One of the components, PCP, corresponds to a basis vector oriented in a direction where both BPND and R-NM increase. The ability of BPND, R-NM and PCP to discriminate between HC and PD groups was compared. Correlation analyses between the motor score of the unified Parkinson's disease rating scale and each metric were also performed. PCP, BPND and R-NM for PD patients were significantly lower than those for HCs (F = 16.26, P<0.001; F = 6.05, P = 0.008; F = 7.31, P = 0.034, respectively). The differential diagnostic performance between the HC and PD groups as assessed by the area under the receiver-operating characteristic curve was best for PCP (0.94, 95% CI: 0.66-1.00). A significant negative correlation was found between the motor severity score and PCp (R = -0.70, P<0.001) and R-NM (R = -0.52, P = 0.015), but not for BPND (R = -0.36, P = 0.110). PCA of multimodal NM-sensitive MRI and DAT PET data provides a metric for nigral DA neuronal density that will help illuminate the pathophysiology of PD in SN. Further studies are required to explore whether PCA is useful for other parkinsonian syndromes.	[Kawaguchi, Hiroshi; Kershaw, Jeff; Ito, Hiroshi] Natl Inst Radiol Sci, Mol Imaging Ctr, Biophys Program, Inage Ku, 4-9-1 Anagawa, Chiba 260, Japan; [Kawaguchi, Hiroshi] Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki, Japan; [Shimada, Hitoshi; Kodaka, Fumitoshi; Suzuki, Masayuki; Shinotoh, Hitoshi; Hirano, Shigeki; Suhara, Tetsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Neuroimaging Program, Inage Ku, 4-9-1 Anagawa, Chiba 260, Japan; [Kodaka, Fumitoshi] Jikei Univ, Sch Med, Dept Psychiat, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo, Japan; [Inoue, Yuichi; Nakamura, Masaki; Sasai, Taeko; Kobayashi, Mina] Neuropsychiat Res Inst, Japan Somnol Ctr, Shinjuku Ku, 91 Benten Cho, Tokyo, Japan; [Ito, Hiroshi] Fukushima Med Univ, Adv Clin Res Ctr, 1 Hikariga Oka, Fukushima, Japan	National Institutes for Quantum Science & Technology; National Institute of Advanced Industrial Science & Technology (AIST); National Institutes for Quantum Science & Technology; Jikei University; Fukushima Medical University	Kawaguchi, H (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Biophys Program, Inage Ku, 4-9-1 Anagawa, Chiba 260, Japan.; Kawaguchi, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki, Japan.	hiroshi.kawaguchi@aist.go.jp	Kawaguchi, Hiroshi/F-8515-2012; Sasai-Sakuma, Taeko/V-7623-2019	Kawaguchi, Hiroshi/0000-0002-1496-2812; SHIMADA, Hitoshi/0000-0002-7139-7178				Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BANNON MJ, 1992, P NATL ACAD SCI USA, V89, P7095, DOI 10.1073/pnas.89.15.7095; Bannon MJ, 1997, NEUROLOGY, V48, P969, DOI 10.1212/WNL.48.4.969; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Enochs WS, 1997, RADIOLOGY, V204, P417, DOI 10.1148/radiology.204.2.9240529; Fazio P, 2015, J NUCL MED, V56, P714, DOI 10.2967/jnumed.114.152421; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Greffard S, 2006, ARCH NEUROL-CHICAGO, V63, P584, DOI 10.1001/archneur.63.4.584; Hall H, 1999, NEUROIMAGE, V9, P108, DOI 10.1006/nimg.1998.0366; HALLIDAY GM, 1990, ANN NEUROL, V27, P373, DOI 10.1002/ana.410270405; Hersch SM, 1997, J COMP NEUROL, V388, P211; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ishikawa A, 2005, IEEE NUCL SCI CONF R, P2497; Ito H, 2008, NEUROIMAGE, V39, P555, DOI 10.1016/j.neuroimage.2007.09.011; Keren NI, 2015, NEUROIMAGE, V113, P235, DOI 10.1016/j.neuroimage.2015.03.020; Kitao S, 2013, NEURORADIOLOGY, V55, P947, DOI 10.1007/s00234-013-1199-9; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Liang CL, 2004, J COMP NEUROL, V473, P97, DOI 10.1002/cne.20098; Ma SY, 1999, J COMP NEUROL, V409, P25, DOI 10.1002/(SICI)1096-9861(19990621)409:1<25::AID-CNE3>3.0.CO;2-E; Matsumoto K, 2006, J NUCL MED, V47, P83; Nakamura K, 2014, NEURAL REGEN RES, V9, P759, DOI 10.4103/1673-5374.131583; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Sasaki M, 2006, NEUROREPORT, V17, P1215, DOI 10.1097/01.wnr.0000227984.84927.a7; Sasaki T, 2012, J NUCL MED, V53, P1065, DOI 10.2967/jnumed.111.101626; Schimanski LA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00026; Schwarz ST, 2011, MOVEMENT DISORD, V26, P1633, DOI 10.1002/mds.23722; Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869; Sulzer D, 2008, J NEUROCHEM, V106, P24, DOI 10.1111/j.1471-4159.2008.05385.x; Suzuki M, 2014, NUCL MED COMMUN, V35, P231, DOI 10.1097/MNM.0000000000000052; Varrone A, 2009, SYNAPSE, V63, P871, DOI 10.1002/syn.20670; Zecca L, 2002, FEBS LETT, V510, P216, DOI 10.1016/S0014-5793(01)03269-0; Zhang W, 2011, NEUROTOX RES, V19, P63, DOI 10.1007/s12640-009-9140-z	34	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151191	10.1371/journal.pone.0151191	http://dx.doi.org/10.1371/journal.pone.0151191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954690	Green Submitted, Green Published, gold			2022-12-27	WOS:000371991300094
J	Omlin, X; Crivelli, F; Heinicke, L; Zaunseder, S; Achermann, P; Riener, R				Omlin, Ximena; Crivelli, Francesco; Heinicke, Lorenz; Zaunseder, Sebastian; Achermann, Peter; Riener, Robert			Effect of Rocking Movements on Respiration	PLOS ONE			English	Article							BLOOD-PRESSURE; ENTRAINMENT; COORDINATION; VENTILATION; RESPONSES; FREQUENCY; SLEEP; HEART	For centuries, rocking has been used to promote sleep in babies or toddlers. Recent research suggested that relaxation could play a role in facilitating the transition from waking to sleep during rocking. Breathing techniques are often used to promote relaxation. However, studies investigating head motions and body rotations showed that vestibular stimulation might elicit a vestibulo-respiratory response, leading to an increase in respiration frequency. An increase in respiration frequency would not be considered to promote relaxation in the first place. On the other hand, a coordination of respiration to rhythmic vestibular stimulation has been observed. Therefore, this study aimed to investigate the effect of different movement frequencies and amplitudes on respiration frequency. Furthermore, we tested whether subjects adapt their respiration to movement frequencies below their spontaneous respiration frequency at rest, which could be beneficial for relaxation. Twenty-one healthy subjects (24-42 years, 12 males) were investigated using an actuated bed, moving along a lateral translation. Following movement frequencies were applied: +30%, +15%, -15%, and -30% of subjects' rest respiration frequency during baseline (no movement). Furthermore, two different movement amplitudes were tested (Amplitudes: 15 cm, 7.5 cm; movement frequency: 0.3 Hz). In addition, five subjects (25-28 years, 2 males) were stimulated with their individual rest respiration frequency. Rocking movements along a lateral translation caused a vestibulo-respiratory adaptation leading to an increase in respiration frequency. The increase was independent of the applied movement frequencies or amplitudes but did not occur when stimulating with subjects' rest respiration frequency. Furthermore, no synchronization of the respiration frequency to the movement frequency was observed. In particular, subjects did not lower their respiration frequency below their resting frequency. Hence, it was not feasible to influence respiration in a manner that might be considered beneficial for relaxation.	[Omlin, Ximena; Crivelli, Francesco; Heinicke, Lorenz; Riener, Robert] ETH, Sensory Motor Syst Lab, Zurich, Switzerland; [Riener, Robert] Univ Zurich, Fac Med, Zurich, Switzerland; [Zaunseder, Sebastian] Tech Univ Dresden, Inst Biomed Engn, Dresden, Germany; [Achermann, Peter] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Achermann, Peter] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Achermann, Peter; Riener, Robert] Univ Zurich, Neurosci Ctr, Zurich, Switzerland; [Achermann, Peter; Riener, Robert] ETH, Zurich, Switzerland; [Achermann, Peter; Riener, Robert] Univ Zurich, Zurich Ctr Interdisciplinary Sleep Res, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva; University of Zurich; Technische Universitat Dresden; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Omlin, X (corresponding author), ETH, Sensory Motor Syst Lab, Zurich, Switzerland.	omlinx@alumni.ethz.ch	Achermann, Peter/N-1215-2014; Zaunseder, Sebastian/AAA-4676-2019	Achermann, Peter/0000-0002-0208-3511; Omlin, Ximena/0000-0003-2508-9956	ETH Zurich Research Grant ETHIIRA [ETH-18 11-1]; NCCR Transfer Projects of the Swiss National Science Foundation [51NF40-1444639]	ETH Zurich Research Grant ETHIIRA; NCCR Transfer Projects of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF))	This project was supported by the ETH Zurich Research Grant ETHIIRA (ETH-18 11-1) (https://www.ethz.ch/en/research/research-promotion/eth-internal-programmes/eth-grants.html) and the NCCR Transfer Projects of the Swiss National Science Foundation (51NF40-1444639) (http://www.snf.ch/en/funding/programmes/national-centres-of-competence-in-research-nccr/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban CD, 1998, J VESTIBUL RES-EQUIL, V8, P7; Bayer L, 2011, CURR BIOL, V21, pR461, DOI 10.1016/j.cub.2011.05.012; BECHBACHE RR, 1977, J PHYSIOL-LONDON, V272, P553, DOI 10.1113/jphysiol.1977.sp012059; BENSON H, 1983, TRENDS NEUROSCI, V6, P281, DOI 10.1016/0166-2236(83)90120-0; BERGER RD, 1986, IEEE T BIO-MED ENG, V33, P900, DOI 10.1109/TBME.1986.325789; BERNASCONI P, 1993, J PHYSIOL-LONDON, V471, P693, DOI 10.1113/jphysiol.1993.sp019923; Bonsignore MR, 1998, MED SCI SPORT EXER, V30, P239, DOI 10.1097/00005768-199802000-00011; BRAMBLE DM, 1983, SCIENCE, V219, P251, DOI 10.1126/science.6849136; Busch V, 2012, PAIN MED, V13, P215, DOI 10.1111/j.1526-4637.2011.01243.x; Camm AJ, 1996, EUR HEART J, V17, P354; Crivelli F, 2014, SOMNOMAT NOVEL DEVIC, P774; Crivelli F, 2015, MED BIOL ENG COMPUT, P1; Ebert D, 2000, EUR J APPL PHYSIOL, V81, P288, DOI 10.1007/s004210050045; HILL AR, 1988, J APPL PHYSIOL, V65, P570, DOI 10.1152/jappl.1988.65.2.570; Jauregui-Renaud K, 2001, NEUROSCI LETT, V298, P17, DOI 10.1016/S0304-3940(00)01731-6; Joseph CN, 2005, HYPERTENSION, V46, P714, DOI 10.1161/01.HYP.0000179581.68566.7d; Krauchi K, 2001, NEUROPSYCHOPHARMACOL, V25, pS92, DOI 10.1016/S0893-133X(01)00315-3; Kuipers NT, 2003, FASEB J, V17, pA823; Monahan KD, 2002, AM J PHYSIOL-REG I, V282, pR689, DOI 10.1152/ajpregu.00568.2001; Montano N, 2009, NEUROSCI BIOBEHAV R, V33, P71, DOI 10.1016/j.neubiorev.2008.07.006; Novak D, 2011, ROBOTICA, V29, P367, DOI 10.1017/S0263574710000184; PERSEGOL L, 1991, J PHYSIOL-PARIS, V85, P38; Rassler B, 2003, EUR J APPL PHYSIOL, V90, P125, DOI 10.1007/s00421-003-0876-5; Rosenthal T, 2001, AM J HYPERTENS, V14, P74, DOI 10.1016/S0895-7061(00)01235-8; SAMMON MP, 1994, J APPL PHYSIOL, V77, P1548, DOI 10.1152/jappl.1994.77.3.1548; Shiba K, 1996, J NEUROPHYSIOL, V76, P2271, DOI 10.1152/jn.1996.76.4.2271; Siegmund GP, 1999, J APPL PHYSIOL, V87, P233, DOI 10.1152/jappl.1999.87.1.233; Singh Savita, 2004, J Assoc Physicians India, V52, P203; Siniaia MS, 1996, BRAIN RES, V736, P160, DOI 10.1016/0006-8993(96)00674-9; Thurrell A, 2003, EXP BRAIN RES, V150, P325, DOI 10.1007/s00221-003-1422-8; VANALPHEN J, 1994, CAN J APPL PHYSIOL, V19, P432, DOI 10.1139/h94-035; Velluti RA, 1997, J SLEEP RES, V6, P61, DOI 10.1046/j.1365-2869.1997.00031.x; Vidaurre C, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/935364; Wolsko PM, 2004, J GEN INTERN MED, V19, P43, DOI 10.1111/j.1525-1497.2004.21019.x; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; YATES BJ, 1993, BRAIN RES, V629, P209, DOI 10.1016/0006-8993(93)91322-J; Yates BJ, 1998, J VESTIBUL RES-EQUIL, V8, P17	37	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150581	10.1371/journal.pone.0150581	http://dx.doi.org/10.1371/journal.pone.0150581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954500	Green Published, Green Accepted, gold			2022-12-27	WOS:000371991300031
J	Di Luca, A; Hamill, RM; Mullen, AM; Slavov, N; Elia, G				Di Luca, Alessio; Hamill, Ruth M.; Mullen, Anne Maria; Slavov, Nikolai; Elia, Giuliano			Comparative Proteomic Profiling of Divergent Phenotypes for Water Holding Capacity across the Post Mortem Ageing Period in Porcine Muscle Exudate	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; VACUUM-PACKAGED PORK; MEAT QUALITY; REFRIGERATED STORAGE; DRIP LOSS; COLOR STABILITY; POST-MORTEM; MU-CALPAIN; STRESS; IDENTIFICATION	Two dimensional Difference Gel Electrophoresis (2-D DIGE) and mass spectrometry were applied to investigate the changes in metabolic proteins that occur over a seven day (day 1, 3 and 7) post mortem ageing period in porcine centrifugal exudate from divergent meat quality phenotypes. The objectives of the research were to enhance our understanding of the phenotype (water holding capacity) and search for biomarkers of this economically significant pork quality attribute. Major changes in protein abundance across nine phenotype-by-time conditions were observed. Proteomic patterns were dominated by post mortem ageing timepoint. Using a machine learning algorithm (l1-regularized logistic regression), a model was derived with the ability to discriminate between high drip and low drip phenotypes using a subset of 25 proteins with an accuracy of 63%. Models discriminating between divergent phenotypes with accuracy of 72% and 73% were also derived comparing respectively, high drip plus intermediate phenotype (considered as one phenotype) versus low drip and comparing low drip plus intermediate phenotype (considered as one phenotype) versus high drip. In all comparisons, the general classes of discriminatory proteins identified include metabolic enzymes, stress response, transport and structural proteins. In this research we have enhanced our understanding of the protein related processes underpinning this phenotype and provided strong data to work toward development of protein biomarkers for water holding capacity.	[Di Luca, Alessio; Hamill, Ruth M.; Mullen, Anne Maria] TEAGASC, Food Res Ctr, Dublin 15, Ireland; [Slavov, Nikolai] Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA; [Elia, Giuliano] UCD Conway Inst Biomol & Biomed Res, Mass Spectrometry Resource, Dublin 4, Ireland	Teagasc; Northeastern University	Hamill, RM (corresponding author), TEAGASC, Food Res Ctr, Dublin 15, Ireland.	ruth.hamill@teagasc.ie	Elia, Giuliano/H-3438-2011; Elia, Giuliano/P-4725-2019; Hamill, Ruth M/G-3336-2017; Slavov, Nikolai/AAH-9525-2019	Elia, Giuliano/0000-0001-8216-9560; Elia, Giuliano/0000-0002-7941-223X; Hamill, Ruth M/0000-0002-7230-6709; Slavov, Nikolai/0000-0003-2035-1820; Mullen, Anne Maria/0000-0003-1769-0768	Irish National Development Plan through the Food Institutional Research Measure of the Department of Food Agriculture; Marine [06RDNUIG470]	Irish National Development Plan through the Food Institutional Research Measure of the Department of Food Agriculture; Marine	This research was funded through the Irish National Development Plan through the Food Institutional Research Measure of the Department of Food Agriculture and the Marine, Project 06RDNUIG470. URL: http://www.agriculture.gov.ie/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Paula Reid for assistance with statistical analysis, Dr Peadar Lawlor for supply of animals. Access to and use of instrumentation of the UCD Conway Mass Spectrometry Resource is gratefully acknowledged. This research was funded through the Irish National Development Plan through the Food Institutional Research Measure of the Department of Food Agriculture and the Marine, Project 06RDNUIG470.	Adzitey F., 2011, International Food Research Journal, V18, P11; Almgren CM, 1999, J VASC RES, V36, P363, DOI 10.1159/000025675; Apple JK, 2002, J MUSCLE FOODS, V13, P103, DOI 10.1111/j.1745-4573.2002.tb00324.x; Apple JK, 2001, MEAT SCI, V57, P43, DOI 10.1016/S0309-1740(00)00075-9; Au Y, 2004, CELL MOL LIFE SCI, V61, P3016, DOI 10.1007/s00018-004-4282-x; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; BENDALL JR, 1988, MEAT SCI, V24, P85, DOI 10.1016/0309-1740(88)90052-6; Bernard C, 2007, J AGR FOOD CHEM, V55, P5229, DOI 10.1021/jf063372l; Bernevic B, 2011, INT J MASS SPECTROM, V305, P217, DOI 10.1016/j.ijms.2010.11.010; Bhattacharyya S, 2004, NEOPLASIA, V6, P674, DOI 10.1593/neo.04262; Bjarnadottir SG, 2010, J AGR FOOD CHEM, V58, P7408, DOI 10.1021/jf100697h; BOLES JA, 1992, J ANIM SCI, V70, P454, DOI 10.2527/1992.702454x; BOLES JA, 1991, J ANIM SCI, V69, P2865, DOI 10.2527/1991.6972865x; BOUTON PE, 1971, J FOOD SCI, V36, P435, DOI 10.1111/j.1365-2621.1971.tb06382.x; CRICHTON RR, 1987, EUR J BIOCHEM, V164, P485, DOI 10.1111/j.1432-1033.1987.tb11155.x; Di Luca A, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-9; Di Luca A, 2013, PROTEOMICS, V13, P1528, DOI 10.1002/pmic.201200145; Di Luca A, 2011, MEAT SCI, V88, P261, DOI 10.1016/j.meatsci.2010.12.033; DWORNICZAK B, 1987, NUCLEIC ACIDS RES, V15, P5181, DOI 10.1093/nar/15.13.5181; Geesink GH, 1999, J ANIM SCI, V77, P2685; Golenhofen N, 2004, HISTOCHEM CELL BIOL, V122, P415, DOI 10.1007/s00418-004-0711-z; Gonzalez B, 2000, PFLUG ARCH EUR J PHY, V440, P42, DOI 10.1007/s004240051020; Honikel KO, 1998, MEAT SCI, V49, P447, DOI 10.1016/S0309-1740(98)00034-5; Huff-Lonergan E, 2007, J ANIM BREED GENET, V124, P19, DOI 10.1111/j.1439-0388.2007.00683.x; Huff-Lonergan E, 2005, MEAT SCI, V71, P194, DOI 10.1016/j.meatsci.2005.04.022; HuffLonergan E, 1996, J ANIM SCI, V74, P993; Hwang IH, 2005, MEAT SCI, V69, P79, DOI 10.1016/j.meatsci.2004.06.019; Jennen DGJ, 2007, J ANIM BREED GENET, V124, P2, DOI 10.1111/j.1439-0388.2007.00681.x; Jessen F, 2002, PROTEOMICS, V2, P32, DOI 10.1002/1615-9861(200201)2:1<32::AID-PROT32>3.3.CO;2-A; Jia X, 2009, J ANIM SCI, V87, P2391, DOI 10.2527/jas.2009-1792; Joo ST, 1999, MEAT SCI, V52, P291, DOI 10.1016/S0309-1740(99)00005-4; Karl J, 2008, CLIN GASTROENTEROL H, V6, P1122, DOI 10.1016/j.cgh.2008.04.021; Karp NA, 2005, PROTEOMICS, V5, P3105, DOI 10.1002/pmic.200500083; Karp NA, 2005, PROTEOMICS, V5, P81, DOI 10.1002/pmic.200400881; KAUFFMAN RG, 1993, MEAT SCI, V34, P283, DOI 10.1016/0309-1740(93)90078-V; Kazemi S, 2011, FOOD BIOPROCESS TECH, V4, P102, DOI 10.1007/s11947-009-0201-3; Kemp CM, 2012, MEAT SCI, V92, P252, DOI 10.1016/j.meatsci.2012.03.013; Koh KM, 2007, J MACH LEARN RES, V8, P1519; Lametsch R, 2004, MEAT SCI, V68, P515, DOI 10.1016/j.meatsci.2004.03.018; Lametsch R, 2003, J AGR FOOD CHEM, V51, P6992, DOI 10.1021/jf034083p; Lametsch R, 2002, J AGR FOOD CHEM, V50, P5508, DOI 10.1021/jf025555n; Lametsch R, 2001, J AGR FOOD CHEM, V49, P4531, DOI 10.1021/jf010103g; Laville E, 2009, J AGR FOOD CHEM, V57, P10755, DOI 10.1021/jf901949r; Laville E, 2009, J AGR FOOD CHEM, V57, P4913, DOI 10.1021/jf900286x; Lawson MA, 2004, MEAT SCI, V68, P559, DOI 10.1016/j.meatsci.2004.05.019; Li JN, 2002, CLIN CHEM, V48, P1296; Lindahl G, 2006, MEAT SCI, V72, P603, DOI 10.1016/j.meatsci.2005.09.018; Liu YF, 2006, FRONT BIOSCI-LANDMRK, V11, P2802, DOI 10.2741/2011; Lomiwes D, 2014, MEAT SCI, V96, P26, DOI 10.1016/j.meatsci.2013.06.008; Lonergan EH, 2010, MEAT SCI, V86, P184, DOI 10.1016/j.meatsci.2010.05.004; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Maribo H, 1998, MEAT SCI, V50, P115, DOI 10.1016/S0309-1740(98)00022-9; Melody JL, 2004, J ANIM SCI, V82, P1195; Morrison EH, 1998, MEAT SCI, V50, P91, DOI 10.1016/S0309-1740(98)00019-9; OFFER G, 1983, MEAT SCI, V8, P245, DOI 10.1016/0309-1740(83)90013-X; Ouali A, 2006, MEAT SCI, V74, P44, DOI 10.1016/j.meatsci.2006.05.010; Pearce KL, 2011, MEAT SCI, V89, P111, DOI 10.1016/j.meatsci.2011.04.007; Pulford DJ, 2009, MEAT SCI, V83, P1, DOI 10.1016/j.meatsci.2008.11.008; Ramagli LS, 1985, QUANTITATION MICROGR, P559; Rosenvold K, 2003, MEAT SCI, V63, P199, DOI 10.1016/S0309-1740(02)00071-2; Rowe LJ, 2004, J ANIM SCI, V82, P3254; Sayd T, 2006, J AGR FOOD CHEM, V54, P2732, DOI 10.1021/jf052569v; Shevade SK, 2003, BIOINFORMATICS, V19, P2246, DOI 10.1093/bioinformatics/btg308; TAYLOR RG, 1995, MOL BIOL REP, V21, P71, DOI 10.1007/BF00990974; te Pas MFW, 2013, MEAT SCI, V95, P679, DOI 10.1016/j.meatsci.2012.12.015; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; van de Wiel DFM, 2007, MEAT SCI, V77, P46, DOI 10.1016/j.meatsci.2007.04.017; Warner RD, 1997, MEAT SCI, V45, P339, DOI 10.1016/S0309-1740(96)00116-7; Wilson GG, 1999, J SCI FOOD AGR, V79, P1939, DOI 10.1002/(SICI)1097-0010(199910)79:13<1939::AID-JSFA469>3.3.CO;2-K; Wu W, 2015, FOOD REV INT, V31, P13, DOI 10.1080/87559129.2014.961073; Zhu LG, 2001, J FOOD SCI, V66, P1230	71	21	21	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150605	10.1371/journal.pone.0150605	http://dx.doi.org/10.1371/journal.pone.0150605			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950297	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100045
J	Hlushchuk, R; Bronnimann, D; Shokiche, CC; Schaad, L; Triet, R; Jazwinska, A; Tschanz, SA; Djonov, V				Hlushchuk, Ruslan; Broennimann, Daniel; Shokiche, Carlos Correa; Schaad, Laura; Triet, Ramona; Jazwinska, Anna; Tschanz, Stefan A.; Djonov, Valentin			Zebrafish Caudal Fin Angiogenesis Assay-Advanced Quantitative Assessment Including 3-Way Correlative Microscopy	PLOS ONE			English	Article							ANIMAL-MODELS; TUMOR; REGENERATION; MECHANISMS; INHIBITOR; EVOLUTION	Background Researchers evaluating angiomodulating compounds as a part of scientific projects or preclinical studies are often confronted with limitations of applied animal models. The rough and insufficient early-stage compound assessment without reliable quantification of the vascular response counts, at least partially, to the low transition rate to clinics. Objective To establish an advanced, rapid and cost-effective angiogenesis assay for the precise and sensitive assessment of angiomodulating compounds using zebrafish caudal fin regeneration. It should provide information regarding the angiogenic mechanisms involved and should include qualitative and quantitative data of drug effects in a non-biased and time-efficient way. Approach & Results Basic vascular parameters (total regenerated area, vascular projection area, contour length, vessel area density) were extracted from in vivo fluorescence microscopy images using a stereological approach. Skeletonization of the vasculature by our custom-made software Skelios provided additional parameters including "graph energy" and "distance to farthest node". The latter gave important insights into the complexity, connectivity and maturation status of the regenerating vascular network. The employment of a reference point (vascular parameters prior amputation) is unique for the model and crucial for a proper assessment. Additionally, the assay provides exceptional possibilities for correlative microscopy by combining in vivo-imaging and morphological investigation of the area of interest. The 3-way correlative microscopy links the dynamic changes in vivo with their structural substrate at the subcellular level. Conclusions The improved zebrafish fin regeneration model with advanced quantitative analysis and optional 3-way correlative morphology is a promising in vivo angiogenesis assay, well-suitable for basic research and preclinical investigations.	[Hlushchuk, Ruslan; Broennimann, Daniel; Shokiche, Carlos Correa; Schaad, Laura; Triet, Ramona; Tschanz, Stefan A.; Djonov, Valentin] Univ Bern, Inst Anat, Bern, Switzerland; [Jazwinska, Anna] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland	University of Bern; University of Fribourg	Djonov, V (corresponding author), Univ Bern, Inst Anat, Bern, Switzerland.	djonov@ana.unibe.ch	Hlushchuk, Ruslan/AAE-7872-2022; Jazwinska, Anna/M-8705-2016	Jazwinska, Anna/0000-0003-3881-9284; Djonov, Valentin/0000-0002-5062-1169; Tschanz, Stefan/0000-0003-3880-4437; Hlushchuk, Ruslan/0000-0002-6722-8996; Bronnimann, Daniel/0000-0003-0476-2590	Novartis Foundation for Biomedical Research [13A52]; Swiss National Foundation [31003A_135740]	Novartis Foundation for Biomedical Research; Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was financially supported by Novartis Foundation for Biomedical Research (Grant Nr13A52 to R.H.) and Swiss National Foundation (Grant Nr 31003A_135740 to V.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2006, TRENDS GENET, V22, P473, DOI 10.1016/j.tig.2006.06.011; Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; AUERBACH R, 1991, PHARMACOL THERAPEUT, V51, P1, DOI 10.1016/0163-7258(91)90038-N; Azevedo AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022820; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; Brautigam L, 2013, P NATL ACAD SCI USA, V110, P20057, DOI 10.1073/pnas.1313753110; Cao ZQ, 2010, NAT PROTOC, V5, P1903, DOI 10.1038/nprot.2010.149; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; de Smet F, 2006, NAT CHEM BIOL, V2, P228, DOI 10.1038/nchembio0506-228; Elagoz S, 2006, PATHOL ONCOL RES, V12, P21, DOI 10.1007/BF02893427; Hlushchuk R, 2008, AM J PATHOL, V173, P1173, DOI 10.2353/ajpath.2008.071131; Hlushchuk R, 2007, MICROCIRCULATION, V14, P813, DOI 10.1080/10739680701370021; Huang CC, 2003, DEV BIOL, V264, P263, DOI 10.1016/j.ydbio.2003.08.016; Iovine MK, 2007, NAT CHEM BIOL, V3, P613, DOI 10.1038/nchembio.2007.36; Jain RK, 1997, NAT MED, V3, P1203, DOI 10.1038/nm1197-1203; Jensen LDE, 2009, P NATL ACAD SCI USA, V106, P18408, DOI 10.1073/pnas.0907608106; Kraljevic S, 2004, EMBO REP, V5, P837, DOI 10.1038/sj.embor.7400236; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Morin-Brureau M, 2012, EPILEPSIA, V53, P64, DOI 10.1111/j.1528-1167.2012.03705.x; Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.1111/j.1582-4934.2006.tb00423.x; Ny A, 2006, EXP CELL RES, V312, P684, DOI 10.1016/j.yexcr.2005.10.018; Painter CA, 2014, METHODS MOL BIOL, V1176, P143, DOI 10.1007/978-1-4939-0992-6_12; Parichy DM, 2006, HEREDITY, V97, P200, DOI 10.1038/sj.hdy.6800867; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Pozzoli O, 2011, ARTERIOSCL THROM VAS, V31, P1589, DOI 10.1161/ATVBAHA.111.226969; Rouhi P, 2010, NAT PROTOC, V5, P1911, DOI 10.1038/nprot.2010.150; Singh M, 2012, NAT BIOTECHNOL, V30, P648, DOI 10.1038/nbt.2286; Weibel E.R., 1979, STEREOLOGICAL METHOD, VI, P1; Wood JM, 2000, CANCER RES, V60, P2178	30	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0149281	10.1371/journal.pone.0149281	http://dx.doi.org/10.1371/journal.pone.0149281			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950851	gold, Green Published			2022-12-27	WOS:000371990100013
J	Jimenez, C; Lopez, MO; Ros, A; Aguilar, A; Menendez, D; Rivas, B; Santana, MJ; Vaca, MA; Escuin, F; Madero, R; Selgas, R				Jimenez, Carlos; Ovidia Lopez, Maria; Ros, Amaia; Aguilar, Ana; Menendez, David; Rivas, Begona; Jose Santana, Maria; Antonio Vaca, Marco; Escuin, Fernando; Madero, Rosario; Selgas, Rafael			The Natural History of Kidney Graft Cortical Microcirculation Determined by Real-Time Contrast-Enhanced Sonography (RT-CES)	PLOS ONE			English	Article							CHRONIC ALLOGRAFT NEPHROPATHY; RENAL-TRANSPLANTATION; RESISTIVE INDEX; ULTRASOUND; DAMAGE; PERFUSION; ANTIBODY; DYSFUNCTION; DIAGNOSIS; SURVIVAL	Background Kidney transplantation is the therapy of choice for end-stage kidney disease. Graft's life span is shorter than expected due in part to the delayed diagnosis of various complications, specifically those related to silent progression. It is recognized that serum creatinine levels and proteinuria are poor markers of mild kidney lesions, which results in delayed clinical information. There are many investigation looking for early markers of graft damage. Decreasing kidney graft cortical microcirculation has been related to poor prognosis in kidney transplantation. Cortical capillary blood flow (CCBF) can be measured by real-time contrast-enhanced sonography (RT-CES). Our aim was to describe the natural history of CCBF over time under diverse conditions of kidney transplantation, to explore the influence of donor conditions and recipient events, and to determine the capacity of CCBF for predicting renal function in medium term. Patients and Methods RT-CES was performed in 79 consecutive kidney transplant recipients during the first year under regular clinical practice. Cortical capillary blood flow was measured. Clinical variables were analyzed. The influence of CCBF has been determined by univariate and multivariate analysis using mixed regression models based on sequential measurements for each patient over time. We used a first-order autoregression model as the structure of the covariation between measures. The post-hoc comparisons were considered using the Bonferroni correction. Results The CCBF values varied significantly over the study periods and were significantly lower at 48 h and day 7. Brain-death donor age and CCBF levels showed an inverse relationship (r: -0.62, p < 0.001). Living donors showed higher mean CCBF levels than brain-death donors at each point in the study. These significant differences persisted at month 12 (54.5 +/- 28.2 vs 33.7 +/- 30 dB/sec, living vs brain-death donor, respectively, p = 0.004) despite similar serum creatinine levels (1.5 +/- 0.3 and 1.5 +/- 0.5 mg/dL). A sole rejection episode was associated with lower overall CCBF values over the first year. CCBF defined better than level of serum creatinine the graft function status at medium-term. Conclusion RT-CES is a non-invasive tool that can quantify and iteratively estimate cortical microcirculation. We have described the natural history of cortical capillary blood flow under regular clinical conditions.	[Jimenez, Carlos; Ovidia Lopez, Maria; Aguilar, Ana; Menendez, David; Rivas, Begona; Jose Santana, Maria; Antonio Vaca, Marco; Escuin, Fernando; Selgas, Rafael] Univ Hosp La Paz, Dept Nephrol, Res Unit, IdiPAZ,IRSIN,REDinREN, Madrid, Spain; [Ros, Amaia] Univ Hosp Donostia, Dept Nephrol, Donostia San Sebastian, Spain; [Madero, Rosario] Univ Hosp La Paz, Dept Biostat, Madrid, Spain	Hospital Universitario La Paz; University Hospital Donostia; Hospital Universitario La Paz	Jimenez, C (corresponding author), Univ Hosp La Paz, Dept Nephrol, Res Unit, IdiPAZ,IRSIN,REDinREN, Madrid, Spain.	cjmartin@salud.madrid.org	Menendez, David/GQP-6429-2022	Jimenez, Carlos/0000-0002-9680-3259; Menendez Gonzalez, David/0000-0003-1352-173X; Lopez-Oliva, Maria Ovidia/0000-0003-3503-3518	Genzyme; Novartis	Genzyme(Sanofi-AventisGenzyme Corporation); Novartis(Novartis)	Funded by Genzyme and Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Benozzi L, 2009, TRANSPL P, V41, P1214, DOI 10.1016/j.transproceed.2009.03.029; Correas Jean-Michel, 2006, Ultrasound Q, V22, P53; Cosio FG, 2005, AM J TRANSPLANT, V5, P2464, DOI 10.1111/j.1600-6143.2005.01050.x; Fischer T, 2006, NEPHROL DIAL TRANSPL, V21, P2921, DOI 10.1093/ndt/gfl313; Halloran PF, 1999, J AM SOC NEPHROL, V10, P167; Hariharan S, 2006, NAT CLIN PRACT NEPHR, V2, P190, DOI 10.1038/ncpneph0150; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; Hidalgo LG, 2009, AM J TRANSPLANT, V9, P2532, DOI 10.1111/j.1600-6143.2009.02800.x; Jakobsen JA, 2005, EUR RADIOL, V15, P941, DOI 10.1007/s00330-004-2601-0; Jimenez C, 2007, J AM SOC NEPHROL; Jimenez C, 2008, J ULTRAS MED, V27, P1607, DOI 10.7863/jum.2008.27.11.1607; Kihm LP, 2012, TRANSPLANTATION, V93, P1125, DOI 10.1097/TP.0b013e31824f3dae; Kihm LP, 2009, TRANSPLANTATION, V88, P261, DOI 10.1097/TP.0b013e3181ac8cdd; Lebkowska U, 2009, TRANSPL P, V41, P3024, DOI 10.1016/j.transproceed.2009.08.023; Ma F, 2012, NEPHROL DIAL TRANSPL, V27, P2891, DOI 10.1093/ndt/gfr789; McArthur C, 2012, CLIN RADIOL, V67, P909, DOI 10.1016/j.crad.2012.01.017; Naesens M, 2013, NEW ENGL J MED, V369, P1797, DOI 10.1056/NEJMoa1301064; Nankivell BJ, 2011, LANCET, V378, P1428, DOI 10.1016/S0140-6736(11)60699-5; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Piscaglia F, 2006, ULTRASOUND MED BIOL, V32, P1369, DOI 10.1016/j.ultrasmedbio.2006.05.031; Roufosse CA, 2012, TRANSPLANTATION, V94, P269, DOI 10.1097/TP.0b013e31825774ab; Salvadori M, 2006, TRANSPLANTATION, V81, P202, DOI 10.1097/01.tp.0000188135.04259.2e; Sanchez-Fructuoso AI, 2000, J AM SOC NEPHROL, V11, P350, DOI 10.1681/ASN.V112350; Schwenger V, 2006, AM J TRANSPLANT, V6, P609, DOI 10.1111/j.1600-6143.2005.01224.x; Seron D, 2007, KIDNEY INT, V72, P690, DOI 10.1038/sj.ki.5002396; Sis B, 2012, AM J TRANSPLANT, V12, P1168, DOI 10.1111/j.1600-6143.2011.03931.x; Wei K, 2001, J AM COLL CARDIOL, V37, P1135, DOI 10.1016/S0735-1097(00)01210-9; Wiebe C, 2012, AM J TRANSPLANT, V12, P1157, DOI 10.1111/j.1600-6143.2012.04013.x; Wong MG, 2008, J AM SOC NEPHROL, V19, P290, DOI 10.1681/ASN.2007020226	30	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150384	10.1371/journal.pone.0150384	http://dx.doi.org/10.1371/journal.pone.0150384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26949940	gold, Green Published, Green Submitted			2022-12-27	WOS:000371990100033
J	Koler, M; Frank, V; Amartely, H; Friedler, A; Vaknin, A				Koler, Moriah; Frank, Vered; Amartely, Hadar; Friedler, Assaf; Vaknin, Ady			Dynamic Clustering of the Bacterial Sensory Kinase BaeS	PLOS ONE			English	Article							SPY GENE-EXPRESSION; ESCHERICHIA-COLI; STRESS; RESISTANCE; MULTIDRUG; PROTEIN; TRANSCRIPTION; SYSTEMS	Several bacterial sensory-kinase receptors form clusters on the cell membrane. However, the dynamics of sensory-kinase clustering are largely unclear. Using measurements of fluorescence anisotropy and time-lapse imaging of Escherichia coli cells, we demonstrate that copper ions trigger self-association of BaeS receptors and lead to rapid formation of clusters, which can be reversibly dispersed by a metal chelator. Copper ions did not trigger self-association of other fluorescently tagged sensory kinases, and other divalent metal ions could not elicit self-association of BaeS. The histidine residues in the BaeS periplasmic domain are essential for copper binding in vitro and are important for the copper-induced BaeS responses in vivo. BaeS clustering was triggered also under conditions that directly triggered BaeS-dependent transcriptional responses. Thus, clustering of sensory kinase receptors can be dynamic and context dependent and can be triggered by specific environmental cues.	[Koler, Moriah; Frank, Vered; Vaknin, Ady] Hebrew Univ Jerusalem, Racah Inst Phys, Safra Campus, IL-91904 Jerusalem, Israel; [Amartely, Hadar; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, Safra Campus, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Vaknin, A (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, Safra Campus, IL-91904 Jerusalem, Israel.	avaknin@phys.huji.ac.il			Minerva Center for Bio-Hybrid Complex Systems; German-Israel cooperation DIP grant; Israel Science foundation; European Research Council under the European Community's Seventh Framework Program (FP7)/ERC Grant [203413]; Dalia and Dan Maydan Fellowship	Minerva Center for Bio-Hybrid Complex Systems; German-Israel cooperation DIP grant; Israel Science foundation(Israel Science Foundation); European Research Council under the European Community's Seventh Framework Program (FP7)/ERC Grant(European Research Council (ERC)); Dalia and Dan Maydan Fellowship	This study was supported by The Minerva Center for Bio-Hybrid Complex Systems (http://www.minerva.mpg.de/minerva_centers/center_12.html); The German-Israel cooperation DIP grant (http://www.dfg.de/en/research_funding/announcements_proposals/2011/info_wissenschaft_11_47/index.html); The Israel Science foundation (http://www.isf.org.il); The European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC Grant agreement no 203413 (https://erc.europa.eu/funding-and-grants/fundingschemes/starting-grants); The Dalia and Dan Maydan Fellowship for advanced degree students at the Hebrew University of Jerusalem.	ADLER J, 1967, J GEN MICROBIOL, V46, P175, DOI 10.1099/00221287-46-2-175; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P113, DOI 10.1016/j.mib.2010.02.003; Calabrese MF, 2008, NAT STRUCT MOL BIOL, V15, P965, DOI 10.1038/nsmb.1483; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Cliff MJ, 2004, J MOL RECOGNIT, V17, P513, DOI 10.1002/jmr.714; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FORST S, 1989, P NATL ACAD SCI USA, V86, P6052, DOI 10.1073/pnas.86.16.6052; Frank V, 2013, MOL MICROBIOL, V88, P634, DOI 10.1111/mmi.12215; Fukushima T, 2008, MOL MICROBIOL, V69, P621, DOI 10.1111/j.1365-2958.2008.06308.x; Vescovi EG, 2010, CURR OPIN MICROBIOL, V13, P210, DOI 10.1016/j.mib.2009.12.012; Goldberg SD, 2010, P NATL ACAD SCI USA, V107, P8141, DOI 10.1073/pnas.1003166107; Guerrero P, 2012, ARCH MICROBIOL, V194, P453, DOI 10.1007/s00203-011-0779-5; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Leblanc SKD, 2011, J BACTERIOL, V193, P3367, DOI 10.1128/JB.01534-10; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Nishino K, 2007, J BACTERIOL, V189, P9066, DOI 10.1128/JB.01045-07; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Quaranta D, 2009, J BACTERIOL, V191, P5304, DOI 10.1128/JB.00551-09; Raffa RG, 2002, MOL MICROBIOL, V45, P1599, DOI 10.1046/j.1365-2958.2002.03112.x; Rahimi Y, 2007, ANAL BIOCHEM, V370, P60, DOI 10.1016/j.ab.2007.05.018; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Scheu P, 2008, MICROBIOL-SGM, V154, P2463, DOI 10.1099/mic.0.2008/018614-0; Sommer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077708; Srivastava SK, 2014, GENE, V548, P142, DOI 10.1016/j.gene.2014.07.003; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Thakur AK, 2011, J BIOL CHEM, V286, P38533, DOI 10.1074/jbc.M111.265645; Tsokos CG, 2011, DEV CELL, V20, P329, DOI 10.1016/j.devcel.2011.01.007; Vaknin A, 2006, P NATL ACAD SCI USA, V103, P592, DOI 10.1073/pnas.0510047103; Vaknin A, 2007, J MOL BIOL, V366, P1416, DOI 10.1016/j.jmb.2006.12.024; Wang D, 2013, METALLOMICS, V5, P372, DOI 10.1039/c3mt20217h; Wu K, 2011, J BIOL CHEM, V286, P2587, DOI 10.1074/jbc.M110.188664; Yagur-Kroll S, 2010, MICROB BIOTECHNOL, V3, P300, DOI 10.1111/j.1751-7915.2009.00149.x; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Yamamoto K, 2008, J BIOTECHNOL, V133, P196, DOI 10.1016/j.jbiotec.2007.08.002; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	41	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150349	10.1371/journal.pone.0150349	http://dx.doi.org/10.1371/journal.pone.0150349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950881	Green Submitted, gold, Green Published			2022-12-27	WOS:000371990100031
J	Du, L; Cai, CP; Wu, S; Zhang, F; Hou, S; Guo, WZ				Du, Lei; Cai, Caiping; Wu, Shuang; Zhang, Fang; Hou, Sen; Guo, Wangzhen			Evaluation and Exploration of Favorable QTL Alleles for Salt Stress Related Traits in Cotton Cultivars (G-hirsutum L.)	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM; SUPEROXIDE-DISMUTASE; ASSOCIATION ANALYSIS; TOLERANCE; QUALITY; DISEQUILIBRIUM; SELECTION; SOFTWARE	Soil salinization is one of the major problems in global agricultural production. Cotton is a pioneer crop with regard to salt stress tolerance, and can be used for saline-alkali land improvement. The large-scale detection of salt tolerance traits in cotton accessions, and the identification of elite quantitative trait loci (QTLs)/genes for salt-tolerance have been very important in salt tolerance breeding. Here, 43 advanced salt-tolerant and 31 highly salt-sensitive cultivars were detected by analyzing ten salt tolerance related traits in 304 upland cotton cultivars. Among them, 11 advanced salt-tolerance and eight highly salt-sensitive cultivars were consistent with previously reported results. Association analysis of ten salt-tolerance related traits and 145 SSRs was performed, and a total of 95 significant associations were detected; 17, 41, and 37 of which were associated with germinative index, seedling stage physiological index, and four seedling stage biochemical indexes, respectively. Of these associations, 20 SSR loci were simultaneously associated with two or more traits. Furthermore, we detected 117 elite alleles associated with salt-tolerance traits, 4 of which were reported previously. Among these loci, 44 (37.60%) were rare alleles with a frequency of less than 5%, 6 only existed in advanced salt-tolerant cultivars, and 2 only in highly salt-sensitive cultivars. As a result, 13 advanced salt-tolerant cultivars were selected to assemble the optimal cross combinations by computer simulation for the development of salt-tolerant accessions. This study lays solid foundations for further improvements in cotton salt-tolerance by referencing elite germplasms, alleles associated with salt-tolerance traits, and optimal crosses.	[Du, Lei; Cai, Caiping; Wu, Shuang; Zhang, Fang; Hou, Sen; Guo, Wangzhen] Nanjing Agr Univ, Minist Educ, Hybrid Cotton R&D Engn Res Ctr, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Guo, WZ (corresponding author), Nanjing Agr Univ, Minist Educ, Hybrid Cotton R&D Engn Res Ctr, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.	moelab@njau.edu.cn			National Transgenic Program [2011ZX08005-004]; Key R AMP; D program in Jiangsu Province [BE2015360]; Priority Academic Program Development of Jiangsu Higher Education Institutions [010-809001]; Jiangsu Collaborative Innovation Center for Modern Crop Production [10]	National Transgenic Program; Key R AMP; D program in Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Collaborative Innovation Center for Modern Crop Production	This program was financially supported in part by the National Transgenic Program (2011ZX08005-004), Key R & D program in Jiangsu Province (BE2015360), the Priority Academic Program Development of Jiangsu Higher Education Institutions (010-809001) and Jiangsu Collaborative Innovation Center for Modern Crop Production (No. 10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; [白灯莎·买买提艾力 Baidengsha Maimaitiaili], 2011, [新疆农业科学, Xinjiang Agricultural Sciences], V48, P18; [白灯莎·买买提艾力 Baidengsha·Maimaitiaili], 2012, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V21, P72; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bie S, 2012, CHINA COTTON, V6, P25; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Cai CP, 2014, J INTEGR PLANT BIOL, V56, P51, DOI 10.1111/jipb.12124; Chen SY, 1989, CHINESE B BOT, V6, P211; Chen YG, 2013, J ECON ENTOMOL, V106, P1053, DOI 10.1603/EC12178; [戴海芳 Dai Haifang], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P1290; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; GOSSETT DR, 1994, CROP SCI, V34, P706, DOI 10.2135/cropsci1994.0011183X003400030020x; Guo JK, 2007, THESIS XINJIANG AGR; Guo Wang-Zhen, 2005, Acta Genetica Sinica, V32, P1275; Guo WZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-314; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Hair JF., 1979, MULTIVARIATE DATA AN; HEDRICK PW, 1987, GENETICS, V117, P331; Hendry G. A. F., 1993, P154; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Jia YH, 2014, J INTEGR AGR, V13, P1845, DOI 10.1016/S2095-3119(13)60668-1; Leidi EO, 1997, PLANT SOIL, V190, P67, DOI 10.1023/A:1004214825946; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li XiaoFen, 2008, Acta Horticulturae Sinica, V35, P351; Ling QH, 2011, PHOTOSYNTH RES, V107, P209, DOI 10.1007/s11120-010-9606-0; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu YaHui, 2014, Jiangsu Journal of Agricultural Sciences, V30, P219; Mancuso F, 2011, SCHIZOPHR RES, V125, P143, DOI 10.1016/j.schres.2010.11.007; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Muhammad Saeed, 2014, Australian Journal of Crop Science, V8, P338; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Long NV, 2013, THEOR APPL GENET, V126, P2335, DOI 10.1007/s00122-013-2139-0; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Peleman JD, 2003, TRENDS PLANT SCI, V8, P330, DOI 10.1016/S1360-1385(03)00134-1; Peng Zhen, 2014, Acta Agronomica Sinica, V40, P476; Pritchard JK, 2004, DOCUMENTATION STRUCT; Putter J., 1974, METHOD ENZYMAT AN, P567; Saeed Muhammad, 2010, THESIS NANJING AGR U; Stich B, 2005, THEOR APPL GENET, V111, P723, DOI 10.1007/s00122-005-2057-x; Sun X, 2000, ACTA BOT BOREALI-OCC, V20, P1027; Tian J, 2010, ACAD MED, V85, P1518, DOI 10.1097/ACM.0b013e3181eac3fb; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wang G, 2013, SHANDONG AGR SCI, V45, P51; Wang JK, 2007, THEOR APPL GENET, V115, P87, DOI 10.1007/s00122-007-0545-x; Wang JianKang, 2011, Acta Agronomica Sinica, V37, P191, DOI 10.3724/SP.J.1006.2011.00191; Wang JK, 2009, THEOR APPL GENET, V119, P65, DOI 10.1007/s00122-009-1017-2; [辛承松 Xin Chengsong], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P180; Ye WW, 2007, THESIS CHINESE ACAD; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang Guo-wei, 2011, Yingyong Shengtai Xuebao, V22, P2045; Zhang J, 2002, THEOR APPL GENET, V105, P1166, DOI 10.1007/s00122-002-1100-4; Zhang LiNa, 2010, Cotton Science, V22, P175; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	55	33	34	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0151076	10.1371/journal.pone.0151076	http://dx.doi.org/10.1371/journal.pone.0151076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943816	Green Published, Green Submitted, gold			2022-12-27	WOS:000371739400077
J	Adams, MO; Fiedler, K				Adams, Marc-Oliver; Fiedler, Konrad			Low Herbivory among Targeted Reforestation Sites in the Andean Highlands of Southern Ecuador	PLOS ONE			English	Article							LEAF-CUTTING ANTS; ASSOCIATIONAL RESISTANCE; ABANDONED PASTURES; INSECT HERBIVORY; TROPICAL PRIMARY; PLANT DIVERSITY; RAIN-FOREST; TREE; BIODIVERSITY; PLANTATIONS	Insect herbivory constitutes an important constraint in the viability and management of targeted reforestation sites. Focusing on young experimental stands at about 2000 m elevation in southern Ecuador, we examined foliar damage over one season as a function of tree species and habitat. Native tree species (Successional hardwood: Cedrela montana and Tabebuia chrysantha; fast-growing pioneer: Heliocarpus americanus) have been planted among prevailing local landcover types (abandoned pasture, secondary shrub vegetation, and a Pinus patula plantation) in 2003/4. Plantation trees were compared to conspecifics in the spontaneous undergrowth of adjacent undisturbed rainforest matched for height and foliar volume. Specifically, we tested the hypotheses that H. americanus as a pioneer species suffers more herbivory compared to the two successional tree species, and that damage is inversely related to habitat complexity. Overall leaf damage caused by folivorous insects (excluding leafcutter ants) was low. Average leaf loss was highest among T. chrysantha (7.50% +/- 0.19 SE of leaf area), followed by H. americanus (4.67% +/- 0.18 SE) and C. montana (3.18% +/- 0.15 SE). Contrary to expectations, leaf area loss was highest among trees in closed-canopy natural rainforest, followed by pine plantation, pasture, and secondary shrub sites. Harvesting activity of leafcutter ants (Acromyrmex sp.) was strongly biased towards T. chrysantha growing in open habitat (mean pasture: 2.5%; shrub: 10.5%) where it could result in considerable damage (>90.0%). Insect folivory is unlikely to pose a barrier for reforestation in the tropical Andean mountain forest zone at present, but leafcutter ants may become problematic if local temperatures increase in the wake of global warming.	[Adams, Marc-Oliver; Fiedler, Konrad] Univ Vienna, Dept Bot & Biodivers Res, Div Trop Ecol & Anim Biodivers, Vienna, Austria	University of Vienna	Adams, MO (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Div Trop Ecol & Anim Biodivers, Vienna, Austria.	marcoliver.adams@gmail.com	Fiedler, Konrad/H-8788-2019	Fiedler, Konrad/0000-0002-4789-3753	Deutsche Forschungsgemeinschaft DFG [Fi 547/10-2, FOR 816]; Deutsche Forschungsgemeinschaft DFG [Fi 547/10-2, FOR 816]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	Research was funded by the Deutsche Forschungsgemeinschaft DFG (project Fi 547/10-2 within FOR 816). The Ministerio del Ambiente, Loja (Ecuador) granted the required research permit No. 023-2011-IC-FLO-DPL-MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M-O., 2014, THESIS; Adams MO, 2015, BIODIVERS CONSERV, V24, P2709, DOI 10.1007/s10531-015-0958-9; Aguirre N., 2007, THESIS; Aguirre N, 2006, LYONIA, V10, P17; Aguirre N, 2011, TROP FOREST, P513, DOI 10.1007/978-3-642-19986-8_33; [Anonymous], 2006, LYONIA; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bauch S, 2009, J FOREST, V107, P132; Beck E., 2008, V198, P1; Bendix J, 2006, INT J BIOMETEOROL, V50, P370, DOI 10.1007/s00484-006-0029-8; Bendix J., 2013, ECOSYSTEM SERVICES B; Borer ET, 2012, ECOL LETT, V15, P1457, DOI 10.1111/ele.12006; Braeuning A., 2008, V198, P291; Breckle Siegmar-Walter, 2005, Ecotropica (Bonn), V11, P79; Brehm G., 2008, V198, P15; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Brockett CD, 2002, LAT AM RES REV, V37, P7; Bruhl CA, 1999, J TROP ECOL, V15, P265, DOI 10.1017/S0266467499000802; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Chacon G, 2009, SOIL USE MANAGE, V25, P427, DOI 10.1111/j.1475-2743.2009.00233.x; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Cuevas-Reyes P, 2011, J TROP ECOL, V27, P383, DOI 10.1017/S026646741100006X; Davis A.S., 2012, CHALLENGING PARADIGM, P293, DOI [10.1007/978-94-007-5326-6_15, DOI 10.1007/978-94-007-5326-6_15, DOI 10.1007/978-94-007-5326-6_]; Dawson W, 2009, DIVERS DISTRIB, V15, P141, DOI 10.1111/j.1472-4642.2008.00527.x; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; DUDT JF, 1994, ECOLOGY, V75, P86, DOI 10.2307/1939385; Zuazo VHD, 2008, AGRON SUSTAIN DEV, V28, P65, DOI [10.1051/agro:2007062, 10.1007/978-90-481-2666-8_48]; Eichhorn MP, 2010, ECOLOGY, V91, P1092, DOI 10.1890/09-0300.1; Endara MJ, 2011, FUNCT ECOL, V25, P389, DOI 10.1111/j.1365-2435.2010.01803.x; Estrada C, 2013, NEW PHYTOL, V198, P241, DOI 10.1111/nph.12140; Fang X, 2011, CURR ORG CHEM, V15, P1363; Farji-Brener AG, 2001, OIKOS, V92, P169, DOI 10.1034/j.1600-0706.2001.920120.x; Tapia-Armijos MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133701; Garcia-Guzman G, 2001, AM J BOT, V88, P634, DOI 10.2307/2657063; Giffard B, 2013, ECOL ENTOMOL, V38, P448, DOI 10.1111/een.12035; Giffard B, 2012, BASIC APPL ECOL, V13, P458, DOI 10.1016/j.baae.2012.08.004; Gossner MM, 2014, BASIC APPL ECOL, V15, P347, DOI 10.1016/j.baae.2014.03.003; Griess VC, 2011, NEW FOREST, V41, P13, DOI 10.1007/s11056-010-9207-y; Gunter S, 2009, FOREST ECOL MANAG, V258, P81, DOI 10.1016/j.foreco.2009.03.042; Guerra PC, 2010, ARTHROPOD-PLANT INTE, V4, P229, DOI 10.1007/s11829-010-9099-y; GUSTAVO A, 1994, J BIOGEOGR, V21, P391, DOI 10.2307/2845757; Hamer U, 2013, BIOGEOCHEMISTRY, V112, P495, DOI 10.1007/s10533-012-9742-z; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hartig Katja, 2003, Ecotropica (Bonn), V9, P3; Hartley MJ, 2002, FOREST ECOL MANAG, V155, P81, DOI 10.1016/S0378-1127(01)00549-7; Henriksson J, 2003, OIKOS, V103, P3, DOI 10.1034/j.1600-0706.2003.12306.x; Hernandez Y, 2014, SOUTHWEST NAT, V59, P66, DOI 10.1894/F09-JC-67.1; Homeier J., 2008, V198, P87; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Hu┬lldobler B., 2010, LEAFCUTTER ANTS CIVI; Jactel H, 2005, ECOL STUD-ANAL SYNTH, V176, P235; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; JAFFE K, 1989, BIOTROPICA, V21, P234, DOI 10.2307/2388649; Juan-Baeza I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128583; Kost C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022340; Kuptz D, 2010, TREES-STRUCT FUNCT, V24, P117, DOI 10.1007/s00468-009-0385-1; Kursar TA, 2003, BIOCHEM SYST ECOL, V31, P929, DOI 10.1016/S0305-1978(03)00087-5; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Longino JT, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00200.1; Loranger H, 2014, OECOLOGIA, V174, P183, DOI 10.1007/s00442-013-2741-5; MARQUIS RJ, 1984, SCIENCE, V226, P537, DOI 10.1126/science.226.4674.537; Massad TJ, 2011, RESTOR ECOL, V19, P257, DOI 10.1111/j.1526-100X.2010.00683.x; Matt F, 2008, GRADIENTS TROPICAL M; Metcalfe DB, 2014, ECOL LETT, V17, P324, DOI 10.1111/ele.12233; Mody K, 2004, ECOL ENTOMOL, V29, P217, DOI 10.1111/j.1365-2311.2004.0588.x; Moles AT, 2011, FUNCT ECOL, V25, P380, DOI 10.1111/j.1365-2435.2010.01814.x; Montagnini F, 2001, INTERCIENCIA, V26, P498; Montoya-Lerma J, 2012, INT J PEST MANAGE, V58, P225, DOI 10.1080/09670874.2012.663946; MOSANDL, 2008, GRADIENTS TROPICAL M; Muth NZ, 2008, ECOSCIENCE, V15, P182, DOI 10.2980/15-2-3095; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; Onyekwelu JC, 2011, TROP FOREST, P399, DOI 10.1007/978-3-642-19986-8_27; Penuelas J, 2010, J CHEM ECOL, V36, P1255, DOI 10.1007/s10886-010-9862-7; Peters T, 2013, ECOSYSTEM SERVICES B, V221, P19, DOI [10.1007/978-3-642-38137-9_2, DOI 10.1007/978-3-642-38137-9_2]; Piotto D, 2003, FOREST ECOL MANAG, V175, P195, DOI 10.1016/S0378-1127(02)00127-5; Plath M, 2012, OECOLOGIA, V169, P477, DOI 10.1007/s00442-011-2215-6; Plath M, 2011, FOREST ECOL MANAG, V261, P741, DOI 10.1016/j.foreco.2010.12.004; Pringle EG, 2011, BIOTROPICA, V43, P299, DOI 10.1111/j.1744-7429.2010.00697.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rasband WS, 2014, IMAGEJ; Neto JDR, 2012, ENTOMOL EXP APPL, V144, P209, DOI 10.1111/j.1570-7458.2012.01283.x; Ribeiro SP, 2006, J ECOL, V94, P932, DOI 10.1111/j.1365-2745.2006.01133.x; RIBEIRO SP, 1994, BIOTROPICA, V26, P302, DOI 10.2307/2388851; Richter M, 2013, ECOSYSTEM SERVICES B; Riedel J, 2013, J APPL ENTOMOL, V137, P418, DOI 10.1111/jen.12009; Roos K, 2010, INVAS PLANT SCI MANA, V3, P402, DOI 10.1614/IPSM-D-09-00031.1; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schuldt A, 2010, J ECOL, V98, P917, DOI 10.1111/j.1365-2745.2010.01659.x; Stimm B., 2008, V198, P417; Turcotte MM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0555; Vasconcelos HL, 1996, ENTOMOL EXP APPL, V78, P215, DOI 10.1007/BF00187519; Vrac M, 2014, CDFT R PACKAGE VERSI; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wassenaar T, 2007, GLOBAL ENVIRON CHANG, V17, P86, DOI 10.1016/j.gloenvcha.2006.03.007; Weber M., 2008, V198, P431; Xiao Y, 2012, CVM2SL2TEST R PACKAG; Zangerl AR, 2002, P NATL ACAD SCI USA, V99, P1088, DOI 10.1073/pnas.022647099; Zhang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13049	104	1	1	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151277	10.1371/journal.pone.0151277	http://dx.doi.org/10.1371/journal.pone.0151277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963395	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000133
J	Chen, C; Li, DH; Wang, ZG; Li, T; Liu, XW; Zhong, J				Chen, Chen; Li, Donghua; Wang, Zhiguo; Li, Tong; Liu, Xunwei; Zhong, Jian			Safety and Efficacy Studies of Vertebroplasty, Kyphoplasty, and Mesh-Container-Plasty for the Treatment of Vertebral Compression Fractures: Preliminary Report	PLOS ONE			English	Article							PERCUTANEOUS VERTEBROPLASTY; DISC DEGENERATION; RISK-FACTORS; CEMENT; AUGMENTATION; BODY; SPINE	To evaluate the clinical safety and efficacies of percutaneous vertebroplasty (PVP), percutaneous kyphoplasty (PKP), and percutaneous mesh-container-plasty (PMCP) for the treatment of vertebral compression fractures (VCFs), a retrospective study of 90 patients with VCFs who had been treated by PVP (n = 30), PKP (n = 30), and PMCP (n = 30) was conducted. The clinical efficacies of these three treatments were evaluated by comparing their PMMA cement leakages, cement patterns, height restoration percentages, wedge angles, visual analogue scales (VAS), and oswestry disability index (ODI) at the pre- and post-operative time points. 6.67%, 3.33%, and 0% of patients had PMMA leakage in PVP, PKP, and PMCP groups, respectively. Three (solid, trabecular, and mixed patterns), two (solid and mixed patterns), and one (mixed patterns) types of cement patterns were observed in PVP, PKP, and PMCP groups, respectively. PKP and PMCP treatments had better height restoration ability than PVP treatment. PVP, PKP, and PMCP treatments had significant and similar ability in pain relief and functional recovery ability for the treatment of VCFs. These results indicate minimally invasive techniques were effective methods for the treatment of VCFs. Moreover, these initial outcomes suggest PMCP treatment may be better than both PVP treatment and PKP treatment.	[Chen, Chen; Zhong, Jian] Gen Hosp Jinan Command, Dept Orthoped Surg, Jinan 250031, Shandong, Peoples R China; [Li, Donghua] Yuncheng Cty Peoples Hosp, Dept Radiol, Yuncheng 274700, Shandong, Peoples R China; [Wang, Zhiguo; Li, Tong; Liu, Xunwei] Gen Hosp Jinan Command, Dept Med Image, Jinan 250031, Shandong, Peoples R China; [Zhong, Jian] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai 201306, Peoples R China	Shanghai Ocean University	Zhong, J (corresponding author), Gen Hosp Jinan Command, Dept Orthoped Surg, Jinan 250031, Shandong, Peoples R China.; Liu, XW (corresponding author), Gen Hosp Jinan Command, Dept Med Image, Jinan 250031, Shandong, Peoples R China.; Zhong, J (corresponding author), Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai 201306, Peoples R China.	dsa_1989@126.com; jzhong@shou.edu.cn	Zhong, Jian/B-3743-2015	Zhong, Jian/0000-0002-2475-3221	National High Technology Research and Development Program of China (863 Program) [2013AA032203]; National Natural Science Foundation of China [51073173, 51203024]; Jinan Military General Hospital [2012ZX002]; Liaoning Medicial University [QM2014013]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jinan Military General Hospital; Liaoning Medicial University	This research has been supported by research grants from the National High Technology Research and Development Program of China (863 Program 2013AA032203), the National Natural Science Foundation of China (51073173, 51203024), the Director Fund of Jinan Military General Hospital (2012ZX002), and the President Fund of Liaoning Medicial University (QM2014013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2006, J BONE MINER RES, V21, P1409, DOI 10.1359/JBMR.060609; Alkalay RN, 2008, SPINE, V33, P1627, DOI 10.1097/BRS.0b013e31817cf7d1; Chandra RV, 2013, PAIN PHYSICIAN, V16, P309; Ee GWW, 2013, J SPINAL DISORD TECH; Gaitanis Ioannis N, 2005, Spine J, V5, P45, DOI 10.1016/j.spinee.2004.05.248; Galibert P, 1990, Chirurgie, V116, P326; GALIBERT P, 1987, NEUROCHIRURGIE, V33, P166; Garfin SR, 2001, SPINE, V26, P1511, DOI 10.1097/00007632-200107150-00002; Graham J, 2003, J BONE JOINT SURG AM, V85A, P1901, DOI 10.2106/00004623-200310000-00006; Hierholzer J, 2008, CARDIOVASC INTER RAD, V31, P1178, DOI 10.1007/s00270-008-9376-7; Hu Y., 2007, TECH REG ANESTH PAIN, V11, P164; Jensen ME, 1997, AM J NEURORADIOL, V18, P1897; Kim MJ, 2006, SPINE, V31, P2079, DOI 10.1097/01.brs.0000231714.15876.76; Kim YJ, 2010, SKELETAL RADIOL, V39, P757, DOI 10.1007/s00256-009-0866-8; Kim YY, 2010, EUR SPINE J, V19, P1907, DOI 10.1007/s00586-010-1479-6; Lane JI, 2002, AM J NEURORADIOL, V23, P1642; Lieberman IH, 2001, SPINE, V26, P1631, DOI 10.1097/00007632-200107150-00026; Liu Fa-jing, 2012, Orthop Surg, V4, P263, DOI 10.1111/os.12010; Longo UG, 2010, CLIN CASES MINER BON, V7, P109; Lopes NM, 2004, ARQ NEURO-PSIQUIAT, V62, P879, DOI 10.1590/S0004-282X2004000500027; Luo J, 2007, BONE, V40, P1110, DOI 10.1016/j.bone.2006.11.021; Mathis JM, 2001, AM J NEURORADIOL, V22, P373; Nieuwenhuijse MJ, 2011, SPINE J, V11, P839, DOI 10.1016/j.spinee.2011.07.027; Ning L, 2015, PAIN PHYSICIAN, V18, P565; Oka M, 2005, ACAD RADIOL, V12, P992, DOI 10.1016/j.acra.2005.05.003; Old JL, 2004, AM FAM PHYSICIAN, V69, P111; Sidhu GS, 2013, J NEUROSURG-SPINE, V19, P61, DOI 10.3171/2013.4.SPINE12978; SILVERMAN SL, 1992, BONE, V13, pS27, DOI 10.1016/8756-3282(92)90193-Z; Sun G, 2011, EUR RADIOL, V21, P2597, DOI 10.1007/s00330-011-2218-z; Sun HL, 2013, SPINE, V38, pE1628, DOI 10.1097/BRS.0b013e3182a8c488; Tancioni F, 2011, ANN SURG ONCOL, P1; Tzermiadianos MN, 2008, EUR SPINE J, V17, P1522, DOI 10.1007/s00586-008-0775-x; Wang Li-jun, 2012, Orthop Surg, V4, P182, DOI 10.1111/j.1757-7861.2012.00193.x; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6; Zhao YT, 2014, SPINE, V39, pE1616, DOI 10.1097/BRS.0000000000000613	35	15	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151492	10.1371/journal.pone.0151492	http://dx.doi.org/10.1371/journal.pone.0151492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963808	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000159
J	Cleary, GP; Parsons, H; Davis, A; Coleman, BR; Jones, DN; Miller, KK; Weston, MA				Cleary, Grainne P.; Parsons, Holly; Davis, Adrian; Coleman, Bill R.; Jones, Darryl N.; Miller, Kelly K.; Weston, Michael A.			Avian Assemblages at Bird Baths: A Comparison of Urban and Rural Bird Baths in Australia	PLOS ONE			English	Article							BIOTIC HOMOGENIZATION; URBANIZATION; LANDSCAPE; HABITATS; GARDENS; FOOD; ENVIRONMENTS; COMMUNITIES; VEGETATION; ECOLOGY	Private gardens provide habitat and resources for many birds living in human-dominated landscapes. While wild bird feeding is recognised as one of the most popular forms of human-wildlife interaction, almost nothing is known about the use of bird baths. This citizen science initiative explores avian assemblages at bird baths in private gardens in south-eastern Australia and how this differs with respect to levels of urbanisation and bioregion. Overall, 992 citizen scientists collected data over two, four-week survey periods during winter 2014 and summer 2015 (43% participated in both years). Avian assemblages at urban and rural bird baths differed between bioregions with aggressive nectar-eating species influenced the avian assemblages visiting urban bird baths in South Eastern Queensland, NSW North Coast and Sydney Basin while introduced birds contributed to differences in South Western Slopes, Southern Volcanic Plains and Victorian Midlands. Small honeyeaters and other small native birds occurred less often at urban bird baths compared to rural bird baths. Our results suggest that differences between urban versus rural areas, as well as bioregion, significantly influence the composition of avian assemblages visiting bird baths in private gardens. We also demonstrate that citizen science monitoring of fixed survey sites such as bird baths is a useful tool in understanding large-scale patterns in avian assemblages which requires a vast amount of data to be collected across broad areas.	[Cleary, Grainne P.] Natl Pk Assoc New South Wales, POB 337, Newtown, NSW, Australia; [Cleary, Grainne P.; Miller, Kelly K.; Weston, Michael A.] Deakin Univ, Geelong, Vic 3217, Australia; [Cleary, Grainne P.; Miller, Kelly K.; Weston, Michael A.] Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood Campus, Burwood, Vic, Australia; [Parsons, Holly] BirdLife Australia, Sydney Olympic Pk, NSW, Australia; [Davis, Adrian] Univ Sydney, Sch Biol Sci, Bot Annex A13, Sydney, NSW 2006, Australia; [Coleman, Bill R.] Evolve Informat Serv, Level 8, Melbourne, Vic, Australia; [Jones, Darryl N.] Griffith Univ, Environm Futures Res Inst, Nathan, Qld 4111, Australia	Deakin University; University of Sydney; Griffith University	Cleary, GP (corresponding author), Natl Pk Assoc New South Wales, POB 337, Newtown, NSW, Australia.; Cleary, GP (corresponding author), Deakin Univ, Geelong, Vic 3217, Australia.; Cleary, GP (corresponding author), Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood Campus, Burwood, Vic, Australia.	g.cleary@deakin.edu.au	Miller, Kelly K/C-9320-2009	Miller, Kelly K/0000-0003-4360-6232; Jones, Darryl/0000-0002-2565-9456; Weston, Michael/0000-0002-8717-0410	National Parks Association of NSW	National Parks Association of NSW	Grainne P Cleary was funded by National Parks Association of NSW. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Co-author Bill R. Coleman is employed by Evolve Information Services. This author's contribution to the research and the writing of this paper was done in his own time and he did not work on the research or paper during the hours he was working for Evolve. Evolve Information Services provided support in the form of salary for author Coleman, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ainsworth GB, 2016, ORYX, V50, P636, DOI 10.1017/S0030605315000538; Alberti M, 2005, INT REGIONAL SCI REV, V28, P168, DOI 10.1177/0160017605275160; Antos MJ, 2006, AUSTRAL ECOL, V31, P254, DOI 10.1111/j.1442-9993.2006.01572.x; Ashley LC, 2009, EMU, V109, P135, DOI 10.1071/MU07043; Ball AP, 1982, NOTES INFECT DIS; Belaire JA, 2014, ECOL APPL, V24, P2132, DOI 10.1890/13-2259.1; Bezzel E., 1985, Ornis Fennica, V62, P90; Blair RB, 2001, BIOTIC HOMOGENIZATION, P33; Blair RB, 2008, LANDSCAPE ECOL, V23, P1157, DOI 10.1007/s10980-008-9267-y; Burgin Shelley, 2007, P185; Butler CJ, 2005, J AVIAN MED SURG, V19, P142, DOI 10.1647/183; Catterall Carla P., 2004, P21; Clergeau P, 2006, BIOL CONSERV, V127, P336, DOI 10.1016/j.biocon.2005.06.035; Coppedge BR, 2001, ECOL APPL, V11, P47, DOI 10.1890/1051-0761(2001)011[0047:ARTLCI]2.0.CO;2; Davis A, 2015, URBAN ECOSYST, V18, P503, DOI 10.1007/s11252-014-0417-5; Davis A, 2012, LANDSCAPE URBAN PLAN, V106, P191, DOI 10.1016/j.landurbplan.2012.03.005; Davis A, 2011, LANDSCAPE URBAN PLAN, V100, P295, DOI 10.1016/j.landurbplan.2010.12.017; Duncan RP, 2001, J ANIM ECOL, V70, P621, DOI 10.1046/j.1365-2656.2001.00517.x; Epanchin P. N., 2009, AUSTR FIELD ORNITHOL, V91, P2406; Field SA, 2002, AUSTRAL ECOL, V27, P624, DOI 10.1046/j.1442-9993.2002.01223.x; Fraser LH, 2013, FRONT ECOL ENVIRON, V11, P147, DOI 10.1890/110279; French K, 2005, BIOL CONSERV, V121, P545, DOI 10.1016/j.biocon.2004.06.004; Fuller RA, 2008, DIVERS DISTRIB, V14, P131, DOI 10.1111/j.1472-4642.2007.00439.x; Gallien L, 2010, DIVERS DISTRIB, V16, P331, DOI 10.1111/j.1472-4642.2010.00652.x; Gaston K. J, 2010, URBAN ECOLOGY; Gaston KJ, 2005, BIODIVERS CONSERV, V14, P3327, DOI 10.1007/s10531-004-9513-9; Grimm NB, 2000, BIOSCIENCE, V50, P571, DOI 10.1641/0006-3568(2000)050[0571:IATLTO]2.0.CO;2; Higgins P. J., 2001, HDB AUSTR NZ ANTARCT, V5; Hoskin ES, 1991, BIRDS OF SYDNEY; Hunt BG, 2009, INT J CLIMATOL, V29, P1715, DOI 10.1002/joc.1820; Jokimaki J, 1996, J BIOGEOGR, V23, P379, DOI 10.1046/j.1365-2699.1996.00033.x; Lambert MS, 2009, PEST MANAG SCI, V65, P1215, DOI 10.1002/ps.1812; LANCASTER RK, 1979, CAN J ZOOL, V57, P2358, DOI 10.1139/z79-307; Lerman SB, 2011, ECOL APPL, V21, P1327, DOI 10.1890/10-0423.1; Low T., 2002, THE NEW NATURE; Major RE, 2010, EMU, V110, P92, DOI 10.1071/MU09058; Manson P, 1985, CORELLA, V9, P14; Maron M, 2013, DIVERS DISTRIB, V19, P1468, DOI 10.1111/ddi.12128; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Miller KK, 2015, ECOL MANAG RESTOR, V16, P156, DOI 10.1111/emr.12157; Moller AP, 2015, OECOLOGIA, V178, P943, DOI 10.1007/s00442-015-3268-8; Nicholls N., 1997, WINDOWS METEOROLOGY, P118; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Parsons H, 2006, AUSTRAL ECOL, V31, P217, DOI 10.1111/j.1442-9993.2006.01584.x; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Shukuroglou P, 2006, AUSTRAL ECOL, V31, P240, DOI 10.1111/j.1442-9993.2006.01588.x; Sorace A, 2008, ACTA OECOL, V33, P15, DOI 10.1016/j.actao.2007.07.003; Suppiah R, 2007, AUST METEOROL MAG, V56, P131; Taschetto AS, 2009, GEOPHYS RES LETT, V36, DOI [10.1029/2009GL038416, 10.1029/2009GL03 8416]; Tryjanowski P, 2015, ENVIRON SCI POLLUT R, V22, P15097, DOI 10.1007/s11356-015-4723-0; Tryjanowski P, 2015, SCI REP-UK, V5, DOI 10.1038/srep11858; Tulloch AIT, 2013, BIOL CONSERV, V165, P128, DOI 10.1016/j.biocon.2013.05.025; White JG, 2005, LANDSCAPE URBAN PLAN, V71, P123, DOI 10.1016/j.landurbplan.2004.02.006; Woodall Peter F., 1995, Sunbird, V25, P1	54	8	9	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150899	10.1371/journal.pone.0150899	http://dx.doi.org/10.1371/journal.pone.0150899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26962857	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000075
J	Yi, J; Zhu, Y; Jia, Y; Jiang, HD; Zheng, X; Liu, DJ; Gao, SX; Sun, MJ; Hu, B; Jiao, BH; Wang, LH; Wang, KH				Yi, Jun; Zhu, Yan; Jia, Yin; Jiang, Hongdie; Zheng, Xin; Liu, Dejing; Gao, Shunxiang; Sun, Mingjuan; Hu, Bo; Jiao, Binghua; Wang, Lianghua; Wang, Kaihui			The Annexin a2 Promotes Development in Arthritis through Neovascularization by Amplification Hedgehog Pathway	PLOS ONE			English	Article							INHIBITS NEOANGIOGENESIS; TUMOR ANGIOGENESIS; RECEPTOR; EXPRESSION; GROWTH; INDUCTION; AUTOANTIBODIES; HETEROTETRAMER; MIGRATION; ADHESION	The neovascularization network of pannus formation plays a crucial role in the development of rheumatoid arthritis (RA). Annexin a2 (Axna2) is an important mediating agent that induces angiogenesis in vascular diseases. The correlation between Axna2 and pannus formation has not been studied. Here, we provided evidence that compared to osteoarthritis (OA) patients and healthy people, the expression of Axna2 and Axna2 receptor (Axna2R) were up-regulated in patients with RA. Joint swelling, inflammation and neovascularization were increased significantly in mice with collagen-induced arthritis (CIA) that were exogenously added Axna2. Cell experiments showed that Axna2 promoted HUVEC proliferation by binding Axna2R, and could activate Hedgehog (HH) signaling and up-regulate the expression of Ihh and Gli. Besides, expression of Ihh, Patched (Ptc), Smoothened (Smo) and Gli and matrix metalloproteinase-2 (MMP-2), vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2), angiogenic growth factor of HH signaling downstream, were down-regulated after inhibition of expression Axna2R on HUVEC. Together, our research definitely observed that over-expression of Axna2 could promote the development of CIA, especially during the process of pannus formation for the first time. Meanwhile, Axna2 depended on combining Axna2R to activate and enlarge HH signaling and the expression of its downstream VEGF, Ang-2 and MMP-2 to promote HUVEC proliferation, and eventually caused to angiogenesis. Therefore, the role of Axna2 is instructive for understanding the development of RA, suppress the effect of Axna2 might provide a new potential measure for treatment of RA.	[Yi, Jun; Wang, Kaihui] Second Mil Med Univ, Dept Med Genet, Shanghai, Peoples R China; [Zhu, Yan; Jia, Yin; Jiang, Hongdie; Zheng, Xin] Second Mil Med Univ, Dept Changhai Hosp, Shanghai, Peoples R China; [Liu, Dejing; Gao, Shunxiang; Sun, Mingjuan; Hu, Bo; Jiao, Binghua; Wang, Lianghua] Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Wang, KH (corresponding author), Second Mil Med Univ, Dept Med Genet, Shanghai, Peoples R China.; Wang, LH (corresponding author), Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China.	wsh928@hotmail.com; khwang0118@sina.cn						Azizi G, 2014, INT J RHEUM DIS, V17, P369, DOI 10.1111/1756-185X.12280; Bharadwaj A, 2013, INT J MOL SCI, V14, P6259, DOI 10.3390/ijms14036259; Campbell V, 2015, STEM CELLS CLONING, V8, P27, DOI 10.2147/SCCAA.S58613; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carpenter RL, 2012, DISCOV MED, V13, P105; CATHCART ES, 1986, LAB INVEST, V54, P26; Cesarman-Maus G, 2006, BLOOD, V107, P4375, DOI 10.1182/blood-2005-07-2636; Chen WW, 2011, P NATL ACAD SCI USA, V108, P9589, DOI 10.1073/pnas.1017945108; D'Souza S, 2012, BLOOD, V119, P1888, DOI 10.1182/blood-2011-11-393348; Emoto K, 2001, ANTICANCER RES, V21, P1339; Esposito I, 2006, J PATHOL, V208, P673, DOI 10.1002/path.1935; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Genetos DC, 2010, BONE, V47, P1013, DOI 10.1016/j.bone.2010.08.024; Gillette JM, 2004, J CELL SCI, V117, P441, DOI 10.1242/jcs.00909; Hah YS, 2013, MOL BIOL REP, V40, P4869, DOI 10.1007/s11033-013-2586-3; Huang BH, 2011, BLOOD, V118, P2918, DOI 10.1182/blood-2011-03-341214; Iaccarino L, 2011, AUTOIMMUN REV, V10, P553, DOI 10.1016/j.autrev.2011.04.007; Isozaki T, 2014, ARTHRITIS RHEUMATOL, V66, P2047, DOI 10.1002/art.38648; Jacovina AT, 2009, J CLIN INVEST, V119, P3384, DOI 10.1172/JCI39591; Justen H P, 2000, Mol Cell Biol Res Commun, V3, P165, DOI 10.1006/mcbr.2000.0211; Kayakabe K, 2012, RHEUMATOLOGY, V51, P1571, DOI 10.1093/rheumatology/kes093; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Koch AE, 1998, ARTHRITIS RHEUM-US, V41, P951, DOI 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D; Laumonnier Y, 2006, BLOOD, V107, P3342, DOI 10.1182/blood-2005-07-2840; Li FH, 2005, J BONE MINER RES, V20, P1161, DOI 10.1359/JBMR.050207; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; Silva RLE, 2010, J CELL PHYSIOL, V225, P855, DOI 10.1002/jcp.22296; Lokman NA, 2011, CANCER MICROENVIRON, V4, P199, DOI 10.1007/s12307-011-0064-9; Romay-Penabad Z, 2009, BLOOD, V114, P3074, DOI 10.1182/blood-2008-11-188698; SEKI N, 1988, J IMMUNOL, V140, P1477; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Sharma M, 2012, EXP MOL PATHOL, V92, P175, DOI 10.1016/j.yexmp.2011.10.003; Sharma M, 2010, EXP MOL PATHOL, V88, P278, DOI 10.1016/j.yexmp.2010.01.001; Sharma MR, 2006, EXP MOL PATHOL, V81, P136, DOI 10.1016/j.yexmp.2006.03.002; Shiozawa Y, 2008, J CELL BIOCHEM, V105, P370, DOI 10.1002/jcb.21835; Swisher JFA, 2007, J LEUKOCYTE BIOL, V82, P1174, DOI 10.1189/jlb.0307154; Swisher JFA, 2010, BLOOD, V115, P549, DOI 10.1182/blood-2009-06-226944; Wang CH, 2012, ARTHRITIS RHEUM-US, V64, P1818, DOI 10.1002/art.34341; Wang JG, 2012, ARTHRITIS RHEUM-US, V64, P993, DOI 10.1002/art.33425; Wang MX, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/401903; Wei LH, 2012, INT J MOL SCI, V13, P9419, DOI 10.3390/ijms13089419; Xiong Y, 2013, APOPTOSIS, V18, P925, DOI 10.1007/s10495-013-0846-2; Yao E, 2015, J FORMOS MED ASSOC, V114, P569, DOI 10.1016/j.jfma.2015.01.005; Yung S, 2010, J AM SOC NEPHROL, V21, P1912, DOI 10.1681/ASN.2009080805; Zhai HY, 2011, J NEUROSCI, V31, P14346, DOI 10.1523/JNEUROSCI.3299-11.2011; Zhang Q, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-103; Zhang W, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002975; Zhao W, 2014, ARTHRITIS RHEUMATOL, V66, P2355, DOI 10.1002/art.38696; Zheng L, 2012, ONCOIMMUNOLOGY, V1, P112, DOI 10.4161/onci.1.1.18017; Zhou S.-W., 2012, MOL CELL PROTEOMICS, P1	50	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150363	10.1371/journal.pone.0150363	http://dx.doi.org/10.1371/journal.pone.0150363			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963384	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000034
J	Haider, SI; Snead, DRJ; Bari, MF				Haider, Sonia Ijaz; Snead, David R. J.; Bari, Muhammad Furqan			Medical Students' Perceptions of Clinical Teachers as Role Model	PLOS ONE			English	Article							PROFESSIONALISM; EDUCATION; ENVIRONMENT; RESIDENTS; PHYSICIAN; SCHOOL; COMMUNITIES; ATTRIBUTES; CHOICE	Introduction Role models facilitate student learning and assists in the development of professional identity. However, social organization and cultural values influence the choice of role models. Considering that the social organization and cultural values in South East Asia are different from other countries, it is important to know whether this affects the characteristics medical students look for in their role models in these societies. Methods A 32 item questionnaire was developed and self-administered to undergraduate medical students. Participants rated the characteristics on a three point scale (0 = not important, 1 = mildly important, 2 = very important). One way ANOVA and student's t-test were used to compare the groups. Results A total of 349 (65.23%) distributed questionnaires were returned. The highest ranked themes were teaching and facilitating learning, patient care and continuing professional development followed by communication and professionalism. Safe environment and guiding personal and professional development was indicated least important. Differences were also observed between scores obtained by males and females. Conclusion Globally there are attributes which are perceived as essential for role models, while others are considered desirable. An understanding of the attributes which are essential and desirable for role models can help medical educators devise strategies which can reinforce those attributes within their institutions.	[Haider, Sonia Ijaz] Aga Khan Univ, Dept Educ Dev, Fac Hlth Sci, Karachi, Pakistan; [Snead, David R. J.] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Pathol, Coventry, W Midlands, England; [Bari, Muhammad Furqan] Dow Univ Hlth Sci, Dow Int Med Coll, Dept Pathol, Karachi, Pakistan	Aga Khan University; University of Warwick; Dow University of Health Sciences	Haider, SI (corresponding author), Aga Khan Univ, Dept Educ Dev, Fac Hlth Sci, Karachi, Pakistan.; Bari, MF (corresponding author), Dow Univ Hlth Sci, Dow Int Med Coll, Dept Pathol, Karachi, Pakistan.	sonia.i.haider@gmail.com; bari.mf@gmail.com	Haider, Sonia Ijaz/AAP-9642-2020	Haider, Sonia Ijaz/0000-0003-4518-0933; SNEAD, DAVID/0000-0002-0766-9650				Althouse LA, 1999, ADV HEALTH SCI EDUC, V4, P111, DOI 10.1023/A:1009768526142; Beaudoin C, 1998, CAN MED ASSOC J, V159, P765; Brownell AKW, 2001, ACAD MED, V76, P734, DOI 10.1097/00001888-200107000-00019; Burgess A, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0303-8; Butani L, 2013, MED TEACH, V35, pE1052, DOI 10.3109/0142159X.2012.733457; Byszewski A, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-115; Council PMaD, PAK MED DENT COUNC S; Curry SE, 2011, MED EDUC, V45, P946, DOI 10.1111/j.1365-2923.2011.04014.x; Educators AoM, 2010, FRAM PROF DEV POSTGR; Egan T, 2009, HEALTH, V13, P107, DOI 10.1177/1363459308097363; Ghaffar A, 2013, LANCET, V381, P2234, DOI 10.1016/S0140-6736(13)60146-4; Haghdoost Ali A, 2006, BMC Med Educ, V6, P9, DOI 10.1186/1472-6920-6-9; Humphrey HJ, 2007, ACAD MED, V82, P1098, DOI 10.1097/01.ACM.0000285344.10311.a8; IRBY DM, 1986, J MED EDUC, V61, P35; Jha V, 2015, MED TEACH, V37, P74, DOI 10.3109/0142159X.2014.920492; Kenny NP, 2003, ACAD MED, V78, P1203, DOI 10.1097/00001888-200312000-00002; Mckimm J., 2009, S E ASIAN J MED, V3, P3; McLean M, 2004, MED TEACH, V26, P133, DOI 10.1080/01421590310001653973; McLean M, 2004, MED TEACH, V26, P142, DOI 10.1080/01421590310001653964; Onyebuchi AA, 2011, PLOS ONE, V6; Passi V, 2013, MED TEACH, V35, pE1422, DOI 10.3109/0142159X.2013.806982; Prideaux D, 2000, MED EDUC, V34, P820, DOI 10.1046/j.1365-2923.2000.00756.x; Ramani S, 2008, MED TEACH, V30, P347, DOI 10.1080/01421590802061613; Shrank WH, 2004, J GEN INTERN MED, V19, P887, DOI 10.1111/j.1525-1497.2004.30635.x; Skeff KM, 1997, ACAD MED, V72, P694, DOI 10.1097/00001888-199708000-00014; Spencer J, 2003, BMJ-BRIT MED J, V326, P591, DOI 10.1136/bmj.326.7389.591; Stern DT, 2006, NEW ENGL J MED, V355, P1794, DOI 10.1056/NEJMra054783; Sutkin Gary, 2008, Acad Med, V83, P452, DOI 10.1097/ACM.0b013e31816bee61; Wenger E, 2000, ORGANIZATION, V7, P225, DOI 10.1177/135050840072002; Wright S, 1997, J GEN INTERN MED, V12, P53, DOI 10.1007/s11606-006-0007-1; Wright SM, 1998, NEW ENGL J MED, V339, P1986, DOI 10.1056/NEJM199812313392706; Wright SM, 2003, ACAD MED, V78, P623, DOI 10.1097/00001888-200306000-00013; Wyber Rosemary, 2007, N Z Med J, V120, pU2518; Yazigi A, 2006, MED EDUC, V40, P654, DOI 10.1111/j.1365-2929.2006.02502.x	34	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150478	10.1371/journal.pone.0150478	http://dx.doi.org/10.1371/journal.pone.0150478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959364	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300052
J	Krober, A; Scherlach, K; Hortschansky, P; Shelest, E; Staib, P; Kniemeyer, O; Brakhage, AA				Krober, Antje; Scherlach, Kirstin; Hortschansky, Peter; Shelest, Ekaterina; Staib, Peter; Kniemeyer, Olaf; Brakhage, Axel A.			HapX Mediates Iron Homeostasis in the Pathogenic Dermatophyte Arthroderma benhamiae but Is Dispensable for Virulence	PLOS ONE			English	Article							CCAAT-BINDING COMPLEX; ASPERGILLUS-FUMIGATUS; PEPTIDE SYNTHETASE; EXTRACELLULAR SIDEROPHORES; GENE-EXPRESSION; TRICHOPHYTON-MENTAGROPHYTES; INFECTION MODEL; FACTOR PHP4; IN-VITRO; TRANSCRIPTION	For many pathogenic fungi, siderophore-mediated iron acquisition is essential for virulence. The process of siderophore production and further mechanisms to adapt to iron limitation are strictly controlled in fungi to maintain iron homeostasis. Here we demonstrate that the human pathogenic dermatophyte Arthroderma benhamiae produces the hydroxamate siderophores ferricrocin and ferrichrome C. Additionally, we show that the iron regulator HapX is crucial for the adaptation to iron starvation and iron excess, but is dispensable for virulence of A. benhamiae. Deletion of hapX caused downregulation of siderophore biosynthesis genes leading to a decreased production of siderophores during iron starvation. Furthermore, HapX was required for transcriptional repression of genes involved in iron-dependent pathways during iron-depleted conditions. Additionally, the Delta hapX mutant of A. benhamiae was sensitive to high-iron concentrations indicating that HapX also contributes to iron detoxification. In contrast to other pathogenic fungi, HapX of A. benhamiae was redundant for virulence and a Delta hapX mutant was still able to infect keratinized host tissues in vitro. Our findings underline the highly conserved role of the transcription factor HapX for maintaining iron homeostasis in ascomycetous fungi but, unlike in many other human and plant pathogenic fungi, HapX of A. benhamiae is not a virulence determinant.	[Krober, Antje; Staib, Peter] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jr Res Grp Fundamental Mol Biol Pathogen Fungi, Jena, Germany; [Krober, Antje; Hortschansky, Peter; Kniemeyer, Olaf; Brakhage, Axel A.] Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Mol & Appl Microbiol, Jena, Germany; [Scherlach, Kirstin] Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Biomol Chem, Jena, Germany; [Shelest, Ekaterina] Leibniz Inst Nat Prod Res & Infect Biol HKI, Syst Biol & Bioinformat, Jena, Germany; [Kniemeyer, Olaf; Brakhage, Axel A.] Univ Jena, Inst Microbiol, Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Brakhage, AA (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Mol & Appl Microbiol, Jena, Germany.; Brakhage, AA (corresponding author), Univ Jena, Inst Microbiol, Jena, Germany.	axel.brakhage@leibniz-hki.de	Kniemeyer, Olaf/K-1253-2013; Shelest, Ekaterina/H-3069-2018	Kniemeyer, Olaf/0000-0002-9493-6402; Shelest, Ekaterina/0000-0002-9751-6702; Scherlach, Kirstin/0000-0002-1326-3761	DFG [GSC 214]; Leibniz Institute for Natural Product Research and Infection Biology	DFG(German Research Foundation (DFG)); Leibniz Institute for Natural Product Research and Infection Biology	lThis work was supported by the DFG funded excellence graduate school Jena School for Microbial Communication (JSMC; GSC 214; www.jsmc.uni-jena.de) and the Leibniz Institute for Natural Product Research and Infection Biology (www.leibniz-hki.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterman RR, 2012, INT J MICROBIOL, DOI 10.1155/2012/358305; Antelo L, 2006, Z NATURFORSCH C, V61, P461; Baldo A, 2010, BRIT J DERMATOL, V162, P990, DOI 10.1111/j.1365-2133.2009.09608.x; BISSETT DL, 1992, J SOC COSMET CHEM, V43, P215; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; Borgers M, 2005, CURR DRUG TARGETS, V6, P849, DOI 10.2174/138945005774912726; BRAKHAGE AA, 1995, J BACTERIOL, V177, P2781, DOI 10.1128/jb.177.10.2781-2788.1995; Brasch J, 2015, MYCOSES, V58, P93, DOI 10.1111/myc.12280; BUDDE AD, 1989, MYCOPATHOLOGIA, V108, P125; Burmester A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r7; CHARLANG G, 1981, MOL CELL BIOL, V1, P94, DOI 10.1128/MCB.1.2.94; CHARLANG G, 1982, J BACTERIOL, V150, P785, DOI 10.1128/JB.150.2.785-787.1982; Chen CB, 2011, CELL HOST MICROBE, V10, P118, DOI 10.1016/j.chom.2011.07.005; Drouot S, 2009, VET DERMATOL, V20, P13, DOI 10.1111/j.1365-3164.2008.00691.x; Eichhorn H, 2006, PLANT CELL, V18, P3332, DOI 10.1105/tpc.106.043588; Eisendle M, 2004, EUKARYOT CELL, V3, P561, DOI 10.1128/EC.3.2.561-563.2004; Eisendle M, 2003, MOL MICROBIOL, V49, P359, DOI 10.1046/j.1365-2958.2003.03586.x; EMERY T, 1980, BIOCHIM BIOPHYS ACTA, V629, P382, DOI 10.1016/0304-4165(80)90110-5; Fachin AL, 2006, J MED MICROBIOL, V55, P1093, DOI 10.1099/jmm.0.46522-0; Ferreira-Nozawa MS, 2006, MED MYCOL, V44, P641, DOI 10.1080/13693780600876553; Fumeaux J, 2004, DERMATOLOGY, V208, P244, DOI 10.1159/000077311; Gavazzoni Dias Maria Fernanda Reis, 2014, Int J Trichology, V6, P95, DOI 10.4103/0974-7753.139078; GREENBERG JH, 1976, J INVEST DERMATOL, V67, P704, DOI 10.1111/1523-1747.ep12598588; Grumbt M, 2011, FEMS MICROBIOL LETT, V320, P79, DOI 10.1111/j.1574-6968.2011.02276.x; Grumbt M, 2011, EUKARYOT CELL, V10, P842, DOI 10.1128/EC.00273-10; Gsaller F, 2014, EMBO J, V33, P2261, DOI 10.15252/embj.201489468; Gsaller F, 2012, METALLOMICS, V4, P1262, DOI 10.1039/c2mt20179h; Haas H, 1999, J BIOL CHEM, V274, P4613, DOI 10.1074/jbc.274.8.4613; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Haas H, 2014, NAT PROD REP, V31, P1266, DOI 10.1039/c4np00071d; Haas H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00028; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hissen AHT, 2004, INFECT IMMUN, V72, P1402, DOI 10.1128/IAI.72.3.1402-1408.2004; HOROWITZ NH, 1976, J BACTERIOL, V127, P135, DOI 10.1128/JB.127.1.135-140.1976; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Hortschansky P, 2015, J BIOL CHEM, V290, P6058, DOI 10.1074/jbc.M114.628677; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; JACOBS A, 1960, BRIT J DERMATOL, V72, P145, DOI 10.1111/j.1365-2133.1960.tb13863.x; Jacobson ES, 1998, INFECT IMMUN, V66, P4169; Jain R, 2011, MOL MICROBIOL, V82, P39, DOI 10.1111/j.1365-2958.2011.07778.x; Jung WH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001209; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; Kragl C, 2007, EUKARYOT CELL, V6, P1278, DOI 10.1128/EC.00066-07; Lambers H., 2006, International Journal of Cosmetic Science, V28, P359, DOI 10.1111/j.1467-2494.2006.00344.x; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Lian TS, 2005, MOL MICROBIOL, V55, P1452, DOI 10.1111/j.1365-2958.2004.04474.x; Liu H, 2010, MOL MICROBIOL, V78, P1038, DOI 10.1111/j.1365-2958.2010.07389.x; Lopez-Berges MS, 2012, PLANT CELL, V24, P3805, DOI 10.1105/tpc.112.098624; LOVRIC VA, 1971, PATHOLOGY, V3, P251, DOI 10.3109/00313027109073742; Machuca A, 2003, LETT APPL MICROBIOL, V36, P177, DOI 10.1046/j.1472-765X.2003.01290.x; Maranhao FCA, 2009, J MED MICROBIOL, V58, P163, DOI 10.1099/jmm.0.002907-0; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Monod M, 2014, BRIT J DERMATOL, V170, P491, DOI 10.1111/bjd.12866; MOR H, 1992, BIOMETALS, V5, P213, DOI 10.1007/BF01061220; Murdan S, 2011, SKIN PHARMACOL PHYS, V24, P175, DOI 10.1159/000324055; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pongpom M, 2015, INFECT IMMUN, V83, P923, DOI 10.1128/IAI.02685-14; Schrettl M, 2004, BIOMETALS, V17, P647, DOI 10.1007/s10534-004-1230-z; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Schrettl M, 2008, MOL MICROBIOL, V70, P27, DOI 10.1111/j.1365-2958.2008.06376.x; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Schrettl M, 2010, MICROBES INFECT, V12, P1035, DOI 10.1016/j.micinf.2010.07.005; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Shi Y, 2016, MED MYCOL, V54, P59, DOI 10.1093/mmy/myv071; Silva-Baila MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105805; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; Staib P, 2010, MICROBIOL-SGM, V156, P884, DOI 10.1099/mic.0.033464-0; Takasuka T, 2000, FEMS IMMUNOL MED MIC, V29, P241, DOI 10.1111/j.1574-695X.2000.tb01529.x; Tobiasen C, 2007, CURR GENET, V51, P43, DOI 10.1007/s00294-006-0103-0; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vermout S, 2007, FEMS MICROBIOL LETT, V275, P38, DOI 10.1111/j.1574-6968.2007.00870.x; WEINTRAUB LR, 1965, AM J PATHOL, V46, P121; WEITZMAN I, 1995, CLIN MICROBIOL REV, V8, P240, DOI 10.1128/CMR.8.2.240; Winterberg B, 2010, MOL MICROBIOL, V75, P1260, DOI 10.1111/j.1365-2958.2010.07048.x; Yasmin S, 2012, P NATL ACAD SCI USA, V109, pE497, DOI 10.1073/pnas.1106399108; Yuan WM, 2001, J BACTERIOL, V183, P4040, DOI 10.1128/JB.183.13.4040-4051.2001; Zaugg C, 2009, EUKARYOT CELL, V8, P241, DOI 10.1128/EC.00208-08	82	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150701	10.1371/journal.pone.0150701	http://dx.doi.org/10.1371/journal.pone.0150701			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960149	gold, Green Published			2022-12-27	WOS:000371992300066
J	Shao, LY; Zhang, XY; Gao, Y; Xu, YY; Zhang, S; Yu, SL; Weng, XH; Shen, HB; Chen, ZW; Jiang, WM; Zhang, WH				Shao, Lingyun; Zhang, Xinyun; Gao, Yan; Xu, Yunya; Zhang, Shu; Yu, Shenglei; Weng, Xinhua; Shen, Hongbo; Chen, Zheng W.; Jiang, Weimin; Zhang, Wenhong			Hierarchy Low CD4+/CD8+T-Cell Counts and IFN-gamma Responses in HIV-1+Individuals Correlate with Active TB and/or M.tb Co-Infection	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CD8(+) T; HIV-INFECTION; CELLS; ANTIGENS; CD4(+); LATENT	Objective Detailed studies of correlation between HIV-M.tb co-infection and hierarchy declines of CD8+/CD4+ T-cell counts and IFN-gamma responses have not been done. We conducted casecontrol studies to address this issue. Methods 164 HIV-1-infected individuals comprised of HIV-1(+)ATB, HIV-1(+)LTB and HIV-1(+)TB(-) groups were evaluated. Immune phenotyping and complete blood count (CBC) were employed to measure CD4+ and CD8+ T-cell counts; T.SPOT.TB and intracellular cytokine staining (ICS) were utilized to detect ESAT6, CFP10 or PPD-specific IFN-gamma responses. Results There were significant differences in median CD4+ T-cell counts between HIV-1(+)ATB (164/mu L), HIV-1(+)LTB (447/mu L) and HIV-1(+)TB-(329/mu L) groups. Hierarchy low CD4+ T-cell counts (<200/mu L, 200-500/mu L, >500/mu L) were correlated significantly with active TB but not M.tb co-infection. Interestingly, hierarchy low CD8+ T-cell counts were not only associated significantly with active TB but also with M. tb co-infection (P<0.001). Immunologically, HIV1-ATB group showed significantly lower numbers of ESAT-6-/CFP-10-specific IFN-gamma+T cells than HIV-1(+)LTB group. Consistently, PPD-specific IFN-gamma+CD4+/CD8+ T effector cells in HIV-1(+) ATB group were significantly lower than those in HIV-1(+)LTB group (P< 0.001). Conclusions Hierarchy low CD8+ T-cell counts and effector function in HIV-1-infected individuals are correlated with both M.tb co-infection and active TB. Hierarchy low CD4+ T-cell counts and Th1 effector function in HIV-1+ individuals are associated with increased frequencies of active TB, but not M.tb co-infection.	[Shao, Lingyun; Zhang, Xinyun; Gao, Yan; Zhang, Shu; Yu, Shenglei; Weng, Xinhua; Jiang, Weimin; Zhang, Wenhong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200040, Peoples R China; [Xu, Yunya] Honghe 1 Peoples Hosp, Dept Infect Dis, Mengzi 661100, Mengzi County, Peoples R China; [Shen, Hongbo] Chinese Acad Sci, Shanghai 200040, Peoples R China; [Shen, Hongbo] Inst Pasteur Shanghai, Shanghai 200040, Peoples R China; [Chen, Zheng W.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Ctr Primate Biomed Res, Chicago, IL 60612 USA; [Zhang, Wenhong] Fudan Univ, Minist Educ & Hlth, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200040, Peoples R China; [Zhang, Wenhong] Fudan Univ, Inst Biomed Sci, Shanghai 200040, Peoples R China	Fudan University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Fudan University; Fudan University	Jiang, WM; Zhang, WH (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200040, Peoples R China.; Zhang, WH (corresponding author), Fudan Univ, Minist Educ & Hlth, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200040, Peoples R China.; Zhang, WH (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200040, Peoples R China.	jiangweimin2004@163.com; zhangwenhong@fudan.edu.cn			Key Technologies Research and Development Program for Infectious Diseases of China [2013ZX10003007-001-002]; Shanghai medical guidance program [124119a6401]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129887] Funding Source: NIH RePORTER	Key Technologies Research and Development Program for Infectious Diseases of China; Shanghai medical guidance program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported in part by the Key Technologies Research and Development Program for Infectious Diseases of China (2013ZX10003007-001-002) and Shanghai medical guidance program (124119a6401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Cingolani A, 2012, CLIN INFECT DIS, V54, P853, DOI 10.1093/cid/cir900; del Amo J, 2012, CLIN INFECT DIS, V54, P1364, DOI 10.1093/cid/cis203; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Geldmacher C, 2012, CURR OPIN HIV AIDS, V7, P268, DOI 10.1097/COH.0b013e3283524e32; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Grant AD, 2009, AIDS, V23, P2507, DOI 10.1097/QAD.0b013e3283320dfd; Jambo KC, 2011, THORAX, V66, P375, DOI 10.1136/thx.2010.153825; Jiang WM, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-31; Kalsdorf B, 2009, AM J RESP CRIT CARE, V180, P1262, DOI 10.1164/rccm.200907-1011OC; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Prevention CfDCa, 2013, GUID PREV TREATM OPP; Shao LY, 2008, AIDS, V22, P2241, DOI 10.1097/QAD.0b013e3283117f18; Shen Y, 2004, J VIROL, V78, P14023, DOI 10.1128/JVI.78.24.14023-14032.2004; Shen Y, 2002, INFECT IMMUN, V70, P869, DOI 10.1128/IAI.70.2.869-877.2002; Sterling TR, 2011, J INFECT DIS, V204, P893, DOI 10.1093/infdis/jir421; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; Yao SY, 2014, J IMMUNOL, V192, P2120, DOI 10.4049/jimmunol.1301373; Zhang S, 2010, CLIN VACCINE IMMUNOL, V17, P1985, DOI 10.1128/CVI.00294-10	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150941	10.1371/journal.pone.0150941	http://dx.doi.org/10.1371/journal.pone.0150941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959228	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300087
J	Xu, HF; Liu, BY; Wu, JN; Du, RS; Liu, XX; Yu, JN; Liu, ZS				Xu, Huanfang; Liu, Baoyan; Wu, Jiani; Du, Ruosang; Liu, Xiaoxu; Yu, Jinna; Liu, Zhishun			A Pilot Randomized Placebo Controlled Trial of Electroacupuncture for Women with Pure Stress Urinary Incontinence	PLOS ONE			English	Article							QUALITY-OF-LIFE; SURGICAL-TREATMENT; MUSCLE; IMPACT; STIMULATION; BIOFEEDBACK; MANAGEMENT; SYMPTOMS; ICIQ	Background Acupuncture is a potential conservative therapy for women with stress urinary incontinence (SUI). There is limited evidence to support its effectiveness due to the poor quality of existing studies. Methods We performed a pilot randomized, controlled trial to preliminarily assess the efficacy of electroacupuncture (EA) in women with pure SUI. A total of 80 women with pure SUI were randomly assigned to receive EA with deep needling at BL33 and BL35 (n = 40) or sham EA with non-penetrating needling at sham acupoints (n = 40) three sessions per week for 6 weeks. The women were followed for 24 weeks. The primary outcome was the change from baseline in the amount of urine leakage measured by a 1-hour pad test after 6 weeks. The secondary outcomes included the 72-hour incontinence episode frequency (IEF), International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) score, and patient self-evaluation of therapeutic effect. Adverse events (AEs) were monitored throughout the trial. Results The median decrease from baseline of urine leakage measured by the 1-hour pad test was 2.5 g [interquartile range (IQR): 1.80-14.6 in the EA group, which was greater than the median decrease of 0.05 g (IQR: -2.80-+0.50) in the sham EA group after 6 weeks (p<0.01). The differences between groups in the decrease from baseline of 72-hour IEF became statistically significant at week 30 with a median decrease of 3.25 g (IQR: 1.25-5.69) in the EA group, and a median decrease of 1.00 g (IQR: -0.69-+2.88) in the sham EA group (p = 0.01). The participants in the EA group showed greater decreases in ICIQ-SF score and higher ratings in the help they received from the treatment than those in the sham EA group at weeks 6,18 and 30 (all p < 0.05). No obvious AEs were observed in either group. Conclusion EA may effectively and safely relieve urinary incontinence symptoms and improve quality of life in women with pure SUI. EA demonstrated more than a placebo effect. Since this is a pilot study, results should be interpreted with caution.	[Xu, Huanfang; Liu, Baoyan; Wu, Jiani; Du, Ruosang; Liu, Xiaoxu; Yu, Jinna; Liu, Zhishun] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Acupuncture & Moxibust, Beijing, Peoples R China; [Liu, Xiaoxu] Beijing Univ Chinese Med, Sch Acupuncture Moxibust & Tuina, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Beijing University of Chinese Medicine	Liu, ZS (corresponding author), China Acad Chinese Med Sci, Guanganmen Hosp, Dept Acupuncture & Moxibust, Beijing, Peoples R China.	liuzhishun@aliyun.com			Ministry of Science and Technology of the People's Republic of China [2012BAI24B01]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was funded by Grant numbers: 2012BAI24B01; Funder' website: http://www.most.gov.cn; Funding institution: Ministry of Science and Technology of the People's Republic of China. ZL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 1988, Scand J Urol Nephrol Suppl, V114, P5; Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Abrams P, 2017, INCONTINENCE 6 INT C; Aksac B, 2003, GYNECOL OBSTET INVES, V56, P23, DOI 10.1159/000072327; Ammi M, 2014, INT UROGYNECOL J, V25, P1065, DOI 10.1007/s00192-014-2359-0; [Anonymous], 2013, URINARY INCONTINENCE; Avery K, 2004, NEUROUROL URODYNAM, V23, P322, DOI 10.1002/nau.20041; Bi W, 2007, CHINESE ARCH TRADITI, V25, P1284; Bo K, 2013, NEUROUROL URODYNAM, V32, P215, DOI 10.1002/nau.22292; Chene G, 2013, EUR J OBSTET GYN R B, V170, P275, DOI 10.1016/j.ejogrb.2013.06.011; Gras S, 2014, J UROLOGY, V192, P850, DOI 10.1016/j.juro.2014.04.005; Hirakawa T, 2013, INT UROGYNECOL J, V24, P1347, DOI 10.1007/s00192-012-2012-8; Horng SS, 2013, NEUROUROL URODYNAM, V32, P371, DOI 10.1002/nau.22302; Huang L, 2008, NEUROUROL URODYNAM, V27, P522, DOI 10.1002/nau.20546; Hui Kathleen K S, 2007, BMC Complement Altern Med, V7, P33, DOI 10.1186/1472-6882-7-33; Kim JH, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-254; Lalos O, 2001, J ADV NURS, V33, P316, DOI 10.1046/j.1365-2648.2001.01667.x; Liebergall-Wischnitzer M, 2009, J WOMENS HEALTH, V18, P377, DOI 10.1089/jwh.2008.0950; Lin Alex Tong-Long, 2008, BMC Urol, V8, P2, DOI 10.1186/1471-2490-8-2; Liu BY, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000200; Lucas MG, 2013, ACTAS UROL ESP, V37, P199, DOI 10.1016/j.acuro.2012.12.001; MacPherson H, 2001, Acupunct Med, V19, P93; Mallinckrodt C H, 2001, J Biopharm Stat, V11, P9, DOI 10.1081/BIP-100104194; Markland AD, 2011, J UROLOGY, V186, P589, DOI 10.1016/j.juro.2011.03.114; Mo Q, 2013, BEIJING J TRADIT CHI, V32, P434; Noblett K, 2014, NEUROUROLOGY URODYNA; Olausson H, 2010, NEUROSCI BIOBEHAV R, V34, P185, DOI 10.1016/j.neubiorev.2008.09.011; Pacific WROftW, 2008, WHO STAND AC POINT L; Sari D, 2009, J WOUND OSTOMY CONT, V36, P429, DOI 10.1097/WON.0b013e3181aaf539; Sjostrom M, 2013, BJU INT, V112, P362, DOI 10.1111/j.1464-410X.2012.11713.x; Smither Anna R, 2007, BMC Urol, V7, P2, DOI 10.1186/1471-2490-7-2; STAMEY TA, 1980, ANN SURG, V192, P465, DOI 10.1097/00000658-198010000-00005; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Sun MJ, 2008, TAIWAN J OBSTET GYNE, V47, P175, DOI 10.1016/S1028-4559(08)60076-5; Swithinbank LV, 1999, WORLD J UROL, V17, P225, DOI 10.1007/s003450050137; Wang Y, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009408.pub2; Wood LN, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4531; Xue CCL, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-169; Yalcin I, 2010, NEUROUROL URODYNAM, V29, P344, DOI 10.1002/nau.20744; Yin CS, 2005, AM J CHINESE MED, V33, P729, DOI 10.1142/S0192415X05003284; Yoshimura N, 2012, INT J UROL, V19, P524, DOI 10.1111/j.1442-2042.2012.02976.x; Zhao Lin, 2013, Zhongguo Zhen Jiu, V33, P1088; Zhu L, 2009, MENOPAUSE, V16, P831, DOI 10.1097/gme.0b013e3181967b5d	43	19	21	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150821	10.1371/journal.pone.0150821	http://dx.doi.org/10.1371/journal.pone.0150821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960195	Green Submitted, gold, Green Published			2022-12-27	WOS:000371992300076
J	Calyjur, PC; Almeida, CD; Ayub-Guerrieri, D; Ribeiro, AF; Fernandes, SD; Ishiba, R; dos Santos, ALF; Onofre-Oliveira, P; Vainzof, M				Calyjur, Priscila Clara; Almeida, Camila de Freitas; Ayub-Guerrieri, Danielle; Ribeiro Junior, Antonio Fernando; Fernandes, Stephanie de Alcantara; Ishiba, Renata; Fernandes dos Santos, Andre Luis; Onofre-Oliveira, Paula; Vainzof, Mariz			The mdx Mutation in the 129/Sv Background Results in a Milder Phenotype: Transcriptome Comparative Analysis Searching for the Protective Factors	PLOS ONE			English	Article							MUSCLE MEMBRANE REPAIR; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; OSTEOPONTIN; EXPRESSION; FIBROSIS; INFLAMMATION; REGENERATION; MOUSE; CELLS	The mdx mouse is a good genetic and molecular murine model for Duchenne Muscular Dystrophy (DMD), a progressive and devastating muscle disease. However, this model is inappropriate for testing new therapies due to its mild phenotype. Here, we transferred the mdx mutation to the 129/Sv strain with the aim to create a more severe model for DMD. Unexpectedly, functional analysis of the first three generations of mdx(129) showed a progressive amelioration of the phenotype, associated to less connective tissue replacement, and more regeneration than the original mdx(C57BL). Transcriptome comparative analysis was performed to identify what is protecting this new model from the dystrophic characteristics. The mdx(C57BL) presents three times more differentially expressed genes (DEGs) than the mdx(129) (371 and 137 DEGs respectively). However, both models present more overexpressed genes than underexpressed, indicating that the dystrophic and regenerative alterations are associated with the activation rather than repression of genes. As to functional categories, the DEGs of both mdx models showed a predominance of immune system genes. Excluding this category, the mdx(129) model showed a decreased participation of the endo/exocytic pathway and homeostasis categories, and an increased participation of the extracellular matrix enzymatic activity categories. Spp1 gene overexpression was the most significant DEG exclusively expressed in the mdx(129) strain. This was confirmed through relative mRNA analysis and osteopontin protein quantification. The amount of the 66 kDa band of the protein, representing the post-translational product of the gene, was about 4,8 times higher on western blotting. Spp1 is a known DMD prognostic biomarker, and our data indicate that its upregulation can benefit phenotype. Modeling the expression of the DEGs involved in the mdx mutation with a benign course should be tested as a possible therapeutic target for the dystrophic process.	[Calyjur, Priscila Clara; Almeida, Camila de Freitas; Ayub-Guerrieri, Danielle; Ribeiro Junior, Antonio Fernando; Fernandes, Stephanie de Alcantara; Ishiba, Renata; Fernandes dos Santos, Andre Luis; Onofre-Oliveira, Paula; Vainzof, Mariz] Univ Sao Paulo, Biosci Inst, Lab Muscle Prot & Comparat Histopathol, Human Genome & Stem Cell Res Ctr, Sao Paulo, Brazil	Universidade de Sao Paulo	Vainzof, M (corresponding author), Univ Sao Paulo, Biosci Inst, Lab Muscle Prot & Comparat Histopathol, Human Genome & Stem Cell Res Ctr, Sao Paulo, Brazil.	mvainzof@usp.br	Junior, Antonio Fernando Ribeiro/HHT-1364-2022; Júnior, Antonio Fernando Ribeiro/AAC-3390-2021; Vainzof, Mariz/J-7150-2012; Vainzof, Mariz/Q-4787-2019; Santos, Andre/F-8349-2012; de Freitas Almeida, Camila/L-6601-2013; Onofre-Oliveira, Paula/B-5378-2008	Junior, Antonio Fernando Ribeiro/0000-0003-0373-9890; Júnior, Antonio Fernando Ribeiro/0000-0003-0373-9890; Vainzof, Mariz/0000-0002-2797-0782; Vainzof, Mariz/0000-0002-2797-0782; Santos, Andre/0000-0001-7053-4989; de Freitas Almeida, Camila/0000-0003-2652-2205; Ishiba, Renata/0000-0003-1985-7752; Onofre-Oliveira, Paula/0000-0002-6509-7697	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [404664/2012-1, 456522/2014-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Centro de Pesquisa, Inovacao e Difusao (FAPESP-CEPID) [2013/08028-1]; CNPq-INCT [610031/2009-0]; Financiadora de Estudos e Projetos (FINEP) [01.08.0579.00]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Comite Frances de Avaliacao da Cooperacao Universitaria com o Brasil (CAPES-COFECUB)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Centro de Pesquisa, Inovacao e Difusao (FAPESP-CEPID)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq-INCT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Comite Frances de Avaliacao da Cooperacao Universitaria com o Brasil (CAPES-COFECUB)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq projetos 404664/2012-1 e 456522/2014-0), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Centro de Pesquisa, Inovacao e Difusao (FAPESP-CEPID- projeto 2013/08028-1), CNPq-INCT (Projeto no: 610031/2009-0), Financiadora de Estudos e Projetos (FINEP - projeto 01.08.0579.00) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Comite Frances de Avaliacao da Cooperacao Universitaria com o Brasil (CAPES-COFECUB).	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Amaro A, 2014, CANCER METAST REV, V33, P657, DOI 10.1007/s10555-013-9470-4; Berman JS, 2004, AM J PHYSIOL-LUNG C, V286, pL1311, DOI 10.1152/ajplung.00394.2003; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Chiavegatto S, 2000, EXP NEUROL, V166, P227, DOI 10.1006/exnr.2000.7504; Coley WD, 2016, HUM MOL GENET, V25, P130, DOI 10.1093/hmg/ddv460; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V4th, P16; Duvall CL, 2007, J BONE MINER RES, V22, P286, DOI 10.1359/JBMR.061103; Fatherazi S, 2009, J DENT RES, V88, P39, DOI 10.1177/0022034508328072; Fukada S, 2010, AM J PATHOL, V176, P2414, DOI 10.2353/ajpath.2010.090887; Giachelli CM, 1998, AM J PATHOL, V152, P353; Gillies AR, 2011, MUSCLE NERVE, V44, P318, DOI 10.1002/mus.22094; Gosselin LE, 2004, MUSCLE NERVE, V30, P645, DOI 10.1002/mus.20150; Han RZ, 2011, SKELET MUSCLE, V1, DOI [10.1186/2044-5040-1-10, 10.1186/2044-5040-1-35]; Hashimoto M, 2007, J NEUROSCI, V27, P3603, DOI 10.1523/JNEUROSCI.4805-06.2007; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; He B, 2012, MOL THER, V20, P727, DOI 10.1038/mt.2012.5; Hirata A, 2003, AM J PATHOL, V163, P203, DOI 10.1016/S0002-9440(10)63644-9; Hoffman EP, 2013, MED SCI SPORT EXER, V45, P1060, DOI 10.1249/MSS.0b013e31828093c1; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Kumar V, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.117903; LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214; Lima BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014136; Lund AK, 2009, ARTERIOSCL THROM VAS, V29, P511, DOI 10.1161/ATVBAHA.108.176107; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; O'Regan A, 2000, INT J EXP PATHOL, V81, P373, DOI 10.1046/j.1365-2613.2000.00163.x; Pagel CN, 2014, J CELL COMMUN SIGNAL, V8, P95, DOI 10.1007/s12079-013-0217-3; Pegoraro E, 2011, NEUROLOGY, V76, P219, DOI 10.1212/WNL.0b013e318207afeb; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Sam F, 2004, AM J HYPERTENS, V17, P188, DOI 10.1016/j.amjhyper.2003.10.007; Shin JH, 2011, MUSCLE NERVE, V43, P283, DOI 10.1002/mus.21873; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Subraman V, 2015, J CLIN DIAGN RES, V9, pZE10, DOI 10.7860/JCDR/2015/12872.6111; Swaggart KA, 2014, P NATL ACAD SCI USA, V111, P6004, DOI 10.1073/pnas.1324242111; Szulzewsky F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116644; Takafuji V, 2007, ONCOGENE, V26, P6361, DOI 10.1038/sj.onc.1210463; Uaesoontrachoon K, 2008, INT J BIOCHEM CELL B, V40, P2303, DOI 10.1016/j.biocel.2008.03.020; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Zangala Tony, 2007, J Vis Exp, P246, DOI 10.3791/246	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150748	10.1371/journal.pone.0150748	http://dx.doi.org/10.1371/journal.pone.0150748			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954670	Green Published, gold			2022-12-27	WOS:000371991300045
J	Li, DQ; Kim, RB; McArthur, E; Fleet, JL; Hegele, RA; Shah, BR; Weir, MA; Molnar, AO; Dixon, S; Tu, JV; Anand, S; Garg, AX				Li, Daniel Q.; Kim, Richard B.; McArthur, Eric; Fleet, Jamie L.; Hegele, Robert A.; Shah, Baiju R.; Weir, Matthew A.; Molnar, Amber O.; Dixon, Stephanie; Tu, Jack V.; Anand, Sonia; Garg, Amit X.			Statin Safety in Chinese: A Population-Based Study of Older Adults	PLOS ONE			English	Article							ADVERSE EVENTS; DOUBLE-BLIND; EFFICACY; RISK; ROSUVASTATIN; ATORVASTATIN; DRUG; OUTCOMES; PHARMACOGENETICS; RHABDOMYOLYSIS	Background Compared to Caucasians, Chinese achieve a higher blood concentration of statin for a given dose. It remains unknown whether this translates to increased risk of serious statin-associated adverse events amongst Chinese patients. Methods We conducted a population-based retrospective cohort study of older adults (mean age, 74 years) newly prescribed a statin in Ontario, Canada between 2002 and 2013, where 19,033 Chinese (assessed through a validated surname algorithm) were matched (1: 3) by propensity score to 57,099 non-Chinese. This study used linked healthcare databases. Findings The follow-up observation period (mean 1.1, maximum 10.8 years) was similar between groups, as were the reasons for censoring the observation period (end of follow-up, death, or statin discontinuation). Forty-seven percent (47%) of Chinese were initiated on a higher than recommended statin dose. Compared to non-Chinese, Chinese ethnicity did not associate with any of the four serious statin-associated adverse events assessed in this study [rhabdomyolysis hazard ratio (HR) 0.61 (95% CI 0.28 to 1.34), incident diabetes HR 1.02 (95% CI 0.80 to 1.30), acute kidney injury HR 0.90 (95% CI 0.72 to 1.13), or all-cause mortality HR 0.88 (95% CI 0.74 to 1.05)]. Similar results were observed in subgroups defined by statin type and dose. Conclusions We observed no higher risk of serious statin toxicity in Chinese than matched non-Chinese older adults with similar indicators of baseline health. Regulatory agencies should review available data, including findings from our study, to decide if a change in their statin dosing recommendations for people of Chinese ethnicity is warranted.	[Li, Daniel Q.; Fleet, Jamie L.; Weir, Matthew A.; Garg, Amit X.] Western Univ, Dept Med, Div Nephrol, London, ON, Canada; [Kim, Richard B.] Western Univ, Dept Med, Div Clin Pharmacol, London, ON, Canada; [McArthur, Eric; Shah, Baiju R.; Weir, Matthew A.; Dixon, Stephanie; Tu, Jack V.; Garg, Amit X.] ICES Western, London, ON, Canada; [Hegele, Robert A.] Univ Western Ontario, Robarts Res Inst, Blackburn Cardiovasc Genet Lab, London, ON, Canada; [Shah, Baiju R.; Tu, Jack V.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Molnar, Amber O.] Univ Ottawa, Dept Med, Div Nephrol, Ottawa, ON, Canada; [Dixon, Stephanie] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Anand, Sonia] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Anand, Sonia] Hamilton Hlth Sci, Hamilton, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Ottawa; Western University (University of Western Ontario); McMaster University; Population Health Research Institute; McMaster University	Garg, AX (corresponding author), Western Univ, Dept Med, Div Nephrol, London, ON, Canada.; Garg, AX (corresponding author), ICES Western, London, ON, Canada.	amit.garg@lhsc.on.ca	Hegele, Robert/AAF-6482-2020; Weir, Matthew/G-3354-2011; Kim, Richard/D-6971-2011; Molnar, Amber/K-6093-2019; Hegele, Robert/G-3301-2011; Fleet, Jamie L/GYJ-7373-2022; Garg, Amit X/G-3295-2011	Hegele, Robert/0000-0003-2861-5325; Kim, Richard/0000-0001-8148-1632; Fleet, Jamie/0000-0002-9468-0697	Institute for Clinical Evaluative Sciences (ICES) Western site; Ontario Ministry of Health and Long-Term Care (MOHLTC); Academic Medical Organization of Southwestern Ontario (AMOSO); Schulich School of Medicine and Dentistry (SSMD), Western University; Lawson Health Research Institute (LHRI); Canadian Institutes of Health Research	Institute for Clinical Evaluative Sciences (ICES) Western site(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario (AMOSO); Schulich School of Medicine and Dentistry (SSMD), Western University; Lawson Health Research Institute (LHRI); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Institute for Clinical Evaluative Sciences (ICES) Western site. ICES is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). Core funding for ICES Western is provided by the Academic Medical Organization of Southwestern Ontario (AMOSO), the Schulich School of Medicine and Dentistry (SSMD), Western University, and the Lawson Health Research Institute (LHRI). This project was conducted with members of the provincial ICES Kidney, Dialysis, and Transplantation Research Program, which receives programmatic grant funding from the Canadian Institutes of Health Research. The opinions, results, and conclusions are those of the authors and are independent from the funding sources. No endorsement by ICES, AMOSO, SSMD, LHRI, or the MOHLTC is intended or should be inferred.	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bailey KM, 2010, CIRC-CARDIOVASC GENE, V3, P276, DOI 10.1161/CIRCGENETICS.109.898502; Bangalore S, 2014, AM J CARDIOL, V113, P2018, DOI 10.1016/j.amjcard.2014.03.046; Brault M, 2014, METABOLISM, V63, P735, DOI 10.1016/j.metabol.2014.02.014; Carter AA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2610; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen GL, 2014, PHARMACOEPIDEM DR S, V23, P719, DOI 10.1002/pds.3646; DeGorter MK, 2012, ANNU REV PHARMACOL, V52, P249, DOI 10.1146/annurev-pharmtox-010611-134529; DeGorter MK, 2013, CIRC-CARDIOVASC GENE, V6, P400, DOI 10.1161/CIRCGENETICS.113.000099; Dormuth C, 2013, BMJ-BRIT MED J, P346; Gandhi S, 2013, JAMA-J AM MED ASSOC, V310, P2544, DOI 10.1001/jama.2013.282426; Government of Canada, CHIN CAN POP; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Gupta M, 2009, J CLIN PHARMACOL, V49, P831, DOI 10.1177/0091270009334376; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; Higashi T, 2004, ANN INTERN MED, V140, P714, DOI 10.7326/0003-4819-140-9-200405040-00011; Huang SM, 2008, CLIN PHARMACOL THER, V84, P287, DOI 10.1038/clpt.2008.144; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Jain AK, 2012, KIDNEY INT, V81, P1248, DOI 10.1038/ki.2012.18; Jha P, 1996, J AM COLL CARDIOL, V27, P1335, DOI 10.1016/0735-1097(96)00018-6; Lai CL, 2015, AM J CARDIOL, V115, P619, DOI 10.1016/j.amjcard.2014.12.009; Lee E, 2005, CLIN PHARMACOL THER, V78, P330, DOI 10.1016/j.clpt.2005.06.013; Leiter LA, 2011, CAN J CARDIOL, V27, DOI [10.1016/j.cjca.2011.01.016, 10.1016/j.cjca.2010.12.054]; Levy A, 2002, CAN J CLIN PHARM, V10, P67; Li DQ, 2015, CAN MED ASSOC J, V187, P174, DOI 10.1503/cmaj.140950; Liao JK, 2007, AM J CARDIOL, V99, P410, DOI 10.1016/j.amjcard.2006.08.051; Mancini GBJ, 2011, CAN J CARDIOL, V27, P635, DOI 10.1016/j.cjca.2011.05.007; Molnar AO, 2011, J AM SOC NEPHROL, V22, P939, DOI 10.1681/ASN.2010050442; Morales D, 2004, CURR MED RES OPIN, V20, P1235, DOI 10.1185/030079904125004367; Patel AM, 2013, ANN INTERN MED, V158, P869, DOI 10.7326/0003-4819-158-12-201306180-00004; Prasad GVR, 2002, TRANSPLANTATION, V74, P1200, DOI 10.1097/01.TP.0000031950.34040.79; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reid RJ, 2001, MED CARE, V39, P86, DOI 10.1097/00005650-200101000-00010; Saito Y, 2002, J ATHEROSCLEROSIS TH, V10, P329; Shah BR, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-42; Shih AWY, 2012, KIDNEY INT, V82, P903, DOI 10.1038/ki.2012.227; Statistics Canada, POP SEX AG GROUP PRO; Statistics Canada, VIS MIN POP PROV TER; United States Census Bureau, 2010, RAC REP AS POP SEL C; United States Food and Drug Administration, FDA EXP ADV STAT RIS; US Food and Drug Administration, FDA PUBL HLTH ADV CR; US Food and Drug Administration, DRUG DEV DRUG INT TA; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Wang KY, 2001, JPN HEART J, V42, P725, DOI 10.1536/jhj.42.725; Wang P, 2011, PHARMACOGENOMICS, V12, P1605, DOI [10.2217/PGS.11.98, 10.2217/pgs.11.98]; Wu CC, 2002, J FORMOS MED ASSOC, V101, P478; Yasuda SU, 2008, CLIN PHARMACOL THER, V84, P417, DOI 10.1038/clpt.2008.141; Zhao YY, 2012, ANN INTERN MED, V156, P560, DOI [10.7326/0003-4819-156-8-201204170-00401, 10.7326/0003-4819-156-8-201204170-00003]; ZHOU HH, 1989, NEW ENGL J MED, V320, P565, DOI 10.1056/NEJM198903023200905	52	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150990	10.1371/journal.pone.0150990	http://dx.doi.org/10.1371/journal.pone.0150990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954681	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300070
J	Breton, CV; Mack, WJ; Yao, J; Berhane, K; Amadeus, M; Lurmann, F; Gilliland, F; McConnell, R; Hodis, HN; Kunzli, N; Avol, E				Breton, Carrie V.; Mack, Wendy J.; Yao, Jin; Berhane, Kiros; Amadeus, Milena; Lurmann, Fred; Gilliland, Frank; McConnell, Rob; Hodis, Howard N.; Kunzli, Nino; Avol, Ed			Prenatal Air Pollution Exposure and Early Cardiovascular Phenotypes in Young Adults	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; SOUTHERN CALIFORNIA COMMUNITIES; CAROTID ARTERIAL STIFFNESS; AMERICAN-HEART-ASSOCIATION; PARTICULATE MATTER; DEVELOPMENTAL ORIGINS; PERSONAL EXPOSURE; OXIDATIVE STRESS; DIFFERING LEVELS; LIFE-STYLE	Exposure to ambient air pollutants increases risk for adverse cardiovascular health outcomes in adults. We aimed to evaluate the contribution of prenatal air pollutant exposure to cardiovascular health, which has not been thoroughly evaluated. The Testing Responses on Youth (TROY) study consists of 768 college students recruited from the University of Southern California in 2007-2009. Participants attended one study visit during which blood pressure, heart rate and carotid artery arterial stiffness (CAS) and carotid artery intimamedia thickness (CIMT) were assessed. Prenatal residential addresses were geocoded and used to assign prenatal and postnatal air pollutant exposure estimates using the U.S. Environmental Protection Agency's Air Quality System (AQS) database. The associations between CAS, CIMT and air pollutants were assessed using linear regression analysis. Prenatal PM10 and PM2.5 exposures were associated with increased CAS. For example, a 2 SD increase in prenatal PM2.5 was associated with CAS indices, including a 5% increase (beta = 1.05, 95% CI 1.00-1.10) in carotid stiffness index beta, a 5% increase (beta = 1.05, 95% CI 1.01-1.10) in Young's elastic modulus and a 5% decrease (beta = 0.95, 95% CI 0.91-0.99) in distensibility. Mutually adjusted models of pre- and postnatal PM2.5 further suggested the prenatal exposure was most relevant exposure period for CAS. No associations were observed for CIMT. In conclusion, prenatal exposure to elevated air pollutants may increase carotid arterial stiffness in a young adult population of college students. Efforts aimed at limiting prenatal exposures are important public health goals.	[Breton, Carrie V.; Mack, Wendy J.; Yao, Jin; Berhane, Kiros; Amadeus, Milena; Gilliland, Frank; McConnell, Rob; Hodis, Howard N.; Avol, Ed] Univ So Calif, Dept Prevent Med, 2001 N Soto St, Los Angeles, CA 90089 USA; [Mack, Wendy J.; Hodis, Howard N.] Univ So Calif, Atherosclerosis Res Unit, 2250 Alcazar St,CSC 132, Los Angeles, CA 90033 USA; [Lurmann, Fred] Sonoma Technol Inc, 1455 N McDowell Blvd,Suite D, Petaluma, CA 94954 USA; [Kunzli, Nino] Swiss Trop & Publ Hlth Inst, 57 POB, CH-4002 Basel, Switzerland; [Kunzli, Nino] Univ Basel, Peterspl 1, CH-4003 Basel, Switzerland	University of Southern California; University of Southern California; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Breton, CV (corresponding author), Univ So Calif, Dept Prevent Med, 2001 N Soto St, Los Angeles, CA 90089 USA.	breton@usc.edu	Kuenzli, Nino/F-7195-2014	Kuenzli, Nino/0000-0001-8360-080X	National Institutes of Health [1K01ES017801, 5R01ES014708, 5P30ES007048, 5P01ES009581, R826708-01, RD831861-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009581, P01ES022845, P30ES007048, R01ES014708, K01ES017801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health 1K01ES017801, http://www.nih.gov/, CVB; National Institutes of Health 5R01ES014708, EA; National Institutes of Health 5P30ES007048, FG; National Institutes of Health 5P01ES009581, FG; National Institutes of Health R826708-01 and RD831861-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Fred Lurmann is employed by Sonoma Technology Inc (STI). STI was paid to conduct the air pollution exposure assignments used in the analyses in this manuscript. The specific roles of these authors are articulated in the 'author contributions' section. One of the authors.	Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 2008, NESTLE NUTR WORKS SE, V61, P21, DOI 10.1159/0000113163; Bauer M, 2010, J AM COLL CARDIOL, V56, P1803, DOI 10.1016/j.jacc.2010.04.065; Bell ML, 2010, EPIDEMIOLOGY, V21, P884, DOI 10.1097/EDE.0b013e3181f2f405; Bianchini E, 2013, CURR PHARM DESIGN, V19, P2390, DOI 10.2174/1381612811319130007; Breton CV, 2012, CIRCULATION, V126, P1614, DOI 10.1161/CIRCULATIONAHA.112.096164; Breton CV, 2011, ATHEROSCLEROSIS, V217, P441, DOI 10.1016/j.atherosclerosis.2011.05.022; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2010, CURR ATHEROSCLER REP, V12, P291, DOI 10.1007/s11883-010-0122-7; Calderon-Garciduenas L, 2008, INHAL TOXICOL, V20, P499, DOI 10.1080/08958370701864797 ; Chirinos JA, 2012, J CARDIOVASC TRANSL, V5, P243, DOI 10.1007/s12265-012-9359-6; Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC; Damaceno-Rodrigues NR, 2009, INHAL TOXICOL, V21, P1129, DOI 10.1080/08958370902798430; Fernhall B, 2008, J APPL PHYSIOL, V105, P325, DOI 10.1152/japplphysiol.00001.2008; Fetterman JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066835; Gillman MW, 2007, PEDIATR RES, V61, P625, DOI 10.1203/pdr.0b013e3180459fcd; Glasser SP, 2011, CURR CARDIOVASC RISK, V5, P187, DOI 10.1007/s12170-010-0151-3; Hannam K, 2013, ENVIRON SCI-PROC IMP, V15, P1562, DOI 10.1039/c3em00112a; Herouvi D, 2013, EUR J PEDIATR, V172, P721, DOI 10.1007/s00431-013-1932-8; Hodis HN, 2002, CIRCULATION, V106, P1453, DOI 10.1161/01.CIR.0000029092.99946.08; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Iannuzzi A, 2010, CARDIOL YOUNG, V20, P186, DOI 10.1017/S1047951109992010; Kannan S, 2006, ENVIRON HEALTH PERSP, V114, P1636, DOI 10.1289/ehp.9081; Kelishadi R, 2014, CURR PROB PEDIATR AD, V44, P54, DOI 10.1016/j.cppeds.2013.12.005; Kelishadi R, 2009, ATHEROSCLEROSIS, V203, P311, DOI 10.1016/j.atherosclerosis.2008.06.022; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Lenters V, 2010, EPIDEMIOLOGY, V21, P512, DOI 10.1097/EDE.0b013e3181dec3a7; Mack WJ, 2003, PREV MED, V37, P148, DOI 10.1016/S0091-7435(03)00097-5; McNeal CJ, 2009, J PEDIATR ENDOCR MET, V22, P195; Mehta AJ, 2014, AM J EPIDEMIOL, V179, P192, DOI 10.1093/aje/kwt271; Newby DE, 2015, EUR HEART J, V36, P83, DOI 10.1093/eurheartj/ehu458; Okada T, 2010, CIRC J, V74, P2299, DOI 10.1253/circj.CJ-10-0850; Perez L, 2015, ENV HLTH PERSPECT; Peters JM, 1999, AM J RESP CRIT CARE, V159, P760, DOI 10.1164/ajrccm.159.3.9804143; Peters JM, 1999, AM J RESP CRIT CARE, V159, P768, DOI 10.1164/ajrccm.159.3.9804144; Rivera-Gonzlez LO, 2015, J AIR WASTE MANAGE, V65, P581, DOI 10.1080/10962247.2015.1020974; SAS/STAT, 2002, VERS 9 PROGR; SELZER RH, 1994, ATHEROSCLEROSIS, V111, P1, DOI 10.1016/0021-9150(94)90186-4; Selzer RH, 2001, ATHEROSCLEROSIS, V154, P185, DOI 10.1016/S0021-9150(00)00461-5; Stabouli S, 2015, J HYPERTENS, V33, P88, DOI 10.1097/HJH.0000000000000369; Strickland MJ, 2009, AM J EPIDEMIOL, V169, P1004, DOI 10.1093/aje/kwp011; Tetreault LF, 2013, INT J PUBLIC HEALTH, V58, P649, DOI 10.1007/s00038-013-0489-7; Urbina E, 2008, HYPERTENSION, V52, P433, DOI 10.1161/HYPERTENSIONAHA.108.190329; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wu CF, 2010, AM J EPIDEMIOL, V171, P1299, DOI 10.1093/aje/kwq060; Zhao XY, 2014, HYPERTENSION, V63, P871, DOI 10.1161/HYPERTENSIONAHA.113.02588	46	27	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150825	10.1371/journal.pone.0150825	http://dx.doi.org/10.1371/journal.pone.0150825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950592	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100065
J	Hellwig, K; Chen, LH; Stancyzk, FZ; Langer-Gould, AM				Hellwig, Kerstin; Chen, Lie H.; Stancyzk, Frank Z.; Langer-Gould, Annette M.			Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility	PLOS ONE			English	Article							CYTOKINE SECRETION; SCLEROSIS PATIENTS; RISK; PREGNANCY	Background The incidence of multiple sclerosis (MS) is rising in women. Objective To determine whether the use of combined oral contraceptives (COCs) are associated with MS risk and whether this varies by progestin content. Methods We conducted a nested case-control study of females ages 14-48 years with incident MS or clinically isolated syndrome (CIS) 2008-2011 from the membership of Kaiser Permanente Southern California. Controls were matched on age, race/ethnicity and membership characteristics. COC use up to ten years prior to symptom onset was obtained from the complete electronic health record. Results We identified 400 women with incident MS/CIS and 3904 matched controls. Forty-percent of cases and 32% of controls had used COCs prior to symptom onset. The use of COCs was associated with a slightly increased risk of MS/CIS (adjusted OR = 1.52, 95% CI = 1.21-1.91; p< 0.001). This risk did not vary by duration of COC use. The association varied by progestin content being more pronounced for levenorgestrol (adjusted OR = 1.75, 95% CI = 1.29-2.37; p< 0.001) than norethindrone (adjusted OR = 1.57, 95% CI = 1.16-2.12; p = 0.003) and absent for the newest progestin, drospirenone (p = 0.95). Conclusions Our findings should be interpreted cautiously. While the use of some combination oral contraceptives may contribute to the rising incidence of MS in women, an unmeasured confounder associated with the modern woman's lifestyle is a more likely explanation for this weak association.	[Hellwig, Kerstin] St Josef Univ Hosp, Neuroimmunol Ward, Bochum, Germany; [Hellwig, Kerstin] St Josef Univ Hosp, Outpatient Clin, Bochum, Germany; [Hellwig, Kerstin; Chen, Lie H.; Langer-Gould, Annette M.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Stancyzk, Frank Z.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Langer-Gould, Annette M.] Kaiser Permanente So Calif, Los Angeles Med Ctr, Dept Neurol, Los Angeles, CA USA	Ruhr University Bochum; Ruhr University Bochum; University of Hamburg; University Medical Center Hamburg-Eppendorf; Kaiser Permanente; University of Southern California; Kaiser Permanente; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Langer-Gould, AM (corresponding author), Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA.; Langer-Gould, AM (corresponding author), Kaiser Permanente So Calif, Los Angeles Med Ctr, Dept Neurol, Los Angeles, CA USA.	Annette.M.Langer-Gould@kp.org			Kaiser Permanente Direct Community Benefit Funds; National Institute of Neurological Disorders and Stroke [1R01NS075308]; National Institute of Neurological Disorders and Stroke (NINDS) [1R01NS075308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075308] Funding Source: NIH RePORTER	Kaiser Permanente Direct Community Benefit Funds; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Kaiser Permanente Direct Community Benefit Funds and National Institute of Neurological Disorders and Stroke 1R01NS075308. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Kaiser Permanente Direct Community Benefit Funds and the National Institute of Neurological Disorders and Stroke (NINDS, 1R01NS075308 PI: Langer-Gould)	Alonso A, 2005, ARCH NEUROL-CHICAGO, V62, P1362, DOI 10.1001/archneur.62.9.1362; Barnes G, 2002, NEUROLOGY, V59, P499, DOI 10.1212/wnl.59.4.499; Correale J, 1998, J IMMUNOL, V161, P3365; Gava G, 2014, FERTIL STERIL, V102, P116, DOI 10.1016/j.fertnstert.2014.03.054; Gilmore W, 1997, J IMMUNOL, V158, P446; GODET PG, 1995, GUT, V37, P668, DOI 10.1136/gut.37.5.668; Hedstrom AK, 2014, MULT SCLER J, V20, P406, DOI 10.1177/1352458513498126; Hernan MA, 2000, NEUROLOGY, V55, P848, DOI 10.1212/WNL.55.6.848; Holmqvist P, 2010, FERTIL STERIL, V94, P2835, DOI 10.1016/j.fertnstert.2010.06.045; Holmqvist P, 2009, EUR J CONTRACEP REPR, V14, P365, DOI 10.3109/13625180903137329; Khalili H, 2013, GUT, V62, P1153, DOI 10.1136/gutjnl-2012-302362; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; Koebnick Corinna, 2012, Perm J, V16, P37; Langer-Gould A, 2011, NEUROLOGY, V77, P1143, DOI 10.1212/WNL.0b013e31822facdd; Langer-Gould A, 2010, MULT SCLER J, V16, P855, DOI 10.1177/1352458510369146; Langer-Gould A, 2013, NEUROLOGY, V80, P1734, DOI 10.1212/WNL.0b013e3182918cc2; Langer-Gould A, 2013, NEUROLOGY, V80, P548, DOI 10.1212/WNL.0b013e31828154f3; McKay KA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/817238; Ngo ST, 2014, FRONTIERS NEUROENDOC; Palacios N, 2011, ANN EPIDEMIOL, V21, P536, DOI 10.1016/j.annepidem.2011.03.001; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ponsonby AL, 2012, NEUROLOGY, V78, P867, DOI 10.1212/WNL.0b013e31824c4648; Sena A, 2012, J NEUROL SCI, V317, P47, DOI 10.1016/j.jns.2012.02.033; Suissa S, 1997, CONTRACEPTION, V56, P141, DOI 10.1016/S0010-7824(97)00119-4; Thorogood M, 1998, BRIT J OBSTET GYNAEC, V105, P1296, DOI 10.1111/j.1471-0528.1998.tb10008.x; VILLARDMACKINTOSH L, 1993, CONTRACEPTION, V47, P161, DOI 10.1016/0010-7824(93)90088-O; WEINSHENKER BG, 1989, NEUROLOGY, V39, P1438, DOI 10.1212/WNL.39.11.1438	27	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0149094	10.1371/journal.pone.0149094	http://dx.doi.org/10.1371/journal.pone.0149094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950301	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100009
J	Ichise, H; Ichise, T; Yoshida, N				Ichise, Hirotake; Ichise, Taeko; Yoshida, Nobuaki			Phospholipase C gamma 2 Is Required for Luminal Expansion of the Epididymal Duct during Postnatal Development in Mice	PLOS ONE			English	Article							LYMPHATIC ENDOTHELIAL-CELLS; RAT EPIDIDYMIS; VASCULAR DEVELOPMENT; TRANSGENIC MICE; BASAL-CELLS; B-CELL; SEPARATION; BLOOD; SYK; EXPRESSION	Phospholipase C gamma 2 (PLC gamma 2)-deficient mice exhibit misconnections of blood and lymphatic vessels, and male infertility. However, the cell type responsible for vascular partitioning and the mechanism for male infertility remain unknown. Accordingly, we generated a mouse line that conditionally expresses endogenous Plcg2 in a Cre/loxP recombination-dependent manner, and found that Tie2-Cre- or Pf4-Cre-driven reactivation of Plcg2 rescues PLC gamma 2-deficient mice from the vascular phenotype. By contrast, male mice rescued from the vascular phenotype exhibited epididymal sperm granulomas. As judged from immunostaining, PLC gamma 2 was expressed in clear cells in the epididymis. PLC gamma 2 deficiency did not compromise differentiation of epididymal epithelial cells, including clear cells, and tube formation at postnatal week 2. However, luminal expansion of the epididymal duct was impaired during the prepubertal period, regardless of epithelial cell polarity and tube architecture. These results suggest that PLC gamma 2-deficient clear cells cause impaired luminal expansion, stenosis of the epididymal duct, attenuation of luminal flow, and subsequent sperm granulomas. Clear cell-mediated luminal expansion is also supported by the observation that PLC gamma 2-deficient males were rescued from infertility by epididymal epithelium-specific reactivation of Plcg2, although the edematous and hemorrhagic phenotype associated with PLC gamma 2 deficiency also caused spontaneous epididymal sperm granulomas in aging males. Collectively, our findings demonstrate that PLC gamma 2 in clear cells plays an essential role in luminal expansion of the epididymis during the prepubertal period in mice, and reveal an unexpected link between PLC gamma 2, clear cells, and epididymal development.	[Ichise, Hirotake; Ichise, Taeko; Yoshida, Nobuaki] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Dev Genet,Minato Ku, Tokyo, Japan	University of Tokyo	Ichise, H (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Dev Genet,Minato Ku, Tokyo, Japan.	h-ichise@ims.u-tokyo.ac.jp	Ichise, Hirotake/V-3536-2019	Ichise, Hirotake/0000-0002-3424-6637; Ichise, Taeko/0000-0002-1441-1463	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22590187]; Grants-in-Aid for Scientific Research [15K08418] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (C) [22590187] (to HI and TI) and Global COE Program "Center of Education and Research for the Advanced Genome-Based Medicine - For personalized medicine and the control of worldwide infectious diseases" (to HI and NY) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2011, ARTHRITIS RHEUM-US, V63, P1301, DOI 10.1002/art.30280; Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Blomqvist SR, 2006, EMBO J, V25, P4131, DOI 10.1038/sj.emboj.7601272; Bohmer R, 2010, DEV CELL, V18, P437, DOI 10.1016/j.devcel.2010.01.009; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; Breton S, 1999, HISTOCHEM CELL BIOL, V111, P97, DOI 10.1007/s004180050339; Calaminus SDJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051361; Carramolino L, 2010, CIRC RES, V106, P1197, DOI 10.1161/CIRCRESAHA.110.218073; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Deng W, 2013, P NATL ACAD SCI USA, V110, P14972, DOI 10.1073/pnas.1220884110; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; HERMO L, 1988, AM J ANAT, V183, P107, DOI 10.1002/aja.1001830202; Ichise H, 2009, DEVELOPMENT, V136, P191, DOI 10.1242/dev.025353; Ichise T, 2010, DEVELOPMENT, V137, P1003, DOI 10.1242/dev.043489; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Osada M, 2012, J BIOL CHEM, V287, P22241, DOI 10.1074/jbc.M111.329987; Raymond AS, 2010, MOL REPROD DEV, V77, P550, DOI 10.1002/mrd.21189; Robaire B, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1071; Sawamoto O, 2003, EXP TOXICOL PATHOL, V55, P121, DOI 10.1078/0940-2993-00316; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; Shum WWC, 2013, REPRODUCTION, V146, P455, DOI 10.1530/REP-12-0510; Shum WWC, 2008, CELL, V135, P1108, DOI 10.1016/j.cell.2008.10.020; Takeuchi T, 2002, BIOCHEM BIOPH RES CO, V293, P953, DOI 10.1016/S0006-291X(02)00321-2; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Yu P, 2005, IMMUNITY, V22, P451, DOI 10.1016/j.immuni.2005.01.018; Zhao GQ, 1998, DEVELOPMENT, V125, P1103	34	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150521	10.1371/journal.pone.0150521	http://dx.doi.org/10.1371/journal.pone.0150521			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950550	Green Published, gold			2022-12-27	WOS:000371990100038
J	Park, KY; Oh, E; Kwak, MK; Jun, HS; Heo, TH				Park, Kyung-Yeon; Oh, Euichaul; Kwak, Mi-Kyoung; Jun, Hyun Sik; Heo, Tae-Hwe			Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice	PLOS ONE			English	Article							AORTIC ATHEROSCLEROSIS; PROGRESSION; MODULATION; RABBITS; DISEASE	Pravastatin is a lipid-lowering agent that attenuates atherosclerosis. However, the multifactorial pathogenesis of atherosclerosis requires other drugs with different anti-atherogenic mechanisms. We chose sarpogrelate as an anti-platelet agent and a novel component of a complex drug with pravastatin due to its high potential but little information on its beneficial effects on atherosclerosis. Low-density lipoprotein receptor-knockout mice were fed a highfat, high-cholesterol diet and treated with pravastatin alone, sarpogrelate alone, or a combination of both drugs. Although sarpogrelate alone did not significantly reduce atherosclerotic plaque areas, co-treatment with pravastatin significantly decreased aortic lesions compared to those of the pravastatin alone treated group. The combined therapy was markedly more effective than that of the single therapies in terms of foam cell formation, smooth muscle cell proliferation, and inflammatory cytokine levels. These results suggest that pravastatin and sarpogrelate combined therapy may provide a new therapeutic strategy for treating atherosclerosis.	[Park, Kyung-Yeon; Oh, Euichaul; Kwak, Mi-Kyoung; Heo, Tae-Hwe] Catholic Univ Korea, Integrated Res Inst Pharmaceut Sci, Coll Pharm, Bucheon, South Korea; [Jun, Hyun Sik] Korea Univ, Dept Biotechnol & Bioinformat, Coll Sci & Technol, Sejong, South Korea	Catholic University of Korea; Korea University	Heo, TH (corresponding author), Catholic Univ Korea, Integrated Res Inst Pharmaceut Sci, Coll Pharm, Bucheon, South Korea.; Jun, HS (corresponding author), Korea Univ, Dept Biotechnol & Bioinformat, Coll Sci & Technol, Sejong, South Korea.	toddjun@gmail.com; thhur92@catholic.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2009176]; Bio & Medical Technology Development Program of the NRF - Ministry of Science, ICT, & Future Planning [NRF-2013M3A9B5075839]; Research Fund of the Catholic University of Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Bio & Medical Technology Development Program of the NRF - Ministry of Science, ICT, & Future Planning; Research Fund of the Catholic University of Korea	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education [2013R1A1A2009176]; the Bio & Medical Technology Development Program of the NRF funded by the Ministry of Science, ICT, & Future Planning [NRF-2013M3A9B5075839]; and Research Fund 2016 of the Catholic University of Korea.	Carter AA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2610; Chogtu B, 2015, WORLD J DIABETES, V6, P352, DOI 10.4239/wjd.v6.i2.352; Rosa Marcelo Pereira da, 2006, Arq. Bras. Cardiol., V87, pe222, DOI 10.1590/S0066-782X2006001800035; Daida Hiroyuki, 2003, J Atheroscler Thromb, V10, P25; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Hayashi T, 2003, ATHEROSCLEROSIS, V168, P23, DOI 10.1016/S0021-9150(03)00054-6; Kim SM, 2013, CARDIOVASC THER, V31, pE94, DOI 10.1111/1755-5922.12042; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Li M, 2007, ATHEROSCLEROSIS, V194, P348, DOI 10.1016/j.atherosclerosis.2006.11.006; Monroe AK, 2014, AHRQ COMP EFFECTIVEN; Pflieger M, 2011, AM FAM PHYSICIAN, V83, P819; PITT B, 1995, J AM COLL CARDIOL, V26, P1133, DOI 10.1016/0735-1097(95)00301-0; Saini HK, 2004, CARDIOVASC DRUG REV, V22, P27; Shiomi M, 1999, ATHEROSCLEROSIS, V142, P345, DOI 10.1016/S0021-9150(98)00259-7; van der Hoorn JWA, 2007, J HYPERTENS, V25, P2454, DOI 10.1097/HJH.0b013e3282ef79f7; Xu YJ, 2012, J CELL MOL MED, V16, P2394, DOI 10.1111/j.1582-4934.2012.01554.x; Zhou XX, 2009, CLIN EXP PHARMACOL P, V36, P373, DOI 10.1111/j.1440-1681.2008.05067.x; Zhou XX, 2008, INT J MOL SCI, V9, P2253, DOI 10.3390/ijms9112253	18	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150791	10.1371/journal.pone.0150791	http://dx.doi.org/10.1371/journal.pone.0150791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950217	Green Submitted, Green Published, gold			2022-12-27	WOS:000371990100062
J	Beston, JA; Diffendorfer, JE; Loss, SR; Johnson, DH				Beston, Julie A.; Diffendorfer, Jay E.; Loss, Scott R.; Johnson, Douglas H.			Prioritizing Avian Species for Their Risk of Population-Level Consequences from Wind Energy Development	PLOS ONE			English	Article							HABITAT LOSS; BIRD FATALITIES; NICHE BREADTH; FARMS; MORTALITY; EXTINCTION; TURBINES; BAT; IMPACTS; FACILITIES	Recent growth in the wind energy industry has increased concerns about its impacts on wildlife populations. Direct impacts of wind energy include bird and bat collisions with turbines whereas indirect impacts include changes in wildlife habitat and behavior. Although many species may withstand these effects, species that are long-lived with low rates of reproduction, have specialized habitat preferences, or are attracted to turbines may be more prone to declines in population abundance. We developed a prioritization system to identify the avian species most likely to experience population declines from wind facilities based on their current conservation status and their expected risk from turbines. We developed 3 metrics of turbine risk that incorporate data on collision fatalities at wind facilities, population size, life history, species' distributions relative to turbine locations, number of suitable habitat types, and species' conservation status. We calculated at least 1 measure of turbine risk for 428 avian species that breed in the United States. We then simulated 100,000 random sets of cutoff criteria (i.e., the metric values used to assign species to different priority categories) for each turbine risk metric and for conservation status. For each set of criteria, we assigned each species a priority score and calculated the average priority score across all sets of criteria. Our prioritization system highlights both species that could potentially experience population decline caused by wind energy and species at low risk of population decline. For instance, several birds of prey, such as the long-eared owl, ferruginous hawk, Swainson's hawk, and golden eagle, were at relatively high risk of population decline across a wide variety of cutoff values, whereas many passerines were at relatively low risk of decline. This prioritization system is a first step that will help researchers, conservationists, managers, and industry target future study and management activity.	[Beston, Julie A.; Diffendorfer, Jay E.] US Geol Survey, Geosci & Environm Change Sci Ctr, Box 25046, Denver, CO 80225 USA; [Loss, Scott R.] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA; [Johnson, Douglas H.] US Geol Survey, Northern Prairie Wildlife Res Ctr, St Paul, MN USA; [Beston, Julie A.] Univ Wisconsin Stout, Dept Biol, Menomonie, WI USA	United States Department of the Interior; United States Geological Survey; Oklahoma State University System; Oklahoma State University - Stillwater; United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Stout	Diffendorfer, JE (corresponding author), US Geol Survey, Geosci & Environm Change Sci Ctr, Box 25046, Denver, CO 80225 USA.	jediffendorfer@usgs.gov		Diffendorfer, Jay/0000-0003-1093-6948; Loss, Scott/0000-0002-8753-2995	Energy Resources Program at the United States Geological Survey	Energy Resources Program at the United States Geological Survey	This research was fully funded through the Energy Resources Program at the United States Geological Survey. No funds, external to USGS, were used. The methodology was reviewed and modified as part of the USGS Fundamental Science Practices http://www.usgs.gov/fsp/ as implemented by the Energy Resources Program.	Andelman SJ, 2004, ACTA OECOL, V26, P75, DOI 10.1016/j.actao.2004.04.005; Andow DA, 2004, BIOSCIENCE, V54, P637, DOI 10.1641/0006-3568(2004)054[0637:SRAFNE]2.0.CO;2; [Anonymous], BIRDS N AM ONLINE; [Anonymous], 2014, R LANG ENV STAT COMP; Arnold TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024708; Barclay RMR, 2007, CAN J ZOOL, V85, P381, DOI 10.1139/Z07-011; Beach R, 2011, STATE WILDLIFE ACTIO; Bellebaum J, 2013, J NAT CONSERV, V21, P394, DOI 10.1016/j.jnc.2013.06.001; Beston JA, 2015, J WILDLIFE MANAGE, V79, P513, DOI 10.1002/jwmg.852; Braunisch V, 2015, J NAT CONSERV, V24, P31, DOI 10.1016/j.jnc.2015.01.003; Carrascal LM, 2014, ECOL RES, V29, P203, DOI 10.1007/s11284-013-1114-1; Carrete M, 2012, BIOL CONSERV, V145, P102, DOI 10.1016/j.biocon.2011.10.017; Carrete M, 2009, BIOL CONSERV, V142, P2954, DOI 10.1016/j.biocon.2009.07.027; Dahl EL, 2012, BIOL CONSERV, V145, P79, DOI 10.1016/j.biocon.2011.10.012; de Lucas M, 2008, J APPL ECOL, V45, P1695, DOI 10.1111/j.1365-2664.2008.01549.x; Desholm M, 2009, J ENVIRON MANAGE, V90, P2672, DOI 10.1016/j.jenvman.2009.02.005; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Erickson ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092132, 10.1371/journal.pone.0107491]; European Commission, 2011, EU GUID WIND EN DEV; Fox AD, 2006, IBIS, V148, P129, DOI 10.1111/j.1474-919X.2006.00510.x; Game ET, 2013, CONSERV BIOL, V27, P480, DOI 10.1111/cobi.12051; Hull CL, 2013, NEW ZEAL J ZOOL, V40, P47, DOI 10.1080/03014223.2012.757243; Hunt G, 2002, PIER CONSULTANT REPO, P52; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Johnston NN, 2013, AVIAN CONSERV ECOL, V8, DOI [10.5751/ACE-00608-080212, DOI 10.5751/ACE-00608-080212]; Kitano M, 2013, WILDLIFE SOC B, V37, P41, DOI 10.1002/wsb.255; Kruger O, 2010, BIOL CONSERV, V143, P710, DOI 10.1016/j.biocon.2009.12.010; Langston R. H. W, 2003, WINDFARMS BIRDS ANAL; Larsen JK, 2007, J APPL ECOL, V44, P516, DOI 10.1111/j.1365-2664.2007.01303.x; Leddy KL, 1999, WILSON BULL, V111, P100; Longcore T, 2013, BIOL CONSERV, V158, P410, DOI 10.1016/j.biocon.2012.09.019; Loss SR, 2013, BIOL CONSERV, V168, P201, DOI 10.1016/j.biocon.2013.10.007; Loss SR, 2012, FRONT ECOL ENVIRON, V10, P357, DOI 10.1890/110251; Manne LL, 2001, ANIM CONSERV, V4, P221, DOI 10.1017/S1367943001001263; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Masden EA, 2010, ENVIRON IMPACT ASSES, V30, P1, DOI 10.1016/j.eiar.2009.05.002; Menendez-Guerrero PA, 2013, ECOGRAPHY, V36, P756, DOI 10.1111/j.1600-0587.2012.07877.x; Michel N, 2006, MONITORING AVIAN PRO; Miller TA, 2014, CONSERV BIOL, V28, P745, DOI 10.1111/cobi.12227; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; O'Grady JJ, 2004, BIOL CONSERV, V118, P513, DOI 10.1016/j.biocon.2003.10.002; Oli MK, 2004, BASIC APPL ECOL, V5, P449, DOI 10.1016/j.baae.2004.06.002; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pearce-Higgins JW, 2009, J APPL ECOL, V46, P1323, DOI 10.1111/j.1365-2664.2009.01715.x; Percival Steve, 2005, British Birds, V98, P194; Peron G, 2013, J ANIM ECOL, V82, P408, DOI 10.1111/1365-2656.12014; Peste F, 2015, ENVIRON IMPACT ASSES, V51, P10, DOI 10.1016/j.eiar.2014.11.001; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Pruett CL, 2009, CONSERV BIOL, V23, P1253, DOI 10.1111/j.1523-1739.2009.01254.x; Regan HM, 2008, DIVERS DISTRIB, V14, P462, DOI 10.1111/j.1472-4642.2007.00447.x; Rickart EA, 2011, DIVERS DISTRIB, V17, P530, DOI 10.1111/j.1472-4642.2011.00758.x; Roscioni F, 2013, BIODIVERS CONSERV, V22, P1821, DOI 10.1007/s10531-013-0515-3; Roscioni F, 2014, LANDSCAPE ECOL, V29, P891, DOI 10.1007/s10980-014-0030-2; Runge MC, 2009, J WILDLIFE MANAGE, V73, P556, DOI 10.2193/2008-090; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Santos H, 2013, BIOL CONSERV, V157, P178, DOI 10.1016/j.biocon.2012.06.017; Schaub M, 2012, BIOL CONSERV, V155, P111, DOI 10.1016/j.biocon.2012.06.021; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Smallwood KS, 2008, J WILDLIFE MANAGE, V72, P215, DOI 10.2193/2007-032; Smallwood KS, 2007, J WILDLIFE MANAGE, V71, P2781, DOI 10.2193/2007-006; Smallwood KS, 2013, WILDLIFE SOC B, V37, P19, DOI 10.1002/wsb.260; Smallwood KS, 2009, J WILDLIFE MANAGE, V73, P1062, DOI 10.2193/2008-464; Stahl JT, 2006, ECOL MODEL, V198, P23, DOI 10.1016/j.ecolmodel.2006.04.001; Stewart GB, 2007, ENVIRON CONSERV, V34, P1, DOI 10.1017/S0376892907003554; Sutter RD, 2006, SEQUENCING CONSERVAT, P257; Swihart RK, 2006, DIVERS DISTRIB, V12, P277, DOI 10.1111/j.1366-9516.2006.00242.x; Swihart RK, 2003, DIVERS DISTRIB, V9, P1, DOI 10.1046/j.1472-4642.2003.00158.x; U.S. Department of Justice, 2013, JUSTICE NEWS    1122; USFWS [U.S. Fish and Wildlife Service], 2013, EAGLE CONSERVATION P; Walker D., 2005, Scottish Birds, V25, P24; Watling JI, 2007, DIVERS DISTRIB, V13, P372, DOI 10.1111/j.1472-4642.2007.00331.x; Wiser R, 2013, WIND TECHNOLOGIES MA; Zimmerling JR, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00609-080210	74	36	36	2	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150813	10.1371/journal.pone.0150813	http://dx.doi.org/10.1371/journal.pone.0150813			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963254	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000066
J	Fei, MH; Gols, R; Zhu, F; Harvey, JA				Fei, Minghui; Gols, Rieta; Zhu, Feng; Harvey, Jeffrey A.			Plant Quantity Affects Development and Survival of a Gregarious Insect Herbivore and Its Endoparasitoid Wasp	PLOS ONE			English	Article							CLUTCH-SIZE; HOST-PLANT; EGG DEPOSITION; TROPHIC LEVELS; QUALITY; MOTH; EVOLUTION; DYNAMICS; LEPIDOPTERA; STARVATION	Virtually all studies of plant-herbivore-natural enemy interactions focus on plant quality as the major constraint on development and survival. However, for many gregarious feeding insect herbivores that feed on small or ephemeral plants, the quantity of resources is much more limiting, yet this area has received virtually no attention. Here, in both lab and semi-field experiments using tents containing variably sized clusters of food plants, we studied the effects of periodic food deprivation in a tri-trophic system where quantitative constraints are profoundly important on insect performance. The large cabbage white Pieris brassicae, is a specialist herbivore of relatively small wild brassicaceous plants that grow in variable densities, with black mustard (Brassica nigra) being one of the most important. Larvae of P. brassicae are in turn attacked by a specialist endoparasitoid wasp, Cotesia glomerata. Increasing the length of food deprivation of newly molted final instar caterpillars significantly decreased herbivore and parasitoid survival and biomass, but shortened their development time. Moreover, the ability of caterpillars to recover when provided with food again was correlated with the length of the food deprivation period. In outdoor tents with natural vegetation, we created conditions similar to those faced by P. brassicae in nature by manipulating plant density. Low densities of B. nigra lead to potential starvation of P. brassicae broods and their parasitoids, replicating nutritional conditions of the lab experiments. The ability of both unparasitized and parasitized caterpillars to find corner plants was similar but decreased with central plant density. Survival of both the herbivore and parasitoid increased with plant density and was higher for unparasitized than for parasitized caterpillars. Our results, in comparison with previous studies, reveal that quantitative constraints are far more important that qualitative constraints on the performance of gregarious insect herbivores and their gregarious parasitoids in nature.	[Fei, Minghui; Harvey, Jeffrey A.] Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands; [Gols, Rieta; Zhu, Feng] Wageningen Univ, Entomol Lab, NL-6700 AP Wageningen, Netherlands; [Harvey, Jeffrey A.] Vrije Univ Amsterdam, Sect Anim Ecol, Dept Ecol Sci, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Vrije Universiteit Amsterdam	Harvey, JA (corresponding author), Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands.; Harvey, JA (corresponding author), Vrije Univ Amsterdam, Sect Anim Ecol, Dept Ecol Sci, Amsterdam, Netherlands.	j.harvey@nioo.knaw.nl	Harvey, Jeffrey A/B-7439-2008; gols, rieta/H-7291-2019; Zhu, Feng/A-3659-2016; KNAW, NIOO-KNAW/A-4320-2012	Harvey, Jeffrey A/0000-0002-4227-7935; Gols, Rieta/0000-0002-6839-8225; Zhu, Feng/0000-0003-2083-3184; KNAW, NIOO-KNAW/0000-0002-3835-159X	China Scholarship Council [2011660018]	China Scholarship Council(China Scholarship Council)	This work is supported by a grant (no. 2011660018) from the China Scholarship Council, http://en.csc.edu.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W., 1949, PRINCIPLES ANIMAL EC; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Battisti A., 1988, J APPL ENTOMOL; Bergstrom A, 2006, ECOL ENTOMOL, V31, P255, DOI 10.1111/j.1365-2311.2006.00782.x; Brown CR, 2001, P ROY SOC B-BIOL SCI, V268, P1833, DOI 10.1098/rspb.2001.1749; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; COURTNEY SP, 1986, ADV ECOL RES, V15, P51, DOI 10.1016/S0065-2504(08)60120-8; DAMMAN H, 1991, Journal of Animal Ecology, V60, P193, DOI 10.2307/5454; DAVIES CR, 1985, OECOLOGIA, V67, P278, DOI 10.1007/BF00384299; DOVER BA, 1990, ENTOMOL EXP APPL, V57, P209, DOI 10.1007/BF00355019; Fei MH, 2014, J ANIM ECOL, V83, P234, DOI 10.1111/1365-2656.12122; Feltwell J., 1982, LARGE WHITE BUTTERFL; Fordyce JA, 2003, OECOLOGIA, V135, P250, DOI 10.1007/s00442-003-1177-8; Geiselhardt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059661; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Harvey JA, 2003, J ANIM ECOL, V72, P520, DOI 10.1046/j.1365-2656.2003.00722.x; Harvey JA, 2005, ENTOMOL EXP APPL, V117, P1, DOI 10.1111/j.1570-7458.2005.00348.x; HARVEY JA, 1995, ENTOMOL EXP APPL, V75, P213, DOI 10.1007/BF02382255; Harvey JA, 2000, ECOL ENTOMOL, V25, P267, DOI 10.1046/j.1365-2311.2000.00265.x; Harvey JA, 2008, PHYSIOL ENTOMOL, V33, P217, DOI 10.1111/j.1365-3032.2008.00623.x; Harvey JA, 2015, ECOL ENTOMOL, V40, P349, DOI 10.1111/een.12204; Hedrick PW, 1997, ANNU REV ECOL SYST, V28, P55, DOI 10.1146/annurev.ecolsys.28.1.55; Hilfiker O, 2014, PLANT J, V80, P1085, DOI 10.1111/tpj.12707; HOCHBERG ME, 1991, J THEOR BIOL, V153, P301, DOI 10.1016/S0022-5193(05)80572-7; Hunter AF, 2000, OIKOS, V91, P213, DOI 10.1034/j.1600-0706.2000.910202.x; Keeling L, 2001, SOCIAL BEHAV FARM AN; Kerslake JE, 1996, B ENTOMOL RES, V86, P155, DOI 10.1017/S0007485300052391; Konvicka M, 2003, EUR J ENTOMOL, V100, P313, DOI 10.14411/eje.2003.050; LEMASURIER AD, 1994, J ANIM ECOL, V63, P677, DOI 10.2307/5233; Liebhold A, 2003, ECOL LETT, V6, P133, DOI 10.1046/j.1461-0248.2003.00405.x; Liebhold A, 2000, POPUL ECOL, V42, P257, DOI 10.1007/PL00012004; Littell RC, 2002, SAS LINEAR MODELS; Loxdale HD, 2011, BIOL J LINN SOC, V103, P1, DOI 10.1111/j.1095-8312.2011.01627.x; Maskato Y, 2014, ARTHROPOD-PLANT INTE, V8, P285, DOI 10.1007/s11829-014-9307-2; Mattiacci L, 2001, CHEMOECOLOGY, V11, P167, DOI 10.1007/PL00001848; Mayhew PJ, 1998, P ROY SOC B-BIOL SCI, V265, P383, DOI 10.1098/rspb.1998.0306; MYERS JH, 1980, OECOLOGIA, V47, P16, DOI 10.1007/BF00541770; Pashalidou FG, 2015, ECOL LETT, V18, P927, DOI 10.1111/ele.12470; Pashalidou FG, 2015, ECOL ENTOMOL, V40, P444, DOI 10.1111/een.12208; PILSON D, 1988, NATURE, V333, P361, DOI 10.1038/333361a0; QUELLER DC, 1988, SCIENCE, V242, P1155, DOI 10.1126/science.242.4882.1155; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; Reader T, 2003, ECOL ENTOMOL, V28, P729, DOI 10.1111/j.1365-2311.2003.00560.x; Riipi M, 2001, NATURE, V413, P512, DOI 10.1038/35097061; RONA RJ, 1981, BRIT MED BULL, V37, P265, DOI 10.1093/oxfordjournals.bmb.a071713; Segoli M, 2010, EVOL ECOL RES, V12, P259; SHORROCKS B, 1990, LIVING PATCHY ENV; SILLENTULLBERG B, 1988, AM NAT, V132, P723, DOI 10.1086/284884; SLANSKY F, 1976, J NEW YORK ENTOMOL S, V84, P91; Soler R, 2005, J ANIM ECOL, V74, P1121, DOI 10.1111/j.1365-2656.2005.01006.x; Sznajder B, 2003, ENTOMOL EXP APPL, V109, P73, DOI 10.1046/j.1570-7458.2003.00096.x	52	9	10	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149539	10.1371/journal.pone.0149539	http://dx.doi.org/10.1371/journal.pone.0149539			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963702	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000015
J	Mincer, TJ; Aicher, AC				Mincer, Tracy J.; Aicher, Athena C.			Methanol Production by a Broad Phylogenetic Array of Marine Phytoplankton	PLOS ONE			English	Article							WATERS; PROCHLOROCOCCUS; TERRESTRIAL; TROPOSPHERE; NOV	Methanol is a major volatile organic compound on Earth and serves as an important carbon and energy substrate for abundant methylotrophic microbes. Previous geochemical surveys coupled with predictive models suggest that the marine contributions are exceedingly large, rivaling terrestrial sources. Although well studied in terrestrial ecosystems, methanol sources are poorly understood in the marine environment and warrant further investigation. To this end, we adapted a Purge and Trap Gas Chromatography/Mass Spectrometry (P&TGC/MS) method which allowed reliable measurements of methanol in seawater and marine phytoplankton cultures with a method detection limit of 120 nanomolar. All phytoplankton tested (cyanobacteria: Synechococcus spp. 8102 and 8103, Trichodesmium erythraeum, and Prochlorococcus marinus), and Eukarya (heterokont diatom: Phaeodactylum tricornutum, coccolithophore: Emiliania huxleyi, cryptophyte: Rhodomonas salina, and non-diatom heterokont: Nannochloropsis oculata) produced methanol, ranging from 0.8-13.7 micromolar in culture and methanol per total cellular carbon were measured in the ranges of 0.090.3%. Phytoplankton culture time-course measurements displayed a punctuated production pattern with maxima near early stationary phase. Stabile isotope labeled bicarbonate incorporation experiments confirmed that methanol was produced from phytoplankton biomass. Overall, our findings suggest that phytoplankton are a major source of methanol in the upper water column of the world's oceans.	[Mincer, Tracy J.; Aicher, Athena C.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Mincer, TJ (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	tmincer@whoi.edu		Mincer, Tracy/0000-0002-4644-5609	National Science Foundation [CHE-OCE 1131415]	National Science Foundation(National Science Foundation (NSF))	This project was solely supported by a grant to TJM from the National Science Foundation (Award# CHE-OCE 1131415).	Andersen RA, 1997, J PHYCOL, V33, P1, DOI 10.1111/j.0022-3646.1997.00001.x; Beale R, 2013, J GEOPHYS RES-OCEANS, V118, P5412, DOI 10.1002/jgrc.20322; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; CHRISTIAN JR, 1995, MAR ECOL PROG SER, V123, P217, DOI 10.3354/meps123217; Dixon JL, 2011, BIOGEOSCIENCES, V8, P2707, DOI 10.5194/bg-8-2707-2011; Dixon JL, 2013, ISME J, V7, P568, DOI 10.1038/ismej.2012.130; Domozych DS, 2014, PLANT PHYSIOL, V165, P105, DOI 10.1104/pp.114.236257; Fall R, 1996, TRENDS PLANT SCI, V1, P296, DOI 10.1016/S1360-1385(96)88175-0; Fawcett DWR, 2004, LIQUIDS SOLUTION INT; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Giovannoni SJ, 2008, ENVIRON MICROBIOL, V10, P1771, DOI 10.1111/j.1462-2920.2008.01598.x; HAMA T, 1983, MAR BIOL, V73, P31, DOI 10.1007/BF00396282; Harley P, 2007, BIOGEOSCIENCES, V4, P1083, DOI 10.5194/bg-4-1083-2007; Heikes BG, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001895; Hmelo LR, 2012, AQUAT MICROB ECOL, V67, P1, DOI 10.3354/ame01571; Hmelo LR, 2010, MICROBIAL INTERACTIO; JANVIER M, 1985, INT J SYST BACTERIOL, V35, P131, DOI 10.1099/00207713-35-2-131; Lidstrom ME, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P618, DOI 10.1007/0-387-30742-7_20; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Millet DB, 2008, ATMOS CHEM PHYS, V8, P6887, DOI 10.5194/acp-8-6887-2008; Moore LR, 2007, LIMNOL OCEANOGR-METH, V5, P353, DOI 10.4319/lom.2007.5.353; Morris RM, 2006, ENVIRON MICROBIOL, V8, P1361, DOI 10.1111/j.1462-2920.2006.01029.x; Omer ZS, 2004, PLANT GROWTH REGUL, V43, P93, DOI 10.1023/B:GROW.0000038360.09079.ad; Omer ZS, 2004, FEMS MICROBIOL ECOL, V47, P319, DOI 10.1016/S0168-6496(04)00003-0; Painter T.J., 1983, POLYSACCHARIDES, P196, DOI DOI 10.1016/B978-0-12-065602-8.50009-1; Riemer D., 1998, THESIS U MIAMI MIAMI; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; SAILER M, 1993, BIOCHEMISTRY-US, V32, P310, DOI 10.1021/bi00052a039; SCHAFER SE, 1995, BIOPOLYMERS, V36, P103, DOI 10.1002/bip.360360109; Singh H, 2001, NATURE, V410, P1078, DOI 10.1038/35074067; Singh H, 2000, J GEOPHYS RES-ATMOS, V105, P3795, DOI 10.1029/1999JD900779; SOWELL SM, 2010, ISME J; Tripp HJ, 2008, PROTOC EXCH, DOI [http://dx.doi.org/10.1038/nprot.2008.29, DOI 10.1038/NPROT.2008.29]; Waterbury JB, 1986, CAN B FISH AQUAT SCI, V214, P71; Waterbury JB, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P1053, DOI 10.1007/0-387-30744-3_38; Wells G., 2011, SIGNAL NOISE DETECTI; Williams TJ, 2012, ISME J, V6, P1883, DOI 10.1038/ismej.2012.28; Wuchter C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00367; Yang M, 2013, P NATL ACAD SCI USA, V110, P20034, DOI 10.1073/pnas.1317840110; Zhuang GC, 2014, MAR CHEM, V160, P82, DOI 10.1016/j.marchem.2014.01.011	41	32	32	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150820	10.1371/journal.pone.0150820	http://dx.doi.org/10.1371/journal.pone.0150820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963515	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000068
J	Muthuri, SK; Oti, SO; Lilford, RJ; Oyebode, O				Muthuri, Stella Kagwiria; Oti, Samuel Oji; Lilford, Richard James; Oyebode, Oyinlola			Salt Reduction Interventions in Sub-Saharan Africa: A Systematic Review	PLOS ONE			English	Review							HEALTHY FOOD PURCHASES; BLOOD-PRESSURE; SOUTH-AFRICA; PROGRAM; HYPERTENSION; DISEASE; BURDEN; DEATH	Background Salt intake is associated with hypertension, the leading risk factor for cardiovascular disease. To promote population-level salt reduction, the World Health Organization recommends intervention around three core pillars: Reformulation of processed foods, consumer awareness, and environmental changes to increase availability and affordability of healthy food. This review investigates salt reduction interventions implemented and evaluated in sub-Saharan Africa (SSA). Methods MEDLINE and google scholar electronic databases were searched for articles meeting inclusion criteria. Studies that reported evaluation results of a salt intervention in SSA were identified. Titles and abstracts were screened, and articles selected for full-text review. Quality of included articles was assessed, and a narrative synthesis of the findings undertaken. PROSPERO registration number CRD42015019055. Results Seven studies representing four countries-South Africa, Nigeria, Ghana, and Tanzania-were included. Two examined product reformulation, one in hypertensive patients and the other in normotensive volunteers. Four examined consumer awareness interventions, including individualised counselling and advisory health sessions delivered to whole villages. One study used an environmental approach by offering discounts on healthy food purchases. All the interventions resulted in at least one significantly improved outcome measure including reduction in systolic blood pressure (BP), 24 hour urinary sodium excretion, or mean arterial BP. Conclusions More high quality studies on salt reduction interventions in the region are needed, particularly focused on consumer awareness and education in urban populations given the context of rapid urbanisation; and essentially, targeting product reformulation and environmental change, for greater promise for propagation across a vast, diverse continent.	[Muthuri, Stella Kagwiria; Oti, Samuel Oji] African Populat & Hlth Res Ctr, POB 10787-00100, Nairobi, Kenya; [Lilford, Richard James; Oyebode, Oyinlola] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	African Population & Health Research Centre; University of Warwick	Oyebode, O (corresponding author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	o.r.o.oyebode@warwick.ac.uk	Oyebode, Oyinlola/ABE-1256-2021	Oyebode, Oyinlola/0000-0003-0925-9839; Lilford, Richard/0000-0002-0634-984X	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) West Midlands	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) West Midlands(National Institute for Health Research (NIHR))	RJL and OO are part supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) West Midlands. Views expressed are those of the authors and not necessarily those of any funding body or the NHS. The funders had no role in any aspect of the manuscript.	Adeyemo Adebowale A., 2002, Ethnicity and Disease, V12, P207; African development bank group, 2012, URB AFR; An RP, 2013, AM J HEALTH BEHAV, V37, P56, DOI 10.5993/AJHB.37.1.6; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Cappuccio FP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-13; Cappuccio FP, 2004, INT J EPIDEMIOL, V33, P387, DOI 10.1093/ije/dyh091; Cappuccio FP, 2000, LANCET, V356, P677, DOI 10.1016/S0140-6736(05)73821-6; Charlton KE, 2008, PUBLIC HEALTH NUTR, V11, P1397, DOI 10.1017/S136898000800342X; Effective Public Health Practice Project (EPHPP), QUAL ASS TOOL QUANT; Forrester T, 2005, J HUM HYPERTENS, V19, P55, DOI 10.1038/sj.jhh.1001782; Gomez G. B., 2005, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V5, P13, DOI 10.2174/1568013053005445; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hofman KJ, 2013, LANCET GLOB HEALTH, V1, pE66, DOI 10.1016/S2214-109X(13)70019-6; Izzo Jr JL, CLIN ADVISORY STATEM; Lachat C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001465; Lawes CMM, 2006, J HYPERTENS, V24, P413, DOI 10.1097/01.hjh.0000199801.72563.6f; Mezue K, 2014, PERSPECT PUBLIC HEAL, V134, P346, DOI 10.1177/1757913913499658; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; MTABAJI JP, 1990, J HUM HYPERTENS, V4, P80; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Organization WH, 2016, GLOBAL STATUS REPORT; Oyebode O, 2016, SALT INTAKES SUBSAHA, V14, P1; Penney S., 2009, DROPPING SALT PRACTI; Sturm R, 2013, AM J PREV MED, V44, P567, DOI 10.1016/j.amepre.2013.02.011; The United Nations Department of Economic and Social Affairs, WORLD URB PROSP 2011; Trieu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130247; Webster J., SALT REDUCTION W PAC; Webster JL, 2011, J HYPERTENS, V29, P1043, DOI 10.1097/HJH.0b013e328345ed83; World Health Organisation Regional Office For Europe, 2008, WHO EUR ACT PLAN FOO; World Health Organization, 2010, SALT RED IOD FORT ST; World Health Organization, 2008, 2008 2013 GLOB ACT P; World Health Organization, 2006, RED SALT INT POP WHO; World Health Organization, 2010, CREAT EN ENV POP BAS; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization [Internet]. WHO Press, 2010, STRAT MON EV POP SOD	35	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149680	10.1371/journal.pone.0149680	http://dx.doi.org/10.1371/journal.pone.0149680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963805	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000016
J	Nagel, AC; Szawinski, J; Zimmermann, M; Preiss, A				Nagel, Anja C.; Szawinski, Jutta; Zimmermann, Mirjam; Preiss, Anette			Drosophila Cyclin G Is a Regulator of the Notch Signalling Pathway during Wing Development	PLOS ONE			English	Article							PROTEIN PHOSPHATASE; HAIRLESS PROTEIN; IMAGINAL DISC; CELL-GROWTH; MELANOGASTER; DELTA; ACTIVATION; EXPRESSION; OOGENESIS; ARREST	Notch signalling regulates a multitude of differentiation processes during Drosophila development. For example, Notch activity is required for proper wing vein differentiation which is hampered in mutants of either the receptor Notch, the ligand Delta or the antagonist Hairless. Moreover, the Notch pathway is involved in several aspects of Drosophila oogenesis as well. We have identified Drosophila Cyclin G (CycG) as a molecular interaction partner of Hairless, the major antagonist in the Notch signalling pathway, in vitro and in vivo. Loss of CycG was shown before to cause female sterility and to disturb the architecture of the egg shell. Nevertheless, Notch dependent processes during oogenesis appeared largely unaffected in cycG mutant egg chambers. Loss of CycG modified the dominant wing phenotypes of Notch, Delta and Hairless mutants. Whereas the Notch loss of function phenotype was ameliorated by a loss of CycG, the phenotypes of either Notch gain of function or of Delta or Hairless loss of function were enhanced. In contrast, loss of CycG had only a minor effect on the wing vein phenotype of mutants affecting the EGFR signalling pathway emphasizing the specificity of the interaction of CycG and Notch pathway members.	[Nagel, Anja C.; Szawinski, Jutta; Zimmermann, Mirjam; Preiss, Anette] Univ Hohenheim, Inst Genet, Garbenstr 30, D-70599 Stuttgart, Germany	University Hohenheim	Preiss, A (corresponding author), Univ Hohenheim, Inst Genet, Garbenstr 30, D-70599 Stuttgart, Germany.	a.preiss@uni-hohenheim.de	Nagel, Anja/AAA-4254-2022	Nagel, Anja/0000-0002-2733-3249	University of Hohenheim; Deutsche Forschungsgemeinschaft (DFG) [NA427/4-1, PR 533/10-1]; Landesgraduiertenforderung Baden-Wurttemberg; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	University of Hohenheim; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Landesgraduiertenforderung Baden-Wurttemberg; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the University of Hohenheim and by grants from the Deutsche Forschungsgemeinschaft (DFG; NA427/4-1, PR 533/10-1) (http://www.dfg.de/) to ACN and AP, respectively. JS received a Ph.D. stipend from the Landesgraduiertenforderung Baden-Wurttemberg. Antisera used in this study were obtained from Developmental Studies Hybridoma Bank, created the National Instiute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242 (http://dshb.biology.uiowa.edu/). Fly stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537; http://flystocks.bio.indiana.edu/) were used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BENDER LB, 1993, GENETICS, V133, P967; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Biehs B, 1998, DEVELOPMENT, V125, P4245; Bose A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101884; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brentrup D, 2000, DEVELOPMENT, V127, P4729; De Celis JF, 1998, INT J DEV BIOL, V42, P335; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; DECELIS JF, 1994, GENETICS, V136, P183; deCelis JF, 1997, DEVELOPMENT, V124, P1919; deCelis JF, 1996, DEVELOPMENT, V122, P359; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; Faradji F, 2011, CELL CYCLE, V10, P805, DOI 10.4161/cc.10.5.14959; Fischer P, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005440; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Grammont M, 2007, J CELL BIOL, V177, P139, DOI 10.1083/jcb.200609079; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Horne MC, 1997, J BIOL CHEM, V272, P12650, DOI 10.1074/jbc.272.19.12650; Johannes B, 2002, MECH DEVELOP, V115, P3, DOI 10.1016/S0925-4773(02)00083-7; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Kanaoka Y, 1997, FEBS LETT, V402, P73, DOI 10.1016/S0014-5793(96)01484-6; Kim Y, 2004, CANCER RES, V64, P8990; Kimura SH, 2002, GENES CELLS, V7, P869, DOI 10.1046/j.1365-2443.2002.00564.x; Kimura SH, 2001, ONCOGENE, V20, P3290, DOI 10.1038/sj.onc.1204270; King R. C., 1970, OVARIAN DEV DROSOPHI; Klein T, 1997, DEV BIOL, V189, P123, DOI 10.1006/dbio.1997.8564; Klovstad M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040031; Kugler SJ, 2010, MOL BIOL CELL, V21, P3443, DOI 10.1091/mbc.E10-03-0212; Kurimchak Alison, 2012, Genes Cancer, V3, P739, DOI 10.1177/1947601912473479; Levine B, 2010, DEV BIOL, V344, P196, DOI 10.1016/j.ydbio.2010.04.030; Lindsley D.L., 1968, GENETIC VARIATIONS D; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; LYMAN D, 1993, P NATL ACAD SCI USA, V90, P10395, DOI 10.1073/pnas.90.21.10395; Maier D, 1999, MECH DEVELOP, V89, P195, DOI 10.1016/S0925-4773(99)00208-7; Maier D, 1997, MECH DEVELOP, V67, P97, DOI 10.1016/S0925-4773(97)00117-2; Maier D, 2006, HEREDITAS, V143, P212, DOI 10.1111/j.2007.0018-0661.01971.x; Maier D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-175; Marquart J, 1999, DEV GENES EVOL, V209, P155, DOI 10.1007/s004270050239; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Mohler JD, 1956, DROS INFORM SERV, V30, P78; Morel V, 2000, GENE DEV, V14, P377; Muller D, 2006, J CELL SCI, V119, P250, DOI 10.1242/jcs.02743; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Nagel AC, 2012, J CELL SCI, V125, P5555, DOI 10.1242/jcs.113902; Nagel AC, 2012, HEREDITAS, V149, P186, DOI 10.1111/j.1601-5223.2012.02273.x; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Pardo B, 2009, CELL MOL LIFE SCI, V66, P1039, DOI 10.1007/s00018-009-8740-3; Parks AL, 2008, GENESIS, V46, P265, DOI 10.1002/dvg.20391; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; RAMOS RGP, 1989, GENETICS, V123, P337; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; Reimers L, 1999, J BIOL CHEM, V274, P11022, DOI 10.1074/jbc.274.16.11022; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Salvaing J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001658; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Seo HR, 2006, CELL DEATH DIFFER, V13, P1475, DOI 10.1038/sj.cdd.4401822; Smith ML, 1997, EXP CELL RES, V230, P61, DOI 10.1006/excr.1996.3402; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Spradling Allan C., 1993, P1; Stanyon CA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r96; Torres IL, 2003, DEV CELL, V5, P547, DOI 10.1016/S1534-5807(03)00272-7; Vereshchagina N, 2008, J CELL SCI, V121, P3383, DOI 10.1242/jcs.035220; Walrad PB, 2011, MOL BIOL CELL, V22, P1364, DOI 10.1091/mbc.E10-06-0483; Ward EJ, 2005, MECH DEVELOP, V122, P241, DOI 10.1016/j.mod.2004.10.006; Ward EJ, 2006, CURR BIOL, V16, P2352, DOI 10.1016/j.cub.2006.10.022; Ward EJ, 2006, DEV BIOL, V297, P461, DOI 10.1016/j.ydbio.2006.05.021; XU T, 1992, DEVELOPMENT, V115, P913; Yakoby N, 2008, DEVELOPMENT, V135, P343, DOI 10.1242/dev.008920; Zhao L, 2003, MOL CANCER RES, V1, P195	72	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151477	10.1371/journal.pone.0151477	http://dx.doi.org/10.1371/journal.pone.0151477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963612	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000157
J	Patel-Chamberlin, M; Kia, MV; Xu, J; Barone, S; Zahedi, K; Soleimani, M				Patel-Chamberlin, Mina; Kia, Mujan Varasteh; Xu, Jie; Barone, Sharon; Zahedi, Kamyar; Soleimani, Manoocher			The Role of Epithelial Sodium Channel ENaC and the Apical Cl-/HCO3- Exchanger Pendrin in Compensatory Salt Reabsorption in the Setting of Na-Cl Cotransporter (NCC) Inactivation	PLOS ONE			English	Article							BICARBONATE SECRETION; INTERCALATED CELLS; VOLUME DEPLETION; ANION-EXCHANGERS; RENAL PHYSIOLOGY; PROXIMAL TUBULE; SLC26A4 PENDRIN; DOUBLE KNOCKOUT; DEFICIENT MICE; MOUSE KIDNEY	Background The absence of NCC does not cause significant salt wasting in NCC deficient mice under basal conditions. We hypothesized that ENaC and pendrin play important roles in compensatory salt absorption in the setting of NCC inactivation, and their inhibition and/or downregulation can cause significant salt wasting in NCC KO mice. Methods WT and NCC KO mice were treated with a daily injection of either amiloride, an inhibitor of ENaC, or acetazolamide (ACTZ), a blocker of salt and bicarbonate reabsorption in the proximal tubule and an inhibitor of carbonic anhydrases in proximal tubule and intercalated cells, or a combination of acetazolamide plus amiloride for defined durations. Animals were subjected to daily balance studies. At the end of treatment, kidneys were harvested and examined. Blood samples were collected for electrolytes and acid base analysis. Results Amiloride injection significantly increased the urine output (UO) in NCC KO mice (from 1.3 ml/day before to 2.5 ml/day after amiloride, p < 0.03, n = 4) but caused only a slight change in UO in WT mice (p > 0.05). The increase in UO in NCC KO mice was associated with a significant increase in sodium excretion (from 0.25 mmol/24 hrs at baseline to 0.35 mmol/24 hrs after amiloride injection, p < 0.05, n = 4). Daily treatment with ACTZ for 6 days resulted in >80% reduction of kidney pendrin expression in both WT and NCC KO mice. However, ACTZ treatment noticeably increased urine output and salt excretion only in NCC KO mice (with urine output increasing from a baseline of 1.1 ml/day to 2.3 ml/day and sodium excretion increasing from 0.22 mmole/day before to 0.31 mmole/day after ACTZ) in NCC KO mice; both parameters were significantly higher than in WT mice. Western blot analysis demonstrated significant enhancement in ENaC expression in medulla and cortex of NCC KO and WT mice in response to ACTZ injection for 6 days, and treatment with amiloride in ACTZ-pretreated mice caused a robust increase in salt excretion in both NCC KO and WT mice. Pendrin KO mice did not display a significant increase in urine output or salt excretion after treatment with amiloride or ACTZ. Conclusion 1. ENaC plays an important role in salt reabsorption in NCC KO mice. 2. NCC contributes to compensatory salt reabsorption in the setting of carbonic anhydrase inhibition, which is associated with increased delivery of salt from the proximal tubule and the down regulation of pendrin. 3. ENaC is upregulated by ACTZ treatment and its inhibition by amiloride causes significant diuresis in NCC KO and WT mice. Despite being considered mild agents individually, we propose that the combination of acetazolamide and amiloride in the setting of NCC inhibition (i.e., hydrochlorothiazide) will be a powerful diuretic regimen.	[Patel-Chamberlin, Mina; Kia, Mujan Varasteh; Xu, Jie; Barone, Sharon; Zahedi, Kamyar; Soleimani, Manoocher] Univ Cincinnati, Ctr Genet Transport & Epithelial Biol, Cincinnati, OH USA; [Barone, Sharon; Zahedi, Kamyar; Soleimani, Manoocher] Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA; [Patel-Chamberlin, Mina; Kia, Mujan Varasteh; Soleimani, Manoocher] Univ Cincinnati, Dept Med, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati	Soleimani, M (corresponding author), Univ Cincinnati, Ctr Genet Transport & Epithelial Biol, Cincinnati, OH USA.; Soleimani, M (corresponding author), Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA.; Soleimani, M (corresponding author), Univ Cincinnati, Dept Med, Cincinnati, OH USA.	Manoocher.Soleimani@uc.edu	Zahedi, Kamyar/AAQ-3428-2021	soleimani, m/0000-0002-3446-8870; Varasteh Kia, Mujan/0000-0002-7689-6400	Merit Review award from the Department of Veterans Affairs; Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati; Dialysis Clinic, Inc. (DCI)	Merit Review award from the Department of Veterans Affairs(US Department of Veterans Affairs); Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati; Dialysis Clinic, Inc. (DCI)	The current studies were supported by a Merit Review award from the Department of Veterans Affairs, funds from the Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati, and grants from Dialysis Clinic, Inc. (DCI). The authors declare no competing interest with regard to the funding by commercial sources in relation to the proposed studies.	Alper SL, 2009, J EXP BIOL, V212, P1672, DOI 10.1242/jeb.029454; Amlal H, 2003, J PHYSIOL-LONDON, V553, P511, DOI 10.1113/jphysiol.2003.053363; Amlal H, 2010, AM J PHYSIOL-CELL PH, V299, pC33, DOI 10.1152/ajpcell.00033.2010; Aronson PS, 1997, AM J PHYSIOL-RENAL, V273, pF179, DOI 10.1152/ajprenal.1997.273.2.F179; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF437, DOI 10.1152/ajprenal.2001.280.3.F437; Baum M, 2008, PEDIATR NEPHROL, V23, P185, DOI 10.1007/s00467-007-0569-0; Bobulescu IA, 2006, SEMIN NEPHROL, V26, P334, DOI 10.1016/j.semnephrol.2006.07.001; Breton S, 1995, AM J PHYSIOL-RENAL, V269, pF761, DOI 10.1152/ajprenal.1995.269.6.F761; Brooks HL, 2001, J PHYSIOL-LONDON, V530, P359, DOI 10.1111/j.1469-7793.2001.0359k.x; Eladari D, 2012, ANNU REV PHYSIOL, V74, P325, DOI 10.1146/annurev-physiol-020911-153225; Hughey RP, 2007, AM J PHYSIOL-RENAL, V293, pF1439, DOI 10.1152/ajprenal.00402.2007; Kim GH, 1998, P NATL ACAD SCI USA, V95, P14552, DOI 10.1073/pnas.95.24.14552; Leviel F, 2010, J CLIN INVEST, V120, P1627, DOI 10.1172/JCI40145; MOLONY DA, 1989, KIDNEY INT, V36, P418, DOI 10.1038/ki.1989.211; Nicoletta JA, 2004, CURR OPIN PEDIATR, V16, P194, DOI 10.1097/00008480-200404000-00014; Arroyo JP, 2013, MOL ASPECTS MED, V34, P288, DOI 10.1016/j.mam.2012.05.002; Arroyo JP, 2011, J AM SOC NEPHROL, V22, P1707, DOI 10.1681/ASN.2011020132; Pech V, 2010, J AM SOC NEPHROL, V21, P1928, DOI 10.1681/ASN.2009121257; Purkerson JM, 2007, KIDNEY INT, V71, P103, DOI 10.1038/sj.ki.5002020; Ronzaud C, 2013, J CLIN INVEST, V123, P657, DOI 10.1172/JCI61110; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Sindic A, 2007, CURR OPIN NEPHROL HY, V16, P484; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Soleimani M, 2013, KIDNEY INT, V84, P657, DOI 10.1038/ki.2013.138; Soleimani M, 2012, P NATL ACAD SCI USA, V109, P13368, DOI 10.1073/pnas.1202671109; Stockand JD, 2010, KIDNEY INT, V78, P849, DOI 10.1038/ki.2010.276; Sun XM, 2008, CELL PHYSIOL BIOCHEM, V21, P95, DOI 10.1159/000113751; Unwin RJ, 2006, CURR OPIN PHARMACOL, V6, P208, DOI 10.1016/j.coph.2006.01.002; Vallet M, 2006, J AM SOC NEPHROL, V17, P2153, DOI 10.1681/ASN.2005101054; Verlander JW, 2003, HYPERTENSION, V42, P356, DOI 10.1161/01.HYP.0000088321.67254.B7; Wagner CA, 2011, CELL PHYSIOL BIOCHEM, V28, P497, DOI 10.1159/000335111; Wall SM, 2004, HYPERTENSION, V44, P982, DOI 10.1161/01.HYP.0000145863.96091.89; Wall SM, 2010, J NEPHROL, V23, pS118; Wang W, 2012, KIDNEY INT, V82, P26, DOI 10.1038/ki.2012.41; Wang XY, 2009, CURR OPIN NEPHROL HY, V18, P412, DOI 10.1097/MNH.0b013e32832f5775; Welsh-Bacic D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025240; Xiang Y, 2004, LIFE SCI, V75, P1277, DOI 10.1016/j.lfs.2003.12.032; Xu J, 2013, CELL PHYSIOL BIOCHEM, V32, P173, DOI 10.1159/000356637; Xu J, 2011, KIDNEY INT, V80, P926, DOI 10.1038/ki.2011.196; Zahedi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079327	42	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150918	10.1371/journal.pone.0150918	http://dx.doi.org/10.1371/journal.pone.0150918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963391	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000078
J	Okun, M; Lak, A; Carandini, M; Harris, KD				Okun, Michael; Lak, Armin; Carandini, Matteo; Harris, Kenneth D.			Long Term Recordings with Immobile Silicon Probes in the Mouse Cortex	PLOS ONE			English	Article							LOCAL-FIELD POTENTIALS; MICROELECTRODE ARRAYS; CEREBRAL-CORTEX; VISUAL-CORTEX; NEURONS; UNIT; ELECTRODES; DYNAMICS; PRIMATES; AWAKE	A key experimental approach in neuroscience involves measuring neuronal activity in behaving animals with extracellular chronic recordings. Such chronic recordings were initially made with single electrodes and tetrodes, and are now increasingly performed with high-density, high-count silicon probes. A common way to achieve long-term chronic recording is to attach the probes to microdrives that progressively advance them into the brain. Here we report, however, that such microdrives are not strictly necessary. Indeed, we obtained high-quality recordings in both head-fixed and freely moving mice for several months following the implantation of immobile chronic probes. Probes implanted into the primary visual cortex yielded well-isolated single units whose spike waveform and orientation tuning were highly reproducible over time. Although electrode drift was not completely absent, stable waveforms occurred in at least 70% of the neurons tested across consecutive days. Thus, immobile silicon probes represent a straightforward and reliable technique to obtain stable, long-term population recordings in mice, and to follow the activity of populations of well-isolated neurons over multiple days.	[Okun, Michael; Harris, Kenneth D.] UCL, UCL Inst Neurol, London WC1N 3BG, England; [Okun, Michael; Harris, Kenneth D.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6DE, England; [Okun, Michael; Lak, Armin; Carandini, Matteo] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England	University of London; University College London; University of London; University College London; University of London; University College London	Okun, M (corresponding author), UCL, UCL Inst Neurol, London WC1N 3BG, England.; Okun, M (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6DE, England.; Okun, M (corresponding author), UCL, UCL Inst Ophthalmol, London EC1V 9EL, England.	m.okun@ucl.ac.uk	Carandini, Matteo/ABD-8296-2021; Lak, Armin/AAP-6271-2020	Carandini, Matteo/0000-0003-4880-7682; Lak, Armin/0000-0003-1926-5458; Okun, Michael/0000-0002-7795-5513; Harris, Kenneth/0000-0002-5930-6456	Wellcome Trust [095668, 095669]; Engineering and Physical Sciences Research Council [EP/I005102/1] Funding Source: researchfish; Wellcome Trust [106101/Z/14/Z] Funding Source: researchfish; EPSRC [EP/I005102/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	KDH and MC are jointly funded by the Wellcome Trust (grants 095668 and 095669). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Buzsaki G, 2015, NEURON, V86, P92, DOI 10.1016/j.neuron.2015.01.028; Chestek CA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045005; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Dhawale AK, 2016, 033266 BIORXIV, DOI [10.1101/033266, DOI 10.1101/033266]; Diba K, 2014, J NEUROSCI, V34, P14984, DOI 10.1523/JNEUROSCI.1091-14.2014; Dickey AS, 2009, J NEUROPHYSIOL, V102, P1331, DOI 10.1152/jn.90920.2008; Einevoll GT, 2012, CURR OPIN NEUROBIOL, V22, P11, DOI 10.1016/j.conb.2011.10.001; Eleryan Ahmed, 2014, Front Neuroeng, V7, P23, DOI 10.3389/fneng.2014.00023; Fraser GW, 2012, J NEUROPHYSIOL, V107, P1970, DOI 10.1152/jn.01012.2010; Freire MAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027554; Hall TM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6462; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; HETKE JF, 1994, IEEE T BIO-MED ENG, V41, P314, DOI 10.1109/10.284959; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Jackson A, 2007, J NEUROPHYSIOL, V98, P3109, DOI 10.1152/jn.00569.2007; Jorfi M, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/011001; Kadir SN, 2014, NEURAL COMPUT, V26, P2379, DOI 10.1162/NECO_a_00661; Karumbaiah L, 2013, BIOMATERIALS, V34, P8061, DOI 10.1016/j.biomaterials.2013.07.016; Kipke DR, 2008, J NEUROSCI, V28, P11830, DOI 10.1523/JNEUROSCI.3879-08.2008; Kipke DR, 2003, IEEE T NEUR SYS REH, V11, P151, DOI 10.1109/TNSRE.2003.814443; Kozai TDY, 2016, J NEUROSCI METH, V258, P46, DOI 10.1016/j.jneumeth.2015.10.007; Lee D, 2014, NAT PROTOC, V9, P2784, DOI 10.1038/nprot.2014.190; Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007; McMahon DBT, 2014, J NEUROPHYSIOL, V112, P1748, DOI 10.1152/jn.00052.2014; Moxon KA, 2004, IEEE T BIO-MED ENG, V51, P881, DOI 10.1109/TBME.2004.827465; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Potter-Baker KA, 2014, BIOMATERIALS, V35, P5637, DOI 10.1016/j.biomaterials.2014.03.076; Reimer J, 2014, NEURON, V84, P355, DOI 10.1016/j.neuron.2014.09.033; Retailleau A, 2013, NEUROBIOL DIS, V59, P151, DOI 10.1016/j.nbd.2013.07.014; Rossant C, NAT NEUROSC IN PRESS; Rozai TDY, 2015, J NEUROSCI METH, V242, P15, DOI 10.1016/j.jneumeth.2014.12.010; Scholvinck ML, 2015, J NEUROSCI, V35, P170, DOI 10.1523/JNEUROSCI.4994-13.2015; Schwindel CD, 2014, J NEUROSCI, V34, P5454, DOI 10.1523/JNEUROSCI.4350-13.2014; Siegle JH, 2015, CURR OPIN NEUROBIOL, V32, P53, DOI 10.1016/j.conb.2014.11.004; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Tolias AS, 2007, J NEUROPHYSIOL, V98, P3780, DOI 10.1152/jn.00260.2007; Vinck M, 2015, NEURON, V86, P740, DOI 10.1016/j.neuron.2015.03.028; Vyazovskiy VV, 2011, NEURONAL NETWORK ANA, P237; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	46	42	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151180	10.1371/journal.pone.0151180	http://dx.doi.org/10.1371/journal.pone.0151180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959638	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300108
J	Riou, V; Fonseca-Batista, D; Roukaerts, A; Biegala, IC; Prakya, SR; Loureiro, CM; Santos, M; Muniz-Piniella, AE; Schmiing, M; Elskens, M; Brion, N; Martins, MA; Dehairs, F				Riou, Virginie; Fonseca-Batista, Debany; Roukaerts, Arnout; Biegala, Isabelle C.; Prakya, Shree Ram; Loureiro, Clara Magalhaes; Santos, Mariana; Muniz-Piniella, Angel E.; Schmiing, Mara; Elskens, Marc; Brion, Natacha; Martins, M. Ana; Dehairs, Frank			Importance of N-2-Fixation on the Productivity at the North-Western Azores Current/Front System, and the Abundance of Diazotrophic Unicellular Cyanobacteria	PLOS ONE			English	Article							NITROGEN-FIXATION; LATITUDINAL DISTRIBUTION; DINITROGEN FIXATION; TRICHODESMIUM SPP.; MEDITERRANEAN SEA; ATLANTIC-OCEAN; N-2 FIXATION; NITRATE; RATES; DISTRIBUTIONS	To understand the impact of the northwestern Azores Current Front (NW-AzC/AzF) system on HCO3-- and N-2-fixation activities and unicellular diazotrophic cyanobacteria (UCYN) distribution, we combined geochemical and biological approaches from the oligotrophic surface to upper mesopelagic waters. N-2-fixation was observed to sustain 45-85% of the HCO3--fixation in the picoplanktonic fraction performing 47% of the total C-fixation at the deep chlorophyll maximum north and south of the AzF. N2-fixation rates as high as 10.9 mu mol N m(-3) d(-1) and surface nitrate delta N-15 as low as 2.7 parts per thousand were found in the warm (18-24 degrees C), most saline (36.5-37.0) and least productive waters south of the AzF, where UCYN were the least abundant. However, picoplanktonic UCYN abundances up to 55 cells mL(-1) were found at 45-200m depths in the coolest nutrient-rich waters north of the AzF. In this area, N-2-fixation rates up to 4.5 mu mol N m(-3) d(-1) were detected, associated with depth-integrated (HCO3-)-C-13-fixation rates at least 50% higher than observed south of the AzF. The numerous eddies generated at the NW-AzC/AzF seem to enhance exchanges of plankton between water masses, as well as vertical and horizontal diapycnal diffusion of nutrients, whose increase probably enhances the growth of diazotrophs and the productivity of C-fixers.	[Riou, Virginie; Fonseca-Batista, Debany; Biegala, Isabelle C.] Aix Marseille Univ, Mediterranean Inst Oceanog, UM CNRS INSU 110, IRD, F-13288 Marseille, France; [Riou, Virginie; Fonseca-Batista, Debany; Biegala, Isabelle C.] Univ Sud Toulon Var, F-83957 La Garde, France; [Riou, Virginie; Prakya, Shree Ram; Schmiing, Mara] Univ Azores, Ctr IMAR, IMAR Inst Marine Res, Horta, Portugal; [Fonseca-Batista, Debany; Roukaerts, Arnout; Muniz-Piniella, Angel E.; Elskens, Marc; Brion, Natacha; Dehairs, Frank] Vrije Univ Brussel, Analyt Environm & Geochem, Brussels, Belgium; [Fonseca-Batista, Debany; Roukaerts, Arnout; Muniz-Piniella, Angel E.; Elskens, Marc; Brion, Natacha; Dehairs, Frank] Vrije Univ Brussel, Earth Syst Sci, Brussels, Belgium; [Loureiro, Clara Magalhaes; Martins, M. Ana] CIBIO, Res Ctr Biodivers & Genet Resources, InBIO Associated Lab, Dept Oceanog & Fisheries, Horta, Portugal; [Santos, Mariana] IP Portuguese Inst Ocean & Atmosphere, IPMA, Lisbon, Portugal; [Santos, Mariana; Schmiing, Mara] MARE Marine & Environm Sci Ctr, Azores, Portugal; [Loureiro, Clara Magalhaes; Schmiing, Mara; Martins, M. Ana] Univ Azores, DOP UAz Dept Oceanog & Fisheries, Azores, Portugal	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Universidade dos Acores; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Universidade dos Acores; Instituto Portugues do Mar e da Atmosfera; Universidade dos Acores	Riou, V (corresponding author), Aix Marseille Univ, Mediterranean Inst Oceanog, UM CNRS INSU 110, IRD, F-13288 Marseille, France.; Riou, V (corresponding author), Univ Sud Toulon Var, F-83957 La Garde, France.; Riou, V (corresponding author), Univ Azores, Ctr IMAR, IMAR Inst Marine Res, Horta, Portugal.	virginie_riou@hotmail.com	Riou, Virginie/K-7874-2016; Brion, Natacha/H-3565-2017; Loureiro, Clara Magalhães/I-8219-2014; da Silva Fernandes Martins, Ana Maria de Pinho Ferreira/X-8053-2019	Riou, Virginie/0000-0002-6549-385X; Brion, Natacha/0000-0002-3021-1445; Loureiro, Clara Magalhães/0000-0002-3972-0078; da Silva Fernandes Martins, Ana Maria de Pinho Ferreira/0000-0002-4169-8201; Schmiing, Mara/0000-0001-7556-217X; Muniz Piniella, Angel/0000-0003-3665-4009; Roukaerts, Arnout/0000-0002-3939-7119; Elskens, Marc/0000-0002-8862-9422; Fonseca Pereira Batista, Debany/0000-0002-0785-5269	European Union Seventh Framework Programme [FP7] [228344]; Portuguese Fundacao para a Ciencia e a Tecnologia; Research Foundation Flanders [G071512N]; Research Council of Vrije Universiteit Brussel [SRP-2]; Instituto do Mar [IMAR]; FISHBOX project [Institut de Recherche pour le Developpement] [FUI 11]; Mediterranean Institute of Oceanography [MIO]; "Investissements d'Avenir", French Government project of the French National Research Agency [ANR] through the A*Midex project [ANR-11-IDEX-0001-02]	European Union Seventh Framework Programme [FP7]; Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Research Foundation Flanders(FWO); Research Council of Vrije Universiteit Brussel; Instituto do Mar [IMAR]; FISHBOX project [Institut de Recherche pour le Developpement]; Mediterranean Institute of Oceanography [MIO]; "Investissements d'Avenir", French Government project of the French National Research Agency [ANR] through the A*Midex project(French National Research Agency (ANR))	The research leading to these results has received funding for data collection from the European Union Seventh Framework Programme [FP7/2007-2013, (http://ec.europa.eu/research/fp7/)] under grant agreement no228344 [EUROFLEETS, (www.eurofleets.eu)]. Funding was also granted for data collection and analysis from the Portuguese Fundacao para a Ciencia e a Tecnologia (www.fct.pt), the Research Foundation Flanders grant noG071512N (www.fwo.be), the Research Council of Vrije Universiteit Brussel [SRP-2, (http://rd-ir.vub.ac.be/)], the Instituto do Mar [IMAR, (http://www.imar.pt/)], the FISHBOX project [FUI 11, Institut de Recherche pour le Developpement, (www.ird.fr)] and the Mediterranean Institute of Oceanography [MIO, (http://mio.pytheas.univ-amu.fr/)]. This work is also a contribution to the Labex OT-Med [ANR-11-LABEX-0061, (www.otmed.fr)] funded by the "Investissements d'Avenir", French Government project of the French National Research Agency [ANR, (www.agence-nationale-recherche.fr/)] through the A*Midex project [ANR-11-IDEX-0001-02], funding VR during the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves M, 2002, DEEP-SEA RES PT II, V49, P3983, DOI 10.1016/S0967-0645(02)00138-8; Bentzon-Tilia M, 2015, ISME J, V9, P273, DOI 10.1038/ismej.2014.119; Biegala IC, 2008, AQUAT MICROB ECOL, V51, P45, DOI 10.3354/ame01185; Bonnet S, 2011, BIOGEOSCIENCES, V8, P2257, DOI 10.5194/bg-8-2257-2011; Bourbonnais A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2007JC004617; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Carpenter EJ, 1997, DEEP-SEA RES PT I, V44, P27, DOI 10.1016/S0967-0637(96)00091-X; Casciotti KL, 2002, ANAL CHEM, V74, P4905, DOI 10.1021/ac020113w; Clark DR, 2008, LIMNOL OCEANOGR, V53, P52, DOI 10.4319/lo.2008.53.1.0052; CORNELL S, 1995, NATURE, V376, P243, DOI 10.1038/376243a0; Dabundo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110335; Dore JE, 2008, PROG OCEANOGR, V76, P2, DOI 10.1016/j.pocean.2007.10.002; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Farnelid H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019223; Fernandez A, 2010, BIOGEOSCIENCES, V7, P3167, DOI 10.5194/bg-7-3167-2010; Fong AA, 2008, ISME J, V2, P663, DOI 10.1038/ismej.2008.22; German CR, 2010, DEEP-SEA RES PT I, V57, P518, DOI 10.1016/j.dsr.2009.12.011; Goebel NL, 2008, J PHYCOL, V44, P1212, DOI 10.1111/j.1529-8817.2008.00581.x; Goikoetxea N, 2007, 212881 MEFEPO EC FP7, P300; GOULD WJ, 1985, PROG OCEANOGR, V14, P167, DOI 10.1016/0079-6611(85)90010-2; Granger J, 2004, LIMNOL OCEANOGR, V49, P1763, DOI 10.4319/lo.2004.49.5.1763; Grosskopf T, 2012, NATURE, V488, P361, DOI 10.1038/nature11338; Hansell DA, 2007, MAR CHEM, V106, P562, DOI 10.1016/j.marchem.2007.06.005; KASE RH, 1982, NATURE, V300, P245, DOI 10.1038/300245a0; KLEIN B, 1989, J GEOPHYS RES-OCEANS, V94, P6159, DOI 10.1029/JC094iC05p06159; Knapp AN, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003107; Krupke A, 2014, ENVIRON MICROBIOL, V16, P3153, DOI 10.1111/1462-2920.12431; Krupke A, 2013, SYST APPL MICROBIOL, V36, P259, DOI 10.1016/j.syapm.2013.02.002; Landrum JP, 2011, DEEP-SEA RES PT I, V58, P615, DOI 10.1016/j.dsr.2011.01.012; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Langlois RJ, 2012, MAR ECOL PROG SER, V470, P1, DOI 10.3354/meps10109; Latysheva N, 2012, BIOINFORMATICS, V28, P603, DOI 10.1093/bioinformatics/bts008; Law CS, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001604; Le Moal M, 2011, BIOGEOSCIENCES, V8, P827, DOI 10.5194/bg-8-827-2011; Le Moal M, 2009, LIMNOL OCEANOGR, V54, P845, DOI 10.4319/lo.2009.54.3.0845; Luo YW, 2012, EARTH SYST SCI DATA, V4, P47, DOI 10.5194/essd-4-47-2012; Macedo MF, 2000, HYDROBIOLOGIA, V441, P155, DOI 10.1023/A:1017519330995; Maranon E, 2000, DEEP-SEA RES PT I, V47, P825, DOI 10.1016/S0967-0637(99)00087-4; Mazard SL, 2004, APPL ENVIRON MICROB, V70, P7355, DOI 10.1128/AEM.70.12.7355-7364.2004; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; Mohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012583; Moisander PH, 2014, ISME J, V8, P1962, DOI 10.1038/ismej.2014.49; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; Monteiro FM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003731; Montoya JP, 2002, LIMNOL OCEANOGR, V47, P1617, DOI 10.4319/lo.2002.47.6.1617; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Moore CM, 2009, NAT GEOSCI, V2, P867, DOI 10.1038/ngeo667; Mulholland MR, 2012, LIMNOL OCEANOGR, V57, P1067, DOI 10.4319/lo.2012.57.4.1067; Needoba JA, 2007, LIMNOL OCEANOGR, V52, P1317, DOI 10.4319/lo.2007.52.4.1317; Palter JB, 2005, NATURE, V437, P687, DOI 10.1038/nature03969; Piazena H, 2002, DEEP-SEA RES PT II, V49, P3513, DOI 10.1016/S0967-0645(02)00093-0; R Core Team, 2013, R LANG ENV STAT COMP; Rees AP, 2009, MAR ECOL PROG SER, V374, P7, DOI 10.3354/meps07771; Riemann L, 2010, AQUAT MICROB ECOL, V61, P225, DOI 10.3354/ame01431; Rijkenberg MJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028989; Scharek R, 1999, MAR ECOL PROG SER, V182, P55, DOI 10.3354/meps182055; SIEGENTHALER U, 1993, NATURE, V365, P119, DOI 10.1038/365119a0; Sigman DM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002458; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; Sigman DM, 2000, J GEOPHYS RES-OCEANS, V105, P19599, DOI 10.1029/2000JC000265; Taniuchi Y, 2012, ENVIRON MICROBIOL, V14, P641, DOI 10.1111/j.1462-2920.2011.02606.x; Thompson AW, 2013, J PHYCOL, V49, P1024, DOI 10.1111/jpy.12117; Thompson AW, 2012, SCIENCE, V337, P1546, DOI 10.1126/science.1222700; Tyrrell T, 2003, J PLANKTON RES, V25, P405, DOI 10.1093/plankt/25.4.405; Waser NA, 2000, DEEP-SEA RES PT I, V47, P1207, DOI 10.1016/S0967-0637(99)00102-8; Wilson ST, 2012, APPL ENVIRON MICROB, V78, P6516, DOI 10.1128/AEM.01146-12; Wu JF, 2011, GEOCHIM COSMOCHIM AC, V75, P460, DOI 10.1016/j.gca.2010.10.024; YENTSCH CS, 1985, J GEOPHYS RES-OCEANS, V90, P3237, DOI 10.1029/JC090iC02p03237	69	7	7	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150827	10.1371/journal.pone.0150827	http://dx.doi.org/10.1371/journal.pone.0150827			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26958844	gold, Green Published, Green Submitted			2022-12-27	WOS:000371992300077
J	Rothnie, KJ; Mullerova, H; Hurst, JR; Smeeth, L; Davis, K; Thomas, SL; Quint, JK				Rothnie, Kieran J.; Muellerova, Hana; Hurst, John R.; Smeeth, Liam; Davis, Kourtney; Thomas, Sara L.; Quint, Jennifer K.			Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE	Background Acute Exacerbations of COPD (AECOPD) identified from electronic healthcare records (EHR) are important for research, public health and to inform healthcare utilisation and service provision. However, there is no standardised method of identifying AECOPD in UK EHR. We aimed to validate the recording of AECOPD in UK EHR. Methods We randomly selected 1385 patients with COPD from the Clinical Practice Research Data-link. We selected dates of possible AECOPD based on 15 different algorithms between January 2004 and August 2013. Questionnaires were sent to GPs asking for confirmation of their patients' AECOPD on the dates identified and for any additional relevant information. Responses were reviewed independently by two respiratory physicians. Positive predictive value (PPV) and sensitivity were calculated. Results The response rate was 71.3%. AECOPD diagnostic codes, lower respiratory tract infection (LRTI) codes, and prescriptions of antibiotics and oral corticosteroids (OCS) together for 5-14 days had a high PPV (>75%) for identifying AECOPD. Symptom-based algorithms and prescription of antibiotics or OCS alone had lower PPVs (60-75%). A combined strategy of antibiotic and OCS prescriptions for 5-14 days, or LRTI or AECOPD code resulted in a PPV of 85.5% (95% CI, 82.7-88.3%) and a sensitivity of 62.9%(55.4-70.4%). Conclusion Using a combination of diagnostic and therapy codes, the validity of AECOPD identified from EHR can be high. These strategies are useful for understanding health-care utilisation for AECOPD, informing service provision and for researchers. These results highlight the need for common coding strategies to be adopted in primary care to allow easy and accurate identification of events.	[Rothnie, Kieran J.; Quint, Jennifer K.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol Occupat Med & Publ Hlth, London, England; [Rothnie, Kieran J.; Smeeth, Liam; Thomas, Sara L.; Quint, Jennifer K.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Muellerova, Hana] GlaxoSmithKline Res & Dev Ltd, Resp Epidemiol, Uxbridge, Middx, England; [Hurst, John R.] UCL, UCL Resp Med, London, England; [Davis, Kourtney] GlaxoSmithKline Res & Dev Ltd, Resp Epidemiol, Collegeville, PA USA	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline; University of London; University College London; GlaxoSmithKline	Rothnie, KJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol Occupat Med & Publ Hlth, London, England.; Rothnie, KJ (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	k.rothnie@imperial.ac.uk	quint, jennifer/ABE-3384-2020; Smeeth, Liam/X-5862-2018	Quint, Jennifer/0000-0003-0149-4869; Smeeth, Liam/0000-0002-9168-6022; Mullerova, Hana/0000-0002-0949-0101; Rothnie, Kieran/0000-0003-4279-1624; Hurst, John/0000-0002-7246-6040	GlaxoSmithKline; Medical Research Council (MRC); BLF; AZ; Wellcome Trust; NIHR; Pharmaceutical company COPD; Pharmaceutical company AZ; Pharmaceutical company Chiesi; Pharmaceutical company GSK; Pharmaceutical company Novartis; Pharmaceutical company Pfizer; Pharmaceutical company Takeda; GSK; GlaxoSmithKline; Medical Research Council (MRC); BLF; AZ; Wellcome Trust; NIHR; Pharmaceutical company COPD; Pharmaceutical company AZ; Pharmaceutical company Chiesi; Pharmaceutical company GSK; Pharmaceutical company Novartis; Pharmaceutical company Pfizer; Pharmaceutical company Takeda; GSK; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BLF; AZ; Wellcome Trust(Wellcome TrustEuropean Commission); NIHR(National Institute for Health Research (NIHR)); Pharmaceutical company COPD; Pharmaceutical company AZ; Pharmaceutical company Chiesi(Chiesi Pharmaceuticals Inc); Pharmaceutical company GSK; Pharmaceutical company Novartis; Pharmaceutical company Pfizer; Pharmaceutical company Takeda; GSK(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BLF; AZ; Wellcome Trust(Wellcome TrustEuropean Commission); NIHR(National Institute for Health Research (NIHR)); Pharmaceutical company COPD; Pharmaceutical company AZ; Pharmaceutical company Chiesi(Chiesi Pharmaceuticals Inc); Pharmaceutical company GSK; Pharmaceutical company Novartis; Pharmaceutical company Pfizer; Pharmaceutical company Takeda; GSK(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was partly supported by a GlaxoSmithKline and Medical Research Council (MRC) industry partnership award. Hana Mullerova and Kourtney Davis are employed by GSK and hold stock and share options of GlaxoSmithKline Plc. JKQ reports grants from MRC and grants from GSK during the conduct of the study; grants from MRC, grants from BLF, personal fees from AZ, personal fees from GSK, and grants from Wellcome Trust outside the submitted work. JRH reports personal fees from Pharmaceutical companies interested in COPD, including AZ, Chiesi, GSK, Novartis, Pfizer, and Takeda, outside the submitted work. Imperial College of Science, Technology and Medicine. LS reports grants from Wellcome Trust, during the conduct of the study; grants from Wellcome Trust, grants from MRC, grants from NIHR, and personal fees from GSK, outside the submitted work. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Department for Communities and Local Government, ENGLISH INDICES DEPR; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Griffin Jane, 2008, Prim Care Respir J, V17, P104, DOI 10.3132/pcrj.2008.00024; Healthcare Commission, 2006, CLEAN AIR NAT STUD C; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Miravitlles M, 2004, THORAX, V59, P387, DOI 10.1136/thx.2003.008730; Mullerova H, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006171; Quint JK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005540; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Schmidt SAJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006720; Stenton C, 2008, OCCUP MED-OXFORD, V58, P226, DOI 10.1093/occmed/kqm162; Suissa S, 2012, THORAX, V67, P957, DOI 10.1136/thoraxjnl-2011-201518; Wedzicha Jadwiga A, 2004, Proc Am Thorac Soc, V1, P115, DOI 10.1513/pats.2306030	14	99	99	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151357	10.1371/journal.pone.0151357	http://dx.doi.org/10.1371/journal.pone.0151357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959820	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000371992300118
J	Telford, RM; Telford, RD; Olive, LS; Cochrane, T; Davey, R				Telford, Rohan M.; Telford, Richard D.; Olive, Lisa S.; Cochrane, Thomas; Davey, Rachel			Why Are Girls Less Physically Active than Boys? Findings from the LOOK Longitudinal Study	PLOS ONE			English	Article							ORGANIZED SPORTS; AEROBIC FITNESS; CHILDREN; ADOLESCENTS; GENDER; PARTICIPATION; PATTERNS; MODERATE; YOUTH	Background A gender-based disparity in physical activity (PA) among youth, whereby girls are less active than boys is a persistent finding in the literature. A greater understanding of the mechanisms underlying this difference has potential to guide PA intervention strategies. Methods Data were collected at age 8 and 12 years (276 boys, 279 girls) from 29 schools as part of the LOOK study. Multilevel linear models were fitted separately for boys and girls to examine effects of individual, family and environmental level correlates on pedometer measured PA. Cardio-respiratory fitness (multi-stage run), percent fat (DEXA), eye-hand coordination (throw and catch test) and perceived competence in physical education (questionnaire) were used as individual level correlates. At the family level, parent's support and education (questionnaire) were used. School attended and extracurricular sport participation were included as environmental level correlates. Results Girls were 19% less active than boys (9420 vs 11360 steps/day, p<0.001, 95% CI [1844, 2626]). Lower PA among girls was associated with weaker influences at the school and family levels and through lower participation in extracurricular sport. School attended explained some of the variation in boys PA (8.4%) but not girls. Girls compared to boys had less favourable individual attributes associated with PA at age 8 years, including 18% lower cardio-respiratory fitness (3.5 vs 4.2, p<0.001, CI [0.5,0.9]), 44% lower eye-hand coordination (11.0 vs 17.3, p<0.001, CI [5.1,9.0]), higher percent body fat (28% vs 23%, p<0.001, CI [3.5,5.7]) and 9% lower perceived competence in physical education (7.7 vs 8.4, p<0.001, CI [0.2,0.9]). Participation in extracurricular sport at either age 8 or 12 years was protective against declines in PA over time among boys but not girls. Conclusion Girls PA was less favourably influenced by socio-ecological factors at the individual, family, school and environmental levels. These factors are potentially modifiable suggesting the gap in PA between boys and girls can be reduced. Strategies aiming to increase PA should be multicomponent and take into consideration that pathways to increasing PA are likely to differ among boys and girls.	[Telford, Rohan M.; Cochrane, Thomas; Davey, Rachel] Univ Canberra, Hlth Res Inst, Ctr Res & Act Publ Hlth, Canberra, ACT 2601, Australia; [Telford, Richard D.] Australian Natl Univ, Coll Med Biol & Environm, Sch Med, Canberra, ACT, Australia; [Telford, Richard D.] Univ Canberra, Exercise & Sport Res Inst, Canberra, ACT 2601, Australia; [Olive, Lisa S.] Australian Natl Univ, Dept Psychol, Canberra, ACT, Australia	University of Canberra; Australian National University; University of Canberra; Australian National University	Telford, RM (corresponding author), Univ Canberra, Hlth Res Inst, Ctr Res & Act Publ Hlth, Canberra, ACT 2601, Australia.	rohan.telford@canberra.edu.au	Cochrane, Tom/M-8588-2015	Cochrane, Tom/0000-0002-6391-2109; Telford, Richard/0000-0003-4485-9362; Olive, Lisa/0000-0003-4643-8561; Telford, Rohan/0000-0002-1723-2559	Commonwealth Education Trust	Commonwealth Education Trust	This study was funded by the Commonwealth Education Trust, http://www.commonwealth.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Armstrong N, 2011, BRIT J SPORT MED, V45, P849, DOI 10.1136/bjsports-2011-090200; Barnett LM, 2015, J SCI MED SPORT, V18, P167, DOI 10.1016/j.jsams.2014.03.001; Basterfield L, 2015, J SCI MED SPORT, V18, P178, DOI 10.1016/j.jsams.2014.03.005; Beets MW, 2010, HEALTH EDUC BEHAV, V37, P621, DOI 10.1177/1090198110363884; Cairney J, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-26; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Craggs C, 2011, AM J PREV MED, V40, P645, DOI 10.1016/j.amepre.2011.02.025; Douglas A, 2014, PACKAGE LME4; Duncan SC, 2004, EXERC SPORT SCI REV, V32, P95, DOI 10.1097/00003677-200407000-00004; Edwardson CL, 2012, J PHYS ACT HEALTH, P1153; Eime RM, 2009, J SCI MED SPORT, V12, P293, DOI 10.1016/j.jsams.2007.11.003; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Faulkner G, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-20; Hale DR, 2014, PREV SCI, V15, P600, DOI 10.1007/s11121-013-0414-6; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hills AP, 2011, BRIT J SPORT MED, V45, P866, DOI 10.1136/bjsports-2011-090199; Kriemler S, 2011, BRIT J SPORT MED, V45, P923, DOI 10.1136/bjsports-2011-090186; Kristensen PL, 2013, J SPORT SCI, V31, P188, DOI 10.1080/02640414.2012.723818; Moore JB, 2014, AM J HEALTH PROMOT, V29, P132, DOI [10.4278/ajhp.121023-ARB-516, 10.4278/Ajhp.121023-ARB-516]; Pearce MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037975; Richard L, 2011, ANNU REV PUBL HEALTH, V32, P307, DOI 10.1146/annurev-publhealth-031210-101141; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Rowe DA, 2004, PEDIATR EXERC SCI, V16, P343, DOI 10.1123/pes.16.4.343; Ruiz JR, 2006, AM J CLIN NUTR, V84, P299; Seabra A, 2013, J SCI MED SPORT, V16, P320, DOI 10.1016/j.jsams.2012.07.008; Telford RD, 2013, SCAND J MED SCI SPOR, V23, pE263, DOI 10.1111/sms.12073; Telford RD, 2009, ANN HUM BIOL, V36, P669, DOI 10.3109/03014460902960271; Telford RD, 2009, J SCI MED SPORT, V12, P156, DOI 10.1016/j.jsams.2007.03.009; Telford RM, 2016, J SCI MED SPORT, V19, P400, DOI 10.1016/j.jsams.2015.04.008; Telford RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-81; Tomkinson GR, 2003, SPORTS MED, V33, P285, DOI 10.2165/00007256-200333040-00003; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-78; Van Sluijs EMF, 2011, INT J PEDIATR OBES, V6, pE574, DOI 10.3109/17477166.2010.518239; Vella SA, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-62; Wickel EE, 2009, J PHYS ACT HEALTH, V6, P597, DOI 10.1123/jpah.6.5.597	37	197	201	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150041	10.1371/journal.pone.0150041	http://dx.doi.org/10.1371/journal.pone.0150041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960199	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300031
J	Wu, MS; Chen, KH; Chen, IF; Huang, SK; Tzeng, PC; Yeh, ML; Lee, FP; Lin, JG; Chen, C				Wu, Ming-Shun; Chen, Kee-Hsin; Chen, I-Fan; Huang, Shihping Kevin; Tzeng, Pei-Chuan; Yeh, Mei-Ling; Lee, Fei-Peng; Lin, Jaung-Geng; Chen, Chiehfeng			The Efficacy of Acupuncture in Post-Operative Pain Management: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ELECTRICAL NERVE-STIMULATION; ANALGESIC REQUIREMENT; ELECTROACUPUNCTURE; ACUPOINT; SURGERY; COMPLICATIONS; RELIEF	Background Postoperative pain resulting from surgical trauma is a significant challenge for healthcare providers. Opioid analgesics are commonly used to treat postoperative pain; however, these drugs are associated with a number of undesirable side effects. Objective This systematic review and meta-analysis evaluated the effectiveness of acupuncture and acupuncture-related techniques in treating postoperative pain. Data Source MEDLINE, Cochrane Library, and EMBASE databases were searched until Sep 30, 2014. Study Eligibility Criteria Randomized controlled trials of adult subjects (>= 18 years) who had undergone surgery and who had received acupuncture, electroacupuncture, or acupoint electrical stimulation for managing acute post-operative pain were included. Results We found that patients treated with acupuncture or related techniques had less pain and used less opioid analgesics on Day 1 after surgery compared with those treated with control (P < 0.001). Sensitivity analysis using the leave-one-out approach indicated the findings are reliable and are not dependent on any one study. In addition, no publication bias was detected. Subgroup analysis indicated that conventional acupuncture and transcutaneous electric acupoint stimulation (TEAS) were associated with less postoperative pain one day following surgery than control treatment, while electroacupuncture was similar to control (P = 0.116). TEAS was associated with significantly greater reduction in opioid analgesic use on Day 1 post surgery than control (P < 0.001); however conventional acupuncture and electroacupuncture showed no benefit in reducing opioid analgesic use compared with control (P >= 0.142). Conclusion Our findings indicate that certain modes of acupuncture improved postoperative pain on the first day after surgery and reduced opioid use. Our findings support the use of acupuncture as adjuvant therapy in treating postoperative pain.	[Wu, Ming-Shun] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Wu, Ming-Shun] Taipei Med Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Internal Med,Coll Med, Taipei, Taiwan; [Chen, Kee-Hsin] Taipei Med Univ, Wan Fang Hosp, Dept Nursing, Taipei, Taiwan; [Chen, Kee-Hsin; Chen, Chiehfeng] Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan; [Chen, Kee-Hsin; Chen, Chiehfeng] Taipei Med Univ, Cochrane Taiwan, Taipei, Taiwan; [Chen, I-Fan; Huang, Shihping Kevin] Natl Chiao Tung Univ, Inst Management Technol, Hsinchu, Taiwan; [Tzeng, Pei-Chuan; Chen, Chiehfeng] Taipei Med Univ, Wan Fang Hosp, Evidence Based Med Ctr, Taipei, Taiwan; [Yeh, Mei-Ling] Natl Taipei Univ Nursing & Hlth Sci, Grad Inst Integrat Tradit Chinese Med Western Nur, Taipei, Taiwan; [Lee, Fei-Peng; Chen, Chiehfeng] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Lee, Fei-Peng] Taipei Med Univ, Shuang Ho Hosp, Dept Otolaryngol, New Taipei, Taiwan; [Lin, Jaung-Geng] China Med Univ, Sch Chinese Med Acupuncture Sci, Taichung, Taiwan; [Chen, Chiehfeng] Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Taipei University of Nursing & Health Science (NTUNHS); Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; China Medical University Taiwan; Taipei Medical University	Chen, C (corresponding author), Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan.; Chen, C (corresponding author), Taipei Med Univ, Cochrane Taiwan, Taipei, Taiwan.; Chen, C (corresponding author), Taipei Med Univ, Wan Fang Hosp, Evidence Based Med Ctr, Taipei, Taiwan.; Chen, C (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.; Chen, C (corresponding author), Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, Taipei, Taiwan.; Chen, C (corresponding author), Taipei Med Univ, Wan Fang Hosp, Div Plast Surg, Dept Surg, Taipei, Taiwan.	chiehfeng@sina.com	Chen, Kee-Hsin/W-3576-2019	Chen, Kee-Hsin/0000-0001-9772-482X; Fei-Peng, Lee/0000-0002-6788-4336; Chen, Chiehfeng/0000-0002-1595-6553	Taipei Medical University - Wan Fang Hospital [103WF-EVA-18]	Taipei Medical University - Wan Fang Hospital	This work was supported by Taipei Medical University - Wan Fang Hospital under the Grant No. 103WF-EVA-18.	Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; Chen L, 1998, ANESTH ANALG, V87, P1129, DOI 10.1097/00000539-199811000-00028; Chen SP, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/609594; Chiu JH, 1999, DIS COLON RECTUM, V42, P180, DOI 10.1007/BF02237124; Cho YJ, 2013, SPINE, V38, P549, DOI 10.1097/BRS.0b013e318275e601; de Leon-Casasola O, 2014, POSTGRAD MED, V126, P42, DOI 10.3810/pgm.2014.07.2782; Erthal V, 2013, LASER MED SCI, V28, P1345, DOI 10.1007/s10103-012-1260-7; Coura LEF, 2011, ACUPUNCT MED, V29, P16, DOI 10.1136/aim.2010.003251; Gan TJ, 2014, CURR MED RES OPIN, V30, P149, DOI 10.1185/03007995.2013.860019; Hartrick Craig T, 2003, Pain Pract, V3, P310; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; HINES R, 1992, ANESTH ANALG, V74, P503; Kotani N, 2001, ANESTHESIOLOGY, V95, P349, DOI 10.1097/00000542-200108000-00015; Lan F, 2012, MINERVA ANESTESIOL, V78, P887; Langenbach MR, 2012, COLORECTAL DIS, V14, pE486, DOI 10.1111/j.1463-1318.2012.02984.x; Lee JH, 2013, CLIN J PAIN, V29, P172, DOI 10.1097/AJP.0b013e31824909f9; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lin JG, 2002, PAIN, V99, P509, DOI 10.1016/S0304-3959(02)00261-0; Mayor D, 2013, ACUPUNCT MED, V31, P409, DOI 10.1136/acupmed-2013-010324; Sim Chin-Keng, 2002, Acupunct Med, V20, P56; Sun Y, 2008, BRIT J ANAESTH, V101, P151, DOI 10.1093/bja/aen146; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Wang BG, 1997, ANESTH ANALG, V85, P406, DOI 10.1097/00000539-199708000-00029; WANG JQ, 1992, INT J NEUROSCI, V65, P117, DOI 10.3109/00207459209003283; Wang RR, 2000, AM J CHINESE MED, V28, P25, DOI 10.1142/S0192415X00000052; Ward U, 2013, CLIN NURS RES, V22, P130, DOI 10.1177/1054773812454136; Wong RHL, 2006, ANN THORAC SURG, V81, P2031, DOI 10.1016/j.athoracsur.2005.12.064; Yamashita H, 1999, J ALTERN COMPLEM MED, V5, P229, DOI 10.1089/acm.1999.5.229; Yeh ML, 2011, INT J NURS STUD, V48, P703, DOI 10.1016/j.ijnurstu.2010.10.009	29	118	127	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150367	10.1371/journal.pone.0150367	http://dx.doi.org/10.1371/journal.pone.0150367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959661	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300045
J	Alexander, DM; Nikolaev, AR; Jurica, P; Zvyagintsev, M; Mathiak, K; van Leeuwen, C				Alexander, David M.; Nikolaev, Andrey R.; Jurica, Peter; Zvyagintsev, Mikhail; Mathiak, Klaus; van Leeuwen, Cees			Global Neuromagnetic Cortical Fields Have Non-Zero Velocity	PLOS ONE			English	Article							TRAVELING ALPHA-WAVES; FUNCTIONAL CONNECTIVITY; PHASE SYNCHRONIZATION; NEOCORTICAL DYNAMICS; INFORMATION-TRANSFER; VISUAL-CORTEX; BRAIN WAVES; EEG; OSCILLATIONS; COHERENCE	Globally coherent patterns of phase can be obscured by analysis techniques that aggregate brain activity measures across-trials, whether prior to source localization or for estimating inter-areal coherence. We analyzed, at single-trial level, whole head MEG recorded during an observer-triggered apparent motion task. Episodes of globally coherent activity occurred in the delta, theta, alpha and beta bands of the signal in the form of large-scale waves, which propagated with a variety of velocities. Their mean speed at each frequency band was proportional to temporal frequency, giving a range of 0.06 to 4.0 m/s, from delta to beta. The wave peaks moved over the entire measurement array, during both ongoing activity and task-relevant intervals; direction of motion was more predictable during the latter. A large proportion of the cortical signal, measurable at the scalp, exists as large-scale coherent motion. We argue that the distribution of observable phase velocities in MEG is dominated by spatial filtering considerations in combination with group velocity of cortical activity. Traveling waves may index processes involved in global coordination of cortical activity.	[Alexander, David M.; Nikolaev, Andrey R.; van Leeuwen, Cees] Univ Leuven, KU Leuven, Brain & Cognit Res Unit, Leuven, Belgium; [Jurica, Peter] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Zvyagintsev, Mikhail; Mathiak, Klaus] Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [van Leeuwen, Cees] Kaiserslautern Univ Technol, Kaiserslautern, Germany	KU Leuven; RIKEN; RWTH Aachen University; University of Kaiserslautern	Alexander, DM (corresponding author), Univ Leuven, KU Leuven, Brain & Cognit Res Unit, Leuven, Belgium.	david.murray.alexander@gmail.com	van Leeuwen, Cees/G-2644-2010; Alexander, David M/J-5829-2017; van Leeuwen, Cees/AAB-9525-2022; Nikolaev, Andrey/I-2807-2017	van Leeuwen, Cees/0000-0002-4441-2440; van Leeuwen, Cees/0000-0002-4441-2440; Nikolaev, Andrey/0000-0001-5126-8566; Alexander, David/0000-0003-4583-8950; Zvyagintsev, Mikhail/0000-0001-9521-042X	Flemish Organization for Science, FWO	Flemish Organization for Science, FWO(FWO)	DMA, ARN and CvL were supported by an Odysseus grant from the Flemish Organization for Science, FWO http://www.fwo.be/en/fellowships-funding/research-projects/odysseusprogramme/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DMA, ARN and CvL were supported by an Odysseus grant from the Flemish Organization for Science, FWO.	Alexander DM, 2006, J NEUROSCI METH, V156, P111, DOI 10.1016/j.jneumeth.2006.02.016; Alexander DM, 2008, CLIN NEUROPHYSIOL, V119, P163, DOI 10.1016/j.clinph.2007.09.119; Alexander David M., 2006, Journal of Integrative Neuroscience, V5, P49, DOI 10.1142/S0219635206001021; Alexander DM, 2013, NEUROIMAGE, V73, P95, DOI 10.1016/j.neuroimage.2013.01.016; Alexander DM, 2011, COGN NEURODYNAMICS, V5, P113, DOI 10.1007/s11571-010-9142-9; Alexander DM, 2009, CLIN NEUROPHYSIOL, V120, P1667, DOI 10.1016/j.clinph.2009.06.020; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Burkitt GR, 2000, CLIN NEUROPHYSIOL, V111, P246, DOI 10.1016/S1388-2457(99)00194-7; Delaunay B., 1934, B LACADEMIE SCI LURS, V6, P793; Eckhorn R, 2004, ACTA NEUROBIOL EXP, V64, P239; Eckhorn R, 2001, VIS COGN, V8, P519, DOI 10.1080/13506280143000098; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Fellinger R, 2012, NEUROIMAGE, V59, P3379, DOI 10.1016/j.neuroimage.2011.11.010; Freeman WJ, 2003, CLIN NEUROPHYSIOL, V114, P1053, DOI 10.1016/S1388-2457(03)00045-2; Freeman WJ, 2000, J NEUROSCI METH, V95, P111, DOI 10.1016/S0165-0270(99)00160-0; Freeman WJ, 2000, J NEUROPHYSIOL, V84, P1266, DOI 10.1152/jn.2000.84.3.1266; Freeman WJ, 1975, MASS ACTION NERVOUS; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; GOLDMAN S, 1949, SCIENCE, V109, P524, DOI 10.1126/science.109.2838.524; Gong P, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011904; HERRMANN CS, 2005, EEG OSCILLATIONS WAV; HUGHES J R, 1992, Brain Topography, V4, P215, DOI 10.1007/BF01131153; HUGHES JR, 1995, CLIN ELECTROENCEPHAL, V26, P7, DOI 10.1177/155005949502600104; HUGHES JR, 1995, CLIN ELECTROENCEPHAL, V26, P1, DOI 10.1177/155005949502600103; Ito J, 2005, BIOL CYBERN, V92, P54, DOI 10.1007/s00422-004-0533-z; Ito J, 2007, HUM BRAIN MAPP, V28, P904, DOI 10.1002/hbm.20316; KAWAGUCHI T, 1993, ELECTROEN CLIN NEURO, V87, P88, DOI 10.1016/0013-4694(93)90115-C; Klimesch W, 2007, J NEUROPHYSIOL, V97, P1311, DOI 10.1152/jn.00876.2006; Llinas RRRU, 1992, INDUCED RHYTHMS BRAI, P147; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Manyakov NV, 2010, IEEE T NEURAL NETWOR, V21, P1892, DOI 10.1109/TNN.2010.2078834; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Nikolaev AR, 2010, CEREB CORTEX, V20, P365, DOI 10.1093/cercor/bhp107; Nolte G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.234101; NUNEZ P L, 1974, Mathematical Biosciences, V21, P279, DOI 10.1016/0025-5564(74)90020-0; Nunez P.L., 2006, ELECT FIELDS BRAIN; Nunez P.L., 1995, NEOCORTICAL DYNAMICS; Nunez PL, 2006, CLIN NEUROPHYSIOL, V117, P2424, DOI 10.1016/j.clinph.2006.06.754; Nunez PL, 2015, CLIN NEUROPHYSIOL, V126, P110, DOI 10.1016/j.clinph.2014.04.003; Nunez PL, 2014, BRAIN RES, V1542, P138, DOI 10.1016/j.brainres.2013.10.036; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Patten TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038392; PETSCHE H, 1968, ELECTROEN CLIN NEURO, V25, P11, DOI 10.1016/0013-4694(68)90081-3; PETSCHE H, 1970, ELECTROEN CLIN NEURO, V28, P592, DOI 10.1016/0013-4694(70)90201-4; Prechtl JC, 1997, P NATL ACAD SCI USA, V94, P7621, DOI 10.1073/pnas.94.14.7621; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ray S, 2011, J NEUROSCI, V31, P12674, DOI 10.1523/JNEUROSCI.1856-11.2011; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sauseng P, 2002, NEUROSCI LETT, V324, P121, DOI 10.1016/S0304-3940(02)00225-2; Schack B, 2003, HUM BRAIN MAPP, V19, P18, DOI 10.1002/hbm.10104; Shevelev IA, 2000, INT J PSYCHOPHYSIOL, V39, P9, DOI 10.1016/S0167-8760(00)00105-7; SILBERSTEIN R B, 1992, Brain Topography, V4, P267, DOI 10.1007/BF01135564; SPAGNOLINI U, 1995, IEEE T GEOSCI REMOTE, V33, P579, DOI 10.1109/36.387574; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; SUZUKI H, 1974, JPN J PHYSIOL, V24, P569; Takahashi K, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00040; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Zhang HH, 2015, J NEUROSCI, V35, P12477, DOI 10.1523/JNEUROSCI.5102-14.2015; Zvyagintsev M, 2008, EXP BRAIN RES, V189, P289, DOI 10.1007/s00221-008-1423-8	65	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0148413	10.1371/journal.pone.0148413	http://dx.doi.org/10.1371/journal.pone.0148413			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953886	Green Published, Green Submitted, gold			2022-12-27	WOS:000371991300003
J	Tan, HQ; Huang, HT; Tie, MM; Tang, Y; Lai, YS; Li, HX				Tan, Huaqiang; Huang, Haitao; Tie, Manman; Tang, Yi; Lai, Yunsong; Li, Huanxiu			Transcriptome Profiling of Two Asparagus Bean (Vigna unguiculata subsp. sesquipedalis) Cultivars Differing in Chilling Tolerance under Cold Stress	PLOS ONE			English	Article							RESPONSIVE GENE-EXPRESSION; RNA-SEQ DATA; FREEZING TOLERANCE; HIGH-SALINITY; PLANT; ACCLIMATION; COWPEA; DROUGHT; REGULATOR; PROTEINS	Cowpea (V. unguiculata L. Walp.) is an important tropical grain legume. Asparagus bean (V. unguiculata ssp. sesquipedialis) is a distinctive subspecies of cowpea, which is considered one of the top ten Asian vegetables. It can be adapted to a wide range of environmental stimuli such as drought and heat. Nevertheless, it is an extremely cold-sensitive tropical species. Improvement of chilling tolerance in asparagus bean may significantly increase its production and prolong its supply. However, gene regulation and signaling pathways related to cold response in this crop remain unknown. Using Illumina sequencing technology, modification of global gene expression in response to chilling stress in two asparagus bean cultivars-"Dubai bean" and "Ningjiang-3", which are tolerant and sensitive to chilling, respectively-were investigated. More than 1.8 million clean reads were obtained from each sample. After de novo assembly, 88,869 unigenes were finally generated with a mean length of 635 bp. Of these unigenes, 41,925 (47.18%) had functional annotations when aligned to public protein databases. Further, we identified 3,510 differentially expressed genes (DEGs) in Dubai bean, including 2,103 up-regulated genes and 1,407 down-regulated genes. While in Ningjiang-3, we found 2,868 DEGs, 1,786 of which were increasing and the others were decreasing. 1,744 DEGs were commonly regulated in two cultivars, suggesting that some genes play fundamental roles in asparagus bean during cold stress. Functional classification of the DEGs in two cultivars using Mercator pipeline indicated that RNA, protein, signaling, stress and hormone metabolism were five major groups. In RNA group, analysis of TFs in DREB subfamily showed that ICE1-CBF3-COR cold responsive cascade may also exist in asparagus bean. Our study is the first to provide the transcriptome sequence resource for asparagus bean, which will accelerate breeding cold resistant asparagus bean varieties through genetic engineering, and advance our knowledge of the genes involved in the complex regulatory networks of this plant under cold stress.	[Tan, Huaqiang; Tang, Yi; Lai, Yunsong; Li, Huanxiu] Sichuan Agr Univ, Coll Hort, Chengdu, Sichuan, Peoples R China; [Huang, Haitao] Mianyang Inst Agr Sci, Mianyang, Sichuan, Peoples R China; [Tie, Manman] Dazhou Inst Agr Sci, Dazhou, Sichuan, Peoples R China	Sichuan Agricultural University	Li, HX (corresponding author), Sichuan Agr Univ, Coll Hort, Chengdu, Sichuan, Peoples R China.	Huanxiuli62@gmail.com	Li, Huanxiu/S-6177-2019					Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asiwe JAN, 2009, AFR J BIOTECHNOL, V8, P226; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Carvallo MA, 2011, J EXP BOT, V62, P3807, DOI 10.1093/jxb/err066; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ehlers JD, 1997, FIELD CROP RES, V53, P187, DOI 10.1016/S0378-4290(97)00031-2; Fang JG, 2007, GENET RESOUR CROP EV, V54, P1197, DOI 10.1007/s10722-006-9101-9; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gillaspie AG, 2005, GENET RESOUR CROP EV, V52, P245, DOI 10.1007/s10722-004-6693-9; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071462; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Hall AE, 2004, EUR J AGRON, V21, P447, DOI 10.1016/j.eja.2004.07.005; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Heidarvand L, 2010, ACTA PHYSIOL PLANT, V32, P419, DOI 10.1007/s11738-009-0451-8; Heino P, 2003, TOP CURR GENET, V4, P151; Ismail AM, 1999, P NATL ACAD SCI USA, V96, P13566, DOI 10.1073/pnas.96.23.13566; Ismail AM, 2002, FIELD CROP RES, V77, P99, DOI 10.1016/S0378-4290(02)00059-X; Ismail AM, 1997, CROP SCI, V37, P1270, DOI 10.2135/cropsci1997.0011183X003700040041x; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Knight MR, 2012, NEW PHYTOL, V195, P737, DOI 10.1111/j.1469-8137.2012.04239.x; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lei XT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114482; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Lohse M, 2014, PLANT CELL ENVIRON, V37, P1250, DOI 10.1111/pce.12231; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Miura K, 2013, INT J MOL SCI, V14, P5312, DOI 10.3390/ijms14035312; Mizoguchi T, 1996, P NATL ACAD SCI USA, V93, P765, DOI 10.1073/pnas.93.2.765; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakashima K, 2006, PHYSIOL PLANTARUM, V126, P62, DOI 10.1111/j.1399-3054.2005.00592.x; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Pang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-488; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Peters JL, 2003, TRENDS PLANT SCI, V8, P484, DOI 10.1016/j.tplants.2003.09.002; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Song YP, 2013, PLANT CELL REP, V32, P1407, DOI 10.1007/s00299-013-1454-x; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2001, PLANT PHYSIOL, V125, P89, DOI 10.1104/pp.125.1.89; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xin HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058740; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Xu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015952; Xu WR, 2014, PLANT MOL BIOL, V86, P527, DOI 10.1007/s11103-014-0245-2; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043274; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010	75	21	22	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151105	10.1371/journal.pone.0151105	http://dx.doi.org/10.1371/journal.pone.0151105			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954786	Green Submitted, gold, Green Published			2022-12-27	WOS:000371991300083
J	Haberg, AK; Hammer, TA; Kvistad, KA; Rydland, J; Muller, TB; Eikenes, L; Garseth, M; Stovner, LJ				Haberg, Asta Kristine; Hammer, Tommy Arild; Kvistad, Kjell Arne; Rydland, Jana; Mueller, Tomm B.; Eikenes, Live; Garseth, Mari; Stovner, Lars Jacob			Incidental Intracranial Findings and Their Clinical Impact; The HUNT MRI Study in a General Population of 1006 Participants between 50-66 Years	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; GLOBAL FUNCTIONAL DECLINE; CORTICAL SURFACE-AREA; NORD-TRONDELAG HEALTH; RISK-FACTORS; CEREBRAL MICROBLEEDS; BRAIN MRI; NATURAL-HISTORY; CARDIOVASCULAR HEALTH; VASCULAR RISK	Objectives Evaluate types and prevalence of all, incidental, and clinically relevant incidental intracranial findings, i.e. those referred to primary physician or clinical specialist, in a cohort between 50 and 66 years from the Nord-Trondelag Health (HUNT) study. Types of follow-up, outcome of repeated neuroimaging and neurosurgical treatment were assessed. Material and Methods 1006 participants (530 women) underwent MRI of the head at 1.5T consisting of T1 weighted sagittal IR-FSPGR volume, axial T2 weighted, gradient echo T2* weighted and FLAIR sequences plus time of flight cerebral angiography covering the circle of Willis. The nature of a finding and if it was incidental were determined from previous radiological examinations, patient records, phone interview, and/or additional neuroimaging. Handling and outcome of the clinically relevant incidental findings were prospectively recorded. True and false positives were estimated from the repeated neuroimaging. Results Prevalence of any intracranial finding was 32.7%. Incidental intracranial findings were present in 27.1% and clinically relevant findings in 15.1% of the participants in the HUNT MRI cohort. 185 individuals (18.4%) were contacted by phone about their findings. 40 participants (6.2%) underwent >= 1 additional neuroimaging session to establish etiology. Most false positives were linked to an initial diagnosis of suspected glioma, and overall positive predictive value of initial MRI was 0.90 across different diagnoses. 90.8% of the clinically relevant incidental findings were developmental and acquired cerebrovascular pathologies, the remaining 9.2% were intracranial tumors, of which extra-axial tumors predominated. In total, 3.9% of the participants were referred to a clinical specialist, and 11.7% to their primary physician. 1.4% underwent neurosurgery/radiotherapy, and 1 (0.1%) experienced a procedure related postoperative deficit. Conclusions In a general population between 50 and 66 years most intracranial findings on MRI were incidental, and > 15% of the cohort was referred to clinical-follow up. Hence good routines for handling of findings need to be in place to ensure timely and appropriate handling.	[Haberg, Asta Kristine; Stovner, Lars Jacob] Norwegian Univ Sci & Technol NTNU, Dept Neurosci, Trondheim, Norway; [Haberg, Asta Kristine; Hammer, Tommy Arild; Kvistad, Kjell Arne; Rydland, Jana] St Olavs Univ Hosp, Dept Radiol, Trondheim, Norway; [Mueller, Tomm B.] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway; [Eikenes, Live] NTNU, Dept Circulat & Med Imaging, Trondheim, Norway; [Garseth, Mari] Levanger Hosp, Dept Radiol, Trondheim, Norway; [Stovner, Lars Jacob] St Olavs Univ Hosp, Dept Neurol & Clin Neurophysiol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Haberg, AK (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Neurosci, Trondheim, Norway.; Haberg, AK (corresponding author), St Olavs Univ Hosp, Dept Radiol, Trondheim, Norway.	asta.haberg@ntnu.no			Helse-Midt Norge	Helse-Midt Norge	Data collection and MRI reading were financed by Helse-Midt Norge. The authors received no specific funding for this work.	Al-Holou WN, 2013, J NEUROSURG, V118, P222, DOI 10.3171/2012.10.JNS12548; [Anonymous], 2009, EPIDEMIOLOGY BRAIN T, P323; Bosnjak J, 2009, ACTA CLIN CROAT, V48, P355; BRETELER MMB, 1994, NEUROLOGY, V44, P1246, DOI 10.1212/WNL.44.7.1246; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Chen CH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8549; Cooper L, 2009, P SOC PHOTO-OPT INS, V7263; Cooper L, 2010, PROC SPIE, V7627, DOI 10.1117/12.843680; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Das RR, 2008, STROKE, V39, P2929, DOI 10.1161/STROKEAHA.108.516575; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Eikenes L, 2012, PEDIATR RES, V72, P649, DOI 10.1038/pr.2012.129; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Fang Jing, 2012, Morbidity and Mortality Weekly Report, V61, P379; FAZEKAS F, 1987, AM J NEURORADIOL, V8, P421; Gaddikeri S, 2013, NEUROSCIENCES, V18, P258; Gupta SN, 2008, J NEUROL SCI, V264, P34, DOI 10.1016/j.jns.2007.06.055; Gur RE, 2013, AM J NEURORADIOL, V34, P2021, DOI 10.3174/ajnr.A3525; Hansen AG, 2014, BMC EAR NOSE THROAT, V14, DOI 10.1186/1472-6815-14-13; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Holmen TL, 2014, INT J EPIDEMIOL, V43, P536, DOI 10.1093/ije/dys232; Honningsvag LM, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-23; Horita Y, 2003, NEUROL SURG TOKYO, V31, P263; Illes J, 2004, NEUROLOGY, V62, P888, DOI 10.1212/01.WNL.0000118531.90418.89; Indredavik B, 2008, INT J STROKE, V3, P205, DOI 10.1111/j.1747-4949.2008.00201.x; Inzitari D, 2007, ARCH INTERN MED, V167, P81, DOI 10.1001/archinte.167.1.81; Inzitari D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2477; Jakola AS, 2012, JAMA-J AM MED ASSOC, V308, P1881, DOI 10.1001/jama.2012.12807; Jeerakathil T, 2004, STROKE, V35, P1831, DOI 10.1161/01.STR.0000131809.35202.1b; JOST BC, 1995, J AM GERIATR SOC, V43, P1248, DOI 10.1111/j.1532-5415.1995.tb07401.x; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Kelly Adam G, 2014, Continuum (Minneap Minn), V20, P387, DOI 10.1212/01.CON.0000446108.12915.65; Kim BS, 2002, AM J NEURORADIOL, V23, P1674; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Kumar R, 2008, ACTA NEUROPSYCHIATR, V20, P87, DOI 10.1111/j.1601-5215.2008.00273.x; Lebedeva A, 2015, NEUROBIOL AGING, V36, P3090, DOI 10.1016/j.neurobiolaging.2015.04.020; Lee SC, 2000, HYPERTENSION, V36, P73, DOI 10.1161/01.HYP.36.1.73-a; Lesgold A, 2014, EXPERTISE COMPLEX SK; Liao DP, 1997, NEUROEPIDEMIOLOGY, V16, P149, DOI 10.1159/000368814; Lonn S, 2004, INT J CANCER, V108, P450, DOI 10.1002/ijc.11578; MCGRATH P, 1971, PATHOLOGY, V3, P123, DOI 10.3109/00313027109071331; Miwa K, 2011, STROKE, V42, P3202, DOI 10.1161/STROKEAHA.111.621193; Morris Z, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3016; Muller TB, 2013, NEUROSURGERY, V73, P256, DOI 10.1227/01.neu.0000430295.23799.16; NAKASU S, 1987, SURG NEUROL, V27, P319, DOI 10.1016/0090-3019(87)90005-X; Nataraj A, 2014, WORLD NEUROSURG, V82, P149, DOI 10.1016/j.wneu.2013.02.064; Oz G, 2015, NEUROCHEM RES, V40, P2473, DOI 10.1007/s11064-015-1664-4; Ohgaki H, 2009, EPIDEMIOLOGY BRAIN T, P323; Pintzka CWS, 2015, NEUROBIOL AGING, V36, P2555, DOI 10.1016/j.neurobiolaging.2015.05.023; Poggesi A, 2011, CEREBROVASC DIS, V32, P577, DOI 10.1159/000334498; Pollock BE, 2003, NEUROSURGERY, V52, P1291, DOI 10.1227/01.NEU.0000064800.26214.FE; Price TR, 1997, STROKE, V28, P1158, DOI 10.1161/01.STR.28.6.1158; Radiologists TRCo, 2011, MAN INC FIND DET RES; Roob G, 1999, NEUROLOGY, V52, P991, DOI 10.1212/WNL.52.5.991; Sadatsafavi M, 2010, VALUE HEALTH, V13, P761, DOI 10.1111/j.1524-4733.2010.00755.x; Salman RAS, 2007, J MED SCREEN, V14, P2, DOI 10.1258/096914107780154530; Sandeman EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071467; Seki A, 2010, J EPIDEMIOL, V20, pS498, DOI 10.2188/jea.JE20090196; Shoemaker JM, 2011, NEUROLOGY, V77, P2123, DOI 10.1212/WNL.0b013e31823d7687; SKOOG I, 1994, DEMENTIA, V5, P137, DOI 10.1159/000106711; Skranes J, 2013, CORTEX, V49, P2264, DOI 10.1016/j.cortex.2013.06.001; Solheim O, 2014, J NEUROSURG, V120, P827, DOI 10.3171/2013.12.JNS131312; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; Stewart Alan R, 2012, J Insur Med, V43, P84; Stewart R, 2003, J AM GERIATR SOC, V51, P1547, DOI 10.1046/j.1532-5415.2003.51504.x; Stovner LJ, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-5; Sveinbjornsdottir S, 2008, J NEUROL NEUROSUR PS, V79, P1002, DOI 10.1136/jnnp.2007.121913; TERAMOTO A, 1994, RADIOLOGY, V193, P161, DOI 10.1148/radiology.193.1.8090885; Tsushima Y, 2002, NEURORADIOLOGY, V44, P31, DOI 10.1007/s002340100649; Verhaaren BFJ, 2013, HYPERTENSION, V61, P1354, DOI 10.1161/HYPERTENSIONAHA.111.00430; Vermeer SE, 2002, STROKE, V33, P21, DOI 10.1161/hs0102.101629; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Weber F, 2006, J NEUROL SCI, V240, P81, DOI 10.1016/j.jns.2005.09.008; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171; Yue NC, 1997, RADIOLOGY, V202, P41, DOI 10.1148/radiology.202.1.8988190	77	64	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0151080	10.1371/journal.pone.0151080	http://dx.doi.org/10.1371/journal.pone.0151080			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950220	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100089
J	Marsh, AG; Hoadley, KD; Warner, ME				Marsh, Adam G.; Hoadley, Kenneth D.; Warner, Mark E.			Distribution of CpG Motifs in Upstream Gene Domains in a Reef Coral and Sea Anemone: Implications for Epigenetics in Cnidarians	PLOS ONE			English	Article							DNA METHYLATION; ISLAND PROMOTERS; EXPRESSION; GENOME; RESISTANCE	Coral reefs are under assault from stressors including global warming, ocean acidification, and urbanization. Knowing how these factors impact the future fate of reefs requires delineating stress responses across ecological, organismal and cellular scales. Recent advances in coral reef biology have integrated molecular processes with ecological fitness and have identified putative suites of temperature acclimation genes in a Scleractinian coral Acropora hyacinthus. We wondered what unique characteristics of these genes determined their coordinate expression in response to temperature acclimation, and whether or not other corals and cnidarians would likewise possess these features. Here, we focus on cytosine methylation as an epigenetic DNA modification that is responsive to environmental stressors. We identify common conserved patterns of cytosine-guanosine dinucleotide (CpG) motif frequencies in upstream promoter domains of different functional gene groups in two cnidarian genomes: a coral (Acropora digitifera) and an anemone (Nematostella vectensis). Our analyses show that CpG motif frequencies are prominent in the promoter domains of functional genes associated with environmental adaptation, particularly those identified in A. hyacinthus. Densities of CpG sites in upstream promoter domains near the transcriptional start site (TSS) are 1.38x higher than genomic background levels upstream of -2000 bp from the TSS. The increase in CpG usage suggests selection to allow for DNA methylation events to occur more frequently within 1 kb of the TSS. In addition, observed shifts in CpG densities among functional groups of genes suggests a potential role for epigenetic DNA methylation within promoter domains to impact functional gene expression responses in A. digitifera and N. vectensis. Identifying promoter epigenetic sequence motifs among genes within specific functional groups establishes an approach to describe integrated cellular responses to environmental stress in reef corals and potential roles of epigenetics on survival and fitness in the face of global climate change.	[Marsh, Adam G.; Hoadley, Kenneth D.; Warner, Mark E.] Univ Delaware, Sch Marine Sci & Policy, Marine Biosci, Lewes, DE 19958 USA; [Marsh, Adam G.] Univ Delaware, Ctr Bioinformat & Computat Biol, Delaware Biotechnol Inst, Newark, DE USA	University of Delaware; University of Delaware	Marsh, AG (corresponding author), Univ Delaware, Sch Marine Sci & Policy, Marine Biosci, Lewes, DE 19958 USA.; Marsh, AG (corresponding author), Univ Delaware, Ctr Bioinformat & Computat Biol, Delaware Biotechnol Inst, Newark, DE USA.	amarsh@udel.edu	Warner, Mark E/J-6241-2013	Warner, Mark/0000-0003-1015-9413; Hoadley, Kenneth/0000-0002-9287-181X	US National Science Foundation [0944557, 1316055]; Emerging Frontiers [1316055] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation, #0944557 to A.M. and #1316055 to M.W. and A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the US National Science Foundation: #0944557 to A.M. and #1316055 to M.W. and A.M.	Aerts S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-34; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Bay RA, 2015, GENOME BIOL EVOL, V7, P1602, DOI 10.1093/gbe/evv085; Bay RA, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.044; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dimond JL, 2016, MOL ECOL, V25, P1895, DOI 10.1111/mec.13414; Dixon GB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1109; Dunlap WC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-509; Granados-Cifuentes C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-228; Hartono SR, 2015, NUCLEIC ACIDS RES, V43, P9729, DOI 10.1093/nar/gkv811; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jiang Q, 2013, GENES GENOM, V35, P641, DOI 10.1007/s13258-013-0114-4; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lechner M, 2013, THEOR BIOSCI, V132, P47, DOI 10.1007/s12064-012-0167-y; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Marsh AG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00173; Miller DJ, 2011, J EXP MAR BIOL ECOL, V408, P114, DOI 10.1016/j.jembe.2011.07.031; Montaggioni LF, 2005, EARTH-SCI REV, V71, P1, DOI 10.1016/j.earscirev.2005.01.002; Olson CE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00224; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Pandolfi JM, 2014, CURR OPIN ENV SUST, V7, P52, DOI 10.1016/j.cosust.2013.11.020; Perfus-Barbeoch L, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00211; Riviere G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00129; Riviere G, 2013, MAR BIOTECHNOL, V15, P739, DOI 10.1007/s10126-013-9523-2; Robinson SA, 2011, GEOLOGY, V39, P51, DOI 10.1130/G31422.1; SCHWARZ JA, 2008, BMC GENOMICS, V9; Sharif J, 2010, DEV GROWTH DIFFER, V52, P545, DOI 10.1111/j.1440-169X.2010.01193.x; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Szulwach KE, 2014, BIOESSAYS, V36, P107, DOI 10.1002/bies.201300090; Vidal-Dupiol J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058652	30	6	6	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150840	10.1371/journal.pone.0150840	http://dx.doi.org/10.1371/journal.pone.0150840			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950882	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100067
J	Norouzi, N; Bhakta, HC; Grover, WH				Norouzi, Nazila; Bhakta, Heran C.; Grover, William H.			Orientation-Based Control of Microfluidics	PLOS ONE			English	Article							DEVICE; VALVES; CELLS; PUMPS	Most microfluidic chips utilize off-chip hardware (syringe pumps, computer-controlled solenoid valves, pressure regulators, etc.) to control fluid flow on-chip. This expensive, bulky, and power-consuming hardware severely limits the utility of microfluidic instruments in resource-limited or point-of-care contexts, where the cost, size, and power consumption of the instrument must be limited. In this work, we present a technique for on-chip fluid control that requires no off-chip hardware. We accomplish this by using inert compounds to change the density of one fluid in the chip. If one fluid is made 2% more dense than a second fluid, when the fluids flow together under laminar flow the interface between the fluids quickly reorients to be orthogonal to Earth's gravitational force. If the channel containing the fluids then splits into two channels, the amount of each fluid flowing into each channel is precisely determined by the angle of the channels relative to gravity. Thus, any fluid can be routed in any direction and mixed in any desired ratio on-chip simply by holding the chip at a certain angle. This approach allows for sophisticated control of on-chip fluids with no off-chip control hardware, significantly reducing the cost of microfluidic instruments in point-of-care or resource-limited settings.	[Norouzi, Nazila; Bhakta, Heran C.; Grover, William H.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA	University of California System; University of California Riverside	Grover, WH (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	wgrover@engr.ucr.edu		Grover, William/0000-0001-6854-8951	National Science Foundation's Instrument Development for Biological Research Program [DBI-1353974]; Direct For Biological Sciences [1353974] Funding Source: National Science Foundation	National Science Foundation's Instrument Development for Biological Research Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors would like to thank Dr. Brian Storey of the Franklin W. Olin College of Engineering for helpful discussions on finite element analysis of fluids with different physical properties. This work was supported in part by the National Science Foundation's Instrument Development for Biological Research Program under award DBI-1353974. There was no additional external funding received for this study.; The authors would like to thank Dr. Brian Storey of the Franklin W. Olin College of Engineering for helpful discussions on finite element analysis of fluids with different physical properties. This work was supported in part by the National Science Foundation's Instrument Development for Biological Research Program under award DBI-1353974. There was no additional external funding received for this study.	BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Cooney CG, 2006, MICROFLUID NANOFLUID, V2, P435, DOI 10.1007/s10404-006-0085-8; Grover WH, 2003, SENSOR ACTUAT B-CHEM, V89, P315, DOI 10.1016/S0925-4005(02)00468-9; Grynne BH, 1994, ACTA RADIOLOGICA S, V399, P265; Hardt S, 2006, MICROFLUID NANOFLUID, V2, P237, DOI 10.1007/s10404-005-0071-6; Karst CM, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4794726; Kim C, 2008, LAB CHIP, V8, P473, DOI 10.1039/b714536e; Mugele F, 2005, J PHYS-CONDENS MAT, V17, pR705, DOI 10.1088/0953-8984/17/28/R01; Neerincx PE, 2011, MACROMOL MATER ENG, V296, P349, DOI 10.1002/mame.201000338; Paegel BM, 2006, ANAL CHEM, V78, P7522, DOI 10.1021/ac0608265; PERTOFT H, 1977, EXP CELL RES, V110, P449, DOI 10.1016/0014-4827(77)90311-1; Pihl J, 2005, ANAL CHEM, V77, P3897, DOI 10.1021/ac050218+; Sugiura S, 2010, ANAL CHEM, V82, P8278, DOI 10.1021/ac1017666; Toh YC, 2009, LAB CHIP, V9, P2026, DOI 10.1039/b900912d; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Voldman J, 2006, ANNU REV BIOMED ENG, V8, P425, DOI 10.1146/annurev.bioeng.8.061505.095739	16	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0149259	10.1371/journal.pone.0149259	http://dx.doi.org/10.1371/journal.pone.0149259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950700	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100012
J	Bee, P; Gibbons, C; Callaghan, P; Fraser, C; Lovell, K				Bee, Penny; Gibbons, Chris; Callaghan, Patrick; Fraser, Claire; Lovell, Karina			Evaluating and Quantifying User and Carer Involvement in Mental Health Care Planning (EQUIP): Co-Development of a New Patient-Reported Outcome Measure	PLOS ONE			English	Article							MOKKEN SCALE ANALYSIS; HOSPITAL ANXIETY; SERVICE USER; MODEL	International and national health policy seeks to increase service user and carer involvement in mental health care planning, but suitable user-centred tools to assess the success of these initiatives are not yet available. The current study describes the development of a new reliable and valid, interval-scaled service-user and carer reported outcome measure for quantifying user/carer involvement in mental health care planning. Psychometric development reduced a 70-item item bank to a short form questionnaire using a combination of Classical Test, Mokken and Rasch Analyses. Test-retest reliability was calculated using t-tests of interval level scores between baseline and 2-4 week follow-up. Items were worded to be relevant to both service users and carers. Nine items were removed following cognitive debriefing with a service user and carer advisory group. An iterative process of item removal reduced the remaining 61 items to a final 14-item scale. The final scale has acceptable scalability (Ho = .69), reliability (alpha = .92), fit to the Rasch model (chi(2)(70) = 97.25, p = .02), and no differential item functioning or locally dependent items. Scores remained stable over the 4 week follow-up period, indicating good test-retest reliability. The 'Evaluating the Quality of User and Carer Involvement in Care Planning (EQUIP)' scale displays excellent psychometric properties and is capable of unidimensional linear measurement. The scale is short, user and carer-centred and will be of direct benefit to clinicians, services, auditors and researchers wishing to quantify levels of user and carer involvement in care planning.	[Bee, Penny; Fraser, Claire; Lovell, Karina] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Gibbons, Chris] Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge, England; [Gibbons, Chris] Univ Cambridge, Judge Business Sch, Psychometr Ctr, Cambridge, England; [Callaghan, Patrick] Univ Nottingham, Queens Med Ctr, Sch Hlth Sci, Nottingham NG7 2RD, England	University of Manchester; University of Cambridge; University of Cambridge; University of Nottingham	Bee, P (corresponding author), Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England.	penny.bee@manchester.ac.uk	Fraser, Claire/O-9023-2014; Lovell, Karina S E/E-6410-2012; Bee, Penny/O-8822-2014	Fraser, Claire/0000-0003-3684-3168; Lovell, Karina S E/0000-0001-8821-895X; Bee, Penny/0000-0002-5600-0400; Callaghan, Patrick/0000-0003-3175-5361	National Institute for Health Research (NIHR) under Programme Grants for Applied Research Programme [RP-PG-1210-12007]; National Institute for Health Research [RP-PG-1210-12007] Funding Source: researchfish	National Institute for Health Research (NIHR) under Programme Grants for Applied Research Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This paper summarises independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-1210-12007). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Andrich D, 2010, RASCH MODELS MEASURE; Bee P, 2014, BR J PSYCHI IN PRESS; Bee P, 2008, INT J NURS STUD, V45, P442, DOI 10.1016/j.ijnurstu.2007.02.008; Bond T. G., 1994, RASCH MEAS T, V8, P347; Care Quality Commission, 2009, SURV MENT HLTH INP S; da Rocha NS, 2013, J PSYCHIATR RES, V47, P141, DOI 10.1016/j.jpsychires.2012.09.014; Department of Health, 2008, REF CAR PROGR APPR P; Department of Health, 1999, EFF CAR COORD MENT H; Fisher WP., 1992, RASCH MEASURE T, V6, P238; Fox J., 2010, POLYCOR POLYCHORIC P; Gibbons CJ, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00178; Gibbons CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081852; Gibbons CJ, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-101; Gibbons CJ, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-82; Guilleux A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083652; Her Majesty's Government, 2011, NO HLTH MENT HLTH CR; Hickey G, 1998, J CLIN NURS, V7, P83, DOI 10.1046/j.1365-2702.1998.00122.x; Holland PaulW., 2012, DIFFERENTIAL ITEM FU; Hudon C, 2011, ANN FAM MED, V9, P155, DOI 10.1370/afm.1226; IBM Corp, 2016, IBM SPSS STAT WIND V; Karabatsos G, 2003, APPL MEAS EDUC, V16, P277, DOI 10.1207/S15324818AME1604_2; Karabatsos G, 2001, J Appl Meas, V2, P389; Linacre J, 2001, RASCH MEAS T; Linacre J., 1994, RASCH MEASUREMENT T, V7, P328; Linacre J.M., 1999, RASCH MEAS T, V13, P675; Makoul G, 2006, PATIENT EDUC COUNS, V60, P301, DOI 10.1016/j.pec.2005.06.010; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; Mokken R. J., 1971, THEORY PROCEDURE SCA, DOI DOI 10.1515/9783110813203; Munro K, 2006, INT J MENT HEALTH PR, V8, P37, DOI DOI 10.1080/14623730.2006.9721738; NHSX, 2022, EL PRESCR MED ADM ME; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Porter M.E., 2006, REDEFINING HLTH CARE; Prieto Luis, 2003, Health Qual Life Outcomes, V1, P27, DOI 10.1186/1477-7525-1-27; R D. C. Team, R LANG ENV STAT COMP; Rasch G., 1960, PROBABILISTIC MODELS; Revelle W., 2014, PSYCH PROCEDURES PER; Revelle W, 2010, MULTIVARIATE BEHAV R, V14, P403; Sideridis GD, 2011, RASCH MEASUREMENT T, V25, P1334; Sijtsma K., 2002, INTRO NONPARAMETRIC, VVol. 5; Smith E V Jr, 2001, J Appl Meas, V2, P281; STEVENS SS, 1946, SCIENCE, V103, P677, DOI 10.1126/science.103.2684.677; Tennant A., 2006, RASCH MEAS T, V20, P1048; van der Ark LA, 2007, J STAT SOFTW, V20; van der Ark LA, 2012, J STAT SOFTW, V48, P1; van Schuur WH, 2003, POLIT ANAL, V11, P139, DOI 10.1093/pan/mpg002; Van Schuur WH., 2011, ORDINAL ITEM RESPONS; Willis GB, 2004, COGNITIVE INTERVIEWI; Wolpert M, 2013, BMJ, V346; Wright B, 1992, RASCH MEAS T, P6	50	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149973	10.1371/journal.pone.0149973	http://dx.doi.org/10.1371/journal.pone.0149973			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TL	26963252	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000022
J	Idbeaa, T; Samad, SA; Husain, H				Idbeaa, Tarik; Samad, Salina Abdul; Husain, Hafizah			A Secure and Robust Compressed Domain Video Steganography for Intra- and Inter-Frames Using Embedding-Based Byte Differencing (EBBD) Scheme	PLOS ONE			English	Article								This paper presents a novel secure and robust steganographic technique in the compressed video domain namely embedding-based byte differencing (EBBD). Unlike most of the current video steganographic techniques which take into account only the intra frames for data embedding, the proposed EBBD technique aims to hide information in both intra and inter frames. The information is embedded into a compressed video by simultaneously manipulating the quantized AC coefficients (AC-QTCs) of luminance components of the frames during MPEG-2 encoding process. Later, during the decoding process, the embedded information can be detected and extracted completely. Furthermore, the EBBD basically deals with two security concepts: data encryption and data concealing. Hence, during the embedding process, secret data is encrypted using the simplified data encryption standard (S-DES) algorithm to provide better security to the implemented system. The security of the method lies in selecting candidate AC-QTCs within each non-overlapping 8 x 8 sub-block using a pseudo random key. Basic performance of this steganographic technique verified through experiments on various existing MPEG-2 encoded videos over a wide range of embedded payload rates. Overall, the experimental results verify the excellent performance of the proposed EBBD with a better trade-off in terms of imperceptibility and payload, as compared with previous techniques while at the same time ensuring minimal bitrate increase and negligible degradation of PSNR values.	[Idbeaa, Tarik; Samad, Salina Abdul; Husain, Hafizah] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Elect Elect & Syst Engn, Bangi 43600, Selangor, Malaysia; [Idbeaa, Tarik] Garyan Univ, Fac Sci, Dept Comp Sci, Garyan, Libya	Universiti Kebangsaan Malaysia	Idbeaa, T (corresponding author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Elect Elect & Syst Engn, Bangi 43600, Selangor, Malaysia.; Idbeaa, T (corresponding author), Garyan Univ, Fac Sci, Dept Comp Sci, Garyan, Libya.	tidbeaa@siswa.ukm.edu.my		Abdul Samad, Salina/0000-0002-5687-9881				Alahmad M, 2012, J ADV COMPUTER SCI T, V2, P127; Alattar AM, 2003, P SOC PHOTO-OPT INS, V5020, P440, DOI 10.1117/12.477306; Ali MA, 2011, J NEXT GENERATION IN, V2, P105; [Anonymous], 2010, INT J DATABASE MANAG, V2, P67, DOI [10.5121/ijdms.2010.2307, DOI 10.5121/IJDMS.2010.2307]; Cedillo-Hernandez A, 2014, SIGNAL PROCESS, V97, P40, DOI 10.1016/j.sigpro.2013.08.019; Chen TH, 2010, INFORM SCIENCES, V180, P1690, DOI 10.1016/j.ins.2009.12.021; Idbeaa TF, 2013, INT J ADV COMPUTING, V5, P157; Idbeaa TF, 2014, ICSPCS2014 P 8 INT C, P1; Kawaguchi E, 1999, P SOC PHOTO-OPT INS, V3528, P464, DOI 10.1117/12.337436; Kok Sheik Wong, 2009, IEEE Transactions on Circuits and Systems for Video Technology, V19, P1499, DOI 10.1109/TCSVT.2009.2022781; Kok Sheik Wong, 2008, Journal of the Institute of Image Electronics Engineers of Japan, V37, P256; Langelaar GC, 1999, WIRELESS COMMUN INTE; Nakajima K, 2005, 2005 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO (ICME), VOLS 1 AND 2, P682, DOI 10.1109/ICME.2005.1521515; Pub F., 1999, FIPS PUB, V46, P53; Rivest R., 1992, RC4 ENCRYPTION ALGOR; Rivest RonaldL., 1983, COMMUN ACM, V26, P96, DOI [10.1145/357980.358017, DOI 10.1145/357980.358017]; Sarkar A, 2007, PROC SPIE, V6505, DOI 10.1117/12.703563; Schaefer E. F., 1996, Cryptologia, V20, P77, DOI 10.1080/0161-119691884799; Standard N.-F., FEDERAL INFORMAT PRO, V197, P1; Swati S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105613; Wang P, 2008, 2008 INTERNATIONAL CONFERENCE ON AUDIO, LANGUAGE AND IMAGE PROCESSING, VOLS 1 AND 2, PROCEEDINGS, P1555, DOI 10.1109/ICALIP.2008.4590271; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wu DC, 2003, PATTERN RECOGN LETT, V24, P1613, DOI 10.1016/S0167-8655(02)00402-6; Xu CY, 2006, ICICIC 2006: FIRST INTERNATIONAL CONFERENCE ON INNOVATIVE COMPUTING, INFORMATION AND CONTROL, VOL 1, PROCEEDINGS, P269	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150732	10.1371/journal.pone.0150732	http://dx.doi.org/10.1371/journal.pone.0150732			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963093	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000054
J	Guo, Q; Pan, Y; Yang, ZH; Liu, RX; Xing, LL; Peng, Z; Zhu, CM				Guo, Qian; Pan, Yun; Yang, Zhenhua; Liu, Ruixi; Xing, Linlin; Peng, Zhe; Zhu, Chaomin			Epidemiology and Clinical Characteristics of Pediatric Drug-Resistant Tuberculosis in Chongqing, China	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ANTIBIOTIC-RESISTANCE; FITNESS COST; CHILDREN; PREVALENCE; ACID	To gain insight into the epidemiology of childhood drug resistant tuberculosis (DR-TB) in China that has the second largest burden of TB and the largest number of multidrug resistant (MDR) TB cases in the world, we performed the cross-sectional study to investigate drug resistance of four first-line anti-TB drugs (isoniazid, rifampicin, streptomycin and ethambutol) using Mycobacterium tuberculosis isolates from 196 culture-confirmed pediatric TB cases diagnosed in the Children's Hospital of Chongqing Medical University, China during 2008-2013. Univariate and multivariate logistic regression analyses were performed to assess the associations between patient demographic and clinical characteristics and DR- and MDR-TB, respectively. Twenty-eight percent (56/196) of the study patients exhibited resistance to at least one of the four first-line anti-TB drugs tested. MDR was found in 4.6% (9/196) of the study patients. More than half (5/9, 55.6%) of the MDR cases were from a single county of Chongqing. A significant association was found between being acid-fast bacilli-smear negative and DR-TB (adjusted OR, 2.33; 95% CI, 1.13-4.80) and between having concurrent thoracic-extrathoracic involvement and MDR-TB (adjusted OR, 9.49; 95% CI, 1.05-85.92), respectively. The findings of this study indicate that the rate of DR is high among pediatric TB patients in Chongqing and suggest an urgent need for studies to identify MDR transmission hotspots in Chongqing, thereby contributing to the control DR- and MDR-TB epidemics in China. The study also generates new insight into the pathogenesis of DR and MDR M. tuberculosis strains and highlights the importance of studying childhood TB to the goal of global TB control.	[Guo, Qian; Pan, Yun; Liu, Ruixi; Xing, Linlin; Peng, Zhe; Zhu, Chaomin] Chongqing Med Univ, Childrens Hosp, Dept Infect Dis, Chongqing, Peoples R China; [Guo, Qian; Pan, Yun; Liu, Ruixi; Xing, Linlin; Peng, Zhe; Zhu, Chaomin] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Guo, Qian; Pan, Yun; Liu, Ruixi; Xing, Linlin; Peng, Zhe; Zhu, Chaomin] Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Yang, Zhenhua] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Chongqing Medical University; University of Michigan System; University of Michigan	Zhu, CM (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Infect Dis, Chongqing, Peoples R China.; Zhu, CM (corresponding author), Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China.; Zhu, CM (corresponding author), Key Lab Pediat Chongqing, Chongqing, Peoples R China.; Yang, ZH (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	zhenhua@umich.edu; zhuchaomin2013@163.com						Alcais A, 2005, J EXP MED, V202, P1617, DOI 10.1084/jem.20052302; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Blount RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097267; Cruz AT, 2007, PAEDIATR RESPIR REV, V8, P107, DOI 10.1016/j.prrv.2007.04.008; Fairlie L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-28; Gagneux S, 2009, CLIN MICROBIOL INFEC, V15, P66, DOI 10.1111/j.1469-0691.2008.02685.x; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Giampaglia CMS, 2005, INT J TUBERC LUNG D, V9, P206; Hesseling AC, 2010, INT J TUBERC LUNG D, V14, P1252; Jiao WW, 2015, TUBERCULOSIS, V95, P315, DOI 10.1016/j.tube.2015.02.041; Jiao WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084315; Li Liang, 2004, Zhonghua Yi Xue Za Zhi, V84, P1678; Luciani F, 2009, P NATL ACAD SCI USA, V106, P14711, DOI 10.1073/pnas.0902437106; Marais BJ, 2004, PEDIATR RADIOL, V34, P886, DOI 10.1007/s00247-004-1238-0; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Prajapati S, 2015, PAEDIATR INT CHILD H; Santiago B, 2014, PEDIATR INFECT DIS J, V33, P345, DOI 10.1097/INF.0000000000000111; Smith KLJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094953; Sreeramareddy CT, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-57; WHO, GLOB TUB REP 2014; World Health Organizaiton, ROADM CHILDH TUB; World Health Organization, 4 WHO; World Health Organization, GUID NAT TUB PROGR M; Wu XR, 2012, PEDIATRICS, V130, pE1433, DOI 10.1542/peds.2011-3742; Yang ZH, 2005, AM J RESP CRIT CARE, V171, P1436, DOI 10.1164/rccm.200408-1147OC; You Y., 2006, CHIN J PEDIAT, V27, P243; Yu Y, 2014, CHIN J ANTITUBERC, V36, P1036, DOI DOI 10.3969/J.ISSN.1000-6621.2014.12.008; Zhang Y, 2002, J MED MICROBIOL, V51, P42, DOI 10.1099/0022-1317-51-1-42; [赵顺英 Zhao Shunying], 2012, [实用儿科临床杂志, Journal of Applied Clinical Pediatrics], V27, P734; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zhou Ze-xin, 2009, Power System Technology, V33, P33	32	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151303	10.1371/journal.pone.0151303	http://dx.doi.org/10.1371/journal.pone.0151303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959480	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300116
J	Shaver, JH; Troughton, G; Sibley, CG; Bulbulia, JA				Shaver, John H.; Troughton, Geoffrey; Sibley, Chris G.; Bulbulia, Joseph A.			Religion and the Unmaking of Prejudice toward Muslims: Evidence from a Large National Sample	PLOS ONE			English	Article							ATTITUDES; EUROPE; DEPRIVATION; INTOLERANCE; EVOLUTION; SOCIETY; WOMENS; RIGHTS; ISLAM	In the West, anti-Muslim sentiments are widespread. It has been theorized that inter-religious tensions fuel anti-Muslim prejudice, yet previous attempts to isolate sectarian motives have been inconclusive. Factors contributing to ambiguous results are: (1) failures to assess and adjust for multi-level denomination effects; (2) inattention to demographic covariates; (3) inadequate methods for comparing anti-Muslim prejudice relative to other minority group prejudices; and (4) ad hoc theories for the mechanisms that underpin prejudice and tolerance. Here we investigate anti-Muslim prejudice using a large national sample of non-Muslim New Zealanders (N = 13,955) who responded to the 2013 New Zealand Attitudes and Values Study. We address previous shortcomings by: (1) building Bayesian multivariate, multi-level regression models with denominations modeled as random effects; (2) including high-resolution demographic information that adjusts for factors known to influence prejudice; (3) simultaneously evaluating the relative strength of anti-Muslim prejudice by comparing it to anti-Arab prejudice and anti-immigrant prejudice within the same statistical model; and (4) testing predictions derived from the Evolutionary Lag Theory of religious prejudice and tolerance. This theory predicts that in countries such as New Zealand, with historically low levels of conflict, religion will tend to increase tolerance generally, and extend to minority religious groups. Results show that anti-Muslim and anti-Arab sentiments are confounded, widespread, and substantially higher than anti-immigrant sentiments. In support of the theory, the intensity of religious commitments was associated with a general increase in tolerance toward minority groups, including a poorly tolerated religious minority group: Muslims. Results clarify religion's power to enhance tolerance in peaceful societies that are nevertheless afflicted by prejudice.	[Shaver, John H.; Troughton, Geoffrey; Bulbulia, Joseph A.] Victoria Univ Wellington, Religious Studies Programme, Wellington, New Zealand; [Sibley, Chris G.] Univ Auckland, Sch Psychol, Auckland 1, New Zealand	Victoria University Wellington; University of Auckland	Shaver, JH (corresponding author), Victoria Univ Wellington, Religious Studies Programme, Wellington, New Zealand.	john.shaver@vuw.ac.nz	Sibley, Chris G/D-2974-2009	Sibley, Chris G/0000-0002-4064-8800; Bulbulia, Joseph/0000-0002-5861-2056; Troughton, Geoffrey/0000-0001-7423-0640; Shaver, John/0000-0002-9522-4765	Templeton World Charity Foundation Grant [0077]; Royal Society of New Zealand Marsden Fund Grant [VUW 1321]	Templeton World Charity Foundation Grant(Templeton World Charity Foundation); Royal Society of New Zealand Marsden Fund Grant(Royal Society of New ZealandMarsden Fund (NZ))	This research was supported by a Templeton World Charity Foundation Grant (ID: 0077 to JAB, CGS, GT; http://www.templetonworldcharity.org) and a Royal Society of New Zealand Marsden Fund Grant (ID: VUW 1321 to JAB & CGS; http://www.royalsociety.org.nz/programmes/funds/marsden/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RO, 1967, J SCI STUD RELIG, V6, P191, DOI 10.2307/1384046; ALLPORT GW, 1967, J PERS SOC PSYCHOL, V5, P432, DOI 10.1037/h0021212; ALLPORT GW, 1966, J SCI STUD RELIG, V5, P447, DOI 10.2307/1384172; Altemeyer Bob, 1992, INT J PSYCHOL RELIG, V2, P113, DOI DOI 10.1207/S15327582IJPR0202_5; [Anonymous], 2009, REL DIV AOT NZ STAT; [Anonymous], SOCIAL INEQUALITIES; Atkinson J., 2014, NZDEP2013 INDEX DEPR; Atran S, 2012, SCIENCE, V336, P855, DOI 10.1126/science.1216902; Batson C D, 1993, RELIG INDIVIDUAL SOC; Belich J., 2001, PARADISE REFORGED HI; Berry J. W., 2006, IMMIGRANT YOUTH CULT; Blackwell M, 2015, SOCIOLOGICAL METHODS; Boston J, 1994, VOICES JUSTICE CHURC; Botero CA, 2014, P NATL ACAD SCI USA, V111, P16784, DOI 10.1073/pnas.1408701111; Bulbulia J., 2005, METHOD THEORY RELIG, V17, P71; Bulbulia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080224; Buuren S, 2011, J STAT SOFTW, V45, P1548; Caldwell Christopher., 2009, REFLECTIONS REVOLUTI; Carter JS, 2005, SOC SCI RES, V34, P408, DOI 10.1016/j.ssresearch.2004.04.004; Chander CR, 2001, SOC SCI J, V38, P177, DOI 10.1016/S0362-3319(01)00106-9; Clements B, 2013, J CONTEMP RELIG, V28, P49, DOI 10.1080/13537903.2013.750836; COWARD H, 1986, STUD RELIG-SCI RELIG, V15, P419, DOI 10.1177/000842988601500402; Crampton P, 2000, HEALTH EDUC BEHAV, V27, P317, DOI 10.1177/109019810002700306; Cronk L., 2013, M GRAND CENTR UND SO; Doebler S, 2014, REV RELIG RES, V56, P61, DOI 10.1007/s13644-013-0126-1; Ekici T, 2015, SOC INDIC RES, V122, P105, DOI 10.1007/s11205-014-0674-y; Ernst CarlW., 2003, FOLLOWING MUHAMMAD R; Evans G, 2002, SOC SCI RES, V31, P653, DOI 10.1016/S0049-089X(02)00018-2; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gelman A, 2015, SUBJECTIVE OBJECTIVE; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Ginges J, 2009, PSYCHOL SCI, V20, P224, DOI 10.1111/j.1467-9280.2009.02270.x; GORSUCH RL, 1974, J SCI STUD RELIG, V13, P281, DOI 10.2307/1384759; Griggs Khalid, 2002, MUSLIM MINORITIES W; Guy Laurie, 2011, SHAPING GODZONE PUBL; Hadfield J., 2015, MCMCGLMM COURSE NOTE; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hall DL, 2015, PSYCHOL SCI, V26, P1368, DOI 10.1177/0956797615576473; Hall DL, 2010, PERS SOC PSYCHOL REV, V14, P126, DOI 10.1177/1088868309352179; Health Utilisation Research Alliance (HURA), 2006, J Health Serv Res Policy, V11, P141, DOI 10.1258/135581906777641721; Hello Evelyn, 2002, SCAND J EDUC RES, V46, P5, DOI [DOI 10.1080/00313830120115589, 10.1080/00313830120115589]; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; Ho C, 2007, WOMEN STUD INT FORUM, V30, P290, DOI 10.1016/j.wsif.2007.05.002; Honaker J, 2011, J STAT SOFTW, V45, P1; Honaker J, 2010, AM J POLIT SCI, V54, P561, DOI 10.1111/j.1540-5907.2010.00447.x; Hoverd W. J., 2013, INT J WELLBEING, V3, P182; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Hunsberger B, 2005, J SOC ISSUES, V61, P807, DOI 10.1111/j.1540-4560.2005.00433.x; Huntington Samuel P., 1997, CLASH CIVILIZATIONS; HUNTINGTON SP, 1993, FOREIGN AFF, V72, P22, DOI 10.2307/20045621; Irons W., 2001, EVOLUTION CAPACITY C, P292; Johnson DDP, 2005, HUM NATURE-INT BIOS, V16, P410, DOI 10.1007/s12110-005-1017-0; Kabir SN, 2012, J MUSLIM MINOR AFF, V32, P324, DOI 10.1080/13602004.2012.727293; Kalkan KO, 2009, J POLIT, V71, P847, DOI 10.1017/S0022381609090756; Kinder DR, 2009, POLIT PSYCHOL, V30, P539, DOI 10.1111/j.1467-9221.2009.00714.x; Kolig E., 2010, NZ MUSLIMS MULTICULT; Konvalinka I, 2011, P NATL ACAD SCI USA, V108, P8514, DOI 10.1073/pnas.1016955108; Matthews LJ, 2013, RELIG BRAIN BEHAV, V3, P3, DOI 10.1080/2153599X.2012.707388; McGeorge C, 1981, CHURCH STATE NZ ED; Mitchell EA, 2000, SOC SCI MED, V51, P147, DOI 10.1016/S0277-9536(99)00415-3; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; Norenzayan A, 2016, BEHAV BRAIN SCI, V39, DOI 10.1017/S0140525X14001356; OECD, 2011, SOC GLANC OECD SOC I; Osborne D, CAMBRIDGE H IN PRESS; Panagopoulos C, 2006, PUBLIC OPIN QUART, V70, P608, DOI 10.1093/poq/nfl029; Paradies Y, CAMBRIDGE H IN PRESS; Purzycki BG, 2009, FRONT COLLECT, P243, DOI 10.1007/978-3-642-00128-4_17; Quillian L, 1996, AM J SOCIOL, V102, P816, DOI 10.1086/230998; QUILLIAN L, 1995, AM SOCIOL REV, V60, P586, DOI 10.2307/2096296; R Core Team, 2013, R LANG ENV STAT COMP; Robertson A., 2006, THESIS VICTORIA U WE; Said E, 2001, CLASH IGNORANCE; Salmond C., 2007, NZDEP2006 INDEX DEPR; Salmond CE, 2012, CAN J PUBLIC HEALTH, V103, pS7; Scheepers P, 2002, REV RELIG RES, V43, P242, DOI 10.2307/3512331; Schjoedt U, 2009, SOC COGN AFFECT NEUR, V4, P199, DOI 10.1093/scan/nsn050; Semyonov M, 2004, SOC SCI RES, V33, P681, DOI 10.1016/j.ssresearch.2003.11.003; Sen A, 1999, J DEMOCR, V10, P3, DOI 10.1353/jod.1999.0055; Shaver JH, 2014, J COGNITIVE SCI RELI, V2, P41; Shaver JH, 2015, RELIG BRAIN BEHAV, V5, P101, DOI 10.1080/2153599X.2014.893253; Shepard W., 2006, NZ J ASIAN STUDIES, V8, P8; Sibley C, 2014, ARCH NZAVS QUESTIONA; Sibley C. G., 2012, J COGNITIVE SCI RELI, V1, P29, DOI DOI 10.1558/JCSR.V1I1.29; Sibley CG., INT J INTERCULTURAL, V37, P700; Sibley CG, 2013, INT J INTERCULT REL, V37, P700, DOI 10.1016/j.ijintrel.2013.09.008; Sibley CG, 2013, NEW ZEAL J PSYCHOL, V42, P13; Sidanius J., 2001, SOCIAL DOMINANCE INT; Slingerlanda E, 2011, RELIGION, V41, P1; Sniderman Paul M., 2007, WAYS LIFE COLLIDE MU; Sosis R, 2007, EVOL HUM BEHAV, V28, P234, DOI 10.1016/j.evolhumbehav.2007.02.007; Sosis R, 2011, AM ANTHROPOL, V113, P40, DOI 10.1111/j.1548-1433.2010.01305.x; Sosis R, 2008, NATURAL SECURITY: A DARWINIAN APPROACH TO A DANGEROUS WORLD, P105; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stout J, 1998, J RELIG ETHICS, V25, P23; Stout J., 2009, DEMOCRACY TRADITION; Strabac Z, 2008, SOC SCI RES, V37, P268, DOI 10.1016/j.ssresearch.2007.02.004; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Troughton G, 2011, NZ JESUS SOCIAL RELI; Turchin Peter, 2007, WAR PEACE WAR RISE F; Vogt W.P., 1997, TOLERANCE ED LEARNIN; White P, 2008, ATLAS SOCIOECONOMIC; Wilson D. S., 2010, DARWINS CATHEDRAL EV; Wilson G.D., 1973, PSYCHOL CONSERVATISM; Zdrenka M, 2015, INT J INTERCULT REL, V49, P114, DOI 10.1016/j.ijintrel.2015.07.003	105	32	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150209	10.1371/journal.pone.0150209	http://dx.doi.org/10.1371/journal.pone.0150209			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DG3TF	26959976	gold, Green Published, Green Submitted			2022-12-27	WOS:000371992300038
J	Zhu, XL; Li, Q; Li, Y; Wu, Z				Zhu, Xiliang; Li, Qian; Li, Yang; Wu, Zhong			Analysis of Bipolar Radiofrequency Ablation in Treatment of Atrial Fibrillation Associated with Rheumatic Heart Disease	PLOS ONE			English	Article							MITRAL-VALVE DISEASE; OBSTRUCTIVE SLEEP-APNEA; SURGICAL-TREATMENT; CATHETER ABLATION; MAZE PROCEDURE; LATE RECURRENCE; CARDIAC-SURGERY; PREDICTORS; IMPACT; REPLACEMENT	Background Among patients with rheumatic heart disease (RHD), 45% to 60% present with atrial fibrillation (AF), which is associated with increased rates of thromboembolism, heart failure, and even death. The bipolar radiofrequency ablation (BRFA) combining with mitral valve procedure has been adopted in patients of AF associated with RHD, but evaluations about its effectiveness are still limited. Methods A total of 87 patients with RHD and long persistent AF who had accepted mitral valve replacement concomitant with BRFA were studied. Clinical data were collected to analyze the midterm results of BRFA and evaluate its efficiency. Univariate and multivariate analyses were used to identify the independent factors associated with late AF recurrence. Results Sixty-six (75.9%) patients maintained sinus rhythm after a mean follow-up of 13.4 +/- 5.2 months. Late AF recurrence had been detected in 21 (24.1%) patients, 11 (12.6%) patients were confirmed to be AF, 8 (9.2%) patients were atrial flutter and 2 (2.3%) patients were junctional rhythm. In Multivariate logistic regression analysis, body mass index (BMI) (OR = 1.756, 95% CI = 1.289-2.391, p = 0.000) and early AF recurrence (OR = 5.479, 95% CI = 1.189-25.254, p = 0.029) were independent predictors of late AF recurrence. In addition, left ventricular ejection fraction (LVEF) and New York Heart Association class showed a greater improvement in patients who maintained sinus rhythm than those who experienced late AF recurrence. Conclusion BRFA is an effective technique for the treatment of long persistent AF associated with RHD during mitral valve replacement. The BMI and early AF recurrence are independent predictors for late AF recurrence. Patients with long-term restoration of sinus rhythm experienced a greater improvement of left ventricular function after BRFA.	[Zhu, Xiliang; Li, Yang; Wu, Zhong] Sichuan Univ, West China Hosp, Dept Cardiovasc Surg, Chengdu 610064, Sichuan Provinc, Peoples R China; [Li, Qian] Sichuan Univ, West China Sch Med, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University	Wu, Z (corresponding author), Sichuan Univ, West China Hosp, Dept Cardiovasc Surg, Chengdu 610064, Sichuan Provinc, Peoples R China.	wuzhong71@163.com			National Natural Science Foundation of China [81371638]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant number 81371638) http://www.nsfc.gov.cn/publish/portal1/; ZW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu CAC, 2005, CIRCULATION, V112, pI20, DOI 10.1161/CIRCULATIONAHA.104.526301; Ad N, 2006, J THORAC CARDIOV SUR, V131, P1073, DOI 10.1016/j.jtcvs.2005.12.047; Anselmino M, 2013, J CARDIOVASC ELECTR, V24, P24, DOI 10.1111/j.1540-8167.2012.02419.x; Arya A, 2010, EUROPACE, V12, P173, DOI 10.1093/europace/eup331; Baek MJ, 2006, EUR J CARDIO-THORAC, V30, P728, DOI 10.1016/j.ejcts.2006.08.016; Balk EM, 2010, J CARDIOVASC ELECTR, V21, P1208, DOI 10.1111/j.1540-8167.2010.01798.x; Cai LY, 2013, INT J CARDIOL, V164, P82, DOI 10.1016/j.ijcard.2011.06.094; Canale LS, 2011, REV BRAS CIR CARDIOV, V26, P565, DOI 10.5935/1678-9741.20110046; Chen LH, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-53; Chilukuri K, 2010, J CARDIOVASC ELECTR, V21, P521, DOI 10.1111/j.1540-8167.2009.01653.x; COX JL, 1991, JAMA-J AM MED ASSOC, V266, P1976, DOI 10.1001/jama.266.14.1976; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Dewland TA, 2013, CIRCULATION, V128, P2470, DOI 10.1161/CIRCULATIONAHA.113.002449; Dong L, 2013, J THORAC CARDIOV SUR, V145, P1013, DOI 10.1016/j.jtcvs.2012.05.009; Dunning J, 2013, EUR J CARDIO-THORAC, V44, P777, DOI 10.1093/ejcts/ezt413; Fein AS, 2013, J AM COLL CARDIOL, V62, P300, DOI 10.1016/j.jacc.2013.03.052; Feyrer R, 2014, ANN THORAC CARDIOVAS, V20, P207, DOI 10.5761/atcs.oa.12.02233; Fragakis N, 2012, EUROPACE, V14, P1545, DOI 10.1093/europace/eus081; Fukada J, 1998, ANN THORAC SURG, V65, P1566, DOI 10.1016/S0003-4975(98)00135-0; Gillinov AM, 2015, NEW ENGL J MED, V372, P1399, DOI 10.1056/NEJMoa1500528; Grubitzsch H, 2008, EUR J CARDIO-THORAC, V34, P67, DOI 10.1016/j.ejcts.2008.03.054; John B, 2008, EUR HEART J, V29, P2234, DOI 10.1093/eurheartj/ehn329; Khargi K, 2005, EUR J CARDIO-THORAC, V27, P258, DOI 10.1016/j.ejcts.2004.11.003; Lee SH, 2011, J THORAC CARDIOV SUR, V141, P1015, DOI 10.1016/j.jtcvs.2010.08.036; Lee SH, 2004, J INTERV CARD ELECTR, V10, P221, DOI 10.1023/B:JICE.0000026915.02503.92; Lee YS, 2010, J CARDIOL, V56, P348, DOI 10.1016/j.jjcc.2010.07.006; Lobo TJ, 2015, ARQ BRAS CARDIOL, V104, P45, DOI 10.5935/abc.20140167; Phan K, 2014, HEART, V100, P722, DOI 10.1136/heartjnl-2013-305351; Prystowsky EN, 2015, JAMA-J AM MED ASSOC, V314, P278, DOI 10.1001/jama.2015.7505; Rostagno C, 2015, HEART VESSELS, V14, P1; Shen J, 2009, HEART RHYTHM, V6, pS45, DOI 10.1016/j.hrthm.2009.05.019; Sie HT, 2001, J THORAC CARDIOV SUR, V122, P249, DOI 10.1067/mtc.2001.114633; Sims JB, 2006, AM J CARDIOL, V97, P1035, DOI 10.1016/j.amjcard.2005.11.023; Sternik L, 2010, ANN THORAC SURG, V89, P1437, DOI 10.1016/j.athoracsur.2010.01.047; Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029; Voeller RK, 2008, J THORAC CARDIOV SUR, V136, P1257, DOI 10.1016/j.jtcvs.2008.01.053; Walters TE, 2015, PROG CARDIOVASC DIS, V58, P136, DOI 10.1016/j.pcad.2015.07.010; Wann LS, 2011, J AM COLL CARDIOL, V57, P223, DOI 10.1016/j.jacc.2010.10.001; Wong KKL, 2012, COMPUT MED IMAG GRAP, V36, P527, DOI 10.1016/j.compmedimag.2012.04.003; Wong KKL, 2009, ANN BIOMED ENG, V37, P1495, DOI 10.1007/s10439-009-9709-y; Zhou Zi-qiang, 2004, Zhonghua Nei Ke Za Zhi, V43, P491	41	3	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151248	10.1371/journal.pone.0151248	http://dx.doi.org/10.1371/journal.pone.0151248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26960188	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300112
J	Bolte, P; Bleibaum, F; Einwich, A; Gunther, A; Liedvogel, M; Heyers, D; Depping, A; Wohlbrand, L; Rabus, R; Janssen-Bienhold, U; Mouritsen, H				Bolte, Petra; Bleibaum, Florian; Einwich, Angelika; Guenther, Anja; Liedvogel, Miriam; Heyers, Dominik; Depping, Anne; Woehlbrand, Lars; Rabus, Ralf; Janssen-Bienhold, Ulrike; Mouritsen, Henrik			Localisation of the Putative Magnetoreceptive Protein Cryptochrome 1b in the Retinae of Migratory Birds and Homing Pigeons	PLOS ONE			English	Article							PHOTORECEPTOR-BASED MAGNETORECEPTION; MAGNETIC COMPASS ORIENTATION; BLUE-LIGHT PHOTORECEPTORS; RADICAL PAIR; CIRCADIAN CLOCK; CHEMICAL MAGNETORECEPTION; EUROPEAN ROBINS; UPPER BEAK; CLUSTER-N; BRAIN	Cryptochromes are ubiquitously expressed in various animal tissues including the retina. Some cryptochromes are involved in regulating circadian activity. Cryptochrome proteins have also been suggested to mediate the primary mechanism in light-dependent magnetic compass orientation in birds. Cryptochrome 1b (Cry1b) exhibits a unique carboxy terminus exclusively found in birds so far, which might be indicative for a specialised function. Cryptochrome 1a (Cry1a) is so far the only cryptochrome protein that has been localised to specific cell types within the retina of migratory birds. Here we show that Cry1b, an alternative splice variant of Cry1a, is also expressed in the retina of migratory birds, but it is primarily located in other cell types than Cry1a. This could suggest different functions for the two splice products. Using diagnostic bird-specific antibodies (that allow for a precise discrimination between both proteins), we show that Cry1b protein is found in the retinae of migratory European robins (Erithacus rubecula), migratory Northern Wheatears (Oenanthe oenanthe) and pigeons (Columba livia). In all three species, retinal Cry1b is localised in cell types which have been discussed as potentially well suited locations for magnetoreception: Cry1b is observed in the cytosol of ganglion cells, displaced ganglion cells, and in photoreceptor inner segments. The cytosolic rather than nucleic location of Cry1b in the retina reported here speaks against a circadian clock regulatory function of Cry1b and it allows for the possible involvement of Cry1b in a radical-pair-based magnetoreception mechanism.	[Bolte, Petra; Bleibaum, Florian; Einwich, Angelika; Guenther, Anja; Heyers, Dominik; Depping, Anne; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, D-26111 Oldenburg, Germany; [Bolte, Petra; Bleibaum, Florian; Einwich, Angelika; Guenther, Anja; Heyers, Dominik; Depping, Anne; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany; [Liedvogel, Miriam] Max Planck Inst Evolutionary Biol, Plon, Germany; [Woehlbrand, Lars; Rabus, Ralf] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, D-26111 Oldenburg, Germany; [Janssen-Bienhold, Ulrike] Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-26111 Oldenburg, Germany; [Bleibaum, Florian] Univ Kiel, Dept Dermatol, Schittenhelmstr 7, Kiel, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Max Planck Society; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; University of Kiel	Bolte, P (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, D-26111 Oldenburg, Germany.; Bolte, P (corresponding author), Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany.	petra.bolte@uni-oldenburg.de	Mouritsen, Henrik/A-5401-2010; Einwich, Angelika/S-2518-2018; Bleibaum, Florian/AAH-7469-2021; Liedvogel, Miriam/S-8341-2019; Liedvogel, Miriam/D-5418-2015; Liedvogel, Miriam/HDM-7933-2022; Heyers, Dominik/D-3885-2015	Mouritsen, Henrik/0000-0001-7082-4839; Liedvogel, Miriam/0000-0002-8372-8560; Heyers, Dominik/0000-0002-2831-6985; Einwich, Angelika/0000-0001-7020-1340; Gunther, Anja/0000-0003-1724-3298	VolkswagenStiftung; Niedersaechsisches Ministerium fur Wissenschaft und Kultur; Deutsche Forschungsgemeinschaft [GRK 1885, HE6221/1-1, MO 1408/1-2]; Defense Adavanced Research Projects Agency [QuBE_N66001-10-1-4061]	VolkswagenStiftung(Volkswagen); Niedersaechsisches Ministerium fur Wissenschaft und Kultur; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Defense Adavanced Research Projects Agency	Study design, data collection and analysis was supported and funded by a Lichtenberg Professorship from the VolkswagenStiftung to HM, by the Niedersaechsisches Ministerium fur Wissenschaft und Kultur to HM, by the Deutsche Forschungsgemeinschaft (GRK 1885: molecular mechanisms of sensory biology) to UJB, RR, AE and HM, by Defense Adavanced Research Projects Agency (QuBE_N66001-10-1-4061) to HM, by the Deutsche Forschungsgemeinschaft (HE6221/1-1) to DH, and MO 1408/1-2 to HM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Biskup T, 2009, ANGEW CHEM INT EDIT, V48, P404, DOI 10.1002/anie.200803102; BRITTO LRG, 1988, J COMP NEUROL, V269, P109, DOI 10.1002/cne.902690109; Burry RW, 2011, J HISTOCHEM CYTOCHEM, V59, P6, DOI 10.1369/jhc.2010.956920; Burry RW, 2000, J HISTOCHEM CYTOCHEM, V48, P163, DOI 10.1177/002215540004800201; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Engels S, 2014, NATURE, V509, P353, DOI 10.1038/nature13290; Engels S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043271; Falkenberg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009231; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; FITE KV, 1981, J COMP NEUROL, V195, P279, DOI 10.1002/cne.901950208; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; Fusani L, 2014, J EXP BIOL, V217, P918, DOI 10.1242/jeb.096479; Giovani B, 2003, NAT STRUCT BIOL, V10, P489, DOI 10.1038/nsb933; Hein CM, 2011, NATURE, V471, pE11, DOI 10.1038/nature09875; Hein CM, 2010, J R SOC INTERFACE, V7, pS227, DOI 10.1098/rsif.2009.0376.focus; Henbest KB, 2008, P NATL ACAD SCI USA, V105, P14395, DOI 10.1073/pnas.0803620105; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; Heyers D, 2010, P NATL ACAD SCI USA, V107, P9394, DOI 10.1073/pnas.0907068107; Hill E, 2010, J R SOC INTERFACE, V7, pS265, DOI 10.1098/rsif.2009.0378.focus; Holmseth S, 2012, J HISTOCHEM CYTOCHEM, V60, P174, DOI 10.1369/0022155411434828; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; Kishkinev DA., 2015, BIOL B REV, V5, P46, DOI [10.1134/S2079086415010041, DOI 10.1134/S2079086415010041]; Kossmehl S, 2013, PROTEOMICS, V13, P2743, DOI 10.1002/pmic.201300112; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lau JCS, 2012, J R SOC INTERFACE, V9, P3329, DOI 10.1098/rsif.2012.0374; Lau JCS, 2010, J R SOC INTERFACE, V7, pS257, DOI 10.1098/rsif.2009.0399.focus; Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Liedvogel M, 2010, J R SOC INTERFACE, V7, pS147, DOI 10.1098/rsif.2009.0411.focus; Liu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050602; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; Maeda K, 2012, P NATL ACAD SCI USA, V109, P4774, DOI 10.1073/pnas.1118959109; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Mouritsen H, 2012, CURR OPIN NEUROBIOL, V22, P343, DOI 10.1016/j.conb.2012.01.005; Niessner C, 2015, SEASONALLY CHANGING; Niessner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020091; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2010, J R SOC INTERFACE, V7, pS135, DOI 10.1098/rsif.2009.0456.focus; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Rodgers CT, 2009, P NATL ACAD SCI USA, V106, P353, DOI 10.1073/pnas.0711968106; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Sancar A, 2000, ANNU REV BIOCHEM, V69, P31, DOI 10.1146/annurev.biochem.69.1.31; Sancar A, 2004, J BIOL CHEM, V279, P34079, DOI 10.1074/jbc.R400016200; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Solomonov I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05987; Solov'yov IA, 2010, BIOPHYS J, V99, P40, DOI 10.1016/j.bpj.2010.03.053; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Treiber CD, 2012, NATURE, V484, P367, DOI 10.1038/nature11046; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Williams MN, 2001, BRAIN RES, V889, P243, DOI 10.1016/S0006-8993(00)03114-0; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; WILTSCHKO W, 1995, J COMP PHYSIOL A, V177, P363; Wiltschko W, 2001, J EXP BIOL, V204, P3295; Wu LQ, 2012, SCIENCE, V336, P1054, DOI 10.1126/science.1216567; Wu LQ, 2011, CURR BIOL, V21, P418, DOI 10.1016/j.cub.2011.01.058; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Zapka M, 2010, EUR J NEUROSCI, V32, P619, DOI 10.1111/j.1460-9568.2010.07311.x; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	68	44	46	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0147819	10.1371/journal.pone.0147819	http://dx.doi.org/10.1371/journal.pone.0147819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953791	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300002
J	Huang, CK; Iwagami, Y; Aihara, A; Chung, WH; de la Monte, S; Thomas, JM; Olsen, M; Carlson, R; Yu, TA; Dong, XQ; Wands, J				Huang, Chiung-Kuei; Iwagami, Yoshifumi; Aihara, Arihiro; Chung, Waihong; de la Monte, Suzanne; Thomas, John-Michael; Olsen, Mark; Carlson, Rolf; Yu, Tunan; Dong, Xiaoqun; Wands, Jack			Anti-Tumor Effects of Second Generation beta-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; MESENCHYMAL STEM-CELLS; GROWTH-FACTOR; INTRAHEPATIC CHOLANGIOCARCINOMA; ANDROGEN RECEPTOR; OVER-EXPRESSION; SELF-RENEWAL; CYCLIN D1; LIVER; OVEREXPRESSION	Cholangiocarcinoma (CCA) has a poor prognosis due to widespread intrahepatic spread. Aspartate beta-hydroxylase (ASPH) is a transmembrane protein and catalyzes the hydroxylation of aspartyl and asparaginyl residues in calcium binding epidermal growth factor (cbEGF)-like domains of various proteins, including Notch receptors and ligands. ASPH is highly overexpressed (> 95%) in human CCA tumors. We explored the molecular mechanisms by which ASPH mediated the CCA malignant phenotype and evaluated the potential of ASPH as a therapeutic target for CCA. The importance of expression and enzymatic activity of ASPH for CCA growth and progression was examined using shRNA "knockdown" and a mutant construct that reduced its catalytic activity. Second generation small molecule inhibitors (SMIs) of beta-hydroxylase activity were developed and used to target ASPH in vitro and in vivo. Subcutaneous and intrahepatic xenograft rodent models were employed to determine anti-tumor effects on CCA growth and development. It was found that the enzymatic activity of ASPH was critical for mediating CCA progression, as well as inhibiting apoptosis. Mechanistically, ASPH overexpression promoted Notch activation and modulated CCA progression through a Notch1-dependent cyclin D1 pathway. Targeting ASPH with shRNAs or a SMI significantly suppressed CCA growth in vivo.	[Huang, Chiung-Kuei; Iwagami, Yoshifumi; Aihara, Arihiro; Chung, Waihong; de la Monte, Suzanne; Carlson, Rolf; Yu, Tunan; Wands, Jack] Brown Univ, Warren Alpert Med Sch, Liver Res Ctr, Providence, RI 02912 USA; [Huang, Chiung-Kuei; Iwagami, Yoshifumi; Aihara, Arihiro; Chung, Waihong; de la Monte, Suzanne; Carlson, Rolf; Yu, Tunan; Wands, Jack] Rhode Isl Hosp, Providence, RI USA; [Thomas, John-Michael; Olsen, Mark] Midwestern Univ, Coll Pharm Glendale, Dept Med Chem, Glendale, AZ USA; [Dong, Xiaoqun] Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Pharm Bldg,7 Greenhouse Rd, Kingston, RI 02881 USA; [Dong, Xiaoqun] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Internal Med, 975 NE10th St, Oklahoma City, OK USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Midwestern University; Midwestern University - College of Pharmacy - Glendale; University of Rhode Island; University of Oklahoma System; University of Oklahoma Health Sciences Center	Wands, J (corresponding author), Brown Univ, Warren Alpert Med Sch, Liver Res Ctr, Providence, RI 02912 USA.; Wands, J (corresponding author), Rhode Isl Hosp, Providence, RI USA.	Jack_Wands_MD@brown.edu	Iwagami, Yoshifumi/AAJ-3184-2021; de la monte, suzanne/L-7670-2019	de la monte, suzanne/0000-0001-5886-2306; Olsen, Mark/0000-0003-2871-1923	National Institutes of Health [R01CA-123544, 8P20GM103430-12]; NATIONAL CANCER INSTITUTE [R01CA123544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided by National Institutes of Health R01CA-123544 and 8P20GM103430-12.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Aihara A, 2014, HEPATOLOGY, V60, P1302, DOI 10.1002/hep.27275; Aishima S, 2006, CANCER SCI, V97, P1182, DOI 10.1111/j.1349-7006.2006.00322.x; Barten Donna M, 2006, Drugs R D, V7, P87, DOI 10.2165/00126839-200607020-00003; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Cantarini MC, 2006, HEPATOLOGY, V44, P446, DOI 10.1002/hep.21272; Chan CH, 2013, CELL, V154, P556, DOI 10.1016/j.cell.2013.06.048; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dinchuk JE, 2002, J BIOL CHEM, V277, P12970, DOI 10.1074/jbc.M110389200; Dong X, 2015, ONCOTARGET, V6, P1231, DOI 10.18632/oncotarget.2840; El-Serag HB, 2009, HEPATOLOGY, V49, P116, DOI 10.1002/hep.22606; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; Fukaya KI, 2001, IN VITRO CELL DEV-AN, V37, P266, DOI 10.1007/bf02577541; Guest RV, 2014, CANCER RES, V74, P1005, DOI 10.1158/0008-5472.CAN-13-1911; Gundogan F, 2011, PATHOL RES PRACT, V207, P545, DOI 10.1016/j.prp.2011.06.001; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Han J, 2013, BIOCHEM BIOPH RES CO, V435, P493, DOI 10.1016/j.bbrc.2013.05.019; Hassan KA, 2013, CLIN CANCER RES, V19, P1972, DOI 10.1158/1078-0432.CCR-12-0370; HE L, 1984, IN VITRO CELL DEV B, V20, P493, DOI 10.1007/BF02619623; Huang CK, 2013, HEPATOLOGY, V57, P1550, DOI 10.1002/hep.26135; Huang CK, 2013, BBA-MOL CELL RES, V1833, P1222, DOI 10.1016/j.bbamcr.2013.01.007; Ince N, 2000, CANCER RES, V60, P1261; JIA S, 1994, P NATL ACAD SCI USA, V91, P7227, DOI 10.1073/pnas.91.15.7227; Lahousse SA, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-41; Lavaissiere L, 1996, J CLIN INVEST, V98, P1313, DOI 10.1172/JCI118918; Lemaigre Frederic P, 2014, Hepatology, V59, P726, DOI 10.1002/hep.26673; Lin QS, 2014, CANCER LETT, V350, P15, DOI 10.1016/j.canlet.2014.04.017; Lin QS, 2014, CANCER LETT, V345, P85, DOI 10.1016/j.canlet.2013.11.014; Luu M, 2009, HUM PATHOL, V40, P639, DOI 10.1016/j.humpath.2008.11.001; Maeda T, 2004, CANCER DETECT PREV, V28, P313, DOI 10.1016/j.cdp.2004.06.001; Maeda T, 2003, J HEPATOL, V38, P615, DOI 10.1016/S0168-8278(03)00052-7; Nakayama M, 2014, J GASTROEN HEPATOL, V29, P1092, DOI 10.1111/jgh.12484; O'Dell MR, 2012, CANCER RES, V72, P1557, DOI 10.1158/0008-5472.CAN-11-3596; Patel N, 2014, AM J HUM GENET, V94, P755, DOI 10.1016/j.ajhg.2014.04.002; Patel T, 2006, NAT CLIN PRACT GASTR, V3, P33, DOI 10.1038/ncpgasthep0389; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rankin EB, 2014, P NATL ACAD SCI USA, V111, P13373, DOI 10.1073/pnas.1404848111; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Safaee M, 2013, INT J ONCOL, V43, P1343, DOI 10.3892/ijo.2013.2075; Sidow A, 1997, NATURE, V389, P722, DOI 10.1038/39587; Sirica AE, 2008, HEPATOLOGY, V47, P1178, DOI 10.1002/hep.22088; Sugimachi K, 2001, J HEPATOL, V35, P74, DOI 10.1016/S0168-8278(01)00079-4; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu XL, 2006, J CLIN INVEST, V116, P1843, DOI 10.1172/JCI27282; Zender S, 2013, CANCER CELL, V23, P784, DOI 10.1016/j.ccr.2013.04.019; Zhu TS, 2011, CANCER RES, V71, P6061, DOI 10.1158/0008-5472.CAN-10-4269	47	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150336	10.1371/journal.pone.0150336	http://dx.doi.org/10.1371/journal.pone.0150336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954680	gold, Green Published			2022-12-27	WOS:000371991300022
J	Caruso, N; Lucherini, M; Fortin, D; Casanave, EB				Caruso, Nicolas; Lucherini, Mauro; Fortin, Daniel; Casanave, Emma B.			Species-Specific Responses of Carnivores to Human-Induced Landscape Changes in Central Argentina	PLOS ONE			English	Article							CAT ONCIFELIS-GEOFFROYI; HABITAT SELECTION; CONEPATUS-CHINGA; HOME-RANGE; SPATIAL-ORGANIZATION; GRASSLAND RELICT; PAMPAS GRASSLAND; PUMA-CONCOLOR; FRAGMENTATION; FOREST	The role that mammalian carnivores play in ecosystems can be deeply altered by human-driven habitat disturbance. While most carnivore species are negatively affected, the impact of habitat changes is expected to depend on their ecological flexibility. We aimed to identify key factors affecting the habitat use by four sympatric carnivore species in landscapes of central Argentina. Camera trapping surveys were carried out at 49 sites from 2011 to 2013. Each site was characterized by 12 habitat attributes, including human disturbance and fragmentation. Four landscape gradients were created from Principal Component Analysis and their influence on species-specific habitat use was studied using Generalized Linear Models. We recorded 74 events of Conepatus chinga, 546 of Pseudalopex gymnocercus, 193 of Leopardus geoffroyi and 45 of Puma concolor. We found that the gradient describing sites away from urban settlements and with low levels of disturbance had the strongest influence. L. geoffroyi was the only species responding significantly to the four gradients and showing a positive response to modified habitats, which could be favored by the low level of persecution by humans. P. concolor made stronger use of most preserved sites with low proportion of cropland, even though the species also used sites with an intermediate level of fragmentation. A more flexible use of space was found for C. chinga and P. gymnocercus. Our results demonstrate that the impact of human activities spans across this guild of carnivores and that species-specific responses appear to be mediated by ecological and behavioral attributes.	[Caruso, Nicolas; Lucherini, Mauro; Casanave, Emma B.] Univ Nacl Sur, Dept Biol Bioquim & Farm, Catedra Fisiol Anim, Grp Ecol Comportamental Mamiferos, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Caruso, Nicolas; Lucherini, Mauro] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Fortin, Daniel] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Fortin, Daniel] Univ Laval, Dept Biol, Ctr Etud Foret, Quebec City, PQ G1K 7P4, Canada; [Casanave, Emma B.] Univ Nacl Sur, Inst Ciencias Biol & Biomed Sur INBIOSUR, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Casanave, Emma B.] Consejo Nacl Invest Cient & Tecn, Bahia Blanca, Buenos Aires, Argentina	National University of the South; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Laval University; Laval University; National University of the South; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Caruso, N (corresponding author), Univ Nacl Sur, Dept Biol Bioquim & Farm, Catedra Fisiol Anim, Grp Ecol Comportamental Mamiferos, RA-8000 Bahia Blanca, Buenos Aires, Argentina.; Caruso, N (corresponding author), Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.	nccaruso@gmail.com	Fortin, Daniel/ABG-3554-2020; Lucherini, Mauro/D-9668-2016	Casanave, Emma Beatriz/0000-0003-3482-8175; Lucherini, Mauro/0000-0002-9695-3943	Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad Nacional del Sur	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional del Sur	This work was funded by Consejo Nacional de Investigaciones Cientificas y Tecnicas (http://www.conicet.gov.ar/) (recipient: ML), and Universidad Nacional del Sur (https://www.uns.edu.ar/) (recipient: EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andera M, 2009, LARGE MAMMALS CZECH, V2; Austen MJW, 2001, CONDOR, V103, P701, DOI 10.1650/0010-5422(2001)103[0701:LCAFEO]2.0.CO;2; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Busso CA, 1997, J ARID ENVIRON, V36, P197, DOI 10.1006/jare.1996.0205; Caruso N, 2015, ECOL MODEL, V297, P11, DOI 10.1016/j.ecolmodel.2014.11.004; Caruso N, ORYX IN PRESS; Castillo D, SMALL CARNI IN PRESS; Castillo DF, 2011, CAN J ZOOL, V89, P229, DOI 10.1139/Z10-110; Castillo DF, 2014, MAMMALIA, V78, P473, DOI 10.1515/mammalia-2013-0020; Castillo Diego F, 2013, Mastozool. neotrop., V20, P373; Castillo Diego F., 2008, Cat News, V49, P27; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; D?az, 2012, LIBRO ROJO MAMIFEROS; De Angelo C, 2011, DIVERS DISTRIB, V17, P422, DOI 10.1111/j.1472-4642.2011.00746.x; de Oliveira TG, 2014, J MAMM EVOL, V21, P427, DOI 10.1007/s10914-013-9251-4; de Oliveira TG, 2005, GUIA CAMPO FELINOS; Di Bitetti MS, 2006, J ZOOL, V270, P153, DOI 10.1111/j.1469-7998.2006.00102.x; Di Bitetti MS, 2009, J MAMMAL, V90, P479, DOI 10.1644/08-MAMM-A-113.1; Dobrovolski R, 2013, BIOL CONSERV, V165, P162, DOI 10.1016/j.biocon.2013.06.004; Emmons L, 2015, CONEPATUS CHINGA; Castillo DF, 2012, J MAMMAL, V93, P716, DOI 10.1644/11-MAMM-A-300.2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAHRIG L, 1995, BIOL CONSERV, V73, P177, DOI 10.1016/0006-3207(94)00102-V; Fazey I, 2005, BIOL CONSERV, V124, P63, DOI 10.1016/j.biocon.2005.01.013; Fernandez OA, 2009, LAND DEGRAD DEV, V20, P431, DOI 10.1002/ldr.851; Fernandez O.A., 1997, RALA REP, V200, P41; Garcia VB, 2005, MAMM BIOL, V70, P218, DOI 10.1016/j.mambio.2004.11.019; Gehring TM, 2003, BIOL CONSERV, V109, P283, DOI 10.1016/S0006-3207(02)00156-8; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.1890/1051-0761(2002)012[0321:ACGOFR]2.0.CO;2; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Jimenez JE, 2015, IUCN RED LIST THREAT; Kanagaraj R, 2011, ECOGRAPHY, V34, P970, DOI 10.1111/j.1600-0587.2010.06482.x; Kasper CB, 2012, MAMM BIOL, V77, P358, DOI 10.1016/j.mambio.2012.03.006; Knopff AA, 2014, BIOL CONSERV, V178, P136, DOI 10.1016/j.biocon.2014.07.017; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Linnell John D. C., 2000, Diversity and Distributions, V6, P169, DOI 10.1046/j.1472-4642.2000.00069.x; Lucherini Mauro, 2008, Mammalian Species, P1, DOI 10.1644/820.1; Vidal EML, 2012, J ZOOL, V287, P133, DOI 10.1111/j.1469-7998.2011.00896.x; Lyra-Jorge MC, 2008, BIODIVERS CONSERV, V17, P1573, DOI 10.1007/s10531-008-9366-8; Lyra-Jorge MC, 2010, EUR J WILDLIFE RES, V56, P359, DOI 10.1007/s10344-009-0324-x; Manfredi C, 2006, J ZOOL, V268, P381, DOI 10.1111/j.1469-7998.2005.00033.x; Manfredi C, 2006, NICHO TROFICO ESPACI; Manfredi C, 2012, MAMMALIA, V76, P105, DOI 10.1515/mammalia-2011-0039; May R, 2008, J APPL ECOL, V45, P1382, DOI 10.1111/j.1365-2664.2008.01527.x; Mazzolli M, 2010, ENVIRON MANAGE, V46, P237, DOI 10.1007/s00267-010-9528-9; Naves J, 2003, CONSERV BIOL, V17, P1276, DOI 10.1046/j.1523-1739.2003.02144.x; Nielsen C., 2015, IUCN RED LIST THREAT, V2015, pET18868A97216466, DOI 10.2305/IUCN.UK.2015-4.RLTS.T18868A50663436.en; Ordenana MA, 2010, J MAMMAL, V91, P1322, DOI 10.1644/09-MAMM-A-312.1; Pereira JA, 2012, J ARID ENVIRON, V76, P36, DOI 10.1016/j.jaridenv.2011.08.006; Pereira JA, 2015, IUCN RED LIST THREAT; Pereira JA, 2006, J MAMMAL, V87, P1132, DOI 10.1644/05-MAMM-A-333R2.1; Pezzola A., 2004, BOL TEC, V12, P1; Porini G, 2007, ESTADO CONOCIMIENTO; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Redford K.H., 1992, MAMMALS NEOTROPICS S; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Salek M, 2010, LANDSCAPE URBAN PLAN, V98, P86, DOI 10.1016/j.landurbplan.2010.07.013; Schadt S, 2002, J APPL ECOL, V39, P189, DOI 10.1046/j.1365-2664.2002.00700.x; Smith JA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2711; TELLERIA JL, 1991, J MAMMAL, V72, P183, DOI 10.2307/1381994; Vanak AT, 2013, ECOLOGY, V94, P2619, DOI 10.1890/13-0217.1; Lantschner MV, 2011, MAMMALIA, V75, P249, DOI 10.1515/MAMM.2011.031; Virgos E, 2002, BIODIVERS CONSERV, V11, P1063, DOI 10.1023/A:1015856703786; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Zar JH, 1999, BIOSTATISTICAL ANAL; Zuur Alain F., 2009, P1	69	22	25	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150488	10.1371/journal.pone.0150488	http://dx.doi.org/10.1371/journal.pone.0150488			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950300	gold, Green Published			2022-12-27	WOS:000371990100036
J	Zhang, XP; Yu, SZ; Wei, L; Ye, RC; Lin, MZ; Li, XM; Li, GM; Cai, YF; Zhao, M				Zhang, Xiaopei; Yu, Shangzhen; Wei, Lin; Ye, Richun; Lin, Meizhen; Li, Xiaomin; Li, Guoming; Cai, Yefeng; Zhao, Min			The A(2)DS(2) Score as a Predictor of Pneumonia and In-Hospital Death after Acute Ischemic Stroke in Chinese Populations	PLOS ONE			English	Article							MEDICAL COMPLICATIONS; RISK-FACTORS; MORTALITY; INFECTION; CARE; INPATIENT; BLOCKERS	Background and Purpose Stroke-associated pneumonia (SAP) is a common complication and an important cause of death during hospitalization. The A(2)DS(2) (Age, Atrial fibrillation, Dysphagia, Sex, Stroke Severity) score was developed from the Berlin Stroke Registry and showed good predictive value for predicting SAP. We sought to identify the association between the A(2)DS(2) score and SAP, and, furthermore, to identify whether the A(2)DS(2) score was a predictor for in-hospital death after acute ischemic stroke in a Chinese population. Methods This was a retrospective study. 1239 acute ischemic stroke patients were classified to low A(2)DS(2) group (0-4) and high A(2)DS(2) score (5-10) group. Primary outcome was in-hospital SAP. Logistic regression analyses were performed to identify the association between the A(2)DS(2) score and SAP, and also the association between the A(2)DS(2) score and in-hospital death. Results The overall incidence rates of SAP and in-hospitalmortality after acute ischemic stroke were 7.3% and 2.4%, respectively. The incidence rate of SAP in low and high A(2)DS(2) score groups was separately 3.3% and 24.7% (P<0.001). During hospitalization, 1.2% patients in low score group and 7.8% patients in high score group died (P<0.001). Multivariate regression demonstrated that patients in high score group had a higher risk of SAP (OR = 8.888, 95% CI: 5.552-14.229) and mortality (OR = 7.833, 95% CI: 3.580-17.137) than patients in low score group. Conclusions The A(2)DS(2) score was a strong predictor for SAP and in-hospital death of Chinese acute ischemic stroke patients. The A(2)DS(2) score might be a useful tool for the identification of patients with a high risk of SAP and death during hospitalization.	[Zhang, Xiaopei; Wei, Lin; Ye, Richun; Lin, Meizhen; Li, Guoming; Cai, Yefeng; Zhao, Min] Guangdong Prov Hosp Chinese Med, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Yu, Shangzhen; Li, Xiaomin] JiangmenWuyi Tradit Chinese Med Hosp, Dept Neurol, Jiangmen, Guangdong, Peoples R China; [Zhao, Min] Southern Med Univ, Nanfang Hosp, State Key Lab Organ Failure Res, Natl Clin Res Ctr Kidney Dis, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Southern Medical University - China	Cai, YF; Zhao, M (corresponding author), Guangdong Prov Hosp Chinese Med, Dept Neurol, Guangzhou, Guangdong, Peoples R China.; Zhao, M (corresponding author), Southern Med Univ, Nanfang Hosp, State Key Lab Organ Failure Res, Natl Clin Res Ctr Kidney Dis, Guangzhou, Guangdong, Peoples R China.	chiefcai@163.com; cassiesandra@163.com		Li, Guoming/0000-0002-8289-3310	Scientific Research Project of Public Welfare Industry, State Administration of Traditional Chinese Medicine of P. R. of China [200707004]; Finance Department of Guangdong Province [[2006] 143]	Scientific Research Project of Public Welfare Industry, State Administration of Traditional Chinese Medicine of P. R. of China; Finance Department of Guangdong Province	This project was supported by the Scientific Research Project of Public Welfare Industry, State Administration of Traditional Chinese Medicine of P. R. of China (No. 200707004); and the Finance Department of Guangdong Province (No. [2006] 143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsumrain M, 2013, J INTENSIVE CARE MED, V28, P118, DOI 10.1177/0885066612437512; Caldeira D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4260; Chumbler NR, 2010, NEUROEPIDEMIOLOGY, V34, P193, DOI 10.1159/000289350; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Harms H, 2013, ACTA NEUROL SCAND, V128, P178, DOI 10.1111/ane.12095; Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Hinchey JA, 2005, STROKE, V36, P1972, DOI 10.1161/01.STR.0000177529.86868.8d; Hoffmann S, 2012, STROKE, V43, P2617, DOI 10.1161/STROKEAHA.112.653055; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; Ji RJ, 2013, STROKE, V44, P1303, DOI 10.1161/STROKEAHA.111.000598; Katzan IL, 2007, NEUROLOGY, V68, P1938, DOI 10.1212/01.wnl.0000263187.08969.45; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Kumar S, 2010, LANCET NEUROL, V9, P105, DOI 10.1016/S1474-4422(09)70266-2; Kwan J, 2013, J NEUROL NEUROSUR PS, V84, P297, DOI 10.1136/jnnp-2012-302552; Kwok CS, 2013, STROKE, V44, P2010, DOI 10.1161/STROKEAHA.113.001148; Kwon HM, 2006, AM J INFECT CONTROL, V34, P64, DOI 10.1016/j.ajic.2005.06.011; Li Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109665, DOI 10.1371/journal.pone.0109665]; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; Reid JM, 2008, STROKE, V39, P1090, DOI 10.1161/STROKEAHA.107.495143; Saposnik G, 2013, NEUROLOGY, V81, P448, DOI 10.1212/WNL.0b013e31829d874e; Saposnik G, 2011, CIRCULATION, V123, P739, DOI 10.1161/CIRCULATIONAHA.110.983353; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; Smith CJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001307; Smith EE, 2010, CIRCULATION, V122, P1496, DOI 10.1161/CIRCULATIONAHA.109.932822; Sui RB, 2011, NEUROL RES, V33, P508, DOI 10.1179/016164111X13007856084205; Sykora M, 2015, STROKE, V46, P1269, DOI 10.1161/STROKEAHA.114.008260; Vermeij FH, 2009, CEREBROVASC DIS, V27, P465, DOI 10.1159/000210093; Walter U, 2007, J NEUROL, V254, P1323, DOI 10.1007/s00415-007-0520-0; Wang PL, 2012, CHINESE MED J-PEKING, V125, P2449, DOI 10.3760/cma.j.issn.0366-6999.2012.14.010; Warusevitane A, 2015, STROKE, V46, P454, DOI 10.1161/STROKEAHA.114.006639; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wilson RD, 2012, J STROKE CEREBROVASC, V21, P61, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.002; Zhang J, 2004, CHINESE J CLIN REHAB, V8, P1201	35	8	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150298	10.1371/journal.pone.0150298	http://dx.doi.org/10.1371/journal.pone.0150298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950337	gold, Green Submitted, Green Published			2022-12-27	WOS:000371990100027
J	Sakamoto, T				Sakamoto, Takuto			Computational Research on Mobile Pastoralism Using Agent-Based Modeling and Satellite Imagery	PLOS ONE			English	Article							LAND-COVER CHANGES; PEACE WORK; MANAGEMENT; CATTLE; KENYA; MOVEMENT; NONEQUILIBRIUM; EQUILIBRIUM; LANDSCAPES; RESOURCES	Dryland pastoralism has long attracted considerable attention from researchers in diverse fields. However, rigorous formal study is made difficult by the high level of mobility of pastoralists as well as by the sizable spatio-temporal variability of their environment. This article presents a new computational approach for studying mobile pastoralism that overcomes these issues. Combining multi-temporal satellite images and agent-based modeling allows a comprehensive examination of pastoral resource access over a realistic dryland landscape with unpredictable ecological dynamics. The article demonstrates the analytical potential of this approach through its application to mobile pastoralism in northeast Nigeria. Employing more than 100 satellite images of the area, extensive simulations are conducted under a wide array of circumstances, including different land-use constraints. The simulation results reveal complex dependencies of pastoral resource access on these circumstances along with persistent patterns of seasonal land use observed at the macro level.	[Sakamoto, Takuto] Japan External Trade Org, Inst Econ Dev, Chiba, Japan		Sakamoto, T (corresponding author), Japan External Trade Org, Inst Econ Dev, Chiba, Japan.	takuto_sakamoto@ide.go.jp		Sakamoto, Takuto/0000-0002-7027-5849	Japan Society for the Promotion of Science (JSPS) [24243023, 24730139, 26-9525, 15KT0137]; European Commission through the European Research Council (ERC) Advanced Investigator Grant 'Momentum' [324247]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Commission through the European Research Council (ERC) Advanced Investigator Grant 'Momentum'	Japan Society for the Promotion of Science (JSPS) provided financial support (JSPS KAKENHI; URL: http://www.jsps.go.jp/english/index.html; Grant Numbers: 24243023, 24730139, 26-9525 and 15KT0137) to TS. TS also acknowledges support provided by the research group of Professor Dirk Helbing at ETH Zurich, who is funded by the European Commission through the European Research Council (ERC) Advanced Investigator Grant 'Momentum' (URL: http://erc.europa.eu/advanced-grants; Grant Number: 324247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriansen HK, 2005, GEOJOURNAL, V64, P177, DOI 10.1007/s10708-005-5646-y; Adriansen HK, 2008, GEOGR J, V174, P207, DOI 10.1111/j.1475-4959.2008.00278.x; Albert M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003705; Angerer J. P., 2012, FAO Animal Production and Health Manual, P165; Bah A, 2006, MATH COMPUT MODEL, V44, P513, DOI 10.1016/j.mcm.2005.02.014; Bassett TJ, 2007, HUM ECOL, V35, P33, DOI 10.1007/s10745-006-9067-4; BASSETT TJ, 1986, GEOGR REV, V76, P233, DOI 10.2307/214143; Behnke R.H., 1993, RANGE ECOLOGY DISEQU, P1; Boone R, 2002, INTEGRATED ASSESSMEN; Boone R.B, 2005, CONSERVAT SOC, V3, P150; Booth DT, 2003, ARID LAND RES MANAG, V17, P455, DOI 10.1080/713936105; Bovin M, 1990, AD STRAT AFR AR LAND; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Boyer D, 2010, PHILOS T R SOC A, V368, P5645, DOI 10.1098/rsta.2010.0275; Butt B, 2010, LAND DEGRAD DEV, V21, P520, DOI 10.1002/ldr.989; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Coppolillo PB, 2000, HUM ECOL, V28, P527, DOI 10.1023/A:1026435714109; Coppolillo PB, 2001, LANDSCAPE ECOL, V16, P205, DOI 10.1023/A:1011148503303; Dahl G, 1976, STUDIES SOCIAL ANTHR; Degteva A, 2013, PASTORALISM, V3, DOI 10.1186/2041-7136-3-15; Dong SK, 2011, ECOL SOC, V16; Eaton D, 2008, AFR AFFAIRS, V107, P243, DOI 10.1093/afraf/adm086; Eaton D, 2008, AFR AFFAIRS, V107, P89, DOI 10.1093/afraf/adm085; Egeru A, 2014, PASTORALISM, V4, DOI 10.1186/2041-7136-4-6; ELLIS JE, 1988, J RANGE MANAGE, V41, P450, DOI 10.2307/3899515; Ericksen P, 2013, PATHWAY SUSTAIN, P71; Ermon S, 2015, 29 AAAI ASS ADV ART; Evans-Pritchard E.E., 1940, NUER DESCRIPTION MOD; FORAN BD, 1991, J ENVIRON MANAGE, V33, P17, DOI 10.1016/S0301-4797(05)80045-3; Fratkin E.M., 2004, PASTORALISTS SETTLE; Galvin KA, 2009, ANNU REV ANTHROPOL, V38, P185, DOI 10.1146/annurev-anthro-091908-164442; Gumel M. A., 2013, Bayero Journal of Pure and Applied Sciences, V6, P127, DOI 10.4314/bajopas.v6i1.25; Hailegiorgis A, 2010, 2010 INT C ENV MOD S; Hay SI, 1996, ANN TROP MED PARASIT, V90, P1; Homewood K., 2008, ECOLOGY AFRICAN PAST; Janssen MA, 2000, ECOL MODEL, V131, P249, DOI 10.1016/S0304-3800(00)00256-8; Kawamura K, 2010, GLOBAL ENV RES, V14, P29; Kuckertz P, 2011, SIMULATION NOTES EUR, V21, P147; MacOpiyo LA, 2005, THESIS TEXAS A M U; McPeak John., 2012, RISK SOCIAL CHANGE A; Miller BW, 2015, NOMAD PEOPLES, V19, P120, DOI 10.3197/np.2015.190108; Moritz M, 2015, ECOL MODEL, V305, P54, DOI 10.1016/j.ecolmodel.2015.03.010; Moritz M, 2013, PASTORALISM, V3, DOI 10.1186/2041-7136-3-26; Moritz M, 2010, HUM ECOL, V38, P775, DOI 10.1007/s10745-010-9361-z; Neely C., 2009, REV EVIDENCE DRYLAND; Niamir-Fuller M., 1999, MANAGING MOBILITY AF; Oba G, 2003, LAND DEGRAD DEV, V14, P83, DOI 10.1002/ldr.524; Oba G, 2000, BIOSCIENCE, V50, P35, DOI 10.1641/0006-3568(2000)050[0035:NPOSGM]2.3.CO;2; PICKUP G, 1988, INT J REMOTE SENS, V9, P1469, DOI 10.1080/01431168808954953; Purdue Research Foundation, MULTISPEC; Raizman EA, 2013, PREV VET MED, V111, P76, DOI 10.1016/j.prevetmed.2013.04.007; Rogers DJ, 1996, ANN TROP MED PARASIT, V90, P225, DOI 10.1080/00034983.1996.11813049; Ruelland D, 2010, INT J APPL EARTH OBS, V12, pS11, DOI 10.1016/j.jag.2009.10.006; Sakamoto T, AGENT BASED SIMULATI; Sandford S., 1983, MANAGEMENT PASTORAL; SATO S, 1980, SENRI ETHNOLOGICAL S, V6, P1; Sayama H, 2013, COMPLEX ADAPT SYST M, V1, DOI 10.1186/2194-3206-1-2; Schlee G., 2012, PASTORALISM POLITICS; SCOONES I, 1995, J ARID ENVIRON, V29, P221, DOI 10.1016/S0140-1963(05)80092-8; Scoones I., 1994, LIVING UNCERTAINTY N; Scoones I., 2013, PASTORALISM DEV AFRI; Steinfeld H., 2010, LIVESTOCK CHANGING L; Stenning Derrick, 1957, J ROYAL ANTHR I GREA, V87, P57, DOI DOI 10.2307/2843971; Stenning Derrick J., 1959, SAVANNAH NOMADS STUD; Sulieman HM, 2013, PASTORALISM, V3, DOI 10.1186/2041-7136-3-22; Thornton PK, 2006, AGR SYST, V87, P331, DOI 10.1016/j.agsy.2005.03.001; TUCKER CJ, 1983, REMOTE SENS ENVIRON, V13, P461, DOI 10.1016/0034-4257(83)90053-6; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; TUCKER CJ, 1985, REMOTE SENS ENVIRON, V17, P233, DOI 10.1016/0034-4257(85)90097-5; TUELLER PT, 1989, J RANGE MANAGE, V42, P442, DOI 10.2307/3899227; Turner M. D., 1999, Managing mobility in African rangelands: the legitimization of transhumance., P97; Turner MD, 2002, LANDSCAPE ECOL, V17, P367, DOI 10.1023/A:1021238208019; USGS, 2011, VEG IND MONTHL L3 GL; USGS, 2011, LAND COV TYP YEARL L; Vetter S, 2005, J ARID ENVIRON, V62, P321, DOI 10.1016/j.jaridenv.2004.11.015; Zengeya FM, 2015, GEOCARTO INT, V30, P905, DOI 10.1080/10106049.2015.1004129	76	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151157	10.1371/journal.pone.0151157	http://dx.doi.org/10.1371/journal.pone.0151157			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963526	gold, Green Published			2022-12-27	WOS:000371993000112
J	Wang, Y; Li, HX; Sun, QX; Yao, YY				Wang, Yu; Li, Hongxia; Sun, Qixia; Yao, Yingyin			Characterization of Small RNAs Derived from tRNAs, rRNAs and snoRNAs and Their Response to Heat Stress in Wheat Seedlings	PLOS ONE			English	Article							THROUGHPUT SEQUENCING REVEALS; MEDIATED RESPONSES; FRAGMENTS TRFS; TARGET GENES; MICRORNAS; IDENTIFICATION; ANGIOGENIN; GENOME; SIRNAS; ARABIDOPSIS	Small RNAs (sRNAs) derived from non-coding RNAs (ncRNAs), such as tRNAs, rRNAs and snoRNAs, have been identified in various organisms. Several observations have indicated that cleavage of tRNAs and rRNAs is induced by various stresses. To clarify whether sRNAs in wheat derived from tRNAs (stRNAs), rRNAs (srRNAs) and snoRNAs (sdRNAs) are produced specifically in association with heat stress responses, we carried out a bioinformatic analysis of sRNA libraries from wheat seedlings and performed comparisons between control and high-temperature-treated samples to measure the differential abundance of stRNAs, srRNAs and sdRNAs. We found that the production of sRNAs from tRNAs, 5.8S rRNAs, and 28S rRNAs was more specific than that from 5S rRNAs and 18S rRNAs, and more than 95% of the stRNAs were processed asymmetrically from the 3' or 5' ends of mature tRNAs. We identified 333 stRNAs and 8,822 srRNAs that were responsive to heat stress. Moreover, the expression of stRNAs derived from tRNA-Val-CAC, tRNA-Thr-UGU, tRNA-Tyr-GUA and tRNA-Ser-UGA was not only up-regulated under heat stress but also induced by osmotic stress, suggesting that the increased cleavage of tRNAs might be a mechanism that developed in wheat seedlings to help them cope with adverse environmental conditions.	[Wang, Yu; Li, Hongxia; Sun, Qixia] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Yao, Yingyin] China Agr Univ, State Key Lab Agrobiotechnol, Key Lab Crop Heterosis & Utilizat MOE, Beijing Key Lab Crop Genet Improvement, Beijing 100094, Peoples R China	Northwest A&F University - China; China Agricultural University	Yao, YY (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Key Lab Crop Heterosis & Utilizat MOE, Beijing Key Lab Crop Genet Improvement, Beijing 100094, Peoples R China.	yingyin@cau.edu.cn			National Natural Science Foundation of China [31401374]; Specialized Research Fund for the Doctoral Program of Higher Education [20130204120033]; Shaanxi Province Agricultural Science and Technology Innovation and Research [2015NY109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shaanxi Province Agricultural Science and Technology Innovation and Research	This work was financially supported by the National Natural Science Foundation of China (31401374), the Specialized Research Fund for the Doctoral Program of Higher Education (20130204120033) and Shaanxi Province Agricultural Science and Technology Innovation and Research (2015NY109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bellutti F, 2015, J VIROL, V89, P1608, DOI 10.1128/JVI.02336-14; Bilichak A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00005; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Budak H, 2015, PLANT SCI, V235, P1, DOI 10.1016/j.plantsci.2015.02.008; Cantu D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-408; Chen CJ, 2011, RNA BIOL, V8, P538, DOI 10.4161/rna.8.3.15199; Chen F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137773; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Eversole K, 2014, SCIENCE, V345, P285, DOI 10.1126/science.1257983; Falaleeva M, 2013, BIOESSAYS, V35, P46, DOI 10.1002/bies.201200117; Garcia-Silva MR, 2010, MOL BIOCHEM PARASIT, V171, P64, DOI 10.1016/j.molbiopara.2010.02.003; Gebetsberger J, 2012, ARCHAEA, V2012, DOI 10.1155/2012/260909; Guerra D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00057; Hackenberg M, 2013, DNA RES, V20, P109, DOI 10.1093/dnares/dss037; Han R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-289; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Heyer R, 2012, RNA BIOL, V9, P1011, DOI 10.4161/rna.20826; Hsieh LC, 2010, PLANT SIGNAL BEHAV, V5, P537, DOI 10.4161/psb.11029; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Ivanov P, 2014, P NATL ACAD SCI USA, V111, P18201, DOI 10.1073/pnas.1407361111; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jung HJ, 2013, J PLANT BIOL, V56, P123, DOI 10.1007/s12374-013-0906-8; Kamthan A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00208; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kenan-Eichler M, 2011, GENETICS, V188, P263, DOI 10.1534/genetics.111.128348; Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Kruszka K, 2014, J EXP BOT, V65, P6123, DOI 10.1093/jxb/eru353; Kumar RR, 2015, FUNCT INTEGR GENOMIC, V15, P323, DOI 10.1007/s10142-014-0421-0; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Lee SR, 2005, J BIOL CHEM, V280, P42744, DOI 10.1074/jbc.M510356200; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li SP, 2012, J CELL PHYSIOL, V227, P2822, DOI 10.1002/jcp.23051; Li YF, 2013, PLANT SCI, V203, P17, DOI 10.1016/j.plantsci.2012.12.014; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; Loss-Morais G, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-6; Luan MD, 2015, GENE, V555, P178, DOI 10.1016/j.gene.2014.11.001; Maute RL, 2013, P NATL ACAD SCI USA, V110, P1404, DOI 10.1073/pnas.1206761110; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Megel C, 2015, INT J MOL SCI, V16, P1873, DOI 10.3390/ijms16011873; Meng FR, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-140; Petsch K, 2015, PLANT CELL, V27, P2163, DOI 10.1105/tpc.15.00194; Porter JR, 1999, EUR J AGRON, V10, P23, DOI 10.1016/S1161-0301(98)00047-1; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Saikia M, 2014, MOL CELL BIOL, V34, P2450, DOI 10.1128/MCB.00136-14; Saikia M, 2012, J BIOL CHEM, V287, P42708, DOI 10.1074/jbc.M112.371799; Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224; Scott MS, 2012, NUCLEIC ACIDS RES, V40, P3676, DOI 10.1093/nar/gkr1233; Scott MS, 2011, BIOCHIMIE, V93, P1987, DOI 10.1016/j.biochi.2011.05.026; Scott MS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000507; Sobala A, 2013, RNA BIOL, V10, P553, DOI 10.4161/rna.24285; Su C, 2014, GENOMICS, V103, P298, DOI 10.1016/j.ygeno.2014.03.002; Sun FL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-142; Sun FL, 2013, GENE, V522, P1, DOI 10.1016/j.gene.2013.03.101; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Tang ZH, 2012, PLANT PHYSIOL, V159, P721, DOI 10.1104/pp.112.196048; Thomson DW, 2015, NUCLEIC ACIDS RES, V43, P470, DOI 10.1093/nar/gku1242; Tuck AC, 2011, TRENDS GENET, V27, P422, DOI 10.1016/j.tig.2011.06.001; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Visser M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-568; Wang L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-289; Wang QR, 2013, MOL THER, V21, P368, DOI 10.1038/mt.2012.237; Wei HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056842; Wei LY, 2014, P NATL ACAD SCI USA, V111, P3877, DOI 10.1073/pnas.1318131111; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Xia KF, 2015, NEW PHYTOL, V208, P790, DOI 10.1111/nph.13513; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yin ZJ, 2010, GENET MOL RES, V9, P1186, DOI 10.4238/vol9-2gmr805; Zhai JX, 2015, P NATL ACAD SCI USA, V112, P3146, DOI 10.1073/pnas.1418918112; Zhang SD, 2009, PLANT PHYSIOL, V150, P378, DOI 10.1104/pp.108.134767; Zheng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113790	80	38	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150933	10.1371/journal.pone.0150933	http://dx.doi.org/10.1371/journal.pone.0150933			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963812	gold, Green Published			2022-12-27	WOS:000371993000082
J	Chen, C; Stedman, A; Havis, E; Anselme, I; Onichtchouk, D; Giudicelli, F; Schneider-Maunoury, S				Chen, Chunhong; Stedman, Aline; Havis, Emmanuelle; Anselme, Isabelle; Onichtchouk, Daria; Giudicelli, Francois; Schneider-Maunoury, Sylvie			Initiation of cyp26a1 Expression in the Zebrafish Anterior Neural Plate by a Novel Cis-Acting Element	PLOS ONE			English	Article							ACID-METABOLIZING ENZYME; RETINOIC ACID; EMBRYONIC-DEVELOPMENT; RESPONSE ELEMENT; HINDBRAIN; GENES; PROMOTER; IDENTIFICATION; CONSERVATION; SOX-2	Early patterning of the vertebrate neural plate involves a complex hierarchy of inductive interactions orchestrated by signalling molecules and their antagonists. The morphogen retinoic acid, together with the Cyp26 enzymes which degrade it, play a central role in this process. The cyp26a1 gene expressed in the anterior neural plate thus contributes to the fine modulation of the rostrocaudal retinoic acid gradient. Despite this important role of cyp26a1 in early brain formation, the mechanisms that control its expression in the anterior neural plate are totally unknown. Here, we present the isolation of a 310-base-pair DNA element adjacent to cyp26a1 promoter, displaying enhancer activity restricted to the anterior neural plate of the zebrafish gastrula. We show that unlike that of cyp26a1, expression driven by this cyp26a1 anterior neural plate element (cANE) is independent of retinoic acid. Through deletion analysis, we identify a 12-nucleotide motif essential for cANE activity. A consensus bipartite binding site for SoxB:Oct transcription factors overlaps with this motif. Mutational analysis suggests that SoxB binding is essential for its activity. We discuss the contribution of this study to the elucidation of the regulatory hierarchy involved in early neural plate patterning.	[Chen, Chunhong; Stedman, Aline; Havis, Emmanuelle; Anselme, Isabelle; Giudicelli, Francois; Schneider-Maunoury, Sylvie] CNRS, UMR 7622, Paris, France; [Chen, Chunhong; Stedman, Aline; Havis, Emmanuelle; Anselme, Isabelle; Giudicelli, Francois; Schneider-Maunoury, Sylvie] Univ Paris 06, Sorbonne Univ, Inst Biol Paris Seine, Dev Biol Lab, Paris, France; [Chen, Chunhong; Stedman, Aline; Havis, Emmanuelle; Anselme, Isabelle; Giudicelli, Francois; Schneider-Maunoury, Sylvie] INSERM, U1156, Paris, France; [Onichtchouk, Daria] Univ Freiburg, Fac Biol, Dev Biol, Inst Biol 1, Hugstetter Str 55, D-79106 Freiburg, Germany; [Stedman, Aline] Inst Pasteur, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Freiburg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Giudicelli, F; Schneider-Maunoury, S (corresponding author), CNRS, UMR 7622, Paris, France.; Giudicelli, F; Schneider-Maunoury, S (corresponding author), Univ Paris 06, Sorbonne Univ, Inst Biol Paris Seine, Dev Biol Lab, Paris, France.; Giudicelli, F; Schneider-Maunoury, S (corresponding author), INSERM, U1156, Paris, France.	francois.giudicelli@upmc.fr; sylvie.schneider-maunoury@upmc.fr	Giudicelli, François/H-2075-2014; Onichtchouk, Daria/E-1741-2012; Schneider-Maunoury, Sylvie/K-6795-2017; Havis, Emmanuelle/K-1874-2017	Giudicelli, François/0000-0003-1320-2958; Onichtchouk, Daria/0000-0001-6497-1445; Schneider-Maunoury, Sylvie/0000-0002-0797-4735; Havis, Emmanuelle/0000-0001-5634-3174; Stedman, Aline/0000-0002-8966-3366	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Pierre et Marie Curie (Sorbonnes Universite UPMC Universite Paris); Agence Nationale pour la Recherche (ANR); Fondation ARC pour la Recherche sur le Cancer; Mairie de Paris ("Research in Paris"); Agence Nationale pour la Recherche	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie (Sorbonnes Universite UPMC Universite Paris); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Mairie de Paris ("Research in Paris"); Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (Inserm), the Universite Pierre et Marie Curie (Sorbonnes Universite UPMC Universite Paris 06), the Agence Nationale pour la Recherche (ANR) and the Fondation ARC pour la Recherche sur le Cancer, and by fellowships from Mairie de Paris ("Research in Paris") to CC and from the Agence Nationale pour la Recherche and the Fondation ARC pour la Recherche sur le Cancer to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Collignon J, 1996, DEVELOPMENT, V122, P509; Dobbs-McAuliffe B, 2004, MECH DEVELOP, V121, P339, DOI 10.1016/j.mod.2004.02.008; Emoto Y, 2005, DEV BIOL, V278, P415, DOI 10.1016/j.ydbio.2004.11.023; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Gomez-Skarmeta JL, 2006, DEV DYNAM, V235, P870, DOI 10.1002/dvdy.20659; Gongal PA, 2008, HUM MOL GENET, V17, P525, DOI 10.1093/hmg/ddm328; Hernandez RE, 2007, DEVELOPMENT, V134, P177, DOI 10.1242/dev.02706; Hu P, 2008, DEV DYNAM, V237, P3798, DOI 10.1002/dvdy.21801; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishi M, 2000, DEVELOPMENT, V127, P791; Kudoh T, 2002, DEVELOPMENT, V129, P4335; Li JY, 2012, ANAT REC, V295, P268, DOI 10.1002/ar.21520; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Maurus D, 2009, GENE DEV, V23, P1461, DOI 10.1101/gad.517009; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Muller F, 2002, BIOESSAYS, V24, P564, DOI 10.1002/bies.10096; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Okuda Y, 2006, DEV DYNAM, V235, P811, DOI 10.1002/dvdy.20678; Okuda Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000936; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Shimozono S, 2013, NATURE, V496, P363, DOI 10.1038/nature12037; Sirbu IO, 2005, DEVELOPMENT, V132, P2611, DOI 10.1242/dev.01845; Staudt N, 2007, PLOS BIOL, V5, P878, DOI 10.1371/journal.pbio.0050069; Stedman A, 2009, DEV BIOL, V327, P566, DOI 10.1016/j.ydbio.2008.12.018; Vakhrusheva OA, 2013, GENOME BIOL EVOL, V5, P532, DOI 10.1093/gbe/evt023; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304	38	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150639	10.1371/journal.pone.0150639	http://dx.doi.org/10.1371/journal.pone.0150639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959238	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300060
J	Miville-Godbout, E; Bourque, M; Morissette, M; Al-Sweidi, S; Smith, T; Mochizuki, A; Senanayake, V; Jayasinghe, D; Wang, L; Goodenowe, D; Di Paolo, T				Miville-Godbout, Edith; Bourque, Melanie; Morissette, Marc; Al-Sweidi, Sara; Smith, Tara; Mochizuki, Asuka; Senanayake, Vijitha; Jayasinghe, Dushmanthi; Wang, Li; Goodenowe, Dayan; Di Paolo, Therese			Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice	PLOS ONE			English	Article							PARKINSONS-DISEASE; MOUSE MODEL; OXIDATIVE STRESS; ANIMAL-MODELS; DEFICIENCY; PROTEIN; CHOLESTEROL; RALOXIFENE; NEURONS; ACID	Plasmalogens are a class of glycerophospholipids shown to play critical roles in membrane structure and function. Decreased plasmalogens are reported in the brain and blood of Parkinson's disease (PD) patients. The present study investigated the hypothesis that augmenting plasmalogens could protect striatal dopamine neurons that degenerate in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment in mice, a PD model. First, in a pre-treatment experiment male mice were treated for 10 days with the docosahexaenoic acid (DHA)-plasmalogen precursor PPI-1011 (10, 50 and 200 mg/kg). On day 5 mice received MPTP and were killed on day 11. Next, in a post-treatment study, male mice were treated with MPTP and then received daily for 5 days PPI-1011 (5, 10 and 50 mg/kg). MPTP treatment reduced serum plasmalogen levels, striatal contents of dopamine (DA) and its metabolites, serotonin, DA transporter (DAT) and vesicular monoamine transporter 2 (VMAT2). Pre-treatment with PPI-1011 (10 and 50 mg/kg) prevented all MPTP-induced effects. Positive correlations were measured between striatal DA contents and serum plasmalogen levels as well as striatal DAT and VMAT2 specific binding. Post-treatment with PPI-1011 prevented all MPTP-induced effects at 50 mg/kg but not at lower doses. Positive correlations were measured between striatal DA contents and serum plasmalogen levels as well as striatal DAT and VMAT2 specific binding in the post-treatment experiment. PPI-1011 treatment (10 days at 5, 10 and 50 mg/kg) of intact mice left unchanged striatal biogenic amine contents. These data demonstrate that treatment with a plasmalogen precursor is capable of protecting striatal dopamine markers in an animal model of PD.	[Miville-Godbout, Edith; Bourque, Melanie; Morissette, Marc; Al-Sweidi, Sara; Di Paolo, Therese] CHU Quebec, CHUL, Ctr Rech, Neurosci Res Unit, Quebec City, PQ, Canada; [Miville-Godbout, Edith; Bourque, Melanie; Di Paolo, Therese] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Smith, Tara; Mochizuki, Asuka; Senanayake, Vijitha; Jayasinghe, Dushmanthi; Wang, Li; Goodenowe, Dayan] Phenomenome Discoveries Inc, Saskatoon, SK, Canada; [Mochizuki, Asuka] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba, Japan	Laval University; Laval University; Chiba University	Di Paolo, T (corresponding author), CHU Quebec, CHUL, Ctr Rech, Neurosci Res Unit, Quebec City, PQ, Canada.; Di Paolo, T (corresponding author), Univ Laval, Fac Pharm, Quebec City, PQ, Canada.	therese.dipaolo@crchul.ulaval.ca		Smith, Tara/0000-0002-1702-8910; Di Paolo, Therese/0000-0003-1020-6566	Canadian Institutes of Health Research (CIHR) [MOP-114916]; Fonds de l<SUP>1</SUP>enseignement et de la recherche (FER) of the Faculty of Pharmacy, Laval University; Phenomenome Discoveries Inc.; Fonds de l'enseignement et de la recherche (FER) of the Faculty of Pharmacy, Laval University	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de l<SUP>1</SUP>enseignement et de la recherche (FER) of the Faculty of Pharmacy, Laval University; Phenomenome Discoveries Inc.; Fonds de l'enseignement et de la recherche (FER) of the Faculty of Pharmacy, Laval University	This research was supported by a grant from the Canadian Institutes of Health Research (CIHR, MOP-114916) to TDP where the study design was described. EMG held a studentship from the Fonds de l<SUP>1</SUP>enseignement et de la recherche (FER) of the Faculty of Pharmacy, Laval University. Phenomenome Discoveries Inc. provided the PlsEtn precursors and analyzed the PLsEtn levels in the blood and brain samples. Phenomenome Discoveries Inc. also provided support in the form of salaries for authors TS, AM, VS, DJ, LW and DG. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant from the Canadian Institutes of Health Research (CIHR) to T.D.P. E.M.G. held a studentship form the Fonds de l'enseignement et de la recherche (FER) of the Faculty of Pharmacy, Laval University. Phenomenome Discoveries Inc. provided the PlsEtn precursors and analyzed the blood and tissue samples.	AGID Y, 1989, MOVEMENT DISORD, V4, pS126, DOI 10.1002/mds.870040514; Bharath S, 2002, NEUROTOXICOLOGY, V23, P479, DOI 10.1016/S0161-813X(02)00035-9; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Bomasang-Layno E, 2015, PARKINSONISM RELAT D, V21, P833, DOI 10.1016/j.parkreldis.2015.04.018; Bourque M, 2014, NEUROBIOL AGING, V35, P2347, DOI 10.1016/j.neurobiolaging.2014.03.017; Bourque M, 2013, NEUROBIOL AGING, V34, P887, DOI 10.1016/j.neurobiolaging.2012.05.022; Bourque M, 2012, FRONT NEUROENDOCRIN, V33, P169, DOI 10.1016/j.yfrne.2012.02.003; Bousquet M, 2008, FASEB J, V22, P1213, DOI 10.1096/fj.07-9677com; Bove J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Callier S, 2001, SYNAPSE, V41, P131, DOI 10.1002/syn.1067; Cartier EA, 2010, J BIOL CHEM, V285, P1957, DOI 10.1074/jbc.M109.054510; Cote M, 2015, NEUROBIOL DIS, V82, P99, DOI 10.1016/j.nbd.2015.05.017; D'Astous M, 2006, MOL PHARMACOL, V69, P1492, DOI 10.1124/mol.105.018671; DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4; Dragonas C, 2009, CLIN CHEM LAB MED, V47, P894, DOI 10.1515/CCLM.2009.205; Fabelo N, 2011, MOL MED, V17, P1107, DOI 10.2119/molmed.2011.00119; Farooqui A.A., 2008, METABOLISM FUNCTIONS; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; GINSBERG L, 1995, BRAIN RES, V698, P223, DOI 10.1016/0006-8993(95)00931-F; Grandbois M, 2000, NEUROREPORT, V11, P343, DOI 10.1097/00001756-200002070-00024; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Hornykiewicz O, 1975, Natl Inst Drug Abuse Res Monogr Ser, P13; Hossain MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083508; Jones KT, 2012, J NEUROCHEM, V123, P700, DOI 10.1111/jnc.12007; Karunakaran S, 2007, FASEB J, V21, P2226, DOI 10.1096/fj.06-7580com; Kilbourn M, 1996, EUR J PHARMACOL, V307, P227, DOI 10.1016/0014-2999(96)00252-X; Kish SJ, 2008, BRAIN, V131, P120, DOI 10.1093/brain/awm239; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Litim N, 2015, NEUROPHARMACOLOGY, V97, P86, DOI 10.1016/j.neuropharm.2015.05.015; Mankidy R, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-62; Munn NJ, 2003, J LIPID RES, V44, P182, DOI 10.1194/jlr.M200363-JLR200; Nishimukai M, 2014, J LIPID RES, V55, P956, DOI 10.1194/jlr.P045591; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; Perichon R, 1998, BIOCHEM BIOPH RES CO, V248, P57, DOI 10.1006/bbrc.1998.8909; Ruffoli R, 2008, BRAIN RES, V1229, P218, DOI 10.1016/j.brainres.2008.06.116; Stenvinkel P, 2004, NEPHROL DIAL TRANSPL, V19, P972, DOI 10.1093/ndt/gfh035; Styger R, 2002, BBA-MOL CELL BIOL L, V1585, P39, DOI 10.1016/S1388-1981(02)00320-7; Tieu K, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a009316; VARTANIAN T, 1988, P NATL ACAD SCI USA, V85, P939, DOI 10.1073/pnas.85.3.939; Wood PL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-227; Wood PL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-182; Wood PL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-214; Yoshihara S, 2000, DRUG METAB DISPOS, V28, P538; Youdim Moussa B H, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS132, DOI 10.1016/S1353-8020(13)70032-4; Zhao Q, 2013, INT J MOL MED, V32, P883, DOI 10.3892/ijmm.2013.1450	46	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151020	10.1371/journal.pone.0151020	http://dx.doi.org/10.1371/journal.pone.0151020			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959819	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300091
J	Pisesky, A; Benchimol, EI; Wong, CA; Hui, C; Crowe, M; Belair, MA; Pojsupap, S; Karnauchow, T; O'Hearn, K; Yasseen, AS; McNally, JD				Pisesky, Andrea; Benchimol, Eric I.; Wong, Coralie A.; Hui, Charles; Crowe, Megan; Belair, Marc-Andre; Pojsupap, Supichaya; Karnauchow, Tim; O'Hearn, Katie; Yasseen, Abdool S., III; McNally, James D.			Incidence of Hospitalization for Respiratory Syncytial Virus Infection amongst Children in Ontario, Canada: A Population-Based Study Using Validated Health Administrative Data	PLOS ONE			English	Article							BRONCHIOLITIS HOSPITALIZATIONS; YOUNG-CHILDREN; UNITED-STATES; DISEASE; BURDEN; EPIDEMIOLOGY; INFANTS; CODES	Importance RSV is a common illness among young children that causes significant morbidity and health care costs. Objective Routinely collected health administrative data can be used to track disease incidence, explore risk factors and conduct health services research. Due to potential for misclassification bias, the accuracy of data-elements should be validated prior to use. The objectives of this study were to validate an algorithm to accurately identify pediatric cases of hospitalized respiratory syncytial virus (RSV) from within Ontario's health administrative data, estimate annual incidence of hospitalization due to RSV and report the prevalence of major risk factors within hospitalized patients. Study Design and Setting A retrospective chart review was performed to establish a reference-standard cohort of children from the Ottawa region admitted to the Children's Hospital of Eastern Ontario (CHEO) for RSV-related disease in 2010 and 2011. Chart review data was linked to Ontario's administrative data and used to evaluate the diagnostic accuracy of algorithms of RSV-related ICD-10 codes within provincial hospitalization and emergency department databases. Age-and sex-standardized incidence was calculated over time, with trends in incidence assessed using Poisson regression. Results From a total of 1411 admissions, chart review identified 327 children hospitalized for laboratory confirmed RSV-related disease. Following linkage to administrative data and restriction to first admissions, there were 289 RSV patients in the reference-standard cohort. The best algorithm, based on hospitalization data, resulted in sensitivity 97.9%(95% CI: 95.5-99.2%), specificity 99.6%(95% CI: 98.2-99.8%), PPV 96.9% (95% CI: 94.2-98.6%), NPV 99.4% (95% CI: 99.4-99.9%). Incidence of hospitalized RSV in Ontario from 2005-2012 was 10.2 per 1000 children under 1 year and 4.8 per 1000 children aged 1 to 3 years. During the surveillance period, there was no identifiable increasing or decreasing linear trend in the incidence of hospitalized RSV, hospital length of stay and PICU admission rates. Among the Ontario RSV cohort, 16.3% had one or more major risk factors, with a decreasing trend observed over time. Conclusion Children hospitalized for RSV-related disease can be accurately identified within population-based health administrative data. RSV is a major public health concern and incidence has not changed over time, suggesting a lack of progress in prevention.	[Pisesky, Andrea; Benchimol, Eric I.; Hui, Charles; Pojsupap, Supichaya; Karnauchow, Tim; McNally, James D.] Univ Ottawa, Dept Pediat, Childrens Hosp Eastern Ontario, Ottawa, ON K1N 6N5, Canada; [Benchimol, Eric I.; O'Hearn, Katie; Yasseen, Abdool S., III; McNally, James D.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Benchimol, Eric I.; Crowe, Megan] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Benchimol, Eric I.; Wong, Coralie A.; Belair, Marc-Andre] Inst Clin Evaluat Sci ICES uOttawa, Ottawa, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa	McNally, JD (corresponding author), Univ Ottawa, Dept Pediat, Childrens Hosp Eastern Ontario, Ottawa, ON K1N 6N5, Canada.; McNally, JD (corresponding author), Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada.	dmcnally@cheo.on.ca	Benchimol, Eric Ian/A-7711-2010	Benchimol, Eric Ian/0000-0001-8855-3598; Yasseen, Abdool S./0000-0001-9814-9249	Institute for Clinical Evaluative Sciences (ICES Ottawa); CHEO RI Cost centre [9715]	Institute for Clinical Evaluative Sciences (ICES Ottawa); CHEO RI Cost centre	Financial support was provided by a grant awarded through the Institute for Clinical Evaluative Sciences (ICES Ottawa) called the ICES Research Grant. This grant was received by JM and EIB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The CHEO RI Cost centre number was 9715 (no other grant number provided). URL: http://www.ices.on.ca/Research/Grants?year=2014&page=6.	[Anonymous], 2003, PEDIATR INFECT DIS J; Benchimol EI, 2014, J CLIN EPIDEMIOL, V67, P887, DOI 10.1016/j.jclinepi.2014.02.019; Benchimol EI, 2011, J CLIN EPIDEMIOL, V64, P821, DOI 10.1016/j.jclinepi.2010.10.006; Ducharme R, 2013, J PEDIATR-US, V163, P1073, DOI 10.1016/j.jpeds.2013.05.034; Fisher WH, 2010, PSYCHIAT SERV, V61, P546, DOI 10.1176/ps.2010.61.6.546; Gil-Prieto R, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000831; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Hsu VP, 2005, PEDIATRICS, V115, P78, DOI 10.1542/peds.2004-0860; Law BJ, 2004, PEDIATR INFECT DIS J, V23, P806, DOI 10.1097/01.inf.0000137568.71589.bd; Luo G, 2014, INT J MED INFORM, V83, P691, DOI 10.1016/j.ijmedinf.2014.07.005; McGuiness CB, 2014, PEDIATR INFECT DIS J, V33, P589, DOI [10.1097/INF.0000000000000257, DOI 10.1097/INF.0000000000000257]; Moth G, 2007, ACTA PAEDIATR, V96, P1470, DOI 10.1111/j.1651-2227.2007.00460.x; Murray J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089186; Nair H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S30; Paes BA, 2011, CAN RESPIR J, V18, pE10, DOI 10.1155/2011/493056; Pelletier AJ, 2006, PEDIATRICS, V118, P2418, DOI 10.1542/peds.2006-1193; Ranmuthugala G, 2011, COMMUN DIS INTELL, V35, P177; Schwartz KL, 2015, HUM VACC IMMUNOTHER, V11, P1840, DOI 10.1080/21645515.2015.1043499; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Shiff NJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-236; Simoes EAF, 2003, PEDIATR INFECT DIS J, V22, pS13, DOI 10.1097/00006454-200302001-00003; Stang P, 2001, ARCH PEDIAT ADOL MED, V155, P95, DOI 10.1001/archpedi.155.1.95; Stockman LJ, 2012, PEDIATR INFECT DIS J, V31, P5, DOI 10.1097/INF.0b013e31822e68e6; To T, 2006, PEDIAT ALLERG IMM-UK, V17, P69, DOI 10.1111/j.1399-3038.2005.00346.x; Welke KF, 2008, CARDIOL YOUNG, V18, P137, DOI 10.1017/S1047951108002837; Williams CL, 2013, VACCINE, V31, pK28, DOI 10.1016/j.vaccine.2013.03.078; Williams DJ, 2013, JAMA PEDIATR, V167, P851, DOI 10.1001/jamapediatrics.2013.186	30	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150416	10.1371/journal.pone.0150416	http://dx.doi.org/10.1371/journal.pone.0150416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26958849	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300050
J	Reeves, DB; Shi, YP; Weaver, JB				Reeves, Daniel B.; Shi, Yipeng; Weaver, John B.			Generalized Scaling and the Master Variable for Brownian Magnetic Nanoparticle Dynamics	PLOS ONE			English	Article							SPIN-VALVE SENSORS; SUPERPARAMAGNETIC NANOPARTICLES; FLUID HYPERTHERMIA; RELAXATION; BIOSENSOR; SPECTROSCOPY; IMMUNOASSAY; FERROFLUIDS; PARTICLES; CANCER	Understanding the dynamics of magnetic particles can help to advance several biomedical nanotechnologies. Previously, scaling relationships have been used in magnetic spectroscopy of nanoparticle Brownian motion (MSB) to measure biologically relevant properties (e.g., temperature, viscosity, bound state) surrounding nanoparticles in vivo. Those scaling relationships can be generalized with the introduction of a master variable found from non-dimensionalizing the dynamical Langevin equation. The variable encapsulates the dynamical variables of the surroundings and additionally includes the particles' size distribution and moment and the applied field's amplitude and frequency. From an applied perspective, the master variable allows tuning to an optimal MSB biosensing sensitivity range by manipulating both frequency and field amplitude. Calculation of magnetization harmonics in an oscillating applied field is also possible with an approximate closed-form solution in terms of the master variable and a single free parameter.	[Reeves, Daniel B.; Shi, Yipeng; Weaver, John B.] Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA; [Weaver, John B.] Geisel Sch Med, Dept Radiol, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Reeves, DB (corresponding author), Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA.	dbr@dartmouth.edu		Reeves, Daniel/0000-0001-5684-9538	National Cancer Institute [1U54CA151662-01]; NIH-NCI [1U54CA151662-01]; NATIONAL CANCER INSTITUTE [U54CA151662] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute grant number 1U54CA151662-01 was used by the three authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the support of an NIH-NCI Grant: No. 1U54CA151662-01. We also thank an anonymous referee who's comments greatly enhanced the paper.	Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; ATKINSON WJ, 1984, IEEE T BIO-MED ENG, V31, P70, DOI 10.1109/TBME.1984.325372; Bordelon DE, 2011, J APPL PHYS, V109, DOI 10.1063/1.3597820; Calero-DdelC VL, 2011, SOFT MATTER, V7, P4497, DOI 10.1039/c0sm00902d; CHANTRELL RW, 1978, IEEE T MAGN, V14, P975, DOI 10.1109/TMAG.1978.1059918; Chemla YR, 2000, P NATL ACAD SCI USA, V97, P14268, DOI 10.1073/pnas.97.26.14268; Chiriac H, 2007, J MAGN MAGN MATER, V311, P425, DOI 10.1016/j.jmmm.2006.11.207; Chung SH, 2004, APPL PHYS LETT, V85, P2971, DOI 10.1063/1.1801687; Coffey W, 1992, ADV CHEM PHYS, V83, P263, DOI [DOI 10.1002/9780470141410.CH5, 10.1002/9780470141410.ch5/summary]; Coffey W, 1996, WORLD SCI, DOI [10.1142/2256, DOI 10.1142/2256]; DAMADIAN R, 1977, PHYSIOL CHEM PHYS M, V9, P97; Debye PJW, 1929, POLAR MOL; Dieckhoff J, 2014, J APPL PHYS, V115, DOI 10.1063/1.4861032; Dieckhoff JH, 2012, IEEE T MAGN, V48, P3792, DOI 10.1109/TMAG.2012.2198797; Eberbeck Dietmar, 2008, Journal of Nanobiotechnology, V6, P4, DOI 10.1186/1477-3155-6-4; Einstein A, 1956, INVESTIGATIONS THEOR; Ferreira HA, 2003, J APPL PHYS, V93, P7281, DOI 10.1063/1.1544449; Frost E B, 1896, Science, V3, P235, DOI 10.1126/science.3.59.235; Garcia-Palacios JL, 1998, PHYS REV B, V58, P14937, DOI 10.1103/PhysRevB.58.14937; Gardiner C, 1985, HDB STOCHASTIC METHO, V4; Goya GF, 2003, J APPL PHYS, V94, P3520, DOI 10.1063/1.1599959; Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8; Khandhar AP, 2012, J BIOMED MATER RES A, V100A, P728, DOI 10.1002/jbm.a.34011; Kloeden P. E., 1992, APPL MATH NEW YORK, V23, DOI [10.1007/978-3-662-12616-5, DOI 10.1007/978-3-662-12616-5]; Koets M, 2009, BIOSENS BIOELECTRON, V24, P1893, DOI 10.1016/j.bios.2008.09.023; Li GX, 2006, SENSOR ACTUAT A-PHYS, V126, P98, DOI 10.1016/j.sna.2005.10.001; Martens MA, 2013, MED PHYS, V40, DOI 10.1118/1.4773869; Pan J, 2007, ANAL BIOANAL CHEM, V388, P279, DOI 10.1007/s00216-007-1224-0; Perez JM, 2002, NAT BIOTECHNOL, V20, P816, DOI 10.1038/nbt720; Perreard I.M., 2014, INST PHYS ENG MED, V59, P1109, DOI DOI 10.1088/0031-9155/59/5/1109; Raible M, 2004, APPL ORGANOMET CHEM, V18, P536, DOI 10.1002/aoc.757; Rauwerdink AM, 2011, MED PHYS, V38, P1136, DOI [10.1118/1.3549762, 10.1118/1.3613584]; Rauwerdink AM, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3291063; Rauwerdink AM, 2010, J MAGN MAGN MATER, V322, P609, DOI 10.1016/j.jmmm.2009.10.024; Reeves DB, 2015, J APPL PHYS, V117, DOI 10.1063/1.4922858; Reeves DB, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/4/045002; Reeves DB, 2012, J APPL PHYS, V112, DOI 10.1063/1.4770322; Rogge H, 2013, BIOMED ENG-BIOMED TE, V58, P601, DOI 10.1515/bmt-2013-0034; Shah SA, 2014, J APPL PHYS, V116, DOI 10.1063/1.4900605; Usov NA, 2012, J APPL PHYS, V112, DOI 10.1063/1.4737126; Weaver J, 2010, MED PHYS, V37, DOI 10.1118/1.3469126; Weaver JB, 2013, BIOMED ENG-BIOMED TE, V58, P547, DOI 10.1515/bmt-2013-0012; Weaver JB, 2012, MED PHYS, V39, P2765, DOI 10.1118/1.3701775; Weaver JB, 2009, MED PHYS, V36, P1822, DOI 10.1118/1.3106342; Weizenecker J, 2010, MAGNETIC NANOPARTICLES: PARTICLE SCIENCE, IMAGING TECHNOLOGY, AND CLINICAL APPLICATIONS, P3, DOI 10.1142/9789814324687_0001; Yang CC, 2012, IEEE MAGN LETT, V3, DOI 10.1109/LMAG.2012.2183858; Yoo D, 2011, ACCOUNTS CHEM RES, V44, P863, DOI 10.1021/ar200085c; Yoshida T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.127002; Zhang XJ, 2013, BIOSENS BIOELECTRON, V50, P441, DOI 10.1016/j.bios.2013.06.049; Zhang XF, 2015, J INEQUAL APPL, DOI 10.1186/1029-242X-2015-1	50	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150856	10.1371/journal.pone.0150856	http://dx.doi.org/10.1371/journal.pone.0150856			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959493	Green Published, gold			2022-12-27	WOS:000371992300080
J	Chen, XJ; Li, CD; Wang, L; Liu, Y; Li, CY; Zhang, JJ				Chen, Xuejie; Li, Chandan; Wang, Li; Liu, Yi; Li, Chuanyou; Zhang, Junjie			The Mechanism of Mycobacterium smegmatis PafA Self-Pupylation	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEIN; PUP; PROTEASOME; TUBERCULOSIS; PATHWAY; DOP; DEPUPYLASE; RESISTANCE; MPA	PafA, the prokaryotic ubiquitin-like protein (Pup) ligase, catalyzes the Pup modification of bacterial proteins and targets the substrates for proteasomal degradation. It has been reported that that M. smegmatis PafA can be poly-pupylated. In this study, the mechanism of PafA self-pupylation is explored. We found that K320 is the major target residue for the pupylation of PafA. During the self-pupylation of PafA, the attachment of the first Pup to PafA is catalyzed by the other PafA molecule through an intermolecular reaction, while the formation of the polymeric Pup chain is carried out in an intramolecular manner through the internal ligase activity of the already pupylated PafA. Among the three lysine residues, K7, K31 and K61, in M. smegmatis Pup, K7 and K31 are involved in the formation of the poly-Pup chain in PafA poly-pupylation. Poly-pupylation of PafA can be reversibly regulated by depupylase Dop. The polymeric Pup chain formed through K7/K31 linkage is much more sensitive to Dop than the mono-Pup directly attached to PafA. Moreover, self-pupylation of PafA is involved in the regulation of its stability in vivo in a proteasome-dependent manner, suggesting that PafA self-pupylation functions as a mechanism in the auto-regulation of the Pup-proteasome system.	[Chen, Xuejie; Li, Chandan; Wang, Li; Liu, Yi; Zhang, Junjie] Beijing Normal Univ, Inst Cell Biol, Key Lab Cell Proliferat & Regulat Biol, Minist Educ,Coll Life Sci, Beijing 100875, Peoples R China; [Liu, Yi; Li, Chuanyou] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Dept Bacteriol & Immunol, Beijing, Peoples R China	Beijing Normal University; Capital Medical University	Zhang, JJ (corresponding author), Beijing Normal Univ, Inst Cell Biol, Key Lab Cell Proliferat & Regulat Biol, Minist Educ,Coll Life Sci, Beijing 100875, Peoples R China.	jjzhang@bnu.edu.cn		Chen, Xuejie/0000-0001-8459-2557; Zhang, Junjie/0000-0001-8809-1485	National Nature Science Foundation [31170064]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation (No. 31170064). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barandun J, 2013, J AM CHEM SOC, V135, P6794, DOI 10.1021/ja4024012; Barandun J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-95; Burns KE, 2010, MOL CELL, V39, P821, DOI 10.1016/j.molcel.2010.07.019; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Cerda-Maira FA, 2010, MOL MICROBIOL, V77, P1123, DOI 10.1111/j.1365-2958.2010.07276.x; Chen X, 2009, J MOL BIOL, V392, P208, DOI 10.1016/j.jmb.2009.07.018; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; De Smet KAL, 1999, MICROBIOL-UK, V145, P3177, DOI 10.1099/00221287-145-11-3177; Delley CL, 2012, J BIOL CHEM, V287, P7907, DOI 10.1074/jbc.M111.331124; Elharar Y, 2014, EMBO J, V33, P1802, DOI 10.15252/embj.201387076; Festa RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008589; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Gandotra S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001040; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guth E, 2011, J BIOL CHEM, V286, P4412, DOI 10.1074/jbc.M110.189282; Imkamp F, 2010, EMBO REP, V11, P791, DOI 10.1038/embor.2010.119; Imkamp F, 2010, MOL MICROBIOL, V75, P744, DOI 10.1111/j.1365-2958.2009.07013.x; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-45; Kendall Sharon L., 2008, V465, P297, DOI 10.1007/978-1-59745-207-6_20; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Liao SH, 2009, BIOCHEM J, V422, P207, DOI 10.1042/BJ20090738; Nagy V, 2010, BIOL CHEM, V391, P163, DOI 10.1515/bc.2010.021; Ozcelik D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2009; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Pearce MJ, 2006, EMBO J, V25, P5423, DOI 10.1038/sj.emboj.7601405; Poulsen C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.39; Regev O, 2015, FEBS J, V282, P4176, DOI 10.1111/febs.13413; Samanovic Marie I, 2013, Subcell Biochem, V66, P267, DOI 10.1007/978-94-007-5940-4_10; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Striebel F, 2010, EMBO J, V29, P1262, DOI 10.1038/emboj.2010.23; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Sutter M, 2010, J AM CHEM SOC, V132, P5610, DOI 10.1021/ja910546x; Sutter M, 2009, FEBS LETT, V583, P3151, DOI 10.1016/j.febslet.2009.09.020; Wang T, 2010, NAT STRUCT MOL BIOL, V17, P1352, DOI 10.1038/nsmb.1918; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	38	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151021	10.1371/journal.pone.0151021	http://dx.doi.org/10.1371/journal.pone.0151021			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953889	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300075
J	Moon, BY; Park, JY; Robinson, DA; Thomas, JC; Park, YH; Thornton, JA; Seo, KS				Moon, Bo Youn; Park, Joo Youn; Robinson, D. Ashley; Thomas, Jonathan C.; Park, Yong Ho; Thornton, Justin A.; Seo, Keun Seok			Mobilization of Genomic Islands of Staphylococcus aureus by Temperate Bacteriophage	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; PATHOGENICITY ISLANDS; EVOLUTION; VIRULENCE; STRAIN; PATHOGENESIS; POLYMORPHISM; RESISTANCE; TOXIN; PHAGE	The virulence of Staphylococcus aureus, in both human and animal hosts, is largely influenced by the acquisition of mobile genetic elements (MGEs). Most S. aureus strains carry a variety of MGEs, including three genomic islands (vSa alpha, vSa beta, vSa gamma) that are diverse in virulence gene content but conserved within strain lineages. Although the mobilization of pathogenicity islands, phages and plasmids has been well studied, the mobilization of genomic islands is poorly understood. We previously demonstrated the mobilization of vSa beta by the adjacent temperate bacteriophage phi SaBov from strain RF122. In this study, we demonstrate that phi SaBov mediates the mobilization of vSa alpha and vSa gamma, which are located remotely from phi SaBov, mostly to recipient strains belonging to ST151. Phage DNA sequence analysis revealed that chromosomal DNA excision events from RF122 were highly specific to MGEs, suggesting sequence-specific DNA excision and packaging events rather than generalized transduction by a temperate phage. Disruption of the int gene in phi SaBov did not affect phage DNA excision, packaging, and integration events. However, disruption of the terL gene completely abolished phage DNA packing events, suggesting that the primary function of temperate phage in the transfer of genomic islands is to allow for phage DNA packaging by TerL and that transducing phage particles are the actual vehicle for transfer. These results extend our understanding of the important role of bacteriophage in the horizontal transfer and evolution of genomic islands in S. aureus.	[Moon, Bo Youn; Park, Joo Youn; Seo, Keun Seok] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Moon, Bo Youn; Park, Yong Ho] Seoul Natl Univ, Coll Vet Med, Dept Microbiol, Seoul 151742, South Korea; [Moon, Bo Youn; Park, Yong Ho] Seoul Natl Univ, Program Vet Sci BK21, Seoul 151742, South Korea; [Robinson, D. Ashley] Univ Mississippi, Med Ctr, Dept Microbiol & Immunol, Jackson, MS 39216 USA; [Thomas, Jonathan C.] Univ Bolton, Dept Biol, Bolton BL3 5AB, Greater Manches, England; [Thornton, Justin A.] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA	Mississippi State University; Seoul National University (SNU); Seoul National University (SNU); University of Mississippi; University of Mississippi Medical Center; University of Bolton; Mississippi State University	Seo, KS (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	seo@cvm.msstate.edu		Thomas, Jonathan/0000-0002-1599-9123	National Institute of Food and Agriculture, United States Department of Agriculture [2008-35204-04582]; Center for Biomedical Research Excellence in Pathogen-Host interactions, National Institute of General Medical Sciences, NIH [1P20GM103646-01A1]; Animal and Plant Quarantine Agency, South Korea Department of Agriculture; National Institute of General Medical Sciences, NIH [GM080602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080602, P20GM103646] Funding Source: NIH RePORTER	National Institute of Food and Agriculture, United States Department of Agriculture(United States Department of Agriculture (USDA)); Center for Biomedical Research Excellence in Pathogen-Host interactions, National Institute of General Medical Sciences, NIH; Animal and Plant Quarantine Agency, South Korea Department of Agriculture; National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by grants from National Institute of Food and Agriculture, United States Department of Agriculture (2008-35204-04582) to K.S.S.; Center for Biomedical Research Excellence in Pathogen-Host interactions, National Institute of General Medical Sciences, NIH (1P20GM103646-01A1) to K.S.S.; Animal and Plant Quarantine Agency, South Korea Department of Agriculture to K.S.S; National Institute of General Medical Sciences, NIH (GM080602) to D.A.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by grants from National Institute of Food and Agriculture, United States Department of Agriculture (2008-35204-04582) to K.S.S.; Center for Biomedical Research Excellence in Pathogen-Host interactions, National Institute of General Medical Sciences, NIH (1P20GM103646-01A1) to K.S.S.; Animal and Plant Quarantine Agency, South Korea Department of Agriculture to K.S.S; National Institute of General Medical Sciences, NIH (GM080602) to D.A.R.	Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bartual SG, 2010, P NATL ACAD SCI USA, V107, P20287, DOI 10.1073/pnas.1011218107; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Chen J, 2015, MOL CELL, V57, P138, DOI 10.1016/j.molcel.2014.11.011; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Everitt RG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4956; Feng Y, 2008, FEMS MICROBIOL REV, V32, P23, DOI 10.1111/j.1574-6976.2007.00086.x; Fitzgerald JR, 2014, INFECT GENET EVOL, V21, P542, DOI 10.1016/j.meegid.2013.04.020; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Hallin M, 2011, INFECT GENET EVOL, V11, P290, DOI 10.1016/j.meegid.2010.10.021; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Hidron AI, 2009, LANCET INFECT DIS, V9, P384, DOI 10.1016/S1473-3099(09)70133-1; Holmes A, 2014, CLIN MICROBIOL INFEC, V20, pO124, DOI 10.1111/1469-0691.12328; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; Mir-Sanchis I, 2012, MOL MICROBIOL, V85, P833, DOI 10.1111/j.1365-2958.2012.08145.x; Moon BY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09784; MURRAY DL, 1994, J IMMUNOL, V152, P87; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Sheikh HQ, 2015, BRIT J HOSP MED, V76, P18, DOI 10.12968/hmed.2015.76.1.18; Smyth DS, 2009, J BACTERIOL, V191, P5964, DOI 10.1128/JB.00352-09; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Ubeda C, 2008, MOL MICROBIOL, V67, P493, DOI 10.1111/j.1365-2958.2007.06027.x; Winstel V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3345; Xia GQ, 2014, INFECT GENET EVOL, V21, P593, DOI 10.1016/j.meegid.2013.04.022; Xia GQ, 2011, J BACTERIOL, V193, P4006, DOI 10.1128/JB.01412-10; Yin JL, 2001, IMMUNOL CELL BIOL, V79, P213, DOI 10.1046/j.1440-1711.2001.01002.x	31	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151409	10.1371/journal.pone.0151409	http://dx.doi.org/10.1371/journal.pone.0151409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953931	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000371991300099
J	Riches, N; Panagioti, M; Alam, R; Cheraghi-Sohi, S; Campbell, S; Esmail, A; Bower, P				Riches, Nicholas; Panagioti, Maria; Alam, Rahul; Cheraghi-Sohi, Sudeh; Campbell, Stephen; Esmail, Aneez; Bower, Peter			The Effectiveness of Electronic Differential Diagnoses (DDX) Generators: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							DECISION-SUPPORT-SYSTEM; MEDICAL REFERENCE QMR; PERFORMANCE; CONSULTATION; ACCURACY; INTERVENTIONS; SERVICE; DESIGN; ERROR; TRIAL	Background Diagnostic errors are costly and they can contribute to adverse patient outcomes, including avoidable deaths. Differential diagnosis (DDX) generators are electronic tools that may facilitate the diagnostic process. Methods and Findings We conducted a systematic review and meta-analysis to investigate the efficacy and utility of DDX generators. We undertook a comprehensive search of the literature including 16 databases from inception to May 2015 and specialist patient safety databases. We also searched the reference lists of included studies. Article screening, selection and data extraction were independently conducted by 2 reviewers. 36 articles met the eligibility criteria and the pooled accurate diagnosis retrieval rate of DDX tools was high with high heterogeneity (pooled rate = 0.70, 95% CI = 0.63 to 0.77; I-2 = 97%, p<0.0001). DDX generators did not demonstrate improved diagnostic retrieval compared to clinicians but small improvements were seen in the before and after studies where clinicians had the opportunity to revisit their diagnoses following DDX generator consultation. Clinical utility data generally indicated high levels of user satisfaction and significant reductions in time taken to use for newer web-based tools. Lengthy differential lists and their low relevance were areas of concern and have the potential to increase diagnostic uncertainty. Data on the number of investigations ordered and on cost-effectiveness remain inconclusive. Conclusions DDX generators have the potential to improve diagnostic practice among clinicians. However, the high levels of heterogeneity, the variable quality of the reported data and the minimal benefits observed for complex cases suggest caution. Further research needs to be undertaken in routine clinical settings with greater consideration of enablers and barriers which are likely to impact on DDX use before their use in routine clinical practice can be recommended.	[Riches, Nicholas; Alam, Rahul; Cheraghi-Sohi, Sudeh; Campbell, Stephen; Esmail, Aneez; Bower, Peter] Univ Manchester, NIHR Greater Manchester Primary Care Patient Safe, Williamson Bldg, Manchester, Lancs, England; [Panagioti, Maria] Univ Manchester, Ctr Primary Care, NIHR Sch Primary Care Res, Inst Populat Hlth, Manchester, Lancs, England	University of Manchester; University of Manchester	Riches, N (corresponding author), Univ Manchester, NIHR Greater Manchester Primary Care Patient Safe, Williamson Bldg, Manchester, Lancs, England.	nick.riches@nhs.net	Bower, Peter/A-1508-2011; Esmail, Aneez/I-6903-2013	Bower, Peter/0000-0001-9558-3349; Esmail, Aneez/0000-0001-7061-7434; Riches, Nicholas/0000-0002-1729-7635; Panagioti, Maria/0000-0002-7153-5745	NIHR	NIHR(National Institute for Health Research (NIHR))	This publication is independent research by the NIHR Greater Manchester Primary Care Patient Safety Translational Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The study was funded by the NIHR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkon M, 2005, ARCH INTERN MED, V165, P2388, DOI 10.1001/archinte.165.20.2388; Arene I, 1998, M D COMPUT, V15, P323; BACCHUS CM, 1994, J GEN INTERN MED, V9, P616, DOI 10.1007/BF02600304; Balla J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001539; Bankowitz R. A., 1987, Proceedings of the Eleventh Annual Symposium on Computer Applications in Medical Care (Cat. No.87CH2446-3), P68; BANKOWITZ RA, 1989, ANN INTERN MED, V110, P824, DOI 10.7326/0003-4819-110-10-824; Bavdekar SB, 2005, INDIAN PEDIATR, V42, P1086; Berner ES, 1999, J AM MED INFORM ASSN, V6, P420, DOI 10.1136/jamia.1999.0060420; BERNER ES, 1994, NEW ENGL J MED, V330, P1792, DOI 10.1056/NEJM199406233302506; Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; Bond W, 2010, 32 ANN M SOC MED DEC; Bond WF, 2012, J GEN INTERN MED, V27, P213, DOI 10.1007/s11606-011-1804-8; Borenstein M., 2005, COMPREHENSIVE META A; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Carlson J, 2011, SIMUL HEALTHC, V6, P11, DOI 10.1097/SIH.0b013e3181f24acd; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Croskerry P, 2003, ACAD MED, V78, P775, DOI 10.1097/00001888-200308000-00003; Durlak JA, 2009, J PEDIATR PSYCHOL, V34, P917, DOI 10.1093/jpepsy/jsp004; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Kareh R, 2013, BMJ QUAL SAF, V22, pii40, DOI 10.1136/bmjqs-2013-001884; Elkin PL, 2010, INT J MED INFORM, V79, P772, DOI 10.1016/j.ijmedinf.2010.09.004; Elstein AS, 1996, J AM MED INFORM ASSN, V3, P422, DOI 10.1136/jamia.1996.97084515; FELDMAN MJ, 1991, COMPUT METH PROG BIO, V35, P261, DOI 10.1016/0169-2607(91)90004-D; Foot C., 2010, QUALITY GP DIAGNOSIS; Friedman CP, 1999, JAMA-J AM MED ASSOC, V282, P1851, DOI 10.1001/jama.282.19.1851; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; GOZUM ME, 1994, J AM MED INFORM ASSN, P991; Graber MA, 2003, EMERG MED J, V20, P426, DOI 10.1136/emj.20.5.426; Graber ML, 2008, AM J MED, V121, P43, DOI 10.1016/j.amjmed.2008.02.006; Graber ML, 2012, BMJ QUAL SAF, V21, P535, DOI 10.1136/bmjqs-2011-000149; Graber ML, 2009, MED TEACH, V31, P522, DOI 10.1080/01421590802167436; Grober ML, 2008, J GEN INTERN MED, V23, P37, DOI 10.1007/s11606-007-0271-8; Hammersley J. R., 1988, Proceedings. The Twelfth Annual Symposium on Computer Applications in Medical Care (IEEE Cat. No.88CH2616-1), P229; HECKERLING PS, 1991, MED INFORM, V16, P363, DOI 10.3109/14639239109067658; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Kostopoulou O, 2008, MED DECIS MAKING, V28, P668, DOI 10.1177/0272989X08319958; Lange LL, 1997, J NURS EDUC, V36, P36; Lau L M, 1995, Top Health Inf Manage, V15, P67; Lemaire LB, 1999, CAN MED ASSOC J, V161, P725; Li Y C, 1995, Proc Annu Symp Comput Appl Med Care, P805; Liberati A., 2009, J CLIN EPIDEMIOL, V62, pE1, DOI [DOI 10.1016/J.JCLINEPI.2009.06.006, 10.1016/j.jclinepi.2009.06.006]; Lincoln M J, 1991, J Med Syst, V15, P93, DOI 10.1007/BF00993883; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; MILLER RA, 1982, NEW ENGL J MED, V307, P468, DOI 10.1056/NEJM198208193070803; MILLER RA, 1986, WESTERN J MED, V145, P816; Murphy G C, 1996, Proc AMIA Annu Fall Symp, P219; NELSON S J, 1985, Journal of Medical Systems, V9, P379, DOI 10.1007/BF00992575; NEURATH PW, 1969, NEW ENGL J MED, V280, P745, DOI 10.1056/NEJM196904032801403; Panic N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083138; Parodi S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S9-S3; Ramnarayan P, 2003, ARCH DIS CHILD, V88, P408, DOI 10.1136/adc.88.5.408; Ramnarayan Padmanabhan, 2006, BMC Med Inform Decis Mak, V6, P37, DOI 10.1186/1472-6947-6-37; Ramnarayan Padmanabhan, 2006, BMC Med Inform Decis Mak, V6, P22, DOI 10.1186/1472-6947-6-22; Ramnarayan P, 2007, EMERG MED J, V24, P619, DOI 10.1136/emj.2006.044107; Rodriguez-Gonzalez A, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/367345; Schiff GD, 2013, JAMA INTERN MED, V173, P2063, DOI 10.1001/jamainternmed.2013.11070; Sedgwick P, 2013, METAANALYSES STANDAR, V11, P16; WAXMAN HS, 1990, MEDICINE, V69, P125, DOI 10.1097/00005792-199005000-00001; WEXLER JR, 1975, AM J DIS CHILD, V129, P203, DOI 10.1001/archpedi.1975.02120390037008; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wolf FM, 1997, J AM MED INFORM ASSN, P263	62	58	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0148991	10.1371/journal.pone.0148991	http://dx.doi.org/10.1371/journal.pone.0148991			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954234	Green Published, gold, Green Submitted			2022-12-27	WOS:000371991300005
J	Waumans, MC; Bersini, H				Waumans, Michael Charles; Bersini, Hugues			Genealogical Trees of Scientific Papers	PLOS ONE			English	Article							NETWORKS; ADVANTAGE	Many results have been obtained when studying scientific papers citations databases in a network perspective. Articles can be ranked according to their current in-degree and their future popularity or citation counts can even be predicted. The dynamical properties of such networks and the observation of the time evolution of their nodes started more recently. This work adopts an evolutionary perspective and proposes an original algorithm for the construction of genealogical trees of scientific papers on the basis of their citation count evolution in time. The fitness of a paper now amounts to its in-degree growing trend and a "dying" paper will suddenly see this trend declining in time. It will give birth and be taken over by some of its most prevalent citing "offspring". Practically, this might be used to trace the successive published milestones of a research field.	[Waumans, Michael Charles; Bersini, Hugues] ULB, Ecole Polytech Bruxelles, CoDE IRIDIA, 50 Av F Roosevelt,CP 194-6, B-1050 Brussels, Belgium; [Waumans, Michael Charles] ULB, CoDE IRIDIA, 50 Av F Roosevelt,CP 194-6, B-1050 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Waumans, MC (corresponding author), ULB, Ecole Polytech Bruxelles, CoDE IRIDIA, 50 Av F Roosevelt,CP 194-6, B-1050 Brussels, Belgium.; Waumans, MC (corresponding author), ULB, CoDE IRIDIA, 50 Av F Roosevelt,CP 194-6, B-1050 Brussels, Belgium.	mwaumans@ulb.ac.be						Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batista PD, 2006, SCIENTOMETRICS, V68, P179, DOI 10.1007/s11192-006-0090-4; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Eom Y-H, 2011, CHARACTERIZING MODEL, DOI [10.1371/journal.pone.0024926, DOI 10.1371/JOURNAL.PONE.0024926]; Ghosh R, 2011, TIME AWARE RANKING D, P373, DOI [10.1109/ICDMW.2011.183, DOI 10.1109/ICDMW.2011.183]; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Ke Q, 2015, P NATL ACAD SCI USA, V112, P7426, DOI 10.1073/pnas.1424329112; Krapivin M, 2008, FOCUSED PAGE RANK SC, P144, DOI [10.1007/978-3-540-89533-6_15, DOI 10.1007/978-3-540-89533-6_15]; Li XL, 2009, LECT NOTES COMPUT SC, V5463, P288, DOI 10.1007/978-3-642-00887-0_25; Medo M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.238701; Newman MEJ, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/28002; Newman MEJ, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/68001; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Pan RK, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/18007; Penner R, 2002, PROGRAMMING MACROM 3; Pepe A, 2010, STRUCTURE EVOLUTION, DOI [10.2139/ssrn.1616935, DOI 10.2139/SSRN.1616935]; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; PRICE DJD, 1965, SCIENCE, V149, P510; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; Sayyadi H., 2009, P 2009 SIAM INT C DA, DOI [10.1137/1.9781611972795.46, DOI 10.1137/1.9781611972795.46]; Sidiropoulos A, 2007, SCIENTOMETRICS, V72, P253, DOI 10.1007/s11192-007-1722-z; Valverde S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046118; Walker D, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/06/P06010; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yao LY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06663	26	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150588	10.1371/journal.pone.0150588	http://dx.doi.org/10.1371/journal.pone.0150588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954677	Green Submitted, Green Published, gold			2022-12-27	WOS:000371991300033
J	Burall, LS; Grim, CJ; Mammel, MK; Datta, AR				Burall, Laurel S.; Grim, Christopher J.; Mammel, Mark K.; Datta, Atin R.			Whole Genome Sequence Analysis Using JSpecies Tool Establishes Clonal Relationships between Listeria monocytogenes Strains from Epidemiologically Unrelated Listeriosis Outbreaks	PLOS ONE			English	Article							SEROTYPE 4B; PHYLOGENIES; SCHEME	In an effort to build a comprehensive genomic approach to food safety challenges, the FDA has implemented a whole genome sequencing effort, GenomeTrakr, which involves the sequencing and analysis of genomes of foodborne pathogens. As a part of this effort, we routinely sequence whole genomes of Listeria monocytogenes (Lm) isolates associated with human listeriosis outbreaks, as well as those isolated through other sources. To rapidly establish genetic relatedness of these genomes, we evaluated tetranucleotide frequency analysis via the JSpecies program to provide a cursory analysis of strain relatedness. The JSpecies tetranucleotide (tetra) analysis plots standardized (z-score) tetramer word frequencies of two strains against each other and uses linear regression analysis to determine similarity (r(2)). This tool was able to validate the close relationships between outbreak related strains from four different outbreaks. Included in this study was the analysis of Lm strains isolated during the recent caramel apple outbreak and stone fruit incident in 2014. We identified that many of the isolates from these two outbreaks shared a common 4b variant (4bV) serotype, also designated as IVb-v1, using a qPCR protocol developed in our laboratory. The 4bV serotype is characterized by the presence of a 6.3 Kb DNA segment normally found in serotype 1/2a, 3a, 1/2c and 3c strains but not in serotype 4b or 1/2b strains. We decided to compare these strains at a genomic level using the JSpecies Tetra tool. Specifically, we compared several 4bV and 4b isolates and identified a high level of similarity between the stone fruit and apple 4bV strains, but not the 4b strains co-identified in the caramel apple outbreak or other 4b or 4bV strains in our collection. This finding was further substantiated by a SNP-based analysis. Additionally, we were able to identify close relatedness between isolates from clinical cases from 1993-1994 and a single case from 2011 as well as links between two isolates from over 30 years ago. The identification of these potential links shows that JSpecies Tetra analysis can be a useful tool in rapidly assessing genetic relatedness of Lm isolates during outbreak investigations and for comparing historical isolates. Our analyses led to the identification of a highly related clonal group involved in two separate outbreaks, stone fruit and caramel apple, and suggests the possibility of a new genotype that may be better adapted for certain foods and/or environment.	[Burall, Laurel S.; Grim, Christopher J.; Mammel, Mark K.; Datta, Atin R.] US FDA, Ctr Food Safety & Appl Nutr, Laurel, MD USA	US Food & Drug Administration (FDA)	Burall, LS; Datta, AR (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, Laurel, MD USA.	Laurel.Burall@fda.hhs.gov; Atin.Datta@fda.hhs.gov			U.S. Food and Drug Administration; U.S. Department of Energy; FDA	U.S. Food and Drug Administration; U.S. Department of Energy(United States Department of Energy (DOE)); FDA(United States Department of Health & Human Services)	This project was supported in part by an appointment to the Internship/Research Participation Program at the Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U.S. Department of Energy and FDA (http://orise.orau.gov/). This funding supported the appointment of CJG. ORISE had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other funding came from the U.S. Food and Drug Administration.	Briers Y, 2011, J BACTERIOL, V193, P4284, DOI 10.1128/JB.05328-11; Burall LS, 2011, J FOOD PROTECT, V74, P403, DOI 10.4315/0362-028X.JFP-10-355; CDC, 2015, MULT OUTBR LIST LINK; CDC, 2014, MULT OUTBR LIST LINK; CDC, 1908, MAX POT REAL TIM WHO; CDC, 2015, MMWR-MORBID MORTAL W, V64, P282; Chen Y, 2011, J BACTERIOL, V193, P3424, DOI 10.1128/JB.05048-11; Cosgrove Shaun, 2011, Morbidity and Mortality Weekly Report, V60, P1357; den Bakker HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067511; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; FDA, 2015, GEN TRAKR NETW 2015; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gardner SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081760; Hain T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-144; Hoffmann M, 2016, J INFECT DIS, V213, P502, DOI 10.1093/infdis/jiv297; Huang BX, 2011, J CLIN MICROBIOL, V49, P426, DOI 10.1128/JCM.01207-10; Jackson BR, 2015, MMWR-MORBID MORTAL W, V64, P282; Laksanalamai P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089024; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032896; Leclercq A, 2011, INT J FOOD MICROBIOL, V147, P74, DOI 10.1016/j.ijfoodmicro.2011.03.010; Lee S, 2012, APPL ENVIRON MICROB, V78, P660, DOI 10.1128/AEM.06378-11; LINNAN MJ, 1988, NEW ENGL J MED, V319, P823, DOI 10.1056/NEJM198809293191303; Lyytikainen O, 2000, J INFECT DIS, V181, P1838, DOI 10.1086/315453; Mohammed M, 2016, EPIDEMIOL INFECT, V144, P576, DOI 10.1017/S0950268815001636; Nei M., 2000, MOL EVOLUTION PHYLOG; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; Pettengill JB, 2014, PEERJ, V2, DOI 10.7717/peerj.620; Pightling Arthur W, 2015, BMC Res Notes, V8, P748, DOI 10.1186/s13104-015-1689-4; Pightling AW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104579; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Ruppitsch W, 2015, J CLIN MICROBIOL, V53, P2869, DOI 10.1128/JCM.01193-15; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmid D, 2014, CLIN MICROBIOL INFEC, V20, P431, DOI 10.1111/1469-0691.12638; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]	35	34	35	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150797	10.1371/journal.pone.0150797	http://dx.doi.org/10.1371/journal.pone.0150797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950338	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100063
J	Worrell, CM; Wiegand, RE; Davis, SM; Odero, KO; Blackstock, A; Cuellar, VM; Njenga, SM; Montgomery, JM; Roy, SL; Fox, LM				Worrell, Caitlin M.; Wiegand, Ryan E.; Davis, Stephanie M.; Odero, Kennedy O.; Blackstock, Anna; Cuellar, Victoria M.; Njenga, Sammy M.; Montgomery, Joel M.; Roy, Sharon L.; Fox, LeAnne M.			A Cross-Sectional Study of Water, Sanitation, and Hygiene-Related Risk Factors for Soil-Transmitted Helminth Infection in Urban School- and Preschool-Aged Children in Kibera, Nairobi	PLOS ONE			English	Article							DRINKING-WATER; HEALTH; SLUM; PREVALENCE; HOOKWORM; DIARRHEA; CONTAMINATION; EPIDEMIOLOGY; REINFECTION; COINFECTION	Soil-transmitted helminth (STH) infections affect persons living in areas with poor water, sanitation, and hygiene (WASH). Preschool-aged children (PSAC) and school-aged children (SAC) are disproportionately affected by STH infections. We aimed to identify WASH factors associated with STH infection among PSAC and SAC in Kibera, Kenya. In 2012, households containing a PSAC or SAC were randomly selected from those enrolled in the International Emerging Infections Program, a population-based surveillance system. We administered a household questionnaire, conducted environmental assessments for WASH, and tested three stools from each child for STH eggs using the Kato-Katz method. WASH factors were evaluated for associations with STH infection using univariable and multivariable Poisson regression. Any-STH prevalence was 40.8% among 201 PSAC and 40.0% among 475 SAC enrolled. Using the Joint Monitoring Programme water and sanitation classifications, 1.5% of households reported piped water on premises versus 98.5% another improved water source; 1.3% reported improved sanitation facilities, while 81.7% used shared sanitation facilities, 13.9% had unimproved facilities, and 3.1% reported no facilities (open defecation). On univariable analysis, STH infection was significantly associated with a household toilet located off-premises (prevalence ratio (PR) = 1.33; p = 0.047), while always treating water (PR = 0.81; p = 0.04), covering drinking water containers (PR = 0.75; p = 0.02), using clean towels during hand drying (PR = 0.58; p < 0.01), having finished household floor material (PR = 0.76; p < 0.01), having electricity (PR = 0.70; p < 0.01), and increasing household elevation in 10-meter increments (PR = 0.89; p < 0.01) were protective against STH infection. On multivariable analysis, usually versus always treating water was associated with increased STH prevalence (adjusted prevalence ratio (aPR) = 1.52; p < 0.01), while having finished household floor material (aPR = 0.76; p = 0.03), reported child deworming in the last year (aPR = 0.76; p < 0.01), and 10-meter household elevation increases (aPR = 0.89; p < 0.01) were protective against infection. The intersection between WASH and STH infection is complex; site-specific WASH interventions should be considered to sustain the gains made by deworming activities.	[Worrell, Caitlin M.; Wiegand, Ryan E.; Davis, Stephanie M.; Fox, LeAnne M.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA; [Odero, Kennedy O.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Nairobi, Kenya; [Blackstock, Anna; Cuellar, Victoria M.; Roy, Sharon L.] Ctr Dis Control & Prevent, Waterborne Dis Prevent Branch, Atlanta, GA USA; [Njenga, Sammy M.] Kenya Govt Med Res Ctr, Eastern & Southern Africa Ctr Int Parasite Contro, Nairobi, Kenya; [Montgomery, Joel M.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Nairobi, Kenya	Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute	Worrell, CM (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA.	cworrell@cdc.gov		Wiegand, Ryan/0000-0002-9486-1850; Njenga, Sammy/0000-0001-6309-476X; Worrell, Caitlin/0000-0003-0229-6565	U.S. Agency for International Development (USAID); Centers for Disease Control and Prevention [OG11-12021]	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for this study was obtained from the U.S. Agency for International Development (USAID) though an inter-agency agreement with the Centers for Disease Control and Prevention (No. OG11-12021). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akullian A, 2015, ENV TRANSMISSION TYP; Albonico M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000126; [Anonymous], 2010, INS IND WOM EXP SLUM; Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Balen J, 2011, INT J PARASITOL, V41, P1165, DOI 10.1016/j.ijpara.2011.07.006; Basualdo Juan A., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P251, DOI 10.1590/S0036-46652007000400011; Breiman RF, 2011, J HEALTH POPUL NUTR, V29, P123; Brocklehurst C, 2005, ROGUES NO MORE WATER; Brooker S, 1999, T ROY SOC TROP MED H, V93, P240, DOI 10.1016/S0035-9203(99)90007-X; Centers for Disease Control and Prevention, 2013, SHOW ME SCI WHY WASH; Chammartin F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-152; Clasen T, 2007, BMJ-BRIT MED J, V334, P782, DOI 10.1136/bmj.39118.489931.BE; Clemens J, 1996, PEDIATR INFECT DIS J, V15, P1113, DOI 10.1097/00006454-199612000-00012; COATES D, 1987, EPIDEMIOL INFECT, V99, P265, DOI 10.1017/S095026880006773X; Crompton DWT, 2002, ANNU REV NUTR, V22, P35, DOI 10.1146/annurev.nutr.22.120501.134539; Crow B, 2010, WATER INT, V35, P733, DOI 10.1080/02508060.2010.533344; Davis SM, 2014, AM J TROP MED HYG, V91, P1002, DOI 10.4269/ajtmh.14-0060; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Fink G, 2014, DEMOGRAPHY, V51, P1175, DOI 10.1007/s13524-014-0302-0; FORRESTER JE, 1990, T ROY SOC TROP MED H, V84, P272, DOI 10.1016/0035-9203(90)90284-L; Freeman MC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002439; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Furst T, 2012, LANCET INFECT DIS, V12, P210, DOI 10.1016/S1473-3099(11)70294-8; GRYSEELS B, 1985, TROP GEOGR MED, V37, P129; Hall A, 1998, WORLD HLTH ORG; Halpenny CM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002070; HAN AM, 1989, TROP GEOGR MED, V41, P138; Harris JR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003590; Heinss U., 1998, SOLIDS SEPARATION PO; HENDRICKSON AE, 1964, BRIT J STATIST PSYCH, V17, P65, DOI 10.1111/j.2044-8317.1964.tb00244.x; Huang CR, 2012, MAYO CLIN PROC, V87, P791, DOI 10.1016/j.mayocp.2012.02.019; Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621; Jonnalagadda Padmaja R., 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P789; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; KHAIRY AEM, 1982, J HYG-CAMBRIDGE, V88, P57, DOI 10.1017/S0022172400069898; Kunii O, 2002, PUBLIC HEALTH, V116, P68, DOI [10.1016/S0033-3506(02)00506-1, 10.1038/sj.ph.1900828]; Luby SP, 2007, TROP MED INT HEALTH, V12, P765, DOI 10.1111/j.1365-3156.2007.01847.x; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Magalhaes RJS, 2011, P NATL ACAD SCI USA, V108, P20084, DOI 10.1073/pnas.1106784108; MAHALANABIS D, 1976, AM J CLIN NUTR, V29, P1372, DOI 10.1093/ajcn/29.12.1372; Matheron G., 1963, ECON GEOL, V58, P1246, DOI DOI 10.2113/GSECONGEO.58.8.1246; MINTZ ED, 1995, JAMA-J AM MED ASSOC, V273, P948, DOI 10.1001/jama.273.12.948; Moore SR, 2001, INT J EPIDEMIOL, V30, P1457, DOI 10.1093/ije/30.6.1457; Morel, 2005, UNDERSTANDING SMALL; Mumtaz Shadma, 2009, JPMA Journal of the Pakistan Medical Association, V59, P216; Palit A, 2012, WATER SCI TECHNOL, V66, P299, DOI 10.2166/wst.2012.177; Patrick DR, 1997, EPIDEMIOL INFECT, V119, P319, DOI 10.1017/S0950268897008261; Person B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074370; Pullan RL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000713; Pullan RL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000352; ROBERTSON LJ, 1992, T ROY SOC TROP MED H, V86, P654, DOI 10.1016/0035-9203(92)90176-D; SPRUNT K, 1973, PEDIATRICS, V52, P264; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491; Stoltzfus RJ, 1997, J NUTR, V127, P1099, DOI 10.1093/jn/127.6.1099; Stoltzfus RJ, 2001, BRIT MED J, V323, P1389, DOI 10.1136/bmj.323.7326.1389; Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620; Suchdev PS, 2014, AM J TROP MED HYG, V90, P299, DOI 10.4269/ajtmh.13-0560; Taylor JH, 2000, J APPL MICROBIOL, V89, P910, DOI 10.1046/j.1365-2672.2000.01122.x; Todd ECD, 2010, J FOOD PROTECT, V73, P1937, DOI 10.4315/0362-028X-73.10.1937; Tumwebaze IK, 2013, INT J ENVIRON HEAL R, V23, P191, DOI 10.1080/09603123.2012.713095; *UN DEV PROGR, 2006, HUM DEV REP 2006 SCA; United Nations Human Settlement Program, 2003, GLOBAL REPORT HUMAN; United Nations Human Settlements Programme, 2006, STAT WORLDS CIT 2006; Walson JL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000644; Watkins WE, 1997, PSYCHOL BULL, V121, P171, DOI 10.1037/0033-2909.121.2.171; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; WHO, 2012, EL SOIL TRANSM HELM; WHO/UNICEF, 2006, COR QUEST DRINK WAT; World Health Organization and United Nations Children's Fund Joint Monitoring Programme for Water Supply and Sanitation (JMP), 2008, PROGR DRINK WAT SAN; Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162	74	36	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150744	10.1371/journal.pone.0150744	http://dx.doi.org/10.1371/journal.pone.0150744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950552	Green Published, gold, Green Submitted			2022-12-27	WOS:000371990100056
J	Zhang, W; Hartmann, R; Tun, HM; Elson, CO; Khafipour, E; Garvey, WT				Zhang, Wei; Hartmann, Riley; Tun, Hein Min; Elson, Charles O.; Khafipour, Ehsan; Garvey, W. Timothy			Deletion of the Toll-Like Receptor 5 Gene Per Se Does Not Determine the Gut Microbiome Profile That Induces Metabolic Syndrome: Environment Trumps Genotype	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; INNATE IMMUNITY; OBESITY; MICE; COMMUNITIES; DIET; SEQUENCE; SHAPES	Over the past decade, emerging evidence has linked alterations in the gut microbial composition to a wide range of diseases including obesity, type 2 diabetes, and cardiovascular disease. Toll-like receptors (TLRs) are the major mediators for the interactions between gut microbiota and host innate immune system, which is involved in the localization and structuring of host gut microbiota. A previous study found that TLR5 deficient mice (TLR5KO1) had altered gut microbial composition which led to the development of metabolic syndrome including hyperlipidemia, hypertension, insulin resistance and increased adiposity. In the current study, a second TLR5-deficient mouse model was studied (TLR5KO2). TLR5 deficient mice did not manifest metabolic abnormalities related to the metabolic syndrome compared with littermate controls maintained on normal chow or after feeding a high fat diet. Analysis of the gut microbial composition of littermate TLR5KO2 and wild type mice revealed no significant difference in the overall microbiota structure between genotypes. However, the TLR5KO2 microbiota was distinctly different from that previously reported for TLR5KO1 mice with metabolic syndrome. We conclude that an altered composition of the microbiota in a given environment can result in metabolic syndrome, but it is not a consequence of TLR5 deficiency per se.	[Zhang, Wei; Garvey, W. Timothy] Univ Alabama Birmingham, Dept Nutr Sci, Sch Hlth Profess, Birmingham, AL 35294 USA; [Hartmann, Riley; Khafipour, Ehsan] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Tun, Hein Min; Khafipour, Ehsan] Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada; [Elson, Charles O.] Univ Alabama Birmingham, Sch Med, Div Gastroenterol & Hepatol, Birmingham, AL USA; [Garvey, W. Timothy] Birmingham VA Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Manitoba; University of Manitoba; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Garvey, WT (corresponding author), Univ Alabama Birmingham, Dept Nutr Sci, Sch Hlth Profess, Birmingham, AL 35294 USA.; Khafipour, E (corresponding author), Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.; Khafipour, E (corresponding author), Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada.; Garvey, WT (corresponding author), Birmingham VA Med Ctr, Birmingham, AL USA.	Ehsan.Khafipour@umanitoba.ca; garveyt@uab.edu	Khafipour, Ehsan/W-9803-2019; Tun, Hein/ACR-0815-2022; Tun, Hein Min/F-4150-2011	Khafipour, Ehsan/0000-0003-4673-7633; Tun, Hein/0000-0001-7597-5062; Tun, Hein Min/0000-0001-7597-5062	UAB Diabetes Research Center (NIDDK) [P60 DK-079626]; National Institutes of Health [RO1 DK083562, R01 DK-38765]; Merit Review Research Grant from the Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083562, P30DK079626, P60DK079626, R01DK038765] Funding Source: NIH RePORTER	UAB Diabetes Research Center (NIDDK); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review Research Grant from the Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge support from UAB Diabetes Research Center (NIDDK, P60 DK-079626), individual research grants from the National Institutes of Health (RO1 DK083562; R01 DK-38765), and a Merit Review Research Grant from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PERMUTATION ANOVA FO; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Carvalho FA, 2012, ANNU REV PHYSIOL, V74, P177, DOI 10.1146/annurev-physiol-020911-153330; Chao A, 1984, SCANDINAVIAN J STAT, V11, P6; Clarke KR, 2006, PRIMER V6 USER MANUA; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; FURNSINN C, 1995, INT J OBESITY, V19, P458; Cano PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041079; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hugon P, 2013, STAND GENOMIC SCI, V7, P427, DOI 10.4056/sigs.3336746; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kitano Y, 2012, J NUTR SCI VITAMINOL, V58, P14, DOI 10.3177/jnsv.58.14; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Loudon AH, 2014, ISME J, V8, P830, DOI 10.1038/ismej.2013.200; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Ordovas JM, 2006, CURR OPIN LIPIDOL, V17, P157, DOI 10.1097/01.mol.0000217897.75068.ba; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Roager HM, 2014, APPL ENVIRON MICROB, V80, P1142, DOI 10.1128/AEM.03549-13; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Sommer F, NATURE REV, V11, P227; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhao Y, 2013, J PROTEOME RES, V12, P2987, DOI 10.1021/pr400263n	47	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150943	10.1371/journal.pone.0150943	http://dx.doi.org/10.1371/journal.pone.0150943			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950299	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100072
J	Wilson, LF; Mishra, GD				Wilson, Louise F.; Mishra, Gita D.			Age at Menarche, Level of Education, Parity and the Risk of Hysterectomy: A Systematic Review and Meta-Analyses of Population-Based Observational Studies	PLOS ONE			English	Review							SOCIOECONOMIC POSITION; UNITED-STATES; WOMENS HEALTH; PREVALENCE; EPIDEMIOLOGY; MENOPAUSE; ENDOMETRIOSIS; DETERMINANTS; COMMUNITY; DISEASE	Background Although rates have declined, hysterectomy is still a frequent gynaecological procedure. To date, there has been no systematic quantification of the relationships between early/mid-life exposures and hysterectomy. We performed a systematic review and meta-analyses to quantify the associations between age at menarche, education level, parity and hysterectomy. Methods Eligible studies were identified by searches in PubMed and Embase through March 2015. Study-specific estimates were summarised using random effects meta-analysis. Heterogeneity was explored using sub-group analysis and meta-regression. Results Thirty-two study populations were identified for inclusion in at least one meta-analysis. Each year older at menarche was associated with lower risk of hysterectomy-summary hazard ratio 0.86 (95% confidence interval: 0.78, 0.95; I-2 = 0%); summary odds ratio 0.88 (95% confidence interval: 0.82, 0.94; I-2 = 61%). Low education levels conferred a higher risk of hysterectomy in the lowest versus highest level meta-analysis (summary hazard ratio 1.87 (95% confidence interval: 1.25, 2.80; I-2 = 86%), summary odds ratio 1.51 (95% confidence interval: 1.35, 1.69; I-2 = 90%)) and dose-response meta-analysis (summary odds ratio 1.17 (95% confidence interval: 1.12, 1.23; I-2 = 85%) per each level lower of education). Sub-group analysis showed that the birth cohort category of study participants, the reference category used for level of education, the year the included article was published, quality of the study (as assessed by the authors) and control for the key variables accounted for the high heterogeneity between studies in the education level meta-analyses. In the meta-analyses of studies of parity and hysterectomy the results were not statistically significant. Conclusions The present meta-analyses suggest that the early life factors of age at menarche and lower education level are associated with hysterectomy, although this evidence should be interpreted with some caution due to variance across the included studies.	[Wilson, Louise F.; Mishra, Gita D.] Univ Queensland, Ctr Longitudinal & Life Course Res, Sch Publ Hlth, Publ Hlth Bldg,Herston Rd, Brisbane, Qld 4006, Australia	University of Queensland	Wilson, LF (corresponding author), Univ Queensland, Ctr Longitudinal & Life Course Res, Sch Publ Hlth, Publ Hlth Bldg,Herston Rd, Brisbane, Qld 4006, Australia.	l.wilson8@uq.edu.au	Wilson, Louise F/P-7250-2014	Wilson, Louise F/0000-0001-8709-8968	Australian Government Department of Health; Australian Research Council [FT120100812]	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); Australian Research Council(Australian Research Council)	The Australian Longitudinal Study on Women's Health was conceived and developed at the Universities of Newcastle and Queensland and is funded by the Australian Government Department of Health. G. D. M. was supported by an Australian Research Council Future Fellowship (FT120100812). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2006, NAT HLTH SURV SUMM R; Bates LM, 2013, WOMEN HLTH, P671; Bower JK, 2009, AM J PUBLIC HEALTH, V99, P300, DOI 10.2105/AJPH.2008.133702; Brett KM, 1997, J WOMENS HEALTH, V6, P309, DOI 10.1089/jwh.1997.6.309; Brett KM, 2003, AM J PUBLIC HEALTH, V93, P307, DOI 10.2105/AJPH.93.2.307; Canoy D, 2015, CIRCULATION, V131, P237, DOI 10.1161/CIRCULATIONAHA.114.010070; Ceausu I, 2006, MATURITAS, V53, P201, DOI 10.1016/j.maturitas.2005.04.005; Charalampopoulos D, 2014, AM J EPIDEMIOL, V180, P29, DOI 10.1093/aje/kwu113; Cooper R, 2008, J EPIDEMIOL COMMUN H, V62, P1057, DOI 10.1136/jech.2007.071001; Cooper R, 2006, J EPIDEMIOL COMMUN H, V60, P993, DOI 10.1136/jech.2005.043182; Cooper R, 2005, BJOG-INT J OBSTET GY, V112, P1126, DOI 10.1111/j.1471-0528.2005.00654.x; Cooper R, 2009, J AFFECT DISORDERS, V115, P122, DOI 10.1016/j.jad.2008.08.017; Cooper R, 2008, MATURITAS, V61, P317, DOI 10.1016/j.maturitas.2008.09.025; Cramer DW, 2002, ANN NY ACAD SCI, V955, P11, DOI 10.1111/j.1749-6632.2002.tb02761.x; De Aloysio D, 2000, MATURITAS, V36, P19; DENNERSTEIN L, 1994, MED J AUSTRALIA, V161, P311, DOI 10.5694/j.1326-5377.1994.tb127452.x; Dharmalingam A, 2000, AM J PUBLIC HEALTH, V90, P1455, DOI 10.2105/AJPH.90.9.1455; Edwards DRV, 2013, AM J EPIDEMIOL, V178, P426, DOI 10.1093/aje/kws585; Erekson EA, 2009, J REPROD MED, V54, P553; Fitzgerald DM, 2009, MENOPAUSE, V16, P279, DOI 10.1097/gme.0b013e3181865373; Garry R, 2005, BJOG-INT J OBSTET GY, V112, P133, DOI 10.1111/j.1471-0528.2004.00431.x; Groot Wavd B, 2006, WHAT DOES ED DO OUR; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Harlow BL, 1999, AM J EPIDEMIOL, V150, P843; Harris MF, 2004, AUST J PRIM HEALTH, V10, P151, DOI DOI 10.1071/PY04060; Hautaniemi SI, 2003, AM J HUM BIOL, V15, P38, DOI 10.1002/ajhb.10110; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kavanagh A, 2010, SOC SCI MED, V71, P1150, DOI 10.1016/j.socscimed.2010.05.038; KJERULFF K, 1993, AM J PUBLIC HEALTH, V83, P106, DOI 10.2105/AJPH.83.1.106; KOEPSELL TD, 1980, AM J PUBLIC HEALTH, V70, P40, DOI 10.2105/AJPH.70.1.40; Kuh DL, 1997, BRIT J OBSTET GYNAEC, V104, P923, DOI 10.1111/j.1471-0528.1997.tb14352.x; Laughlin SK, 2010, SEMIN REPROD MED, V28, P203, DOI 10.1055/s-0030-1251477; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MACLENNAN AH, 1993, MED J AUSTRALIA, V158, P807, DOI 10.5694/j.1326-5377.1993.tb137666.x; Marks NF, 1997, AM J PUBLIC HEALTH, V87, P1507, DOI 10.2105/AJPH.87.9.1507; MEILAHN EN, 1989, MATURITAS, V11, P319, DOI 10.1016/0378-5122(89)90028-5; Merrill RM, 2008, MED SCI MONITOR, V14, pCR24; Michelsen TM, 2013, GYNECOL OBSTET INVES, V75, P61, DOI 10.1159/000345072; Missmer SA, 2004, OBSTET GYNECOL, V104, P965, DOI 10.1097/01.AOG.0000142714.54857.f8; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mueller NT, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-22; Nagata C, 2001, EUR J CLIN NUTR, V55, P773, DOI 10.1038/sj.ejcn.1601223; Nnoaham KE, 2012, FERTIL STERIL, V98, P702, DOI 10.1016/j.fertnstert.2012.05.035; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Palmer JR, 1999, AM J EPIDEMIOL, V150, P1309; Parker WH, 2009, OBSTET GYNECOL, V113, P1027, DOI 10.1097/AOG.0b013e3181a11c64; Powell LH, 2005, WOMEN HEALTH ISS, V15, P179, DOI 10.1016/j.whi.2005.05.002; Qi LH, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.027; Redburn JC, 2001, BRIT J OBSTET GYNAEC, V108, P388; Rositch AF, 2014, CANCER-AM CANCER SOC, V120, P2032, DOI 10.1002/cncr.28548; SANTOW G, 1992, SOC SCI MED, V34, P929, DOI 10.1016/0277-9536(92)90261-N; SANTOW G, 1995, AUST NZ J OBSTET GYN, V35, P60, DOI 10.1111/j.1479-828X.1995.tb01833.x; Schoenaker DAJM, 2014, INT J EPIDEMIOL, V43, P1542, DOI 10.1093/ije/dyu094; SCHOFIELD MJ, 1991, AUST NZ J OBSTET GYN, V31, P153, DOI 10.1111/j.1479-828X.1991.tb01806.x; Settnes A, 1996, ACTA OBSTET GYN SCAN, V75, P274, DOI 10.3109/00016349609047101; Settnes A, 1997, INT J EPIDEMIOL, V26, P364, DOI 10.1093/ije/26.2.364; Sievert LL, 2013, MATURITAS, V76, P334, DOI 10.1016/j.maturitas.2013.08.007; Stang A, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-10; Stockl D, 2012, DIABETOLOGIA, V55, P681, DOI 10.1007/s00125-011-2410-3; UDRY JR, 1982, DEMOGRAPHY, V19, P53, DOI 10.2307/2061128; Yeh JS, 2013, INT J CARDIOL, V168, P2616, DOI 10.1016/j.ijcard.2013.03.042	62	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151398	10.1371/journal.pone.0151398	http://dx.doi.org/10.1371/journal.pone.0151398			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TL	26963512	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000145
J	Boland, JE; Queen, R				Boland, Julie E.; Queen, Robin			If You're House Is Still Available, Send Me an Email: Personality Influences Reactions to Written Errors in Email Messages	PLOS ONE			English	Article							EYE-MOVEMENTS; LANGUAGE USE; SENTENCE; COMPREHENSION; INFORMATION; INTEGRATION; PERCEPTION; ACTIVATION	The increasing prevalence of social media means that we often encounter written language characterized by both stylistic variation and outright errors. How does the personality of the reader modulate reactions to non-standard text? Experimental participants read 'email responses' to an ad for a housemate that either contained no errors or had been altered to include either typos (e.g., teh) or homophonous grammar errors (grammos, e.g., to/too, it's/its). Participants completed a 10-item evaluation scale for each message, which measured their impressions of the writer. In addition participants completed a Big Five personality assessment and answered demographic and language attitude questions. Both typos and grammos had a negative impact on the evaluation scale. This negative impact was not modulated by age, education, electronic communication frequency, or pleasure reading time. In contrast, personality traits did modulate assessments, and did so in distinct ways for grammos and typos.	[Boland, Julie E.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Queen, Robin] Univ Michigan, Dept Linguist, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Boland, JE (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI USA.	jeboland@umich.edu		Boland, Julie/0000-0002-3343-496X				Altmann GTM, 2007, J MEM LANG, V57, P502, DOI 10.1016/j.jml.2006.12.004; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baron N., 2008, ALWAYS LANGUAGE ONLI; Buffardi LE, 2008, PERS SOC PSYCHOL B, V34, P1303, DOI 10.1177/0146167208320061; Chen LL, 2008, MEM COGNITION, V36, P1306, DOI 10.3758/MC.36.7.1306; Clifton C, 2001, ANNU REV PSYCHOL, V52, P167, DOI 10.1146/annurev.psych.52.1.167; Creel SC, 2011, J MEM LANG, V65, P264, DOI 10.1016/j.jml.2011.06.005; Crystal David., 2001, LANGUAGE INTERNET; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; FERREIRA F, 1986, J MEM LANG, V25, P348, DOI 10.1016/0749-596X(86)90006-9; FRAZIER L, 1982, COGNITIVE PSYCHOL, V14, P178, DOI 10.1016/0010-0285(82)90008-1; FRAZIER L, 1987, ATTENTION PERFORM, P559; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Ghose A, 2011, IEEE T KNOWL DATA EN, V23, P1498, DOI 10.1109/TKDE.2010.188; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; Hansen J, 2008, J EXP SOC PSYCHOL, V44, P687, DOI 10.1016/j.jesp.2007.04.005; Hanulikova A, 2012, J COGNITIVE NEUROSCI, V24, P878, DOI 10.1162/jocn_a_00103; Herring Susan C., 1996, COMPUTER MEDIATED CO; Hucks RJ, 2015, THESIS U MICHIGAN; John O, 1991, BIG 5 INVENTORY VERS; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; Kamide Y, 2008, LANG LINGUIST COMPAS, V2, DOI 10.1111/j.1749-818x.2008.00072.x; Kreiner DS, 2002, J GEN PSYCHOL, V129, P5, DOI 10.1080/00221300209602029; Laserna CM, 2014, J LANG SOC PSYCHOL, V33, P328, DOI 10.1177/0261927X14526993; Lev-Ari S, 2010, J EXP SOC PSYCHOL, V46, P1093, DOI 10.1016/j.jesp.2010.05.025; Li S, 2014, SOC COGN AFFECT NEUR, V9, P1166, DOI 10.1093/scan/nst091; Lippi-Green R., 2011, ENGLISH ACCENT; Mehl MR, 2006, J PERS SOC PSYCHOL, V90, P862, DOI 10.1037/0022-3514.90.5.862; Mitchell Don C., 1994, HDB PSYCHOLINGUISTIC, P375; Moore K, 2012, COMPUT HUM BEHAV, V28, P267, DOI 10.1016/j.chb.2011.09.009; Nadkarni A, 2012, PERS INDIV DIFFER, V52, P243, DOI 10.1016/j.paid.2011.11.007; Niedzielski N, 1999, J LANG SOC PSYCHOL, V18, P62, DOI 10.1177/0261927X99018001005; Park G, 2015, J PERS SOC PSYCHOL, V108, P934, DOI 10.1037/pspp0000020; Pennebaker JW, 2003, ANNU REV PSYCHOL, V54, P547, DOI 10.1146/annurev.psych.54.101601.145041; Pennebaker JW, 1999, J PERS SOC PSYCHOL, V77, P1296, DOI 10.1037/0022-3514.77.6.1296; Pickering MJ, 2013, BEHAV BRAIN SCI, V36, P329, DOI 10.1017/S0140525X12001495; Queen R, 2015, LINGUISTICS VANGUARD; Ross C, 2009, COMPUT HUM BEHAV, V25, P578, DOI 10.1016/j.chb.2008.12.024; Sereno SC, 2003, PSYCHOL SCI, V14, P328, DOI 10.1111/1467-9280.14471; Song HJ, 2008, PSYCHOL SCI, V19, P986, DOI 10.1111/j.1467-9280.2008.02189.x; Squires L, 2010, LANG SOC, V39, P457, DOI 10.1017/S0047404510000412; Stefanone MA, 2011, CYBERPSYCH BEH SOC N, V14, P41, DOI 10.1089/cyber.2010.0049; Stiff C, 2012, J INTERNET COMMER, V11, P41, DOI 10.1080/15332861.2012.650988; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Thurlow C, 2003, J LANG SOC PSYCHOL, V22, P94, DOI 10.1177/0261927X02250060; Van Berkum JJA, 2008, J COGNITIVE NEUROSCI, V20, P580, DOI 10.1162/jocn.2008.20054; van den Brink D, 2012, SOC COGN AFFECT NEUR, V7, P173, DOI 10.1093/scan/nsq094; Vignovic JA, 2010, J APPL PSYCHOL, V95, P265, DOI 10.1037/a0018628; Wilson K, 2010, CYBERPSYCH BEH SOC N, V13, P173, DOI 10.1089/cyber.2009.0094; Yarkoni T, 2010, J RES PERS, V44, P363, DOI 10.1016/j.jrp.2010.04.001	50	21	21	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149885	10.1371/journal.pone.0149885	http://dx.doi.org/10.1371/journal.pone.0149885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TF	26959823	Green Published, gold, Green Submitted			2022-12-27	WOS:000371992300028
J	Gonzalez-Pena, D; Nixon, SE; O'Connor, JC; Southey, BR; Lawson, MA; McCusker, RH; Borras, T; Machuca, D; Hernandez, AG; Dantzer, R; Kelley, KW; Rodriguez-Zas, SL				Gonzalez-Pena, Dianelys; Nixon, Scott E.; O'Connor, Jason C.; Southey, Bruce R.; Lawson, Marcus A.; McCusker, Robert H.; Borras, Tania; Machuca, Debbie; Hernandez, Alvaro G.; Dantzer, Robert; Kelley, Keith W.; Rodriguez-Zas, Sandra L.			Microglia Transcriptome Changes in a Model of Depressive Behavior after Immune Challenge	PLOS ONE			English	Article							BACILLE CALMETTE-GUERIN; GUILLAIN-BARRE-SYNDROME; NITRIC-OXIDE SYNTHASE; GENE-EXPRESSION; ACTIVATED MICROGLIA; INDOLEAMINE 2,3-DIOXYGENASE; ARGININE METABOLISM; MAJOR DEPRESSION; CYTOKINE LEVELS; MYELOID CELLS	Depression symptoms following immune response to a challenge have been reported after the recovery from sickness. A RNA-Seq study of the dysregulation of the microglia transcriptome in a model of inflammation-associated depressive behavior was undertaken. The transcriptome of microglia from mice at day 7 after Bacille Calmette Guerin (BCG) challenge was compared to that from unchallenged Control mice and to the transcriptome from peripheral macrophages from the same mice. Among the 562 and 3,851 genes differentially expressed between BCG-challenged and Control mice in microglia and macrophages respectively, 353 genes overlapped between these cells types. Among the most differentially expressed genes in the microglia, serum amyloid A3 (Saa3) and cell adhesion molecule 3 (Cadm3) were over-expressed and coiled-coil domain containing 162 (Ccdc162) and titin-cap (Tcap) were under-expressed in BCG-challenged relative to Control. Many of the differentially expressed genes between BCG-challenged and Control mice were associated with neurological disorders encompassing depression symptoms. Across cell types, S100 calcium binding protein A9 (S100A9), interleukin 1 beta (ll1b) and kynurenine 3-monooxygenase (Kmo) were differentially expressed between challenged and control mice. Immune response, chemotaxis, and chemokine activity were among the functional categories enriched by the differentially expressed genes. Functional categories enriched among the 9,117 genes differentially expressed between cell types included leukocyte regulation and activation, chemokine and cytokine activities, MAP kinase activity, and apoptosis. More than 200 genes exhibited alternative splicing events between cell types including WNK lysine deficient protein kinase 1 (Wnk1) and microtubule-actin crosslinking factor 1 (Macf1). Network visualization revealed the capability of microglia to exhibit transcriptome dysregulation in response to immune challenge still after resolution of sickness symptoms, albeit lower than that observed in macrophages. The persistent transcriptome dysregulation in the microglia shared patterns with neurological disorders indicating that the associated persistent depressive symptoms share a common transcriptome basis.	[Gonzalez-Pena, Dianelys; Southey, Bruce R.; Lawson, Marcus A.; McCusker, Robert H.; Borras, Tania; Machuca, Debbie; Kelley, Keith W.; Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Nixon, Scott E.] Univ Illinois, Illinois Informat Inst, Urbana, IL USA; [O'Connor, Jason C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Hernandez, Alvaro G.] Univ Illinois, High Throughput Sequencing & Genotyping Unit, Roy J Carver Biotechnol Ctr, Champaign, IL USA; [Dantzer, Robert] Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA; [Kelley, Keith W.] Univ Illinois, Coll Med, Integrat Immunol & Behav Program, Champaign, IL USA; [Kelley, Keith W.] Univ Illinois, Coll Med, Dept Pathol, Champaign, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Stat, Champaign, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Carle Woese Inst Genom Biol, Champaign, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Health San Antonio; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; UTMD Anderson Cancer Center; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL USA.; Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Stat, Champaign, IL USA.; Rodriguez-Zas, SL (corresponding author), Univ Illinois, Carle Woese Inst Genom Biol, Champaign, IL USA.	rodrgzzs@illinois.edu	Peña, Dianelys Gonzalez/AAF-4021-2019	Peña, Dianelys Gonzalez/0000-0003-4846-7569; Southey, Bruce/0000-0002-8959-7709; Dantzer, Robert/0000-0001-9399-6107; Rodriguez-Zas, Sandra/0000-0003-1122-4758	National Institutes of Health [R21 MH 096030, R01 MH 090127, R01 SUB UT 00000712, R01 MH083767]; US Department of Agriculture [ILLU-538-632, ILLU-538-909]; National Institute of Drug Abuse [5P30DA018310]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH096030, R01MH101145, R01MH083767, R01MH090127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Agriculture(United States Department of Agriculture (USDA)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study is supported by the National Institutes of Health R21 MH 096030 (SRZ), http://ww.nih.gov; National Institutes of Health R01 MH 090127 (RM), http://www.nih.gov; National Institutes of Health R01 SUB UT 00000712 (KWK), http://www.nih.gov; National Institutes of Health R01 MH083767 (KWK), http://www.nih.gov; US Department of Agriculture ILLU-538-632 (SRZ), http://www.usda.gov; US Department of Agriculture ILLU-538-909 (SRZ), http://www.usda.gov; 5P30DA018310 NIH National Institute of Drug Abuse to Bruce Southey (BRS).	Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Bedard A, 2007, GLIA, V55, P777, DOI 10.1002/glia.20477; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bousman CA, 2010, AM J MED GENET B, V153B, P494, DOI 10.1002/ajmg.b.31006; Brodziak F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072317; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Buga AM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039302, 10.1371/journal.pone.0050985]; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Caetano-Anolles K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116828; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Chen M, 2010, INVEST OPHTH VIS SCI, V51, P5888, DOI 10.1167/iovs.09-5103; Chiappelli J, 2015, NEUROPSYCHOPHARMACOL, V40, P2157, DOI 10.1038/npp.2015.57; Clarke RA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.75; Connor TJ, 2008, NEUROSCI LETT, V441, P29, DOI 10.1016/j.neulet.2008.06.007; Corona AW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-93; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Das A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121117; Delfino KR, 2011, CANCER GENOM PROTEOM, V8, P173; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Ebert S, 2012, ADV EXP MED BIOL, V723, P619, DOI 10.1007/978-1-4614-0631-0_79; Eilat E, 1999, J IMMUNOL, V163, P533; Eue I, 2000, INT IMMUNOL, V12, P1593, DOI 10.1093/intimm/12.11.1593; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; FORD AL, 1995, J IMMUNOL, V154, P4309; Foster AM, 2014, J IMMUNOL, V192, P6053, DOI 10.4049/jimmunol.1301481; Fox MA, 2008, CURR OPIN CELL BIOL, V20, P508, DOI 10.1016/j.ceb.2008.05.003; Fuller JP, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00235; Fumagalli S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00081; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Ghorpade DS, 2012, MOL CELL BIOL, V32, P2239, DOI 10.1128/MCB.06597-11; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gonzalez-Pena D, 2014, 6 INT C BIOINF COMP, V1; Gormanns P, 2011, J PSYCHIATR RES, V45, P973, DOI 10.1016/j.jpsychires.2010.12.010; Goshen I, 2008, MOL PSYCHIATR, V13, P717, DOI 10.1038/sj.mp.4002055; Ha TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008840; He L, 2006, J IMMUNOL, V177, P3644, DOI 10.4049/jimmunol.177.6.3644; Hernandez ME, 2008, EUR NEUROPSYCHOPHARM, V18, P917, DOI 10.1016/j.euroneuro.2008.08.001; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubert T, 2009, CELL MOL LIFE SCI, V66, P1223, DOI 10.1007/s00018-008-8561-9; Hwang Y, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.94; Institute B, 2013, FASTQC QUAL CONTR TO; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Jou I, 1998, GLIA, V24, P408, DOI 10.1002/(SICI)1098-1136(199812)24:4<408::AID-GLIA6>3.3.CO;2-4; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kelley KW, 2013, BRAIN BEHAV IMMUN, V32, P63, DOI 10.1016/j.bbi.2013.02.003; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kitazawa M, 2011, J IMMUNOL, V187, P6539, DOI 10.4049/jimmunol.1100620; Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300; Krause D, 2014, EUR ARCH PSY CLIN N, V264, P615, DOI 10.1007/s00406-014-0494-8; Lazic D, 2011, J DERMATOL SCI, V62, P84, DOI 10.1016/j.jdermsci.2011.02.006; Levine J, 1999, NEUROPSYCHOBIOLOGY, V40, P171, DOI 10.1159/000026615; Li P, 1997, J CELL BIOCHEM, V64, P27, DOI 10.1002/(SICI)1097-4644(199701)64:1<27::AID-JCB5>3.0.CO;2-1; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu B, 2001, J NEUROCHEM, V77, P182, DOI 10.1046/j.1471-4159.2001.t01-1-00216.x; Liu MY, 2013, MOL BIOL REP, V40, P3731, DOI 10.1007/s11033-012-2449-3; Mabbott NA, 2011, IMMUNOLOGY, V133, P482, DOI 10.1111/j.1365-2567.2011.03461.x; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MAES M, 1995, PROG NEURO-PSYCHOPH, V19, P11, DOI 10.1016/0278-5846(94)00101-M; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Martinez AN, 2013, J INFECT DIS, V207, P1253, DOI 10.1093/infdis/jit037; Merner ND, 2012, AM J HUM GENET, V91, P313, DOI 10.1016/j.ajhg.2012.07.002; MILANO S, 1995, PROSTAG OTH LIPID M, V49, P105, DOI 10.1016/0090-6980(94)00004-G; Molteni R, 2013, EUR NEUROPSYCHOPHARM, V23, P1645, DOI 10.1016/j.euroneuro.2013.03.008; Moreau M, 2008, BRAIN BEHAV IMMUN, V22, P1087, DOI 10.1016/j.bbi.2008.04.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Myint AM, 2005, J AFFECT DISORDERS, V88, P167, DOI 10.1016/j.jad.2005.07.008; Nag A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059061; Nikodemova M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-147; Nixon SE, 2015, J BIOINF COMPUT BIOL, V13, DOI 10.1142/S0219720015500109; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Norman GJ, 2010, MOL PSYCHIATR, V15, P404, DOI 10.1038/mp.2009.91; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; O'Connor JC, 2009, J NEUROSCI, V29, P4200, DOI 10.1523/JNEUROSCI.5032-08.2009; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; Okada K, 2015, BIOCHEM BIOPH RES CO, V456, P415, DOI 10.1016/j.bbrc.2014.11.099; Palmer GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098388; Pan FG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051988; Parrott JM, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00116; Pavon L, 2006, J NEUROIMMUNOL, V172, P156, DOI 10.1016/j.jneuroim.2005.08.014; Preissler J, 2015, GLIA, V63, P206, DOI 10.1002/glia.22744; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Rempel JD, 2005, J VIROL, V79, P4369, DOI 10.1128/JVI.79.7.4369-4381.2005; Reno C, 1997, BIOTECHNIQUES, V22, P1082, DOI 10.2144/97226bm16; Rodriguez-Zas SL, 2015, BRAIN BEHAV IMMUN, V44, P176, DOI 10.1016/j.bbi.2014.09.018; Ryan MM, 2006, MOL PSYCHIATR, V11, P965, DOI 10.1038/sj.mp.4001875; Sadeque A, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-59; Schindler H, 2001, J IMMUNOL, V166, P3075, DOI 10.4049/jimmunol.166.5.3075; Serao NVL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078530; Serao NVL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-94; Serao NVL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-49; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Simon NM, 2008, EUR NEUROPSYCHOPHARM, V18, P230, DOI 10.1016/j.euroneuro.2007.06.004; Smith RP, 2008, TRANSCRIPTIONAL REGU; Solga AC, 2015, GLIA, V63, P531, DOI 10.1002/glia.22754; Sonoki T, 1997, J BIOL CHEM, V272, P3689, DOI 10.1074/jbc.272.6.3689; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Stewart SE, 2013, MOL PSYCHIATR, V18, P788, DOI 10.1038/mp.2012.85; Stier MT, 2012, MAMM GENOME, V23, P250, DOI 10.1007/s00335-011-9368-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suga A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094556; Svensson C, 2011, BIOCHEM BIOPH RES CO, V406, P488, DOI 10.1016/j.bbrc.2011.02.083; Szulzewsky F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116644; Takasaki I, 2012, PAIN, V153, P585, DOI 10.1016/j.pain.2011.11.022; Tamayo P, 2012, STAT METHODS MED RES; Teng Chih-Chung, 2013, Front Biosci (Schol Ed), V5, P72; Trager N, 2014, ANONYMOUS ROLE PROTE, P3; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Ufimtseva E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/948131; van Sorge NM, 2005, J NEUROIMMUNOL, V162, P157, DOI 10.1016/j.jneuroim.2005.01.016; Vedeler CA, 2001, J NEUROIMMUNOL, V118, P187, DOI 10.1016/S0165-5728(01)00344-7; Virag L, 2003, TOXICOL LETT, V140, P113, DOI 10.1016/S0378-4274(02)00508-8; VIRTANEVA KI, 1994, IMMUNOGENETICS, V39, P329; Wang J, 1999, J CLIN INVEST, V103, P1023, DOI 10.1172/JCI6224; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; Weisser SB, 2011, EUR J IMMUNOL, V41, P1742, DOI 10.1002/eji.201041105; Winkler D, 2013, J BIOMOL SCREEN, V18, P879, DOI 10.1177/1087057113489731; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Xaus J, 2000, BLOOD, V95, P3823; Yamashita N, 2013, PEDIATR INT, V55, P572, DOI 10.1111/ped.12139; Zhang G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088703; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zong YY, 2015, BRAIN RES, V1624, P95, DOI 10.1016/j.brainres.2015.07.022; Zunszain PA, 2012, NEUROPSYCHOPHARMACOL, V37, P939, DOI 10.1038/npp.2011.277	133	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150858	10.1371/journal.pone.0150858	http://dx.doi.org/10.1371/journal.pone.0150858			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959683	Green Submitted, gold, Green Published			2022-12-27	WOS:000371992300081
J	Kami, YN; Sumi, M; Takagi, Y; Sasaki, M; Uetani, M; Nakamura, T				Kami, Yukiko N.; Sumi, Misa; Takagi, Yukinori; Sasaki, Miho; Uetani, Masataka; Nakamura, Takashi			Arterial Spin Labeling Imaging for the Parotid Glands of Patients with Sjogren's Syndrome	PLOS ONE			English	Article							GUSTATORY STIMULATION; DIAGNOSTIC-CRITERIA; BLOOD-FLOW; INITIAL-EXPERIENCE; SALIVARY-GLANDS; PERFUSION; DIFFUSION; TUMORS; DIFFERENTIATION; BENIGN	Sjogren's syndrome (SS) is characterized by hypofunction of the salivary and lacrimal glands. The salivary function is largely dependent upon the blood supply in the glands. However, the diseased states of the gland perfusion are not well understood. The arterial spin labeling (ASL) technique allows noninvasive quantitative assessment of tissue perfusion without the need for contrast agent. Here, we prospectively compared the perfusion properties of the parotid glands between patients with SS and those with healthy glands using ASL MR imaging. We analyzed salivary blood flow (SBF) kinetics of 22 healthy parotid glands from 11 volunteers and 28 parotid glands from 14 SS patients using 3T pseudo-continuous ASL imaging. SBF was determined in resting state (base SBF) and at 3 sequential segments after gustatory stimulation. SBF kinetic profiles were characterized by base SBF level, increment ratio at the SBF peak, and the differences in segments where the peak appeared (SBF types). Base SBFs of the SS glands were significantly higher than those of healthy glands (59.2 +/- 22.8 vs. 46.3 +/- 9.0 mL/min/100 g, p = 0.01). SBF kinetic profiles of the SS glands also exhibited significantly later SBF peaks (p < 0.001) and higher SBF increment ratios (74 +/- 49% vs. 47 +/- 39%, p = 0.04) than the healthy glands. The best SBF criterion (= 51.2 mL/min/100 mg)differentiated between control subjects and SS patients with 71% sensitivity and 82% specificity. Taken together, these results showed that the SS parotid glands were mostly hyperemic and the SS gland responses to gustatory stimulation were stronger and more prolonged than those of the healthy glands. The ASL may be a promising technique for assessing the diseased salivary gland vascularization of SS patients.	[Kami, Yukiko N.; Sumi, Misa; Takagi, Yukinori; Sasaki, Miho; Nakamura, Takashi] Nagasaki Univ, Sch Med, Dept Radiol & Canc Biol, Nagasaki 852, Japan; [Uetani, Masataka] Nagasaki Univ, Dept Radiol, Grad Sch Biosci, Nagasaki 852, Japan	Nagasaki University; Nagasaki University	Nakamura, T (corresponding author), Nagasaki Univ, Sch Med, Dept Radiol & Canc Biol, Nagasaki 852, Japan.	taku@nagasaki-u.ac.jp	Uetani, Masataka/ABF-7525-2021		 [24792292];  [24592837]	; 	This study was supported by Grant-in-Aid for Scientific research 24592837 (Japan) and Grant-in-Aid for Young Scientists 24792292 (Japan). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 1998, RADIOLOGY, V208, P410, DOI 10.1148/radiology.208.2.9680569; Bisdas S, 2007, EUR J RADIOL, V64, P258, DOI 10.1016/j.ejrad.2007.02.032; Chikui T, 2000, J RHEUMATOL, V27, P1222; Cornec D, 2013, ARTHRITIS RHEUM-US, V65, P216, DOI [10.1002/art.37698, 10.1002/art.37944]; Fisher BA, 2015, ANN RHEUM DIS, V74, P1645, DOI 10.1136/annrheumdis-2015-207499; Gerli R, 2010, ARTHRIT CARE RES, V62, P712, DOI 10.1002/acr.20117; Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Izumi M, 1996, AM J ROENTGENOL, V166, P1483, DOI 10.2214/ajr.166.6.8633469; Jousse-Joulin S, 2016, RHEUMATOLOGY, V55, P789, DOI 10.1093/rheumatology/kev385; Jousse-Joulin S, 2007, BIOL-TARGETS THER, V1, P311; Kamel UF, 2009, RHEUMATOLOGY, V48, P1512, DOI 10.1093/rheumatology/kep249; Kato H, 2015, EUR RADIOL, V25, P3247, DOI 10.1007/s00330-015-3755-7; Kato H, 2011, J MAGN RESON IMAGING, V34, P904, DOI 10.1002/jmri.22729; Lanzman RS, 2012, RADIOLOGY, V265, P799, DOI 10.1148/radiol.12112260; Pijpe J, 2007, RHEUMATOLOGY, V46, P335, DOI 10.1093/rheumatology/kel266; Pirildar T, 2005, RHEUMATOL INT, V25, P536, DOI 10.1007/s00296-005-0599-5; Principles of Neurological Surgery, 2012, PRINCIPLES NEUROLOGI; Roberts C, 2008, RADIOLOGY, V246, P845, DOI 10.1148/radiol.2463070298; Saito N, 2013, J COMPUT ASSIST TOMO, V37, P272, DOI 10.1097/RCT.0b013e31827b4729; Schwenzer NF, 2008, NMR BIOMED, V21, P598, DOI 10.1002/nbm.1231; Sumi M, 2012, RADIOLOGY, V263, P770, DOI 10.1148/radiol.12111248; Takagi Y, 2005, AM J NEURORADIOL, V26, P1207; Thoeny HC, 2005, RADIOLOGY, V235, P629, DOI 10.1148/radiol.2352040127; Tsuboi H, 2013, MOD RHEUMATOL, V23, P219, DOI 10.1007/s10165-012-0812-9; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212	27	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150680	10.1371/journal.pone.0150680	http://dx.doi.org/10.1371/journal.pone.0150680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959680	Green Submitted, gold, Green Published			2022-12-27	WOS:000371992300063
J	Stone, BW; Tinker, J				Stone, Brian W.; Tinker, Jessica			Multisensory Tracking of Objects in Darkness: Capture of Positive Afterimages by the Tactile and Proprioceptive Senses	PLOS ONE			English	Article							PROLONGED VISUAL AFTERIMAGE; RUBBER HAND ILLUSION; EXTERNAL OBJECTS; TOOL-USE; SIZE; TOUCH; INTEGRATION; APPEARANCE; LOCATIONS; MOVEMENTS	This paper reports on three experiments investigating the contribution of different sensory modalities to the tracking of objects moved in total darkness. Participants sitting in the dark were exposed to a brief, bright flash which reliably induced a positive visual afterimage of the scene so illuminated. If the participants subsequently move their hand in the darkness, the visual afterimage of that hand fades or disappears; this is presumably due to conflict between the illusory visual afterimage (of the hand in its original location) and other information (e.g., proprioceptive) from a general mechanism for tracking body parts. This afterimage disappearance effect also occurs for held objects which are moved in the dark, and some have argued that this represents a case of body schema extension, i.e. the rapid incorporation of held external objects into the body schema. We demonstrate that the phenomenon is not limited to held objects and occurs in conditions where incorporation into the body schema is unlikely. Instead, we propose that the disappearance of afterimages of objects moved in darkness comes from a general mechanism for object tracking which integrates input from multiple sensory systems. This mechanism need not be limited to tracking body parts, and thus we need not invoke body schema extension to explain the afterimage disappearance. In this series of experiments, we test whether auditory feedback of object movement can induce afterimage disappearance, demonstrate that the disappearance effect scales with the magnitude of proprioceptive feedback, and show that tactile feedback alone is sufficient for the effect. Together, these data demonstrate that the visual percept of a positive afterimage is constructed not just from visual input of the scene when light reaches the eyes, but in conjunction with input from multiple other senses.	[Stone, Brian W.; Tinker, Jessica] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Stone, Brian W.] Boise State Univ, Dept Psychol, Boise, ID 83725 USA	University System of Georgia; University of Georgia; Idaho; Boise State University	Stone, BW (corresponding author), Boise State Univ, Dept Psychol, Boise, ID 83725 USA.	brianwstone@gmail.com		Stone, Brian/0000-0002-4911-8419				Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Bischoff M, 2007, NEUROPSYCHOLOGIA, V45, P578, DOI 10.1016/j.neuropsychologia.2006.03.008; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bross M, 2000, PERCEPTION, V29, P1385, DOI 10.1068/p3038; Bruggeman H, 2013, PSYCHOL SCI, V24, P1063, DOI 10.1177/0956797612457398; Carey DP, 1996, EXP BRAIN RES, V110, P482; Carlson TA, 2010, PSYCHOL SCI, V21, P1000, DOI 10.1177/0956797610371962; DAVIES P, 1973, PERCEPTION, V2, P147, DOI 10.1068/p020147; DAVIES P, 1973, PERCEPTION, V2, P155, DOI 10.1068/p020155; Dieter KC, 2014, PSYCHOL SCI, V25, P66, DOI 10.1177/0956797613497968; Emmert E., 1881, KLIN MONATSBL AUGENH, P443; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Ghahramani Z, 1997, ADV PSYCHOL, V119, P117; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 1997, SCIENCE, V277, P239, DOI 10.1126/science.277.5323.239; GREGORY RL, 1959, Q J EXP PSYCHOL, V11, P54, DOI 10.1080/17470215908416288; HARRIS CS, 1965, PSYCHOL REV, V72, P419, DOI 10.1037/h0022616; HAY JC, 1965, PSYCHON SCI, V2, P215, DOI 10.3758/BF03343413; HAYHOE MM, 1984, PERCEPTION, V13, P455, DOI 10.1068/p130455; Hogendoorn H, 2009, NEUROPSYCHOLOGIA, V47, P2698, DOI 10.1016/j.neuropsychologia.2009.05.014; Holmes NP, 2007, CORTEX, V43, P469, DOI 10.1016/S0010-9452(08)70471-4; Horowitz TS, 2004, J VISION, V4, P585, DOI 10.1167/4.7.6; Hulme OJ, 2007, CEREB CORTEX, V17, P1197, DOI 10.1093/cercor/bhl031; IJsselsteijn WA, 2006, PRESENCE-TELEOP VIRT, V15, P455, DOI 10.1162/pres.15.4.455; Imaruoka T, 2005, NEUROIMAGE, V26, P277, DOI 10.1016/j.neuroimage.2005.01.045; Iriki A, 1996, NEUROREPORT, V7, P2325; Maravita A, 2002, COGNITION, V83, pB25, DOI 10.1016/S0010-0277(02)00003-3; PADGHAM CA, 1953, BRIT J OPHTHALMOL, V37, P165, DOI 10.1136/bjo.37.3.165; Rademaker RL, 2014, NEUROPSYCHOLOGIA, V56, P196, DOI 10.1016/j.neuropsychologia.2014.01.011; Ramsay AIG, 2007, EXP BRAIN RES, V176, P173, DOI 10.1007/s00221-006-0609-1; Ritchie JB, 2013, PSYCHOL SCI, V24, P1066, DOI 10.1177/0956797612459768; Shinskey JL, 2008, DEV PSYCHOL, V44, P1715, DOI 10.1037/a0012836; Shuwairi SM, 2007, J COGNITIVE NEUROSCI, V19, P1275, DOI 10.1162/jocn.2007.19.8.1275; SUZUKI K, 1986, JPN PSYCHOL RES, V28, P168, DOI 10.4992/psycholres1954.28.168; SWANSTON MT, 1981, PERCEPTION, V10, P339, DOI 10.1068/p100339; Taylor FV, 1941, J EXP PSYCHOL, V29, P75, DOI 10.1037/h0058125; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2008, NEUROPSYCHOLOGIA, V46, P3014, DOI 10.1016/j.neuropsychologia.2008.06.004; Weber EH, 1834, EH WEBER TACTILE SEN, P60	40	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150714	10.1371/journal.pone.0150714	http://dx.doi.org/10.1371/journal.pone.0150714			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TF	26959233	gold, Green Published			2022-12-27	WOS:000371992300069
J	Fall, ML; Van der Heyden, H; Carisse, O				Fall, Mamadou Lamine; Van der Heyden, Herve; Carisse, Odile			A Quantitative Dynamic Simulation of Bremia lactucae Airborne Conidia Concentration above a Lettuce Canopy	PLOS ONE			English	Article							DOWNY MILDEW; PHYTOPHTHORA-INFESTANS; FIELD-EVALUATION; TEMPERATURE; SPORANGIA; INFORMATION; PERIODICITY; SPORULATION; RELEASE; MODELS	Lettuce downy mildew, caused by the oomycete Bremia lactucae Regel, is a major threat to lettuce production worldwide. Lettuce downy mildew is a polycyclic disease driven by airborne spores. A weather-based dynamic simulation model for B. lactucae airborne spores was developed to simulate the aerobiological characteristics of the pathogen. The model was built using the STELLA platform by following the system dynamics methodology. The model was developed using published equations describing disease subprocesses (e.g., sporulation) and assembled knowledge of the interactions among pathogen, host, and weather. The model was evaluated with four years of independent data by comparing model simulations with observations of hourly and daily airborne spore concentrations. The results show an accurate simulation of the trend and shape of B. lactucae temporal dynamics of airborne spore concentration. The model simulated hourly and daily peaks in airborne spore concentrations. More than 95% of the simulation runs, the daily-simulated airborne conidia concentration was 0 when airborne conidia were not observed. Also, the relationship between the simulated and the observed airborne spores was linear. In more than 94% of the simulation runs, the proportion of the linear variation in the hourly-observed values explained by the variation in the hourly-simulated values was greater than 0.7 in all years except one. Most of the errors came from the deviation from the 1: 1 line, and the proportion of errors due to the model bias was low. This model is the only dynamic model developed to mimic the dynamics of airborne inoculum and represents an initial step towards improved lettuce downy mildew understanding, forecasting and management.	[Fall, Mamadou Lamine] Univ Sherbrooke, Dept Biol, 2500 Univ Blvd, Sherbrooke, PQ J1K 2R1, Canada; [Fall, Mamadou Lamine; Van der Heyden, Herve] Compagnie Rech Phytodata Inc, 111 Rang St Patrice, Sherrington, PQ J0L 2N0, Canada; [Carisse, Odile] Agr & Agri Food Canada, Hort Res & Dev Ctr, 430 Gouin Blvd, St Jean, PQ J3B 3E6, Canada	University of Sherbrooke; Agriculture & Agri Food Canada	Carisse, O (corresponding author), Agr & Agri Food Canada, Hort Res & Dev Ctr, 430 Gouin Blvd, St Jean, PQ J3B 3E6, Canada.	odile.carisse@agr.gc.ca	Van der Heyden, Hervé/AAT-8247-2021; vanderheyden, Herve/GYD-6202-2022; Fall, Mamadou/GXG-1190-2022	Van der Heyden, Herve/0000-0003-4085-6658; Fall, Mamadou Lamine/0000-0002-1747-6481	Compagnie de recherche Phytodata inc.	Compagnie de recherche Phytodata inc.	Compagnie de recherche Phytodata inc. provided support in the form of salaries for HVdH. HVdH was involved in the decision to publish and preparation of the manuscript. Compagnie de recherche Phytodata inc. did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aylor DE, 2001, PHYTOPATHOLOGY, V91, P1189, DOI 10.1094/PHYTO.2001.91.12.1189; Aylor DE, 2011, AGR FOREST METEOROL, V151, P251, DOI 10.1016/j.agrformet.2010.10.013; Bugiani R., 1995, Aerobiologia, V11, P41, DOI 10.1007/BF02136143; Carisse O, 2002, CAN J PLANT PATHOL, V24, P184, DOI 10.1080/07060660309506994; Fall ML, 2015, PLANT DIS, V99, P1010, DOI 10.1094/PDIS-05-14-0548-RE; Fall ML, 2015, PLANT PATHOL, V64, P178, DOI 10.1111/ppa.12235; FLETCHER JT, 1976, ANN APPL BIOL, V84, P294, DOI 10.1111/j.1744-7348.1976.tb01770.x; Ford A., 2009, MODELING ENV, V2nd; Hadders Jan, 2008, V3, P179, DOI 10.1007/978-1-4020-8571-0_9; Hovius MHY, 2007, CAN J PLANT PATHOL, V29, P9, DOI 10.1080/07060660709507432; Kranz J, 1974, ECOLOGICAL STUDIES, V13; Kushalappa AC, 2001, INT J PEST MANAGE, V47, P1, DOI 10.1080/09670870150215540; Lebeda A, 2004, PLANT PATHOL, V53, P316, DOI 10.1111/j.0032-0862.2004.01003.x; Michelmore R.W., 1988, ADV PLANT PATHOLOGY, V6, P53; Nieto H, 2010, AGR FOREST METEOROL, V150, P861, DOI 10.1016/j.agrformet.2010.02.007; Nordskog B, 2007, PHYTOPATHOLOGY, V97, P979, DOI 10.1094/PHYTO-97-8-0979; NORWOOD JM, 1985, PLANT PATHOL, V34, P481, DOI 10.1111/j.1365-3059.1985.tb01397.x; Olanya O. M., 2012, Archives of Phytopathology and Plant Protection, V45, P1558, DOI 10.1080/03235408.2012.681502; Pineiro G, 2008, ECOL MODEL, V216, P316, DOI 10.1016/j.ecolmodel.2008.05.006; POWLESLAND RUTH, 1954, TRANS BRIT MYCOL SOC, V37, P362; Reddy M. V. Bhaskara, 1996, Phytoprotection, V77, P137; Rossi V, 2008, ECOL MODEL, V212, P480, DOI 10.1016/j.ecolmodel.2007.10.046; SCHERM H, 1993, AGR FOREST METEOROL, V66, P229, DOI 10.1016/0168-1923(93)90073-Q; SCHERM H, 1995, PLANT DIS, V79, P511, DOI 10.1094/PD-79-0511; SCHERM H, 1994, PHYTOPATHOLOGY, V84, P860, DOI 10.1094/Phyto-84-860; Skelsey P, 2009, PHYTOPATHOLOGY, V99, P887, DOI 10.1094/PHYTO-99-7-0887; SMITH EP, 1995, ECOL MODEL, V77, P49, DOI 10.1016/0304-3800(93)E0074-D; Su H, 2004, PHYTOPATHOLOGY, V94, P396, DOI 10.1094/PHYTO.2004.94.4.396; Su H, 2000, PHYTOPATHOLOGY, V90, P67, DOI 10.1094/PHYTO.2000.90.1.67; Tchervenivanova E, 1995, THESIS MCGILL U MONT; Wu BM, 2002, PHYTOPATHOLOGY, V92, P631, DOI 10.1094/PHYTO.2002.92.6.631; Wu BM, 2001, PHYTOPATHOLOGY, V91, P134, DOI 10.1094/PHYTO.2001.91.2.134; Wu BM, 2000, PHYTOPATHOLOGY, V90, P827, DOI 10.1094/PHYTO.2000.90.8.827	33	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0144573	10.1371/journal.pone.0144573	http://dx.doi.org/10.1371/journal.pone.0144573			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953691	gold, Green Published, Green Submitted			2022-12-27	WOS:000371991300001
J	Vallejo, J; Spence, M; Cheng, AL; Brotto, L; Edens, NK; Garvey, SM; Brotto, M				Vallejo, Julian; Spence, Madoka; Cheng, An-Lin; Brotto, Leticia; Edens, Neile K.; Garvey, Sean M.; Brotto, Marco			Cellular and Physiological Effects of Dietary Supplementation with beta-Hydroxy-beta-Methylbutyrate (HMB) and beta-Alanine in Late Middle-Aged Mice	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; BODY-COMPOSITION; OLDER-ADULTS; NUTRITIONAL SUPPLEMENTATION; CARNOSINE CONCENTRATIONS; PROTEIN-METABOLISM; FORCE PRODUCTION; STRENGTH; SARCOPENIA; CALCIUM	There is growing evidence that severe decline of skeletal muscle mass and function with age may be mitigated by exercise and dietary supplementation with protein and amino acid ingredient technologies. The purposes of this study were to examine the effects of the leucine catabolite, beta-hydroxy-beta-methylbutyrate (HMB), in C2C12 myoblasts and myotubes, and to investigate the effects of dietary supplementation with HMB, the amino acid beta-alanine and the combination thereof, on muscle contractility in a preclinical model of pre-sarcopenia. In C2C12 myotubes, HMB enhanced sarcoplasmic reticulum(SR) calcium release beyond vehicle control in the presence of all SR agonists tested (KCl, P<0.01; caffeine, P = 0.03; ionomycin, P = 0.03). HMB also improved C2C12 myoblast viability (25 mu M HMB, P = 0.03) and increased proliferation (25 mu M HMB, P = 0.04; 125 mu M HMB, P<0.01). Furthermore, an ex vivo muscle contractility study was performed on EDL and soleus muscle from 19 month old, male C57BL/6nTac mice. For 8 weeks, mice were fed control AIN-93M diet, diet with HMB, diet with beta-alanine, or diet with HMB and beta-alanine. In beta-alanine fed mice, EDL muscle showed a 7% increase in maximum absolute force compared to the control diet (202 +/- 3vs. 188 +/- 5 mN, P = 0.02). At submaximal frequency of stimulation (20 Hz), EDL from mice fed HMB plus beta-alanine showed an 11% increase in absolute force (88.6 +/- 2.2 vs. 79.8 +/- 2.4 mN, P = 0.025) and a 13% increase in specific force (12.2 +/- 0.4 vs. 10.8 +/- 0.4 N/cm(2), P = 0.021). Also in EDL muscle, beta-alanine increased the rate of force development at all frequencies tested (P<0.025), while HMB reduced the time to reach peak contractile force (TTP), with a significant effect at 80 Hz (P = 0.0156). In soleus muscle, all experimental diets were associated with a decrease in TTP, compared to control diet. Our findings highlight beneficial effects of HMB and beta-alanine supplementation on skeletal muscle function in aging mice.	[Vallejo, Julian; Spence, Madoka; Cheng, An-Lin; Brotto, Leticia; Brotto, Marco] Univ Missouri, Muscle Biol Res Grp, Sch Nursing & Hlth Studies, Kansas City, MO 64110 USA; [Edens, Neile K.; Garvey, Sean M.] Abbott Nutr R&D, Columbus, OH USA; [Brotto, Leticia; Brotto, Marco] Univ Texas Arlington, Coll Nursing & Hlth Innovat, Arlington, TX 76019 USA; [Edens, Neile K.] Common Threads, Austin, TX USA	University of Missouri System; University of Missouri Kansas City; University of Texas System; University of Texas Arlington	Brotto, M (corresponding author), Univ Missouri, Muscle Biol Res Grp, Sch Nursing & Hlth Studies, Kansas City, MO 64110 USA.; Garvey, SM (corresponding author), Abbott Nutr R&D, Columbus, OH USA.	sean.garvey@abbott.com; marco.brotto@uta.edu		Garvey, Sean/0000-0003-1013-7871	Abbott Nutrition	Abbott Nutrition(Abbott Laboratories)	Funding for this project was provided by Abbott Nutrition. The funders had no role in data collection and analysis. SMG is an employee of Abbott Nutrition, a division of Abbott Laboratories, Inc. At the time of study, NKE was also an employee of Abbott Nutrition. Both SMG and NKE had roles in study design and preparation of the manuscript. The funder Abbott Nutrition therefore had a role in study design and preparation of the manuscript, but had no role in data collection and analysis or decision to publish.	Abe H, 2000, BIOCHEMISTRY-MOSCOW+, V65, P757; ALLEN DG, 1995, J PHYSIOL-LONDON, V487, P331, DOI 10.1113/jphysiol.1995.sp020883; Alway SE, 2013, EXP GERONTOL, V48, P973, DOI 10.1016/j.exger.2013.06.005; Aversa Z, 2011, INT J ONCOL, V38, P713, DOI 10.3892/ijo.2010.885; Berton L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141757; Brotto MAD, 2000, PFLUG ARCH EUR J PHY, V440, P727; Brotto MAD, 2002, EXP PHYSIOL, V87, P77, DOI 10.1113/eph8702224; Brotto MAP, 2004, CELL RES, V14, P373, DOI 10.1038/sj.cr.7290237; Brotto M, 2012, J PHARMACOL EXP THER, V343, P540, DOI 10.1124/jpet.112.191759; Brotto M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/931903; Brotto MD, 2001, PFLUG ARCH EUR J PHY, V442, P738, DOI 10.1007/s004240100587; Pinheiro CHDJ, 2012, EUR J APPL PHYSIOL, V112, P2531, DOI 10.1007/s00421-011-2224-5; del Favero S, 2012, AMINO ACIDS, V43, P49, DOI 10.1007/s00726-011-1190-x; Delbono O, 1995, J MEMBRANE BIOL, V148, P211; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; Deschenes Michael R, 2013, Curr Aging Sci, V6, P266; Deutz NEP, 2013, CLIN NUTR, V32, P704, DOI 10.1016/j.clnu.2013.02.011; Dutka TL, 2012, J APPL PHYSIOL, V112, P728, DOI 10.1152/japplphysiol.01331.2011; Dutka TL, 2004, J MUSCLE RES CELL M, V25, P203, DOI 10.1023/B:JURE.0000038265.37022.c5; EDWARDS RHT, 1977, CLIN SCI MOL MED, V52, P283, DOI 10.1042/cs0520283; EDWARDS RHT, 1977, J PHYSIOL-LONDON, V272, P769, DOI 10.1113/jphysiol.1977.sp012072; Eley HL, 2007, AM J PHYSIOL-ENDOC M, V293, pE923, DOI 10.1152/ajpendo.00314.2007; Everaert I, 2013, MED SCI SPORT EXER, V45, P43, DOI 10.1249/MSS.0b013e31826cdb68; FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Fitschen PJ, 2013, NUTRITION, V29, P29, DOI 10.1016/j.nut.2012.05.005; Flakoll P, 2004, NUTRITION, V20, P445, DOI 10.1016/j.nut.2004.01.009; FRONTERA WR, 1990, J APPL PHYSIOL, V68, P329, DOI 10.1152/jappl.1990.68.1.329; Fuller JC, 2011, JPEN-PARENTER ENTER, V35, P757, DOI 10.1177/0148607111413903; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hao YL, 2011, AM J PHYSIOL-REG I, V301, pR701, DOI 10.1152/ajpregu.00840.2010; Harris RC, 1998, J SPORT SCI, V16, P639; Hill CA, 2007, AMINO ACIDS, V32, P225, DOI 10.1007/s00726-006-0364-4; Hsieh LC, 2010, ASIA PAC J CLIN NUTR, V19, P200; Huang J, 2014, J BONE MINER RES, V29, P1531, DOI 10.1002/jbmr.2200; Jahn K, 2012, EUR CELLS MATER, V24, P197; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Kendrick IP, 2008, AMINO ACIDS, V34, P547, DOI 10.1007/s00726-007-0008-3; Kendrick IP, 2009, EUR J APPL PHYSIOL, V106, P131, DOI 10.1007/s00421-009-0998-5; Kirn DR, 2015, CONTEMP CLIN TRIALS, V43, P164, DOI 10.1016/j.cct.2015.06.001; Kornasio R, 2009, BBA-MOL CELL RES, V1793, P755, DOI 10.1016/j.bbamcr.2008.12.017; LAMONT C, 1992, J PHYSIOL-LONDON, V454, P421, DOI 10.1113/jphysiol.1992.sp019271; Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007; Latres E, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0060-8; Leung J, 2015, LUNG; Li Y, 2011, J NEUROSCI, V31, P14910, DOI 10.1523/JNEUROSCI.3590-11.2011; Malafarina V, 2012, MATURITAS, V71, P109, DOI 10.1016/j.maturitas.2011.11.012; MANNION AF, 1994, EUR J APPL PHYSIOL O, V68, P356, DOI 10.1007/BF00571457; McCormack WP, 2013, EXP GERONTOL, V48, P933, DOI 10.1016/j.exger.2013.06.003; McQuail JA, 2015, TRENDS MOL MED; Mo Chenglin, 2012, Recent Pat Biotechnol, V6, P223; MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127; O'Connor DM, 2007, J STRENGTH COND RES, V21, P419, DOI 10.1519/R-15974.1; Panton LB, 2000, NUTRITION, V16, P734, DOI 10.1016/S0899-9007(00)00376-2; Papanicolaou DA, 2013, J NUTR HEALTH AGING, V17, P533, DOI 10.1007/s12603-013-0335-x; Park KH, 2012, JOVE-J VIS EXP, DOI 10.3791/4198; Pimentel GD, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-11; Purves-Smith FM, 2012, EXP GERONTOL, V47, P913, DOI 10.1016/j.exger.2012.07.013; Ransone J, 2003, J STRENGTH COND RES, V17, P34; Romero-Suarez S, 2010, AGING-US, V2, P504, DOI 10.18632/aging.100190; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; RUDNEY H, 1957, J BIOL CHEM, V227, P363; Russ DW, 2014, EXP GERONTOL, V50, P40, DOI 10.1016/j.exger.2013.11.018; Russell ST, 2009, MOL CELL BIOCHEM, V330, P171, DOI 10.1007/s11010-009-0130-5; Sakuma Kunihiro, 2012, J Aging Res, V2012, P251217, DOI 10.1155/2012/251217; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Shen JH, 2009, NAT CELL BIOL, V11, P769, DOI 10.1038/ncb1884; Shioi T, 2012, J CARDIOL, V60, P423, DOI 10.1016/j.jjcc.2012.07.015; Slater G, 2001, INT J SPORT NUTR EXE, V11, P384, DOI 10.1123/ijsnem.11.3.384; Smith HJ, 2005, CANCER RES, V65, P277; Stout JR, 2013, EXP GERONTOL, V48, P1303, DOI 10.1016/j.exger.2013.08.007; Tahara M, 2013, BIOCHEM BIOPH RES CO, V434, P753, DOI 10.1016/j.bbrc.2013.03.128; Thornton AM, 2011, AGING-US, V3, P621, DOI 10.18632/aging.100335; Trabal J, 2015, CLIN INTERV AGING, V10, P713, DOI 10.2147/CIA.S75271; Tracy BL, 1999, J APPL PHYSIOL, V86, P195, DOI 10.1152/jappl.1999.86.1.195; Tudorascu I, 2014, ROM J MORPHOL EMBRYO, V55, P1295; VANKOEVERING M, 1992, AM J PHYSIOL, V262, pE27, DOI 10.1152/ajpendo.1992.262.1.E27; Verdijk LB, 2007, AM J PHYSIOL-ENDOC M, V292, pE151, DOI 10.1152/ajpendo.00278.2006; Verdijk LB, 2012, MED SCI SPORT EXER, V44, P2322, DOI 10.1249/MSS.0b013e3182667c2e; Visser M, 2011, CLIN GERIATR MED, V27, P387, DOI 10.1016/j.cger.2011.03.006; Vukovich MD, 2001, J NUTR, V131, P2049, DOI 10.1093/jn/131.7.2049; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; WENDT IR, 1983, PFLUG ARCH EUR J PHY, V398, P210, DOI 10.1007/BF00657153; Wilkinson DJ, 2013, J PHYSIOL-LONDON, V591, P2911, DOI 10.1113/jphysiol.2013.253203	84	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150066	10.1371/journal.pone.0150066	http://dx.doi.org/10.1371/journal.pone.0150066			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953693	Green Submitted, gold, Green Published			2022-12-27	WOS:000371991300013
J	Wu, YY; Huang, TC; Tsai, TN; Chen, JH; Dai, MS; Chang, PY; Ho, CL; Ye, RH; Chung, TR; Chen, YC; Chao, TY				Wu, Yi-Ying; Huang, Tzu-Chuan; Tsai, Tsung-Neng; Chen, Jia-Hong; Dai, Ming-Shen; Chang, Ping-Ying; Ho, Ching-Liang; Ye, Ren-Hua; Chung, Tsai-Rong; Chen, Yeu-Chin; Chao, Tsu-Yi			The Clinical Efficacy and Cardiotoxicity of Fixed-Dose Monthly Trastuzumab in HER2-Positive Breast Cancer: A Single Institutional Analysis	PLOS ONE			English	Article							ADJUVANT RADIOTHERAPY; MONOCLONAL-ANTIBODY; COST-EFFECTIVENESS; HEART-FAILURE; CHEMOTHERAPY; THERAPY; TRIAL; HERCEPTIN; SAFETY; MORBIDITY	Objective Trastuzumab-containing treatment regimens have been shown to improve survival outcomes in HER2-positive breast cancer (BC). It is much easier to infuse a fixed one-vial dose to every patient on a regular schedule in the general clinical setting. The aims of this study were evaluating the efficacy of a 440 mg fixed-dose of trastuzumab administered on a monthly infusion schedule, and the risk factors for cardiac events. Patients and methods We retrospectively reviewed data from 300 HER2-positive BC patients in our institute: 208 were early-stage BC patients undergoing adjuvant trastuzumab treatment, and 92 were metastatic BC patients treated with trastuzumab infusions until disease progression. There were 181 patients receiving regular trastuzumab infusions every 3 weeks (Q3W; 8 mg/kg loading dose followed by 6 mg/kg every 3 weeks), and the other 119 patients were treated monthly with a fixed 440 mg dose (QM; fixed 440 mg every 4 weeks). Results The medians of progression-free survival (PFS) and overall survival (OS) in the adjuvant setting were not reached in both treatment groups. In the metastatic setting, there was no significant difference between groups in PFS or OS. The median time to significant cardiovascular (CV) dysfunction was 4.54 months. The incidence of congestive heart failure requiring medication in our cohort was 3.4%. Conclusion In our study, we found that fixed-dose monthly trastuzumab was feasible and effective. In addition, the CV risk was not higher with the fixed-dose protocol. This treatment modality could lower the cost and was easier to implement in clinical practice. Larger prospective randomized studies with longer-term follow up are needed to confirm our results.	[Wu, Yi-Ying; Huang, Tzu-Chuan; Chen, Jia-Hong; Dai, Ming-Shen; Chang, Ping-Ying; Ho, Ching-Liang; Ye, Ren-Hua; Chen, Yeu-Chin] Tri Serv Gen Hosp, Dept Med, Div Hematol Oncol, Taipei, Taiwan; [Wu, Yi-Ying; Tsai, Tsung-Neng; Chao, Tsu-Yi] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Tsai, Tsung-Neng] Tri Serv Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Chen, Jia-Hong; Chao, Tsu-Yi] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chung, Tsai-Rong] Natl Inst Canc Res, Zhunan, Miaoli County, Taiwan; [Chao, Tsu-Yi] Taipei Med Univ, Shuang Ho Hosp, Dept Med, Div Hematol & Oncol, New Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital	Chao, TY (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Chao, TY (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Chao, TY (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Med, Div Hematol & Oncol, New Taipei, Taiwan.	10575@s.tmu.edu.tw	DAI, M/GPS-8291-2022	Wu, Yi-Ying/0000-0003-0411-6265	Tri-Service General Hospital [TSGH-C105-166]	Tri-Service General Hospital	This study was supported by a grant issued from the Tri-Service General Hospital (TSGH-C105-166). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Anthony Janckila for critical review of the manuscript. This study was supported by a grant issued from the Tri-Service General Hospital (TSGH-C105-166).	Balduzzi S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006242.pub2; Bartlett JMS, 2007, J CLIN ONCOL, V25, P4423, DOI 10.1200/JCO.2007.11.0973; Belkacemi Y, 2008, ANN ONCOL, V19, P1110, DOI 10.1093/annonc/mdn029; Cardinale D, 2010, J CLIN ONCOL, V28, P3910, DOI 10.1200/JCO.2009.27.3615; Chan ALF, 2009, ANN PHARMACOTHER, V43, P296, DOI 10.1345/aph.1L504; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Ewer MS, 2005, J CLIN ONCOL, V23, P7820, DOI 10.1200/JCO.2005.13.300; Giordano SH, 2005, JNCI-J NATL CANCER I, V97, P419, DOI 10.1093/jnci/dji067; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Harries M, 2002, ENDOCR-RELAT CANCER, V9, DOI 10.1677/erc.0.0090075; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Katsurada K, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-620; Mortensen SA, 2014, JACC-HEART FAIL, V2, P641, DOI 10.1016/j.jchf.2014.06.008; Onitilo AA, 2014, THER ADV DRUG SAF, V5, P154, DOI 10.1177/2042098614529603; Patt DA, 2005, J CLIN ONCOL, V23, P7475, DOI 10.1200/JCO.2005.13.755; Pearson SA, 2007, J CLIN ONCOL, V25, P3688, DOI 10.1200/JCO.2007.11.2516; Perez EA, 2008, J CLIN ONCOL, V26, P1231, DOI 10.1200/JCO.2007.13.5467; Perez-Ellis C, 2009, AM J CLIN ONCOL-CANC, V32, P492, DOI 10.1097/COC.0b013e3181931277; Puputti M, 2006, CANCER GENET CYTOGEN, V167, P32, DOI 10.1016/j.cancergencyto.2004.09.023; Purmonen TT, 2011, ACTA ONCOL, V50, P344, DOI 10.3109/0284186X.2011.553841; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Russo G, 2014, J CARDIOVASC MED, V15, P141, DOI 10.2459/JCM.0b013e328365afb5; Sawyer DB, 2002, CIRCULATION, V105, P1551, DOI 10.1161/01.CIR.0000013839.41224.1C; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Suter TM, 2007, J CLIN ONCOL, V25, P3859, DOI 10.1200/JCO.2006.09.1611; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Ward S, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13suppl1/01	29	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0151112	10.1371/journal.pone.0151112	http://dx.doi.org/10.1371/journal.pone.0151112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953588	Green Submitted, gold, Green Published			2022-12-27	WOS:000371991300084
J	Choudhury, MG; Saha, N				Choudhury, Mahua G.; Saha, Nirmalendu			Induction of Inducible Nitric Oxide Synthase by Lipopolysaccharide and the Influences of Cell Volume Changes, Stress Hormones and Oxidative Stress on Nitric Oxide Efflux from the Perfused Liver of Air-Breathing Catfish, Heteropneustes fossilis	PLOS ONE			English	Article							FRESH-WATER; IN-VIVO; ADENOSINE RELEASE; CHANNEL CATFISH; EXPRESSION; ENDOTOXIN; GENE; UREOGENESIS; EXERCISE; BIOSYNTHESIS	The air-breathing singhi catfish (Heteropneustes fossilis) is frequently being challenged by bacterial contaminants, and different environmental insults like osmotic, hyper-ammonia, dehydration and oxidative stresses in its natural habitats throughout the year. The main objectives of the present investigation were to determine (a) the possible induction of inducible nitric oxide synthase (iNOS) gene with enhanced production of nitric oxide (NO) by intra-peritoneal injection of lipopolysaccharide (LPS) (a bacterial endotoxin), and (b) to determine the effects of hepatic cell volume changes due to anisotonicity or by infusion of certain metabolites, stress hormones and by induction of oxidative stress on production of NO from the iNOS-induced perfused liver of singhi catfish. Intra-peritoneal injection of LPS led to induction of iNOS gene and localized tissue specific expression of iNOS enzyme with more production and accumulation of NO in different tissues of singhi catfish. Further, changes of hydration status/cell volume, caused either by anisotonicity or by infusion of certain metabolites such as glutamine plus glycine and adenosine, affected the NO production from the perfused liver of iNOS-induced singhi catfish. In general, increase of hydration status/cell swelling due to hypotonicity caused decrease, and decrease of hydration status/cell shrinkage due to hypertonicity caused increase of NO efflux from the perfused liver, thus suggesting that changes in hydration status/cell volume of hepatic cells serve as a potent modulator for regulating the NO production. Significant increase of NO efflux from the perfused liver was also observed while infusing the liver with stress hormones like epinephrine and norepinephrine, accompanied with decrease of hydration status/cell volume of hepatic cells. Further, oxidative stress, caused due to infusion of t-butyl hydroperoxide and hydrogen peroxide separately, in the perfused liver of singhi catfish, resulted in significant increase of NO efflux accompanied with decrease of hydration status/cell volume of hepatic cells. However, the reasons for these cell volume-sensitive changes of NO efflux from the liver of singhi catfish are not fully understood with the available data. Nonetheless, enhanced or decreased production of NO from the perfused liver under osmotic stress, in presence of stress hormones and oxidative stress reflected its potential role in cellular homeostasis and also for better adaptations under environmental challenges. This is the first report of osmosensitive and oxidative stress-induced changes of NO production and efflux from the liver of any teleosts. Further, the level of expression of iNOS in this singhi catfish could also serve as an important indicator to determine the pathological status of the external environment.	[Choudhury, Mahua G.; Saha, Nirmalendu] NE Hill Univ, Dept Zool, Biochem Adaptat Lab, Shillong 793022, Meghalaya, India	North Eastern Hill University	Saha, N (corresponding author), NE Hill Univ, Dept Zool, Biochem Adaptat Lab, Shillong 793022, Meghalaya, India.	nsaha@nehu.ac.in	Saha, Nirmalendu/AAH-7792-2021	Saha, Nirmalendu/0000-0002-9635-3024; Gupta Choudhury, Mahua/0000-0002-4586-8060	Department of Science and Technology, New Delhi; University Grants Commission, New Delhi; Department of Biotechnology, New Delhi; DSA programme to the Department of Zoology North-Eastern Hill University, Shillong; UPE-Bioscience project to the North-Eastern Hill University, Shillong	Department of Science and Technology, New Delhi(Department of Science & Technology (India)); University Grants Commission, New Delhi(University Grants Commission, India); Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); DSA programme to the Department of Zoology North-Eastern Hill University, Shillong; UPE-Bioscience project to the North-Eastern Hill University, Shillong	This study was supported by a project sanctioned to NS by the Department of Science and Technology, New Delhi, the DSA programme to the Department of Zoology and the UPE-Bioscience project to the North-Eastern Hill University, Shillong, by the University Grants Commission, New Delhi. Also this study was supported by a project sanctioned to MGC by the Department of Biotechnology, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnisola C, 2005, COMP BIOCHEM PHYS A, V142, P178, DOI 10.1016/j.cbpb.2005.05.051; Bagnyukova TV, 2006, AQUAT TOXICOL, V78, P325, DOI 10.1016/j.aquatox.2006.04.005; BERCZI I, 1966, CAN J MICROBIOL, V12, P1070, DOI 10.1139/m66-143; Bishop Russell E., 2005, V12, P1, DOI 10.1159/000081687; Biswas K, 2010, FISH PHYSIOL BIOCHEM, V36, P17, DOI 10.1007/s10695-008-9275-5; Biswas K, 2009, J EXP ZOOL PART A, V311A, P115, DOI 10.1002/jez.508; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; BRIAN JE, 1995, STROKE, V26, P277, DOI 10.1161/01.STR.26.2.277; BRIAN JE, 1995, AM J PHYSIOL-HEART C, V269, pH783, DOI 10.1152/ajpheart.1995.269.3.H783; Choudhury MG, 2012, NITRIC OXIDE-BIOL CH, V27, P219, DOI 10.1016/j.niox.2012.07.006; Choudhury MG, 2012, AQUAT TOXICOL, V116, P43, DOI 10.1016/j.aquatox.2012.03.006; Cioni C, 2002, COMP BIOCHEM PHYS B, V132, P57, DOI 10.1016/S1096-4959(01)00532-2; CRONSTEIN BN, 1993, J CLIN INVEST, V92, P2675, DOI 10.1172/JCI116884; CRONSTEIN BN, 1991, P NATL ACAD SCI USA, V88, P2441, DOI 10.1073/pnas.88.6.2441; DIGIULIO RT, 1989, ENVIRON TOXICOL CHEM, V8, P1103, DOI 10.1002/etc.5620081203; Dini L, 2006, ITAL J ZOOL, V73, P117, DOI 10.1080/11250000600679652; Dubey RK, 1998, HYPERTENSION, V31, P296, DOI 10.1161/01.HYP.31.1.296; Fiol DF, 2007, FEBS J, V274, P5790, DOI 10.1111/j.1742-4658.2007.06099.x; Fritsche R, 2000, AM J PHYSIOL-REG I, V279, pR2200, DOI 10.1152/ajpregu.2000.279.6.R2200; GALEA E, 1994, J NEUROSCI RES, V37, P406, DOI 10.1002/jnr.490370313; Gong L, 2004, CURR OPIN HEMATOL, V11, P7, DOI 10.1097/00062752-200401000-00003; GONZALEZ C, 1992, BIOCHEM BIOPH RES CO, V186, P150, DOI 10.1016/S0006-291X(05)80787-9; Goswami C, 2004, J BIOSCIENCES, V29, P337, DOI 10.1007/BF02702616; Goswami C, 1998, COMP BIOCHEM PHYS A, V119, P999, DOI 10.1016/S1095-6433(98)00017-8; Goswami C, 2006, J BIOSCIENCES, V31, P589, DOI 10.1007/BF02708411; GRAF J, 1988, RENAL PHYSIOL BIOCH, V11, P202; HALLBRUCKER C, 1993, EUR J BIOCHEM, V211, P449, DOI 10.1111/j.1432-1033.1993.tb17570.x; Haussinger D, 1996, BIOCHEM J, V313, P697; Haussinger D, 1996, PR MED BIOL, V4, P187; Heneka MT, 2001, J NEUROIMMUNOL, V114, P8, DOI 10.1016/S0165-5728(01)00246-6; HIRAI T, 1994, J APPL PHYSIOL, V77, P1288, DOI 10.1152/jappl.1994.77.3.1288; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Imbrogno S, 2001, J EXP BIOL, V204, P1719; Ito K, 2004, KIDNEY INT, V66, P1365, DOI 10.1111/j.1523-1755.2004.00899.x; Iwama George K., 2006, P319; Jaffrey SR, 1995, ANNU REV CELL DEV BI, V11, P417; Jimenez A, 2001, J CHEM NEUROANAT, V21, P289, DOI 10.1016/S0891-0618(01)00116-8; Kelly SA, 1998, ENVIRON HEALTH PERSP, V106, P375, DOI 10.2307/3434064; Knowles RG, 1998, METH MOL B, V100, P67; Li CY, 2003, ANESTH ANALG, V97, P210, DOI 10.1213/01.ANE.0000066257.38180.04; Lin WC, 2005, ANESTH ANALG, V101, P226, DOI 10.1213/01.ANE.0000153860.71992.29; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; Malyshev IY, 1998, BIOCHEMISTRY-MOSCOW+, V63, P840; Milsom WK, 1999, COMP BIOCHEM PHYS A, V124, P253, DOI 10.1016/S1095-6433(99)00113-0; MincGolomb D, 1996, J NEUROCHEM, V66, P1504; MINCGOLOMB D, 1994, BRIT J PHARMACOL, V112, P720, DOI 10.1111/j.1476-5381.1994.tb13136.x; Murakami S, 2002, J DENT RES, V81, P236, DOI 10.1177/154405910208100403; NATHAN C, 1994, J BIOL CHEM, V269, P13725; Olsson C, 1997, COMP BIOCHEM PHYS A, V118, P959, DOI 10.1016/S0300-9629(97)00025-X; OLTMAN CL, 1995, J APPL PHYSIOL, V79, P33, DOI 10.1152/jappl.1995.79.1.33; Palumbo A, 2005, COMP BIOCHEM PHYS A, V142, P241, DOI 10.1016/j.cbpb.2005.05.043; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Peatman E, 2013, MOL IMMUNOL, V56, P317, DOI 10.1016/j.molimm.2013.04.014; Perlman DF, 1999, J EXP ZOOL, V283, P725, DOI 10.1002/(SICI)1097-010X(19990601)283:7<725::AID-JEZ10>3.3.CO;2-R; Peter MCS, 2011, GEN COMP ENDOCR, V172, P198, DOI 10.1016/j.ygcen.2011.02.023; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rio DC., 2010, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; Saha N, 2007, FISH PHYSIOL BIOCHEM, V33, P283, DOI 10.1007/s10695-007-9172-3; Saha N, 2004, J BIOSCIENCES, V29, P179, DOI 10.1007/BF02703416; Saha N, 1995, COMP BIOCHEM PHYS B, V112, P733, DOI 10.1016/0305-0491(95)00115-8; SAHA N, 1989, J EXP ZOOL, V252, P1, DOI 10.1002/jez.1402520102; SAHA N, 1993, BIOCHEM J, V296, P701, DOI 10.1042/bj2960701; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sen TK, 1985, RECORDS ZOOLOGICAL S, P217; SESSA WC, 1994, CIRC RES, V74, P349, DOI 10.1161/01.RES.74.2.349; SHEN WQ, 1995, MED SCI SPORT EXER, V27, P1125; Sies H., 1985, OXIDATIVE STRESS, V1, P73, DOI DOI 10.1016/B978-0-12-642760-8.50008-9; Stratakis CA, 1995, ANN NY ACAD SCI, V771, P1, DOI 10.1111/j.1749-6632.1995.tb44666.x; Symeonides S, 1999, INFECT DIS CLIN N AM, V13, P449, DOI 10.1016/S0891-5520(05)70085-4; Tipsmark CK, 2003, J EXP BIOL, V206, P1503, DOI 10.1242/jeb.00284; Tota B, 2005, COMP BIOCHEM PHYS A, V142, P164, DOI 10.1016/j.cbpb.2005.04.019; Victor VM, 2004, INT IMMUNOPHARMACOL, V4, P327, DOI 10.1016/j.intimp.2004.01.020; VORHABEN JE, 1972, J BIOL CHEM, V247, P2763; Weimann J, 1999, ANESTHESIOLOGY, V91, P1744, DOI 10.1097/00000542-199912000-00028; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Wong J M, 1995, Adv Pharmacol, V34, P155; Yao J, 2014, DEV COMP IMMUNOL, V45, P74, DOI 10.1016/j.dci.2014.02.005; ZANCHI A, 1995, CARDIOVASC RES, V30, P122	78	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150469	10.1371/journal.pone.0150469	http://dx.doi.org/10.1371/journal.pone.0150469			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950213	gold, Green Submitted, Green Published			2022-12-27	WOS:000371990100035
J	Li, P; Zhang, GJ; Li, J; Yang, R; Chen, SS; Wu, SJ; Zhang, FR; Bai, Y; Zhao, HS; Wang, YY; Dun, SZ; Chen, XN; Sun, QQ; Zhao, GQ				Li, Ping; Zhang, Guojun; Li, Juan; Yang, Rui; Chen, Shanshan; Wu, Shujun; Zhang, Furui; Bai, Yong; Zhao, Huasi; Wang, Yuanyuan; Dun, Shaozhi; Chen, Xiaonan; Sun, Qianqian; Zhao, Guoqiang			Long Noncoding RNA RGMB-AS1 Indicates a Poor Prognosis and Modulates Cell Proliferation, Migration and Invasion in Lung Adenocarcinoma	PLOS ONE			English	Article							REPULSIVE GUIDANCE MOLECULE; PROSTATE-CANCER; HOTAIR; METASTASIS; PROTEIN; IDENTIFICATION; DRAGON; GROWTH; EXPRESSION; SURVIVAL	Lung cancer is the most common cause of cancer-related mortality worldwide. It is a complex disease involving multiple genetic and epigenetic alterations. The development of transcriptomics revealed the important role of long non-coding RNAs (lncRNAs) in lung cancer occurrence and development. Here, microarray analysis of lung adenocarcinoma tissues showed the abnormal expression of lncRNA RGMB-AS1. However, the role of lncRNA RGMB-AS1 in lung adenocarcinoma remains largely unknown. We showed that upregulation of lncRNA RGMB-AS1 was significantly correlated with differentiation, TNM stage, and lymph node metastasis. In lung adenocarcinoma cells, downregulation of lncRNA RGMB-AS1 inhibited cell proliferation, migration, invasion, and caused cell cycle arrest at the G1/G0 phase. In vivo experiments showed that lncRNA RGMB-AS1 downregulation significantly suppressed the growth of lung adenocarcinoma. The expression of lncRNA RGMB-AS1 was inversely correlated with that of repulsive guidance molecule b (RGMB) in lung adenocarcinoma tissues, and UCSC analysis and fluorescence detection assay indicated that lncRNA RGMB-AS1 may be involved in the development of human lung adenocarcinoma by regulating RGMB expression though exon2 of RGMB. In summary, our findings indicate that lncRNA RGMB-AS1 may play an important role in lung adenocarcinoma and may serve as a potential therapeutic target.	[Li, Ping; Zhang, Guojun; Li, Juan; Yang, Rui; Chen, Shanshan; Wu, Shujun; Zhang, Furui; Bai, Yong; Zhao, Huasi] Zhengzhou Univ, Dept Resp Med, Affiliated Hosp 1, Zhengzhou 450052, Henan Province, Peoples R China; [Wang, Yuanyuan; Chen, Xiaonan; Sun, Qianqian; Zhao, Guoqiang] Zhengzhou Univ, Dept Microbiol & Immunol, Coll Basic Med Sci, Zhengzhou 450052, Henan Province, Peoples R China; [Dun, Shaozhi] Zhengzhou Univ, Emergency Dept, Zhengzhou Cent Hosp, Zhengzhou 450052, Henan Province, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Zhang, GJ (corresponding author), Zhengzhou Univ, Dept Resp Med, Affiliated Hosp 1, Zhengzhou 450052, Henan Province, Peoples R China.; Zhao, GQ (corresponding author), Zhengzhou Univ, Dept Microbiol & Immunol, Coll Basic Med Sci, Zhengzhou 450052, Henan Province, Peoples R China.	gjzhangzzu@126.com; zhaogq@zzu.edu.cn	Chen, Xiaonan/AGX-9058-2022	Chen, Xiaonan/0000-0003-0680-546X	Ministry of Major Science & Technology of Henan [201401005]	Ministry of Major Science & Technology of Henan	This study was supported by Ministry of Major Science & Technology of Henan (201401005).	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Berrondo C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147236; Bida O, 2015, ONCOTARGET, V6, P27880, DOI 10.18632/oncotarget.4944; Chen SS, 2015, CELL PHYSIOL BIOCHEM, V35, P997, DOI 10.1159/000369755; Cui WR, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S7-S3; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fang S, 2016, LAB INVEST, V96, P60, DOI 10.1038/labinvest.2015.123; Hung CL, 2014, P NATL ACAD SCI USA, V111, P18697, DOI 10.1073/pnas.1415669112; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kabbout M, 2013, CLIN CANCER RES, V19, P3383, DOI 10.1158/1078-0432.CCR-13-0341; Kanomata K, 2009, GENES CELLS, V14, P695, DOI 10.1111/j.1365-2443.2009.01302.x; Khandelwal A, 2015, MOL CARCINOGEN, V54, P1235, DOI 10.1002/mc.22362; Kim HJ, 2015, INT J ONCOL, V46, P521, DOI 10.3892/ijo.2014.2758; Li J, 2012, J CELL BIOCHEM, V113, P2523, DOI 10.1002/jcb.24128; Li J, 2012, INT J ONCOL, V40, P544, DOI 10.3892/ijo.2011.1251; Li J, 2011, ANTICANCER RES, V31, P1703; Li J, 2015, TUMOR BIOL, V36, P685, DOI 10.1007/s13277-014-2698-y; Liu XH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-464; Liu ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077293; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Nakagawa T, 2013, BIOCHEM BIOPH RES CO, V436, P319, DOI 10.1016/j.bbrc.2013.05.101; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Ono H, 2014, CANCER MED-US, V3, P632, DOI 10.1002/cam4.220; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718; Qiu JJ, 2014, GYNECOL ONCOL, V134, P121, DOI 10.1016/j.ygyno.2014.03.556; Saji H, 2013, ONCOL REP, V29, P1902, DOI 10.3892/or.2013.2332; Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Severyn CJ, 2009, BIOCHEM J, V422, P393, DOI 10.1042/BJ20090978; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang WB, 2002, ACTA BIOCH BIOPH SIN, V34, P273; Wang Y, 2015, P NATL ACAD SCI USA, V112, pE3883, DOI 10.1073/pnas.1501662112; Xia T, 2015, SCI REP-UK, V5, DOI 10.1038/srep13445; Xu C, 2013, CANCER RES, V73, P3181, DOI 10.1158/0008-5472.CAN-12-4403	38	39	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150790	10.1371/journal.pone.0150790	http://dx.doi.org/10.1371/journal.pone.0150790			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950071	gold, Green Published, Green Submitted			2022-12-27	WOS:000371990100061
J	Ruas, JS; Siqueira-Santos, ES; Amigo, I; Rodrigues-Silva, E; Kowaltowski, AJ; Castilho, RF				Ruas, Juliana S.; Siqueira-Santos, Edilene S.; Amigo, Ignacio; Rodrigues-Silva, Erika; Kowaltowski, Alicia J.; Castilho, Roger F.			Underestimation of the Maximal Capacity of the Mitochondrial Electron Transport System in Oligomycin-Treated Cells	PLOS ONE			English	Article							ATP SYNTHASE; CANCER; CITREOVIRIDIN; INHIBITOR; DEHYDROGENASE; RESPIRATION; METABOLISM; BIOLOGY; TUMORS; TOXIN	The maximal capacity of the mitochondrial electron transport system (ETS) in intact cells is frequently estimated by promoting protonophore-induced maximal oxygen consumption preceded by inhibition of oxidative phosphorylation by oligomycin. In the present study, human glioma (T98G and U-87MG) and prostate cancer (PC-3) cells were titrated with different concentrations of the protonophore CCCP to induce maximal oxygen consumption rate (OCR) within respirometers in a conventional growth medium. The results demonstrate that the presence of oligomycin or its A-isomer leads to underestimation of maximal ETS capacity. In the presence of oligomycin, the spare respiratory capacity (SRC), i.e., the difference between the maximal and basal cellular OCR, was underestimated by 25 to 45%. The inhibitory effect of oligomycin on SRC was more pronounced in T98G cells and was observed in both suspended and attached cells. Underestimation of SRC also occurred when oxidative phosphorylation was fully inhibited by the ATP synthase inhibitor citreoviridin. Further experiments indicated that oligomycin cannot be replaced by the adenine nucleotide translocase inhibitors bongkrekic acid or carboxyatractyloside because, although these compounds have effects in permeabilized cells, they do not inhibit oxidative phosphorylation in intact cells. We replaced CCCP by FCCP, another potent protonophore and similar results were observed. Lower maximal OCR and SRC values were obtained with the weaker protonophore 2,4-dinitrophenol, and these parameters were not affected by the presence of oligomycin. In permeabilized cells or isolated brain mitochondria incubated with respiratory substrates, only a minor inhibitory effect of oligomycin on CCCP-induced maximal OCR was observed. We conclude that unless a previously validated protocol is employed, maximal ETS capacity in intact cells should be estimated without oligomycin. The inhibitory effect of an ATP synthase blocker on potent protonophore-induced maximal OCR may be associated with impaired metabolism of mitochondrial respiratory substrates.	[Ruas, Juliana S.; Siqueira-Santos, Edilene S.; Rodrigues-Silva, Erika; Castilho, Roger F.] Univ Estadual Campinas, UNICAMP, Dept Patol Clin, Fac Ciencias Med, Campinas, SP, Brazil; [Amigo, Ignacio; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, SP, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo	Castilho, RF (corresponding author), Univ Estadual Campinas, UNICAMP, Dept Patol Clin, Fac Ciencias Med, Campinas, SP, Brazil.	roger@fcm.unicamp.br	Ruas, Juliana Silveira/M-9293-2019; Kowaltowski, Alicia J/H-8698-2012; Castilho, Roger F/G-3906-2012	Ruas, Juliana Silveira/0000-0002-5967-5235; Castilho, Roger/0000-0003-2338-8717	Sao Paulo Research Foundation (FAPESP) [11/50400-0, 10/51906-1, 13/07937-8]; Brazilian National Council for Scientific and Technological Development (CNPq); CAPES; FAPESP [12/51288-1]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from the Sao Paulo Research Foundation (FAPESP, #11/50400-0, #10/51906-1 and #13/07937-8) and the Brazilian National Council for Scientific and Technological Development (CNPq). JSR and ER-S are recipients of CAPES fellowships and IA is recipient of a FAPESP (#12/51288-1) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Castilho RF, 1998, J NEUROSCI, V18, P10277; CHANCE B, 1963, J BIOL CHEM, V238, P439; Chinopoulos C, 2011, FEBS LETT, V585, P1255, DOI 10.1016/j.febslet.2011.04.004; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Chweih H, 2015, EXP PHYSIOL, V100, P1073, DOI 10.1113/EP085248; DATTA SC, 1981, FOLIA MICROBIOL, V26, P408, DOI 10.1007/BF02927336; DATTA SC, 1981, TOXICON, V19, P217, DOI 10.1016/0041-0101(81)90024-6; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Devenish RJ, 2000, J BIOENERG BIOMEMBR, V32, P507, DOI 10.1023/A:1005621125812; Feniouk Boris A., 2008, V45, P279, DOI 10.1007/400_2007_043; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; GABRIEL JL, 1986, METABOLISM, V35, P661, DOI 10.1016/0026-0495(86)90175-7; GAUSE EM, 1981, J BIOL CHEM, V256, P557; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hao WS, 2010, J BIOL CHEM, V285, P12647, DOI 10.1074/jbc.M109.084194; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HENDERSON PJ, 1970, J BIOL CHEM, V245, P1319; HERS HG, 1982, BIOCHEM J, V206, P1; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; Israel M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-70; Ivanes F, 2014, BRIT J PHARMACOL, V171, P4193, DOI 10.1111/bph.12638; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; LARDY HA, 1965, BIOCHEMISTRY-US, V4, P552, DOI 10.1021/bi00879a027; Li M, 2012, ARCH BIOCHEM BIOPHYS, V519, P69, DOI 10.1016/j.abb.2011.10.015; LINNETT PE, 1978, BIOCHEM J, V170, P503, DOI 10.1042/bj1700503; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; Maldonado EN, 2014, MITOCHONDRION, V19, P78, DOI 10.1016/j.mito.2014.09.002; Michelini LGB, 2015, NEUROSCI LETT, V589, P25, DOI 10.1016/j.neulet.2015.01.030; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Obre E, 2015, INT J BIOCHEM CELL B, V59, P167, DOI 10.1016/j.biocel.2014.12.008; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; ROBERTON AM, 1968, BIOCHEM J, V108, P445, DOI 10.1042/bj1080445; ROSENTHAL RE, 1987, J CEREBR BLOOD F MET, V7, P752, DOI 10.1038/jcbfm.1987.130; Senyilmaz Deniz, 2015, F1000Prime Rep, V7, P41, DOI 10.12703/P7-41; SteinlechnerMaran R, 1996, AM J PHYSIOL-CELL PH, V271, pC2053, DOI 10.1152/ajpcell.1996.271.6.C2053; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Traba J, 2012, CELL DEATH DIFFER, V19, P650, DOI 10.1038/cdd.2011.139; Viale A, 2015, CANCER RES, V75, P3687, DOI 10.1158/0008-5472.CAN-15-0491; VIGNAIS PV, 1973, BIOCHEMISTRY-US, V12, P1508, DOI 10.1021/bi00732a007; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; WILLIAMSON JR, 1980, FEBS LETT, V117, pK73, DOI 10.1016/0014-5793(80)80572-2; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003	51	44	44	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150967	10.1371/journal.pone.0150967	http://dx.doi.org/10.1371/journal.pone.0150967			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950698	Green Submitted, Green Published, gold			2022-12-27	WOS:000371990100075
J	Watanabe, N; Kaminuma, O; Kitamura, N; Hiroi, T				Watanabe, Nobumasa; Kaminuma, Osamu; Kitamura, Noriko; Hiroi, Takachika			Induced Treg Cells Augment the Th17-Mediated Intestinal Inflammatory Response in a CTLA4-Dependent Manner	PLOS ONE			English	Article							REGULATORY T-CELLS; TH17 CELLS; FUNCTIONAL SPECIALIZATION; ULCERATIVE-COLITIS; CROHNS-DISEASE; ORAL TOLERANCE; T(H)17 CELLS; TGF-BETA; IN-VITRO; TH2	Th17 cells and Foxp3(+) regulatory T cells (Tregs) are thought to promote and suppress inflammatory responses, respectively. However, whether they counteract each other or synergize in regulating immune reactions remains controversial. To determine their interactions, we describe the results of experiments employing mouse models of intestinal inflammation by transferring antigen-specific Th cells (Th1, Th2, and Th17) differentiated in vitro followed by the administration of the cognate antigen via enema. We show that cotransfer of induced Tregs (iTregs) suppressed Th1- and Th2-mediated colon inflammation. In contrast, colon inflammation induced by transfer of Th17 cells, was augmented by the cotransfer of iTregs. Furthermore, oral delivery of antigen potentiated Th17-mediated colon inflammation. Administration of a blocking antibody against cytotoxic T lymphocyte-associated antigen 4 (CTLA4) abrogated the effects of cotransfer of iTregs, while the injection of a soluble recombinant immunoglobulin (Ig) fusion protein, CTLA4-Ig substituted for the cotransfer of iTregs. These results suggest that antigen-specific activation of iTregs in a local environment stimulates the Th17-mediated inflammatory response in a CTLA4-dependent manner.	[Watanabe, Nobumasa; Kaminuma, Osamu; Kitamura, Noriko; Hiroi, Takachika] Tokyo Metropolitan Inst Med Sci, Allergy & Immunol Project, Tokyo 113, Japan	Tokyo Metropolitan Institute of Medical Science	Hiroi, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Allergy & Immunol Project, Tokyo 113, Japan.	hiroi-tk@igakuken.or.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [GMC0009]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	Support was provided by a Genomics for agricultural innovation GMC0009 project grant (TH) and Agri-Health 2 (TH) from the Ministry of Agriculture, Forestry and Fisheries of Japan.	Amezcua-Guerra LM, 2006, GUT, V55, P1059, DOI 10.1136/gut.2006.095539; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bouguermouh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005087; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Chang SH, 2014, P NATL ACAD SCI USA, V111, P5664, DOI 10.1073/pnas.1319051111; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen X, 2014, J LEUKOCYTE BIOL, V95, P723, DOI 10.1189/jlb.1213633; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Delisle JS, 2013, GENES IMMUN, V14, P115, DOI 10.1038/gene.2012.63; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Girtsman T, 2010, J LEUKOCYTE BIOL, V88, P537, DOI 10.1189/jlb.0110044; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Huter EN, 2008, J IMMUNOL, V181, P8209, DOI 10.4049/jimmunol.181.12.8209; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kaminuma O, 2012, CLIN EXP ALLERGY, V42, P315, DOI 10.1111/j.1365-2222.2011.03847.x; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Mayer L, 2004, NAT REV IMMUNOL, V4, P407, DOI 10.1038/nri1370; Moore-Connors JM, 2013, J IMMUNOL, V191, P3430, DOI 10.4049/jimmunol.1301136; Moreland L, 2006, NAT REV DRUG DISCOV, V5, P185, DOI 10.1038/nrd1989; Motohashi R, 2014, SCAND J GASTROENTERO, V49, P1270, DOI 10.3109/00365521.2014.946087; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Neurath MF, 2009, IMMUNITY, V31, P357, DOI 10.1016/j.immuni.2009.08.016; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Rosenblum MD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003504; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sandborn WJ, 2012, GASTROENTEROLOGY, V143, P62, DOI 10.1053/j.gastro.2012.04.010; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Stummvoll GH, 2008, J IMMUNOL, V181, P1908, DOI 10.4049/jimmunol.181.3.1908; Tian L, 2011, BLOOD, V118, P1845, DOI 10.1182/blood-2011-04-346056; Tsuji NM, 2008, TRENDS IMMUNOL, V29, P532, DOI 10.1016/j.it.2008.09.002; van de Veerdonk FL, 2009, BMB REP, V42, P776, DOI 10.5483/BMBRep.2009.42.12.776; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vokaer BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076040; Vokaer B, 2010, J IMMUNOL, V185, P3417, DOI 10.4049/jimmunol.0903961; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Wing JB, 2014, INT IMMUNOL, V26, P61, DOI 10.1093/intimm/dxt060; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496	51	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150244	10.1371/journal.pone.0150244	http://dx.doi.org/10.1371/journal.pone.0150244			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950218	gold, Green Published, Green Submitted			2022-12-27	WOS:000371990100026
J	Whitworth, A; Villacampa, J; Brown, A; Huarcaya, RP; Downie, R; MacLeod, R				Whitworth, Andrew; Villacampa, Jaime; Brown, Alice; Pillco Huarcaya, Ruthmery; Downie, Roger; MacLeod, Ross			Past Human Disturbance Effects upon Biodiversity are Greatest in the Canopy; A Case Study on Rainforest Butterflies	PLOS ONE			English	Article							VERTICAL STRATIFICATION; SPECIES RICHNESS; LAND-USE; COMMUNITY; HABITAT; DIVERSITY; SECONDARY; RESPONSES; ECOLOGY; CHRONOSEQUENCE	A key part of tropical forest spatial complexity is the vertical stratification of biodiversity, with widely differing communities found in higher rainforest strata compared to terrestrial levels. Despite this, our understanding of how human disturbance may differentially affect biodiversity across vertical strata of tropical forests has been slow to develop. For the first time, how the patterns of current biodiversity vary between three vertical strata within a single forest, subject to three different types of historic anthropogenic disturbance, was directly assessed. In total, 229 species of butterfly were detected, with a total of 5219 individual records. Butterfly species richness, species diversity, abundance and community evenness differed markedly between vertical strata. We show for the first time, for any group of rainforest biodiversity, that different vertical strata within the same rainforest, responded differently in areas with different historic human disturbance. Differences were most notable within the canopy. Regenerating forest following complete clearance had 47% lower canopy species richness than regenerating forest that was once selectively logged, while the reduction in the mid-storey was 33% and at ground level, 30%. These results also show for the first time that even long term regeneration (over the course of 30 years) may be insufficient to erase differences in biodiversity linked to different types of human disturbance. We argue, along with other studies, that ignoring the potential for more pronounced effects of disturbance on canopy fauna, could lead to the underestimation of the effects of habitat disturbance on biodiversity, and thus the overestimation of the conservation value of regenerating forests more generally.	[Whitworth, Andrew; Downie, Roger; MacLeod, Ross] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Whitworth, Andrew; Villacampa, Jaime; Brown, Alice; Pillco Huarcaya, Ruthmery] Crees Fdn, Urb Mariscal Gamarra B-5,Zona 1, Cuzco, Peru; [Pillco Huarcaya, Ruthmery] Univ Nacl San Antonio Abad Cusco, Cuzco, Peru	University of Glasgow; Universidad Nacional de San Antonio Abad del Cusco	Whitworth, A (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.; Whitworth, A (corresponding author), Crees Fdn, Urb Mariscal Gamarra B-5,Zona 1, Cuzco, Peru.	andy.w.whitworth@gmail.com		Pillco Huarcaya, Ruthmery/0000-0003-0068-3852; Whitworth, Andrew/0000-0001-6197-996X; Macleod, Ross/0000-0001-5508-0202	Crees Foundation; TJMF Foundation; University of Glasgow	Crees Foundation; TJMF Foundation; University of Glasgow	The Crees Foundation (www.crees-manu.org) and its director Quinn Meyer have supported this research as part of their conservation and biodiversity monitoring programme and the University of Glasgow have supported field work conducted at the Manu Learning Centre. The TJMF Foundation provided crucial support for this work through their Amazon Research Programme grant to the University of Glasgow. The Darwin Initiative provided financial support of the Sustainable Manu project, a collaborative initiative between the Crees Foundation and The University of Glasgow that supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aduse-Poku K, 2012, AFR J ECOL, V50, P326, DOI 10.1111/j.1365-2028.2012.01328.x; Affre L, 2010, BIOL INVASIONS, V12, P2537, DOI 10.1007/s10530-009-9662-6; Armstrong Claire, 2010, Plymouth Student Scientist, V3, P3; Austin George T., 1995, Tropical Lepidoptera, V6, P5; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Basset Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144110; Beirne C, 2013, HERPETOL J, V23, P209; Bonebrake TC, 2010, BIOL CONSERV, V143, P1831, DOI 10.1016/j.biocon.2010.04.044; Bowen ME, 2007, BIOL CONSERV, V140, P273, DOI 10.1016/j.biocon.2007.08.012; Bruton MJ, 2013, BIOL CONSERV, V165, P95, DOI 10.1016/j.biocon.2013.05.018; Colwell R. K., 2013, STAT ESTIMATION SPEC; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Cortes-Gomez AM, 2013, TROP CONSERV SCI, V6, P749, DOI 10.1177/194008291300600604; de Faria Lopes S, 2014, BIOSCIENCE J, V30; de la Pena-Domene M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104656; DeVries PJ, 1997, BIOL J LINN SOC, V62, P343, DOI 10.1111/j.1095-8312.1997.tb01630.x; Devries PJ, 2001, BIOL J LINN SOC, V74, P1, DOI 10.1006/bijl.2001.0571; DeVries PJ, 1999, BIOL J LINN SOC, V67, P73, DOI 10.1111/j.1095-8312.1999.tb01930.x; Devy MS, 2001, CURR SCI INDIA, V80, P400; Dumbrell AJ, 2005, BIOL CONSERV, V125, P123, DOI 10.1016/j.biocon.2005.02.016; Edwards DP, 2014, TRENDS ECOL EVOL, V29, P511, DOI 10.1016/j.tree.2014.07.003; Fermon H, 2005, BIODIVERS CONSERV, V14, P333, DOI 10.1007/s10531-004-5354-9; FRANCIS CM, 1994, J TROP ECOL, V10, P523, DOI 10.1017/S0266467400008191; GARDNER T, 2012, MONITORING FOREST BI; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gotelli Nicholas J., 2011, P39; Haefke Brandon J., 2013, Transactions of the Kansas Academy of Science, V116, P119; Hall JPW, 2000, BIOL J LINN SOC, V69, P1, DOI 10.1111/j.1095-8312.2000.tb01666.x; Hamer KC, 2003, J APPL ECOL, V40, P150, DOI 10.1046/j.1365-2664.2003.00783.x; Heffner RA, 1996, ECOLOGY, V77, P2558, DOI 10.2307/2265754; Hilje B, 2012, BIOL CONSERV, V146, P170, DOI 10.1016/j.biocon.2011.12.007; Hill JK, 1995, J APPL ECOL, V32, P754, DOI 10.2307/2404815; Hill JK, 2001, OECOLOGIA, V128, P294, DOI 10.1007/s004420100651; Horner-Devine MC, 2003, CONSERV BIOL, V17, P168, DOI 10.1046/j.1523-1739.2003.01310.x; Hu Y, 2013, BIOL CONSERV, V166, P76, DOI 10.1016/j.biocon.2013.05.019; Hughes JB, 1998, REV BIOL TROP, V46, P697; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Kays R, 2001, PLANT ECOL, V153, P109, DOI 10.1023/A:1017585622940; Klimes P, 2012, J ANIM ECOL, V81, P1103, DOI 10.1111/j.1365-2656.2012.02002.x; Koh LP, 2008, J APPL ECOL, V45, P1002, DOI 10.1111/j.1365-2664.2008.01491.x; Kudavidanage EP, 2012, ANIM CONSERV, V15, P253, DOI 10.1111/j.1469-1795.2011.00507.x; Letcher SG, 2009, BIOTROPICA, V41, P608, DOI 10.1111/j.1744-7429.2009.00517.x; Lewis OT, 2001, CONSERV BIOL, V15, P389, DOI 10.1046/j.1523-1739.2001.015002389.x; Linden VMG, 2014, ACTA CHIROPTEROL, V16, P27, DOI 10.3161/150811014X683246; Maguire DY, 2014, ENVIRON ENTOMOL, V43, P9, DOI 10.1603/EN13056; Oksanen J., 2016, R PACKAG; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Posa MRC, 2006, BIOL CONSERV, V129, P256, DOI 10.1016/j.biocon.2005.10.041; R Core Team, 2012, R LANG ENV STAT COMP; Ramage BS, 2013, CONSERV BIOL, V27, P364, DOI 10.1111/cobi.12004; Reese GC, 2014, GLOBAL ECOL BIOGEOGR, V23, P585, DOI 10.1111/geb.12144; Ribeiro DB, 2012, J INSECT CONSERV, V16, P733, DOI 10.1007/s10841-012-9458-3; Ribeiro DB, 2016, AUSTRAL ENTOMOL, V55, P112, DOI 10.1111/aen.12157; Robbins R.K., 1996, TAXONOMIC COMPOSITIO, P217; Ross KA, 2002, J BIOGEOGR, V29, P749, DOI 10.1046/j.1365-2699.2002.00722.x; Rossi J. P., 2011, Diversity, V3, P112, DOI 10.3390/d3010112; Seshadri KS, 2014, BIOTROPICA, V46, P615, DOI 10.1111/btp.12141; Sourakov Andrei, 1995, Tropical Lepidoptera, V6, P1; Tregidgo DJ, 2010, BIOTROPICA, V42, P521, DOI 10.1111/j.1744-7429.2010.00649.x; Trimble MJ, 2014, ANIM CONSERV, V17, P441, DOI 10.1111/acv.12111; von May R, 2009, AUSTRAL ECOL, V34, P613, DOI 10.1111/j.1442-9993.2009.01965.x; Walther BA, 2002, J ORNITHOL, V143, P64, DOI 10.1007/BF02465460; Whitworth A, DATA HIST HUMAN DIST, DOI [10.5525/gla.researchdata.2412015, DOI 10.5525/GLA.RESEARCHDATA.2412015]; Whitworth A, 2016, TROPICAL CO IN PRESS; Whitworth A, 2015, BIODIVERS CONSERV, V24, P1657, DOI 10.1007/s10531-015-0883-y	67	19	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150520	10.1371/journal.pone.0150520	http://dx.doi.org/10.1371/journal.pone.0150520			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950438	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000371990100037
J	Ahmad, A; Sattar, MA; Rathore, HA; Abdulla, MH; Khan, SA; Azam, M; Abdullah, NA; Johns, EJ				Ahmad, Ashfaq; Sattar, Munavvar A.; Rathore, Hassaan A.; Abdulla, Mohammed H.; Khan, Safia A.; Azam, Maleeha; Abdullah, Nor A.; Johns, Edward J.			Up Regulation of cystathione gamma lyase and Hydrogen Sulphide in the Myocardium Inhibits the Progression of Isoproterenol-Caffeine Induced Left Ventricular Hypertrophy in Wistar Kyoto Rats	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RAT; INDUCED CARDIAC-HYPERTROPHY; INDUCED OXIDATIVE STRESS; SMOOTH-MUSCLE-CELLS; HEART-FAILURE; NITRIC-OXIDE; ARTERIAL STIFFNESS; PRESSURE-OVERLOAD; ENDOTHELIAL-CELLS; GENE-EXPRESSION	Hydrogen sulphide (H2S) is an emerging molecule in many cardiovascular complications but its role in left ventricular hypertrophy (LVH) is unknown. The present study explored the effect of exogenous H2S administration in the regression of LVH by modulating oxidative stress, arterial stiffness and expression of cystathione gamma lyase (CSE) in the myocardium. Animals were divided into four groups: Control, LVH, Control-H2S and LVH-H2S. LVH was induced by administering isoprenaline (5mg/kg, every 72 hours, S/C) and caffeine in drinking water (62mg/L) for 2 weeks. Intraperitoneal NaHS, 56 mu M/kg/day for 5 weeks, was given as an H2S donor. Myocardial expression of Cystathione gamma lyase (CSE) mRNA was quantified using real time polymerase chain reaction (qPCR). There was a 3 fold reduction in the expression of myocardial CSE mRNA in LVH but it was up regulated by 7 and 4 fold in the Control-H2S and LVH-H2S myocardium, respectively. Systolic blood pressure, mean arterial pressure, pulse wave velocity were reduced (all P<0.05) in LVH-H2S when compared to the LVH group. Heart, LV weight, myocardial thickness were reduced while LV internal diameter was increased (all P<0.05) in the LVH-H2S when compared to the LVH group. Exogenous administration of H2S in LVH increased superoxide dismutase, glutathione and total antioxidant capacity but significantly reduced (all P<0.05) plasma malanodialdehyde in the LVH-H2S compared to the LVH group. The renal cortical blood perfusion increased by 40% in LVH-H2S as compared to the LVH group. Exogenous administration of H2S suppressed the progression of LVH which was associated with an up regulation of myocardial CSE mRNA/H2S and a reduction in pulse wave velocity with a blunting of systemic hemodynamic. This CSE/H2S pathway exhibits an antihypertrophic role by antagonizing the hypertrophic actions of angiotensin II(Ang II) and noradrenaline (NA) but attenuates oxidative stress and improves pulse wave velocity which helps to suppress LVH. Exogenous administration of H2S augmented the reduced renal cortical blood perfusion in the LVH state.	[Ahmad, Ashfaq; Sattar, Munavvar A.; Rathore, Hassaan A.; Khan, Safia A.] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia; [Abdulla, Mohammed H.; Johns, Edward J.] Natl Univ Ireland Univ Coll Cork, Dept Physiol, Cork, Ireland; [Azam, Maleeha] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Abdullah, Nor A.] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia	Universiti Sains Malaysia; University College Cork; COMSATS University Islamabad (CUI); Universiti Malaya	Ahmad, A; Sattar, MA (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia.	raza_chohan487@hotmail.com; munavvar@usm.my	Rathore, Hassaan Anwer/P-1407-2015; Azam, Maleeha/AAD-9924-2022; Abdulla, Mohammed H./V-4987-2019; ABDULLAH, NOR AZIZAN/B-9302-2010; Rathore, Hassaan A/A-6016-2012; Azam, Maleeha/L-1721-2017	Rathore, Hassaan Anwer/0000-0002-1154-9395; Abdulla, Mohammed H./0000-0001-5496-5017; Rathore, Hassaan A/0000-0002-1154-9395; Azam, Maleeha/0000-0003-0170-3325	Institute of Postgraduate Studies (IPS) [1002/JHEA/ATSG4001]; USM-RU grant [1001/PFARMASI/815078]; HIR grant [UM.0000069/HIR.C3]	Institute of Postgraduate Studies (IPS); USM-RU grant; HIR grant	The Institute of Postgraduate Studies (IPS) is acknowledged for the provision of a USM fellowship (Teaching) to Ashfaq Ahmad (APEX (1002/JHEA/ATSG4001). The authors fully acknowledge USM-RU grant no. 1001/PFARMASI/815078 and HIR grant UM.0000069/HIR.C3 for this work.	Ahmad A, 2015, INDIAN J PHARMACOL, V47, P243, DOI 10.4103/0253-7613.157106; Ahmad A, 2014, CAN J PHYSIOL PHARM, V92, P1029, DOI 10.1139/cjpp-2014-0236; Ali MY, 2006, BRIT J PHARMACOL, V149, P625, DOI 10.1038/sj.bjp.0706906; Bell DG, 2001, MED SCI SPORT EXER, V33, P1399, DOI 10.1097/00005768-200108000-00024; Beltowski J., 2010, Cardiovascular & Hematological Agents in Medicinal Chemistry, V8, P173; Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; BING OHL, 1995, J MOL CELL CARDIOL, V27, P383, DOI 10.1016/S0022-2828(08)80035-1; Buckley MMJ, 2011, IMPACT L NAME CARDIO; Cannino G, 2009, MITOCHONDRION, V9, P471, DOI 10.1016/j.mito.2009.08.007; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; COLEMAN JE, 1967, J BIOL CHEM, V242, P5212; COLLOMP K, 1991, INT J SPORTS MED, V12, P439, DOI 10.1055/s-2007-1024710; DEVEREUX RB, 1983, CIRCULATION, V68, P470, DOI 10.1161/01.CIR.68.3.470; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Fagard RH, 2009, HYPERTENSION, V54, P1084, DOI 10.1161/HYPERTENSIONAHA.109.136655; Flanagan ET, 2008, EXP PHYSIOL, V93, P1058, DOI 10.1113/expphysiol.2008.043216; Gao L, 2004, CIRC RES, V95, P937, DOI 10.1161/01.RES.0000146676.04359.64; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Gwathmey JK, 1999, AM J PHYSIOL-HEART C, V276, pH1678, DOI 10.1152/ajpheart.1999.276.5.H1678; Han Y, 2005, BRAIN RES, V1058, P82, DOI 10.1016/j.brainres.2005.07.055; Hassan MI, 2012, BRIT J PHARMACOL, V166, P2231, DOI 10.1111/j.1476-5381.2012.01949.x; Hori M, 2008, CARDIOVASCULAR RES; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Huang JL, 2012, MOL MED REP, V5, P923, DOI 10.3892/mmr.2012.748; Indolfi C, 2002, CIRCULATION, V106, P2118, DOI 10.1161/01.CIR.0000034047.70205.97; Jou SB, 1997, J AUTONOM NERV SYST, V66, P126, DOI 10.1016/S0165-1838(97)00069-6; Kao MPC, 2010, J HUM HYPERTENS, V24, P1, DOI 10.1038/jhh.2009.70; Kelm M, 1996, J HYPERTENS, V14, P1357, DOI 10.1097/00004872-199611000-00015; Kimura H, 2015, NITRIC OXIDE-BIOL CH, V46, P1, DOI 10.1016/j.niox.2014.10.001; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; KOBAYASHI R, 1993, HYPERTENSION, V21, P1051, DOI 10.1161/01.HYP.21.6.1051; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Laggner H, 2007, J HYPERTENS, V25, P2100, DOI 10.1097/HJH.0b013e32829b8fd0; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Leenen FHH, 2001, AM J PHYSIOL-HEART C, V281, pH2410, DOI 10.1152/ajpheart.2001.281.6.H2410; Caldas FRL, 2015, J CARDIOVASC PHARM, V65, P393, DOI 10.1097/FJC.0000000000000210; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Santiago Luis F, 2007, J Mol Cell Cardiol, V43, P636, DOI 10.1016/j.yjmcc.2007.07.062; Lu M, 2010, J AM SOC NEPHROL, V21, P993, DOI 10.1681/ASN.2009090949; Mahmud A, 2004, J RENIN-ANGIO-ALDO S, V5, P102, DOI 10.3317/jraas.2004.025; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; McLerie M, 2003, J MOL CELL CARDIOL, V35, P367, DOI 10.1016/S0022-2828(03)00014-2; Mitchell GF, 1997, J APPL PHYSIOL, V82, P203, DOI 10.1152/jappl.1997.82.1.203; Moore PK, 2003, TRENDS PHARMACOL SCI, V24, P609, DOI 10.1016/j.tips.2003.10.007; Muellner MK, 2009, BIOCHEM J, V420, P277, DOI 10.1042/BJ20082421; Muthuramu I, 2015, J MOL MED, V93, P609, DOI 10.1007/s00109-015-1281-3; Muzaffar S, 2008, J VASC RES, V45, P521, DOI 10.1159/000129686; Nabeebaccus A, 2011, HEART FAIL REV, V16, P5, DOI 10.1007/s10741-010-9186-2; PFEFFER JM, 1982, P NATL ACAD SCI-BIOL, V79, P3310, DOI 10.1073/pnas.79.10.3310; Plantinga Y, 2007, AM J HYPERTENS, V20, P392, DOI 10.1016/j.amjhyper.2006.09.021; Rector TS, 1996, CIRCULATION, V93, P2135, DOI 10.1161/01.CIR.93.12.2135; Romero JC, 1999, HYPERTENSION, V34, P943, DOI 10.1161/01.HYP.34.4.943; Ruzicka M, 1999, HEART FAIL REV, V3, P169; Santha P, 2012, IDEGGYOGY SZEMLE, V65, P195; Schreier SM, 2010, NEUROTOX RES, V17, P249, DOI 10.1007/s12640-009-9099-9; Schulman SP, 2006, JAMA-J AM MED ASSOC, V295, P58, DOI 10.1001/jama.295.1.58; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Sun YG, 2008, CARDIOVASC RES, V79, P632, DOI 10.1093/cvr/cvn140; Swarup KRLA, 2010, PHARMACOGN RES, V2, P31, DOI 10.4103/0974-8490.60582; Tang Chaoshu, 2006, Current Vascular Pharmacology, V4, P17; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Tyagi N, 2009, ANTIOXID REDOX SIGN, V11, P25, DOI 10.1089/ars.2008.2073; Wagner CA, 2009, J NEPHROL, V22, P173; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2009, KIDNEY INT, V76, P700, DOI 10.1038/ki.2009.221; Wei HL, 2008, ACTA PHARMACOL SIN, V29, P670, DOI 10.1111/j.1745-7254.2008.00796.x; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Whiteman M, 2009, J CELL MOL MED, V13, P488, DOI 10.1111/j.1582-4934.2009.00645.x; Wilkinson IB, 2002, CIRCULATION, V105, P213, DOI 10.1161/hc0202.101970; Xia M, 2009, J PHARMACOL EXP THER, V329, P1056, DOI 10.1124/jpet.108.149963; Yan H, 2004, BIOCHEM BIOPH RES CO, V313, P22, DOI 10.1016/j.bbrc.2003.11.081; Yan SK, 2006, BIOCHEM BIOPH RES CO, V351, P485, DOI 10.1016/j.bbrc.2006.10.058; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yasunari K., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P61, DOI 10.2174/1568016052773342; Yong QC, 2008, J MOL CELL CARDIOL, V44, P701, DOI 10.1016/j.yjmcc.2008.01.007; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	81	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150137	10.1371/journal.pone.0150137	http://dx.doi.org/10.1371/journal.pone.0150137			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963622	gold, Green Published			2022-12-27	WOS:000371993000025
J	Bae, C; Suchyna, TM; Ziegler, L; Sachs, F; Gottlieb, PA				Bae, Chilman; Suchyna, Thomas M.; Ziegler, Lynn; Sachs, Frederick; Gottlieb, Philip A.			Human PIEZO1 Ion Channel Functions as a Split Protein	PLOS ONE			English	Article							CATION CHANNELS; MERKEL CELLS; MUTATIONS; ARCHITECTURE; DOMAINS	PIEZO1 is a mechanosensitive eukaryotic cation-selective channel that rapidly inactivates in a voltage-dependent manner. We previously showed that a fluorescent protein could be encoded within the hPIEZO1 sequence without loss of function. In this work, we split the channel into two at this site and asked if coexpression would produce a functional channel or whether gating and permeation might be contained in either segment. The split protein was expressed in two segments by a bicistronic plasmid where the first segment spanned residues 1 to 1591, and the second segment spanned 1592 to 2521. When the "split protein" is coexpressed, the parts associate to form a normal channel. We measured the whole-cell, cell-attached and outside-out patch currents in transfected HEK293 cells. Indentation produced whole-cell currents monotonic with the stimulus. Single channel recordings showed voltage-dependent inactivation. The Boltzmann activation curve for outside-out patches had a slope of 8.6/mmHg vs 8.1 for wild type, and a small leftward shift in the midpoint (32 mmHg vs 41 mmHg). The association of the two channel domains was confirmed by FRET measurements of mCherry on the N-terminus and EGFP on the C-terminus. Neither of the individual protein segments produced current when expressed alone.	[Bae, Chilman; Suchyna, Thomas M.; Ziegler, Lynn; Sachs, Frederick; Gottlieb, Philip A.] SUNY Buffalo, Dept Physiol & Biophys, 302 Cary Hall, Buffalo, NY 14260 USA; [Bae, Chilman] Univ Texas Med Branch, Dept Neurosci & Cell Biol, 2-154 Med Res Bldg,301 Univ Blvd, Galveston, TX 77555 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Texas System; University of Texas Medical Branch Galveston	Gottlieb, PA (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 302 Cary Hall, Buffalo, NY 14260 USA.	philgott@buffalo.edu	Gottlieb, Philip/C-3113-2019	Gottlieb, Philip/0000-0003-3764-9885	National Institutes of Health [5R01HL0054887]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health-5R01HL0054887. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuisson J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2899; Andolfo I, 2013, BLOOD, V121, P3925, DOI 10.1182/blood-2013-02-482489; Bae C, 2013, BIOPHYS J, V105, P880, DOI 10.1016/j.bpj.2013.07.019; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Blumenthal NR, 2014, P NATL ACAD SCI USA, V111, P16124, DOI 10.1073/pnas.1412740111; Coste B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8223; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Edelstein A., 2010, CURR PROTOC MOL BIOL, V14, P20; Faucherre A, 2014, HAEMATOLOGICA, V99, P70, DOI 10.3324/haematol.2013.086090; Ge JP, 2015, NATURE, V527, P64, DOI 10.1038/nature15247; Gnanasambandam R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125503; Gottlieb PA, 2012, CHANNELS, V6, P282, DOI 10.4161/chan.21064; Ikeda R, 2014, NEUROSCI LETT, V583, P210, DOI 10.1016/j.neulet.2014.05.055; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Lee W, 2014, P NATL ACAD SCI USA, V111, pE5114, DOI 10.1073/pnas.1414298111; Lewis AH, 2015, ELIFE, V4, DOI 10.7554/eLife.12088; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Park KH, 2004, BIOPHYS J, V86, P2129, DOI 10.1016/S0006-3495(04)74272-1; Pathak MM, 2014, P NATL ACAD SCI USA, V111, P16148, DOI 10.1073/pnas.1409802111; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Saldana C, 2002, J BIOL CHEM, V277, P4797, DOI 10.1074/jbc.M107957200; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253	29	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151289	10.1371/journal.pone.0151289	http://dx.doi.org/10.1371/journal.pone.0151289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963637	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000135
J	Bayu, H; Berhe, Y; Mulat, A; Alemu, A				Bayu, Hinsermu; Berhe, Yibrah; Mulat, Amlaku; Alemu, Amare			Cervical Cancer Screening Service Uptake and Associated Factors among Age Eligible Women in Mekelle Zone, Northern Ethiopia, 2015: A Community Based Study Using Health Belief Model	PLOS ONE			English	Article							KNOWLEDGE	Introduction Cervical cancer is the third most common cancer among women worldwide, with about 500,000 new patients diagnosed and over 250,000 deaths every year. Cervical cancer screening offers protective benefits and is associated with a reduction in the incidence of invasive cervical cancer and cervical cancer mortality. But there is very low participation rate in screening for cervical cancer among low and middle-income countries. Objective This study aimed to determine cervical cancer screening service uptake and its associated factor among age eligible women in Mekelle zone, northern Ethiopia, 2015. Methods A community based cross-sectional study was conducted in Mekelle zone among age eligible women from February to June 2015. Systematic sampling technique was used to select 1286 women in to the study. A pre-tested structured questionnaire was used to collect relevant data. Data was entered and cleaned using EPINFO and analyzed using SPSS version 20 software package. Bivariate and Multivariate logistic regression was performed to assess association between dependent and independent variables with 95% CI and p-value less than 0.05 was set for association. Results The study revealed that among 1186 age eligible women, only 235(19.8%) have been screened for cervical cancer. Age (AOR = 1.799, 95% CI = 1.182-2.739), history of multiple sexual partners (AOR = 1.635, 95%CI = 1.094-2.443), history of sexually transmitted disease (AOR = 1.635,95%CI = 1.094-2.443), HIV sero status (AOR = 5.614, 95%CI = 2.595-12.144), perceived susceptibility to cervical cancer (AOR = 2.225, 95% CI = 1.308-3.783), perceived barriers to premalignant cervical lesions screening (AOR = 2.256, 95%CI = 1.447-3.517) and knowledge on cervical cancer and screening (AOR = 2.355, 95%CI = 1.155-4.802) were significant predictors of cervical cancer screening service uptake. Conclusion Magnitude of cervical cancer screening service uptake among age eligible women is still unacceptably low. Age of the women, history of multiple sexual partners and sexually transmitted disease, HIV sero-positivity, Knowledge, Perceived susceptibility and Perceived Barrier were important predictors of cervical cancer screening service uptake.	[Bayu, Hinsermu; Mulat, Amlaku] Mekelle Univ, Dept Midwifery, Coll Hlth Sci, Mekelle, Ethiopia; [Berhe, Yibrah] Mekelle Univ, Dept Obstet & Gynaecol, Coll Hlth Sci, Mekelle, Ethiopia; [Alemu, Amare] Bahirdar Univ, Dept Midwifery, Coll Hlth Sci, Bahirdar, Ethiopia	Mekelle University; Mekelle University; Bahir Dar University	Bayu, H (corresponding author), Mekelle Univ, Dept Midwifery, Coll Hlth Sci, Mekelle, Ethiopia.	henybayu1@gmail.com	Aweke, Amlaku Mulat/AAX-4484-2020	Mulat, Amlaku/0000-0002-1064-4585	Mekelle university [CHS-MU/21/2014]; Mekelle University College of Health Sciences	Mekelle university; Mekelle University College of Health Sciences	Mekelle university funded the work as small scale research with a grant number of CHS-MU/21/2014. Mekelle university was involved in the project through monitoring and evaluation of the work from the very beginning to the result submission, including ethical approval.; We are very grateful to Mekelle University College of Health Sciences for funding this research project. Our sincere and deepest gratitude goes to Tigray Regional Health Bureau for their crucial assistance and facilitation of fieldwork. We would also like to extend our heartfelt appreciation to the study participants for their cooperation, data collectors and all our associates.	Ansink AC, 2008, T ROY SOC TROP MED H, V102, P499, DOI 10.1016/j.trstmh.2008.01.022; Aswathy S, 2012, INDIAN J MED RES, V136, P205; Bessler Patricia, 2007, Cancer Control, V14, P396; Botha H, 2010, SOUTH AFR J GYNAECOL, V2, P23; Broutet N, 2013, WHO GUIDELINES SCREE, V15, P1; DeCherney A, 2012, CURRENT DIAGNOSIS TR; Dhendup T, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-44; Ebu NI, 2015, INT J WOMENS HEALTH, V7, P31, DOI 10.2147/IJWH.S71797; Ethiopian Federal Ministry of Health, 2015, GUID CERV CANC PREV; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Hoque ME, 2014, CERVICAL CANC SCREEN, V9, DOI [10.1371/journal.pone.0111557, DOI 10.1371/JOURNAL.PONE.0111557]; Jia Y, 2013, KNOWLEDGE CERVICAL C, V8, DOI [10.1371/journal.pone.0067005, DOI 10.1371/JOURNAL.PONE.0067005]; Lyimo FS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-22; Marlow LAV, 2015, J FAM PLAN REPROD H, V41, P248, DOI 10.1136/jfprhc-2014-101082; Mingo AM, 2012, INT J GYNECOL CANCER, V22, P638, DOI 10.1097/IGC.0b013e318249470a; Montano D.M., 2008, HLTH BEHAV HLTH ED T, P67; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Mulindi H, 2013, PLOS ONE, V8; Ndikom CM, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-11; Peirson L, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-35; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; Sawaya GF, 2001, J AM GERIATR SOC, V49, P1499, DOI 10.1046/j.1532-5415.2001.4911243.x; Smith AMA, 2011, J WOMENS HEALTH, V20, P1091, DOI 10.1089/jwh.2010.2585; Thippeveeranna C, 2013, ASIAN PAC J CANCER P, V14, P849, DOI 10.7314/APJCP.2013.14.2.849; Twinomujuni C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128498; UNFPA, 2014, AFR CERV CANC MULT I; WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), 2007, SUMM REP HPV CERV CA; World Health Organization, 2012, PREV CERV CANC SCREE, V33; World Health organization: Comprehensive cancer control, 2006, WHO COMPR CANC CONTR	29	72	74	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149908	10.1371/journal.pone.0149908	http://dx.doi.org/10.1371/journal.pone.0149908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963098	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000021
J	Clay, HB; Parl, AK; Mitchell, SL; Singh, L; Bell, LN; Murdock, DG				Clay, Hayley B.; Parl, Angelika K.; Mitchell, Sabrina L.; Singh, Larry; Bell, Lauren N.; Murdock, Deborah G.			Altering the Mitochondrial Fatty Acid Synthesis (mtFASII) Pathway Modulates Cellular Metabolic States and Bioactive Lipid Profiles as Revealed by Metabolomic Profiling	PLOS ONE			English	Article							ACYL-CARRIER PROTEIN; NADH-UBIQUINONE OXIDOREDUCTASE; 2-ENOYL THIOESTER REDUCTASE; SYNTHESIS TYPE-II; SACCHAROMYCES-CEREVISIAE; NEUROSPORA-CRASSA; OXIDATIVE STRESS; TRIACYLGLYCEROL SYNTHESIS; MAMMALIAN MITOCHONDRIA; ESCHERICHIA-COLI	Despite the presence of a cytosolic fatty acid synthesis pathway, mitochondria have retained their own means of creating fatty acids via the mitochondrial fatty acid synthesis (mtFASII) pathway. The reason for its conservation has not yet been elucidated. Therefore, to better understand the role of mtFASII in the cell, we used thin layer chromatography to characterize the contribution of the mtFASII pathway to the fatty acid composition of selected mitochondrial lipids. Next, we performed metabolomic analysis on HeLa cells in which the mtFASII pathway was either hypofunctional (through knockdown of mitochondrial acyl carrier protein, ACP) or hyperfunctional (through overexpression of mitochondrial enoyl-CoA reductase, MECR). Our results indicate that the mtFASII pathway contributes little to the fatty acid composition of mitochondrial lipid species examined. Additionally, loss of mtFASII function results in changes in biochemical pathways suggesting alterations in glucose utilization and redox state. Interestingly, levels of bioactive lipids, including lysophospholipids and sphingolipids, directly correlate with mtFASII function, indicating that mtFASII may be involved in the regulation of bioactive lipid levels. Regulation of bioactive lipid levels by mtFASII implicates the pathway as a mediator of intracellular signaling.	[Clay, Hayley B.; Parl, Angelika K.; Mitchell, Sabrina L.; Murdock, Deborah G.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA; [Clay, Hayley B.] Vanderbilt Univ, Neurosci Grad Program, 221 Kirkland Hall, Nashville, TN 37235 USA; [Singh, Larry] Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA; [Bell, Lauren N.] Metabolon Inc, Durham, NC USA	Vanderbilt University; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Metabolon	Murdock, DG (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA.	murdockd@email.chop.edu	Singh, Larry N./AAG-6880-2021	Singh, Larry N./0000-0002-2478-5864; Mitchell, Sabrina/0000-0001-7930-2447	National Institute of General Medical Sciences [R01GM090308]; Metabolon, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090308] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Metabolon, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences award R01GM090308. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Metabolon, Inc. provided support in the form of salaries for author LNB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Berkeley LI, 2003, J BIOCHEM MOL TOXIC, V17, P95, DOI 10.1002/jbt.10069; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; Chen ZJ, 2008, J MOL BIOL, V379, P830, DOI 10.1016/j.jmb.2008.04.041; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Goetzl EJ, 2000, ANN NY ACAD SCI, V905, P177; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Gueguen V, 2000, J BIOL CHEM, V275, P5016, DOI 10.1074/jbc.275.7.5016; HARINGTON A, 1993, MOL MICROBIOL, V9, P545, DOI 10.1111/j.1365-2958.1993.tb01715.x; Hassoun SM, 2006, MITOCHONDRION, V6, P149, DOI 10.1016/j.mito.2006.05.001; Hiltunen JK, 2010, PROG LIPID RES, V49, P27, DOI 10.1016/j.plipres.2009.08.001; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; KADISH AH, 1965, CLIN CHEM, V11, P869; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kogot-Levin A, 2014, BIOCHIMIE, V100, P88, DOI 10.1016/j.biochi.2013.07.027; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Lewin TM, 2004, J BIOL CHEM, V279, P13488, DOI 10.1074/jbc.M314032200; Masuda N, 1998, GENE, V221, P225, DOI 10.1016/S0378-1119(98)00461-2; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; MIKOLAJCZYK S, 1990, EUR J BIOCHEM, V187, P431, DOI 10.1111/j.1432-1033.1990.tb15322.x; Misra A, 2009, MOL BIOSYST, V5, P651, DOI 10.1039/b820420a; Morgan DML, 1999, MOL BIOTECHNOL, V11, P229, DOI 10.1007/BF02788682; MORRISON WR, 1964, J LIPID RES, V5, P600; Pan A, 2013, BIOCHEM BIOPH RES CO, V441, P418, DOI 10.1016/j.bbrc.2013.10.072; Park MH, 2013, BIOMOL THER, V21, P1, DOI 10.4062/biomolther.2012.097; RICHARDSON DK, 1978, AM J PHYSIOL, V234, pE182, DOI 10.1152/ajpendo.1978.234.2.E182; Ronnebaum SM, 2008, J BIOL CHEM, V283, P14248, DOI 10.1074/jbc.M800119200; RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3; Schneider R, 1995, CURR GENET, V29, P10, DOI 10.1007/BF00313188; Schonauer MS, 2008, MOL CELL BIOL, V28, P6646, DOI 10.1128/MCB.01162-08; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Smirnova OA, 2012, BIOCHIMIE, V94, P1876, DOI 10.1016/j.biochi.2012.04.023; Smith S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047196; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; SRIVASTA.SK, 1969, J BIOL CHEM, V244, P9; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Stiban J, 2006, APOPTOSIS, V11, P773, DOI 10.1007/s10495-006-5882-8; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tkachenko AG, 2003, BIOCHEMISTRY-MOSCOW+, V68, P850, DOI 10.1023/A:1025790729797; Tkachenko AG, 2012, RES MICROBIOL, V163, P83, DOI 10.1016/j.resmic.2011.10.009; Wada H, 1997, P NATL ACAD SCI USA, V94, P1591, DOI 10.1073/pnas.94.4.1591; WAKIL SJ, 1962, COMP BIOCHEM PHYSIOL, V4, P123, DOI 10.1016/0010-406X(62)90002-6; Wang XF, 2000, J NEUROCHEM, V74, P1434, DOI 10.1046/j.1471-4159.2000.0741434.x; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; Witkowski A, 2011, J BIOL CHEM, V286, P33729, DOI 10.1074/jbc.M111.291591; ZENSEN R, 1992, FEBS LETT, V310, P179, DOI 10.1016/0014-5793(92)81324-F; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200	57	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151171	10.1371/journal.pone.0151171	http://dx.doi.org/10.1371/journal.pone.0151171			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963735	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000114
J	Gottschalk, A; Welp, HA; Leser, L; Lanckohr, C; Wempe, C; Ellger, B				Gottschalk, Antje; Welp, Henryk A.; Leser, Laura; Lanckohr, Christian; Wempe, Carola; Ellger, Bjoern			Continuous Glucose Monitoring in Patients Undergoing Extracorporeal Ventricular Assist Therapy	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE INSULIN THERAPY; BLOOD-GLUCOSE; GLYCEMIC CONTROL; CRITICAL ILLNESS; HYPOGLYCEMIA; VARIABILITY; MORTALITY; REAL; TIME	Background Dysregulations of blood glucose (BG) are associated with adverse outcome in critical illness; controlling BG to target appears to improve outcome. Since BG-control is challenging in daily intensive care practice BG-control remains poor especially in patients with rapidly fluctuating BG. To improve BG-control and to avoid deleterious hypoglycemia, automated online-measurement tools are advocated. We thus evaluated the point-accuracy of the subcutaneous Sentrino (R) Continuous Glucose Monitoring System (CGM, Medtronic Diabetes, Northridge, California) in patients undergoing extracorporeal cardiac life support (ECLS) for cardiogenic shock. Methods Management of BG was performed according to institute's standard aiming at BG-levels between 100-145 mg/dl. CGM-values were recorded without taking measures into therapeutic account. Point-accuracy in comparison to intermittent BG-measurement by the ABL-blood-gas analyzer was determined. Results CGM (n = 25 patients) correlated significantly with ABL-values (r = 0.733, p<0.001). Mean error from standard was 15.0 mg/dl (11.9%). 44.2% of the readings were outside a 15% range around ABL-values. In one of 635 paired data-points, ABL revealed hypoglycemia (BG 32 mg/dl) whereas CGM did not show hypoglycemic values (132mg/dl). Conclusions CGM reveals minimally invasive BG-values in critically ill adults with dynamically impaired tissue perfusion. Because of potential deviations from standard, CGM-readings must be interpreted with caution in specific ICU-populations.	[Gottschalk, Antje; Leser, Laura; Lanckohr, Christian; Wempe, Carola; Ellger, Bjoern] Univ Hosp Munster, Dept Anesthesiol Intens Care & Pain Med, Munster, Germany; [Welp, Henryk A.] Univ Hosp Munster, Div Cardiac Surg, Dept Cardiothorac Surg, Munster, Germany	University of Munster; University of Munster	Welp, HA (corresponding author), Univ Hosp Munster, Div Cardiac Surg, Dept Cardiothorac Surg, Munster, Germany.	henryk.welp@ukmuenster.de	Gottschalk, Antje/AAM-5266-2021		Medtronic GmbH, Earl-Bakken-Platz, Meerbusch, Germany [40670]; Medtronic GmbH, Earl-Bakken-Platz, Meerbusch, Germany [40670]	Medtronic GmbH, Earl-Bakken-Platz, Meerbusch, Germany(Medtronic); Medtronic GmbH, Earl-Bakken-Platz, Meerbusch, Germany(Medtronic)	This work was supported from institutional and departmental sources and from Medtronic GmbH, Earl-Bakken-Platz 1, 40670 Meerbusch, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein K, 2012, DIABETES TECHNOL THE, V14, P690, DOI 10.1089/dia.2012.0021; Blixt C, 2013, CRIT CARE, V17, DOI 10.1186/cc12713; Bothe MK, 2013, EXPERT REV MED DEVIC, V10, P661, DOI 10.1586/17434440.2013.827515; Brunner R, 2012, CRIT CARE, V16, DOI 10.1186/cc11657; Brunner R, 2011, CRIT CARE MED, V39, P659, DOI 10.1097/CCM.0b013e318206bf2e; Corstjens AM, 2006, CRIT CARE, V10, DOI 10.1186/cc5048; Dell'Aquila AM, 2013, CURR OPIN ANESTHESIO, V26, P438, DOI 10.1097/ACO.0b013e328362d16a; Duning T, 2009, BEST PRACT RES-CLIN, V23, P473, DOI 10.1016/j.bpa.2009.09.002; Duning T, 2010, DIABETES CARE, V33, P639, DOI 10.2337/dc09-1740; Egi M, 2008, CRIT CARE MED, V36, P2249, DOI 10.1097/CCM.0b013e318181039a; Egi Moritoki, 2009, J Diabetes Sci Technol, V3, P1302; Egi M, 2010, MAYO CLIN PROC, V85, P217, DOI 10.4065/mcp.2009.0394; Egi M, 2009, CRIT CARE, V13, DOI 10.1186/cc7755; Eslami S, 2011, INTENS CARE MED, V37, P583, DOI 10.1007/s00134-010-2129-5; Farrokhi F, 2011, BEST PRACT RES CL EN, V25, P813, DOI 10.1016/j.beem.2011.05.004; Finfer S, 2013, CRIT CARE, V17, DOI 10.1186/cc12537; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Holzinger U, 2010, DIABETES CARE, V33, P467, DOI 10.2337/dc09-1352; Honiden Shyoko, 2011, J Intensive Care Med, V26, P135, DOI 10.1177/0885066610387892; Jacobi J, 2012, CRIT CARE MED, V40, P3251, DOI 10.1097/CCM.0b013e3182653269; Kosiborod M, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000037; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Krinsley JS, 2013, CRIT CARE, V17, DOI 10.1186/cc12547; Kuppinger D, 2013, NUTRITION, V29, P708, DOI 10.1016/j.nut.2012.11.019; Ng Lit Soo, 2012, J Diabetes Sci Technol, V6, P58; Okabayashi T, 2014, CURR OPIN CLIN NUTR, V17, P190, DOI 10.1097/MCO.0000000000000026; Punke MA, 2015, MED KLIN-INTENSIVMED, V110, P360, DOI 10.1007/s00063-014-0453-1; Rattan Rishi, 2013, J Diabetes Sci Technol, V7, P548; Scurlock C, 2011, CURR OPIN CLIN NUTR, V14, P209, DOI 10.1097/MCO.0b013e3283437bc4; Van Herpe T, 2009, BEST PRACT RES-CLIN, V23, P69, DOI 10.1016/j.bpa.2008.07.003	31	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0148778	10.1371/journal.pone.0148778	http://dx.doi.org/10.1371/journal.pone.0148778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963806	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000005
J	Sanchez, R; Mackenzie, SA				Sanchez, Robersy; Mackenzie, Sally A.			Information Thermodynamics of Cytosine DNA Methylation	PLOS ONE			English	Article							SINGLE-MOLECULE; PATTERNS; ENERGY	Cytosine DNA methylation (CDM) is a stable epigenetic modification to the genome and a widespread regulatory process in living organisms that involves multicomponent molecular machines. Genome-wide cytosine methylation patterning participates in the epigenetic reprogramming of a cell, suggesting that the biological information contained within methylation positions may be amenable to decoding. Adaptation to a new cellular or organismal environment also implies the potential for genome-wide redistribution of CDM changes that will ensure the stability of DNA molecules. This raises the question of whether or not we would be able to sort out the regulatory methylation signals from the CDM background ("noise") induced by thermal fluctuations. Here, we propose a novel statistical and information thermodynamic description of the CDM changes to address the last question. The physical basis of our statistical mechanical model was evaluated in two respects: 1) the adherence to Landauer's principle, according to which molecular machines must dissipate a minimum energy epsilon = k(B)T ln2 at each logic operation, where k(B) is the Boltzmann constant, and T is the absolute temperature and 2) whether or not the binary stretch of methylation marks on the DNA molecule comprise a language of sorts, properly constrained by thermodynamic principles. The study was performed for genome-wide methylation data from 152 ecotypes and 40 trans-generational variations of Arabidopsis thaliana and 93 human tissues. The DNA persistence length, a basic mechanical property altered by CDM, was estimated with values from 39 to 66.9 nm. Classical methylome analysis can be retrieved by applying information thermodynamic modelling, which is able to discriminate signal from noise. Our finding suggests that the CDM signal comprises a language scheme properly constrained by molecular thermodynamic principles, which is part of an epigenomic communication system that obeys the same thermodynamic rules as do current human communication systems.	[Sanchez, Robersy; Mackenzie, Sally A.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln	Sanchez, R; Mackenzie, SA (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA.	robersy@unl.edu; sally.mackenzie@unl.edu	Sanchez, Robersy/Q-7978-2019	Sanchez, Robersy/0000-0002-5246-1453	Bill and Melinda Gates Foundation [OPP1088661]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by a grant from the Bill and Melinda Gates Foundation (OPP1088661, http://www.gatesfoundation.org/) to SAM.	Adami C, 2004, PHYS LIFE REV, V1, P3, DOI 10.1016/j.plrev.2004.01.002; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Armond JW, 2014, SCI REP-UK, V4, DOI 10.1038/srep03692; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Berut A, 2012, NATURE, V483, P187, DOI 10.1038/nature10872; Brunet A, 2015, MACROMOLECULES, V48, P3641, DOI 10.1021/acs.macromol.5b00735; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Crooks GE, 2010, AMOROSO DISTRIBUTION, P1; Dawy Z, 2007, EUR T TELECOMMUN, V18, P873, DOI 10.1002/ett.1201; DeCarlo LT, 2012, J MATH PSYCHOL, V56, P196, DOI 10.1016/j.jmp.2012.02.004; EHRLICH M, 1975, BIOCHIM BIOPHYS ACTA, V395, P109, DOI 10.1016/0005-2787(75)90149-5; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; GILL JE, 1974, BIOCHIM BIOPHYS ACTA, V335, P330, DOI 10.1016/0005-2787(74)90157-9; Havecker ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045242; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Kahn JD, 2014, BIOPHYS J, V107, P282, DOI 10.1016/j.bpj.2014.06.007; Kaur P, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/6/065001; Koslover EF, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011906; Laprise SL, 2007, GENE, V391, P45, DOI 10.1016/j.gene.2006.12.002; Lavelle C, 2014, CURR OPIN GENET DEV, V25, P74, DOI 10.1016/j.gde.2014.01.001; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328; Lazarovici A, 2013, P NATL ACAD SCI USA, V110, P6376, DOI 10.1073/pnas.1216822110; Leek JT, 2015, NATURE, V520, P612, DOI 10.1038/520612a; Lienhard JH, 1967, Q J APPL MATH, V25, P550; Lorenzo-Ginori JV, 2009, CURR BIOINFORM, V4, P28, DOI 10.2174/157489309787158134; Lu YJ, 2001, BIOPOLYMERS, V61, P261, DOI 10.1002/bip.10151; Machado ACD, 2015, BRIEF FUNCT GENOMICS, V14, P61, DOI 10.1093/bfgp/elu040; Mercadante D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087581; Nardo L, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv884; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Osakabe A, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150128; Phelps C, 2013, P NATL ACAD SCI USA, V110, P17320, DOI 10.1073/pnas.1314862110; R Core Team, 2014, LANG ENV STAT COMP; Ramchandani S, 1999, P NATL ACAD SCI USA, V96, P6107, DOI 10.1073/pnas.96.11.6107; Robinson MD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00324; Rubin A, 2014, BIOL MED PHYS BIOMED, P117, DOI 10.1007/978-1-4614-8702-9_8; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; SCHNEIDER TD, 1991, J THEOR BIOL, V148, P125, DOI 10.1016/S0022-5193(05)80467-9; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Severin PMD, 2013, BIOPHYS J, V104, P208, DOI 10.1016/j.bpj.2012.11.013; Severin PMD, 2011, NUCLEIC ACIDS RES, V39, P8740, DOI 10.1093/nar/gkr578; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; STACY EW, 1962, ANN MATH STAT, V33, P1187, DOI 10.1214/aoms/1177704481; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th edition.; Toyabe S, 2010, NAT PHYS, V6, P988, DOI 10.1038/NPHYS1821; TRIBUS M, 1971, SCI AM, V225, P179, DOI 10.1038/scientificamerican0971-179; Tuzlukov VP, 1998, DIGIT SIGNAL PROCESS, V8, P166, DOI 10.1006/dspr.1998.0315; Wiley RH, 2013, ANIMAL COMMUNICATION THEORY: INFORMATION AND INFLUENCE, P113; Wiley RH, 2013, BEHAVIOUR, V150, P957, DOI 10.1163/1568539X-00003063; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Xie HH, 2011, NUCLEIC ACIDS RES, V39, P4099, DOI 10.1093/nar/gkr017; Yusufaly TI, 2013, J PHYS CHEM B, V117, P16436, DOI 10.1021/jp409887t	58	7	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150427	10.1371/journal.pone.0150427	http://dx.doi.org/10.1371/journal.pone.0150427			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963711	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000037
J	Zawbaa, HM; Emary, E; Grosan, C				Zawbaa, Hossam M.; Emary, E.; Grosan, Crina			Feature Selection via Chaotic Antlion Optimization	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; CLASSIFICATION	Background Selecting a subset of relevant properties from a large set of features that describe a dataset is a challenging machine learning task. In biology, for instance, the advances in the available technologies enable the generation of a very large number of biomarkers that describe the data. Choosing the more informative markers along with performing a high-accuracy classification over the data can be a daunting task, particularly if the data are high dimensional. An often adopted approach is to formulate the feature selection problem as a biobjective optimization problem, with the aim of maximizing the performance of the data analysis model (the quality of the data training fitting) while minimizing the number of features used. Results We propose an optimization approach for the feature selection problem that considers a "chaotic" version of the antlion optimizer method, a nature-inspired algorithm that mimics the hunting mechanism of antlions in nature. The balance between exploration of the search space and exploitation of the best solutions is a challenge in multi-objective optimization. The exploration/exploitation rate is controlled by the parameter I that limits the random walk range of the ants/prey. This variable is increased iteratively in a quasi-linear manner to decrease the exploration rate as the optimization progresses. The quasi-linear decrease in the variable I may lead to immature convergence in some cases and trapping in local minima in other cases. The chaotic system proposed here attempts to improve the tradeoff between exploration and exploitation. The methodology is evaluated using different chaotic maps on a number of feature selection datasets. To ensure generality, we used ten biological datasets, but we also used other types of data from various sources. The results are compared with the particle swarm optimizer and with genetic algorithm variants for feature selection using a set of quality metrics.	[Zawbaa, Hossam M.; Grosan, Crina] Univ Babes Bolyai, Fac Math & Comp Sci, R-3400 Cluj Napoca, Romania; [Zawbaa, Hossam M.] Beni Suef Univ, Fac Comp & Informat, Bani Suwayf, Egypt; [Emary, E.] Cairo Univ, Fac Comp & Informat, Cairo, Egypt; [Emary, E.] Arab Open Univ, Fac Comp Studies, Cairo, Egypt; [Grosan, Crina] Brunel Univ, Coll Engn Design & Phys Sci, London, England	Babes Bolyai University from Cluj; Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Cairo University; Brunel University	Zawbaa, HM (corresponding author), Univ Babes Bolyai, Fac Math & Comp Sci, R-3400 Cluj Napoca, Romania.; Zawbaa, HM (corresponding author), Beni Suef Univ, Fac Comp & Informat, Bani Suwayf, Egypt.	hossam.zawbaa@gmail.com	Grosan, Crina/B-8435-2011; Emary, Eid M/C-6131-2017; Zawbaa, Hossam M./O-6203-2014	Emary, Eid M/0000-0002-9537-2530; Zawbaa, Hossam M./0000-0001-6548-2993; Grosan, Crina/0000-0003-1049-2136	IPROCOM Marie Curie initial training network; European Union [316555]; Romanian National Authority for Scientific Research, CNDI-UEFISCDI [PN-II-PT-PCCA-2011-3.2-0917]	IPROCOM Marie Curie initial training network; European Union(European Commission); Romanian National Authority for Scientific Research, CNDI-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was partially supported by the IPROCOM Marie Curie initial training network, funded through the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/under REA grants agreement No. 316555, and by the Romanian National Authority for Scientific Research, CNDI-UEFISCDI, project number PN-II-PT-PCCA-2011-3.2-0917. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Raouf Osama, 2014, International Journal of Modern Education and Computer Science, V6, P18, DOI 10.5815/ijmecs.2014.08.03; Aguirregabiria JM, 2009, CHAOS SOLITON FRACT, V42, P2531, DOI 10.1016/j.chaos.2009.03.196; Bache Kevin, 2013, UCI MACHINE LEARNING; Bingqun Ren, 2011, Information Technology Journal, V10, P1908, DOI 10.3923/itj.2011.1908.1916; Chakraborty B, 2002, ISIE 2002: PROCEEDINGS OF THE 2002 IEEE INTERNATIONAL SYMPOSIUM ON INDUSTRIAL ELECTRONICS, VOLS 1-4, P315, DOI 10.1109/ISIE.2002.1026085; Chakraborty B, 2008, 2008 3RD INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEM AND KNOWLEDGE ENGINEERING, VOLS 1 AND 2, P1038, DOI 10.1109/ISKE.2008.4731082; Chen H, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.27463; Chen YM, 2010, PATTERN RECOGN LETT, V31, P226, DOI 10.1016/j.patrec.2009.10.013; Chuang LY, 2011, EXPERT SYST APPL, V38, P12699, DOI 10.1016/j.eswa.2011.04.057; Dash M., 1997, Intelligent Data Analysis, V1; Duda R.O., 2000, PATTERN CLASSIFICATI; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Eiben AE, 1994, LECT NOTES COMPUT SC, V866, P78; Gao HH, 2005, PROCEEDINGS OF 2005 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-9, P3871; Gholipour A, 2006, NEURAL PROCESS LETT, V24, P217, DOI 10.1007/s11063-006-9021-x; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Holland J. H., 1992, ADAPTATION NATURAL A; Huang CL, 2009, NEUROCOMPUTING, V73, P438, DOI 10.1016/j.neucom.2009.07.014; Jiang CW, 2005, MATH COMPUT SIMULAT, V68, P57, DOI 10.1016/j.matcom.2004.10.003; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kim H, 2005, J MACH LEARN RES, V6, P37; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Landassuri-Moreno V, 2011, ELECT ROBOT AUTO MEC, P71, DOI 10.1109/CERMA.2011.19; MARILL T, 1963, IEEE T INFORM THEORY, V9, P11, DOI 10.1109/TIT.1963.1057810; Ming H, 2008, KAM: 2008 INTERNATIONAL SYMPOSIUM ON KNOWLEDGE ACQUISITION AND MODELING, PROCEEDINGS, P585, DOI 10.1109/KAM.2008.12; Mirjalili S, 2015, ADV ENG SOFTW, V83, P80, DOI 10.1016/j.advengsoft.2015.01.010; Neshatian K, 2002, GENETIC PROGRAMMING, P121; Oh IS, 2004, IEEE T PATTERN ANAL, V26, P1424, DOI 10.1109/TPAMI.2004.105; Raman B., 2002, MACH LEARN RES, V1, P1; Saremi S, 2014, NEURAL COMPUT, V26, P1329, DOI 10.1162/NECO_a_00607; Shoghian S., 2012, INT J COMPUT INF ENG, V6, P1619; Vieira SM, 2010, EXPERT SYST APPL, V37, P2714, DOI 10.1016/j.eswa.2009.08.026; Vohra R, 2012, COMMUNICATION NETWOR, V1, P75; WHITNEY AW, 1971, IEEE T COMPUT, VC 20, P1100, DOI 10.1109/T-C.1971.223410; Xue B, 2014, APPL SOFT COMPUT, V18, P261, DOI 10.1016/j.asoc.2013.09.018; Xue B, 2013, IEEE T CYBERNETICS, V43, P1656, DOI 10.1109/TSMCB.2012.2227469; Yang X., 2008, NATURE INSPIRED META, V2nd	37	105	105	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150652	10.1371/journal.pone.0150652	http://dx.doi.org/10.1371/journal.pone.0150652			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963715	Green Submitted, gold, Green Published			2022-12-27	WOS:000371993000048
J	Berman, AH; Liu, BJ; Ullman, S; Jadback, I; Engstrom, K				Berman, Anne H.; Liu, Bojing; Ullman, Sara; Jadback, Isabel; Engstrom, Karin			Children's Quality of Life Based on the KIDSCREEN-27: Child Self-Report, Parent Ratings and Child-Parent Agreement in a Swedish Random Population Sample	PLOS ONE			English	Article							MENTAL-HEALTH; VALIDITY; QUESTIONNAIRE; RELIABILITY	Background The KIDSCREEN-27 is a measure of child and adolescent quality of life (QoL), with excellent psychometric properties, available in child-report and parent-rating versions in 38 languages. This study provides child-reported and parent-rated norms for the KIDSCREEN-27 among Swedish 11-16 year-olds, as well as child-parent agreement. Sociodemographic correlates of self-reported wellbeing and parent-rated wellbeing were also measured. Methods A random population sample consisting of 600 children aged 11-16, 100 per age group and one of their parents (N = 1200), were approached for response to self-reported and parentrated versions of the KIDSCREEN-27. Parents were also asked about their education, employment status and their own QoL based on the 26-item WHOQOL-Bref. Based on the final sampling pool of 1158 persons, a 34.8% response rate of 403 individuals was obtained, including 175 child-parent pairs, 27 child singleton responders and 26 parent singletons. Gender and age differences for parent ratings and child-reported data were analyzed using t-tests and the Mann-Whitney U-test. Post-hoc Dunn tests were conducted for pairwise comparisons when the p-value for specific subscales was 0.05 or lower. Child-parent agreement was tested item-by-item, using the Prevalence-and Bias-Adjusted Kappa (PABAK) coefficient for ordinal data (PABAK-OS); dimensional and total score agreement was evaluated based on dichotomous cut-offs for lower well-being, using the PABAK and total, continuous scores were evaluated using Bland-Altman plots. Results Compared to European norms, Swedish children in this sample scored lower on Physical wellbeing (48.8 SE/49.94 EU) but higher on the other KIDSCREEN-27 dimensions: Psychological wellbeing (53.4/49.77), Parent relations and autonomy (55.1/49.99), Social Support and peers (54.1/49.94) and School (55.8/50.01). Older children self-reported lower wellbeing than younger children. No significant self-reported gender differences occurred and parent ratings showed no gender or age differences. Item-by-item child-parent agreement was slight for 14 items (51.9%), fair for 12 items (44.4%), and less than chance for one item (3.7%), but agreement on all dimensions as well as the total score was substantial according to the PABAK-OS. Visual interpretation of the Bland-Altman plot suggested that when children's average wellbeing score was lower parents seemed to rate their children as having relatively higher total wellbeing, but as children's average wellbeing score increased, parents tended to rate their children as having relatively lower total wellbeing. Children living with both parents had higher wellbeing than those who lived with only one parent. Conclusions Results agreed with European findings that adolescent wellbeing decreases with age but contrasted with some prior Swedish research identifying better wellbeing for boys on all dimensions but Social support and peers. The study suggests the importance of considering children's own reports and not only parental or other informant ratings. Future research should be conducted at regular intervals and encompass larger samples.	[Berman, Anne H.; Liu, Bojing] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden; [Jadback, Isabel] Uppsala Univ, Dept Psychol, Uppsala, Sweden; [Liu, Bojing; Ullman, Sara; Engstrom, Karin] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Liu, Bojing] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ullman, Sara] Swedish Police, Dept Invest, Stockholm, Sweden; [Jadback, Isabel] Tellas Consulting AB, Malmo, Sweden	Karolinska Institutet; Uppsala University; Karolinska Institutet; Karolinska Institutet	Berman, AH (corresponding author), Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden.	anne.h.berman@ki.se	Berman, Anne H/C-4636-2011	Berman, Anne H/0000-0002-7709-0230; Liu, Bojing/0000-0002-0366-6989	Soderstrom-Konigska Foundation; Mayflower Charity Foundation for Children; FP7 COPING project (Children of Prisoners, Interventions & Mitigations to Strengthen Mental Health) [241988]	Soderstrom-Konigska Foundation; Mayflower Charity Foundation for Children; FP7 COPING project (Children of Prisoners, Interventions & Mitigations to Strengthen Mental Health)	Data collection was funded by the Soderstrom-Konigska Foundation. Data analysis was funded via a stipend to author BL from the Mayflower Charity Foundation for Children. Authors AHB and SU's contributions were partly supported by grant no. 241988 for the FP7 COPING project (Children of Prisoners, Interventions & Mitigations to Strengthen Mental Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom M, 2014, SCAND J PSYCHOL, V55, P433, DOI 10.1111/sjop.12148; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Currie C, 2015, EUR J PUBLIC HEALTH, V25, P4, DOI 10.1093/eurpub/ckv017; Currie C, 2009, INT J PUBLIC HEALTH, V54, P131, DOI 10.1007/s00038-009-5404-x; Dal H, 2008, 20086 KAR I STOCKH C; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Dey M, 2013, SOC PSYCH PSYCH EPID, V48, P503, DOI 10.1007/s00127-012-0556-z; Dickinson HO, 2007, LANCET, V369, P2171, DOI 10.1016/S0140-6736(07)61013-7; Elliott AC, 2011, COMPUT METH PROG BIO, V102, P75, DOI 10.1016/j.cmpb.2010.11.002; Erhart M, 2009, INT J PUBLIC HEALTH, V54, P160, DOI 10.1007/s00038-009-5407-7; Hagquist C, 2005, MATNING BARN UNGDOMA; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Liu B, 2015, CHILD SELF REP UNPUB; Matza LS, 2004, VALUE HEALTH, V7, P79, DOI 10.1111/j.1524-4733.2004.71273.x; Noerholm V, 2004, QUAL LIFE RES, V13, P531, DOI 10.1023/B:QURE.0000018485.05372.d6; Parker R, 2013, INTERRATER IN PRESS; Rafdzah Z, 2012, PLOS ONE, DOI [10.1371/journal.pone.0037908, DOI 10.1371/JOURNAL.PONE.0037908]; Rajmil L, 2014, INT J PUBLIC HEALTH, V59, P95, DOI 10.1007/s00038-013-0479-9; Rajmil L, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-101; Ravens-Sieberer U, 2006, KIDSCREEN QUESTIONNA; Ravens-Sieberer U, 2013, ISRN PUBLIC HLTH, V2013; Ravens-Sieberer U, 2007, QUAL LIFE RES, V16, P1347, DOI 10.1007/s11136-007-9240-2; Ravens-Sieberer Ulrike, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P353, DOI 10.1586/14737167.5.3.353; Ravens-Sieberer U, 2014, QUAL LIFE RES, V23, P791, DOI 10.1007/s11136-013-0428-3; Robitail S, 2007, QUAL LIFE RES, V16, P1335, DOI 10.1007/s11136-007-9241-1; Robitail S, 2007, J CLIN EPIDEMIOL, V60, P469, DOI 10.1016/j.jclinepi.2006.09.007; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Stevanovic D, 2013, QUAL LIFE RES, V22, P1729, DOI 10.1007/s11136-012-0286-4; Swedish National Institute of Public Health, 2013, KARTL PSYK HALS BLAN; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Viera AJ, 2005, FAM MED, V37, P360; WHO, 2005, ATL CHILD AD MENT HL	34	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150545	10.1371/journal.pone.0150545	http://dx.doi.org/10.1371/journal.pone.0150545			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TF	26959992	gold, Green Submitted, Green Published			2022-12-27	WOS:000371992300056
J	Gutnik, L; Moses, A; Stanley, C; Tembo, T; Lee, C; Gopal, S				Gutnik, Lily; Moses, Agnes; Stanley, Christopher; Tembo, Tapiwa; Lee, Clara; Gopal, Satish			From Community Laywomen to Breast Health Workers: A Pilot Training Model to Implement Clinical Breast Exam Screening in Malawi	PLOS ONE			English	Article							CANCER; VOLUNTEERS; INDIA; NEPAL	Background Breast cancer burden is high in low-income countries. Inadequate early detection contributes to late diagnosis and increased mortality. We describe the training program for Malawi's first clinical breast exam (CBE) screening effort. Methods Laywomen were recruited as Breast Health Workers (BHWs) with the help of local staff and breast cancer advocates. The four-week training consisted of lectures, online modules, role-playing, case discussions, CBE using simulators and patients, and practice presentations. Ministry of Health trainers taught health communication, promotion, and education skills. Breast cancer survivors shared their experiences. Clinicians taught breast cancer epidemiology, prevention, detection, and clinical care. Clinicians and research staff taught research ethics, informed consent, data collection, and professionalism. Breast cancer knowledge was measured using pre- and post-training surveys. Concordance between BHW and clinician CBE was assessed. Breast cancer talks by BHW were evaluated on a 5-point scale in 22 areas by 3 judges. Results We interviewed 12 women, and 4 were selected as BHWs including 1 breast cancer survivor. Training was dynamic with modification based on trainee response and progress. A higher-than-anticipated level of comprehension and interest led to inclusion of additional topics like breast reconstruction. Pre-training knowledge increased from 49% to 91% correct (p<0.0001). Clinician and BHW CBE had 88% concordance (kappa 0.43). The mean rating of BHW educational talks was 4.4 (standard deviation 0.7). Conclusions Malawian laywomen successfully completed training and demonstrated competency to conduct CBE and deliver breast cancer educational talks. Knowledge increased after training, and concordance was high between BHW and clinician CBE.	[Gutnik, Lily; Moses, Agnes; Stanley, Christopher; Tembo, Tapiwa; Lee, Clara; Gopal, Satish] UNC Project Malawi, Lilongwe, Malawi; [Gutnik, Lily] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Surg, Bronx, NY 10467 USA; [Moses, Agnes; Lee, Clara; Gopal, Satish] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lee, Clara] Univ N Carolina, Dept Surg, Chapel Hill, NC USA; [Gopal, Satish] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA; [Gopal, Satish] Univ Malawi, Coll Med, Blantyre, Malawi	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Malawi	Gopal, S (corresponding author), UNC Project Malawi, Lilongwe, Malawi.; Gopal, S (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Gopal, S (corresponding author), Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA.; Gopal, S (corresponding author), Univ Malawi, Coll Med, Blantyre, Malawi.	gopal@med.unc.edu	Gutnik, Lily/AAV-5256-2020	Gutnik, Lily/0000-0001-8674-7655	UJMT Fogarty Global Health Fellows Program [R25TW009340]; National Institutes of Health [K01TW009488, R21CA180815, U54CA190152]; Kamuzu Central Hospital; Malawi Ministry of Health; UNC Project-Malawi; Lineberger Comprehensive Cancer Center; FOGARTY INTERNATIONAL CENTER [R25TW009340, K01TW009488] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016086, R21CA180815, P50CA058223, U54CA190152] Funding Source: NIH RePORTER	UJMT Fogarty Global Health Fellows Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kamuzu Central Hospital; Malawi Ministry of Health; UNC Project-Malawi; Lineberger Comprehensive Cancer Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the UJMT Fogarty Global Health Fellows Program (grant R25TW009340). SG is supported by grants from the National Institutes of Health (K01TW009488, R21CA180815 and U54CA190152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the UJMT Fogarty Global Health Fellows Program (grant R25TW009340). SG is supported by grants from the National Institutes of Health (K01TW009488, R21CA180815 and U54CA190152). We additionally acknowledge leadership of Kamuzu Central Hospital, Malawi Ministry of Health, UNC Project-Malawi, and Lineberger Comprehensive Cancer Center for their support of this project.	Abuidris DO, 2013, LANCET ONCOL, V14, P363, DOI 10.1016/S1470-2045(12)70583-1; Boulos S, 2005, BREAST, V14, P340, DOI 10.1016/j.breast.2005.07.002; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Edge J, 2014, BREAST CARE HLTH PRO; Ferlay J, 2013, IARC CANCERBASE; Forouzanfar M, 2011, CHALLENGES AHEAD PRO; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, P614, DOI DOI 10.1136/BMJ.E614; Ginsburg OM, 2014, ONCOLOGIST, V19, P177, DOI 10.1634/theoncologist.2013-0314; Glenton C, 2010, SOC SCI MED, V70, P1920, DOI 10.1016/j.socscimed.2010.02.034; Hyoju SK, 2011, ASIAN PAC J CANCER P, V12, P3353; Keating NL, 2014, ONCOLOGIST, V19, P1091, DOI 10.1634/theoncologist.2014-0104; Kendig Claire E, 2013, World J Oncol, V4, P142; Kredo T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007331.pub3; Ngoma T, 2014, INT J CANC; Penazzato M, 2014, JAIDS-J ACQ IMM DEF, V65, P414, DOI 10.1097/QAI.0000000000000024; Reddy N, 2012, ASIAN PAC J CANCER P, V13, P6067, DOI 10.7314/APJCP.2012.13.12.6067; Sankaranarayanan R, 2011, JNCI-J NATL CANCER I, V103, P1476, DOI 10.1093/jnci/djr304; University of Arizona, COMM HLTH WORK EV TO; Vermont Department of Health, CLIN BREAST EX PROF; World Health Organization, WHO POS PAP MAMM SCR; Yip CH, 2008, CANCER-AM CANCER SOC, V113, P2244, DOI 10.1002/cncr.23842	21	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151389	10.1371/journal.pone.0151389	http://dx.doi.org/10.1371/journal.pone.0151389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959980	gold, Green Published, Green Submitted			2022-12-27	WOS:000371992300119
J	Hoppentocht, M; Akkerman, OW; Hagedoorn, P; Alffenaar, JWC; van der Werf, TS; Kerstjens, HAM; Frijlink, HW; de Boer, AH				Hoppentocht, Marcel; Akkerman, Onno W.; Hagedoorn, Paul; Alffenaar, Jan-Willem C.; van der Werf, Tjip S.; Kerstjens, Huib A. M.; Frijlink, Henderik W.; de Boer, Anne H.			Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA INFECTION; INHALATION; COLONIZATION; DELIVERY; SAFETY	Rationale Bronchiectasis is a condition characterised by dilated and thick-walled bronchi. The presence of Pseudomonas aeruginosa in bronchiectasis is associated with a higher hospitalisation frequency and a reduced quality of life, requiring frequent and adequate treatment with antibiotics. Objectives To assess local tolerability and the pharmacokinetic parameters of inhaled excipient free dry powder tobramycin as free base administered with the Cyclops dry powder inhaler to participants with non-cystic fibrosis bronchiectasis. The free base and absence of excipients reduces the inhaled powder dose. Methods Eight participants in the study were trained in handling the device and inhaling correctly. During drug administration the inspiratory flow curve was recorded. Local tolerability was assessed by spirometry and recording adverse events. Serum samples were collected before, and 15, 30, 45, 60, 75, 90, 105, 120 min; 4, 8 and 12 h after inhalation. Results and Discussion Dry powder tobramycin base was well tolerated and mild tobramycin-related cough was reported only once. A good drug dose-serum concentration correlation was obtained. Relatively small inhaled volumes were computed from the recorded flow curves, resulting in presumably substantial deposition in the central airways-i.e., at the site of infection. Conclusions In this first study of inhaled dry powder tobramycin free base in non-cystic fibrosis bronchiectasis patients, the free base of tobramycin and the administration with the Cyclops dry powder device were well tolerated. Our data support further clinical studies to evaluate safety and efficacy of this compound in this population.	[Hoppentocht, Marcel; Hagedoorn, Paul; Frijlink, Henderik W.; de Boer, Anne H.] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands; [Akkerman, Onno W.; van der Werf, Tjip S.; Kerstjens, Huib A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands; [Alffenaar, Jan-Willem C.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [van der Werf, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Hoppentocht, M (corresponding author), Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands.	m.hoppentocht@rug.nl	Frijlink, Henderik Willem/AAD-7382-2020; Kerstjens, Huib/N-4754-2017	Frijlink, Henderik Willem/0000-0001-7901-8198; Kerstjens, Huib/0000-0001-7705-7927; van der Werf, Tjip/0000-0002-4824-1642; Akkerman, Onno/0000-0001-5638-9260	NanoNextNL [03D.09]	NanoNextNL	Part of this study was sponsored by NanoNextNL (03D.09), http://www.nanonextnl.nl/nl/. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other costs were payed for with Novolizer royalty income. There was no additional external funding received for this study.	ALEXANDER MR, 1979, CHEST, V75, P675, DOI 10.1378/chest.75.6.675; Altenburg J, 2011, RESPIRATION, V81, P67, DOI 10.1159/000320319; Angrill J, 2002, THORAX, V57, P15, DOI 10.1136/thorax.57.1.15; Angrill J, 2001, AM J RESP CRIT CARE, V164, P1628, DOI 10.1164/ajrccm.164.9.2105083; Barker AF, 2000, AM J RESP CRIT CARE, V162, P481, DOI 10.1164/ajrccm.162.2.9910086; Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; Bilton D, 2006, CHEST, V130, P1503, DOI 10.1378/chest.130.5.1503; Boiselle PM, 2008, CT OF THE AIRWAYS, DOI [10.1007/978-1-59745-139-0, DOI 10.1007/978-1-59745-139-0]; Geller DE, 2007, PEDIATR PULM, V42, P307, DOI 10.1002/ppul.20594; Ho PL, 1998, CHEST, V114, P1594, DOI 10.1378/chest.114.6.1594; Hoppentocht M, 2015, EUR J PHARM BIOPHARM, V90, P8, DOI 10.1016/j.ejpb.2015.01.012; Hoppentocht M, 2014, EUR J PHARM BIOPHARM, V86, P23, DOI 10.1016/j.ejpb.2013.10.019; Hoppentocht M., 2015, J APPL BIOANAL, V1, P123; Konstan MW, 2011, PEDIATR PULM, V46, P230, DOI 10.1002/ppul.21356; Konstan MW, 2011, J CYST FIBROS, V10, P54, DOI 10.1016/j.jcf.2010.10.003; Labiris NR, 2003, BRIT J CLIN PHARMACO, V56, P588, DOI 10.1046/j.1365-2125.2003.01892.x; Lynch DA, 2013, CORRELATION CT FINDI; MACLUSKY IB, 1989, PEDIATR PULM, V7, P42, DOI 10.1002/ppul.1950070110; Miszkiel KA, 1997, THORAX, V52, P260, DOI 10.1136/thx.52.3.260; Newhouse MT, 2003, CHEST, V124, P360, DOI 10.1378/chest.124.1.360; NICOTRA MB, 1995, CHEST, V108, P955, DOI 10.1378/chest.108.4.955; Panidis D, 2005, CHEST, V128, P545, DOI 10.1378/chest.128.2.545; Pappalettera M, 2009, CLIN RESPIR J, V3, P126, DOI 10.1111/j.1752-699X.2009.00131.x; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Patton JS, 2010, J AEROSOL MED PULM D, V23, pS71, DOI 10.1089/jamp.2010.0836; PROOST JH, 1992, COMPUT BIOL MED, V22, P155, DOI 10.1016/0010-4825(92)90011-B; Scheinberg P, 2005, CHEST, V127, P1420, DOI 10.1378/chest.127.4.1420; SMITH AL, 1989, PEDIATR PULM, V7, P265, DOI 10.1002/ppul.1950070413; STEINKAMP G, 1989, PEDIATR PULM, V6, P91, DOI 10.1002/ppul.1950060207; Vendrell Montserrat, 2015, Open Respir Med J, V9, P30, DOI 10.2174/1874306401509010030; Westerman E M, 2004, J Cyst Fibros, V3, P23, DOI 10.1016/j.jcf.2003.12.005; Wilson CB, 1997, EUR RESPIR J, V10, P1754, DOI 10.1183/09031936.97.10081754	32	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0149768	10.1371/journal.pone.0149768	http://dx.doi.org/10.1371/journal.pone.0149768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959239	Green Published, Green Submitted, gold			2022-12-27	WOS:000371992300024
J	Losick, VP; Jun, AS; Spradling, AC				Losick, Vicki P.; Jun, Albert S.; Spradling, Allan C.			Wound-Induced Polyploidization: Regulation by Hippo and JNK Signaling and Conservation in Mammals	PLOS ONE			English	Article							COMPENSATORY CELLULAR HYPERTROPHY; NUCLEAR-DNA CONTENT; MOUSE MODEL; PATHWAY; GROWTH; DIVISION; SIZE; DIFFERENTIATION; PROLIFERATION; REGENERATION	Tissue integrity and homeostasis often rely on the proliferation of stem cells or differentiated cells to replace lost, aged, or damaged cells. Recently, we described an alternative source of cell replacement-the expansion of resident, non-dividing diploid cells by wound-induced polyploidization (WIP). Here we show that the magnitude of WIP is proportional to the extent of cell loss using a new semi-automated assay with single cell resolution. Hippo and JNK signaling regulate WIP; unexpectedly however, JNK signaling through AP-1 limits rather than stimulates the level of Yki activation and polyploidization in the Drosophila epidermis. We found that polyploidization also quantitatively compensates for cell loss in a mammalian tissue, mouse corneal endothelium, where increased cell death occurs with age in a mouse model of Fuchs Endothelial Corneal Dystrophy (FECD). Our results suggest that WIP is an evolutionarily conserved homeostatic mechanism that maintains the size and synthetic capacity of adult tissues.	[Losick, Vicki P.; Spradling, Allan C.] Howard Hughes Med Inst, Carnegie Inst Sci, Dept Embryol, 3250 San Martin Dr, Baltimore, MD 21218 USA; [Jun, Albert S.] Johns Hopkins Sch Med, Wilmer Eye Inst, 400 N Broadway, Baltimore, MD 21231 USA	Carnegie Institution for Science; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Spradling, AC (corresponding author), Howard Hughes Med Inst, Carnegie Inst Sci, Dept Embryol, 3250 San Martin Dr, Baltimore, MD 21218 USA.	spradling@ciwemb.edu		Losick, Vicki/0000-0003-4608-2980	Howard Hughes Medical Institute; Jane Coffin Childs postdoctoral fellowship; National Institutes of Health [EY019874]; NATIONAL EYE INSTITUTE [R01EY019874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104318, R01GM084947] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Jane Coffin Childs postdoctoral fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The support of this research was provided by the Howard Hughes Medical Institute to A.C.S, a Jane Coffin Childs postdoctoral fellowship received by V.P.L., and a grant from the National Institutes of Health (EY019874) to A.S.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylon Y, 2011, MOL ONCOL, V5, P315, DOI 10.1016/j.molonc.2011.07.007; Botting KJ, 2012, CLIN EXP PHARMACOL P, V39, P814, DOI 10.1111/j.1440-1681.2011.05649.x; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Bunker BD, 2015, ELIFE, V4, DOI 10.7554/eLife.03189; Rios-Barrera LD, 2013, GENESIS, V51, P147, DOI 10.1002/dvg.22354; Dej KJ, 1999, DEVELOPMENT, V126, P293; Denchi EL, 2006, GENE DEV, V20, P2648, DOI 10.1101/gad.1453606; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; Djabrayan NJV, 2014, CELL REP, V9, P859, DOI 10.1016/j.celrep.2014.09.043; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Edgar BA, 2014, NAT REV MOL CELL BIO, V15, P197, DOI 10.1038/nrm3756; Enomoto M, 2015, DEV BIOL, V403, P162, DOI 10.1016/j.ydbio.2015.05.001; Enomoto M, 2013, EMBO REP, V14, P65, DOI 10.1038/embor.2012.185; Fox DT, 2010, GENE DEV, V24, P2294, DOI 10.1101/gad.1952710; Gaspar P, 2014, CURR OPIN CELL BIOL, V31, P74, DOI 10.1016/j.ceb.2014.09.003; Gehart H, 2015, TRENDS GENET, V31, P344, DOI 10.1016/j.tig.2015.04.005; Gentric G, 2015, J CLIN INVEST, V125, P981, DOI 10.1172/JCI73957; Gokhale RH, 2015, WIRES DEV BIOL, V4, P335, DOI 10.1002/wdev.181; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Harashima H, 2013, TRENDS CELL BIOL, V23, P345, DOI 10.1016/j.tcb.2013.03.002; Haskins JW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005770; Hayashi S, 1996, DEVELOPMENT, V122, P1051; Hsu SH, 2015, HEPATOLOGY; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; IKEBE H, 1988, EXP EYE RES, V47, P205, DOI 10.1016/0014-4835(88)90004-8; IKEBE H, 1986, EXP EYE RES, V43, P251, DOI 10.1016/S0014-4835(86)80093-8; Joyce NC, 2005, EXP EYE RES, V81, P629, DOI 10.1016/j.exer.2005.06.012; Jun AS, 2012, HUM MOL GENET, V21, P384, DOI 10.1093/hmg/ddr473; Kim M, 2011, P NATL ACAD SCI USA, V108, P650, DOI 10.1073/pnas.1016386108; Korzelius J, 2014, EMBO J, V33, P2967, DOI 10.15252/embj.201489072; Lilly MA, 1996, GENE DEV, V10, P2514, DOI 10.1101/gad.10.19.2514; Liu ZP, 2010, CIRC RES, V106, P1498, DOI 10.1161/CIRCRESAHA.109.211888; Losick VP, 2013, CURR BIOL, V23, P2224, DOI 10.1016/j.cub.2013.09.029; Losick VP, 2014, ADV WOUND CARE; Loza-Coll MA, 2014, EMBO J, V33, P2983, DOI 10.15252/embj.201489050; Lucchetta EM, 2012, WIRES DEV BIOL, V1, P781, DOI 10.1002/wdev.51; Maqbool SB, 2010, J CELL SCI, V123, P4095, DOI 10.1242/jcs.064519; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Matthaei M, 2013, INVEST OPHTH VIS SCI, V54, P1931, DOI 10.1167/iovs.12-10898; Matthaei M, 2012, INVEST OPHTH VIS SCI, V53, P6718, DOI 10.1167/iovs.12-9669; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Orr-Weaver TL, 2015, TRENDS GENET; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; Razzell W, 2011, DIS MODEL MECH, V4, P569, DOI 10.1242/dmm.006825; Roberts-Galbraith RH, 2015, CURR OPIN GENET DEV, V32, P37, DOI 10.1016/j.gde.2015.01.009; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Schmedt T, 2012, EXP EYE RES, V95, P24, DOI 10.1016/j.exer.2011.08.002; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shen ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117522; Simon A, 2013, WIRES DEV BIOL, V2, P291, DOI 10.1002/wdev.73; Sun GP, 2014, CURR TOP DEV BIOL, V108, P95, DOI 10.1016/B978-0-12-391498-9.00003-6; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Tamori Y, 2014, TRENDS CELL BIOL, V24, P230, DOI 10.1016/j.tcb.2013.10.005; Tamori Y, 2013, DEV CELL, V25, P350, DOI 10.1016/j.devcel.2013.04.013; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Tornini VA, 2014, DEV CELL, V29, P139, DOI 10.1016/j.devcel.2014.04.007; Unhavaithaya Y, 2012, GENE DEV, V26, P31, DOI 10.1101/gad.177436.111; Weigmann K, 1997, DEVELOPMENT, V124, P3555; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang J, 2015, EXP EYE RES, V130, P97, DOI 10.1016/j.exer.2014.10.023; Zielke N, 2011, NATURE, V480, P123, DOI 10.1038/nature10579	64	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151251	10.1371/journal.pone.0151251	http://dx.doi.org/10.1371/journal.pone.0151251			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26958853	gold, Green Published			2022-12-27	WOS:000371992300113
J	Oliveira, BAP; Pinhel, MAS; Nicoletti, CF; Oliveira, CC; Quinhoneiro, DCG; Noronha, NY; Marchini, JS; Marchry, AJ; Junior, WS; Nonino, CB				Oliveira, Bruno A. P.; Pinhel, Marcela A. S.; Nicoletti, Carolina F.; Oliveira, Cristiana C.; Quinhoneiro, Driele C. G.; Noronha, Natalia Y.; Marchini, Julio S.; Marchry, Ana J.; Junior, Wilson S.; Nonino, Carla B.			UCP1 and UCP3 Expression Is Associated with Lipid and Carbohydrate Oxidation and Body Composition	PLOS ONE			English	Article							Y GASTRIC BYPASS; ENERGY-EXPENDITURE; ADIPOSE-TISSUE; UNCOUPLING PROTEINS; BARIATRIC SURGERY; GENE-EXPRESSION; OBESE SUBJECTS; WEIGHT-LOSS; METABOLISM; GUIDELINES	Background/Objective Uncoupling proteins (UCPs) are located in the inner membrane of mitochondria. These proteins participate in thermogenesis and energy expenditure. This study aimed to evaluate how UCP1 and UCP3 expression influences substrate oxidation and elicits possible changes in body composition in patients submitted to bariatric surgery. Subjects/Methods This is a longitudinal study comprising 13 women with obesity grade III that underwent bariatric surgery and 10 healthy weight individuals (control group). Body composition was assessed by bioelectrical impedance. Carbohydrate and fat oxidation was determined by indirect calorimetry. Subcutaneous adipose tissue was collected for gene expression analysis. QPCR was used to evaluate UCP1 and UCP3 expression. Results Obese patients and the control group differed significantly in terms of lipid and carbohydrate oxidation. Six months after bariatric surgery, the differences disappeared. Lipid oxidation correlated with the percentage of fat mass in the postoperative period. Multiple linear regression analysis showed that the UCP1 and UCP3 genes contributed to lipid and carbohydrate oxidation. Additionally, UCP3 expression was associated with BMI, percentage of lean body mass, and percentage of mass in the postoperative period. Conclusions UCP1 and UCP3 expression is associated with lipid and carbohydrate oxidation in patients submitted to bariatric surgery. In addition, UCP3 participates in body composition modulation six months postoperatively.	[Oliveira, Bruno A. P.; Pinhel, Marcela A. S.; Nicoletti, Carolina F.; Oliveira, Cristiana C.; Quinhoneiro, Driele C. G.; Noronha, Natalia Y.; Marchini, Julio S.; Marchry, Ana J.; Nonino, Carla B.] Univ Sao Paulo, Dept Internal Med, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, SP, Brazil; [Junior, Wilson S.] Univ Sao Paulo, Dept Surg & Anat, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Nonino, CB (corresponding author), Univ Sao Paulo, Dept Internal Med, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, SP, Brazil.	carla@fmrp.usp.br	Noronha, Natália Yumi/T-7080-2018; Salgado, Wilson/L-1470-2016; Marchini, Julio S/K-1992-2016; Nonino, Carla B/D-4637-2012; Noronha, Natalia Yumi/AAQ-6468-2020	Noronha, Natália Yumi/0000-0001-9589-8586; Marchini, Julio S/0000-0001-9999-9149; Nonino, Carla B/0000-0001-8559-0772; Noronha, Natalia Yumi/0000-0001-9589-8586; Oliveira, Bruno/0000-0002-4233-5517; Cortes de Oliveira, Cristiana/0000-0003-3638-3050	Sao Paulo Research Foundation (FAPESP) [2013/06563-7, 2013/08916-4]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grant #2013/06563-7 and #2013/08916-4 from the Sao Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bat BS, 2012, NATURE REV ENDOCRINO, V8, P544, DOI [10.1038/nrendo.2012.48, DOI 10.1038/NREND0.2012A8]; Bracale R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098244; Brondani LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096411; Busiello RA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00036; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carey DG, 2006, OBES SURG, V16, P469; Carrasco F, 2007, OBES SURG, V17, P608, DOI 10.1007/s11695-007-9117-z; Cesar MD, 2008, OBES SURG, V18, P1376, DOI 10.1007/s11695-008-9460-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cioffi F, 2009, BIOFACTORS, V35, P417, DOI 10.1002/biof.54; Depieri Tatiane Z., 2004, Arq Bras Endocrinol Metab, V48, P337, DOI 10.1590/S0004-27302004000300003; Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003; Dulloo AG, 2001, BRIT J NUTR, V86, P123, DOI 10.1079/BJN2001412; Faria SL, 2012, OBES SURG, V22, P1450, DOI 10.1007/s11695-012-0672-6; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Fried M, 2014, OBES SURG, V24, P42, DOI 10.1007/s11695-013-1079-8; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Hall KD, 2007, INT J OBESITY, V31, P1378, DOI 10.1038/sj.ijo.0803608; Hartwig Tiago Wally, 2013, Rev. bras. cineantropom. desempenho hum., V15, P686, DOI 10.5007/1980-0037.2013v15n6p686; Hosseini A, 2010, J ANIM PHYSIOL AN N, V94, pe178, DOI 10.1111/j.1439-0396.2010.01002.x; Jakicic JM, 1998, INT J OBESITY, V22, P243, DOI 10.1038/sj.ijo.0800576; Klaus S, 2004, CURR DRUG TARGETS, V5, P241, DOI 10.2174/1389450043490523; Klaus S, 2012, GENES NUTR, V7, P369, DOI 10.1007/s12263-011-0260-8; Kopecky J, 2004, PHYSIOL RES, V53, pS225; Labayen I, 2004, CLIN NUTR, V23, P571, DOI 10.1016/j.clnu.2003.10.004; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; Mandal Abhijit, 2014, J Family Med Prim Care, V3, P25, DOI 10.4103/2249-4863.130265; da Silva MAM, 2013, REV ASSOC MED BRAS, V59, P381, DOI 10.1016/j.ramb.2013.02.009; Mingrone G, 2003, OBES RES, V11, P632, DOI 10.1038/oby.2003.91; Moncada R, 2015, OBESITY SURG; Nicoletti CF, 2013, REV CHIL NUTR, V40, P39; Nicoletti CF, 2015, OBES SURG, V25, P279, DOI 10.1007/s11695-014-1349-0; Smith CE, 2012, NUTR REV, V70, P611, DOI 10.1111/j.1753-4887.2012.00515.x; Sonko BJ, 2005, J NUTR, V135, P2159, DOI 10.1093/jn/135.9.2159; Toda C, 2014, BEST PRACT RES CL EN, V28, P757, DOI 10.1016/j.beem.2014.02.006; Weijs PJM, 2010, CLIN NUTR, V29, P347, DOI 10.1016/j.clnu.2009.09.009	36	15	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0150811	10.1371/journal.pone.0150811	http://dx.doi.org/10.1371/journal.pone.0150811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959981	gold, Green Published, Green Submitted			2022-12-27	WOS:000371992300074
J	Wogan, GOU				Wogan, Guinevere O. U.			Life History Traits and Niche Instability Impact Accuracy and Temporal Transferability for Historically Calibrated Distribution Models of North American Birds	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; CLIMATE-CHANGE; ENVELOPE MODELS; RANGE; PERFORMANCE; PREDICTION; HABITAT; MAXENT; CONSTRAINTS; PREVALENCE	A primary assumption of environmental niche models (ENMs) is that models are both accurate and transferable across geography or time; however, recent work has shown that models may be accurate but not highly transferable. While some of this is due to modeling technique, individual species ecologies may also underlie this phenomenon. Life history traits certainly influence the accuracy of predictive ENMs, but their impact on model transferability is less understood. This study investigated how life history traits influence the predictive accuracy and transferability of ENMs using historically calibrated models for birds. In this study I used historical occurrence and climate data (1950-1990s) to build models for a sample of birds, and then projected them forward to the 'future' (1960-1990s). The models were then validated against models generated from occurrence data at that 'future' time. Internal and external validation metrics, as well as metrics assessing transferability, and Generalized Linear Models were used to identify life history traits that were significant predictors of accuracy and transferability. This study found that the predictive ability of ENMs differs with regard to life history characteristics such as range, migration, and habitat, and that the rarity versus commonness of a species affects the predicted stability and overlap and hence the transferability of projected models. Projected ENMs with both high accuracy and transferability scores, still sometimes suffered from over-or under-predicted species ranges. Life history traits certainly influenced the accuracy of predictive ENMs for birds, but while aspects of geographic range impact model transferability, the mechanisms underlying this are less understood.	[Wogan, Guinevere O. U.] Natl Audubon Soc, Emeryville, CA USA; [Wogan, Guinevere O. U.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Wogan, Guinevere O. U.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wogan, GOU (corresponding author), Natl Audubon Soc, Emeryville, CA USA.; Wogan, GOU (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.; Wogan, GOU (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	gwogan@berkeley.edu	Wogan, Guinevere O.U./C-4613-2013	Wogan, Guinevere O.U./0000-0003-1877-0591	National Audubon Society	National Audubon Society	Salary was provided by a grant to the National Audubon Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 1998, PAT BIRD ID INF VERS; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Braunisch V, 2013, ECOGRAPHY, V36, P971, DOI 10.1111/j.1600-0587.2013.00138.x; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Butcher GS, 2007, COMBINING DATA CHRIS; Cao Y, 2013, ECOL MODEL, V259, P30, DOI 10.1016/j.ecolmodel.2013.03.012; Constable H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000309; Dobrowski SZ, 2011, ECOL MONOGR, V81, P241, DOI 10.1890/10-1325.1; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Franklin J, 2009, MAPPING SPECIES DIST; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Garrison BA, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P367; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Heikkinen RK, 2012, ECOGRAPHY, V35, P276, DOI 10.1111/j.1600-0587.2011.06999.x; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Illan JG, 2014, GLOBAL CHANGE BIOL, V20, P3351, DOI 10.1111/gcb.12642; IUCN, 2012, IUCN RED LIST THREAT; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jimenez-Valverde A, 2014, BIODIVERS CONSERV, V23, P369, DOI 10.1007/s10531-013-0606-1; Kharouba HM, 2009, ECOLOGY, V90, P2213, DOI 10.1890/08-1304.1; Kuemmerle T, 2011, ECOL APPL, V21, P830, DOI 10.1890/10-0073.1; Kuemmerle T, 2010, BIOL CONSERV, V143, P908, DOI 10.1016/j.biocon.2009.12.038; Lane MA, 2007, SYSTEMATICS ASS, V73; Lee PY, 2005, J BIOGEOGR, V32, P1139, DOI 10.1111/j.1365-2699.2005.01254.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Matthews SN, 2011, ECOGRAPHY, V34, P933, DOI 10.1111/j.1600-0587.2011.06803.x; McPherson JM, 2007, ECOGRAPHY, V30, P135, DOI 10.1111/j.2006.0906-7590.04823.x; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Monahan WB, 2008, BIOL LETTERS, V4, P595, DOI 10.1098/rsbl.2008.0154; Moore RP, 2008, ECOL LETT, V11, P960, DOI 10.1111/j.1461-0248.2008.01196.x; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Naimi B., 2015, R PACKAGE VERSION, P1; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; O'Connor Raymond J., 1996, Biodiversity Letters, V3, P97, DOI 10.2307/2999723; Owens HL, 2013, ECOL MODEL, V263, P10, DOI 10.1016/j.ecolmodel.2013.04.011; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Poyry J, 2008, GLOBAL ECOL BIOGEOGR, V17, P403, DOI 10.1111/j.1466-8238.2007.00373.x; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Rapacciuolo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040212; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Rubidge EM, 2011, GLOBAL CHANGE BIOL, V17, P696, DOI 10.1111/j.1365-2486.2010.02297.x; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Smith AB, 2013, ECOGRAPHY, V36, P1017, DOI 10.1111/j.1600-0587.2013.00107.x; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Stokland JN, 2011, ECOL MODEL, V222, P1800, DOI 10.1016/j.ecolmodel.2011.02.025; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Syphard AD, 2010, J VEG SCI, V21, P177, DOI 10.1111/j.1654-1103.2009.01133.x; The Christmas Bird Count Historical Results, 2010, CHRISTM BIRD COUNT H; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Warren DL, 2012, TRENDS ECOL EVOL, V27, P497, DOI 10.1016/j.tree.2012.03.010; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Zuur A. F., 2011, MIXED EFFECTS MODELS	83	27	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2016	11	3							e0151024	10.1371/journal.pone.0151024	http://dx.doi.org/10.1371/journal.pone.0151024			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TF	26959979	Green Submitted, Green Published, gold			2022-12-27	WOS:000371992300092
J	Bush, SD; Rudd, JA; Stevens, MT; Tanner, KD; Williams, KS				Bush, Seth D.; Rudd, James A., II; Stevens, Michael T.; Tanner, Kimberly D.; Williams, Kathy S.			Fostering Change from Within: Influencing Teaching Practices of Departmental Colleagues by Science Faculty with Education Specialties	PLOS ONE			English	Article								Globally, calls for the improvement of science education are frequent and fervent. In parallel, the phenomenon of having Science Faculty with Education Specialties (SFES) within science departments appears to have grown in recent decades. In the context of an interview study of a randomized, stratified sample of SFES from across the United States, we discovered that most SFES interviewed (82%) perceived having professional impacts in the realm of improving undergraduate science education, more so than in research in science education or K-12 science education. While SFES reported a rich variety of efforts towards improving undergraduate science education, the most prevalent reported impact by far was influencing the teaching practices of their departmental colleagues. Since college and university science faculty continue to be hired with little to no training in effective science teaching, the seeding of science departments with science education specialists holds promise for fostering change in science education from within biology, chemistry, geoscience, and physics departments.	[Bush, Seth D.] Calif Polytech State Univ San Luis Obispo, Dept Chem & Biochem, San Luis Obispo, CA 93407 USA; [Rudd, James A., II] Calif State Univ Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90032 USA; [Stevens, Michael T.] Utah Valley Univ, Dept Biol, Orem, UT USA; [Tanner, Kimberly D.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Williams, Kathy S.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; California Polytechnic State University San Luis Obispo; California State University System; California State University Los Angeles; Utah System of Higher Education; Utah Valley University; California State University System; San Francisco State University; California State University System; San Diego State University	Bush, SD (corresponding author), Calif Polytech State Univ San Luis Obispo, Dept Chem & Biochem, San Luis Obispo, CA 93407 USA.	sbush@calpoly.edu	Stevens, Michael/AAC-4660-2021	Stevens, Michael/0000-0003-3267-2285	National Science Foundation Division of Undergraduate Education [1228657]	National Science Foundation Division of Undergraduate Education(National Science Foundation (NSF))	This work was supported by National Science Foundation Division of Undergraduate Education 1228657, www.nsf.gov, to SB, JR, MS, KT, and KW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy T. M., 2015, J COLL SCI TEACH, V44, P91; American Physical Society, 1999, RES PHYS ED; Association of University Teachers, 2005, RIS TEACH ONL AC CHA; Bautista N. U., 2010, J COLL SCI TEACH, V40, P56; Beach A.L., 2012, CHANGE, V44, P52, DOI [10.1080/00091383.2012.728955, DOI 10.1080/00091383.2012.728955]; Borrego M, 2014, J ENG EDUC, V103, P220, DOI 10.1002/jee.20040; Bretz SL, 2002, J CHEM EDUC, V79, P1307, DOI 10.1021/ed079p1307; Bretz SL, 2009, CHEM NATL SCI ED STA; Bush S D, 2006, CBE Life Sci Educ, V5, P297, DOI 10.1187/cbe.06-09-0189; Bush SD, 2008, SCIENCE, V322, P1795, DOI 10.1126/science.1162072; Bush SD, 2015, BIOSCIENCE, V65, P81, DOI 10.1093/biosci/biu186; Bush SD, 2013, P NATL ACAD SCI USA, V110, P7170, DOI 10.1073/pnas.1218821110; Bush SD, 2011, CBE-LIFE SCI EDUC, V10, P25, DOI 10.1187/cbe.10-08-0106; Caprile M., 2015, ENCOURAGING STEM STU; Charmaz K, 2007, SAGE HDB GROUNDED TH, DOI DOI 10.4135/9781848607941; Chevaillier T, 2000, CHANGING CONDITIONS; Clark I., 2009, ACAD TRANSFORMATIONS; Committee on Science Engineering and Public Policy (COSEPUP) and Policy on Global Affairs (PGA), 2007, RIS GATH STORM EN EM; Dancy M, 2010, AM J PHYS, V78, P1056, DOI 10.1119/1.3446763; Fairweather J., 2008, LINKING EVIDENCE PRO; Foertsch J, 1997, PERSUADING PROFESSOR; Forsthuber B., 2011, SCI ED EUROPE NATL P; Gaffney JD., 2008, J COLL SCI TEACH, V37, P48; Grunwald H, 2003, RES HIGH EDUC, V44, P173, DOI 10.1023/A:1022051728874; Henard F., 2009, LEARNING OUR LESSON; Henderson C., 2011, INCREASING IMPACT DI; Henderson C, 2011, J RES SCI TEACH, V48, P952, DOI 10.1002/tea.20439; Holme T, 2010, CHEM EDUC RES PRACT, V11, P92, DOI 10.1039/C005352J; Hubball HT, 2006, INNOV HIGH EDUC, V30, P327, DOI 10.1007/s10755-005-9000-6; Hutchings P.A., 2010, 1 NAT I LEARN OUTC A, V4(1); Johnson ED, 2012, J UNIV TEACH LEARN P, V9; Labov JB, 2009, CBE-LIFE SCI EDUC, V8, P157, DOI 10.1187/cbe.09-06-0038; Lave J., 1991, SITUATED LEARNING LE; Loucks-Horsley S., 2009, DESIGNING PROFESSION; Merriam S. B., 1998, QUALITATIVE RES GUID; National Research Council, 2012, DISCIPLINE BASED ED, DOI 10.17226/13362; National Science Board, 2007, NAT ACT PLAN ADDR CR; *OECD, 2006, OECD PUBL; Ong M, 2010, MIN WOM COL SCI TECH; Pollon D., 2011, TEACHING STREAM FACU; President's Council of Advisors on Science and Technology (PCAST), 2012, ENGAGE EXCEL PRODUCI; Probert B., 2013, TEACHING FOCUSED ACA; Schussler E., 2008, J COLL SCI TEACH, V38, P32; Seymour E., 1997, TALKING LEAVING WHY; Stake R.E., 2010, QUALITATIVE RES STUD; Sunal D., 2001, SCHOOL SCI MATH, V101, P246, DOI [10.1111/j.1949-8594.2001.tb18027.x, DOI 10.1111/J.1949-8594.2001.TB18027.X]; Sursock A, 2015, TRENDS 2015 LEARNING; Trainor AA, 2013, REV QUALITATIVE RES, P123; Walczyk JJ, 2007, J RES SCI TEACH, V44, P85, DOI 10.1002/tea.20119	50	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150914	10.1371/journal.pone.0150914	http://dx.doi.org/10.1371/journal.pone.0150914			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SW	26954776	Green Published, gold			2022-12-27	WOS:000371991300059
J	Chen, TH; Huang, JJ; Chang, FC; Chang, YT; Chuang, HY				Chen, Tzu-Hua; Huang, Joh-Jong; Chang, Fong-Ching; Chang, Yu-Tsz; Chuang, Hung-Yi			Effect of Workplace Counseling Interventions Launched by Workplace Health Promotion and Tobacco Control Centers in Taiwan: An Evaluation Based on the Ottawa Charter	PLOS ONE			English	Article							SMOKE-FREE WORKPLACES; MUSCULOSKELETAL PROBLEMS; CARDIOVASCULAR-DISEASE; PHYSICAL WORK; LIFE-STYLE; PROGRAM; METAANALYSIS; STRESSORS; EMPLOYEES; IMPACT	Workplace health promotion (WHP) is important to prevent work-related diseases, reduce workplace hazards, and improve personal health of the workers. Health promotion projects were launched through the centers of WHP funded by the Taiwan Bureau of Health Promotion since 2003. Hence, the aim of this study is to evaluate the impact of WHP programs intervention from 2003 to 2007. The intervention group consisted of 838 business entities which had ever undergone counseling of the three centers in northern, central, and southern Taiwan from 2003 to 2007. The control group was composed of 1000 business entities randomly selected from the business directories of the Ministry of Economic Affairs, Taiwan. The questionnaire survey included general company profiles and the assessment of workplace health according to the five action areas of the Ottawa Charter for Health Promotion. We have received 447 (53.3%) questionnaires from the intervention group and 97 questionnaires from the control group. The intervention group was more effective in using the external resources and medical consultation, and they had better follow-up rates of the abnormal results of annual health examinations. Compared to the control group, the intervention group had a significantly decreased smoking rate in 246 companies (61.2%) and a reduced second-hand smoke exposure in 323 companies (78.6%) (p<0.001). By means of the intervention of WHP programs, we can enhance the awareness of the enterprises and the employees to improve worksite health and to create a healthy work environment.	[Chen, Tzu-Hua] Kaohsiung Municipal Tatung Hosp, Dept Family Med, Kaohsiung, Taiwan; [Chen, Tzu-Hua; Huang, Joh-Jong] Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Chang, Fong-Ching] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan; [Chen, Tzu-Hua; Chang, Yu-Tsz; Chuang, Hung-Yi] Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan; [Chuang, Hung-Yi] Kaohsiung Med Univ Hosp, Dept Occupat & Environm Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Taiwan Normal University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chuang, HY (corresponding author), Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan.; Chuang, HY (corresponding author), Kaohsiung Med Univ Hosp, Dept Occupat & Environm Med, Kaohsiung, Taiwan.	hychuang@gmail.com	Chuang, H. Y./AAM-3118-2021; Chuang, Hung-Yi/C-9143-2009	Chuang, H. Y./0000-0002-8321-8720; Chuang, Hung-Yi/0000-0002-8321-8720; Chang, Fong-Ching/0000-0002-8279-0434	National Science Council of Taiwan [NSC102-2314-B-037-064 -MY3]; Kaohsiung Medical University Hospital [KMUH-1R64, KMUH102-2R59]; Kaohsiung Medical University "Aim for the Top Universities Grant" [KMU-TP10A29]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital; Kaohsiung Medical University "Aim for the Top Universities Grant"	This work was supported by the National Science Council of Taiwan (NSC102-2314-B-037-064 -MY3) and a grant from the Kaohsiung Medical University Hospital (KMUH-1R64; KMUH102-2R59). This study is supported partially by Kaohsiung Medical University "Aim for the Top Universities Grant, grant No. KMU-TP10A29". The authors have nothing to disclose and declare no conflicts of interest.; We thank the workers and employers for their cooperation. This work was supported by the National Science Council of Taiwan (NSC102-2314-B-037-064 -MY3) and a grant from the Kaohsiung Medical University Hospital (KMUH-1R64; KMUH102-2R59). This study is supported partially by Kaohsiung Medical University "Aim for the Top Universities Grant, grant No. KMU-TP10A29" The authors have nothing to disclose and declare no conflicts of interest.	Allwright S, 2005, BMJ-BRIT MED J, V331, P1117, DOI 10.1136/bmj.38636.499225.55; Brissette Ian, 2008, Prev Chronic Dis, V5, pA37; Bultmann U, 2002, INT ARCH OCC ENV HEA, V75, P259, DOI 10.1007/s00420-001-0294-0; Bureau of Health Promotion DoH Taiwan, 2010, TAIW TOB CONTR ANN R; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Farrelly MC, 1999, TOB CONTROL, V8, P272, DOI 10.1136/tc.8.3.272; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; FIELDING JE, 1994, J OCCUP ENVIRON MED, V36, P743; Groeneveld IF, 2010, SCAND J WORK ENV HEA, V36, P202, DOI 10.5271/sjweh.2891; Gunnarsdottir S, 2003, SCAND J CARING SCI, V17, P66, DOI 10.1046/j.1471-6712.2003.00122.x; Holtermann A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-120; HOUTMAN ILD, 1994, SCAND J WORK ENV HEA, V20, P139, DOI 10.5271/sjweh.1419; Kawakami N, 1997, SCAND J WORK ENV HEA, V23, P54, DOI 10.5271/sjweh.179; Lang J, 2012, SOC SCI MED, V75, P1163, DOI 10.1016/j.socscimed.2012.04.015; Muto T, 2001, PREV MED, V33, P571, DOI 10.1006/pmed.2001.0923; Nurminen E, 2002, SCAND J WORK ENV HEA, V28, P85, DOI 10.5271/sjweh.652; Ohta M., 2006, INT CONGR SER, V1294, P123, DOI [10.1016/j.ics.2006.01.021, DOI 10.1016/J.ICS.2006.01.021]; Ottawa Charter for Health Promotion, 1986, 1 INT C HLTH PROM NO; Rabacow FM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-317; Rongen A, 2013, AM J PREV MED, V44, P406, DOI 10.1016/j.amepre.2012.12.007; Suzuki T AM, 2006, INT C SERIES, V1294, P139; Tsai SP, 2005, TOB CONTROL, V14, pI33, DOI 10.1136/tc.2003.005561; Tsutsumi A, 2005, J OCCUP HEALTH, V47, P226, DOI 10.1539/joh.47.226	23	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150710	10.1371/journal.pone.0150710	http://dx.doi.org/10.1371/journal.pone.0150710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SW	26954498	Green Submitted, Green Published, gold			2022-12-27	WOS:000371991300043
J	Li, XF; Schmid, B; Wang, F; Paine, CET				Li, Xuefei; Schmid, Bernhard; Wang, Fei; Paine, C. E. Timothy			Net Assimilation Rate Determines the Growth Rates of 14 Species of Subtropical Forest Trees	PLOS ONE			English	Article							FUNCTIONAL TRAITS; LEAF-AREA; PLANT-GROWTH; SEEDLINGS; LIGHT; MASS; COMPONENTS; ECONOMY; CARBON; SIZE	Growth rates are of fundamental importance for plants, as individual size affects myriad ecological processes. We determined the factors that generate variation in RGR among 14 species of trees and shrubs that are abundant in subtropical Chinese forests. We grew seedlings for two years at four light levels in a shade-house experiment. We monitored the growth of every juvenile plant every two weeks. After one and two years, we destructively harvested individuals and measured their functional traits and gas-exchange rates. After calculating individual biomass trajectories, we estimated relative growth rates using nonlinear growth functions. We decomposed the variance in log(RGR) to evaluate the relationships of RGR with its components: specific leaf area (SLA), net assimilation rate (NAR) and leaf mass ratio (LMR). We found that variation in NAR was the primary determinant of variation in RGR at all light levels, whereas SLA and LMR made smaller contributions. Furthermore, NAR was strongly and positively associated with area-based photosynthetic rate and leaf nitrogen content. Photosynthetic rate and leaf nitrogen concentration can, therefore, be good predictors of growth in woody species.	[Li, Xuefei; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Li, Xuefei] Univ Helsinki, Dept Phys, Helsinki, Finland; [Wang, Fei] Chinese Acad Sci, Inst Bot, West China Subalpine Bot Garden, Dujiangyan, Peoples R China; [Paine, C. E. Timothy] Univ Stirling, Biol & Environm Sci, Stirling FK9 4LA, Scotland	University of Zurich; University of Helsinki; Chinese Academy of Sciences; University of Stirling	Paine, CET (corresponding author), Univ Stirling, Biol & Environm Sci, Stirling FK9 4LA, Scotland.	c.e.t.paine@stir.ac.uk	Schmid, Bernhard/C-8625-2009; Li, Xuefei/AAC-6421-2019; Paine, C. E. Timothy/R-8108-2019	Schmid, Bernhard/0000-0002-8430-3214; Paine, C. E. Timothy/0000-0001-8705-3719	Swiss National Science Foundation [IZL CZ 123883, 130720]; German Science Foundation [DFG FOR 891/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Science Foundation(German Research Foundation (DFG))	Funding was provided by the Swiss National Science Foundation to BS (grants IZL CZ 123883 and 130720) and the German Science Foundation to BS (DFG FOR 891/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, FLORA CHINA; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BREWSTER JL, 1981, J APPL ECOL, V18, P589, DOI 10.2307/2402419; GARNIER E, 1992, J ECOL, V80, P665, DOI 10.2307/2260858; GRIME JP, 1975, J ECOL, V63, P393, DOI 10.2307/2258728; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; Hunt R, 1982, MATH PLANT PHYSL; Konings H., 1989, CAUSES CONSEQUENCES, P101; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Li X, 2011, THESIS U ZURICH; Meziane D, 1999, FUNCT ECOL, V13, P611, DOI 10.1046/j.1365-2435.1999.00359.x; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; Osnas JLD, 2013, SCIENCE, V340, P741, DOI 10.1126/science.1231574; Paine CET, 2015, J ECOL, V103, P978, DOI 10.1111/1365-2745.12401; Paine CET, 2012, METHODS ECOL EVOL, V3, P245, DOI 10.1111/j.2041-210X.2011.00155.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P1191, DOI 10.1071/PP99173; POORTER H, 1990, OECOLOGIA, V83, P553, DOI 10.1007/BF00317209; POORTER H, 1992, NEW PHYTOL, V120, P159, DOI 10.1111/j.1469-8137.1992.tb01069.x; POORTER H, 1990, PLANT PHYSIOL, V94, P621, DOI 10.1104/pp.94.2.621; Poorter H., 1989, CAUSES CONSEQUENCES, P45; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Quero JL, 2008, FUNCT PLANT BIOL, V35, P725, DOI 10.1071/FP08149; R Core Team, 2021, R LANGUAGE ENV STAT; Rees M, 2010, AM NAT, V176, pE152, DOI 10.1086/657037; Reich PB, 1998, FUNCT ECOL, V12, P327, DOI 10.1046/j.1365-2435.1998.00208.x; Shipley B, 2006, FUNCT ECOL, V20, P565, DOI 10.1111/j.1365-2435.2006.01135.x; Shipley B, 2002, FUNCT ECOL, V16, P682, DOI 10.1046/j.1365-2435.2002.00672.x; Turnbull LA, 2008, ECOLOGY, V89, P1352, DOI 10.1890/07-1531.1; Villar R, 2005, PLANT SOIL, V272, P11, DOI 10.1007/s11104-004-3846-8; WALTERS MB, 1993, OECOLOGIA, V96, P219, DOI 10.1007/BF00317735; Warton DI, 2011, METHODS ECOL EVOL; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	33	34	36	8	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0150644	10.1371/journal.pone.0150644	http://dx.doi.org/10.1371/journal.pone.0150644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26953884	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000371991300039
J	Warid, W; Hizam, H; Mariun, N; Abdul-Wahab, NI				Warid, Warid; Hizam, Hashim; Mariun, Norman; Abdul-Wahab, Noor Izzri			An Efficacious Multi-Objective Fuzzy Linear Programming Approach for Optimal Power Flow Considering Distributed Generation	PLOS ONE			English	Article							IMPROVING VOLTAGE STABILITY; ALGORITHM; DISPATCH; MANAGEMENT; SYSTEM; OPTIMIZATION; EMISSION; SEARCH; MARGIN	This paper proposes a new formulation for the multi-objective optimal power flow (MOOPF) problem for meshed power networks considering distributed generation. An efficacious multi-objective fuzzy linear programming optimization (MFLP) algorithm is proposed to solve the aforementioned problem with and without considering the distributed generation (DG) effect. A variant combination of objectives is considered for simultaneous optimization, including power loss, voltage stability, and shunt capacitors MVAR reserve. Fuzzy membership functions for these objectives are designed with extreme targets, whereas the inequality constraints are treated as hard constraints. The multi-objective fuzzy optimal power flow (OPF) formulation was converted into a crisp OPF in a successive linear programming (SLP) framework and solved using an efficient interior point method (IPM). To test the efficacy of the proposed approach, simulations are performed on the IEEE 30-busand IEEE 118-bus test systems. The MFLP optimization is solved for several optimization cases. The obtained results are compared with those presented in the literature. A unique solution with a high satisfaction for the assigned targets is gained. Results demonstrate the effectiveness of the proposed MFLP technique in terms of solution optimality and rapid convergence. Moreover, the results indicate that using the optimal DG location with the MFLP algorithm provides the solution with the highest quality.	[Warid, Warid; Hizam, Hashim; Mariun, Norman; Abdul-Wahab, Noor Izzri] Univ Putra Malaysia, Fac Engn, Dept Elect & Elect Engn, Upm Serdang 43400, Selangor, Malaysia; [Warid, Warid] Southern Tech Univ, Tech Inst Shatra, Fdn Tech Educ, Minist Higher Educ & Sci Res, Basrah, Iraq; [Warid, Warid; Hizam, Hashim; Mariun, Norman; Abdul-Wahab, Noor Izzri] Univ Putra Malaysia, Fac Engn, Ctr Adv Power & Energy Res, Upm Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia; Southern Technical University; Universiti Putra Malaysia	Hizam, H (corresponding author), Univ Putra Malaysia, Fac Engn, Dept Elect & Elect Engn, Upm Serdang 43400, Selangor, Malaysia.; Hizam, H (corresponding author), Univ Putra Malaysia, Fac Engn, Ctr Adv Power & Energy Res, Upm Serdang 43400, Selangor, Malaysia.	hhizam@upm.edu.my	Alzihaymee, Warid Sayel Warid/J-6700-2019; BIN ABDUL WAHAB, NOOR IZZRI/A-5696-2017; hizam, hashim/AAF-5759-2020	Alzihaymee, Warid Sayel Warid/0000-0002-2511-2733; BIN ABDUL WAHAB, NOOR IZZRI/0000-0002-9042-9796; 	Iraqi Ministry of Higher Education & Scientific Research; Foundation of Technical Education; Southern Technical University	Iraqi Ministry of Higher Education & Scientific Research; Foundation of Technical Education; Southern Technical University	The authors gratefully acknowledge the University Putra Malaysia, Faculty of Engineering, Department of Electrical and Electronic Engineering, for providing the necessary facilities. The author Warid Warid would like to thank the Iraqi Ministry of Higher Education & Scientific Research, Foundation of Technical Education and Southern Technical University for the unceasing encouragement, support and attention.	Abido MA, 2006, IEEE T EVOLUT COMPUT, V10, P315, DOI 10.1109/TEVC.2005.857073; Abido MA, 2009, 2009 INTERNATIONAL CONFERENCE ON POWER ENGINEERING, ENERGY AND ELECTRICAL DRIVES, P101, DOI 10.1109/POWERENG.2009.4915212; Abou El-Ela AA, 2007, ELECTR POW SYST RES, V77, P421, DOI 10.1016/j.epsr.2006.04.004; Bansal RC, 2003, IEEE T POWER SYST, V18, P1291, DOI 10.1109/TPWRS.2003.818595; Bansilal, 1996, INT J ELEC POWER, V18, P461, DOI 10.1016/0142-0615(96)00004-X; Chen HN, 2014, INT J ELEC POWER, V60, P203, DOI 10.1016/j.ijepes.2014.02.017; Chen YL, 2004, IEE P-GENER TRANSM D, V151, P555, DOI 10.1049/ip-gtd:20040645; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Dong F, 2005, IEEE T POWER SYST, V20, P338, DOI 10.1109/TPWRS.2004.841241; El Sehiemy R, 2013, IET GENER TRANSM DIS, V7, P1453, DOI 10.1049/iet-gtd.2013.0051; El-Ela AAA, 2005, ELECTR POW SYST RES, V74, P147, DOI 10.1016/j.epsr.2004.08.014; Elsaiah S, 2015, IET GENER TRANSM DIS, V9, P417, DOI 10.1049/iet-gtd.2014.0130; Frank S, 2012, ENERGY SYST, V3, P259, DOI 10.1007/s12667-012-0057-x; Frank S, 2012, ENERGY SYST, V3, P221, DOI 10.1007/s12667-012-0056-y; Ghosh S, 2010, INT J ELEC POWER, V32, P849, DOI 10.1016/j.ijepes.2010.01.029; Hazra J, 2011, EUR T ELECTR POWER, V21, P1028, DOI 10.1002/etep.494; Hu XS, 2015, IEEE T IND ELECTRON, V62, P7847, DOI 10.1109/TIE.2015.2463770; Khorsandi A, 2013, ELECTR POW SYST RES, V95, P206, DOI 10.1016/j.epsr.2012.09.002; Khorsandi A, 2011, IET GENER TRANSM DIS, V5, P249, DOI 10.1049/iet-gtd.2010.0256; Kumari MS, 2010, INT J ELEC POWER, V32, P736, DOI 10.1016/j.ijepes.2010.01.010; LEE KY, 1985, IEEE T POWER AP SYST, V104, P1147, DOI 10.1109/TPAS.1985.323466; Liu L, 2009, IEEE T POWER SYST, V24, P1182, DOI 10.1109/TPWRS.2009.2023258; Mousavi OA, 2013, ELECTR POW SYST RES, V96, P36, DOI 10.1016/j.epsr.2012.10.005; Niknam T, 2013, IEEE SYST J, V7, P742, DOI 10.1109/JSYST.2012.2227217; Sheng WX, 2014, IET GENER TRANSM DIS, V8, P261, DOI 10.1049/iet-gtd.2013.0389; Soliman SAH, 2012, ENERG SYST, P1, DOI 10.1007/978-1-4614-1752-1; Stom R., 1995, 95012 TR INT COMP SC; Taghavi R, 2012, INT J ELEC POWER, V42, P375, DOI 10.1016/j.ijepes.2012.04.002; Venkatesh B, 2000, IEEE T POWER SYST, V15, P844, DOI 10.1109/59.867183; Venkatesh B, 2001, ELECTR POW SYST RES, V59, P89, DOI 10.1016/S0378-7796(01)00146-8; Xiaosong H, 2015, ASME 2015 DYN SYST C; Yamashita K, 2008, EUR T ELECTR POWER, V18, P854, DOI 10.1002/etep.304; Younes M, 2014, ENERGY, V67, P595, DOI 10.1016/j.energy.2013.12.043; Yu ZW, 2011, IEEE T EVOLUT COMPUT, V15, P812, DOI 10.1109/TEVC.2010.2051444; Zhou B, 2014, IEEE T IND INFORM, V10, P1012, DOI 10.1109/TII.2014.2310634	36	1	1	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2016	11	3							e0149589	10.1371/journal.pone.0149589	http://dx.doi.org/10.1371/journal.pone.0149589			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SW	26954783	gold, Green Published			2022-12-27	WOS:000371991300011
J	Borthwick, LA; Kerbiriou, M; Taylor, CJ; Cozza, G; Lascu, I; Postel, EH; Cassidy, D; Trouve, P; Mehta, A; Robson, L; Muimo, R				Borthwick, Lee A.; Kerbiriou, Mathieu; Taylor, Christopher J.; Cozza, Giorgio; Lascu, Ioan; Postel, Edith H.; Cassidy, Diane; Trouve, Pascal; Mehta, Anil; Robson, Louise; Muimo, Richmond			Role of Interaction and Nucleoside Diphosphate Kinase B in Regulation of the Cystic Fibrosis Transmembrane Conductance Regulator Function by cAMP-Dependent Protein Kinase A	PLOS ONE			English	Article							RECTIFYING CHLORIDE CHANNELS; EPITHELIAL SODIUM-CHANNEL; HETEROTRIMERIC G-PROTEINS; ENERGY PHOSPHATE TRANSFER; GTP-BINDING PROTEINS; HISTIDINE PHOSPHORYLATION; SUBCELLULAR-LOCALIZATION; NUCLEAR-LOCALIZATION; AIRWAY EPITHELIUM; CRYSTAL-STRUCTURE	Cystic fibrosis results from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), a cAMP-dependent protein kinase A (PKA) and ATP-regulated chloride channel. Here, we demonstrate that nucleoside diphosphate kinase B (NDPK-B, NM23-H2) forms a functional complex with CFTR. In airway epithelia forskolin/IBMX significantly increases NDPK-B co-localisation with CFTR whereas PKA inhibitors attenuate complex formation. Furthermore, an NDPK-B derived peptide (but not its NDPK-A equivalent) disrupts the NDPK-B/CFTR complex in vitro (19-mers comprising amino acids 36-54 from NDPK-B or NDPK-A). Overlay (Far-Western) and Surface Plasmon Resonance (SPR) analysis both demonstrate that NDPK-B binds CFTR within its first nucleotide binding domain (NBD1, CFTR amino acids 351-727). Analysis of chloride currents reflective of CFTR or outwardly rectifying chloride channels (ORCC, DIDS-sensitive) showed that the 19-mer NDPK-B peptide (but not its NDPK-A equivalent) reduced both chloride conductances. Additionally, the NDPK-B (but not NDPK-A) peptide also attenuated acetylcholine-induced intestinal short circuit currents. In silico analysis of the NBD1/NDPK-B complex reveals an extended interaction surface between the two proteins. This binding zone is also target of the 19-mer NDPK-B peptide, thus confirming its capability to disrupt NDPK-B/CFTR complex. We propose that NDPK-B forms part of the complex that controls chloride currents in epithelia.	[Borthwick, Lee A.; Kerbiriou, Mathieu; Muimo, Richmond] Univ Sheffield, Sch Med, Dept Infect & Immun, Acad Unit Resp Med, Sheffield S10 2RX, S Yorkshire, England; [Taylor, Christopher J.] Univ Sheffield, Stephenson Wing, Sheffield Childrens Hosp, Acad Unit Child Hlth, Sheffield S10 2TH, S Yorkshire, England; [Robson, Louise] Univ Sheffield, Dept Biomed Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Cozza, Giorgio] Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58-B, I-35131 Padua, Italy; [Lascu, Ioan] Univ Bordeaux, Bordeaux, France; [Lascu, Ioan] CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France; [Postel, Edith H.] UMDNJ, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Cassidy, Diane; Mehta, Anil] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst CVS Diabet Lung, Dundee DD1 9SY, Scotland; [Kerbiriou, Mathieu; Trouve, Pascal] INSERM, UMR 1078, Genet Genom Fonct & Biotechnol, 46 Rue Felix Le Dantec, F-29218 Brest 2, France	University of Sheffield; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Sheffield; University of Sheffield; University of Padua; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Dundee; Institut National de la Sante et de la Recherche Medicale (Inserm)	Muimo, R (corresponding author), Univ Sheffield, Sch Med, Dept Infect & Immun, Acad Unit Resp Med, Sheffield S10 2RX, S Yorkshire, England.	r.muimo@sheffield.ac.uk	Robson, Louise/Y-3794-2018	Robson, Louise/0000-0003-2984-6520; COZZA, GIORGIO/0000-0002-5155-4682	Wellcome Trust [086370/Z/08/Z]; Cystic Fibrosis Trust; association Gaetan Salaun; French CF foundation "Vaincre la Mucoviscidose"	Wellcome Trust(Wellcome TrustEuropean Commission); Cystic Fibrosis Trust; association Gaetan Salaun; French CF foundation "Vaincre la Mucoviscidose"	This study was supported, in part, by grants from the Wellcome Trust (086370/Z/08/Z) (RM), the Cystic Fibrosis Trust and from the association Gaetan Salaun and the French CF foundation "Vaincre la Mucoviscidose" (MK, PT).	Amaral MD, 2015, J CYST FIBROS, V14, P687, DOI 10.1016/j.jcf.2015.09.006; Anciaux K, 1997, FEBS LETT, V400, P75, DOI 10.1016/S0014-5793(96)01358-0; Annesley SJ, 2011, N-S ARCH PHARMACOL, V384, P341, DOI 10.1007/s00210-011-0615-0; Bachhuber T, 2005, J BIOL CHEM, V280, P31587, DOI 10.1074/jbc.M504347200; Balch WE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004499; Borthwick LA, 2007, MOL BIOL CELL, V18, P3388, DOI 10.1091/mbc.E07-02-0126; Borthwick LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023226; Bosnar MH, 2009, MOL CELL BIOCHEM, V329, P63, DOI 10.1007/s11010-009-0107-4; Bosnar MH, 2004, EXP CELL RES, V298, P275, DOI 10.1016/j.yexcr.2004.04.018; BRADBURY NA, 1992, SCIENCE, V256, P530, DOI 10.1126/science.1373908; Carson MR, 1995, BIOPHYS J, V69, P2443, DOI 10.1016/S0006-3495(95)80113-X; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Copolovici DM, 2014, ACS NANO, V8, P1972, DOI 10.1021/nn4057269; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Cuello F, 2003, J BIOL CHEM, V278, P7220, DOI 10.1074/jbc.M210304200; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; EGAN M, 1992, NATURE, V358, P581, DOI 10.1038/358581a0; ENGEL M, 1995, EUR J BIOCHEM, V234, P200, DOI 10.1111/j.1432-1033.1995.200_c.x; ENGEL M, 1994, BIOCHEM BIOPH RES CO, V199, P1041, DOI 10.1006/bbrc.1994.1334; GABRIEL SE, 1993, NATURE, V363, P263, DOI 10.1038/363263a0; Gadsby David C., 1999, Physiological Reviews, V79, pS77; GILLES AM, 1991, J BIOL CHEM, V266, P8784; Gruenert D C, 2004, J Cyst Fibros, V3 Suppl 2, P191, DOI 10.1016/j.jcf.2004.05.040; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hardcastle J, 2001, J PHARM PHARMACOL, V53, P1457, DOI 10.1211/0022357011777990; HEIDBUCHEL H, 1993, PFLUG ARCH EUR J PHY, V422, P316, DOI 10.1007/BF00374286; Hemandez-Jimenez F, 2008, J CYST FIBROS, V7, P343, DOI 10.1016/j.jcf.2008.02.006; Hippe HJ, 2011, CELL SIGNAL, V23, P579, DOI 10.1016/j.cellsig.2010.11.010; Hippe HJ, 2003, J BIOL CHEM, V278, P7227, DOI 10.1074/jbc.M210305200; Ji HL, 2000, J BIOL CHEM, V275, P27947; Jih KY, 2013, P NATL ACAD SCI USA, V110, P4404, DOI 10.1073/pnas.1215982110; Jilling T, 1996, J BIOL CHEM, V271, P4381; Kalin N, 1999, J CLIN INVEST, V103, P1379, DOI 10.1172/JCI5731; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; King JD, 2012, J BIOL CHEM, V287, P33389, DOI 10.1074/jbc.M112.396036; KOPITO RR, 1999, PHYSIOL REV, V79, P167; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kraeft SK, 1996, EXP CELL RES, V227, P63, DOI 10.1006/excr.1996.0250; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212; Lepple-Wienhues A, 2001, FASEB J, V15, P927, DOI 10.1096/fj.00-0264com; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Lu M, 2006, J CLIN INVEST, V116, P797, DOI 10.1172/JCI26961; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MACDONALD NJ, 1993, J BIOL CHEM, V268, P25780; Maisonneuve P, 2003, JNCI-J NATL CANCER I, V95, P381, DOI 10.1093/jnci/95.5.381; Marshall LJ, 1999, AM J PHYSIOL-CELL PH, V276, pC109, DOI 10.1152/ajpcell.1999.276.1.C109; Mesnildrey S, 1997, FEBS LETT, V418, P53, DOI 10.1016/S0014-5793(97)01292-1; Morera S, 1995, STRUCTURE, V3, P1307, DOI 10.1016/S0969-2126(01)00268-4; Muimo R, 2000, J BIOL CHEM, V275, P36632, DOI 10.1074/jbc.M000829200; Muimo R, 1998, AM J RESP CELL MOL, V18, P270, DOI 10.1165/ajrcmb.18.2.2850; Muimo R, 2006, J BIOENERG BIOMEMBR, V38, P181, DOI 10.1007/s10863-006-9033-2; Mwimbi XKMS, 2003, CELL SIGNAL, V15, P395, DOI 10.1016/S0898-6568(02)00143-2; Naren AP, 2000, J CLIN INVEST, V105, P377, DOI 10.1172/JCI8631; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; ORIORDAN CR, 1995, J BIOL CHEM, V270, P17033, DOI 10.1074/jbc.270.28.17033; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; Penque D, 2000, LAB INVEST, V80, P857, DOI 10.1038/labinvest.3780090; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pinon VPB, 1999, EXP CELL RES, V246, P355, DOI 10.1006/excr.1998.4318; Postel EH, 1998, INT J BIOCHEM CELL B, V30, P1291, DOI 10.1016/S1357-2725(98)00087-9; Ramjeesingh M, 1999, BIOCHEMISTRY-US, V38, P1463, DOI 10.1021/bi982243y; Ramjeesingh M, 2003, BIOCHEM J, V374, P793, DOI 10.1042/BJ20030683; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rochdi MD, 2004, J BIOL CHEM, V279, P18981, DOI 10.1074/jbc.M312621200; Roymans D, 2002, CLIN EXP METASTAS, V19, P465, DOI 10.1023/A:1020396722860; SCHWIEBERT EM, 1992, P NATL ACAD SCI USA, V89, P10623, DOI 10.1073/pnas.89.22.10623; SCHWIEBERT EM, 1994, AM J PHYSIOL, V266, pC1464, DOI 10.1152/ajpcell.1994.266.5.C1464; SMITH DL, 1974, BIOCHEMISTRY-US, V13, P3780, DOI 10.1021/bi00715a025; Sorum B, 2015, CELL, V163, P724, DOI 10.1016/j.cell.2015.09.052; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; Stoltz DA, 2015, NEW ENGL J MED, V372, P351, DOI 10.1056/NEJMra1300109; STRELKOV SV, 1995, J MOL BIOL, V249, P665, DOI 10.1006/jmbi.1995.0327; Stutts MJ, 1997, J BIOL CHEM, V272, P14037, DOI 10.1074/jbc.272.22.14037; STUTTS MJ, 1995, AM J PHYSIOL-CELL PH, V268, pC425, DOI 10.1152/ajpcell.1995.268.2.C425; Takacs-Vellai K, 2015, CELL MOL LIFE SCI, V72, P1447, DOI 10.1007/s00018-014-1803-0; WEBB PA, 1995, J MOL BIOL, V251, P574, DOI 10.1006/jmbi.1995.0457; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200; Yoo D, 2004, J BIOL CHEM, V279, P6863, DOI 10.1074/jbc.M311599200	81	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0149097	10.1371/journal.pone.0149097	http://dx.doi.org/10.1371/journal.pone.0149097			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950439	Green Published, Green Accepted, gold			2022-12-27	WOS:000371990100010
J	Jiao, JJ; Watt, GP; Lee, M; Rahbar, MH; Vatcheva, KP; Pan, JJ; McCormick, JB; Fisher-Hoch, SP; Fallon, MB; Beretta, L				Jiao, Jingjing; Watt, Gordon P.; Lee, MinJae; Rahbar, Mohammad H.; Vatcheva, Kristina P.; Pan, Jen-Jung; McCormick, Joseph B.; Fisher-Hoch, Susan P.; Fallon, Michael B.; Beretta, Laura			Cirrhosis and Advanced Fibrosis in Hispanics in Texas: The Dominant Contribution of Central Obesity	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; CHRONIC HEPATITIS-C; GREATER-THAN-G; 3 GENE PNPLA3; HEPATOCELLULAR-CARCINOMA; UNITED-STATES; VIRUS-INFECTION; G POLYMORPHISM; I148M VARIANT; DISEASE	Liver cirrhosis is a leading cause of death in Hispanics and Hispanics who live in South Texas have the highest incidence of liver cancer in the United States. We aimed at determining the prevalence and associated risk factors of cirrhosis in this population. Clinical and demographic variables were extracted for 2466 participants in the community-based Cameron County Hispanic Cohort in South Texas. Aspartate transaminase to Platelet Ratio Index (APRI) was used to predict cirrhosis in Cameron County Hispanic Cohort. The prevalence of cirrhosis using APRI >= 2 was 0.94%, which is nearly 4-fold higher than the national prevalence. Using APRI >= 1, the overall prevalence of cirrhosis/advanced fibrosis was 3.54%. In both analyses, highest prevalence was observed in males, specifically in the 2534 age group. Risk factors independently associated with APRI >= 2 and APRI >= 1 included hepatitis C, diabetes and central obesity with a remarkable population attributable fraction of 52.5% and 65.3% from central obesity, respectively. Excess alcohol consumption was also independently associated with APRI >= 2. The presence of patatin-like phospholipase domain-containing-3 gene variants was independently associated with APRI >= 1 in participants > 50 years old. Males with both central obesity and excess alcohol consumption presented with cirrhosis/advanced fibrosis at a young age. Alarmingly high prevalence of cirrhosis and advanced fibrosis was identified in Hispanics in South Texas, affecting young males in particular. Central obesity was identified as the major risk factor. Public health efforts are urgently needed to increase awareness and diagnosis of advanced liver fibrosis in Hispanics.	[Jiao, Jingjing; Beretta, Laura] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Watt, Gordon P.; Vatcheva, Kristina P.; McCormick, Joseph B.; Fisher-Hoch, Susan P.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Brownsville Reg Campus, Brownsville, TX USA; [Lee, MinJae; Rahbar, Mohammad H.] Univ Texas Houston, Dept Internal Med, Med Sch Houston, Div Clin & Translat Sci, Houston, TX USA; [Lee, MinJae; Rahbar, Mohammad H.] Univ Texas Hlth Sci Ctr Houston, Ctr Clin & Translat Sci, Biostat Epidemiol Res Design BERD Core, Houston, TX 77030 USA; [Rahbar, Mohammad H.] Univ Texas Houston, Sch Publ Hlth Houston, Houston, TX USA; [Pan, Jen-Jung; Fallon, Michael B.] Univ Texas Houston, Dept Internal Med, Med Sch Houston, Div Gastroenterol Hepatol & Nutr, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Beretta, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Fallon, MB (corresponding author), Univ Texas Houston, Dept Internal Med, Med Sch Houston, Div Gastroenterol Hepatol & Nutr, Houston, TX USA.	Michael.B.Fallon@uth.tmc.edu; LBeretta@mdanderson.org	Lee, MinJae/AAK-1972-2020; Watt, Gordon/AAR-6987-2021	Lee, MinJae/0000-0002-4329-506X; Watt, Gordon/0000-0002-2024-0015; McCormick, Joseph/0000-0002-5844-8102; Laura, Beretta/0000-0002-2054-684X; Vatcheva, Kristina/0000-0002-7260-2524	UTHealth Innovation in Cancer Prevention Research Training Program Post-doctoral Fellowship (Cancer Prevention and Research Institute of Texas) [RP140103]; Trans-Texas HCC Study from The University of Texas MD Anderson Cancer Center; National Center on Minority Health and Health disparities [MD000170 P20]; Centers for Clinical and Translational Science Award from the National Center for Advancing Translational Science [UL1 TR000371]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	UTHealth Innovation in Cancer Prevention Research Training Program Post-doctoral Fellowship (Cancer Prevention and Research Institute of Texas); Trans-Texas HCC Study from The University of Texas MD Anderson Cancer Center; National Center on Minority Health and Health disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Centers for Clinical and Translational Science Award from the National Center for Advancing Translational Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by UTHealth Innovation in Cancer Prevention Research Training Program Post-doctoral Fellowship (Cancer Prevention and Research Institute of Texas) (RP140103 to JJ) (http://www.cprit.state.tx.us/), the Trans-Texas HCC Study from The University of Texas MD Anderson Cancer Center (to LB) (http://www.mdanderson.org/), the National Center on Minority Health and Health disparities (MD000170 P20 to SFH) (http://www.nih.gov/about-nih/what-we-do/nih-almanac/national-institute-minority-health-health-disparities-nimhd), and the Centers for Clinical and Translational Science Award from the National Center for Advancing Translational Science (UL1 TR000371 to SFH) (https://ncats.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P645, DOI 10.1038/nrgastro.2013.182; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Carrion AF, 2011, CLIN GASTROENTEROL H, V9, P834, DOI 10.1016/j.cgh.2011.04.027; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Fisher-Hoch SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133135; Fisher-Hoch SP, 2010, PREV CHRONIC DIS, V7; Garza AL, 2016, J RACIAL ETHN HEALTH, V3, P1, DOI 10.1007/s40615-015-0104-0; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Heron M, 2013, NATL VITAL STAT REP, V62, P1; Huang CF, 2015, J HEPATOL, V62, P512, DOI 10.1016/j.jhep.2014.10.011; Huang HJ, 2007, HEPATOLOGY, V46, P297, DOI 10.1002/hep.21695; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Koehler EM, 2016, HEPATOLOGY, V63, P138, DOI 10.1002/hep.27981; Krawczyk M, 2011, J HEPATOL, V55, P299, DOI 10.1016/j.jhep.2010.10.042; Li Q, 2012, CLIN INVEST MED, V35, pL237; Li YL, 2012, HEPATOLOGY, V55, P327, DOI 10.1002/hep.24659; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Liu YL, 2014, J HEPATOL, V61, P75, DOI 10.1016/j.jhep.2014.02.030; Liu YL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5309; Manco M, 2008, GUT, V57, P1283, DOI 10.1136/gut.2007.142919; Marcolongo M, 2009, HEPATOLOGY, V50, P1038, DOI 10.1002/hep.23111; Marzuillo P, 2014, WORLD J GASTROENTERO, V20, P7347, DOI 10.3748/wjg.v20.i23.7347; Mokdad AA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0145-y; Nakaoka K, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0870-5; NOVICK DM, 1985, GUT, V26, P8, DOI 10.1136/gut.26.1.8; Pan JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021515; Ramirez AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035573; Rentfro AR, 2011, PREV CHRONIC DIS, V8; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sajja KC, 2014, J INVEST MED, V62, P920, DOI 10.1097/JIM.0000000000000106; Scaglione S, 2015, J CLIN GASTROENTEROL, V49, P690, DOI 10.1097/MCG.0000000000000208; Schlesinger S, 2013, INT J CANCER, V132, P645, DOI 10.1002/ijc.27645; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Shen JH, 2015, J LIPID RES, V56, P167, DOI 10.1194/jlr.M048777; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2014, HEPATOLOGY, V59, P2170, DOI 10.1002/hep.26767; Trepo E, 2012, HEPATOLOGY, V55, P1307, DOI 10.1002/hep.25518; Trepo E, 2011, J HEPATOL, V55, P906, DOI 10.1016/j.jhep.2011.01.028; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; van der Poorten D, 2008, HEPATOLOGY, V48, P449, DOI 10.1002/hep.22350; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Weston SR, 2005, HEPATOLOGY, V41, P372, DOI 10.1002/hep.20554; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Xiao GQ, 2015, HEPATOLOGY, V61, P292, DOI 10.1002/hep.27382; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09284; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2016	11	3							e0150978	10.1371/journal.pone.0150978	http://dx.doi.org/10.1371/journal.pone.0150978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SL	26950933	Green Published, Green Submitted, gold			2022-12-27	WOS:000371990100077
J	De Rubeis, J; Sutterlin, S; Lange, D; Pawelzik, M; van Randenborgh, A; Victor, D; Vogele, C				De Rubeis, Jannika; Sutterlin, Stefan; Lange, Diane; Pawelzik, Markus; van Randenborgh, Annette; Victor, Daniela; Vogele, Claus			Attachment Status Affects Heart Rate Responses to Experimental Ostracism in Inpatients with Depression	PLOS ONE			English	Article							ADULT ATTACHMENT; SOCIAL EXCLUSION; CARDIOVASCULAR REACTIVITY; INTERPERSONAL REJECTION; DISORGANIZED ATTACHMENT; CONVERGING EVIDENCE; EMOTION REGULATION; GENDER-DIFFERENCES; YOUNG-ADULTS; BEHAVIOR	Depression is assumed to be both a risk factor for rejection and a result of it, and as such constitutes an important factor in rejection research. Attachment theory has been applied to understand psychological disorders, such as depression, and can explain individual differences in responses to rejection. Research on autonomic nervous system activity to rejection experiences has been contradictory, with opposing strings of argumentation (activating vs. numbing). We investigated autonomic nervous system-mediated peripheral physiological responses (heart rate) to experimentally manipulated ostracism (Cyberball) in 97 depressed patients with organized (n = 52) and disorganized attachment status (n = 45). Controlling for baseline mean heart rate levels, depressed patients with disorganized attachment status responded to ostracism with significantly higher increases in heart rate than depressed patients with organized attachment status (p = .029; eta p(2) = .051). These results suggest that attachment status may be a useful indicator of autonomic responses to perceived social threat, which in turn may affect the therapeutic process and the patient-therapist relationship.	[De Rubeis, Jannika; Lange, Diane; Pawelzik, Markus; Victor, Daniela] Alexianer GmbH, Eos Klin Psychotherapie, Munster, Germany; [De Rubeis, Jannika; Vogele, Claus] Univ Luxembourg, Res Unit INSIDE, Inst Hlth & Behav, Esch Sur Alzette, Luxembourg; [Sutterlin, Stefan] Lillehammer Univ Coll, Dept Psychol, Lillehammer, North Ireland; [Sutterlin, Stefan] Oslo Univ Hosp, Rikshosp, Dept Psychosomat Med, Div Surg & Clin Neurosci, N-0450 Oslo, Norway; [van Randenborgh, Annette] Univ Appl Sci Munster, Munster, Germany; [Vogele, Claus] Univ Leuven, Res Grp Hlth Psychol, Leuven, Belgium	University of Luxembourg; University of Oslo; National Hospital Norway; University of Applied Sciences, Muenster; KU Leuven	De Rubeis, J (corresponding author), Alexianer GmbH, Eos Klin Psychotherapie, Munster, Germany.; De Rubeis, J (corresponding author), Univ Luxembourg, Res Unit INSIDE, Inst Hlth & Behav, Esch Sur Alzette, Luxembourg.	derubeis.jannika@gmail.com	Vögele, Claus/I-5682-2013	Vogele, Claus/0000-0001-8086-0788; Sutterlin, Stefan/0000-0002-4337-1296	Alexianer GmbH	Alexianer GmbH	The authors received no specific funding for this work. Alexianer GmbH, who is the holding company of the hospital where data collection took place, provided support in the form of salaries for authors JDR, MP, DL, and DV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abrams D, 2011, BRIT J DEV PSYCHOL, V29, P110, DOI 10.1348/026151010X494089; Aikins JW, 2009, ATTACH HUM DEV, V11, P491, DOI 10.1080/14616730903017019; Ainsworth M., 1978, PATTERNS ATTACHMENT; Aldao A, 2012, BEHAV RES THER, V50, P122, DOI 10.1016/j.brat.2011.12.004; Ayduk O, 2001, PERS SOC PSYCHOL B, V27, P868, DOI 10.1177/0146167201277009; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; Baumeister RF, 2005, J PERS SOC PSYCHOL, V88, P589, DOI 10.1037/0022-3514.88.4.589; Baumeister RF, 2009, PERSPECT PSYCHOL SCI, V4, P489, DOI 10.1111/j.1745-6924.2009.01159.x; Beck A. T., 1984, FDN COGNITIVE THERAP, P155, DOI [10.1007/978-1-4613-2641-0_7, DOI 10.1007/978-1-4613-2641-0_7]; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bernstein MJ, 2012, PERS SOC PSYCHOL B, V38, P185, DOI 10.1177/0146167211422449; Besser A, 2009, J PERS, V77, P287, DOI 10.1111/j.1467-6494.2008.00546.x; Bibbey A, 2013, INT J PSYCHOPHYSIOL, V90, P28, DOI 10.1016/j.ijpsycho.2012.10.018; Biosign GmbH, 2009, BIOS HRV SCANN VERS; Bowlby J, 1973, ATTACHMENT LOSS SEPA; Bowlby J., 1979, MAKING BREAKING AFFE; Bowlby J, 1982, ATTACHMENT LOSS ATTA, V1; Brennan K., 1998, ATTACHMENT THEORY CL, P46; Brosschot JF, 2006, J PSYCHOSOM RES, V60, P113, DOI 10.1016/j.jpsychores.2005.06.074; Buchheim A, 2006, PSYCHOPATHOLOGY, V39, P144, DOI 10.1159/000091800; Buchheim A, 2003, PSYCHOTHER PSYCH MED, V53, P419; Buchheim A, 2002, PSYCHOTHER PSYCH MED, V52, P128, DOI 10.1055/s-2002-24958; Buchheim A, 2008, PSYCHIAT RES-NEUROIM, V163, P223, DOI 10.1016/j.pscychresns.2007.07.001; Buck R., 1984, COMMUNICATION EMOTIO; Buckley KE, 2004, J EXP SOC PSYCHOL, V40, P14, DOI 10.1016/S0022-1031(03)00064-7; Butler EA, 2006, PSYCHOPHYSIOLOGY, V43, P612, DOI 10.1111/j.1469-8986.2006.00467.x; Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049; Campbell L, 2005, J PERS SOC PSYCHOL, V88, P510, DOI 10.1037/0022-3514.88.3.510; CARLSON V, 1989, DEV PSYCHOL, V25, P525, DOI 10.1037/0012-1649.25.4.525; CROWELL JA, 1995, SOC DEV, V4, P294, DOI 10.1111/j.1467-9507.1995.tb00067.x; Dallaire DH, 2007, J APPL DEV PSYCHOL, V28, P477, DOI 10.1016/j.appdev.2007.06.005; Derogatis LR, 1986, COLLEGIUM INTERNATIO; Deutsches Institut fur Medizinische Dokumentation und Information, 2015, AN THER TISCH CHEM K; DeWall CN, 2006, J PERS SOC PSYCHOL, V91, P1, DOI 10.1037/0022-3514.91.1.1; DeWall CN, 2011, J PERS SOC PSYCHOL, V101, P1302, DOI 10.1037/a0025497; DeWall CN, 2010, PSYCHOL SCI, V21, P931, DOI 10.1177/0956797610374741; Diamond LM, 2010, J SOC PERS RELAT, V27, P218, DOI 10.1177/0265407509360906; Dickerson SS, 2004, J PERS, V72, P1191, DOI 10.1111/j.1467-6494.2004.00295.x; DOZIER M, 1992, CHILD DEV, V63, P1473, DOI 10.2307/1131569; Dozier M., 1993, ANN PROG CHILD PSYCH, P80; Edelstein RS, 2008, PERS SOC PSYCHOL B, V34, P171, DOI 10.1177/0146167207310024; Ehrenthal JC, 2011, STRESS HEALTH, V27, P251, DOI 10.1002/smi.1326; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Eisenberger NI, 2004, TRENDS COGN SCI, V8, P294, DOI 10.1016/j.tics.2004.05.010; Fearon RP, 2010, CHILD DEV, V81, P435, DOI 10.1111/j.1467-8624.2009.01405.x; Fincham FD, 1997, PSYCHOL SCI, V8, P351, DOI 10.1111/j.1467-9280.1997.tb00424.x; Finn SE, 2011, J PERS ASSESS, V93, P427, DOI 10.1080/00223891.2011.595744; Fraley R., 2000, REV GEN PSYCHOL, V4, P132, DOI [DOI 10.1037/1089-2680.4.2.132, 10.1037/1089-2680.4.2.132, DOI 10.1037/0022-3514.52.3.511]; Fraley RC, 2007, J PERS, V75, P1033, DOI 10.1111/j.1467-6494.2007.00465.x; Fraley RC, 2000, J PERS SOC PSYCHOL, V79, P816, DOI 10.1037/0022-3514.79.5.816; Franke G., 1995, SYMPTOM CHECK LISTE; Fydrich T., 1997, STRUKTURIERTES KLINI; Gander M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00079; George C, 1999, ATTACHMENT DISORGANIZATION, P318; George C, 1996, INF MENTAL HLTH J, V17, P198, DOI 10.1002/(SICI)1097-0355(199623)17:3<198::AID-IMHJ2>3.0.CO;2-L; George C, 2001, Attach Hum Dev, V3, P30; George C, 1999, BRIT J MED PSYCHOL, V72, P285, DOI 10.1348/000711299159998; George C., 1985, COMMUNICATION; George C., 2003, COMPREHENSIVE HDB PS, V2, P431; George C, 1984, COMMUNICATION; George C., 1996, COMMUNICATION; George C., 1999, HDB ATTACH THEORY RE, p649; George C., 2012, ADULT ATTACHMENT PRO; George C, 2008, ADULT ATTACHME UNPUB; George C., 2001, BINDUNG ERWACHSENENA, P364; Gerber J, 2009, PERSPECT PSYCHOL SCI, V4, P468, DOI 10.1111/j.1745-6924.2009.01158.x; Gillath O, 2005, NEUROIMAGE, V28, P835, DOI 10.1016/j.neuroimage.2005.06.048; Groh AM, 2012, CHILD DEV, V83, P591, DOI 10.1111/j.1467-8624.2011.01711.x; Guyll M, 2001, HEALTH PSYCHOL, V20, P315, DOI 10.1037/0278-6133.20.5.315; HAMMEN C, 1990, ARCH GEN PSYCHIAT, V47, P1112; Harrell JP, 2003, AM J PUBLIC HEALTH, V93, P243, DOI 10.2105/AJPH.93.2.243; Hautzinger M, 1994, BECK DEPRESSIONS INV; Herzberg PY, 2008, REP PSYCHOL, V33, P301; Hesse E, 2000, J AM PSYCHOANAL ASS, V48, P1097, DOI 10.1177/00030651000480041101; Hesse E, 1996, INF MENTAL HLTH J, V17, P4, DOI 10.1002/(SICI)1097-0355(199621)17:1<4::AID-IMHJ1>3.0.CO;2-S; Hessel A, 2001, DIAGNOSTICA, V47, P27, DOI 10.1026//0012-1924.47.1.27; Hill-Soderlund AL, 2008, DEV PSYCHOBIOL, V50, P361, DOI 10.1002/dev.20302; Holland AS, 2010, DEV PSYCHOL, V46, P552, DOI 10.1037/a0018542; Iffland B, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00026; Jain E, 2010, BIOL PSYCHOL, V84, P497, DOI 10.1016/j.biopsycho.2010.03.008; JOINER TE, 1992, J ABNORM PSYCHOL, V101, P165, DOI 10.1037/0021-843X.101.1.165; Kaufmann T, 2011, BEHAV RES METHODS, V43, P1161, DOI 10.3758/s13428-011-0107-7; KAZDIN AE, 1985, J AM ACAD CHILD PSY, V24, P303, DOI 10.1016/S0002-7138(09)61091-8; KIECOLTGLASER JK, 1993, PSYCHOSOM MED, V55, P395, DOI 10.1097/00006842-199309000-00001; Kim J, 2003, J CLIN CHILD ADOLESC, V32, P106; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Knight EL, 2008, THESIS OHIO STATE U; Labouvie-Vief G, 2003, EMOTION, V3, P115, DOI 10.1037/1528-3542.3.2.115; Leary MR, 2006, PERS SOC PSYCHOL REV, V10, P111, DOI 10.1207/s15327957pspr1002_2; Lyons-Ruth K, 1999, HDB ATTACHMENT THEOR, P520; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; MacDonald Geoff., 2005, SOCIAL OUTCAST OSTRA, P77; Magai C, 2001, HDB MIDLIFE DEV, P310; Maier MA, 2004, INT J BEHAV DEV, V28, P180, DOI 10.1080/01650250344000398; MAIN M, 1990, HUM DEV, V33, P48, DOI 10.1159/000276502; Main M, 1995, ATTACHMENT THEORY, P407; Main M, 1990, ATTACHMENT PRESCHOOL, P121; Maunder RG, 2001, PSYCHOSOM MED, V63, P556, DOI 10.1097/00006842-200107000-00006; McDougall P, 2001, INTERPERSONAL REJECT, P214; Mikulincer M, 2004, J PERS SOC PSYCHOL, V87, P940, DOI 10.1037/0022-3514.87.6.940; Mikulincer M, 2002, J PERS SOC PSYCHOL, V83, P881, DOI 10.1037//0022-3514.83.4.881; Mikulincer M., 2007, ATTACHMENT ADULTHOOD; Moor BG, 2010, PSYCHOL SCI, V21, P1326, DOI 10.1177/0956797610379236; Nolan SA, 2003, J PERS SOC PSYCHOL, V85, P745, DOI 10.1037/0022-3514.85.4.745; OCONNOR MJ, 1987, J CONSULT CLIN PSYCH, V55, P831, DOI 10.1037/0022-006X.55.6.831; Page T., 1999, CHILD ADOLESC SOC WO, V16, P419, DOI [10.1023/A:1022397204929, DOI 10.1023/A:1022397204929]; PENNEBAKER JW, 1992, J SOC CLIN PSYCHOL, V11, P199, DOI 10.1521/jscp.1992.11.3.199; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Potreck-Rose F, 2015, PSYCHOTHERAPEUTISCHE; Richman LS, 2009, PSYCHOL REV, V116, P365, DOI 10.1037/a0015250; Richman LS, 2013, OXFORD HDB SOCIAL EX, P43; Riggs SA, 2007, DEV PSYCHOPATHOL, V19, P263, DOI 10.1017/S0954579407070149; Roisman GI, 2007, DEV PSYCHOL, V43, P39, DOI 10.1037/0012-1649.43.1.39; Sacco DF, 2011, J EXP SOC PSYCHOL, V47, P836, DOI 10.1016/j.jesp.2011.03.001; Saffrey C, 2007, PERS RELATIONSHIP, V14, P351, DOI 10.1111/j.1475-6811.2007.00160.x; SHARPLEY CF, 1993, PSYCHOL SCHOOLS, V30, P119, DOI 10.1002/1520-6807(199304)30:2<119::AID-PITS2310300203>3.0.CO;2-M; Shaver P. R., 2013, OXFORD HDB SOCIAL EX, P238; Simpson JA, 1996, J PERS SOC PSYCHOL, V71, P899, DOI 10.1037/0022-3514.71.5.899; Solomon J, 2006, CAMB ST SOC, P265, DOI 10.1017/CBO9780511499869.010; Solomon Judith, 1999, ATTACHMENT DISORGANI; SPANGLER G, 1993, CHILD DEV, V64, P1439, DOI 10.2307/1131544; Sroufe LA, 2005, ATTACH HUM DEV, V7, P349, DOI 10.1080/14616730500365928; SROUFE LA, 1990, CHILD DEV, V61, P1363, DOI 10.1111/j.1467-8624.1990.tb02867.x; SROUFE LA, 1977, MERRILL PALMER QUART, V23, P3; Stanley SM, 2006, ATTACHMENT PREFRONTA, P66; Stroud LR, 2000, ANN BEHAV MED, V22, P204, DOI 10.1007/BF02895115; TETI DM, 1995, DEV PSYCHOL, V31, P364, DOI 10.1037/0012-1649.31.3.364; TOMKINS S, 1982, PERS SOC PSYCHOL B, V8, P608; Twenge JM, 2001, J PERS SOC PSYCHOL, V81, P1058, DOI 10.1037//0022-3514.81.6.1058; van Ijzendoorn MH, 1999, DEV PSYCHOPATHOL, V11, P225, DOI 10.1017/S0954579499002035; Van Orden K.A., 2013, OXFORD HDB SOCIAL EX, P211, DOI [10.1093/oxfordhb/9780195398700.013.0019, DOI 10.1093/OXFORDHB/9780195398700.013.0019]; Vervoort T, 2014, PAIN, V155, P1453, DOI 10.1016/j.pain.2014.04.015; Vogele C, 2010, BIOL PSYCHOL, V85, P465, DOI 10.1016/j.biopsycho.2010.09.010; Vrticka P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002868; West M, 1999, Attach Hum Dev, V1, P137, DOI 10.1080/14616739900134201; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Williams KD, 2009, ADV EXP SOC PSYCHOL, V41, P275, DOI 10.1016/S0065-2601(08)00406-1; Wittchen HU, 1997, SKID; Zilberstein K, 2010, CLIN SOC WORK J, V38, P85, DOI 10.1007/s10615-007-0097-1	141	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150375	10.1371/journal.pone.0150375	http://dx.doi.org/10.1371/journal.pone.0150375			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG0FG	26943924	Green Published, gold, Green Submitted			2022-12-27	WOS:000371739400024
J	Glant, TT; Ocsko, T; Markovics, A; Szekanecz, Z; Katz, RS; Rauch, TA; Mikecz, K				Glant, Tibor T.; Ocsko, Timea; Markovics, Adrienn; Szekanecz, Zoltan; Katz, Robert S.; Rauch, Tibor A.; Mikecz, Katalin			Characterization and Localization of Citrullinated Proteoglycan Aggrecan in Human Articular Cartilage	PLOS ONE			English	Article							PROTEIN-RELATED EPITOPES; SWISS-MODEL WORKSPACE; RHEUMATOID-ARTHRITIS; BALB/C MICE; SYNOVIAL-FLUID; ANTIBODIES; AUTOANTIGENS; PEPTIDES; CELLS; AUTOANTIBODIES	Background Rheumatoid arthritis (RA) is an autoimmune disease of the synovial joints. The autoimmune character of RA is underscored by prominent production of autoantibodies such as those against IgG (rheumatoid factor), and a broad array of joint tissue-specific and other endogenous citrullinated proteins. Anti-citrullinated protein antibodies (ACPA) can be detected in the sera and synovial fluids of RA patients and ACPA seropositivity is one of the diagnostic criteria of RA. Studies have demonstrated that RA T cells respond to citrullinated peptides (epitopes) of proteoglycan (PG) aggrecan, which is one of the most abundant macromolecules of articular cartilage. However, it is not known if the PG molecule is citrullinated in vivo in human cartilage, and if so, whether citrulline-containing neoepitopes of PG (CitPG) can contribute to autoimmunity in RA. Methods CitPG was detected in human cartilage extracts using ACPA+ RA sera in dot blot and Western blot. Citrullination status of in vitro citrullinated recombinant G1 domain of human PG (rhG1) was confirmed by antibody-based and chemical methods, and potential sites of citrullination in rhG1 were explored by molecular modeling. CitPG-specific serum autoantibodies were quantified by enzyme-linked immunosorbent assays, and CitPG was localized in osteoarthritic (OA) and RA cartilage using immunohistochemistry. Findings Sera from ACPA+ RA patients reacted with PG purified from normal human cartilage specimens. PG fragments (mainly those containing the G1 domain) from OA or RA cartilage extracts were recognized by ACPA+ sera but not by serum from ACPA-individuals. ACPA+ sera also reacted with in vitro citrullinated rhG1 and G3 domain-containing fragment(s) of PG. Molecular modeling suggested multiple sites of potential citrullination within the G1 domain. The immunohistochemical localization of CitPG was different in OA and RA cartilage. Conclusions CitPG is a new member of citrullinated proteins identified in human joints. CitPG could be found in both normal and diseased cartilage specimens. Antibodies against CitPG may trigger or augment arthritis by forming immune complexes with this autoantigen in the joints of ACPA+ RA patients.	[Glant, Tibor T.; Mikecz, Katalin] Rush Univ, Med Ctr, Sect Mol Med, Dept Orthoped Surg, Chicago, IL 60612 USA; [Glant, Tibor T.; Mikecz, Katalin] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Glant, Tibor T.; Mikecz, Katalin] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Ocsko, Timea; Markovics, Adrienn; Rauch, Tibor A.] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Szekanecz, Zoltan] Univ Debrecen, Fac Med, Inst Med, Dept Rheumatol, H-4012 Debrecen, Hungary; [Katz, Robert S.] Rush Univ, Med Ctr, Rheumatol Associates, Chicago, IL 60612 USA	Rush University; Rush University; Rush University; Rush University; University of Debrecen; Rush University	Mikecz, K (corresponding author), Rush Univ, Med Ctr, Sect Mol Med, Dept Orthoped Surg, Chicago, IL 60612 USA.; Mikecz, K (corresponding author), Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA.; Mikecz, K (corresponding author), Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA.	Katalin_Mikecz@rush.edu	Szekanecz, Zoltán/GXN-0235-2022		National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases [R01 AR064206, R01 AR059356]; Grainger Foundation (Lake Forest, IL, USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059356, R01AR064206] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grainger Foundation (Lake Forest, IL, USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases. R01 AR064206 for KM and R01 AR059356 for TTG. The study was supported in part by the J.O. Galante MD, DMSc Endowment Chair of Orthopedic Surgery (Rush University Medical Center, Chicago, IL, USA) for TTG, and by The Grainger Foundation (Lake Forest, IL, USA) for TTG and KM. The funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2013, RHEUMATOL INT, V33, P2359, DOI 10.1007/s00296-013-2731-2; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bas S, 2002, RHEUMATOLOGY, V41, P809, DOI 10.1093/rheumatology/41.7.809; Bicker KL, 2012, J AM CHEM SOC, V134, P17015, DOI 10.1021/ja308871v; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BUZAS EI, 1994, CELL IMMUNOL, V158, P292, DOI 10.1006/cimm.1994.1277; Buzas EI, 2005, CELL IMMUNOL, V235, P98, DOI 10.1016/j.cellimm.2004.08.006; Chang X, 2005, RHEUMATOLOGY, V44, P40, DOI 10.1093/rheumatology/keh414; de Jong H, 2010, ANN RHEUM DIS, V69, P255, DOI 10.1136/ard.2008.103978; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Firestein GS, 2005, KELLEYS TXB RHEUMATO, P996; Fox DA, 2005, ARTHRITIS ALLIED CON, P1085; Giant TT, 2004, METH MOLEC MED, V102, P313; Glant TT, 2011, ARTHRITIS RHEUM-US, V63, P1312, DOI 10.1002/art.30261; Glant TT, 1998, J IMMUNOL, V160, P3812; Glant TT, 1998, ARTHRITIS RHEUM, V41, P1007, DOI 10.1002/1529-0131(199806)41:6<1007::AID-ART7>3.0.CO;2-6; GLANT TT, 1986, BIOCHEM J, V234, P31, DOI 10.1042/bj2340031; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; GLANT TT, 1985, HISTOCHEMISTRY, V82, P149, DOI 10.1007/BF00708199; GLANT TT, 1986, BIOCHEM J, V236, P71, DOI 10.1042/bj2360071; Karopoulos C, 1996, ARTHRITIS RHEUM, V39, P1990, DOI 10.1002/art.1780391207; Kinloch A, 2008, ARTHRITIS RHEUM, V58, P2287, DOI 10.1002/art.23618; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Law SC, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3848; Lundberg K, 2005, ARTHRITIS RES THER, V7, pR458, DOI 10.1186/ar1697; Matsuo K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2085; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Misjak P, 2013, IMMUNOL LETT, V152, P25, DOI 10.1016/j.imlet.2013.03.005; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Rosenberg L, 1975, DYNAMICS CONNECTIVE, P105; Sakkas LI, 2014, AUTOIMMUN REV, V13, P1114, DOI 10.1016/j.autrev.2014.08.012; Sandy JD, 2001, BIOCHEM J, V358, P615, DOI 10.1042/0264-6021:3580615; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; SENSHU T, 1992, ANAL BIOCHEM, V203, P94, DOI 10.1016/0003-2697(92)90047-B; Snir O, 2010, ARTHRITIS RHEUM-US, V62, P44, DOI 10.1002/art.25036; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P1984, DOI 10.1002/art.20285; Szodoray P, 2010, AUTOIMMUN REV, V9, P140, DOI 10.1016/j.autrev.2009.04.006; Taylor P, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/815038; Thiele GM, 2012, INT IMMUNOPHARMACOL, V13, P424, DOI 10.1016/j.intimp.2012.05.007; Trouw LA, 2013, ANN RHEUM DIS, V72, P132, DOI 10.1136/annrheumdis-2012-202349; van de Stadt LA, 2011, ARTHRITIS RHEUM-US, V63, P3226, DOI 10.1002/art.30537; van Venrooij WJ, 2011, NAT REV RHEUMATOL, V7, P391, DOI 10.1038/nrrheum.2011.76; von Delwig A, 2010, ARTHRITIS RHEUM-US, V62, P143, DOI 10.1002/art.25064; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x; Zhao XY, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2478	47	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150784	10.1371/journal.pone.0150784	http://dx.doi.org/10.1371/journal.pone.0150784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943656	Green Published, gold, Green Submitted			2022-12-27	WOS:000371739400049
J	Ingberman, B; Fusco-Costa, R; Monteiro, ELD				Ingberman, Bianca; Fusco-Costa, Roberto; de Araujo Monteiro-Filho, Emygdio Leite			A Current Perspective on the Historical Geographic Distribution of the Endangered Muriquis (Brachyteles spp.): Implications for Conservation	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; SPATIAL AUTOCORRELATION; DISTRIBUTION MODELS; POPULATION-SIZE; ATLANTIC FOREST; SAMPLE-SIZE; PRIMATES; HABITAT; NICHE; PERFORMANCE	The muriqui (Brachyteles spp.), endemic to the Atlantic Forest of Brazil, is the largest primate in South America and is endangered, mainly due to habitat loss. Its distribution limits are still uncertain and need to be resolved in order to determine their true conservation status. Species distribution modeling (SDM) has been used to estimate potential species distributions, even when information is incomplete. Here, we developed an environmental suitability model for the two endangered species of muriqui (Brachyteles hypoxanthus and B. arachnoides) using Maxent software. Due to historical absence of muriquis, areas with predicted high habitat suitability yet historically never occupied, were excluded from the predicted historical distribution. Combining that information with the model, it is evident that rivers are potential dispersal barriers for the muriquis. Moreover, although the two species are environmentally separated in a large part of its distribution, there is a potential contact zone where the species apparently do not overlap. This separation might be due to either a physical (i.e.,Serra da Mantiqueira mountains) or a biotic barrier (the species exclude one another). Therefore, in addition to environmental characteristics, physical and biotic barriers potentially shaped the limits of the muriqui historical range. Based on these considerations, we proposed the adjustment of their historical distributional limits. Currently only 7.6% of the predicted historical distribution of B. hypoxanthus and 12.9% of B. arachnoides remains forested and able to sustain viable muriqui populations. In addition to measurement of habitat loss we also identified areas for conservation concern where new muriqui populations might be found.	[Ingberman, Bianca] Univ Fed Parana UFPR, Programa Posgrad Ecol & Conservacao, Curitiba, Parana, Brazil; [Ingberman, Bianca; Fusco-Costa, Roberto; de Araujo Monteiro-Filho, Emygdio Leite] Inst Pesquisas Cananeia IPeC, Wildlife Res Dept, Cananeia, SP, Brazil; [de Araujo Monteiro-Filho, Emygdio Leite] UFPR, Dept Zool, Curitiba, Parana, Brazil; [de Araujo Monteiro-Filho, Emygdio Leite] Univ Fed Parana, Ctr Politecn, Setor Ciencias Biol, Dept Zool,Lab Biol & Ecol Vertebrados, Caixa Postal 19020, BR-81531990 Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Universidade Federal do Parana	Ingberman, B (corresponding author), Univ Fed Parana UFPR, Programa Posgrad Ecol & Conservacao, Curitiba, Parana, Brazil.; Ingberman, B (corresponding author), Inst Pesquisas Cananeia IPeC, Wildlife Res Dept, Cananeia, SP, Brazil.	ing.bi79@gmail.com		Fusco-Costa, Roberto/0000-0002-9026-0679; Ingberman, Bianca/0000-0001-5378-7132	Coordenacao da Aperfeicoamento de Pessoal de Nivel Superior	Coordenacao da Aperfeicoamento de Pessoal de Nivel Superior	Coordenacao da Aperfeicoamento de Pessoal de Nivel Superior conceived a PhD Scholarship to BI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AC, 1971, AN ACAD BRAS CIENC, P1; Alves MC, 1986, PRIMATOLOGIA BRASIL, V2, P367; Anderson RP, 2004, BIOL CONSERV, V116, P167, DOI 10.1016/S0006-3207(03)00187-3; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Brito D, 2008, BIODIVERS CONSERV, V17, P3255, DOI 10.1007/s10531-008-9427-z; Brito D, 2006, BIODIVERS CONSERV, V15, P4197, DOI 10.1007/s10531-005-3575-1; Cowlishaw G, 2000, PRIMATE CONSERVATION, P242; Cunha AA, 2009, ORYX, V43, P254, DOI 10.1017/S003060530700230X; de Gusmao Camara Ibsen, 1995, Neotropical Primates, V3, P19; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ferraz, 2004, NEOTROP PRIMATES, V12, P139; Fontes MAL, 1996, NEOTROPICAL PRIMATES, P23; Fowler J, 1990, PRACTICAL STATISTICS, P130; Franklin J, 2009, MAPPING SPECIES DIST; Fundacao SOS Mata Atlantica INPE IN de PE, 2008, ATL REM FLOR MAT ATL; Fundacao SOS Mata Atlantica Instituto Nacional de Pesquisas Espaciais, 2013, ATL REM FLOR MAT ATL; Garcia Vania Luciane Alves, 2005, Neotropical Primates, V13, P73; Giovanelli JGR, 2010, ECOL MODEL, V221, P215, DOI 10.1016/j.ecolmodel.2009.10.009; Gonzalez-Solis J, 2001, BIODIVERS CONSERV, V10, P1267, DOI 10.1023/A:1016678126099; Gray TNE, 2010, ANIM CONSERV, V13, P324, DOI 10.1111/j.1469-1795.2010.00351.x; Groves C.P., 2001, PRIMATE TAXONOMY; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harcourt AH, 2012, INT J PRIMATOL, V33, P168, DOI 10.1007/s10764-011-9558-z; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirsch A, 2002, NEOTROP PRIMATES, V10; IBGE, 2012, AN EST BRAS, P458; Ingberman B, 2015, FATORES ECOLOGICOS I; Jerusalinsky L, 2011, SERIE ESPE ICMBIO; Kamilar JM, 2011, AM J PHYS ANTHROPOL, V144, P131, DOI 10.1002/ajpa.21380; Koehler Alexandre, 2002, Estudos de Biologia (Curitiba), V24, P25; Koehler Alexandre B., 2005, Neotropical Primates, V13, P67; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Lane Frederico, 1990, Primate Conservation, V11, P23; Legendre P, 2002, ECOGRAPHY, V25, P601, DOI 10.1034/j.1600-0587.2002.250508.x; Lehman SM, 2004, INT J PRIMATOL, V25, P73, DOI 10.1023/B:IJOP.0000014646.82182.51; Lemos de Sa Rosa M., 1990, Primate Conservation, V11, P26; Loretto Diogo, 2005, Neotropical Primates, V13, P28, DOI 10.1896/1413-4705.13.2.28; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Marco-Junior PD, 2009, MEGADIVERSIDADE, V5, P65; Marino J, 2011, DIVERS DISTRIB, V17, P311, DOI 10.1111/j.1472-4642.2011.00744.x; Marroig Gabriel, 2001, Neotropical Primates, V9, P75; Martuscelli Paulo, 1994, Neotropical Primates, V2, P12; Mendes Sergio L., 2005, Neotropical Primates, V13, P31; Mendes Sergio L., 2005, Neotropical Primates, V13, P7; MENDES SL, 1991, PRIMATOLOGIA NO BRAS, V3, P347; Mendes SL, 2008, IUCN 2012 IUCN RED L; Mercado NI, 2010, TROP CONSERV SCI, V3, P200, DOI 10.1177/194008291000300207; Meyer ALS, 2014, AM J PRIMATOL, V76, P551, DOI 10.1002/ajp.22247; Millar CS, 2012, J NAT CONSERV, V20, P18, DOI 10.1016/j.jnc.2011.07.004; Mittermeier RA, 1987, PRIMATE CONSERVATION, V8, P143; Moreira DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110929; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nishimura A., 1988, P577; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peck M, 2011, INT J PRIMATOL, V32, P134, DOI 10.1007/s10764-010-9445-z; Peres Carlos A., 1999, P55, DOI 10.1017/CBO9780511542381.004; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; PINTO LPS, 1993, FOLIA PRIMATOL, V61, P135, DOI 10.1159/000156740; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rylands Anthony B., 1995, Neotropical Primates, V3, P113; Segurado P, 2006, J APPL ECOL, V43, P433, DOI 10.1111/j.1365-2664.2006.01162.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Strier Karen B., 2006, Primate Conservation, V20, P53, DOI 10.1896/0898-6207.20.1.53; Strier KB, 2000, BIOTROPICA, V32, P903; Strier KB, 2011, PLANO ACAO NACL CONS, P84; Strier KB, PRIMATE CONSERV, V17, P131; Talebi Mauricio, 2005, Neotropical Primates, V13, P53; Talebi MG, 2011, LANO ACAO NACL CONSE, P19; Thorn JS, 2009, DIVERS DISTRIB, V15, P289, DOI 10.1111/j.1472-4642.2008.00535.x; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Vieira Luciano A., 2005, Neotropical Primates, V13, P37; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	82	7	8	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150906	10.1371/journal.pone.0150906	http://dx.doi.org/10.1371/journal.pone.0150906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943910	Green Submitted, Green Published, gold			2022-12-27	WOS:000371739400060
J	Zhao, HY; Shen, A; Xiang, YK; Corey, DP				Zhao, Hongyu; Shen, Ao; Xiang, Yang K.; Corey, David P.			Three Recombinant Engineered Antibodies against Recombinant Tags with High Affinity and Specificity	PLOS ONE			English	Article							ALPHA-BUNGAROTOXIN; RECEPTOR DIMERIZATION; MEMBRANE-PROTEINS; BINDING ASSAYS; CELLS; PEPTIDE; NANOBODIES; SYSTEM; DOMAIN; SITE	We describe three recombinant engineered antibodies against three recombinant epitope tags, constructed with divalent binding arms to recognize divalent epitopes and so achieve high affinity and specificity. In two versions, an epitope is inserted in tandem into a protein of interest, and a homodimeric antibody is constructed by fusing a high-affinity epitope-binding domain to a human or mouse Fc domain. In a third, a heterodimeric antibody is constructed by fusing two different epitope-binding domains which target two different binding sites in GFP, to polarized Fc fragments. These antibody/epitope pairs have affinities in the low picomolar range and are useful tools for many antibody-based applications.	[Zhao, Hongyu; Corey, David P.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Zhao, Hongyu; Corey, David P.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Shen, Ao; Xiang, Yang K.] Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Davis	Corey, DP (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	dcorey@hms.harvard.edu	, PEP-MX Core/AGV-4051-2022	SHEN, AO/0000-0002-1559-3895; Corey, David/0000-0003-4497-6016	HOWARD HUGHES MEDICAL INSTITUTE; NATIONAL INSTITUTE OF HEALTH [HL082846, DC002281]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002281] Funding Source: NIH RePORTER	HOWARD HUGHES MEDICAL INSTITUTE(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	HZ and DPC were supported by HOWARD HUGHES MEDICAL INSTITUTE, http://www.hhmi.org/; NATIONAL INSTITUTE OF HEALTH HL082846, http://www.nih.gov/; and NATIONAL INSTITUTE OF HEALTH DC002281, http://www.nih.gov/.	Bates SR, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3211382; Berger C, 1999, FEBS LETT, V450, P149, DOI 10.1016/S0014-5793(99)00458-5; Boersma YL, 2011, J BIOL CHEM, V286, P41273, DOI 10.1074/jbc.M111.293266; Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; COCHET C, 1988, J BIOL CHEM, V263, P3290; Flanagan Meg L, 2007, Methods Mol Biol, V378, P33, DOI 10.1007/978-1-59745-323-3_3; Fuchs S, 2003, ANN NY ACAD SCI, V998, P93, DOI 10.1196/annals.1254.011; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Hanes J, 1998, P NATL ACAD SCI USA, V95, P14130, DOI 10.1073/pnas.95.24.14130; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Kasher R, 2001, CHEM BIOL, V8, P147, DOI 10.1016/S1074-5521(00)90063-2; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; McCann CM, 2005, BIOTECHNIQUES, V38, P945, DOI 10.2144/05386IT02; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Roovers RC, 2011, INT J CANCER, V129, P2013, DOI 10.1002/ijc.26145; Scherf T, 2001, P NATL ACAD SCI USA, V98, P6629, DOI 10.1073/pnas.111164298; Schiweck W, 1997, FEBS LETT, V414, P33, DOI 10.1016/S0014-5793(97)00983-6; Scott N, 2010, MOL IMMUNOL, V47, P1931, DOI 10.1016/j.molimm.2010.02.020; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Tang JCY, 2013, CELL, V154, P928, DOI 10.1016/j.cell.2013.07.021; Wegner GJ, 2002, ANAL CHEM, V74, P5161, DOI 10.1021/ac025922u; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zhang W, 2009, P NATL ACAD SCI USA, V106, P15679, DOI 10.1073/pnas.0908279106	30	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150125	10.1371/journal.pone.0150125	http://dx.doi.org/10.1371/journal.pone.0150125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0FG	26943906	Green Published, Green Submitted, gold			2022-12-27	WOS:000371739400014
J	Zubiaga, A; Liakata, M; Procter, R; Hoi, GWS; Tolmie, P				Zubiaga, Arkaitz; Liakata, Maria; Procter, Rob; Hoi, Geraldine Wong Sak; Tolmie, Peter			Analysing How People Orient to and Spread Rumours in Social Media by Looking at Conversational Threads	PLOS ONE			English	Article							PSYCHOLOGY	As breaking news unfolds people increasingly rely on social media to stay abreast of the latest updates. The use of social media in such situations comes with the caveat that new information being released piecemeal may encourage rumours, many of which remain unverified long after their point of release. Little is known, however, about the dynamics of the life cycle of a social media rumour. In this paper we present a methodology that has enabled us to collect, identify and annotate a dataset of 330 rumour threads (4,842 tweets) associated with 9 newsworthy events. We analyse this dataset to understand how users spread, support, or deny rumours that are later proven true or false, by distinguishing two levels of status in a rumour life cycle i.e., before and after its veracity status is resolved. The identification of rumours associated with each event, as well as the tweet that resolved each rumour as true or false, was performed by journalist members of the research team who tracked the events in real time. Our study shows that rumours that are ultimately proven true tend to be resolved faster than those that turn out to be false. Whilst one can readily see users denying rumours once they have been debunked, users appear to be less capable of distinguishing true from false rumours when their veracity remains in question. In fact, we show that the prevalent tendency for users is to support every unverified rumour. We also analyse the role of different types of users, finding that highly reputable users such as news organisations endeavour to post well-grounded statements, which appear to be certain and accompanied by evidence. Nevertheless, these often prove to be unverified pieces of information that give rise to false rumours. Our study reinforces the need for developing robust machine learning techniques that can provide assistance in real time for assessing the veracity of rumours. The findings of our study provide useful insights for achieving this aim.	[Zubiaga, Arkaitz; Liakata, Maria; Procter, Rob; Tolmie, Peter] Univ Warwick, Dept Comp Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England; [Hoi, Geraldine Wong Sak] Swissinfo Ch, Bern, Switzerland	University of Warwick	Zubiaga, A (corresponding author), Univ Warwick, Dept Comp Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	a.zubiaga@warwick.ac.uk		Liakata, Maria/0000-0001-5765-0416; Zubiaga, Arkaitz/0000-0003-4583-3623; Tolmie, Peter/0000-0003-2548-2125	seventh framework programme (FP7) [611233]	seventh framework programme (FP7)(European Commission)	This work has been supported by the seventh framework programme (FP7), under grant No. 611233 (PHEME): http://www.pheme.eu/.	Allport G.W., 1947, PSYCHOL RUMOR; Allport GW, 1946, PUBLIC OPIN QUART, V10, P501, DOI 10.1086/265813; Boczkowski P., 2010, NEWS AT WORK; Bordia P, 1996, BEHAV RES METH INSTR, V28, P149, DOI 10.3758/BF03204753; Castillo C, 2013, INTERNET RES, V23, P560, DOI 10.1108/IntR-05-2012-0095; Cotter C., 2010, NEWS TALK INVESTIGAT; Derczynski L, 2014, P ISA; DiFonzo N, 2007, DIOGENES, V54, P19, DOI 10.1177/0392192107073433; Donovan P, 2007, DIOGENES, V54, P59, DOI 10.1177/0392192107073434; Friggeri A, 2014, P AAAI C WEBL SOC ME; Hannak A, 2014, P AAAI C WEBL SOC ME; JAEGER ME, 1980, PERS SOC PSYCHOL B, V6, P473, DOI 10.1177/014616728063024; Knapp RH, 1944, PUBLIC OPIN QUART, V8, P22, DOI 10.1086/265665; Kwak H., 2010, WEB C 2010 P WORLD W, P591; Lukasik M., 2015, P 2015 C EMPIRICAL M, P2590, DOI [10.18653/v1/D15-1311, DOI 10.18653/V1/D15-1311]; Prasad J, 1935, B J PSYCHOL-GEN SECT, V26, P1, DOI 10.1111/j.2044-8295.1935.tb00770.x; Procter R, 2013, ECSCW 2013 ADJ P, V3; Procter R, 2013, INT J SOC RES METHOD, V16, P197, DOI 10.1080/13645579.2013.774172; Qazvinian V., 2011, P C EMP METH NAT LAN, P1589; Rosnow RL., 2005, PSYCHOL SCI AGENDA, V19, P1; Sacks H, 1992, LECT CONVERSATION; Saunders KW, 1984, SETON HALL LAW REV, V15, P276; Sauri R, 2009, LANG RESOUR EVAL, V43, P227, DOI 10.1007/s10579-009-9089-9; SCANLON TJ, 1977, MASS EMERGENCIES, V2, P121; Silverman C., 2013, VERIFICATION HDB; Sinha D, 1952, B J PSYCHOL-GEN SECT, V43, P200, DOI 10.1111/j.2044-8295.1952.tb00343.x; Starbird K, 2014, P ICONFERENCE ISCHOO; Takayasu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121443; Tolmie P, 2015, ARXIV E PRINTS; Ward SJA, DIGITAL MEDIA ETCHIC; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Zubiaga A, 2016, PHEME RUMOUR SCHEME, P2, DOI [10.6084/m9.figshare.2068650.v1, DOI 10.6084/M9.FIGSHARE.2068650.V1]; Zubiaga A, 2015, P WORLD WID WEB C CO; Zubiaga A, 2015, P AAAI WORKSH AI CIT; Zubiaga A, 2014, SOC NETW ANAL MIN, V4, DOI 10.1007/s13278-014-0163-y	35	234	242	9	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2016	11	3							e0150989	10.1371/journal.pone.0150989	http://dx.doi.org/10.1371/journal.pone.0150989			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG0FG	26943909	Green Submitted, Green Published, gold			2022-12-27	WOS:000371739400069
